WO2024036143A2 - Methods for modulating rna splicing - Google Patents
Methods for modulating rna splicing Download PDFInfo
- Publication number
- WO2024036143A2 WO2024036143A2 PCT/US2023/071833 US2023071833W WO2024036143A2 WO 2024036143 A2 WO2024036143 A2 WO 2024036143A2 US 2023071833 W US2023071833 W US 2023071833W WO 2024036143 A2 WO2024036143 A2 WO 2024036143A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- 6alkyl
- compound
- formula
- halo
- amino
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 45
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 70
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims abstract description 59
- 150000001875 compounds Chemical class 0.000 claims abstract description 54
- 108091027974 Mature messenger RNA Proteins 0.000 claims abstract description 45
- 108020004999 messenger RNA Proteins 0.000 claims abstract description 35
- -1 halo-C1-6alkyl Chemical group 0.000 claims description 233
- 239000002773 nucleotide Substances 0.000 claims description 89
- 125000003729 nucleotide group Chemical group 0.000 claims description 89
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 52
- 125000005843 halogen group Chemical group 0.000 claims description 28
- 125000001072 heteroaryl group Chemical group 0.000 claims description 28
- 125000000623 heterocyclic group Chemical group 0.000 claims description 28
- 108020004414 DNA Proteins 0.000 claims description 26
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 24
- 125000005842 heteroatom Chemical group 0.000 claims description 24
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 24
- 125000002950 monocyclic group Chemical group 0.000 claims description 24
- 229910052760 oxygen Inorganic materials 0.000 claims description 24
- 229910052717 sulfur Inorganic materials 0.000 claims description 24
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 23
- 108020005067 RNA Splice Sites Proteins 0.000 claims description 22
- 229910052739 hydrogen Inorganic materials 0.000 claims description 16
- 239000001257 hydrogen Substances 0.000 claims description 16
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 16
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 16
- 125000001424 substituent group Chemical group 0.000 claims description 16
- 108700005078 Synthetic Genes Proteins 0.000 claims description 15
- 102000004169 proteins and genes Human genes 0.000 claims description 14
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims description 12
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims description 12
- 150000001721 carbon Chemical group 0.000 claims description 12
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 12
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 claims description 10
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 9
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 claims description 8
- 238000004113 cell culture Methods 0.000 claims description 7
- 239000013592 cell lysate Substances 0.000 claims description 7
- 238000001727 in vivo Methods 0.000 claims description 7
- 108700024394 Exon Proteins 0.000 claims description 6
- 238000011144 upstream manufacturing Methods 0.000 claims description 6
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims description 4
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 claims description 4
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 4
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 4
- 125000005241 heteroarylamino group Chemical group 0.000 claims description 4
- 125000004043 oxo group Chemical group O=* 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 239000012453 solvate Substances 0.000 claims description 4
- 230000001105 regulatory effect Effects 0.000 claims description 3
- 108091092195 Intron Proteins 0.000 claims description 2
- 108020003584 RNA Isoforms Proteins 0.000 claims 2
- 230000001404 mediated effect Effects 0.000 claims 1
- 150000003254 radicals Chemical class 0.000 description 12
- 102100037880 GTP-binding protein REM 1 Human genes 0.000 description 9
- 101001095995 Homo sapiens GTP-binding protein REM 1 Proteins 0.000 description 9
- 230000001594 aberrant effect Effects 0.000 description 9
- 238000000988 reflection electron microscopy Methods 0.000 description 9
- 230000014509 gene expression Effects 0.000 description 7
- 101150009379 AS1 gene Proteins 0.000 description 6
- 101100324551 Chlamydomonas reinhardtii ARSA1 gene Proteins 0.000 description 6
- 102000016304 Origin Recognition Complex Human genes 0.000 description 6
- 108010067244 Origin Recognition Complex Proteins 0.000 description 6
- 101100146539 Podospora anserina RPS15 gene Proteins 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 108010018525 NFATC Transcription Factors Proteins 0.000 description 4
- 102000002673 NFATC Transcription Factors Human genes 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 108010018650 MEF2 Transcription Factors Proteins 0.000 description 3
- 102000008935 SMN Complex Proteins Human genes 0.000 description 3
- 108010049037 SMN Complex Proteins Proteins 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 238000001415 gene therapy Methods 0.000 description 3
- 230000014616 translation Effects 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- BSFODEXXVBBYOC-UHFFFAOYSA-N 8-[4-(dimethylamino)butan-2-ylamino]quinolin-6-ol Chemical compound C1=CN=C2C(NC(CCN(C)C)C)=CC(O)=CC2=C1 BSFODEXXVBBYOC-UHFFFAOYSA-N 0.000 description 2
- 102100033281 ADP-ribosylation factor GTPase-activating protein 3 Human genes 0.000 description 2
- 102100022911 ADP-ribosylation factor-like protein 17 Human genes 0.000 description 2
- 102100028783 AP-3 complex subunit sigma-2 Human genes 0.000 description 2
- 102100040038 Amyloid beta precursor like protein 2 Human genes 0.000 description 2
- 102100023927 Asparagine synthetase [glutamine-hydrolyzing] Human genes 0.000 description 2
- 102100026189 Beta-galactosidase Human genes 0.000 description 2
- 102100028723 BolA-like protein 2 Human genes 0.000 description 2
- 102100033680 Bombesin receptor-activated protein C6orf89 Human genes 0.000 description 2
- 102100021984 C-C motif chemokine 4-like Human genes 0.000 description 2
- 102100029396 CLIP-associating protein 1 Human genes 0.000 description 2
- 102100032583 Calcium-dependent secretion activator 2 Human genes 0.000 description 2
- 102100040753 Casein kinase II subunit alpha' Human genes 0.000 description 2
- 102100029583 DDB1- and CUL4-associated factor 5 Human genes 0.000 description 2
- 102100037810 DEP domain-containing protein 1B Human genes 0.000 description 2
- 102100038023 DNA fragmentation factor subunit beta Human genes 0.000 description 2
- 102100037980 Disks large-associated protein 5 Human genes 0.000 description 2
- 102100035102 E3 ubiquitin-protein ligase MYCBP2 Human genes 0.000 description 2
- 102100024516 F-box only protein 5 Human genes 0.000 description 2
- 102100034553 Fanconi anemia group J protein Human genes 0.000 description 2
- 102100032789 Formin-like protein 3 Human genes 0.000 description 2
- 102100036000 G-protein coupled receptor-associated sorting protein 2 Human genes 0.000 description 2
- 102100035205 GA-binding protein subunit beta-1 Human genes 0.000 description 2
- 102100027234 General transcription factor IIH subunit 2-like protein Human genes 0.000 description 2
- 102100041034 Glucosamine-6-phosphate isomerase 1 Human genes 0.000 description 2
- 108010070600 Glucose-6-phosphate isomerase Proteins 0.000 description 2
- 102100022761 Glutamate receptor ionotropic, kainate 5 Human genes 0.000 description 2
- 102100038720 Histone deacetylase 9 Human genes 0.000 description 2
- 102100038970 Histone-lysine N-methyltransferase EZH2 Human genes 0.000 description 2
- 101000927505 Homo sapiens ADP-ribosylation factor GTPase-activating protein 3 Proteins 0.000 description 2
- 101000974511 Homo sapiens ADP-ribosylation factor-like protein 17 Proteins 0.000 description 2
- 101000768007 Homo sapiens AP-3 complex subunit sigma-2 Proteins 0.000 description 2
- 101000614487 Homo sapiens Adenylate kinase 4, mitochondrial Proteins 0.000 description 2
- 101000890401 Homo sapiens Amyloid beta precursor like protein 2 Proteins 0.000 description 2
- 101000975992 Homo sapiens Asparagine synthetase [glutamine-hydrolyzing] Proteins 0.000 description 2
- 101000765010 Homo sapiens Beta-galactosidase Proteins 0.000 description 2
- 101000695323 Homo sapiens BolA-like protein 2 Proteins 0.000 description 2
- 101000944524 Homo sapiens Bombesin receptor-activated protein C6orf89 Proteins 0.000 description 2
- 101000896959 Homo sapiens C-C motif chemokine 4-like Proteins 0.000 description 2
- 101000990005 Homo sapiens CLIP-associating protein 1 Proteins 0.000 description 2
- 101000867778 Homo sapiens Calcium-dependent secretion activator 2 Proteins 0.000 description 2
- 101000892015 Homo sapiens Casein kinase II subunit alpha' Proteins 0.000 description 2
- 101000919644 Homo sapiens Collagen alpha-3(IX) chain Proteins 0.000 description 2
- 101000711004 Homo sapiens Cx9C motif-containing protein 4 Proteins 0.000 description 2
- 101000917422 Homo sapiens DDB1- and CUL4-associated factor 5 Proteins 0.000 description 2
- 101000950656 Homo sapiens DEP domain-containing protein 1B Proteins 0.000 description 2
- 101000951365 Homo sapiens Disks large-associated protein 5 Proteins 0.000 description 2
- 101001010541 Homo sapiens Electron transfer flavoprotein subunit alpha, mitochondrial Proteins 0.000 description 2
- 101001052797 Homo sapiens F-box only protein 5 Proteins 0.000 description 2
- 101000848171 Homo sapiens Fanconi anemia group J protein Proteins 0.000 description 2
- 101001021404 Homo sapiens G-protein coupled receptor-associated sorting protein 2 Proteins 0.000 description 2
- 101001022098 Homo sapiens GA-binding protein subunit beta-1 Proteins 0.000 description 2
- 101000836301 Homo sapiens General transcription factor IIH subunit 2-like protein Proteins 0.000 description 2
- 101000903313 Homo sapiens Glutamate receptor ionotropic, kainate 5 Proteins 0.000 description 2
- 101000882127 Homo sapiens Histone-lysine N-methyltransferase EZH2 Proteins 0.000 description 2
- 101000926535 Homo sapiens Interferon-induced, double-stranded RNA-activated protein kinase Proteins 0.000 description 2
- 101001046974 Homo sapiens KAT8 regulatory NSL complex subunit 1 Proteins 0.000 description 2
- 101000577058 Homo sapiens M-phase phosphoprotein 6 Proteins 0.000 description 2
- 101001115426 Homo sapiens MAGUK p55 subfamily member 3 Proteins 0.000 description 2
- 101001005718 Homo sapiens Melanoma-associated antigen 2 Proteins 0.000 description 2
- 101001057193 Homo sapiens Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 Proteins 0.000 description 2
- 101000615492 Homo sapiens Methyl-CpG-binding domain protein 4 Proteins 0.000 description 2
- 101000581940 Homo sapiens Napsin-A Proteins 0.000 description 2
- 101001060736 Homo sapiens Peptidyl-prolyl cis-trans isomerase FKBP1B Proteins 0.000 description 2
- 101001092004 Homo sapiens Rho GTPase-activating protein 21 Proteins 0.000 description 2
- 101000927796 Homo sapiens Rho guanine nucleotide exchange factor 7 Proteins 0.000 description 2
- 102100034170 Interferon-induced, double-stranded RNA-activated protein kinase Human genes 0.000 description 2
- 102100039062 Interleukin enhancer-binding factor 3 Human genes 0.000 description 2
- 102100022903 KAT8 regulatory NSL complex subunit 1 Human genes 0.000 description 2
- 102100029825 Leptin receptor gene-related protein Human genes 0.000 description 2
- 102100038805 Lysophospholipid acyltransferase 2 Human genes 0.000 description 2
- 102100025307 M-phase phosphoprotein 6 Human genes 0.000 description 2
- 102100023260 MAGUK p55 subfamily member 3 Human genes 0.000 description 2
- 102100025081 Melanoma-associated antigen 2 Human genes 0.000 description 2
- 102100027240 Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 Human genes 0.000 description 2
- 102100021290 Methyl-CpG-binding domain protein 4 Human genes 0.000 description 2
- 102100027343 Napsin-A Human genes 0.000 description 2
- 102100023602 Protein Hook homolog 1 Human genes 0.000 description 2
- 102100023075 Protein Niban 2 Human genes 0.000 description 2
- 102100024245 Putative inactive carbonic anhydrase 5B-like protein Human genes 0.000 description 2
- 102100035753 Rho GTPase-activating protein 21 Human genes 0.000 description 2
- 102100033200 Rho guanine nucleotide exchange factor 7 Human genes 0.000 description 2
- 101150113054 SELE gene Proteins 0.000 description 2
- 102100031075 Serine/threonine-protein kinase Chk2 Human genes 0.000 description 2
- 102100035820 Unconventional myosin-Ie Human genes 0.000 description 2
- 102100034074 Voltage-gated potassium channel subunit beta-2 Human genes 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- HONKEGXLWUDTCF-YFKPBYRVSA-N (2s)-2-amino-2-methyl-4-phosphonobutanoic acid Chemical compound OC(=O)[C@](N)(C)CCP(O)(O)=O HONKEGXLWUDTCF-YFKPBYRVSA-N 0.000 description 1
- JPKJQBJPBRLVTM-OSLIGDBKSA-N (2s)-2-amino-n-[(2s,3r)-3-hydroxy-1-[[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2r)-1-(1h-indol-3-yl)-3-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxobutan-2-yl]-6-iminohexanamide Chemical compound C([C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCC=N)[C@H](O)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C=O)C1=CC=CC=C1 JPKJQBJPBRLVTM-OSLIGDBKSA-N 0.000 description 1
- WKVZMKDXJFCMMD-UVWUDEKDSA-L (5ar,8ar,9r)-5-[[(2r,4ar,6r,7r,8r,8as)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5h-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one;azanide;n,3-bis(2-chloroethyl)-2-ox Chemical compound [NH2-].[NH2-].Cl[Pt+2]Cl.ClCCNP1(=O)OCCCN1CCCl.COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3C(O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 WKVZMKDXJFCMMD-UVWUDEKDSA-L 0.000 description 1
- PJOHVEQSYPOERL-SHEAVXILSA-N (e)-n-[(4r,4as,7ar,12br)-3-(cyclopropylmethyl)-9-hydroxy-7-oxo-2,4,5,6,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-4a-yl]-3-(4-methylphenyl)prop-2-enamide Chemical compound C1=CC(C)=CC=C1\C=C\C(=O)N[C@]1(CCC(=O)[C@@H]2O3)[C@H]4CC5=CC=C(O)C3=C5[C@]12CCN4CC1CC1 PJOHVEQSYPOERL-SHEAVXILSA-N 0.000 description 1
- 102100032386 1,5-anhydro-D-fructose reductase Human genes 0.000 description 1
- 102100030471 1-acyl-sn-glycerol-3-phosphate acyltransferase delta Human genes 0.000 description 1
- 102100026152 1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon Human genes 0.000 description 1
- 102100038368 1-acyl-sn-glycerol-3-phosphate acyltransferase gamma Human genes 0.000 description 1
- 102100039583 116 kDa U5 small nuclear ribonucleoprotein component Human genes 0.000 description 1
- 102100031592 12S rRNA N4-methylcytidine (m4C) methyltransferase Human genes 0.000 description 1
- 102100037425 17-beta-hydroxysteroid dehydrogenase 14 Human genes 0.000 description 1
- 102100021403 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing], mitochondrial Human genes 0.000 description 1
- TYIRBZOAKBEYEJ-UHFFFAOYSA-N 2-(1,3-dimethyl-2,6-dioxopurin-7-yl)ethyl 2-[1-methyl-5-(4-methylbenzoyl)pyrrol-2-yl]acetate Chemical compound C1=CC(C)=CC=C1C(=O)C(N1C)=CC=C1CC(=O)OCCN1C(C(=O)N(C)C(=O)N2C)=C2N=C1 TYIRBZOAKBEYEJ-UHFFFAOYSA-N 0.000 description 1
- 102100031599 2-(3-amino-3-carboxypropyl)histidine synthase subunit 1 Human genes 0.000 description 1
- 102100024830 2-(3-amino-3-carboxypropyl)histidine synthase subunit 2 Human genes 0.000 description 1
- KIAPWMKFHIKQOZ-UHFFFAOYSA-N 2-[[(4-fluorophenyl)-oxomethyl]amino]benzoic acid methyl ester Chemical compound COC(=O)C1=CC=CC=C1NC(=O)C1=CC=C(F)C=C1 KIAPWMKFHIKQOZ-UHFFFAOYSA-N 0.000 description 1
- 101710186714 2-acylglycerol O-acyltransferase 1 Proteins 0.000 description 1
- 102100023287 2-acylglycerol O-acyltransferase 3 Human genes 0.000 description 1
- 102100025230 2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial Human genes 0.000 description 1
- OTJMDLIUFVHKNU-UHFFFAOYSA-N 2-hydroxy-5-methylidene-3-(piperidin-1-ylamino)cyclopent-2-en-1-one Chemical compound C1C(=C)C(=O)C(O)=C1NN1CCCCC1 OTJMDLIUFVHKNU-UHFFFAOYSA-N 0.000 description 1
- 102100027324 2-hydroxyacyl-CoA lyase 1 Human genes 0.000 description 1
- 102100027328 2-hydroxyacyl-CoA lyase 2 Human genes 0.000 description 1
- 102100037295 2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial Human genes 0.000 description 1
- 102100026941 2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2 Human genes 0.000 description 1
- 102100026947 2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3 Human genes 0.000 description 1
- 102100026936 2-oxoglutarate dehydrogenase, mitochondrial Human genes 0.000 description 1
- 102100030162 2-oxoglutarate dehydrogenase-like, mitochondrial Human genes 0.000 description 1
- 102100035315 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial Human genes 0.000 description 1
- 102100038697 24-hydroxycholesterol 7-alpha-hydroxylase Human genes 0.000 description 1
- 108010073030 25-Hydroxyvitamin D3 1-alpha-Hydroxylase Proteins 0.000 description 1
- 102100036285 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial Human genes 0.000 description 1
- 102100029444 28S ribosomal protein S10, mitochondrial Human genes 0.000 description 1
- 102100027087 28S ribosomal protein S18c, mitochondrial Human genes 0.000 description 1
- 102100028830 28S ribosomal protein S25, mitochondrial Human genes 0.000 description 1
- 102100029829 28S ribosomal protein S29, mitochondrial Human genes 0.000 description 1
- 102100024419 28S ribosomal protein S31, mitochondrial Human genes 0.000 description 1
- 102100024385 28S ribosomal protein S35, mitochondrial Human genes 0.000 description 1
- 102100028810 28S ribosomal protein S5, mitochondrial Human genes 0.000 description 1
- 102100027824 3'(2'),5'-bisphosphate nucleotidase 1 Human genes 0.000 description 1
- 102100030786 3'-5' exoribonuclease 1 Human genes 0.000 description 1
- KIUMMUBSPKGMOY-UHFFFAOYSA-N 3,3'-Dithiobis(6-nitrobenzoic acid) Chemical compound C1=C([N+]([O-])=O)C(C(=O)O)=CC(SSC=2C=C(C(=CC=2)[N+]([O-])=O)C(O)=O)=C1 KIUMMUBSPKGMOY-UHFFFAOYSA-N 0.000 description 1
- 102100029077 3-hydroxy-3-methylglutaryl-coenzyme A reductase Human genes 0.000 description 1
- 102100021834 3-hydroxyacyl-CoA dehydrogenase Human genes 0.000 description 1
- 102100026188 3-hydroxybutyrate dehydrogenase type 2 Human genes 0.000 description 1
- 108020003281 3-hydroxyisobutyrate dehydrogenase Proteins 0.000 description 1
- 102100021388 3-hydroxyisobutyrate dehydrogenase, mitochondrial Human genes 0.000 description 1
- 102100034767 3-hydroxyisobutyryl-CoA hydrolase, mitochondrial Human genes 0.000 description 1
- 102100029103 3-ketoacyl-CoA thiolase Human genes 0.000 description 1
- 102100021908 3-mercaptopyruvate sulfurtransferase Human genes 0.000 description 1
- 102100035241 3-oxoacyl-[acyl-carrier-protein] reductase Human genes 0.000 description 1
- 101710138614 3-oxoacyl-[acyl-carrier-protein] reductase Proteins 0.000 description 1
- 102100026146 39S ribosomal protein L13, mitochondrial Human genes 0.000 description 1
- 102100027556 39S ribosomal protein L17, mitochondrial Human genes 0.000 description 1
- 102100028103 39S ribosomal protein L18, mitochondrial Human genes 0.000 description 1
- 102100034043 39S ribosomal protein L21, mitochondrial Human genes 0.000 description 1
- 102100034036 39S ribosomal protein L22, mitochondrial Human genes 0.000 description 1
- 102100022030 39S ribosomal protein L24, mitochondrial Human genes 0.000 description 1
- 102100039520 39S ribosomal protein L33, mitochondrial Human genes 0.000 description 1
- 102100027561 39S ribosomal protein L37, mitochondrial Human genes 0.000 description 1
- 102100027395 39S ribosomal protein L38, mitochondrial Human genes 0.000 description 1
- 102100034140 39S ribosomal protein L43, mitochondrial Human genes 0.000 description 1
- 102100033756 39S ribosomal protein L45, mitochondrial Human genes 0.000 description 1
- 102100033750 39S ribosomal protein L47, mitochondrial Human genes 0.000 description 1
- 102100033746 39S ribosomal protein L48, mitochondrial Human genes 0.000 description 1
- 102100021751 39S ribosomal protein L52, mitochondrial Human genes 0.000 description 1
- 102100039822 39S ribosomal protein L55, mitochondrial Human genes 0.000 description 1
- 102100040272 39S ribosomal protein L9, mitochondrial Human genes 0.000 description 1
- 102100034488 39S ribosomal protein S18a, mitochondrial Human genes 0.000 description 1
- QHXIQBNUQFLDAB-UHFFFAOYSA-N 4-N,6-N-dimethyl-2-N-propan-2-yl-1,3,5-triazine-2,4,6-triamine Chemical compound CNC1=NC(NC)=NC(NC(C)C)=N1 QHXIQBNUQFLDAB-UHFFFAOYSA-N 0.000 description 1
- 101710137984 4-O-beta-D-mannosyl-D-glucose phosphorylase Proteins 0.000 description 1
- 108010071258 4-hydroxy-2-oxoglutarate aldolase Proteins 0.000 description 1
- 102100027715 4-hydroxy-2-oxoglutarate aldolase, mitochondrial Human genes 0.000 description 1
- 102100027451 4-hydroxybenzoate polyprenyltransferase, mitochondrial Human genes 0.000 description 1
- MXCVHSXCXPHOLP-UHFFFAOYSA-N 4-oxo-6-propylchromene-2-carboxylic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=CC(CCC)=CC=C21 MXCVHSXCXPHOLP-UHFFFAOYSA-N 0.000 description 1
- 102100034095 5'(3')-deoxyribonucleotidase, cytosolic type Human genes 0.000 description 1
- 102100038693 5'(3')-deoxyribonucleotidase, mitochondrial Human genes 0.000 description 1
- 102100034406 5'-deoxynucleotidase HDDC2 Human genes 0.000 description 1
- 102100038686 5'-nucleotidase domain-containing protein 2 Human genes 0.000 description 1
- SVDVJBWDBYSQLO-UHFFFAOYSA-N 5-(4-hydroxy-3-methoxyphenyl)-5-phenylimidazolidine-2,4-dione Chemical compound C1=C(O)C(OC)=CC(C2(C(NC(=O)N2)=O)C=2C=CC=CC=2)=C1 SVDVJBWDBYSQLO-UHFFFAOYSA-N 0.000 description 1
- 102100030755 5-aminolevulinate synthase, nonspecific, mitochondrial Human genes 0.000 description 1
- 102100021324 5-azacytidine-induced protein 2 Human genes 0.000 description 1
- 102100029272 5-demethoxyubiquinone hydroxylase, mitochondrial Human genes 0.000 description 1
- 102100031739 5-formyltetrahydrofolate cyclo-ligase Human genes 0.000 description 1
- 108020005541 5-formyltetrahydrofolate cyclo-ligase Proteins 0.000 description 1
- 102100021548 5-methylcytosine rRNA methyltransferase NSUN4 Human genes 0.000 description 1
- 102100025908 5-oxoprolinase Human genes 0.000 description 1
- 102100031126 6-phosphogluconolactonase Human genes 0.000 description 1
- 102100038954 60S ribosomal export protein NMD3 Human genes 0.000 description 1
- 102100029405 60S ribosome subunit biogenesis protein NIP7 homolog Human genes 0.000 description 1
- 102100028713 7-methylguanosine phosphate-specific 5'-nucleotidase Human genes 0.000 description 1
- 102100031912 A-kinase anchor protein 1, mitochondrial Human genes 0.000 description 1
- 102100033822 A-kinase anchor protein 10, mitochondrial Human genes 0.000 description 1
- 102100033811 A-kinase anchor protein 11 Human genes 0.000 description 1
- 102100033824 A-kinase anchor protein 12 Human genes 0.000 description 1
- 102100024049 A-kinase anchor protein 13 Human genes 0.000 description 1
- 102100031901 A-kinase anchor protein 2 Human genes 0.000 description 1
- 102100040077 A-kinase anchor protein 6 Human genes 0.000 description 1
- 102100031908 A-kinase anchor protein 7 isoform gamma Human genes 0.000 description 1
- 102100040086 A-kinase anchor protein 8 Human genes 0.000 description 1
- 102100040084 A-kinase anchor protein 9 Human genes 0.000 description 1
- 102100039720 A-kinase-interacting protein 1 Human genes 0.000 description 1
- 102100028324 ADP-ribose glycohydrolase MACROD1 Human genes 0.000 description 1
- 102100028323 ADP-ribose glycohydrolase MACROD2 Human genes 0.000 description 1
- 102100027783 ADP-ribose glycohydrolase OARD1 Human genes 0.000 description 1
- 102100033282 ADP-ribosylation factor GTPase-activating protein 2 Human genes 0.000 description 1
- 102100040164 ADP-ribosylation factor-binding protein GGA1 Human genes 0.000 description 1
- 102100040193 ADP-ribosylation factor-binding protein GGA3 Human genes 0.000 description 1
- 102100023971 ADP-ribosylation factor-like protein 13B Human genes 0.000 description 1
- 102100022910 ADP-ribosylation factor-like protein 15 Human genes 0.000 description 1
- 102100022912 ADP-ribosylation factor-like protein 16 Human genes 0.000 description 1
- 102100039650 ADP-ribosylation factor-like protein 2 Human genes 0.000 description 1
- 102100039646 ADP-ribosylation factor-like protein 3 Human genes 0.000 description 1
- 102100022870 ADP-ribosylation factor-like protein 5B Human genes 0.000 description 1
- 102100028359 ADP-ribosylation factor-like protein 6 Human genes 0.000 description 1
- 102100030672 ADP-ribosylation factor-like protein 6-interacting protein 6 Human genes 0.000 description 1
- 102100028358 ADP-ribosylation factor-like protein 8A Human genes 0.000 description 1
- 102100038776 ADP-ribosylation factor-related protein 1 Human genes 0.000 description 1
- 102100024379 AF4/FMR2 family member 1 Human genes 0.000 description 1
- 102100024387 AF4/FMR2 family member 3 Human genes 0.000 description 1
- 102100024381 AF4/FMR2 family member 4 Human genes 0.000 description 1
- 102100034212 AFG1-like ATPase Human genes 0.000 description 1
- 102100034215 AFG3-like protein 2 Human genes 0.000 description 1
- 101710083984 AH receptor-interacting protein Proteins 0.000 description 1
- 101150059521 AHRR gene Proteins 0.000 description 1
- 102100026449 AKT-interacting protein Human genes 0.000 description 1
- 102000010553 ALAD Human genes 0.000 description 1
- 101150082527 ALAD gene Proteins 0.000 description 1
- 102100032091 ALK and LTK ligand 2 Human genes 0.000 description 1
- 102100033793 ALK tyrosine kinase receptor Human genes 0.000 description 1
- 102100025676 AMMECR1-like protein Human genes 0.000 description 1
- 102100032897 AMP deaminase 2 Human genes 0.000 description 1
- 102100034482 AP-1 complex subunit beta-1 Human genes 0.000 description 1
- 102100033938 AP-1 complex subunit gamma-1 Human genes 0.000 description 1
- 102100034526 AP-1 complex subunit mu-1 Human genes 0.000 description 1
- 102100028780 AP-1 complex subunit sigma-2 Human genes 0.000 description 1
- 102100028781 AP-1 complex subunit sigma-3 Human genes 0.000 description 1
- 102100034481 AP-1 complex-associated regulatory protein Human genes 0.000 description 1
- 102100022984 AP-2 complex subunit alpha-1 Human genes 0.000 description 1
- 102100022974 AP-2 complex subunit alpha-2 Human genes 0.000 description 1
- 102100033347 AP-2 complex subunit beta Human genes 0.000 description 1
- 102100031315 AP-2 complex subunit mu Human genes 0.000 description 1
- 102100033936 AP-3 complex subunit beta-1 Human genes 0.000 description 1
- 102100033935 AP-3 complex subunit beta-2 Human genes 0.000 description 1
- 102100033926 AP-3 complex subunit delta-1 Human genes 0.000 description 1
- 102100040005 AP-3 complex subunit mu-1 Human genes 0.000 description 1
- 102100040008 AP-3 complex subunit mu-2 Human genes 0.000 description 1
- 102100040009 AP-3 complex subunit sigma-1 Human genes 0.000 description 1
- 102100036454 AP-4 complex subunit beta-1 Human genes 0.000 description 1
- 102100036458 AP-4 complex subunit epsilon-1 Human genes 0.000 description 1
- 102100036459 AP-4 complex subunit mu-1 Human genes 0.000 description 1
- 102100040060 AP-5 complex subunit mu-1 Human genes 0.000 description 1
- 102100040057 AP-5 complex subunit sigma-1 Human genes 0.000 description 1
- 102100039602 ARF GTPase-activating protein GIT2 Human genes 0.000 description 1
- 102100040071 ARL14 effector protein Human genes 0.000 description 1
- 108010088547 ARNTL Transcription Factors Proteins 0.000 description 1
- 102100029798 ASNSD1 upstream open reading frame protein Human genes 0.000 description 1
- 102100024408 AT-hook DNA-binding motif-containing protein 1 Human genes 0.000 description 1
- 102100034571 AT-rich interactive domain-containing protein 1B Human genes 0.000 description 1
- 102100023157 AT-rich interactive domain-containing protein 2 Human genes 0.000 description 1
- 102100030841 AT-rich interactive domain-containing protein 4A Human genes 0.000 description 1
- 102100030840 AT-rich interactive domain-containing protein 4B Human genes 0.000 description 1
- 102100030834 AT-rich interactive domain-containing protein 5A Human genes 0.000 description 1
- 102100030835 AT-rich interactive domain-containing protein 5B Human genes 0.000 description 1
- 102000000872 ATM Human genes 0.000 description 1
- 102100023619 ATP synthase F(0) complex subunit B1, mitochondrial Human genes 0.000 description 1
- 102100028814 ATP synthase mitochondrial F1 complex assembly factor 1 Human genes 0.000 description 1
- 102100027520 ATP synthase mitochondrial F1 complex assembly factor 2 Human genes 0.000 description 1
- 102100026788 ATP synthase subunit C lysine N-methyltransferase Human genes 0.000 description 1
- 102100021870 ATP synthase subunit O, mitochondrial Human genes 0.000 description 1
- 102100027757 ATP synthase subunit d, mitochondrial Human genes 0.000 description 1
- 102100027790 ATP synthase subunit e, mitochondrial Human genes 0.000 description 1
- 102100026564 ATP synthase subunit f, mitochondrial Human genes 0.000 description 1
- 102100032763 ATP synthase subunit gamma, mitochondrial Human genes 0.000 description 1
- 102100030454 ATP synthase subunit s, mitochondrial Human genes 0.000 description 1
- 102100027782 ATP synthase-coupling factor 6, mitochondrial Human genes 0.000 description 1
- 102100029160 ATP-dependent (S)-NAD(P)H-hydrate dehydratase Human genes 0.000 description 1
- 102100025339 ATP-dependent DNA helicase DDX11 Human genes 0.000 description 1
- 102100022410 ATP-dependent DNA/RNA helicase DHX36 Human genes 0.000 description 1
- 102100021405 ATP-dependent RNA helicase DDX1 Human genes 0.000 description 1
- 102100024738 ATP-dependent RNA helicase DDX19A Human genes 0.000 description 1
- 102100024736 ATP-dependent RNA helicase DDX19B Human genes 0.000 description 1
- 102100035720 ATP-dependent RNA helicase DDX42 Human genes 0.000 description 1
- 102100024768 ATP-dependent RNA helicase DDX50 Human genes 0.000 description 1
- 102100038263 ATP-dependent RNA helicase DDX55 Human genes 0.000 description 1
- 102100023388 ATP-dependent RNA helicase DHX15 Human genes 0.000 description 1
- 102100023439 ATP-dependent RNA helicase DHX29 Human genes 0.000 description 1
- 102100022413 ATP-dependent RNA helicase DHX30 Human genes 0.000 description 1
- 102100022423 ATP-dependent RNA helicase DHX33 Human genes 0.000 description 1
- 102100030089 ATP-dependent RNA helicase DHX8 Human genes 0.000 description 1
- 102100036237 ATP-dependent RNA helicase DQX1 Human genes 0.000 description 1
- 102100024825 ATPase MORC2 Human genes 0.000 description 1
- 102100039864 ATPase family AAA domain-containing protein 2 Human genes 0.000 description 1
- 102100032792 ATPase family AAA domain-containing protein 2B Human genes 0.000 description 1
- 102100032787 ATPase family AAA domain-containing protein 3A Human genes 0.000 description 1
- 102100032794 ATPase family AAA domain-containing protein 3B Human genes 0.000 description 1
- 102100028080 ATPase family AAA domain-containing protein 5 Human genes 0.000 description 1
- 101150020330 ATRX gene Proteins 0.000 description 1
- 102100028175 Abasic site processing protein HMCES Human genes 0.000 description 1
- 102100022117 Abnormal spindle-like microcephaly-associated protein Human genes 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 102100029271 Acetylcholinesterase collagenic tail peptide Human genes 0.000 description 1
- 101800001241 Acetylglutamate kinase Proteins 0.000 description 1
- 102100021624 Acid-sensing ion channel 1 Human genes 0.000 description 1
- 101710099904 Acid-sensing ion channel 1 Proteins 0.000 description 1
- 102100022097 Acid-sensing ion channel 3 Human genes 0.000 description 1
- 101710099898 Acid-sensing ion channel 3 Proteins 0.000 description 1
- 102100027863 Acidic fibroblast growth factor intracellular-binding protein Human genes 0.000 description 1
- 102100022997 Acidic leucine-rich nuclear phosphoprotein 32 family member A Human genes 0.000 description 1
- 101710109946 Actin-binding protein IPP Proteins 0.000 description 1
- 102100033889 Actin-related protein 2/3 complex subunit 3 Human genes 0.000 description 1
- 102100026401 Actin-related protein 2/3 complex subunit 5-like protein Human genes 0.000 description 1
- 108010075348 Activated-Leukocyte Cell Adhesion Molecule Proteins 0.000 description 1
- 102100027166 Activating molecule in BECN1-regulated autophagy protein 1 Human genes 0.000 description 1
- 102100021028 Activating signal cointegrator 1 complex subunit 1 Human genes 0.000 description 1
- 102100021031 Activating signal cointegrator 1 complex subunit 2 Human genes 0.000 description 1
- 102100021029 Activating signal cointegrator 1 complex subunit 3 Human genes 0.000 description 1
- 102100030865 Activating transcription factor 7-interacting protein 2 Human genes 0.000 description 1
- 102100034542 Acyl-CoA (8-3)-desaturase Human genes 0.000 description 1
- 102100034544 Acyl-CoA 6-desaturase Human genes 0.000 description 1
- 102100021305 Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 Human genes 0.000 description 1
- 102100022089 Acyl-[acyl-carrier-protein] hydrolase Human genes 0.000 description 1
- 102100036191 Acyl-coenzyme A diphosphatase NUDT19 Human genes 0.000 description 1
- 102100040280 Acyl-protein thioesterase 1 Human genes 0.000 description 1
- 102100032488 Acylamino-acid-releasing enzyme Human genes 0.000 description 1
- 102100022388 Acylglycerol kinase, mitochondrial Human genes 0.000 description 1
- 102100039140 Acyloxyacyl hydrolase Human genes 0.000 description 1
- 102100023063 Adaptin ear-binding coat-associated protein 2 Human genes 0.000 description 1
- 102100035886 Adenine DNA glycosylase Human genes 0.000 description 1
- 102100039162 Adenine nucleotide translocase lysine N-methyltransferase Human genes 0.000 description 1
- 102100034540 Adenomatous polyposis coli protein Human genes 0.000 description 1
- 102100025291 Adenosine 5'-monophosphoramidase HINT3 Human genes 0.000 description 1
- 102100022476 Adenosylhomocysteinase 3 Human genes 0.000 description 1
- 102100040439 Adenylate kinase 4, mitochondrial Human genes 0.000 description 1
- 102100025151 Adenylate kinase 8 Human genes 0.000 description 1
- 102100025153 Adenylate kinase 9 Human genes 0.000 description 1
- 102100020775 Adenylosuccinate lyase Human genes 0.000 description 1
- 108700040193 Adenylosuccinate lyases Proteins 0.000 description 1
- 102100024396 Adrenodoxin, mitochondrial Human genes 0.000 description 1
- 108010087522 Aeromonas hydrophilia lipase-acyltransferase Proteins 0.000 description 1
- 102100036775 Afadin Human genes 0.000 description 1
- 102100028443 Aflatoxin B1 aldehyde reductase member 2 Human genes 0.000 description 1
- 102100040026 Agrin Human genes 0.000 description 1
- 102100024948 Aldehyde dehydrogenase family 16 member A1 Human genes 0.000 description 1
- 102100026608 Aldehyde dehydrogenase family 3 member A2 Human genes 0.000 description 1
- 102100026609 Aldehyde dehydrogenase family 3 member B1 Human genes 0.000 description 1
- 102100033816 Aldehyde dehydrogenase, mitochondrial Human genes 0.000 description 1
- 102100036826 Aldehyde oxidase Human genes 0.000 description 1
- 102100026448 Aldo-keto reductase family 1 member A1 Human genes 0.000 description 1
- 102100040436 Alkylated DNA repair protein alkB homolog 8 Human genes 0.000 description 1
- 102100034112 Alkyldihydroxyacetonephosphate synthase, peroxisomal Human genes 0.000 description 1
- 102100027714 Alpha-(1,3)-fucosyltransferase 10 Human genes 0.000 description 1
- 102100021266 Alpha-(1,6)-fucosyltransferase Human genes 0.000 description 1
- 102100026611 Alpha-1,2-mannosyltransferase ALG9 Human genes 0.000 description 1
- 102100022622 Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase Human genes 0.000 description 1
- 102100037995 Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B Human genes 0.000 description 1
- 102100037996 Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C Human genes 0.000 description 1
- 102100037982 Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A Human genes 0.000 description 1
- 102100031317 Alpha-N-acetylgalactosaminidase Human genes 0.000 description 1
- 102100024085 Alpha-aminoadipic semialdehyde dehydrogenase Human genes 0.000 description 1
- 102100033407 Alpha-amylase 2B Human genes 0.000 description 1
- 102100031090 Alpha-catulin Human genes 0.000 description 1
- 102100040622 Alpha-ketoglutarate dehydrogenase component 4 Human genes 0.000 description 1
- 102100030461 Alpha-ketoglutarate-dependent dioxygenase FTO Human genes 0.000 description 1
- 102100039086 Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 Human genes 0.000 description 1
- 102100040433 Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 Human genes 0.000 description 1
- 102100023165 Alpha-mannosidase 2C1 Human genes 0.000 description 1
- 102100040410 Alpha-methylacyl-CoA racemase Human genes 0.000 description 1
- 108010044434 Alpha-methylacyl-CoA racemase Proteins 0.000 description 1
- 102100033805 Alpha-protein kinase 1 Human genes 0.000 description 1
- 102100033804 Alpha-protein kinase 2 Human genes 0.000 description 1
- 102100032047 Alsin Human genes 0.000 description 1
- 102100022416 Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 Human genes 0.000 description 1
- 102100022417 Aminoacyl tRNA synthase complex-interacting multifunctional protein 2 Human genes 0.000 description 1
- 102100039338 Aminomethyltransferase, mitochondrial Human genes 0.000 description 1
- 102100033830 Amphiphysin Human genes 0.000 description 1
- 102100040894 Amylo-alpha-1,6-glucosidase Human genes 0.000 description 1
- 102100040055 Amyloid beta precursor like protein 1 Human genes 0.000 description 1
- 102100036438 Amyloid beta precursor protein binding family B member 2 Human genes 0.000 description 1
- 102100033972 Amyloid protein-binding protein 2 Human genes 0.000 description 1
- 102100036514 Amyloid-beta A4 precursor protein-binding family A member 1 Human genes 0.000 description 1
- 102100036441 Amyloid-beta A4 precursor protein-binding family A member 2 Human genes 0.000 description 1
- 102100036440 Amyloid-beta A4 precursor protein-binding family A member 3 Human genes 0.000 description 1
- 102100021697 Anamorsin Human genes 0.000 description 1
- 101150115961 Anapc10 gene Proteins 0.000 description 1
- 102000052567 Anaphase-Promoting Complex-Cyclosome Apc1 Subunit Human genes 0.000 description 1
- 108700004581 Anaphase-Promoting Complex-Cyclosome Apc1 Subunit Proteins 0.000 description 1
- 102000052587 Anaphase-Promoting Complex-Cyclosome Apc3 Subunit Human genes 0.000 description 1
- 108700004606 Anaphase-Promoting Complex-Cyclosome Apc3 Subunit Proteins 0.000 description 1
- 108700004605 Anaphase-Promoting Complex-Cyclosome Apc4 Subunit Proteins 0.000 description 1
- 102000052589 Anaphase-Promoting Complex-Cyclosome Apc4 Subunit Human genes 0.000 description 1
- 102000052591 Anaphase-Promoting Complex-Cyclosome Apc6 Subunit Human genes 0.000 description 1
- 108700004603 Anaphase-Promoting Complex-Cyclosome Apc6 Subunit Proteins 0.000 description 1
- 108700004602 Anaphase-Promoting Complex-Cyclosome Apc7 Subunit Proteins 0.000 description 1
- 102000052584 Anaphase-Promoting Complex-Cyclosome Apc7 Subunit Human genes 0.000 description 1
- 102000052583 Anaphase-Promoting Complex-Cyclosome Apc8 Subunit Human genes 0.000 description 1
- 102100033973 Anaphase-promoting complex subunit 10 Human genes 0.000 description 1
- 102100033723 Anaphase-promoting complex subunit 15 Human genes 0.000 description 1
- 102100026468 Androgen-induced gene 1 protein Human genes 0.000 description 1
- 102100026683 Angiogenic factor with G patch and FHA domains 1 Human genes 0.000 description 1
- 102100040360 Angiomotin Human genes 0.000 description 1
- 102100040357 Angiomotin-like protein 1 Human genes 0.000 description 1
- 102100034594 Angiopoietin-1 Human genes 0.000 description 1
- 102100033393 Anillin Human genes 0.000 description 1
- 102100036819 Ankyrin repeat and EF-hand domain-containing protein 1 Human genes 0.000 description 1
- 102100039722 Ankyrin repeat and IBR domain-containing protein 1 Human genes 0.000 description 1
- 102100036822 Ankyrin repeat and KH domain-containing protein 1 Human genes 0.000 description 1
- 102100039161 Ankyrin repeat and LEM domain-containing protein 2 Human genes 0.000 description 1
- 102100033395 Ankyrin repeat and MYND domain-containing protein 1 Human genes 0.000 description 1
- 102100033396 Ankyrin repeat and MYND domain-containing protein 2 Human genes 0.000 description 1
- 102100027139 Ankyrin repeat and SAM domain-containing protein 1A Human genes 0.000 description 1
- 102100039394 Ankyrin repeat and SAM domain-containing protein 3 Human genes 0.000 description 1
- 102100039379 Ankyrin repeat and SAM domain-containing protein 6 Human genes 0.000 description 1
- 102100033897 Ankyrin repeat and SOCS box protein 1 Human genes 0.000 description 1
- 102100033900 Ankyrin repeat and SOCS box protein 13 Human genes 0.000 description 1
- 102100021625 Ankyrin repeat and SOCS box protein 3 Human genes 0.000 description 1
- 102100021618 Ankyrin repeat and SOCS box protein 6 Human genes 0.000 description 1
- 102100033397 Ankyrin repeat and zinc finger domain-containing protein 1 Human genes 0.000 description 1
- 102100034615 Ankyrin repeat domain-containing protein 10 Human genes 0.000 description 1
- 102100034614 Ankyrin repeat domain-containing protein 11 Human genes 0.000 description 1
- 102100034611 Ankyrin repeat domain-containing protein 12 Human genes 0.000 description 1
- 102100034270 Ankyrin repeat domain-containing protein 13A Human genes 0.000 description 1
- 102100034297 Ankyrin repeat domain-containing protein 13C Human genes 0.000 description 1
- 102100023004 Ankyrin repeat domain-containing protein 13D Human genes 0.000 description 1
- 102100034609 Ankyrin repeat domain-containing protein 17 Human genes 0.000 description 1
- 102100034280 Ankyrin repeat domain-containing protein 26 Human genes 0.000 description 1
- 102100034286 Ankyrin repeat domain-containing protein 27 Human genes 0.000 description 1
- 102100034562 Ankyrin repeat domain-containing protein 33B Human genes 0.000 description 1
- 102100033306 Ankyrin repeat domain-containing protein 35 Human genes 0.000 description 1
- 102100034564 Ankyrin repeat domain-containing protein 36A Human genes 0.000 description 1
- 102100033307 Ankyrin repeat domain-containing protein 37 Human genes 0.000 description 1
- 102100033368 Ankyrin repeat domain-containing protein 39 Human genes 0.000 description 1
- 102100033330 Ankyrin repeat domain-containing protein 45 Human genes 0.000 description 1
- 102100039179 Ankyrin repeat domain-containing protein 46 Human genes 0.000 description 1
- 102100039148 Ankyrin repeat domain-containing protein 49 Human genes 0.000 description 1
- 102100039159 Ankyrin repeat domain-containing protein 54 Human genes 0.000 description 1
- 102100039378 Ankyrin repeat domain-containing protein 6 Human genes 0.000 description 1
- 102100031329 Ankyrin repeat family A protein 2 Human genes 0.000 description 1
- 102100036818 Ankyrin-2 Human genes 0.000 description 1
- 102100036817 Ankyrin-3 Human genes 0.000 description 1
- 102100028118 Annexin A11 Human genes 0.000 description 1
- 102100034613 Annexin A2 Human genes 0.000 description 1
- 102100034612 Annexin A4 Human genes 0.000 description 1
- 102100034278 Annexin A6 Human genes 0.000 description 1
- 102100034273 Annexin A7 Human genes 0.000 description 1
- 102100036525 Anoctamin-4 Human genes 0.000 description 1
- 102100036524 Anoctamin-5 Human genes 0.000 description 1
- 102100036523 Anoctamin-6 Human genes 0.000 description 1
- 102100036815 Anoctamin-8 Human genes 0.000 description 1
- 102100025511 Anti-Muellerian hormone type-2 receptor Human genes 0.000 description 1
- 102100021253 Antileukoproteinase Human genes 0.000 description 1
- 102100032252 Antizyme inhibitor 2 Human genes 0.000 description 1
- 102100034156 Apical endosomal glycoprotein Human genes 0.000 description 1
- 102100036517 Apolipoprotein L domain-containing protein 1 Human genes 0.000 description 1
- 102100030762 Apolipoprotein L1 Human genes 0.000 description 1
- 102100030761 Apolipoprotein L2 Human genes 0.000 description 1
- 102100030766 Apolipoprotein L3 Human genes 0.000 description 1
- 102100039986 Apoptosis inhibitor 5 Human genes 0.000 description 1
- 102100027308 Apoptosis regulator BAX Human genes 0.000 description 1
- 108050006685 Apoptosis regulator BAX Proteins 0.000 description 1
- 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 1
- 102100040124 Apoptosis-inducing factor 1, mitochondrial Human genes 0.000 description 1
- 102100034342 Apoptosis-resistant E3 ubiquitin protein ligase 1 Human genes 0.000 description 1
- 102100034524 Apoptotic protease-activating factor 1 Human genes 0.000 description 1
- 102100024044 Aprataxin Human genes 0.000 description 1
- 101100005736 Arabidopsis thaliana APC6 gene Proteins 0.000 description 1
- 101000693933 Arabidopsis thaliana Fructose-bisphosphate aldolase 8, cytosolic Proteins 0.000 description 1
- 101001059203 Arabidopsis thaliana Heterodimeric geranylgeranyl pyrophosphate synthase large subunit 1, chloroplastic Proteins 0.000 description 1
- 101000957326 Arabidopsis thaliana Lysophospholipid acyltransferase 1 Proteins 0.000 description 1
- 101000957318 Arabidopsis thaliana Lysophospholipid acyltransferase 2 Proteins 0.000 description 1
- 101000775252 Arabidopsis thaliana NADPH-dependent oxidoreductase 2-alkenal reductase Proteins 0.000 description 1
- 102100040158 Archaemetzincin-2 Human genes 0.000 description 1
- 102100024371 Arf-GAP domain and FG repeat-containing protein 2 Human genes 0.000 description 1
- 102100036783 Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1 Human genes 0.000 description 1
- 102100036779 Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3 Human genes 0.000 description 1
- 102100036787 Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 6 Human genes 0.000 description 1
- 102100036785 Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 9 Human genes 0.000 description 1
- 102100033652 Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1 Human genes 0.000 description 1
- 102100033653 Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 2 Human genes 0.000 description 1
- 102100024003 Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 Human genes 0.000 description 1
- 102100026291 Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 Human genes 0.000 description 1
- 102100026288 Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3 Human genes 0.000 description 1
- 102100030287 Arfaptin-1 Human genes 0.000 description 1
- 102100038779 Arfaptin-2 Human genes 0.000 description 1
- 102100031378 Arginine-hydroxylase NDUFAF5, mitochondrial Human genes 0.000 description 1
- 108700040066 Argininosuccinate lyases Proteins 0.000 description 1
- 102100039995 Arginyl-tRNA-protein transferase 1 Human genes 0.000 description 1
- 102100031464 Armadillo repeat protein deleted in velo-cardio-facial syndrome Human genes 0.000 description 1
- 102100034225 Armadillo repeat-containing X-linked protein 1 Human genes 0.000 description 1
- 102100034224 Armadillo repeat-containing X-linked protein 2 Human genes 0.000 description 1
- 102100034304 Armadillo repeat-containing X-linked protein 3 Human genes 0.000 description 1
- 102100034222 Armadillo repeat-containing X-linked protein 5 Human genes 0.000 description 1
- 102100028493 Armadillo repeat-containing protein 10 Human genes 0.000 description 1
- 102100023182 Armadillo repeat-containing protein 2 Human genes 0.000 description 1
- 102100023186 Armadillo repeat-containing protein 6 Human genes 0.000 description 1
- 102100036880 Armadillo repeat-containing protein 7 Human genes 0.000 description 1
- 102100036875 Armadillo repeat-containing protein 8 Human genes 0.000 description 1
- 102100030825 Armadillo-like helical domain containing protein 1 Human genes 0.000 description 1
- 102100030829 Armadillo-like helical domain-containing protein 3 Human genes 0.000 description 1
- 102100038238 Aromatic-L-amino-acid decarboxylase Human genes 0.000 description 1
- 102100026444 Arrestin domain-containing protein 1 Human genes 0.000 description 1
- 102100026442 Arrestin domain-containing protein 2 Human genes 0.000 description 1
- 102100026424 Arrestin domain-containing protein 3 Human genes 0.000 description 1
- 102100022143 Arsenite methyltransferase Human genes 0.000 description 1
- 102100030907 Aryl hydrocarbon receptor nuclear translocator Human genes 0.000 description 1
- 102100027839 Aryl hydrocarbon receptor nuclear translocator 2 Human genes 0.000 description 1
- 102100037211 Aryl hydrocarbon receptor nuclear translocator-like protein 1 Human genes 0.000 description 1
- 102100021661 Aryl hydrocarbon receptor nuclear translocator-like protein 2 Human genes 0.000 description 1
- 102100026789 Aryl hydrocarbon receptor repressor Human genes 0.000 description 1
- 102100031491 Arylsulfatase B Human genes 0.000 description 1
- 102100033887 Arylsulfatase D Human genes 0.000 description 1
- 102100033893 Arylsulfatase J Human genes 0.000 description 1
- 102100023944 Arylsulfatase K Human genes 0.000 description 1
- 101150010890 Asb3 gene Proteins 0.000 description 1
- 101150025804 Asl gene Proteins 0.000 description 1
- 102100038063 Asparagine synthetase domain-containing protein 1 Human genes 0.000 description 1
- 102100028820 Aspartate-tRNA ligase, cytoplasmic Human genes 0.000 description 1
- 102100026198 Aspartate-tRNA ligase, mitochondrial Human genes 0.000 description 1
- 102100033261 Aspartyl aminopeptidase Human genes 0.000 description 1
- 102100022108 Aspartyl/asparaginyl beta-hydroxylase Human genes 0.000 description 1
- 101000690509 Aspergillus oryzae (strain ATCC 42149 / RIB 40) Alpha-glucosidase Proteins 0.000 description 1
- 102100027705 Astrotactin-2 Human genes 0.000 description 1
- 108010004586 Ataxia Telangiectasia Mutated Proteins Proteins 0.000 description 1
- 102000007372 Ataxin-1 Human genes 0.000 description 1
- 108010032963 Ataxin-1 Proteins 0.000 description 1
- 102100035021 Ataxin-1-like Human genes 0.000 description 1
- 102000002785 Ataxin-10 Human genes 0.000 description 1
- 108010043914 Ataxin-10 Proteins 0.000 description 1
- 102100035022 Ataxin-2-like protein Human genes 0.000 description 1
- 108010032947 Ataxin-3 Proteins 0.000 description 1
- 102100021321 Ataxin-3 Human genes 0.000 description 1
- 108010032953 Ataxin-7 Proteins 0.000 description 1
- 102000007368 Ataxin-7 Human genes 0.000 description 1
- 102100022999 Ataxin-7-like protein 1 Human genes 0.000 description 1
- 102100023002 Ataxin-7-like protein 2 Human genes 0.000 description 1
- 102100023025 Ataxin-7-like protein 3 Human genes 0.000 description 1
- 102000007370 Ataxin2 Human genes 0.000 description 1
- 108010032951 Ataxin2 Proteins 0.000 description 1
- 102100027766 Atlastin-1 Human genes 0.000 description 1
- 102100027765 Atlastin-2 Human genes 0.000 description 1
- 102100027620 Atlastin-3 Human genes 0.000 description 1
- 102100039339 Atrial natriuretic peptide receptor 1 Human genes 0.000 description 1
- 102100020741 Atrophin-1 Human genes 0.000 description 1
- 102100027936 Attractin Human genes 0.000 description 1
- 102100027935 Attractin-like protein 1 Human genes 0.000 description 1
- 102100035958 Atypical kinase COQ8A, mitochondrial Human genes 0.000 description 1
- 102100035952 Atypical kinase COQ8B, mitochondrial Human genes 0.000 description 1
- 102000004000 Aurora Kinase A Human genes 0.000 description 1
- 108090000461 Aurora Kinase A Proteins 0.000 description 1
- 102100039723 Aurora kinase A-interacting protein Human genes 0.000 description 1
- 102100032306 Aurora kinase B Human genes 0.000 description 1
- 102100035553 Autism susceptibility gene 2 protein Human genes 0.000 description 1
- 108010092776 Autophagy-Related Protein 5 Proteins 0.000 description 1
- 102000016614 Autophagy-Related Protein 5 Human genes 0.000 description 1
- 108010092778 Autophagy-Related Protein 7 Proteins 0.000 description 1
- 102100020689 Autophagy-related protein 13 Human genes 0.000 description 1
- 102100040355 Autophagy-related protein 16-1 Human genes 0.000 description 1
- 102100023610 Autophagy-related protein 2 homolog B Human genes 0.000 description 1
- 102100020823 Autophagy-related protein 9A Human genes 0.000 description 1
- 102100022414 Axin interactor, dorsalization-associated protein Human genes 0.000 description 1
- 102100035682 Axin-1 Human genes 0.000 description 1
- 102100039409 Axonemal dynein light intermediate polypeptide 1 Human genes 0.000 description 1
- 102100029844 B box and SPRY domain-containing protein Human genes 0.000 description 1
- 102100029822 B- and T-lymphocyte attenuator Human genes 0.000 description 1
- 102100021630 B-cell CLL/lymphoma 7 protein family member A Human genes 0.000 description 1
- 102100032426 B-cell CLL/lymphoma 7 protein family member B Human genes 0.000 description 1
- 102100032430 B-cell CLL/lymphoma 7 protein family member C Human genes 0.000 description 1
- 102100032481 B-cell CLL/lymphoma 9 protein Human genes 0.000 description 1
- 102100032424 B-cell CLL/lymphoma 9-like protein Human genes 0.000 description 1
- 102100035634 B-cell linker protein Human genes 0.000 description 1
- 102100022976 B-cell lymphoma/leukemia 11A Human genes 0.000 description 1
- 102100038080 B-cell receptor CD22 Human genes 0.000 description 1
- 102100027449 B9 domain-containing protein 1 Human genes 0.000 description 1
- 102100027444 B9 domain-containing protein 2 Human genes 0.000 description 1
- 102000010595 BABAM2 Human genes 0.000 description 1
- 102100027955 BAG family molecular chaperone regulator 4 Human genes 0.000 description 1
- 102100027360 BAH and coiled-coil domain-containing protein 1 Human genes 0.000 description 1
- 101700002522 BARD1 Proteins 0.000 description 1
- 102100035777 BBSome-interacting protein 1 Human genes 0.000 description 1
- 102100026434 BCAS3 microtubule associated cell migration factor Human genes 0.000 description 1
- 102100021247 BCL-6 corepressor Human genes 0.000 description 1
- 102100021256 BCL-6 corepressor-like protein 1 Human genes 0.000 description 1
- 108091012583 BCL2 Proteins 0.000 description 1
- 102100037135 BCL2/adenovirus E1B 19 kDa protein-interacting protein 2 Human genes 0.000 description 1
- 102100032427 BCLAF1 and THRAP3 family member 3 Human genes 0.000 description 1
- 102000017915 BDKRB2 Human genes 0.000 description 1
- 102100035080 BDNF/NT-3 growth factors receptor Human genes 0.000 description 1
- 102100021621 BEN domain-containing protein 5 Human genes 0.000 description 1
- 102100037546 BEN domain-containing protein 6 Human genes 0.000 description 1
- 102100037541 BEN domain-containing protein 7 Human genes 0.000 description 1
- 102100035901 BICD family-like cargo adapter 1 Human genes 0.000 description 1
- 108091007065 BIRCs Proteins 0.000 description 1
- 102100025143 BLOC-1-related complex subunit 8 Human genes 0.000 description 1
- 102100024507 BMP-2-inducible protein kinase Human genes 0.000 description 1
- 102100025985 BMP/retinoic acid-inducible neural-specific protein 3 Human genes 0.000 description 1
- 102000036365 BRCA1 Human genes 0.000 description 1
- 108700020463 BRCA1 Proteins 0.000 description 1
- 101150072950 BRCA1 gene Proteins 0.000 description 1
- 102100028714 BRCA1-associated ATM activator 1 Human genes 0.000 description 1
- 102100028048 BRCA1-associated RING domain protein 1 Human genes 0.000 description 1
- 102000052609 BRCA2 Human genes 0.000 description 1
- 108700020462 BRCA2 Proteins 0.000 description 1
- 102100035584 BRCA2 and CDKN1A-interacting protein Human genes 0.000 description 1
- 102100027161 BRCA2-interacting transcriptional repressor EMSY Human genes 0.000 description 1
- 102100035755 BRD4-interacting chromatin-remodeling complex-associated protein Human genes 0.000 description 1
- 102100035745 BRD4-interacting chromatin-remodeling complex-associated protein-like Human genes 0.000 description 1
- 102100021745 BRO1 domain-containing protein BROX Human genes 0.000 description 1
- 102100024808 BSD domain-containing protein 1 Human genes 0.000 description 1
- 102100029828 BTB/POZ domain-containing protein 19 Human genes 0.000 description 1
- 102100024272 BTB/POZ domain-containing protein 2 Human genes 0.000 description 1
- 102100024273 BTB/POZ domain-containing protein 3 Human genes 0.000 description 1
- 102100024281 BTB/POZ domain-containing protein 7 Human genes 0.000 description 1
- 102100021746 BTB/POZ domain-containing protein 9 Human genes 0.000 description 1
- 102100022806 BTB/POZ domain-containing protein KCTD14 Human genes 0.000 description 1
- 102100022802 BTB/POZ domain-containing protein KCTD15 Human genes 0.000 description 1
- 102100033155 BTB/POZ domain-containing protein KCTD17 Human genes 0.000 description 1
- 102100033152 BTB/POZ domain-containing protein KCTD20 Human genes 0.000 description 1
- 102100040534 BTB/POZ domain-containing protein KCTD3 Human genes 0.000 description 1
- 102100028299 BTB/POZ domain-containing protein KCTD9 Human genes 0.000 description 1
- 102100027137 BUD13 homolog Human genes 0.000 description 1
- 102100021676 Baculoviral IAP repeat-containing protein 1 Human genes 0.000 description 1
- 102100021663 Baculoviral IAP repeat-containing protein 5 Human genes 0.000 description 1
- 102100027515 Baculoviral IAP repeat-containing protein 6 Human genes 0.000 description 1
- 102100024747 Band 4.1-like protein 1 Human genes 0.000 description 1
- 102100023045 Band 4.1-like protein 2 Human genes 0.000 description 1
- 102100023046 Band 4.1-like protein 3 Human genes 0.000 description 1
- 102100023054 Band 4.1-like protein 4A Human genes 0.000 description 1
- 102100023053 Band 4.1-like protein 5 Human genes 0.000 description 1
- 102100027884 Bardet-Biedl syndrome 4 protein Human genes 0.000 description 1
- 102100027878 Bardet-Biedl syndrome 5 protein Human genes 0.000 description 1
- 102100027880 Basal body-orientation factor 1 Human genes 0.000 description 1
- 102100021950 Basic immunoglobulin-like variable motif-containing protein Human genes 0.000 description 1
- 102100022440 Battenin Human genes 0.000 description 1
- 102100032305 Bcl-2 homologous antagonist/killer Human genes 0.000 description 1
- 108010040168 Bcl-2-Like Protein 11 Proteins 0.000 description 1
- 102000001765 Bcl-2-Like Protein 11 Human genes 0.000 description 1
- 102100032423 Bcl-2-associated transcription factor 1 Human genes 0.000 description 1
- 102100021573 Bcl-2-binding component 3, isoforms 3/4 Human genes 0.000 description 1
- 102100026596 Bcl-2-like protein 1 Human genes 0.000 description 1
- 102100021894 Bcl-2-like protein 12 Human genes 0.000 description 1
- 102100021895 Bcl-2-like protein 13 Human genes 0.000 description 1
- 102100023932 Bcl-2-like protein 2 Human genes 0.000 description 1
- 102100021670 Bcl-2-modifying factor Human genes 0.000 description 1
- 102100022541 Bcl-2-related ovarian killer protein Human genes 0.000 description 1
- 101150008012 Bcl2l1 gene Proteins 0.000 description 1
- 102100021251 Beclin-1 Human genes 0.000 description 1
- 102100025616 Beta-1,3-N-acetylglucosaminyltransferase manic fringe Human genes 0.000 description 1
- 102100039888 Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase Human genes 0.000 description 1
- 102100027934 Beta-1,3-glucosyltransferase Human genes 0.000 description 1
- 102100034732 Beta-1,3-glucuronyltransferase LARGE1 Human genes 0.000 description 1
- 102100031505 Beta-1,4 N-acetylgalactosaminyltransferase 1 Human genes 0.000 description 1
- 102100026340 Beta-1,4-galactosyltransferase 4 Human genes 0.000 description 1
- 102100027387 Beta-1,4-galactosyltransferase 5 Human genes 0.000 description 1
- 102100027386 Beta-1,4-galactosyltransferase 6 Human genes 0.000 description 1
- 102100027321 Beta-1,4-galactosyltransferase 7 Human genes 0.000 description 1
- 102100027314 Beta-2-microglobulin Human genes 0.000 description 1
- 102100021738 Beta-adrenergic receptor kinase 1 Human genes 0.000 description 1
- 102100037281 Beta-adrenergic receptor kinase 2 Human genes 0.000 description 1
- 102100029649 Beta-arrestin-1 Human genes 0.000 description 1
- 102100029648 Beta-arrestin-2 Human genes 0.000 description 1
- 102100031680 Beta-catenin-interacting protein 1 Human genes 0.000 description 1
- 102100031109 Beta-catenin-like protein 1 Human genes 0.000 description 1
- 102100026031 Beta-glucuronidase Human genes 0.000 description 1
- 102100022548 Beta-hexosaminidase subunit alpha Human genes 0.000 description 1
- 102100022549 Beta-hexosaminidase subunit beta Human genes 0.000 description 1
- 102100032487 Beta-mannosidase Human genes 0.000 description 1
- 102100040904 Beta-parvin Human genes 0.000 description 1
- 102100021257 Beta-secretase 1 Human genes 0.000 description 1
- 102100026151 Bifunctional apoptosis regulator Human genes 0.000 description 1
- 102100023960 Bifunctional peptidase and (3S)-lysyl hydroxylase JMJD7 Human genes 0.000 description 1
- 102100037468 Bifunctional peptidase and arginyl-hydroxylase JMJD5 Human genes 0.000 description 1
- 102100035752 Biliverdin reductase A Human genes 0.000 description 1
- 102100033549 Biogenesis of lysosome-related organelles complex 1 subunit 5 Human genes 0.000 description 1
- 102100033565 Biogenesis of lysosome-related organelles complex 1 subunit 6 Human genes 0.000 description 1
- 102100025442 Biorientation of chromosomes in cell division protein 1 Human genes 0.000 description 1
- 102100035754 Biorientation of chromosomes in cell division protein 1-like 1 Human genes 0.000 description 1
- 102100033743 Biotin-[acetyl-CoA-carboxylase] ligase Human genes 0.000 description 1
- 102100026044 Biotinidase Human genes 0.000 description 1
- 102100037674 Bis(5'-adenosyl)-triphosphatase Human genes 0.000 description 1
- 102100036461 Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical] Human genes 0.000 description 1
- 102100027058 Bleomycin hydrolase Human genes 0.000 description 1
- 102100035631 Bloom syndrome protein Human genes 0.000 description 1
- 108091009167 Bloom syndrome protein Proteins 0.000 description 1
- 102100028741 BolA-like protein 1 Human genes 0.000 description 1
- 102100028724 BolA-like protein 3 Human genes 0.000 description 1
- 102100024506 Bone morphogenetic protein 2 Human genes 0.000 description 1
- 102100022544 Bone morphogenetic protein 7 Human genes 0.000 description 1
- 102100027052 Bone morphogenetic protein receptor type-1B Human genes 0.000 description 1
- 102100025422 Bone morphogenetic protein receptor type-2 Human genes 0.000 description 1
- 101001042041 Bos taurus Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial Proteins 0.000 description 1
- 101000741307 Bothrops atrox Batroxicidin Proteins 0.000 description 1
- 101000741308 Bothrops lutzi Lutzicidin Proteins 0.000 description 1
- 102100027951 Brain and acute leukemia cytoplasmic protein Human genes 0.000 description 1
- 102100028265 Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1 Human genes 0.000 description 1
- 102100026437 Branched-chain-amino-acid aminotransferase, cytosolic Human genes 0.000 description 1
- 102100026413 Branched-chain-amino-acid aminotransferase, mitochondrial Human genes 0.000 description 1
- 101150008921 Brca2 gene Proteins 0.000 description 1
- 102100024776 Break repair meiotic recombinase recruitment factor 1 Human genes 0.000 description 1
- 102100028237 Breast cancer anti-estrogen resistance protein 1 Human genes 0.000 description 1
- 102100028253 Breast cancer anti-estrogen resistance protein 3 Human genes 0.000 description 1
- 102100024791 Breast cancer metastasis-suppressor 1-like protein Human genes 0.000 description 1
- 102100026435 Breast carcinoma-amplified sequence 4 Human genes 0.000 description 1
- 102100025994 Brefeldin A-inhibited guanine nucleotide-exchange protein 1 Human genes 0.000 description 1
- 102100028573 Brefeldin A-inhibited guanine nucleotide-exchange protein 2 Human genes 0.000 description 1
- 102100037500 Bridging integrator 3 Human genes 0.000 description 1
- 102100027310 Bromodomain adjacent to zinc finger domain protein 1A Human genes 0.000 description 1
- 102100021576 Bromodomain adjacent to zinc finger domain protein 2A Human genes 0.000 description 1
- 102100021574 Bromodomain adjacent to zinc finger domain protein 2B Human genes 0.000 description 1
- 102100021743 Bromodomain and PHD finger-containing protein 3 Human genes 0.000 description 1
- 102100029892 Bromodomain and WD repeat-containing protein 1 Human genes 0.000 description 1
- 102100029833 Bromodomain and WD repeat-containing protein 3 Human genes 0.000 description 1
- 102100033640 Bromodomain-containing protein 1 Human genes 0.000 description 1
- 102100033642 Bromodomain-containing protein 3 Human genes 0.000 description 1
- 102100029897 Bromodomain-containing protein 7 Human genes 0.000 description 1
- 102100029896 Bromodomain-containing protein 8 Human genes 0.000 description 1
- 102100025441 Brother of CDO Human genes 0.000 description 1
- 102100027157 Butyrophilin subfamily 2 member A1 Human genes 0.000 description 1
- 102100027155 Butyrophilin subfamily 3 member A2 Human genes 0.000 description 1
- 102100027154 Butyrophilin subfamily 3 member A3 Human genes 0.000 description 1
- 102100025374 Butyrophilin-like protein 9 Human genes 0.000 description 1
- 102100025074 C-C chemokine receptor-like 2 Human genes 0.000 description 1
- 102100025903 C-Jun-amino-terminal kinase-interacting protein 3 Human genes 0.000 description 1
- 102100031184 C-Maf-inducing protein Human genes 0.000 description 1
- 102100030630 C-myc promoter-binding protein Human genes 0.000 description 1
- 102100021390 C-terminal-binding protein 1 Human genes 0.000 description 1
- 102100021411 C-terminal-binding protein 2 Human genes 0.000 description 1
- 102100026197 C-type lectin domain family 2 member D Human genes 0.000 description 1
- 102100028667 C-type lectin domain family 4 member A Human genes 0.000 description 1
- 102100040841 C-type lectin domain family 5 member A Human genes 0.000 description 1
- 102100040840 C-type lectin domain family 7 member A Human genes 0.000 description 1
- 102100025351 C-type mannose receptor 2 Human genes 0.000 description 1
- 102100032955 C2 domain-containing protein 3 Human genes 0.000 description 1
- 102100024068 C2 domain-containing protein 5 Human genes 0.000 description 1
- 102100032957 C5a anaphylatoxin chemotactic receptor 1 Human genes 0.000 description 1
- 102000014817 CACNA1A Human genes 0.000 description 1
- 102000014814 CACNA1C Human genes 0.000 description 1
- 102100028737 CAP-Gly domain-containing linker protein 1 Human genes 0.000 description 1
- 102100028743 CAP-Gly domain-containing linker protein 2 Human genes 0.000 description 1
- 102100028738 CAP-Gly domain-containing linker protein 3 Human genes 0.000 description 1
- 102100028742 CAP-Gly domain-containing linker protein 4 Human genes 0.000 description 1
- 102100025752 CASP8 and FADD-like apoptosis regulator Human genes 0.000 description 1
- 102100024080 CASP8-associated protein 2 Human genes 0.000 description 1
- 108010032389 CBFA2T2 myeloid-transforming gene-related protein Proteins 0.000 description 1
- 102100039527 CBP80/20-dependent translation initiation factor Human genes 0.000 description 1
- 102100024936 CBY1-interacting BAR domain-containing protein 1 Human genes 0.000 description 1
- 102100037676 CCAAT/enhancer-binding protein zeta Human genes 0.000 description 1
- 108010014064 CCCTC-Binding Factor Proteins 0.000 description 1
- 102100031024 CCR4-NOT transcription complex subunit 1 Human genes 0.000 description 1
- 102100031023 CCR4-NOT transcription complex subunit 11 Human genes 0.000 description 1
- 102100031025 CCR4-NOT transcription complex subunit 2 Human genes 0.000 description 1
- 102100032981 CCR4-NOT transcription complex subunit 4 Human genes 0.000 description 1
- 102100032976 CCR4-NOT transcription complex subunit 6 Human genes 0.000 description 1
- 102100032986 CCR4-NOT transcription complex subunit 8 Human genes 0.000 description 1
- 102100032982 CCR4-NOT transcription complex subunit 9 Human genes 0.000 description 1
- 102100037917 CD109 antigen Human genes 0.000 description 1
- 108010017009 CD11b Antigen Proteins 0.000 description 1
- 102100035893 CD151 antigen Human genes 0.000 description 1
- 102100024210 CD166 antigen Human genes 0.000 description 1
- 102100027209 CD2-associated protein Human genes 0.000 description 1
- 102100038077 CD226 antigen Human genes 0.000 description 1
- 102100038078 CD276 antigen Human genes 0.000 description 1
- 102100025238 CD302 antigen Human genes 0.000 description 1
- 102100025240 CD320 antigen Human genes 0.000 description 1
- 102000049320 CD36 Human genes 0.000 description 1
- 108010045374 CD36 Antigens Proteins 0.000 description 1
- 101150013553 CD40 gene Proteins 0.000 description 1
- 102100032912 CD44 antigen Human genes 0.000 description 1
- 102100022002 CD59 glycoprotein Human genes 0.000 description 1
- 108010062802 CD66 antigens Proteins 0.000 description 1
- 102100025221 CD70 antigen Human genes 0.000 description 1
- 102100025463 CD99 antigen-like protein 2 Human genes 0.000 description 1
- 102100027201 CDAN1-interacting nuclease 1 Human genes 0.000 description 1
- 101150017278 CDC16 gene Proteins 0.000 description 1
- 101150108242 CDC27 gene Proteins 0.000 description 1
- 102100030154 CDC42 small effector protein 1 Human genes 0.000 description 1
- 102100030155 CDC42 small effector protein 2 Human genes 0.000 description 1
- 102100030933 CDK-activating kinase assembly factor MAT1 Human genes 0.000 description 1
- 102100038451 CDK5 regulatory subunit-associated protein 2 Human genes 0.000 description 1
- 102100029871 CDKN2A-interacting protein Human genes 0.000 description 1
- 108091008064 CDKN2B-AS1 Proteins 0.000 description 1
- 102100027194 CDP-diacylglycerol-inositol 3-phosphatidyltransferase Human genes 0.000 description 1
- 108010066050 CDP-diacylglycerol-inositol 3-phosphatidyltransferase Proteins 0.000 description 1
- 108700015925 CELF1 Proteins 0.000 description 1
- 101150107790 CELF1 gene Proteins 0.000 description 1
- 101710038256 CEP112 Proteins 0.000 description 1
- 101710036791 CEP192 Proteins 0.000 description 1
- 101700004197 CEP68 Proteins 0.000 description 1
- 101710115366 CEP83 Proteins 0.000 description 1
- 101150085314 CERS4 gene Proteins 0.000 description 1
- 101150061077 CERS6 gene Proteins 0.000 description 1
- 101150031621 CGAS gene Proteins 0.000 description 1
- 102100031198 CGG triplet repeat-binding protein 1 Human genes 0.000 description 1
- 102000014572 CHFR Human genes 0.000 description 1
- 102000017926 CHRM2 Human genes 0.000 description 1
- 102100040530 CKLF-like MARVEL transmembrane domain-containing protein 1 Human genes 0.000 description 1
- 102100040527 CKLF-like MARVEL transmembrane domain-containing protein 3 Human genes 0.000 description 1
- 102100040855 CKLF-like MARVEL transmembrane domain-containing protein 7 Human genes 0.000 description 1
- 102100039553 CKLF-like MARVEL transmembrane domain-containing protein 8 Human genes 0.000 description 1
- 102100029395 CLIP-associating protein 2 Human genes 0.000 description 1
- 102100023463 CLK4-associating serine/arginine rich protein Human genes 0.000 description 1
- 102100028637 CLOCK-interacting pacemaker Human genes 0.000 description 1
- 102100029390 CMRF35-like molecule 1 Human genes 0.000 description 1
- 102100025503 CMT1A duplicated region transcript 4 protein Human genes 0.000 description 1
- 102100032932 COBW domain-containing protein 1 Human genes 0.000 description 1
- 102100032933 COBW domain-containing protein 2 Human genes 0.000 description 1
- 102100032906 COBW domain-containing protein 3 Human genes 0.000 description 1
- 102100032907 COBW domain-containing protein 6 Human genes 0.000 description 1
- 108060001826 COP1 Proteins 0.000 description 1
- 102100031629 COP9 signalosome complex subunit 1 Human genes 0.000 description 1
- 102100027648 COP9 signalosome complex subunit 3 Human genes 0.000 description 1
- 102100028245 COP9 signalosome complex subunit 7a Human genes 0.000 description 1
- 102100028244 COP9 signalosome complex subunit 7b Human genes 0.000 description 1
- 102100028879 COP9 signalosome complex subunit 8 Human genes 0.000 description 1
- 102100022210 COX assembly mitochondrial protein 2 homolog Human genes 0.000 description 1
- 102100026625 COX assembly mitochondrial protein homolog Human genes 0.000 description 1
- 101150110330 CRAT gene Proteins 0.000 description 1
- 102000015367 CRBN Human genes 0.000 description 1
- 102100021975 CREB-binding protein Human genes 0.000 description 1
- 102100040775 CREB-regulated transcription coactivator 1 Human genes 0.000 description 1
- 102100040755 CREB-regulated transcription coactivator 3 Human genes 0.000 description 1
- 102100040805 CREB/ATF bZIP transcription factor Human genes 0.000 description 1
- 102100038733 CREB3 regulatory factor Human genes 0.000 description 1
- 102100027674 CTD small phosphatase-like protein Human genes 0.000 description 1
- 102100028011 CTD small phosphatase-like protein 2 Human genes 0.000 description 1
- 102100039914 CTP synthase 2 Human genes 0.000 description 1
- 102100031625 CTTNBP2 N-terminal-like protein Human genes 0.000 description 1
- 102100040785 CUB and sushi domain-containing protein 2 Human genes 0.000 description 1
- 102100021288 CUE domain-containing protein 1 Human genes 0.000 description 1
- 102100033676 CUGBP Elav-like family member 1 Human genes 0.000 description 1
- 102100033210 CUGBP Elav-like family member 2 Human genes 0.000 description 1
- 102100025492 CUGBP Elav-like family member 3 Human genes 0.000 description 1
- 102100032944 CWF19-like protein 1 Human genes 0.000 description 1
- 102100032945 CWF19-like protein 2 Human genes 0.000 description 1
- 102100022443 CXADR-like membrane protein Human genes 0.000 description 1
- 102100036168 CXXC-type zinc finger protein 1 Human genes 0.000 description 1
- 102100026860 CYFIP-related Rac1 interactor A Human genes 0.000 description 1
- 102100026861 CYFIP-related Rac1 interactor B Human genes 0.000 description 1
- 108091007763 CYTOR Proteins 0.000 description 1
- 102100025659 Cadherin EGF LAG seven-pass G-type receptor 1 Human genes 0.000 description 1
- 102100035680 Cadherin EGF LAG seven-pass G-type receptor 2 Human genes 0.000 description 1
- 102100035671 Cadherin EGF LAG seven-pass G-type receptor 3 Human genes 0.000 description 1
- 102100022509 Cadherin-23 Human genes 0.000 description 1
- 102100022508 Cadherin-24 Human genes 0.000 description 1
- 102100039316 Cadherin-like and PC-esterase domain-containing protein 1 Human genes 0.000 description 1
- 101000690445 Caenorhabditis elegans Aryl hydrocarbon receptor nuclear translocator homolog Proteins 0.000 description 1
- 101000928995 Caenorhabditis elegans Putative deoxyribose-phosphate aldolase Proteins 0.000 description 1
- 102100031277 Calcineurin B homologous protein 1 Human genes 0.000 description 1
- 102100024123 Calcineurin-binding protein cabin-1 Human genes 0.000 description 1
- 102100024654 Calcitonin gene-related peptide type 1 receptor Human genes 0.000 description 1
- 102100032220 Calcium and integrin-binding family member 2 Human genes 0.000 description 1
- 102100020720 Calcium channel flower homolog Human genes 0.000 description 1
- 102100038597 Calcium homeostasis modulator protein 2 Human genes 0.000 description 1
- 102100034161 Calcium uniporter protein, mitochondrial Human genes 0.000 description 1
- 102100039372 Calcium uniporter regulatory subunit MCUb, mitochondrial Human genes 0.000 description 1
- 102100025523 Calcium uptake protein 2, mitochondrial Human genes 0.000 description 1
- 102100023073 Calcium-activated potassium channel subunit alpha-1 Human genes 0.000 description 1
- 102100023241 Calcium-activated potassium channel subunit beta-4 Human genes 0.000 description 1
- 102100036362 Calcium-binding and coiled-coil domain-containing protein 1 Human genes 0.000 description 1
- 102100022533 Calcium-binding protein 39 Human genes 0.000 description 1
- 102100021629 Calcium-binding protein 39-like Human genes 0.000 description 1
- 102100025338 Calcium-binding tyrosine phosphorylation-regulated protein Human genes 0.000 description 1
- 102100029801 Calcium-transporting ATPase type 2C member 1 Human genes 0.000 description 1
- 102100021535 Calcium/calmodulin-dependent protein kinase kinase 1 Human genes 0.000 description 1
- 102100021534 Calcium/calmodulin-dependent protein kinase kinase 2 Human genes 0.000 description 1
- 102100033086 Calcium/calmodulin-dependent protein kinase type 1 Human genes 0.000 description 1
- 102100033088 Calcium/calmodulin-dependent protein kinase type 1D Human genes 0.000 description 1
- 102100033093 Calcium/calmodulin-dependent protein kinase type II subunit alpha Human genes 0.000 description 1
- 102100025228 Calcium/calmodulin-dependent protein kinase type II subunit delta Human genes 0.000 description 1
- 102100025227 Calcium/calmodulin-dependent protein kinase type II subunit gamma Human genes 0.000 description 1
- 102100022789 Calcium/calmodulin-dependent protein kinase type IV Human genes 0.000 description 1
- 102100024436 Caldesmon Human genes 0.000 description 1
- 102100026092 Calmegin Human genes 0.000 description 1
- 102100033560 Calmodulin-binding transcription activator 2 Human genes 0.000 description 1
- 102100036338 Calmodulin-like protein 4 Human genes 0.000 description 1
- 102100031185 Calmodulin-lysine N-methyltransferase Human genes 0.000 description 1
- 102100025593 Calmodulin-regulated spectrin-associated protein 2 Human genes 0.000 description 1
- 102100038612 Calmodulin-regulated spectrin-associated protein 3 Human genes 0.000 description 1
- 102100025172 Calpain-1 catalytic subunit Human genes 0.000 description 1
- 102100025465 Calpain-10 Human genes 0.000 description 1
- 102100025168 Calpain-15 Human genes 0.000 description 1
- 102100030010 Calpain-7 Human genes 0.000 description 1
- 102100028801 Calsyntenin-1 Human genes 0.000 description 1
- 102100028802 Calsyntenin-3 Human genes 0.000 description 1
- 102100029226 Cancer-related nucleoside-triphosphatase Human genes 0.000 description 1
- 101000841393 Candida albicans Probable NADPH dehydrogenase Proteins 0.000 description 1
- 102100038712 Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1 Human genes 0.000 description 1
- 102100038716 Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2 Human genes 0.000 description 1
- 102100029876 Capping protein, Arp2/3 and myosin-I linker protein 2 Human genes 0.000 description 1
- 102100038710 Capping protein-inhibiting regulator of actin dynamics Human genes 0.000 description 1
- 102100032581 Caprin-2 Human genes 0.000 description 1
- 102100032145 Carbohydrate sulfotransferase 10 Human genes 0.000 description 1
- 102100032144 Carbohydrate sulfotransferase 9 Human genes 0.000 description 1
- 102100037403 Carbohydrate-responsive element-binding protein Human genes 0.000 description 1
- 102100027667 Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2 Human genes 0.000 description 1
- 102100038930 Carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein Human genes 0.000 description 1
- 102100036808 Carboxylesterase 3 Human genes 0.000 description 1
- 102100036807 Carboxylesterase 4A Human genes 0.000 description 1
- 102100035023 Carboxypeptidase B2 Human genes 0.000 description 1
- 102100026679 Carboxypeptidase Q Human genes 0.000 description 1
- 102100024533 Carcinoembryonic antigen-related cell adhesion molecule 1 Human genes 0.000 description 1
- 102100024531 Carcinoembryonic antigen-related cell adhesion molecule 21 Human genes 0.000 description 1
- 102100021753 Cardiolipin synthase (CMP-forming) Human genes 0.000 description 1
- 102100036357 Carnitine O-acetyltransferase Human genes 0.000 description 1
- 102100027946 Carnitine O-palmitoyltransferase 1, brain isoform Human genes 0.000 description 1
- 102100027943 Carnitine O-palmitoyltransferase 1, liver isoform Human genes 0.000 description 1
- 102100024853 Carnitine O-palmitoyltransferase 2, mitochondrial Human genes 0.000 description 1
- 102100032203 Carnosine synthase 1 Human genes 0.000 description 1
- 102100026619 Cartilage intermediate layer protein 2 Human genes 0.000 description 1
- 102100037402 Casein kinase I isoform delta Human genes 0.000 description 1
- 102100037397 Casein kinase I isoform gamma-1 Human genes 0.000 description 1
- 102100023067 Casein kinase I isoform gamma-3 Human genes 0.000 description 1
- 102100034663 Caseinolytic peptidase B protein homolog Human genes 0.000 description 1
- 102100027996 Caskin-1 Human genes 0.000 description 1
- 108090000397 Caspase 3 Proteins 0.000 description 1
- 102100024246 Caspase activity and apoptosis inhibitor 1 Human genes 0.000 description 1
- 102100024965 Caspase recruitment domain-containing protein 11 Human genes 0.000 description 1
- 102100025634 Caspase recruitment domain-containing protein 16 Human genes 0.000 description 1
- 102100025606 Caspase recruitment domain-containing protein 19 Human genes 0.000 description 1
- 102100024955 Caspase recruitment domain-containing protein 6 Human genes 0.000 description 1
- 102100024974 Caspase recruitment domain-containing protein 8 Human genes 0.000 description 1
- 102100035904 Caspase-1 Human genes 0.000 description 1
- 102100026549 Caspase-10 Human genes 0.000 description 1
- 102100032616 Caspase-2 Human genes 0.000 description 1
- 102100029855 Caspase-3 Human genes 0.000 description 1
- 102100038902 Caspase-7 Human genes 0.000 description 1
- 102100026548 Caspase-8 Human genes 0.000 description 1
- 102100026550 Caspase-9 Human genes 0.000 description 1
- 102100035370 Cat eye syndrome critical region protein 2 Human genes 0.000 description 1
- 102100033621 Catechol O-methyltransferase domain-containing protein 1 Human genes 0.000 description 1
- 102100028002 Catenin alpha-2 Human genes 0.000 description 1
- 102100028906 Catenin delta-1 Human genes 0.000 description 1
- 102100025953 Cathepsin F Human genes 0.000 description 1
- 102100030245 Cation channel sperm-associated auxiliary subunit zeta Human genes 0.000 description 1
- 102100028004 Cation channel sperm-associated protein 1 Human genes 0.000 description 1
- 102100028061 Cation channel sperm-associated protein 3 Human genes 0.000 description 1
- 102100024911 Caveolae-associated protein 4 Human genes 0.000 description 1
- 102100021956 Caytaxin Human genes 0.000 description 1
- ZEOWTGPWHLSLOG-UHFFFAOYSA-N Cc1ccc(cc1-c1ccc2c(n[nH]c2c1)-c1cnn(c1)C1CC1)C(=O)Nc1cccc(c1)C(F)(F)F Chemical compound Cc1ccc(cc1-c1ccc2c(n[nH]c2c1)-c1cnn(c1)C1CC1)C(=O)Nc1cccc(c1)C(F)(F)F ZEOWTGPWHLSLOG-UHFFFAOYSA-N 0.000 description 1
- 102000011068 Cdc42 Human genes 0.000 description 1
- 108091007854 Cdh1/Fizzy-related Proteins 0.000 description 1
- 102000038594 Cdh1/Fizzy-related Human genes 0.000 description 1
- 102100024646 Cell adhesion molecule 2 Human genes 0.000 description 1
- 102100024045 Cell adhesion molecule 4 Human genes 0.000 description 1
- 102100031667 Cell adhesion molecule-related/down-regulated by oncogenes Human genes 0.000 description 1
- 102100036568 Cell cycle and apoptosis regulator protein 2 Human genes 0.000 description 1
- 102100026866 Cell cycle regulator of non-homologous end joining Human genes 0.000 description 1
- 102100027835 Cell death regulator Aven Human genes 0.000 description 1
- 102100025053 Cell division control protein 45 homolog Human genes 0.000 description 1
- 102100027047 Cell division control protein 6 homolog Human genes 0.000 description 1
- 102100032860 Cell division cycle 5-like protein Human genes 0.000 description 1
- 102100034744 Cell division cycle 7-related protein kinase Human genes 0.000 description 1
- 102100036569 Cell division cycle and apoptosis regulator protein 1 Human genes 0.000 description 1
- 102100022006 Cell division cycle protein 123 homolog Human genes 0.000 description 1
- 102100031584 Cell division cycle-associated 7-like protein Human genes 0.000 description 1
- 102100024479 Cell division cycle-associated protein 3 Human genes 0.000 description 1
- 102100024482 Cell division cycle-associated protein 4 Human genes 0.000 description 1
- 102100024485 Cell division cycle-associated protein 7 Human genes 0.000 description 1
- 102100024852 Cell growth regulator with RING finger domain protein 1 Human genes 0.000 description 1
- 102100023473 Cell growth-regulating nucleolar protein Human genes 0.000 description 1
- 102100023126 Cell surface glycoprotein MUC18 Human genes 0.000 description 1
- 108010091675 Cellular Apoptosis Susceptibility Protein Proteins 0.000 description 1
- 102100031608 Centlein Human genes 0.000 description 1
- 102100027426 Centriolar coiled-coil protein of 110 kDa Human genes 0.000 description 1
- 102100031456 Centriolin Human genes 0.000 description 1
- 102000011682 Centromere Protein A Human genes 0.000 description 1
- 108010076303 Centromere Protein A Proteins 0.000 description 1
- 102100025828 Centromere protein C Human genes 0.000 description 1
- 102100023443 Centromere protein H Human genes 0.000 description 1
- 102100023343 Centromere protein I Human genes 0.000 description 1
- 102100023444 Centromere protein K Human genes 0.000 description 1
- 102100035375 Centromere protein L Human genes 0.000 description 1
- 102100035366 Centromere protein M Human genes 0.000 description 1
- 102100031214 Centromere protein N Human genes 0.000 description 1
- 102100031221 Centromere protein O Human genes 0.000 description 1
- 102100031222 Centromere protein P Human genes 0.000 description 1
- 102100038125 Centromere protein Q Human genes 0.000 description 1
- 102100038122 Centromere protein R Human genes 0.000 description 1
- 102100038117 Centromere protein S Human genes 0.000 description 1
- 102100037622 Centromere protein T Human genes 0.000 description 1
- 102100037635 Centromere protein U Human genes 0.000 description 1
- 102100037623 Centromere protein V Human genes 0.000 description 1
- 102100033674 Centromere protein X Human genes 0.000 description 1
- 102100025832 Centromere-associated protein E Human genes 0.000 description 1
- 102100032551 Centrosomal AT-AC splicing factor Human genes 0.000 description 1
- 102100034793 Centrosomal protein 20 Human genes 0.000 description 1
- 102100031203 Centrosomal protein 43 Human genes 0.000 description 1
- 102100035165 Centrosomal protein CCDC61 Human genes 0.000 description 1
- 102100035365 Centrosomal protein CEP57L1 Human genes 0.000 description 1
- 101710195848 Centrosomal protein CEP57L1 Proteins 0.000 description 1
- 102100034888 Centrosomal protein kizuna Human genes 0.000 description 1
- 102100033158 Centrosomal protein of 104 kDa Human genes 0.000 description 1
- 101710101016 Centrosomal protein of 104 kDa Proteins 0.000 description 1
- 102100033129 Centrosomal protein of 112 kDa Human genes 0.000 description 1
- 102100023308 Centrosomal protein of 126 kDa Human genes 0.000 description 1
- 102100023310 Centrosomal protein of 128 kDa Human genes 0.000 description 1
- 101710170458 Centrosomal protein of 128 kDa Proteins 0.000 description 1
- 102100038737 Centrosomal protein of 131 kDa Human genes 0.000 description 1
- 102100038741 Centrosomal protein of 135 kDa Human genes 0.000 description 1
- 101710117958 Centrosomal protein of 135 kDa Proteins 0.000 description 1
- 102100023255 Centrosomal protein of 162 kDa Human genes 0.000 description 1
- 101710087485 Centrosomal protein of 162 kDa Proteins 0.000 description 1
- 102100036180 Centrosomal protein of 164 kDa Human genes 0.000 description 1
- 101710131445 Centrosomal protein of 164 kDa Proteins 0.000 description 1
- 102100036179 Centrosomal protein of 170 kDa Human genes 0.000 description 1
- 101710142011 Centrosomal protein of 170 kDa Proteins 0.000 description 1
- 102100036178 Centrosomal protein of 192 kDa Human genes 0.000 description 1
- 102100035673 Centrosomal protein of 290 kDa Human genes 0.000 description 1
- 101710198317 Centrosomal protein of 290 kDa Proteins 0.000 description 1
- 102100035672 Centrosomal protein of 295 kDa Human genes 0.000 description 1
- 102100024503 Centrosomal protein of 41 kDa Human genes 0.000 description 1
- 101710193262 Centrosomal protein of 41 kDa Proteins 0.000 description 1
- 102100031220 Centrosomal protein of 44 kDa Human genes 0.000 description 1
- 101710118432 Centrosomal protein of 44 kDa Proteins 0.000 description 1
- 102100031219 Centrosomal protein of 55 kDa Human genes 0.000 description 1
- 101710092479 Centrosomal protein of 55 kDa Proteins 0.000 description 1
- 102100031213 Centrosomal protein of 57 kDa Human genes 0.000 description 1
- 101710147964 Centrosomal protein of 57 kDa Proteins 0.000 description 1
- 102100033671 Centrosomal protein of 63 kDa Human genes 0.000 description 1
- 101710120612 Centrosomal protein of 63 kDa Proteins 0.000 description 1
- 102100033228 Centrosomal protein of 68 kDa Human genes 0.000 description 1
- 102100033229 Centrosomal protein of 70 kDa Human genes 0.000 description 1
- 101710121715 Centrosomal protein of 70 kDa Proteins 0.000 description 1
- 102100033187 Centrosomal protein of 72 kDa Human genes 0.000 description 1
- 101710202346 Centrosomal protein of 72 kDa Proteins 0.000 description 1
- 102100034790 Centrosomal protein of 76 kDa Human genes 0.000 description 1
- 101710184857 Centrosomal protein of 76 kDa Proteins 0.000 description 1
- 102100034791 Centrosomal protein of 78 kDa Human genes 0.000 description 1
- 101710117840 Centrosomal protein of 78 kDa Proteins 0.000 description 1
- 102100034754 Centrosomal protein of 83 kDa Human genes 0.000 description 1
- 102100034755 Centrosomal protein of 85 kDa Human genes 0.000 description 1
- 102100035444 Centrosomal protein of 85 kDa-like Human genes 0.000 description 1
- 108050004729 Centrosomal protein of 85kDa Proteins 0.000 description 1
- 102100034794 Centrosomal protein of 89 kDa Human genes 0.000 description 1
- 101710192994 Centrosomal protein of 89 kDa Proteins 0.000 description 1
- 102100034753 Centrosomal protein of 95 kDa Human genes 0.000 description 1
- 101710155447 Centrosomal protein of 95 kDa Proteins 0.000 description 1
- 102100025829 Centrosomal protein of 97 kDa Human genes 0.000 description 1
- 101710147144 Centrosomal protein of 97 kDa Proteins 0.000 description 1
- 102100028776 Centrosome and spindle pole-associated protein 1 Human genes 0.000 description 1
- 102100039219 Centrosome-associated protein CEP250 Human genes 0.000 description 1
- 101710110151 Centrosome-associated protein CEP250 Proteins 0.000 description 1
- 102100035418 Ceramide synthase 4 Human genes 0.000 description 1
- 102100035417 Ceramide synthase 5 Human genes 0.000 description 1
- 102100035434 Ceramide synthase 6 Human genes 0.000 description 1
- 102100035437 Ceramide transfer protein Human genes 0.000 description 1
- 102100035361 Cerebellar degeneration-related protein 2 Human genes 0.000 description 1
- 102100035197 Cerebral cavernous malformations 2 protein Human genes 0.000 description 1
- 102100034505 Ceroid-lipofuscinosis neuronal protein 5 Human genes 0.000 description 1
- 102100034480 Ceroid-lipofuscinosis neuronal protein 6 Human genes 0.000 description 1
- 101150004299 Cers5 gene Proteins 0.000 description 1
- 102100032402 Charged multivesicular body protein 1a Human genes 0.000 description 1
- 102100029295 Charged multivesicular body protein 3 Human genes 0.000 description 1
- 102100037828 Charged multivesicular body protein 7 Human genes 0.000 description 1
- 101710153987 Charged multivesicular body protein 7 Proteins 0.000 description 1
- 102100031011 Chemerin-like receptor 1 Human genes 0.000 description 1
- 102100025942 Chemokine-like protein TAFA-5 Human genes 0.000 description 1
- 102100030298 Chitinase domain-containing protein 1 Human genes 0.000 description 1
- 108010066813 Chitinase-3-Like Protein 1 Proteins 0.000 description 1
- 102100038196 Chitinase-3-like protein 1 Human genes 0.000 description 1
- 102100040428 Chitobiosyldiphosphodolichol beta-mannosyltransferase Human genes 0.000 description 1
- 241000839426 Chlamydia virus Chp1 Species 0.000 description 1
- 102100029397 Chloride channel CLIC-like protein 1 Human genes 0.000 description 1
- 102100023509 Chloride channel protein 2 Human genes 0.000 description 1
- 102100031065 Choline kinase alpha Human genes 0.000 description 1
- 102100025708 Choline/ethanolaminephosphotransferase 1 Human genes 0.000 description 1
- 102100032404 Cholinesterase Human genes 0.000 description 1
- 102100031263 Chondroitin sulfate N-acetylgalactosaminyltransferase 2 Human genes 0.000 description 1
- 102100029296 Chondroitin sulfate glucuronyltransferase Human genes 0.000 description 1
- 102100029318 Chondroitin sulfate synthase 1 Human genes 0.000 description 1
- 102100039361 Chondrosarcoma-associated gene 2/3 protein Human genes 0.000 description 1
- 102100032405 Chromatin accessibility complex protein 1 Human genes 0.000 description 1
- 102100038602 Chromatin assembly factor 1 subunit A Human genes 0.000 description 1
- 102100021585 Chromatin assembly factor 1 subunit B Human genes 0.000 description 1
- 102100037146 Chromatin complexes subunit BAP18 Human genes 0.000 description 1
- 102100040509 Chromatin modification-related protein MEAF6 Human genes 0.000 description 1
- 102100036956 Chromatin target of PRMT1 protein Human genes 0.000 description 1
- 102100032920 Chromobox protein homolog 2 Human genes 0.000 description 1
- 102100032918 Chromobox protein homolog 5 Human genes 0.000 description 1
- 102100031668 Chromodomain Y-like protein Human genes 0.000 description 1
- 102100031235 Chromodomain-helicase-DNA-binding protein 1 Human genes 0.000 description 1
- 102100031239 Chromodomain-helicase-DNA-binding protein 1-like Human genes 0.000 description 1
- 102100031265 Chromodomain-helicase-DNA-binding protein 2 Human genes 0.000 description 1
- 102100031266 Chromodomain-helicase-DNA-binding protein 3 Human genes 0.000 description 1
- 102100038214 Chromodomain-helicase-DNA-binding protein 4 Human genes 0.000 description 1
- 102100038220 Chromodomain-helicase-DNA-binding protein 6 Human genes 0.000 description 1
- 102100038165 Chromodomain-helicase-DNA-binding protein 8 Human genes 0.000 description 1
- 102100038164 Chromodomain-helicase-DNA-binding protein 9 Human genes 0.000 description 1
- 102100025590 Chromosome transmission fidelity protein 8 homolog Human genes 0.000 description 1
- 102100020736 Chromosome-associated kinesin KIF4A Human genes 0.000 description 1
- 102100025762 Cilia- and flagella-associated protein 119 Human genes 0.000 description 1
- 102100034628 Cilia- and flagella-associated protein 206 Human genes 0.000 description 1
- 102100024291 Cilia- and flagella-associated protein 298 Human genes 0.000 description 1
- 102100024293 Cilia- and flagella-associated protein 299 Human genes 0.000 description 1
- 102100024298 Cilia- and flagella-associated protein 300 Human genes 0.000 description 1
- 102100023329 Cilia- and flagella-associated protein 36 Human genes 0.000 description 1
- 102100034761 Cilia- and flagella-associated protein 418 Human genes 0.000 description 1
- 102100023327 Cilia- and flagella-associated protein 44 Human genes 0.000 description 1
- 102100033685 Cilia- and flagella-associated protein 58 Human genes 0.000 description 1
- 102100031615 Ciliary neurotrophic factor receptor subunit alpha Human genes 0.000 description 1
- 102100026328 Ciliogenesis and planar polarity effector 1 Human genes 0.000 description 1
- 102100033361 Cilium assembly protein DZIP1 Human genes 0.000 description 1
- 102100032247 Cilium assembly protein DZIP1L Human genes 0.000 description 1
- 102100034497 Cip1-interacting zinc finger protein Human genes 0.000 description 1
- 102100032392 Circadian-associated transcriptional repressor Human genes 0.000 description 1
- 101710082464 Cis-aconitate decarboxylase Proteins 0.000 description 1
- 102100040484 Claspin Human genes 0.000 description 1
- 102100034665 Clathrin heavy chain 2 Human genes 0.000 description 1
- 102100034666 Clathrin heavy chain linker domain-containing protein 1 Human genes 0.000 description 1
- 102100036444 Clathrin interactor 1 Human genes 0.000 description 1
- 102100034467 Clathrin light chain A Human genes 0.000 description 1
- 102100026099 Claudin domain-containing protein 1 Human genes 0.000 description 1
- 102100039518 Claudin-12 Human genes 0.000 description 1
- 102100038641 Cleavage and polyadenylation specificity factor subunit 1 Human genes 0.000 description 1
- 102100038642 Cleavage and polyadenylation specificity factor subunit 2 Human genes 0.000 description 1
- 102100030953 Cleavage and polyadenylation specificity factor subunit 4 Human genes 0.000 description 1
- 102100026529 Cleavage and polyadenylation specificity factor subunit 6 Human genes 0.000 description 1
- 102100026421 Cleavage and polyadenylation specificity factor subunit 7 Human genes 0.000 description 1
- 102100040269 Cleavage stimulation factor subunit 2 Human genes 0.000 description 1
- 102100040267 Cleavage stimulation factor subunit 3 Human genes 0.000 description 1
- 102100033538 Clusterin-associated protein 1 Human genes 0.000 description 1
- 102100022589 Coatomer subunit beta' Human genes 0.000 description 1
- 102100028289 Coatomer subunit delta Human genes 0.000 description 1
- 102100037290 Coatomer subunit gamma-1 Human genes 0.000 description 1
- 102100024253 Coatomer subunit zeta-2 Human genes 0.000 description 1
- 102100021864 Cocaine esterase Human genes 0.000 description 1
- 102100040996 Cochlin Human genes 0.000 description 1
- 102100024079 Coiled-coil and C2 domain-containing protein 2A Human genes 0.000 description 1
- 102100038941 Coiled-coil domain-containing protein 102B Human genes 0.000 description 1
- 102100032376 Coiled-coil domain-containing protein 106 Human genes 0.000 description 1
- 102100032369 Coiled-coil domain-containing protein 112 Human genes 0.000 description 1
- 102100023661 Coiled-coil domain-containing protein 115 Human genes 0.000 description 1
- 102100030444 Coiled-coil domain-containing protein 125 Human genes 0.000 description 1
- 102100030615 Coiled-coil domain-containing protein 126 Human genes 0.000 description 1
- 102100030503 Coiled-coil domain-containing protein 127 Human genes 0.000 description 1
- 102100030502 Coiled-coil domain-containing protein 134 Human genes 0.000 description 1
- 102100035217 Coiled-coil domain-containing protein 136 Human genes 0.000 description 1
- 102100035232 Coiled-coil domain-containing protein 137 Human genes 0.000 description 1
- 102100035231 Coiled-coil domain-containing protein 138 Human genes 0.000 description 1
- 102100031045 Coiled-coil domain-containing protein 14 Human genes 0.000 description 1
- 102100025737 Coiled-coil domain-containing protein 149 Human genes 0.000 description 1
- 102100025819 Coiled-coil domain-containing protein 150 Human genes 0.000 description 1
- 102100025816 Coiled-coil domain-containing protein 152 Human genes 0.000 description 1
- 102100034965 Coiled-coil domain-containing protein 159 Human genes 0.000 description 1
- 102100034946 Coiled-coil domain-containing protein 169 Human genes 0.000 description 1
- 102100036571 Coiled-coil domain-containing protein 171 Human genes 0.000 description 1
- 102100031087 Coiled-coil domain-containing protein 18 Human genes 0.000 description 1
- 102100030507 Coiled-coil domain-containing protein 181 Human genes 0.000 description 1
- 102100030518 Coiled-coil domain-containing protein 183 Human genes 0.000 description 1
- 102100023674 Coiled-coil domain-containing protein 186 Human genes 0.000 description 1
- 102100023675 Coiled-coil domain-containing protein 188 Human genes 0.000 description 1
- 102100023670 Coiled-coil domain-containing protein 191 Human genes 0.000 description 1
- 102100023755 Coiled-coil domain-containing protein 192 Human genes 0.000 description 1
- 102100032390 Coiled-coil domain-containing protein 25 Human genes 0.000 description 1
- 102100021982 Coiled-coil domain-containing protein 28B Human genes 0.000 description 1
- 102100021965 Coiled-coil domain-containing protein 32 Human genes 0.000 description 1
- 102100036616 Coiled-coil domain-containing protein 40 Human genes 0.000 description 1
- 102100024137 Coiled-coil domain-containing protein 43 Human genes 0.000 description 1
- 102100035163 Coiled-coil domain-containing protein 57 Human genes 0.000 description 1
- 102100034952 Coiled-coil domain-containing protein 66 Human genes 0.000 description 1
- 102100031049 Coiled-coil domain-containing protein 7 Human genes 0.000 description 1
- 102100026766 Coiled-coil domain-containing protein 74B Human genes 0.000 description 1
- 102100023717 Coiled-coil domain-containing protein 77 Human genes 0.000 description 1
- 102100023716 Coiled-coil domain-containing protein 78 Human genes 0.000 description 1
- 102100025823 Coiled-coil domain-containing protein 82 Human genes 0.000 description 1
- 102100026782 Coiled-coil domain-containing protein 85A Human genes 0.000 description 1
- 102100032374 Coiled-coil domain-containing protein 85C Human genes 0.000 description 1
- 102100031088 Coiled-coil domain-containing protein 9 Human genes 0.000 description 1
- 102100032371 Coiled-coil domain-containing protein 90B, mitochondrial Human genes 0.000 description 1
- 102100032351 Coiled-coil domain-containing protein 91 Human genes 0.000 description 1
- 102100032355 Coiled-coil domain-containing protein 92 Human genes 0.000 description 1
- 102100032348 Coiled-coil domain-containing protein 93 Human genes 0.000 description 1
- 102100023691 Coiled-coil-helix-coiled-coil-helix domain-containing protein 5 Human genes 0.000 description 1
- 102100031634 Cold shock domain-containing protein E1 Human genes 0.000 description 1
- 102100022145 Collagen alpha-1(IV) chain Human genes 0.000 description 1
- 102100040993 Collagen alpha-1(XIII) chain Human genes 0.000 description 1
- 102100030781 Collagen alpha-1(XXIII) chain Human genes 0.000 description 1
- 102100037285 Collagen alpha-1(XXIV) chain Human genes 0.000 description 1
- 102100031576 Collagen alpha-1(XXV) chain Human genes 0.000 description 1
- 102100028284 Collagen alpha-1(XXVI) chain Human genes 0.000 description 1
- 102100031544 Collagen alpha-1(XXVII) chain Human genes 0.000 description 1
- 102100031518 Collagen alpha-2(VI) chain Human genes 0.000 description 1
- 102100030977 Collagen alpha-3(IX) chain Human genes 0.000 description 1
- 102100024338 Collagen alpha-3(VI) chain Human genes 0.000 description 1
- 102100033775 Collagen alpha-5(IV) chain Human genes 0.000 description 1
- 102100033773 Collagen alpha-6(IV) chain Human genes 0.000 description 1
- 102100025880 Complement C1q tumor necrosis factor-related protein 2 Human genes 0.000 description 1
- 102100030137 Complement C1q tumor necrosis factor-related protein 6 Human genes 0.000 description 1
- 102100025680 Complement decay-accelerating factor Human genes 0.000 description 1
- 102100038256 Complex I intermediate-associated protein 30, mitochondrial Human genes 0.000 description 1
- 102100025150 Complex III assembly factor LYRM7 Human genes 0.000 description 1
- 102100032952 Condensin complex subunit 3 Human genes 0.000 description 1
- 102100032978 Condensin-2 complex subunit D3 Human genes 0.000 description 1
- 102100032980 Condensin-2 complex subunit G2 Human genes 0.000 description 1
- 102100040453 Connector enhancer of kinase suppressor of ras 2 Human genes 0.000 description 1
- 102100030794 Conserved oligomeric Golgi complex subunit 1 Human genes 0.000 description 1
- 102100030797 Conserved oligomeric Golgi complex subunit 2 Human genes 0.000 description 1
- 102100029265 Conserved oligomeric Golgi complex subunit 3 Human genes 0.000 description 1
- 102100036044 Conserved oligomeric Golgi complex subunit 4 Human genes 0.000 description 1
- 102100036030 Conserved oligomeric Golgi complex subunit 5 Human genes 0.000 description 1
- 102100040998 Conserved oligomeric Golgi complex subunit 6 Human genes 0.000 description 1
- 102100029158 Consortin Human genes 0.000 description 1
- 102100023768 Constitutive coactivator of PPAR-gamma-like protein 1 Human genes 0.000 description 1
- 102100039201 Constitutive coactivator of peroxisome proliferator-activated receptor gamma Human genes 0.000 description 1
- 102100024326 Contactin-1 Human genes 0.000 description 1
- 102100024325 Contactin-3 Human genes 0.000 description 1
- 102100024340 Contactin-4 Human genes 0.000 description 1
- 102100040501 Contactin-associated protein 1 Human genes 0.000 description 1
- 102100040498 Contactin-associated protein-like 3 Human genes 0.000 description 1
- 102100041019 Coordinator of PRMT5 and differentiation stimulator Human genes 0.000 description 1
- 102100032636 Copine-1 Human genes 0.000 description 1
- 102100032644 Copine-2 Human genes 0.000 description 1
- 102100032648 Copine-3 Human genes 0.000 description 1
- 102100032643 Copine-5 Human genes 0.000 description 1
- 102100029386 Copine-7 Human genes 0.000 description 1
- 102100031397 Copper homeostasis protein cutC homolog Human genes 0.000 description 1
- 108010022637 Copper-Transporting ATPases Proteins 0.000 description 1
- 102100027587 Copper-transporting ATPase 1 Human genes 0.000 description 1
- 102100027591 Copper-transporting ATPase 2 Human genes 0.000 description 1
- 102100029653 Cordon-bleu protein-like 1 Human genes 0.000 description 1
- 108010060313 Core Binding Factor beta Subunit Proteins 0.000 description 1
- 102000008147 Core Binding Factor beta Subunit Human genes 0.000 description 1
- 102100023778 Corepressor interacting with RBPJ 1 Human genes 0.000 description 1
- 102100041025 Coronin-1B Human genes 0.000 description 1
- 102100038812 Coronin-7 Human genes 0.000 description 1
- 102100023376 Corrinoid adenosyltransferase Human genes 0.000 description 1
- 102100022615 Cotranscriptional regulator FAM172A Human genes 0.000 description 1
- 102100025278 Coxsackievirus and adenovirus receptor Human genes 0.000 description 1
- 102100033283 Creatine kinase U-type, mitochondrial Human genes 0.000 description 1
- 108010031504 Crk Associated Substrate Protein Proteins 0.000 description 1
- 101000741306 Crotalus durissus cascavella Cathelicidin-related peptide isoform 3 Proteins 0.000 description 1
- 101000741303 Crotalus durissus terrificus Crotalicidin Proteins 0.000 description 1
- 102100031096 Cubilin Human genes 0.000 description 1
- 102100039195 Cullin-1 Human genes 0.000 description 1
- 102100028908 Cullin-3 Human genes 0.000 description 1
- 102100028901 Cullin-4B Human genes 0.000 description 1
- 102100025525 Cullin-5 Human genes 0.000 description 1
- 102100025522 Cullin-7 Human genes 0.000 description 1
- 102100025524 Cullin-9 Human genes 0.000 description 1
- 102100034275 Cx9C motif-containing protein 4 Human genes 0.000 description 1
- 102100023033 Cyclic AMP-dependent transcription factor ATF-2 Human genes 0.000 description 1
- 102100023583 Cyclic AMP-dependent transcription factor ATF-6 alpha Human genes 0.000 description 1
- 102100023578 Cyclic AMP-dependent transcription factor ATF-7 Human genes 0.000 description 1
- 102100026359 Cyclic AMP-responsive element-binding protein 1 Human genes 0.000 description 1
- 102100021307 Cyclic AMP-responsive element-binding protein 3-like protein 4 Human genes 0.000 description 1
- 102100027309 Cyclic AMP-responsive element-binding protein 5 Human genes 0.000 description 1
- 102100031256 Cyclic GMP-AMP synthase Human genes 0.000 description 1
- 102100021430 Cyclic pyranopterin monophosphate synthase Human genes 0.000 description 1
- 102100024170 Cyclin-C Human genes 0.000 description 1
- 102100035373 Cyclin-D-binding Myb-like transcription factor 1 Human genes 0.000 description 1
- 102100021934 Cyclin-D1-binding protein 1 Human genes 0.000 description 1
- 108010024986 Cyclin-Dependent Kinase 2 Proteins 0.000 description 1
- 108010025454 Cyclin-Dependent Kinase 5 Proteins 0.000 description 1
- 108010025468 Cyclin-Dependent Kinase 6 Proteins 0.000 description 1
- 102100038254 Cyclin-F Human genes 0.000 description 1
- 102100039683 Cyclin-G-associated kinase Human genes 0.000 description 1
- 102100036873 Cyclin-I Human genes 0.000 description 1
- 102100036871 Cyclin-J Human genes 0.000 description 1
- 102100036872 Cyclin-J-like protein Human genes 0.000 description 1
- 102100036876 Cyclin-K Human genes 0.000 description 1
- 102100021899 Cyclin-L2 Human genes 0.000 description 1
- 102100021898 Cyclin-Q Human genes 0.000 description 1
- 102100024109 Cyclin-T1 Human genes 0.000 description 1
- 102100024112 Cyclin-T2 Human genes 0.000 description 1
- 102100036273 Cyclin-Y-like protein 1 Human genes 0.000 description 1
- 102100036272 Cyclin-Y-like protein 2 Human genes 0.000 description 1
- 102100023263 Cyclin-dependent kinase 10 Human genes 0.000 description 1
- 102100037912 Cyclin-dependent kinase 11A Human genes 0.000 description 1
- 102100037916 Cyclin-dependent kinase 11B Human genes 0.000 description 1
- 102100038113 Cyclin-dependent kinase 14 Human genes 0.000 description 1
- 102100033250 Cyclin-dependent kinase 15 Human genes 0.000 description 1
- 102100033245 Cyclin-dependent kinase 16 Human genes 0.000 description 1
- 102100033145 Cyclin-dependent kinase 19 Human genes 0.000 description 1
- 102100036239 Cyclin-dependent kinase 2 Human genes 0.000 description 1
- 102100035353 Cyclin-dependent kinase 2-associated protein 1 Human genes 0.000 description 1
- 102100036988 Cyclin-dependent kinase 2-interacting protein Human genes 0.000 description 1
- 102100034741 Cyclin-dependent kinase 20 Human genes 0.000 description 1
- 102100036329 Cyclin-dependent kinase 3 Human genes 0.000 description 1
- 102100026804 Cyclin-dependent kinase 6 Human genes 0.000 description 1
- 102100026810 Cyclin-dependent kinase 7 Human genes 0.000 description 1
- 102100024456 Cyclin-dependent kinase 8 Human genes 0.000 description 1
- 102100031684 Cyclin-dependent kinase-like 3 Human genes 0.000 description 1
- 102100026805 Cyclin-dependent-like kinase 5 Human genes 0.000 description 1
- SXVPOSFURRDKBO-UHFFFAOYSA-N Cyclododecanone Chemical compound O=C1CCCCCCCCCCC1 SXVPOSFURRDKBO-UHFFFAOYSA-N 0.000 description 1
- 101710095827 Cyclopropane mycolic acid synthase 1 Proteins 0.000 description 1
- 101710095826 Cyclopropane mycolic acid synthase 2 Proteins 0.000 description 1
- 101710095828 Cyclopropane mycolic acid synthase 3 Proteins 0.000 description 1
- 101710110342 Cyclopropane mycolic acid synthase MmaA2 Proteins 0.000 description 1
- 108010076010 Cystathionine beta-lyase Proteins 0.000 description 1
- 102100031620 Cysteine and glycine-rich protein 3 Human genes 0.000 description 1
- 102100035406 Cysteine desulfurase, mitochondrial Human genes 0.000 description 1
- 102100035342 Cysteine dioxygenase type 1 Human genes 0.000 description 1
- 102100021901 Cysteine protease ATG4A Human genes 0.000 description 1
- 102100021903 Cysteine protease ATG4B Human genes 0.000 description 1
- 102100021902 Cysteine protease ATG4C Human genes 0.000 description 1
- 102100027713 Cysteine protease ATG4D Human genes 0.000 description 1
- 102100026278 Cysteine sulfinic acid decarboxylase Human genes 0.000 description 1
- 102100036259 Cysteine-rich DPF motif domain-containing protein 1 Human genes 0.000 description 1
- 102100032759 Cysteine-rich motor neuron 1 protein Human genes 0.000 description 1
- 102100032757 Cysteine-rich protein 2 Human genes 0.000 description 1
- 102100030115 Cysteine-tRNA ligase, cytoplasmic Human genes 0.000 description 1
- 102100031128 Cysteine/serine-rich nuclear protein 2 Human genes 0.000 description 1
- 102100031061 Cysteine/serine-rich nuclear protein 3 Human genes 0.000 description 1
- 102100031089 Cystinosin Human genes 0.000 description 1
- 102100031565 Cytidine and dCMP deaminase domain-containing protein 1 Human genes 0.000 description 1
- 102100027413 Cytochrome P450 20A1 Human genes 0.000 description 1
- 102100036696 Cytochrome P450 27C1 Human genes 0.000 description 1
- 102100026515 Cytochrome P450 2S1 Human genes 0.000 description 1
- 102100026513 Cytochrome P450 2U1 Human genes 0.000 description 1
- 102100022028 Cytochrome P450 4V2 Human genes 0.000 description 1
- 102100037186 Cytochrome b-245 chaperone 1 Human genes 0.000 description 1
- 102100025620 Cytochrome b-245 light chain Human genes 0.000 description 1
- 102100033149 Cytochrome b5 reductase 4 Human genes 0.000 description 1
- 102100029079 Cytochrome c oxidase assembly protein COX15 homolog Human genes 0.000 description 1
- 102100035955 Cytochrome c oxidase assembly protein COX16 homolog, mitochondrial Human genes 0.000 description 1
- 102100038800 Cytochrome c oxidase assembly protein COX20, mitochondrial Human genes 0.000 description 1
- 102100036035 Cytochrome c oxidase copper chaperone Human genes 0.000 description 1
- 102100034025 Cytohesin-1 Human genes 0.000 description 1
- 102100034031 Cytohesin-2 Human genes 0.000 description 1
- 102100034032 Cytohesin-3 Human genes 0.000 description 1
- 102100026234 Cytokine receptor common subunit gamma Human genes 0.000 description 1
- 102100038417 Cytoplasmic FMR1-interacting protein 1 Human genes 0.000 description 1
- 102100038418 Cytoplasmic FMR1-interacting protein 2 Human genes 0.000 description 1
- 102100031635 Cytoplasmic dynein 1 heavy chain 1 Human genes 0.000 description 1
- 102100037147 Cytoplasmic dynein 2 heavy chain 1 Human genes 0.000 description 1
- 102100037064 Cytoplasmic dynein 2 light intermediate chain 1 Human genes 0.000 description 1
- 102100039223 Cytoplasmic polyadenylation element-binding protein 1 Human genes 0.000 description 1
- 102100039224 Cytoplasmic polyadenylation element-binding protein 2 Human genes 0.000 description 1
- 102100039221 Cytoplasmic polyadenylation element-binding protein 3 Human genes 0.000 description 1
- 102100039315 Cytoplasmic polyadenylation element-binding protein 4 Human genes 0.000 description 1
- 102100036952 Cytoplasmic protein NCK2 Human genes 0.000 description 1
- 102100025508 Cytoplasmic tRNA 2-thiolation protein 2 Human genes 0.000 description 1
- 102100039523 Cytoskeleton-associated protein 2-like Human genes 0.000 description 1
- 102100028624 Cytoskeleton-associated protein 5 Human genes 0.000 description 1
- 102100035861 Cytosolic 5'-nucleotidase 1A Human genes 0.000 description 1
- 102100028717 Cytosolic 5'-nucleotidase 3A Human genes 0.000 description 1
- 102100036958 Cytosolic Fe-S cluster assembly factor NUBP1 Human genes 0.000 description 1
- 102100035648 Cytosolic arginine sensor for mTORC1 subunit 1 Human genes 0.000 description 1
- 102100035027 Cytosolic carboxypeptidase 1 Human genes 0.000 description 1
- 102100025707 Cytosolic carboxypeptidase 3 Human genes 0.000 description 1
- 102100032406 Cytosolic carboxypeptidase 6 Human genes 0.000 description 1
- 102100023759 Cytosolic iron-sulfur assembly component 2A Human genes 0.000 description 1
- 102100034460 Cytosolic iron-sulfur assembly component 3 Human genes 0.000 description 1
- 102100040628 Cytosolic phospholipase A2 beta Human genes 0.000 description 1
- 102100028712 Cytosolic purine 5'-nucleotidase Human genes 0.000 description 1
- 101710186775 D-2-hydroxyglutarate dehydrogenase Proteins 0.000 description 1
- 102100025481 D-2-hydroxyglutarate dehydrogenase, mitochondrial Human genes 0.000 description 1
- 102100029010 D-aminoacyl-tRNA deacylase 1 Human genes 0.000 description 1
- 102100029011 D-aminoacyl-tRNA deacylase 2 Human genes 0.000 description 1
- 102100022768 D-beta-hydroxybutyrate dehydrogenase, mitochondrial Human genes 0.000 description 1
- 102100028697 D-glucuronyl C5-epimerase Human genes 0.000 description 1
- 102100033937 D-glutamate cyclase, mitochondrial Human genes 0.000 description 1
- 101700026669 DACH1 Proteins 0.000 description 1
- 102100033673 DAZ-associated protein 1 Human genes 0.000 description 1
- 102100033212 DAZ-associated protein 2 Human genes 0.000 description 1
- 102100024395 DCC-interacting protein 13-alpha Human genes 0.000 description 1
- 102100026985 DCN1-like protein 2 Human genes 0.000 description 1
- 102100037098 DCN1-like protein 4 Human genes 0.000 description 1
- 102100037055 DCN1-like protein 5 Human genes 0.000 description 1
- 102100029582 DDB1- and CUL4-associated factor 1 Human genes 0.000 description 1
- 102100025182 DDB1- and CUL4-associated factor 10 Human genes 0.000 description 1
- 102100025183 DDB1- and CUL4-associated factor 11 Human genes 0.000 description 1
- 102100039823 DDB1- and CUL4-associated factor 13 Human genes 0.000 description 1
- 102100029586 DDB1- and CUL4-associated factor 16 Human genes 0.000 description 1
- 102100029581 DDB1- and CUL4-associated factor 17 Human genes 0.000 description 1
- 102100029587 DDB1- and CUL4-associated factor 6 Human genes 0.000 description 1
- 102100024460 DDB1- and CUL4-associated factor 8 Human genes 0.000 description 1
- 108010060424 DEAD Box Protein 20 Proteins 0.000 description 1
- 102100033488 DENN domain-containing protein 10 Human genes 0.000 description 1
- 102100033465 DENN domain-containing protein 11 Human genes 0.000 description 1
- 102100033466 DENN domain-containing protein 1A Human genes 0.000 description 1
- 102100033462 DENN domain-containing protein 1B Human genes 0.000 description 1
- 102100033507 DENN domain-containing protein 1C Human genes 0.000 description 1
- 102100025268 DENN domain-containing protein 2C Human genes 0.000 description 1
- 102100030418 DENN domain-containing protein 3 Human genes 0.000 description 1
- 102100025280 DENN domain-containing protein 4B Human genes 0.000 description 1
- 102100025270 DENN domain-containing protein 4C Human genes 0.000 description 1
- 102100025267 DENN domain-containing protein 5A Human genes 0.000 description 1
- 102100025405 DENN domain-containing protein 5B Human genes 0.000 description 1
- 102100029816 DEP domain-containing mTOR-interacting protein Human genes 0.000 description 1
- 102100037753 DEP domain-containing protein 1A Human genes 0.000 description 1
- 102000012677 DET1 Human genes 0.000 description 1
- 101150113651 DET1 gene Proteins 0.000 description 1
- 102100037969 DIS3-like exonuclease 1 Human genes 0.000 description 1
- 102100038017 DIS3-like exonuclease 2 Human genes 0.000 description 1
- 102100032679 DISP complex protein LRCH3 Human genes 0.000 description 1
- 108091028710 DLEU2 Proteins 0.000 description 1
- 108010009540 DNA (Cytosine-5-)-Methyltransferase 1 Proteins 0.000 description 1
- 102100036279 DNA (cytosine-5)-methyltransferase 1 Human genes 0.000 description 1
- 102100024812 DNA (cytosine-5)-methyltransferase 3A Human genes 0.000 description 1
- 102100024810 DNA (cytosine-5)-methyltransferase 3B Human genes 0.000 description 1
- 101710123222 DNA (cytosine-5)-methyltransferase 3B Proteins 0.000 description 1
- 108010024491 DNA Methyltransferase 3A Proteins 0.000 description 1
- 102100040264 DNA dC->dU-editing enzyme APOBEC-3D Human genes 0.000 description 1
- 102100040266 DNA dC->dU-editing enzyme APOBEC-3F Human genes 0.000 description 1
- 102100038050 DNA dC->dU-editing enzyme APOBEC-3H Human genes 0.000 description 1
- 101710082737 DNA dC->dU-editing enzyme APOBEC-3H Proteins 0.000 description 1
- 102100021122 DNA damage-binding protein 2 Human genes 0.000 description 1
- 102100029133 DNA damage-induced apoptosis suppressor protein Human genes 0.000 description 1
- 102100020800 DNA damage-regulated autophagy modulator protein 1 Human genes 0.000 description 1
- 102100040489 DNA damage-regulated autophagy modulator protein 2 Human genes 0.000 description 1
- 102100035186 DNA excision repair protein ERCC-1 Human genes 0.000 description 1
- 102100021603 DNA excision repair protein ERCC-6-like 2 Human genes 0.000 description 1
- 102100031868 DNA excision repair protein ERCC-8 Human genes 0.000 description 1
- 102100038026 DNA fragmentation factor subunit alpha Human genes 0.000 description 1
- 101710147299 DNA fragmentation factor subunit beta Proteins 0.000 description 1
- 102100038826 DNA helicase MCM8 Human genes 0.000 description 1
- 102100038830 DNA helicase MCM9 Human genes 0.000 description 1
- 102100035925 DNA methyltransferase 1-associated protein 1 Human genes 0.000 description 1
- 102100028849 DNA mismatch repair protein Mlh3 Human genes 0.000 description 1
- 102100034157 DNA mismatch repair protein Msh2 Human genes 0.000 description 1
- 102100037700 DNA mismatch repair protein Msh3 Human genes 0.000 description 1
- 102100039084 DNA oxidative demethylase ALKBH2 Human genes 0.000 description 1
- 102100036951 DNA polymerase subunit gamma-1 Human genes 0.000 description 1
- 102100033072 DNA replication ATP-dependent helicase DNA2 Human genes 0.000 description 1
- 102100027564 DNA replication complex GINS protein PSF1 Human genes 0.000 description 1
- 102100036740 DNA replication complex GINS protein PSF3 Human genes 0.000 description 1
- 102100030960 DNA replication licensing factor MCM2 Human genes 0.000 description 1
- 102100021389 DNA replication licensing factor MCM4 Human genes 0.000 description 1
- 102100024762 DNA-binding death effector domain-containing protein 2 Human genes 0.000 description 1
- 102100037799 DNA-binding protein Ikaros Human genes 0.000 description 1
- 102100040104 DNA-directed RNA polymerase III subunit RPC9 Human genes 0.000 description 1
- 102100027617 DNA/RNA-binding protein KIN17 Human genes 0.000 description 1
- 101700083528 DNAL1 Proteins 0.000 description 1
- 102100022934 DPH3 homolog Human genes 0.000 description 1
- 102100028735 Dachshund homolog 1 Human genes 0.000 description 1
- 102100038571 Damage-control phosphatase ARMT1 Human genes 0.000 description 1
- 101100444936 Danio rerio eif3ha gene Proteins 0.000 description 1
- 101100444938 Danio rerio eif3ja gene Proteins 0.000 description 1
- 101100457345 Danio rerio mapk14a gene Proteins 0.000 description 1
- 101100457347 Danio rerio mapk14b gene Proteins 0.000 description 1
- 102100024693 Death effector domain-containing protein Human genes 0.000 description 1
- 102100038587 Death-associated protein kinase 1 Human genes 0.000 description 1
- 102100038606 Death-associated protein kinase 3 Human genes 0.000 description 1
- 102100031601 Dedicator of cytokinesis protein 11 Human genes 0.000 description 1
- 102100031597 Dedicator of cytokinesis protein 2 Human genes 0.000 description 1
- 102100024352 Dedicator of cytokinesis protein 4 Human genes 0.000 description 1
- 102100024347 Dedicator of cytokinesis protein 5 Human genes 0.000 description 1
- 102100024354 Dedicator of cytokinesis protein 6 Human genes 0.000 description 1
- 102100024351 Dedicator of cytokinesis protein 7 Human genes 0.000 description 1
- 102100024353 Dedicator of cytokinesis protein 9 Human genes 0.000 description 1
- 102100036727 Deformed epidermal autoregulatory factor 1 homolog Human genes 0.000 description 1
- 102100036511 Dehydrodolichyl diphosphate synthase complex subunit DHDDS Human genes 0.000 description 1
- 102100035409 Dehydrodolichyl diphosphate synthase complex subunit NUS1 Human genes 0.000 description 1
- 102100034022 Dehydrogenase/reductase SDR family member 12 Human genes 0.000 description 1
- 102100037846 Dehydrogenase/reductase SDR family member 4 Human genes 0.000 description 1
- 102100020753 Dehydrogenase/reductase SDR family member 4-like 2 Human genes 0.000 description 1
- 102100036500 Dehydrogenase/reductase SDR family member 7 Human genes 0.000 description 1
- 102100037699 Dehydrogenase/reductase SDR family member 7B Human genes 0.000 description 1
- 102100034690 Delta(14)-sterol reductase LBR Human genes 0.000 description 1
- 102100022283 Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial Human genes 0.000 description 1
- 102100036337 Dematin Human genes 0.000 description 1
- 102100030312 Dendrin Human genes 0.000 description 1
- 102100022692 Density-regulated protein Human genes 0.000 description 1
- 102100021215 Denticleless protein homolog Human genes 0.000 description 1
- 101800000026 Dentin sialoprotein Proteins 0.000 description 1
- 102100037101 Deoxycytidylate deaminase Human genes 0.000 description 1
- 102100036853 Deoxyguanosine kinase, mitochondrial Human genes 0.000 description 1
- 102100031242 Deoxyhypusine synthase Human genes 0.000 description 1
- 102100024730 Deoxynucleotidyltransferase terminal-interacting protein 1 Human genes 0.000 description 1
- 102100024737 Deoxynucleotidyltransferase terminal-interacting protein 2 Human genes 0.000 description 1
- 102100022882 Deoxyribonuclease-2-alpha Human genes 0.000 description 1
- 102100037802 Deoxyribose-phosphate aldolase Human genes 0.000 description 1
- 102100037458 Dephospho-CoA kinase Human genes 0.000 description 1
- 102100024469 Dephospho-CoA kinase domain-containing protein Human genes 0.000 description 1
- 102100030438 Derlin-1 Human genes 0.000 description 1
- 102100040606 Dermatan-sulfate epimerase Human genes 0.000 description 1
- 102100033582 Dermokine Human genes 0.000 description 1
- 102100036496 Desert hedgehog protein Human genes 0.000 description 1
- 101710115068 Desert hedgehog protein Proteins 0.000 description 1
- 102100038199 Desmoplakin Human genes 0.000 description 1
- 102100036898 Desumoylating isopeptidase 1 Human genes 0.000 description 1
- 102100035091 Deubiquitinase MYSM1 Human genes 0.000 description 1
- 102100040561 Deubiquitinase OTUD6B Human genes 0.000 description 1
- 108010086291 Deubiquitinating Enzyme CYLD Proteins 0.000 description 1
- 102100037711 Developmentally-regulated GTP-binding protein 2 Human genes 0.000 description 1
- 102100037417 Dexamethasone-induced protein Human genes 0.000 description 1
- 102100036495 Di-N-acetylchitobiase Human genes 0.000 description 1
- 102100033189 Diablo IAP-binding mitochondrial protein Human genes 0.000 description 1
- 102100022735 Diacylglycerol kinase alpha Human genes 0.000 description 1
- 102100022733 Diacylglycerol kinase epsilon Human genes 0.000 description 1
- 102100030215 Diacylglycerol kinase eta Human genes 0.000 description 1
- 102100030214 Diacylglycerol kinase iota Human genes 0.000 description 1
- 102100030221 Diacylglycerol kinase theta Human genes 0.000 description 1
- 102100030220 Diacylglycerol kinase zeta Human genes 0.000 description 1
- 102100037794 Diacylglycerol lipase-beta Human genes 0.000 description 1
- 101000904064 Dictyostelium discoideum Glucosamine 6-phosphate N-acetyltransferase 1 Proteins 0.000 description 1
- 101001071611 Dictyostelium discoideum Glutathione reductase Proteins 0.000 description 1
- 101100216227 Dictyostelium discoideum anapc3 gene Proteins 0.000 description 1
- 101100327311 Dictyostelium discoideum anapc6 gene Proteins 0.000 description 1
- 101100226017 Dictyostelium discoideum repD gene Proteins 0.000 description 1
- 102100025344 Differentially expressed in FDCP 8 homolog Human genes 0.000 description 1
- 102100024746 Dihydrofolate reductase Human genes 0.000 description 1
- 102100023319 Dihydrolipoyl dehydrogenase, mitochondrial Human genes 0.000 description 1
- 102100027152 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial Human genes 0.000 description 1
- 102100031920 Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial Human genes 0.000 description 1
- 108010052167 Dihydroorotate Dehydrogenase Proteins 0.000 description 1
- 102100032823 Dihydroorotate dehydrogenase (quinone), mitochondrial Human genes 0.000 description 1
- 102100022188 Dihydropyrimidinase-related protein 1 Human genes 0.000 description 1
- 102100024426 Dihydropyrimidinase-related protein 2 Human genes 0.000 description 1
- 102100024425 Dihydropyrimidinase-related protein 3 Human genes 0.000 description 1
- 102100024443 Dihydropyrimidinase-related protein 4 Human genes 0.000 description 1
- 102100024441 Dihydropyrimidinase-related protein 5 Human genes 0.000 description 1
- 102100022334 Dihydropyrimidine dehydrogenase [NADP(+)] Human genes 0.000 description 1
- 102100040679 Dihydroxyacetone phosphate acyltransferase Human genes 0.000 description 1
- 102100029921 Dipeptidyl peptidase 1 Human genes 0.000 description 1
- 102100020751 Dipeptidyl peptidase 2 Human genes 0.000 description 1
- 102100025012 Dipeptidyl peptidase 4 Human genes 0.000 description 1
- 102100036968 Dipeptidyl peptidase 8 Human genes 0.000 description 1
- 102100036969 Dipeptidyl peptidase 9 Human genes 0.000 description 1
- 101710087012 Dipeptidyl-peptidase 7 Proteins 0.000 description 1
- 102100029579 Diphosphoinositol polyphosphate phosphohydrolase 1 Human genes 0.000 description 1
- 102100038390 Diphosphomevalonate decarboxylase Human genes 0.000 description 1
- 102100028686 Diphthine methyl ester synthase Human genes 0.000 description 1
- 102100024400 Diphthine methyltransferase Human genes 0.000 description 1
- 102100028684 Diphthine-ammonia ligase Human genes 0.000 description 1
- 102100028572 Disabled homolog 2 Human genes 0.000 description 1
- 102100028571 Disabled homolog 2-interacting protein Human genes 0.000 description 1
- 102100037922 Disco-interacting protein 2 homolog A Human genes 0.000 description 1
- 102100037923 Disco-interacting protein 2 homolog B Human genes 0.000 description 1
- 102100037928 Disco-interacting protein 2 homolog C Human genes 0.000 description 1
- 102100027023 Discoidin, CUB and LCCL domain-containing protein 1 Human genes 0.000 description 1
- 102100027043 Discoidin, CUB and LCCL domain-containing protein 2 Human genes 0.000 description 1
- 102100028555 Disheveled-associated activator of morphogenesis 1 Human genes 0.000 description 1
- 102100022264 Disks large homolog 4 Human genes 0.000 description 1
- 102100022258 Disks large homolog 5 Human genes 0.000 description 1
- 102100037983 Disks large-associated protein 4 Human genes 0.000 description 1
- 102100035589 Distal membrane-arm assembly complex protein 2 Human genes 0.000 description 1
- 102100037849 Divergent protein kinase domain 1B Human genes 0.000 description 1
- 102100035372 DmX-like protein 1 Human genes 0.000 description 1
- 102100035347 DmX-like protein 2 Human genes 0.000 description 1
- 102100037888 DnaJ homolog subfamily B member 12 Human genes 0.000 description 1
- 102100029707 DnaJ homolog subfamily B member 4 Human genes 0.000 description 1
- 102100034109 DnaJ homolog subfamily C member 13 Human genes 0.000 description 1
- 102100022267 DnaJ homolog subfamily C member 17 Human genes 0.000 description 1
- 102100031695 DnaJ homolog subfamily C member 2 Human genes 0.000 description 1
- 102100022266 DnaJ homolog subfamily C member 22 Human genes 0.000 description 1
- 102100026984 DnaJ homolog subfamily C member 25 Human genes 0.000 description 1
- 102100031682 DnaJ homolog subfamily C member 4 Human genes 0.000 description 1
- 102100031675 DnaJ homolog subfamily C member 5 Human genes 0.000 description 1
- 102100022839 DnaJ homolog subfamily C member 8 Human genes 0.000 description 1
- 102100037832 Docking protein 1 Human genes 0.000 description 1
- 102100037830 Docking protein 2 Human genes 0.000 description 1
- 102100037829 Docking protein 3 Human genes 0.000 description 1
- 102100031134 Docking protein 6 Human genes 0.000 description 1
- 102100039059 Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase Human genes 0.000 description 1
- 102100027189 Dolichyl-phosphate beta-glucosyltransferase Human genes 0.000 description 1
- 102100033140 Dolichyldiphosphatase 1 Human genes 0.000 description 1
- 102100033156 Dopamine beta-hydroxylase Human genes 0.000 description 1
- 102100037698 Dorsal root ganglia homeobox protein Human genes 0.000 description 1
- 102100033996 Double-strand break repair protein MRE11 Human genes 0.000 description 1
- 102100035316 Doublesex- and mab-3-related transcription factor A2 Human genes 0.000 description 1
- 102100028570 Drebrin-like protein Human genes 0.000 description 1
- 101001092183 Drosophila melanogaster Regulator of gene activity Proteins 0.000 description 1
- 101100220697 Drosophila melanogaster cid gene Proteins 0.000 description 1
- 102100029638 Dual serine/threonine and tyrosine protein kinase Human genes 0.000 description 1
- 102100031480 Dual specificity mitogen-activated protein kinase kinase 1 Human genes 0.000 description 1
- 102100023274 Dual specificity mitogen-activated protein kinase kinase 4 Human genes 0.000 description 1
- 102100023272 Dual specificity mitogen-activated protein kinase kinase 5 Human genes 0.000 description 1
- 102100023401 Dual specificity mitogen-activated protein kinase kinase 6 Human genes 0.000 description 1
- 102100023332 Dual specificity mitogen-activated protein kinase kinase 7 Human genes 0.000 description 1
- 102100040862 Dual specificity protein kinase CLK1 Human genes 0.000 description 1
- 102100040844 Dual specificity protein kinase CLK2 Human genes 0.000 description 1
- 102100040856 Dual specificity protein kinase CLK3 Human genes 0.000 description 1
- 102100040858 Dual specificity protein kinase CLK4 Human genes 0.000 description 1
- 102100037570 Dual specificity protein phosphatase 16 Human genes 0.000 description 1
- 102100033992 Dual specificity protein phosphatase 22 Human genes 0.000 description 1
- 102100025734 Dual specificity protein phosphatase CDC14A Human genes 0.000 description 1
- 102100025699 Dual specificity protein phosphatase CDC14B Human genes 0.000 description 1
- 102100028554 Dual specificity tyrosine-phosphorylation-regulated kinase 1A Human genes 0.000 description 1
- 102100023115 Dual specificity tyrosine-phosphorylation-regulated kinase 2 Human genes 0.000 description 1
- 102100023114 Dual specificity tyrosine-phosphorylation-regulated kinase 3 Human genes 0.000 description 1
- 102100023112 Dual specificity tyrosine-phosphorylation-regulated kinase 4 Human genes 0.000 description 1
- 102100021242 Dymeclin Human genes 0.000 description 1
- 102100036654 Dynactin subunit 1 Human genes 0.000 description 1
- 102100021076 Dynactin subunit 2 Human genes 0.000 description 1
- 102100021074 Dynactin subunit 4 Human genes 0.000 description 1
- 102100021071 Dynactin subunit 5 Human genes 0.000 description 1
- 108010044191 Dynamin II Proteins 0.000 description 1
- 102100021236 Dynamin-1 Human genes 0.000 description 1
- 102100024827 Dynamin-1-like protein Human genes 0.000 description 1
- 102100021238 Dynamin-2 Human genes 0.000 description 1
- 102100021179 Dynamin-3 Human genes 0.000 description 1
- 102100024821 Dynamin-binding protein Human genes 0.000 description 1
- 102100024282 Dynein axonemal assembly factor 11 Human genes 0.000 description 1
- 102100032233 Dynein axonemal assembly factor 4 Human genes 0.000 description 1
- 102100032238 Dynein axonemal assembly factor 5 Human genes 0.000 description 1
- 102100032299 Dynein axonemal heavy chain 10 Human genes 0.000 description 1
- 102100032298 Dynein axonemal heavy chain 14 Human genes 0.000 description 1
- 102100031636 Dynein axonemal heavy chain 9 Human genes 0.000 description 1
- 102100030055 Dynein light chain roadblock-type 1 Human genes 0.000 description 1
- 102100037730 Dynein regulatory complex protein 8 Human genes 0.000 description 1
- 102100037734 Dynein regulatory complex protein 9 Human genes 0.000 description 1
- 102100040610 Dynein regulatory complex subunit 4 Human genes 0.000 description 1
- 102100040620 Dynein regulatory complex subunit 6 Human genes 0.000 description 1
- 108010045061 Dysbindin Proteins 0.000 description 1
- 102000005611 Dysbindin Human genes 0.000 description 1
- 102100032248 Dysferlin Human genes 0.000 description 1
- 102100025907 Dyslexia-associated protein KIAA0319-like protein Human genes 0.000 description 1
- 102100032249 Dystonin Human genes 0.000 description 1
- 102100024074 Dystrobrevin alpha Human genes 0.000 description 1
- 102100025682 Dystroglycan 1 Human genes 0.000 description 1
- 102100024108 Dystrophin Human genes 0.000 description 1
- 102100038913 E1A-binding protein p400 Human genes 0.000 description 1
- 102100039922 E3 ISG15-protein ligase HERC5 Human genes 0.000 description 1
- 102100032917 E3 SUMO-protein ligase CBX4 Human genes 0.000 description 1
- 102100022867 E3 SUMO-protein ligase KIAA1586 Human genes 0.000 description 1
- 102100028836 E3 SUMO-protein ligase NSE2 Human genes 0.000 description 1
- 102100038513 E3 ubiquitin-protein ligase ARIH2 Human genes 0.000 description 1
- 102100035813 E3 ubiquitin-protein ligase CBL Human genes 0.000 description 1
- 102100035273 E3 ubiquitin-protein ligase CBL-B Human genes 0.000 description 1
- 102100024214 E3 ubiquitin-protein ligase DCST1 Human genes 0.000 description 1
- 102100033360 E3 ubiquitin-protein ligase DZIP3 Human genes 0.000 description 1
- 102100027325 E3 ubiquitin-protein ligase HACE1 Human genes 0.000 description 1
- 102100034677 E3 ubiquitin-protein ligase HECTD1 Human genes 0.000 description 1
- 102100034674 E3 ubiquitin-protein ligase HECW1 Human genes 0.000 description 1
- 102100034675 E3 ubiquitin-protein ligase HECW2 Human genes 0.000 description 1
- 102100034745 E3 ubiquitin-protein ligase HERC2 Human genes 0.000 description 1
- 102100034893 E3 ubiquitin-protein ligase HUWE1 Human genes 0.000 description 1
- 102100030370 E3 ubiquitin-protein ligase Hakai Human genes 0.000 description 1
- 102100032710 E3 ubiquitin-protein ligase Jade-2 Human genes 0.000 description 1
- 102100032049 E3 ubiquitin-protein ligase LRSAM1 Human genes 0.000 description 1
- 102100038616 E3 ubiquitin-protein ligase MARCHF1 Human genes 0.000 description 1
- 102100040931 E3 ubiquitin-protein ligase MARCHF3 Human genes 0.000 description 1
- 102100040877 E3 ubiquitin-protein ligase MARCHF5 Human genes 0.000 description 1
- 102100023149 E3 ubiquitin-protein ligase MARCHF6 Human genes 0.000 description 1
- 102100023147 E3 ubiquitin-protein ligase MARCHF7 Human genes 0.000 description 1
- 102100023196 E3 ubiquitin-protein ligase MARCHF8 Human genes 0.000 description 1
- 102100037994 E3 ubiquitin-protein ligase MGRN1 Human genes 0.000 description 1
- 102100022183 E3 ubiquitin-protein ligase MIB1 Human genes 0.000 description 1
- 102100022199 E3 ubiquitin-protein ligase MIB2 Human genes 0.000 description 1
- 102100031788 E3 ubiquitin-protein ligase MYLIP Human genes 0.000 description 1
- 102000012199 E3 ubiquitin-protein ligase Mdm2 Human genes 0.000 description 1
- 108050002772 E3 ubiquitin-protein ligase Mdm2 Proteins 0.000 description 1
- 102100031918 E3 ubiquitin-protein ligase NEDD4 Human genes 0.000 description 1
- 102100035493 E3 ubiquitin-protein ligase NEDD4-like Human genes 0.000 description 1
- 102100035489 E3 ubiquitin-protein ligase NEURL1B Human genes 0.000 description 1
- 102100021766 E3 ubiquitin-protein ligase RNF138 Human genes 0.000 description 1
- 102100033594 E3 ubiquitin-protein ligase makorin-1 Human genes 0.000 description 1
- 102100033612 E3 ubiquitin-protein ligase makorin-2 Human genes 0.000 description 1
- 102100021758 E3 ubiquitin-protein transferase MAEA Human genes 0.000 description 1
- 102100032058 EARP and GARP complex-interacting protein 1 Human genes 0.000 description 1
- 102100040956 EEF1A lysine methyltransferase 1 Human genes 0.000 description 1
- 102100040938 EEF1A lysine methyltransferase 2 Human genes 0.000 description 1
- 102100040464 EF-hand calcium-binding domain-containing protein 11 Human genes 0.000 description 1
- 102100037359 EF-hand calcium-binding domain-containing protein 13 Human genes 0.000 description 1
- 102100037358 EF-hand calcium-binding domain-containing protein 14 Human genes 0.000 description 1
- 102100037643 EF-hand calcium-binding domain-containing protein 4A Human genes 0.000 description 1
- 102100037661 EF-hand calcium-binding domain-containing protein 4B Human genes 0.000 description 1
- 102100033906 EF-hand calcium-binding domain-containing protein 5 Human genes 0.000 description 1
- 102100033905 EF-hand calcium-binding domain-containing protein 7 Human genes 0.000 description 1
- 102100031418 EF-hand domain-containing protein D2 Human genes 0.000 description 1
- 102100031947 EGF domain-specific O-linked N-acetylglucosamine transferase Human genes 0.000 description 1
- 102100031814 EGF-containing fibulin-like extracellular matrix protein 1 Human genes 0.000 description 1
- 102100032449 EGF-like repeat and discoidin I-like domain-containing protein 3 Human genes 0.000 description 1
- 102100029652 EH domain-binding protein 1 Human genes 0.000 description 1
- 102100029650 EH domain-binding protein 1-like protein 1 Human genes 0.000 description 1
- 101150061947 EIF2D gene Proteins 0.000 description 1
- 101150073788 EIF3K gene Proteins 0.000 description 1
- 101150015614 EIF3M gene Proteins 0.000 description 1
- 108700015856 ELAV-Like Protein 1 Proteins 0.000 description 1
- 108010008795 ELAV-Like Protein 2 Proteins 0.000 description 1
- 108010008802 ELAV-Like Protein 4 Proteins 0.000 description 1
- 102100034235 ELAV-like protein 1 Human genes 0.000 description 1
- 102100034234 ELAV-like protein 2 Human genes 0.000 description 1
- 102100021665 ELAV-like protein 4 Human genes 0.000 description 1
- 102100038415 ELKS/Rab6-interacting/CAST family member 1 Human genes 0.000 description 1
- 102100021785 ELL-associated factor 1 Human genes 0.000 description 1
- 102100023456 ELMO domain-containing protein 1 Human genes 0.000 description 1
- 102100027111 ELMO domain-containing protein 2 Human genes 0.000 description 1
- 102100027108 ELMO domain-containing protein 3 Human genes 0.000 description 1
- 208000037595 EN1-related dorsoventral syndrome Diseases 0.000 description 1
- 101150076616 EPHA2 gene Proteins 0.000 description 1
- 101150016325 EPHA3 gene Proteins 0.000 description 1
- 101150097734 EPHB2 gene Proteins 0.000 description 1
- 108091016436 EPS8 Proteins 0.000 description 1
- 102000020045 EPS8 Human genes 0.000 description 1
- 102100021799 ER degradation-enhancing alpha-mannosidase-like protein 2 Human genes 0.000 description 1
- 102100032443 ER degradation-enhancing alpha-mannosidase-like protein 3 Human genes 0.000 description 1
- 102100021650 ER membrane protein complex subunit 1 Human genes 0.000 description 1
- 102100037527 ER membrane protein complex subunit 2 Human genes 0.000 description 1
- 102100035084 ER membrane protein complex subunit 4 Human genes 0.000 description 1
- 102100035092 ER membrane protein complex subunit 5 Human genes 0.000 description 1
- 102100034240 ER membrane protein complex subunit 8 Human genes 0.000 description 1
- 102100035183 ERC protein 2 Human genes 0.000 description 1
- 101150105460 ERCC2 gene Proteins 0.000 description 1
- 102100030787 ERI1 exoribonuclease 2 Human genes 0.000 description 1
- 102100025537 ERI1 exoribonuclease 3 Human genes 0.000 description 1
- 102100029994 ERO1-like protein alpha Human genes 0.000 description 1
- 101150017533 ERP44 gene Proteins 0.000 description 1
- 102100030816 ESF1 homolog Human genes 0.000 description 1
- 102100032057 ETS domain-containing protein Elk-1 Human genes 0.000 description 1
- 102100039563 ETS translocation variant 1 Human genes 0.000 description 1
- 102100039562 ETS translocation variant 3 Human genes 0.000 description 1
- 102100039578 ETS translocation variant 4 Human genes 0.000 description 1
- 102100035078 ETS-related transcription factor Elf-2 Human genes 0.000 description 1
- 102100039247 ETS-related transcription factor Elf-4 Human genes 0.000 description 1
- 102100023078 Early endosome antigen 1 Human genes 0.000 description 1
- 102100021720 Early growth response protein 4 Human genes 0.000 description 1
- 102100027094 Echinoderm microtubule-associated protein-like 1 Human genes 0.000 description 1
- 102100027126 Echinoderm microtubule-associated protein-like 2 Human genes 0.000 description 1
- 102100027095 Echinoderm microtubule-associated protein-like 3 Human genes 0.000 description 1
- 102100027100 Echinoderm microtubule-associated protein-like 4 Human genes 0.000 description 1
- 102100030204 Echinoderm microtubule-associated protein-like 5 Human genes 0.000 description 1
- 102100030205 Echinoderm microtubule-associated protein-like 6 Human genes 0.000 description 1
- 102100036992 Ecto-ADP-ribosyltransferase 5 Human genes 0.000 description 1
- 102100029724 Ectonucleoside triphosphate diphosphohydrolase 4 Human genes 0.000 description 1
- 102100036437 Ectonucleoside triphosphate diphosphohydrolase 6 Human genes 0.000 description 1
- 102100030281 Ectopic P granules protein 5 homolog Human genes 0.000 description 1
- 102100037249 Egl nine homolog 1 Human genes 0.000 description 1
- 101150028132 Eif3h gene Proteins 0.000 description 1
- 101150011861 Elavl1 gene Proteins 0.000 description 1
- 102100031799 Electron transfer flavoprotein regulatory factor 1 Human genes 0.000 description 1
- 102100030695 Electron transfer flavoprotein subunit alpha, mitochondrial Human genes 0.000 description 1
- 102100027262 Electron transfer flavoprotein subunit beta Human genes 0.000 description 1
- 102100031804 Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial Human genes 0.000 description 1
- 102100037074 Ellis-van Creveld syndrome protein Human genes 0.000 description 1
- 101150030061 Eloc gene Proteins 0.000 description 1
- 102100030808 Elongation factor 1-delta Human genes 0.000 description 1
- 102100037642 Elongation factor G, mitochondrial Human genes 0.000 description 1
- 102100031417 Elongation factor-like GTPase 1 Human genes 0.000 description 1
- 102100032055 Elongation of very long chain fatty acids protein 1 Human genes 0.000 description 1
- 102100032050 Elongation of very long chain fatty acids protein 2 Human genes 0.000 description 1
- 102100032053 Elongation of very long chain fatty acids protein 4 Human genes 0.000 description 1
- 102100039248 Elongation of very long chain fatty acids protein 7 Human genes 0.000 description 1
- 102100039246 Elongator complex protein 1 Human genes 0.000 description 1
- 101710167754 Elongator complex protein 1 Proteins 0.000 description 1
- 102100034241 Elongator complex protein 2 Human genes 0.000 description 1
- 101710167764 Elongator complex protein 2 Proteins 0.000 description 1
- 102100035074 Elongator complex protein 3 Human genes 0.000 description 1
- 102100021666 Elongator complex protein 5 Human genes 0.000 description 1
- 102100021649 Elongator complex protein 6 Human genes 0.000 description 1
- 102100037114 Elongin-C Human genes 0.000 description 1
- 102100021658 Embigin Human genes 0.000 description 1
- 102100024125 Embryonal Fyn-associated substrate Human genes 0.000 description 1
- 102100032222 Emopamil-binding protein-like Human genes 0.000 description 1
- 102100030806 Endogenous retrovirus group K member 13-1 Env polyprotein Human genes 0.000 description 1
- 102100028779 Endonuclease 8-like 2 Human genes 0.000 description 1
- 102100028773 Endonuclease 8-like 3 Human genes 0.000 description 1
- 102100021008 Endonuclease G, mitochondrial Human genes 0.000 description 1
- 102100021710 Endonuclease III-like protein 1 Human genes 0.000 description 1
- 102100037696 Endonuclease V Human genes 0.000 description 1
- 102100031726 Endoplasmic reticulum junction formation protein lunapark Human genes 0.000 description 1
- 102100039609 Endoplasmic reticulum lectin 1 Human genes 0.000 description 1
- 102100031702 Endoplasmic reticulum membrane sensor NFE2L1 Human genes 0.000 description 1
- 102100030207 Endoplasmic reticulum membrane-associated RNA degradation protein Human genes 0.000 description 1
- 102100033933 Endoplasmic reticulum protein SC65 Human genes 0.000 description 1
- 102100031853 Endoplasmic reticulum resident protein 44 Human genes 0.000 description 1
- 102100031862 Endoplasmic reticulum-Golgi intermediate compartment protein 1 Human genes 0.000 description 1
- 102100031863 Endoplasmic reticulum-Golgi intermediate compartment protein 2 Human genes 0.000 description 1
- 102100029988 Endoplasmic reticulum-Golgi intermediate compartment protein 3 Human genes 0.000 description 1
- 102100023387 Endoribonuclease Dicer Human genes 0.000 description 1
- 102100034237 Endosome/lysosome-associated apoptosis and autophagy regulator 1 Human genes 0.000 description 1
- 102100034236 Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 Human genes 0.000 description 1
- 102100036448 Endothelial PAS domain-containing protein 1 Human genes 0.000 description 1
- 102100031785 Endothelial transcription factor GATA-2 Human genes 0.000 description 1
- 102100027118 Engulfment and cell motility protein 1 Human genes 0.000 description 1
- 102100027117 Engulfment and cell motility protein 2 Human genes 0.000 description 1
- 102100021579 Enhancer of filamentation 1 Human genes 0.000 description 1
- 102100037374 Enhancer of mRNA-decapping protein 3 Human genes 0.000 description 1
- 102100030727 Enkurin domain-containing protein 1 Human genes 0.000 description 1
- 102100021823 Enoyl-CoA delta isomerase 2 Human genes 0.000 description 1
- 102100030881 Enoyl-CoA hydratase domain-containing protein 2, mitochondrial Human genes 0.000 description 1
- 102100039327 Enoyl-[acyl-carrier-protein] reductase, mitochondrial Human genes 0.000 description 1
- 108010055323 EphB4 Receptor Proteins 0.000 description 1
- 102100030340 Ephrin type-A receptor 2 Human genes 0.000 description 1
- 102100030324 Ephrin type-A receptor 3 Human genes 0.000 description 1
- 102100021604 Ephrin type-A receptor 6 Human genes 0.000 description 1
- 102100021601 Ephrin type-A receptor 8 Human genes 0.000 description 1
- 102100031968 Ephrin type-B receptor 2 Human genes 0.000 description 1
- 102100031983 Ephrin type-B receptor 4 Human genes 0.000 description 1
- 108010043945 Ephrin-A1 Proteins 0.000 description 1
- 102100040954 Ephrin-A1 Human genes 0.000 description 1
- 102100033940 Ephrin-A3 Human genes 0.000 description 1
- 102100033942 Ephrin-A4 Human genes 0.000 description 1
- 108010043939 Ephrin-A5 Proteins 0.000 description 1
- 102100033941 Ephrin-A5 Human genes 0.000 description 1
- 102100023733 Ephrin-B3 Human genes 0.000 description 1
- 108010044085 Ephrin-B3 Proteins 0.000 description 1
- 102100039369 Epidermal growth factor receptor substrate 15 Human genes 0.000 description 1
- 102100030778 Epidermal growth factor receptor substrate 15-like 1 Human genes 0.000 description 1
- 102100032031 Epidermal growth factor-like protein 7 Human genes 0.000 description 1
- 102100023164 Epididymis-specific alpha-mannosidase Human genes 0.000 description 1
- 102100030323 Epigen Human genes 0.000 description 1
- 102100030146 Epithelial membrane protein 3 Human genes 0.000 description 1
- 102100039621 Epithelial-stromal interaction protein 1 Human genes 0.000 description 1
- 102100025403 Epoxide hydrolase 1 Human genes 0.000 description 1
- 102100039354 Epoxide hydrolase 4 Human genes 0.000 description 1
- 102100030082 Epsin-1 Human genes 0.000 description 1
- 102100030083 Epsin-2 Human genes 0.000 description 1
- 102100035177 Ergosterol biosynthetic protein 28 homolog Human genes 0.000 description 1
- 102100039607 Erlin-1 Human genes 0.000 description 1
- 102100036823 Erlin-2 Human genes 0.000 description 1
- 102100040463 Erythroid differentiation-related factor 1 Human genes 0.000 description 1
- 102100036825 Erythroid membrane-associated protein Human genes 0.000 description 1
- 101000755748 Escherichia coli AIDA-I autotransporter Proteins 0.000 description 1
- 102100031808 Espin-like protein Human genes 0.000 description 1
- 102100031855 Estrogen-related receptor gamma Human genes 0.000 description 1
- 102100029106 Ethylmalonyl-CoA decarboxylase Human genes 0.000 description 1
- 102100027270 Etoposide-induced protein 2.4 homolog Human genes 0.000 description 1
- 102000005233 Eukaryotic Initiation Factor-4E Human genes 0.000 description 1
- 108060002636 Eukaryotic Initiation Factor-4E Proteins 0.000 description 1
- 102100021808 Eukaryotic elongation factor 2 kinase Human genes 0.000 description 1
- 102100022462 Eukaryotic initiation factor 4A-II Human genes 0.000 description 1
- 102100036816 Eukaryotic peptide chain release factor GTP-binding subunit ERF3A Human genes 0.000 description 1
- 102100039408 Eukaryotic translation initiation factor 1A, X-chromosomal Human genes 0.000 description 1
- 102100035549 Eukaryotic translation initiation factor 2 subunit 1 Human genes 0.000 description 1
- 102100027327 Eukaryotic translation initiation factor 2 subunit 2 Human genes 0.000 description 1
- 102100040015 Eukaryotic translation initiation factor 2 subunit 3 Human genes 0.000 description 1
- 102100038075 Eukaryotic translation initiation factor 2D Human genes 0.000 description 1
- 102100035045 Eukaryotic translation initiation factor 3 subunit C Human genes 0.000 description 1
- 102100027114 Eukaryotic translation initiation factor 3 subunit C-like protein Human genes 0.000 description 1
- 102100037115 Eukaryotic translation initiation factor 3 subunit H Human genes 0.000 description 1
- 102100029782 Eukaryotic translation initiation factor 3 subunit I Human genes 0.000 description 1
- 102100034226 Eukaryotic translation initiation factor 3 subunit J Human genes 0.000 description 1
- 102100037110 Eukaryotic translation initiation factor 3 subunit K Human genes 0.000 description 1
- 102100029777 Eukaryotic translation initiation factor 3 subunit M Human genes 0.000 description 1
- 102100039735 Eukaryotic translation initiation factor 4 gamma 1 Human genes 0.000 description 1
- 102100040022 Eukaryotic translation initiation factor 4 gamma 3 Human genes 0.000 description 1
- 102100029602 Eukaryotic translation initiation factor 4B Human genes 0.000 description 1
- 102100029922 Eukaryotic translation initiation factor 4E type 2 Human genes 0.000 description 1
- 102100029925 Eukaryotic translation initiation factor 4E type 3 Human genes 0.000 description 1
- 102100026765 Eukaryotic translation initiation factor 4H Human genes 0.000 description 1
- 102100040002 Eukaryotic translation initiation factor 6 Human genes 0.000 description 1
- 102100031627 Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial Human genes 0.000 description 1
- 102100036935 Ewing's tumor-associated antigen 1 Human genes 0.000 description 1
- 102100030843 Exocyst complex component 2 Human genes 0.000 description 1
- 102100030860 Exocyst complex component 3 Human genes 0.000 description 1
- 102100026979 Exocyst complex component 4 Human genes 0.000 description 1
- 102100026980 Exocyst complex component 5 Human genes 0.000 description 1
- 102100026976 Exocyst complex component 6 Human genes 0.000 description 1
- 102100029907 Exocyst complex component 6B Human genes 0.000 description 1
- 102100039540 Exocyst complex component 7 Human genes 0.000 description 1
- 102100029075 Exonuclease 1 Human genes 0.000 description 1
- 102100029908 Exonuclease 3'-5' domain-containing protein 2 Human genes 0.000 description 1
- 102100037091 Exonuclease V Human genes 0.000 description 1
- 102100038195 Exonuclease mut-7 homolog Human genes 0.000 description 1
- 102100037123 Exosome RNA helicase MTR4 Human genes 0.000 description 1
- 102100038980 Exosome complex component CSL4 Human genes 0.000 description 1
- 102100038984 Exosome complex component RRP4 Human genes 0.000 description 1
- 102100038982 Exosome complex component RRP40 Human genes 0.000 description 1
- 102100026045 Exosome complex component RRP42 Human genes 0.000 description 1
- 102100026064 Exosome complex component RRP43 Human genes 0.000 description 1
- 102100026059 Exosome complex component RRP45 Human genes 0.000 description 1
- 102100024359 Exosome complex exonuclease RRP44 Human genes 0.000 description 1
- 102100029074 Exostosin-2 Human genes 0.000 description 1
- 102100035977 Exostosin-like 2 Human genes 0.000 description 1
- 102100035976 Exostosin-like 3 Human genes 0.000 description 1
- 102100029091 Exportin-2 Human genes 0.000 description 1
- 102100036763 Extended synaptotagmin-1 Human genes 0.000 description 1
- 102100036762 Extended synaptotagmin-2 Human genes 0.000 description 1
- 102100037122 Extracellular matrix organizing protein FRAS1 Human genes 0.000 description 1
- 102100031758 Extracellular matrix protein 1 Human genes 0.000 description 1
- 102100030863 Eyes absent homolog 1 Human genes 0.000 description 1
- 102100030861 Eyes absent homolog 3 Human genes 0.000 description 1
- 102100030910 Eyes absent homolog 4 Human genes 0.000 description 1
- 102100040651 F-BAR and double SH3 domains protein 1 Human genes 0.000 description 1
- 102100040650 F-BAR and double SH3 domains protein 2 Human genes 0.000 description 1
- 102100026104 F-BAR domain only protein 1 Human genes 0.000 description 1
- 102100038584 F-BAR domain only protein 2 Human genes 0.000 description 1
- 102100031807 F-box DNA helicase 1 Human genes 0.000 description 1
- 102100038003 F-box only protein 16 Human genes 0.000 description 1
- 102100038032 F-box only protein 17 Human genes 0.000 description 1
- 102100038029 F-box only protein 21 Human genes 0.000 description 1
- 102100038031 F-box only protein 22 Human genes 0.000 description 1
- 102100022114 F-box only protein 25 Human genes 0.000 description 1
- 102100040667 F-box only protein 33 Human genes 0.000 description 1
- 102100040641 F-box only protein 34 Human genes 0.000 description 1
- 102100040674 F-box only protein 38 Human genes 0.000 description 1
- 102100024524 F-box only protein 4 Human genes 0.000 description 1
- 102100026083 F-box only protein 41 Human genes 0.000 description 1
- 102100026079 F-box only protein 42 Human genes 0.000 description 1
- 102100026080 F-box only protein 44 Human genes 0.000 description 1
- 102100026081 F-box only protein 46 Human genes 0.000 description 1
- 102100029525 F-box only protein 7 Human genes 0.000 description 1
- 102100029186 F-box only protein 9 Human genes 0.000 description 1
- 102100039836 F-box/LRR-repeat protein 12 Human genes 0.000 description 1
- 102100027747 F-box/LRR-repeat protein 20 Human genes 0.000 description 1
- 102100037315 F-box/LRR-repeat protein 3 Human genes 0.000 description 1
- 102100037316 F-box/LRR-repeat protein 4 Human genes 0.000 description 1
- 102100037338 F-box/LRR-repeat protein 5 Human genes 0.000 description 1
- 102100037343 F-box/LRR-repeat protein 6 Human genes 0.000 description 1
- 102100028066 F-box/LRR-repeat protein 8 Human genes 0.000 description 1
- 102100038577 F-box/WD repeat-containing protein 11 Human genes 0.000 description 1
- 102100038576 F-box/WD repeat-containing protein 1A Human genes 0.000 description 1
- 102100028147 F-box/WD repeat-containing protein 4 Human genes 0.000 description 1
- 101710105178 F-box/WD repeat-containing protein 7 Proteins 0.000 description 1
- 102100028138 F-box/WD repeat-containing protein 7 Human genes 0.000 description 1
- 102100028137 F-box/WD repeat-containing protein 8 Human genes 0.000 description 1
- 102100040672 F-box/WD repeat-containing protein 9 Human genes 0.000 description 1
- 102100034545 FAD synthase region Human genes 0.000 description 1
- 102100036335 FAD-dependent oxidoreductase domain-containing protein 1 Human genes 0.000 description 1
- 102100036315 FAD-dependent oxidoreductase domain-containing protein 2 Human genes 0.000 description 1
- 102000012040 FAM76A Human genes 0.000 description 1
- 108050002538 FAM76A Proteins 0.000 description 1
- 102000012031 FAM76B Human genes 0.000 description 1
- 108050002540 FAM76B Proteins 0.000 description 1
- 102100027279 FAS-associated factor 1 Human genes 0.000 description 1
- 102100022354 FAS-associated factor 2 Human genes 0.000 description 1
- 102100037789 FAST kinase domain-containing protein 1, mitochondrial Human genes 0.000 description 1
- 102000013339 FBXL17 Human genes 0.000 description 1
- 101150000662 FBXL17 gene Proteins 0.000 description 1
- 102000013340 FBXL7 Human genes 0.000 description 1
- 108091007098 FBXO33 Proteins 0.000 description 1
- 102100027623 FERM and PDZ domain-containing protein 4 Human genes 0.000 description 1
- 102100038514 FERM domain-containing protein 3 Human genes 0.000 description 1
- 102100029327 FERM domain-containing protein 4A Human genes 0.000 description 1
- 102100038516 FERM domain-containing protein 6 Human genes 0.000 description 1
- 102100036068 FERM domain-containing protein 8 Human genes 0.000 description 1
- 102100027267 FERM, ARHGEF and pleckstrin domain-containing protein 1 Human genes 0.000 description 1
- 102100037577 FERM, ARHGEF and pleckstrin domain-containing protein 2 Human genes 0.000 description 1
- 102100040135 FGFR1 oncogene partner 2 Human genes 0.000 description 1
- 102100038665 FGGY carbohydrate kinase domain-containing protein Human genes 0.000 description 1
- 102100040130 FH1/FH2 domain-containing protein 1 Human genes 0.000 description 1
- 102100027868 FHF complex subunit HOOK interacting protein 1A Human genes 0.000 description 1
- 102100037683 FHF complex subunit HOOK interacting protein 1B Human genes 0.000 description 1
- 102100037684 FHF complex subunit HOOK interacting protein 2B Human genes 0.000 description 1
- 102100040351 FK506-binding protein 15 Human genes 0.000 description 1
- 102100036136 FLYWCH family member 2 Human genes 0.000 description 1
- 102100036144 FLYWCH-type zinc finger-containing protein 1 Human genes 0.000 description 1
- 102100038547 FSD1-like protein Human genes 0.000 description 1
- 108091007695 FTX Proteins 0.000 description 1
- 102100040834 FXYD domain-containing ion transport regulator 5 Human genes 0.000 description 1
- 102100040936 FXYD domain-containing ion transport regulator 6 Human genes 0.000 description 1
- 102100038636 FYVE, RhoGEF and PH domain-containing protein 2 Human genes 0.000 description 1
- 102100023636 FYVE, RhoGEF and PH domain-containing protein 4 Human genes 0.000 description 1
- 102100040809 Failed axon connections homolog Human genes 0.000 description 1
- 102000009095 Fanconi Anemia Complementation Group A protein Human genes 0.000 description 1
- 108010087740 Fanconi Anemia Complementation Group A protein Proteins 0.000 description 1
- 102000018825 Fanconi Anemia Complementation Group C protein Human genes 0.000 description 1
- 108010027673 Fanconi Anemia Complementation Group C protein Proteins 0.000 description 1
- 102000013601 Fanconi Anemia Complementation Group D2 protein Human genes 0.000 description 1
- 108010026653 Fanconi Anemia Complementation Group D2 protein Proteins 0.000 description 1
- 102000010634 Fanconi Anemia Complementation Group E protein Human genes 0.000 description 1
- 108010077898 Fanconi Anemia Complementation Group E protein Proteins 0.000 description 1
- 102000007122 Fanconi Anemia Complementation Group G protein Human genes 0.000 description 1
- 108010033305 Fanconi Anemia Complementation Group G protein Proteins 0.000 description 1
- 102000052930 Fanconi Anemia Complementation Group L protein Human genes 0.000 description 1
- 108700026162 Fanconi Anemia Complementation Group L protein Proteins 0.000 description 1
- 108010067741 Fanconi Anemia Complementation Group N protein Proteins 0.000 description 1
- 102100027639 Fanconi anemia core complex-associated protein 20 Human genes 0.000 description 1
- 102100022352 Fanconi anemia core complex-associated protein 24 Human genes 0.000 description 1
- 102100027280 Fanconi anemia group A protein Human genes 0.000 description 1
- 102100027285 Fanconi anemia group B protein Human genes 0.000 description 1
- 102100034554 Fanconi anemia group I protein Human genes 0.000 description 1
- 102100034552 Fanconi anemia group M protein Human genes 0.000 description 1
- 102100027284 Fanconi-associated nuclease 1 Human genes 0.000 description 1
- 102100036118 Far upstream element-binding protein 1 Human genes 0.000 description 1
- 102100036123 Far upstream element-binding protein 2 Human genes 0.000 description 1
- 102100036113 Far upstream element-binding protein 3 Human genes 0.000 description 1
- 102100037819 Fas apoptotic inhibitory molecule 1 Human genes 0.000 description 1
- 102100029531 Fas-activated serine/threonine kinase Human genes 0.000 description 1
- 102100031806 Fas-binding factor 1 Human genes 0.000 description 1
- 102100037682 Fasciculation and elongation protein zeta-1 Human genes 0.000 description 1
- 102100037679 Fasciculation and elongation protein zeta-2 Human genes 0.000 description 1
- 102100031106 Fatty acid hydroxylase domain-containing protein 2 Human genes 0.000 description 1
- 102100022366 Fatty acyl-CoA reductase 1 Human genes 0.000 description 1
- 102100029111 Fatty-acid amide hydrolase 1 Human genes 0.000 description 1
- 102100029114 Fatty-acid amide hydrolase 2 Human genes 0.000 description 1
- 101150049384 Fbxl7 gene Proteins 0.000 description 1
- 102100031381 Fc receptor-like A Human genes 0.000 description 1
- 102100039036 Feline leukemia virus subgroup C receptor-related protein 1 Human genes 0.000 description 1
- 102100035049 Feline leukemia virus subgroup C receptor-related protein 2 Human genes 0.000 description 1
- 102100023378 Fer-1-like protein 4 Human genes 0.000 description 1
- 102100040684 Fermitin family homolog 2 Human genes 0.000 description 1
- 102100026117 Ferredoxin-2, mitochondrial Human genes 0.000 description 1
- 102100030771 Ferrochelatase, mitochondrial Human genes 0.000 description 1
- 102100021056 Ferroptosis suppressor protein 1 Human genes 0.000 description 1
- 102100031509 Fibrillin-1 Human genes 0.000 description 1
- 102100031510 Fibrillin-2 Human genes 0.000 description 1
- 102100028417 Fibroblast growth factor 12 Human genes 0.000 description 1
- 102100028073 Fibroblast growth factor 5 Human genes 0.000 description 1
- 102100023593 Fibroblast growth factor receptor 1 Human genes 0.000 description 1
- 101710182386 Fibroblast growth factor receptor 1 Proteins 0.000 description 1
- 102100023600 Fibroblast growth factor receptor 2 Human genes 0.000 description 1
- 101710182389 Fibroblast growth factor receptor 2 Proteins 0.000 description 1
- 102100027842 Fibroblast growth factor receptor 3 Human genes 0.000 description 1
- 101710182396 Fibroblast growth factor receptor 3 Proteins 0.000 description 1
- 102100027844 Fibroblast growth factor receptor 4 Human genes 0.000 description 1
- 102100021066 Fibroblast growth factor receptor substrate 2 Human genes 0.000 description 1
- 102100037362 Fibronectin Human genes 0.000 description 1
- 102100027634 Fibronectin type 3 and ankyrin repeat domains protein 1 Human genes 0.000 description 1
- 102100038546 Fibronectin type III and SPRY domain-containing protein 1 Human genes 0.000 description 1
- 102100026545 Fibronectin type III domain-containing protein 3B Human genes 0.000 description 1
- 102100026542 Fibronectin type-III domain-containing protein 3A Human genes 0.000 description 1
- 102100024459 Fibrosin-1-like protein Human genes 0.000 description 1
- 102100031383 Fibulin-7 Human genes 0.000 description 1
- 102100037000 Fidgetin-like protein 1 Human genes 0.000 description 1
- 102100026561 Filamin-A Human genes 0.000 description 1
- 102100026559 Filamin-B Human genes 0.000 description 1
- 102100037564 Filamin-binding LIM protein 1 Human genes 0.000 description 1
- 102100035831 Filensin Human genes 0.000 description 1
- 102100024058 Flap endonuclease GEN homolog 1 Human genes 0.000 description 1
- 102100023513 Flotillin-2 Human genes 0.000 description 1
- 102100020825 Flt3-interacting zinc finger protein 1 Human genes 0.000 description 1
- 102100027560 Focadhesin Human genes 0.000 description 1
- 102100035139 Folate receptor alpha Human genes 0.000 description 1
- 102100027909 Folliculin Human genes 0.000 description 1
- 102100028819 Folliculin-interacting protein 1 Human genes 0.000 description 1
- 102100028823 Folliculin-interacting protein 2 Human genes 0.000 description 1
- 102100029378 Follistatin-related protein 1 Human genes 0.000 description 1
- 102100020913 Follistatin-related protein 5 Human genes 0.000 description 1
- 108010009307 Forkhead Box Protein O3 Proteins 0.000 description 1
- 102100035128 Forkhead box protein J3 Human genes 0.000 description 1
- 102100035129 Forkhead box protein K2 Human genes 0.000 description 1
- 102100023374 Forkhead box protein M1 Human genes 0.000 description 1
- 102100023360 Forkhead box protein N2 Human genes 0.000 description 1
- 102100023359 Forkhead box protein N3 Human genes 0.000 description 1
- 102100035421 Forkhead box protein O3 Human genes 0.000 description 1
- 102100028122 Forkhead box protein P1 Human genes 0.000 description 1
- 102100028115 Forkhead box protein P2 Human genes 0.000 description 1
- 102100027581 Forkhead box protein P3 Human genes 0.000 description 1
- 102100027579 Forkhead box protein P4 Human genes 0.000 description 1
- 102100027870 Forkhead-associated domain-containing protein 1 Human genes 0.000 description 1
- 102100028924 Formin-2 Human genes 0.000 description 1
- 102100040680 Formin-binding protein 1 Human genes 0.000 description 1
- 102100031389 Formin-binding protein 1-like Human genes 0.000 description 1
- 102100040988 Formin-binding protein 4 Human genes 0.000 description 1
- 102100028931 Formin-like protein 2 Human genes 0.000 description 1
- 102100038644 Four and a half LIM domains protein 2 Human genes 0.000 description 1
- 102100036334 Fragile X mental retardation syndrome-related protein 1 Human genes 0.000 description 1
- 102100036336 Fragile X mental retardation syndrome-related protein 2 Human genes 0.000 description 1
- 102100021262 Frizzled-3 Human genes 0.000 description 1
- 102100039799 Frizzled-6 Human genes 0.000 description 1
- 102100035068 Fructosamine-3-kinase Human genes 0.000 description 1
- 102100022277 Fructose-bisphosphate aldolase A Human genes 0.000 description 1
- 102100027269 Fructose-bisphosphate aldolase C Human genes 0.000 description 1
- 102100037047 Fucose-1-phosphate guanylyltransferase Human genes 0.000 description 1
- 102100022351 Fumarylacetoacetate hydrolase domain-containing protein 2A Human genes 0.000 description 1
- 102100029590 Fumarylacetoacetate hydrolase domain-containing protein 2B Human genes 0.000 description 1
- 102100035233 Furin Human genes 0.000 description 1
- 101150111025 Furin gene Proteins 0.000 description 1
- 102100020976 G kinase-anchoring protein 1 Human genes 0.000 description 1
- 102100023936 G patch domain-containing protein 11 Human genes 0.000 description 1
- 102100039805 G patch domain-containing protein 2 Human genes 0.000 description 1
- 102100023938 G patch domain-containing protein 2-like Human genes 0.000 description 1
- 102100039830 G patch domain-containing protein 4 Human genes 0.000 description 1
- 102100039833 G patch domain-containing protein 8 Human genes 0.000 description 1
- 102100022148 G protein pathway suppressor 2 Human genes 0.000 description 1
- 102100023734 G protein-coupled receptor kinase 4 Human genes 0.000 description 1
- 102100023685 G protein-coupled receptor kinase 5 Human genes 0.000 description 1
- 102100023686 G protein-coupled receptor kinase 6 Human genes 0.000 description 1
- 102100030393 G-patch domain and KOW motifs-containing protein Human genes 0.000 description 1
- 102100025361 G-protein coupled receptor 161 Human genes 0.000 description 1
- 102100021200 G-protein coupled receptor 176 Human genes 0.000 description 1
- 102100030656 G-protein coupled receptor-associated protein LMBRD2 Human genes 0.000 description 1
- 102100036001 G-protein coupled receptor-associated sorting protein 1 Human genes 0.000 description 1
- 102100023940 G-protein-signaling modulator 1 Human genes 0.000 description 1
- 102100023941 G-protein-signaling modulator 2 Human genes 0.000 description 1
- 102100037859 G1/S-specific cyclin-D3 Human genes 0.000 description 1
- 102100037854 G1/S-specific cyclin-E2 Human genes 0.000 description 1
- 102100037488 G2 and S phase-expressed protein 1 Human genes 0.000 description 1
- 102100035577 G2/M phase-specific E3 ubiquitin-protein ligase Human genes 0.000 description 1
- 102100032340 G2/mitotic-specific cyclin-B1 Human genes 0.000 description 1
- 102100035237 GA-binding protein alpha chain Human genes 0.000 description 1
- 102000017694 GABRA3 Human genes 0.000 description 1
- 102000017707 GABRB3 Human genes 0.000 description 1
- 102000019448 GART Human genes 0.000 description 1
- 102100031411 GAS2-like protein 1 Human genes 0.000 description 1
- 102100031158 GAS2-like protein 3 Human genes 0.000 description 1
- 102100022688 GATOR complex protein DEPDC5 Human genes 0.000 description 1
- 102100037807 GATOR complex protein MIOS Human genes 0.000 description 1
- 102100022360 GATOR complex protein NPRL2 Human genes 0.000 description 1
- 102100022357 GATOR complex protein NPRL3 Human genes 0.000 description 1
- 102100033425 GDNF family receptor alpha-2 Human genes 0.000 description 1
- 102100034600 GDNF-inducible zinc finger protein 1 Human genes 0.000 description 1
- 102100033821 GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase Human genes 0.000 description 1
- 108010062427 GDP-mannose 4,6-dehydratase Proteins 0.000 description 1
- 102000002312 GDPmannose 4,6-dehydratase Human genes 0.000 description 1
- 102100034265 GEM-interacting protein Human genes 0.000 description 1
- 101710102635 GEM-interacting protein Proteins 0.000 description 1
- 102000018134 GID8 Human genes 0.000 description 1
- 101150039487 GID8 gene Proteins 0.000 description 1
- 102100021189 GMP reductase 2 Human genes 0.000 description 1
- 108091060519 GNAS-AS1 Proteins 0.000 description 1
- 102100025328 GON-4-like protein Human genes 0.000 description 1
- 102100036715 GPALPP motifs-containing protein 1 Human genes 0.000 description 1
- 102100025089 GPN-loop GTPase 1 Human genes 0.000 description 1
- 102100033884 GPN-loop GTPase 3 Human genes 0.000 description 1
- 102100036838 GRAM domain-containing protein 2B Human genes 0.000 description 1
- 102100038392 GRAM domain-containing protein 4 Human genes 0.000 description 1
- 108700031835 GRB10 Adaptor Proteins 0.000 description 1
- 102100040178 GRB10-interacting GYF protein 1 Human genes 0.000 description 1
- 102100040196 GRB10-interacting GYF protein 2 Human genes 0.000 description 1
- 102100035950 GRB2-associated and regulator of MAPK protein 1 Human genes 0.000 description 1
- 102100037759 GRB2-associated-binding protein 2 Human genes 0.000 description 1
- 102100023930 GREB1-like protein Human genes 0.000 description 1
- 102100028617 GRIP and coiled-coil domain-containing protein 2 Human genes 0.000 description 1
- 101710185062 GSK3-beta interaction protein Proteins 0.000 description 1
- 102100038107 GSK3B-interacting protein Human genes 0.000 description 1
- 101710149581 GSK3B-interacting protein Proteins 0.000 description 1
- 102100027346 GTP cyclohydrolase 1 Human genes 0.000 description 1
- 102100023448 GTP-binding protein 1 Human genes 0.000 description 1
- 102100023466 GTP-binding protein 2 Human genes 0.000 description 1
- 102100036483 GTP-binding protein 8 Human genes 0.000 description 1
- 102100037941 GTP-binding protein Di-Ras1 Human genes 0.000 description 1
- 102100033512 GTP:AMP phosphotransferase AK3, mitochondrial Human genes 0.000 description 1
- 102100029974 GTPase HRas Human genes 0.000 description 1
- 102100035945 GTPase-activating Rap/Ran-GAP domain-like protein 3 Human genes 0.000 description 1
- 102100031692 GTPase-activating protein and VPS9 domain-containing protein 1 Human genes 0.000 description 1
- 102100037777 Galactokinase Human genes 0.000 description 1
- 102100036291 Galactose-1-phosphate uridylyltransferase Human genes 0.000 description 1
- 102100028464 Galactose-3-O-sulfotransferase 4 Human genes 0.000 description 1
- 102100039554 Galectin-8 Human genes 0.000 description 1
- 102100031351 Galectin-9 Human genes 0.000 description 1
- 102100028652 Gamma-enolase Human genes 0.000 description 1
- 102100034013 Gamma-glutamyl phosphate reductase Human genes 0.000 description 1
- 102100024375 Gamma-glutamylaminecyclotransferase Human genes 0.000 description 1
- 101710201613 Gamma-glutamylaminecyclotransferase Proteins 0.000 description 1
- 102100040004 Gamma-glutamylcyclotransferase Human genes 0.000 description 1
- 102100022951 Gamma-secretase subunit APH-1A Human genes 0.000 description 1
- 102100033713 Gamma-secretase subunit APH-1B Human genes 0.000 description 1
- 102100039718 Gamma-secretase-activating protein Human genes 0.000 description 1
- 101710184700 Gamma-secretase-activating protein Proteins 0.000 description 1
- 102100030916 Gamma-soluble NSF attachment protein Human genes 0.000 description 1
- 102100024411 Ganglioside-induced differentiation-associated protein 1 Human genes 0.000 description 1
- 101710143708 Ganglioside-induced differentiation-associated protein 1 Proteins 0.000 description 1
- 102100034327 Ganglioside-induced differentiation-associated protein 1-like 1 Human genes 0.000 description 1
- 102100024084 Ganglioside-induced differentiation-associated protein 2 Human genes 0.000 description 1
- 102100028953 Gelsolin Human genes 0.000 description 1
- 102100039956 Geminin Human genes 0.000 description 1
- 102100035184 General transcription and DNA repair factor IIH helicase subunit XPD Human genes 0.000 description 1
- 102100036536 General transcription factor 3C polypeptide 2 Human genes 0.000 description 1
- 102100036531 General transcription factor 3C polypeptide 3 Human genes 0.000 description 1
- 102100036530 General transcription factor 3C polypeptide 4 Human genes 0.000 description 1
- 102100035099 General transcription factor 3C polypeptide 5 Human genes 0.000 description 1
- 102100022967 General transcription factor II-I repeat domain-containing protein 1 Human genes 0.000 description 1
- 102100037472 General transcription factor II-I repeat domain-containing protein 2A Human genes 0.000 description 1
- 102100037475 General transcription factor II-I repeat domain-containing protein 2B Human genes 0.000 description 1
- 102100033840 General transcription factor IIF subunit 1 Human genes 0.000 description 1
- 102100038308 General transcription factor IIH subunit 1 Human genes 0.000 description 1
- 102100032864 General transcription factor IIH subunit 2 Human genes 0.000 description 1
- 102100032863 General transcription factor IIH subunit 3 Human genes 0.000 description 1
- 102100039291 Geranylgeranyl pyrophosphate synthase Human genes 0.000 description 1
- 102100023303 Germ cell-less protein-like 1 Human genes 0.000 description 1
- 102100037412 Germinal-center associated nuclear protein Human genes 0.000 description 1
- 101710194542 Germinal-center associated nuclear protein Proteins 0.000 description 1
- 102100036769 Girdin Human genes 0.000 description 1
- 102100041013 Glia maturation factor beta Human genes 0.000 description 1
- 102100041007 Glia maturation factor gamma Human genes 0.000 description 1
- 102100025894 Glomulin Human genes 0.000 description 1
- 102100041011 Glucocorticoid modulatory element-binding protein 1 Human genes 0.000 description 1
- 102100033417 Glucocorticoid receptor Human genes 0.000 description 1
- 102100028689 Glucocorticoid-induced transcript 1 protein Human genes 0.000 description 1
- 102100023951 Glucosamine 6-phosphate N-acetyltransferase Human genes 0.000 description 1
- 102100036702 Glucosamine-6-phosphate isomerase 2 Human genes 0.000 description 1
- 102100036327 Glucose-6-phosphatase 3 Human genes 0.000 description 1
- 102100031132 Glucose-6-phosphate isomerase Human genes 0.000 description 1
- 102100029017 Glucose-fructose oxidoreductase domain-containing protein 2 Human genes 0.000 description 1
- 102100028650 Glucose-induced degradation protein 4 homolog Human genes 0.000 description 1
- 102100030669 Glutamate receptor 3 Human genes 0.000 description 1
- 102100022626 Glutamate receptor ionotropic, NMDA 2D Human genes 0.000 description 1
- 102100038958 Glutamate receptor ionotropic, NMDA 3B Human genes 0.000 description 1
- 102100039696 Glutamate-cysteine ligase catalytic subunit Human genes 0.000 description 1
- 102100025536 Glutamate-rich protein 1 Human genes 0.000 description 1
- 102100025563 Glutamate-rich protein 2 Human genes 0.000 description 1
- 102100025961 Glutaminase liver isoform, mitochondrial Human genes 0.000 description 1
- 102100036270 Glutamine amidotransferase-like class 1 domain-containing protein 1 Human genes 0.000 description 1
- 102100020972 Glutamine amidotransferase-like class 1 domain-containing protein 3, mitochondrial Human genes 0.000 description 1
- 102100023518 Glutamine-dependent NAD(+) synthetase Human genes 0.000 description 1
- 102100033429 Glutamine-fructose-6-phosphate aminotransferase [isomerizing] 1 Human genes 0.000 description 1
- 102100033424 Glutamine-fructose-6-phosphate aminotransferase [isomerizing] 2 Human genes 0.000 description 1
- 102100036596 Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial Human genes 0.000 description 1
- 102100036424 Glutaredoxin-3 Human genes 0.000 description 1
- 102100037467 Glutaredoxin-like protein C5orf63 Human genes 0.000 description 1
- 102100028603 Glutaryl-CoA dehydrogenase, mitochondrial Human genes 0.000 description 1
- 102100033369 Glutathione S-transferase A4 Human genes 0.000 description 1
- 102100022981 Glutathione S-transferase C-terminal domain-containing protein Human genes 0.000 description 1
- 102100036533 Glutathione S-transferase Mu 2 Human genes 0.000 description 1
- 102100023523 Glutathione S-transferase Mu 4 Human genes 0.000 description 1
- 102100039651 Glutathione S-transferase kappa 1 Human genes 0.000 description 1
- 102100038055 Glutathione S-transferase theta-1 Human genes 0.000 description 1
- 102100033931 Glutathione S-transferase theta-2B Human genes 0.000 description 1
- 102100033932 Glutathione S-transferase theta-4 Human genes 0.000 description 1
- 102100034062 Glutathione hydrolase 5 proenzyme Human genes 0.000 description 1
- 102100036755 Glutathione peroxidase 7 Human genes 0.000 description 1
- 102100036442 Glutathione reductase, mitochondrial Human genes 0.000 description 1
- 102100032923 Glutathione-specific gamma-glutamylcyclotransferase 2 Human genes 0.000 description 1
- 102100025591 Glycerate kinase Human genes 0.000 description 1
- 102100025376 Glycerol-3-phosphate acyltransferase 4 Human genes 0.000 description 1
- 101710199766 Glycerol-3-phosphate acyltransferase 4 Proteins 0.000 description 1
- 102100022556 Glycerol-3-phosphate dehydrogenase 1-like protein Human genes 0.000 description 1
- 102100021192 Glycerophosphocholine phosphodiesterase GPCPD1 Human genes 0.000 description 1
- 102100040782 Glycerophosphodiester phosphodiesterase domain-containing protein 5 Human genes 0.000 description 1
- 102100040677 Glycine N-methyltransferase Human genes 0.000 description 1
- 102100025506 Glycine cleavage system H protein, mitochondrial Human genes 0.000 description 1
- 102100033495 Glycine dehydrogenase (decarboxylating), mitochondrial Human genes 0.000 description 1
- 102100033958 Glycine receptor subunit beta Human genes 0.000 description 1
- 108010051975 Glycogen Synthase Kinase 3 beta Proteins 0.000 description 1
- 102100038104 Glycogen synthase kinase-3 beta Human genes 0.000 description 1
- 102100039280 Glycogenin-1 Human genes 0.000 description 1
- 102100025303 Glycogenin-2 Human genes 0.000 description 1
- 102100034551 Glycolipid transfer protein Human genes 0.000 description 1
- 101710094738 Glycolipid transfer protein Proteins 0.000 description 1
- 102100023179 Glycoprotein endo-alpha-1,2-mannosidase-like protein Human genes 0.000 description 1
- 102100034034 Glycoprotein integral membrane protein 1 Human genes 0.000 description 1
- 102100021700 Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 Human genes 0.000 description 1
- 102100037825 Glycosaminoglycan xylosylkinase Human genes 0.000 description 1
- 102100025888 Glycosylated lysosomal membrane protein Human genes 0.000 description 1
- 102100036716 Glycosylphosphatidylinositol anchor attachment 1 protein Human genes 0.000 description 1
- 102100040139 Glycosyltransferase 1 domain-containing protein 1 Human genes 0.000 description 1
- 102100028698 Glycosyltransferase 8 domain-containing protein 1 Human genes 0.000 description 1
- 102100024404 Glycosyltransferase 8 domain-containing protein 2 Human genes 0.000 description 1
- 102100037474 Glycosyltransferase-like domain-containing protein 1 Human genes 0.000 description 1
- 102100028085 Glycylpeptide N-tetradecanoyltransferase 1 Human genes 0.000 description 1
- 102100023122 Glycylpeptide N-tetradecanoyltransferase 2 Human genes 0.000 description 1
- 102100030648 Glyoxylate reductase/hydroxypyruvate reductase Human genes 0.000 description 1
- 102100021196 Glypican-5 Human genes 0.000 description 1
- 102100021194 Glypican-6 Human genes 0.000 description 1
- 102100023324 Golgi SNAP receptor complex member 1 Human genes 0.000 description 1
- 102100034223 Golgi apparatus protein 1 Human genes 0.000 description 1
- 102100021182 Golgi integral membrane protein 4 Human genes 0.000 description 1
- 102100033802 Golgi pH regulator A Human genes 0.000 description 1
- 102100033801 Golgi pH regulator B Human genes 0.000 description 1
- 102100035710 Golgi phosphoprotein 3-like Human genes 0.000 description 1
- 102100036698 Golgi reassembly-stacking protein 1 Human genes 0.000 description 1
- 102100036700 Golgi reassembly-stacking protein 2 Human genes 0.000 description 1
- 102100040000 Golgi to ER traffic protein 4 homolog Human genes 0.000 description 1
- 102100036675 Golgi-associated PDZ and coiled-coil motif-containing protein Human genes 0.000 description 1
- 102100031488 Golgi-associated plant pathogenesis-related protein 1 Human genes 0.000 description 1
- 102100033325 Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 Human genes 0.000 description 1
- 102100032564 Golgin subfamily A member 2 Human genes 0.000 description 1
- 102100032565 Golgin subfamily A member 3 Human genes 0.000 description 1
- 102100032560 Golgin subfamily A member 4 Human genes 0.000 description 1
- 102100040159 Golgin subfamily A member 6-like protein 10 Human genes 0.000 description 1
- 102100040187 Golgin subfamily A member 6-like protein 9 Human genes 0.000 description 1
- 102100041033 Golgin subfamily B member 1 Human genes 0.000 description 1
- 102100025326 Golgin-45 Human genes 0.000 description 1
- 102100034228 Grainyhead-like protein 1 homolog Human genes 0.000 description 1
- 102100033505 Granule associated Rac and RHOG effector protein 1 Human genes 0.000 description 1
- 101150090959 Grb10 gene Proteins 0.000 description 1
- 102100038353 Gremlin-2 Human genes 0.000 description 1
- 102100031150 Growth arrest and DNA damage-inducible protein GADD45 alpha Human genes 0.000 description 1
- 102100031487 Growth arrest-specific protein 6 Human genes 0.000 description 1
- 102100031493 Growth arrest-specific protein 7 Human genes 0.000 description 1
- 102100023910 Growth factor receptor-bound protein 10 Human genes 0.000 description 1
- 102100023001 Growth hormone-regulated TBC protein 1 Human genes 0.000 description 1
- 102100023683 GrpE protein homolog 2, mitochondrial Human genes 0.000 description 1
- 102100021383 Guanine nucleotide exchange factor DBS Human genes 0.000 description 1
- 102100035910 Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 Human genes 0.000 description 1
- 102100035913 Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4 Human genes 0.000 description 1
- 102100035786 Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 Human genes 0.000 description 1
- 102100035354 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 Human genes 0.000 description 1
- 102100032610 Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas Human genes 0.000 description 1
- 102100036733 Guanine nucleotide-binding protein subunit alpha-12 Human genes 0.000 description 1
- 102100036703 Guanine nucleotide-binding protein subunit alpha-13 Human genes 0.000 description 1
- 102100035340 Guanine nucleotide-binding protein subunit beta-4 Human genes 0.000 description 1
- 102100023281 Guanine nucleotide-binding protein subunit beta-5 Human genes 0.000 description 1
- 102100024979 Guanine nucleotide-binding protein subunit beta-like protein 1 Human genes 0.000 description 1
- 102100040468 Guanylate kinase Human genes 0.000 description 1
- 102100028539 Guanylate-binding protein 5 Human genes 0.000 description 1
- 102100033969 Guanylyl cyclase-activating protein 1 Human genes 0.000 description 1
- 102100025594 Guided entry of tail-anchored proteins factor CAMLG Human genes 0.000 description 1
- 102100034058 Gypsy retrotransposon integrase-like protein 1 Human genes 0.000 description 1
- 102100034477 H(+)/Cl(-) exchange transporter 3 Human genes 0.000 description 1
- 102100034471 H(+)/Cl(-) exchange transporter 5 Human genes 0.000 description 1
- 102100034473 H(+)/Cl(-) exchange transporter 6 Human genes 0.000 description 1
- 102100039334 HAUS augmin-like complex subunit 1 Human genes 0.000 description 1
- 102100039333 HAUS augmin-like complex subunit 2 Human genes 0.000 description 1
- 102100039317 HAUS augmin-like complex subunit 3 Human genes 0.000 description 1
- 102100039336 HAUS augmin-like complex subunit 4 Human genes 0.000 description 1
- 102100039335 HAUS augmin-like complex subunit 5 Human genes 0.000 description 1
- 102100039318 HAUS augmin-like complex subunit 6 Human genes 0.000 description 1
- 102100039321 HAUS augmin-like complex subunit 7 Human genes 0.000 description 1
- 102100034454 HAUS augmin-like complex subunit 8 Human genes 0.000 description 1
- 102100027377 HBS1-like protein Human genes 0.000 description 1
- 102100034445 HCLS1-associated protein X-1 Human genes 0.000 description 1
- 108091005772 HDAC11 Proteins 0.000 description 1
- 102100030493 HEAT repeat-containing protein 1 Human genes 0.000 description 1
- 102100030494 HEAT repeat-containing protein 3 Human genes 0.000 description 1
- 102100028490 HEAT repeat-containing protein 5A Human genes 0.000 description 1
- 102100028484 HEAT repeat-containing protein 5B Human genes 0.000 description 1
- 102100030488 HEAT repeat-containing protein 6 Human genes 0.000 description 1
- 102000016052 HEXIM2 Human genes 0.000 description 1
- 108050004369 HEXIM2 Proteins 0.000 description 1
- 102100031610 HIRA-interacting protein 3 Human genes 0.000 description 1
- 102100028972 HLA class I histocompatibility antigen, A alpha chain Human genes 0.000 description 1
- 102100028971 HLA class I histocompatibility antigen, C alpha chain Human genes 0.000 description 1
- 102100028966 HLA class I histocompatibility antigen, alpha chain F Human genes 0.000 description 1
- 102100028636 HLA class II histocompatibility antigen, DR beta 4 chain Human genes 0.000 description 1
- 102100040485 HLA class II histocompatibility antigen, DRB1 beta chain Human genes 0.000 description 1
- 108010075704 HLA-A Antigens Proteins 0.000 description 1
- 108010052199 HLA-C Antigens Proteins 0.000 description 1
- 108010039343 HLA-DRB1 Chains Proteins 0.000 description 1
- 108010040960 HLA-DRB4 Chains Proteins 0.000 description 1
- 102100022969 HMG box transcription factor BBX Human genes 0.000 description 1
- 102100028151 HMG domain-containing protein 3 Human genes 0.000 description 1
- 102100028150 HMG domain-containing protein 4 Human genes 0.000 description 1
- 101150027051 HO1 gene Proteins 0.000 description 1
- 102100030373 HSPB1-associated protein 1 Human genes 0.000 description 1
- 101150106066 HSPBP1 gene Proteins 0.000 description 1
- 102100034680 Haloacid dehalogenase-like hydrolase domain-containing 5 Human genes 0.000 description 1
- 102100039392 Haloacid dehalogenase-like hydrolase domain-containing protein 2 Human genes 0.000 description 1
- 102100031628 Heat shock 70 kDa protein 12A Human genes 0.000 description 1
- 102100021410 Heat shock 70 kDa protein 14 Human genes 0.000 description 1
- 102100028765 Heat shock 70 kDa protein 4 Human genes 0.000 description 1
- 102100034048 Heat shock factor 2-binding protein Human genes 0.000 description 1
- 102100032606 Heat shock factor protein 1 Human genes 0.000 description 1
- 102100034049 Heat shock factor protein 2 Human genes 0.000 description 1
- 102100034047 Heat shock factor protein 4 Human genes 0.000 description 1
- 102100034051 Heat shock protein HSP 90-alpha Human genes 0.000 description 1
- 102100027489 Helicase-like transcription factor Human genes 0.000 description 1
- 102100031963 Heme-binding protein 2 Human genes 0.000 description 1
- 102100028893 Hemicentin-1 Human genes 0.000 description 1
- 101800000637 Hemokinin Proteins 0.000 description 1
- 102100029001 Heparan sulfate 2-O-sulfotransferase 1 Human genes 0.000 description 1
- 102100031497 Heparan sulfate N-sulfotransferase 1 Human genes 0.000 description 1
- 102100023929 Heparan sulfate glucosamine 3-O-sulfotransferase 3A1 Human genes 0.000 description 1
- 102100039991 Heparan-alpha-glucosaminide N-acetyltransferase Human genes 0.000 description 1
- 102100039383 Heparan-sulfate 6-O-sulfotransferase 1 Human genes 0.000 description 1
- 102100039381 Heparan-sulfate 6-O-sulfotransferase 2 Human genes 0.000 description 1
- 102100024025 Heparanase Human genes 0.000 description 1
- 102100022557 Hepatocyte growth factor-regulated tyrosine kinase substrate Human genes 0.000 description 1
- 102100031001 Hepatoma-derived growth factor-related protein 2 Human genes 0.000 description 1
- 102100039389 Hepatoma-derived growth factor-related protein 3 Human genes 0.000 description 1
- 102100028902 Hermansky-Pudlak syndrome 1 protein Human genes 0.000 description 1
- 102100028716 Hermansky-Pudlak syndrome 3 protein Human genes 0.000 description 1
- 102100028715 Hermansky-Pudlak syndrome 4 protein Human genes 0.000 description 1
- 102100028721 Hermansky-Pudlak syndrome 5 protein Human genes 0.000 description 1
- 102100037848 Heterochromatin protein 1-binding protein 3 Human genes 0.000 description 1
- 102100035617 Heterogeneous nuclear ribonucleoprotein A/B Human genes 0.000 description 1
- 102100035621 Heterogeneous nuclear ribonucleoprotein A1 Human genes 0.000 description 1
- 102100028155 Heterogeneous nuclear ribonucleoprotein A1-like 2 Human genes 0.000 description 1
- 102100035669 Heterogeneous nuclear ribonucleoprotein A3 Human genes 0.000 description 1
- 102100027706 Heterogeneous nuclear ribonucleoprotein D-like Human genes 0.000 description 1
- 102100033985 Heterogeneous nuclear ribonucleoprotein D0 Human genes 0.000 description 1
- 102100027738 Heterogeneous nuclear ribonucleoprotein H Human genes 0.000 description 1
- 102100028909 Heterogeneous nuclear ribonucleoprotein K Human genes 0.000 description 1
- 102100028818 Heterogeneous nuclear ribonucleoprotein L Human genes 0.000 description 1
- 102100033993 Heterogeneous nuclear ribonucleoprotein L-like Human genes 0.000 description 1
- 102100028895 Heterogeneous nuclear ribonucleoprotein M Human genes 0.000 description 1
- 102100023999 Heterogeneous nuclear ribonucleoprotein R Human genes 0.000 description 1
- 102100033998 Heterogeneous nuclear ribonucleoprotein U-like protein 1 Human genes 0.000 description 1
- 102100035616 Heterogeneous nuclear ribonucleoproteins A2/B1 Human genes 0.000 description 1
- 102100033994 Heterogeneous nuclear ribonucleoproteins C1/C2 Human genes 0.000 description 1
- 102100036269 Hexosaminidase D Human genes 0.000 description 1
- 102100026122 High affinity immunoglobulin gamma Fc receptor I Human genes 0.000 description 1
- 102100035108 High affinity nerve growth factor receptor Human genes 0.000 description 1
- 102100031336 High mobility group nucleosome-binding domain-containing protein 3 Human genes 0.000 description 1
- 102100028177 High mobility group nucleosome-binding domain-containing protein 4 Human genes 0.000 description 1
- 102100028176 High mobility group nucleosome-binding domain-containing protein 5 Human genes 0.000 description 1
- 102100029009 High mobility group protein HMG-I/HMG-Y Human genes 0.000 description 1
- 102100038561 Highly divergent homeobox Human genes 0.000 description 1
- 102100028993 Hippocalcin-like protein 1 Human genes 0.000 description 1
- 102100029747 Hippocampus abundant transcript-like protein 1 Human genes 0.000 description 1
- 102100029746 Hippocampus abundant transcript-like protein 2 Human genes 0.000 description 1
- 102100031004 Histidine-tRNA ligase, cytoplasmic Human genes 0.000 description 1
- 102100030673 Histone H2A.V Human genes 0.000 description 1
- 102100030689 Histone H2B type 1-D Human genes 0.000 description 1
- 102100030445 Histone H4 transcription factor Human genes 0.000 description 1
- 102100022901 Histone acetyltransferase KAT2A Human genes 0.000 description 1
- 102100022893 Histone acetyltransferase KAT5 Human genes 0.000 description 1
- 102100033071 Histone acetyltransferase KAT6A Human genes 0.000 description 1
- 102100033070 Histone acetyltransferase KAT6B Human genes 0.000 description 1
- 102100033068 Histone acetyltransferase KAT7 Human genes 0.000 description 1
- 102100033069 Histone acetyltransferase KAT8 Human genes 0.000 description 1
- 102100038885 Histone acetyltransferase p300 Human genes 0.000 description 1
- 102100021467 Histone acetyltransferase type B catalytic subunit Human genes 0.000 description 1
- 102100039996 Histone deacetylase 1 Human genes 0.000 description 1
- 102100039385 Histone deacetylase 11 Human genes 0.000 description 1
- 102100039999 Histone deacetylase 2 Human genes 0.000 description 1
- 102100021455 Histone deacetylase 3 Human genes 0.000 description 1
- 102100021454 Histone deacetylase 4 Human genes 0.000 description 1
- 102100021453 Histone deacetylase 5 Human genes 0.000 description 1
- 102100038715 Histone deacetylase 8 Human genes 0.000 description 1
- 102100022103 Histone-lysine N-methyltransferase 2A Human genes 0.000 description 1
- 102100022102 Histone-lysine N-methyltransferase 2B Human genes 0.000 description 1
- 102100027755 Histone-lysine N-methyltransferase 2C Human genes 0.000 description 1
- 102100027768 Histone-lysine N-methyltransferase 2D Human genes 0.000 description 1
- 102100026265 Histone-lysine N-methyltransferase ASH1L Human genes 0.000 description 1
- 102100035043 Histone-lysine N-methyltransferase EHMT1 Human genes 0.000 description 1
- 102100027770 Histone-lysine N-methyltransferase KMT5B Human genes 0.000 description 1
- 102100027788 Histone-lysine N-methyltransferase KMT5C Human genes 0.000 description 1
- 102100039121 Histone-lysine N-methyltransferase MECOM Human genes 0.000 description 1
- 102100029234 Histone-lysine N-methyltransferase NSD2 Human genes 0.000 description 1
- 102100029235 Histone-lysine N-methyltransferase NSD3 Human genes 0.000 description 1
- 102100029239 Histone-lysine N-methyltransferase, H3 lysine-36 specific Human genes 0.000 description 1
- 102100039489 Histone-lysine N-methyltransferase, H3 lysine-79 specific Human genes 0.000 description 1
- 102100022107 Holliday junction recognition protein Human genes 0.000 description 1
- 102100026342 Homeobox protein BarH-like 2 Human genes 0.000 description 1
- 102100030087 Homeobox protein DLX-1 Human genes 0.000 description 1
- 102100023830 Homeobox protein EMX2 Human genes 0.000 description 1
- 102100030309 Homeobox protein Hox-A1 Human genes 0.000 description 1
- 102100039541 Homeobox protein Hox-A3 Human genes 0.000 description 1
- 102100025110 Homeobox protein Hox-A5 Human genes 0.000 description 1
- 102100022649 Homeobox protein Hox-A6 Human genes 0.000 description 1
- 102100021090 Homeobox protein Hox-A9 Human genes 0.000 description 1
- 102100028411 Homeobox protein Hox-B3 Human genes 0.000 description 1
- 102100025056 Homeobox protein Hox-B6 Human genes 0.000 description 1
- 102100025061 Homeobox protein Hox-B7 Human genes 0.000 description 1
- 102100029423 Homeobox protein Hox-B8 Human genes 0.000 description 1
- 102100020759 Homeobox protein Hox-C4 Human genes 0.000 description 1
- 102100020762 Homeobox protein Hox-C5 Human genes 0.000 description 1
- 102100029695 Homeobox protein Meis1 Human genes 0.000 description 1
- 102100034826 Homeobox protein Meis2 Human genes 0.000 description 1
- 102100030234 Homeobox protein cut-like 1 Human genes 0.000 description 1
- 102100030231 Homeobox protein cut-like 2 Human genes 0.000 description 1
- 102100028171 Homeobox-containing protein 1 Human genes 0.000 description 1
- 102100032822 Homeodomain-interacting protein kinase 1 Human genes 0.000 description 1
- 102100032826 Homeodomain-interacting protein kinase 3 Human genes 0.000 description 1
- 102100023605 Homer protein homolog 2 Human genes 0.000 description 1
- 101000797917 Homo sapiens 1,5-anhydro-D-fructose reductase Proteins 0.000 description 1
- 101001126450 Homo sapiens 1-acyl-sn-glycerol-3-phosphate acyltransferase delta Proteins 0.000 description 1
- 101000691569 Homo sapiens 1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon Proteins 0.000 description 1
- 101000605576 Homo sapiens 1-acyl-sn-glycerol-3-phosphate acyltransferase gamma Proteins 0.000 description 1
- 101000608799 Homo sapiens 116 kDa U5 small nuclear ribonucleoprotein component Proteins 0.000 description 1
- 101001013578 Homo sapiens 12S rRNA N4-methylcytidine (m4C) methyltransferase Proteins 0.000 description 1
- 101000806245 Homo sapiens 17-beta-hydroxysteroid dehydrogenase 14 Proteins 0.000 description 1
- 101001041661 Homo sapiens 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing], mitochondrial Proteins 0.000 description 1
- 101000866191 Homo sapiens 2-(3-amino-3-carboxypropyl)histidine synthase subunit 1 Proteins 0.000 description 1
- 101000909233 Homo sapiens 2-(3-amino-3-carboxypropyl)histidine synthase subunit 2 Proteins 0.000 description 1
- 101001115709 Homo sapiens 2-acylglycerol O-acyltransferase 3 Proteins 0.000 description 1
- 101001009252 Homo sapiens 2-hydroxyacyl-CoA lyase 1 Proteins 0.000 description 1
- 101001009238 Homo sapiens 2-hydroxyacyl-CoA lyase 2 Proteins 0.000 description 1
- 101000952940 Homo sapiens 2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial Proteins 0.000 description 1
- 101000982620 Homo sapiens 2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2 Proteins 0.000 description 1
- 101000982616 Homo sapiens 2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3 Proteins 0.000 description 1
- 101000982656 Homo sapiens 2-oxoglutarate dehydrogenase, mitochondrial Proteins 0.000 description 1
- 101000585732 Homo sapiens 2-oxoglutarate dehydrogenase-like, mitochondrial Proteins 0.000 description 1
- 101000597680 Homo sapiens 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial Proteins 0.000 description 1
- 101000957683 Homo sapiens 24-hydroxycholesterol 7-alpha-hydroxylase Proteins 0.000 description 1
- 101000699882 Homo sapiens 28S ribosomal protein S10, mitochondrial Proteins 0.000 description 1
- 101000694321 Homo sapiens 28S ribosomal protein S18c, mitochondrial Proteins 0.000 description 1
- 101000858479 Homo sapiens 28S ribosomal protein S25, mitochondrial Proteins 0.000 description 1
- 101000727483 Homo sapiens 28S ribosomal protein S28, mitochondrial Proteins 0.000 description 1
- 101000727490 Homo sapiens 28S ribosomal protein S29, mitochondrial Proteins 0.000 description 1
- 101000689847 Homo sapiens 28S ribosomal protein S31, mitochondrial Proteins 0.000 description 1
- 101000689823 Homo sapiens 28S ribosomal protein S35, mitochondrial Proteins 0.000 description 1
- 101000858488 Homo sapiens 28S ribosomal protein S5, mitochondrial Proteins 0.000 description 1
- 101000935623 Homo sapiens 3'(2'),5'-bisphosphate nucleotidase 1 Proteins 0.000 description 1
- 101000938755 Homo sapiens 3'-5' exoribonuclease 1 Proteins 0.000 description 1
- 101000866618 Homo sapiens 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase Proteins 0.000 description 1
- 101000988577 Homo sapiens 3-hydroxy-3-methylglutaryl-coenzyme A reductase Proteins 0.000 description 1
- 101000896020 Homo sapiens 3-hydroxyacyl-CoA dehydrogenase Proteins 0.000 description 1
- 101000764864 Homo sapiens 3-hydroxybutyrate dehydrogenase type 2 Proteins 0.000 description 1
- 101000872461 Homo sapiens 3-hydroxyisobutyryl-CoA hydrolase, mitochondrial Proteins 0.000 description 1
- 101000841262 Homo sapiens 3-ketoacyl-CoA thiolase Proteins 0.000 description 1
- 101000753843 Homo sapiens 3-mercaptopyruvate sulfurtransferase Proteins 0.000 description 1
- 101000691550 Homo sapiens 39S ribosomal protein L13, mitochondrial Proteins 0.000 description 1
- 101000650291 Homo sapiens 39S ribosomal protein L17, mitochondrial Proteins 0.000 description 1
- 101001079807 Homo sapiens 39S ribosomal protein L18, mitochondrial Proteins 0.000 description 1
- 101000670366 Homo sapiens 39S ribosomal protein L2, mitochondrial Proteins 0.000 description 1
- 101000711427 Homo sapiens 39S ribosomal protein L21, mitochondrial Proteins 0.000 description 1
- 101000711436 Homo sapiens 39S ribosomal protein L22, mitochondrial Proteins 0.000 description 1
- 101001107423 Homo sapiens 39S ribosomal protein L24, mitochondrial Proteins 0.000 description 1
- 101000670355 Homo sapiens 39S ribosomal protein L33, mitochondrial Proteins 0.000 description 1
- 101000650367 Homo sapiens 39S ribosomal protein L38, mitochondrial Proteins 0.000 description 1
- 101000711507 Homo sapiens 39S ribosomal protein L43, mitochondrial Proteins 0.000 description 1
- 101000733888 Homo sapiens 39S ribosomal protein L45, mitochondrial Proteins 0.000 description 1
- 101000733895 Homo sapiens 39S ribosomal protein L47, mitochondrial Proteins 0.000 description 1
- 101000733907 Homo sapiens 39S ribosomal protein L48, mitochondrial Proteins 0.000 description 1
- 101001107014 Homo sapiens 39S ribosomal protein L52, mitochondrial Proteins 0.000 description 1
- 101000667530 Homo sapiens 39S ribosomal protein L55, mitochondrial Proteins 0.000 description 1
- 101001104245 Homo sapiens 39S ribosomal protein L9, mitochondrial Proteins 0.000 description 1
- 101000639842 Homo sapiens 39S ribosomal protein S18a, mitochondrial Proteins 0.000 description 1
- 101000725614 Homo sapiens 4-hydroxybenzoate polyprenyltransferase, mitochondrial Proteins 0.000 description 1
- 101000591192 Homo sapiens 5'(3')-deoxyribonucleotidase, cytosolic type Proteins 0.000 description 1
- 101000604437 Homo sapiens 5'(3')-deoxyribonucleotidase, mitochondrial Proteins 0.000 description 1
- 101001066900 Homo sapiens 5'-deoxynucleotidase HDDC2 Proteins 0.000 description 1
- 101000604533 Homo sapiens 5'-nucleotidase domain-containing protein 2 Proteins 0.000 description 1
- 101000843649 Homo sapiens 5-aminolevulinate synthase, nonspecific, mitochondrial Proteins 0.000 description 1
- 101000895045 Homo sapiens 5-azacytidine-induced protein 2 Proteins 0.000 description 1
- 101000770593 Homo sapiens 5-demethoxyubiquinone hydroxylase, mitochondrial Proteins 0.000 description 1
- 101001108645 Homo sapiens 5-methylcytosine rRNA methyltransferase NSUN4 Proteins 0.000 description 1
- 101000720962 Homo sapiens 5-oxoprolinase Proteins 0.000 description 1
- 101001066181 Homo sapiens 6-phosphogluconolactonase Proteins 0.000 description 1
- 101000603190 Homo sapiens 60S ribosomal export protein NMD3 Proteins 0.000 description 1
- 101001125072 Homo sapiens 60S ribosome subunit biogenesis protein NIP7 homolog Proteins 0.000 description 1
- 101000915160 Homo sapiens 7-methylguanosine phosphate-specific 5'-nucleotidase Proteins 0.000 description 1
- 101000774717 Homo sapiens A-kinase anchor protein 1, mitochondrial Proteins 0.000 description 1
- 101000779365 Homo sapiens A-kinase anchor protein 10, mitochondrial Proteins 0.000 description 1
- 101000779390 Homo sapiens A-kinase anchor protein 11 Proteins 0.000 description 1
- 101000779382 Homo sapiens A-kinase anchor protein 12 Proteins 0.000 description 1
- 101000833679 Homo sapiens A-kinase anchor protein 13 Proteins 0.000 description 1
- 101000774738 Homo sapiens A-kinase anchor protein 2 Proteins 0.000 description 1
- 101000890611 Homo sapiens A-kinase anchor protein 6 Proteins 0.000 description 1
- 101000774725 Homo sapiens A-kinase anchor protein 7 isoform gamma Proteins 0.000 description 1
- 101000774727 Homo sapiens A-kinase anchor protein 7 isoforms alpha and beta Proteins 0.000 description 1
- 101000890594 Homo sapiens A-kinase anchor protein 8 Proteins 0.000 description 1
- 101000890598 Homo sapiens A-kinase anchor protein 9 Proteins 0.000 description 1
- 101000959553 Homo sapiens A-kinase-interacting protein 1 Proteins 0.000 description 1
- 101000578912 Homo sapiens ADP-ribose glycohydrolase MACROD1 Proteins 0.000 description 1
- 101000578915 Homo sapiens ADP-ribose glycohydrolase MACROD2 Proteins 0.000 description 1
- 101001008861 Homo sapiens ADP-ribose glycohydrolase OARD1 Proteins 0.000 description 1
- 101000751611 Homo sapiens ADP-ribosylation factor GTPase-activating protein 1 Proteins 0.000 description 1
- 101000927511 Homo sapiens ADP-ribosylation factor GTPase-activating protein 2 Proteins 0.000 description 1
- 101001037093 Homo sapiens ADP-ribosylation factor-binding protein GGA1 Proteins 0.000 description 1
- 101001037079 Homo sapiens ADP-ribosylation factor-binding protein GGA3 Proteins 0.000 description 1
- 101000757620 Homo sapiens ADP-ribosylation factor-like protein 13B Proteins 0.000 description 1
- 101000974504 Homo sapiens ADP-ribosylation factor-like protein 15 Proteins 0.000 description 1
- 101000974510 Homo sapiens ADP-ribosylation factor-like protein 16 Proteins 0.000 description 1
- 101000886101 Homo sapiens ADP-ribosylation factor-like protein 2 Proteins 0.000 description 1
- 101000886004 Homo sapiens ADP-ribosylation factor-like protein 3 Proteins 0.000 description 1
- 101000974439 Homo sapiens ADP-ribosylation factor-like protein 5B Proteins 0.000 description 1
- 101000769028 Homo sapiens ADP-ribosylation factor-like protein 6 Proteins 0.000 description 1
- 101000793563 Homo sapiens ADP-ribosylation factor-like protein 6-interacting protein 6 Proteins 0.000 description 1
- 101000769035 Homo sapiens ADP-ribosylation factor-like protein 8A Proteins 0.000 description 1
- 101000809413 Homo sapiens ADP-ribosylation factor-related protein 1 Proteins 0.000 description 1
- 101000833180 Homo sapiens AF4/FMR2 family member 1 Proteins 0.000 description 1
- 101000833166 Homo sapiens AF4/FMR2 family member 3 Proteins 0.000 description 1
- 101000833170 Homo sapiens AF4/FMR2 family member 4 Proteins 0.000 description 1
- 101000780581 Homo sapiens AFG1-like ATPase Proteins 0.000 description 1
- 101000780591 Homo sapiens AFG3-like protein 2 Proteins 0.000 description 1
- 101000718065 Homo sapiens AKT-interacting protein Proteins 0.000 description 1
- 101000776351 Homo sapiens ALK and LTK ligand 2 Proteins 0.000 description 1
- 101000779641 Homo sapiens ALK tyrosine kinase receptor Proteins 0.000 description 1
- 101000719174 Homo sapiens AMMECR1-like protein Proteins 0.000 description 1
- 101000797458 Homo sapiens AMP deaminase 2 Proteins 0.000 description 1
- 101000779222 Homo sapiens AP-1 complex subunit beta-1 Proteins 0.000 description 1
- 101000779234 Homo sapiens AP-1 complex subunit gamma-1 Proteins 0.000 description 1
- 101000924643 Homo sapiens AP-1 complex subunit mu-1 Proteins 0.000 description 1
- 101000768016 Homo sapiens AP-1 complex subunit sigma-2 Proteins 0.000 description 1
- 101000768014 Homo sapiens AP-1 complex subunit sigma-3 Proteins 0.000 description 1
- 101000779216 Homo sapiens AP-1 complex-associated regulatory protein Proteins 0.000 description 1
- 101000757299 Homo sapiens AP-2 complex subunit alpha-1 Proteins 0.000 description 1
- 101000757394 Homo sapiens AP-2 complex subunit alpha-2 Proteins 0.000 description 1
- 101000732341 Homo sapiens AP-2 complex subunit beta Proteins 0.000 description 1
- 101000796047 Homo sapiens AP-2 complex subunit mu Proteins 0.000 description 1
- 101000779239 Homo sapiens AP-3 complex subunit beta-1 Proteins 0.000 description 1
- 101000779237 Homo sapiens AP-3 complex subunit beta-2 Proteins 0.000 description 1
- 101000779252 Homo sapiens AP-3 complex subunit delta-1 Proteins 0.000 description 1
- 101000959726 Homo sapiens AP-3 complex subunit mu-1 Proteins 0.000 description 1
- 101000959718 Homo sapiens AP-3 complex subunit mu-2 Proteins 0.000 description 1
- 101000959710 Homo sapiens AP-3 complex subunit sigma-1 Proteins 0.000 description 1
- 101000928581 Homo sapiens AP-4 complex subunit beta-1 Proteins 0.000 description 1
- 101000928557 Homo sapiens AP-4 complex subunit epsilon-1 Proteins 0.000 description 1
- 101000928565 Homo sapiens AP-4 complex subunit mu-1 Proteins 0.000 description 1
- 101000890223 Homo sapiens AP-5 complex subunit mu-1 Proteins 0.000 description 1
- 101000890230 Homo sapiens AP-5 complex subunit sigma-1 Proteins 0.000 description 1
- 101100323521 Homo sapiens APOL1 gene Proteins 0.000 description 1
- 101000888642 Homo sapiens ARF GTPase-activating protein GIT2 Proteins 0.000 description 1
- 101000890563 Homo sapiens ARL14 effector protein Proteins 0.000 description 1
- 101000728238 Homo sapiens ASNSD1 upstream open reading frame protein Proteins 0.000 description 1
- 101000833502 Homo sapiens AT-hook DNA-binding motif-containing protein 1 Proteins 0.000 description 1
- 101000924255 Homo sapiens AT-rich interactive domain-containing protein 1B Proteins 0.000 description 1
- 101000685261 Homo sapiens AT-rich interactive domain-containing protein 2 Proteins 0.000 description 1
- 101000792933 Homo sapiens AT-rich interactive domain-containing protein 4A Proteins 0.000 description 1
- 101000792935 Homo sapiens AT-rich interactive domain-containing protein 4B Proteins 0.000 description 1
- 101000792952 Homo sapiens AT-rich interactive domain-containing protein 5A Proteins 0.000 description 1
- 101000792947 Homo sapiens AT-rich interactive domain-containing protein 5B Proteins 0.000 description 1
- 101000905623 Homo sapiens ATP synthase F(0) complex subunit B1, mitochondrial Proteins 0.000 description 1
- 101000789413 Homo sapiens ATP synthase mitochondrial F1 complex assembly factor 1 Proteins 0.000 description 1
- 101000936108 Homo sapiens ATP synthase mitochondrial F1 complex assembly factor 2 Proteins 0.000 description 1
- 101000833848 Homo sapiens ATP synthase subunit C lysine N-methyltransferase Proteins 0.000 description 1
- 101000970995 Homo sapiens ATP synthase subunit O, mitochondrial Proteins 0.000 description 1
- 101000936976 Homo sapiens ATP synthase subunit d, mitochondrial Proteins 0.000 description 1
- 101000936958 Homo sapiens ATP synthase subunit e, mitochondrial Proteins 0.000 description 1
- 101000765664 Homo sapiens ATP synthase subunit f, mitochondrial Proteins 0.000 description 1
- 101000730170 Homo sapiens ATP synthase subunit gamma, mitochondrial Proteins 0.000 description 1
- 101000701311 Homo sapiens ATP synthase subunit s, mitochondrial Proteins 0.000 description 1
- 101000936965 Homo sapiens ATP synthase-coupling factor 6, mitochondrial Proteins 0.000 description 1
- 101001124829 Homo sapiens ATP-dependent (S)-NAD(P)H-hydrate dehydratase Proteins 0.000 description 1
- 101000722210 Homo sapiens ATP-dependent DNA helicase DDX11 Proteins 0.000 description 1
- 101000901942 Homo sapiens ATP-dependent DNA/RNA helicase DHX36 Proteins 0.000 description 1
- 101001041697 Homo sapiens ATP-dependent RNA helicase DDX1 Proteins 0.000 description 1
- 101000830459 Homo sapiens ATP-dependent RNA helicase DDX19A Proteins 0.000 description 1
- 101000830477 Homo sapiens ATP-dependent RNA helicase DDX19B Proteins 0.000 description 1
- 101000874173 Homo sapiens ATP-dependent RNA helicase DDX42 Proteins 0.000 description 1
- 101000830424 Homo sapiens ATP-dependent RNA helicase DDX50 Proteins 0.000 description 1
- 101000883820 Homo sapiens ATP-dependent RNA helicase DDX55 Proteins 0.000 description 1
- 101000907886 Homo sapiens ATP-dependent RNA helicase DHX15 Proteins 0.000 description 1
- 101000907919 Homo sapiens ATP-dependent RNA helicase DHX29 Proteins 0.000 description 1
- 101000901948 Homo sapiens ATP-dependent RNA helicase DHX30 Proteins 0.000 description 1
- 101000901934 Homo sapiens ATP-dependent RNA helicase DHX33 Proteins 0.000 description 1
- 101000864666 Homo sapiens ATP-dependent RNA helicase DHX8 Proteins 0.000 description 1
- 101000930807 Homo sapiens ATP-dependent RNA helicase DQX1 Proteins 0.000 description 1
- 101001051808 Homo sapiens ATPase MORC2 Proteins 0.000 description 1
- 101000887284 Homo sapiens ATPase family AAA domain-containing protein 2 Proteins 0.000 description 1
- 101000923353 Homo sapiens ATPase family AAA domain-containing protein 2B Proteins 0.000 description 1
- 101000923360 Homo sapiens ATPase family AAA domain-containing protein 3A Proteins 0.000 description 1
- 101000923358 Homo sapiens ATPase family AAA domain-containing protein 3B Proteins 0.000 description 1
- 101000789829 Homo sapiens ATPase family AAA domain-containing protein 5 Proteins 0.000 description 1
- 101001006387 Homo sapiens Abasic site processing protein HMCES Proteins 0.000 description 1
- 101000900939 Homo sapiens Abnormal spindle-like microcephaly-associated protein Proteins 0.000 description 1
- 101000770471 Homo sapiens Acetylcholinesterase collagenic tail peptide Proteins 0.000 description 1
- 101001060527 Homo sapiens Acidic fibroblast growth factor intracellular-binding protein Proteins 0.000 description 1
- 101000757200 Homo sapiens Acidic leucine-rich nuclear phosphoprotein 32 family member A Proteins 0.000 description 1
- 101000925574 Homo sapiens Actin-related protein 2/3 complex subunit 3 Proteins 0.000 description 1
- 101000785745 Homo sapiens Actin-related protein 2/3 complex subunit 5-like protein Proteins 0.000 description 1
- 101000836967 Homo sapiens Activating molecule in BECN1-regulated autophagy protein 1 Proteins 0.000 description 1
- 101000784207 Homo sapiens Activating signal cointegrator 1 complex subunit 1 Proteins 0.000 description 1
- 101000784204 Homo sapiens Activating signal cointegrator 1 complex subunit 2 Proteins 0.000 description 1
- 101000784211 Homo sapiens Activating signal cointegrator 1 complex subunit 3 Proteins 0.000 description 1
- 101000583789 Homo sapiens Activating transcription factor 7-interacting protein 2 Proteins 0.000 description 1
- 101000848239 Homo sapiens Acyl-CoA (8-3)-desaturase Proteins 0.000 description 1
- 101000848255 Homo sapiens Acyl-CoA 6-desaturase Proteins 0.000 description 1
- 101001042227 Homo sapiens Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 Proteins 0.000 description 1
- 101000824278 Homo sapiens Acyl-[acyl-carrier-protein] hydrolase Proteins 0.000 description 1
- 101000594506 Homo sapiens Acyl-coenzyme A diphosphatase NUDT19 Proteins 0.000 description 1
- 101001038518 Homo sapiens Acyl-protein thioesterase 1 Proteins 0.000 description 1
- 101000798584 Homo sapiens Acylamino-acid-releasing enzyme Proteins 0.000 description 1
- 101000889541 Homo sapiens Acyloxyacyl hydrolase Proteins 0.000 description 1
- 101000979309 Homo sapiens Adaptin ear-binding coat-associated protein 2 Proteins 0.000 description 1
- 101001000351 Homo sapiens Adenine DNA glycosylase Proteins 0.000 description 1
- 101000889392 Homo sapiens Adenine nucleotide translocase lysine N-methyltransferase Proteins 0.000 description 1
- 101000924577 Homo sapiens Adenomatous polyposis coli protein Proteins 0.000 description 1
- 101001006021 Homo sapiens Adenosine 5'-monophosphoramidase HINT3 Proteins 0.000 description 1
- 101000822527 Homo sapiens Adenosylhomocysteinase 3 Proteins 0.000 description 1
- 101001077073 Homo sapiens Adenylate kinase 8 Proteins 0.000 description 1
- 101001077066 Homo sapiens Adenylate kinase 9 Proteins 0.000 description 1
- 101000897856 Homo sapiens Adenylyl cyclase-associated protein 2 Proteins 0.000 description 1
- 101000833098 Homo sapiens Adrenodoxin, mitochondrial Proteins 0.000 description 1
- 101000928246 Homo sapiens Afadin Proteins 0.000 description 1
- 101000959594 Homo sapiens Agrin Proteins 0.000 description 1
- 101000761405 Homo sapiens Aldehyde dehydrogenase family 16 member A1 Proteins 0.000 description 1
- 101000717967 Homo sapiens Aldehyde dehydrogenase family 3 member A2 Proteins 0.000 description 1
- 101000717973 Homo sapiens Aldehyde dehydrogenase family 3 member B1 Proteins 0.000 description 1
- 101000928314 Homo sapiens Aldehyde oxidase Proteins 0.000 description 1
- 101000718007 Homo sapiens Aldo-keto reductase family 1 member A1 Proteins 0.000 description 1
- 101000891521 Homo sapiens Alkylated DNA repair protein alkB homolog 8 Proteins 0.000 description 1
- 101000799143 Homo sapiens Alkyldihydroxyacetonephosphate synthase, peroxisomal Proteins 0.000 description 1
- 101000862183 Homo sapiens Alpha-(1,3)-fucosyltransferase 10 Proteins 0.000 description 1
- 101000819490 Homo sapiens Alpha-(1,6)-fucosyltransferase Proteins 0.000 description 1
- 101000717828 Homo sapiens Alpha-1,2-mannosyltransferase ALG9 Proteins 0.000 description 1
- 101000951413 Homo sapiens Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B Proteins 0.000 description 1
- 101000951398 Homo sapiens Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C Proteins 0.000 description 1
- 101000891547 Homo sapiens Alpha-1,3/1,6-mannosyltransferase ALG2 Proteins 0.000 description 1
- 101000951392 Homo sapiens Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A Proteins 0.000 description 1
- 101000588435 Homo sapiens Alpha-N-acetylgalactosaminidase Proteins 0.000 description 1
- 101000690235 Homo sapiens Alpha-aminoadipic semialdehyde dehydrogenase Proteins 0.000 description 1
- 101000732641 Homo sapiens Alpha-amylase 2B Proteins 0.000 description 1
- 101000922043 Homo sapiens Alpha-catulin Proteins 0.000 description 1
- 101000614179 Homo sapiens Alpha-ketoglutarate dehydrogenase component 4 Proteins 0.000 description 1
- 101001062620 Homo sapiens Alpha-ketoglutarate-dependent dioxygenase FTO Proteins 0.000 description 1
- 101000959152 Homo sapiens Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 Proteins 0.000 description 1
- 101000891530 Homo sapiens Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 Proteins 0.000 description 1
- 101000979029 Homo sapiens Alpha-mannosidase 2C1 Proteins 0.000 description 1
- 101000779568 Homo sapiens Alpha-protein kinase 1 Proteins 0.000 description 1
- 101000779565 Homo sapiens Alpha-protein kinase 2 Proteins 0.000 description 1
- 101000825859 Homo sapiens Alpha-soluble NSF attachment protein Proteins 0.000 description 1
- 101000776160 Homo sapiens Alsin Proteins 0.000 description 1
- 101000924727 Homo sapiens Alternative prion protein Proteins 0.000 description 1
- 101000755762 Homo sapiens Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 Proteins 0.000 description 1
- 101000755758 Homo sapiens Aminoacyl tRNA synthase complex-interacting multifunctional protein 2 Proteins 0.000 description 1
- 101000887804 Homo sapiens Aminomethyltransferase, mitochondrial Proteins 0.000 description 1
- 101000779845 Homo sapiens Amphiphysin Proteins 0.000 description 1
- 101000893559 Homo sapiens Amylo-alpha-1,6-glucosidase Proteins 0.000 description 1
- 101000890407 Homo sapiens Amyloid beta precursor like protein 1 Proteins 0.000 description 1
- 101000928680 Homo sapiens Amyloid beta precursor protein binding family B member 2 Proteins 0.000 description 1
- 101000779309 Homo sapiens Amyloid protein-binding protein 2 Proteins 0.000 description 1
- 101000928690 Homo sapiens Amyloid-beta A4 precursor protein-binding family A member 1 Proteins 0.000 description 1
- 101000928677 Homo sapiens Amyloid-beta A4 precursor protein-binding family A member 2 Proteins 0.000 description 1
- 101000928673 Homo sapiens Amyloid-beta A4 precursor protein-binding family A member 3 Proteins 0.000 description 1
- 101000896743 Homo sapiens Anamorsin Proteins 0.000 description 1
- 101000733701 Homo sapiens Anaphase-promoting complex subunit 15 Proteins 0.000 description 1
- 101000718108 Homo sapiens Androgen-induced gene 1 protein Proteins 0.000 description 1
- 101000690725 Homo sapiens Angiogenic factor with G patch and FHA domains 1 Proteins 0.000 description 1
- 101000891154 Homo sapiens Angiomotin Proteins 0.000 description 1
- 101000891169 Homo sapiens Angiomotin-like protein 1 Proteins 0.000 description 1
- 101000924552 Homo sapiens Angiopoietin-1 Proteins 0.000 description 1
- 101000732632 Homo sapiens Anillin Proteins 0.000 description 1
- 101000928347 Homo sapiens Ankyrin repeat and EF-hand domain-containing protein 1 Proteins 0.000 description 1
- 101000959548 Homo sapiens Ankyrin repeat and IBR domain-containing protein 1 Proteins 0.000 description 1
- 101000928335 Homo sapiens Ankyrin repeat and KH domain-containing protein 1 Proteins 0.000 description 1
- 101000889389 Homo sapiens Ankyrin repeat and LEM domain-containing protein 2 Proteins 0.000 description 1
- 101000732621 Homo sapiens Ankyrin repeat and MYND domain-containing protein 1 Proteins 0.000 description 1
- 101000732622 Homo sapiens Ankyrin repeat and MYND domain-containing protein 2 Proteins 0.000 description 1
- 101000694621 Homo sapiens Ankyrin repeat and SAM domain-containing protein 1A Proteins 0.000 description 1
- 101000961316 Homo sapiens Ankyrin repeat and SAM domain-containing protein 3 Proteins 0.000 description 1
- 101000961279 Homo sapiens Ankyrin repeat and SAM domain-containing protein 6 Proteins 0.000 description 1
- 101000925496 Homo sapiens Ankyrin repeat and SOCS box protein 1 Proteins 0.000 description 1
- 101000925512 Homo sapiens Ankyrin repeat and SOCS box protein 13 Proteins 0.000 description 1
- 101000754296 Homo sapiens Ankyrin repeat and SOCS box protein 3 Proteins 0.000 description 1
- 101000754305 Homo sapiens Ankyrin repeat and SOCS box protein 6 Proteins 0.000 description 1
- 101000732626 Homo sapiens Ankyrin repeat and zinc finger domain-containing protein 1 Proteins 0.000 description 1
- 101000924478 Homo sapiens Ankyrin repeat domain-containing protein 10 Proteins 0.000 description 1
- 101000924476 Homo sapiens Ankyrin repeat domain-containing protein 11 Proteins 0.000 description 1
- 101000924485 Homo sapiens Ankyrin repeat domain-containing protein 12 Proteins 0.000 description 1
- 101000780149 Homo sapiens Ankyrin repeat domain-containing protein 13A Proteins 0.000 description 1
- 101000780039 Homo sapiens Ankyrin repeat domain-containing protein 13C Proteins 0.000 description 1
- 101000757210 Homo sapiens Ankyrin repeat domain-containing protein 13D Proteins 0.000 description 1
- 101000924481 Homo sapiens Ankyrin repeat domain-containing protein 17 Proteins 0.000 description 1
- 101000780116 Homo sapiens Ankyrin repeat domain-containing protein 26 Proteins 0.000 description 1
- 101000780114 Homo sapiens Ankyrin repeat domain-containing protein 27 Proteins 0.000 description 1
- 101000924356 Homo sapiens Ankyrin repeat domain-containing protein 33B Proteins 0.000 description 1
- 101000732537 Homo sapiens Ankyrin repeat domain-containing protein 35 Proteins 0.000 description 1
- 101000924343 Homo sapiens Ankyrin repeat domain-containing protein 36A Proteins 0.000 description 1
- 101000732539 Homo sapiens Ankyrin repeat domain-containing protein 37 Proteins 0.000 description 1
- 101000732378 Homo sapiens Ankyrin repeat domain-containing protein 39 Proteins 0.000 description 1
- 101000732375 Homo sapiens Ankyrin repeat domain-containing protein 45 Proteins 0.000 description 1
- 101000889428 Homo sapiens Ankyrin repeat domain-containing protein 46 Proteins 0.000 description 1
- 101000889457 Homo sapiens Ankyrin repeat domain-containing protein 49 Proteins 0.000 description 1
- 101000889572 Homo sapiens Ankyrin repeat domain-containing protein 54 Proteins 0.000 description 1
- 101000961303 Homo sapiens Ankyrin repeat domain-containing protein 6 Proteins 0.000 description 1
- 101000796083 Homo sapiens Ankyrin repeat family A protein 2 Proteins 0.000 description 1
- 101000928344 Homo sapiens Ankyrin-2 Proteins 0.000 description 1
- 101000928342 Homo sapiens Ankyrin-3 Proteins 0.000 description 1
- 101000768066 Homo sapiens Annexin A11 Proteins 0.000 description 1
- 101000924474 Homo sapiens Annexin A2 Proteins 0.000 description 1
- 101000924461 Homo sapiens Annexin A4 Proteins 0.000 description 1
- 101000780137 Homo sapiens Annexin A6 Proteins 0.000 description 1
- 101000780144 Homo sapiens Annexin A7 Proteins 0.000 description 1
- 101000928366 Homo sapiens Anoctamin-4 Proteins 0.000 description 1
- 101000928364 Homo sapiens Anoctamin-5 Proteins 0.000 description 1
- 101000928362 Homo sapiens Anoctamin-6 Proteins 0.000 description 1
- 101000928357 Homo sapiens Anoctamin-8 Proteins 0.000 description 1
- 101000693801 Homo sapiens Anti-Muellerian hormone type-2 receptor Proteins 0.000 description 1
- 101000615334 Homo sapiens Antileukoproteinase Proteins 0.000 description 1
- 101000798222 Homo sapiens Antizyme inhibitor 2 Proteins 0.000 description 1
- 101000780564 Homo sapiens Apical endosomal glycoprotein Proteins 0.000 description 1
- 101000928701 Homo sapiens Apolipoprotein L domain-containing protein 1 Proteins 0.000 description 1
- 101000793430 Homo sapiens Apolipoprotein L2 Proteins 0.000 description 1
- 101000793443 Homo sapiens Apolipoprotein L3 Proteins 0.000 description 1
- 101000959871 Homo sapiens Apoptosis inhibitor 5 Proteins 0.000 description 1
- 101000890622 Homo sapiens Apoptosis-inducing factor 1, mitochondrial Proteins 0.000 description 1
- 101000923549 Homo sapiens Apoptosis-resistant E3 ubiquitin protein ligase 1 Proteins 0.000 description 1
- 101000924629 Homo sapiens Apoptotic protease-activating factor 1 Proteins 0.000 description 1
- 101000757586 Homo sapiens Aprataxin Proteins 0.000 description 1
- 101000889833 Homo sapiens Archaemetzincin-2 Proteins 0.000 description 1
- 101000833311 Homo sapiens Arf-GAP domain and FG repeat-containing protein 2 Proteins 0.000 description 1
- 101000928218 Homo sapiens Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1 Proteins 0.000 description 1
- 101000928222 Homo sapiens Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3 Proteins 0.000 description 1
- 101000928209 Homo sapiens Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 6 Proteins 0.000 description 1
- 101000928207 Homo sapiens Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 9 Proteins 0.000 description 1
- 101000733555 Homo sapiens Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1 Proteins 0.000 description 1
- 101000733557 Homo sapiens Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 2 Proteins 0.000 description 1
- 101000975752 Homo sapiens Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 Proteins 0.000 description 1
- 101000785915 Homo sapiens Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 Proteins 0.000 description 1
- 101000785919 Homo sapiens Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3 Proteins 0.000 description 1
- 101000792706 Homo sapiens Arfaptin-1 Proteins 0.000 description 1
- 101000809446 Homo sapiens Arfaptin-2 Proteins 0.000 description 1
- 101000588484 Homo sapiens Arginine-hydroxylase NDUFAF5, mitochondrial Proteins 0.000 description 1
- 101000886906 Homo sapiens Arginyl-tRNA-protein transferase 1 Proteins 0.000 description 1
- 101000923072 Homo sapiens Armadillo repeat protein deleted in velo-cardio-facial syndrome Proteins 0.000 description 1
- 101000925943 Homo sapiens Armadillo repeat-containing X-linked protein 1 Proteins 0.000 description 1
- 101000925939 Homo sapiens Armadillo repeat-containing X-linked protein 2 Proteins 0.000 description 1
- 101000925948 Homo sapiens Armadillo repeat-containing X-linked protein 3 Proteins 0.000 description 1
- 101000925931 Homo sapiens Armadillo repeat-containing X-linked protein 5 Proteins 0.000 description 1
- 101000769233 Homo sapiens Armadillo repeat-containing protein 10 Proteins 0.000 description 1
- 101000684967 Homo sapiens Armadillo repeat-containing protein 2 Proteins 0.000 description 1
- 101000685097 Homo sapiens Armadillo repeat-containing protein 6 Proteins 0.000 description 1
- 101000927955 Homo sapiens Armadillo repeat-containing protein 7 Proteins 0.000 description 1
- 101000927961 Homo sapiens Armadillo repeat-containing protein 8 Proteins 0.000 description 1
- 101000792888 Homo sapiens Armadillo-like helical domain containing protein 1 Proteins 0.000 description 1
- 101000792905 Homo sapiens Armadillo-like helical domain-containing protein 3 Proteins 0.000 description 1
- 101000785762 Homo sapiens Arrestin domain-containing protein 1 Proteins 0.000 description 1
- 101000785765 Homo sapiens Arrestin domain-containing protein 2 Proteins 0.000 description 1
- 101000785775 Homo sapiens Arrestin domain-containing protein 3 Proteins 0.000 description 1
- 101000901111 Homo sapiens Arsenite methyltransferase Proteins 0.000 description 1
- 101000785776 Homo sapiens Artemin Proteins 0.000 description 1
- 101000793115 Homo sapiens Aryl hydrocarbon receptor nuclear translocator Proteins 0.000 description 1
- 101000768838 Homo sapiens Aryl hydrocarbon receptor nuclear translocator 2 Proteins 0.000 description 1
- 101000740484 Homo sapiens Aryl hydrocarbon receptor nuclear translocator-like protein 1 Proteins 0.000 description 1
- 101000923070 Homo sapiens Arylsulfatase B Proteins 0.000 description 1
- 101000925559 Homo sapiens Arylsulfatase D Proteins 0.000 description 1
- 101000925514 Homo sapiens Arylsulfatase J Proteins 0.000 description 1
- 101000975821 Homo sapiens Arylsulfatase K Proteins 0.000 description 1
- 101000884244 Homo sapiens Asparagine synthetase domain-containing protein 1 Proteins 0.000 description 1
- 101000696909 Homo sapiens Aspartate-tRNA ligase, cytoplasmic Proteins 0.000 description 1
- 101000630206 Homo sapiens Aspartate-tRNA ligase, mitochondrial Proteins 0.000 description 1
- 101000927708 Homo sapiens Aspartyl aminopeptidase Proteins 0.000 description 1
- 101000901030 Homo sapiens Aspartyl/asparaginyl beta-hydroxylase Proteins 0.000 description 1
- 101000936743 Homo sapiens Astrotactin-2 Proteins 0.000 description 1
- 101000873101 Homo sapiens Ataxin-1-like Proteins 0.000 description 1
- 101000873088 Homo sapiens Ataxin-2-like protein Proteins 0.000 description 1
- 101000974896 Homo sapiens Ataxin-7-like protein 1 Proteins 0.000 description 1
- 101000974898 Homo sapiens Ataxin-7-like protein 2 Proteins 0.000 description 1
- 101000974945 Homo sapiens Ataxin-7-like protein 3 Proteins 0.000 description 1
- 101000936983 Homo sapiens Atlastin-1 Proteins 0.000 description 1
- 101000936988 Homo sapiens Atlastin-2 Proteins 0.000 description 1
- 101000936990 Homo sapiens Atlastin-3 Proteins 0.000 description 1
- 101000961044 Homo sapiens Atrial natriuretic peptide receptor 1 Proteins 0.000 description 1
- 101000961040 Homo sapiens Atrial natriuretic peptide receptor 2 Proteins 0.000 description 1
- 101000785083 Homo sapiens Atrophin-1 Proteins 0.000 description 1
- 101000697936 Homo sapiens Attractin Proteins 0.000 description 1
- 101000697938 Homo sapiens Attractin-like protein 1 Proteins 0.000 description 1
- 101000875771 Homo sapiens Atypical kinase COQ8A, mitochondrial Proteins 0.000 description 1
- 101000875775 Homo sapiens Atypical kinase COQ8B, mitochondrial Proteins 0.000 description 1
- 101000798306 Homo sapiens Aurora kinase B Proteins 0.000 description 1
- 101000874361 Homo sapiens Autism susceptibility gene 2 protein Proteins 0.000 description 1
- 101000785138 Homo sapiens Autophagy-related protein 13 Proteins 0.000 description 1
- 101000964092 Homo sapiens Autophagy-related protein 16-1 Proteins 0.000 description 1
- 101000905703 Homo sapiens Autophagy-related protein 2 homolog B Proteins 0.000 description 1
- 101000785057 Homo sapiens Autophagy-related protein 9A Proteins 0.000 description 1
- 101000755749 Homo sapiens Axin interactor, dorsalization-associated protein Proteins 0.000 description 1
- 101000874566 Homo sapiens Axin-1 Proteins 0.000 description 1
- 101001036313 Homo sapiens Axonemal dynein light intermediate polypeptide 1 Proteins 0.000 description 1
- 101000864323 Homo sapiens B box and SPRY domain-containing protein Proteins 0.000 description 1
- 101000864344 Homo sapiens B- and T-lymphocyte attenuator Proteins 0.000 description 1
- 101000971230 Homo sapiens B-cell CLL/lymphoma 7 protein family member A Proteins 0.000 description 1
- 101000798484 Homo sapiens B-cell CLL/lymphoma 7 protein family member B Proteins 0.000 description 1
- 101000798476 Homo sapiens B-cell CLL/lymphoma 7 protein family member C Proteins 0.000 description 1
- 101000798495 Homo sapiens B-cell CLL/lymphoma 9 protein Proteins 0.000 description 1
- 101000798491 Homo sapiens B-cell CLL/lymphoma 9-like protein Proteins 0.000 description 1
- 101000803266 Homo sapiens B-cell linker protein Proteins 0.000 description 1
- 101000903703 Homo sapiens B-cell lymphoma/leukemia 11A Proteins 0.000 description 1
- 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 description 1
- 101000695703 Homo sapiens B2 bradykinin receptor Proteins 0.000 description 1
- 101000936600 Homo sapiens B9 domain-containing protein 1 Proteins 0.000 description 1
- 101000936627 Homo sapiens B9 domain-containing protein 2 Proteins 0.000 description 1
- 101000697866 Homo sapiens BAG family molecular chaperone regulator 4 Proteins 0.000 description 1
- 101000937836 Homo sapiens BAH and coiled-coil domain-containing protein 1 Proteins 0.000 description 1
- 101000874276 Homo sapiens BBSome-interacting protein 1 Proteins 0.000 description 1
- 101000766273 Homo sapiens BCAS3 microtubule associated cell migration factor Proteins 0.000 description 1
- 101000894688 Homo sapiens BCL-6 corepressor-like protein 1 Proteins 0.000 description 1
- 101000740576 Homo sapiens BCL2/adenovirus E1B 19 kDa protein-interacting protein 2 Proteins 0.000 description 1
- 101000798486 Homo sapiens BCLAF1 and THRAP3 family member 3 Proteins 0.000 description 1
- 101100165236 Homo sapiens BCOR gene Proteins 0.000 description 1
- 101000596896 Homo sapiens BDNF/NT-3 growth factors receptor Proteins 0.000 description 1
- 101000971247 Homo sapiens BEN domain-containing protein 5 Proteins 0.000 description 1
- 101000739794 Homo sapiens BEN domain-containing protein 6 Proteins 0.000 description 1
- 101000739800 Homo sapiens BEN domain-containing protein 7 Proteins 0.000 description 1
- 101000873626 Homo sapiens BICD family-like cargo adapter 1 Proteins 0.000 description 1
- 101000934605 Homo sapiens BLOC-1-related complex subunit 8 Proteins 0.000 description 1
- 101000762370 Homo sapiens BMP-2-inducible protein kinase Proteins 0.000 description 1
- 101000933354 Homo sapiens BMP/retinoic acid-inducible neural-specific protein 3 Proteins 0.000 description 1
- 101100437786 Homo sapiens BOC gene Proteins 0.000 description 1
- 101000695387 Homo sapiens BRCA1-associated ATM activator 1 Proteins 0.000 description 1
- 101000984746 Homo sapiens BRCA1-associated protein Proteins 0.000 description 1
- 101000874304 Homo sapiens BRCA2 and CDKN1A-interacting protein Proteins 0.000 description 1
- 101001057996 Homo sapiens BRCA2-interacting transcriptional repressor EMSY Proteins 0.000 description 1
- 101000802816 Homo sapiens BRD4-interacting chromatin-remodeling complex-associated protein Proteins 0.000 description 1
- 101000802808 Homo sapiens BRD4-interacting chromatin-remodeling complex-associated protein-like Proteins 0.000 description 1
- 101000874539 Homo sapiens BRISC and BRCA1-A complex member 2 Proteins 0.000 description 1
- 101000896790 Homo sapiens BRO1 domain-containing protein BROX Proteins 0.000 description 1
- 101000761810 Homo sapiens BSD domain-containing protein 1 Proteins 0.000 description 1
- 101000794087 Homo sapiens BTB/POZ domain-containing protein 19 Proteins 0.000 description 1
- 101000761884 Homo sapiens BTB/POZ domain-containing protein 2 Proteins 0.000 description 1
- 101000761886 Homo sapiens BTB/POZ domain-containing protein 3 Proteins 0.000 description 1
- 101000761879 Homo sapiens BTB/POZ domain-containing protein 7 Proteins 0.000 description 1
- 101000896814 Homo sapiens BTB/POZ domain-containing protein 9 Proteins 0.000 description 1
- 101000974808 Homo sapiens BTB/POZ domain-containing protein KCTD14 Proteins 0.000 description 1
- 101000974798 Homo sapiens BTB/POZ domain-containing protein KCTD15 Proteins 0.000 description 1
- 101001135515 Homo sapiens BTB/POZ domain-containing protein KCTD17 Proteins 0.000 description 1
- 101001135509 Homo sapiens BTB/POZ domain-containing protein KCTD20 Proteins 0.000 description 1
- 101000613894 Homo sapiens BTB/POZ domain-containing protein KCTD3 Proteins 0.000 description 1
- 101001007328 Homo sapiens BTB/POZ domain-containing protein KCTD9 Proteins 0.000 description 1
- 101000985003 Homo sapiens BUD13 homolog Proteins 0.000 description 1
- 101000936081 Homo sapiens Baculoviral IAP repeat-containing protein 6 Proteins 0.000 description 1
- 101001049977 Homo sapiens Band 4.1-like protein 2 Proteins 0.000 description 1
- 101001049975 Homo sapiens Band 4.1-like protein 3 Proteins 0.000 description 1
- 101001049968 Homo sapiens Band 4.1-like protein 4A Proteins 0.000 description 1
- 101001049973 Homo sapiens Band 4.1-like protein 5 Proteins 0.000 description 1
- 101000697660 Homo sapiens Bardet-Biedl syndrome 4 protein Proteins 0.000 description 1
- 101000697666 Homo sapiens Bardet-Biedl syndrome 5 protein Proteins 0.000 description 1
- 101000697681 Homo sapiens Basal body-orientation factor 1 Proteins 0.000 description 1
- 101000970720 Homo sapiens Basic immunoglobulin-like variable motif-containing protein Proteins 0.000 description 1
- 101000901683 Homo sapiens Battenin Proteins 0.000 description 1
- 101000798320 Homo sapiens Bcl-2 homologous antagonist/killer Proteins 0.000 description 1
- 101000798490 Homo sapiens Bcl-2-associated transcription factor 1 Proteins 0.000 description 1
- 101000971203 Homo sapiens Bcl-2-binding component 3, isoforms 1/2 Proteins 0.000 description 1
- 101000971209 Homo sapiens Bcl-2-binding component 3, isoforms 3/4 Proteins 0.000 description 1
- 101000971073 Homo sapiens Bcl-2-like protein 12 Proteins 0.000 description 1
- 101000971074 Homo sapiens Bcl-2-like protein 13 Proteins 0.000 description 1
- 101000904691 Homo sapiens Bcl-2-like protein 2 Proteins 0.000 description 1
- 101000896211 Homo sapiens Bcl-2-modifying factor Proteins 0.000 description 1
- 101000899346 Homo sapiens Bcl-2-related ovarian killer protein Proteins 0.000 description 1
- 101000894649 Homo sapiens Beclin-1 Proteins 0.000 description 1
- 101000575420 Homo sapiens Beta-1,3-N-acetylglucosaminyltransferase manic fringe Proteins 0.000 description 1
- 101000887645 Homo sapiens Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase Proteins 0.000 description 1
- 101000697896 Homo sapiens Beta-1,3-glucosyltransferase Proteins 0.000 description 1
- 101001090662 Homo sapiens Beta-1,3-glucuronyltransferase LARGE1 Proteins 0.000 description 1
- 101000729811 Homo sapiens Beta-1,4 N-acetylgalactosaminyltransferase 1 Proteins 0.000 description 1
- 101000766179 Homo sapiens Beta-1,4-galactosyltransferase 4 Proteins 0.000 description 1
- 101000937496 Homo sapiens Beta-1,4-galactosyltransferase 5 Proteins 0.000 description 1
- 101000937502 Homo sapiens Beta-1,4-galactosyltransferase 6 Proteins 0.000 description 1
- 101000937508 Homo sapiens Beta-1,4-galactosyltransferase 7 Proteins 0.000 description 1
- 101001052060 Homo sapiens Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase Proteins 0.000 description 1
- 101000937544 Homo sapiens Beta-2-microglobulin Proteins 0.000 description 1
- 101000751445 Homo sapiens Beta-adrenergic receptor kinase 1 Proteins 0.000 description 1
- 101000806653 Homo sapiens Beta-adrenergic receptor kinase 2 Proteins 0.000 description 1
- 101000993469 Homo sapiens Beta-catenin-interacting protein 1 Proteins 0.000 description 1
- 101000922061 Homo sapiens Beta-catenin-like protein 1 Proteins 0.000 description 1
- 101000933465 Homo sapiens Beta-glucuronidase Proteins 0.000 description 1
- 101001045440 Homo sapiens Beta-hexosaminidase subunit alpha Proteins 0.000 description 1
- 101001045433 Homo sapiens Beta-hexosaminidase subunit beta Proteins 0.000 description 1
- 101001016707 Homo sapiens Beta-mannosidase Proteins 0.000 description 1
- 101000613557 Homo sapiens Beta-parvin Proteins 0.000 description 1
- 101000894895 Homo sapiens Beta-secretase 1 Proteins 0.000 description 1
- 101000764928 Homo sapiens Bifunctional apoptosis regulator Proteins 0.000 description 1
- 101000975540 Homo sapiens Bifunctional peptidase and (3S)-lysyl hydroxylase JMJD7 Proteins 0.000 description 1
- 101001025948 Homo sapiens Bifunctional peptidase and arginyl-hydroxylase JMJD5 Proteins 0.000 description 1
- 101000802825 Homo sapiens Biliverdin reductase A Proteins 0.000 description 1
- 101000872086 Homo sapiens Biogenesis of lysosome-related organelles complex 1 subunit 5 Proteins 0.000 description 1
- 101000872147 Homo sapiens Biogenesis of lysosome-related organelles complex 1 subunit 6 Proteins 0.000 description 1
- 101000934628 Homo sapiens Biorientation of chromosomes in cell division protein 1 Proteins 0.000 description 1
- 101000874052 Homo sapiens Biorientation of chromosomes in cell division protein 1-like 1 Proteins 0.000 description 1
- 101000871771 Homo sapiens Biotin-[acetyl-CoA-carboxylase] ligase Proteins 0.000 description 1
- 101000933545 Homo sapiens Biotinidase Proteins 0.000 description 1
- 101000928573 Homo sapiens Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical] Proteins 0.000 description 1
- 101000984541 Homo sapiens Bleomycin hydrolase Proteins 0.000 description 1
- 101000695294 Homo sapiens BolA-like protein 1 Proteins 0.000 description 1
- 101000695321 Homo sapiens BolA-like protein 3 Proteins 0.000 description 1
- 101000762366 Homo sapiens Bone morphogenetic protein 2 Proteins 0.000 description 1
- 101000899361 Homo sapiens Bone morphogenetic protein 7 Proteins 0.000 description 1
- 101000984546 Homo sapiens Bone morphogenetic protein receptor type-1B Proteins 0.000 description 1
- 101000934635 Homo sapiens Bone morphogenetic protein receptor type-2 Proteins 0.000 description 1
- 101000697853 Homo sapiens Brain and acute leukemia cytoplasmic protein Proteins 0.000 description 1
- 101000935886 Homo sapiens Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1 Proteins 0.000 description 1
- 101000766268 Homo sapiens Branched-chain-amino-acid aminotransferase, cytosolic Proteins 0.000 description 1
- 101000766294 Homo sapiens Branched-chain-amino-acid aminotransferase, mitochondrial Proteins 0.000 description 1
- 101000761844 Homo sapiens Break repair meiotic recombinase recruitment factor 1 Proteins 0.000 description 1
- 101000935648 Homo sapiens Breast cancer anti-estrogen resistance protein 3 Proteins 0.000 description 1
- 101000761835 Homo sapiens Breast cancer metastasis-suppressor 1-like protein Proteins 0.000 description 1
- 101000766275 Homo sapiens Breast carcinoma-amplified sequence 4 Proteins 0.000 description 1
- 101000933371 Homo sapiens Brefeldin A-inhibited guanine nucleotide-exchange protein 1 Proteins 0.000 description 1
- 101000695920 Homo sapiens Brefeldin A-inhibited guanine nucleotide-exchange protein 2 Proteins 0.000 description 1
- 101000739614 Homo sapiens Bridging integrator 3 Proteins 0.000 description 1
- 101000937778 Homo sapiens Bromodomain adjacent to zinc finger domain protein 1A Proteins 0.000 description 1
- 101000971147 Homo sapiens Bromodomain adjacent to zinc finger domain protein 2A Proteins 0.000 description 1
- 101000971143 Homo sapiens Bromodomain adjacent to zinc finger domain protein 2B Proteins 0.000 description 1
- 101000896771 Homo sapiens Bromodomain and PHD finger-containing protein 3 Proteins 0.000 description 1
- 101000794040 Homo sapiens Bromodomain and WD repeat-containing protein 1 Proteins 0.000 description 1
- 101000794050 Homo sapiens Bromodomain and WD repeat-containing protein 3 Proteins 0.000 description 1
- 101000871846 Homo sapiens Bromodomain-containing protein 1 Proteins 0.000 description 1
- 101000871851 Homo sapiens Bromodomain-containing protein 3 Proteins 0.000 description 1
- 101000794019 Homo sapiens Bromodomain-containing protein 7 Proteins 0.000 description 1
- 101000794020 Homo sapiens Bromodomain-containing protein 8 Proteins 0.000 description 1
- 101000984926 Homo sapiens Butyrophilin subfamily 2 member A1 Proteins 0.000 description 1
- 101000984917 Homo sapiens Butyrophilin subfamily 3 member A2 Proteins 0.000 description 1
- 101000984916 Homo sapiens Butyrophilin subfamily 3 member A3 Proteins 0.000 description 1
- 101000934743 Homo sapiens Butyrophilin-like protein 9 Proteins 0.000 description 1
- 101000716068 Homo sapiens C-C chemokine receptor type 6 Proteins 0.000 description 1
- 101001076874 Homo sapiens C-Jun-amino-terminal kinase-interacting protein 3 Proteins 0.000 description 1
- 101000993081 Homo sapiens C-Maf-inducing protein Proteins 0.000 description 1
- 101000584310 Homo sapiens C-myc promoter-binding protein Proteins 0.000 description 1
- 101000912615 Homo sapiens C-type lectin domain family 2 member D Proteins 0.000 description 1
- 101000766908 Homo sapiens C-type lectin domain family 4 member A Proteins 0.000 description 1
- 101000749314 Homo sapiens C-type lectin domain family 5 member A Proteins 0.000 description 1
- 101000749325 Homo sapiens C-type lectin domain family 7 member A Proteins 0.000 description 1
- 101000576898 Homo sapiens C-type mannose receptor 2 Proteins 0.000 description 1
- 101000867970 Homo sapiens C2 domain-containing protein 3 Proteins 0.000 description 1
- 101000910420 Homo sapiens C2 domain-containing protein 5 Proteins 0.000 description 1
- 101000867983 Homo sapiens C5a anaphylatoxin chemotactic receptor 1 Proteins 0.000 description 1
- 101100019716 Homo sapiens CAMK1D gene Proteins 0.000 description 1
- 101000767052 Homo sapiens CAP-Gly domain-containing linker protein 1 Proteins 0.000 description 1
- 101000767059 Homo sapiens CAP-Gly domain-containing linker protein 2 Proteins 0.000 description 1
- 101000767055 Homo sapiens CAP-Gly domain-containing linker protein 3 Proteins 0.000 description 1
- 101000767061 Homo sapiens CAP-Gly domain-containing linker protein 4 Proteins 0.000 description 1
- 101000914211 Homo sapiens CASP8 and FADD-like apoptosis regulator Proteins 0.000 description 1
- 101000910382 Homo sapiens CASP8-associated protein 2 Proteins 0.000 description 1
- 101100222245 Homo sapiens CATSPER1 gene Proteins 0.000 description 1
- 101100222250 Homo sapiens CATSPER3 gene Proteins 0.000 description 1
- 101000746131 Homo sapiens CBP80/20-dependent translation initiation factor Proteins 0.000 description 1
- 101000761497 Homo sapiens CBY1-interacting BAR domain-containing protein 1 Proteins 0.000 description 1
- 101000880588 Homo sapiens CCAAT/enhancer-binding protein zeta Proteins 0.000 description 1
- 101000919672 Homo sapiens CCR4-NOT transcription complex subunit 1 Proteins 0.000 description 1
- 101000919678 Homo sapiens CCR4-NOT transcription complex subunit 11 Proteins 0.000 description 1
- 101000919667 Homo sapiens CCR4-NOT transcription complex subunit 2 Proteins 0.000 description 1
- 101000942594 Homo sapiens CCR4-NOT transcription complex subunit 4 Proteins 0.000 description 1
- 101000942595 Homo sapiens CCR4-NOT transcription complex subunit 6 Proteins 0.000 description 1
- 101000942586 Homo sapiens CCR4-NOT transcription complex subunit 8 Proteins 0.000 description 1
- 101000942590 Homo sapiens CCR4-NOT transcription complex subunit 9 Proteins 0.000 description 1
- 101000738399 Homo sapiens CD109 antigen Proteins 0.000 description 1
- 101000914499 Homo sapiens CD2-associated protein Proteins 0.000 description 1
- 101000884279 Homo sapiens CD276 antigen Proteins 0.000 description 1
- 101000934351 Homo sapiens CD302 antigen Proteins 0.000 description 1
- 101000934335 Homo sapiens CD320 antigen Proteins 0.000 description 1
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 1
- 101000897400 Homo sapiens CD59 glycoprotein Proteins 0.000 description 1
- 101000934356 Homo sapiens CD70 antigen Proteins 0.000 description 1
- 101000984082 Homo sapiens CD99 antigen-like protein 2 Proteins 0.000 description 1
- 101000914529 Homo sapiens CDAN1-interacting nuclease 1 Proteins 0.000 description 1
- 101000794295 Homo sapiens CDC42 small effector protein 1 Proteins 0.000 description 1
- 101000794294 Homo sapiens CDC42 small effector protein 2 Proteins 0.000 description 1
- 101000583935 Homo sapiens CDK-activating kinase assembly factor MAT1 Proteins 0.000 description 1
- 101000882873 Homo sapiens CDK5 regulatory subunit-associated protein 2 Proteins 0.000 description 1
- 101000793819 Homo sapiens CDKN2A-interacting protein Proteins 0.000 description 1
- 101000776617 Homo sapiens CGG triplet repeat-binding protein 1 Proteins 0.000 description 1
- 101100382122 Homo sapiens CIITA gene Proteins 0.000 description 1
- 101000749418 Homo sapiens CKLF-like MARVEL transmembrane domain-containing protein 1 Proteins 0.000 description 1
- 101000749433 Homo sapiens CKLF-like MARVEL transmembrane domain-containing protein 3 Proteins 0.000 description 1
- 101000749308 Homo sapiens CKLF-like MARVEL transmembrane domain-containing protein 7 Proteins 0.000 description 1
- 101000888512 Homo sapiens CKLF-like MARVEL transmembrane domain-containing protein 8 Proteins 0.000 description 1
- 101000989987 Homo sapiens CLIP-associating protein 2 Proteins 0.000 description 1
- 101000906672 Homo sapiens CLK4-associating serine/arginine rich protein Proteins 0.000 description 1
- 101000766839 Homo sapiens CLOCK-interacting pacemaker Proteins 0.000 description 1
- 101000990055 Homo sapiens CMRF35-like molecule 1 Proteins 0.000 description 1
- 101000914279 Homo sapiens CMT1A duplicated region transcript 4 protein Proteins 0.000 description 1
- 101000797557 Homo sapiens COBW domain-containing protein 1 Proteins 0.000 description 1
- 101000797558 Homo sapiens COBW domain-containing protein 2 Proteins 0.000 description 1
- 101000797562 Homo sapiens COBW domain-containing protein 3 Proteins 0.000 description 1
- 101000797565 Homo sapiens COBW domain-containing protein 6 Proteins 0.000 description 1
- 101000940485 Homo sapiens COP9 signalosome complex subunit 1 Proteins 0.000 description 1
- 101000726002 Homo sapiens COP9 signalosome complex subunit 3 Proteins 0.000 description 1
- 101000860484 Homo sapiens COP9 signalosome complex subunit 7a Proteins 0.000 description 1
- 101000860489 Homo sapiens COP9 signalosome complex subunit 7b Proteins 0.000 description 1
- 101000916502 Homo sapiens COP9 signalosome complex subunit 8 Proteins 0.000 description 1
- 101000900446 Homo sapiens COX assembly mitochondrial protein 2 homolog Proteins 0.000 description 1
- 101000855210 Homo sapiens COX assembly mitochondrial protein homolog Proteins 0.000 description 1
- 101000896987 Homo sapiens CREB-binding protein Proteins 0.000 description 1
- 101000891939 Homo sapiens CREB-regulated transcription coactivator 1 Proteins 0.000 description 1
- 101000891906 Homo sapiens CREB-regulated transcription coactivator 3 Proteins 0.000 description 1
- 101000964541 Homo sapiens CREB/ATF bZIP transcription factor Proteins 0.000 description 1
- 101000957828 Homo sapiens CREB3 regulatory factor Proteins 0.000 description 1
- 101000725950 Homo sapiens CTD small phosphatase-like protein Proteins 0.000 description 1
- 101000859047 Homo sapiens CTD small phosphatase-like protein 2 Proteins 0.000 description 1
- 101001101885 Homo sapiens CTP synthase 2 Proteins 0.000 description 1
- 101000940745 Homo sapiens CTTNBP2 N-terminal-like protein Proteins 0.000 description 1
- 101000892047 Homo sapiens CUB and sushi domain-containing protein 2 Proteins 0.000 description 1
- 101000894809 Homo sapiens CUE domain-containing protein 1 Proteins 0.000 description 1
- 101000944442 Homo sapiens CUGBP Elav-like family member 2 Proteins 0.000 description 1
- 101000914299 Homo sapiens CUGBP Elav-like family member 3 Proteins 0.000 description 1
- 101000867944 Homo sapiens CWF19-like protein 1 Proteins 0.000 description 1
- 101000867952 Homo sapiens CWF19-like protein 2 Proteins 0.000 description 1
- 101000901723 Homo sapiens CXADR-like membrane protein Proteins 0.000 description 1
- 101000947157 Homo sapiens CXXC-type zinc finger protein 1 Proteins 0.000 description 1
- 101000912003 Homo sapiens CYFIP-related Rac1 interactor A Proteins 0.000 description 1
- 101000911995 Homo sapiens CYFIP-related Rac1 interactor B Proteins 0.000 description 1
- 101000914155 Homo sapiens Cadherin EGF LAG seven-pass G-type receptor 1 Proteins 0.000 description 1
- 101000715674 Homo sapiens Cadherin EGF LAG seven-pass G-type receptor 2 Proteins 0.000 description 1
- 101000715671 Homo sapiens Cadherin EGF LAG seven-pass G-type receptor 3 Proteins 0.000 description 1
- 101000899442 Homo sapiens Cadherin-23 Proteins 0.000 description 1
- 101000899448 Homo sapiens Cadherin-24 Proteins 0.000 description 1
- 101000745641 Homo sapiens Cadherin-like and PC-esterase domain-containing protein 1 Proteins 0.000 description 1
- 101000777252 Homo sapiens Calcineurin B homologous protein 1 Proteins 0.000 description 1
- 101000910452 Homo sapiens Calcineurin-binding protein cabin-1 Proteins 0.000 description 1
- 101000760563 Homo sapiens Calcitonin gene-related peptide type 1 receptor Proteins 0.000 description 1
- 101000943456 Homo sapiens Calcium and integrin-binding family member 2 Proteins 0.000 description 1
- 101000932468 Homo sapiens Calcium channel flower homolog Proteins 0.000 description 1
- 101000741349 Homo sapiens Calcium homeostasis modulator protein 2 Proteins 0.000 description 1
- 101000574820 Homo sapiens Calcium uptake protein 2, mitochondrial Proteins 0.000 description 1
- 101001049859 Homo sapiens Calcium-activated potassium channel subunit alpha-1 Proteins 0.000 description 1
- 101001049842 Homo sapiens Calcium-activated potassium channel subunit beta-4 Proteins 0.000 description 1
- 101000714589 Homo sapiens Calcium-binding and coiled-coil domain-containing protein 1 Proteins 0.000 description 1
- 101000899411 Homo sapiens Calcium-binding protein 39 Proteins 0.000 description 1
- 101000898517 Homo sapiens Calcium-binding protein 39-like Proteins 0.000 description 1
- 101000935132 Homo sapiens Calcium-binding tyrosine phosphorylation-regulated protein Proteins 0.000 description 1
- 101000728145 Homo sapiens Calcium-transporting ATPase type 2C member 1 Proteins 0.000 description 1
- 101000971625 Homo sapiens Calcium/calmodulin-dependent protein kinase kinase 1 Proteins 0.000 description 1
- 101000971617 Homo sapiens Calcium/calmodulin-dependent protein kinase kinase 2 Proteins 0.000 description 1
- 101000944250 Homo sapiens Calcium/calmodulin-dependent protein kinase type 1 Proteins 0.000 description 1
- 101000944249 Homo sapiens Calcium/calmodulin-dependent protein kinase type II subunit alpha Proteins 0.000 description 1
- 101001077338 Homo sapiens Calcium/calmodulin-dependent protein kinase type II subunit delta Proteins 0.000 description 1
- 101001077334 Homo sapiens Calcium/calmodulin-dependent protein kinase type II subunit gamma Proteins 0.000 description 1
- 101000974816 Homo sapiens Calcium/calmodulin-dependent protein kinase type IV Proteins 0.000 description 1
- 101000947048 Homo sapiens Calcyphosin-2 Proteins 0.000 description 1
- 101000910297 Homo sapiens Caldesmon Proteins 0.000 description 1
- 101000912631 Homo sapiens Calmegin Proteins 0.000 description 1
- 101000945304 Homo sapiens Calmodulin-binding transcription activator 2 Proteins 0.000 description 1
- 101000714684 Homo sapiens Calmodulin-like protein 4 Proteins 0.000 description 1
- 101000993070 Homo sapiens Calmodulin-lysine N-methyltransferase Proteins 0.000 description 1
- 101000932961 Homo sapiens Calmodulin-regulated spectrin-associated protein 2 Proteins 0.000 description 1
- 101000741294 Homo sapiens Calmodulin-regulated spectrin-associated protein 3 Proteins 0.000 description 1
- 101000934069 Homo sapiens Calpain-1 catalytic subunit Proteins 0.000 description 1
- 101000984149 Homo sapiens Calpain-10 Proteins 0.000 description 1
- 101000934071 Homo sapiens Calpain-15 Proteins 0.000 description 1
- 101000793684 Homo sapiens Calpain-7 Proteins 0.000 description 1
- 101000916423 Homo sapiens Calsyntenin-1 Proteins 0.000 description 1
- 101000916414 Homo sapiens Calsyntenin-3 Proteins 0.000 description 1
- 101001124534 Homo sapiens Cancer-related nucleoside-triphosphatase Proteins 0.000 description 1
- 101000875075 Homo sapiens Cannabinoid receptor 2 Proteins 0.000 description 1
- 101000883304 Homo sapiens Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1 Proteins 0.000 description 1
- 101000883291 Homo sapiens Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2 Proteins 0.000 description 1
- 101000793825 Homo sapiens Capping protein, Arp2/3 and myosin-I linker protein 2 Proteins 0.000 description 1
- 101000957909 Homo sapiens Capping protein-inhibiting regulator of actin dynamics Proteins 0.000 description 1
- 101000867742 Homo sapiens Caprin-2 Proteins 0.000 description 1
- 101000855412 Homo sapiens Carbamoyl-phosphate synthase [ammonia], mitochondrial Proteins 0.000 description 1
- 101000775595 Homo sapiens Carbohydrate sulfotransferase 10 Proteins 0.000 description 1
- 101000775602 Homo sapiens Carbohydrate sulfotransferase 9 Proteins 0.000 description 1
- 101000952179 Homo sapiens Carbohydrate-responsive element-binding protein Proteins 0.000 description 1
- 101000714497 Homo sapiens Carbonic anhydrase 5B, mitochondrial Proteins 0.000 description 1
- 101000725947 Homo sapiens Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2 Proteins 0.000 description 1
- 101000741259 Homo sapiens Carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein Proteins 0.000 description 1
- 101000851624 Homo sapiens Carboxylesterase 3 Proteins 0.000 description 1
- 101000851617 Homo sapiens Carboxylesterase 4A Proteins 0.000 description 1
- 101000946518 Homo sapiens Carboxypeptidase B2 Proteins 0.000 description 1
- 101000910846 Homo sapiens Carboxypeptidase Q Proteins 0.000 description 1
- 101000981110 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 21 Proteins 0.000 description 1
- 101000895518 Homo sapiens Cardiolipin synthase (CMP-forming) Proteins 0.000 description 1
- 101000859578 Homo sapiens Carnitine O-palmitoyltransferase 1, brain isoform Proteins 0.000 description 1
- 101000859570 Homo sapiens Carnitine O-palmitoyltransferase 1, liver isoform Proteins 0.000 description 1
- 101000909313 Homo sapiens Carnitine O-palmitoyltransferase 2, mitochondrial Proteins 0.000 description 1
- 101000920980 Homo sapiens Carnosine synthase 1 Proteins 0.000 description 1
- 101000913768 Homo sapiens Cartilage intermediate layer protein 2 Proteins 0.000 description 1
- 101000725508 Homo sapiens Cartilage oligomeric matrix protein Proteins 0.000 description 1
- 101001026336 Homo sapiens Casein kinase I isoform delta Proteins 0.000 description 1
- 101001026384 Homo sapiens Casein kinase I isoform gamma-1 Proteins 0.000 description 1
- 101001049879 Homo sapiens Casein kinase I isoform gamma-3 Proteins 0.000 description 1
- 101000892026 Homo sapiens Casein kinase II subunit alpha Proteins 0.000 description 1
- 101000946436 Homo sapiens Caseinolytic peptidase B protein homolog Proteins 0.000 description 1
- 101000858678 Homo sapiens Caskin-1 Proteins 0.000 description 1
- 101000762197 Homo sapiens Caspase activity and apoptosis inhibitor 1 Proteins 0.000 description 1
- 101000761179 Homo sapiens Caspase recruitment domain-containing protein 11 Proteins 0.000 description 1
- 101000933107 Homo sapiens Caspase recruitment domain-containing protein 19 Proteins 0.000 description 1
- 101000761252 Homo sapiens Caspase recruitment domain-containing protein 6 Proteins 0.000 description 1
- 101000761247 Homo sapiens Caspase recruitment domain-containing protein 8 Proteins 0.000 description 1
- 101000715398 Homo sapiens Caspase-1 Proteins 0.000 description 1
- 101000983518 Homo sapiens Caspase-10 Proteins 0.000 description 1
- 101000867612 Homo sapiens Caspase-2 Proteins 0.000 description 1
- 101000741014 Homo sapiens Caspase-7 Proteins 0.000 description 1
- 101000983528 Homo sapiens Caspase-8 Proteins 0.000 description 1
- 101000983523 Homo sapiens Caspase-9 Proteins 0.000 description 1
- 101000737671 Homo sapiens Cat eye syndrome critical region protein 2 Proteins 0.000 description 1
- 101000945323 Homo sapiens Catechol O-methyltransferase domain-containing protein 1 Proteins 0.000 description 1
- 101000859073 Homo sapiens Catenin alpha-2 Proteins 0.000 description 1
- 101000916264 Homo sapiens Catenin delta-1 Proteins 0.000 description 1
- 101000933218 Homo sapiens Cathepsin F Proteins 0.000 description 1
- 101000726696 Homo sapiens Cation channel sperm-associated auxiliary subunit zeta Proteins 0.000 description 1
- 101000761524 Homo sapiens Caveolae-associated protein 4 Proteins 0.000 description 1
- 101000753243 Homo sapiens Caytaxin Proteins 0.000 description 1
- 101000760622 Homo sapiens Cell adhesion molecule 2 Proteins 0.000 description 1
- 101000910447 Homo sapiens Cell adhesion molecule 4 Proteins 0.000 description 1
- 101000777781 Homo sapiens Cell adhesion molecule-related/down-regulated by oncogenes Proteins 0.000 description 1
- 101000715194 Homo sapiens Cell cycle and apoptosis regulator protein 2 Proteins 0.000 description 1
- 101000912020 Homo sapiens Cell cycle regulator of non-homologous end joining Proteins 0.000 description 1
- 101000698131 Homo sapiens Cell death regulator Aven Proteins 0.000 description 1
- 101000934421 Homo sapiens Cell division control protein 45 homolog Proteins 0.000 description 1
- 101000914465 Homo sapiens Cell division control protein 6 homolog Proteins 0.000 description 1
- 101000868318 Homo sapiens Cell division cycle 5-like protein Proteins 0.000 description 1
- 101000945740 Homo sapiens Cell division cycle 7-related protein kinase Proteins 0.000 description 1
- 101000715197 Homo sapiens Cell division cycle and apoptosis regulator protein 1 Proteins 0.000 description 1
- 101000897353 Homo sapiens Cell division cycle protein 123 homolog Proteins 0.000 description 1
- 101000912124 Homo sapiens Cell division cycle protein 23 homolog Proteins 0.000 description 1
- 101000777638 Homo sapiens Cell division cycle-associated 7-like protein Proteins 0.000 description 1
- 101000980907 Homo sapiens Cell division cycle-associated protein 3 Proteins 0.000 description 1
- 101000980898 Homo sapiens Cell division cycle-associated protein 4 Proteins 0.000 description 1
- 101000980893 Homo sapiens Cell division cycle-associated protein 7 Proteins 0.000 description 1
- 101000979920 Homo sapiens Cell growth regulator with RING finger domain protein 1 Proteins 0.000 description 1
- 101000622133 Homo sapiens Cell growth-regulating nucleolar protein Proteins 0.000 description 1
- 101000623903 Homo sapiens Cell surface glycoprotein MUC18 Proteins 0.000 description 1
- 101000993339 Homo sapiens Centlein Proteins 0.000 description 1
- 101000725200 Homo sapiens Centriolar coiled-coil protein of 110 kDa Proteins 0.000 description 1
- 101000941711 Homo sapiens Centriolin Proteins 0.000 description 1
- 101000907934 Homo sapiens Centromere protein H Proteins 0.000 description 1
- 101000907944 Homo sapiens Centromere protein I Proteins 0.000 description 1
- 101000907931 Homo sapiens Centromere protein K Proteins 0.000 description 1
- 101000737741 Homo sapiens Centromere protein L Proteins 0.000 description 1
- 101000737696 Homo sapiens Centromere protein M Proteins 0.000 description 1
- 101000776412 Homo sapiens Centromere protein N Proteins 0.000 description 1
- 101000776468 Homo sapiens Centromere protein O Proteins 0.000 description 1
- 101000776463 Homo sapiens Centromere protein P Proteins 0.000 description 1
- 101000884553 Homo sapiens Centromere protein Q Proteins 0.000 description 1
- 101000884559 Homo sapiens Centromere protein R Proteins 0.000 description 1
- 101000884588 Homo sapiens Centromere protein S Proteins 0.000 description 1
- 101000880504 Homo sapiens Centromere protein T Proteins 0.000 description 1
- 101000880512 Homo sapiens Centromere protein U Proteins 0.000 description 1
- 101000880492 Homo sapiens Centromere protein V Proteins 0.000 description 1
- 101000944476 Homo sapiens Centromere protein X Proteins 0.000 description 1
- 101000914247 Homo sapiens Centromere-associated protein E Proteins 0.000 description 1
- 101000867633 Homo sapiens Centrosomal AT-AC splicing factor Proteins 0.000 description 1
- 101000945861 Homo sapiens Centrosomal protein 20 Proteins 0.000 description 1
- 101000776477 Homo sapiens Centrosomal protein 43 Proteins 0.000 description 1
- 101000737080 Homo sapiens Centrosomal protein CCDC61 Proteins 0.000 description 1
- 101000737689 Homo sapiens Centrosomal protein CEP57L1 Proteins 0.000 description 1
- 101001091251 Homo sapiens Centrosomal protein kizuna Proteins 0.000 description 1
- 101000908170 Homo sapiens Centrosomal protein of 126 kDa Proteins 0.000 description 1
- 101000957451 Homo sapiens Centrosomal protein of 131 kDa Proteins 0.000 description 1
- 101000715662 Homo sapiens Centrosomal protein of 295 kDa Proteins 0.000 description 1
- 101000737643 Homo sapiens Centrosomal protein of 85 kDa-like Proteins 0.000 description 1
- 101000916452 Homo sapiens Centrosome and spindle pole-associated protein 1 Proteins 0.000 description 1
- 101000737563 Homo sapiens Ceramide transfer protein Proteins 0.000 description 1
- 101000737796 Homo sapiens Cerebellar degeneration-related protein 2 Proteins 0.000 description 1
- 101000737028 Homo sapiens Cerebral cavernous malformations 2 protein Proteins 0.000 description 1
- 101000710208 Homo sapiens Ceroid-lipofuscinosis neuronal protein 5 Proteins 0.000 description 1
- 101000710215 Homo sapiens Ceroid-lipofuscinosis neuronal protein 6 Proteins 0.000 description 1
- 101000989626 Homo sapiens Charged multivesicular body protein 3 Proteins 0.000 description 1
- 101000919756 Homo sapiens Chemerin-like receptor 1 Proteins 0.000 description 1
- 101000888518 Homo sapiens Chemokine-like factor Proteins 0.000 description 1
- 101000788164 Homo sapiens Chemokine-like protein TAFA-5 Proteins 0.000 description 1
- 101000991102 Homo sapiens Chitinase domain-containing protein 1 Proteins 0.000 description 1
- 101000891557 Homo sapiens Chitobiosyldiphosphodolichol beta-mannosyltransferase Proteins 0.000 description 1
- 101000989992 Homo sapiens Chloride channel CLIC-like protein 1 Proteins 0.000 description 1
- 101000906633 Homo sapiens Chloride channel protein 2 Proteins 0.000 description 1
- 101000777314 Homo sapiens Choline kinase alpha Proteins 0.000 description 1
- 101000914238 Homo sapiens Choline/ethanolaminephosphotransferase 1 Proteins 0.000 description 1
- 101000943274 Homo sapiens Cholinesterase Proteins 0.000 description 1
- 101000776623 Homo sapiens Chondroitin sulfate N-acetylgalactosaminyltransferase 2 Proteins 0.000 description 1
- 101000989616 Homo sapiens Chondroitin sulfate glucuronyltransferase Proteins 0.000 description 1
- 101000989500 Homo sapiens Chondroitin sulfate synthase 1 Proteins 0.000 description 1
- 101000745414 Homo sapiens Chondrosarcoma-associated gene 2/3 protein Proteins 0.000 description 1
- 101000943248 Homo sapiens Chromatin accessibility complex protein 1 Proteins 0.000 description 1
- 101000741348 Homo sapiens Chromatin assembly factor 1 subunit A Proteins 0.000 description 1
- 101000898225 Homo sapiens Chromatin assembly factor 1 subunit B Proteins 0.000 description 1
- 101000740094 Homo sapiens Chromatin complexes subunit BAP18 Proteins 0.000 description 1
- 101000817406 Homo sapiens Chromatin modification-related protein MEAF6 Proteins 0.000 description 1
- 101000737958 Homo sapiens Chromatin target of PRMT1 protein Proteins 0.000 description 1
- 101000797586 Homo sapiens Chromobox protein homolog 2 Proteins 0.000 description 1
- 101000797581 Homo sapiens Chromobox protein homolog 5 Proteins 0.000 description 1
- 101000777795 Homo sapiens Chromodomain Y-like protein Proteins 0.000 description 1
- 101000777047 Homo sapiens Chromodomain-helicase-DNA-binding protein 1 Proteins 0.000 description 1
- 101000777053 Homo sapiens Chromodomain-helicase-DNA-binding protein 1-like Proteins 0.000 description 1
- 101000777079 Homo sapiens Chromodomain-helicase-DNA-binding protein 2 Proteins 0.000 description 1
- 101000777071 Homo sapiens Chromodomain-helicase-DNA-binding protein 3 Proteins 0.000 description 1
- 101000883749 Homo sapiens Chromodomain-helicase-DNA-binding protein 4 Proteins 0.000 description 1
- 101000883736 Homo sapiens Chromodomain-helicase-DNA-binding protein 6 Proteins 0.000 description 1
- 101000883545 Homo sapiens Chromodomain-helicase-DNA-binding protein 8 Proteins 0.000 description 1
- 101000883548 Homo sapiens Chromodomain-helicase-DNA-binding protein 9 Proteins 0.000 description 1
- 101000856249 Homo sapiens Chromosome transmission fidelity protein 8 homolog Proteins 0.000 description 1
- 101001139157 Homo sapiens Chromosome-associated kinesin KIF4A Proteins 0.000 description 1
- 101000914179 Homo sapiens Cilia- and flagella-associated protein 119 Proteins 0.000 description 1
- 101000710053 Homo sapiens Cilia- and flagella-associated protein 206 Proteins 0.000 description 1
- 101000980087 Homo sapiens Cilia- and flagella-associated protein 298 Proteins 0.000 description 1
- 101000980085 Homo sapiens Cilia- and flagella-associated protein 299 Proteins 0.000 description 1
- 101000980067 Homo sapiens Cilia- and flagella-associated protein 300 Proteins 0.000 description 1
- 101000907994 Homo sapiens Cilia- and flagella-associated protein 36 Proteins 0.000 description 1
- 101000945747 Homo sapiens Cilia- and flagella-associated protein 418 Proteins 0.000 description 1
- 101000907982 Homo sapiens Cilia- and flagella-associated protein 44 Proteins 0.000 description 1
- 101000944500 Homo sapiens Cilia- and flagella-associated protein 58 Proteins 0.000 description 1
- 101000776612 Homo sapiens Cilia- and flagella-associated protein 73 Proteins 0.000 description 1
- 101000993348 Homo sapiens Ciliary neurotrophic factor receptor subunit alpha Proteins 0.000 description 1
- 101000855375 Homo sapiens Ciliogenesis and planar polarity effector 1 Proteins 0.000 description 1
- 101000926718 Homo sapiens Cilium assembly protein DZIP1 Proteins 0.000 description 1
- 101001016178 Homo sapiens Cilium assembly protein DZIP1L Proteins 0.000 description 1
- 101000710327 Homo sapiens Cip1-interacting zinc finger protein Proteins 0.000 description 1
- 101000943130 Homo sapiens Circadian-associated transcriptional repressor Proteins 0.000 description 1
- 101000750011 Homo sapiens Claspin Proteins 0.000 description 1
- 101000946482 Homo sapiens Clathrin heavy chain 2 Proteins 0.000 description 1
- 101000946483 Homo sapiens Clathrin heavy chain linker domain-containing protein 1 Proteins 0.000 description 1
- 101000851951 Homo sapiens Clathrin interactor 1 Proteins 0.000 description 1
- 101000710244 Homo sapiens Clathrin light chain A Proteins 0.000 description 1
- 101000912657 Homo sapiens Claudin domain-containing protein 1 Proteins 0.000 description 1
- 101000888566 Homo sapiens Claudin-12 Proteins 0.000 description 1
- 101000957603 Homo sapiens Cleavage and polyadenylation specificity factor subunit 1 Proteins 0.000 description 1
- 101000957590 Homo sapiens Cleavage and polyadenylation specificity factor subunit 2 Proteins 0.000 description 1
- 101000727105 Homo sapiens Cleavage and polyadenylation specificity factor subunit 4 Proteins 0.000 description 1
- 101000855366 Homo sapiens Cleavage and polyadenylation specificity factor subunit 6 Proteins 0.000 description 1
- 101000855404 Homo sapiens Cleavage and polyadenylation specificity factor subunit 7 Proteins 0.000 description 1
- 101000891793 Homo sapiens Cleavage stimulation factor subunit 2 Proteins 0.000 description 1
- 101000891801 Homo sapiens Cleavage stimulation factor subunit 3 Proteins 0.000 description 1
- 101000945060 Homo sapiens Clusterin-associated protein 1 Proteins 0.000 description 1
- 101000899916 Homo sapiens Coatomer subunit beta' Proteins 0.000 description 1
- 101000860881 Homo sapiens Coatomer subunit delta Proteins 0.000 description 1
- 101000952964 Homo sapiens Coatomer subunit gamma-1 Proteins 0.000 description 1
- 101000909619 Homo sapiens Coatomer subunit zeta-2 Proteins 0.000 description 1
- 101000898006 Homo sapiens Cocaine esterase Proteins 0.000 description 1
- 101000748988 Homo sapiens Cochlin Proteins 0.000 description 1
- 101000910414 Homo sapiens Coiled-coil and C2 domain-containing protein 2A Proteins 0.000 description 1
- 101000740823 Homo sapiens Coiled-coil domain-containing protein 102B Proteins 0.000 description 1
- 101000868799 Homo sapiens Coiled-coil domain-containing protein 106 Proteins 0.000 description 1
- 101000868825 Homo sapiens Coiled-coil domain-containing protein 112 Proteins 0.000 description 1
- 101000978267 Homo sapiens Coiled-coil domain-containing protein 115 Proteins 0.000 description 1
- 101000772526 Homo sapiens Coiled-coil domain-containing protein 125 Proteins 0.000 description 1
- 101000772539 Homo sapiens Coiled-coil domain-containing protein 126 Proteins 0.000 description 1
- 101000772625 Homo sapiens Coiled-coil domain-containing protein 127 Proteins 0.000 description 1
- 101000772627 Homo sapiens Coiled-coil domain-containing protein 134 Proteins 0.000 description 1
- 101000737212 Homo sapiens Coiled-coil domain-containing protein 136 Proteins 0.000 description 1
- 101000737227 Homo sapiens Coiled-coil domain-containing protein 137 Proteins 0.000 description 1
- 101000737225 Homo sapiens Coiled-coil domain-containing protein 138 Proteins 0.000 description 1
- 101000777340 Homo sapiens Coiled-coil domain-containing protein 14 Proteins 0.000 description 1
- 101000932597 Homo sapiens Coiled-coil domain-containing protein 149 Proteins 0.000 description 1
- 101000932655 Homo sapiens Coiled-coil domain-containing protein 150 Proteins 0.000 description 1
- 101000932658 Homo sapiens Coiled-coil domain-containing protein 152 Proteins 0.000 description 1
- 101000946686 Homo sapiens Coiled-coil domain-containing protein 159 Proteins 0.000 description 1
- 101000946663 Homo sapiens Coiled-coil domain-containing protein 169 Proteins 0.000 description 1
- 101000715241 Homo sapiens Coiled-coil domain-containing protein 171 Proteins 0.000 description 1
- 101000777411 Homo sapiens Coiled-coil domain-containing protein 18 Proteins 0.000 description 1
- 101000772632 Homo sapiens Coiled-coil domain-containing protein 181 Proteins 0.000 description 1
- 101000772595 Homo sapiens Coiled-coil domain-containing protein 183 Proteins 0.000 description 1
- 101000978247 Homo sapiens Coiled-coil domain-containing protein 186 Proteins 0.000 description 1
- 101000978246 Homo sapiens Coiled-coil domain-containing protein 188 Proteins 0.000 description 1
- 101000978239 Homo sapiens Coiled-coil domain-containing protein 191 Proteins 0.000 description 1
- 101000978235 Homo sapiens Coiled-coil domain-containing protein 192 Proteins 0.000 description 1
- 101000868760 Homo sapiens Coiled-coil domain-containing protein 25 Proteins 0.000 description 1
- 101000896972 Homo sapiens Coiled-coil domain-containing protein 28B Proteins 0.000 description 1
- 101000897095 Homo sapiens Coiled-coil domain-containing protein 32 Proteins 0.000 description 1
- 101000715283 Homo sapiens Coiled-coil domain-containing protein 40 Proteins 0.000 description 1
- 101000910679 Homo sapiens Coiled-coil domain-containing protein 43 Proteins 0.000 description 1
- 101000737066 Homo sapiens Coiled-coil domain-containing protein 57 Proteins 0.000 description 1
- 101000946606 Homo sapiens Coiled-coil domain-containing protein 66 Proteins 0.000 description 1
- 101000777368 Homo sapiens Coiled-coil domain-containing protein 7 Proteins 0.000 description 1
- 101000910812 Homo sapiens Coiled-coil domain-containing protein 74B Proteins 0.000 description 1
- 101000978318 Homo sapiens Coiled-coil domain-containing protein 77 Proteins 0.000 description 1
- 101000978324 Homo sapiens Coiled-coil domain-containing protein 78 Proteins 0.000 description 1
- 101000932751 Homo sapiens Coiled-coil domain-containing protein 82 Proteins 0.000 description 1
- 101000910797 Homo sapiens Coiled-coil domain-containing protein 85A Proteins 0.000 description 1
- 101000868816 Homo sapiens Coiled-coil domain-containing protein 85C Proteins 0.000 description 1
- 101000777407 Homo sapiens Coiled-coil domain-containing protein 9 Proteins 0.000 description 1
- 101000868844 Homo sapiens Coiled-coil domain-containing protein 90B, mitochondrial Proteins 0.000 description 1
- 101000797737 Homo sapiens Coiled-coil domain-containing protein 91 Proteins 0.000 description 1
- 101000797732 Homo sapiens Coiled-coil domain-containing protein 92 Proteins 0.000 description 1
- 101000797736 Homo sapiens Coiled-coil domain-containing protein 93 Proteins 0.000 description 1
- 101000906987 Homo sapiens Coiled-coil-helix-coiled-coil-helix domain-containing protein 5 Proteins 0.000 description 1
- 101000940535 Homo sapiens Cold shock domain-containing protein E1 Proteins 0.000 description 1
- 101000901150 Homo sapiens Collagen alpha-1(IV) chain Proteins 0.000 description 1
- 101000749004 Homo sapiens Collagen alpha-1(XIII) chain Proteins 0.000 description 1
- 101000920176 Homo sapiens Collagen alpha-1(XXIII) chain Proteins 0.000 description 1
- 101000952969 Homo sapiens Collagen alpha-1(XXIV) chain Proteins 0.000 description 1
- 101000940250 Homo sapiens Collagen alpha-1(XXV) chain Proteins 0.000 description 1
- 101000860862 Homo sapiens Collagen alpha-1(XXVI) chain Proteins 0.000 description 1
- 101000940372 Homo sapiens Collagen alpha-1(XXVII) chain Proteins 0.000 description 1
- 101000919645 Homo sapiens Collagen alpha-2(IX) chain Proteins 0.000 description 1
- 101000941585 Homo sapiens Collagen alpha-2(VI) chain Proteins 0.000 description 1
- 101000909506 Homo sapiens Collagen alpha-3(VI) chain Proteins 0.000 description 1
- 101000710886 Homo sapiens Collagen alpha-5(IV) chain Proteins 0.000 description 1
- 101000710885 Homo sapiens Collagen alpha-6(IV) chain Proteins 0.000 description 1
- 101000933663 Homo sapiens Complement C1q tumor necrosis factor-related protein 2 Proteins 0.000 description 1
- 101000794256 Homo sapiens Complement C1q tumor necrosis factor-related protein 6 Proteins 0.000 description 1
- 101000856022 Homo sapiens Complement decay-accelerating factor Proteins 0.000 description 1
- 101000884127 Homo sapiens Complex I intermediate-associated protein 30, mitochondrial Proteins 0.000 description 1
- 101001005524 Homo sapiens Complex III assembly factor LYRM7 Proteins 0.000 description 1
- 101000942622 Homo sapiens Condensin complex subunit 3 Proteins 0.000 description 1
- 101000942612 Homo sapiens Condensin-2 complex subunit D3 Proteins 0.000 description 1
- 101000942591 Homo sapiens Condensin-2 complex subunit G2 Proteins 0.000 description 1
- 101000749824 Homo sapiens Connector enhancer of kinase suppressor of ras 2 Proteins 0.000 description 1
- 101000749829 Homo sapiens Connector enhancer of kinase suppressor of ras 3 Proteins 0.000 description 1
- 101000920124 Homo sapiens Conserved oligomeric Golgi complex subunit 1 Proteins 0.000 description 1
- 101000920113 Homo sapiens Conserved oligomeric Golgi complex subunit 2 Proteins 0.000 description 1
- 101000770432 Homo sapiens Conserved oligomeric Golgi complex subunit 3 Proteins 0.000 description 1
- 101000876012 Homo sapiens Conserved oligomeric Golgi complex subunit 4 Proteins 0.000 description 1
- 101000876001 Homo sapiens Conserved oligomeric Golgi complex subunit 5 Proteins 0.000 description 1
- 101000748957 Homo sapiens Conserved oligomeric Golgi complex subunit 6 Proteins 0.000 description 1
- 101000771062 Homo sapiens Consortin Proteins 0.000 description 1
- 101001048826 Homo sapiens Constitutive coactivator of PPAR-gamma-like protein 1 Proteins 0.000 description 1
- 101000813317 Homo sapiens Constitutive coactivator of peroxisome proliferator-activated receptor gamma Proteins 0.000 description 1
- 101000909520 Homo sapiens Contactin-1 Proteins 0.000 description 1
- 101000909517 Homo sapiens Contactin-3 Proteins 0.000 description 1
- 101000909504 Homo sapiens Contactin-4 Proteins 0.000 description 1
- 101000749872 Homo sapiens Contactin-associated protein 1 Proteins 0.000 description 1
- 101000749881 Homo sapiens Contactin-associated protein-like 3 Proteins 0.000 description 1
- 101000748895 Homo sapiens Coordinator of PRMT5 and differentiation stimulator Proteins 0.000 description 1
- 101000941754 Homo sapiens Copine-1 Proteins 0.000 description 1
- 101000941777 Homo sapiens Copine-2 Proteins 0.000 description 1
- 101000941769 Homo sapiens Copine-3 Proteins 0.000 description 1
- 101000941772 Homo sapiens Copine-5 Proteins 0.000 description 1
- 101000919214 Homo sapiens Copine-7 Proteins 0.000 description 1
- 101000941325 Homo sapiens Copper homeostasis protein cutC homolog Proteins 0.000 description 1
- 101000936280 Homo sapiens Copper-transporting ATPase 2 Proteins 0.000 description 1
- 101000939779 Homo sapiens Cordon-bleu protein-like 1 Proteins 0.000 description 1
- 101000906759 Homo sapiens Corepressor interacting with RBPJ 1 Proteins 0.000 description 1
- 101000748846 Homo sapiens Coronin-1B Proteins 0.000 description 1
- 101000957299 Homo sapiens Coronin-7 Proteins 0.000 description 1
- 101001114650 Homo sapiens Corrinoid adenosyltransferase Proteins 0.000 description 1
- 101000823488 Homo sapiens Cotranscriptional regulator FAM172A Proteins 0.000 description 1
- 101000858031 Homo sapiens Coxsackievirus and adenovirus receptor Proteins 0.000 description 1
- 101001135413 Homo sapiens Creatine kinase U-type, mitochondrial Proteins 0.000 description 1
- 101000922080 Homo sapiens Cubilin Proteins 0.000 description 1
- 101000746063 Homo sapiens Cullin-1 Proteins 0.000 description 1
- 101000916238 Homo sapiens Cullin-3 Proteins 0.000 description 1
- 101000916231 Homo sapiens Cullin-4B Proteins 0.000 description 1
- 101000856414 Homo sapiens Cullin-5 Proteins 0.000 description 1
- 101000856425 Homo sapiens Cullin-7 Proteins 0.000 description 1
- 101000856395 Homo sapiens Cullin-9 Proteins 0.000 description 1
- 101000974934 Homo sapiens Cyclic AMP-dependent transcription factor ATF-2 Proteins 0.000 description 1
- 101000905751 Homo sapiens Cyclic AMP-dependent transcription factor ATF-6 alpha Proteins 0.000 description 1
- 101000905723 Homo sapiens Cyclic AMP-dependent transcription factor ATF-7 Proteins 0.000 description 1
- 101000855516 Homo sapiens Cyclic AMP-responsive element-binding protein 1 Proteins 0.000 description 1
- 101000895309 Homo sapiens Cyclic AMP-responsive element-binding protein 3-like protein 4 Proteins 0.000 description 1
- 101000726193 Homo sapiens Cyclic AMP-responsive element-binding protein 5 Proteins 0.000 description 1
- 101000969676 Homo sapiens Cyclic pyranopterin monophosphate synthase Proteins 0.000 description 1
- 101000980770 Homo sapiens Cyclin-C Proteins 0.000 description 1
- 101000804518 Homo sapiens Cyclin-D-binding Myb-like transcription factor 1 Proteins 0.000 description 1
- 101000897488 Homo sapiens Cyclin-D1-binding protein 1 Proteins 0.000 description 1
- 101000884183 Homo sapiens Cyclin-F Proteins 0.000 description 1
- 101000886209 Homo sapiens Cyclin-G-associated kinase Proteins 0.000 description 1
- 101000713124 Homo sapiens Cyclin-I Proteins 0.000 description 1
- 101000713131 Homo sapiens Cyclin-J Proteins 0.000 description 1
- 101000713133 Homo sapiens Cyclin-J-like protein Proteins 0.000 description 1
- 101000713127 Homo sapiens Cyclin-K Proteins 0.000 description 1
- 101000716088 Homo sapiens Cyclin-L1 Proteins 0.000 description 1
- 101000897452 Homo sapiens Cyclin-L2 Proteins 0.000 description 1
- 101000897449 Homo sapiens Cyclin-Q Proteins 0.000 description 1
- 101000910488 Homo sapiens Cyclin-T1 Proteins 0.000 description 1
- 101000910484 Homo sapiens Cyclin-T2 Proteins 0.000 description 1
- 101000716073 Homo sapiens Cyclin-Y-like protein 1 Proteins 0.000 description 1
- 101000716071 Homo sapiens Cyclin-Y-like protein 2 Proteins 0.000 description 1
- 101000908138 Homo sapiens Cyclin-dependent kinase 10 Proteins 0.000 description 1
- 101000738403 Homo sapiens Cyclin-dependent kinase 11A Proteins 0.000 description 1
- 101000738400 Homo sapiens Cyclin-dependent kinase 11B Proteins 0.000 description 1
- 101000884374 Homo sapiens Cyclin-dependent kinase 14 Proteins 0.000 description 1
- 101000944355 Homo sapiens Cyclin-dependent kinase 15 Proteins 0.000 description 1
- 101000944357 Homo sapiens Cyclin-dependent kinase 16 Proteins 0.000 description 1
- 101000944345 Homo sapiens Cyclin-dependent kinase 19 Proteins 0.000 description 1
- 101000737813 Homo sapiens Cyclin-dependent kinase 2-associated protein 1 Proteins 0.000 description 1
- 101000737869 Homo sapiens Cyclin-dependent kinase 2-interacting protein Proteins 0.000 description 1
- 101000945708 Homo sapiens Cyclin-dependent kinase 20 Proteins 0.000 description 1
- 101000911952 Homo sapiens Cyclin-dependent kinase 7 Proteins 0.000 description 1
- 101000980937 Homo sapiens Cyclin-dependent kinase 8 Proteins 0.000 description 1
- 101000945639 Homo sapiens Cyclin-dependent kinase inhibitor 3 Proteins 0.000 description 1
- 101000777768 Homo sapiens Cyclin-dependent kinase-like 3 Proteins 0.000 description 1
- 101000940764 Homo sapiens Cysteine and glycine-rich protein 3 Proteins 0.000 description 1
- 101000943802 Homo sapiens Cysteine and histidine-rich domain-containing protein 1 Proteins 0.000 description 1
- 101001023837 Homo sapiens Cysteine desulfurase, mitochondrial Proteins 0.000 description 1
- 101000737778 Homo sapiens Cysteine dioxygenase type 1 Proteins 0.000 description 1
- 101000753414 Homo sapiens Cysteine protease ATG4A Proteins 0.000 description 1
- 101000753468 Homo sapiens Cysteine protease ATG4B Proteins 0.000 description 1
- 101000753453 Homo sapiens Cysteine protease ATG4C Proteins 0.000 description 1
- 101000936854 Homo sapiens Cysteine protease ATG4D Proteins 0.000 description 1
- 101000855583 Homo sapiens Cysteine sulfinic acid decarboxylase Proteins 0.000 description 1
- 101000715907 Homo sapiens Cysteine-rich DPF motif domain-containing protein 1 Proteins 0.000 description 1
- 101000942095 Homo sapiens Cysteine-rich motor neuron 1 protein Proteins 0.000 description 1
- 101000942088 Homo sapiens Cysteine-rich protein 2 Proteins 0.000 description 1
- 101000586290 Homo sapiens Cysteine-tRNA ligase, cytoplasmic Proteins 0.000 description 1
- 101000922195 Homo sapiens Cysteine/serine-rich nuclear protein 2 Proteins 0.000 description 1
- 101000922013 Homo sapiens Cysteine/serine-rich nuclear protein 3 Proteins 0.000 description 1
- 101000922034 Homo sapiens Cystinosin Proteins 0.000 description 1
- 101000777693 Homo sapiens Cytidine and dCMP deaminase domain-containing protein 1 Proteins 0.000 description 1
- 101000725160 Homo sapiens Cytochrome P450 20A1 Proteins 0.000 description 1
- 101000714865 Homo sapiens Cytochrome P450 27C1 Proteins 0.000 description 1
- 101000855328 Homo sapiens Cytochrome P450 2S1 Proteins 0.000 description 1
- 101000855331 Homo sapiens Cytochrome P450 2U1 Proteins 0.000 description 1
- 101000896951 Homo sapiens Cytochrome P450 4V2 Proteins 0.000 description 1
- 101000954166 Homo sapiens Cytochrome b-245 chaperone 1 Proteins 0.000 description 1
- 101000856723 Homo sapiens Cytochrome b-245 light chain Proteins 0.000 description 1
- 101000998613 Homo sapiens Cytochrome b5 reductase 4 Proteins 0.000 description 1
- 101000770637 Homo sapiens Cytochrome c oxidase assembly protein COX15 homolog Proteins 0.000 description 1
- 101000875881 Homo sapiens Cytochrome c oxidase assembly protein COX16 homolog, mitochondrial Proteins 0.000 description 1
- 101000957223 Homo sapiens Cytochrome c oxidase assembly protein COX20, mitochondrial Proteins 0.000 description 1
- 101000875933 Homo sapiens Cytochrome c oxidase copper chaperone Proteins 0.000 description 1
- 101000870136 Homo sapiens Cytohesin-1 Proteins 0.000 description 1
- 101000870120 Homo sapiens Cytohesin-2 Proteins 0.000 description 1
- 101000870123 Homo sapiens Cytohesin-3 Proteins 0.000 description 1
- 101001055227 Homo sapiens Cytokine receptor common subunit gamma Proteins 0.000 description 1
- 101000956872 Homo sapiens Cytoplasmic FMR1-interacting protein 1 Proteins 0.000 description 1
- 101000956870 Homo sapiens Cytoplasmic FMR1-interacting protein 2 Proteins 0.000 description 1
- 101000866326 Homo sapiens Cytoplasmic dynein 1 heavy chain 1 Proteins 0.000 description 1
- 101000881344 Homo sapiens Cytoplasmic dynein 2 heavy chain 1 Proteins 0.000 description 1
- 101000954716 Homo sapiens Cytoplasmic dynein 2 light intermediate chain 1 Proteins 0.000 description 1
- 101000745747 Homo sapiens Cytoplasmic polyadenylation element-binding protein 1 Proteins 0.000 description 1
- 101000745751 Homo sapiens Cytoplasmic polyadenylation element-binding protein 2 Proteins 0.000 description 1
- 101000745755 Homo sapiens Cytoplasmic polyadenylation element-binding protein 3 Proteins 0.000 description 1
- 101000745636 Homo sapiens Cytoplasmic polyadenylation element-binding protein 4 Proteins 0.000 description 1
- 101001024712 Homo sapiens Cytoplasmic protein NCK2 Proteins 0.000 description 1
- 101000856509 Homo sapiens Cytoplasmic tRNA 2-thiolation protein 2 Proteins 0.000 description 1
- 101000888538 Homo sapiens Cytoskeleton-associated protein 2-like Proteins 0.000 description 1
- 101000766864 Homo sapiens Cytoskeleton-associated protein 5 Proteins 0.000 description 1
- 101000802744 Homo sapiens Cytosolic 5'-nucleotidase 1A Proteins 0.000 description 1
- 101000915170 Homo sapiens Cytosolic 5'-nucleotidase 3A Proteins 0.000 description 1
- 101000598198 Homo sapiens Cytosolic Fe-S cluster assembly factor NUBP1 Proteins 0.000 description 1
- 101000947090 Homo sapiens Cytosolic arginine sensor for mTORC1 subunit 1 Proteins 0.000 description 1
- 101000946505 Homo sapiens Cytosolic carboxypeptidase 1 Proteins 0.000 description 1
- 101000932588 Homo sapiens Cytosolic carboxypeptidase 3 Proteins 0.000 description 1
- 101000868785 Homo sapiens Cytosolic carboxypeptidase 6 Proteins 0.000 description 1
- 101000906806 Homo sapiens Cytosolic iron-sulfur assembly component 2A Proteins 0.000 description 1
- 101000710266 Homo sapiens Cytosolic iron-sulfur assembly component 3 Proteins 0.000 description 1
- 101000614102 Homo sapiens Cytosolic phospholipase A2 beta Proteins 0.000 description 1
- 101000915162 Homo sapiens Cytosolic purine 5'-nucleotidase Proteins 0.000 description 1
- 101000838688 Homo sapiens D-aminoacyl-tRNA deacylase 1 Proteins 0.000 description 1
- 101000838681 Homo sapiens D-aminoacyl-tRNA deacylase 2 Proteins 0.000 description 1
- 101000903373 Homo sapiens D-beta-hydroxybutyrate dehydrogenase, mitochondrial Proteins 0.000 description 1
- 101001058422 Homo sapiens D-glucuronyl C5-epimerase Proteins 0.000 description 1
- 101000996136 Homo sapiens D-glutamate cyclase, mitochondrial Proteins 0.000 description 1
- 101000871284 Homo sapiens DAZ-associated protein 1 Proteins 0.000 description 1
- 101000871240 Homo sapiens DAZ-associated protein 2 Proteins 0.000 description 1
- 101001053277 Homo sapiens DCC-interacting protein 13-alpha Proteins 0.000 description 1
- 101001053257 Homo sapiens DCC-interacting protein 13-beta Proteins 0.000 description 1
- 101000911740 Homo sapiens DCN1-like protein 2 Proteins 0.000 description 1
- 101000954846 Homo sapiens DCN1-like protein 4 Proteins 0.000 description 1
- 101000954832 Homo sapiens DCN1-like protein 5 Proteins 0.000 description 1
- 101000917426 Homo sapiens DDB1- and CUL4-associated factor 1 Proteins 0.000 description 1
- 101000721261 Homo sapiens DDB1- and CUL4-associated factor 10 Proteins 0.000 description 1
- 101000721268 Homo sapiens DDB1- and CUL4-associated factor 11 Proteins 0.000 description 1
- 101000885476 Homo sapiens DDB1- and CUL4-associated factor 13 Proteins 0.000 description 1
- 101000917435 Homo sapiens DDB1- and CUL4-associated factor 16 Proteins 0.000 description 1
- 101000917433 Homo sapiens DDB1- and CUL4-associated factor 17 Proteins 0.000 description 1
- 101000917420 Homo sapiens DDB1- and CUL4-associated factor 6 Proteins 0.000 description 1
- 101000832316 Homo sapiens DDB1- and CUL4-associated factor 8 Proteins 0.000 description 1
- 101000870988 Homo sapiens DENN domain-containing protein 10 Proteins 0.000 description 1
- 101000870898 Homo sapiens DENN domain-containing protein 11 Proteins 0.000 description 1
- 101000870904 Homo sapiens DENN domain-containing protein 1A Proteins 0.000 description 1
- 101000870914 Homo sapiens DENN domain-containing protein 1B Proteins 0.000 description 1
- 101000870874 Homo sapiens DENN domain-containing protein 1C Proteins 0.000 description 1
- 101000722278 Homo sapiens DENN domain-containing protein 2C Proteins 0.000 description 1
- 101000842747 Homo sapiens DENN domain-containing protein 3 Proteins 0.000 description 1
- 101000722282 Homo sapiens DENN domain-containing protein 4B Proteins 0.000 description 1
- 101000722273 Homo sapiens DENN domain-containing protein 4C Proteins 0.000 description 1
- 101000722275 Homo sapiens DENN domain-containing protein 5A Proteins 0.000 description 1
- 101000722005 Homo sapiens DENN domain-containing protein 5B Proteins 0.000 description 1
- 101000865183 Homo sapiens DEP domain-containing mTOR-interacting protein Proteins 0.000 description 1
- 101000950642 Homo sapiens DEP domain-containing protein 1A Proteins 0.000 description 1
- 101000951181 Homo sapiens DIS3-like exonuclease 1 Proteins 0.000 description 1
- 101000951062 Homo sapiens DIS3-like exonuclease 2 Proteins 0.000 description 1
- 101000941890 Homo sapiens DISP complex protein LRCH3 Proteins 0.000 description 1
- 101000964382 Homo sapiens DNA dC->dU-editing enzyme APOBEC-3D Proteins 0.000 description 1
- 101000964377 Homo sapiens DNA dC->dU-editing enzyme APOBEC-3F Proteins 0.000 description 1
- 101001041466 Homo sapiens DNA damage-binding protein 2 Proteins 0.000 description 1
- 101000918646 Homo sapiens DNA damage-induced apoptosis suppressor protein Proteins 0.000 description 1
- 101000931929 Homo sapiens DNA damage-regulated autophagy modulator protein 1 Proteins 0.000 description 1
- 101000968012 Homo sapiens DNA damage-regulated autophagy modulator protein 2 Proteins 0.000 description 1
- 101000876529 Homo sapiens DNA excision repair protein ERCC-1 Proteins 0.000 description 1
- 101000898683 Homo sapiens DNA excision repair protein ERCC-6-like 2 Proteins 0.000 description 1
- 101000920778 Homo sapiens DNA excision repair protein ERCC-8 Proteins 0.000 description 1
- 101000950906 Homo sapiens DNA fragmentation factor subunit alpha Proteins 0.000 description 1
- 101000950965 Homo sapiens DNA fragmentation factor subunit beta Proteins 0.000 description 1
- 101000957174 Homo sapiens DNA helicase MCM8 Proteins 0.000 description 1
- 101000957164 Homo sapiens DNA helicase MCM9 Proteins 0.000 description 1
- 101000930289 Homo sapiens DNA methyltransferase 1-associated protein 1 Proteins 0.000 description 1
- 101000577867 Homo sapiens DNA mismatch repair protein Mlh3 Proteins 0.000 description 1
- 101001134036 Homo sapiens DNA mismatch repair protein Msh2 Proteins 0.000 description 1
- 101001027762 Homo sapiens DNA mismatch repair protein Msh3 Proteins 0.000 description 1
- 101000959163 Homo sapiens DNA oxidative demethylase ALKBH2 Proteins 0.000 description 1
- 101000927313 Homo sapiens DNA replication ATP-dependent helicase DNA2 Proteins 0.000 description 1
- 101001080484 Homo sapiens DNA replication complex GINS protein PSF1 Proteins 0.000 description 1
- 101001136564 Homo sapiens DNA replication complex GINS protein PSF3 Proteins 0.000 description 1
- 101000583807 Homo sapiens DNA replication licensing factor MCM2 Proteins 0.000 description 1
- 101000615280 Homo sapiens DNA replication licensing factor MCM4 Proteins 0.000 description 1
- 101000830366 Homo sapiens DNA-binding death effector domain-containing protein 2 Proteins 0.000 description 1
- 101000599038 Homo sapiens DNA-binding protein Ikaros Proteins 0.000 description 1
- 101001104144 Homo sapiens DNA-directed RNA polymerase III subunit RPC9 Proteins 0.000 description 1
- 101001008941 Homo sapiens DNA/RNA-binding protein KIN17 Proteins 0.000 description 1
- 101000902716 Homo sapiens DPH3 homolog Proteins 0.000 description 1
- 101000808719 Homo sapiens Damage-control phosphatase ARMT1 Proteins 0.000 description 1
- 101000830359 Homo sapiens Death effector domain-containing protein Proteins 0.000 description 1
- 101000956145 Homo sapiens Death-associated protein kinase 1 Proteins 0.000 description 1
- 101000956149 Homo sapiens Death-associated protein kinase 3 Proteins 0.000 description 1
- 101000866270 Homo sapiens Dedicator of cytokinesis protein 11 Proteins 0.000 description 1
- 101000866237 Homo sapiens Dedicator of cytokinesis protein 2 Proteins 0.000 description 1
- 101001052955 Homo sapiens Dedicator of cytokinesis protein 4 Proteins 0.000 description 1
- 101001052956 Homo sapiens Dedicator of cytokinesis protein 5 Proteins 0.000 description 1
- 101001052950 Homo sapiens Dedicator of cytokinesis protein 6 Proteins 0.000 description 1
- 101001052952 Homo sapiens Dedicator of cytokinesis protein 7 Proteins 0.000 description 1
- 101001052948 Homo sapiens Dedicator of cytokinesis protein 9 Proteins 0.000 description 1
- 101000929421 Homo sapiens Deformed epidermal autoregulatory factor 1 homolog Proteins 0.000 description 1
- 101000928713 Homo sapiens Dehydrodolichyl diphosphate synthase complex subunit DHDDS Proteins 0.000 description 1
- 101001023820 Homo sapiens Dehydrodolichyl diphosphate synthase complex subunit NUS1 Proteins 0.000 description 1
- 101000869990 Homo sapiens Dehydrogenase/reductase SDR family member 12 Proteins 0.000 description 1
- 101000806138 Homo sapiens Dehydrogenase/reductase SDR family member 4 Proteins 0.000 description 1
- 101000931852 Homo sapiens Dehydrogenase/reductase SDR family member 4-like 2 Proteins 0.000 description 1
- 101000928758 Homo sapiens Dehydrogenase/reductase SDR family member 7 Proteins 0.000 description 1
- 101000880879 Homo sapiens Dehydrogenase/reductase SDR family member 7B Proteins 0.000 description 1
- 101001053992 Homo sapiens Deleted in lung and esophageal cancer protein 1 Proteins 0.000 description 1
- 101000945982 Homo sapiens Delta(14)-sterol reductase LBR Proteins 0.000 description 1
- 101000755868 Homo sapiens Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial Proteins 0.000 description 1
- 101000929217 Homo sapiens Dematin Proteins 0.000 description 1
- 101000842847 Homo sapiens Dendrin Proteins 0.000 description 1
- 101001044612 Homo sapiens Density-regulated protein Proteins 0.000 description 1
- 101000968287 Homo sapiens Denticleless protein homolog Proteins 0.000 description 1
- 101000955042 Homo sapiens Deoxycytidylate deaminase Proteins 0.000 description 1
- 101000928003 Homo sapiens Deoxyguanosine kinase, mitochondrial Proteins 0.000 description 1
- 101000844963 Homo sapiens Deoxyhypusine synthase Proteins 0.000 description 1
- 101000626101 Homo sapiens Deoxynucleotidyltransferase terminal-interacting protein 1 Proteins 0.000 description 1
- 101000626071 Homo sapiens Deoxynucleotidyltransferase terminal-interacting protein 2 Proteins 0.000 description 1
- 101000902850 Homo sapiens Deoxyribonuclease-2-alpha Proteins 0.000 description 1
- 101000952691 Homo sapiens Dephospho-CoA kinase Proteins 0.000 description 1
- 101000832260 Homo sapiens Dephospho-CoA kinase domain-containing protein Proteins 0.000 description 1
- 101000842611 Homo sapiens Derlin-1 Proteins 0.000 description 1
- 101000816698 Homo sapiens Dermatan-sulfate epimerase Proteins 0.000 description 1
- 101000872044 Homo sapiens Dermokine Proteins 0.000 description 1
- 101000928089 Homo sapiens Desumoylating isopeptidase 1 Proteins 0.000 description 1
- 101001023119 Homo sapiens Deubiquitinase MYSM1 Proteins 0.000 description 1
- 101000613797 Homo sapiens Deubiquitinase OTUD6B Proteins 0.000 description 1
- 101000880940 Homo sapiens Developmentally-regulated GTP-binding protein 2 Proteins 0.000 description 1
- 101000806442 Homo sapiens Dexamethasone-induced protein Proteins 0.000 description 1
- 101000928786 Homo sapiens Di-N-acetylchitobiase Proteins 0.000 description 1
- 101000871228 Homo sapiens Diablo IAP-binding mitochondrial protein Proteins 0.000 description 1
- 101001044817 Homo sapiens Diacylglycerol kinase alpha Proteins 0.000 description 1
- 101001044812 Homo sapiens Diacylglycerol kinase epsilon Proteins 0.000 description 1
- 101000864599 Homo sapiens Diacylglycerol kinase eta Proteins 0.000 description 1
- 101000864600 Homo sapiens Diacylglycerol kinase iota Proteins 0.000 description 1
- 101000864574 Homo sapiens Diacylglycerol kinase theta Proteins 0.000 description 1
- 101000864576 Homo sapiens Diacylglycerol kinase zeta Proteins 0.000 description 1
- 101000950829 Homo sapiens Diacylglycerol lipase-beta Proteins 0.000 description 1
- 101000722118 Homo sapiens Differentially expressed in FDCP 8 homolog Proteins 0.000 description 1
- 101001122360 Homo sapiens Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial Proteins 0.000 description 1
- 101000992065 Homo sapiens Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial Proteins 0.000 description 1
- 101000900531 Homo sapiens Dihydropyrimidinase-related protein 1 Proteins 0.000 description 1
- 101001053503 Homo sapiens Dihydropyrimidinase-related protein 2 Proteins 0.000 description 1
- 101001053501 Homo sapiens Dihydropyrimidinase-related protein 3 Proteins 0.000 description 1
- 101001053490 Homo sapiens Dihydropyrimidinase-related protein 4 Proteins 0.000 description 1
- 101001053479 Homo sapiens Dihydropyrimidinase-related protein 5 Proteins 0.000 description 1
- 101000902632 Homo sapiens Dihydropyrimidine dehydrogenase [NADP(+)] Proteins 0.000 description 1
- 101001039272 Homo sapiens Dihydroxyacetone phosphate acyltransferase Proteins 0.000 description 1
- 101000793922 Homo sapiens Dipeptidyl peptidase 1 Proteins 0.000 description 1
- 101000908391 Homo sapiens Dipeptidyl peptidase 4 Proteins 0.000 description 1
- 101000804947 Homo sapiens Dipeptidyl peptidase 8 Proteins 0.000 description 1
- 101000804945 Homo sapiens Dipeptidyl peptidase 9 Proteins 0.000 description 1
- 101000632920 Homo sapiens Diphosphoinositol polyphosphate phosphohydrolase 1 Proteins 0.000 description 1
- 101000958922 Homo sapiens Diphosphomevalonate decarboxylase Proteins 0.000 description 1
- 101000837321 Homo sapiens Diphthine methyl ester synthase Proteins 0.000 description 1
- 101000837451 Homo sapiens Diphthine-ammonia ligase Proteins 0.000 description 1
- 101000915391 Homo sapiens Disabled homolog 2 Proteins 0.000 description 1
- 101000915396 Homo sapiens Disabled homolog 2-interacting protein Proteins 0.000 description 1
- 101000805876 Homo sapiens Disco-interacting protein 2 homolog A Proteins 0.000 description 1
- 101000805871 Homo sapiens Disco-interacting protein 2 homolog B Proteins 0.000 description 1
- 101000805870 Homo sapiens Disco-interacting protein 2 homolog C Proteins 0.000 description 1
- 101000911798 Homo sapiens Discoidin, CUB and LCCL domain-containing protein 1 Proteins 0.000 description 1
- 101000911787 Homo sapiens Discoidin, CUB and LCCL domain-containing protein 2 Proteins 0.000 description 1
- 101000915413 Homo sapiens Disheveled-associated activator of morphogenesis 1 Proteins 0.000 description 1
- 101001053984 Homo sapiens Disks large homolog 1 Proteins 0.000 description 1
- 101000902100 Homo sapiens Disks large homolog 3 Proteins 0.000 description 1
- 101000902096 Homo sapiens Disks large homolog 4 Proteins 0.000 description 1
- 101000902114 Homo sapiens Disks large homolog 5 Proteins 0.000 description 1
- 101000844774 Homo sapiens Disks large-associated protein 3 Proteins 0.000 description 1
- 101000951335 Homo sapiens Disks large-associated protein 4 Proteins 0.000 description 1
- 101000930307 Homo sapiens Distal membrane-arm assembly complex protein 2 Proteins 0.000 description 1
- 101000806069 Homo sapiens Divergent protein kinase domain 1B Proteins 0.000 description 1
- 101000804531 Homo sapiens DmX-like protein 1 Proteins 0.000 description 1
- 101000804534 Homo sapiens DmX-like protein 2 Proteins 0.000 description 1
- 101000805849 Homo sapiens DnaJ homolog subfamily B member 12 Proteins 0.000 description 1
- 101000866008 Homo sapiens DnaJ homolog subfamily B member 4 Proteins 0.000 description 1
- 101000870239 Homo sapiens DnaJ homolog subfamily C member 13 Proteins 0.000 description 1
- 101000902079 Homo sapiens DnaJ homolog subfamily C member 17 Proteins 0.000 description 1
- 101000845887 Homo sapiens DnaJ homolog subfamily C member 2 Proteins 0.000 description 1
- 101000902105 Homo sapiens DnaJ homolog subfamily C member 22 Proteins 0.000 description 1
- 101001054519 Homo sapiens DnaJ homolog subfamily C member 25 Proteins 0.000 description 1
- 101000845897 Homo sapiens DnaJ homolog subfamily C member 4 Proteins 0.000 description 1
- 101000845893 Homo sapiens DnaJ homolog subfamily C member 5 Proteins 0.000 description 1
- 101000903063 Homo sapiens DnaJ homolog subfamily C member 8 Proteins 0.000 description 1
- 101000805172 Homo sapiens Docking protein 1 Proteins 0.000 description 1
- 101000805166 Homo sapiens Docking protein 2 Proteins 0.000 description 1
- 101000805167 Homo sapiens Docking protein 3 Proteins 0.000 description 1
- 101000845687 Homo sapiens Docking protein 6 Proteins 0.000 description 1
- 101000958975 Homo sapiens Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase Proteins 0.000 description 1
- 101000694130 Homo sapiens Dolichyl-phosphate beta-glucosyltransferase Proteins 0.000 description 1
- 101000927648 Homo sapiens Dolichyldiphosphatase 1 Proteins 0.000 description 1
- 101000927562 Homo sapiens Dopamine beta-hydroxylase Proteins 0.000 description 1
- 101000880911 Homo sapiens Dorsal root ganglia homeobox protein Proteins 0.000 description 1
- 101000591400 Homo sapiens Double-strand break repair protein MRE11 Proteins 0.000 description 1
- 101000949728 Homo sapiens Doublesex- and mab-3-related transcription factor A2 Proteins 0.000 description 1
- 101000880945 Homo sapiens Down syndrome cell adhesion molecule Proteins 0.000 description 1
- 101000915399 Homo sapiens Drebrin-like protein Proteins 0.000 description 1
- 101000865739 Homo sapiens Dual serine/threonine and tyrosine protein kinase Proteins 0.000 description 1
- 101001115395 Homo sapiens Dual specificity mitogen-activated protein kinase kinase 4 Proteins 0.000 description 1
- 101000624426 Homo sapiens Dual specificity mitogen-activated protein kinase kinase 6 Proteins 0.000 description 1
- 101000624594 Homo sapiens Dual specificity mitogen-activated protein kinase kinase 7 Proteins 0.000 description 1
- 101000749294 Homo sapiens Dual specificity protein kinase CLK1 Proteins 0.000 description 1
- 101000749291 Homo sapiens Dual specificity protein kinase CLK2 Proteins 0.000 description 1
- 101000749304 Homo sapiens Dual specificity protein kinase CLK3 Proteins 0.000 description 1
- 101000749298 Homo sapiens Dual specificity protein kinase CLK4 Proteins 0.000 description 1
- 101000881117 Homo sapiens Dual specificity protein phosphatase 16 Proteins 0.000 description 1
- 101001017467 Homo sapiens Dual specificity protein phosphatase 22 Proteins 0.000 description 1
- 101000932600 Homo sapiens Dual specificity protein phosphatase CDC14A Proteins 0.000 description 1
- 101000932592 Homo sapiens Dual specificity protein phosphatase CDC14B Proteins 0.000 description 1
- 101000838016 Homo sapiens Dual specificity tyrosine-phosphorylation-regulated kinase 1A Proteins 0.000 description 1
- 101001049990 Homo sapiens Dual specificity tyrosine-phosphorylation-regulated kinase 2 Proteins 0.000 description 1
- 101001049991 Homo sapiens Dual specificity tyrosine-phosphorylation-regulated kinase 3 Proteins 0.000 description 1
- 101001049983 Homo sapiens Dual specificity tyrosine-phosphorylation-regulated kinase 4 Proteins 0.000 description 1
- 101000817629 Homo sapiens Dymeclin Proteins 0.000 description 1
- 101000929626 Homo sapiens Dynactin subunit 1 Proteins 0.000 description 1
- 101001041190 Homo sapiens Dynactin subunit 2 Proteins 0.000 description 1
- 101001041189 Homo sapiens Dynactin subunit 4 Proteins 0.000 description 1
- 101001041180 Homo sapiens Dynactin subunit 5 Proteins 0.000 description 1
- 101000817604 Homo sapiens Dynamin-1 Proteins 0.000 description 1
- 101000909218 Homo sapiens Dynamin-1-like protein Proteins 0.000 description 1
- 101000817599 Homo sapiens Dynamin-3 Proteins 0.000 description 1
- 101000909230 Homo sapiens Dynamin-binding protein Proteins 0.000 description 1
- 101000722054 Homo sapiens Dynamin-like 120 kDa protein, mitochondrial Proteins 0.000 description 1
- 101000831210 Homo sapiens Dynein axonemal assembly factor 11 Proteins 0.000 description 1
- 101000869199 Homo sapiens Dynein axonemal assembly factor 4 Proteins 0.000 description 1
- 101000869175 Homo sapiens Dynein axonemal assembly factor 5 Proteins 0.000 description 1
- 101001016205 Homo sapiens Dynein axonemal heavy chain 10 Proteins 0.000 description 1
- 101001016204 Homo sapiens Dynein axonemal heavy chain 14 Proteins 0.000 description 1
- 101000966403 Homo sapiens Dynein light chain 1, cytoplasmic Proteins 0.000 description 1
- 101000864766 Homo sapiens Dynein light chain roadblock-type 1 Proteins 0.000 description 1
- 101000880830 Homo sapiens Dynein regulatory complex protein 8 Proteins 0.000 description 1
- 101000880811 Homo sapiens Dynein regulatory complex protein 9 Proteins 0.000 description 1
- 101000816970 Homo sapiens Dynein regulatory complex subunit 4 Proteins 0.000 description 1
- 101000816907 Homo sapiens Dynein regulatory complex subunit 6 Proteins 0.000 description 1
- 101001016184 Homo sapiens Dysferlin Proteins 0.000 description 1
- 101001076904 Homo sapiens Dyslexia-associated protein KIAA0319-like protein Proteins 0.000 description 1
- 101001016186 Homo sapiens Dystonin Proteins 0.000 description 1
- 101001053689 Homo sapiens Dystrobrevin alpha Proteins 0.000 description 1
- 101000855983 Homo sapiens Dystroglycan 1 Proteins 0.000 description 1
- 101001053946 Homo sapiens Dystrophin Proteins 0.000 description 1
- 101000882371 Homo sapiens E1A-binding protein p400 Proteins 0.000 description 1
- 101001035145 Homo sapiens E3 ISG15-protein ligase HERC5 Proteins 0.000 description 1
- 101000797579 Homo sapiens E3 SUMO-protein ligase CBX4 Proteins 0.000 description 1
- 101000577736 Homo sapiens E3 SUMO-protein ligase NSE2 Proteins 0.000 description 1
- 101000808888 Homo sapiens E3 ubiquitin-protein ligase ARIH2 Proteins 0.000 description 1
- 101000737265 Homo sapiens E3 ubiquitin-protein ligase CBL-B Proteins 0.000 description 1
- 101000942970 Homo sapiens E3 ubiquitin-protein ligase CHFR Proteins 0.000 description 1
- 101000832062 Homo sapiens E3 ubiquitin-protein ligase DCST1 Proteins 0.000 description 1
- 101000926716 Homo sapiens E3 ubiquitin-protein ligase DZIP3 Proteins 0.000 description 1
- 101001009246 Homo sapiens E3 ubiquitin-protein ligase HACE1 Proteins 0.000 description 1
- 101000872880 Homo sapiens E3 ubiquitin-protein ligase HECTD1 Proteins 0.000 description 1
- 101000872869 Homo sapiens E3 ubiquitin-protein ligase HECW1 Proteins 0.000 description 1
- 101000872871 Homo sapiens E3 ubiquitin-protein ligase HECW2 Proteins 0.000 description 1
- 101000872516 Homo sapiens E3 ubiquitin-protein ligase HERC2 Proteins 0.000 description 1
- 101001019732 Homo sapiens E3 ubiquitin-protein ligase HUWE1 Proteins 0.000 description 1
- 101001083405 Homo sapiens E3 ubiquitin-protein ligase Hakai Proteins 0.000 description 1
- 101000994468 Homo sapiens E3 ubiquitin-protein ligase Jade-2 Proteins 0.000 description 1
- 101000994641 Homo sapiens E3 ubiquitin-protein ligase KCMF1 Proteins 0.000 description 1
- 101000620132 Homo sapiens E3 ubiquitin-protein ligase LNX Proteins 0.000 description 1
- 101001065747 Homo sapiens E3 ubiquitin-protein ligase LRSAM1 Proteins 0.000 description 1
- 101000957748 Homo sapiens E3 ubiquitin-protein ligase MARCHF1 Proteins 0.000 description 1
- 101001040043 Homo sapiens E3 ubiquitin-protein ligase MARCHF3 Proteins 0.000 description 1
- 101001039881 Homo sapiens E3 ubiquitin-protein ligase MARCHF5 Proteins 0.000 description 1
- 101000978676 Homo sapiens E3 ubiquitin-protein ligase MARCHF6 Proteins 0.000 description 1
- 101000978673 Homo sapiens E3 ubiquitin-protein ligase MARCHF7 Proteins 0.000 description 1
- 101000978729 Homo sapiens E3 ubiquitin-protein ligase MARCHF8 Proteins 0.000 description 1
- 101000951423 Homo sapiens E3 ubiquitin-protein ligase MGRN1 Proteins 0.000 description 1
- 101000973503 Homo sapiens E3 ubiquitin-protein ligase MIB1 Proteins 0.000 description 1
- 101000973495 Homo sapiens E3 ubiquitin-protein ligase MIB2 Proteins 0.000 description 1
- 101001128447 Homo sapiens E3 ubiquitin-protein ligase MYLIP Proteins 0.000 description 1
- 101000636713 Homo sapiens E3 ubiquitin-protein ligase NEDD4 Proteins 0.000 description 1
- 101001023703 Homo sapiens E3 ubiquitin-protein ligase NEDD4-like Proteins 0.000 description 1
- 101001023726 Homo sapiens E3 ubiquitin-protein ligase NEURL1B Proteins 0.000 description 1
- 101001095815 Homo sapiens E3 ubiquitin-protein ligase RING2 Proteins 0.000 description 1
- 101001106980 Homo sapiens E3 ubiquitin-protein ligase RNF138 Proteins 0.000 description 1
- 101001038784 Homo sapiens E3 ubiquitin-protein ligase listerin Proteins 0.000 description 1
- 101001018965 Homo sapiens E3 ubiquitin-protein ligase makorin-1 Proteins 0.000 description 1
- 101001018973 Homo sapiens E3 ubiquitin-protein ligase makorin-2 Proteins 0.000 description 1
- 101000616009 Homo sapiens E3 ubiquitin-protein transferase MAEA Proteins 0.000 description 1
- 101000921326 Homo sapiens EARP and GARP complex-interacting protein 1 Proteins 0.000 description 1
- 101000965480 Homo sapiens EEF1A lysine methyltransferase 1 Proteins 0.000 description 1
- 101000965473 Homo sapiens EEF1A lysine methyltransferase 2 Proteins 0.000 description 1
- 101000967387 Homo sapiens EF-hand calcium-binding domain-containing protein 11 Proteins 0.000 description 1
- 101000880228 Homo sapiens EF-hand calcium-binding domain-containing protein 13 Proteins 0.000 description 1
- 101000880230 Homo sapiens EF-hand calcium-binding domain-containing protein 14 Proteins 0.000 description 1
- 101000880360 Homo sapiens EF-hand calcium-binding domain-containing protein 4A Proteins 0.000 description 1
- 101000880368 Homo sapiens EF-hand calcium-binding domain-containing protein 4B Proteins 0.000 description 1
- 101000925431 Homo sapiens EF-hand calcium-binding domain-containing protein 5 Proteins 0.000 description 1
- 101000925424 Homo sapiens EF-hand calcium-binding domain-containing protein 7 Proteins 0.000 description 1
- 101000866913 Homo sapiens EF-hand domain-containing protein D2 Proteins 0.000 description 1
- 101000920640 Homo sapiens EGF domain-specific O-linked N-acetylglucosamine transferase Proteins 0.000 description 1
- 101001065272 Homo sapiens EGF-containing fibulin-like extracellular matrix protein 1 Proteins 0.000 description 1
- 101001016381 Homo sapiens EGF-like repeat and discoidin I-like domain-containing protein 3 Proteins 0.000 description 1
- 101001012951 Homo sapiens EH domain-binding protein 1 Proteins 0.000 description 1
- 101001012961 Homo sapiens EH domain-binding protein 1-like protein 1 Proteins 0.000 description 1
- 101001100208 Homo sapiens ELKS/Rab6-interacting/CAST family member 1 Proteins 0.000 description 1
- 101000895942 Homo sapiens ELL-associated factor 1 Proteins 0.000 description 1
- 101001048694 Homo sapiens ELMO domain-containing protein 1 Proteins 0.000 description 1
- 101001057872 Homo sapiens ELMO domain-containing protein 2 Proteins 0.000 description 1
- 101001057868 Homo sapiens ELMO domain-containing protein 3 Proteins 0.000 description 1
- 101000895713 Homo sapiens ER degradation-enhancing alpha-mannosidase-like protein 2 Proteins 0.000 description 1
- 101001016391 Homo sapiens ER degradation-enhancing alpha-mannosidase-like protein 3 Proteins 0.000 description 1
- 101000896333 Homo sapiens ER membrane protein complex subunit 1 Proteins 0.000 description 1
- 101000880998 Homo sapiens ER membrane protein complex subunit 2 Proteins 0.000 description 1
- 101000877430 Homo sapiens ER membrane protein complex subunit 4 Proteins 0.000 description 1
- 101000877400 Homo sapiens ER membrane protein complex subunit 5 Proteins 0.000 description 1
- 101000925848 Homo sapiens ER membrane protein complex subunit 8 Proteins 0.000 description 1
- 101000876444 Homo sapiens ERC protein 2 Proteins 0.000 description 1
- 101000938751 Homo sapiens ERI1 exoribonuclease 2 Proteins 0.000 description 1
- 101001056896 Homo sapiens ERI1 exoribonuclease 3 Proteins 0.000 description 1
- 101001010853 Homo sapiens ERO1-like protein alpha Proteins 0.000 description 1
- 101000938692 Homo sapiens ESF1 homolog Proteins 0.000 description 1
- 101000813729 Homo sapiens ETS translocation variant 1 Proteins 0.000 description 1
- 101000813726 Homo sapiens ETS translocation variant 3 Proteins 0.000 description 1
- 101000813747 Homo sapiens ETS translocation variant 4 Proteins 0.000 description 1
- 101000877377 Homo sapiens ETS-related transcription factor Elf-2 Proteins 0.000 description 1
- 101000813135 Homo sapiens ETS-related transcription factor Elf-4 Proteins 0.000 description 1
- 101001050162 Homo sapiens Early endosome antigen 1 Proteins 0.000 description 1
- 101000896533 Homo sapiens Early growth response protein 4 Proteins 0.000 description 1
- 101001057941 Homo sapiens Echinoderm microtubule-associated protein-like 1 Proteins 0.000 description 1
- 101001057942 Homo sapiens Echinoderm microtubule-associated protein-like 2 Proteins 0.000 description 1
- 101001057939 Homo sapiens Echinoderm microtubule-associated protein-like 3 Proteins 0.000 description 1
- 101001057929 Homo sapiens Echinoderm microtubule-associated protein-like 4 Proteins 0.000 description 1
- 101001011842 Homo sapiens Echinoderm microtubule-associated protein-like 5 Proteins 0.000 description 1
- 101001011835 Homo sapiens Echinoderm microtubule-associated protein-like 6 Proteins 0.000 description 1
- 101001024566 Homo sapiens Ecto-ADP-ribosyltransferase 4 Proteins 0.000 description 1
- 101001024570 Homo sapiens Ecto-ADP-ribosyltransferase 5 Proteins 0.000 description 1
- 101001012435 Homo sapiens Ectonucleoside triphosphate diphosphohydrolase 4 Proteins 0.000 description 1
- 101000851972 Homo sapiens Ectonucleoside triphosphate diphosphohydrolase 6 Proteins 0.000 description 1
- 101000938359 Homo sapiens Ectopic P granules protein 5 homolog Proteins 0.000 description 1
- 101000881648 Homo sapiens Egl nine homolog 1 Proteins 0.000 description 1
- 101000851054 Homo sapiens Elastin Proteins 0.000 description 1
- 101000920909 Homo sapiens Electron transfer flavoprotein regulatory factor 1 Proteins 0.000 description 1
- 101001057122 Homo sapiens Electron transfer flavoprotein subunit beta Proteins 0.000 description 1
- 101000920874 Homo sapiens Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial Proteins 0.000 description 1
- 101000881890 Homo sapiens Ellis-van Creveld syndrome protein Proteins 0.000 description 1
- 101000920062 Homo sapiens Elongation factor 1-delta Proteins 0.000 description 1
- 101000880344 Homo sapiens Elongation factor G, mitochondrial Proteins 0.000 description 1
- 101000866914 Homo sapiens Elongation factor-like GTPase 1 Proteins 0.000 description 1
- 101000921370 Homo sapiens Elongation of very long chain fatty acids protein 1 Proteins 0.000 description 1
- 101000921368 Homo sapiens Elongation of very long chain fatty acids protein 2 Proteins 0.000 description 1
- 101000921354 Homo sapiens Elongation of very long chain fatty acids protein 4 Proteins 0.000 description 1
- 101000813103 Homo sapiens Elongation of very long chain fatty acids protein 7 Proteins 0.000 description 1
- 101000877382 Homo sapiens Elongator complex protein 3 Proteins 0.000 description 1
- 101000896261 Homo sapiens Elongator complex protein 5 Proteins 0.000 description 1
- 101000896299 Homo sapiens Elongator complex protein 6 Proteins 0.000 description 1
- 101000896275 Homo sapiens Embigin Proteins 0.000 description 1
- 101001053896 Homo sapiens Embryonal Fyn-associated substrate Proteins 0.000 description 1
- 101001015930 Homo sapiens Emopamil-binding protein-like Proteins 0.000 description 1
- 101001064125 Homo sapiens Endogenous retrovirus group K member 13-1 Env polyprotein Proteins 0.000 description 1
- 101001123823 Homo sapiens Endonuclease 8-like 2 Proteins 0.000 description 1
- 101001123819 Homo sapiens Endonuclease 8-like 3 Proteins 0.000 description 1
- 101001137538 Homo sapiens Endonuclease G, mitochondrial Proteins 0.000 description 1
- 101000970385 Homo sapiens Endonuclease III-like protein 1 Proteins 0.000 description 1
- 101000880860 Homo sapiens Endonuclease V Proteins 0.000 description 1
- 101000941029 Homo sapiens Endoplasmic reticulum junction formation protein lunapark Proteins 0.000 description 1
- 101000813998 Homo sapiens Endoplasmic reticulum lectin 1 Proteins 0.000 description 1
- 101000588298 Homo sapiens Endoplasmic reticulum membrane sensor NFE2L1 Proteins 0.000 description 1
- 101001011818 Homo sapiens Endoplasmic reticulum membrane-associated RNA degradation protein Proteins 0.000 description 1
- 101000639962 Homo sapiens Endoplasmic reticulum protein SC65 Proteins 0.000 description 1
- 101000920804 Homo sapiens Endoplasmic reticulum-Golgi intermediate compartment protein 1 Proteins 0.000 description 1
- 101000920800 Homo sapiens Endoplasmic reticulum-Golgi intermediate compartment protein 2 Proteins 0.000 description 1
- 101001010804 Homo sapiens Endoplasmic reticulum-Golgi intermediate compartment protein 3 Proteins 0.000 description 1
- 101000907904 Homo sapiens Endoribonuclease Dicer Proteins 0.000 description 1
- 101000925880 Homo sapiens Endosome/lysosome-associated apoptosis and autophagy regulator 1 Proteins 0.000 description 1
- 101000925877 Homo sapiens Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 Proteins 0.000 description 1
- 101001066265 Homo sapiens Endothelial transcription factor GATA-2 Proteins 0.000 description 1
- 101001057862 Homo sapiens Engulfment and cell motility protein 1 Proteins 0.000 description 1
- 101001057855 Homo sapiens Engulfment and cell motility protein 2 Proteins 0.000 description 1
- 101000898310 Homo sapiens Enhancer of filamentation 1 Proteins 0.000 description 1
- 101000880050 Homo sapiens Enhancer of mRNA-decapping protein 3 Proteins 0.000 description 1
- 101001064111 Homo sapiens Enkurin domain-containing protein 1 Proteins 0.000 description 1
- 101000896042 Homo sapiens Enoyl-CoA delta isomerase 2 Proteins 0.000 description 1
- 101000919883 Homo sapiens Enoyl-CoA hydratase domain-containing protein 2, mitochondrial Proteins 0.000 description 1
- 101000961707 Homo sapiens Enoyl-[acyl-carrier-protein] reductase, mitochondrial Proteins 0.000 description 1
- 101000898696 Homo sapiens Ephrin type-A receptor 6 Proteins 0.000 description 1
- 101000898676 Homo sapiens Ephrin type-A receptor 8 Proteins 0.000 description 1
- 101000925241 Homo sapiens Ephrin-A3 Proteins 0.000 description 1
- 101000925259 Homo sapiens Ephrin-A4 Proteins 0.000 description 1
- 101000812517 Homo sapiens Epidermal growth factor receptor substrate 15 Proteins 0.000 description 1
- 101001064156 Homo sapiens Epidermal growth factor receptor substrate 15-like 1 Proteins 0.000 description 1
- 101000921195 Homo sapiens Epidermal growth factor-like protein 7 Proteins 0.000 description 1
- 101000979031 Homo sapiens Epididymis-specific alpha-mannosidase Proteins 0.000 description 1
- 101000938352 Homo sapiens Epigen Proteins 0.000 description 1
- 101001011788 Homo sapiens Epithelial membrane protein 3 Proteins 0.000 description 1
- 101000814134 Homo sapiens Epithelial-stromal interaction protein 1 Proteins 0.000 description 1
- 101001077852 Homo sapiens Epoxide hydrolase 1 Proteins 0.000 description 1
- 101000812405 Homo sapiens Epoxide hydrolase 4 Proteins 0.000 description 1
- 101001012105 Homo sapiens Epsin-1 Proteins 0.000 description 1
- 101001012093 Homo sapiens Epsin-2 Proteins 0.000 description 1
- 101000876557 Homo sapiens Ergosterol biosynthetic protein 28 homolog Proteins 0.000 description 1
- 101000814010 Homo sapiens Erlin-1 Proteins 0.000 description 1
- 101000851719 Homo sapiens Erlin-2 Proteins 0.000 description 1
- 101000967448 Homo sapiens Erythroid differentiation-related factor 1 Proteins 0.000 description 1
- 101000851733 Homo sapiens Erythroid membrane-associated protein Proteins 0.000 description 1
- 101000920839 Homo sapiens Espin-like protein Proteins 0.000 description 1
- 101000920831 Homo sapiens Estrogen-related receptor gamma Proteins 0.000 description 1
- 101000841277 Homo sapiens Ethylmalonyl-CoA decarboxylase Proteins 0.000 description 1
- 101001057564 Homo sapiens Etoposide-induced protein 2.4 homolog Proteins 0.000 description 1
- 101000895759 Homo sapiens Eukaryotic elongation factor 2 kinase Proteins 0.000 description 1
- 101001044475 Homo sapiens Eukaryotic initiation factor 4A-II Proteins 0.000 description 1
- 101000851788 Homo sapiens Eukaryotic peptide chain release factor GTP-binding subunit ERF3A Proteins 0.000 description 1
- 101001036349 Homo sapiens Eukaryotic translation initiation factor 1A, X-chromosomal Proteins 0.000 description 1
- 101001020112 Homo sapiens Eukaryotic translation initiation factor 2 subunit 1 Proteins 0.000 description 1
- 101001081893 Homo sapiens Eukaryotic translation initiation factor 2 subunit 2 Proteins 0.000 description 1
- 101000959829 Homo sapiens Eukaryotic translation initiation factor 2 subunit 3 Proteins 0.000 description 1
- 101000926530 Homo sapiens Eukaryotic translation initiation factor 2-alpha kinase 1 Proteins 0.000 description 1
- 101000810350 Homo sapiens Eukaryotic translation initiation factor 2A Proteins 0.000 description 1
- 101001057847 Homo sapiens Eukaryotic translation initiation factor 3 subunit C-like protein Proteins 0.000 description 1
- 101001034825 Homo sapiens Eukaryotic translation initiation factor 4 gamma 1 Proteins 0.000 description 1
- 101001034840 Homo sapiens Eukaryotic translation initiation factor 4 gamma 3 Proteins 0.000 description 1
- 101000840282 Homo sapiens Eukaryotic translation initiation factor 4B Proteins 0.000 description 1
- 101001011096 Homo sapiens Eukaryotic translation initiation factor 4E type 2 Proteins 0.000 description 1
- 101001011076 Homo sapiens Eukaryotic translation initiation factor 4E type 3 Proteins 0.000 description 1
- 101001054360 Homo sapiens Eukaryotic translation initiation factor 4H Proteins 0.000 description 1
- 101000959746 Homo sapiens Eukaryotic translation initiation factor 6 Proteins 0.000 description 1
- 101000866489 Homo sapiens Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial Proteins 0.000 description 1
- 101000851494 Homo sapiens Ewing's tumor-associated antigen 1 Proteins 0.000 description 1
- 101000938459 Homo sapiens Exocyst complex component 2 Proteins 0.000 description 1
- 101000938444 Homo sapiens Exocyst complex component 3 Proteins 0.000 description 1
- 101000911699 Homo sapiens Exocyst complex component 4 Proteins 0.000 description 1
- 101000911703 Homo sapiens Exocyst complex component 5 Proteins 0.000 description 1
- 101000911670 Homo sapiens Exocyst complex component 6 Proteins 0.000 description 1
- 101001011230 Homo sapiens Exocyst complex component 6B Proteins 0.000 description 1
- 101000813489 Homo sapiens Exocyst complex component 7 Proteins 0.000 description 1
- 101000918264 Homo sapiens Exonuclease 1 Proteins 0.000 description 1
- 101001011220 Homo sapiens Exonuclease 3'-5' domain-containing protein 2 Proteins 0.000 description 1
- 101000881977 Homo sapiens Exonuclease V Proteins 0.000 description 1
- 101000958030 Homo sapiens Exonuclease mut-7 homolog Proteins 0.000 description 1
- 101001029120 Homo sapiens Exosome RNA helicase MTR4 Proteins 0.000 description 1
- 101000882169 Homo sapiens Exosome complex component CSL4 Proteins 0.000 description 1
- 101000882168 Homo sapiens Exosome complex component RRP4 Proteins 0.000 description 1
- 101000882159 Homo sapiens Exosome complex component RRP40 Proteins 0.000 description 1
- 101001055992 Homo sapiens Exosome complex component RRP42 Proteins 0.000 description 1
- 101001055989 Homo sapiens Exosome complex component RRP43 Proteins 0.000 description 1
- 101001055965 Homo sapiens Exosome complex component RRP45 Proteins 0.000 description 1
- 101000627103 Homo sapiens Exosome complex exonuclease RRP44 Proteins 0.000 description 1
- 101000918275 Homo sapiens Exostosin-2 Proteins 0.000 description 1
- 101000875558 Homo sapiens Exostosin-like 2 Proteins 0.000 description 1
- 101000875556 Homo sapiens Exostosin-like 3 Proteins 0.000 description 1
- 101000851525 Homo sapiens Extended synaptotagmin-1 Proteins 0.000 description 1
- 101000851521 Homo sapiens Extended synaptotagmin-2 Proteins 0.000 description 1
- 101001029168 Homo sapiens Extracellular matrix organizing protein FRAS1 Proteins 0.000 description 1
- 101000866526 Homo sapiens Extracellular matrix protein 1 Proteins 0.000 description 1
- 101000938435 Homo sapiens Eyes absent homolog 1 Proteins 0.000 description 1
- 101000938441 Homo sapiens Eyes absent homolog 3 Proteins 0.000 description 1
- 101000938422 Homo sapiens Eyes absent homolog 4 Proteins 0.000 description 1
- 101000892423 Homo sapiens F-BAR and double SH3 domains protein 1 Proteins 0.000 description 1
- 101000892420 Homo sapiens F-BAR and double SH3 domains protein 2 Proteins 0.000 description 1
- 101000913095 Homo sapiens F-BAR domain only protein 1 Proteins 0.000 description 1
- 101001030672 Homo sapiens F-BAR domain only protein 2 Proteins 0.000 description 1
- 101001065291 Homo sapiens F-box DNA helicase 1 Proteins 0.000 description 1
- 101000878641 Homo sapiens F-box only protein 16 Proteins 0.000 description 1
- 101000878584 Homo sapiens F-box only protein 17 Proteins 0.000 description 1
- 101000878583 Homo sapiens F-box only protein 21 Proteins 0.000 description 1
- 101000878586 Homo sapiens F-box only protein 22 Proteins 0.000 description 1
- 101000824144 Homo sapiens F-box only protein 25 Proteins 0.000 description 1
- 101000824114 Homo sapiens F-box only protein 31 Proteins 0.000 description 1
- 101000892349 Homo sapiens F-box only protein 34 Proteins 0.000 description 1
- 101000892310 Homo sapiens F-box only protein 38 Proteins 0.000 description 1
- 101001052775 Homo sapiens F-box only protein 4 Proteins 0.000 description 1
- 101000913310 Homo sapiens F-box only protein 41 Proteins 0.000 description 1
- 101000913306 Homo sapiens F-box only protein 42 Proteins 0.000 description 1
- 101000913298 Homo sapiens F-box only protein 44 Proteins 0.000 description 1
- 101000913300 Homo sapiens F-box only protein 46 Proteins 0.000 description 1
- 101000917536 Homo sapiens F-box only protein 7 Proteins 0.000 description 1
- 101000917834 Homo sapiens F-box only protein 9 Proteins 0.000 description 1
- 101000885591 Homo sapiens F-box/LRR-repeat protein 12 Proteins 0.000 description 1
- 101000862163 Homo sapiens F-box/LRR-repeat protein 20 Proteins 0.000 description 1
- 101001026868 Homo sapiens F-box/LRR-repeat protein 3 Proteins 0.000 description 1
- 101001026867 Homo sapiens F-box/LRR-repeat protein 4 Proteins 0.000 description 1
- 101001026853 Homo sapiens F-box/LRR-repeat protein 5 Proteins 0.000 description 1
- 101001026845 Homo sapiens F-box/LRR-repeat protein 6 Proteins 0.000 description 1
- 101001060250 Homo sapiens F-box/LRR-repeat protein 8 Proteins 0.000 description 1
- 101001030696 Homo sapiens F-box/WD repeat-containing protein 11 Proteins 0.000 description 1
- 101001030691 Homo sapiens F-box/WD repeat-containing protein 1A Proteins 0.000 description 1
- 101001060244 Homo sapiens F-box/WD repeat-containing protein 4 Proteins 0.000 description 1
- 101001060235 Homo sapiens F-box/WD repeat-containing protein 8 Proteins 0.000 description 1
- 101000892315 Homo sapiens F-box/WD repeat-containing protein 9 Proteins 0.000 description 1
- 101000848289 Homo sapiens FAD synthase region Proteins 0.000 description 1
- 101000930949 Homo sapiens FAD-dependent oxidoreductase domain-containing protein 1 Proteins 0.000 description 1
- 101000930979 Homo sapiens FAD-dependent oxidoreductase domain-containing protein 2 Proteins 0.000 description 1
- 101100119754 Homo sapiens FANCL gene Proteins 0.000 description 1
- 101000914654 Homo sapiens FAS-associated factor 1 Proteins 0.000 description 1
- 101000824586 Homo sapiens FAS-associated factor 2 Proteins 0.000 description 1
- 101000878541 Homo sapiens FAST kinase domain-containing protein 1, mitochondrial Proteins 0.000 description 1
- 101000862373 Homo sapiens FERM and PDZ domain-containing protein 4 Proteins 0.000 description 1
- 101001030545 Homo sapiens FERM domain-containing protein 3 Proteins 0.000 description 1
- 101001062454 Homo sapiens FERM domain-containing protein 4A Proteins 0.000 description 1
- 101001030537 Homo sapiens FERM domain-containing protein 6 Proteins 0.000 description 1
- 101001021984 Homo sapiens FERM domain-containing protein 8 Proteins 0.000 description 1
- 101000914701 Homo sapiens FERM, ARHGEF and pleckstrin domain-containing protein 1 Proteins 0.000 description 1
- 101001028283 Homo sapiens FERM, ARHGEF and pleckstrin domain-containing protein 2 Proteins 0.000 description 1
- 101000890644 Homo sapiens FGFR1 oncogene partner 2 Proteins 0.000 description 1
- 101001031630 Homo sapiens FGGY carbohydrate kinase domain-containing protein Proteins 0.000 description 1
- 101000890761 Homo sapiens FH1/FH2 domain-containing protein 1 Proteins 0.000 description 1
- 101000890757 Homo sapiens FH1/FH2 domain-containing protein 3 Proteins 0.000 description 1
- 101001060551 Homo sapiens FHF complex subunit HOOK interacting protein 1A Proteins 0.000 description 1
- 101001027535 Homo sapiens FHF complex subunit HOOK interacting protein 1B Proteins 0.000 description 1
- 101001027524 Homo sapiens FHF complex subunit HOOK interacting protein 2B Proteins 0.000 description 1
- 101000891018 Homo sapiens FK506-binding protein 15 Proteins 0.000 description 1
- 101000930670 Homo sapiens FLYWCH family member 2 Proteins 0.000 description 1
- 101000930684 Homo sapiens FLYWCH-type zinc finger-containing protein 1 Proteins 0.000 description 1
- 101001030528 Homo sapiens FSD1-like protein Proteins 0.000 description 1
- 101000893718 Homo sapiens FXYD domain-containing ion transport regulator 5 Proteins 0.000 description 1
- 101000893722 Homo sapiens FXYD domain-containing ion transport regulator 6 Proteins 0.000 description 1
- 101001031749 Homo sapiens FYVE, RhoGEF and PH domain-containing protein 2 Proteins 0.000 description 1
- 101000827819 Homo sapiens FYVE, RhoGEF and PH domain-containing protein 4 Proteins 0.000 description 1
- 101000892039 Homo sapiens Failed axon connections homolog Proteins 0.000 description 1
- 101000937164 Homo sapiens Fanconi anemia core complex-associated protein 20 Proteins 0.000 description 1
- 101000824568 Homo sapiens Fanconi anemia core complex-associated protein 24 Proteins 0.000 description 1
- 101000914673 Homo sapiens Fanconi anemia group A protein Proteins 0.000 description 1
- 101000914679 Homo sapiens Fanconi anemia group B protein Proteins 0.000 description 1
- 101000848174 Homo sapiens Fanconi anemia group I protein Proteins 0.000 description 1
- 101000848187 Homo sapiens Fanconi anemia group M protein Proteins 0.000 description 1
- 101000914689 Homo sapiens Fanconi-associated nuclease 1 Proteins 0.000 description 1
- 101000930770 Homo sapiens Far upstream element-binding protein 1 Proteins 0.000 description 1
- 101000930766 Homo sapiens Far upstream element-binding protein 2 Proteins 0.000 description 1
- 101000930753 Homo sapiens Far upstream element-binding protein 3 Proteins 0.000 description 1
- 101000878509 Homo sapiens Fas apoptotic inhibitory molecule 1 Proteins 0.000 description 1
- 101000917570 Homo sapiens Fas-activated serine/threonine kinase Proteins 0.000 description 1
- 101001065295 Homo sapiens Fas-binding factor 1 Proteins 0.000 description 1
- 101001027414 Homo sapiens Fasciculation and elongation protein zeta-2 Proteins 0.000 description 1
- 101000937693 Homo sapiens Fatty acid 2-hydroxylase Proteins 0.000 description 1
- 101001066086 Homo sapiens Fatty acid hydroxylase domain-containing protein 2 Proteins 0.000 description 1
- 101000824458 Homo sapiens Fatty acyl-CoA reductase 1 Proteins 0.000 description 1
- 101000918494 Homo sapiens Fatty-acid amide hydrolase 1 Proteins 0.000 description 1
- 101000918490 Homo sapiens Fatty-acid amide hydrolase 2 Proteins 0.000 description 1
- 101000846860 Homo sapiens Fc receptor-like A Proteins 0.000 description 1
- 101001029786 Homo sapiens Feline leukemia virus subgroup C receptor-related protein 1 Proteins 0.000 description 1
- 101001022717 Homo sapiens Feline leukemia virus subgroup C receptor-related protein 2 Proteins 0.000 description 1
- 101000907567 Homo sapiens Fer-1-like protein 4 Proteins 0.000 description 1
- 101000892677 Homo sapiens Fermitin family homolog 2 Proteins 0.000 description 1
- 101000912981 Homo sapiens Ferredoxin-2, mitochondrial Proteins 0.000 description 1
- 101000843611 Homo sapiens Ferrochelatase, mitochondrial Proteins 0.000 description 1
- 101000818014 Homo sapiens Ferroptosis suppressor protein 1 Proteins 0.000 description 1
- 101000846893 Homo sapiens Fibrillin-1 Proteins 0.000 description 1
- 101000846890 Homo sapiens Fibrillin-2 Proteins 0.000 description 1
- 101000917234 Homo sapiens Fibroblast growth factor 12 Proteins 0.000 description 1
- 101001060267 Homo sapiens Fibroblast growth factor 5 Proteins 0.000 description 1
- 101000917134 Homo sapiens Fibroblast growth factor receptor 4 Proteins 0.000 description 1
- 101000818410 Homo sapiens Fibroblast growth factor receptor substrate 2 Proteins 0.000 description 1
- 101001027128 Homo sapiens Fibronectin Proteins 0.000 description 1
- 101000937169 Homo sapiens Fibronectin type 3 and ankyrin repeat domains protein 1 Proteins 0.000 description 1
- 101001030521 Homo sapiens Fibronectin type III and SPRY domain-containing protein 1 Proteins 0.000 description 1
- 101000913642 Homo sapiens Fibronectin type III domain-containing protein 3B Proteins 0.000 description 1
- 101000913670 Homo sapiens Fibronectin type-III domain-containing protein 3A Proteins 0.000 description 1
- 101001052714 Homo sapiens Fibrosin-1-like protein Proteins 0.000 description 1
- 101000846874 Homo sapiens Fibulin-7 Proteins 0.000 description 1
- 101000878272 Homo sapiens Fidgetin-like protein 1 Proteins 0.000 description 1
- 101000913549 Homo sapiens Filamin-A Proteins 0.000 description 1
- 101000913551 Homo sapiens Filamin-B Proteins 0.000 description 1
- 101001028052 Homo sapiens Filamin-binding LIM protein 1 Proteins 0.000 description 1
- 101000873715 Homo sapiens Filensin Proteins 0.000 description 1
- 101000833646 Homo sapiens Flap endonuclease GEN homolog 1 Proteins 0.000 description 1
- 101000828609 Homo sapiens Flotillin-2 Proteins 0.000 description 1
- 101000932136 Homo sapiens Flt3-interacting zinc finger protein 1 Proteins 0.000 description 1
- 101000861534 Homo sapiens Focadhesin Proteins 0.000 description 1
- 101001023230 Homo sapiens Folate receptor alpha Proteins 0.000 description 1
- 101001060703 Homo sapiens Folliculin Proteins 0.000 description 1
- 101001059623 Homo sapiens Folliculin-interacting protein 1 Proteins 0.000 description 1
- 101001059639 Homo sapiens Folliculin-interacting protein 2 Proteins 0.000 description 1
- 101001062535 Homo sapiens Follistatin-related protein 1 Proteins 0.000 description 1
- 101000931687 Homo sapiens Follistatin-related protein 5 Proteins 0.000 description 1
- 101001023387 Homo sapiens Forkhead box protein J3 Proteins 0.000 description 1
- 101001023393 Homo sapiens Forkhead box protein K2 Proteins 0.000 description 1
- 101000907578 Homo sapiens Forkhead box protein M1 Proteins 0.000 description 1
- 101000907593 Homo sapiens Forkhead box protein N2 Proteins 0.000 description 1
- 101000907594 Homo sapiens Forkhead box protein N3 Proteins 0.000 description 1
- 101001059893 Homo sapiens Forkhead box protein P1 Proteins 0.000 description 1
- 101001059881 Homo sapiens Forkhead box protein P2 Proteins 0.000 description 1
- 101000861452 Homo sapiens Forkhead box protein P3 Proteins 0.000 description 1
- 101000861403 Homo sapiens Forkhead box protein P4 Proteins 0.000 description 1
- 101001060563 Homo sapiens Forkhead-associated domain-containing protein 1 Proteins 0.000 description 1
- 101001059398 Homo sapiens Formin-2 Proteins 0.000 description 1
- 101000892722 Homo sapiens Formin-binding protein 1 Proteins 0.000 description 1
- 101000846884 Homo sapiens Formin-binding protein 1-like Proteins 0.000 description 1
- 101000892778 Homo sapiens Formin-binding protein 4 Proteins 0.000 description 1
- 101001059384 Homo sapiens Formin-like protein 2 Proteins 0.000 description 1
- 101000847535 Homo sapiens Formin-like protein 3 Proteins 0.000 description 1
- 101001031714 Homo sapiens Four and a half LIM domains protein 2 Proteins 0.000 description 1
- 101000930945 Homo sapiens Fragile X mental retardation syndrome-related protein 1 Proteins 0.000 description 1
- 101000930952 Homo sapiens Fragile X mental retardation syndrome-related protein 2 Proteins 0.000 description 1
- 101000819458 Homo sapiens Frizzled-3 Proteins 0.000 description 1
- 101000885673 Homo sapiens Frizzled-6 Proteins 0.000 description 1
- 101001061405 Homo sapiens Frizzled-9 Proteins 0.000 description 1
- 101001022433 Homo sapiens Fructosamine-3-kinase Proteins 0.000 description 1
- 101000755879 Homo sapiens Fructose-bisphosphate aldolase A Proteins 0.000 description 1
- 101000836545 Homo sapiens Fructose-bisphosphate aldolase C Proteins 0.000 description 1
- 101001029296 Homo sapiens Fucose-1-phosphate guanylyltransferase Proteins 0.000 description 1
- 101000918487 Homo sapiens Fumarylacetoacetase Proteins 0.000 description 1
- 101000824573 Homo sapiens Fumarylacetoacetate hydrolase domain-containing protein 2A Proteins 0.000 description 1
- 101000917336 Homo sapiens Fumarylacetoacetate hydrolase domain-containing protein 2B Proteins 0.000 description 1
- 101001075222 Homo sapiens G kinase-anchoring protein 1 Proteins 0.000 description 1
- 101000904738 Homo sapiens G patch domain-containing protein 11 Proteins 0.000 description 1
- 101001034114 Homo sapiens G patch domain-containing protein 2 Proteins 0.000 description 1
- 101000904740 Homo sapiens G patch domain-containing protein 2-like Proteins 0.000 description 1
- 101001034100 Homo sapiens G patch domain-containing protein 4 Proteins 0.000 description 1
- 101001034097 Homo sapiens G patch domain-containing protein 8 Proteins 0.000 description 1
- 101000900320 Homo sapiens G protein pathway suppressor 2 Proteins 0.000 description 1
- 101000829481 Homo sapiens G protein-coupled receptor kinase 4 Proteins 0.000 description 1
- 101000829476 Homo sapiens G protein-coupled receptor kinase 5 Proteins 0.000 description 1
- 101000829473 Homo sapiens G protein-coupled receptor kinase 6 Proteins 0.000 description 1
- 101001009694 Homo sapiens G-patch domain and KOW motifs-containing protein Proteins 0.000 description 1
- 101000857756 Homo sapiens G-protein coupled receptor 161 Proteins 0.000 description 1
- 101001040723 Homo sapiens G-protein coupled receptor 176 Proteins 0.000 description 1
- 101001064250 Homo sapiens G-protein coupled receptor-associated protein LMBRD2 Proteins 0.000 description 1
- 101001021410 Homo sapiens G-protein coupled receptor-associated sorting protein 1 Proteins 0.000 description 1
- 101000904748 Homo sapiens G-protein-signaling modulator 1 Proteins 0.000 description 1
- 101000904754 Homo sapiens G-protein-signaling modulator 2 Proteins 0.000 description 1
- 101000738559 Homo sapiens G1/S-specific cyclin-D3 Proteins 0.000 description 1
- 101000738575 Homo sapiens G1/S-specific cyclin-E2 Proteins 0.000 description 1
- 101001026457 Homo sapiens G2 and S phase-expressed protein 1 Proteins 0.000 description 1
- 101001000828 Homo sapiens G2/M phase-specific E3 ubiquitin-protein ligase Proteins 0.000 description 1
- 101000868643 Homo sapiens G2/mitotic-specific cyclin-B1 Proteins 0.000 description 1
- 101001022105 Homo sapiens GA-binding protein alpha chain Proteins 0.000 description 1
- 101001022101 Homo sapiens GA-binding protein subunit beta-2 Proteins 0.000 description 1
- 101000922847 Homo sapiens GAS2-like protein 1 Proteins 0.000 description 1
- 101001066167 Homo sapiens GAS2-like protein 3 Proteins 0.000 description 1
- 101001044724 Homo sapiens GATOR complex protein DEPDC5 Proteins 0.000 description 1
- 101000950705 Homo sapiens GATOR complex protein MIOS Proteins 0.000 description 1
- 101000997967 Homo sapiens GDNF family receptor alpha-2 Proteins 0.000 description 1
- 101001067667 Homo sapiens GDNF-inducible zinc finger protein 1 Proteins 0.000 description 1
- 101000779347 Homo sapiens GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase Proteins 0.000 description 1
- 101001040774 Homo sapiens GMP reductase 2 Proteins 0.000 description 1
- 101000857895 Homo sapiens GON-4-like protein Proteins 0.000 description 1
- 101001072428 Homo sapiens GPALPP motifs-containing protein 1 Proteins 0.000 description 1
- 101000857481 Homo sapiens GPN-loop GTPase 1 Proteins 0.000 description 1
- 101001068964 Homo sapiens GPN-loop GTPase 3 Proteins 0.000 description 1
- 101001071433 Homo sapiens GRAM domain-containing protein 2B Proteins 0.000 description 1
- 101001033004 Homo sapiens GRAM domain-containing protein 4 Proteins 0.000 description 1
- 101001037070 Homo sapiens GRB10-interacting GYF protein 1 Proteins 0.000 description 1
- 101001037074 Homo sapiens GRB10-interacting GYF protein 2 Proteins 0.000 description 1
- 101001021428 Homo sapiens GRB2-associated and regulator of MAPK protein 1 Proteins 0.000 description 1
- 101001024902 Homo sapiens GRB2-associated-binding protein 2 Proteins 0.000 description 1
- 101000904872 Homo sapiens GREB1-like protein Proteins 0.000 description 1
- 101001058870 Homo sapiens GRIP and coiled-coil domain-containing protein 2 Proteins 0.000 description 1
- 101000862581 Homo sapiens GTP cyclohydrolase 1 Proteins 0.000 description 1
- 101000828872 Homo sapiens GTP-binding protein 1 Proteins 0.000 description 1
- 101000828869 Homo sapiens GTP-binding protein 2 Proteins 0.000 description 1
- 101001071663 Homo sapiens GTP-binding protein 8 Proteins 0.000 description 1
- 101000951240 Homo sapiens GTP-binding protein Di-Ras1 Proteins 0.000 description 1
- 101000998053 Homo sapiens GTP:AMP phosphotransferase AK3, mitochondrial Proteins 0.000 description 1
- 101000584633 Homo sapiens GTPase HRas Proteins 0.000 description 1
- 101001021434 Homo sapiens GTPase-activating Rap/Ran-GAP domain-like protein 3 Proteins 0.000 description 1
- 101001066325 Homo sapiens GTPase-activating protein and VPS9 domain-containing protein 1 Proteins 0.000 description 1
- 101001024874 Homo sapiens Galactokinase Proteins 0.000 description 1
- 101001021379 Homo sapiens Galactose-1-phosphate uridylyltransferase Proteins 0.000 description 1
- 101001061348 Homo sapiens Galactose-3-O-sulfotransferase 4 Proteins 0.000 description 1
- 101000608769 Homo sapiens Galectin-8 Proteins 0.000 description 1
- 101001130151 Homo sapiens Galectin-9 Proteins 0.000 description 1
- 101000893321 Homo sapiens Gamma-aminobutyric acid receptor subunit alpha-3 Proteins 0.000 description 1
- 101001073597 Homo sapiens Gamma-aminobutyric acid receptor subunit beta-3 Proteins 0.000 description 1
- 101001058231 Homo sapiens Gamma-enolase Proteins 0.000 description 1
- 101001133924 Homo sapiens Gamma-glutamyl phosphate reductase Proteins 0.000 description 1
- 101000886680 Homo sapiens Gamma-glutamylcyclotransferase Proteins 0.000 description 1
- 101000757496 Homo sapiens Gamma-secretase subunit APH-1A Proteins 0.000 description 1
- 101000733778 Homo sapiens Gamma-secretase subunit APH-1B Proteins 0.000 description 1
- 101000702693 Homo sapiens Gamma-soluble NSF attachment protein Proteins 0.000 description 1
- 101000926071 Homo sapiens Ganglioside-induced differentiation-associated protein 1-like 1 Proteins 0.000 description 1
- 101000833522 Homo sapiens Ganglioside-induced differentiation-associated protein 2 Proteins 0.000 description 1
- 101001059150 Homo sapiens Gelsolin Proteins 0.000 description 1
- 101000886596 Homo sapiens Geminin Proteins 0.000 description 1
- 101000714246 Homo sapiens General transcription factor 3C polypeptide 2 Proteins 0.000 description 1
- 101000714253 Homo sapiens General transcription factor 3C polypeptide 3 Proteins 0.000 description 1
- 101000714252 Homo sapiens General transcription factor 3C polypeptide 4 Proteins 0.000 description 1
- 101000596761 Homo sapiens General transcription factor 3C polypeptide 5 Proteins 0.000 description 1
- 101000903798 Homo sapiens General transcription factor II-I repeat domain-containing protein 1 Proteins 0.000 description 1
- 101001026143 Homo sapiens General transcription factor II-I repeat domain-containing protein 2A Proteins 0.000 description 1
- 101001026144 Homo sapiens General transcription factor II-I repeat domain-containing protein 2B Proteins 0.000 description 1
- 101000640758 Homo sapiens General transcription factor IIF subunit 1 Proteins 0.000 description 1
- 101000666405 Homo sapiens General transcription factor IIH subunit 1 Proteins 0.000 description 1
- 101000655398 Homo sapiens General transcription factor IIH subunit 2 Proteins 0.000 description 1
- 101000655391 Homo sapiens General transcription factor IIH subunit 3 Proteins 0.000 description 1
- 101000888406 Homo sapiens Geranylgeranyl pyrophosphate synthase Proteins 0.000 description 1
- 101000830085 Homo sapiens Germ cell-less protein-like 1 Proteins 0.000 description 1
- 101001071367 Homo sapiens Girdin Proteins 0.000 description 1
- 101001039387 Homo sapiens Glia maturation factor beta Proteins 0.000 description 1
- 101001039458 Homo sapiens Glia maturation factor gamma Proteins 0.000 description 1
- 101000997829 Homo sapiens Glial cell line-derived neurotrophic factor Proteins 0.000 description 1
- 101000857303 Homo sapiens Glomulin Proteins 0.000 description 1
- 101001039401 Homo sapiens Glucocorticoid modulatory element-binding protein 1 Proteins 0.000 description 1
- 101000926939 Homo sapiens Glucocorticoid receptor Proteins 0.000 description 1
- 101001058426 Homo sapiens Glucocorticoid-induced transcript 1 protein Proteins 0.000 description 1
- 101000904068 Homo sapiens Glucosamine 6-phosphate N-acetyltransferase Proteins 0.000 description 1
- 101001039324 Homo sapiens Glucosamine-6-phosphate isomerase 1 Proteins 0.000 description 1
- 101001072480 Homo sapiens Glucosamine-6-phosphate isomerase 2 Proteins 0.000 description 1
- 101000930935 Homo sapiens Glucose-6-phosphatase 3 Proteins 0.000 description 1
- 101001059180 Homo sapiens Glucose-fructose oxidoreductase domain-containing protein 2 Proteins 0.000 description 1
- 101001058369 Homo sapiens Glucose-induced degradation protein 4 homolog Proteins 0.000 description 1
- 101001010434 Homo sapiens Glutamate receptor 3 Proteins 0.000 description 1
- 101000972840 Homo sapiens Glutamate receptor ionotropic, NMDA 2D Proteins 0.000 description 1
- 101000603185 Homo sapiens Glutamate receptor ionotropic, NMDA 3B Proteins 0.000 description 1
- 101000903346 Homo sapiens Glutamate receptor ionotropic, kainate 2 Proteins 0.000 description 1
- 101001034527 Homo sapiens Glutamate-cysteine ligase catalytic subunit Proteins 0.000 description 1
- 101001056895 Homo sapiens Glutamate-rich protein 1 Proteins 0.000 description 1
- 101001056889 Homo sapiens Glutamate-rich protein 2 Proteins 0.000 description 1
- 101000856993 Homo sapiens Glutaminase liver isoform, mitochondrial Proteins 0.000 description 1
- 101001021278 Homo sapiens Glutamine amidotransferase-like class 1 domain-containing protein 1 Proteins 0.000 description 1
- 101001002170 Homo sapiens Glutamine amidotransferase-like class 1 domain-containing protein 3, mitochondrial Proteins 0.000 description 1
- 101001112831 Homo sapiens Glutamine-dependent NAD(+) synthetase Proteins 0.000 description 1
- 101000997929 Homo sapiens Glutamine-fructose-6-phosphate aminotransferase [isomerizing] 1 Proteins 0.000 description 1
- 101000997966 Homo sapiens Glutamine-fructose-6-phosphate aminotransferase [isomerizing] 2 Proteins 0.000 description 1
- 101001073064 Homo sapiens Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial Proteins 0.000 description 1
- 101001071851 Homo sapiens Glutaredoxin-3 Proteins 0.000 description 1
- 101000952500 Homo sapiens Glutaredoxin-like protein C5orf63 Proteins 0.000 description 1
- 101001058943 Homo sapiens Glutaryl-CoA dehydrogenase, mitochondrial Proteins 0.000 description 1
- 101000870514 Homo sapiens Glutathione S-transferase A4 Proteins 0.000 description 1
- 101000903695 Homo sapiens Glutathione S-transferase C-terminal domain-containing protein Proteins 0.000 description 1
- 101001071691 Homo sapiens Glutathione S-transferase Mu 2 Proteins 0.000 description 1
- 101000906399 Homo sapiens Glutathione S-transferase Mu 4 Proteins 0.000 description 1
- 101001034434 Homo sapiens Glutathione S-transferase kappa 1 Proteins 0.000 description 1
- 101001032462 Homo sapiens Glutathione S-transferase theta-1 Proteins 0.000 description 1
- 101001068329 Homo sapiens Glutathione S-transferase theta-2B Proteins 0.000 description 1
- 101001068333 Homo sapiens Glutathione S-transferase theta-4 Proteins 0.000 description 1
- 101000926237 Homo sapiens Glutathione hydrolase 5 proenzyme Proteins 0.000 description 1
- 101001071391 Homo sapiens Glutathione peroxidase 7 Proteins 0.000 description 1
- 101001071608 Homo sapiens Glutathione reductase, mitochondrial Proteins 0.000 description 1
- 101001069973 Homo sapiens Glutathione synthetase Proteins 0.000 description 1
- 101000942766 Homo sapiens Glutathione-specific gamma-glutamylcyclotransferase 2 Proteins 0.000 description 1
- 101000856267 Homo sapiens Glycerate kinase Proteins 0.000 description 1
- 101000900194 Homo sapiens Glycerol-3-phosphate dehydrogenase 1-like protein Proteins 0.000 description 1
- 101001040698 Homo sapiens Glycerophosphocholine phosphodiesterase GPCPD1 Proteins 0.000 description 1
- 101001038855 Homo sapiens Glycerophosphodiester phosphodiesterase domain-containing protein 5 Proteins 0.000 description 1
- 101001039280 Homo sapiens Glycine N-methyltransferase Proteins 0.000 description 1
- 101000856845 Homo sapiens Glycine cleavage system H protein, mitochondrial Proteins 0.000 description 1
- 101000998096 Homo sapiens Glycine dehydrogenase (decarboxylating), mitochondrial Proteins 0.000 description 1
- 101000996225 Homo sapiens Glycine receptor subunit beta Proteins 0.000 description 1
- 101000888201 Homo sapiens Glycogenin-1 Proteins 0.000 description 1
- 101000857856 Homo sapiens Glycogenin-2 Proteins 0.000 description 1
- 101000978842 Homo sapiens Glycoprotein endo-alpha-1,2-mannosidase-like protein Proteins 0.000 description 1
- 101000926275 Homo sapiens Glycoprotein integral membrane protein 1 Proteins 0.000 description 1
- 101000805056 Homo sapiens Glycosaminoglycan xylosylkinase Proteins 0.000 description 1
- 101000857309 Homo sapiens Glycosylated lysosomal membrane protein Proteins 0.000 description 1
- 101001072432 Homo sapiens Glycosylphosphatidylinositol anchor attachment 1 protein Proteins 0.000 description 1
- 101001037042 Homo sapiens Glycosyltransferase 1 domain-containing protein 1 Proteins 0.000 description 1
- 101001058421 Homo sapiens Glycosyltransferase 8 domain-containing protein 1 Proteins 0.000 description 1
- 101000833040 Homo sapiens Glycosyltransferase 8 domain-containing protein 2 Proteins 0.000 description 1
- 101001026170 Homo sapiens Glycosyltransferase-like domain-containing protein 1 Proteins 0.000 description 1
- 101000578329 Homo sapiens Glycylpeptide N-tetradecanoyltransferase 1 Proteins 0.000 description 1
- 101000979544 Homo sapiens Glycylpeptide N-tetradecanoyltransferase 2 Proteins 0.000 description 1
- 101001010442 Homo sapiens Glyoxylate reductase/hydroxypyruvate reductase Proteins 0.000 description 1
- 101001040711 Homo sapiens Glypican-5 Proteins 0.000 description 1
- 101001040704 Homo sapiens Glypican-6 Proteins 0.000 description 1
- 101000829933 Homo sapiens Golgi SNAP receptor complex member 1 Proteins 0.000 description 1
- 101001069963 Homo sapiens Golgi apparatus protein 1 Proteins 0.000 description 1
- 101001040736 Homo sapiens Golgi integral membrane protein 4 Proteins 0.000 description 1
- 101001069247 Homo sapiens Golgi pH regulator A Proteins 0.000 description 1
- 101001069245 Homo sapiens Golgi pH regulator B Proteins 0.000 description 1
- 101001074265 Homo sapiens Golgi phosphoprotein 3-like Proteins 0.000 description 1
- 101001072488 Homo sapiens Golgi reassembly-stacking protein 1 Proteins 0.000 description 1
- 101001072495 Homo sapiens Golgi reassembly-stacking protein 2 Proteins 0.000 description 1
- 101000886726 Homo sapiens Golgi to ER traffic protein 4 homolog Proteins 0.000 description 1
- 101001072499 Homo sapiens Golgi-associated PDZ and coiled-coil motif-containing protein Proteins 0.000 description 1
- 101000922994 Homo sapiens Golgi-associated plant pathogenesis-related protein 1 Proteins 0.000 description 1
- 101000926793 Homo sapiens Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 Proteins 0.000 description 1
- 101001014629 Homo sapiens Golgin subfamily A member 2 Proteins 0.000 description 1
- 101001014634 Homo sapiens Golgin subfamily A member 3 Proteins 0.000 description 1
- 101001014636 Homo sapiens Golgin subfamily A member 4 Proteins 0.000 description 1
- 101001037096 Homo sapiens Golgin subfamily A member 6-like protein 10 Proteins 0.000 description 1
- 101001037089 Homo sapiens Golgin subfamily A member 6-like protein 9 Proteins 0.000 description 1
- 101001039321 Homo sapiens Golgin subfamily B member 1 Proteins 0.000 description 1
- 101000857912 Homo sapiens Golgin-45 Proteins 0.000 description 1
- 101001069933 Homo sapiens Grainyhead-like protein 1 homolog Proteins 0.000 description 1
- 101000870788 Homo sapiens Granule associated Rac and RHOG effector protein 1 Proteins 0.000 description 1
- 101001032861 Homo sapiens Gremlin-2 Proteins 0.000 description 1
- 101001066158 Homo sapiens Growth arrest and DNA damage-inducible protein GADD45 alpha Proteins 0.000 description 1
- 101000923005 Homo sapiens Growth arrest-specific protein 6 Proteins 0.000 description 1
- 101000923044 Homo sapiens Growth arrest-specific protein 7 Proteins 0.000 description 1
- 101000903509 Homo sapiens Growth hormone-regulated TBC protein 1 Proteins 0.000 description 1
- 101000829465 Homo sapiens GrpE protein homolog 2, mitochondrial Proteins 0.000 description 1
- 101000615232 Homo sapiens Guanine nucleotide exchange factor DBS Proteins 0.000 description 1
- 101001073272 Homo sapiens Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 Proteins 0.000 description 1
- 101001073261 Homo sapiens Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4 Proteins 0.000 description 1
- 101001073247 Homo sapiens Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 Proteins 0.000 description 1
- 101001024316 Homo sapiens Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 Proteins 0.000 description 1
- 101001014590 Homo sapiens Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas Proteins 0.000 description 1
- 101001014594 Homo sapiens Guanine nucleotide-binding protein G(s) subunit alpha isoforms short Proteins 0.000 description 1
- 101001072398 Homo sapiens Guanine nucleotide-binding protein subunit alpha-12 Proteins 0.000 description 1
- 101001072481 Homo sapiens Guanine nucleotide-binding protein subunit alpha-13 Proteins 0.000 description 1
- 101001024249 Homo sapiens Guanine nucleotide-binding protein subunit beta-4 Proteins 0.000 description 1
- 101000829985 Homo sapiens Guanine nucleotide-binding protein subunit beta-5 Proteins 0.000 description 1
- 101000830152 Homo sapiens Guanine nucleotide-binding protein subunit beta-like protein 1 Proteins 0.000 description 1
- 101000614191 Homo sapiens Guanylate kinase Proteins 0.000 description 1
- 101001058850 Homo sapiens Guanylate-binding protein 5 Proteins 0.000 description 1
- 101001068480 Homo sapiens Guanylyl cyclase-activating protein 1 Proteins 0.000 description 1
- 101000932902 Homo sapiens Guided entry of tail-anchored proteins factor CAMLG Proteins 0.000 description 1
- 101000926251 Homo sapiens Gypsy retrotransposon integrase-like protein 1 Proteins 0.000 description 1
- 101000710223 Homo sapiens H(+)/Cl(-) exchange transporter 3 Proteins 0.000 description 1
- 101000710225 Homo sapiens H(+)/Cl(-) exchange transporter 5 Proteins 0.000 description 1
- 101000710240 Homo sapiens H(+)/Cl(-) exchange transporter 6 Proteins 0.000 description 1
- 101001035831 Homo sapiens HAUS augmin-like complex subunit 1 Proteins 0.000 description 1
- 101001035826 Homo sapiens HAUS augmin-like complex subunit 2 Proteins 0.000 description 1
- 101001035819 Homo sapiens HAUS augmin-like complex subunit 3 Proteins 0.000 description 1
- 101001035823 Homo sapiens HAUS augmin-like complex subunit 4 Proteins 0.000 description 1
- 101001035821 Homo sapiens HAUS augmin-like complex subunit 5 Proteins 0.000 description 1
- 101001035815 Homo sapiens HAUS augmin-like complex subunit 6 Proteins 0.000 description 1
- 101001035814 Homo sapiens HAUS augmin-like complex subunit 7 Proteins 0.000 description 1
- 101001068141 Homo sapiens HAUS augmin-like complex subunit 8 Proteins 0.000 description 1
- 101001009070 Homo sapiens HBS1-like protein Proteins 0.000 description 1
- 101001068173 Homo sapiens HCLS1-associated protein X-1 Proteins 0.000 description 1
- 101000990572 Homo sapiens HEAT repeat-containing protein 1 Proteins 0.000 description 1
- 101000990570 Homo sapiens HEAT repeat-containing protein 3 Proteins 0.000 description 1
- 101000839976 Homo sapiens HEAT repeat-containing protein 5A Proteins 0.000 description 1
- 101000839975 Homo sapiens HEAT repeat-containing protein 5B Proteins 0.000 description 1
- 101000990566 Homo sapiens HEAT repeat-containing protein 6 Proteins 0.000 description 1
- 101000993314 Homo sapiens HIRA-interacting protein 3 Proteins 0.000 description 1
- 101000986080 Homo sapiens HLA class I histocompatibility antigen, alpha chain F Proteins 0.000 description 1
- 101000903732 Homo sapiens HMG box transcription factor BBX Proteins 0.000 description 1
- 101001006302 Homo sapiens HMG domain-containing protein 3 Proteins 0.000 description 1
- 101001006303 Homo sapiens HMG domain-containing protein 4 Proteins 0.000 description 1
- 101000843045 Homo sapiens HSPB1-associated protein 1 Proteins 0.000 description 1
- 101000872857 Homo sapiens Haloacid dehalogenase-like hydrolase domain-containing 5 Proteins 0.000 description 1
- 101001035680 Homo sapiens Haloacid dehalogenase-like hydrolase domain-containing protein 2 Proteins 0.000 description 1
- 101000866485 Homo sapiens Heat shock 70 kDa protein 12A Proteins 0.000 description 1
- 101001041756 Homo sapiens Heat shock 70 kDa protein 14 Proteins 0.000 description 1
- 101001078692 Homo sapiens Heat shock 70 kDa protein 4 Proteins 0.000 description 1
- 101001016882 Homo sapiens Heat shock factor 2-binding protein Proteins 0.000 description 1
- 101000867525 Homo sapiens Heat shock factor protein 1 Proteins 0.000 description 1
- 101001016883 Homo sapiens Heat shock factor protein 2 Proteins 0.000 description 1
- 101001016879 Homo sapiens Heat shock factor protein 4 Proteins 0.000 description 1
- 101001016865 Homo sapiens Heat shock protein HSP 90-alpha Proteins 0.000 description 1
- 101001081105 Homo sapiens Helicase-like transcription factor Proteins 0.000 description 1
- 101000843836 Homo sapiens Heme-binding protein 2 Proteins 0.000 description 1
- 101000839060 Homo sapiens Hemicentin-1 Proteins 0.000 description 1
- 101000838692 Homo sapiens Heparan sulfate 2-O-sulfotransferase 1 Proteins 0.000 description 1
- 101000588589 Homo sapiens Heparan sulfate N-sulfotransferase 1 Proteins 0.000 description 1
- 101001048118 Homo sapiens Heparan sulfate glucosamine 3-O-sulfotransferase 3A1 Proteins 0.000 description 1
- 101001035092 Homo sapiens Heparan-alpha-glucosaminide N-acetyltransferase Proteins 0.000 description 1
- 101001035618 Homo sapiens Heparan-sulfate 6-O-sulfotransferase 1 Proteins 0.000 description 1
- 101001035622 Homo sapiens Heparan-sulfate 6-O-sulfotransferase 2 Proteins 0.000 description 1
- 101001047819 Homo sapiens Heparanase Proteins 0.000 description 1
- 101000898034 Homo sapiens Hepatocyte growth factor Proteins 0.000 description 1
- 101001045469 Homo sapiens Hepatocyte growth factor-regulated tyrosine kinase substrate Proteins 0.000 description 1
- 101001083788 Homo sapiens Hepatoma-derived growth factor-related protein 2 Proteins 0.000 description 1
- 101001035685 Homo sapiens Hepatoma-derived growth factor-related protein 3 Proteins 0.000 description 1
- 101000838926 Homo sapiens Hermansky-Pudlak syndrome 1 protein Proteins 0.000 description 1
- 101000985492 Homo sapiens Hermansky-Pudlak syndrome 3 protein Proteins 0.000 description 1
- 101000985501 Homo sapiens Hermansky-Pudlak syndrome 4 protein Proteins 0.000 description 1
- 101000985516 Homo sapiens Hermansky-Pudlak syndrome 5 protein Proteins 0.000 description 1
- 101001025546 Homo sapiens Heterochromatin protein 1-binding protein 3 Proteins 0.000 description 1
- 101000854036 Homo sapiens Heterogeneous nuclear ribonucleoprotein A/B Proteins 0.000 description 1
- 101000854014 Homo sapiens Heterogeneous nuclear ribonucleoprotein A1 Proteins 0.000 description 1
- 101001079106 Homo sapiens Heterogeneous nuclear ribonucleoprotein A1-like 2 Proteins 0.000 description 1
- 101000854041 Homo sapiens Heterogeneous nuclear ribonucleoprotein A3 Proteins 0.000 description 1
- 101001081145 Homo sapiens Heterogeneous nuclear ribonucleoprotein D-like Proteins 0.000 description 1
- 101001017535 Homo sapiens Heterogeneous nuclear ribonucleoprotein D0 Proteins 0.000 description 1
- 101001081149 Homo sapiens Heterogeneous nuclear ribonucleoprotein H Proteins 0.000 description 1
- 101000838964 Homo sapiens Heterogeneous nuclear ribonucleoprotein K Proteins 0.000 description 1
- 101000839078 Homo sapiens Heterogeneous nuclear ribonucleoprotein L Proteins 0.000 description 1
- 101001017573 Homo sapiens Heterogeneous nuclear ribonucleoprotein L-like Proteins 0.000 description 1
- 101000839073 Homo sapiens Heterogeneous nuclear ribonucleoprotein M Proteins 0.000 description 1
- 101001047853 Homo sapiens Heterogeneous nuclear ribonucleoprotein R Proteins 0.000 description 1
- 101001017567 Homo sapiens Heterogeneous nuclear ribonucleoprotein U-like protein 1 Proteins 0.000 description 1
- 101000854026 Homo sapiens Heterogeneous nuclear ribonucleoproteins A2/B1 Proteins 0.000 description 1
- 101001017574 Homo sapiens Heterogeneous nuclear ribonucleoproteins C1/C2 Proteins 0.000 description 1
- 101001021275 Homo sapiens Hexosaminidase D Proteins 0.000 description 1
- 101000913074 Homo sapiens High affinity immunoglobulin gamma Fc receptor I Proteins 0.000 description 1
- 101000596894 Homo sapiens High affinity nerve growth factor receptor Proteins 0.000 description 1
- 101000866771 Homo sapiens High mobility group nucleosome-binding domain-containing protein 3 Proteins 0.000 description 1
- 101001006375 Homo sapiens High mobility group nucleosome-binding domain-containing protein 4 Proteins 0.000 description 1
- 101001006376 Homo sapiens High mobility group nucleosome-binding domain-containing protein 5 Proteins 0.000 description 1
- 101000986380 Homo sapiens High mobility group protein HMG-I/HMG-Y Proteins 0.000 description 1
- 101001030706 Homo sapiens Highly divergent homeobox Proteins 0.000 description 1
- 101000838883 Homo sapiens Hippocalcin-like protein 1 Proteins 0.000 description 1
- 101001012556 Homo sapiens Hippocampus abundant transcript-like protein 1 Proteins 0.000 description 1
- 101001012557 Homo sapiens Hippocampus abundant transcript-like protein 2 Proteins 0.000 description 1
- 101001016841 Homo sapiens Histamine H1 receptor Proteins 0.000 description 1
- 101001016827 Homo sapiens Histamine H2 receptor Proteins 0.000 description 1
- 101000843187 Homo sapiens Histidine-tRNA ligase, cytoplasmic Proteins 0.000 description 1
- 101000696493 Homo sapiens Histidine-tRNA ligase, mitochondrial Proteins 0.000 description 1
- 101001084711 Homo sapiens Histone H2A.V Proteins 0.000 description 1
- 101001084684 Homo sapiens Histone H2B type 1-D Proteins 0.000 description 1
- 101000842273 Homo sapiens Histone H4 transcription factor Proteins 0.000 description 1
- 101001047783 Homo sapiens Histone PARylation factor 1 Proteins 0.000 description 1
- 101001046967 Homo sapiens Histone acetyltransferase KAT2A Proteins 0.000 description 1
- 101001046996 Homo sapiens Histone acetyltransferase KAT5 Proteins 0.000 description 1
- 101000944179 Homo sapiens Histone acetyltransferase KAT6A Proteins 0.000 description 1
- 101000944174 Homo sapiens Histone acetyltransferase KAT6B Proteins 0.000 description 1
- 101000944166 Homo sapiens Histone acetyltransferase KAT7 Proteins 0.000 description 1
- 101000944170 Homo sapiens Histone acetyltransferase KAT8 Proteins 0.000 description 1
- 101000882390 Homo sapiens Histone acetyltransferase p300 Proteins 0.000 description 1
- 101000898976 Homo sapiens Histone acetyltransferase type B catalytic subunit Proteins 0.000 description 1
- 101001035024 Homo sapiens Histone deacetylase 1 Proteins 0.000 description 1
- 101001035011 Homo sapiens Histone deacetylase 2 Proteins 0.000 description 1
- 101000899282 Homo sapiens Histone deacetylase 3 Proteins 0.000 description 1
- 101000899259 Homo sapiens Histone deacetylase 4 Proteins 0.000 description 1
- 101000899255 Homo sapiens Histone deacetylase 5 Proteins 0.000 description 1
- 101001032113 Homo sapiens Histone deacetylase 7 Proteins 0.000 description 1
- 101001032118 Homo sapiens Histone deacetylase 8 Proteins 0.000 description 1
- 101001032092 Homo sapiens Histone deacetylase 9 Proteins 0.000 description 1
- 101001045846 Homo sapiens Histone-lysine N-methyltransferase 2A Proteins 0.000 description 1
- 101001045848 Homo sapiens Histone-lysine N-methyltransferase 2B Proteins 0.000 description 1
- 101001008892 Homo sapiens Histone-lysine N-methyltransferase 2C Proteins 0.000 description 1
- 101001008894 Homo sapiens Histone-lysine N-methyltransferase 2D Proteins 0.000 description 1
- 101000785963 Homo sapiens Histone-lysine N-methyltransferase ASH1L Proteins 0.000 description 1
- 101000877314 Homo sapiens Histone-lysine N-methyltransferase EHMT1 Proteins 0.000 description 1
- 101001028782 Homo sapiens Histone-lysine N-methyltransferase EZH1 Proteins 0.000 description 1
- 101001008821 Homo sapiens Histone-lysine N-methyltransferase KMT5B Proteins 0.000 description 1
- 101001008824 Homo sapiens Histone-lysine N-methyltransferase KMT5C Proteins 0.000 description 1
- 101000634048 Homo sapiens Histone-lysine N-methyltransferase NSD2 Proteins 0.000 description 1
- 101000634046 Homo sapiens Histone-lysine N-methyltransferase NSD3 Proteins 0.000 description 1
- 101000634050 Homo sapiens Histone-lysine N-methyltransferase, H3 lysine-36 specific Proteins 0.000 description 1
- 101000963360 Homo sapiens Histone-lysine N-methyltransferase, H3 lysine-79 specific Proteins 0.000 description 1
- 101001045907 Homo sapiens Holliday junction recognition protein Proteins 0.000 description 1
- 101000766187 Homo sapiens Homeobox protein BarH-like 2 Proteins 0.000 description 1
- 101000864690 Homo sapiens Homeobox protein DLX-1 Proteins 0.000 description 1
- 101001048970 Homo sapiens Homeobox protein EMX2 Proteins 0.000 description 1
- 101001083156 Homo sapiens Homeobox protein Hox-A1 Proteins 0.000 description 1
- 101000962622 Homo sapiens Homeobox protein Hox-A3 Proteins 0.000 description 1
- 101001077568 Homo sapiens Homeobox protein Hox-A5 Proteins 0.000 description 1
- 101001045083 Homo sapiens Homeobox protein Hox-A6 Proteins 0.000 description 1
- 101000839775 Homo sapiens Homeobox protein Hox-B3 Proteins 0.000 description 1
- 101001077542 Homo sapiens Homeobox protein Hox-B6 Proteins 0.000 description 1
- 101001077539 Homo sapiens Homeobox protein Hox-B7 Proteins 0.000 description 1
- 101000988994 Homo sapiens Homeobox protein Hox-B8 Proteins 0.000 description 1
- 101001002994 Homo sapiens Homeobox protein Hox-C4 Proteins 0.000 description 1
- 101001002966 Homo sapiens Homeobox protein Hox-C5 Proteins 0.000 description 1
- 101001019057 Homo sapiens Homeobox protein Meis2 Proteins 0.000 description 1
- 101001019059 Homo sapiens Homeobox protein Meis3 Proteins 0.000 description 1
- 101000726740 Homo sapiens Homeobox protein cut-like 1 Proteins 0.000 description 1
- 101000726714 Homo sapiens Homeobox protein cut-like 2 Proteins 0.000 description 1
- 101001006354 Homo sapiens Homeobox-containing protein 1 Proteins 0.000 description 1
- 101001066404 Homo sapiens Homeodomain-interacting protein kinase 1 Proteins 0.000 description 1
- 101001066389 Homo sapiens Homeodomain-interacting protein kinase 3 Proteins 0.000 description 1
- 101001048464 Homo sapiens Homer protein homolog 2 Proteins 0.000 description 1
- 101001035137 Homo sapiens Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein Proteins 0.000 description 1
- 101001035135 Homo sapiens Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 2 protein Proteins 0.000 description 1
- 101001005187 Homo sapiens Hormone-sensitive lipase Proteins 0.000 description 1
- 101001083536 Homo sapiens Host cell factor 2 Proteins 0.000 description 1
- 101000988793 Homo sapiens Host cell factor C1 regulator 1 Proteins 0.000 description 1
- 101000988648 Homo sapiens Humanin-like 2 Proteins 0.000 description 1
- 101001021527 Homo sapiens Huntingtin-interacting protein 1 Proteins 0.000 description 1
- 101001079904 Homo sapiens Hyaluronan and proteoglycan link protein 1 Proteins 0.000 description 1
- 101001081176 Homo sapiens Hyaluronan mediated motility receptor Proteins 0.000 description 1
- 101001041128 Homo sapiens Hyaluronidase-3 Proteins 0.000 description 1
- 101001045123 Homo sapiens Hyccin Proteins 0.000 description 1
- 101001083553 Homo sapiens Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial Proteins 0.000 description 1
- 101000839393 Homo sapiens Hydroxyacyl-thioester dehydratase type 2, mitochondrial Proteins 0.000 description 1
- 101001040270 Homo sapiens Hydroxyacylglutathione hydrolase, mitochondrial Proteins 0.000 description 1
- 101001068011 Homo sapiens Hydroxyacylglutathione hydrolase-like protein Proteins 0.000 description 1
- 101001047912 Homo sapiens Hydroxymethylglutaryl-CoA lyase, mitochondrial Proteins 0.000 description 1
- 101000839025 Homo sapiens Hydroxymethylglutaryl-CoA synthase, cytoplasmic Proteins 0.000 description 1
- 101000928767 Homo sapiens Hydroxysteroid 11-beta-dehydrogenase 1-like protein Proteins 0.000 description 1
- 101001042781 Homo sapiens Hydroxysteroid dehydrogenase-like protein 2 Proteins 0.000 description 1
- 101001003102 Homo sapiens Hypoxia up-regulated protein 1 Proteins 0.000 description 1
- 101001046870 Homo sapiens Hypoxia-inducible factor 1-alpha Proteins 0.000 description 1
- 101001082574 Homo sapiens Hypoxia-inducible factor 1-alpha inhibitor Proteins 0.000 description 1
- 101001076297 Homo sapiens IGF-like family receptor 1 Proteins 0.000 description 1
- 101100508538 Homo sapiens IKBKE gene Proteins 0.000 description 1
- 101000998490 Homo sapiens INO80 complex subunit C Proteins 0.000 description 1
- 101000998472 Homo sapiens INO80 complex subunit E Proteins 0.000 description 1
- 101001011412 Homo sapiens IQ calmodulin-binding motif-containing protein 1 Proteins 0.000 description 1
- 101001011420 Homo sapiens IQ domain-containing protein C Proteins 0.000 description 1
- 101001011421 Homo sapiens IQ domain-containing protein E Proteins 0.000 description 1
- 101001053578 Homo sapiens IQ domain-containing protein H Proteins 0.000 description 1
- 101001053590 Homo sapiens IQ domain-containing protein K Proteins 0.000 description 1
- 101001077644 Homo sapiens IQ motif and SEC7 domain-containing protein 1 Proteins 0.000 description 1
- 101000994787 Homo sapiens IQCJ-SCHIP1 readthrough transcript protein Proteins 0.000 description 1
- 101001050487 Homo sapiens IST1 homolog Proteins 0.000 description 1
- 101000840540 Homo sapiens Iduronate 2-sulfatase Proteins 0.000 description 1
- 101000913079 Homo sapiens IgG receptor FcRn large subunit p51 Proteins 0.000 description 1
- 101000840263 Homo sapiens IgLON family member 5 Proteins 0.000 description 1
- 101001034663 Homo sapiens Immunoglobulin superfamily DCC subclass member 4 Proteins 0.000 description 1
- 101000977643 Homo sapiens Immunoglobulin superfamily containing leucine-rich repeat protein 2 Proteins 0.000 description 1
- 101001002508 Homo sapiens Immunoglobulin-binding protein 1 Proteins 0.000 description 1
- 101001010614 Homo sapiens Immunoglobulin-like domain-containing receptor 2 Proteins 0.000 description 1
- 101001001478 Homo sapiens Importin subunit alpha-3 Proteins 0.000 description 1
- 101001054807 Homo sapiens Importin subunit alpha-6 Proteins 0.000 description 1
- 101001054793 Homo sapiens Importin subunit alpha-7 Proteins 0.000 description 1
- 101000852543 Homo sapiens Importin-4 Proteins 0.000 description 1
- 101000599445 Homo sapiens Importin-7 Proteins 0.000 description 1
- 101000599449 Homo sapiens Importin-8 Proteins 0.000 description 1
- 101000599453 Homo sapiens Importin-9 Proteins 0.000 description 1
- 101000599573 Homo sapiens InaD-like protein Proteins 0.000 description 1
- 101000902205 Homo sapiens Inactive cytidine monophosphate-N-acetylneuraminic acid hydroxylase Proteins 0.000 description 1
- 101000903806 Homo sapiens Inactive glycosyltransferase 25 family member 3 Proteins 0.000 description 1
- 101001008896 Homo sapiens Inactive histone-lysine N-methyltransferase 2E Proteins 0.000 description 1
- 101000609277 Homo sapiens Inactive serine protease PAMR1 Proteins 0.000 description 1
- 101000721401 Homo sapiens Inactive ubiquitin thioesterase OTULINL Proteins 0.000 description 1
- 101000998524 Homo sapiens Indolethylamine N-methyltransferase Proteins 0.000 description 1
- 101000633984 Homo sapiens Influenza virus NS1A-binding protein Proteins 0.000 description 1
- 101001053716 Homo sapiens Inhibitor of growth protein 3 Proteins 0.000 description 1
- 101001001418 Homo sapiens Inhibitor of growth protein 4 Proteins 0.000 description 1
- 101001001416 Homo sapiens Inhibitor of growth protein 5 Proteins 0.000 description 1
- 101001043772 Homo sapiens Inhibitor of nuclear factor kappa-B kinase-interacting protein Proteins 0.000 description 1
- 101000960484 Homo sapiens Inner centromere protein Proteins 0.000 description 1
- 101001059713 Homo sapiens Inner nuclear membrane protein Man1 Proteins 0.000 description 1
- 101001056794 Homo sapiens Inosine triphosphate pyrophosphatase Proteins 0.000 description 1
- 101001044118 Homo sapiens Inosine-5'-monophosphate dehydrogenase 1 Proteins 0.000 description 1
- 101000852486 Homo sapiens Inositol 1,4,5-triphosphate receptor associated 2 Proteins 0.000 description 1
- 101000975428 Homo sapiens Inositol 1,4,5-trisphosphate receptor type 1 Proteins 0.000 description 1
- 101000975421 Homo sapiens Inositol 1,4,5-trisphosphate receptor type 2 Proteins 0.000 description 1
- 101001011985 Homo sapiens Inositol hexakisphosphate kinase 1 Proteins 0.000 description 1
- 101001011989 Homo sapiens Inositol hexakisphosphate kinase 2 Proteins 0.000 description 1
- 101001001429 Homo sapiens Inositol monophosphatase 1 Proteins 0.000 description 1
- 101001044094 Homo sapiens Inositol monophosphatase 2 Proteins 0.000 description 1
- 101001053320 Homo sapiens Inositol polyphosphate 5-phosphatase K Proteins 0.000 description 1
- 101000982538 Homo sapiens Inositol polyphosphate 5-phosphatase OCRL Proteins 0.000 description 1
- 101001053362 Homo sapiens Inositol polyphosphate-4-phosphatase type I A Proteins 0.000 description 1
- 101000962413 Homo sapiens Inositol polyphosphate-5-phosphatase A Proteins 0.000 description 1
- 101000998969 Homo sapiens Inositol-3-phosphate synthase 1 Proteins 0.000 description 1
- 101000993973 Homo sapiens Inositol-pentakisphosphate 2-kinase Proteins 0.000 description 1
- 101001046674 Homo sapiens Inositol-tetrakisphosphate 1-kinase Proteins 0.000 description 1
- 101001053263 Homo sapiens Insulin gene enhancer protein ISL-1 Proteins 0.000 description 1
- 101000852815 Homo sapiens Insulin receptor Proteins 0.000 description 1
- 101001044342 Homo sapiens Insulin-degrading enzyme Proteins 0.000 description 1
- 101000599779 Homo sapiens Insulin-like growth factor 2 mRNA-binding protein 2 Proteins 0.000 description 1
- 101000599782 Homo sapiens Insulin-like growth factor 2 mRNA-binding protein 3 Proteins 0.000 description 1
- 101000840582 Homo sapiens Insulin-like growth factor-binding protein 6 Proteins 0.000 description 1
- 101001050472 Homo sapiens Integral membrane protein 2A Proteins 0.000 description 1
- 101001056814 Homo sapiens Integral membrane protein 2C Proteins 0.000 description 1
- 101001003262 Homo sapiens Integral membrane protein DGCR2/IDD Proteins 0.000 description 1
- 101001000784 Homo sapiens Integral membrane protein GPR137 Proteins 0.000 description 1
- 101001000801 Homo sapiens Integral membrane protein GPR137B Proteins 0.000 description 1
- 101001066074 Homo sapiens Integral membrane protein GPR137C Proteins 0.000 description 1
- 101001039295 Homo sapiens Integral membrane protein GPR155 Proteins 0.000 description 1
- 101001040800 Homo sapiens Integral membrane protein GPR180 Proteins 0.000 description 1
- 101001053423 Homo sapiens Integrator complex subunit 11 Proteins 0.000 description 1
- 101000599647 Homo sapiens Integrator complex subunit 12 Proteins 0.000 description 1
- 101001054645 Homo sapiens Integrator complex subunit 13 Proteins 0.000 description 1
- 101001054651 Homo sapiens Integrator complex subunit 14 Proteins 0.000 description 1
- 101000998808 Homo sapiens Integrator complex subunit 2 Proteins 0.000 description 1
- 101000998800 Homo sapiens Integrator complex subunit 3 Proteins 0.000 description 1
- 101001033770 Homo sapiens Integrator complex subunit 4 Proteins 0.000 description 1
- 101001011755 Homo sapiens Integrator complex subunit 7 Proteins 0.000 description 1
- 101001011746 Homo sapiens Integrator complex subunit 8 Proteins 0.000 description 1
- 101001011825 Homo sapiens Integrator complex subunit 9 Proteins 0.000 description 1
- 101001078158 Homo sapiens Integrin alpha-1 Proteins 0.000 description 1
- 101001078149 Homo sapiens Integrin alpha-10 Proteins 0.000 description 1
- 101000994378 Homo sapiens Integrin alpha-3 Proteins 0.000 description 1
- 101000994322 Homo sapiens Integrin alpha-8 Proteins 0.000 description 1
- 101001035232 Homo sapiens Integrin alpha-9 Proteins 0.000 description 1
- 101001046687 Homo sapiens Integrin alpha-E Proteins 0.000 description 1
- 101001046677 Homo sapiens Integrin alpha-V Proteins 0.000 description 1
- 101001046668 Homo sapiens Integrin alpha-X Proteins 0.000 description 1
- 101000997642 Homo sapiens Integrin beta-1-binding protein 1 Proteins 0.000 description 1
- 101001015059 Homo sapiens Integrin beta-5 Proteins 0.000 description 1
- 101001002695 Homo sapiens Integrin-linked protein kinase Proteins 0.000 description 1
- 101000609417 Homo sapiens Inter-alpha-trypsin inhibitor heavy chain H5 Proteins 0.000 description 1
- 101001055250 Homo sapiens Interactor of HORMAD1 protein 1 Proteins 0.000 description 1
- 101001044929 Homo sapiens Interactor protein for cytohesin exchange factors 1 Proteins 0.000 description 1
- 101001037249 Homo sapiens Interferon alpha-inducible protein 27-like protein 1 Proteins 0.000 description 1
- 101001037247 Homo sapiens Interferon alpha-inducible protein 27-like protein 2 Proteins 0.000 description 1
- 101000852870 Homo sapiens Interferon alpha/beta receptor 1 Proteins 0.000 description 1
- 101000852865 Homo sapiens Interferon alpha/beta receptor 2 Proteins 0.000 description 1
- 101001011393 Homo sapiens Interferon regulatory factor 2 Proteins 0.000 description 1
- 101001011382 Homo sapiens Interferon regulatory factor 3 Proteins 0.000 description 1
- 101001011441 Homo sapiens Interferon regulatory factor 4 Proteins 0.000 description 1
- 101001011446 Homo sapiens Interferon regulatory factor 6 Proteins 0.000 description 1
- 101001128393 Homo sapiens Interferon-induced GTP-binding protein Mx1 Proteins 0.000 description 1
- 101000959664 Homo sapiens Interferon-induced protein 44-like Proteins 0.000 description 1
- 101001034844 Homo sapiens Interferon-induced transmembrane protein 1 Proteins 0.000 description 1
- 101000999377 Homo sapiens Interferon-related developmental regulator 1 Proteins 0.000 description 1
- 101001033293 Homo sapiens Interleukin enhancer-binding factor 3 Proteins 0.000 description 1
- 101001076319 Homo sapiens Interleukin-1 receptor-associated kinase 1-binding protein 1 Proteins 0.000 description 1
- 101000977768 Homo sapiens Interleukin-1 receptor-associated kinase 3 Proteins 0.000 description 1
- 101000977771 Homo sapiens Interleukin-1 receptor-associated kinase 4 Proteins 0.000 description 1
- 101000852255 Homo sapiens Interleukin-1 receptor-associated kinase-like 2 Proteins 0.000 description 1
- 101001083151 Homo sapiens Interleukin-10 receptor subunit alpha Proteins 0.000 description 1
- 101001003147 Homo sapiens Interleukin-11 receptor subunit alpha Proteins 0.000 description 1
- 101001003138 Homo sapiens Interleukin-12 receptor subunit beta-2 Proteins 0.000 description 1
- 101001003135 Homo sapiens Interleukin-13 receptor subunit alpha-1 Proteins 0.000 description 1
- 101001003140 Homo sapiens Interleukin-15 receptor subunit alpha Proteins 0.000 description 1
- 101001019598 Homo sapiens Interleukin-17 receptor A Proteins 0.000 description 1
- 101001019600 Homo sapiens Interleukin-17 receptor B Proteins 0.000 description 1
- 101001019602 Homo sapiens Interleukin-17 receptor C Proteins 0.000 description 1
- 101001019590 Homo sapiens Interleukin-17 receptor E Proteins 0.000 description 1
- 101001019615 Homo sapiens Interleukin-18 receptor accessory protein Proteins 0.000 description 1
- 101001019591 Homo sapiens Interleukin-18-binding protein Proteins 0.000 description 1
- 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 description 1
- 101000998139 Homo sapiens Interleukin-32 Proteins 0.000 description 1
- 101001033312 Homo sapiens Interleukin-4 receptor subunit alpha Proteins 0.000 description 1
- 101001076408 Homo sapiens Interleukin-6 Proteins 0.000 description 1
- 101000599048 Homo sapiens Interleukin-6 receptor subunit alpha Proteins 0.000 description 1
- 101000599056 Homo sapiens Interleukin-6 receptor subunit beta Proteins 0.000 description 1
- 101001043809 Homo sapiens Interleukin-7 receptor subunit alpha Proteins 0.000 description 1
- 101001026236 Homo sapiens Intermediate conductance calcium-activated potassium channel protein 4 Proteins 0.000 description 1
- 101001056724 Homo sapiens Intersectin-1 Proteins 0.000 description 1
- 101001056699 Homo sapiens Intersectin-2 Proteins 0.000 description 1
- 101001035935 Homo sapiens Intracellular hyaluronan-binding protein 4 Proteins 0.000 description 1
- 101001044336 Homo sapiens Intraflagellar transport protein 122 homolog Proteins 0.000 description 1
- 101000960200 Homo sapiens Intraflagellar transport protein 140 homolog Proteins 0.000 description 1
- 101000960114 Homo sapiens Intraflagellar transport protein 172 homolog Proteins 0.000 description 1
- 101001055333 Homo sapiens Intraflagellar transport protein 20 homolog Proteins 0.000 description 1
- 101001055334 Homo sapiens Intraflagellar transport protein 22 homolog Proteins 0.000 description 1
- 101000961164 Homo sapiens Intraflagellar transport protein 43 homolog Proteins 0.000 description 1
- 101001044438 Homo sapiens Intraflagellar transport protein 52 homolog Proteins 0.000 description 1
- 101001010842 Homo sapiens Intraflagellar transport protein 57 homolog Proteins 0.000 description 1
- 101001010727 Homo sapiens Intraflagellar transport protein 80 homolog Proteins 0.000 description 1
- 101001010731 Homo sapiens Intraflagellar transport protein 81 homolog Proteins 0.000 description 1
- 101001010724 Homo sapiens Intraflagellar transport protein 88 homolog Proteins 0.000 description 1
- 101000862611 Homo sapiens Intron Large complex component GCFC2 Proteins 0.000 description 1
- 101000998711 Homo sapiens Inversin Proteins 0.000 description 1
- 101001012154 Homo sapiens Inverted formin-2 Proteins 0.000 description 1
- 101000994167 Homo sapiens Iron-sulfur cluster assembly 1 homolog, mitochondrial Proteins 0.000 description 1
- 101001080292 Homo sapiens Iron-sulfur cluster co-chaperone protein HscB Proteins 0.000 description 1
- 101001107782 Homo sapiens Iron-sulfur protein NUBPL Proteins 0.000 description 1
- 101001081606 Homo sapiens Islet cell autoantigen 1 Proteins 0.000 description 1
- 101001081548 Homo sapiens Islet cell autoantigen 1-like protein Proteins 0.000 description 1
- 101000994186 Homo sapiens Isochorismatase domain-containing protein 2 Proteins 0.000 description 1
- 101000960234 Homo sapiens Isocitrate dehydrogenase [NADP] cytoplasmic Proteins 0.000 description 1
- 101001042036 Homo sapiens Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial Proteins 0.000 description 1
- 101001042038 Homo sapiens Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial Proteins 0.000 description 1
- 101000960245 Homo sapiens Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial Proteins 0.000 description 1
- 101001081533 Homo sapiens Isopentenyl-diphosphate Delta-isomerase 1 Proteins 0.000 description 1
- 101000997838 Homo sapiens Janus kinase and microtubule-interacting protein 2 Proteins 0.000 description 1
- 101000975533 Homo sapiens JmjC domain-containing protein 8 Proteins 0.000 description 1
- 101000833492 Homo sapiens Jouberin Proteins 0.000 description 1
- 101001050282 Homo sapiens Jupiter microtubule associated homolog 2 Proteins 0.000 description 1
- 101000975000 Homo sapiens KAT8 regulatory NSL complex subunit 1-like protein Proteins 0.000 description 1
- 101001046964 Homo sapiens KAT8 regulatory NSL complex subunit 2 Proteins 0.000 description 1
- 101001026582 Homo sapiens KAT8 regulatory NSL complex subunit 3 Proteins 0.000 description 1
- 101000972654 Homo sapiens KATNB1-like protein 1 Proteins 0.000 description 1
- 101001050607 Homo sapiens KH domain-containing, RNA-binding, signal transduction-associated protein 3 Proteins 0.000 description 1
- 101000971790 Homo sapiens KH homology domain-containing protein 1 Proteins 0.000 description 1
- 101000976710 Homo sapiens KICSTOR complex protein ITFG2 Proteins 0.000 description 1
- 101001051753 Homo sapiens KICSTOR complex protein kaptin Proteins 0.000 description 1
- 101001046985 Homo sapiens KN motif and ankyrin repeat domain-containing protein 1 Proteins 0.000 description 1
- 101001046980 Homo sapiens KN motif and ankyrin repeat domain-containing protein 2 Proteins 0.000 description 1
- 101001026902 Homo sapiens KRAB domain-containing protein 4 Proteins 0.000 description 1
- 101000975105 Homo sapiens Katanin p60 ATPase-containing subunit A-like 1 Proteins 0.000 description 1
- 101000975108 Homo sapiens Katanin p60 ATPase-containing subunit A-like 2 Proteins 0.000 description 1
- 101000604641 Homo sapiens Katanin p60 ATPase-containing subunit A1 Proteins 0.000 description 1
- 101001057012 Homo sapiens Katanin-interacting protein Proteins 0.000 description 1
- 101000614666 Homo sapiens Kazrin Proteins 0.000 description 1
- 101001027146 Homo sapiens Kelch domain-containing protein 10 Proteins 0.000 description 1
- 101000945442 Homo sapiens Kelch domain-containing protein 3 Proteins 0.000 description 1
- 101000945443 Homo sapiens Kelch domain-containing protein 4 Proteins 0.000 description 1
- 101000945451 Homo sapiens Kelch domain-containing protein 8B Proteins 0.000 description 1
- 101000997318 Homo sapiens Kelch repeat and BTB domain-containing protein 2 Proteins 0.000 description 1
- 101001047014 Homo sapiens Kelch repeat and BTB domain-containing protein 3 Proteins 0.000 description 1
- 101001047047 Homo sapiens Kelch repeat and BTB domain-containing protein 8 Proteins 0.000 description 1
- 101001091328 Homo sapiens Kelch-like protein 12 Proteins 0.000 description 1
- 101001091320 Homo sapiens Kelch-like protein 13 Proteins 0.000 description 1
- 101001049220 Homo sapiens Kelch-like protein 17 Proteins 0.000 description 1
- 101001049206 Homo sapiens Kelch-like protein 18 Proteins 0.000 description 1
- 101001045822 Homo sapiens Kelch-like protein 2 Proteins 0.000 description 1
- 101001049204 Homo sapiens Kelch-like protein 20 Proteins 0.000 description 1
- 101001006882 Homo sapiens Kelch-like protein 22 Proteins 0.000 description 1
- 101001006878 Homo sapiens Kelch-like protein 24 Proteins 0.000 description 1
- 101001008853 Homo sapiens Kelch-like protein 5 Proteins 0.000 description 1
- 101001008857 Homo sapiens Kelch-like protein 7 Proteins 0.000 description 1
- 101001008914 Homo sapiens Kelch-like protein 8 Proteins 0.000 description 1
- 101000975496 Homo sapiens Keratin, type II cytoskeletal 8 Proteins 0.000 description 1
- 101001050606 Homo sapiens Ketohexokinase Proteins 0.000 description 1
- 101001026998 Homo sapiens Ketosamine-3-kinase Proteins 0.000 description 1
- 101001049181 Homo sapiens Killer cell lectin-like receptor subfamily B member 1 Proteins 0.000 description 1
- 101000971533 Homo sapiens Killer cell lectin-like receptor subfamily G member 1 Proteins 0.000 description 1
- 101000971530 Homo sapiens Killer cell lectin-like receptor subfamily G member 2 Proteins 0.000 description 1
- 101001139019 Homo sapiens Kin of IRRE-like protein 1 Proteins 0.000 description 1
- 101000945500 Homo sapiens Kin of IRRE-like protein 3 Proteins 0.000 description 1
- 101000975939 Homo sapiens Kinase D-interacting substrate of 220 kDa Proteins 0.000 description 1
- 101001137642 Homo sapiens Kinase suppressor of Ras 1 Proteins 0.000 description 1
- 101001090172 Homo sapiens Kinectin Proteins 0.000 description 1
- 101001006789 Homo sapiens Kinesin heavy chain isoform 5C Proteins 0.000 description 1
- 101000605496 Homo sapiens Kinesin light chain 1 Proteins 0.000 description 1
- 101000605508 Homo sapiens Kinesin light chain 4 Proteins 0.000 description 1
- 101001006782 Homo sapiens Kinesin-associated protein 3 Proteins 0.000 description 1
- 101001008953 Homo sapiens Kinesin-like protein KIF11 Proteins 0.000 description 1
- 101001091266 Homo sapiens Kinesin-like protein KIF13A Proteins 0.000 description 1
- 101001091256 Homo sapiens Kinesin-like protein KIF13B Proteins 0.000 description 1
- 101001008949 Homo sapiens Kinesin-like protein KIF14 Proteins 0.000 description 1
- 101001008951 Homo sapiens Kinesin-like protein KIF15 Proteins 0.000 description 1
- 101001091229 Homo sapiens Kinesin-like protein KIF16B Proteins 0.000 description 1
- 101001091232 Homo sapiens Kinesin-like protein KIF18B Proteins 0.000 description 1
- 101000971638 Homo sapiens Kinesin-like protein KIF1A Proteins 0.000 description 1
- 101000971697 Homo sapiens Kinesin-like protein KIF1B Proteins 0.000 description 1
- 101000971703 Homo sapiens Kinesin-like protein KIF1C Proteins 0.000 description 1
- 101001027628 Homo sapiens Kinesin-like protein KIF21A Proteins 0.000 description 1
- 101001027634 Homo sapiens Kinesin-like protein KIF21B Proteins 0.000 description 1
- 101000605743 Homo sapiens Kinesin-like protein KIF23 Proteins 0.000 description 1
- 101000605741 Homo sapiens Kinesin-like protein KIF24 Proteins 0.000 description 1
- 101001027602 Homo sapiens Kinesin-like protein KIF26B Proteins 0.000 description 1
- 101000605746 Homo sapiens Kinesin-like protein KIF27 Proteins 0.000 description 1
- 101001050577 Homo sapiens Kinesin-like protein KIF2A Proteins 0.000 description 1
- 101001050567 Homo sapiens Kinesin-like protein KIF2C Proteins 0.000 description 1
- 101001050565 Homo sapiens Kinesin-like protein KIF3A Proteins 0.000 description 1
- 101001006780 Homo sapiens Kinesin-like protein KIF9 Proteins 0.000 description 1
- 101001006776 Homo sapiens Kinesin-like protein KIFC1 Proteins 0.000 description 1
- 101000590482 Homo sapiens Kinetochore protein Nuf2 Proteins 0.000 description 1
- 101000971521 Homo sapiens Kinetochore scaffold 1 Proteins 0.000 description 1
- 101001006909 Homo sapiens Kinetochore-associated protein 1 Proteins 0.000 description 1
- 101001053809 Homo sapiens Kinetochore-associated protein DSN1 homolog Proteins 0.000 description 1
- 101001108770 Homo sapiens Kinetochore-associated protein NSL1 homolog Proteins 0.000 description 1
- 101000716729 Homo sapiens Kit ligand Proteins 0.000 description 1
- 101000604876 Homo sapiens Kremen protein 1 Proteins 0.000 description 1
- 101001006886 Homo sapiens Krueppel-like factor 12 Proteins 0.000 description 1
- 101001139130 Homo sapiens Krueppel-like factor 5 Proteins 0.000 description 1
- 101001139115 Homo sapiens Krueppel-like factor 8 Proteins 0.000 description 1
- 101000614145 Homo sapiens Kynurenine formamidase Proteins 0.000 description 1
- 101000614821 Homo sapiens Kynurenine-oxoglutarate transaminase 1 Proteins 0.000 description 1
- 101001046999 Homo sapiens Kynurenine-oxoglutarate transaminase 3 Proteins 0.000 description 1
- 101001138081 Homo sapiens L-2-hydroxyglutarate dehydrogenase, mitochondrial Proteins 0.000 description 1
- 101000892430 Homo sapiens L-fucose kinase Proteins 0.000 description 1
- 101001130171 Homo sapiens L-lactate dehydrogenase C chain Proteins 0.000 description 1
- 101001010223 Homo sapiens LBH domain-containing protein 1 Proteins 0.000 description 1
- 101100454393 Homo sapiens LCOR gene Proteins 0.000 description 1
- 101001007417 Homo sapiens LEM domain-containing protein 2 Proteins 0.000 description 1
- 101000956778 Homo sapiens LETM1 domain-containing protein 1 Proteins 0.000 description 1
- 101000608555 Homo sapiens LETM1 domain-containing protein LETM2, mitochondrial Proteins 0.000 description 1
- 101001004313 Homo sapiens LHFPL tetraspan subfamily member 2 protein Proteins 0.000 description 1
- 101001134676 Homo sapiens LIM and calponin homology domains-containing protein 1 Proteins 0.000 description 1
- 101001043996 Homo sapiens LIM and cysteine-rich domains protein 1 Proteins 0.000 description 1
- 101001042354 Homo sapiens LIM and senescent cell antigen-like-containing domain protein 2 Proteins 0.000 description 1
- 101001042360 Homo sapiens LIM domain kinase 2 Proteins 0.000 description 1
- 101001135088 Homo sapiens LIM domain only protein 7 Proteins 0.000 description 1
- 101001022948 Homo sapiens LIM domain-binding protein 2 Proteins 0.000 description 1
- 101001005196 Homo sapiens LIX1-like protein Proteins 0.000 description 1
- 101001047511 Homo sapiens LLGL scribble cell polarity complex component 2 Proteins 0.000 description 1
- 101001037999 Homo sapiens LON peptidase N-terminal domain and RING finger protein 1 Proteins 0.000 description 1
- 101001037993 Homo sapiens LON peptidase N-terminal domain and RING finger protein 3 Proteins 0.000 description 1
- 101001065536 Homo sapiens LYR motif-containing protein 1 Proteins 0.000 description 1
- 101001138022 Homo sapiens La-related protein 1 Proteins 0.000 description 1
- 101001010163 Homo sapiens La-related protein 1B Proteins 0.000 description 1
- 101001138020 Homo sapiens La-related protein 4 Proteins 0.000 description 1
- 101001010164 Homo sapiens La-related protein 4B Proteins 0.000 description 1
- 101001008442 Homo sapiens La-related protein 7 Proteins 0.000 description 1
- 101001034314 Homo sapiens Lactadherin Proteins 0.000 description 1
- 101000876418 Homo sapiens Laforin Proteins 0.000 description 1
- 101000882389 Homo sapiens Laforin, isoform 9 Proteins 0.000 description 1
- 101000745469 Homo sapiens Lambda-crystallin homolog Proteins 0.000 description 1
- 101000972491 Homo sapiens Laminin subunit alpha-2 Proteins 0.000 description 1
- 101001008527 Homo sapiens Laminin subunit alpha-5 Proteins 0.000 description 1
- 101001008558 Homo sapiens Laminin subunit beta-2 Proteins 0.000 description 1
- 101000946306 Homo sapiens Laminin subunit gamma-1 Proteins 0.000 description 1
- 101001023261 Homo sapiens Laminin subunit gamma-3 Proteins 0.000 description 1
- 101001065660 Homo sapiens Lanosterol synthase Proteins 0.000 description 1
- 101000984653 Homo sapiens Large subunit GTPase 1 homolog Proteins 0.000 description 1
- 101001041031 Homo sapiens Lariat debranching enzyme Proteins 0.000 description 1
- 101000730000 Homo sapiens Late secretory pathway protein AVL9 homolog Proteins 0.000 description 1
- 101001054659 Homo sapiens Latent-transforming growth factor beta-binding protein 1 Proteins 0.000 description 1
- 101001054649 Homo sapiens Latent-transforming growth factor beta-binding protein 2 Proteins 0.000 description 1
- 101001054646 Homo sapiens Latent-transforming growth factor beta-binding protein 3 Proteins 0.000 description 1
- 101000978212 Homo sapiens Latent-transforming growth factor beta-binding protein 4 Proteins 0.000 description 1
- 101001005090 Homo sapiens Lck-interacting transmembrane adapter 1 Proteins 0.000 description 1
- 101001063370 Homo sapiens Legumain Proteins 0.000 description 1
- 101001005155 Homo sapiens Leishmanolysin-like peptidase Proteins 0.000 description 1
- 101001007419 Homo sapiens Lens epithelial cell protein LEP503 Proteins 0.000 description 1
- 101000585618 Homo sapiens Leptin receptor gene-related protein Proteins 0.000 description 1
- 101000970921 Homo sapiens Leptin receptor overlapping transcript-like 1 Proteins 0.000 description 1
- 101001047515 Homo sapiens Lethal(2) giant larvae protein homolog 1 Proteins 0.000 description 1
- 101000966290 Homo sapiens Lethal(3)malignant brain tumor-like protein 2 Proteins 0.000 description 1
- 101000966275 Homo sapiens Lethal(3)malignant brain tumor-like protein 3 Proteins 0.000 description 1
- 101001042527 Homo sapiens Leucine carboxyl methyltransferase 1 Proteins 0.000 description 1
- 101001065853 Homo sapiens Leucine repeat adapter protein 25 Proteins 0.000 description 1
- 101001054848 Homo sapiens Leucine zipper protein 1 Proteins 0.000 description 1
- 101000616300 Homo sapiens Leucine zipper transcription factor-like protein 1 Proteins 0.000 description 1
- 101000966742 Homo sapiens Leucine-rich PPR motif-containing protein, mitochondrial Proteins 0.000 description 1
- 101000579578 Homo sapiens Leucine-rich melanocyte differentiation-associated protein Proteins 0.000 description 1
- 101000941892 Homo sapiens Leucine-rich repeat and calponin homology domain-containing protein 4 Proteins 0.000 description 1
- 101000941901 Homo sapiens Leucine-rich repeat and coiled-coil domain-containing protein 1 Proteins 0.000 description 1
- 101000981675 Homo sapiens Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 2 Proteins 0.000 description 1
- 101001017828 Homo sapiens Leucine-rich repeat flightless-interacting protein 1 Proteins 0.000 description 1
- 101000941884 Homo sapiens Leucine-rich repeat flightless-interacting protein 2 Proteins 0.000 description 1
- 101000941865 Homo sapiens Leucine-rich repeat neuronal protein 3 Proteins 0.000 description 1
- 101001038321 Homo sapiens Leucine-rich repeat protein 1 Proteins 0.000 description 1
- 101000941877 Homo sapiens Leucine-rich repeat serine/threonine-protein kinase 1 Proteins 0.000 description 1
- 101000893530 Homo sapiens Leucine-rich repeat transmembrane protein FLRT3 Proteins 0.000 description 1
- 101001063456 Homo sapiens Leucine-rich repeat-containing G-protein coupled receptor 5 Proteins 0.000 description 1
- 101001017864 Homo sapiens Leucine-rich repeat-containing protein 14 Proteins 0.000 description 1
- 101001039189 Homo sapiens Leucine-rich repeat-containing protein 17 Proteins 0.000 description 1
- 101001039170 Homo sapiens Leucine-rich repeat-containing protein 23 Proteins 0.000 description 1
- 101001004871 Homo sapiens Leucine-rich repeat-containing protein 28 Proteins 0.000 description 1
- 101000579876 Homo sapiens Leucine-rich repeat-containing protein 34 Proteins 0.000 description 1
- 101000972549 Homo sapiens Leucine-rich repeat-containing protein 37A2 Proteins 0.000 description 1
- 101000967545 Homo sapiens Leucine-rich repeat-containing protein 37B Proteins 0.000 description 1
- 101000984851 Homo sapiens Leucine-rich repeat-containing protein 40 Proteins 0.000 description 1
- 101000984841 Homo sapiens Leucine-rich repeat-containing protein 42 Proteins 0.000 description 1
- 101000619105 Homo sapiens Leucine-rich repeat-containing protein 45 Proteins 0.000 description 1
- 101000619606 Homo sapiens Leucine-rich repeat-containing protein 49 Proteins 0.000 description 1
- 101000619610 Homo sapiens Leucine-rich repeat-containing protein 4B Proteins 0.000 description 1
- 101000579912 Homo sapiens Leucine-rich repeat-containing protein 58 Proteins 0.000 description 1
- 101000965735 Homo sapiens Leucine-rich repeat-containing protein 69 Proteins 0.000 description 1
- 101000619656 Homo sapiens Leucine-rich repeat-containing protein 70 Proteins 0.000 description 1
- 101000965731 Homo sapiens Leucine-rich repeat-containing protein 73 Proteins 0.000 description 1
- 101001065857 Homo sapiens Leucine-rich repeat-containing protein 75B Proteins 0.000 description 1
- 101000619640 Homo sapiens Leucine-rich repeats and immunoglobulin-like domains protein 1 Proteins 0.000 description 1
- 101000619642 Homo sapiens Leucine-rich repeats and immunoglobulin-like domains protein 2 Proteins 0.000 description 1
- 101001017855 Homo sapiens Leucine-rich repeats and immunoglobulin-like domains protein 3 Proteins 0.000 description 1
- 101000624524 Homo sapiens Leucine-tRNA ligase, cytoplasmic Proteins 0.000 description 1
- 101000624540 Homo sapiens Leucine-tRNA ligase, mitochondrial Proteins 0.000 description 1
- 101001063878 Homo sapiens Leukemia-associated protein 1 Proteins 0.000 description 1
- 101000984197 Homo sapiens Leukocyte immunoglobulin-like receptor subfamily A member 2 Proteins 0.000 description 1
- 101000984192 Homo sapiens Leukocyte immunoglobulin-like receptor subfamily B member 3 Proteins 0.000 description 1
- 101001007394 Homo sapiens Leukocyte receptor cluster member 8 Proteins 0.000 description 1
- 101000868279 Homo sapiens Leukocyte surface antigen CD47 Proteins 0.000 description 1
- 101000980823 Homo sapiens Leukocyte surface antigen CD53 Proteins 0.000 description 1
- 101000619898 Homo sapiens Leukotriene A-4 hydrolase Proteins 0.000 description 1
- 101001017968 Homo sapiens Leukotriene B4 receptor 1 Proteins 0.000 description 1
- 101000942133 Homo sapiens Leupaxin Proteins 0.000 description 1
- 101000620138 Homo sapiens Ligand of Numb protein X 2 Proteins 0.000 description 1
- 101000605076 Homo sapiens Ligand-dependent nuclear receptor corepressor-like protein Proteins 0.000 description 1
- 101000619643 Homo sapiens Ligand-dependent nuclear receptor-interacting factor 1 Proteins 0.000 description 1
- 101000966257 Homo sapiens Limb region 1 protein homolog Proteins 0.000 description 1
- 101001047640 Homo sapiens Linker for activation of T-cells family member 1 Proteins 0.000 description 1
- 101001130192 Homo sapiens Lipid droplet-associated hydrolase Proteins 0.000 description 1
- 101000697929 Homo sapiens Lipid droplet-regulating VLDL assembly factor AUP1 Proteins 0.000 description 1
- 101001122174 Homo sapiens Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial Proteins 0.000 description 1
- 101001065663 Homo sapiens Lipolysis-stimulated lipoprotein receptor Proteins 0.000 description 1
- 101001003687 Homo sapiens Lipoma-preferred partner Proteins 0.000 description 1
- 101001017764 Homo sapiens Lipopolysaccharide-responsive and beige-like anchor protein Proteins 0.000 description 1
- 101000968127 Homo sapiens Lipoyl synthase, mitochondrial Proteins 0.000 description 1
- 101001005211 Homo sapiens Lipoyltransferase 1, mitochondrial Proteins 0.000 description 1
- 101000927946 Homo sapiens LisH domain-containing protein ARMC9 Proteins 0.000 description 1
- 101001036256 Homo sapiens Little elongation complex subunit 1 Proteins 0.000 description 1
- 101000938676 Homo sapiens Liver carboxylesterase 1 Proteins 0.000 description 1
- 101001005245 Homo sapiens Lon protease homolog 2, peroxisomal Proteins 0.000 description 1
- 101000923835 Homo sapiens Low density lipoprotein receptor adapter protein 1 Proteins 0.000 description 1
- 101001051093 Homo sapiens Low-density lipoprotein receptor Proteins 0.000 description 1
- 101001065841 Homo sapiens Low-density lipoprotein receptor class A domain-containing protein 3 Proteins 0.000 description 1
- 101001065832 Homo sapiens Low-density lipoprotein receptor class A domain-containing protein 4 Proteins 0.000 description 1
- 101000984624 Homo sapiens Low-density lipoprotein receptor-related protein 11 Proteins 0.000 description 1
- 101000984626 Homo sapiens Low-density lipoprotein receptor-related protein 12 Proteins 0.000 description 1
- 101001043562 Homo sapiens Low-density lipoprotein receptor-related protein 2 Proteins 0.000 description 1
- 101001043594 Homo sapiens Low-density lipoprotein receptor-related protein 5 Proteins 0.000 description 1
- 101001039207 Homo sapiens Low-density lipoprotein receptor-related protein 8 Proteins 0.000 description 1
- 101001008498 Homo sapiens Luc7-like protein 3 Proteins 0.000 description 1
- 101001023359 Homo sapiens Lung adenoma susceptibility protein 2 Proteins 0.000 description 1
- 101001038505 Homo sapiens Ly6/PLAUR domain-containing protein 1 Proteins 0.000 description 1
- 101000940827 Homo sapiens Ly6/PLAUR domain-containing protein 6B Proteins 0.000 description 1
- 101001018034 Homo sapiens Lymphocyte antigen 75 Proteins 0.000 description 1
- 101001063392 Homo sapiens Lymphocyte function-associated antigen 3 Proteins 0.000 description 1
- 101000972291 Homo sapiens Lymphoid enhancer-binding factor 1 Proteins 0.000 description 1
- 101000899339 Homo sapiens Lymphoid-specific helicase Proteins 0.000 description 1
- 101000871869 Homo sapiens Lys-63-specific deubiquitinase BRCC36 Proteins 0.000 description 1
- 101000958241 Homo sapiens LysM and putative peptidoglycan-binding domain-containing protein 1 Proteins 0.000 description 1
- 101001005464 Homo sapiens LysM and putative peptidoglycan-binding domain-containing protein 4 Proteins 0.000 description 1
- 101000971423 Homo sapiens Lysine-rich nucleolar protein 1 Proteins 0.000 description 1
- 101000613958 Homo sapiens Lysine-specific demethylase 2A Proteins 0.000 description 1
- 101000614013 Homo sapiens Lysine-specific demethylase 2B Proteins 0.000 description 1
- 101000614017 Homo sapiens Lysine-specific demethylase 3A Proteins 0.000 description 1
- 101000614020 Homo sapiens Lysine-specific demethylase 3B Proteins 0.000 description 1
- 101000613625 Homo sapiens Lysine-specific demethylase 4A Proteins 0.000 description 1
- 101000613629 Homo sapiens Lysine-specific demethylase 4B Proteins 0.000 description 1
- 101001088893 Homo sapiens Lysine-specific demethylase 4C Proteins 0.000 description 1
- 101001088895 Homo sapiens Lysine-specific demethylase 4D Proteins 0.000 description 1
- 101001088892 Homo sapiens Lysine-specific demethylase 5A Proteins 0.000 description 1
- 101001088883 Homo sapiens Lysine-specific demethylase 5B Proteins 0.000 description 1
- 101001088887 Homo sapiens Lysine-specific demethylase 5C Proteins 0.000 description 1
- 101001088879 Homo sapiens Lysine-specific demethylase 5D Proteins 0.000 description 1
- 101001025967 Homo sapiens Lysine-specific demethylase 6A Proteins 0.000 description 1
- 101001025945 Homo sapiens Lysine-specific demethylase 7A Proteins 0.000 description 1
- 101001050886 Homo sapiens Lysine-specific histone demethylase 1A Proteins 0.000 description 1
- 101000613960 Homo sapiens Lysine-specific histone demethylase 1B Proteins 0.000 description 1
- 101001047677 Homo sapiens Lysocardiolipin acyltransferase 1 Proteins 0.000 description 1
- 101000966782 Homo sapiens Lysophosphatidic acid receptor 1 Proteins 0.000 description 1
- 101001038001 Homo sapiens Lysophosphatidic acid receptor 2 Proteins 0.000 description 1
- 101001038006 Homo sapiens Lysophosphatidic acid receptor 3 Proteins 0.000 description 1
- 101001113704 Homo sapiens Lysophosphatidylcholine acyltransferase 1 Proteins 0.000 description 1
- 101001113698 Homo sapiens Lysophosphatidylcholine acyltransferase 2 Proteins 0.000 description 1
- 101000956612 Homo sapiens Lysophospholipase-like protein 1 Proteins 0.000 description 1
- 101000957316 Homo sapiens Lysophospholipid acyltransferase 2 Proteins 0.000 description 1
- 101001039669 Homo sapiens Lysophospholipid acyltransferase 5 Proteins 0.000 description 1
- 101001039696 Homo sapiens Lysophospholipid acyltransferase 7 Proteins 0.000 description 1
- 101000940817 Homo sapiens Lysophospholipid acyltransferase LPCAT4 Proteins 0.000 description 1
- 101000997662 Homo sapiens Lysosomal acid glucosylceramidase Proteins 0.000 description 1
- 101001004953 Homo sapiens Lysosomal acid lipase/cholesteryl ester hydrolase Proteins 0.000 description 1
- 101000941071 Homo sapiens Lysosomal cobalamin transport escort protein LMBD1 Proteins 0.000 description 1
- 101001122938 Homo sapiens Lysosomal protective protein Proteins 0.000 description 1
- 101001018064 Homo sapiens Lysosomal-trafficking regulator Proteins 0.000 description 1
- 101000605006 Homo sapiens Lysosome-associated membrane glycoprotein 5 Proteins 0.000 description 1
- 101001043352 Homo sapiens Lysyl oxidase homolog 2 Proteins 0.000 description 1
- 101001043354 Homo sapiens Lysyl oxidase homolog 3 Proteins 0.000 description 1
- 101000624625 Homo sapiens M-phase inducer phosphatase 1 Proteins 0.000 description 1
- 101000624631 Homo sapiens M-phase inducer phosphatase 2 Proteins 0.000 description 1
- 101000624643 Homo sapiens M-phase inducer phosphatase 3 Proteins 0.000 description 1
- 101001115417 Homo sapiens M-phase phosphoprotein 8 Proteins 0.000 description 1
- 101001115414 Homo sapiens M-phase phosphoprotein 9 Proteins 0.000 description 1
- 101000590691 Homo sapiens MAGUK p55 subfamily member 2 Proteins 0.000 description 1
- 101001115423 Homo sapiens MAGUK p55 subfamily member 4 Proteins 0.000 description 1
- 101000616810 Homo sapiens MAL-like protein Proteins 0.000 description 1
- 101001059644 Homo sapiens MAP kinase-activating death domain protein Proteins 0.000 description 1
- 101000573522 Homo sapiens MAP kinase-interacting serine/threonine-protein kinase 1 Proteins 0.000 description 1
- 101001018978 Homo sapiens MAP kinase-interacting serine/threonine-protein kinase 2 Proteins 0.000 description 1
- 101001059427 Homo sapiens MAP/microtubule affinity-regulating kinase 4 Proteins 0.000 description 1
- 101000578859 Homo sapiens MAP6 domain-containing protein 1 Proteins 0.000 description 1
- 101000578949 Homo sapiens MAP7 domain-containing protein 1 Proteins 0.000 description 1
- 101000980566 Homo sapiens MAPK regulated corepressor interacting protein 2 Proteins 0.000 description 1
- 101001014223 Homo sapiens MAPK/MAK/MRK overlapping kinase Proteins 0.000 description 1
- 101100400377 Homo sapiens MARVELD2 gene Proteins 0.000 description 1
- 101000972918 Homo sapiens MAX gene-associated protein Proteins 0.000 description 1
- 101000615509 Homo sapiens MBT domain-containing protein 1 Proteins 0.000 description 1
- 101100290461 Homo sapiens MCUB gene Proteins 0.000 description 1
- 101100076418 Homo sapiens MECOM gene Proteins 0.000 description 1
- 101000991061 Homo sapiens MHC class I polypeptide-related sequence B Proteins 0.000 description 1
- 101001052383 Homo sapiens MICAL-like protein 1 Proteins 0.000 description 1
- 101001052384 Homo sapiens MICAL-like protein 2 Proteins 0.000 description 1
- 101001018939 Homo sapiens MICOS complex subunit MIC10 Proteins 0.000 description 1
- 101001121062 Homo sapiens MICOS complex subunit MIC25 Proteins 0.000 description 1
- 101001121099 Homo sapiens MICOS complex subunit MIC26 Proteins 0.000 description 1
- 101001013046 Homo sapiens MICOS complex subunit MIC27 Proteins 0.000 description 1
- 101000572820 Homo sapiens MICOS complex subunit MIC60 Proteins 0.000 description 1
- 101001012662 Homo sapiens MIF4G domain-containing protein Proteins 0.000 description 1
- 101001011619 Homo sapiens MIT domain-containing protein 1 Proteins 0.000 description 1
- 101001120854 Homo sapiens MKI67 FHA domain-interacting nucleolar phosphoprotein Proteins 0.000 description 1
- 101000952181 Homo sapiens MLX-interacting protein Proteins 0.000 description 1
- 101000977270 Homo sapiens MMS19 nucleotide excision repair protein homolog Proteins 0.000 description 1
- 101000576156 Homo sapiens MOB kinase activator 3A Proteins 0.000 description 1
- 101001051810 Homo sapiens MORC family CW-type zinc finger protein 3 Proteins 0.000 description 1
- 101000987090 Homo sapiens MORF4 family-associated protein 1 Proteins 0.000 description 1
- 101001115722 Homo sapiens MORN repeat-containing protein 3 Proteins 0.000 description 1
- 101000590679 Homo sapiens MPN domain-containing protein Proteins 0.000 description 1
- 101000591230 Homo sapiens MRN complex-interacting protein Proteins 0.000 description 1
- 101001045534 Homo sapiens MTRF1L release factor glutamine methyltransferase Proteins 0.000 description 1
- 101000934372 Homo sapiens Macrosialin Proteins 0.000 description 1
- 101000969827 Homo sapiens Maestro heat-like repeat-containing protein family member 1 Proteins 0.000 description 1
- 101000969829 Homo sapiens Maestro heat-like repeat-containing protein family member 6 Proteins 0.000 description 1
- 101000963523 Homo sapiens Magnesium transporter MRS2 homolog, mitochondrial Proteins 0.000 description 1
- 101000578262 Homo sapiens Magnesium transporter NIPA1 Proteins 0.000 description 1
- 101000578266 Homo sapiens Magnesium transporter NIPA2 Proteins 0.000 description 1
- 101001018720 Homo sapiens Magnesium-dependent phosphatase 1 Proteins 0.000 description 1
- 101000989652 Homo sapiens Major facilitator superfamily domain-containing protein 10 Proteins 0.000 description 1
- 101000989639 Homo sapiens Major facilitator superfamily domain-containing protein 12 Proteins 0.000 description 1
- 101000575450 Homo sapiens Major facilitator superfamily domain-containing protein 6 Proteins 0.000 description 1
- 101000575454 Homo sapiens Major facilitator superfamily domain-containing protein 8 Proteins 0.000 description 1
- 101000575457 Homo sapiens Major facilitator superfamily domain-containing protein 9 Proteins 0.000 description 1
- 101000866855 Homo sapiens Major histocompatibility complex class I-related gene protein Proteins 0.000 description 1
- 101000573901 Homo sapiens Major prion protein Proteins 0.000 description 1
- 101001027796 Homo sapiens Male-specific lethal 1 homolog Proteins 0.000 description 1
- 101001014562 Homo sapiens Male-specific lethal 3 homolog Proteins 0.000 description 1
- 101000956314 Homo sapiens Maleylacetoacetate isomerase Proteins 0.000 description 1
- 101001039753 Homo sapiens Malignant T-cell-amplified sequence 1 Proteins 0.000 description 1
- 101001034310 Homo sapiens Malignant fibrous histiocytoma-amplified sequence 1 Proteins 0.000 description 1
- 101000937642 Homo sapiens Malonyl-CoA-acyl carrier protein transacylase, mitochondrial Proteins 0.000 description 1
- 101001052076 Homo sapiens Maltase-glucoamylase Proteins 0.000 description 1
- 101001012021 Homo sapiens Mammalian ependymin-related protein 1 Proteins 0.000 description 1
- 101001040781 Homo sapiens Mannose-1-phosphate guanyltransferase beta Proteins 0.000 description 1
- 101001051053 Homo sapiens Mannose-6-phosphate isomerase Proteins 0.000 description 1
- 101000576989 Homo sapiens Mannose-P-dolichol utilization defect 1 protein Proteins 0.000 description 1
- 101000615932 Homo sapiens Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB Proteins 0.000 description 1
- 101000615941 Homo sapiens Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC Proteins 0.000 description 1
- 101000980579 Homo sapiens Mapk-regulated corepressor-interacting protein 1 Proteins 0.000 description 1
- 101001057249 Homo sapiens Mastermind-like domain-containing protein 1 Proteins 0.000 description 1
- 101001005664 Homo sapiens Mastermind-like protein 1 Proteins 0.000 description 1
- 101001005668 Homo sapiens Mastermind-like protein 3 Proteins 0.000 description 1
- 101000957559 Homo sapiens Matrin-3 Proteins 0.000 description 1
- 101001011886 Homo sapiens Matrix metalloproteinase-16 Proteins 0.000 description 1
- 101001011896 Homo sapiens Matrix metalloproteinase-19 Proteins 0.000 description 1
- 101000627851 Homo sapiens Matrix metalloproteinase-23 Proteins 0.000 description 1
- 101000636210 Homo sapiens Matrix-remodeling-associated protein 7 Proteins 0.000 description 1
- 101001036585 Homo sapiens Max dimerization protein 3 Proteins 0.000 description 1
- 101001000302 Homo sapiens Max-interacting protein 1 Proteins 0.000 description 1
- 101000573510 Homo sapiens McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin Proteins 0.000 description 1
- 101001120868 Homo sapiens Meckel syndrome type 1 protein Proteins 0.000 description 1
- 101000962131 Homo sapiens Mediator of RNA polymerase II transcription subunit 1 Proteins 0.000 description 1
- 101000614970 Homo sapiens Mediator of RNA polymerase II transcription subunit 11 Proteins 0.000 description 1
- 101000614988 Homo sapiens Mediator of RNA polymerase II transcription subunit 12 Proteins 0.000 description 1
- 101001017597 Homo sapiens Mediator of RNA polymerase II transcription subunit 12-like protein Proteins 0.000 description 1
- 101001055427 Homo sapiens Mediator of RNA polymerase II transcription subunit 13 Proteins 0.000 description 1
- 101001017592 Homo sapiens Mediator of RNA polymerase II transcription subunit 13-like Proteins 0.000 description 1
- 101001019104 Homo sapiens Mediator of RNA polymerase II transcription subunit 14 Proteins 0.000 description 1
- 101001013208 Homo sapiens Mediator of RNA polymerase II transcription subunit 15 Proteins 0.000 description 1
- 101000582813 Homo sapiens Mediator of RNA polymerase II transcription subunit 16 Proteins 0.000 description 1
- 101000575066 Homo sapiens Mediator of RNA polymerase II transcription subunit 17 Proteins 0.000 description 1
- 101000955310 Homo sapiens Mediator of RNA polymerase II transcription subunit 19 Proteins 0.000 description 1
- 101001055444 Homo sapiens Mediator of RNA polymerase II transcription subunit 20 Proteins 0.000 description 1
- 101000582846 Homo sapiens Mediator of RNA polymerase II transcription subunit 22 Proteins 0.000 description 1
- 101001019117 Homo sapiens Mediator of RNA polymerase II transcription subunit 23 Proteins 0.000 description 1
- 101001019109 Homo sapiens Mediator of RNA polymerase II transcription subunit 24 Proteins 0.000 description 1
- 101000574982 Homo sapiens Mediator of RNA polymerase II transcription subunit 25 Proteins 0.000 description 1
- 101000955282 Homo sapiens Mediator of RNA polymerase II transcription subunit 27 Proteins 0.000 description 1
- 101001055346 Homo sapiens Mediator of RNA polymerase II transcription subunit 30 Proteins 0.000 description 1
- 101001033754 Homo sapiens Mediator of RNA polymerase II transcription subunit 31 Proteins 0.000 description 1
- 101001055354 Homo sapiens Mediator of RNA polymerase II transcription subunit 6 Proteins 0.000 description 1
- 101000979998 Homo sapiens Mediator of RNA polymerase II transcription subunit 8 Proteins 0.000 description 1
- 101001033395 Homo sapiens Mediator of RNA polymerase II transcription subunit 9 Proteins 0.000 description 1
- 101001059535 Homo sapiens Megakaryocyte-associated tyrosine-protein kinase Proteins 0.000 description 1
- 101000575011 Homo sapiens Meiosis inhibitor protein 1 Proteins 0.000 description 1
- 101000957743 Homo sapiens Meiosis regulator and mRNA stability factor 1 Proteins 0.000 description 1
- 101000592685 Homo sapiens Meiotic nuclear division protein 1 homolog Proteins 0.000 description 1
- 101000949825 Homo sapiens Meiotic recombination protein DMC1/LIM15 homolog Proteins 0.000 description 1
- 101001012669 Homo sapiens Melanoma inhibitory activity protein 2 Proteins 0.000 description 1
- 101001005717 Homo sapiens Melanoma-associated antigen 12 Proteins 0.000 description 1
- 101001055386 Homo sapiens Melanophilin Proteins 0.000 description 1
- 101000625226 Homo sapiens Melanoregulin Proteins 0.000 description 1
- 101000798109 Homo sapiens Melanotransferrin Proteins 0.000 description 1
- 101000961414 Homo sapiens Membrane cofactor protein Proteins 0.000 description 1
- 101000589436 Homo sapiens Membrane progestin receptor alpha Proteins 0.000 description 1
- 101000589441 Homo sapiens Membrane progestin receptor beta Proteins 0.000 description 1
- 101000589407 Homo sapiens Membrane progestin receptor gamma Proteins 0.000 description 1
- 101000823485 Homo sapiens Membrane protein FAM174A Proteins 0.000 description 1
- 101000573526 Homo sapiens Membrane protein MLC1 Proteins 0.000 description 1
- 101000578932 Homo sapiens Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 Proteins 0.000 description 1
- 101000578936 Homo sapiens Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 Proteins 0.000 description 1
- 101000687968 Homo sapiens Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase Proteins 0.000 description 1
- 101001017332 Homo sapiens Membrane-bound transcription factor site-1 protease Proteins 0.000 description 1
- 101000581514 Homo sapiens Membrane-bound transcription factor site-2 protease Proteins 0.000 description 1
- 101000956335 Homo sapiens Membrane-spanning 4-domains subfamily A member 14 Proteins 0.000 description 1
- 101001014566 Homo sapiens Membrane-spanning 4-domains subfamily A member 3 Proteins 0.000 description 1
- 101000956317 Homo sapiens Membrane-spanning 4-domains subfamily A member 4A Proteins 0.000 description 1
- 101000956320 Homo sapiens Membrane-spanning 4-domains subfamily A member 6A Proteins 0.000 description 1
- 101001014567 Homo sapiens Membrane-spanning 4-domains subfamily A member 7 Proteins 0.000 description 1
- 101000954986 Homo sapiens Merlin Proteins 0.000 description 1
- 101001013023 Homo sapiens Mesoderm induction early response protein 1 Proteins 0.000 description 1
- 101001013017 Homo sapiens Mesoderm induction early response protein 2 Proteins 0.000 description 1
- 101001013009 Homo sapiens Mesoderm induction early response protein 3 Proteins 0.000 description 1
- 101001027295 Homo sapiens Metabotropic glutamate receptor 8 Proteins 0.000 description 1
- 101000945411 Homo sapiens Metal transporter CNNM1 Proteins 0.000 description 1
- 101000993455 Homo sapiens Metal transporter CNNM2 Proteins 0.000 description 1
- 101000993450 Homo sapiens Metal transporter CNNM3 Proteins 0.000 description 1
- 101000967087 Homo sapiens Metal-response element-binding transcription factor 2 Proteins 0.000 description 1
- 101001122313 Homo sapiens Metalloendopeptidase OMA1, mitochondrial Proteins 0.000 description 1
- 101000969780 Homo sapiens Metallophosphoesterase 1 Proteins 0.000 description 1
- 101000969792 Homo sapiens Metallophosphoesterase MPPED2 Proteins 0.000 description 1
- 101001027925 Homo sapiens Metastasis-associated protein MTA1 Proteins 0.000 description 1
- 101000588067 Homo sapiens Metaxin-1 Proteins 0.000 description 1
- 101000623878 Homo sapiens Metaxin-2 Proteins 0.000 description 1
- 101000623873 Homo sapiens Metaxin-3 Proteins 0.000 description 1
- 101000574631 Homo sapiens Meteorin Proteins 0.000 description 1
- 101000985328 Homo sapiens Methenyltetrahydrofolate cyclohydrolase Proteins 0.000 description 1
- 101000985376 Homo sapiens Methenyltetrahydrofolate cyclohydrolase Proteins 0.000 description 1
- 101000587083 Homo sapiens Methenyltetrahydrofolate synthase domain-containing protein Proteins 0.000 description 1
- 101000583944 Homo sapiens Methionine adenosyltransferase 2 subunit beta Proteins 0.000 description 1
- 101000979001 Homo sapiens Methionine aminopeptidase 2 Proteins 0.000 description 1
- 101001013648 Homo sapiens Methionine synthase Proteins 0.000 description 1
- 101001116314 Homo sapiens Methionine synthase reductase Proteins 0.000 description 1
- 101000581507 Homo sapiens Methyl-CpG-binding domain protein 1 Proteins 0.000 description 1
- 101000615495 Homo sapiens Methyl-CpG-binding domain protein 3 Proteins 0.000 description 1
- 101000615498 Homo sapiens Methyl-CpG-binding domain protein 5 Proteins 0.000 description 1
- 101000581533 Homo sapiens Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial Proteins 0.000 description 1
- 101001056160 Homo sapiens Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial Proteins 0.000 description 1
- 101000936433 Homo sapiens Methylglutaconyl-CoA hydratase, mitochondrial Proteins 0.000 description 1
- 101001003205 Homo sapiens Methylosome subunit pICln Proteins 0.000 description 1
- 101001030284 Homo sapiens Methylthioribulose-1-phosphate dehydratase Proteins 0.000 description 1
- 101001000090 Homo sapiens Methyltransferase N6AMT1 Proteins 0.000 description 1
- 101001028136 Homo sapiens Methyltransferase-like 26 Proteins 0.000 description 1
- 101001033173 Homo sapiens Methyltransferase-like protein 22 Proteins 0.000 description 1
- 101000581289 Homo sapiens Microcephalin Proteins 0.000 description 1
- 101000628796 Homo sapiens Microsomal glutathione S-transferase 2 Proteins 0.000 description 1
- 101000628785 Homo sapiens Microsomal glutathione S-transferase 3 Proteins 0.000 description 1
- 101000980562 Homo sapiens Microspherule protein 1 Proteins 0.000 description 1
- 101001013999 Homo sapiens Microtubule cross-linking factor 1 Proteins 0.000 description 1
- 101000928479 Homo sapiens Microtubule organization protein AKNA Proteins 0.000 description 1
- 101000578920 Homo sapiens Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5 Proteins 0.000 description 1
- 101000969087 Homo sapiens Microtubule-associated protein 2 Proteins 0.000 description 1
- 101000616438 Homo sapiens Microtubule-associated protein 4 Proteins 0.000 description 1
- 101000616432 Homo sapiens Microtubule-associated protein 6 Proteins 0.000 description 1
- 101001016777 Homo sapiens Microtubule-associated protein 9 Proteins 0.000 description 1
- 101000891579 Homo sapiens Microtubule-associated protein tau Proteins 0.000 description 1
- 101001052512 Homo sapiens Microtubule-associated proteins 1A/1B light chain 3B Proteins 0.000 description 1
- 101001018259 Homo sapiens Microtubule-associated serine/threonine-protein kinase 1 Proteins 0.000 description 1
- 101001018300 Homo sapiens Microtubule-associated serine/threonine-protein kinase 2 Proteins 0.000 description 1
- 101001018294 Homo sapiens Microtubule-associated serine/threonine-protein kinase 3 Proteins 0.000 description 1
- 101001018298 Homo sapiens Microtubule-associated serine/threonine-protein kinase 4 Proteins 0.000 description 1
- 101000588145 Homo sapiens Microtubule-associated tumor suppressor 1 Proteins 0.000 description 1
- 101000581272 Homo sapiens Midasin Proteins 0.000 description 1
- 101000572892 Homo sapiens Migration and invasion-inhibitory protein Proteins 0.000 description 1
- 101000581428 Homo sapiens Mini-chromosome maintenance complex-binding protein Proteins 0.000 description 1
- 101000988591 Homo sapiens Minor histocompatibility antigen H13 Proteins 0.000 description 1
- 101000628946 Homo sapiens Mirror-image polydactyly gene 1 protein Proteins 0.000 description 1
- 101000578867 Homo sapiens Mis18-binding protein 1 Proteins 0.000 description 1
- 101000573441 Homo sapiens Misshapen-like kinase 1 Proteins 0.000 description 1
- 101000959028 Homo sapiens Mitochondrial 10-formyltetrahydrofolate dehydrogenase Proteins 0.000 description 1
- 101000962648 Homo sapiens Mitochondrial assembly of ribosomal large subunit protein 1 Proteins 0.000 description 1
- 101000961382 Homo sapiens Mitochondrial calcium uniporter regulator 1 Proteins 0.000 description 1
- 101001013994 Homo sapiens Mitochondrial carrier homolog 2 Proteins 0.000 description 1
- 101000697649 Homo sapiens Mitochondrial chaperone BCS1 Proteins 0.000 description 1
- 101000877521 Homo sapiens Mitochondrial enolase superfamily member 1 Proteins 0.000 description 1
- 101000827338 Homo sapiens Mitochondrial fission 1 protein Proteins 0.000 description 1
- 101000574253 Homo sapiens Mitochondrial fission factor Proteins 0.000 description 1
- 101000623675 Homo sapiens Mitochondrial fission process protein 1 Proteins 0.000 description 1
- 101000623673 Homo sapiens Mitochondrial fission regulator 1 Proteins 0.000 description 1
- 101000623681 Homo sapiens Mitochondrial fission regulator 2 Proteins 0.000 description 1
- 101000574302 Homo sapiens Mitochondrial genome maintenance exonuclease 1 Proteins 0.000 description 1
- 101000669640 Homo sapiens Mitochondrial import inner membrane translocase subunit TIM14 Proteins 0.000 description 1
- 101000831175 Homo sapiens Mitochondrial import inner membrane translocase subunit TIM16 Proteins 0.000 description 1
- 101000975170 Homo sapiens Mitochondrial inner membrane protease ATP23 homolog Proteins 0.000 description 1
- 101000960590 Homo sapiens Mitochondrial inner membrane protease subunit 1 Proteins 0.000 description 1
- 101000960626 Homo sapiens Mitochondrial inner membrane protease subunit 2 Proteins 0.000 description 1
- 101000628925 Homo sapiens Mitochondrial intermediate peptidase Proteins 0.000 description 1
- 101001013832 Homo sapiens Mitochondrial peptide methionine sulfoxide reductase Proteins 0.000 description 1
- 101000608551 Homo sapiens Mitochondrial proton/calcium exchanger protein Proteins 0.000 description 1
- 101001014546 Homo sapiens Mitochondrial ribonuclease P catalytic subunit Proteins 0.000 description 1
- 101001132833 Homo sapiens Mitochondrial ribosome-associated GTPase 2 Proteins 0.000 description 1
- 101000882884 Homo sapiens Mitochondrial tRNA methylthiotransferase CDK5RAP1 Proteins 0.000 description 1
- 101001133767 Homo sapiens Mitochondrial transcription rescue factor 1 Proteins 0.000 description 1
- 101000577080 Homo sapiens Mitochondrial-processing peptidase subunit alpha Proteins 0.000 description 1
- 101001019367 Homo sapiens Mitofusin-1 Proteins 0.000 description 1
- 101001018717 Homo sapiens Mitofusin-2 Proteins 0.000 description 1
- 101001052493 Homo sapiens Mitogen-activated protein kinase 1 Proteins 0.000 description 1
- 101000628949 Homo sapiens Mitogen-activated protein kinase 10 Proteins 0.000 description 1
- 101000628954 Homo sapiens Mitogen-activated protein kinase 12 Proteins 0.000 description 1
- 101000628968 Homo sapiens Mitogen-activated protein kinase 13 Proteins 0.000 description 1
- 101001052490 Homo sapiens Mitogen-activated protein kinase 3 Proteins 0.000 description 1
- 101000950710 Homo sapiens Mitogen-activated protein kinase 6 Proteins 0.000 description 1
- 101000950687 Homo sapiens Mitogen-activated protein kinase 7 Proteins 0.000 description 1
- 101000950695 Homo sapiens Mitogen-activated protein kinase 8 Proteins 0.000 description 1
- 101000950669 Homo sapiens Mitogen-activated protein kinase 9 Proteins 0.000 description 1
- 101000958409 Homo sapiens Mitogen-activated protein kinase kinase kinase 10 Proteins 0.000 description 1
- 101001005552 Homo sapiens Mitogen-activated protein kinase kinase kinase 15 Proteins 0.000 description 1
- 101001018141 Homo sapiens Mitogen-activated protein kinase kinase kinase 2 Proteins 0.000 description 1
- 101001018157 Homo sapiens Mitogen-activated protein kinase kinase kinase 20 Proteins 0.000 description 1
- 101001018149 Homo sapiens Mitogen-activated protein kinase kinase kinase 21 Proteins 0.000 description 1
- 101001018145 Homo sapiens Mitogen-activated protein kinase kinase kinase 3 Proteins 0.000 description 1
- 101001018147 Homo sapiens Mitogen-activated protein kinase kinase kinase 4 Proteins 0.000 description 1
- 101001018196 Homo sapiens Mitogen-activated protein kinase kinase kinase 5 Proteins 0.000 description 1
- 101001055092 Homo sapiens Mitogen-activated protein kinase kinase kinase 7 Proteins 0.000 description 1
- 101001055091 Homo sapiens Mitogen-activated protein kinase kinase kinase 8 Proteins 0.000 description 1
- 101001055085 Homo sapiens Mitogen-activated protein kinase kinase kinase 9 Proteins 0.000 description 1
- 101001059991 Homo sapiens Mitogen-activated protein kinase kinase kinase kinase 1 Proteins 0.000 description 1
- 101001059990 Homo sapiens Mitogen-activated protein kinase kinase kinase kinase 2 Proteins 0.000 description 1
- 101001059989 Homo sapiens Mitogen-activated protein kinase kinase kinase kinase 3 Proteins 0.000 description 1
- 101001059984 Homo sapiens Mitogen-activated protein kinase kinase kinase kinase 4 Proteins 0.000 description 1
- 101001059982 Homo sapiens Mitogen-activated protein kinase kinase kinase kinase 5 Proteins 0.000 description 1
- 101001036653 Homo sapiens Mitogen-activated protein kinase-binding protein 1 Proteins 0.000 description 1
- 101000973601 Homo sapiens Mitoguardin 1 Proteins 0.000 description 1
- 101000896657 Homo sapiens Mitotic checkpoint serine/threonine-protein kinase BUB1 Proteins 0.000 description 1
- 101000957106 Homo sapiens Mitotic spindle assembly checkpoint protein MAD1 Proteins 0.000 description 1
- 101000963903 Homo sapiens Modulator of smoothened protein Proteins 0.000 description 1
- 101000987144 Homo sapiens Molybdenum cofactor sulfurase Proteins 0.000 description 1
- 101001074975 Homo sapiens Molybdopterin molybdenumtransferase Proteins 0.000 description 1
- 101000591936 Homo sapiens Molybdopterin synthase catalytic subunit Proteins 0.000 description 1
- 101000963255 Homo sapiens Molybdopterin synthase sulfur carrier subunit Proteins 0.000 description 1
- 101000613610 Homo sapiens Monocyte to macrophage differentiation factor Proteins 0.000 description 1
- 101000969546 Homo sapiens Mortality factor 4-like protein 1 Proteins 0.000 description 1
- 101000992748 Homo sapiens Mortality factor 4-like protein 2 Proteins 0.000 description 1
- 101000624982 Homo sapiens Motile sperm domain-containing protein 1 Proteins 0.000 description 1
- 101000623712 Homo sapiens Motile sperm domain-containing protein 2 Proteins 0.000 description 1
- 101000623713 Homo sapiens Motile sperm domain-containing protein 3 Proteins 0.000 description 1
- 101001039757 Homo sapiens Multiple C2 and transmembrane domain-containing protein 1 Proteins 0.000 description 1
- 101001039762 Homo sapiens Multiple C2 and transmembrane domain-containing protein 2 Proteins 0.000 description 1
- 101000969697 Homo sapiens Multiple PDZ domain protein Proteins 0.000 description 1
- 101000955255 Homo sapiens Multiple epidermal growth factor-like domains protein 11 Proteins 0.000 description 1
- 101000955263 Homo sapiens Multiple epidermal growth factor-like domains protein 6 Proteins 0.000 description 1
- 101000955249 Homo sapiens Multiple epidermal growth factor-like domains protein 8 Proteins 0.000 description 1
- 101000955254 Homo sapiens Multiple epidermal growth factor-like domains protein 9 Proteins 0.000 description 1
- 101000957346 Homo sapiens Multivesicular body subunit 12A Proteins 0.000 description 1
- 101000957340 Homo sapiens Multivesicular body subunit 12B Proteins 0.000 description 1
- 101000928929 Homo sapiens Muscarinic acetylcholine receptor M2 Proteins 0.000 description 1
- 101000583839 Homo sapiens Muscleblind-like protein 1 Proteins 0.000 description 1
- 101000583841 Homo sapiens Muscleblind-like protein 2 Proteins 0.000 description 1
- 101000957333 Homo sapiens Muscleblind-like protein 3 Proteins 0.000 description 1
- 101000573513 Homo sapiens Muskelin Proteins 0.000 description 1
- 101000593398 Homo sapiens Myb-related protein A Proteins 0.000 description 1
- 101000593405 Homo sapiens Myb-related protein B Proteins 0.000 description 1
- 101000624869 Homo sapiens Myb/SANT-like DNA-binding domain-containing protein 2 Proteins 0.000 description 1
- 101001013759 Homo sapiens Myb/SANT-like DNA-binding domain-containing protein 4 Proteins 0.000 description 1
- 101001128429 Homo sapiens Myelin expression factor 2 Proteins 0.000 description 1
- 101000969763 Homo sapiens Myelin protein zero-like protein 1 Proteins 0.000 description 1
- 101000969766 Homo sapiens Myelin protein zero-like protein 3 Proteins 0.000 description 1
- 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 description 1
- 101001013158 Homo sapiens Myeloid leukemia factor 1 Proteins 0.000 description 1
- 101001018553 Homo sapiens MyoD family inhibitor Proteins 0.000 description 1
- 101001128505 Homo sapiens Myocardial zonula adherens protein Proteins 0.000 description 1
- 101000591286 Homo sapiens Myocardin-related transcription factor A Proteins 0.000 description 1
- 101000591295 Homo sapiens Myocardin-related transcription factor B Proteins 0.000 description 1
- 101001023037 Homo sapiens Myoferlin Proteins 0.000 description 1
- 101000585775 Homo sapiens Myoneurin Proteins 0.000 description 1
- 101000635885 Homo sapiens Myosin light chain 1/3, skeletal muscle isoform Proteins 0.000 description 1
- 101001128464 Homo sapiens Myosin light chain 6B Proteins 0.000 description 1
- 101001022780 Homo sapiens Myosin light chain kinase, smooth muscle Proteins 0.000 description 1
- 101001028827 Homo sapiens Myosin phosphatase Rho-interacting protein Proteins 0.000 description 1
- 101001000109 Homo sapiens Myosin-10 Proteins 0.000 description 1
- 101000588964 Homo sapiens Myosin-14 Proteins 0.000 description 1
- 101000958744 Homo sapiens Myosin-7B Proteins 0.000 description 1
- 101001132874 Homo sapiens Myotubularin Proteins 0.000 description 1
- 101000969334 Homo sapiens Myotubularin-related protein 1 Proteins 0.000 description 1
- 101001116519 Homo sapiens Myotubularin-related protein 10 Proteins 0.000 description 1
- 101001116518 Homo sapiens Myotubularin-related protein 12 Proteins 0.000 description 1
- 101000594120 Homo sapiens Myotubularin-related protein 14 Proteins 0.000 description 1
- 101000966872 Homo sapiens Myotubularin-related protein 2 Proteins 0.000 description 1
- 101000966881 Homo sapiens Myotubularin-related protein 3 Proteins 0.000 description 1
- 101000966829 Homo sapiens Myotubularin-related protein 6 Proteins 0.000 description 1
- 101000966843 Homo sapiens Myotubularin-related protein 7 Proteins 0.000 description 1
- 101001116608 Homo sapiens Myotubularin-related protein 8 Proteins 0.000 description 1
- 101001116601 Homo sapiens Myotubularin-related protein 9 Proteins 0.000 description 1
- 101001012535 Homo sapiens N(6)-adenine-specific methyltransferase METTL4 Proteins 0.000 description 1
- 101000873851 Homo sapiens N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 Proteins 0.000 description 1
- 101001024511 Homo sapiens N-acetyl-D-glucosamine kinase Proteins 0.000 description 1
- 101000766148 Homo sapiens N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 Proteins 0.000 description 1
- 101001128148 Homo sapiens N-acetylated-alpha-linked acidic dipeptidase 2 Proteins 0.000 description 1
- 101001024872 Homo sapiens N-acetylgalactosamine kinase Proteins 0.000 description 1
- 101001066305 Homo sapiens N-acetylgalactosamine-6-sulfatase Proteins 0.000 description 1
- 101000886220 Homo sapiens N-acetylgalactosaminyltransferase 7 Proteins 0.000 description 1
- 101000962156 Homo sapiens N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase Proteins 0.000 description 1
- 101001072477 Homo sapiens N-acetylglucosamine-1-phosphotransferase subunit gamma Proteins 0.000 description 1
- 101000588448 Homo sapiens N-acetylglucosamine-6-phosphate deacetylase Proteins 0.000 description 1
- 101000829992 Homo sapiens N-acetylglucosamine-6-sulfatase Proteins 0.000 description 1
- 101000829958 Homo sapiens N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase Proteins 0.000 description 1
- 101000997654 Homo sapiens N-acetylmannosamine kinase Proteins 0.000 description 1
- 101000761218 Homo sapiens N-acetylneuraminate 9-O-acetyltransferase Proteins 0.000 description 1
- 101001109518 Homo sapiens N-acetylneuraminate lyase Proteins 0.000 description 1
- 101000938702 Homo sapiens N-acetyltransferase ESCO1 Proteins 0.000 description 1
- 101000938705 Homo sapiens N-acetyltransferase ESCO2 Proteins 0.000 description 1
- 101000958771 Homo sapiens N-acylethanolamine-hydrolyzing acid amidase Proteins 0.000 description 1
- 101000982000 Homo sapiens N-alpha-acetyltransferase 15, NatA auxiliary subunit Proteins 0.000 description 1
- 101000981997 Homo sapiens N-alpha-acetyltransferase 16, NatA auxiliary subunit Proteins 0.000 description 1
- 101001128489 Homo sapiens N-alpha-acetyltransferase 25, NatB auxiliary subunit Proteins 0.000 description 1
- 101001128274 Homo sapiens N-alpha-acetyltransferase 35, NatC auxiliary subunit Proteins 0.000 description 1
- 101000636581 Homo sapiens N-alpha-acetyltransferase 40 Proteins 0.000 description 1
- 101000636582 Homo sapiens N-alpha-acetyltransferase 50 Proteins 0.000 description 1
- 101000958778 Homo sapiens N-alpha-acetyltransferase 60 Proteins 0.000 description 1
- 101000958781 Homo sapiens N-alpha-acetyltransferase 80 Proteins 0.000 description 1
- 101000906927 Homo sapiens N-chimaerin Proteins 0.000 description 1
- 101000983292 Homo sapiens N-fatty-acyl-amino acid synthase/hydrolase PM20D1 Proteins 0.000 description 1
- 101001008816 Homo sapiens N-lysine methyltransferase KMT5A Proteins 0.000 description 1
- 101000979223 Homo sapiens N-terminal EF-hand calcium-binding protein 3 Proteins 0.000 description 1
- 101000970374 Homo sapiens N-terminal Xaa-Pro-Lys N-methyltransferase 1 Proteins 0.000 description 1
- 101001013582 Homo sapiens N6-adenosine-methyltransferase non-catalytic subunit Proteins 0.000 description 1
- 101001128135 Homo sapiens NACHT, LRR and PYD domains-containing protein 4 Proteins 0.000 description 1
- 101001109455 Homo sapiens NACHT, LRR and PYD domains-containing protein 6 Proteins 0.000 description 1
- 101001112714 Homo sapiens NAD kinase Proteins 0.000 description 1
- 101000589671 Homo sapiens NAD kinase 2, mitochondrial Proteins 0.000 description 1
- 101000973778 Homo sapiens NAD(P)H dehydrogenase [quinone] 1 Proteins 0.000 description 1
- 101000632037 Homo sapiens NAD(P)H-hydrate epimerase Proteins 0.000 description 1
- 101001016790 Homo sapiens NAD-dependent malic enzyme, mitochondrial Proteins 0.000 description 1
- 101000588491 Homo sapiens NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 Proteins 0.000 description 1
- 101001023542 Homo sapiens NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 2 Proteins 0.000 description 1
- 101000973447 Homo sapiens NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 8 Proteins 0.000 description 1
- 101001023507 Homo sapiens NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial Proteins 0.000 description 1
- 101000973461 Homo sapiens NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12 Proteins 0.000 description 1
- 101001111238 Homo sapiens NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3 Proteins 0.000 description 1
- 101000970029 Homo sapiens NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4-like 2 Proteins 0.000 description 1
- 101000573234 Homo sapiens NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8 Proteins 0.000 description 1
- 101000601625 Homo sapiens NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial Proteins 0.000 description 1
- 101000601568 Homo sapiens NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6 Proteins 0.000 description 1
- 101001111250 Homo sapiens NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial Proteins 0.000 description 1
- 101001023560 Homo sapiens NADH dehydrogenase [ubiquinone] 1 subunit C2, isoform 2 Proteins 0.000 description 1
- 101001111195 Homo sapiens NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial Proteins 0.000 description 1
- 101001111187 Homo sapiens NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial Proteins 0.000 description 1
- 101001023640 Homo sapiens NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial Proteins 0.000 description 1
- 101000573300 Homo sapiens NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial Proteins 0.000 description 1
- 101000636705 Homo sapiens NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial Proteins 0.000 description 1
- 101000638289 Homo sapiens NADH-cytochrome b5 reductase 1 Proteins 0.000 description 1
- 101000998596 Homo sapiens NADH-cytochrome b5 reductase 2 Proteins 0.000 description 1
- 101000962076 Homo sapiens NADH-cytochrome b5 reductase-like Proteins 0.000 description 1
- 101000973439 Homo sapiens NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial Proteins 0.000 description 1
- 101000636654 Homo sapiens NADPH-dependent diflavin oxidoreductase 1 Proteins 0.000 description 1
- 101000928259 Homo sapiens NADPH:adrenodoxin oxidoreductase, mitochondrial Proteins 0.000 description 1
- 101001128142 Homo sapiens NALCN channel auxiliary factor 1 Proteins 0.000 description 1
- 101001128139 Homo sapiens NALCN channel auxiliary factor 2 Proteins 0.000 description 1
- 101000962088 Homo sapiens NBAS subunit of NRZ tethering complex Proteins 0.000 description 1
- 101000651236 Homo sapiens NCK-interacting protein with SH3 domain Proteins 0.000 description 1
- 101000979357 Homo sapiens NEDD4 family-interacting protein 2 Proteins 0.000 description 1
- 101001030447 Homo sapiens NEDD4-binding protein 2-like 1 Proteins 0.000 description 1
- 101001030451 Homo sapiens NEDD4-binding protein 2-like 2 Proteins 0.000 description 1
- 101000970017 Homo sapiens NEDD8 ultimate buster 1 Proteins 0.000 description 1
- 101000973618 Homo sapiens NF-kappa-B essential modulator Proteins 0.000 description 1
- 101000997257 Homo sapiens NF-kappa-B inhibitor-interacting Ras-like protein 1 Proteins 0.000 description 1
- 101000997252 Homo sapiens NF-kappa-B inhibitor-interacting Ras-like protein 2 Proteins 0.000 description 1
- 101001111288 Homo sapiens NFU1 iron-sulfur cluster scaffold homolog, mitochondrial Proteins 0.000 description 1
- 101000583053 Homo sapiens NGFI-A-binding protein 1 Proteins 0.000 description 1
- 101000583057 Homo sapiens NGFI-A-binding protein 2 Proteins 0.000 description 1
- 101000601127 Homo sapiens NHL repeat-containing protein 3 Proteins 0.000 description 1
- 101000637181 Homo sapiens NHS-like protein 1 Proteins 0.000 description 1
- 101000601056 Homo sapiens NIF3-like protein 1 Proteins 0.000 description 1
- 101100026468 Homo sapiens NIPSNAP1 gene Proteins 0.000 description 1
- 101100026471 Homo sapiens NIPSNAP2 gene Proteins 0.000 description 1
- 101000979578 Homo sapiens NK-tumor recognition protein Proteins 0.000 description 1
- 101001109501 Homo sapiens NKG2-D type II integral membrane protein Proteins 0.000 description 1
- 101000979575 Homo sapiens NLR family CARD domain-containing protein 3 Proteins 0.000 description 1
- 101001109452 Homo sapiens NLR family member X1 Proteins 0.000 description 1
- 101000979909 Homo sapiens NMDA receptor synaptonuclear signaling and neuronal migration factor Proteins 0.000 description 1
- 101001124388 Homo sapiens NPC intracellular cholesterol transporter 1 Proteins 0.000 description 1
- 101001124062 Homo sapiens NSFL1 cofactor p47 Proteins 0.000 description 1
- 101000721717 Homo sapiens NTF2-related export protein 2 Proteins 0.000 description 1
- 101000594775 Homo sapiens NXPE family member 3 Proteins 0.000 description 1
- 101001108356 Homo sapiens Nardilysin Proteins 0.000 description 1
- 101000971513 Homo sapiens Natural killer cells antigen CD94 Proteins 0.000 description 1
- 101001024714 Homo sapiens Nck-associated protein 1 Proteins 0.000 description 1
- 101001024703 Homo sapiens Nck-associated protein 5 Proteins 0.000 description 1
- 101001024710 Homo sapiens Nck-associated protein 5-like Proteins 0.000 description 1
- 101000995194 Homo sapiens Nebulette Proteins 0.000 description 1
- 101000979297 Homo sapiens Negative elongation factor A Proteins 0.000 description 1
- 101000979293 Homo sapiens Negative elongation factor C/D Proteins 0.000 description 1
- 101000962085 Homo sapiens Negative regulator of P-body association Proteins 0.000 description 1
- 101000636823 Homo sapiens Neogenin Proteins 0.000 description 1
- 101000978743 Homo sapiens Nephrocystin-1 Proteins 0.000 description 1
- 101000978734 Homo sapiens Nephrocystin-3 Proteins 0.000 description 1
- 101000978705 Homo sapiens Nephrocystin-4 Proteins 0.000 description 1
- 101000995832 Homo sapiens Nephronectin Proteins 0.000 description 1
- 101000604463 Homo sapiens Netrin-G1 Proteins 0.000 description 1
- 101000604469 Homo sapiens Netrin-G2 Proteins 0.000 description 1
- 101000636811 Homo sapiens Neudesin Proteins 0.000 description 1
- 101000973264 Homo sapiens Neuferricin Proteins 0.000 description 1
- 101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 description 1
- 101000979122 Homo sapiens Neurensin-2 Proteins 0.000 description 1
- 101000969961 Homo sapiens Neurexin-3 Proteins 0.000 description 1
- 101000969963 Homo sapiens Neurexin-3-beta Proteins 0.000 description 1
- 101000577555 Homo sapiens Neuritin Proteins 0.000 description 1
- 101000962041 Homo sapiens Neurobeachin Proteins 0.000 description 1
- 101000962058 Homo sapiens Neurobeachin-like protein 1 Proteins 0.000 description 1
- 101000962052 Homo sapiens Neurobeachin-like protein 2 Proteins 0.000 description 1
- 101000775053 Homo sapiens Neuroblast differentiation-associated protein AHNAK Proteins 0.000 description 1
- 101001024607 Homo sapiens Neuroblastoma breakpoint family member 1 Proteins 0.000 description 1
- 101001024606 Homo sapiens Neuroblastoma breakpoint family member 10 Proteins 0.000 description 1
- 101001024599 Homo sapiens Neuroblastoma breakpoint family member 11 Proteins 0.000 description 1
- 101001024600 Homo sapiens Neuroblastoma breakpoint family member 12 Proteins 0.000 description 1
- 101001024597 Homo sapiens Neuroblastoma breakpoint family member 14 Proteins 0.000 description 1
- 101001024598 Homo sapiens Neuroblastoma breakpoint family member 15 Proteins 0.000 description 1
- 101001024603 Homo sapiens Neuroblastoma breakpoint family member 19 Proteins 0.000 description 1
- 101001024604 Homo sapiens Neuroblastoma breakpoint family member 20 Proteins 0.000 description 1
- 101001024601 Homo sapiens Neuroblastoma breakpoint family member 26 Proteins 0.000 description 1
- 101001024608 Homo sapiens Neuroblastoma breakpoint family member 3 Proteins 0.000 description 1
- 101001024616 Homo sapiens Neuroblastoma breakpoint family member 9 Proteins 0.000 description 1
- 101000602237 Homo sapiens Neuroblastoma suppressor of tumorigenicity 1 Proteins 0.000 description 1
- 101000581961 Homo sapiens Neurocalcin-delta Proteins 0.000 description 1
- 101001014610 Homo sapiens Neuroendocrine secretory protein 55 Proteins 0.000 description 1
- 101000927793 Homo sapiens Neuroepithelial cell-transforming gene 1 protein Proteins 0.000 description 1
- 101001023793 Homo sapiens Neurofascin Proteins 0.000 description 1
- 101000637326 Homo sapiens Neuroguidin Proteins 0.000 description 1
- 101000603239 Homo sapiens Neuroligin-1 Proteins 0.000 description 1
- 101000603173 Homo sapiens Neuroligin-2 Proteins 0.000 description 1
- 101000979259 Homo sapiens Neurolysin, mitochondrial Proteins 0.000 description 1
- 101000582002 Homo sapiens Neuron navigator 2 Proteins 0.000 description 1
- 101000582005 Homo sapiens Neuron navigator 3 Proteins 0.000 description 1
- 101000634538 Homo sapiens Neuronal PAS domain-containing protein 1 Proteins 0.000 description 1
- 101000634537 Homo sapiens Neuronal PAS domain-containing protein 2 Proteins 0.000 description 1
- 101000745163 Homo sapiens Neuronal acetylcholine receptor subunit alpha-3 Proteins 0.000 description 1
- 101000745175 Homo sapiens Neuronal acetylcholine receptor subunit alpha-5 Proteins 0.000 description 1
- 101000678747 Homo sapiens Neuronal acetylcholine receptor subunit beta-4 Proteins 0.000 description 1
- 101000637977 Homo sapiens Neuronal calcium sensor 1 Proteins 0.000 description 1
- 101001108364 Homo sapiens Neuronal cell adhesion molecule Proteins 0.000 description 1
- 101000577541 Homo sapiens Neuronal regeneration-related protein Proteins 0.000 description 1
- 101000596404 Homo sapiens Neuronal vesicle trafficking-associated protein 1 Proteins 0.000 description 1
- 101000634561 Homo sapiens Neuropeptide FF receptor 2 Proteins 0.000 description 1
- 101001023729 Homo sapiens Neuropilin and tolloid-like protein 2 Proteins 0.000 description 1
- 101000596892 Homo sapiens Neurotrimin Proteins 0.000 description 1
- 101001072765 Homo sapiens Neutral alpha-glucosidase AB Proteins 0.000 description 1
- 101001025772 Homo sapiens Neutral alpha-glucosidase C Proteins 0.000 description 1
- 101000637249 Homo sapiens Nexilin Proteins 0.000 description 1
- 101001024605 Homo sapiens Next to BRCA1 gene 1 protein Proteins 0.000 description 1
- 101000981336 Homo sapiens Nibrin Proteins 0.000 description 1
- 101000578062 Homo sapiens Nicastrin Proteins 0.000 description 1
- 101000578083 Homo sapiens Nicolin-1 Proteins 0.000 description 1
- 101000633302 Homo sapiens Nicotinamide riboside kinase 1 Proteins 0.000 description 1
- 101000996052 Homo sapiens Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 Proteins 0.000 description 1
- 101000601048 Homo sapiens Nidogen-2 Proteins 0.000 description 1
- 101000979497 Homo sapiens Ninein Proteins 0.000 description 1
- 101001024120 Homo sapiens Nipped-B-like protein Proteins 0.000 description 1
- 101001109426 Homo sapiens Nitric oxide-associated protein 1 Proteins 0.000 description 1
- 101000578295 Homo sapiens NmrA-like family domain-containing protein 1 Proteins 0.000 description 1
- 101000604223 Homo sapiens Nocturnin Proteins 0.000 description 1
- 101000578353 Homo sapiens Nodal modulator 2 Proteins 0.000 description 1
- 101000978541 Homo sapiens Noelin-2 Proteins 0.000 description 1
- 101000866795 Homo sapiens Non-histone chromosomal protein HMG-14 Proteins 0.000 description 1
- 101001010832 Homo sapiens Non-homologous end joining factor IFFO1 Proteins 0.000 description 1
- 101000578059 Homo sapiens Non-homologous end-joining factor 1 Proteins 0.000 description 1
- 101000859679 Homo sapiens Non-lysosomal glucosylceramidase Proteins 0.000 description 1
- 101000577645 Homo sapiens Non-structural maintenance of chromosomes element 1 homolog Proteins 0.000 description 1
- 101001124034 Homo sapiens Non-structural maintenance of chromosomes element 4 homolog A Proteins 0.000 description 1
- 101000591187 Homo sapiens Notch homolog 2 N-terminal-like protein A Proteins 0.000 description 1
- 101001024286 Homo sapiens Notchless protein homolog 1 Proteins 0.000 description 1
- 101000589497 Homo sapiens Nuclear cap-binding protein subunit 3 Proteins 0.000 description 1
- 101000979687 Homo sapiens Nuclear distribution protein nudE homolog 1 Proteins 0.000 description 1
- 101000979681 Homo sapiens Nuclear distribution protein nudE-like 1 Proteins 0.000 description 1
- 101000973615 Homo sapiens Nuclear envelope integral membrane protein 1 Proteins 0.000 description 1
- 101000995353 Homo sapiens Nuclear envelope phosphatase-regulatory subunit 1 Proteins 0.000 description 1
- 101001109633 Homo sapiens Nuclear exosome regulator NRDE2 Proteins 0.000 description 1
- 101000973211 Homo sapiens Nuclear factor 1 B-type Proteins 0.000 description 1
- 101000973200 Homo sapiens Nuclear factor 1 C-type Proteins 0.000 description 1
- 101000979347 Homo sapiens Nuclear factor 1 X-type Proteins 0.000 description 1
- 101000979342 Homo sapiens Nuclear factor NF-kappa-B p105 subunit Proteins 0.000 description 1
- 101001023768 Homo sapiens Nuclear factor related to kappa-B-binding protein Proteins 0.000 description 1
- 101000590492 Homo sapiens Nuclear fragile X mental retardation-interacting protein 1 Proteins 0.000 description 1
- 101000590493 Homo sapiens Nuclear fragile X mental retardation-interacting protein 2 Proteins 0.000 description 1
- 101000598160 Homo sapiens Nuclear mitotic apparatus protein 1 Proteins 0.000 description 1
- 101000896414 Homo sapiens Nuclear nucleic acid-binding protein C1D Proteins 0.000 description 1
- 101001107586 Homo sapiens Nuclear pore complex protein Nup107 Proteins 0.000 description 1
- 101000970315 Homo sapiens Nuclear pore complex protein Nup133 Proteins 0.000 description 1
- 101000970403 Homo sapiens Nuclear pore complex protein Nup153 Proteins 0.000 description 1
- 101001108932 Homo sapiens Nuclear pore complex protein Nup155 Proteins 0.000 description 1
- 101000996563 Homo sapiens Nuclear pore complex protein Nup214 Proteins 0.000 description 1
- 101001121654 Homo sapiens Nuclear pore complex protein Nup50 Proteins 0.000 description 1
- 101001007862 Homo sapiens Nuclear pore complex protein Nup85 Proteins 0.000 description 1
- 101001007901 Homo sapiens Nuclear pore complex protein Nup88 Proteins 0.000 description 1
- 101001007909 Homo sapiens Nuclear pore complex protein Nup93 Proteins 0.000 description 1
- 101000603420 Homo sapiens Nuclear pore complex-interacting protein family member A1 Proteins 0.000 description 1
- 101000603429 Homo sapiens Nuclear pore complex-interacting protein family member B5 Proteins 0.000 description 1
- 101000961846 Homo sapiens Nuclear prelamin A recognition factor Proteins 0.000 description 1
- 101000615538 Homo sapiens Nuclear protein MDM1 Proteins 0.000 description 1
- 101000604027 Homo sapiens Nuclear protein localization protein 4 homolog Proteins 0.000 description 1
- 101000602926 Homo sapiens Nuclear receptor coactivator 1 Proteins 0.000 description 1
- 101000602930 Homo sapiens Nuclear receptor coactivator 2 Proteins 0.000 description 1
- 101000974349 Homo sapiens Nuclear receptor coactivator 6 Proteins 0.000 description 1
- 101000974345 Homo sapiens Nuclear receptor coactivator 7 Proteins 0.000 description 1
- 101000974340 Homo sapiens Nuclear receptor corepressor 1 Proteins 0.000 description 1
- 101000582254 Homo sapiens Nuclear receptor corepressor 2 Proteins 0.000 description 1
- 101001109700 Homo sapiens Nuclear receptor subfamily 4 group A member 1 Proteins 0.000 description 1
- 101001109682 Homo sapiens Nuclear receptor subfamily 6 group A member 1 Proteins 0.000 description 1
- 101000577335 Homo sapiens Nuclear receptor-binding factor 2 Proteins 0.000 description 1
- 101000577547 Homo sapiens Nuclear respiratory factor 1 Proteins 0.000 description 1
- 101000634091 Homo sapiens Nuclear speckle splicing regulatory protein 1 Proteins 0.000 description 1
- 101000973405 Homo sapiens Nuclear transcription factor Y subunit beta Proteins 0.000 description 1
- 101000588345 Homo sapiens Nuclear transcription factor Y subunit gamma Proteins 0.000 description 1
- 101001124017 Homo sapiens Nuclear transport factor 2 Proteins 0.000 description 1
- 101000991533 Homo sapiens Nuclear valosin-containing protein-like Proteins 0.000 description 1
- 101000813497 Homo sapiens Nuclease EXOG, mitochondrial Proteins 0.000 description 1
- 101000836620 Homo sapiens Nucleic acid dioxygenase ALKBH1 Proteins 0.000 description 1
- 101001008429 Homo sapiens Nucleobindin-2 Proteins 0.000 description 1
- 101000995979 Homo sapiens Nucleolar GTP-binding protein 2 Proteins 0.000 description 1
- 101001109620 Homo sapiens Nucleolar and coiled-body phosphoprotein 1 Proteins 0.000 description 1
- 101000634679 Homo sapiens Nucleolar complex protein 2 homolog Proteins 0.000 description 1
- 101000578361 Homo sapiens Nucleolar complex protein 4 homolog Proteins 0.000 description 1
- 101000973957 Homo sapiens Nucleolar protein 12 Proteins 0.000 description 1
- 101000634768 Homo sapiens Nucleolar protein 16 Proteins 0.000 description 1
- 101000973960 Homo sapiens Nucleolar protein 3 Proteins 0.000 description 1
- 101001038562 Homo sapiens Nucleolar protein 4 Proteins 0.000 description 1
- 101001038567 Homo sapiens Nucleolar protein 4-like Proteins 0.000 description 1
- 101000995932 Homo sapiens Nucleolar protein 58 Proteins 0.000 description 1
- 101001109602 Homo sapiens Nucleolar protein 8 Proteins 0.000 description 1
- 101001123843 Homo sapiens Nucleolus and neural progenitor protein Proteins 0.000 description 1
- 101001109719 Homo sapiens Nucleophosmin Proteins 0.000 description 1
- 101001109512 Homo sapiens Nucleoplasmin-3 Proteins 0.000 description 1
- 101001024723 Homo sapiens Nucleoporin NDC1 Proteins 0.000 description 1
- 101001108862 Homo sapiens Nucleoporin NUP188 Proteins 0.000 description 1
- 101000598403 Homo sapiens Nucleoporin NUP42 Proteins 0.000 description 1
- 101000598495 Homo sapiens Nucleoporin Nup37 Proteins 0.000 description 1
- 101000598421 Homo sapiens Nucleoporin Nup43 Proteins 0.000 description 1
- 101001121642 Homo sapiens Nucleoporin p54 Proteins 0.000 description 1
- 101001121636 Homo sapiens Nucleoporin p58/p45 Proteins 0.000 description 1
- 101001000091 Homo sapiens Nucleoporin-62 C-terminal-like protein Proteins 0.000 description 1
- 101000594764 Homo sapiens Nucleoredoxin Proteins 0.000 description 1
- 101001128748 Homo sapiens Nucleoside diphosphate kinase 3 Proteins 0.000 description 1
- 101001128739 Homo sapiens Nucleoside diphosphate kinase 6 Proteins 0.000 description 1
- 101001128732 Homo sapiens Nucleoside diphosphate kinase 7 Proteins 0.000 description 1
- 101000851976 Homo sapiens Nucleoside diphosphate phosphatase ENTPD5 Proteins 0.000 description 1
- 101000594495 Homo sapiens Nucleoside diphosphate-linked moiety X motif 17 Proteins 0.000 description 1
- 101000974015 Homo sapiens Nucleosome assembly protein 1-like 1 Proteins 0.000 description 1
- 101000973997 Homo sapiens Nucleosome assembly protein 1-like 4 Proteins 0.000 description 1
- 101000934489 Homo sapiens Nucleosome-remodeling factor subunit BPTF Proteins 0.000 description 1
- 101000812677 Homo sapiens Nucleotide pyrophosphatase Proteins 0.000 description 1
- 101000958669 Homo sapiens Nucleus accumbens-associated protein 2 Proteins 0.000 description 1
- 101001109278 Homo sapiens NudC domain-containing protein 2 Proteins 0.000 description 1
- 101001121964 Homo sapiens OCIA domain-containing protein 1 Proteins 0.000 description 1
- 101001121958 Homo sapiens OCIA domain-containing protein 2 Proteins 0.000 description 1
- 101001121168 Homo sapiens ORM1-like protein 1 Proteins 0.000 description 1
- 101001121166 Homo sapiens ORM1-like protein 2 Proteins 0.000 description 1
- 101000721386 Homo sapiens OTU domain-containing protein 5 Proteins 0.000 description 1
- 101000597499 Homo sapiens Obg-like ATPase 1 Proteins 0.000 description 1
- 101000585675 Homo sapiens Obscurin Proteins 0.000 description 1
- 101000992104 Homo sapiens Obscurin-like protein 1 Proteins 0.000 description 1
- 101001086722 Homo sapiens Occludin/ELL domain-containing protein 1 Proteins 0.000 description 1
- 101001122145 Homo sapiens Odontogenic ameloblast-associated protein Proteins 0.000 description 1
- 101001137060 Homo sapiens Oligophrenin-1 Proteins 0.000 description 1
- 101000983294 Homo sapiens Oligosaccharyltransferase complex subunit OSTC Proteins 0.000 description 1
- 101000996087 Homo sapiens Omega-amidase NIT2 Proteins 0.000 description 1
- 101001120794 Homo sapiens Opioid growth factor receptor-like protein 1 Proteins 0.000 description 1
- 101000720966 Homo sapiens Opsin-3 Proteins 0.000 description 1
- 101000992283 Homo sapiens Optineurin Proteins 0.000 description 1
- 101000721946 Homo sapiens Oral-facial-digital syndrome 1 protein Proteins 0.000 description 1
- 101000986786 Homo sapiens Orexin/Hypocretin receptor type 1 Proteins 0.000 description 1
- 101000594698 Homo sapiens Ornithine decarboxylase antizyme 1 Proteins 0.000 description 1
- 101000982883 Homo sapiens Ornithine decarboxylase antizyme 3 Proteins 0.000 description 1
- 101001134210 Homo sapiens Otogelin-like protein Proteins 0.000 description 1
- 101001120706 Homo sapiens Outer dense fiber protein 2 Proteins 0.000 description 1
- 101000722306 Homo sapiens Outer dense fiber protein 3B Proteins 0.000 description 1
- 101001137510 Homo sapiens Outer dynein arm-docking complex subunit 2 Proteins 0.000 description 1
- 101000887280 Homo sapiens Outer mitochondrial transmembrane helix translocase Proteins 0.000 description 1
- 101001122162 Homo sapiens Overexpressed in colon carcinoma 1 protein Proteins 0.000 description 1
- 101001134134 Homo sapiens Oxidation resistance protein 1 Proteins 0.000 description 1
- 101001121326 Homo sapiens Oxidative stress-induced growth inhibitor 2 Proteins 0.000 description 1
- 101000598781 Homo sapiens Oxidative stress-responsive serine-rich protein 1 Proteins 0.000 description 1
- 101000744394 Homo sapiens Oxidized purine nucleoside triphosphate hydrolase Proteins 0.000 description 1
- 101000614300 Homo sapiens Oxidoreductase NAD-binding domain-containing protein 1 Proteins 0.000 description 1
- 101001021103 Homo sapiens Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial Proteins 0.000 description 1
- 101000992378 Homo sapiens Oxysterol-binding protein 2 Proteins 0.000 description 1
- 101000720693 Homo sapiens Oxysterol-binding protein-related protein 1 Proteins 0.000 description 1
- 101000992396 Homo sapiens Oxysterol-binding protein-related protein 3 Proteins 0.000 description 1
- 101000992392 Homo sapiens Oxysterol-binding protein-related protein 6 Proteins 0.000 description 1
- 101000992390 Homo sapiens Oxysterol-binding protein-related protein 7 Proteins 0.000 description 1
- 101000992388 Homo sapiens Oxysterol-binding protein-related protein 8 Proteins 0.000 description 1
- 101000992387 Homo sapiens Oxysterol-binding protein-related protein 9 Proteins 0.000 description 1
- 101001131829 Homo sapiens P protein Proteins 0.000 description 1
- 101001098179 Homo sapiens P2X purinoceptor 4 Proteins 0.000 description 1
- 101001098175 Homo sapiens P2X purinoceptor 7 Proteins 0.000 description 1
- 101000986826 Homo sapiens P2Y purinoceptor 6 Proteins 0.000 description 1
- 101000613363 Homo sapiens PABIR family member 1 Proteins 0.000 description 1
- 101000613365 Homo sapiens PABIR family member 2 Proteins 0.000 description 1
- 101001133603 Homo sapiens PACRG-like protein Proteins 0.000 description 1
- 101000982939 Homo sapiens PAN2-PAN3 deadenylation complex catalytic subunit PAN2 Proteins 0.000 description 1
- 101001113056 Homo sapiens PAN2-PAN3 deadenylation complex subunit PAN3 Proteins 0.000 description 1
- 101000613563 Homo sapiens PAS domain-containing serine/threonine-protein kinase Proteins 0.000 description 1
- 101001098523 Homo sapiens PAX-interacting protein 1 Proteins 0.000 description 1
- 101000579851 Homo sapiens PC-esterase domain-containing protein 1A Proteins 0.000 description 1
- 101000579857 Homo sapiens PC-esterase domain-containing protein 1B Proteins 0.000 description 1
- 101000610034 Homo sapiens PCI domain-containing protein 2 Proteins 0.000 description 1
- 101000886818 Homo sapiens PDZ domain-containing protein GIPC1 Proteins 0.000 description 1
- 101001072590 Homo sapiens POZ-, AT hook-, and zinc finger-containing protein 1 Proteins 0.000 description 1
- 101000871508 Homo sapiens PTB domain-containing engulfment adapter protein 1 Proteins 0.000 description 1
- 101001131670 Homo sapiens PWWP domain-containing DNA repair factor 3A Proteins 0.000 description 1
- 101000613490 Homo sapiens Paired box protein Pax-3 Proteins 0.000 description 1
- 101000601724 Homo sapiens Paired box protein Pax-5 Proteins 0.000 description 1
- 101000735213 Homo sapiens Palladin Proteins 0.000 description 1
- 101000981497 Homo sapiens Pantothenate kinase 1 Proteins 0.000 description 1
- 101000981502 Homo sapiens Pantothenate kinase 2, mitochondrial Proteins 0.000 description 1
- 101000735228 Homo sapiens Paralemmin-1 Proteins 0.000 description 1
- 101000735217 Homo sapiens Paralemmin-2 Proteins 0.000 description 1
- 101001135199 Homo sapiens Partitioning defective 3 homolog Proteins 0.000 description 1
- 101001113467 Homo sapiens Partitioning defective 6 homolog gamma Proteins 0.000 description 1
- 101001090948 Homo sapiens Peptide chain release factor 1, mitochondrial Proteins 0.000 description 1
- 101001090954 Homo sapiens Peptide chain release factor 1-like, mitochondrial Proteins 0.000 description 1
- 101000603761 Homo sapiens Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase Proteins 0.000 description 1
- 101000891031 Homo sapiens Peptidyl-prolyl cis-trans isomerase FKBP10 Proteins 0.000 description 1
- 101000891014 Homo sapiens Peptidyl-prolyl cis-trans isomerase FKBP14 Proteins 0.000 description 1
- 101000914053 Homo sapiens Peptidyl-prolyl cis-trans isomerase FKBP2 Proteins 0.000 description 1
- 101000878253 Homo sapiens Peptidyl-prolyl cis-trans isomerase FKBP5 Proteins 0.000 description 1
- 101000878215 Homo sapiens Peptidyl-prolyl cis-trans isomerase FKBP7 Proteins 0.000 description 1
- 101001031398 Homo sapiens Peptidyl-prolyl cis-trans isomerase FKBP9 Proteins 0.000 description 1
- 101001091194 Homo sapiens Peptidyl-prolyl cis-trans isomerase G Proteins 0.000 description 1
- 101000896765 Homo sapiens Peregrin Proteins 0.000 description 1
- 101000922137 Homo sapiens Peripheral plasma membrane protein CASK Proteins 0.000 description 1
- 101001041673 Homo sapiens Peroxisomal 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing] Proteins 0.000 description 1
- 101001098482 Homo sapiens Peroxisomal N(1)-acetyl-spermine/spermidine oxidase Proteins 0.000 description 1
- 101000599612 Homo sapiens Peroxisomal carnitine O-octanoyltransferase Proteins 0.000 description 1
- 101000595347 Homo sapiens Peroxisomal coenzyme A diphosphatase NUDT7 Proteins 0.000 description 1
- 101001045218 Homo sapiens Peroxisomal multifunctional enzyme type 2 Proteins 0.000 description 1
- 101000938567 Homo sapiens Persulfide dioxygenase ETHE1, mitochondrial Proteins 0.000 description 1
- 101000660828 Homo sapiens Phenylalanine-tRNA ligase beta subunit Proteins 0.000 description 1
- 101000842043 Homo sapiens Phenylalanine-tRNA ligase, mitochondrial Proteins 0.000 description 1
- 101000983854 Homo sapiens Phosphatidate phosphatase LPIN1 Proteins 0.000 description 1
- 101001130226 Homo sapiens Phosphatidylcholine-sterol acyltransferase Proteins 0.000 description 1
- 101000869523 Homo sapiens Phosphatidylinositide phosphatase SAC2 Proteins 0.000 description 1
- 101000688606 Homo sapiens Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 Proteins 0.000 description 1
- 101001053329 Homo sapiens Phosphatidylinositol polyphosphate 5-phosphatase type IV Proteins 0.000 description 1
- 101000734579 Homo sapiens Phosphoenolpyruvate carboxykinase [GTP], mitochondrial Proteins 0.000 description 1
- 101001133640 Homo sapiens Phosphofurin acidic cluster sorting protein 1 Proteins 0.000 description 1
- 101001133637 Homo sapiens Phosphofurin acidic cluster sorting protein 2 Proteins 0.000 description 1
- 101000595786 Homo sapiens Phospholipase A and acyltransferase 1 Proteins 0.000 description 1
- 101000870426 Homo sapiens Phospholipase DDHD1 Proteins 0.000 description 1
- 101000870428 Homo sapiens Phospholipase DDHD2 Proteins 0.000 description 1
- 101000867941 Homo sapiens Phospholipid transfer protein C2CD2L Proteins 0.000 description 1
- 101000923320 Homo sapiens Phospholipid-transporting ATPase IF Proteins 0.000 description 1
- 101000923328 Homo sapiens Phospholipid-transporting ATPase IG Proteins 0.000 description 1
- 101000923322 Homo sapiens Phospholipid-transporting ATPase IH Proteins 0.000 description 1
- 101000905839 Homo sapiens Phospholipid-transporting ATPase VA Proteins 0.000 description 1
- 101000923326 Homo sapiens Phospholipid-transporting ATPase VD Proteins 0.000 description 1
- 101000981515 Homo sapiens Phospholysine phosphohistidine inorganic pyrophosphate phosphatase Proteins 0.000 description 1
- 101000692259 Homo sapiens Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 Proteins 0.000 description 1
- 101001081953 Homo sapiens Phosphoribosylaminoimidazole carboxylase Proteins 0.000 description 1
- 101000893745 Homo sapiens Plasma alpha-L-fucosidase Proteins 0.000 description 1
- 101000728095 Homo sapiens Plasma membrane calcium-transporting ATPase 1 Proteins 0.000 description 1
- 101000728117 Homo sapiens Plasma membrane calcium-transporting ATPase 4 Proteins 0.000 description 1
- 101000987238 Homo sapiens Platelet-activating factor acetylhydrolase 2, cytoplasmic Proteins 0.000 description 1
- 101001113440 Homo sapiens Poly [ADP-ribose] polymerase 2 Proteins 0.000 description 1
- 101000833167 Homo sapiens Poly(A) RNA polymerase GLD2 Proteins 0.000 description 1
- 101000610204 Homo sapiens Poly(A) polymerase alpha Proteins 0.000 description 1
- 101000610208 Homo sapiens Poly(A) polymerase gamma Proteins 0.000 description 1
- 101001113490 Homo sapiens Poly(A)-specific ribonuclease PARN Proteins 0.000 description 1
- 101000589450 Homo sapiens Poly(ADP-ribose) glycohydrolase Proteins 0.000 description 1
- 101000735358 Homo sapiens Poly(rC)-binding protein 2 Proteins 0.000 description 1
- 101000735360 Homo sapiens Poly(rC)-binding protein 3 Proteins 0.000 description 1
- 101000735365 Homo sapiens Poly(rC)-binding protein 4 Proteins 0.000 description 1
- 101000609211 Homo sapiens Polyadenylate-binding protein 2 Proteins 0.000 description 1
- 101000609219 Homo sapiens Polyadenylate-binding protein 4 Proteins 0.000 description 1
- 101001133624 Homo sapiens Polyadenylate-binding protein-interacting protein 1 Proteins 0.000 description 1
- 101001035694 Homo sapiens Polyamine deacetylase HDAC10 Proteins 0.000 description 1
- 101000887201 Homo sapiens Polyamine-transporting ATPase 13A2 Proteins 0.000 description 1
- 101000887199 Homo sapiens Polyamine-transporting ATPase 13A3 Proteins 0.000 description 1
- 101000613334 Homo sapiens Polycomb group RING finger protein 1 Proteins 0.000 description 1
- 101000613343 Homo sapiens Polycomb group RING finger protein 2 Proteins 0.000 description 1
- 101000613347 Homo sapiens Polycomb group RING finger protein 3 Proteins 0.000 description 1
- 101000613350 Homo sapiens Polycomb group RING finger protein 5 Proteins 0.000 description 1
- 101000613355 Homo sapiens Polycomb group RING finger protein 6 Proteins 0.000 description 1
- 101000728236 Homo sapiens Polycomb group protein ASXL1 Proteins 0.000 description 1
- 101000866766 Homo sapiens Polycomb protein EED Proteins 0.000 description 1
- 101001109588 Homo sapiens Polynucleotide 5'-hydroxyl-kinase NOL9 Proteins 0.000 description 1
- 101000829578 Homo sapiens Polypeptide N-acetylgalactosaminyltransferase 10 Proteins 0.000 description 1
- 101000829574 Homo sapiens Polypeptide N-acetylgalactosaminyltransferase 11 Proteins 0.000 description 1
- 101000829541 Homo sapiens Polypeptide N-acetylgalactosaminyltransferase 13 Proteins 0.000 description 1
- 101000829538 Homo sapiens Polypeptide N-acetylgalactosaminyltransferase 15 Proteins 0.000 description 1
- 101000888117 Homo sapiens Polypeptide N-acetylgalactosaminyltransferase 18 Proteins 0.000 description 1
- 101001002235 Homo sapiens Polypeptide N-acetylgalactosaminyltransferase 2 Proteins 0.000 description 1
- 101000886179 Homo sapiens Polypeptide N-acetylgalactosaminyltransferase 3 Proteins 0.000 description 1
- 101000886231 Homo sapiens Polypeptide N-acetylgalactosaminyltransferase 6 Proteins 0.000 description 1
- 101000827703 Homo sapiens Polyphosphoinositide phosphatase Proteins 0.000 description 1
- 101001049831 Homo sapiens Potassium channel subfamily K member 4 Proteins 0.000 description 1
- 101000944000 Homo sapiens Potassium channel subfamily T member 2 Proteins 0.000 description 1
- 101001047102 Homo sapiens Potassium voltage-gated channel subfamily G member 1 Proteins 0.000 description 1
- 101001047090 Homo sapiens Potassium voltage-gated channel subfamily H member 2 Proteins 0.000 description 1
- 101000994656 Homo sapiens Potassium voltage-gated channel subfamily KQT member 5 Proteins 0.000 description 1
- 101001077441 Homo sapiens Potassium voltage-gated channel subfamily S member 3 Proteins 0.000 description 1
- 101000610107 Homo sapiens Pre-B-cell leukemia transcription factor 1 Proteins 0.000 description 1
- 101000613207 Homo sapiens Pre-B-cell leukemia transcription factor-interacting protein 1 Proteins 0.000 description 1
- 101000846284 Homo sapiens Pre-mRNA 3'-end-processing factor FIP1 Proteins 0.000 description 1
- 101001122801 Homo sapiens Pre-mRNA-processing factor 17 Proteins 0.000 description 1
- 101001124937 Homo sapiens Pre-mRNA-splicing factor 38B Proteins 0.000 description 1
- 101001122811 Homo sapiens Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 Proteins 0.000 description 1
- 101000894618 Homo sapiens Pre-mRNA-splicing factor CWC22 homolog Proteins 0.000 description 1
- 101000856372 Homo sapiens Pre-mRNA-splicing factor CWC25 homolog Proteins 0.000 description 1
- 101000609379 Homo sapiens Pre-mRNA-splicing factor ISY1 homolog Proteins 0.000 description 1
- 101001028874 Homo sapiens Primary cilium assembly protein FAM149B1 Proteins 0.000 description 1
- 101001109792 Homo sapiens Pro-neuregulin-2, membrane-bound isoform Proteins 0.000 description 1
- 101001109765 Homo sapiens Pro-neuregulin-3, membrane-bound isoform Proteins 0.000 description 1
- 101001109767 Homo sapiens Pro-neuregulin-4, membrane-bound isoform Proteins 0.000 description 1
- 101000984960 Homo sapiens Probable 18S rRNA (guanine-N(7))-methyltransferase Proteins 0.000 description 1
- 101001054596 Homo sapiens Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial Proteins 0.000 description 1
- 101000843497 Homo sapiens Probable ATP-dependent DNA helicase HFM1 Proteins 0.000 description 1
- 101001041721 Homo sapiens Probable ATP-dependent RNA helicase DDX17 Proteins 0.000 description 1
- 101000870728 Homo sapiens Probable ATP-dependent RNA helicase DDX27 Proteins 0.000 description 1
- 101000870734 Homo sapiens Probable ATP-dependent RNA helicase DDX31 Proteins 0.000 description 1
- 101000874165 Homo sapiens Probable ATP-dependent RNA helicase DDX41 Proteins 0.000 description 1
- 101000874142 Homo sapiens Probable ATP-dependent RNA helicase DDX46 Proteins 0.000 description 1
- 101000830410 Homo sapiens Probable ATP-dependent RNA helicase DDX49 Proteins 0.000 description 1
- 101000883801 Homo sapiens Probable ATP-dependent RNA helicase DDX52 Proteins 0.000 description 1
- 101000952097 Homo sapiens Probable ATP-dependent RNA helicase DDX59 Proteins 0.000 description 1
- 101000952078 Homo sapiens Probable ATP-dependent RNA helicase DDX60 Proteins 0.000 description 1
- 101000952073 Homo sapiens Probable ATP-dependent RNA helicase DDX60-like Proteins 0.000 description 1
- 101000901938 Homo sapiens Probable ATP-dependent RNA helicase DHX34 Proteins 0.000 description 1
- 101000901928 Homo sapiens Probable ATP-dependent RNA helicase DHX35 Proteins 0.000 description 1
- 101000864678 Homo sapiens Probable ATP-dependent RNA helicase DHX37 Proteins 0.000 description 1
- 101000915002 Homo sapiens Probable C-mannosyltransferase DPY19L1 Proteins 0.000 description 1
- 101000915000 Homo sapiens Probable C-mannosyltransferase DPY19L2 Proteins 0.000 description 1
- 101000915008 Homo sapiens Probable C-mannosyltransferase DPY19L3 Proteins 0.000 description 1
- 101000914997 Homo sapiens Probable C-mannosyltransferase DPY19L4 Proteins 0.000 description 1
- 101000838314 Homo sapiens Probable E3 ubiquitin-protein ligase DTX2 Proteins 0.000 description 1
- 101000872867 Homo sapiens Probable E3 ubiquitin-protein ligase HECTD4 Proteins 0.000 description 1
- 101000872514 Homo sapiens Probable E3 ubiquitin-protein ligase HERC1 Proteins 0.000 description 1
- 101001035260 Homo sapiens Probable E3 ubiquitin-protein ligase HERC3 Proteins 0.000 description 1
- 101001035259 Homo sapiens Probable E3 ubiquitin-protein ligase HERC4 Proteins 0.000 description 1
- 101001035144 Homo sapiens Probable E3 ubiquitin-protein ligase HERC6 Proteins 0.000 description 1
- 101000766246 Homo sapiens Probable E3 ubiquitin-protein ligase MID2 Proteins 0.000 description 1
- 101000887420 Homo sapiens Probable G-protein coupled receptor 141 Proteins 0.000 description 1
- 101000857740 Homo sapiens Probable G-protein coupled receptor 160 Proteins 0.000 description 1
- 101001014654 Homo sapiens Probable G-protein coupled receptor 171 Proteins 0.000 description 1
- 101001014640 Homo sapiens Probable G-protein coupled receptor 173 Proteins 0.000 description 1
- 101001069617 Homo sapiens Probable G-protein coupled receptor 63 Proteins 0.000 description 1
- 101001069583 Homo sapiens Probable G-protein coupled receptor 85 Proteins 0.000 description 1
- 101001028703 Homo sapiens Probable JmjC domain-containing histone demethylation protein 2C Proteins 0.000 description 1
- 101000881614 Homo sapiens Probable RNA-binding protein EIF1AD Proteins 0.000 description 1
- 101000640325 Homo sapiens Probable asparagine-tRNA ligase, mitochondrial Proteins 0.000 description 1
- 101000919183 Homo sapiens Probable carboxypeptidase X1 Proteins 0.000 description 1
- 101000630121 Homo sapiens Probable cysteine-tRNA ligase, mitochondrial Proteins 0.000 description 1
- 101000951118 Homo sapiens Probable dimethyladenosine transferase Proteins 0.000 description 1
- 101000717815 Homo sapiens Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase Proteins 0.000 description 1
- 101000917550 Homo sapiens Probable fibrosin-1 Proteins 0.000 description 1
- 101000904181 Homo sapiens Probable gluconokinase Proteins 0.000 description 1
- 101001009588 Homo sapiens Probable glutathione peroxidase 8 Proteins 0.000 description 1
- 101001083769 Homo sapiens Probable helicase with zinc finger domain Proteins 0.000 description 1
- 101000779672 Homo sapiens Probable inactive allantoicase Proteins 0.000 description 1
- 101001033177 Homo sapiens Probable methyltransferase-like protein 23 Proteins 0.000 description 1
- 101001033206 Homo sapiens Probable methyltransferase-like protein 25 Proteins 0.000 description 1
- 101000729626 Homo sapiens Probable phospholipid-transporting ATPase IIA Proteins 0.000 description 1
- 101000729531 Homo sapiens Probable phospholipid-transporting ATPase IIB Proteins 0.000 description 1
- 101000701518 Homo sapiens Probable phospholipid-transporting ATPase IM Proteins 0.000 description 1
- 101000745667 Homo sapiens Probable serine carboxypeptidase CPVL Proteins 0.000 description 1
- 101000793153 Homo sapiens Probable splicing factor YJU2B Proteins 0.000 description 1
- 101001121320 Homo sapiens Probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial Proteins 0.000 description 1
- 101000896369 Homo sapiens Probable transmembrane reductase CYB561D1 Proteins 0.000 description 1
- 101001052471 Homo sapiens Probable ubiquitin carboxyl-terminal hydrolase MINDY-4 Proteins 0.000 description 1
- 101000983583 Homo sapiens Procathepsin L Proteins 0.000 description 1
- 101000589403 Homo sapiens Progestin and adipoQ receptor family member 3 Proteins 0.000 description 1
- 101000928339 Homo sapiens Progressive ankylosis protein homolog Proteins 0.000 description 1
- 101000945496 Homo sapiens Proliferation marker protein Ki-67 Proteins 0.000 description 1
- 101000690268 Homo sapiens Proline-rich AKT1 substrate 1 Proteins 0.000 description 1
- 101000630284 Homo sapiens Proline-tRNA ligase Proteins 0.000 description 1
- 101001043564 Homo sapiens Prolow-density lipoprotein receptor-related protein 1 Proteins 0.000 description 1
- 101001133941 Homo sapiens Prolyl 3-hydroxylase 1 Proteins 0.000 description 1
- 101000614345 Homo sapiens Prolyl 4-hydroxylase subunit alpha-1 Proteins 0.000 description 1
- 101000614347 Homo sapiens Prolyl 4-hydroxylase subunit alpha-2 Proteins 0.000 description 1
- 101001098989 Homo sapiens Propionyl-CoA carboxylase alpha chain, mitochondrial Proteins 0.000 description 1
- 101001098982 Homo sapiens Propionyl-CoA carboxylase beta chain, mitochondrial Proteins 0.000 description 1
- 101000981455 Homo sapiens Prostate androgen-regulated mucin-like protein 1 Proteins 0.000 description 1
- 101000585054 Homo sapiens Proteasomal ATPase-associated factor 1 Proteins 0.000 description 1
- 101001050220 Homo sapiens Proteasome adapter and scaffold protein ECM29 Proteins 0.000 description 1
- 101000920629 Homo sapiens Protein 4.1 Proteins 0.000 description 1
- 101000718497 Homo sapiens Protein AF-10 Proteins 0.000 description 1
- 101000959489 Homo sapiens Protein AF-9 Proteins 0.000 description 1
- 101000797903 Homo sapiens Protein ALEX Proteins 0.000 description 1
- 101000797593 Homo sapiens Protein AMN1 homolog Proteins 0.000 description 1
- 101000752520 Homo sapiens Protein ARMCX6 Proteins 0.000 description 1
- 101000754240 Homo sapiens Protein ARV1 Proteins 0.000 description 1
- 101000964373 Homo sapiens Protein Abitram Proteins 0.000 description 1
- 101000728208 Homo sapiens Protein Aster-A Proteins 0.000 description 1
- 101000964086 Homo sapiens Protein Atg16l2 Proteins 0.000 description 1
- 101000971151 Homo sapiens Protein BANP Proteins 0.000 description 1
- 101000722261 Homo sapiens Protein BCAP Proteins 0.000 description 1
- 101000894654 Homo sapiens Protein BEAN1 Proteins 0.000 description 1
- 101000933255 Homo sapiens Protein BEX4 Proteins 0.000 description 1
- 101000794237 Homo sapiens Protein BRAWNIN Proteins 0.000 description 1
- 101000933607 Homo sapiens Protein BTG3 Proteins 0.000 description 1
- 101000989787 Homo sapiens Protein C12orf4 Proteins 0.000 description 1
- 101000715341 Homo sapiens Protein C3orf33 Proteins 0.000 description 1
- 101000947115 Homo sapiens Protein CASC3 Proteins 0.000 description 1
- 101000761460 Homo sapiens Protein CASP Proteins 0.000 description 1
- 101001132819 Homo sapiens Protein CBFA2T3 Proteins 0.000 description 1
- 101000980965 Homo sapiens Protein CDV3 homolog Proteins 0.000 description 1
- 101000945509 Homo sapiens Protein CEBPZOS Proteins 0.000 description 1
- 101000710074 Homo sapiens Protein CFAP20DC Proteins 0.000 description 1
- 101000766826 Homo sapiens Protein CIP2A Proteins 0.000 description 1
- 101000946275 Homo sapiens Protein CLEC16A Proteins 0.000 description 1
- 101000771012 Homo sapiens Protein CMSS1 Proteins 0.000 description 1
- 101000884108 Homo sapiens Protein Churchill Proteins 0.000 description 1
- 101000721172 Homo sapiens Protein DBF4 homolog A Proteins 0.000 description 1
- 101000721176 Homo sapiens Protein DBF4 homolog B Proteins 0.000 description 1
- 101000912957 Homo sapiens Protein DEK Proteins 0.000 description 1
- 101000722011 Homo sapiens Protein DENND6A Proteins 0.000 description 1
- 101000930001 Homo sapiens Protein DGCR6L Proteins 0.000 description 1
- 101000805129 Homo sapiens Protein DPCD Proteins 0.000 description 1
- 101000956094 Homo sapiens Protein Daple Proteins 0.000 description 1
- 101000817237 Homo sapiens Protein ECT2 Proteins 0.000 description 1
- 101000925095 Homo sapiens Protein EFR3 homolog A Proteins 0.000 description 1
- 101000881752 Homo sapiens Protein ELYS Proteins 0.000 description 1
- 101000925651 Homo sapiens Protein ENL Proteins 0.000 description 1
- 101000881943 Homo sapiens Protein EURL homolog Proteins 0.000 description 1
- 101001063926 Homo sapiens Protein FAM102A Proteins 0.000 description 1
- 101001063923 Homo sapiens Protein FAM104A Proteins 0.000 description 1
- 101000911753 Homo sapiens Protein FAM107B Proteins 0.000 description 1
- 101000875501 Homo sapiens Protein FAM114A2 Proteins 0.000 description 1
- 101000875514 Homo sapiens Protein FAM117A Proteins 0.000 description 1
- 101001048762 Homo sapiens Protein FAM117B Proteins 0.000 description 1
- 101001048764 Homo sapiens Protein FAM118A Proteins 0.000 description 1
- 101001048767 Homo sapiens Protein FAM118B Proteins 0.000 description 1
- 101000813325 Homo sapiens Protein FAM126B Proteins 0.000 description 1
- 101000882154 Homo sapiens Protein FAM131A Proteins 0.000 description 1
- 101000882136 Homo sapiens Protein FAM133B Proteins 0.000 description 1
- 101000882083 Homo sapiens Protein FAM135A Proteins 0.000 description 1
- 101001062760 Homo sapiens Protein FAM13A Proteins 0.000 description 1
- 101001062758 Homo sapiens Protein FAM13B Proteins 0.000 description 1
- 101000875639 Homo sapiens Protein FAM151B Proteins 0.000 description 1
- 101000875616 Homo sapiens Protein FAM161A Proteins 0.000 description 1
- 101001048811 Homo sapiens Protein FAM162A Proteins 0.000 description 1
- 101001048843 Homo sapiens Protein FAM163A Proteins 0.000 description 1
- 101000854603 Homo sapiens Protein FAM168A Proteins 0.000 description 1
- 101001062793 Homo sapiens Protein FAM171A1 Proteins 0.000 description 1
- 101000823451 Homo sapiens Protein FAM174C Proteins 0.000 description 1
- 101001028900 Homo sapiens Protein FAM177A1 Proteins 0.000 description 1
- 101000877832 Homo sapiens Protein FAM184A Proteins 0.000 description 1
- 101000877816 Homo sapiens Protein FAM185A Proteins 0.000 description 1
- 101001048943 Homo sapiens Protein FAM189A2 Proteins 0.000 description 1
- 101001048947 Homo sapiens Protein FAM189B Proteins 0.000 description 1
- 101001048938 Homo sapiens Protein FAM193A Proteins 0.000 description 1
- 101000848933 Homo sapiens Protein FAM193B Proteins 0.000 description 1
- 101000848930 Homo sapiens Protein FAM199X Proteins 0.000 description 1
- 101000882270 Homo sapiens Protein FAM204A Proteins 0.000 description 1
- 101000882257 Homo sapiens Protein FAM210A Proteins 0.000 description 1
- 101000911541 Homo sapiens Protein FAM214A Proteins 0.000 description 1
- 101000911547 Homo sapiens Protein FAM214B Proteins 0.000 description 1
- 101000911517 Homo sapiens Protein FAM216A Proteins 0.000 description 1
- 101000918444 Homo sapiens Protein FAM217B Proteins 0.000 description 1
- 101000918451 Homo sapiens Protein FAM219B Proteins 0.000 description 1
- 101000918431 Homo sapiens Protein FAM221A Proteins 0.000 description 1
- 101000937720 Homo sapiens Protein FAM222B Proteins 0.000 description 1
- 101001062794 Homo sapiens Protein FAM228B Proteins 0.000 description 1
- 101001062779 Homo sapiens Protein FAM229B Proteins 0.000 description 1
- 101001062776 Homo sapiens Protein FAM234A Proteins 0.000 description 1
- 101001027865 Homo sapiens Protein FAM241B Proteins 0.000 description 1
- 101000937691 Homo sapiens Protein FAM24B Proteins 0.000 description 1
- 101000891860 Homo sapiens Protein FAM3A Proteins 0.000 description 1
- 101000891845 Homo sapiens Protein FAM3C Proteins 0.000 description 1
- 101001027846 Homo sapiens Protein FAM53B Proteins 0.000 description 1
- 101000848922 Homo sapiens Protein FAM72A Proteins 0.000 description 1
- 101000848918 Homo sapiens Protein FAM72C Proteins 0.000 description 1
- 101000848917 Homo sapiens Protein FAM72D Proteins 0.000 description 1
- 101001049023 Homo sapiens Protein FAM78B Proteins 0.000 description 1
- 101001049018 Homo sapiens Protein FAM81A Proteins 0.000 description 1
- 101000877851 Homo sapiens Protein FAM83D Proteins 0.000 description 1
- 101000911553 Homo sapiens Protein FAM91A1 Proteins 0.000 description 1
- 101000823407 Homo sapiens Protein FAM98B Proteins 0.000 description 1
- 101000823410 Homo sapiens Protein FAM98C Proteins 0.000 description 1
- 101000937172 Homo sapiens Protein FAN Proteins 0.000 description 1
- 101000911776 Homo sapiens Protein FRA10AC1 Proteins 0.000 description 1
- 101001061041 Homo sapiens Protein FRG1 Proteins 0.000 description 1
- 101001070474 Homo sapiens Protein GPR107 Proteins 0.000 description 1
- 101001070470 Homo sapiens Protein GPR108 Proteins 0.000 description 1
- 101001009852 Homo sapiens Protein GUCD1 Proteins 0.000 description 1
- 101000898018 Homo sapiens Protein HGH1 homolog Proteins 0.000 description 1
- 101001046894 Homo sapiens Protein HID1 Proteins 0.000 description 1
- 101000842368 Homo sapiens Protein HIRA Proteins 0.000 description 1
- 101000897999 Homo sapiens Protein Hikeshi Proteins 0.000 description 1
- 101001048454 Homo sapiens Protein Hook homolog 1 Proteins 0.000 description 1
- 101000866633 Homo sapiens Protein Hook homolog 3 Proteins 0.000 description 1
- 101001028689 Homo sapiens Protein JTB Proteins 0.000 description 1
- 101000994476 Homo sapiens Protein Jade-3 Proteins 0.000 description 1
- 101001056567 Homo sapiens Protein Jumonji Proteins 0.000 description 1
- 101001026914 Homo sapiens Protein KRBA1 Proteins 0.000 description 1
- 101001137717 Homo sapiens Protein KRI1 homolog Proteins 0.000 description 1
- 101000966243 Homo sapiens Protein LMBR1L Proteins 0.000 description 1
- 101001004752 Homo sapiens Protein LSM12 homolog Proteins 0.000 description 1
- 101000579580 Homo sapiens Protein LSM14 homolog A Proteins 0.000 description 1
- 101000579584 Homo sapiens Protein LSM14 homolog B Proteins 0.000 description 1
- 101000619488 Homo sapiens Protein LTO1 homolog Proteins 0.000 description 1
- 101001065541 Homo sapiens Protein LYRIC Proteins 0.000 description 1
- 101000981685 Homo sapiens Protein Lines homolog 1 Proteins 0.000 description 1
- 101001059604 Homo sapiens Protein MAK16 homolog Proteins 0.000 description 1
- 101001016806 Homo sapiens Protein MANBAL Proteins 0.000 description 1
- 101001019885 Homo sapiens Protein MGARP Proteins 0.000 description 1
- 101000577964 Homo sapiens Protein MIX23 Proteins 0.000 description 1
- 101000573316 Homo sapiens Protein MMP24OS Proteins 0.000 description 1
- 101000977257 Homo sapiens Protein MMS22-like Proteins 0.000 description 1
- 101000623849 Homo sapiens Protein MTO1 homolog, mitochondrial Proteins 0.000 description 1
- 101000966589 Homo sapiens Protein MTSS 2 Proteins 0.000 description 1
- 101000625256 Homo sapiens Protein Mis18-beta Proteins 0.000 description 1
- 101000969776 Homo sapiens Protein Mpv17 Proteins 0.000 description 1
- 101000594428 Homo sapiens Protein N-lysine methyltransferase METTL21A Proteins 0.000 description 1
- 101000996830 Homo sapiens Protein N-terminal asparagine amidohydrolase Proteins 0.000 description 1
- 101000979748 Homo sapiens Protein NDRG1 Proteins 0.000 description 1
- 101000995300 Homo sapiens Protein NDRG2 Proteins 0.000 description 1
- 101000995290 Homo sapiens Protein NDRG3 Proteins 0.000 description 1
- 101000995332 Homo sapiens Protein NDRG4 Proteins 0.000 description 1
- 101001023689 Homo sapiens Protein NEDD1 Proteins 0.000 description 1
- 101000979565 Homo sapiens Protein NLRC5 Proteins 0.000 description 1
- 101000594765 Homo sapiens Protein NOXP20 Proteins 0.000 description 1
- 101000979460 Homo sapiens Protein Niban 1 Proteins 0.000 description 1
- 101000979461 Homo sapiens Protein Niban 2 Proteins 0.000 description 1
- 101000600900 Homo sapiens Protein Njmu-R1 Proteins 0.000 description 1
- 101000585728 Homo sapiens Protein O-GlcNAcase Proteins 0.000 description 1
- 101000595899 Homo sapiens Protein O-glucosyltransferase 2 Proteins 0.000 description 1
- 101000595897 Homo sapiens Protein O-glucosyltransferase 3 Proteins 0.000 description 1
- 101001130763 Homo sapiens Protein OS-9 Proteins 0.000 description 1
- 101000598778 Homo sapiens Protein OSCP1 Proteins 0.000 description 1
- 101001133654 Homo sapiens Protein PALS1 Proteins 0.000 description 1
- 101001133650 Homo sapiens Protein PALS2 Proteins 0.000 description 1
- 101001098498 Homo sapiens Protein PAT1 homolog 1 Proteins 0.000 description 1
- 101001072579 Homo sapiens Protein PAXX Proteins 0.000 description 1
- 101000610095 Homo sapiens Protein PBDC1 Proteins 0.000 description 1
- 101000738546 Homo sapiens Protein PTHB1 Proteins 0.000 description 1
- 101000685818 Homo sapiens Protein SIX6OS1 Proteins 0.000 description 1
- 101000595876 Homo sapiens Protein TASOR Proteins 0.000 description 1
- 101000596012 Homo sapiens Protein TASOR 2 Proteins 0.000 description 1
- 101000757196 Homo sapiens Protein angel homolog 1 Proteins 0.000 description 1
- 101000757241 Homo sapiens Protein angel homolog 2 Proteins 0.000 description 1
- 101000973453 Homo sapiens Protein arginine methyltransferase NDUFAF7, mitochondrial Proteins 0.000 description 1
- 101000720958 Homo sapiens Protein artemis Proteins 0.000 description 1
- 101000923332 Homo sapiens Protein asteroid homolog 1 Proteins 0.000 description 1
- 101000871761 Homo sapiens Protein aurora borealis Proteins 0.000 description 1
- 101000873646 Homo sapiens Protein bicaudal C homolog 1 Proteins 0.000 description 1
- 101000873612 Homo sapiens Protein bicaudal D homolog 1 Proteins 0.000 description 1
- 101000900789 Homo sapiens Protein canopy homolog 2 Proteins 0.000 description 1
- 101000710817 Homo sapiens Protein canopy homolog 3 Proteins 0.000 description 1
- 101000710830 Homo sapiens Protein canopy homolog 4 Proteins 0.000 description 1
- 101000941994 Homo sapiens Protein cereblon Proteins 0.000 description 1
- 101000910825 Homo sapiens Protein chibby homolog 1 Proteins 0.000 description 1
- 101000952631 Homo sapiens Protein cordon-bleu Proteins 0.000 description 1
- 101000900767 Homo sapiens Protein cornichon homolog 1 Proteins 0.000 description 1
- 101000909811 Homo sapiens Protein cornichon homolog 2 Proteins 0.000 description 1
- 101000909879 Homo sapiens Protein cornichon homolog 3 Proteins 0.000 description 1
- 101000909882 Homo sapiens Protein cornichon homolog 4 Proteins 0.000 description 1
- 101000726148 Homo sapiens Protein crumbs homolog 1 Proteins 0.000 description 1
- 101000928791 Homo sapiens Protein diaphanous homolog 1 Proteins 0.000 description 1
- 101000928408 Homo sapiens Protein diaphanous homolog 2 Proteins 0.000 description 1
- 101000928406 Homo sapiens Protein diaphanous homolog 3 Proteins 0.000 description 1
- 101000930354 Homo sapiens Protein dispatched homolog 1 Proteins 0.000 description 1
- 101000919288 Homo sapiens Protein disulfide isomerase CRELD1 Proteins 0.000 description 1
- 101000919297 Homo sapiens Protein disulfide isomerase CRELD2 Proteins 0.000 description 1
- 101001064096 Homo sapiens Protein disulfide-thiol oxidoreductase Proteins 0.000 description 1
- 101000863994 Homo sapiens Protein dopey-1 Proteins 0.000 description 1
- 101000863978 Homo sapiens Protein downstream neighbor of Son Proteins 0.000 description 1
- 101000902641 Homo sapiens Protein dpy-30 homolog Proteins 0.000 description 1
- 101000877404 Homo sapiens Protein enabled homolog Proteins 0.000 description 1
- 101000920916 Homo sapiens Protein eva-1 homolog A Proteins 0.000 description 1
- 101000861587 Homo sapiens Protein farnesyltransferase subunit beta Proteins 0.000 description 1
- 101000877589 Homo sapiens Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha Proteins 0.000 description 1
- 101000893493 Homo sapiens Protein flightless-1 homolog Proteins 0.000 description 1
- 101000931680 Homo sapiens Protein furry homolog Proteins 0.000 description 1
- 101000931682 Homo sapiens Protein furry homolog-like Proteins 0.000 description 1
- 101001000956 Homo sapiens Protein fuzzy homolog Proteins 0.000 description 1
- 101000993776 Homo sapiens Protein inturned Proteins 0.000 description 1
- 101000972637 Homo sapiens Protein kintoun Proteins 0.000 description 1
- 101001064515 Homo sapiens Protein lin-37 homolog Proteins 0.000 description 1
- 101001004288 Homo sapiens Protein lin-52 homolog Proteins 0.000 description 1
- 101001004334 Homo sapiens Protein lin-54 homolog Proteins 0.000 description 1
- 101000942742 Homo sapiens Protein lin-7 homolog A Proteins 0.000 description 1
- 101000981667 Homo sapiens Protein lin-9 homolog Proteins 0.000 description 1
- 101000628776 Homo sapiens Protein mago nashi homolog Proteins 0.000 description 1
- 101000628758 Homo sapiens Protein mago nashi homolog 2 Proteins 0.000 description 1
- 101000623801 Homo sapiens Protein misato homolog 1 Proteins 0.000 description 1
- 101000613612 Homo sapiens Protein mono-ADP-ribosyltransferase PARP11 Proteins 0.000 description 1
- 101000613620 Homo sapiens Protein mono-ADP-ribosyltransferase PARP15 Proteins 0.000 description 1
- 101000735463 Homo sapiens Protein mono-ADP-ribosyltransferase PARP4 Proteins 0.000 description 1
- 101000735465 Homo sapiens Protein mono-ADP-ribosyltransferase PARP6 Proteins 0.000 description 1
- 101000735466 Homo sapiens Protein mono-ADP-ribosyltransferase PARP8 Proteins 0.000 description 1
- 101000735459 Homo sapiens Protein mono-ADP-ribosyltransferase PARP9 Proteins 0.000 description 1
- 101000597932 Homo sapiens Protein numb homolog Proteins 0.000 description 1
- 101000597553 Homo sapiens Protein odr-4 homolog Proteins 0.000 description 1
- 101001122471 Homo sapiens Protein orai-3 Proteins 0.000 description 1
- 101001014035 Homo sapiens Protein p13 MTCP-1 Proteins 0.000 description 1
- 101000742083 Homo sapiens Protein phosphatase 1 regulatory subunit 29 Proteins 0.000 description 1
- 101000609959 Homo sapiens Protein piccolo Proteins 0.000 description 1
- 101000601770 Homo sapiens Protein polybromo-1 Proteins 0.000 description 1
- 101000702132 Homo sapiens Protein spinster homolog 1 Proteins 0.000 description 1
- 101000630088 Homo sapiens Protein-L-histidine N-pros-methyltransferase Proteins 0.000 description 1
- 101000842302 Homo sapiens Protein-cysteine N-palmitoyltransferase HHAT Proteins 0.000 description 1
- 101001050438 Homo sapiens Protein-lysine N-methyltransferase EEF2KMT Proteins 0.000 description 1
- 101000824318 Homo sapiens Protocadherin Fat 1 Proteins 0.000 description 1
- 101000824415 Homo sapiens Protocadherin Fat 3 Proteins 0.000 description 1
- 101001116931 Homo sapiens Protocadherin alpha-6 Proteins 0.000 description 1
- 101000613400 Homo sapiens Protocadherin alpha-C1 Proteins 0.000 description 1
- 101000610019 Homo sapiens Protocadherin beta-11 Proteins 0.000 description 1
- 101000735377 Homo sapiens Protocadherin-7 Proteins 0.000 description 1
- 101000735368 Homo sapiens Protocadherin-9 Proteins 0.000 description 1
- 101000692612 Homo sapiens Pterin-4-alpha-carbinolamine dehydratase 2 Proteins 0.000 description 1
- 101000592517 Homo sapiens Puromycin-sensitive aminopeptidase Proteins 0.000 description 1
- 101000722214 Homo sapiens Putative ATP-dependent RNA helicase DDX12 Proteins 0.000 description 1
- 101000864681 Homo sapiens Putative ATP-dependent RNA helicase DHX57 Proteins 0.000 description 1
- 101000914992 Homo sapiens Putative C-mannosyltransferase DPY19L2P1 Proteins 0.000 description 1
- 101000919023 Homo sapiens Putative DENN domain-containing protein 10 B Proteins 0.000 description 1
- 101000908767 Homo sapiens Putative EP400-like protein Proteins 0.000 description 1
- 101000862167 Homo sapiens Putative F-box/LRR-repeat protein 21 Proteins 0.000 description 1
- 101001037674 Homo sapiens Putative HERC2-like protein 3 Proteins 0.000 description 1
- 101000752764 Homo sapiens Putative L-aspartate dehydrogenase Proteins 0.000 description 1
- 101000979901 Homo sapiens Putative NOL1/NOP2/Sun domain family member 5B Proteins 0.000 description 1
- 101001120091 Homo sapiens Putative P2Y purinoceptor 10 Proteins 0.000 description 1
- 101000728110 Homo sapiens Putative Polycomb group protein ASXL3 Proteins 0.000 description 1
- 101000622041 Homo sapiens Putative RNA-binding protein Luc7-like 1 Proteins 0.000 description 1
- 101000797990 Homo sapiens Putative activator of 90 kDa heat shock protein ATPase homolog 2 Proteins 0.000 description 1
- 101000797874 Homo sapiens Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13 Proteins 0.000 description 1
- 101000920979 Homo sapiens Putative ciliary rootlet coiled-coil protein-like 1 protein Proteins 0.000 description 1
- 101000868776 Homo sapiens Putative coiled-coil domain-containing protein 26 Proteins 0.000 description 1
- 101000931842 Homo sapiens Putative dehydrogenase/reductase SDR family member 4-like 1 Proteins 0.000 description 1
- 101001040122 Homo sapiens Putative glycerol kinase 5 Proteins 0.000 description 1
- 101000836459 Homo sapiens Putative glycosyltransferase ALG1-like Proteins 0.000 description 1
- 101001037087 Homo sapiens Putative golgin subfamily A member 2B Proteins 0.000 description 1
- 101000575036 Homo sapiens Putative homeobox protein Meis3-like 1 Proteins 0.000 description 1
- 101000935817 Homo sapiens Putative inactive beta-glucuronidase protein GUSBP11 Proteins 0.000 description 1
- 101001009894 Homo sapiens Putative inactive beta-glucuronidase-like protein SMA3 Proteins 0.000 description 1
- 101000762195 Homo sapiens Putative inactive carbonic anhydrase 5B-like protein Proteins 0.000 description 1
- 101000784192 Homo sapiens Putative inactive neutral ceramidase B Proteins 0.000 description 1
- 101000979900 Homo sapiens Putative methyltransferase NSUN5C Proteins 0.000 description 1
- 101001024615 Homo sapiens Putative neuroblastoma breakpoint family member 8 Proteins 0.000 description 1
- 101000996935 Homo sapiens Putative oxidoreductase GLYR1 Proteins 0.000 description 1
- 101000901964 Homo sapiens Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX32 Proteins 0.000 description 1
- 101000910029 Homo sapiens Putative protein CASTOR 3 Proteins 0.000 description 1
- 101000942692 Homo sapiens Putative protein CLUHP3 Proteins 0.000 description 1
- 101000875655 Homo sapiens Putative protein FAM157A Proteins 0.000 description 1
- 101000875661 Homo sapiens Putative protein FAM157B Proteins 0.000 description 1
- 101001048921 Homo sapiens Putative protein FAM86C1P Proteins 0.000 description 1
- 101001048978 Homo sapiens Putative protein FAM86C2P Proteins 0.000 description 1
- 101000611731 Homo sapiens Putative tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase Proteins 0.000 description 1
- 101000715813 Homo sapiens Putative transcriptional regulator encoded by LINC00473 Proteins 0.000 description 1
- 101000904783 Homo sapiens Putative tyrosine-protein phosphatase auxilin Proteins 0.000 description 1
- 101000785941 Homo sapiens Putative uncharacterized protein ASB16-AS1 Proteins 0.000 description 1
- 101000789825 Homo sapiens Putative uncharacterized protein ATP1A1-AS1 Proteins 0.000 description 1
- 101000864381 Homo sapiens Putative uncharacterized protein BVES-AS1 Proteins 0.000 description 1
- 101000914635 Homo sapiens Putative uncharacterized protein C8orf44 Proteins 0.000 description 1
- 101000899838 Homo sapiens Putative uncharacterized protein CCDC28A-AS1 Proteins 0.000 description 1
- 101000944527 Homo sapiens Putative uncharacterized protein LINC02901 Proteins 0.000 description 1
- 101000906818 Homo sapiens Putative uncharacterized protein encoded by LINC00476 Proteins 0.000 description 1
- 101000911557 Homo sapiens Putative uncharacterized protein encoded by LINC00869 Proteins 0.000 description 1
- 101000956303 Homo sapiens Putative uncharacterized protein encoded by MAPKAPK5-AS1 Proteins 0.000 description 1
- 101000878920 Homo sapiens Putative uncharacterized protein encoded by MIR22HG Proteins 0.000 description 1
- 101001131748 Homo sapiens Quinone oxidoreductase Proteins 0.000 description 1
- 101000713809 Homo sapiens Quinone oxidoreductase-like protein 1 Proteins 0.000 description 1
- 101000708591 Homo sapiens RAB11-binding protein RELCH Proteins 0.000 description 1
- 101001072492 Homo sapiens RAB6-interacting golgin Proteins 0.000 description 1
- 101001075671 Homo sapiens RAB7A-interacting MON1-CCZ1 complex subunit 1 Proteins 0.000 description 1
- 101000779418 Homo sapiens RAC-alpha serine/threonine-protein kinase Proteins 0.000 description 1
- 101000798015 Homo sapiens RAC-beta serine/threonine-protein kinase Proteins 0.000 description 1
- 101000798007 Homo sapiens RAC-gamma serine/threonine-protein kinase Proteins 0.000 description 1
- 101000990485 Homo sapiens RNA N6-adenosine-methyltransferase METTL16 Proteins 0.000 description 1
- 101001108656 Homo sapiens RNA cytosine C(5)-methyltransferase NSUN2 Proteins 0.000 description 1
- 101000959153 Homo sapiens RNA demethylase ALKBH5 Proteins 0.000 description 1
- 101001077478 Homo sapiens RNA guanine-N7 methyltransferase activating subunit Proteins 0.000 description 1
- 101000956729 Homo sapiens RNA helicase Mov10l1 Proteins 0.000 description 1
- 101000927086 Homo sapiens RNA helicase aquarius Proteins 0.000 description 1
- 101001048695 Homo sapiens RNA polymerase II elongation factor ELL Proteins 0.000 description 1
- 101001048702 Homo sapiens RNA polymerase II elongation factor ELL2 Proteins 0.000 description 1
- 101000629813 Homo sapiens RNA-binding protein MEX3B Proteins 0.000 description 1
- 101000591115 Homo sapiens RNA-binding protein Musashi homolog 1 Proteins 0.000 description 1
- 101000881131 Homo sapiens RNA/RNP complex-1-interacting phosphatase Proteins 0.000 description 1
- 101001132499 Homo sapiens RPA-related protein RADX Proteins 0.000 description 1
- 101000635838 Homo sapiens RUS family member 1 Proteins 0.000 description 1
- 101000620777 Homo sapiens Rab proteins geranylgeranyltransferase component A 1 Proteins 0.000 description 1
- 101000889795 Homo sapiens Rabankyrin-5 Proteins 0.000 description 1
- 101001017956 Homo sapiens Ragulator complex protein LAMTOR4 Proteins 0.000 description 1
- 101000994788 Homo sapiens Ras GTPase-activating-like protein IQGAP3 Proteins 0.000 description 1
- 101000744515 Homo sapiens Ras-related protein M-Ras Proteins 0.000 description 1
- 101001099877 Homo sapiens Ras-related protein Rab-43 Proteins 0.000 description 1
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 1
- 101001062222 Homo sapiens Receptor-binding cancer antigen expressed on SiSo cells Proteins 0.000 description 1
- 101000742934 Homo sapiens Retinol dehydrogenase 14 Proteins 0.000 description 1
- 101001090901 Homo sapiens Retroelement silencing factor 1 Proteins 0.000 description 1
- 101000856728 Homo sapiens Rho GDP-dissociation inhibitor 1 Proteins 0.000 description 1
- 101001106406 Homo sapiens Rho GTPase-activating protein 1 Proteins 0.000 description 1
- 101000581153 Homo sapiens Rho GTPase-activating protein 10 Proteins 0.000 description 1
- 101000707664 Homo sapiens Rho GTPase-activating protein 11A Proteins 0.000 description 1
- 101000581155 Homo sapiens Rho GTPase-activating protein 12 Proteins 0.000 description 1
- 101000581173 Homo sapiens Rho GTPase-activating protein 17 Proteins 0.000 description 1
- 101000581129 Homo sapiens Rho GTPase-activating protein 19 Proteins 0.000 description 1
- 101001091996 Homo sapiens Rho GTPase-activating protein 22 Proteins 0.000 description 1
- 101001091998 Homo sapiens Rho GTPase-activating protein 23 Proteins 0.000 description 1
- 101001091990 Homo sapiens Rho GTPase-activating protein 24 Proteins 0.000 description 1
- 101001091984 Homo sapiens Rho GTPase-activating protein 26 Proteins 0.000 description 1
- 101001075528 Homo sapiens Rho GTPase-activating protein 28 Proteins 0.000 description 1
- 101001075558 Homo sapiens Rho GTPase-activating protein 29 Proteins 0.000 description 1
- 101001075565 Homo sapiens Rho GTPase-activating protein 30 Proteins 0.000 description 1
- 101001075563 Homo sapiens Rho GTPase-activating protein 31 Proteins 0.000 description 1
- 101001075561 Homo sapiens Rho GTPase-activating protein 32 Proteins 0.000 description 1
- 101000703465 Homo sapiens Rho GTPase-activating protein 33 Proteins 0.000 description 1
- 101000703428 Homo sapiens Rho GTPase-activating protein 36 Proteins 0.000 description 1
- 101000703425 Homo sapiens Rho GTPase-activating protein 39 Proteins 0.000 description 1
- 101000703439 Homo sapiens Rho GTPase-activating protein 42 Proteins 0.000 description 1
- 101001081189 Homo sapiens Rho GTPase-activating protein 45 Proteins 0.000 description 1
- 101001106395 Homo sapiens Rho GTPase-activating protein 5 Proteins 0.000 description 1
- 101001106322 Homo sapiens Rho GTPase-activating protein 7 Proteins 0.000 description 1
- 101001106309 Homo sapiens Rho GTPase-activating protein 8 Proteins 0.000 description 1
- 101000927778 Homo sapiens Rho guanine nucleotide exchange factor 10 Proteins 0.000 description 1
- 101000885382 Homo sapiens Rho guanine nucleotide exchange factor 10-like protein Proteins 0.000 description 1
- 101000927776 Homo sapiens Rho guanine nucleotide exchange factor 11 Proteins 0.000 description 1
- 101000927774 Homo sapiens Rho guanine nucleotide exchange factor 12 Proteins 0.000 description 1
- 101000731730 Homo sapiens Rho guanine nucleotide exchange factor 18 Proteins 0.000 description 1
- 101000752221 Homo sapiens Rho guanine nucleotide exchange factor 2 Proteins 0.000 description 1
- 101000731733 Homo sapiens Rho guanine nucleotide exchange factor 25 Proteins 0.000 description 1
- 101000731737 Homo sapiens Rho guanine nucleotide exchange factor 26 Proteins 0.000 description 1
- 101000733257 Homo sapiens Rho guanine nucleotide exchange factor 28 Proteins 0.000 description 1
- 101000752249 Homo sapiens Rho guanine nucleotide exchange factor 3 Proteins 0.000 description 1
- 101000733264 Homo sapiens Rho guanine nucleotide exchange factor 33 Proteins 0.000 description 1
- 101000733268 Homo sapiens Rho guanine nucleotide exchange factor 39 Proteins 0.000 description 1
- 101000752241 Homo sapiens Rho guanine nucleotide exchange factor 4 Proteins 0.000 description 1
- 101000886098 Homo sapiens Rho guanine nucleotide exchange factor 40 Proteins 0.000 description 1
- 101000927799 Homo sapiens Rho guanine nucleotide exchange factor 6 Proteins 0.000 description 1
- 101000927773 Homo sapiens Rho guanine nucleotide exchange factor 9 Proteins 0.000 description 1
- 101000846198 Homo sapiens Ribitol 5-phosphate transferase FKRP Proteins 0.000 description 1
- 101000846336 Homo sapiens Ribitol-5-phosphate transferase FKTN Proteins 0.000 description 1
- 101000854388 Homo sapiens Ribonuclease 3 Proteins 0.000 description 1
- 101000575639 Homo sapiens Ribonucleoside-diphosphate reductase subunit M2 Proteins 0.000 description 1
- 101001023680 Homo sapiens Ribosomal RNA small subunit methyltransferase NEP1 Proteins 0.000 description 1
- 101000712821 Homo sapiens Ribosomal biogenesis factor Proteins 0.000 description 1
- 101001008515 Homo sapiens Ribosomal biogenesis protein LAS1L Proteins 0.000 description 1
- 101000984584 Homo sapiens Ribosome biogenesis protein BOP1 Proteins 0.000 description 1
- 101000652153 Homo sapiens Ribosome biogenesis protein SLX9 homolog Proteins 0.000 description 1
- 101000973629 Homo sapiens Ribosome quality control complex subunit NEMF Proteins 0.000 description 1
- 101000719024 Homo sapiens Ribosome-releasing factor 2, mitochondrial Proteins 0.000 description 1
- 101000920971 Homo sapiens Rootletin Proteins 0.000 description 1
- 101001010890 Homo sapiens S-formylglutathione hydrolase Proteins 0.000 description 1
- 101001046948 Homo sapiens SANT and BTB domain regulator of class switch recombination Proteins 0.000 description 1
- 101000650863 Homo sapiens SH2 domain-containing protein 1A Proteins 0.000 description 1
- 101000616556 Homo sapiens SH3 domain-containing protein 19 Proteins 0.000 description 1
- 101000824890 Homo sapiens SOSS complex subunit B2 Proteins 0.000 description 1
- 101000711793 Homo sapiens SOSS complex subunit C Proteins 0.000 description 1
- 101000588012 Homo sapiens SREBP regulating gene protein Proteins 0.000 description 1
- 101000867039 Homo sapiens SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related Proteins 0.000 description 1
- 101000936917 Homo sapiens Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 Proteins 0.000 description 1
- 101000836983 Homo sapiens Secretoglobin family 1D member 1 Proteins 0.000 description 1
- 101000867413 Homo sapiens Segment polarity protein dishevelled homolog DVL-1 Proteins 0.000 description 1
- 101000867469 Homo sapiens Segment polarity protein dishevelled homolog DVL-3 Proteins 0.000 description 1
- 101000898985 Homo sapiens Seipin Proteins 0.000 description 1
- 101000739577 Homo sapiens Selenocysteine-specific elongation factor Proteins 0.000 description 1
- 101000851593 Homo sapiens Separin Proteins 0.000 description 1
- 101000604981 Homo sapiens Serine beta-lactamase-like protein LACTB, mitochondrial Proteins 0.000 description 1
- 101000868088 Homo sapiens Serine-rich coiled-coil domain-containing protein 1 Proteins 0.000 description 1
- 101000868090 Homo sapiens Serine-rich coiled-coil domain-containing protein 2 Proteins 0.000 description 1
- 101000771237 Homo sapiens Serine/threonine-protein kinase A-Raf Proteins 0.000 description 1
- 101000984753 Homo sapiens Serine/threonine-protein kinase B-raf Proteins 0.000 description 1
- 101000794043 Homo sapiens Serine/threonine-protein kinase BRSK2 Proteins 0.000 description 1
- 101000777293 Homo sapiens Serine/threonine-protein kinase Chk1 Proteins 0.000 description 1
- 101000777277 Homo sapiens Serine/threonine-protein kinase Chk2 Proteins 0.000 description 1
- 101000885387 Homo sapiens Serine/threonine-protein kinase DCLK2 Proteins 0.000 description 1
- 101000913761 Homo sapiens Serine/threonine-protein kinase ICK Proteins 0.000 description 1
- 101001047642 Homo sapiens Serine/threonine-protein kinase LATS1 Proteins 0.000 description 1
- 101001047637 Homo sapiens Serine/threonine-protein kinase LATS2 Proteins 0.000 description 1
- 101001038341 Homo sapiens Serine/threonine-protein kinase LMTK3 Proteins 0.000 description 1
- 101001059443 Homo sapiens Serine/threonine-protein kinase MARK1 Proteins 0.000 description 1
- 101001059454 Homo sapiens Serine/threonine-protein kinase MARK2 Proteins 0.000 description 1
- 101000576901 Homo sapiens Serine/threonine-protein kinase MRCK alpha Proteins 0.000 description 1
- 101000576904 Homo sapiens Serine/threonine-protein kinase MRCK beta Proteins 0.000 description 1
- 101001123846 Homo sapiens Serine/threonine-protein kinase Nek1 Proteins 0.000 description 1
- 101001123812 Homo sapiens Serine/threonine-protein kinase Nek11 Proteins 0.000 description 1
- 101000601460 Homo sapiens Serine/threonine-protein kinase Nek4 Proteins 0.000 description 1
- 101000588545 Homo sapiens Serine/threonine-protein kinase Nek7 Proteins 0.000 description 1
- 101000588553 Homo sapiens Serine/threonine-protein kinase Nek9 Proteins 0.000 description 1
- 101001098464 Homo sapiens Serine/threonine-protein kinase OSR1 Proteins 0.000 description 1
- 101000987310 Homo sapiens Serine/threonine-protein kinase PAK 2 Proteins 0.000 description 1
- 101000987315 Homo sapiens Serine/threonine-protein kinase PAK 3 Proteins 0.000 description 1
- 101000987297 Homo sapiens Serine/threonine-protein kinase PAK 4 Proteins 0.000 description 1
- 101001036145 Homo sapiens Serine/threonine-protein kinase greatwall Proteins 0.000 description 1
- 101000780111 Homo sapiens Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A Proteins 0.000 description 1
- 101000732374 Homo sapiens Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B Proteins 0.000 description 1
- 101000875296 Homo sapiens Serine/threonine-protein phosphatase CPPED1 Proteins 0.000 description 1
- 101000836079 Homo sapiens Serpin B8 Proteins 0.000 description 1
- 101000703089 Homo sapiens Set1/Ash2 histone methyltransferase complex subunit ASH2 Proteins 0.000 description 1
- 101000632626 Homo sapiens Shieldin complex subunit 2 Proteins 0.000 description 1
- 101000863858 Homo sapiens Sialic acid synthase Proteins 0.000 description 1
- 101000884271 Homo sapiens Signal transducer CD24 Proteins 0.000 description 1
- 101000911790 Homo sapiens Sister chromatid cohesion protein DCC1 Proteins 0.000 description 1
- 101000897669 Homo sapiens Small RNA 2'-O-methyltransferase Proteins 0.000 description 1
- 101000687673 Homo sapiens Small integral membrane protein 6 Proteins 0.000 description 1
- 101000651933 Homo sapiens Small kinetochore-associated protein Proteins 0.000 description 1
- 101000654381 Homo sapiens Sodium channel protein type 8 subunit alpha Proteins 0.000 description 1
- 101000631937 Homo sapiens Sodium- and chloride-dependent glycine transporter 2 Proteins 0.000 description 1
- 101000639975 Homo sapiens Sodium-dependent noradrenaline transporter Proteins 0.000 description 1
- 101001125064 Homo sapiens Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 1 Proteins 0.000 description 1
- 101000974834 Homo sapiens Sodium/potassium-transporting ATPase subunit beta-3 Proteins 0.000 description 1
- 101000910249 Homo sapiens Soluble calcium-activated nucleotidase 1 Proteins 0.000 description 1
- 101000911601 Homo sapiens Soluble lamin-associated protein of 75 kDa Proteins 0.000 description 1
- 101000868152 Homo sapiens Son of sevenless homolog 1 Proteins 0.000 description 1
- 101000642315 Homo sapiens Spermatogenesis-associated protein 17 Proteins 0.000 description 1
- 101000889087 Homo sapiens Spliceosome-associated protein CWC27 homolog Proteins 0.000 description 1
- 101000878981 Homo sapiens Squalene synthase Proteins 0.000 description 1
- 101000829367 Homo sapiens Src substrate cortactin Proteins 0.000 description 1
- 101000861263 Homo sapiens Steroid 21-hydroxylase Proteins 0.000 description 1
- 101000851696 Homo sapiens Steroid hormone receptor ERR2 Proteins 0.000 description 1
- 101000634060 Homo sapiens Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating Proteins 0.000 description 1
- 101000829168 Homo sapiens Succinate-semialdehyde dehydrogenase, mitochondrial Proteins 0.000 description 1
- 101000716763 Homo sapiens Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial Proteins 0.000 description 1
- 101000852716 Homo sapiens T-cell immunomodulatory protein Proteins 0.000 description 1
- 101000946863 Homo sapiens T-cell surface glycoprotein CD3 delta chain Proteins 0.000 description 1
- 101000946833 Homo sapiens T-cell surface glycoprotein CD8 beta chain Proteins 0.000 description 1
- 101000595467 Homo sapiens T-complex protein 1 subunit gamma Proteins 0.000 description 1
- 101000653469 Homo sapiens T-complex protein 1 subunit zeta Proteins 0.000 description 1
- 101000694973 Homo sapiens TATA-binding protein-associated factor 172 Proteins 0.000 description 1
- 101000831671 Homo sapiens TLC domain-containing protein 3A Proteins 0.000 description 1
- 101000795744 Homo sapiens TPA-induced transmembrane protein Proteins 0.000 description 1
- 101000652747 Homo sapiens Target of rapamycin complex 2 subunit MAPKAP1 Proteins 0.000 description 1
- 101000800495 Homo sapiens Telomere length and silencing protein 1 homolog Proteins 0.000 description 1
- 101000735431 Homo sapiens Terminal nucleotidyltransferase 4A Proteins 0.000 description 1
- 101000735429 Homo sapiens Terminal nucleotidyltransferase 4B Proteins 0.000 description 1
- 101000728490 Homo sapiens Tether containing UBX domain for GLUT4 Proteins 0.000 description 1
- 101000737828 Homo sapiens Threonylcarbamoyladenosine tRNA methylthiotransferase Proteins 0.000 description 1
- 101001027052 Homo sapiens Thymidylate kinase Proteins 0.000 description 1
- 101000890857 Homo sapiens Trans-3-hydroxy-L-proline dehydratase Proteins 0.000 description 1
- 101000819111 Homo sapiens Trans-acting T-cell-specific transcription factor GATA-3 Proteins 0.000 description 1
- 101000984924 Homo sapiens Transcription factor BTF3 homolog 4 Proteins 0.000 description 1
- 101000909637 Homo sapiens Transcription factor COE1 Proteins 0.000 description 1
- 101000909629 Homo sapiens Transcription factor COE4 Proteins 0.000 description 1
- 101000904150 Homo sapiens Transcription factor E2F3 Proteins 0.000 description 1
- 101000866340 Homo sapiens Transcription factor E2F6 Proteins 0.000 description 1
- 101000866292 Homo sapiens Transcription factor E2F7 Proteins 0.000 description 1
- 101000879604 Homo sapiens Transcription factor E4F1 Proteins 0.000 description 1
- 101000813738 Homo sapiens Transcription factor ETV6 Proteins 0.000 description 1
- 101001057127 Homo sapiens Transcription factor ETV7 Proteins 0.000 description 1
- 101000819074 Homo sapiens Transcription factor GATA-4 Proteins 0.000 description 1
- 101000843562 Homo sapiens Transcription factor HES-4 Proteins 0.000 description 1
- 101000723923 Homo sapiens Transcription factor HIVEP2 Proteins 0.000 description 1
- 101000723938 Homo sapiens Transcription factor HIVEP3 Proteins 0.000 description 1
- 101000740968 Homo sapiens Transcription factor IIIB 50 kDa subunit Proteins 0.000 description 1
- 101000714243 Homo sapiens Transcription factor IIIB 90 kDa subunit Proteins 0.000 description 1
- 101000946163 Homo sapiens Transcription factor LBX2 Proteins 0.000 description 1
- 101000962473 Homo sapiens Transcription factor MafG Proteins 0.000 description 1
- 101000933296 Homo sapiens Transcription factor TFIIIB component B'' homolog Proteins 0.000 description 1
- 101000838169 Homo sapiens Transcription initiation factor IIA subunit 2 Proteins 0.000 description 1
- 101000800860 Homo sapiens Transcription initiation factor IIB Proteins 0.000 description 1
- 101000894871 Homo sapiens Transcription regulator protein BACH1 Proteins 0.000 description 1
- 101000904499 Homo sapiens Transcription regulator protein BACH2 Proteins 0.000 description 1
- 101000594308 Homo sapiens Transcription termination factor 4, mitochondrial Proteins 0.000 description 1
- 101000687727 Homo sapiens Transcriptional regulator PINT87aa Proteins 0.000 description 1
- 101001125582 Homo sapiens Transcriptional repressor NF-X1 Proteins 0.000 description 1
- 101001098095 Homo sapiens Transcriptional repressor p66-alpha Proteins 0.000 description 1
- 101001098093 Homo sapiens Transcriptional repressor p66-beta Proteins 0.000 description 1
- 101001071076 Homo sapiens Translation factor GUF1, mitochondrial Proteins 0.000 description 1
- 101000840378 Homo sapiens Translation initiation factor IF-2, mitochondrial Proteins 0.000 description 1
- 101001034442 Homo sapiens Translation initiation factor IF-3, mitochondrial Proteins 0.000 description 1
- 101000925985 Homo sapiens Translation initiation factor eIF-2B subunit epsilon Proteins 0.000 description 1
- 101001049688 Homo sapiens Translation initiation factor eIF-2B subunit gamma Proteins 0.000 description 1
- 101000895030 Homo sapiens Transmembrane ascorbate-dependent reductase CYB561 Proteins 0.000 description 1
- 101000798702 Homo sapiens Transmembrane protease serine 4 Proteins 0.000 description 1
- 101001012550 Homo sapiens Transmembrane protein 180 Proteins 0.000 description 1
- 101000946675 Homo sapiens Transmembrane protein CCDC163 Proteins 0.000 description 1
- 101000896379 Homo sapiens Transmembrane reductase CYB561D2 Proteins 0.000 description 1
- 101000837854 Homo sapiens Transport and Golgi organization protein 1 homolog Proteins 0.000 description 1
- 101000679907 Homo sapiens Tumor necrosis factor receptor superfamily member 27 Proteins 0.000 description 1
- 101000962366 Homo sapiens Type II inositol 1,4,5-trisphosphate 5-phosphatase Proteins 0.000 description 1
- 101000690425 Homo sapiens Type-1 angiotensin II receptor Proteins 0.000 description 1
- 101000765743 Homo sapiens Type-1 angiotensin II receptor-associated protein Proteins 0.000 description 1
- 101000971144 Homo sapiens Tyrosine-protein kinase BAZ1B Proteins 0.000 description 1
- 101000864342 Homo sapiens Tyrosine-protein kinase BTK Proteins 0.000 description 1
- 101001026790 Homo sapiens Tyrosine-protein kinase Fes/Fps Proteins 0.000 description 1
- 101001022129 Homo sapiens Tyrosine-protein kinase Fyn Proteins 0.000 description 1
- 101000997835 Homo sapiens Tyrosine-protein kinase JAK1 Proteins 0.000 description 1
- 101000934996 Homo sapiens Tyrosine-protein kinase JAK3 Proteins 0.000 description 1
- 101001087412 Homo sapiens Tyrosine-protein phosphatase non-receptor type 18 Proteins 0.000 description 1
- 101000639802 Homo sapiens U2 small nuclear ribonucleoprotein B'' Proteins 0.000 description 1
- 101000638903 Homo sapiens U3 small nucleolar RNA-associated protein 25 homolog Proteins 0.000 description 1
- 101001017896 Homo sapiens U6 snRNA-associated Sm-like protein LSm1 Proteins 0.000 description 1
- 101000579613 Homo sapiens U6 snRNA-associated Sm-like protein LSm5 Proteins 0.000 description 1
- 101000697875 Homo sapiens UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 1 Proteins 0.000 description 1
- 101000697888 Homo sapiens UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2 Proteins 0.000 description 1
- 101000798377 Homo sapiens UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1 Proteins 0.000 description 1
- 101000836466 Homo sapiens UDP-N-acetylglucosamine transferase subunit ALG14 homolog Proteins 0.000 description 1
- 101000819146 Homo sapiens UDP-glucose 4-epimerase Proteins 0.000 description 1
- 101000989650 Homo sapiens UNC93-like protein MFSD11 Proteins 0.000 description 1
- 101000710897 Homo sapiens UPF0235 protein C15orf40 Proteins 0.000 description 1
- 101000942220 Homo sapiens UPF0449 protein C19orf25 Proteins 0.000 description 1
- 101000884249 Homo sapiens UPF0462 protein C4orf33 Proteins 0.000 description 1
- 101000945558 Homo sapiens UPF0489 protein C5orf22 Proteins 0.000 description 1
- 101000910952 Homo sapiens UPF0538 protein C2orf76 Proteins 0.000 description 1
- 101000889074 Homo sapiens UPF0545 protein C22orf39 Proteins 0.000 description 1
- 101000855244 Homo sapiens UPF0547 protein C16orf87 Proteins 0.000 description 1
- 101000894586 Homo sapiens UPF0687 protein C20orf27 Proteins 0.000 description 1
- 101000956262 Homo sapiens UPF0692 protein C19orf54 Proteins 0.000 description 1
- 101000957919 Homo sapiens UPF0711 protein C18orf21 Proteins 0.000 description 1
- 101000860842 Homo sapiens Ubiquinone biosynthesis O-methyltransferase, mitochondrial Proteins 0.000 description 1
- 101000952936 Homo sapiens Ubiquinone biosynthesis monooxygenase COQ6, mitochondrial Proteins 0.000 description 1
- 101000875780 Homo sapiens Ubiquinone biosynthesis protein COQ4 homolog, mitochondrial Proteins 0.000 description 1
- 101000860835 Homo sapiens Ubiquinone biosynthesis protein COQ9, mitochondrial Proteins 0.000 description 1
- 101000740048 Homo sapiens Ubiquitin carboxyl-terminal hydrolase BAP1 Proteins 0.000 description 1
- 101000573455 Homo sapiens Ubiquitin carboxyl-terminal hydrolase MINDY-1 Proteins 0.000 description 1
- 101001052436 Homo sapiens Ubiquitin carboxyl-terminal hydrolase MINDY-2 Proteins 0.000 description 1
- 101001052435 Homo sapiens Ubiquitin carboxyl-terminal hydrolase MINDY-3 Proteins 0.000 description 1
- 101000721404 Homo sapiens Ubiquitin thioesterase otulin Proteins 0.000 description 1
- 101000671855 Homo sapiens Ubiquitin-associated and SH3 domain-containing protein A Proteins 0.000 description 1
- 101000789849 Homo sapiens Ubiquitin-like-conjugating enzyme ATG10 Proteins 0.000 description 1
- 101000887051 Homo sapiens Ubiquitin-like-conjugating enzyme ATG3 Proteins 0.000 description 1
- 101000989779 Homo sapiens Uncharacterized protein C12orf29 Proteins 0.000 description 1
- 101000912683 Homo sapiens Uncharacterized protein C12orf76 Proteins 0.000 description 1
- 101000900761 Homo sapiens Uncharacterized protein C14orf93 Proteins 0.000 description 1
- 101000941633 Homo sapiens Uncharacterized protein C16orf46 Proteins 0.000 description 1
- 101000855256 Homo sapiens Uncharacterized protein C16orf74 Proteins 0.000 description 1
- 101000878916 Homo sapiens Uncharacterized protein C17orf80 Proteins 0.000 description 1
- 101000942211 Homo sapiens Uncharacterized protein C19orf44 Proteins 0.000 description 1
- 101000956356 Homo sapiens Uncharacterized protein C19orf47 Proteins 0.000 description 1
- 101000956263 Homo sapiens Uncharacterized protein C19orf48 Proteins 0.000 description 1
- 101000894576 Homo sapiens Uncharacterized protein C20orf96 Proteins 0.000 description 1
- 101000983603 Homo sapiens Uncharacterized protein C2orf27A Proteins 0.000 description 1
- 101000983556 Homo sapiens Uncharacterized protein C2orf42 Proteins 0.000 description 1
- 101000910945 Homo sapiens Uncharacterized protein C2orf74 Proteins 0.000 description 1
- 101000932572 Homo sapiens Uncharacterized protein C3orf62 Proteins 0.000 description 1
- 101000944530 Homo sapiens Uncharacterized protein C6orf62 Proteins 0.000 description 1
- 101000709998 Homo sapiens Uncharacterized protein C7orf26 Proteins 0.000 description 1
- 101000709994 Homo sapiens Uncharacterized protein C7orf31 Proteins 0.000 description 1
- 101000709986 Homo sapiens Uncharacterized protein C7orf50 Proteins 0.000 description 1
- 101000914628 Homo sapiens Uncharacterized protein C8orf34 Proteins 0.000 description 1
- 101000914632 Homo sapiens Uncharacterized protein C8orf58 Proteins 0.000 description 1
- 101000944558 Homo sapiens Uncharacterized protein C8orf88 Proteins 0.000 description 1
- 101000989478 Homo sapiens Uncharacterized protein C9orf85 Proteins 0.000 description 1
- 101000942290 Homo sapiens Uncharacterized protein CLBA1 Proteins 0.000 description 1
- 101000947196 Homo sapiens Uncharacterized protein CXorf38 Proteins 0.000 description 1
- 101000889122 Homo sapiens Uncharacterized protein CXorf65 Proteins 0.000 description 1
- 101000813311 Homo sapiens Uncharacterized protein FAM120AOS Proteins 0.000 description 1
- 101001028389 Homo sapiens Uncharacterized protein KIAA0895-like Proteins 0.000 description 1
- 101000972817 Homo sapiens Uncharacterized protein NKAPD1 Proteins 0.000 description 1
- 101000746197 Homo sapiens Uncharacterized protein encoded by LINC01547 Proteins 0.000 description 1
- 101000958729 Homo sapiens Unconventional myosin-IXa Proteins 0.000 description 1
- 101000958733 Homo sapiens Unconventional myosin-IXb Proteins 0.000 description 1
- 101000982054 Homo sapiens Unconventional myosin-Ib Proteins 0.000 description 1
- 101001000122 Homo sapiens Unconventional myosin-Ie Proteins 0.000 description 1
- 101000583031 Homo sapiens Unconventional myosin-Va Proteins 0.000 description 1
- 101000582993 Homo sapiens Unconventional myosin-Vb Proteins 0.000 description 1
- 101001128483 Homo sapiens Unconventional myosin-Vc Proteins 0.000 description 1
- 101001030255 Homo sapiens Unconventional myosin-XVIIIa Proteins 0.000 description 1
- 101000991938 Homo sapiens Uridine diphosphate glucose pyrophosphatase NUDT14 Proteins 0.000 description 1
- 101000590277 Homo sapiens Uridine diphosphate glucose pyrophosphatase NUDT22 Proteins 0.000 description 1
- 101000805729 Homo sapiens V-type proton ATPase 116 kDa subunit a 1 Proteins 0.000 description 1
- 101000854879 Homo sapiens V-type proton ATPase 116 kDa subunit a 2 Proteins 0.000 description 1
- 101000641419 Homo sapiens V-type proton ATPase 16 kDa proteolipid subunit c Proteins 0.000 description 1
- 101000806601 Homo sapiens V-type proton ATPase catalytic subunit A Proteins 0.000 description 1
- 101000775702 Homo sapiens V-type proton ATPase subunit C 2 Proteins 0.000 description 1
- 101000850489 Homo sapiens V-type proton ATPase subunit D Proteins 0.000 description 1
- 101000670960 Homo sapiens V-type proton ATPase subunit E 1 Proteins 0.000 description 1
- 101000807961 Homo sapiens V-type proton ATPase subunit H Proteins 0.000 description 1
- 101000807892 Homo sapiens V-type proton ATPase subunit S1-like protein Proteins 0.000 description 1
- 101000852150 Homo sapiens V-type proton ATPase subunit d 1 Proteins 0.000 description 1
- 101000749359 Homo sapiens V-type proton ATPase subunit e 1 Proteins 0.000 description 1
- 101001038317 Homo sapiens VIP36-like protein Proteins 0.000 description 1
- 101000591906 Homo sapiens Vacuolar fusion protein MON1 homolog A Proteins 0.000 description 1
- 101000851018 Homo sapiens Vascular endothelial growth factor receptor 1 Proteins 0.000 description 1
- 101001070756 Homo sapiens Vasculin Proteins 0.000 description 1
- 101001070761 Homo sapiens Vasculin-like protein 1 Proteins 0.000 description 1
- 101000859452 Homo sapiens Very large A-kinase anchor protein Proteins 0.000 description 1
- 101000806266 Homo sapiens Very-long-chain 3-oxoacyl-CoA reductase Proteins 0.000 description 1
- 101000904204 Homo sapiens Vesicle transport protein GOT1B Proteins 0.000 description 1
- 101000873111 Homo sapiens Vesicle transport protein SEC20 Proteins 0.000 description 1
- 101000596394 Homo sapiens Vesicle-fusing ATPase Proteins 0.000 description 1
- 101000805481 Homo sapiens Vigilin Proteins 0.000 description 1
- 101000742236 Homo sapiens Vitamin K-dependent gamma-carboxylase Proteins 0.000 description 1
- 101000867811 Homo sapiens Voltage-dependent L-type calcium channel subunit alpha-1C Proteins 0.000 description 1
- 101000932850 Homo sapiens Voltage-dependent L-type calcium channel subunit beta-1 Proteins 0.000 description 1
- 101000983936 Homo sapiens Voltage-dependent L-type calcium channel subunit beta-3 Proteins 0.000 description 1
- 101000983947 Homo sapiens Voltage-dependent L-type calcium channel subunit beta-4 Proteins 0.000 description 1
- 101000935117 Homo sapiens Voltage-dependent P/Q-type calcium channel subunit alpha-1A Proteins 0.000 description 1
- 101000868398 Homo sapiens Voltage-dependent calcium channel gamma-7 subunit Proteins 0.000 description 1
- 101000740755 Homo sapiens Voltage-dependent calcium channel subunit alpha-2/delta-1 Proteins 0.000 description 1
- 101000740759 Homo sapiens Voltage-dependent calcium channel subunit alpha-2/delta-2 Proteins 0.000 description 1
- 101000740762 Homo sapiens Voltage-dependent calcium channel subunit alpha-2/delta-3 Proteins 0.000 description 1
- 101000740765 Homo sapiens Voltage-dependent calcium channel subunit alpha-2/delta-4 Proteins 0.000 description 1
- 101000997307 Homo sapiens Voltage-gated potassium channel subunit beta-2 Proteins 0.000 description 1
- 101000997303 Homo sapiens Voltage-gated potassium channel subunit beta-3 Proteins 0.000 description 1
- 101000965721 Homo sapiens Volume-regulated anion channel subunit LRRC8A Proteins 0.000 description 1
- 101000965724 Homo sapiens Volume-regulated anion channel subunit LRRC8B Proteins 0.000 description 1
- 101000965705 Homo sapiens Volume-regulated anion channel subunit LRRC8D Proteins 0.000 description 1
- 101000723920 Homo sapiens Zinc finger protein 40 Proteins 0.000 description 1
- 101000964789 Homo sapiens Zinc finger protein 83 Proteins 0.000 description 1
- 101000785596 Homo sapiens Zinc finger protein 875 Proteins 0.000 description 1
- 101000931048 Homo sapiens Zinc finger protein DPF3 Proteins 0.000 description 1
- 101000599046 Homo sapiens Zinc finger protein Eos Proteins 0.000 description 1
- 101001059220 Homo sapiens Zinc finger protein Gfi-1 Proteins 0.000 description 1
- 101001002579 Homo sapiens Zinc finger protein Pegasus Proteins 0.000 description 1
- 101000740482 Homo sapiens Zinc finger protein basonuclin-2 Proteins 0.000 description 1
- 101000864118 Homo sapiens Zinc finger protein neuro-d4 Proteins 0.000 description 1
- 101000669028 Homo sapiens Zinc phosphodiesterase ELAC protein 2 Proteins 0.000 description 1
- 101000991029 Homo sapiens [F-actin]-monooxygenase MICAL2 Proteins 0.000 description 1
- 101000991054 Homo sapiens [F-actin]-monooxygenase MICAL3 Proteins 0.000 description 1
- 101001013509 Homo sapiens bMERB domain-containing protein 1 Proteins 0.000 description 1
- 101000919269 Homo sapiens cAMP-responsive element modulator Proteins 0.000 description 1
- 101000926525 Homo sapiens eIF-2-alpha kinase GCN2 Proteins 0.000 description 1
- 101000862627 Homo sapiens eIF-2-alpha kinase activator GCN1 Proteins 0.000 description 1
- 101000744322 Homo sapiens eIF5-mimic protein 1 Proteins 0.000 description 1
- 101001059630 Homo sapiens m-AAA protease-interacting protein 1, mitochondrial Proteins 0.000 description 1
- 101000873780 Homo sapiens m7GpppN-mRNA hydrolase Proteins 0.000 description 1
- 101000871498 Homo sapiens m7GpppX diphosphatase Proteins 0.000 description 1
- 101001012525 Homo sapiens mRNA N(3)-methylcytidine methyltransferase METTL8 Proteins 0.000 description 1
- 101000802094 Homo sapiens mRNA decay activator protein ZFP36L1 Proteins 0.000 description 1
- 101000802101 Homo sapiens mRNA decay activator protein ZFP36L2 Proteins 0.000 description 1
- 101001039228 Homo sapiens mRNA export factor GLE1 Proteins 0.000 description 1
- 101000873785 Homo sapiens mRNA-decapping enzyme 1A Proteins 0.000 description 1
- 101000873789 Homo sapiens mRNA-decapping enzyme 1B Proteins 0.000 description 1
- 101000730577 Homo sapiens p21-activated protein kinase-interacting protein 1 Proteins 0.000 description 1
- 101001012529 Homo sapiens rRNA N6-adenosine-methyltransferase METTL5 Proteins 0.000 description 1
- 101000824120 Homo sapiens rRNA-processing protein FCF1 homolog Proteins 0.000 description 1
- 101001108648 Homo sapiens tRNA (cytosine(34)-C(5))-methyltransferase, mitochondrial Proteins 0.000 description 1
- 101001108578 Homo sapiens tRNA (cytosine(72)-C(5))-methyltransferase NSUN6 Proteins 0.000 description 1
- 101000830183 Homo sapiens tRNA (guanine-N(7)-)-methyltransferase Proteins 0.000 description 1
- 101001033204 Homo sapiens tRNA N(3)-methylcytidine methyltransferase METTL2A Proteins 0.000 description 1
- 101000582267 Homo sapiens tRNA N(3)-methylcytidine methyltransferase METTL2B Proteins 0.000 description 1
- 101001012521 Homo sapiens tRNA N(3)-methylcytidine methyltransferase METTL6 Proteins 0.000 description 1
- 101000924022 Homo sapiens tRNA-dihydrouridine(16/17) synthase [NAD(P)(+)]-like Proteins 0.000 description 1
- 101000838340 Homo sapiens tRNA-dihydrouridine(20) synthase [NAD(P)+]-like Proteins 0.000 description 1
- 101001057626 Homo sapiens tRNA-dihydrouridine(20a/20b) synthase [NAD(P)+]-like Proteins 0.000 description 1
- 101000923892 Homo sapiens tRNA-uridine aminocarboxypropyltransferase 1 Proteins 0.000 description 1
- 102100039923 Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein Human genes 0.000 description 1
- 102100039926 Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 2 protein Human genes 0.000 description 1
- 102100026020 Hormone-sensitive lipase Human genes 0.000 description 1
- 108010027310 Host Cell Factor C1 Proteins 0.000 description 1
- 102100030355 Host cell factor 1 Human genes 0.000 description 1
- 102100030357 Host cell factor 2 Human genes 0.000 description 1
- 102100029105 Host cell factor C1 regulator 1 Human genes 0.000 description 1
- 102100031716 Hsp70-binding protein 1 Human genes 0.000 description 1
- 101150069138 HtrA2 gene Proteins 0.000 description 1
- 102100029066 Humanin-like 2 Human genes 0.000 description 1
- 102100035957 Huntingtin-interacting protein 1 Human genes 0.000 description 1
- 102100028084 Hyaluronan and proteoglycan link protein 1 Human genes 0.000 description 1
- 102100027735 Hyaluronan mediated motility receptor Human genes 0.000 description 1
- 102100021082 Hyaluronidase-3 Human genes 0.000 description 1
- 102100022652 Hyccin Human genes 0.000 description 1
- 102100030358 Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial Human genes 0.000 description 1
- 102100027953 Hydroxyacyl-thioester dehydratase type 2, mitochondrial Human genes 0.000 description 1
- 102100040544 Hydroxyacylglutathione hydrolase, mitochondrial Human genes 0.000 description 1
- 102100034468 Hydroxyacylglutathione hydrolase-like protein Human genes 0.000 description 1
- 102100024004 Hydroxymethylglutaryl-CoA lyase, mitochondrial Human genes 0.000 description 1
- 102100028888 Hydroxymethylglutaryl-CoA synthase, cytoplasmic Human genes 0.000 description 1
- 102100036501 Hydroxysteroid 11-beta-dehydrogenase 1-like protein Human genes 0.000 description 1
- 102100021656 Hydroxysteroid dehydrogenase-like protein 2 Human genes 0.000 description 1
- 102100020755 Hypoxia up-regulated protein 1 Human genes 0.000 description 1
- 102100022875 Hypoxia-inducible factor 1-alpha Human genes 0.000 description 1
- 102100030481 Hypoxia-inducible factor 1-alpha inhibitor Human genes 0.000 description 1
- 102000001284 I-kappa-B kinase Human genes 0.000 description 1
- 108060006678 I-kappa-B kinase Proteins 0.000 description 1
- 102100025958 IGF-like family receptor 1 Human genes 0.000 description 1
- 101150009156 IGSF1 gene Proteins 0.000 description 1
- 102100033277 INO80 complex subunit C Human genes 0.000 description 1
- 102100033276 INO80 complex subunit E Human genes 0.000 description 1
- 102100029842 IQ calmodulin-binding motif-containing protein 1 Human genes 0.000 description 1
- 102100029841 IQ domain-containing protein C Human genes 0.000 description 1
- 102100029840 IQ domain-containing protein E Human genes 0.000 description 1
- 102100024415 IQ domain-containing protein K Human genes 0.000 description 1
- 102100025097 IQ motif and SEC7 domain-containing protein 1 Human genes 0.000 description 1
- 102100034416 IQCJ-SCHIP1 readthrough transcript protein Human genes 0.000 description 1
- 102100023423 IST1 homolog Human genes 0.000 description 1
- 102100029199 Iduronate 2-sulfatase Human genes 0.000 description 1
- 102100026120 IgG receptor FcRn large subunit p51 Human genes 0.000 description 1
- 102100029612 IgLON family member 5 Human genes 0.000 description 1
- 101150018316 Igsf3 gene Proteins 0.000 description 1
- 102100039724 Immunoglobulin superfamily DCC subclass member 4 Human genes 0.000 description 1
- 102100023540 Immunoglobulin superfamily containing leucine-rich repeat protein 2 Human genes 0.000 description 1
- 102100022514 Immunoglobulin superfamily member 1 Human genes 0.000 description 1
- 102100022519 Immunoglobulin superfamily member 3 Human genes 0.000 description 1
- 102100021042 Immunoglobulin-binding protein 1 Human genes 0.000 description 1
- 102100030712 Immunoglobulin-like domain-containing receptor 2 Human genes 0.000 description 1
- 102100036188 Importin subunit alpha-3 Human genes 0.000 description 1
- 102100027007 Importin subunit alpha-6 Human genes 0.000 description 1
- 102100027002 Importin subunit alpha-7 Human genes 0.000 description 1
- 102100036341 Importin-4 Human genes 0.000 description 1
- 102100037963 Importin-7 Human genes 0.000 description 1
- 102100037966 Importin-8 Human genes 0.000 description 1
- 102100037961 Importin-9 Human genes 0.000 description 1
- 102100037978 InaD-like protein Human genes 0.000 description 1
- 102100022247 Inactive cytidine monophosphate-N-acetylneuraminic acid hydroxylase Human genes 0.000 description 1
- 102100022966 Inactive glycosyltransferase 25 family member 3 Human genes 0.000 description 1
- 102100027767 Inactive histone-lysine N-methyltransferase 2E Human genes 0.000 description 1
- 102100039437 Inactive serine protease PAMR1 Human genes 0.000 description 1
- 102100025186 Inactive ubiquitin thioesterase OTULINL Human genes 0.000 description 1
- 102100033180 Indolethylamine N-methyltransferase Human genes 0.000 description 1
- 102100029241 Influenza virus NS1A-binding protein Human genes 0.000 description 1
- 102000055031 Inhibitor of Apoptosis Proteins Human genes 0.000 description 1
- 102100024070 Inhibitor of growth protein 3 Human genes 0.000 description 1
- 102100035677 Inhibitor of growth protein 4 Human genes 0.000 description 1
- 102100035676 Inhibitor of growth protein 5 Human genes 0.000 description 1
- 102100021857 Inhibitor of nuclear factor kappa-B kinase subunit epsilon Human genes 0.000 description 1
- 102100021595 Inhibitor of nuclear factor kappa-B kinase-interacting protein Human genes 0.000 description 1
- 102100039872 Inner centromere protein Human genes 0.000 description 1
- 102100028799 Inner nuclear membrane protein Man1 Human genes 0.000 description 1
- 102100025458 Inosine triphosphate pyrophosphatase Human genes 0.000 description 1
- 102100021602 Inosine-5'-monophosphate dehydrogenase 1 Human genes 0.000 description 1
- 102100036343 Inositol 1,4,5-triphosphate receptor associated 2 Human genes 0.000 description 1
- 102100024039 Inositol 1,4,5-trisphosphate receptor type 1 Human genes 0.000 description 1
- 102100024037 Inositol 1,4,5-trisphosphate receptor type 2 Human genes 0.000 description 1
- 102100030213 Inositol hexakisphosphate kinase 1 Human genes 0.000 description 1
- 102100030212 Inositol hexakisphosphate kinase 2 Human genes 0.000 description 1
- 102100035679 Inositol monophosphatase 1 Human genes 0.000 description 1
- 102100021608 Inositol monophosphatase 2 Human genes 0.000 description 1
- 102100026819 Inositol polyphosphate 1-phosphatase Human genes 0.000 description 1
- 101710133957 Inositol polyphosphate 1-phosphatase Proteins 0.000 description 1
- 102100024368 Inositol polyphosphate 5-phosphatase K Human genes 0.000 description 1
- 102100026724 Inositol polyphosphate 5-phosphatase OCRL Human genes 0.000 description 1
- 102100024367 Inositol polyphosphate-4-phosphatase type I A Human genes 0.000 description 1
- 102100039253 Inositol polyphosphate-5-phosphatase A Human genes 0.000 description 1
- 102100036881 Inositol-3-phosphate synthase 1 Human genes 0.000 description 1
- 102100031525 Inositol-pentakisphosphate 2-kinase Human genes 0.000 description 1
- 102100022296 Inositol-tetrakisphosphate 1-kinase Human genes 0.000 description 1
- 102100024392 Insulin gene enhancer protein ISL-1 Human genes 0.000 description 1
- 102100036721 Insulin receptor Human genes 0.000 description 1
- 102100021496 Insulin-degrading enzyme Human genes 0.000 description 1
- 102100037919 Insulin-like growth factor 2 mRNA-binding protein 2 Human genes 0.000 description 1
- 102100037920 Insulin-like growth factor 2 mRNA-binding protein 3 Human genes 0.000 description 1
- 102100029180 Insulin-like growth factor-binding protein 6 Human genes 0.000 description 1
- 102100023351 Integral membrane protein 2A Human genes 0.000 description 1
- 102100025464 Integral membrane protein 2C Human genes 0.000 description 1
- 102100020700 Integral membrane protein DGCR2/IDD Human genes 0.000 description 1
- 102100035568 Integral membrane protein GPR137 Human genes 0.000 description 1
- 102100035571 Integral membrane protein GPR137B Human genes 0.000 description 1
- 102100031110 Integral membrane protein GPR137C Human genes 0.000 description 1
- 102100041017 Integral membrane protein GPR155 Human genes 0.000 description 1
- 102100021244 Integral membrane protein GPR180 Human genes 0.000 description 1
- 102100024370 Integrator complex subunit 11 Human genes 0.000 description 1
- 102100037944 Integrator complex subunit 12 Human genes 0.000 description 1
- 102100027019 Integrator complex subunit 13 Human genes 0.000 description 1
- 102100027018 Integrator complex subunit 14 Human genes 0.000 description 1
- 102100033265 Integrator complex subunit 2 Human genes 0.000 description 1
- 102100033263 Integrator complex subunit 3 Human genes 0.000 description 1
- 102100039134 Integrator complex subunit 4 Human genes 0.000 description 1
- 102100030147 Integrator complex subunit 7 Human genes 0.000 description 1
- 102100030148 Integrator complex subunit 8 Human genes 0.000 description 1
- 102100030206 Integrator complex subunit 9 Human genes 0.000 description 1
- 102100025323 Integrin alpha-1 Human genes 0.000 description 1
- 102100025310 Integrin alpha-10 Human genes 0.000 description 1
- 102100032819 Integrin alpha-3 Human genes 0.000 description 1
- 102100032832 Integrin alpha-7 Human genes 0.000 description 1
- 102100032825 Integrin alpha-8 Human genes 0.000 description 1
- 102100039903 Integrin alpha-9 Human genes 0.000 description 1
- 102100022341 Integrin alpha-E Human genes 0.000 description 1
- 102100022338 Integrin alpha-M Human genes 0.000 description 1
- 102100022337 Integrin alpha-V Human genes 0.000 description 1
- 102100022297 Integrin alpha-X Human genes 0.000 description 1
- 102100033335 Integrin beta-1-binding protein 1 Human genes 0.000 description 1
- 102100033010 Integrin beta-5 Human genes 0.000 description 1
- 101710160759 Integrin-linked kinase-associated serine/threonine phosphatase 2C Proteins 0.000 description 1
- 102100039884 Integrin-linked kinase-associated serine/threonine phosphatase 2C Human genes 0.000 description 1
- 102100020944 Integrin-linked protein kinase Human genes 0.000 description 1
- 102100039454 Inter-alpha-trypsin inhibitor heavy chain H5 Human genes 0.000 description 1
- 102100026213 Interactor of HORMAD1 protein 1 Human genes 0.000 description 1
- 102100022711 Interactor protein for cytohesin exchange factors 1 Human genes 0.000 description 1
- 102100040064 Interferon alpha-inducible protein 27-like protein 1 Human genes 0.000 description 1
- 102100040063 Interferon alpha-inducible protein 27-like protein 2 Human genes 0.000 description 1
- 102100036714 Interferon alpha/beta receptor 1 Human genes 0.000 description 1
- 102100036718 Interferon alpha/beta receptor 2 Human genes 0.000 description 1
- 102100036157 Interferon gamma receptor 2 Human genes 0.000 description 1
- 102100029838 Interferon regulatory factor 2 Human genes 0.000 description 1
- 102100029843 Interferon regulatory factor 3 Human genes 0.000 description 1
- 102100030126 Interferon regulatory factor 4 Human genes 0.000 description 1
- 102100030130 Interferon regulatory factor 6 Human genes 0.000 description 1
- 102100031802 Interferon-induced GTP-binding protein Mx1 Human genes 0.000 description 1
- 102100039953 Interferon-induced protein 44-like Human genes 0.000 description 1
- 102100040021 Interferon-induced transmembrane protein 1 Human genes 0.000 description 1
- 102100036527 Interferon-related developmental regulator 1 Human genes 0.000 description 1
- 102100025957 Interleukin-1 receptor-associated kinase 1-binding protein 1 Human genes 0.000 description 1
- 102100023530 Interleukin-1 receptor-associated kinase 3 Human genes 0.000 description 1
- 102100023533 Interleukin-1 receptor-associated kinase 4 Human genes 0.000 description 1
- 102100036433 Interleukin-1 receptor-associated kinase-like 2 Human genes 0.000 description 1
- 102100030236 Interleukin-10 receptor subunit alpha Human genes 0.000 description 1
- 102100020787 Interleukin-11 receptor subunit alpha Human genes 0.000 description 1
- 102100020792 Interleukin-12 receptor subunit beta-2 Human genes 0.000 description 1
- 102100020791 Interleukin-13 receptor subunit alpha-1 Human genes 0.000 description 1
- 102000003812 Interleukin-15 Human genes 0.000 description 1
- 108090000172 Interleukin-15 Proteins 0.000 description 1
- 102100020789 Interleukin-15 receptor subunit alpha Human genes 0.000 description 1
- 102100035018 Interleukin-17 receptor A Human genes 0.000 description 1
- 102100035014 Interleukin-17 receptor B Human genes 0.000 description 1
- 102100035012 Interleukin-17 receptor C Human genes 0.000 description 1
- 102100035016 Interleukin-17 receptor E Human genes 0.000 description 1
- 102100033096 Interleukin-17D Human genes 0.000 description 1
- 102100035010 Interleukin-18 receptor accessory protein Human genes 0.000 description 1
- 102100035017 Interleukin-18-binding protein Human genes 0.000 description 1
- 102100026878 Interleukin-2 receptor subunit alpha Human genes 0.000 description 1
- 108010017411 Interleukin-21 Receptors Proteins 0.000 description 1
- 102100030699 Interleukin-21 receptor Human genes 0.000 description 1
- 108010066979 Interleukin-27 Proteins 0.000 description 1
- 102100033501 Interleukin-32 Human genes 0.000 description 1
- 102100039078 Interleukin-4 receptor subunit alpha Human genes 0.000 description 1
- 102100037792 Interleukin-6 receptor subunit alpha Human genes 0.000 description 1
- 102100037795 Interleukin-6 receptor subunit beta Human genes 0.000 description 1
- 102100021593 Interleukin-7 receptor subunit alpha Human genes 0.000 description 1
- 102100037441 Intermediate conductance calcium-activated potassium channel protein 4 Human genes 0.000 description 1
- 102100025494 Intersectin-1 Human genes 0.000 description 1
- 102100025505 Intersectin-2 Human genes 0.000 description 1
- 102100039227 Intracellular hyaluronan-binding protein 4 Human genes 0.000 description 1
- 102100021502 Intraflagellar transport protein 122 homolog Human genes 0.000 description 1
- 102100039927 Intraflagellar transport protein 140 homolog Human genes 0.000 description 1
- 102100039929 Intraflagellar transport protein 172 homolog Human genes 0.000 description 1
- 102100026220 Intraflagellar transport protein 20 homolog Human genes 0.000 description 1
- 102100026218 Intraflagellar transport protein 22 homolog Human genes 0.000 description 1
- 102100039349 Intraflagellar transport protein 25 homolog Human genes 0.000 description 1
- 101710134808 Intraflagellar transport protein 25 homolog Proteins 0.000 description 1
- 102100039343 Intraflagellar transport protein 27 homolog Human genes 0.000 description 1
- 101710119233 Intraflagellar transport protein 27 homolog Proteins 0.000 description 1
- 102100039342 Intraflagellar transport protein 43 homolog Human genes 0.000 description 1
- 102100022470 Intraflagellar transport protein 52 homolog Human genes 0.000 description 1
- 102100029996 Intraflagellar transport protein 57 homolog Human genes 0.000 description 1
- 102100030002 Intraflagellar transport protein 80 homolog Human genes 0.000 description 1
- 102100030001 Intraflagellar transport protein 81 homolog Human genes 0.000 description 1
- 102100030007 Intraflagellar transport protein 88 homolog Human genes 0.000 description 1
- 102100030498 Intron Large complex component GCFC2 Human genes 0.000 description 1
- 102100033257 Inversin Human genes 0.000 description 1
- 102100030075 Inverted formin-2 Human genes 0.000 description 1
- 108090001028 Iron regulatory protein 2 Proteins 0.000 description 1
- 102000004902 Iron regulatory protein 2 Human genes 0.000 description 1
- 102100031404 Iron-sulfur cluster assembly 1 homolog, mitochondrial Human genes 0.000 description 1
- 102100027530 Iron-sulfur cluster co-chaperone protein HscB Human genes 0.000 description 1
- 102100021998 Iron-sulfur protein NUBPL Human genes 0.000 description 1
- 102100027640 Islet cell autoantigen 1 Human genes 0.000 description 1
- 102100027664 Islet cell autoantigen 1-like protein Human genes 0.000 description 1
- 102100031385 Isochorismatase domain-containing protein 2 Human genes 0.000 description 1
- 102100039905 Isocitrate dehydrogenase [NADP] cytoplasmic Human genes 0.000 description 1
- 102100021332 Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial Human genes 0.000 description 1
- 102100021311 Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial Human genes 0.000 description 1
- 102100039906 Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial Human genes 0.000 description 1
- 102100027665 Isopentenyl-diphosphate Delta-isomerase 1 Human genes 0.000 description 1
- 108060001621 Isoprenylcysteine carboxyl methyltransferase Proteins 0.000 description 1
- 102100025392 Isovaleryl-CoA dehydrogenase, mitochondrial Human genes 0.000 description 1
- 101710201965 Isovaleryl-CoA dehydrogenase, mitochondrial Proteins 0.000 description 1
- 102100025837 JNK1/MAPK8-associated membrane protein Human genes 0.000 description 1
- 101710176060 JNK1/MAPK8-associated membrane protein Proteins 0.000 description 1
- 102100033439 Janus kinase and microtubule-interacting protein 2 Human genes 0.000 description 1
- 102100023958 JmjC domain-containing protein 8 Human genes 0.000 description 1
- 102100024407 Jouberin Human genes 0.000 description 1
- 102100023957 Junctional protein associated with coronary artery disease Human genes 0.000 description 1
- 101710116238 Junctional protein associated with coronary artery disease Proteins 0.000 description 1
- 102100023130 Jupiter microtubule associated homolog 2 Human genes 0.000 description 1
- 108091007984 KARS Proteins 0.000 description 1
- 102100023009 KAT8 regulatory NSL complex subunit 1-like protein Human genes 0.000 description 1
- 102100022902 KAT8 regulatory NSL complex subunit 2 Human genes 0.000 description 1
- 102100037489 KAT8 regulatory NSL complex subunit 3 Human genes 0.000 description 1
- 102100022592 KATNB1-like protein 1 Human genes 0.000 description 1
- 102000017839 KCMF1 Human genes 0.000 description 1
- 108010011185 KCNQ1 Potassium Channel Proteins 0.000 description 1
- 102100023428 KH domain-containing, RNA-binding, signal transduction-associated protein 3 Human genes 0.000 description 1
- 102100021448 KH homology domain-containing protein 1 Human genes 0.000 description 1
- 101710015718 KIAA0100 Proteins 0.000 description 1
- 101710015514 KIAA0232 Proteins 0.000 description 1
- 101710036322 KIAA0586 Proteins 0.000 description 1
- 101710041373 KIAA0753 Proteins 0.000 description 1
- 101710041042 KIAA0825 Proteins 0.000 description 1
- 101710047833 KIAA0895 Proteins 0.000 description 1
- 101710024993 KIAA1109 Proteins 0.000 description 1
- 101710059984 KIAA1191 Proteins 0.000 description 1
- 101710059804 KIAA1217 Proteins 0.000 description 1
- 101710059787 KIAA1328 Proteins 0.000 description 1
- 101710060083 KIAA1522 Proteins 0.000 description 1
- 101710029140 KIAA1549 Proteins 0.000 description 1
- 101710169267 KIAA1586 Proteins 0.000 description 1
- 101710058882 KIAA1671 Proteins 0.000 description 1
- 101710059175 KIAA1958 Proteins 0.000 description 1
- 101710042703 KIAA2026 Proteins 0.000 description 1
- 102100023500 KICSTOR complex protein ITFG2 Human genes 0.000 description 1
- 102100024883 KICSTOR complex protein kaptin Human genes 0.000 description 1
- 102100022891 KN motif and ankyrin repeat domain-containing protein 1 Human genes 0.000 description 1
- 102100022888 KN motif and ankyrin repeat domain-containing protein 2 Human genes 0.000 description 1
- 102100037326 KRAB domain-containing protein 4 Human genes 0.000 description 1
- 108700042464 KRIT1 Proteins 0.000 description 1
- 101150090242 KRIT1 gene Proteins 0.000 description 1
- 102100029874 Kappa-casein Human genes 0.000 description 1
- 102100022968 Katanin p60 ATPase-containing subunit A-like 1 Human genes 0.000 description 1
- 102100022971 Katanin p60 ATPase-containing subunit A-like 2 Human genes 0.000 description 1
- 102100038197 Katanin p60 ATPase-containing subunit A1 Human genes 0.000 description 1
- 102100025636 Katanin-interacting protein Human genes 0.000 description 1
- 102100021190 Kazrin Human genes 0.000 description 1
- 102100037645 Kelch domain-containing protein 10 Human genes 0.000 description 1
- 102100033602 Kelch domain-containing protein 3 Human genes 0.000 description 1
- 102100033603 Kelch domain-containing protein 4 Human genes 0.000 description 1
- 102100033604 Kelch domain-containing protein 8B Human genes 0.000 description 1
- 102100034075 Kelch repeat and BTB domain-containing protein 2 Human genes 0.000 description 1
- 102100022837 Kelch repeat and BTB domain-containing protein 3 Human genes 0.000 description 1
- 102100022830 Kelch repeat and BTB domain-containing protein 8 Human genes 0.000 description 1
- 108090000484 Kelch-Like ECH-Associated Protein 1 Proteins 0.000 description 1
- 102000004034 Kelch-Like ECH-Associated Protein 1 Human genes 0.000 description 1
- 102100034855 Kelch-like protein 12 Human genes 0.000 description 1
- 102100034861 Kelch-like protein 13 Human genes 0.000 description 1
- 102100023684 Kelch-like protein 17 Human genes 0.000 description 1
- 102100023680 Kelch-like protein 18 Human genes 0.000 description 1
- 102100022120 Kelch-like protein 2 Human genes 0.000 description 1
- 102100023681 Kelch-like protein 20 Human genes 0.000 description 1
- 102100027793 Kelch-like protein 22 Human genes 0.000 description 1
- 102100027794 Kelch-like protein 24 Human genes 0.000 description 1
- 102100027785 Kelch-like protein 5 Human genes 0.000 description 1
- 102100027789 Kelch-like protein 7 Human genes 0.000 description 1
- 102100027615 Kelch-like protein 8 Human genes 0.000 description 1
- 102100023972 Keratin, type II cytoskeletal 8 Human genes 0.000 description 1
- 102100023418 Ketohexokinase Human genes 0.000 description 1
- 102100037378 Ketosamine-3-kinase Human genes 0.000 description 1
- 102100023678 Killer cell lectin-like receptor subfamily B member 1 Human genes 0.000 description 1
- 102100021457 Killer cell lectin-like receptor subfamily G member 1 Human genes 0.000 description 1
- 102100021465 Killer cell lectin-like receptor subfamily G member 2 Human genes 0.000 description 1
- 102100020687 Kin of IRRE-like protein 1 Human genes 0.000 description 1
- 102100034831 Kin of IRRE-like protein 3 Human genes 0.000 description 1
- 102100023924 Kinase D-interacting substrate of 220 kDa Human genes 0.000 description 1
- 102100021001 Kinase suppressor of Ras 1 Human genes 0.000 description 1
- 102100034751 Kinectin Human genes 0.000 description 1
- 102100027928 Kinesin heavy chain isoform 5C Human genes 0.000 description 1
- 102100038306 Kinesin light chain 1 Human genes 0.000 description 1
- 102100038316 Kinesin light chain 4 Human genes 0.000 description 1
- 102100027930 Kinesin-associated protein 3 Human genes 0.000 description 1
- 102100027629 Kinesin-like protein KIF11 Human genes 0.000 description 1
- 102100034865 Kinesin-like protein KIF13A Human genes 0.000 description 1
- 102100034863 Kinesin-like protein KIF13B Human genes 0.000 description 1
- 102100027631 Kinesin-like protein KIF14 Human genes 0.000 description 1
- 102100027630 Kinesin-like protein KIF15 Human genes 0.000 description 1
- 102100034894 Kinesin-like protein KIF16B Human genes 0.000 description 1
- 102100034896 Kinesin-like protein KIF18B Human genes 0.000 description 1
- 102100021527 Kinesin-like protein KIF1A Human genes 0.000 description 1
- 102100021524 Kinesin-like protein KIF1B Human genes 0.000 description 1
- 102100021525 Kinesin-like protein KIF1C Human genes 0.000 description 1
- 102100037688 Kinesin-like protein KIF21A Human genes 0.000 description 1
- 102100037690 Kinesin-like protein KIF21B Human genes 0.000 description 1
- 102100038406 Kinesin-like protein KIF23 Human genes 0.000 description 1
- 102100038403 Kinesin-like protein KIF24 Human genes 0.000 description 1
- 102100037692 Kinesin-like protein KIF26B Human genes 0.000 description 1
- 102100038405 Kinesin-like protein KIF27 Human genes 0.000 description 1
- 102100023426 Kinesin-like protein KIF2A Human genes 0.000 description 1
- 102100023424 Kinesin-like protein KIF2C Human genes 0.000 description 1
- 102100023425 Kinesin-like protein KIF3A Human genes 0.000 description 1
- 102100027926 Kinesin-like protein KIF9 Human genes 0.000 description 1
- 102100027942 Kinesin-like protein KIFC1 Human genes 0.000 description 1
- 102100032431 Kinetochore protein Nuf2 Human genes 0.000 description 1
- 102100021464 Kinetochore scaffold 1 Human genes 0.000 description 1
- 102100028394 Kinetochore-associated protein 1 Human genes 0.000 description 1
- 102100024062 Kinetochore-associated protein DSN1 homolog Human genes 0.000 description 1
- 102100020880 Kit ligand Human genes 0.000 description 1
- 102100038173 Kremen protein 1 Human genes 0.000 description 1
- 102100035878 Krev interaction trapped protein 1 Human genes 0.000 description 1
- 102100027792 Krueppel-like factor 12 Human genes 0.000 description 1
- 102100020680 Krueppel-like factor 5 Human genes 0.000 description 1
- 102100020691 Krueppel-like factor 8 Human genes 0.000 description 1
- 102100040621 Kynurenine formamidase Human genes 0.000 description 1
- 102100021209 Kynurenine-oxoglutarate transaminase 1 Human genes 0.000 description 1
- 102100022892 Kynurenine-oxoglutarate transaminase 3 Human genes 0.000 description 1
- 102100020920 L-2-hydroxyglutarate dehydrogenase, mitochondrial Human genes 0.000 description 1
- 102100040648 L-fucose kinase Human genes 0.000 description 1
- 102100031357 L-lactate dehydrogenase C chain Human genes 0.000 description 1
- 102100029137 L-xylulose reductase Human genes 0.000 description 1
- 108010080643 L-xylulose reductase Proteins 0.000 description 1
- 102100030818 LBH domain-containing protein 1 Human genes 0.000 description 1
- 102100028291 LEM domain-containing protein 2 Human genes 0.000 description 1
- 102100038448 LETM1 domain-containing protein 1 Human genes 0.000 description 1
- 102100039183 LETM1 domain-containing protein LETM2, mitochondrial Human genes 0.000 description 1
- PWOLHTNHGNWQMH-UHFFFAOYSA-N LGPVTQE Natural products CC(C)CC(N)C(=O)NCC(=O)N1CCCC1C(=O)NC(C(C)C)C(=O)NC(C(C)O)C(=O)NC(CCC(N)=O)C(=O)NC(CCC(O)=O)C(O)=O PWOLHTNHGNWQMH-UHFFFAOYSA-N 0.000 description 1
- 102100025687 LHFPL tetraspan subfamily member 2 protein Human genes 0.000 description 1
- 102100033338 LIM and calponin homology domains-containing protein 1 Human genes 0.000 description 1
- 102100021620 LIM and cysteine-rich domains protein 1 Human genes 0.000 description 1
- 102100021755 LIM and senescent cell antigen-like-containing domain protein 2 Human genes 0.000 description 1
- 102100021756 LIM domain kinase 2 Human genes 0.000 description 1
- 102100033515 LIM domain only protein 7 Human genes 0.000 description 1
- 102100035113 LIM domain-binding protein 2 Human genes 0.000 description 1
- 108091007710 LINC00665 Proteins 0.000 description 1
- 108091007705 LINC00673 Proteins 0.000 description 1
- 102100025850 LIX1-like protein Human genes 0.000 description 1
- 102100022957 LLGL scribble cell polarity complex component 2 Human genes 0.000 description 1
- 102100040390 LON peptidase N-terminal domain and RING finger protein 1 Human genes 0.000 description 1
- 102100040389 LON peptidase N-terminal domain and RING finger protein 3 Human genes 0.000 description 1
- 101150116611 LRRC51 gene Proteins 0.000 description 1
- 102000016443 LTN1 Human genes 0.000 description 1
- 102100032135 LYR motif-containing protein 1 Human genes 0.000 description 1
- 102100020859 La-related protein 1 Human genes 0.000 description 1
- 102100030947 La-related protein 1B Human genes 0.000 description 1
- 102100020861 La-related protein 4 Human genes 0.000 description 1
- 102100030946 La-related protein 4B Human genes 0.000 description 1
- 102100027436 La-related protein 7 Human genes 0.000 description 1
- 101000741319 Lachesis muta rhombeata Lachesicidin Proteins 0.000 description 1
- 102100039648 Lactadherin Human genes 0.000 description 1
- 102100035192 Laforin Human genes 0.000 description 1
- 102100039324 Lambda-crystallin homolog Human genes 0.000 description 1
- 102100022745 Laminin subunit alpha-2 Human genes 0.000 description 1
- 102100022743 Laminin subunit alpha-4 Human genes 0.000 description 1
- 102100027450 Laminin subunit alpha-5 Human genes 0.000 description 1
- 102100027454 Laminin subunit beta-2 Human genes 0.000 description 1
- 102100035158 Laminin subunit gamma-3 Human genes 0.000 description 1
- 102100032011 Lanosterol synthase Human genes 0.000 description 1
- 102100038235 Large neutral amino acids transporter small subunit 2 Human genes 0.000 description 1
- 102100027113 Large subunit GTPase 1 homolog Human genes 0.000 description 1
- 102100021155 Lariat debranching enzyme Human genes 0.000 description 1
- 102100032642 Late secretory pathway protein AVL9 homolog Human genes 0.000 description 1
- 102100027000 Latent-transforming growth factor beta-binding protein 1 Human genes 0.000 description 1
- 102100027017 Latent-transforming growth factor beta-binding protein 2 Human genes 0.000 description 1
- 102100023757 Latent-transforming growth factor beta-binding protein 4 Human genes 0.000 description 1
- 101000740049 Latilactobacillus curvatus Bioactive peptide 1 Proteins 0.000 description 1
- 102100026029 Lck-interacting transmembrane adapter 1 Human genes 0.000 description 1
- 102100030985 Legumain Human genes 0.000 description 1
- 102100026040 Leishmanolysin-like peptidase Human genes 0.000 description 1
- 102100028295 Lens epithelial cell protein LEP503 Human genes 0.000 description 1
- 102100021883 Leptin receptor overlapping transcript-like 1 Human genes 0.000 description 1
- 102100040546 Lethal(3)malignant brain tumor-like protein 2 Human genes 0.000 description 1
- 102100040548 Lethal(3)malignant brain tumor-like protein 3 Human genes 0.000 description 1
- 102100021737 Leucine carboxyl methyltransferase 1 Human genes 0.000 description 1
- 102100032097 Leucine repeat adapter protein 25 Human genes 0.000 description 1
- 102100026915 Leucine zipper protein 1 Human genes 0.000 description 1
- 101710142669 Leucine zipper putative tumor suppressor 1 Proteins 0.000 description 1
- 102100021803 Leucine zipper transcription factor-like protein 1 Human genes 0.000 description 1
- 108010020246 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 Proteins 0.000 description 1
- 102100040589 Leucine-rich PPR motif-containing protein, mitochondrial Human genes 0.000 description 1
- 102100028268 Leucine-rich melanocyte differentiation-associated protein Human genes 0.000 description 1
- 102100032680 Leucine-rich repeat and calponin homology domain-containing protein 4 Human genes 0.000 description 1
- 102100032676 Leucine-rich repeat and coiled-coil domain-containing protein 1 Human genes 0.000 description 1
- 102100024103 Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 2 Human genes 0.000 description 1
- 102100033303 Leucine-rich repeat flightless-interacting protein 1 Human genes 0.000 description 1
- 102100032694 Leucine-rich repeat flightless-interacting protein 2 Human genes 0.000 description 1
- 102100032657 Leucine-rich repeat neuronal protein 3 Human genes 0.000 description 1
- 102100040249 Leucine-rich repeat protein 1 Human genes 0.000 description 1
- 102100032656 Leucine-rich repeat serine/threonine-protein kinase 1 Human genes 0.000 description 1
- 102100032693 Leucine-rich repeat serine/threonine-protein kinase 2 Human genes 0.000 description 1
- 102100040900 Leucine-rich repeat transmembrane protein FLRT3 Human genes 0.000 description 1
- 102100031036 Leucine-rich repeat-containing G-protein coupled receptor 5 Human genes 0.000 description 1
- 102100033287 Leucine-rich repeat-containing protein 14 Human genes 0.000 description 1
- 102100040690 Leucine-rich repeat-containing protein 17 Human genes 0.000 description 1
- 102100040691 Leucine-rich repeat-containing protein 23 Human genes 0.000 description 1
- 102100025949 Leucine-rich repeat-containing protein 28 Human genes 0.000 description 1
- 102100027500 Leucine-rich repeat-containing protein 34 Human genes 0.000 description 1
- 102100022675 Leucine-rich repeat-containing protein 37A2 Human genes 0.000 description 1
- 102100040480 Leucine-rich repeat-containing protein 37B Human genes 0.000 description 1
- 102100027151 Leucine-rich repeat-containing protein 40 Human genes 0.000 description 1
- 102100027170 Leucine-rich repeat-containing protein 42 Human genes 0.000 description 1
- 102100022562 Leucine-rich repeat-containing protein 45 Human genes 0.000 description 1
- 102100022179 Leucine-rich repeat-containing protein 49 Human genes 0.000 description 1
- 102100022182 Leucine-rich repeat-containing protein 4B Human genes 0.000 description 1
- 102100022186 Leucine-rich repeat-containing protein 51 Human genes 0.000 description 1
- 102100027507 Leucine-rich repeat-containing protein 58 Human genes 0.000 description 1
- 102100040979 Leucine-rich repeat-containing protein 69 Human genes 0.000 description 1
- 102100022176 Leucine-rich repeat-containing protein 70 Human genes 0.000 description 1
- 102100040981 Leucine-rich repeat-containing protein 73 Human genes 0.000 description 1
- 102100032096 Leucine-rich repeat-containing protein 75B Human genes 0.000 description 1
- 102100022170 Leucine-rich repeats and immunoglobulin-like domains protein 1 Human genes 0.000 description 1
- 102100022173 Leucine-rich repeats and immunoglobulin-like domains protein 2 Human genes 0.000 description 1
- 102100033284 Leucine-rich repeats and immunoglobulin-like domains protein 3 Human genes 0.000 description 1
- 102100023339 Leucine-tRNA ligase, cytoplasmic Human genes 0.000 description 1
- 102100023342 Leucine-tRNA ligase, mitochondrial Human genes 0.000 description 1
- 102100030893 Leukemia-associated protein 1 Human genes 0.000 description 1
- 102100025586 Leukocyte immunoglobulin-like receptor subfamily A member 2 Human genes 0.000 description 1
- 102100025582 Leukocyte immunoglobulin-like receptor subfamily B member 3 Human genes 0.000 description 1
- 102100028297 Leukocyte receptor cluster member 8 Human genes 0.000 description 1
- 102100032913 Leukocyte surface antigen CD47 Human genes 0.000 description 1
- 102100024221 Leukocyte surface antigen CD53 Human genes 0.000 description 1
- 102100022118 Leukotriene A-4 hydrolase Human genes 0.000 description 1
- 102100033374 Leukotriene B4 receptor 1 Human genes 0.000 description 1
- 102100032755 Leupaxin Human genes 0.000 description 1
- 102100022408 Ligand of Numb protein X 2 Human genes 0.000 description 1
- 102100038260 Ligand-dependent corepressor Human genes 0.000 description 1
- 102100038259 Ligand-dependent nuclear receptor corepressor-like protein Human genes 0.000 description 1
- 102100022172 Ligand-dependent nuclear receptor-interacting factor 1 Human genes 0.000 description 1
- 102100040547 Limb region 1 protein homolog Human genes 0.000 description 1
- 102100031360 Lipid droplet-associated hydrolase Human genes 0.000 description 1
- 102100027931 Lipid droplet-regulating VLDL assembly factor AUP1 Human genes 0.000 description 1
- 102100027064 Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial Human genes 0.000 description 1
- 102100032010 Lipolysis-stimulated lipoprotein receptor Human genes 0.000 description 1
- 102100026358 Lipoma-preferred partner Human genes 0.000 description 1
- 102100033353 Lipopolysaccharide-responsive and beige-like anchor protein Human genes 0.000 description 1
- 102100021174 Lipoyl synthase, mitochondrial Human genes 0.000 description 1
- 102100025853 Lipoyltransferase 1, mitochondrial Human genes 0.000 description 1
- 102100036882 LisH domain-containing protein ARMC9 Human genes 0.000 description 1
- 102100039423 Little elongation complex subunit 1 Human genes 0.000 description 1
- 102100025889 Lon protease homolog 2, peroxisomal Human genes 0.000 description 1
- 102100034389 Low density lipoprotein receptor adapter protein 1 Human genes 0.000 description 1
- 102100024640 Low-density lipoprotein receptor Human genes 0.000 description 1
- 102100032092 Low-density lipoprotein receptor class A domain-containing protein 3 Human genes 0.000 description 1
- 102100032094 Low-density lipoprotein receptor class A domain-containing protein 4 Human genes 0.000 description 1
- 102100027119 Low-density lipoprotein receptor-related protein 11 Human genes 0.000 description 1
- 102100027120 Low-density lipoprotein receptor-related protein 12 Human genes 0.000 description 1
- 102100021922 Low-density lipoprotein receptor-related protein 2 Human genes 0.000 description 1
- 102100021926 Low-density lipoprotein receptor-related protein 5 Human genes 0.000 description 1
- 102100040705 Low-density lipoprotein receptor-related protein 8 Human genes 0.000 description 1
- 102100027434 Luc7-like protein 3 Human genes 0.000 description 1
- 102100035138 Lung adenoma susceptibility protein 2 Human genes 0.000 description 1
- 102100040284 Ly6/PLAUR domain-containing protein 1 Human genes 0.000 description 1
- 102100031745 Ly6/PLAUR domain-containing protein 6B Human genes 0.000 description 1
- 108010066789 Lymphocyte Antigen 96 Proteins 0.000 description 1
- 102000018671 Lymphocyte Antigen 96 Human genes 0.000 description 1
- 102100033486 Lymphocyte antigen 75 Human genes 0.000 description 1
- 102100030984 Lymphocyte function-associated antigen 3 Human genes 0.000 description 1
- 102100022699 Lymphoid enhancer-binding factor 1 Human genes 0.000 description 1
- 102100022539 Lymphoid-specific helicase Human genes 0.000 description 1
- 102100038228 LysM and putative peptidoglycan-binding domain-containing protein 1 Human genes 0.000 description 1
- 102100025174 LysM and putative peptidoglycan-binding domain-containing protein 4 Human genes 0.000 description 1
- 102100021547 Lysine-rich nucleolar protein 1 Human genes 0.000 description 1
- 102100040598 Lysine-specific demethylase 2A Human genes 0.000 description 1
- 102100040584 Lysine-specific demethylase 2B Human genes 0.000 description 1
- 102100040581 Lysine-specific demethylase 3A Human genes 0.000 description 1
- 102100040582 Lysine-specific demethylase 3B Human genes 0.000 description 1
- 102100040863 Lysine-specific demethylase 4A Human genes 0.000 description 1
- 102100040860 Lysine-specific demethylase 4B Human genes 0.000 description 1
- 102100033230 Lysine-specific demethylase 4C Human genes 0.000 description 1
- 102100033231 Lysine-specific demethylase 4D Human genes 0.000 description 1
- 102100033246 Lysine-specific demethylase 5A Human genes 0.000 description 1
- 102100033247 Lysine-specific demethylase 5B Human genes 0.000 description 1
- 102100033249 Lysine-specific demethylase 5C Human genes 0.000 description 1
- 102100033143 Lysine-specific demethylase 5D Human genes 0.000 description 1
- 102100037462 Lysine-specific demethylase 6A Human genes 0.000 description 1
- 102100037465 Lysine-specific demethylase 7A Human genes 0.000 description 1
- 102100024985 Lysine-specific histone demethylase 1A Human genes 0.000 description 1
- 102100040596 Lysine-specific histone demethylase 1B Human genes 0.000 description 1
- 102100035529 Lysine-tRNA ligase Human genes 0.000 description 1
- 102100024033 Lysocardiolipin acyltransferase 1 Human genes 0.000 description 1
- 102100040607 Lysophosphatidic acid receptor 1 Human genes 0.000 description 1
- 102100040387 Lysophosphatidic acid receptor 2 Human genes 0.000 description 1
- 102100040388 Lysophosphatidic acid receptor 3 Human genes 0.000 description 1
- 102100023740 Lysophosphatidylcholine acyltransferase 1 Human genes 0.000 description 1
- 102100023738 Lysophosphatidylcholine acyltransferase 2 Human genes 0.000 description 1
- 102100038490 Lysophospholipase-like protein 1 Human genes 0.000 description 1
- 102100040944 Lysophospholipid acyltransferase 5 Human genes 0.000 description 1
- 102100040986 Lysophospholipid acyltransferase 7 Human genes 0.000 description 1
- 102100033342 Lysosomal acid glucosylceramidase Human genes 0.000 description 1
- 102100026001 Lysosomal acid lipase/cholesteryl ester hydrolase Human genes 0.000 description 1
- 102100031335 Lysosomal cobalamin transport escort protein LMBD1 Human genes 0.000 description 1
- 102100028524 Lysosomal protective protein Human genes 0.000 description 1
- 108010009491 Lysosomal-Associated Membrane Protein 2 Proteins 0.000 description 1
- 102100033472 Lysosomal-trafficking regulator Human genes 0.000 description 1
- 102100038225 Lysosome-associated membrane glycoprotein 2 Human genes 0.000 description 1
- 102100038212 Lysosome-associated membrane glycoprotein 5 Human genes 0.000 description 1
- 102100021948 Lysyl oxidase homolog 2 Human genes 0.000 description 1
- 102100021949 Lysyl oxidase homolog 3 Human genes 0.000 description 1
- 102100023326 M-phase inducer phosphatase 1 Human genes 0.000 description 1
- 102100023325 M-phase inducer phosphatase 2 Human genes 0.000 description 1
- 102100023330 M-phase inducer phosphatase 3 Human genes 0.000 description 1
- 102100023268 M-phase phosphoprotein 8 Human genes 0.000 description 1
- 102100023269 M-phase phosphoprotein 9 Human genes 0.000 description 1
- 102100021832 MAL-like protein Human genes 0.000 description 1
- 101150113681 MALT1 gene Proteins 0.000 description 1
- 108010068342 MAP Kinase Kinase 1 Proteins 0.000 description 1
- 108010068305 MAP Kinase Kinase 5 Proteins 0.000 description 1
- 102100028397 MAP kinase-activated protein kinase 3 Human genes 0.000 description 1
- 102100028396 MAP kinase-activated protein kinase 5 Human genes 0.000 description 1
- 102100028822 MAP kinase-activating death domain protein Human genes 0.000 description 1
- 102100026299 MAP kinase-interacting serine/threonine-protein kinase 1 Human genes 0.000 description 1
- 102100033610 MAP kinase-interacting serine/threonine-protein kinase 2 Human genes 0.000 description 1
- 108010041980 MAP-kinase-activated kinase 3 Proteins 0.000 description 1
- 108010041164 MAP-kinase-activated kinase 5 Proteins 0.000 description 1
- 102100028913 MAP/microtubule affinity-regulating kinase 4 Human genes 0.000 description 1
- 102100028423 MAP6 domain-containing protein 1 Human genes 0.000 description 1
- 102100028241 MAP7 domain-containing protein 1 Human genes 0.000 description 1
- 102100024163 MAPK regulated corepressor interacting protein 2 Human genes 0.000 description 1
- 102100031520 MAPK/MAK/MRK overlapping kinase Human genes 0.000 description 1
- 108700012928 MAPK14 Proteins 0.000 description 1
- 108700008222 MARVEL Domain Containing 2 Proteins 0.000 description 1
- 102000049280 MARVEL Domain Containing 2 Human genes 0.000 description 1
- 102100022621 MAX gene-associated protein Human genes 0.000 description 1
- 102100021282 MBT domain-containing protein 1 Human genes 0.000 description 1
- 102000003624 MCOLN1 Human genes 0.000 description 1
- 101150091161 MCOLN1 gene Proteins 0.000 description 1
- 102000003625 MCOLN3 Human genes 0.000 description 1
- 102000017274 MDM4 Human genes 0.000 description 1
- 108050005300 MDM4 Proteins 0.000 description 1
- 108700024831 MDS1 and EVI1 Complex Locus Proteins 0.000 description 1
- 101150083522 MECP2 gene Proteins 0.000 description 1
- 102000055120 MEF2 Transcription Factors Human genes 0.000 description 1
- 101150029107 MEIS1 gene Proteins 0.000 description 1
- 101710164279 METTL13 Proteins 0.000 description 1
- 102100030300 MHC class I polypeptide-related sequence B Human genes 0.000 description 1
- 102100026371 MHC class II transactivator Human genes 0.000 description 1
- 108700002010 MHC class II transactivator Proteins 0.000 description 1
- 102100024302 MICAL-like protein 1 Human genes 0.000 description 1
- 102100024307 MICAL-like protein 2 Human genes 0.000 description 1
- 102000044235 MICAL3 Human genes 0.000 description 1
- 102100033551 MICOS complex subunit MIC10 Human genes 0.000 description 1
- 102100026629 MICOS complex subunit MIC25 Human genes 0.000 description 1
- 102100026636 MICOS complex subunit MIC26 Human genes 0.000 description 1
- 102100029628 MICOS complex subunit MIC27 Human genes 0.000 description 1
- 102100026639 MICOS complex subunit MIC60 Human genes 0.000 description 1
- 102100029806 MIF4G domain-containing protein Human genes 0.000 description 1
- 102100030158 MIT domain-containing protein 1 Human genes 0.000 description 1
- 102100026050 MKI67 FHA domain-interacting nucleolar phosphoprotein Human genes 0.000 description 1
- 101150088406 MLST8 gene Proteins 0.000 description 1
- 102100037406 MLX-interacting protein Human genes 0.000 description 1
- 102100023474 MMS19 nucleotide excision repair protein homolog Human genes 0.000 description 1
- 102100024997 MOB kinase activator 1B Human genes 0.000 description 1
- 102100025930 MOB kinase activator 3A Human genes 0.000 description 1
- 101700028414 MOB1B Proteins 0.000 description 1
- 102100024822 MORC family CW-type zinc finger protein 3 Human genes 0.000 description 1
- 102100027862 MORF4 family-associated protein 1 Human genes 0.000 description 1
- 102100023288 MORN repeat-containing protein 3 Human genes 0.000 description 1
- 102100032496 MPN domain-containing protein Human genes 0.000 description 1
- 102100034087 MRN complex-interacting protein Human genes 0.000 description 1
- 108091007709 MRPS30-DT Proteins 0.000 description 1
- 229910015837 MSH2 Inorganic materials 0.000 description 1
- 101150108253 MTERF2 gene Proteins 0.000 description 1
- 101710045703 MTERF3 Proteins 0.000 description 1
- 102100022211 MTRF1L release factor glutamine methyltransferase Human genes 0.000 description 1
- 108091007877 MYCBP2 Proteins 0.000 description 1
- 101700049202 MYO1C Proteins 0.000 description 1
- 102100025354 Macrophage mannose receptor 1 Human genes 0.000 description 1
- 102100025136 Macrosialin Human genes 0.000 description 1
- 102100021343 Maestro heat-like repeat-containing protein family member 1 Human genes 0.000 description 1
- 102100021323 Maestro heat-like repeat-containing protein family member 6 Human genes 0.000 description 1
- 102100039143 Magnesium transporter MRS2 homolog, mitochondrial Human genes 0.000 description 1
- 102100028112 Magnesium transporter NIPA1 Human genes 0.000 description 1
- 102100028111 Magnesium transporter NIPA2 Human genes 0.000 description 1
- 102100021760 Magnesium transporter protein 1 Human genes 0.000 description 1
- 101150017238 Magt1 gene Proteins 0.000 description 1
- 102100029285 Major facilitator superfamily domain-containing protein 10 Human genes 0.000 description 1
- 102100029281 Major facilitator superfamily domain-containing protein 12 Human genes 0.000 description 1
- 102100025608 Major facilitator superfamily domain-containing protein 6 Human genes 0.000 description 1
- 102100025613 Major facilitator superfamily domain-containing protein 8 Human genes 0.000 description 1
- 102100025611 Major facilitator superfamily domain-containing protein 9 Human genes 0.000 description 1
- 102100031328 Major histocompatibility complex class I-related gene protein Human genes 0.000 description 1
- 102100025818 Major prion protein Human genes 0.000 description 1
- 102100032515 Male-specific lethal 3 homolog Human genes 0.000 description 1
- 102100038560 Maleylacetoacetate isomerase Human genes 0.000 description 1
- 102100040888 Malignant T-cell-amplified sequence 1 Human genes 0.000 description 1
- 102100039668 Malignant fibrous histiocytoma-amplified sequence 1 Human genes 0.000 description 1
- 102100027329 Malonyl-CoA-acyl carrier protein transacylase, mitochondrial Human genes 0.000 description 1
- 102100030031 Mammalian ependymin-related protein 1 Human genes 0.000 description 1
- 108010031099 Mannose Receptor Proteins 0.000 description 1
- 102100021171 Mannose-1-phosphate guanyltransferase beta Human genes 0.000 description 1
- 102100025297 Mannose-P-dolichol utilization defect 1 protein Human genes 0.000 description 1
- 102100021767 Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB Human genes 0.000 description 1
- 102100021770 Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC Human genes 0.000 description 1
- 102100024162 Mapk-regulated corepressor-interacting protein 1 Human genes 0.000 description 1
- 101150003941 Mapk14 gene Proteins 0.000 description 1
- 102100027235 Mastermind-like domain-containing protein 1 Human genes 0.000 description 1
- 102100025129 Mastermind-like protein 1 Human genes 0.000 description 1
- 102100025134 Mastermind-like protein 3 Human genes 0.000 description 1
- 102100024299 Maternal embryonic leucine zipper kinase Human genes 0.000 description 1
- 101710154611 Maternal embryonic leucine zipper kinase Proteins 0.000 description 1
- 102100038645 Matrin-3 Human genes 0.000 description 1
- 102100039809 Matrix Gla protein Human genes 0.000 description 1
- 101710147263 Matrix Gla protein Proteins 0.000 description 1
- 102100030200 Matrix metalloproteinase-16 Human genes 0.000 description 1
- 102100030218 Matrix metalloproteinase-19 Human genes 0.000 description 1
- 102100024130 Matrix metalloproteinase-23 Human genes 0.000 description 1
- 102100030775 Matrix-remodeling-associated protein 7 Human genes 0.000 description 1
- 102100039513 Max dimerization protein 3 Human genes 0.000 description 1
- 102100035880 Max-interacting protein 1 Human genes 0.000 description 1
- 102100026300 McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin Human genes 0.000 description 1
- 101150115158 Mcoln3 gene Proteins 0.000 description 1
- 102100026048 Meckel syndrome type 1 protein Human genes 0.000 description 1
- 102100021089 Mediator of RNA polymerase II transcription subunit 11 Human genes 0.000 description 1
- 102100021070 Mediator of RNA polymerase II transcription subunit 12 Human genes 0.000 description 1
- 102100034160 Mediator of RNA polymerase II transcription subunit 12-like protein Human genes 0.000 description 1
- 102100026161 Mediator of RNA polymerase II transcription subunit 13 Human genes 0.000 description 1
- 102100034164 Mediator of RNA polymerase II transcription subunit 13-like Human genes 0.000 description 1
- 102100034820 Mediator of RNA polymerase II transcription subunit 14 Human genes 0.000 description 1
- 102100029663 Mediator of RNA polymerase II transcription subunit 15 Human genes 0.000 description 1
- 102100030253 Mediator of RNA polymerase II transcription subunit 16 Human genes 0.000 description 1
- 102100025530 Mediator of RNA polymerase II transcription subunit 17 Human genes 0.000 description 1
- 102100039000 Mediator of RNA polymerase II transcription subunit 19 Human genes 0.000 description 1
- 102100026165 Mediator of RNA polymerase II transcription subunit 20 Human genes 0.000 description 1
- 102100034771 Mediator of RNA polymerase II transcription subunit 23 Human genes 0.000 description 1
- 102100034821 Mediator of RNA polymerase II transcription subunit 24 Human genes 0.000 description 1
- 102100025548 Mediator of RNA polymerase II transcription subunit 25 Human genes 0.000 description 1
- 102100039001 Mediator of RNA polymerase II transcription subunit 27 Human genes 0.000 description 1
- 102100026176 Mediator of RNA polymerase II transcription subunit 30 Human genes 0.000 description 1
- 102100039122 Mediator of RNA polymerase II transcription subunit 31 Human genes 0.000 description 1
- 102100026174 Mediator of RNA polymerase II transcription subunit 6 Human genes 0.000 description 1
- 102100024294 Mediator of RNA polymerase II transcription subunit 8 Human genes 0.000 description 1
- 102100028905 Megakaryocyte-associated tyrosine-protein kinase Human genes 0.000 description 1
- 102100025550 Meiosis inhibitor protein 1 Human genes 0.000 description 1
- 102100038620 Meiosis regulator and mRNA stability factor 1 Human genes 0.000 description 1
- 102100033679 Meiotic nuclear division protein 1 homolog Human genes 0.000 description 1
- 102100035285 Meiotic recombination protein DMC1/LIM15 homolog Human genes 0.000 description 1
- 102100029778 Melanoma inhibitory activity protein 2 Human genes 0.000 description 1
- 102100025084 Melanoma-associated antigen 12 Human genes 0.000 description 1
- 102100026158 Melanophilin Human genes 0.000 description 1
- 102100024976 Melanoregulin Human genes 0.000 description 1
- 102100032239 Melanotransferrin Human genes 0.000 description 1
- 102100039373 Membrane cofactor protein Human genes 0.000 description 1
- 102100032328 Membrane progestin receptor alpha Human genes 0.000 description 1
- 102100032326 Membrane progestin receptor beta Human genes 0.000 description 1
- 102100032334 Membrane progestin receptor gamma Human genes 0.000 description 1
- 102100022634 Membrane protein FAM174A Human genes 0.000 description 1
- 102100026290 Membrane protein MLC1 Human genes 0.000 description 1
- 102100028328 Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 Human genes 0.000 description 1
- 102100028327 Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 Human genes 0.000 description 1
- 102100024262 Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase Human genes 0.000 description 1
- 102100034028 Membrane-bound transcription factor site-1 protease Human genes 0.000 description 1
- 102100027382 Membrane-bound transcription factor site-2 protease Human genes 0.000 description 1
- 102100038465 Membrane-spanning 4-domains subfamily A member 14 Human genes 0.000 description 1
- 102100032517 Membrane-spanning 4-domains subfamily A member 3 Human genes 0.000 description 1
- 102100038555 Membrane-spanning 4-domains subfamily A member 6A Human genes 0.000 description 1
- 102100032512 Membrane-spanning 4-domains subfamily A member 7 Human genes 0.000 description 1
- 102100037106 Merlin Human genes 0.000 description 1
- 102100029623 Mesoderm induction early response protein 1 Human genes 0.000 description 1
- 102100029625 Mesoderm induction early response protein 2 Human genes 0.000 description 1
- 102100029626 Mesoderm induction early response protein 3 Human genes 0.000 description 1
- 102100038294 Metabotropic glutamate receptor 7 Human genes 0.000 description 1
- 102100037636 Metabotropic glutamate receptor 8 Human genes 0.000 description 1
- 102100033593 Metal transporter CNNM1 Human genes 0.000 description 1
- 102100031677 Metal transporter CNNM2 Human genes 0.000 description 1
- 102100031678 Metal transporter CNNM3 Human genes 0.000 description 1
- 102100040632 Metal-response element-binding transcription factor 2 Human genes 0.000 description 1
- 102100027104 Metalloendopeptidase OMA1, mitochondrial Human genes 0.000 description 1
- 102100021274 Metallophosphoesterase 1 Human genes 0.000 description 1
- 102100021276 Metallophosphoesterase MPPED2 Human genes 0.000 description 1
- 102100037517 Metastasis-associated protein MTA1 Human genes 0.000 description 1
- 102100031603 Metaxin-1 Human genes 0.000 description 1
- 102100023138 Metaxin-2 Human genes 0.000 description 1
- 102100023139 Metaxin-3 Human genes 0.000 description 1
- 102100025695 Meteorin Human genes 0.000 description 1
- 102100028691 Methenyltetrahydrofolate cyclohydrolase Human genes 0.000 description 1
- 102100028687 Methenyltetrahydrofolate cyclohydrolase Human genes 0.000 description 1
- 102100029682 Methenyltetrahydrofolate synthase domain-containing protein Human genes 0.000 description 1
- 102100030932 Methionine adenosyltransferase 2 subunit beta Human genes 0.000 description 1
- 102100031551 Methionine synthase Human genes 0.000 description 1
- 102100024614 Methionine synthase reductase Human genes 0.000 description 1
- 102100027383 Methyl-CpG-binding domain protein 1 Human genes 0.000 description 1
- 102100021291 Methyl-CpG-binding domain protein 3 Human genes 0.000 description 1
- 102100021292 Methyl-CpG-binding domain protein 5 Human genes 0.000 description 1
- 102100039124 Methyl-CpG-binding protein 2 Human genes 0.000 description 1
- 102100025825 Methylated-DNA-protein-cysteine methyltransferase Human genes 0.000 description 1
- 102100027320 Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial Human genes 0.000 description 1
- 102100026552 Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial Human genes 0.000 description 1
- 102100027392 Methylglutaconyl-CoA hydratase, mitochondrial Human genes 0.000 description 1
- 102100020846 Methylosome subunit pICln Human genes 0.000 description 1
- 102100038593 Methylthioribulose-1-phosphate dehydratase Human genes 0.000 description 1
- 102100036543 Methyltransferase N6AMT1 Human genes 0.000 description 1
- 102100037543 Methyltransferase-like 26 Human genes 0.000 description 1
- 102100038290 Methyltransferase-like protein 22 Human genes 0.000 description 1
- 102100022259 Mevalonate kinase Human genes 0.000 description 1
- 108700040132 Mevalonate kinases Proteins 0.000 description 1
- 101001083117 Microbacterium liquefaciens Hydantoin permease Proteins 0.000 description 1
- 102100027632 Microcephalin Human genes 0.000 description 1
- 108010050345 Microphthalmia-Associated Transcription Factor Proteins 0.000 description 1
- 102100030157 Microphthalmia-associated transcription factor Human genes 0.000 description 1
- 102100026741 Microsomal glutathione S-transferase 1 Human genes 0.000 description 1
- 102100026723 Microsomal glutathione S-transferase 2 Human genes 0.000 description 1
- 102100026722 Microsomal glutathione S-transferase 3 Human genes 0.000 description 1
- 102100024160 Microspherule protein 1 Human genes 0.000 description 1
- 102100031339 Microtubule cross-linking factor 1 Human genes 0.000 description 1
- 102100036470 Microtubule organization protein AKNA Human genes 0.000 description 1
- 102100028322 Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5 Human genes 0.000 description 1
- 102100021118 Microtubule-associated protein 2 Human genes 0.000 description 1
- 102100021794 Microtubule-associated protein 4 Human genes 0.000 description 1
- 102100021791 Microtubule-associated protein 6 Human genes 0.000 description 1
- 102100032485 Microtubule-associated protein 9 Human genes 0.000 description 1
- 101710099430 Microtubule-associated protein RP/EB family member 3 Proteins 0.000 description 1
- 102100040243 Microtubule-associated protein tau Human genes 0.000 description 1
- 102100024177 Microtubule-associated proteins 1A/1B light chain 3B Human genes 0.000 description 1
- 102100033253 Microtubule-associated serine/threonine-protein kinase 2 Human genes 0.000 description 1
- 102100033251 Microtubule-associated serine/threonine-protein kinase 3 Human genes 0.000 description 1
- 102100033252 Microtubule-associated serine/threonine-protein kinase 4 Human genes 0.000 description 1
- 102100031550 Microtubule-associated tumor suppressor 1 Human genes 0.000 description 1
- 102100027666 Midasin Human genes 0.000 description 1
- 102100026584 Migration and invasion-inhibitory protein Human genes 0.000 description 1
- 102100027372 Mini-chromosome maintenance complex-binding protein Human genes 0.000 description 1
- 102100029083 Minor histocompatibility antigen H13 Human genes 0.000 description 1
- 102100026928 Mirror-image polydactyly gene 1 protein Human genes 0.000 description 1
- 102100028344 Mis18-binding protein 1 Human genes 0.000 description 1
- 102100026287 Misshapen-like kinase 1 Human genes 0.000 description 1
- 102100039076 Mitochondrial 10-formyltetrahydrofolate dehydrogenase Human genes 0.000 description 1
- 108010009513 Mitochondrial Aldehyde Dehydrogenase Proteins 0.000 description 1
- 102100033255 Mitochondrial amidoxime-reducing component 1 Human genes 0.000 description 1
- 102100023727 Mitochondrial antiviral-signaling protein Human genes 0.000 description 1
- 101710142315 Mitochondrial antiviral-signaling protein Proteins 0.000 description 1
- 102100039539 Mitochondrial assembly of ribosomal large subunit protein 1 Human genes 0.000 description 1
- 102100039374 Mitochondrial calcium uniporter regulator 1 Human genes 0.000 description 1
- 102100031332 Mitochondrial carrier homolog 2 Human genes 0.000 description 1
- 102100027891 Mitochondrial chaperone BCS1 Human genes 0.000 description 1
- 102100035387 Mitochondrial enolase superfamily member 1 Human genes 0.000 description 1
- 102100023845 Mitochondrial fission 1 protein Human genes 0.000 description 1
- 102100025782 Mitochondrial fission factor Human genes 0.000 description 1
- 102100023200 Mitochondrial fission process protein 1 Human genes 0.000 description 1
- 102100023197 Mitochondrial fission regulator 1 Human genes 0.000 description 1
- 102100023199 Mitochondrial fission regulator 2 Human genes 0.000 description 1
- 102100025785 Mitochondrial genome maintenance exonuclease 1 Human genes 0.000 description 1
- 102100039325 Mitochondrial import inner membrane translocase subunit TIM14 Human genes 0.000 description 1
- 102100024285 Mitochondrial import inner membrane translocase subunit TIM16 Human genes 0.000 description 1
- 102100022963 Mitochondrial inner membrane protease ATP23 homolog Human genes 0.000 description 1
- 102100039842 Mitochondrial inner membrane protease subunit 1 Human genes 0.000 description 1
- 102100039840 Mitochondrial inner membrane protease subunit 2 Human genes 0.000 description 1
- 102100026934 Mitochondrial intermediate peptidase Human genes 0.000 description 1
- 102100031767 Mitochondrial peptide methionine sulfoxide reductase Human genes 0.000 description 1
- 102100039186 Mitochondrial proton/calcium exchanger protein Human genes 0.000 description 1
- 102100032519 Mitochondrial ribonuclease P catalytic subunit Human genes 0.000 description 1
- 102100033820 Mitochondrial ribosome-associated GTPase 2 Human genes 0.000 description 1
- 102100038450 Mitochondrial tRNA methylthiotransferase CDK5RAP1 Human genes 0.000 description 1
- 102100034059 Mitochondrial transcription rescue factor 1 Human genes 0.000 description 1
- 102100034715 Mitofusin-1 Human genes 0.000 description 1
- 102100033703 Mitofusin-2 Human genes 0.000 description 1
- 102100024193 Mitogen-activated protein kinase 1 Human genes 0.000 description 1
- 102100026931 Mitogen-activated protein kinase 10 Human genes 0.000 description 1
- 102100026932 Mitogen-activated protein kinase 12 Human genes 0.000 description 1
- 102100026930 Mitogen-activated protein kinase 13 Human genes 0.000 description 1
- 102000054819 Mitogen-activated protein kinase 14 Human genes 0.000 description 1
- 102100024192 Mitogen-activated protein kinase 3 Human genes 0.000 description 1
- 102100037801 Mitogen-activated protein kinase 6 Human genes 0.000 description 1
- 102100037805 Mitogen-activated protein kinase 7 Human genes 0.000 description 1
- 102100037808 Mitogen-activated protein kinase 8 Human genes 0.000 description 1
- 102100037809 Mitogen-activated protein kinase 9 Human genes 0.000 description 1
- 102100038243 Mitogen-activated protein kinase kinase kinase 10 Human genes 0.000 description 1
- 102100025216 Mitogen-activated protein kinase kinase kinase 15 Human genes 0.000 description 1
- 102100033058 Mitogen-activated protein kinase kinase kinase 2 Human genes 0.000 description 1
- 102100033116 Mitogen-activated protein kinase kinase kinase 20 Human genes 0.000 description 1
- 102100033054 Mitogen-activated protein kinase kinase kinase 21 Human genes 0.000 description 1
- 102100033059 Mitogen-activated protein kinase kinase kinase 3 Human genes 0.000 description 1
- 102100033060 Mitogen-activated protein kinase kinase kinase 4 Human genes 0.000 description 1
- 102100033127 Mitogen-activated protein kinase kinase kinase 5 Human genes 0.000 description 1
- 102100026888 Mitogen-activated protein kinase kinase kinase 7 Human genes 0.000 description 1
- 102100026907 Mitogen-activated protein kinase kinase kinase 8 Human genes 0.000 description 1
- 102100026909 Mitogen-activated protein kinase kinase kinase 9 Human genes 0.000 description 1
- 102100028199 Mitogen-activated protein kinase kinase kinase kinase 1 Human genes 0.000 description 1
- 102100028192 Mitogen-activated protein kinase kinase kinase kinase 2 Human genes 0.000 description 1
- 102100028193 Mitogen-activated protein kinase kinase kinase kinase 3 Human genes 0.000 description 1
- 102100028194 Mitogen-activated protein kinase kinase kinase kinase 4 Human genes 0.000 description 1
- 102100028195 Mitogen-activated protein kinase kinase kinase kinase 5 Human genes 0.000 description 1
- 102100039508 Mitogen-activated protein kinase-binding protein 1 Human genes 0.000 description 1
- 102100022238 Mitoguardin 1 Human genes 0.000 description 1
- 102100021691 Mitotic checkpoint serine/threonine-protein kinase BUB1 Human genes 0.000 description 1
- 102100038828 Mitotic spindle assembly checkpoint protein MAD1 Human genes 0.000 description 1
- 102100040097 Modulator of smoothened protein Human genes 0.000 description 1
- 102100027983 Molybdenum cofactor sulfurase Human genes 0.000 description 1
- 102100035971 Molybdopterin molybdenumtransferase Human genes 0.000 description 1
- 102100039428 Molybdopterin synthase sulfur carrier subunit Human genes 0.000 description 1
- 102100040849 Monocyte to macrophage differentiation factor Human genes 0.000 description 1
- 102100021395 Mortality factor 4-like protein 1 Human genes 0.000 description 1
- 102100031304 Mortality factor 4-like protein 2 Human genes 0.000 description 1
- 102100023314 Motile sperm domain-containing protein 1 Human genes 0.000 description 1
- 102100023092 Motile sperm domain-containing protein 2 Human genes 0.000 description 1
- 102100023091 Motile sperm domain-containing protein 3 Human genes 0.000 description 1
- 101150097381 Mtor gene Proteins 0.000 description 1
- 108700026676 Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Proteins 0.000 description 1
- 102100038732 Mucosa-associated lymphoid tissue lymphoma translocation protein 1 Human genes 0.000 description 1
- 102100040889 Multiple C2 and transmembrane domain-containing protein 1 Human genes 0.000 description 1
- 102100040886 Multiple C2 and transmembrane domain-containing protein 2 Human genes 0.000 description 1
- 102100021286 Multiple PDZ domain protein Human genes 0.000 description 1
- 102100039008 Multiple epidermal growth factor-like domains protein 11 Human genes 0.000 description 1
- 102100039005 Multiple epidermal growth factor-like domains protein 6 Human genes 0.000 description 1
- 102100038990 Multiple epidermal growth factor-like domains protein 8 Human genes 0.000 description 1
- 102100038989 Multiple epidermal growth factor-like domains protein 9 Human genes 0.000 description 1
- 102100038747 Multivesicular body subunit 12A Human genes 0.000 description 1
- 102100038748 Multivesicular body subunit 12B Human genes 0.000 description 1
- 101100387582 Mus musculus Dnai1 gene Proteins 0.000 description 1
- 102100030965 Muscleblind-like protein 1 Human genes 0.000 description 1
- 102100030964 Muscleblind-like protein 2 Human genes 0.000 description 1
- 102100038751 Muscleblind-like protein 3 Human genes 0.000 description 1
- 102100026301 Muskelin Human genes 0.000 description 1
- 102000013609 MutL Protein Homolog 1 Human genes 0.000 description 1
- 108010026664 MutL Protein Homolog 1 Proteins 0.000 description 1
- 102100034711 Myb-related protein A Human genes 0.000 description 1
- 102100034670 Myb-related protein B Human genes 0.000 description 1
- 102100023248 Myb/SANT-like DNA-binding domain-containing protein 2 Human genes 0.000 description 1
- 102100031642 Myb/SANT-like DNA-binding domain-containing protein 4 Human genes 0.000 description 1
- 101000890749 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) F420-dependent hydroxymycolic acid dehydrogenase Proteins 0.000 description 1
- 102100031790 Myelin expression factor 2 Human genes 0.000 description 1
- 102100021270 Myelin protein zero-like protein 1 Human genes 0.000 description 1
- 102100021271 Myelin protein zero-like protein 3 Human genes 0.000 description 1
- 108700041619 Myeloid Ecotropic Viral Integration Site 1 Proteins 0.000 description 1
- 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 description 1
- 102100029691 Myeloid leukemia factor 1 Human genes 0.000 description 1
- 102100033694 MyoD family inhibitor Human genes 0.000 description 1
- 102100032160 Myocardial zonula adherens protein Human genes 0.000 description 1
- 102100034099 Myocardin-related transcription factor A Human genes 0.000 description 1
- 102100034100 Myocardin-related transcription factor B Human genes 0.000 description 1
- 102100021148 Myocyte-specific enhancer factor 2A Human genes 0.000 description 1
- 102100039229 Myocyte-specific enhancer factor 2C Human genes 0.000 description 1
- 102100035083 Myoferlin Human genes 0.000 description 1
- 102100030166 Myoneurin Human genes 0.000 description 1
- 102100031828 Myosin light chain 6B Human genes 0.000 description 1
- 102100035044 Myosin light chain kinase, smooth muscle Human genes 0.000 description 1
- 102100037183 Myosin phosphatase Rho-interacting protein Human genes 0.000 description 1
- 102100036640 Myosin-10 Human genes 0.000 description 1
- 102100032972 Myosin-14 Human genes 0.000 description 1
- 108010052185 Myotonin-Protein Kinase Proteins 0.000 description 1
- 102100022437 Myotonin-protein kinase Human genes 0.000 description 1
- 102100033817 Myotubularin Human genes 0.000 description 1
- 102100021416 Myotubularin-related protein 1 Human genes 0.000 description 1
- 102100024958 Myotubularin-related protein 10 Human genes 0.000 description 1
- 102100024957 Myotubularin-related protein 12 Human genes 0.000 description 1
- 102100035739 Myotubularin-related protein 14 Human genes 0.000 description 1
- 102100040602 Myotubularin-related protein 2 Human genes 0.000 description 1
- 102100040600 Myotubularin-related protein 3 Human genes 0.000 description 1
- 102100040603 Myotubularin-related protein 6 Human genes 0.000 description 1
- 102100040601 Myotubularin-related protein 7 Human genes 0.000 description 1
- 102100024938 Myotubularin-related protein 8 Human genes 0.000 description 1
- 102100029738 N(6)-adenine-specific methyltransferase METTL4 Human genes 0.000 description 1
- 102100035854 N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 Human genes 0.000 description 1
- CZSLEMCYYGEGKP-UHFFFAOYSA-N N-(2-chlorobenzyl)-1-(2,5-dimethylphenyl)benzimidazole-5-carboxamide Chemical compound CC1=CC=C(C)C(N2C3=CC=C(C=C3N=C2)C(=O)NCC=2C(=CC=CC=2)Cl)=C1 CZSLEMCYYGEGKP-UHFFFAOYSA-N 0.000 description 1
- 102100035286 N-acetyl-D-glucosamine kinase Human genes 0.000 description 1
- 102100026347 N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 Human genes 0.000 description 1
- 102100031895 N-acetylated-alpha-linked acidic dipeptidase 2 Human genes 0.000 description 1
- 102100037774 N-acetylgalactosamine kinase Human genes 0.000 description 1
- 102100031688 N-acetylgalactosamine-6-sulfatase Human genes 0.000 description 1
- 102100039267 N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase Human genes 0.000 description 1
- 102100036713 N-acetylglucosamine-1-phosphotransferase subunit gamma Human genes 0.000 description 1
- 102100031324 N-acetylglucosamine-6-phosphate deacetylase Human genes 0.000 description 1
- 102100023282 N-acetylglucosamine-6-sulfatase Human genes 0.000 description 1
- 102100023315 N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase Human genes 0.000 description 1
- 102100033341 N-acetylmannosamine kinase Human genes 0.000 description 1
- 102100024973 N-acetylneuraminate 9-O-acetyltransferase Human genes 0.000 description 1
- 102100022686 N-acetylneuraminate lyase Human genes 0.000 description 1
- 102100030815 N-acetyltransferase ESCO1 Human genes 0.000 description 1
- 102100030822 N-acetyltransferase ESCO2 Human genes 0.000 description 1
- 102100038360 N-acylethanolamine-hydrolyzing acid amidase Human genes 0.000 description 1
- 102100031349 N-acylneuraminate cytidylyltransferase Human genes 0.000 description 1
- 102100026781 N-alpha-acetyltransferase 15, NatA auxiliary subunit Human genes 0.000 description 1
- 102100026783 N-alpha-acetyltransferase 16, NatA auxiliary subunit Human genes 0.000 description 1
- 102100031832 N-alpha-acetyltransferase 25, NatB auxiliary subunit Human genes 0.000 description 1
- 102100031869 N-alpha-acetyltransferase 35, NatC auxiliary subunit Human genes 0.000 description 1
- 102100031958 N-alpha-acetyltransferase 40 Human genes 0.000 description 1
- 102100031957 N-alpha-acetyltransferase 50 Human genes 0.000 description 1
- 102100038334 N-alpha-acetyltransferase 60 Human genes 0.000 description 1
- 102100038333 N-alpha-acetyltransferase 80 Human genes 0.000 description 1
- 102100023648 N-chimaerin Human genes 0.000 description 1
- 102100026873 N-fatty-acyl-amino acid synthase/hydrolase PM20D1 Human genes 0.000 description 1
- 102100027771 N-lysine methyltransferase KMT5A Human genes 0.000 description 1
- 102100023213 N-terminal EF-hand calcium-binding protein 3 Human genes 0.000 description 1
- 102100021721 N-terminal Xaa-Pro-Lys N-methyltransferase 1 Human genes 0.000 description 1
- 102100031578 N6-adenosine-methyltransferase non-catalytic subunit Human genes 0.000 description 1
- 102100022691 NACHT, LRR and PYD domains-containing protein 3 Human genes 0.000 description 1
- 102100022696 NACHT, LRR and PYD domains-containing protein 6 Human genes 0.000 description 1
- 102100023515 NAD kinase Human genes 0.000 description 1
- 102100032217 NAD kinase 2, mitochondrial Human genes 0.000 description 1
- 102100022365 NAD(P)H dehydrogenase [quinone] 1 Human genes 0.000 description 1
- 102100028167 NAD(P)H-hydrate epimerase Human genes 0.000 description 1
- 102100031377 NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 Human genes 0.000 description 1
- 102100035384 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 2 Human genes 0.000 description 1
- 102100022194 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 8 Human genes 0.000 description 1
- 102100035390 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial Human genes 0.000 description 1
- 102100022198 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12 Human genes 0.000 description 1
- 102100023948 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3 Human genes 0.000 description 1
- 102100021734 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4-like 2 Human genes 0.000 description 1
- 102100026377 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8 Human genes 0.000 description 1
- 102100037507 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial Human genes 0.000 description 1
- 102100037524 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6 Human genes 0.000 description 1
- 102100023953 NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial Human genes 0.000 description 1
- 102100035479 NADH dehydrogenase [ubiquinone] 1 subunit C2, isoform 2 Human genes 0.000 description 1
- 102100023963 NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial Human genes 0.000 description 1
- 102100023964 NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial Human genes 0.000 description 1
- 102100035478 NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial Human genes 0.000 description 1
- 102100026360 NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial Human genes 0.000 description 1
- 102100031919 NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial Human genes 0.000 description 1
- 102100032083 NADH-cytochrome b5 reductase 1 Human genes 0.000 description 1
- 102100033168 NADH-cytochrome b5 reductase 2 Human genes 0.000 description 1
- 102100039232 NADH-cytochrome b5 reductase-like Human genes 0.000 description 1
- 102100022195 NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial Human genes 0.000 description 1
- 108010082699 NADPH Oxidase 4 Proteins 0.000 description 1
- 108010082695 NADPH Oxidase 5 Proteins 0.000 description 1
- 102100021872 NADPH oxidase 4 Human genes 0.000 description 1
- 102100021871 NADPH oxidase 5 Human genes 0.000 description 1
- 102100031925 NADPH-dependent diflavin oxidoreductase 1 Human genes 0.000 description 1
- 102100036777 NADPH:adrenodoxin oxidoreductase, mitochondrial Human genes 0.000 description 1
- 108091007791 NAE1 Proteins 0.000 description 1
- 102100031891 NALCN channel auxiliary factor 1 Human genes 0.000 description 1
- 102100031896 NALCN channel auxiliary factor 2 Human genes 0.000 description 1
- 102100039210 NBAS subunit of NRZ tethering complex Human genes 0.000 description 1
- 102100027673 NCK-interacting protein with SH3 domain Human genes 0.000 description 1
- 102100023052 NEDD4 family-interacting protein 2 Human genes 0.000 description 1
- 102100038552 NEDD4-binding protein 1 Human genes 0.000 description 1
- 101710081124 NEDD4-binding protein 1 Proteins 0.000 description 1
- 108050006691 NEDD4-binding protein 2 Proteins 0.000 description 1
- 102100036542 NEDD4-binding protein 2 Human genes 0.000 description 1
- 102100038596 NEDD4-binding protein 2-like 1 Human genes 0.000 description 1
- 102100038544 NEDD4-binding protein 2-like 2 Human genes 0.000 description 1
- 102100021741 NEDD8 ultimate buster 1 Human genes 0.000 description 1
- 102100029781 NEDD8-activating enzyme E1 regulatory subunit Human genes 0.000 description 1
- 108091007368 NEURL4 Proteins 0.000 description 1
- 102100022219 NF-kappa-B essential modulator Human genes 0.000 description 1
- 102100034306 NF-kappa-B inhibitor-interacting Ras-like protein 1 Human genes 0.000 description 1
- 102100034325 NF-kappa-B inhibitor-interacting Ras-like protein 2 Human genes 0.000 description 1
- 102100024011 NFU1 iron-sulfur cluster scaffold homolog, mitochondrial Human genes 0.000 description 1
- 102000002587 NFX1 Human genes 0.000 description 1
- 102100030407 NGFI-A-binding protein 1 Human genes 0.000 description 1
- 102100030391 NGFI-A-binding protein 2 Human genes 0.000 description 1
- 102100037365 NHL repeat-containing protein 3 Human genes 0.000 description 1
- 102100031821 NHS-like protein 1 Human genes 0.000 description 1
- 102100037380 NIF3-like protein 1 Human genes 0.000 description 1
- 102100023384 NK-tumor recognition protein Human genes 0.000 description 1
- 102100022680 NKG2-D type II integral membrane protein Human genes 0.000 description 1
- 102100023382 NLR family CARD domain-containing protein 3 Human genes 0.000 description 1
- 102100022697 NLR family member X1 Human genes 0.000 description 1
- 102100024546 NMDA receptor synaptonuclear signaling and neuronal migration factor Human genes 0.000 description 1
- 102100029565 NPC intracellular cholesterol transporter 1 Human genes 0.000 description 1
- 102000002451 NPR2 Human genes 0.000 description 1
- 108010017405 NRH - quinone oxidoreductase2 Proteins 0.000 description 1
- 102100028383 NSFL1 cofactor p47 Human genes 0.000 description 1
- 102100029166 NT-3 growth factor receptor Human genes 0.000 description 1
- 102100025112 NTF2-related export protein 2 Human genes 0.000 description 1
- 101710104492 NUP210 Proteins 0.000 description 1
- 102100036101 NXPE family member 3 Human genes 0.000 description 1
- 102100021850 Nardilysin Human genes 0.000 description 1
- 102100038082 Natural killer cell receptor 2B4 Human genes 0.000 description 1
- 102100021462 Natural killer cells antigen CD94 Human genes 0.000 description 1
- 102100036954 Nck-associated protein 1 Human genes 0.000 description 1
- 102100036946 Nck-associated protein 5 Human genes 0.000 description 1
- 102100036953 Nck-associated protein 5-like Human genes 0.000 description 1
- 102100034431 Nebulette Human genes 0.000 description 1
- 102100023062 Negative elongation factor A Human genes 0.000 description 1
- 102100023069 Negative elongation factor C/D Human genes 0.000 description 1
- 102100039230 Negative regulator of P-body association Human genes 0.000 description 1
- 102100031900 Neogenin Human genes 0.000 description 1
- 102100023187 Nephrocystin-1 Human genes 0.000 description 1
- 102100023188 Nephrocystin-3 Human genes 0.000 description 1
- 102100023192 Nephrocystin-4 Human genes 0.000 description 1
- 102100034595 Nephronectin Human genes 0.000 description 1
- 102100038699 Netrin-G2 Human genes 0.000 description 1
- 102100031903 Neudesin Human genes 0.000 description 1
- 102100022158 Neuferricin Human genes 0.000 description 1
- 108010012255 Neural Cell Adhesion Molecule L1 Proteins 0.000 description 1
- 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 description 1
- 102100024964 Neural cell adhesion molecule L1 Human genes 0.000 description 1
- 102100023071 Neuralized-like protein 4 Human genes 0.000 description 1
- 102000048238 Neuregulin-1 Human genes 0.000 description 1
- 108090000556 Neuregulin-1 Proteins 0.000 description 1
- 102100023232 Neurensin-2 Human genes 0.000 description 1
- 102100021310 Neurexin-3 Human genes 0.000 description 1
- 102100028749 Neuritin Human genes 0.000 description 1
- 102100039234 Neurobeachin Human genes 0.000 description 1
- 102100039231 Neurobeachin-like protein 1 Human genes 0.000 description 1
- 102100039235 Neurobeachin-like protein 2 Human genes 0.000 description 1
- 102100031837 Neuroblast differentiation-associated protein AHNAK Human genes 0.000 description 1
- 102100036997 Neuroblastoma breakpoint family member 1 Human genes 0.000 description 1
- 102100037003 Neuroblastoma breakpoint family member 10 Human genes 0.000 description 1
- 102100037030 Neuroblastoma breakpoint family member 11 Human genes 0.000 description 1
- 102100037005 Neuroblastoma breakpoint family member 12 Human genes 0.000 description 1
- 102100037032 Neuroblastoma breakpoint family member 14 Human genes 0.000 description 1
- 102100037031 Neuroblastoma breakpoint family member 15 Human genes 0.000 description 1
- 102100037007 Neuroblastoma breakpoint family member 19 Human genes 0.000 description 1
- 102100037006 Neuroblastoma breakpoint family member 20 Human genes 0.000 description 1
- 102100037004 Neuroblastoma breakpoint family member 26 Human genes 0.000 description 1
- 102100036999 Neuroblastoma breakpoint family member 3 Human genes 0.000 description 1
- 102100037013 Neuroblastoma breakpoint family member 9 Human genes 0.000 description 1
- 102100037142 Neuroblastoma suppressor of tumorigenicity 1 Human genes 0.000 description 1
- 102100027348 Neurocalcin-delta Human genes 0.000 description 1
- 102100035414 Neurofascin Human genes 0.000 description 1
- 102000007530 Neurofibromin 1 Human genes 0.000 description 1
- 108010085793 Neurofibromin 1 Proteins 0.000 description 1
- 102100023181 Neurogenic locus notch homolog protein 1 Human genes 0.000 description 1
- 108700037638 Neurogenic locus notch homolog protein 1 Proteins 0.000 description 1
- 102100032139 Neuroguidin Human genes 0.000 description 1
- 102100038992 Neuroligin-1 Human genes 0.000 description 1
- 102100038939 Neuroligin-2 Human genes 0.000 description 1
- 102100023072 Neurolysin, mitochondrial Human genes 0.000 description 1
- 102100030465 Neuron navigator 2 Human genes 0.000 description 1
- 102100030464 Neuron navigator 3 Human genes 0.000 description 1
- 108010006696 Neuronal Apoptosis-Inhibitory Protein Proteins 0.000 description 1
- 102100029052 Neuronal PAS domain-containing protein 1 Human genes 0.000 description 1
- 102100029045 Neuronal PAS domain-containing protein 2 Human genes 0.000 description 1
- 102100039908 Neuronal acetylcholine receptor subunit alpha-3 Human genes 0.000 description 1
- 102100039907 Neuronal acetylcholine receptor subunit alpha-5 Human genes 0.000 description 1
- 102100022728 Neuronal acetylcholine receptor subunit beta-4 Human genes 0.000 description 1
- 102100032077 Neuronal calcium sensor 1 Human genes 0.000 description 1
- 102100021852 Neuronal cell adhesion molecule Human genes 0.000 description 1
- 102100028745 Neuronal regeneration-related protein Human genes 0.000 description 1
- 102100035072 Neuronal vesicle trafficking-associated protein 1 Human genes 0.000 description 1
- 102100029050 Neuropeptide FF receptor 2 Human genes 0.000 description 1
- 102100035485 Neuropilin and tolloid-like protein 2 Human genes 0.000 description 1
- 108090000772 Neuropilin-1 Proteins 0.000 description 1
- 101000914065 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) FK506-binding protein 2 Proteins 0.000 description 1
- 101000996085 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) Nitrogen catabolic enzyme regulatory protein Proteins 0.000 description 1
- 102100035107 Neurotrimin Human genes 0.000 description 1
- 102100036592 Neutral alpha-glucosidase AB Human genes 0.000 description 1
- 102100037413 Neutral alpha-glucosidase C Human genes 0.000 description 1
- 102100023617 Neutrophil cytosol factor 4 Human genes 0.000 description 1
- 102100031801 Nexilin Human genes 0.000 description 1
- 102100037001 Next to BRCA1 gene 1 protein Human genes 0.000 description 1
- 102100024403 Nibrin Human genes 0.000 description 1
- 102100028056 Nicastrin Human genes 0.000 description 1
- 102100028055 Nicolin-1 Human genes 0.000 description 1
- 108010064862 Nicotinamide phosphoribosyltransferase Proteins 0.000 description 1
- 102000015532 Nicotinamide phosphoribosyltransferase Human genes 0.000 description 1
- 102100029562 Nicotinamide riboside kinase 1 Human genes 0.000 description 1
- 102100034451 Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 Human genes 0.000 description 1
- 102100037371 Nidogen-2 Human genes 0.000 description 1
- 102100023121 Ninein Human genes 0.000 description 1
- 102100035377 Nipped-B-like protein Human genes 0.000 description 1
- 102100022495 Nitric oxide-associated protein 1 Human genes 0.000 description 1
- 102100028083 NmrA-like family domain-containing protein 1 Human genes 0.000 description 1
- 102100038815 Nocturnin Human genes 0.000 description 1
- 102100027967 Nodal modulator 2 Human genes 0.000 description 1
- 102100023729 Noelin-2 Human genes 0.000 description 1
- 102100031353 Non-histone chromosomal protein HMG-14 Human genes 0.000 description 1
- 102100029980 Non-homologous end joining factor IFFO1 Human genes 0.000 description 1
- 102100028156 Non-homologous end-joining factor 1 Human genes 0.000 description 1
- 102100027814 Non-lysosomal glucosylceramidase Human genes 0.000 description 1
- 102100028884 Non-structural maintenance of chromosomes element 1 homolog Human genes 0.000 description 1
- 102100028403 Non-structural maintenance of chromosomes element 4 homolog A Human genes 0.000 description 1
- 102100034093 Notch homolog 2 N-terminal-like protein A Human genes 0.000 description 1
- 102000001756 Notch2 Receptor Human genes 0.000 description 1
- 108010029751 Notch2 Receptor Proteins 0.000 description 1
- 102000001760 Notch3 Receptor Human genes 0.000 description 1
- 108010029756 Notch3 Receptor Proteins 0.000 description 1
- 102100035358 Notchless protein homolog 1 Human genes 0.000 description 1
- 101150074217 Nprl2 gene Proteins 0.000 description 1
- 101150009730 Nprl3 gene Proteins 0.000 description 1
- 108010010424 Nuclear Factor 90 Proteins Proteins 0.000 description 1
- 108010062309 Nuclear Receptor Interacting Protein 1 Proteins 0.000 description 1
- 102100023904 Nuclear autoantigenic sperm protein Human genes 0.000 description 1
- 101710149564 Nuclear autoantigenic sperm protein Proteins 0.000 description 1
- 102100032343 Nuclear cap-binding protein subunit 3 Human genes 0.000 description 1
- 102100023311 Nuclear distribution protein nudE homolog 1 Human genes 0.000 description 1
- 102100023312 Nuclear distribution protein nudE-like 1 Human genes 0.000 description 1
- 102100022220 Nuclear envelope integral membrane protein 1 Human genes 0.000 description 1
- 102100034422 Nuclear envelope phosphatase-regulatory subunit 1 Human genes 0.000 description 1
- 102100022727 Nuclear exosome regulator NRDE2 Human genes 0.000 description 1
- 102100022165 Nuclear factor 1 B-type Human genes 0.000 description 1
- 102100022162 Nuclear factor 1 C-type Human genes 0.000 description 1
- 102100023049 Nuclear factor 1 X-type Human genes 0.000 description 1
- 102100023050 Nuclear factor NF-kappa-B p105 subunit Human genes 0.000 description 1
- 102100035397 Nuclear factor related to kappa-B-binding protein Human genes 0.000 description 1
- 102100032428 Nuclear fragile X mental retardation-interacting protein 1 Human genes 0.000 description 1
- 102100032422 Nuclear fragile X mental retardation-interacting protein 2 Human genes 0.000 description 1
- 102100036961 Nuclear mitotic apparatus protein 1 Human genes 0.000 description 1
- 102100021713 Nuclear nucleic acid-binding protein C1D Human genes 0.000 description 1
- 102100021976 Nuclear pore complex protein Nup107 Human genes 0.000 description 1
- 102100021726 Nuclear pore complex protein Nup133 Human genes 0.000 description 1
- 102100021706 Nuclear pore complex protein Nup153 Human genes 0.000 description 1
- 102100021512 Nuclear pore complex protein Nup155 Human genes 0.000 description 1
- 102100033819 Nuclear pore complex protein Nup214 Human genes 0.000 description 1
- 102100025447 Nuclear pore complex protein Nup50 Human genes 0.000 description 1
- 102100027582 Nuclear pore complex protein Nup85 Human genes 0.000 description 1
- 102100027586 Nuclear pore complex protein Nup88 Human genes 0.000 description 1
- 102100027585 Nuclear pore complex protein Nup93 Human genes 0.000 description 1
- 102100025372 Nuclear pore complex protein Nup98-Nup96 Human genes 0.000 description 1
- 102100038845 Nuclear pore complex-interacting protein family member A1 Human genes 0.000 description 1
- 102100038852 Nuclear pore complex-interacting protein family member B5 Human genes 0.000 description 1
- 102100035570 Nuclear pore membrane glycoprotein 210 Human genes 0.000 description 1
- 102100021278 Nuclear protein MDM1 Human genes 0.000 description 1
- 102100038438 Nuclear protein localization protein 4 homolog Human genes 0.000 description 1
- 102100037223 Nuclear receptor coactivator 1 Human genes 0.000 description 1
- 102100037226 Nuclear receptor coactivator 2 Human genes 0.000 description 1
- 102100022929 Nuclear receptor coactivator 6 Human genes 0.000 description 1
- 102100022930 Nuclear receptor coactivator 7 Human genes 0.000 description 1
- 102100022935 Nuclear receptor corepressor 1 Human genes 0.000 description 1
- 102100030569 Nuclear receptor corepressor 2 Human genes 0.000 description 1
- 102100023171 Nuclear receptor subfamily 1 group D member 2 Human genes 0.000 description 1
- 102100028470 Nuclear receptor subfamily 2 group C member 1 Human genes 0.000 description 1
- 102100028448 Nuclear receptor subfamily 2 group C member 2 Human genes 0.000 description 1
- 102100022679 Nuclear receptor subfamily 4 group A member 1 Human genes 0.000 description 1
- 102100022670 Nuclear receptor subfamily 6 group A member 1 Human genes 0.000 description 1
- 102100028791 Nuclear receptor-binding factor 2 Human genes 0.000 description 1
- 102100029558 Nuclear receptor-interacting protein 1 Human genes 0.000 description 1
- 102100029230 Nuclear speckle splicing regulatory protein 1 Human genes 0.000 description 1
- 102100022201 Nuclear transcription factor Y subunit beta Human genes 0.000 description 1
- 102100031719 Nuclear transcription factor Y subunit gamma Human genes 0.000 description 1
- 102100028418 Nuclear transport factor 2 Human genes 0.000 description 1
- 102100030921 Nuclear valosin-containing protein-like Human genes 0.000 description 1
- 102100039557 Nuclease EXOG, mitochondrial Human genes 0.000 description 1
- 102100027051 Nucleic acid dioxygenase ALKBH1 Human genes 0.000 description 1
- 102100027441 Nucleobindin-2 Human genes 0.000 description 1
- 102100034507 Nucleolar GTP-binding protein 2 Human genes 0.000 description 1
- 102100022726 Nucleolar and coiled-body phosphoprotein 1 Human genes 0.000 description 1
- 102100029101 Nucleolar complex protein 2 homolog Human genes 0.000 description 1
- 102100027986 Nucleolar complex protein 4 homolog Human genes 0.000 description 1
- 102100022401 Nucleolar protein 12 Human genes 0.000 description 1
- 102100029102 Nucleolar protein 16 Human genes 0.000 description 1
- 102100022400 Nucleolar protein 3 Human genes 0.000 description 1
- 102100040316 Nucleolar protein 4 Human genes 0.000 description 1
- 102100040313 Nucleolar protein 4-like Human genes 0.000 description 1
- 102100034532 Nucleolar protein 58 Human genes 0.000 description 1
- 102100022740 Nucleolar protein 8 Human genes 0.000 description 1
- 102100028752 Nucleolus and neural progenitor protein Human genes 0.000 description 1
- 102100022678 Nucleophosmin Human genes 0.000 description 1
- 102100022684 Nucleoplasmin-3 Human genes 0.000 description 1
- 102100037826 Nucleoporin NDC1 Human genes 0.000 description 1
- 102100021530 Nucleoporin NUP188 Human genes 0.000 description 1
- 102100037821 Nucleoporin NUP42 Human genes 0.000 description 1
- 102100037837 Nucleoporin Nup37 Human genes 0.000 description 1
- 102100037823 Nucleoporin Nup43 Human genes 0.000 description 1
- 102100025453 Nucleoporin p54 Human genes 0.000 description 1
- 102100025794 Nucleoporin p58/p45 Human genes 0.000 description 1
- 102100036544 Nucleoporin-62 C-terminal-like protein Human genes 0.000 description 1
- 102100036206 Nucleoredoxin Human genes 0.000 description 1
- 102100032209 Nucleoside diphosphate kinase 3 Human genes 0.000 description 1
- 102100032113 Nucleoside diphosphate kinase 6 Human genes 0.000 description 1
- 102100032115 Nucleoside diphosphate kinase 7 Human genes 0.000 description 1
- 102100036518 Nucleoside diphosphate phosphatase ENTPD5 Human genes 0.000 description 1
- 102100036149 Nucleoside diphosphate-linked moiety X motif 17 Human genes 0.000 description 1
- 102100022389 Nucleosome assembly protein 1-like 1 Human genes 0.000 description 1
- 102100022396 Nucleosome assembly protein 1-like 4 Human genes 0.000 description 1
- 102100025062 Nucleosome-remodeling factor subunit BPTF Human genes 0.000 description 1
- 102100039306 Nucleotide pyrophosphatase Human genes 0.000 description 1
- 102100038140 Nucleus accumbens-associated protein 2 Human genes 0.000 description 1
- 102100022473 NudC domain-containing protein 2 Human genes 0.000 description 1
- 102100027183 OCIA domain-containing protein 1 Human genes 0.000 description 1
- 102100027182 OCIA domain-containing protein 2 Human genes 0.000 description 1
- 108700027852 ORAI2 Proteins 0.000 description 1
- 101150002636 ORAI2 gene Proteins 0.000 description 1
- 102100026499 ORM1-like protein 1 Human genes 0.000 description 1
- 102100026498 ORM1-like protein 2 Human genes 0.000 description 1
- 102100025194 OTU domain-containing protein 5 Human genes 0.000 description 1
- 102100037589 OX-2 membrane glycoprotein Human genes 0.000 description 1
- 102100035415 Obg-like ATPase 1 Human genes 0.000 description 1
- 102100030127 Obscurin Human genes 0.000 description 1
- 102100031914 Obscurin-like protein 1 Human genes 0.000 description 1
- 102100032603 Occludin/ELL domain-containing protein 1 Human genes 0.000 description 1
- 102100027069 Odontogenic ameloblast-associated protein Human genes 0.000 description 1
- 102100035592 Oligophrenin-1 Human genes 0.000 description 1
- 102100026241 Oligosaccharyltransferase complex subunit OSTC Human genes 0.000 description 1
- 102100034446 Omega-amidase NIT2 Human genes 0.000 description 1
- 102100026074 Opioid growth factor receptor-like protein 1 Human genes 0.000 description 1
- 102100026742 Opioid-binding protein/cell adhesion molecule Human genes 0.000 description 1
- 101710096745 Opioid-binding protein/cell adhesion molecule Proteins 0.000 description 1
- 102100025909 Opsin-3 Human genes 0.000 description 1
- 102100031822 Optineurin Human genes 0.000 description 1
- 102100025410 Oral-facial-digital syndrome 1 protein Human genes 0.000 description 1
- 102100028141 Orexin/Hypocretin receptor type 1 Human genes 0.000 description 1
- 102100036199 Ornithine decarboxylase antizyme 1 Human genes 0.000 description 1
- 102100026971 Ornithine decarboxylase antizyme 3 Human genes 0.000 description 1
- 102100040558 Osteoclast-stimulating factor 1 Human genes 0.000 description 1
- 102100034206 Otogelin-like protein Human genes 0.000 description 1
- 102100026069 Outer dense fiber protein 2 Human genes 0.000 description 1
- 102100025285 Outer dense fiber protein 3B Human genes 0.000 description 1
- 102100035706 Outer dynein arm-docking complex subunit 2 Human genes 0.000 description 1
- 102100039867 Outer mitochondrial transmembrane helix translocase Human genes 0.000 description 1
- 102100027063 Overexpressed in colon carcinoma 1 protein Human genes 0.000 description 1
- 102100026317 Oxidative stress-induced growth inhibitor 2 Human genes 0.000 description 1
- 102100037780 Oxidative stress-responsive serine-rich protein 1 Human genes 0.000 description 1
- 102100025386 Oxidized low-density lipoprotein receptor 1 Human genes 0.000 description 1
- 102100039792 Oxidized purine nucleoside triphosphate hydrolase Human genes 0.000 description 1
- 102100040459 Oxidoreductase NAD-binding domain-containing protein 1 Human genes 0.000 description 1
- 102100036201 Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial Human genes 0.000 description 1
- 102100032164 Oxysterol-binding protein 2 Human genes 0.000 description 1
- 102100025924 Oxysterol-binding protein-related protein 1 Human genes 0.000 description 1
- 102100032154 Oxysterol-binding protein-related protein 3 Human genes 0.000 description 1
- 102100032149 Oxysterol-binding protein-related protein 6 Human genes 0.000 description 1
- 102100032150 Oxysterol-binding protein-related protein 7 Human genes 0.000 description 1
- 102100032151 Oxysterol-binding protein-related protein 8 Human genes 0.000 description 1
- 102100032162 Oxysterol-binding protein-related protein 9 Human genes 0.000 description 1
- 102100034574 P protein Human genes 0.000 description 1
- 102100037601 P2X purinoceptor 4 Human genes 0.000 description 1
- 102100037602 P2X purinoceptor 7 Human genes 0.000 description 1
- 102100028074 P2Y purinoceptor 6 Human genes 0.000 description 1
- 102100040915 PABIR family member 1 Human genes 0.000 description 1
- 102100040912 PABIR family member 2 Human genes 0.000 description 1
- 102100034305 PACRG-like protein Human genes 0.000 description 1
- 101700056750 PAK1 Proteins 0.000 description 1
- 102100027016 PAN2-PAN3 deadenylation complex catalytic subunit PAN2 Human genes 0.000 description 1
- 102100040902 PAS domain-containing serine/threonine-protein kinase Human genes 0.000 description 1
- 102100037141 PAX-interacting protein 1 Human genes 0.000 description 1
- 108010032788 PAX6 Transcription Factor Proteins 0.000 description 1
- 102100027496 PC-esterase domain-containing protein 1A Human genes 0.000 description 1
- 102100027501 PC-esterase domain-containing protein 1B Human genes 0.000 description 1
- 102100040140 PCI domain-containing protein 2 Human genes 0.000 description 1
- 102100032341 PCNA-interacting partner Human genes 0.000 description 1
- 101710196737 PCNA-interacting partner Proteins 0.000 description 1
- 102100039983 PDZ domain-containing protein GIPC1 Human genes 0.000 description 1
- 102100036665 POZ-, AT hook-, and zinc finger-containing protein 1 Human genes 0.000 description 1
- MIQYPPGTNIFAPO-CABCVRRESA-N PS(6:0/6:0) Chemical compound CCCCCC(=O)OC[C@@H](OC(=O)CCCCC)COP(O)(=O)OC[C@H](N)C(O)=O MIQYPPGTNIFAPO-CABCVRRESA-N 0.000 description 1
- 102100033719 PTB domain-containing engulfment adapter protein 1 Human genes 0.000 description 1
- 102100040891 Paired box protein Pax-3 Human genes 0.000 description 1
- 102100037504 Paired box protein Pax-5 Human genes 0.000 description 1
- 102100037506 Paired box protein Pax-6 Human genes 0.000 description 1
- 102100035031 Palladin Human genes 0.000 description 1
- 102100024122 Pantothenate kinase 1 Human genes 0.000 description 1
- 102100024127 Pantothenate kinase 2, mitochondrial Human genes 0.000 description 1
- 102100035006 Paralemmin-1 Human genes 0.000 description 1
- 102100035032 Paralemmin-2 Human genes 0.000 description 1
- 102100033496 Partitioning defective 3 homolog Human genes 0.000 description 1
- 102100023654 Partitioning defective 6 homolog gamma Human genes 0.000 description 1
- 102100040884 Partner and localizer of BRCA2 Human genes 0.000 description 1
- 102100035019 Peptide chain release factor 1, mitochondrial Human genes 0.000 description 1
- 102100035038 Peptide chain release factor 1-like, mitochondrial Human genes 0.000 description 1
- 102100038551 Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase Human genes 0.000 description 1
- 101710189920 Peptidyl-alpha-hydroxyglycine alpha-amidating lyase Proteins 0.000 description 1
- 102100040349 Peptidyl-prolyl cis-trans isomerase FKBP10 Human genes 0.000 description 1
- 102100040350 Peptidyl-prolyl cis-trans isomerase FKBP14 Human genes 0.000 description 1
- 102100027914 Peptidyl-prolyl cis-trans isomerase FKBP1B Human genes 0.000 description 1
- 102100026408 Peptidyl-prolyl cis-trans isomerase FKBP2 Human genes 0.000 description 1
- 102100037026 Peptidyl-prolyl cis-trans isomerase FKBP5 Human genes 0.000 description 1
- 102100036983 Peptidyl-prolyl cis-trans isomerase FKBP7 Human genes 0.000 description 1
- 102100038809 Peptidyl-prolyl cis-trans isomerase FKBP9 Human genes 0.000 description 1
- 102100021698 Peregrin Human genes 0.000 description 1
- 102100021404 Peroxisomal 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing] Human genes 0.000 description 1
- 102100037209 Peroxisomal N(1)-acetyl-spermine/spermidine oxidase Human genes 0.000 description 1
- 102100037974 Peroxisomal carnitine O-octanoyltransferase Human genes 0.000 description 1
- 102100036024 Peroxisomal coenzyme A diphosphatase NUDT7 Human genes 0.000 description 1
- 102100022587 Peroxisomal multifunctional enzyme type 2 Human genes 0.000 description 1
- 102100030940 Persulfide dioxygenase ETHE1, mitochondrial Human genes 0.000 description 1
- 102100035312 Phenylalanine-tRNA ligase beta subunit Human genes 0.000 description 1
- 102100029354 Phenylalanine-tRNA ligase, mitochondrial Human genes 0.000 description 1
- 101710178747 Phosphatidate cytidylyltransferase 1 Proteins 0.000 description 1
- 102100025731 Phosphatidate phosphatase LPIN1 Human genes 0.000 description 1
- 102100031538 Phosphatidylcholine-sterol acyltransferase Human genes 0.000 description 1
- 102100032287 Phosphatidylinositide phosphatase SAC2 Human genes 0.000 description 1
- 102100024242 Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 Human genes 0.000 description 1
- 102100024369 Phosphatidylinositol polyphosphate 5-phosphatase type IV Human genes 0.000 description 1
- 102100034792 Phosphoenolpyruvate carboxykinase [GTP], mitochondrial Human genes 0.000 description 1
- 102100034078 Phosphofurin acidic cluster sorting protein 1 Human genes 0.000 description 1
- 102100034077 Phosphofurin acidic cluster sorting protein 2 Human genes 0.000 description 1
- 102100036072 Phospholipase A and acyltransferase 1 Human genes 0.000 description 1
- 102100034178 Phospholipase DDHD1 Human genes 0.000 description 1
- 102100034179 Phospholipase DDHD2 Human genes 0.000 description 1
- 102100032943 Phospholipid transfer protein C2CD2L Human genes 0.000 description 1
- 102100032687 Phospholipid-transporting ATPase IF Human genes 0.000 description 1
- 102100032660 Phospholipid-transporting ATPase IG Human genes 0.000 description 1
- 102100032688 Phospholipid-transporting ATPase IH Human genes 0.000 description 1
- 102100023496 Phospholipid-transporting ATPase VA Human genes 0.000 description 1
- 102100032689 Phospholipid-transporting ATPase VD Human genes 0.000 description 1
- 102100024111 Phospholysine phosphohistidine inorganic pyrophosphate phosphatase Human genes 0.000 description 1
- 102100026066 Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 Human genes 0.000 description 1
- 102100027330 Phosphoribosylaminoimidazole carboxylase Human genes 0.000 description 1
- 108010064209 Phosphoribosylglycinamide formyltransferase Proteins 0.000 description 1
- 102100040523 Plasma alpha-L-fucosidase Human genes 0.000 description 1
- 102100029751 Plasma membrane calcium-transporting ATPase 1 Human genes 0.000 description 1
- 102100029743 Plasma membrane calcium-transporting ATPase 4 Human genes 0.000 description 1
- 102100027932 Platelet-activating factor acetylhydrolase 2, cytoplasmic Human genes 0.000 description 1
- 102100023652 Poly [ADP-ribose] polymerase 2 Human genes 0.000 description 1
- 102100024380 Poly(A) RNA polymerase GLD2 Human genes 0.000 description 1
- 102100040155 Poly(A) polymerase alpha Human genes 0.000 description 1
- 102100040153 Poly(A) polymerase gamma Human genes 0.000 description 1
- 102100023715 Poly(A)-specific ribonuclease PARN Human genes 0.000 description 1
- 102100032347 Poly(ADP-ribose) glycohydrolase Human genes 0.000 description 1
- 102100034961 Poly(rC)-binding protein 2 Human genes 0.000 description 1
- 102100034955 Poly(rC)-binding protein 3 Human genes 0.000 description 1
- 102100034956 Poly(rC)-binding protein 4 Human genes 0.000 description 1
- 102100039427 Polyadenylate-binding protein 2 Human genes 0.000 description 1
- 102100039424 Polyadenylate-binding protein 4 Human genes 0.000 description 1
- 102100034080 Polyadenylate-binding protein-interacting protein 1 Human genes 0.000 description 1
- 102100039388 Polyamine deacetylase HDAC10 Human genes 0.000 description 1
- 102100039917 Polyamine-transporting ATPase 13A2 Human genes 0.000 description 1
- 102100039916 Polyamine-transporting ATPase 13A3 Human genes 0.000 description 1
- 101000616469 Polybia paulista Mastoparan-1 Proteins 0.000 description 1
- 102100040921 Polycomb group RING finger protein 1 Human genes 0.000 description 1
- 102100040919 Polycomb group RING finger protein 2 Human genes 0.000 description 1
- 102100040920 Polycomb group RING finger protein 3 Human genes 0.000 description 1
- 102100040916 Polycomb group RING finger protein 5 Human genes 0.000 description 1
- 102100040917 Polycomb group RING finger protein 6 Human genes 0.000 description 1
- 102100029799 Polycomb group protein ASXL1 Human genes 0.000 description 1
- 102100031338 Polycomb protein EED Human genes 0.000 description 1
- 102100022739 Polynucleotide 5'-hydroxyl-kinase NOL9 Human genes 0.000 description 1
- 102100023217 Polypeptide N-acetylgalactosaminyltransferase 10 Human genes 0.000 description 1
- 102100023218 Polypeptide N-acetylgalactosaminyltransferase 11 Human genes 0.000 description 1
- 102100023209 Polypeptide N-acetylgalactosaminyltransferase 13 Human genes 0.000 description 1
- 102100023229 Polypeptide N-acetylgalactosaminyltransferase 15 Human genes 0.000 description 1
- 102100039225 Polypeptide N-acetylgalactosaminyltransferase 18 Human genes 0.000 description 1
- 102100020950 Polypeptide N-acetylgalactosaminyltransferase 2 Human genes 0.000 description 1
- 102100039685 Polypeptide N-acetylgalactosaminyltransferase 3 Human genes 0.000 description 1
- 102100039695 Polypeptide N-acetylgalactosaminyltransferase 6 Human genes 0.000 description 1
- 102100023591 Polyphosphoinositide phosphatase Human genes 0.000 description 1
- 102100034391 Porphobilinogen deaminase Human genes 0.000 description 1
- 101710189720 Porphobilinogen deaminase Proteins 0.000 description 1
- 101710170827 Porphobilinogen deaminase, chloroplastic Proteins 0.000 description 1
- 102100023205 Potassium channel subfamily K member 4 Human genes 0.000 description 1
- 102100033524 Potassium channel subfamily T member 2 Human genes 0.000 description 1
- 102100022783 Potassium voltage-gated channel subfamily G member 1 Human genes 0.000 description 1
- 102100022807 Potassium voltage-gated channel subfamily H member 2 Human genes 0.000 description 1
- 101710163352 Potassium voltage-gated channel subfamily H member 4 Proteins 0.000 description 1
- 101710163348 Potassium voltage-gated channel subfamily H member 8 Proteins 0.000 description 1
- 102100025073 Potassium voltage-gated channel subfamily H member 8 Human genes 0.000 description 1
- 102100037444 Potassium voltage-gated channel subfamily KQT member 1 Human genes 0.000 description 1
- 102100034365 Potassium voltage-gated channel subfamily KQT member 5 Human genes 0.000 description 1
- 102100025068 Potassium voltage-gated channel subfamily S member 3 Human genes 0.000 description 1
- 102100040171 Pre-B-cell leukemia transcription factor 1 Human genes 0.000 description 1
- 102100040169 Pre-B-cell leukemia transcription factor 3 Human genes 0.000 description 1
- 102100040882 Pre-B-cell leukemia transcription factor-interacting protein 1 Human genes 0.000 description 1
- 102100031755 Pre-mRNA 3'-end-processing factor FIP1 Human genes 0.000 description 1
- 102100028730 Pre-mRNA-processing factor 17 Human genes 0.000 description 1
- 102100029436 Pre-mRNA-splicing factor 38B Human genes 0.000 description 1
- 102100028729 Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 Human genes 0.000 description 1
- 102100021427 Pre-mRNA-splicing factor CWC22 homolog Human genes 0.000 description 1
- 102100025585 Pre-mRNA-splicing factor CWC25 homolog Human genes 0.000 description 1
- 102100037177 Primary cilium assembly protein FAM149B1 Human genes 0.000 description 1
- 102100022668 Pro-neuregulin-2, membrane-bound isoform Human genes 0.000 description 1
- 102100022659 Pro-neuregulin-3, membrane-bound isoform Human genes 0.000 description 1
- 102100022658 Pro-neuregulin-4, membrane-bound isoform Human genes 0.000 description 1
- 102100027142 Probable 18S rRNA (guanine-N(7))-methyltransferase Human genes 0.000 description 1
- 102100026970 Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial Human genes 0.000 description 1
- 102100030730 Probable ATP-dependent DNA helicase HFM1 Human genes 0.000 description 1
- 102100021409 Probable ATP-dependent RNA helicase DDX17 Human genes 0.000 description 1
- 102100026091 Probable ATP-dependent RNA helicase DDX20 Human genes 0.000 description 1
- 102100033405 Probable ATP-dependent RNA helicase DDX27 Human genes 0.000 description 1
- 102100033401 Probable ATP-dependent RNA helicase DDX31 Human genes 0.000 description 1
- 102100035727 Probable ATP-dependent RNA helicase DDX41 Human genes 0.000 description 1
- 102100035725 Probable ATP-dependent RNA helicase DDX46 Human genes 0.000 description 1
- 102100024765 Probable ATP-dependent RNA helicase DDX49 Human genes 0.000 description 1
- 102100038267 Probable ATP-dependent RNA helicase DDX52 Human genes 0.000 description 1
- 102100037436 Probable ATP-dependent RNA helicase DDX59 Human genes 0.000 description 1
- 102100037439 Probable ATP-dependent RNA helicase DDX60 Human genes 0.000 description 1
- 102100037440 Probable ATP-dependent RNA helicase DDX60-like Human genes 0.000 description 1
- 102100022411 Probable ATP-dependent RNA helicase DHX34 Human genes 0.000 description 1
- 102100022424 Probable ATP-dependent RNA helicase DHX35 Human genes 0.000 description 1
- 102100030093 Probable ATP-dependent RNA helicase DHX37 Human genes 0.000 description 1
- 102100028693 Probable C-mannosyltransferase DPY19L1 Human genes 0.000 description 1
- 102100028694 Probable C-mannosyltransferase DPY19L2 Human genes 0.000 description 1
- 102100028677 Probable C-mannosyltransferase DPY19L3 Human genes 0.000 description 1
- 102100028695 Probable C-mannosyltransferase DPY19L4 Human genes 0.000 description 1
- 101710119292 Probable D-lactate dehydrogenase, mitochondrial Proteins 0.000 description 1
- 102100028977 Probable E3 ubiquitin-protein ligase DTX2 Human genes 0.000 description 1
- 102100034679 Probable E3 ubiquitin-protein ligase HECTD4 Human genes 0.000 description 1
- 102100034747 Probable E3 ubiquitin-protein ligase HERC1 Human genes 0.000 description 1
- 102100039910 Probable E3 ubiquitin-protein ligase HERC3 Human genes 0.000 description 1
- 102100039913 Probable E3 ubiquitin-protein ligase HERC4 Human genes 0.000 description 1
- 102100039921 Probable E3 ubiquitin-protein ligase HERC6 Human genes 0.000 description 1
- 102100026310 Probable E3 ubiquitin-protein ligase MID2 Human genes 0.000 description 1
- 102100039863 Probable G-protein coupled receptor 141 Human genes 0.000 description 1
- 102100025346 Probable G-protein coupled receptor 160 Human genes 0.000 description 1
- 102100032555 Probable G-protein coupled receptor 171 Human genes 0.000 description 1
- 102100032561 Probable G-protein coupled receptor 173 Human genes 0.000 description 1
- 102100033862 Probable G-protein coupled receptor 63 Human genes 0.000 description 1
- 102100033863 Probable G-protein coupled receptor 85 Human genes 0.000 description 1
- 102100037169 Probable JmjC domain-containing histone demethylation protein 2C Human genes 0.000 description 1
- 102100037234 Probable RNA-binding protein EIF1AD Human genes 0.000 description 1
- 102100033917 Probable asparagine-tRNA ligase, mitochondrial Human genes 0.000 description 1
- 102100029401 Probable carboxypeptidase X1 Human genes 0.000 description 1
- 101710145525 Probable cinnamyl alcohol dehydrogenase Proteins 0.000 description 1
- 102100026179 Probable cysteine-tRNA ligase, mitochondrial Human genes 0.000 description 1
- 102100038011 Probable dimethyladenosine transferase Human genes 0.000 description 1
- 102100026610 Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase Human genes 0.000 description 1
- 102100029532 Probable fibrosin-1 Human genes 0.000 description 1
- 102100024009 Probable gluconokinase Human genes 0.000 description 1
- 102100030285 Probable glutathione peroxidase 8 Human genes 0.000 description 1
- 102100031018 Probable helicase with zinc finger domain Human genes 0.000 description 1
- 102100033794 Probable inactive allantoicase Human genes 0.000 description 1
- 102100038289 Probable methyltransferase-like protein 23 Human genes 0.000 description 1
- 102100038292 Probable methyltransferase-like protein 25 Human genes 0.000 description 1
- 102100031600 Probable phospholipid-transporting ATPase IIA Human genes 0.000 description 1
- 102100031575 Probable phospholipid-transporting ATPase IIB Human genes 0.000 description 1
- 102100030468 Probable phospholipid-transporting ATPase IM Human genes 0.000 description 1
- 101710100896 Probable porphobilinogen deaminase Proteins 0.000 description 1
- 102100039310 Probable serine carboxypeptidase CPVL Human genes 0.000 description 1
- 102100030966 Probable splicing factor YJU2B Human genes 0.000 description 1
- 102100026319 Probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial Human genes 0.000 description 1
- 102100021727 Probable transmembrane reductase CYB561D1 Human genes 0.000 description 1
- 102100024191 Probable ubiquitin carboxyl-terminal hydrolase MINDY-4 Human genes 0.000 description 1
- 102100026534 Procathepsin L Human genes 0.000 description 1
- 102100032359 Progestin and adipoQ receptor family member 3 Human genes 0.000 description 1
- 102100034785 Programmed cell death protein 6 Human genes 0.000 description 1
- 102100036812 Progressive ankylosis protein homolog Human genes 0.000 description 1
- 102100034836 Proliferation marker protein Ki-67 Human genes 0.000 description 1
- 102100024091 Proline-rich AKT1 substrate 1 Human genes 0.000 description 1
- 102100026126 Proline-tRNA ligase Human genes 0.000 description 1
- 102100034144 Prolyl 3-hydroxylase 1 Human genes 0.000 description 1
- 102100040477 Prolyl 4-hydroxylase subunit alpha-1 Human genes 0.000 description 1
- 102100040478 Prolyl 4-hydroxylase subunit alpha-2 Human genes 0.000 description 1
- 102100039022 Propionyl-CoA carboxylase alpha chain, mitochondrial Human genes 0.000 description 1
- 102100039025 Propionyl-CoA carboxylase beta chain, mitochondrial Human genes 0.000 description 1
- 102100024055 Prostate androgen-regulated mucin-like protein 1 Human genes 0.000 description 1
- 102100029959 Proteasomal ATPase-associated factor 1 Human genes 0.000 description 1
- 102100023080 Proteasome adapter and scaffold protein ECM29 Human genes 0.000 description 1
- 102100031952 Protein 4.1 Human genes 0.000 description 1
- 102100026286 Protein AF-10 Human genes 0.000 description 1
- 102100039686 Protein AF-9 Human genes 0.000 description 1
- 102100032914 Protein AMN1 homolog Human genes 0.000 description 1
- 102100022029 Protein ARMCX6 Human genes 0.000 description 1
- 102100021622 Protein ARV1 Human genes 0.000 description 1
- 102100040265 Protein Abitram Human genes 0.000 description 1
- 102100029800 Protein Aster-A Human genes 0.000 description 1
- 102100040354 Protein Atg16l2 Human genes 0.000 description 1
- 102100021567 Protein BANP Human genes 0.000 description 1
- 102100025312 Protein BCAP Human genes 0.000 description 1
- 102100021252 Protein BEAN1 Human genes 0.000 description 1
- 102100026003 Protein BEX4 Human genes 0.000 description 1
- 102100030143 Protein BRAWNIN Human genes 0.000 description 1
- 102100026035 Protein BTG3 Human genes 0.000 description 1
- 102100029336 Protein C12orf4 Human genes 0.000 description 1
- 102100035828 Protein C3orf33 Human genes 0.000 description 1
- 102100035601 Protein CASC3 Human genes 0.000 description 1
- 102100024949 Protein CBFA2T2 Human genes 0.000 description 1
- 102100033812 Protein CBFA2T3 Human genes 0.000 description 1
- 102100024449 Protein CDV3 homolog Human genes 0.000 description 1
- 102100034810 Protein CEBPZOS Human genes 0.000 description 1
- 102100034625 Protein CFAP20DC Human genes 0.000 description 1
- 102100028634 Protein CIP2A Human genes 0.000 description 1
- 102100034718 Protein CLEC16A Human genes 0.000 description 1
- 102100029154 Protein CMSS1 Human genes 0.000 description 1
- 102100038239 Protein Churchill Human genes 0.000 description 1
- 102100025198 Protein DBF4 homolog A Human genes 0.000 description 1
- 102100025199 Protein DBF4 homolog B Human genes 0.000 description 1
- 102100026113 Protein DEK Human genes 0.000 description 1
- 102100025389 Protein DENND6A Human genes 0.000 description 1
- 102100035761 Protein DGCR6L Human genes 0.000 description 1
- 102100037836 Protein DPCD Human genes 0.000 description 1
- 102100038589 Protein Daple Human genes 0.000 description 1
- 102100040437 Protein ECT2 Human genes 0.000 description 1
- 102100033963 Protein EFR3 homolog A Human genes 0.000 description 1
- 102100037113 Protein ELYS Human genes 0.000 description 1
- 102100033813 Protein ENL Human genes 0.000 description 1
- 102100037083 Protein EURL homolog Human genes 0.000 description 1
- 102100030899 Protein FAM102A Human genes 0.000 description 1
- 102100030901 Protein FAM104A Human genes 0.000 description 1
- 102100026983 Protein FAM107B Human genes 0.000 description 1
- 102100035993 Protein FAM114A2 Human genes 0.000 description 1
- 102100035995 Protein FAM117A Human genes 0.000 description 1
- 102100023780 Protein FAM117B Human genes 0.000 description 1
- 102100023783 Protein FAM118A Human genes 0.000 description 1
- 102100023785 Protein FAM118B Human genes 0.000 description 1
- 102100039199 Protein FAM126B Human genes 0.000 description 1
- 102100038987 Protein FAM131A Human genes 0.000 description 1
- 102100038971 Protein FAM133B Human genes 0.000 description 1
- 102100039003 Protein FAM135A Human genes 0.000 description 1
- 102100030557 Protein FAM13A Human genes 0.000 description 1
- 102100030558 Protein FAM13B Human genes 0.000 description 1
- 102100036003 Protein FAM151B Human genes 0.000 description 1
- 102100036002 Protein FAM161A Human genes 0.000 description 1
- 102100023788 Protein FAM162A Human genes 0.000 description 1
- 102100023773 Protein FAM163A Human genes 0.000 description 1
- 102100020938 Protein FAM168A Human genes 0.000 description 1
- 102100030534 Protein FAM171A1 Human genes 0.000 description 1
- 102100022628 Protein FAM174C Human genes 0.000 description 1
- 102100037216 Protein FAM177A1 Human genes 0.000 description 1
- 102100035471 Protein FAM184A Human genes 0.000 description 1
- 102100035455 Protein FAM185A Human genes 0.000 description 1
- 102100023841 Protein FAM189A2 Human genes 0.000 description 1
- 102100023844 Protein FAM189B Human genes 0.000 description 1
- 102100023842 Protein FAM193A Human genes 0.000 description 1
- 102100034506 Protein FAM193B Human genes 0.000 description 1
- 102100034511 Protein FAM199X Human genes 0.000 description 1
- 102100038860 Protein FAM204A Human genes 0.000 description 1
- 102100038863 Protein FAM210A Human genes 0.000 description 1
- 102100026957 Protein FAM214A Human genes 0.000 description 1
- 102100026954 Protein FAM214B Human genes 0.000 description 1
- 102100026729 Protein FAM216A Human genes 0.000 description 1
- 102100029118 Protein FAM217B Human genes 0.000 description 1
- 102100029122 Protein FAM219B Human genes 0.000 description 1
- 102100029121 Protein FAM221A Human genes 0.000 description 1
- 102100027295 Protein FAM222B Human genes 0.000 description 1
- 102100030533 Protein FAM228B Human genes 0.000 description 1
- 102100030531 Protein FAM229B Human genes 0.000 description 1
- 102100030560 Protein FAM234A Human genes 0.000 description 1
- 102100037538 Protein FAM241B Human genes 0.000 description 1
- 102100027326 Protein FAM24B Human genes 0.000 description 1
- 102100040819 Protein FAM3A Human genes 0.000 description 1
- 102100040823 Protein FAM3C Human genes 0.000 description 1
- 102100037523 Protein FAM53B Human genes 0.000 description 1
- 102100034514 Protein FAM72A Human genes 0.000 description 1
- 102100034520 Protein FAM72C Human genes 0.000 description 1
- 102100034519 Protein FAM72D Human genes 0.000 description 1
- 102100023807 Protein FAM78B Human genes 0.000 description 1
- 102100023805 Protein FAM81A Human genes 0.000 description 1
- 102100035447 Protein FAM83D Human genes 0.000 description 1
- 102100026955 Protein FAM91A1 Human genes 0.000 description 1
- 102100022569 Protein FAM98B Human genes 0.000 description 1
- 102100022568 Protein FAM98C Human genes 0.000 description 1
- 102100027633 Protein FAN Human genes 0.000 description 1
- 102100027038 Protein FRA10AC1 Human genes 0.000 description 1
- 102100028387 Protein FRG1 Human genes 0.000 description 1
- 102100021180 Protein GOLM2 Human genes 0.000 description 1
- 101710197448 Protein GOLM2 Proteins 0.000 description 1
- 102100034143 Protein GPR107 Human genes 0.000 description 1
- 102100034142 Protein GPR108 Human genes 0.000 description 1
- 102100030846 Protein GUCD1 Human genes 0.000 description 1
- 102100021865 Protein HGH1 homolog Human genes 0.000 description 1
- 102100030473 Protein HIRA Human genes 0.000 description 1
- 102100021863 Protein Hikeshi Human genes 0.000 description 1
- 102100031717 Protein Hook homolog 3 Human genes 0.000 description 1
- 102100037171 Protein JTB Human genes 0.000 description 1
- 102100032707 Protein Jade-3 Human genes 0.000 description 1
- 102100025733 Protein Jumonji Human genes 0.000 description 1
- 102100037163 Protein KIAA0100 Human genes 0.000 description 1
- 102100037318 Protein KRBA1 Human genes 0.000 description 1
- 102100020994 Protein KRI1 homolog Human genes 0.000 description 1
- 102100040549 Protein LMBR1L Human genes 0.000 description 1
- 102100025612 Protein LSM12 homolog Human genes 0.000 description 1
- 102100028259 Protein LSM14 homolog A Human genes 0.000 description 1
- 102100028258 Protein LSM14 homolog B Human genes 0.000 description 1
- 102100022152 Protein LTO1 homolog Human genes 0.000 description 1
- 102100032133 Protein LYRIC Human genes 0.000 description 1
- 102100024087 Protein Lines homolog 1 Human genes 0.000 description 1
- 102100028815 Protein MAK16 homolog Human genes 0.000 description 1
- 102100032473 Protein MANBAL Human genes 0.000 description 1
- 102100035797 Protein MGARP Human genes 0.000 description 1
- 102100028174 Protein MIX23 Human genes 0.000 description 1
- 102100026361 Protein MMP24OS Human genes 0.000 description 1
- 102100023475 Protein MMS22-like Human genes 0.000 description 1
- 102100023083 Protein MTO1 homolog, mitochondrial Human genes 0.000 description 1
- 102100040532 Protein MTSS 2 Human genes 0.000 description 1
- 102100025034 Protein Mis18-beta Human genes 0.000 description 1
- 102100021273 Protein Mpv17 Human genes 0.000 description 1
- 102100035607 Protein N-lysine methyltransferase METTL21A Human genes 0.000 description 1
- 102100034233 Protein N-terminal asparagine amidohydrolase Human genes 0.000 description 1
- 102100024980 Protein NDRG1 Human genes 0.000 description 1
- 102100034436 Protein NDRG2 Human genes 0.000 description 1
- 102100034435 Protein NDRG3 Human genes 0.000 description 1
- 102100034432 Protein NDRG4 Human genes 0.000 description 1
- 102100035492 Protein NEDD1 Human genes 0.000 description 1
- 102100023432 Protein NLRC5 Human genes 0.000 description 1
- 102100036207 Protein NOXP20 Human genes 0.000 description 1
- 102100023076 Protein Niban 1 Human genes 0.000 description 1
- 102100022561 Protein NipSnap homolog 1 Human genes 0.000 description 1
- 102100022564 Protein NipSnap homolog 2 Human genes 0.000 description 1
- 102100037347 Protein Njmu-R1 Human genes 0.000 description 1
- 102100030122 Protein O-GlcNAcase Human genes 0.000 description 1
- 102100035204 Protein O-glucosyltransferase 2 Human genes 0.000 description 1
- 102100035203 Protein O-glucosyltransferase 3 Human genes 0.000 description 1
- 102100031492 Protein OS-9 Human genes 0.000 description 1
- 102100037778 Protein OSCP1 Human genes 0.000 description 1
- 102100034054 Protein PALS1 Human genes 0.000 description 1
- 102100037041 Protein PAT1 homolog 1 Human genes 0.000 description 1
- 102100036663 Protein PAXX Human genes 0.000 description 1
- 102100040170 Protein PBDC1 Human genes 0.000 description 1
- 102100037873 Protein PTHB1 Human genes 0.000 description 1
- 102100023134 Protein SIX6OS1 Human genes 0.000 description 1
- 102100028545 Protein TALPID3 Human genes 0.000 description 1
- 102100035191 Protein TASOR Human genes 0.000 description 1
- 102100035171 Protein TASOR 2 Human genes 0.000 description 1
- 102100022998 Protein angel homolog 1 Human genes 0.000 description 1
- 102100022990 Protein angel homolog 2 Human genes 0.000 description 1
- 102100022196 Protein arginine methyltransferase NDUFAF7, mitochondrial Human genes 0.000 description 1
- 102100025918 Protein artemis Human genes 0.000 description 1
- 102100032661 Protein asteroid homolog 1 Human genes 0.000 description 1
- 102100033727 Protein aurora borealis Human genes 0.000 description 1
- 102100035896 Protein bicaudal C homolog 1 Human genes 0.000 description 1
- 102100035898 Protein bicaudal D homolog 1 Human genes 0.000 description 1
- 102100022050 Protein canopy homolog 2 Human genes 0.000 description 1
- 102100033856 Protein canopy homolog 3 Human genes 0.000 description 1
- 102100033847 Protein canopy homolog 4 Human genes 0.000 description 1
- 102100026774 Protein chibby homolog 1 Human genes 0.000 description 1
- 102100037447 Protein cordon-bleu Human genes 0.000 description 1
- 102100022049 Protein cornichon homolog 1 Human genes 0.000 description 1
- 102100024446 Protein cornichon homolog 2 Human genes 0.000 description 1
- 102100024518 Protein cornichon homolog 3 Human genes 0.000 description 1
- 102100024517 Protein cornichon homolog 4 Human genes 0.000 description 1
- 102100027331 Protein crumbs homolog 1 Human genes 0.000 description 1
- 102100036490 Protein diaphanous homolog 1 Human genes 0.000 description 1
- 102100036469 Protein diaphanous homolog 2 Human genes 0.000 description 1
- 102100036468 Protein diaphanous homolog 3 Human genes 0.000 description 1
- 102100035622 Protein dispatched homolog 1 Human genes 0.000 description 1
- 102100029371 Protein disulfide isomerase CRELD1 Human genes 0.000 description 1
- 102100029370 Protein disulfide isomerase CRELD2 Human genes 0.000 description 1
- 102100030728 Protein disulfide-thiol oxidoreductase Human genes 0.000 description 1
- 102100029936 Protein dopey-1 Human genes 0.000 description 1
- 102100029926 Protein downstream neighbor of Son Human genes 0.000 description 1
- 102100022946 Protein dpy-30 homolog Human genes 0.000 description 1
- 102100035093 Protein enabled homolog Human genes 0.000 description 1
- 102100031798 Protein eva-1 homolog A Human genes 0.000 description 1
- 102100027569 Protein farnesyltransferase subunit beta Human genes 0.000 description 1
- 102100035480 Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha Human genes 0.000 description 1
- 102100040923 Protein flightless-1 homolog Human genes 0.000 description 1
- 102100020918 Protein furry homolog Human genes 0.000 description 1
- 102100020916 Protein furry homolog-like Human genes 0.000 description 1
- 102100035618 Protein fuzzy homolog Human genes 0.000 description 1
- 102100025385 Protein hinderin Human genes 0.000 description 1
- 102100031753 Protein inturned Human genes 0.000 description 1
- 102100023068 Protein kinase C-binding protein NELL1 Human genes 0.000 description 1
- 102100022660 Protein kintoun Human genes 0.000 description 1
- 102100031959 Protein lin-37 homolog Human genes 0.000 description 1
- 102100025689 Protein lin-52 homolog Human genes 0.000 description 1
- 102100025692 Protein lin-54 homolog Human genes 0.000 description 1
- 102100032928 Protein lin-7 homolog A Human genes 0.000 description 1
- 102100024097 Protein lin-9 homolog Human genes 0.000 description 1
- 102100026740 Protein mago nashi homolog Human genes 0.000 description 1
- 102100026743 Protein mago nashi homolog 2 Human genes 0.000 description 1
- 102100023096 Protein misato homolog 1 Human genes 0.000 description 1
- 102100040850 Protein mono-ADP-ribosyltransferase PARP11 Human genes 0.000 description 1
- 102100040846 Protein mono-ADP-ribosyltransferase PARP15 Human genes 0.000 description 1
- 102100034931 Protein mono-ADP-ribosyltransferase PARP4 Human genes 0.000 description 1
- 102100034932 Protein mono-ADP-ribosyltransferase PARP6 Human genes 0.000 description 1
- 102100034933 Protein mono-ADP-ribosyltransferase PARP8 Human genes 0.000 description 1
- 102100034930 Protein mono-ADP-ribosyltransferase PARP9 Human genes 0.000 description 1
- 102100023399 Protein moonraker Human genes 0.000 description 1
- 102100036985 Protein numb homolog Human genes 0.000 description 1
- 102100035450 Protein odr-4 homolog Human genes 0.000 description 1
- 102100027134 Protein orai-2 Human genes 0.000 description 1
- 102100027135 Protein orai-3 Human genes 0.000 description 1
- 102100031352 Protein p13 MTCP-1 Human genes 0.000 description 1
- 102100038668 Protein phosphatase 1 regulatory subunit 29 Human genes 0.000 description 1
- 102100039154 Protein piccolo Human genes 0.000 description 1
- 102100037516 Protein polybromo-1 Human genes 0.000 description 1
- 102100030293 Protein spinster homolog 1 Human genes 0.000 description 1
- 102100026221 Protein-L-histidine N-pros-methyltransferase Human genes 0.000 description 1
- 102100035033 Protein-S-isoprenylcysteine O-methyltransferase Human genes 0.000 description 1
- 102100030616 Protein-cysteine N-palmitoyltransferase HHAT Human genes 0.000 description 1
- 102100023369 Protein-lysine N-methyltransferase EEF2KMT Human genes 0.000 description 1
- 102100022095 Protocadherin Fat 1 Human genes 0.000 description 1
- 102100022134 Protocadherin Fat 3 Human genes 0.000 description 1
- 102100024278 Protocadherin alpha-6 Human genes 0.000 description 1
- 102100040926 Protocadherin alpha-C1 Human genes 0.000 description 1
- 102100034941 Protocadherin-7 Human genes 0.000 description 1
- 102100034957 Protocadherin-9 Human genes 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 101000932958 Pseudonaja textilis Cathelicidin-related peptide Pt_CRAMP1 Proteins 0.000 description 1
- 101000741290 Pseudonaja textilis Cathelicidin-related peptide Pt_CRAMP2 Proteins 0.000 description 1
- 102100026595 Pterin-4-alpha-carbinolamine dehydratase 2 Human genes 0.000 description 1
- 102100033192 Puromycin-sensitive aminopeptidase Human genes 0.000 description 1
- 102100025313 Putative ATP-dependent RNA helicase DDX12 Human genes 0.000 description 1
- 102100030092 Putative ATP-dependent RNA helicase DHX57 Human genes 0.000 description 1
- 102100028690 Putative C-mannosyltransferase DPY19L2P1 Human genes 0.000 description 1
- 102100029479 Putative DENN domain-containing protein 10 B Human genes 0.000 description 1
- 102100024744 Putative EP400-like protein Human genes 0.000 description 1
- 102100027753 Putative F-box/LRR-repeat protein 21 Human genes 0.000 description 1
- 102100040369 Putative HERC2-like protein 3 Human genes 0.000 description 1
- 102100021974 Putative L-aspartate dehydrogenase Human genes 0.000 description 1
- 102100024552 Putative NOL1/NOP2/Sun domain family member 5B Human genes 0.000 description 1
- 102100026173 Putative P2Y purinoceptor 10 Human genes 0.000 description 1
- 102100029749 Putative Polycomb group protein ASXL3 Human genes 0.000 description 1
- 102100023468 Putative RNA-binding protein Luc7-like 1 Human genes 0.000 description 1
- 102100032319 Putative activator of 90 kDa heat shock protein ATPase homolog 2 Human genes 0.000 description 1
- 102100032337 Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13 Human genes 0.000 description 1
- 102100032204 Putative ciliary rootlet coiled-coil protein-like 1 protein Human genes 0.000 description 1
- 102100032409 Putative coiled-coil domain-containing protein 26 Human genes 0.000 description 1
- 102100020752 Putative dehydrogenase/reductase SDR family member 4-like 1 Human genes 0.000 description 1
- 102100040908 Putative glycerol kinase 5 Human genes 0.000 description 1
- 102100027276 Putative glycosyltransferase ALG1-like Human genes 0.000 description 1
- 102100040189 Putative golgin subfamily A member 2B Human genes 0.000 description 1
- 102100025551 Putative homeobox protein Meis3-like 1 Human genes 0.000 description 1
- 102100028283 Putative inactive beta-glucuronidase protein GUSBP11 Human genes 0.000 description 1
- 102100030866 Putative inactive beta-glucuronidase-like protein SMA3 Human genes 0.000 description 1
- 102100021030 Putative inactive neutral ceramidase B Human genes 0.000 description 1
- 102100024551 Putative methyltransferase NSUN5C Human genes 0.000 description 1
- 102100030016 Putative monooxygenase p33MONOX Human genes 0.000 description 1
- 102100037017 Putative neuroblastoma breakpoint family member 8 Human genes 0.000 description 1
- 102100034301 Putative oxidoreductase GLYR1 Human genes 0.000 description 1
- 102100022412 Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX32 Human genes 0.000 description 1
- 102100024356 Putative protein CASTOR 3 Human genes 0.000 description 1
- 102100032886 Putative protein CLUHP3 Human genes 0.000 description 1
- 102100035999 Putative protein FAM157A Human genes 0.000 description 1
- 102100035949 Putative protein FAM157B Human genes 0.000 description 1
- 102100023834 Putative protein FAM86C1P Human genes 0.000 description 1
- 102100023812 Putative protein FAM86C2P Human genes 0.000 description 1
- 102100040688 Putative tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase Human genes 0.000 description 1
- 102100036114 Putative transcriptional regulator encoded by LINC00473 Human genes 0.000 description 1
- 102100023922 Putative tyrosine-protein phosphatase auxilin Human genes 0.000 description 1
- 102100026295 Putative uncharacterized protein ASB16-AS1 Human genes 0.000 description 1
- 102100028076 Putative uncharacterized protein ATP1A1-AS1 Human genes 0.000 description 1
- 102100030161 Putative uncharacterized protein BVES-AS1 Human genes 0.000 description 1
- 102100029919 Putative uncharacterized protein C2orf48 Human genes 0.000 description 1
- 102100027175 Putative uncharacterized protein C8orf44 Human genes 0.000 description 1
- 102100022657 Putative uncharacterized protein CCDC28A-AS1 Human genes 0.000 description 1
- 102100033681 Putative uncharacterized protein LINC02901 Human genes 0.000 description 1
- 102100023767 Putative uncharacterized protein encoded by LINC00476 Human genes 0.000 description 1
- 102100026960 Putative uncharacterized protein encoded by LINC00869 Human genes 0.000 description 1
- 102100038558 Putative uncharacterized protein encoded by MAPKAPK5-AS1 Human genes 0.000 description 1
- 102100037987 Putative uncharacterized protein encoded by MIR22HG Human genes 0.000 description 1
- 108010001946 Pyrin Domain-Containing 3 Protein NLR Family Proteins 0.000 description 1
- 102100034576 Quinone oxidoreductase Human genes 0.000 description 1
- 102100036521 Quinone oxidoreductase-like protein 1 Human genes 0.000 description 1
- 102100032798 RAB11-binding protein RELCH Human genes 0.000 description 1
- 102100036699 RAB6-interacting golgin Human genes 0.000 description 1
- 102100020934 RAB7A-interacting MON1-CCZ1 complex subunit 1 Human genes 0.000 description 1
- 102100033810 RAC-alpha serine/threonine-protein kinase Human genes 0.000 description 1
- 102100032315 RAC-beta serine/threonine-protein kinase Human genes 0.000 description 1
- 102100032314 RAC-gamma serine/threonine-protein kinase Human genes 0.000 description 1
- 102100030522 RNA N6-adenosine-methyltransferase METTL16 Human genes 0.000 description 1
- 102100021555 RNA cytosine C(5)-methyltransferase NSUN2 Human genes 0.000 description 1
- 102100039083 RNA demethylase ALKBH5 Human genes 0.000 description 1
- 102100025054 RNA guanine-N7 methyltransferase activating subunit Human genes 0.000 description 1
- 102100038488 RNA helicase Mov10l1 Human genes 0.000 description 1
- 102100033483 RNA helicase aquarius Human genes 0.000 description 1
- 102100023449 RNA polymerase II elongation factor ELL Human genes 0.000 description 1
- 102100023750 RNA polymerase II elongation factor ELL2 Human genes 0.000 description 1
- 102000004229 RNA-binding protein EWS Human genes 0.000 description 1
- 108090000740 RNA-binding protein EWS Proteins 0.000 description 1
- 102100026869 RNA-binding protein MEX3B Human genes 0.000 description 1
- 102100034026 RNA-binding protein Musashi homolog 1 Human genes 0.000 description 1
- 102100037566 RNA/RNP complex-1-interacting phosphatase Human genes 0.000 description 1
- 102100033967 RPA-related protein RADX Human genes 0.000 description 1
- 102100030858 RUS family member 1 Human genes 0.000 description 1
- 102100022881 Rab proteins geranylgeranyltransferase component A 1 Human genes 0.000 description 1
- 102100040160 Rabankyrin-5 Human genes 0.000 description 1
- 102100033372 Ragulator complex protein LAMTOR4 Human genes 0.000 description 1
- 101000962158 Ralstonia sp Maleylpyruvate isomerase Proteins 0.000 description 1
- 102100034417 Ras GTPase-activating-like protein IQGAP3 Human genes 0.000 description 1
- 102100039789 Ras-related protein M-Ras Human genes 0.000 description 1
- 102100038479 Ras-related protein Rab-43 Human genes 0.000 description 1
- 101000832669 Rattus norvegicus Probable alcohol sulfotransferase Proteins 0.000 description 1
- 101000727837 Rattus norvegicus Reduced folate transporter Proteins 0.000 description 1
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 1
- 102100029165 Receptor-binding cancer antigen expressed on SiSo cells Human genes 0.000 description 1
- 102100034981 Retroelement silencing factor 1 Human genes 0.000 description 1
- 108091008770 Rev-ErbAß Proteins 0.000 description 1
- 101001030849 Rhinella marina Mesotocin receptor Proteins 0.000 description 1
- 102100025642 Rho GDP-dissociation inhibitor 1 Human genes 0.000 description 1
- 102100021433 Rho GTPase-activating protein 1 Human genes 0.000 description 1
- 102100031354 Rho GTPase-activating protein 11A Human genes 0.000 description 1
- 102100027663 Rho GTPase-activating protein 12 Human genes 0.000 description 1
- 102100027656 Rho GTPase-activating protein 17 Human genes 0.000 description 1
- 102100027604 Rho GTPase-activating protein 19 Human genes 0.000 description 1
- 102100035757 Rho GTPase-activating protein 22 Human genes 0.000 description 1
- 102100035758 Rho GTPase-activating protein 23 Human genes 0.000 description 1
- 102100035741 Rho GTPase-activating protein 24 Human genes 0.000 description 1
- 102100035744 Rho GTPase-activating protein 26 Human genes 0.000 description 1
- 102100020896 Rho GTPase-activating protein 28 Human genes 0.000 description 1
- 102100020899 Rho GTPase-activating protein 29 Human genes 0.000 description 1
- 102100020887 Rho GTPase-activating protein 30 Human genes 0.000 description 1
- 102100020890 Rho GTPase-activating protein 31 Human genes 0.000 description 1
- 102100020900 Rho GTPase-activating protein 32 Human genes 0.000 description 1
- 102100030682 Rho GTPase-activating protein 33 Human genes 0.000 description 1
- 102100030752 Rho GTPase-activating protein 36 Human genes 0.000 description 1
- 102100030748 Rho GTPase-activating protein 39 Human genes 0.000 description 1
- 102100030757 Rho GTPase-activating protein 42 Human genes 0.000 description 1
- 102100027748 Rho GTPase-activating protein 45 Human genes 0.000 description 1
- 102100021428 Rho GTPase-activating protein 5 Human genes 0.000 description 1
- 102100021446 Rho GTPase-activating protein 7 Human genes 0.000 description 1
- 102100021443 Rho GTPase-activating protein 8 Human genes 0.000 description 1
- 108010053823 Rho Guanine Nucleotide Exchange Factors Proteins 0.000 description 1
- 102100021708 Rho guanine nucleotide exchange factor 1 Human genes 0.000 description 1
- 102100033203 Rho guanine nucleotide exchange factor 10 Human genes 0.000 description 1
- 102100039777 Rho guanine nucleotide exchange factor 10-like protein Human genes 0.000 description 1
- 102100033194 Rho guanine nucleotide exchange factor 11 Human genes 0.000 description 1
- 102100033193 Rho guanine nucleotide exchange factor 12 Human genes 0.000 description 1
- 102100032432 Rho guanine nucleotide exchange factor 18 Human genes 0.000 description 1
- 102100021707 Rho guanine nucleotide exchange factor 2 Human genes 0.000 description 1
- 102100032451 Rho guanine nucleotide exchange factor 25 Human genes 0.000 description 1
- 102100032447 Rho guanine nucleotide exchange factor 26 Human genes 0.000 description 1
- 102100033204 Rho guanine nucleotide exchange factor 28 Human genes 0.000 description 1
- 102100021689 Rho guanine nucleotide exchange factor 3 Human genes 0.000 description 1
- 102100033205 Rho guanine nucleotide exchange factor 33 Human genes 0.000 description 1
- 102100033207 Rho guanine nucleotide exchange factor 39 Human genes 0.000 description 1
- 102100021709 Rho guanine nucleotide exchange factor 4 Human genes 0.000 description 1
- 102100039653 Rho guanine nucleotide exchange factor 40 Human genes 0.000 description 1
- 102100033202 Rho guanine nucleotide exchange factor 6 Human genes 0.000 description 1
- 102100033221 Rho guanine nucleotide exchange factor 9 Human genes 0.000 description 1
- 102100031774 Ribitol 5-phosphate transferase FKRP Human genes 0.000 description 1
- 102100031754 Ribitol-5-phosphate transferase FKTN Human genes 0.000 description 1
- 102100035491 Ribosomal RNA small subunit methyltransferase NEP1 Human genes 0.000 description 1
- 102100033169 Ribosomal biogenesis factor Human genes 0.000 description 1
- 102100027433 Ribosomal biogenesis protein LAS1L Human genes 0.000 description 1
- 102100027055 Ribosome biogenesis protein BOP1 Human genes 0.000 description 1
- 102100030570 Ribosome biogenesis protein SLX9 homolog Human genes 0.000 description 1
- 102100022213 Ribosome quality control complex subunit NEMF Human genes 0.000 description 1
- 102100022945 Ribosome-recycling factor, mitochondrial Human genes 0.000 description 1
- 102100025784 Ribosome-releasing factor 2, mitochondrial Human genes 0.000 description 1
- 102100022353 Ribosyldihydronicotinamide dehydrogenase [quinone] Human genes 0.000 description 1
- 102100032198 Rootletin Human genes 0.000 description 1
- 102100029991 S-formylglutathione hydrolase Human genes 0.000 description 1
- 102100022847 SANT and BTB domain regulator of class switch recombination Human genes 0.000 description 1
- 108091007628 SLC49A4 Proteins 0.000 description 1
- 108091006238 SLC7A8 Proteins 0.000 description 1
- 102100022380 SOSS complex subunit B2 Human genes 0.000 description 1
- 102100034200 SOSS complex subunit C Human genes 0.000 description 1
- 102100031580 SREBP regulating gene protein Human genes 0.000 description 1
- 102100031482 SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related Human genes 0.000 description 1
- 101001053942 Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) Diphosphomevalonate decarboxylase Proteins 0.000 description 1
- 101100127690 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) FAA2 gene Proteins 0.000 description 1
- 102100027733 Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 Human genes 0.000 description 1
- 101100225588 Schizosaccharomyces pombe (strain 972 / ATCC 24843) nip1 gene Proteins 0.000 description 1
- 101100279513 Schizosaccharomyces pombe (strain 972 / ATCC 24843) sum1 gene Proteins 0.000 description 1
- 102100030053 Secreted frizzled-related protein 3 Human genes 0.000 description 1
- 102100032758 Segment polarity protein dishevelled homolog DVL-1 Human genes 0.000 description 1
- 102100032754 Segment polarity protein dishevelled homolog DVL-3 Human genes 0.000 description 1
- 102100021463 Seipin Human genes 0.000 description 1
- 102100037498 Selenocysteine-specific elongation factor Human genes 0.000 description 1
- 102100036750 Separin Human genes 0.000 description 1
- 102100038230 Serine beta-lactamase-like protein LACTB, mitochondrial Human genes 0.000 description 1
- 102100021117 Serine protease HTRA2, mitochondrial Human genes 0.000 description 1
- 102100032880 Serine-rich coiled-coil domain-containing protein 1 Human genes 0.000 description 1
- 102100032895 Serine-rich coiled-coil domain-containing protein 2 Human genes 0.000 description 1
- 102100029437 Serine/threonine-protein kinase A-Raf Human genes 0.000 description 1
- 102100027103 Serine/threonine-protein kinase B-raf Human genes 0.000 description 1
- 102100029891 Serine/threonine-protein kinase BRSK2 Human genes 0.000 description 1
- 102100031081 Serine/threonine-protein kinase Chk1 Human genes 0.000 description 1
- 102100039775 Serine/threonine-protein kinase DCLK2 Human genes 0.000 description 1
- 102100026621 Serine/threonine-protein kinase ICK Human genes 0.000 description 1
- 102100024031 Serine/threonine-protein kinase LATS1 Human genes 0.000 description 1
- 102100024043 Serine/threonine-protein kinase LATS2 Human genes 0.000 description 1
- 102100040291 Serine/threonine-protein kinase LMTK3 Human genes 0.000 description 1
- 102100028921 Serine/threonine-protein kinase MARK1 Human genes 0.000 description 1
- 102100028904 Serine/threonine-protein kinase MARK2 Human genes 0.000 description 1
- 102100025352 Serine/threonine-protein kinase MRCK alpha Human genes 0.000 description 1
- 102100025347 Serine/threonine-protein kinase MRCK beta Human genes 0.000 description 1
- 102100028751 Serine/threonine-protein kinase Nek1 Human genes 0.000 description 1
- 102100028775 Serine/threonine-protein kinase Nek11 Human genes 0.000 description 1
- 102100037705 Serine/threonine-protein kinase Nek4 Human genes 0.000 description 1
- 102100031400 Serine/threonine-protein kinase Nek7 Human genes 0.000 description 1
- 102100031398 Serine/threonine-protein kinase Nek9 Human genes 0.000 description 1
- 102100037143 Serine/threonine-protein kinase OSR1 Human genes 0.000 description 1
- 102100027910 Serine/threonine-protein kinase PAK 1 Human genes 0.000 description 1
- 102100027939 Serine/threonine-protein kinase PAK 2 Human genes 0.000 description 1
- 102100027940 Serine/threonine-protein kinase PAK 4 Human genes 0.000 description 1
- 102100039278 Serine/threonine-protein kinase greatwall Human genes 0.000 description 1
- 102100023085 Serine/threonine-protein kinase mTOR Human genes 0.000 description 1
- 102100034285 Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A Human genes 0.000 description 1
- 102100033329 Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B Human genes 0.000 description 1
- 102100036209 Serine/threonine-protein phosphatase CPPED1 Human genes 0.000 description 1
- 102100030733 Set1/Ash2 histone methyltransferase complex subunit ASH2 Human genes 0.000 description 1
- 102100028378 Shieldin complex subunit 2 Human genes 0.000 description 1
- 102100029954 Sialic acid synthase Human genes 0.000 description 1
- 102100034258 Sialomucin core protein 24 Human genes 0.000 description 1
- 102100021400 Sickle tail protein homolog Human genes 0.000 description 1
- 102100038081 Signal transducer CD24 Human genes 0.000 description 1
- 102100027040 Sister chromatid cohesion protein DCC1 Human genes 0.000 description 1
- 102100021887 Small RNA 2'-O-methyltransferase Human genes 0.000 description 1
- 102100024806 Small integral membrane protein 6 Human genes 0.000 description 1
- 102100027344 Small kinetochore-associated protein Human genes 0.000 description 1
- 102100031371 Sodium channel protein type 8 subunit alpha Human genes 0.000 description 1
- 102100029410 Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 1 Human genes 0.000 description 1
- 102100022792 Sodium/potassium-transporting ATPase subunit beta-3 Human genes 0.000 description 1
- 102100024397 Soluble calcium-activated nucleotidase 1 Human genes 0.000 description 1
- 102100026937 Soluble lamin-associated protein of 75 kDa Human genes 0.000 description 1
- 102100037945 Solute carrier family 49 member 4 Human genes 0.000 description 1
- 102100032929 Son of sevenless homolog 1 Human genes 0.000 description 1
- 102100036408 Spermatogenesis-associated protein 17 Human genes 0.000 description 1
- 102100039430 Spliceosome-associated protein CWC27 homolog Human genes 0.000 description 1
- 102100037997 Squalene synthase Human genes 0.000 description 1
- 102100023719 Src substrate cortactin Human genes 0.000 description 1
- 102100036831 Steroid hormone receptor ERR2 Human genes 0.000 description 1
- 102100029238 Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating Human genes 0.000 description 1
- 102100023673 Succinate-semialdehyde dehydrogenase, mitochondrial Human genes 0.000 description 1
- 102100020868 Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial Human genes 0.000 description 1
- 108010002687 Survivin Proteins 0.000 description 1
- 101000987219 Sus scrofa Pregnancy-associated glycoprotein 1 Proteins 0.000 description 1
- 102100036378 T-cell immunomodulatory protein Human genes 0.000 description 1
- 102100035891 T-cell surface glycoprotein CD3 delta chain Human genes 0.000 description 1
- 102100034928 T-cell surface glycoprotein CD8 beta chain Human genes 0.000 description 1
- 102100036049 T-complex protein 1 subunit gamma Human genes 0.000 description 1
- 102100030664 T-complex protein 1 subunit zeta Human genes 0.000 description 1
- 102100028639 TATA-binding protein-associated factor 172 Human genes 0.000 description 1
- 102100024247 TLC domain-containing protein 3A Human genes 0.000 description 1
- 101710149776 TNFAIP3-interacting protein 1 Proteins 0.000 description 1
- 102100037667 TNFAIP3-interacting protein 1 Human genes 0.000 description 1
- 102100031626 TPA-induced transmembrane protein Human genes 0.000 description 1
- 102100030904 Target of rapamycin complex 2 subunit MAPKAP1 Human genes 0.000 description 1
- 102100027802 Target of rapamycin complex subunit LST8 Human genes 0.000 description 1
- 102100033113 Telomere length and silencing protein 1 homolog Human genes 0.000 description 1
- 102100034939 Terminal nucleotidyltransferase 4A Human genes 0.000 description 1
- 102100034938 Terminal nucleotidyltransferase 4B Human genes 0.000 description 1
- 102100029773 Tether containing UBX domain for GLUT4 Human genes 0.000 description 1
- 102100035310 Threonylcarbamoyladenosine tRNA methylthiotransferase Human genes 0.000 description 1
- 102100037357 Thymidylate kinase Human genes 0.000 description 1
- 101150104365 Tomt gene Proteins 0.000 description 1
- 102100040116 Trans-3-hydroxy-L-proline dehydratase Human genes 0.000 description 1
- 102100021386 Trans-acting T-cell-specific transcription factor GATA-3 Human genes 0.000 description 1
- 108010068068 Transcription Factor TFIIIA Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102100027158 Transcription factor BTF3 homolog 4 Human genes 0.000 description 1
- 102100024207 Transcription factor COE1 Human genes 0.000 description 1
- 102100024200 Transcription factor COE3 Human genes 0.000 description 1
- 102100024201 Transcription factor COE4 Human genes 0.000 description 1
- 102100024027 Transcription factor E2F3 Human genes 0.000 description 1
- 102100031631 Transcription factor E2F6 Human genes 0.000 description 1
- 102100031556 Transcription factor E2F7 Human genes 0.000 description 1
- 102100037331 Transcription factor E4F1 Human genes 0.000 description 1
- 102100039580 Transcription factor ETV6 Human genes 0.000 description 1
- 102100027263 Transcription factor ETV7 Human genes 0.000 description 1
- 102100021380 Transcription factor GATA-4 Human genes 0.000 description 1
- 102100030774 Transcription factor HES-4 Human genes 0.000 description 1
- 102100028438 Transcription factor HIVEP2 Human genes 0.000 description 1
- 102100028336 Transcription factor HIVEP3 Human genes 0.000 description 1
- 102100028509 Transcription factor IIIA Human genes 0.000 description 1
- 102100034737 Transcription factor LBX2 Human genes 0.000 description 1
- 102100039188 Transcription factor MafG Human genes 0.000 description 1
- 102100028604 Transcription initiation factor IIA subunit 2 Human genes 0.000 description 1
- 102100033662 Transcription initiation factor IIB Human genes 0.000 description 1
- 102100023998 Transcription regulator protein BACH2 Human genes 0.000 description 1
- 102100035550 Transcription termination factor 2, mitochondrial Human genes 0.000 description 1
- 102100035551 Transcription termination factor 3, mitochondrial Human genes 0.000 description 1
- 102100035552 Transcription termination factor 4, mitochondrial Human genes 0.000 description 1
- 102100023931 Transcriptional regulator ATRX Human genes 0.000 description 1
- 102100024797 Transcriptional regulator PINT87aa Human genes 0.000 description 1
- 102100027671 Transcriptional repressor CTCF Human genes 0.000 description 1
- 102100037558 Transcriptional repressor p66-alpha Human genes 0.000 description 1
- 102100037556 Transcriptional repressor p66-beta Human genes 0.000 description 1
- 102100033095 Translation factor GUF1, mitochondrial Human genes 0.000 description 1
- 102100029550 Translation initiation factor IF-2, mitochondrial Human genes 0.000 description 1
- 102100039649 Translation initiation factor IF-3, mitochondrial Human genes 0.000 description 1
- 102100034267 Translation initiation factor eIF-2B subunit epsilon Human genes 0.000 description 1
- 102100023225 Translation initiation factor eIF-2B subunit gamma Human genes 0.000 description 1
- 102100021338 Transmembrane ascorbate-dependent reductase CYB561 Human genes 0.000 description 1
- 102100032471 Transmembrane protease serine 4 Human genes 0.000 description 1
- 102100029732 Transmembrane protein 180 Human genes 0.000 description 1
- 102100034947 Transmembrane protein CCDC163 Human genes 0.000 description 1
- 102100025378 Transmembrane protein KIAA1109 Human genes 0.000 description 1
- 102100021728 Transmembrane reductase CYB561D2 Human genes 0.000 description 1
- 102100028569 Transport and Golgi organization protein 1 homolog Human genes 0.000 description 1
- 102100022202 Tumor necrosis factor receptor superfamily member 27 Human genes 0.000 description 1
- 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 1
- 102100039257 Type II inositol 1,4,5-trisphosphate 5-phosphatase Human genes 0.000 description 1
- 102100026803 Type-1 angiotensin II receptor Human genes 0.000 description 1
- 102100026563 Type-1 angiotensin II receptor-associated protein Human genes 0.000 description 1
- 108010035075 Tyrosine decarboxylase Proteins 0.000 description 1
- 102100021575 Tyrosine-protein kinase BAZ1B Human genes 0.000 description 1
- 102100029823 Tyrosine-protein kinase BTK Human genes 0.000 description 1
- 102100024537 Tyrosine-protein kinase Fer Human genes 0.000 description 1
- 102100037333 Tyrosine-protein kinase Fes/Fps Human genes 0.000 description 1
- 102100035221 Tyrosine-protein kinase Fyn Human genes 0.000 description 1
- 102100033438 Tyrosine-protein kinase JAK1 Human genes 0.000 description 1
- 102100025387 Tyrosine-protein kinase JAK3 Human genes 0.000 description 1
- 102100022356 Tyrosine-protein kinase Mer Human genes 0.000 description 1
- 102100033018 Tyrosine-protein phosphatase non-receptor type 18 Human genes 0.000 description 1
- 102100034461 U2 small nuclear ribonucleoprotein B'' Human genes 0.000 description 1
- 102100031542 U3 small nucleolar RNA-associated protein 25 homolog Human genes 0.000 description 1
- 102100033314 U6 snRNA-associated Sm-like protein LSm1 Human genes 0.000 description 1
- 102100028261 U6 snRNA-associated Sm-like protein LSm5 Human genes 0.000 description 1
- 102100027960 UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 1 Human genes 0.000 description 1
- 102100027958 UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2 Human genes 0.000 description 1
- 102100032289 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1 Human genes 0.000 description 1
- 102100027277 UDP-N-acetylglucosamine transferase subunit ALG14 homolog Human genes 0.000 description 1
- 102100021436 UDP-glucose 4-epimerase Human genes 0.000 description 1
- 102100029286 UNC93-like protein MFSD11 Human genes 0.000 description 1
- 102100033873 UPF0235 protein C15orf40 Human genes 0.000 description 1
- 102100032602 UPF0449 protein C19orf25 Human genes 0.000 description 1
- 102100038065 UPF0462 protein C4orf33 Human genes 0.000 description 1
- 102100034823 UPF0489 protein C5orf22 Human genes 0.000 description 1
- 102100026670 UPF0538 protein C2orf76 Human genes 0.000 description 1
- 102100039432 UPF0545 protein C22orf39 Human genes 0.000 description 1
- 102100026604 UPF0547 protein C16orf87 Human genes 0.000 description 1
- 102100022865 UPF0606 protein KIAA1549 Human genes 0.000 description 1
- 102100021441 UPF0687 protein C20orf27 Human genes 0.000 description 1
- 102100038574 UPF0692 protein C19orf54 Human genes 0.000 description 1
- 102100038729 UPF0711 protein C18orf21 Human genes 0.000 description 1
- 102100028229 Ubiquinone biosynthesis O-methyltransferase, mitochondrial Human genes 0.000 description 1
- 102100037292 Ubiquinone biosynthesis monooxygenase COQ6, mitochondrial Human genes 0.000 description 1
- 102100035953 Ubiquinone biosynthesis protein COQ4 homolog, mitochondrial Human genes 0.000 description 1
- 102100028230 Ubiquinone biosynthesis protein COQ9, mitochondrial Human genes 0.000 description 1
- 102100024250 Ubiquitin carboxyl-terminal hydrolase CYLD Human genes 0.000 description 1
- 102100026279 Ubiquitin carboxyl-terminal hydrolase MINDY-1 Human genes 0.000 description 1
- 102100024198 Ubiquitin carboxyl-terminal hydrolase MINDY-2 Human genes 0.000 description 1
- 102100024205 Ubiquitin carboxyl-terminal hydrolase MINDY-3 Human genes 0.000 description 1
- 102100025187 Ubiquitin thioesterase otulin Human genes 0.000 description 1
- 102100022979 Ubiquitin-like modifier-activating enzyme ATG7 Human genes 0.000 description 1
- 102100028060 Ubiquitin-like-conjugating enzyme ATG10 Human genes 0.000 description 1
- 102100039930 Ubiquitin-like-conjugating enzyme ATG3 Human genes 0.000 description 1
- 102100029353 Uncharacterized protein C12orf29 Human genes 0.000 description 1
- 102100026138 Uncharacterized protein C12orf76 Human genes 0.000 description 1
- 102100022058 Uncharacterized protein C14orf93 Human genes 0.000 description 1
- 102100031447 Uncharacterized protein C16orf46 Human genes 0.000 description 1
- 102100026591 Uncharacterized protein C16orf74 Human genes 0.000 description 1
- 102100037950 Uncharacterized protein C17orf80 Human genes 0.000 description 1
- 102100032607 Uncharacterized protein C19orf44 Human genes 0.000 description 1
- 102100038502 Uncharacterized protein C19orf47 Human genes 0.000 description 1
- 102100038573 Uncharacterized protein C19orf48 Human genes 0.000 description 1
- 102100021438 Uncharacterized protein C20orf96 Human genes 0.000 description 1
- 102100026633 Uncharacterized protein C2orf27A Human genes 0.000 description 1
- 102100026538 Uncharacterized protein C2orf42 Human genes 0.000 description 1
- 102100026673 Uncharacterized protein C2orf74 Human genes 0.000 description 1
- 102100025713 Uncharacterized protein C3orf62 Human genes 0.000 description 1
- 102100033655 Uncharacterized protein C6orf62 Human genes 0.000 description 1
- 102100034638 Uncharacterized protein C7orf26 Human genes 0.000 description 1
- 102100034637 Uncharacterized protein C7orf31 Human genes 0.000 description 1
- 102100034425 Uncharacterized protein C7orf50 Human genes 0.000 description 1
- 102100027225 Uncharacterized protein C8orf34 Human genes 0.000 description 1
- 102100027226 Uncharacterized protein C8orf58 Human genes 0.000 description 1
- 102100033666 Uncharacterized protein C8orf88 Human genes 0.000 description 1
- 102100029322 Uncharacterized protein C9orf85 Human genes 0.000 description 1
- 102100032531 Uncharacterized protein CLBA1 Human genes 0.000 description 1
- 102100036175 Uncharacterized protein CXorf38 Human genes 0.000 description 1
- 102100039400 Uncharacterized protein CXorf65 Human genes 0.000 description 1
- 102100039202 Uncharacterized protein FAM120AOS Human genes 0.000 description 1
- 102100037145 Uncharacterized protein KIAA0232 Human genes 0.000 description 1
- 102100025706 Uncharacterized protein KIAA0825 Human genes 0.000 description 1
- 102100025704 Uncharacterized protein KIAA0895 Human genes 0.000 description 1
- 102100037161 Uncharacterized protein KIAA0895-like Human genes 0.000 description 1
- 102100025382 Uncharacterized protein KIAA1522 Human genes 0.000 description 1
- 102100022862 Uncharacterized protein KIAA1671 Human genes 0.000 description 1
- 102100022848 Uncharacterized protein KIAA1958 Human genes 0.000 description 1
- 102100022853 Uncharacterized protein KIAA2026 Human genes 0.000 description 1
- 102100022559 Uncharacterized protein NKAPD1 Human genes 0.000 description 1
- 102100039598 Uncharacterized protein encoded by LINC01547 Human genes 0.000 description 1
- 102100038307 Unconventional myosin-IXa Human genes 0.000 description 1
- 102100038325 Unconventional myosin-IXb Human genes 0.000 description 1
- 102100026776 Unconventional myosin-Ib Human genes 0.000 description 1
- 102100030409 Unconventional myosin-Va Human genes 0.000 description 1
- 102100030366 Unconventional myosin-Vb Human genes 0.000 description 1
- 102100031833 Unconventional myosin-Vc Human genes 0.000 description 1
- 102100038932 Unconventional myosin-XVIIIa Human genes 0.000 description 1
- 102100030663 Uridine diphosphate glucose pyrophosphatase NUDT14 Human genes 0.000 description 1
- 102100032304 Uridine diphosphate glucose pyrophosphatase NUDT22 Human genes 0.000 description 1
- 102100037979 V-type proton ATPase 116 kDa subunit a 1 Human genes 0.000 description 1
- 102100020745 V-type proton ATPase 116 kDa subunit a 2 Human genes 0.000 description 1
- 102100034171 V-type proton ATPase 16 kDa proteolipid subunit c Human genes 0.000 description 1
- 102100037466 V-type proton ATPase catalytic subunit A Human genes 0.000 description 1
- 102100032185 V-type proton ATPase subunit C 2 Human genes 0.000 description 1
- 102100033478 V-type proton ATPase subunit D Human genes 0.000 description 1
- 102100039465 V-type proton ATPase subunit E 1 Human genes 0.000 description 1
- 102100039006 V-type proton ATPase subunit H Human genes 0.000 description 1
- 102100037100 V-type proton ATPase subunit S1-like protein Human genes 0.000 description 1
- 102100036507 V-type proton ATPase subunit d 1 Human genes 0.000 description 1
- 102100040563 V-type proton ATPase subunit e 1 Human genes 0.000 description 1
- 102100040248 VIP36-like protein Human genes 0.000 description 1
- 102100033389 Vacuolar fusion protein MON1 homolog A Human genes 0.000 description 1
- 108010053100 Vascular Endothelial Growth Factor Receptor-3 Proteins 0.000 description 1
- 102100033178 Vascular endothelial growth factor receptor 1 Human genes 0.000 description 1
- 102100033179 Vascular endothelial growth factor receptor 3 Human genes 0.000 description 1
- 102100034166 Vasculin Human genes 0.000 description 1
- 102100034167 Vasculin-like protein 1 Human genes 0.000 description 1
- 102100027989 Very large A-kinase anchor protein Human genes 0.000 description 1
- 102100033637 Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 1 Human genes 0.000 description 1
- 101710141122 Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 1 Proteins 0.000 description 1
- 102100031034 Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 4 Human genes 0.000 description 1
- 101710141116 Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 4 Proteins 0.000 description 1
- 102100037438 Very-long-chain 3-oxoacyl-CoA reductase Human genes 0.000 description 1
- 102100024018 Vesicle transport protein GOT1B Human genes 0.000 description 1
- 102100035030 Vesicle transport protein SEC20 Human genes 0.000 description 1
- 102100035054 Vesicle-fusing ATPase Human genes 0.000 description 1
- 102100037814 Vigilin Human genes 0.000 description 1
- 102100038182 Vitamin K-dependent gamma-carboxylase Human genes 0.000 description 1
- 102100025568 Voltage-dependent L-type calcium channel subunit beta-1 Human genes 0.000 description 1
- 102100025838 Voltage-dependent L-type calcium channel subunit beta-3 Human genes 0.000 description 1
- 102100025836 Voltage-dependent L-type calcium channel subunit beta-4 Human genes 0.000 description 1
- 102100032869 Voltage-dependent calcium channel gamma-7 subunit Human genes 0.000 description 1
- 102100037059 Voltage-dependent calcium channel subunit alpha-2/delta-1 Human genes 0.000 description 1
- 102100037058 Voltage-dependent calcium channel subunit alpha-2/delta-2 Human genes 0.000 description 1
- 102100037054 Voltage-dependent calcium channel subunit alpha-2/delta-3 Human genes 0.000 description 1
- 102100037053 Voltage-dependent calcium channel subunit alpha-2/delta-4 Human genes 0.000 description 1
- 102100034073 Voltage-gated potassium channel subunit beta-3 Human genes 0.000 description 1
- 102100040985 Volume-regulated anion channel subunit LRRC8A Human genes 0.000 description 1
- 102100040982 Volume-regulated anion channel subunit LRRC8B Human genes 0.000 description 1
- 102100040987 Volume-regulated anion channel subunit LRRC8D Human genes 0.000 description 1
- 108010020277 WD repeat containing planar cell polarity effector Proteins 0.000 description 1
- 108700042462 X-linked Nuclear Proteins 0.000 description 1
- 101100445056 Xenopus laevis elavl1-a gene Proteins 0.000 description 1
- 101100445057 Xenopus laevis elavl1-b gene Proteins 0.000 description 1
- 108700031763 Xeroderma Pigmentosum Group D Proteins 0.000 description 1
- 101001038499 Yarrowia lipolytica (strain CLIB 122 / E 150) Lysine acetyltransferase Proteins 0.000 description 1
- 101100022813 Zea mays MEG3 gene Proteins 0.000 description 1
- 108010088665 Zinc Finger Protein Gli2 Proteins 0.000 description 1
- 102100028440 Zinc finger protein 40 Human genes 0.000 description 1
- 102100040639 Zinc finger protein 83 Human genes 0.000 description 1
- 102100026512 Zinc finger protein 875 Human genes 0.000 description 1
- 102100036296 Zinc finger protein DPF3 Human genes 0.000 description 1
- 102100037793 Zinc finger protein Eos Human genes 0.000 description 1
- 102100035558 Zinc finger protein GLI2 Human genes 0.000 description 1
- 102100029004 Zinc finger protein Gfi-1 Human genes 0.000 description 1
- 102100020893 Zinc finger protein Pegasus Human genes 0.000 description 1
- 102100037208 Zinc finger protein basonuclin-2 Human genes 0.000 description 1
- 102100029859 Zinc finger protein neuro-d4 Human genes 0.000 description 1
- 102100039877 Zinc phosphodiesterase ELAC protein 2 Human genes 0.000 description 1
- ZPCCSZFPOXBNDL-ZSTSFXQOSA-N [(4r,5s,6s,7r,9r,10r,11e,13e,16r)-6-[(2s,3r,4r,5s,6r)-5-[(2s,4r,5s,6s)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2r,5s,6r)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoe Chemical compound O([C@H]1/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]([C@@H]([C@H]([C@@H](CC=O)C[C@H]1C)O[C@H]1[C@@H]([C@H]([C@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@](C)(O)C2)[C@@H](C)O1)N(C)C)O)OC)OC(C)=O)[C@H]1CC[C@H](N(C)C)[C@@H](C)O1 ZPCCSZFPOXBNDL-ZSTSFXQOSA-N 0.000 description 1
- WSBTVXLTRDAUDB-XPWSMXQVSA-N [3-[2-(2,5-dioxopyrrolidin-1-yl)ethoxy-hydroxyphosphoryl]oxy-2-[(e)-octadec-9-enoyl]oxypropyl] (e)-octadec-9-enoate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C\CCCCCCCC)COP(O)(=O)OCCN1C(=O)CCC1=O WSBTVXLTRDAUDB-XPWSMXQVSA-N 0.000 description 1
- UGXQOOQUZRUVSS-ZZXKWVIFSA-N [5-[3,5-dihydroxy-2-(1,3,4-trihydroxy-5-oxopentan-2-yl)oxyoxan-4-yl]oxy-3,4-dihydroxyoxolan-2-yl]methyl (e)-3-(4-hydroxyphenyl)prop-2-enoate Chemical compound OC1C(OC(CO)C(O)C(O)C=O)OCC(O)C1OC1C(O)C(O)C(COC(=O)\C=C\C=2C=CC(O)=CC=2)O1 UGXQOOQUZRUVSS-ZZXKWVIFSA-N 0.000 description 1
- 102100030295 [F-actin]-monooxygenase MICAL2 Human genes 0.000 description 1
- BOPGDPNILDQYTO-NDOGXIPWSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2r,3r,4r,5r)-5-(3-carbamoyl-4h-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NDOGXIPWSA-N 0.000 description 1
- 108010078976 aflatoxin B1 aldehyde reductase Proteins 0.000 description 1
- CWJNMKKMGIAGDK-UHFFFAOYSA-N amtolmetin guacil Chemical compound COC1=CC=CC=C1OC(=O)CNC(=O)CC(N1C)=CC=C1C(=O)C1=CC=C(C)C=C1 CWJNMKKMGIAGDK-UHFFFAOYSA-N 0.000 description 1
- 101150072346 anapc1 gene Proteins 0.000 description 1
- 101150001938 anapc4 gene Proteins 0.000 description 1
- 101150085085 anapc7 gene Proteins 0.000 description 1
- 102100031147 bMERB domain-containing protein 1 Human genes 0.000 description 1
- 108700000711 bcl-X Proteins 0.000 description 1
- 108010032969 beta-Arrestin 1 Proteins 0.000 description 1
- 108010032967 beta-Arrestin 2 Proteins 0.000 description 1
- 108010005713 bis(5'-adenosyl)triphosphatase Proteins 0.000 description 1
- 108010018804 c-Mer Tyrosine Kinase Proteins 0.000 description 1
- 101150000895 c1galt1 gene Proteins 0.000 description 1
- 102100029387 cAMP-responsive element modulator Human genes 0.000 description 1
- 108010051348 cdc42 GTP-Binding Protein Proteins 0.000 description 1
- 108010031373 centromere protein C Proteins 0.000 description 1
- CWJSHJJYOPWUGX-UHFFFAOYSA-N chlorpropham Chemical compound CC(C)OC(=O)NC1=CC=CC(Cl)=C1 CWJSHJJYOPWUGX-UHFFFAOYSA-N 0.000 description 1
- 101150018325 chmp1a gene Proteins 0.000 description 1
- 208000035196 congenital hypomyelinating 2 neuropathy Diseases 0.000 description 1
- 101150118453 ctbp-1 gene Proteins 0.000 description 1
- 101150052649 ctbp2 gene Proteins 0.000 description 1
- RGLYKWWBQGJZGM-ISLYRVAYSA-N diethylstilbestrol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(\CC)C1=CC=C(O)C=C1 RGLYKWWBQGJZGM-ISLYRVAYSA-N 0.000 description 1
- 108020001096 dihydrofolate reductase Proteins 0.000 description 1
- BRFKTXCAUCYQBT-KIXJXINUSA-N dinophysistoxin 2 Chemical compound C([C@H](O1)[C@H](C)/C=C/[C@H]2CC[C@@]3(CC[C@H]4O[C@@H](C([C@@H](O)[C@@H]4O3)=C)[C@@H](O)C[C@H](C)[C@H]3O[C@@]4([C@@H](CCCO4)C)CCC3)O2)C(C)=C[C@]21O[C@H](C[C@@](C)(O)C(O)=O)CC[C@H]2O BRFKTXCAUCYQBT-KIXJXINUSA-N 0.000 description 1
- 229940090124 dipeptidyl peptidase 4 (dpp-4) inhibitors for blood glucose lowering Drugs 0.000 description 1
- 108010049792 diphthine methyltransferase Proteins 0.000 description 1
- 102100023730 eEF1A N-terminal methyltransferase Human genes 0.000 description 1
- 102100034175 eIF-2-alpha kinase GCN2 Human genes 0.000 description 1
- 102100030495 eIF-2-alpha kinase activator GCN1 Human genes 0.000 description 1
- 101150093313 eIF3c gene Proteins 0.000 description 1
- 101150004703 eIF3i gene Proteins 0.000 description 1
- 101150029915 eIF3j gene Proteins 0.000 description 1
- 102100039119 eIF5-mimic protein 1 Human genes 0.000 description 1
- 108010018033 endothelial PAS domain-containing protein 1 Proteins 0.000 description 1
- 108010041998 erythrocyte membrane protein band 4.1-like 1 Proteins 0.000 description 1
- 238000000249 far-infrared magnetic resonance spectroscopy Methods 0.000 description 1
- 102000003684 fibroblast growth factor 13 Human genes 0.000 description 1
- 108090000047 fibroblast growth factor 13 Proteins 0.000 description 1
- 101150077246 gas5 gene Proteins 0.000 description 1
- 101150055960 hemB gene Proteins 0.000 description 1
- 108010027263 homeobox protein HOXA9 Proteins 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 108010092830 integrin alpha7beta1 Proteins 0.000 description 1
- 108010085650 interferon gamma receptor Proteins 0.000 description 1
- 108010008094 laminin alpha 3 Proteins 0.000 description 1
- 108010019813 leptin receptors Proteins 0.000 description 1
- 102000004311 liver X receptors Human genes 0.000 description 1
- 108090000865 liver X receptors Proteins 0.000 description 1
- 102100028825 m-AAA protease-interacting protein 1, mitochondrial Human genes 0.000 description 1
- 102100035860 m7GpppN-mRNA hydrolase Human genes 0.000 description 1
- 102100033718 m7GpppX diphosphatase Human genes 0.000 description 1
- 102100029741 mRNA N(3)-methylcytidine methyltransferase METTL8 Human genes 0.000 description 1
- 102100034702 mRNA decay activator protein ZFP36L1 Human genes 0.000 description 1
- 102100034703 mRNA decay activator protein ZFP36L2 Human genes 0.000 description 1
- 102100040700 mRNA export factor GLE1 Human genes 0.000 description 1
- 102100035856 mRNA-decapping enzyme 1A Human genes 0.000 description 1
- 102100035858 mRNA-decapping enzyme 1B Human genes 0.000 description 1
- PCTLYGKHPBZRCZ-UKLTVQOFSA-N maitotoxin-3 Chemical compound C[C@H]1CC[C@H]2O[C@@]3(C)C[C@H]4O[C@H]5C[C@H]6O[C@](O)(C[C@@H](O)CO)[C@@H](O)[C@@H](OS(O)(=O)=O)[C@@H]6O[C@@H]5C=C[C@@H]4O[C@@H]3CC[C@@H]2O[C@@H]2C[C@@H]3O[C@]4(C)CC(=C)C[C@](C)(O[C@H]4C[C@H]3O[C@@H]12)[C@@H](O)CC(=O)CC\C=C(/C)C=C PCTLYGKHPBZRCZ-UKLTVQOFSA-N 0.000 description 1
- 108010038449 metabotropic glutamate receptor 7 Proteins 0.000 description 1
- 108040008770 methylated-DNA-[protein]-cysteine S-methyltransferase activity proteins Proteins 0.000 description 1
- 108091051364 miR-1268a stem-loop Proteins 0.000 description 1
- 108091054834 miR-548g stem-loop Proteins 0.000 description 1
- 108091024683 miR-548h-3 stem-loop Proteins 0.000 description 1
- 108091041881 miR-548h-4 stem-loop Proteins 0.000 description 1
- 108091024672 miR-548n stem-loop Proteins 0.000 description 1
- 108091085840 miR-548n-1 stem-loop Proteins 0.000 description 1
- 108091063358 miR-548n-2 stem-loop Proteins 0.000 description 1
- 108010074917 microsomal glutathione S-transferase-I Proteins 0.000 description 1
- 108010024786 mitochondrial calcium uniporter Proteins 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 101150080343 mtarc1 gene Proteins 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 101150091791 mvk gene Proteins 0.000 description 1
- LBCGUKCXRVUULK-QGZVFWFLSA-N n-[2-(1,3-benzodioxol-5-yl)ethyl]-1-[2-(1h-imidazol-1-yl)-6-methylpyrimidin-4-yl]-d-prolinamide Chemical compound N=1C(C)=CC(N2[C@H](CCC2)C(=O)NCCC=2C=C3OCOC3=CC=2)=NC=1N1C=CN=C1 LBCGUKCXRVUULK-QGZVFWFLSA-N 0.000 description 1
- 108010086154 neutrophil cytosol factor 40K Proteins 0.000 description 1
- 108010054452 nuclear pore complex protein 98 Proteins 0.000 description 1
- 108010027635 osteoclast stimulating factor Proteins 0.000 description 1
- 102100032579 p21-activated protein kinase-interacting protein 1 Human genes 0.000 description 1
- 108010083945 potassium channel protein TREK-1 Proteins 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 108010051009 proto-oncogene protein Pbx3 Proteins 0.000 description 1
- 108010067366 proto-oncogene protein c-fes-fps Proteins 0.000 description 1
- 102100029739 rRNA N6-adenosine-methyltransferase METTL5 Human genes 0.000 description 1
- 102100022111 rRNA-processing protein FCF1 homolog Human genes 0.000 description 1
- 108010037379 ribosome releasing factor Proteins 0.000 description 1
- 108091005418 scavenger receptor class E Proteins 0.000 description 1
- 230000009919 sequestration Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 1
- 102100021554 tRNA (cytosine(34)-C(5))-methyltransferase, mitochondrial Human genes 0.000 description 1
- 102100021560 tRNA (cytosine(72)-C(5))-methyltransferase NSUN6 Human genes 0.000 description 1
- 102100025028 tRNA (guanine-N(7)-)-methyltransferase Human genes 0.000 description 1
- 102100038283 tRNA N(3)-methylcytidine methyltransferase METTL2A Human genes 0.000 description 1
- 102100030609 tRNA N(3)-methylcytidine methyltransferase METTL2B Human genes 0.000 description 1
- 102100029735 tRNA N(3)-methylcytidine methyltransferase METTL6 Human genes 0.000 description 1
- 102100034429 tRNA-dihydrouridine(16/17) synthase [NAD(P)(+)]-like Human genes 0.000 description 1
- 102100028986 tRNA-dihydrouridine(20) synthase [NAD(P)+]-like Human genes 0.000 description 1
- 102100027091 tRNA-dihydrouridine(20a/20b) synthase [NAD(P)+]-like Human genes 0.000 description 1
- 102100034440 tRNA-uridine aminocarboxypropyltransferase 1 Human genes 0.000 description 1
- 108091008744 testicular receptors 2 Proteins 0.000 description 1
- 108091008743 testicular receptors 4 Proteins 0.000 description 1
- JREYOWJEWZVAOR-UHFFFAOYSA-N triazanium;[3-methylbut-3-enoxy(oxido)phosphoryl] phosphate Chemical compound [NH4+].[NH4+].[NH4+].CC(=C)CCOP([O-])(=O)OP([O-])([O-])=O JREYOWJEWZVAOR-UHFFFAOYSA-N 0.000 description 1
- 108010064892 trkC Receptor Proteins 0.000 description 1
- SQQWBSBBCSFQGC-JLHYYAGUSA-N ubiquinone-2 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CCC=C(C)C)=C(C)C1=O SQQWBSBBCSFQGC-JLHYYAGUSA-N 0.000 description 1
- DBESHHFMIFSNRV-RJYQSXAYSA-N ubiquinone-7 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O DBESHHFMIFSNRV-RJYQSXAYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4743—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/712—Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose
Definitions
- RNA nucleotide sequence or an RNA nucleotide sequence comprising a DNA or RNA recognition element for splicing modifier (a DNA REMS or RNA REMS) recognized by a compound described herein.
- a DNA REMS or RNA REMS a DNA REMS or RNA REMS
- RNA REMS RNA REMS
- described herein are methods for modulating the amount or type of RNA transcript or protein product encoded by a gene, wherein a pre-mRNA transcript transcribed from the gene comprises a RNA REMS, by utilizing a compound described herein.
- a pre-mRNA transcript transcribed from the gene comprises a RNA REMS
- described herein is a plurality of artificial gene constructs, comprising a DNA REMS or RNA REMS and uses thereof, for use in a method for modulating an amount or type of a pre-mRNA transcript or protein encoded by a gene transfected with an artificial gene construct, by utilizing a compound described herein.
- a number of diseases are associated with aberrant expression of a gene product (e.g., an RNA transcript or protein) of a gene.
- An aberrant amount or type of RNA transcript may lead to disease due to corresponding changes in protein expression. Changes in the amount or type of a particular RNA transcript may be the result of several factors. For example, changes in the amount or type of an RNA transcript may be due to an aberrant level of transcription of a particular gene, such as by the perturbation of a transcription factor or a portion of the transcription process, resulting in a change in the expression level of a particular RNA transcript.
- changes in the splicing of particular RNA transcripts can change the levels of a particular RNA transcript.
- changes to the stability of a particular RNA transcript or to components that maintain RNA transcript stability such as the process of poly-A tail incorporation or an effect on certain factors or proteins that bind to and stabilize RNA transcripts, may lead to changes in the levels of a particular RNA transcript.
- changes in the level of translation of a particular RNA transcript can affect the amount or type of those transcripts, affecting or upregulating RNA transcript decay processes.
- aberrant RNA transport or RNA sequestration may lead to changes in functional levels of RNA transcripts, and may have an effect on the stability, further processing, or translation of the RNA transcripts.
- RNA transcripts or associated proteins may be treated with a focus on the aberrant protein expression.
- the processes responsible for changing the amount or type of aberrant RNA such as components of the splicing process, associated translation factors or associated stability factors, could be targeted by treatment with a small molecule, it may be possible to restore protein expression levels and avoid the expression of an aberrant RNA transcript or associated protein. Accordingly, there remains a need for methods of modulating the amount or type of aberrant RNA encoded by a gene to prevent or treat diseases associated with expression of aberrant RNA transcripts or associated proteins.
- RNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 1 to SEQ ID NO. 5775, as shown in Table 1, and the pre-mRNA transcript transcribed from the gene comprises a RNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 5776 to SEQ ID NO.
- Ri, Rs, Ri, R5, and Re as defined herein, wherein the compound is contacted with the RNA REMS nucleotide sequence in a cell lysate or in a cell in cell culture, whether in vivo or ex vivo, to express the mature RNA transcript, wherein the amount or type of mature RNA transcript expressed in the presence of the compound is modulated compared to the amount or type of mature RNA transcript expressed in the absence of the compound, and wherein the mature RNA transcript is selected from a wildtype or non-wildtype mature RNA transcript.
- described herein are methods for modulating the amount or type of mature mRNA transcript produced from pre-mRNA containing a RNA REMS.
- artificial gene constructs comprising a DNA REMS or RNA REMS, which may be used in the context of, e.g., gene therapy or reporter assays.
- methods for engineering a gene to become such an artificial gene construct from an endogenous gene wherein the artificial gene construct contains a non-wildtype DNA REMS or a non-wildtype RNA REMS.
- the REMS is an endogenous 5’ splice site in a pre-mRNA.
- the REMS is a canonical endogenous 5’ splice site in a pre-mRNA. In another aspect, the REMS is a noncanonical endogenous 5’ splice site in a pre- mRNA.
- RNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 1 to SEQ ID NO. 5775, (b) transcribed from a gene selected from Table 5, and/or (c) comprises an RNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 5776 to SEQ ID NO.
- the compound of Formula (I) has a structure having Ri, R3, R4, R5, and Re as defined herein, wherein the compound is contacted with the RNA REMS nucleotide sequence in a cell lysate or in a cell in cell culture, whether in vivo or ex vivo, to express the mature RNA transcript, wherein the amount or type of mature RNA transcript expressed in the presence of the compound is modulated compared to the amount or type of mature RNA transcript expressed in the absence of the compound, and wherein the mature RNA transcript is selected from a wildtype or non-wildtype mature RNA transcript.
- an artificial gene construct which comprises (a) DNA encoding exons, a 3' splice site(s) and a branch point(s), wherein a nucleotide sequence encoding an exon, which is upstream of a nucleotide sequence encoding a branch point and a nucleotide sequence encoding a 3' splice site, (b) DNA encoding exons and one, two or more introns, wherein a nucleotide sequence encoding a 5' splice site, which is upstream of a nucleotide sequence encoding a branch point and a nucleotide sequence encoding a 3' splice site; or (c) DNA encoding exons, a 5' splice site(s), a 3' splice site(s) and a branch point(s), wherein a nucleotide sequence encoding a 5'
- a method of regulating the amount or type of a protein produced by a gene comprising contacting a compound of Formula (I), or form thereof, with a pre-mRNA transcript transcribed from a gene, wherein the gene comprises a DNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 1 to SEQ ID NO. 5775, and the pre-mRNA transcript transcribed from the gene comprises a RNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 5776 to SEQ ID NO.
- the compound of Formula (I) has the structure having Ri, R3, R4, R5, and Re as defined herein, wherein the compound is contacted with the RNA REMS nucleotide sequence in a cell lysate or in a cell in cell culture, whether in vivo or ex vivo, to express the mature RNA transcript, wherein the amount or type of mature RNA transcript expressed in the presence of the compound is modulated compared to the amount or type of mature RNA transcript expressed in the absence of the compound, and wherein the mature RNA transcript is selected from a wildtype or non-wildtype mature RNA transcript.
- RNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 1 to SEQ ID NO. 5775
- pre-mRNA transcript transcribed from the gene comprises a RNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 5776 to SEQ ID NO. 11550, wherein, the compound of Formula (I) has the structure:
- Ri is phenyl or heteroaryl, optionally substituted with one, two, three, or four, independently selected Ria substituents,
- heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S;
- R1a is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, or C1-6alkoxy;
- R3 is hydrogen, C1-6alkyl, C2-salkenyl, C2-6alkynyl, and C1-6alkyl-amino, wherein C1-6alkyl, C2-6alkenyl, and C2-6alkynyl is optionally substituted with one, two, three, or four independently selected Ria substituents, and
- each instance of C1-6alkyl, C2-6alkenyl, and C2-6alkynyl may optionally contain a chiral carbon having an (R) or (S) configuration;
- R3a is cyano, halo, hydroxy, oxo, C1-6alkyl, halo-C1-6alkyl, Ci-oalkoxy, halo-C1-6alkoxy, carboxyl, amino, C1-6alkoxy-carbonyl, C1-6alkyl-amino, halo-C1-6alkyl-amino, ( C1-6alkyl)2-amino, phenyl-amino, heterocyclyl-amino, heteroaryl-amino, phenyl-(C1-6alkyl)-amino, heterocyclyl-(C1-6alkyl)-amino, heteroaryl-(C1-6alkyl)-amino, C1-6alkyl-thio, C1-6alkyl-sulfoxyl, and C1-6alkyl-sulfonyl, [0023] wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms
- heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S;
- each instance of phenyl, heterocyclyl, and heteroaryl is optionally substituted with one, two, three or four independently selected Rsa’ substituents;
- Raa’ is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, or amino;
- Rr is hydrogen, cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, halo-C1-6alkoxy, amino, C1-6alkyl-amino, (C1-6alkyl)2-amino, C3-10cycloalkyl, phenyl, heterocyclyl, or heteroaryl,
- heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S,
- heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S, and
- each instance of C1-6alkyl, C3-10cycloalkyl, phenyl, heterocyclyl, or heteroaryl are optionally substituted with one, two, three, or four independently selected R4a substituents;
- R4a is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, or C1-6alkoxy;
- R5 is hydrogen, cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, carbamoyl, C3-10cycloalkyl, or heterocyclyl,
- heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S;
- Re is hydrogen, halo, or C1-6alkyl
- the compound is contacted with the RNA REMS nucleotide sequence in a cell lysate or in a cell in cell culture, whether in vivo or ex vivo, to express the mature RNA transcript, wherein the amount or type of mature RNA transcript expressed in the presence of the compound is modulated compared to the amount or type of mature RNA transcript expressed in the absence of the compound, and wherein the mature RNA transcript is selected from a wildtype or non-wildtype mature RNA transcript.
- RNA REMS nucleotide sequence sele cted from the group consisting of SEQ ID NO. 1 to SEQ ID NO. 5775
- c comprises an RNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 5776 to SEQ ID NO. 11550, wherein the compound of Formula (I) has the structure:
- Ri is phenyl or heteroaryl, optionally substituted with one, two, three, or four, independently selected Ria substituents,
- heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S;
- Ria is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, or C1-6alkoxy;
- R3 is hydrogen, C1-6alkyl, C2-salkenyl, C2-6alkynyl, and C1-6alkyl-amino,
- C1-6alkyl, C2-6alkenyl, and C2-6alkynyl is optionally substituted with one, two, three, or four independently selected Ria substituents, and
- each instance of C1-6alkyl, C2-6alkenyl, and C2-6alkynyl may optionally contain a chiral carbon having an (R) or (S) configuration;
- Ria is cyano, halo, hydroxy, oxo, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, halo-C1-6alkoxy, carboxyl, amino, C1-6alkoxy-carbonyl, C1-6alkyl-amino, halo-C1-6alkyl-amino, (C1-6alkyl)2-amino, phenyl-amino, heterocyclyl-amino, heteroaryl-amino, phenyl-(C1-6alkyl)-amino, heterocyclyl-(C1-6alkyl)-amino, heteroaryl-(C1-6alkyl)-amino, C1-6alkyl-thio, C1-6alkyl-sulfoxyl, and C1-6alkyl-sulfonyl,
- heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S
- heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S;
- each instance of phenyl, heterocyclyl, and heteroaryl is optionally substituted with one, two, three or four independently selected Raa’ substituents;
- Rja’ is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, or amino;
- Rr is hydrogen, cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, halo-C1-6alkoxy, amino, C1-6alkyl-amino, (C1-6alkyl)2-amino, C3-10cycloalkyl, phenyl, heterocyclyl, or heteroaryl,
- heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S,
- heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S, and
- each instance of C1-6alkyl, C3-10cycloalkyl, phenyl, heterocyclyl, or heteroaryl are optionally substituted with one, two, three, or four independently selected R4a substituents;
- R4a is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, or C1-6alkoxy;
- R5 is hydrogen, cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, carbamoyl, C3-10cycloalkyl, or heterocyclyl,
- heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S;
- Re is hydrogen, halo, or C1-6alkyl
- the compound is contacted with the RNA REMS nucleotide sequence in a cell lysate or in a cell in cell culture, whether in vivo or ex vivo, to express the mature RNA transcript, wherein the amount or type of mature RNA transcript expressed in the presence of the compound is modulated compared to the amount or type of mature RNA transcript expressed in the absence of the compound, and wherein the mature RNA transcript is selected from a wildtype or non-wildtype mature RNA transcript.
- described herein are methods for modulating the amount or type of mature mRNA transcript produced from pre-mRNA containing a RNA REMS.
- artificial gene constructs comprising a DNA REMS or RNA REMS, which may be used in the context of, e.g., gene therapy or reporter assays.
- methods for engineering a gene to become such an artificial gene construct from an endogenous gene wherein the artificial gene construct contains a non-wildtype DNA REMS or a non-wildtype RNA REMS.
- the REMS is an endogenous 5’ splice site in a pre-mRNA.
- the REMS is a canonical endogenous 5’ splice site in a pre-mRNA. In another aspect, the REMS is a noncanonical endogenous 5’ splice site in a pre- mRNA.
- described herein are methods for modulating the amount or type of mature mRNA transcript produced from pre-mRNA containing a RNA REMS.
- artificial gene constructs comprising a DNA REMS or RNA REMS, which may be used in the context of, e.g., gene therapy or reporter assays.
- methods for engineering a gene to become such an artificial gene construct from an endogenous gene wherein the artificial gene construct contains a non-wildtype DNA REMS or a non -wildtype RNA REMS.
- RNA transcripts or proteins thereof expressed as the product of one or more genes, wherein the pre-mRNA transcripts transcribed by the one or more genes comprise a REMS, the methods comprising contacting a cell with a compound of Formula (I)
- the pre-mRNA transcript is transcribed from a gene comprising a DNA REMs sequence set forth in Table la, wherein the nucleotide sequence ANNNrrrrrr comprises N exonic nucleotides selected from A, C, G or T, and r intronic nucleotides selected from a, c, g or t); Table lb, wherein the nucleotide sequence CNNNrrrrrr comprises N exonic nucleotides selected from A, C, G or T, and r intronic nucleotides selected from a, c, g or t); Table 1c, wherein the nucleotide sequence GNNNrrrrrr comprises N exonic nucleotides selected from A, C, G or T, and r intronic nucleotides selected from a, c, g or t); and, Table Id, wherein the nucleotide sequence TNNNrrrrrr comprises N exonic nucleotides selected
- the pre-mRNA transcript is transcribed from a gene comprising a RNA REMs sequence set forth in Table 2a, wherein the nucleotide sequence ANNNrrrrrr comprises N exonic nucleotides selected from A, C, G or U, and r intronic nucleotides selected from a, c, g or u); Table 2b, wherein the nucleotide sequence CNNNrrrrrr comprises N exonic nucleotides selected from A, C, G or U, and r intronic nucleotides selected from a, c, g or u); Table 2c, wherein the nucleotide sequence GNNNrrrrrrr comprises N exonic nucleotides selected from A, C, G or U, and r intronic nucleotides selected from a, c, g or u); and, Table 2d, wherein the nucleotide sequence TNNNrrrrrr comprises N
- the pre-mRNA transcript is transcribed from a gene comprising a DNA REMs sequence set forth in Table 3a, wherein the nucleotide sequence ANNNrrrrrr comprises N exonic nucleotides selected from A, C, G or T, and r intronic nucleotides selected from a, c, g or t); Table 3b, wherein the nucleotide sequence CNNNrrrrrrr comprises N exonic nucleotides selected from A, C, G or T, and r intronic nucleotides selected from a, c, g or t); Table 3c, wherein the nucleotide sequence GNNNrrrrrr comprises N exonic nucleotides selected from A, C, G or T, and r intronic nucleotides selected from a, c, g or t); and, Table 3d, wherein the nucleotide sequence TNNNrrrrrr comprises N exonic nucleotides
- the pre-mRNA transcript is transcribed from a gene comprising a RNA REMs sequence set forth in Table 4a, wherein the nucleotide sequence ANNNrrrrrr comprises N exonic nucleotides selected from A, C, G or U, and r intronic nucleotides selected from a, c, g or u); Table 4b, wherein the nucleotide sequence CNNNrrrrrr comprises N exonic nucleotides selected from A, C, G or U, and r intronic nucleotides selected from a, c, g or u); Table 4c, wherein the nucleotide sequence GNNNrrrrrrr comprises N exonic nucleotides selected from A, C, G or U, and r intronic nucleotides selected from a, c, g or u); and, Table 4d, wherein the nucleotide sequence TNNNrrrrrr comprises N
- RNA REMS Table 4a [0081] RNA REMS Table 4b
- a pre-mRNA transcript comprises a REMs sequence transcribed from a gene is selected from a DNA REMs sequence set forth in Table 1 and Table 3 and comprises a REMs sequence expressed from a gene selected from a RNA REMs sequence set forth in Table 2 and Table 4; and, wherein the gene transcribed or expressed is selected from the group consisting of genes in Table 5.
- TSHZ2 TSKS, TSNARE1, TSNAX, TSNAXIP1, TSPAN12, TSPAN13, TSPAN TSPAN17, TSPAN18, TSPAN31, TSPAN4, TSPAN5, TSPAN9, TSP0AP1-AS1
- the pre-mRNA transcript comprising a REMs sequence is selected from a DNA REMs sequence set forth in Table 3 and a RNA REMs sequence set forth in Table 4; and, wherein the gene transcribed or expressed is selected from the group consisting of genes in Table 6.
- Table 6 Selected Genes Expressing a REMs Sequence C19orf25, C19orf47, C19orf48, C19orf54, C19orf57, C1QTNF3-AMACR, C1QTNF6, Clorfl09, Clorf54, C2CD2L, C2CD3, C2CD5, C2orf48, C2orf76, C3orf67, C4orfi3, C5, C5orf42, C5orf63, C5orf66, C6orE>9, C8orf31, C8orf44-SGK3, C9orf3, C9orf85, CA5BP1, CACNA2D1, CACNA2D3, CACNB1, CACNB4, CADM2, CALCRL, CAMK1, CAMK2A, CAMK4, CAMSAP1, CAMSAP3, CAMTAI, CAP2, CAPN15, CAPRIN2, CAPS2, CARE, CASD1, CASP8, CASP9, CATS
- LOC441242 LOC642852, LOC645166, LOC653080, LOC727751, LOC728730, LOC729732, LOC729970, L0NP2, L0XL2, LPAR1, LPAR2, LPCAT2, LPCAT4, LPIN1, LPP, LRCH3, LRIG1, LRIG3, LRMDA, LRP1, LRP2, LRP8, LRRC28, LRRC34, LRRC37A2, LRRC37B, LRRC40, LRRC58, LRRC6, LRRCC1, LRRFIP2, LRSAM1, LRTOMT, LSM12, LSS, LTB4R, LTBP1, LT
- a pre-mRNA transcript of a gene wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the method comprising contacting a cell or cell lysate with a compound of Formula (I) or a form thereof, wherein the gene is not disclosed in International Patent Application No. PCT/US2016/013553 (International Publication No. WO2016/115434).
- a pre-mRNA transcript of a gene wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the method comprising contacting a cell or cell lysate with a compound of Formula (I) or a form thereof, wherein the gene is not disclosed in International Patent Application No. PCT/US2020/017430 (International Publication No. WO2020/167628).
- a pre-mRNA transcript of a gene wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the method comprising contacting a cell or cell lysate with a compound of Formula (I) or a form thereof, wherein the gene is not disclosed in International Patent Application No. PCT/US2021/012103 (International Publication No. WO2021/138678).
- RNA transcripts of a gene wherein the pre-mRNA transcript transcribed from the gene comprises a REMS
- the method comprising contacting a cell with a compound of Formula (I) or a form thereof.
- a cell or cell lysate is contacted with the compound of Formula (1) or a form thereof, where the cell may be in cell culture, in vitro, in vivo or ex vivo.
- the cell is contacted with the compound of Formula (I) or a form thereof in a subject (e.g., a non-human animal subject or a human subject).
- RNA transcripts of a gene wherein the pre-mRNA transcript transcribed from the gene comprises a REMS
- the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
- RNA transcripts of a gene by way of nonlimiting example, comprising a REMS sequence or a gene described herein, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
- a compound of Formula (I) is a compound selected from a compound described herein.
- RNA transcripts of a gene comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
- a compound of Formula (I) is a compound selected from a compound described herein.
- RNA transcripts of a gene other than a gene comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
- a compound of Formula (I) is a compound selected from a compound described herein.
- a disease associated with the aberrant expression of a product of a gene e.g., an mRNA transcript or protein
- the pre-mRNA transcript transcribed from the gene comprises a REMS
- the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
- a compound of Formula (I) is a compound selected from a compound described herein.
- a disease associated with aberrant expression of a product of a gene e.g., an mRNA, RNA transcript or protein
- a product of a gene e.g., an mRNA, RNA transcript or protein
- the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
- a disease associated with aberrant expression of a product of a gene e.g., an mRNA, RNA transcript or protein
- a gene e.g., an mRNA, RNA transcript or protein
- the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
- a disease associated with aberrant expression of a product of a gene e.g., an mRNA, RNA transcript or protein
- a gene e.g., an mRNA, RNA transcript or protein
- the gene is not disclosed in International Patent Application No. PCT/US2016/013553 (International Publication No. WO2016/115434)
- the pre-mRNA transcript transcribed from the gene comprises a REMS
- the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
- a disease associated with aberrant expression of a product of a gene e.g., an mRNA, RNA transcript or protein
- a gene e.g., an mRNA, RNA transcript or protein
- the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
- a compound of Formula (I) is a compound selected from a compound described herein.
- RNA isoforms encoded by a gene are beneficial to the prevention and/or treatment of the disease, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
- RNA isoforms encoded by a gene by way of nonlimiting example, comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5, is beneficial to the prevention and/or treatment of the disease, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
- RNA isoforms encoded by a gene not disclosed in Tables W-Z, infra
- the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
- RNA isoforms encoded by a gene wherein the gene is not disclosed in International Patent Application No. PCT/US2016/013553 (International Publication No.
- WO2016/115434 is beneficial to the prevention and/or treatment of the disease, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
- RNA isoforms encoded by a gene other than a gene comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5, is beneficial to the prevention and/or treatment of the disease, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
- a compound of Formula (I) is a compound selected from a compound described herein.
- a change in the level of expression of one, two, three or more protein isoforms encoded by a gene is beneficial to the prevention and/or treatment of the disease, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
- a disease in which the alteration (e.g., increase or decrease) in the expression one, two, three or more protein isoforms encoded by a gene comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5, is beneficial to the prevention and/or treatment of the disease, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
- a compound of Formula (1) is a compound selected from a compound described herein.
- a disease in which the alteration (e.g., increase or decrease) in the expression one, two, three or more protein isoforms encoded by a gene, not disclosed in Tables W-Z, infra, is beneficial to the prevention and/or treatment of the disease, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
- the alteration e.g., increase or decrease
- the expression one, two, three or more protein isoforms encoded by a gene not disclosed in Tables W-Z, infra
- the pre-mRNA transcript transcribed from the gene comprises a REMS
- a disease in which the alteration (e.g., increase or decrease) in the expression one, two, three or more protein isoforms encoded by a gene, wherein the gene is not disclosed in International Patent Application No. PCT/US2016/013553 (International Publication No. WO2016/115434), and is beneficial to the prevention and/or treatment of the disease, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
- a disease in which the alteration (e.g., increase or decrease) in the expression one, two, three or more protein isoforms encoded by a gene other than a gene comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5, is beneficial to the prevention and/or treatment of the disease, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
- a compound of Formula (I) is a compound selected from a compound described herein.
- described herein are artificial gene constructs.
- an artificial gene construct comprising DNA encoding exons, a 3’ splice site(s) and a branch point(s), wherein a nucleotide sequence encoding an exon, which is upstream of a nucleotide sequence encoding a branch point and a nucleotide sequence encoding a 3’ splice site, is modified to introduce a nucleotide sequence encoding a REMS.
- an artificial gene construct comprising DNA encoding exons and one, two or more introns, wherein a nucleotide sequence encoding a 5’ splice site, which is upstream of a nucleotide sequence encoding a branch point and a nucleotide sequence encoding a 3’ splice site, is modified to introduce a nucleotide sequence encoding a REMS.
- an artificial gene construct comprising DNA encoding exons, a 5’ splice site(s), a 3’ splice site(s) and a branch point(s), wherein a nucleotide sequence encoding a 5’ splice site, which is upstream of a nucleotide sequence encoding a 3’ splice site, is modified to introduce a nucleotide sequence encoding a REMS.
- the artificial gene construct encodes a therapeutic protein.
- the artificial gene construct encodes a detectable reporter protein.
- the nucleotide sequence encoding an endogenous RNA REMS comprises a DNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 1 to SEQ ID NO. 5775.
- the nucleotide sequence encloding the RNA REMS is selected from the group consisting of SEQ ID NO. 5776 to SEQ ID NO. 11550.
- the nucleotide sequence encoding the RNA REMS is a nucleotide sequence encoding a non-endogenous DNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 1 to SEQ ID NO. 5775, i.e., not naturally found in the DNA sequence of the artificial construct.
- described herein is a vector comprising the artificial gene construct described herein.
- described herein is a cell comprising an artificial gene construct described herein or a vector comprising an artificial gene construct described herein.
- described herein is a method of modulating the amount or type of a functional protein produced by a cell containing an artificial gene construct described herein.
- described herein is a method of modulating the amount or type of a functional protein produced by a cell containing an artificial gene construct described herein, the method comprising contacting the cell with a compound of Formula (I) or a form thereof.
- the artificial gene construct encodes a therapeutic protein.
- the artificial gene construct encodes a detectable reporter protein.
- described herein is a method of modulating the amount or type of a functional protein produced by a subject, wherein the subject is or was administered an artificial gene construct described herein.
- described herein is method of regulating the amount or type of a functional protein produced by a subject, the mehod comprising: (a) administering an artificial gene construct or a vector comprising the artificial gene construct described herein to the subject; and (b) administering a compound of Formula (I) or a form thereof to the subject.
- described herein is a method of regulating the amount or type of a functional protein produced by a subject, the method comprising administering a compound of Formula (I) or a form thereof to a subject carrying a gene containing a nucleotide sequence encoding a REMS.
- described herein is a method of regulating the amount or type of a functional protein produced by a subject, the method comprising administering a compound of Formula (I) to the subject, wherein the subject was previously administered an artificial gene construct described herein.
- the artificial gene construct encodes a therapeutic protein.
- the artificial gene construct encodes a detectable reporter protein.
- the subject is a non-human. In another aspect, the subject is a human.
- RNA transcript produced from pre-mRNA containing a non-endogenous recognition element for splicing modifier comprising contacting the pre-mRNA with a compound of Formula (I) or a form thereof, wherein the non-endogenous RNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 5776 to SEQ ID NO. 11550, and the compound is a compound of Formula (I)
- One aspect of the present description relates to a use of a compound comprising, a compound of Formula (I):
- Ri is phenyl or heteroaryl, optionally substituted with one, two, three, or four, independently selected Ria substituents,
- heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S;
- Ria is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, or C1-6alkoxy;
- R3 is hydrogen, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, and C1-6alkyl-amino,
- C1-6alkyl, C2-6alkenyl, and C2-6alkynyl is optionally substituted with one, two, three, or four independently selected R3a substituents, and
- each instance of C1-6alkyl, C2-6alkenyl, and C2-6alkynyl may optionally contain a chiral carbon having an (R) or (S) configuration;
- Rsa is cyano, halo, hydroxy, oxo, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, halo- C1-6alkoxy, carboxyl, amino, C1-6alkoxy-carbonyl, C1-6alkyl-amino, halo-C1-6alkyl-amino, (C1-6alkyl)2-amino, phenyl-amino, heterocyclyl-amino, heteroaryl-amino, phenyl-(C1-6alkyl)- amino, heterocyclyl-(C1-6alkyl)-amino, heteroaryl-(C1-6alkyl)-amino, C1-6alkyl-thio, C1-6alkyl-sulfoxyl,
- heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S,
- heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S;
- each instance of phenyl, heterocyclyl, and heteroaryl is optionally substituted with one, two, three or four independently selected Rsa' substituents;
- Rr is hydrogen, cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, or amino; [00120] Rr is hydrogen, cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, halo-C1-6alkoxy, amino, C1-6alkyl-amino, (C1-6alkyl)2-amino, C3-10cycloalkyl, phenyl, heterocyclyl, or heteroaryl,
- heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S,
- heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S, and
- each instance of C1-6alkyl, C3-10cycloalkyl, phenyl, heterocyclyl, or heteroaryl are optionally substituted with one, two, three, or four independently selected R4a substituents;
- R4a is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, or C1-6alkoxy;
- R5 is hydrogen, cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, carbamoyl, C3-10cycloalkyl, or heterocyclyl,
- heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S;
- Re is hydrogen, halo, or C1-6alkyl
- One aspect includes use of a compound of Formula (I), wherein Ri is phenyl or heteroaryl, optionally substituted with one, two, three, or four, independently selected Ria substituents, wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S.
- Another aspect includes use of a compound of Formula (I), wherein Ri is phenyl, optionally substituted with one, two, three, or four, independently selected Ria substituents.
- Another aspect includes use of a compound of Formula (I), wherein Ri is phenyl, optionally substituted with one Ria substituent.
- Another aspect includes use of a compound of Formula (I), wherein Ri is heteroaryl, optionally substituted with one, two, three, or four, independently selected Ria substituents, wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S.
- Another aspect includes use of a compound of Formula (I), wherein Ri is heteroaryl, optionally substituted with one Ria substituent, wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S.
- Another aspect includes use of a compound of Formula (I), wherein Ri is heteroaryl selected from furanyl, thiophenyl, IH-pyrazolyl, IH-imidazolyl, isoxazolyl, 1,3 -thiazolyl, 1,3- oxazolyl, tetrazolyl, 1,2,3-triazolyl, 1,2,4-oxadiazolyl, 1,3,4-oxadiazolyl, 1,2,3-thiadiazolyl, pyridinyl, pyrimidinyl, pyrazinyl, pyridazinyl, Another aspect , and quinolinyl, wherein heteroaryl is optionally substituted with one, two, three, or four, independently Ria substituents.
- Ri is heteroaryl selected from furanyl, thiophenyl, IH-pyrazolyl, IH-imidazolyl, isoxazolyl, 1,3 -thiazolyl, 1,3- oxazoly
- Another aspect includes use of a compound of Formula (I), wherein Ri is heteroaryl selected from furanyl, thiophenyl, 1,3 -thiazolyl, and pyridinyl, wherein heteroaryl is optionally substituted with one, two, three, or four, independently Ria substituents.
- Ri is heteroaryl selected from furanyl, thiophenyl, 1,3 -thiazolyl, and pyridinyl, wherein heteroaryl is optionally substituted with one, two, three, or four, independently Ria substituents.
- Another aspect includes use of a compound of Formula (I), wherein Ri is heteroaryl selected from furan-2-yl, furan-3-yl, thi ophen-2 -yl, thi ophen-3 -yl, IH-pyrazol-l-yl, lH-pyrazol-3-yl, lH-pyrazol-4-yl, lH-pyrazol-5-yl, IH-imidazol-l-yl, lH-imidazol-4-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, l,3-thiazol-2-yl, l,3-thiazol-4-yl, l,3-thiazol-5-yl, l,3-oxazol-2-yl, l,3-oxazol-4-yl, l,3-oxazol-5-yl, l,2,4-ox
- Another aspect includes use of a compound of Formula (I), wherein Ri is heteroaryl selected from furan-2-yl, thiophen-2-yl, l,3-thiazol-2-yl, and pyridin-4-yl, wherein heteroaryl is optionally substituted with one, two, three, or four, independently Ria substituents.
- One aspect includes use of a compound of Formula (I), wherein Ria is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, or C1-6alkoxy.
- Another aspect includes use of a compound of Formula (I), wherein Ria is halo.
- Another aspect includes use of a compound of Formula (I), wherein Ri a is halo selected from fluoro, chloro, bromo, and iodo.
- Another aspect includes use of a compound of Formula (I), wherein Ria is fluoro.
- One aspect includes use of a compound of Formula (I), wherein R3 is hydrogen, C1-6alkyl, C1-6alkenyl, C1-6alkynyl, or C1-6alkyl-amino,
- each instance of C1-6alkyl, C2-6alkenyl, and C2-6alkynyl is optionally substituted with one, two, three, or four independently selected Rsa substituents
- each instance of C1-6alkyl, C2-6alkenyl, and C2-6alkynyl may optionally contain a chiral carbon having an (R) or (S) configuration.
- Another aspect includes use of a compound of Formula (I), wherein R3 is hydrogen, C1-6alkyl, C2-6alkenyl, or C2-6alkynyl, optionally substituted with one, two, three, or four, independently selected R3a substituents, wherein C1-6alkyl, C2-6alkenyl, or C2-6alkynyl may optionally contain a chiral carbon having an (R) or (S) configuration.
- R3 is hydrogen, C1-6alkyl, C2-6alkenyl, or C2-6alkynyl, optionally substituted with one, two, three, or four, independently selected R3a substituents, wherein C1-6alkyl, C2-6alkenyl, or C2-6alkynyl may optionally contain a chiral carbon having an (R) or (S) configuration.
- Another aspect includes use of a compound of Formula (I), wherein R3 is hydrogen.
- Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl, optionally substituted with one, two, three, or four, independently selected Rs a substituents, and wherein, C1-6alkyl optionally contains a chiral carbon having an (R) or (S) configuration.
- Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl, optionally substituted with one, two, three, or four independently selected R3 a substituents.
- Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl selected from methyl, ethyl, propyl, butyl, pentyl, and hexyl, optionally substituted with one, two, three, or four independently selected Ria substituents.
- Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl selected from methyl, ethyl, propyl, butyl, and pentyl, optionally substituted with one, two, three, or four independently selected R3a substituents.
- Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C1-6alkyl optionally contains a chiral carbon having an (R) configuration.
- Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl selected from methyl, ethyl, propyl, butyl, pentyl, and hexyl, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C1-6alkyl optionally contains a chiral carbon having an (R) configuration.
- R3 is C1-6alkyl selected from methyl, ethyl, propyl, butyl, pentyl, and hexyl, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C1-6alkyl optionally contains a chiral carbon having an (R) configuration.
- Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl selected from methyl, ethyl, propyl, butyl, and pentyl, optionally substituted with one, two, three, or four independently selected Rsa substituents, and wherein C1-6alkyl optionally contains a chiral carbon having an (R) configuration.
- R3 is C1-6alkyl selected from methyl, ethyl, propyl, butyl, and pentyl, optionally substituted with one, two, three, or four independently selected Rsa substituents, and wherein C1-6alkyl optionally contains a chiral carbon having an (R) configuration.
- Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C1-6alkyl optionally contains a chiral carbon having an (S) configuration.
- Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl selected from methyl, ethyl, propyl, butyl, pentyl, and hexyl, optionally substituted with one, two, three, or four independently selected Ria substituents, and wherein C1-6alkyl optionally contains a chiral carbon having an (S) configuration.
- R3 is C1-6alkyl selected from methyl, ethyl, propyl, butyl, pentyl, and hexyl, optionally substituted with one, two, three, or four independently selected Ria substituents, and wherein C1-6alkyl optionally contains a chiral carbon having an (S) configuration.
- Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl selected from methyl, ethyl, propyl, butyl, and pentyl, optionally substituted with one, two, three, or four independently selected Rsa substituents, and wherein C1-6alkyl optionally contains a chiral carbon having an (S) configuration.
- R3 is C2-6alkenyl, optionally substituted with one, two, three, or four, independently selected Ria substituents, and wherein, C2-6alkenyl optionally contains a chiral carbon having an (R) or (S) configuration.
- Another aspect includes use of a compound of Formula (I), wherein R3 is C2-6alkenyl selected from ethenyl, propenyl, butenyl, pentenyl, hexenyl, and heptenyl, optionally substituted with one, two, three, or four independently selected R3a substituents.
- R3 is C2-6alkenyl selected from ethenyl, propenyl, butenyl, pentenyl, hexenyl, and heptenyl, optionally substituted with one, two, three, or four independently selected R3a substituents.
- Another aspect includes use of a compound of Formula (I), wherein R3 is butenyl, optionally substituted with one, two, three, or four independently selected R3a substituents.
- Another aspect includes use of a compound of Formula (I), wherein R3 is C2-6alkenyl selected from ethenyl, propenyl, butenyl, pentenyl, hexenyl, and heptenyl, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C2-6alkenyl optionally contains a chiral carbon having an (R) configuration.
- R3 is C2-6alkenyl selected from ethenyl, propenyl, butenyl, pentenyl, hexenyl, and heptenyl, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C2-6alkenyl optionally contains a chiral carbon having an (R) configuration.
- Another aspect includes use of a compound of Formula (I), wherein R3 is butenyl, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C2-6alkenyl optionally contains a chiral carbon having an (R) configuration.
- Another aspect includes use of a compound of Formula (I), wherein R3 is C2-6alkynyl, optionally substituted with one, two, three, or four, independently selected Ria substituents, and wherein, C2-6alkynyl optionally contains a chiral carbon having an (R) or (S) configuration.
- Another aspect includes use of a compound of Formula (I), wherein R3 is C2-6alkenyl selected from ethenyl, propenyl, butenyl, pentenyl, hexenyl, and heptenyl, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C2-6alkenyl optionally contains a chiral carbon having an (S) configuration.
- R3 is C2-6alkenyl selected from ethenyl, propenyl, butenyl, pentenyl, hexenyl, and heptenyl, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C2-6alkenyl optionally contains a chiral carbon having an (S) configuration.
- Another aspect includes use of a compound of Formula (I), wherein R3 is butenyl, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C2-6alkenyl optionally contains a chiral carbon having an (S) configuration.
- Another aspect includes use of a compound of Formula (I), wherein R3 is C2-6alkynyl selected from ethynyl, propynyl, butynyl, pentynyl, hexynyl, and heptynyl, optionally substituted with one, two, three, or four independently selected R3a substituents.
- R3 is C2-6alkynyl selected from ethynyl, propynyl, butynyl, pentynyl, hexynyl, and heptynyl, optionally substituted with one, two, three, or four independently selected R3a substituents.
- Another aspect includes use of a compound of Formula (I), wherein R3 is butynyl, optionally substituted with one, two, three, or four independently selected R3a substituents.
- Another aspect includes use of a compound of Formula (I), wherein R3 is C2-6alkynyl selected from ethynyl, propynyl, butynyl, pentynyl, hexynyl, and heptynyl, optionally substituted with one, two, three, or four independently selected Rsa substituents, and wherein C2-6alkynyl optionally contains a chiral carbon having an (R) configuration.
- Another aspect includes use of a compound of Formula (I), wherein R3 is butynyl, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C2-6alkynyl optionally contains a chiral carbon having an (R) configuration.
- Another aspect includes use of a compound of Formula (I), wherein R3 is C2-6alkynyl selected from ethynyl, propynyl, butynyl, pentynyl, hexynyl, and heptynyl, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C2-6alkynyl optionally contains a chiral carbon having an (S) configuration.
- R3 is C2-6alkynyl selected from ethynyl, propynyl, butynyl, pentynyl, hexynyl, and heptynyl, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C2-6alkynyl optionally contains a chiral carbon having an (S) configuration.
- Another aspect includes use of a compound of Formula (I), wherein R3 is butynyl, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C?-r>alkynyl optionally contains a chiral carbon having an (8) configuration.
- Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl-amino, optionally substituted with one, two, three, or four, independently selected R3a substituents, and wherein, C1-6alkyl optionally contains a chiral carbon having an (R) or (8) configuration.
- Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl-amino, optionally substituted with one, two, three, or four independently selected R3a substituents.
- Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl-amino, wherein Ci-calkyl is selected from methyl, ethyl, propyl, isopropyl, butyl, sec- butyl, isobutyl, and tert-butyl, optionally substituted with one, two, three, or four independently selected R3a substituents.
- Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl-amino, wherein C1-6alkyl is propyl, optionally substituted with one, two, three, or four independently selected R3a substituents.
- Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl-amino, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C1-6alkyl optionally contains a chiral carbon having an (R) configuration.
- Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl-amino, wherein C1-6alkyl is selected from methyl, ethyl, propyl, isopropyl, butyl, sec- butyl, isobutyl, and tert-butyl, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C1-6alkyl optionally contains a chiral carbon having an (R) configuration.
- R3 is C1-6alkyl-amino
- C1-6alkyl is selected from methyl, ethyl, propyl, isopropyl, butyl, sec- butyl, isobutyl, and tert-butyl, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C1-6alkyl optionally contains a chiral carbon having an (R) configuration.
- Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl-amino, wherein C1-6alkyl is propyl, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C1-6alkyl optionally contains a chiral carbon having an (R) configuration.
- Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl-amino, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C1-6alkyl optionally contains a chiral carbon having an (S) configuration.
- Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl-amino, wherein C1-6alkyl is selected from methyl, ethyl, propyl, isopropyl, butyl, sec- butyl, isobutyl, and tert-butyl, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C1-6alkyl optionally contains a chiral carbon having an (S) configuration.
- R3 is C1-6alkyl-amino
- C1-6alkyl is selected from methyl, ethyl, propyl, isopropyl, butyl, sec- butyl, isobutyl, and tert-butyl, optionally substituted with one, two, three, or four independently selected R3a substituents
- C1-6alkyl optionally contains a chiral carbon having an (S) configuration.
- Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl-amino, wherein C1-6alkyl is propyl, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C1-6alkyl optionally contains a chiral carbon having an (S) configuration.
- Another aspect includes use of a compound of Formula (I), wherein R3 is Ci-iocycloalkyl selected from cyclopropyl, cyclobutyl, cyclopentyl, cylcohexyl, cycloheptyl, and cyclooctyl, optionally substituted with one, two, three or four independently selected R3a substituents.
- R3 is cyclopropyl or cyclopentyl, optionally substituted with one, two, three or four independently selected Rja substituents.
- Another aspect includes use of a compound of Formula (I), wherein R3 is heterocyclyl, optionally substituted with one, two, three, or four, independently selected R3a substituents, wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S, and wherein heterocyclyl optionally contains a chiral carbon having an (R) or (S) configuration.
- R3 is heterocyclyl, optionally substituted with one, two, three, or four, independently selected R3a substituents
- heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S
- heterocyclyl optionally contains a chiral carbon having an (R) or (S) configuration.
- Another aspect includes use of a compound of Formula (I), wherein R3 is heterocyclyl selected from azetidinyl, oxetanyl, pyrazolidinyl, tetrahydrofuranyl, oxazolidinyl, thiazolidinyl, isothiazolidinyl, pyrrolidinyl, piperidinyl, piperazinyl, 2H-pyranyl, tetrahydropyranyl, morpholinyl, 1,3-oxazinanyl, and azepanyl, optionally substituted with one, two, three, or four independently selected R3a substituents.
- R3 is heterocyclyl selected from azetidinyl, oxetanyl, pyrazolidinyl, tetrahydrofuranyl, oxazolidinyl, thiazolidinyl, isothiazolidinyl, pyrrolidinyl, piperidinyl,
- Another aspect includes use of a compound of Formula (I), wherein R3 is azetidinyl, optionally substituted with one, two, three, or four independently selected R3a substituents.
- Another aspect includes use of a compound of Formula (I), wherein R3 is heterocyclyl selected from azetidin-2-yl, azeti din-3 -yl, oxetan-2-yl, oxetan-3-yl, pyrazolidine-l-yl, pyrazolidine-2-yl, pyrazolidine-3-yl, pyrazolidine-4-yl, pyrazolidine-5-yl, tetrahydrofuran- 1-yl, tetrahydrofuran-2-yl, oxazolidin-2-yl, oxazolidin-4-yl, oxazolidine-5-yl, thiazolidin-2-yl, thiazolidin-4-yl, thiazolidin-5-yl, isothiazolidin-3-yl, isothiazolidin-4-yl, isothiazolidin-5-yl, pyrrolidin-2-yl
- Another aspect includes use of a compound of Formula (I), wherein R3 is azeti din-3 -yl, optionally substituted with one, two, three, or four independently selected R3a substituents.
- R3 is azeti din-3 -yl, optionally substituted with one, two, three, or four independently selected R3a substituents.
- One aspect includes use of a compound of Formula (I), wherein Rsa is cyano, halo, hydroxy, oxo, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, halo-C1-6alkoxy, carboxyl, amino, C1-6alkoxy-carbonyl, C1-6alkyl-amino, halo-C1-6alkyl-amino, (C1-6alkyl)2-amino, phenyl-amino, heterocyclyl-amino, heteroaryl-amino, phenyl-(C1-6alkyl)-amino,
- Another aspect includes use of a compound of Formula (I), wherein Raa is cyano, halo, hydroxy, oxo, C1-6alkyl, C1-6alkoxy, halo-C1-6alkoxy, carboxyl, amino, C1-6alkoxy- carbonyl, C1-6alkyl-amino, halo-C1-6alkyl-amino, (C1-6alkyl)2-amino, phenyl-amino, heteroaryl- amino, phenyl-(C1-6alkyl)-amino, heterocyclyl-(C1-6alkyl)-amino, heteroaryl-(C1-6alkyl)-amino, C1-6alkyl-thio, C1-6alkyl-sulfoxyl, or C1-6alkyl-sulfonyl, wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S, wherein heterocyclyl
- Another aspect includes use of a compound of Formula (I), wherein Raa is cyano.
- Another aspect includes use of a compound of Formula (I), wherein Raa is halo selected from fluoro, chloro, bromo, and iodo.
- Another aspect includes use of a compound of Formula (I), wherein Raa is fluoro.
- Another aspect includes use of a compound of Formula (I), wherein Raa is hydroxy.
- Another aspect includes use of a compound of Formula (I), wherein Raa is oxo.
- Raa is C1-6alkyl selected from C1-6alkyl selected from methyl, ethyl, propyl, butyl, pentyl, and hexyl.
- Another aspect includes use of a compound of Formula (I), wherein Raa is C1-6alkyl selected from methyl and isopropyl.
- Another aspect includes use of a compound of Formula (I), wherein Raa is C1-6alkoxy selected from methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butoxy, iso-butoxy, tert- butoxy, pentoxy, and hexyloxy.
- Another aspect includes use of a compound of Formula (I), wherein Raa methoxy.
- Another aspect includes use of a compound of Formula (I), wherein Raa is halo- C1-6alkoxy wherein C1-6alkoxy is selected from methoxy, methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butoxy, iso-butoxy, tert-butoxy, pentoxy, and hexyloxy partially or completely substituted with one or more halogen atoms where allowed by available valences.
- Another aspect includes use of a compound of Formula (I), wherein Raa is halo- C1-6alkoxy, wherein C1-6alkoxy is methoxy substituted with three fluorine atoms.
- Another aspect includes use of a compound of Formula (I), wherein Raa is carboxyl.
- Another aspect includes use of a compound of Formula (I), wherein Raa is amino.
- Another aspect includes use of a compound of Formula (I), wherein Raa is C1-6alkoxy- carbonyl wherein C1-6alkoxy is selected from methoxy, methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butoxy, iso-butoxy, tert-butoxy, pentoxy, and hexyloxy.
- Another aspect includes use of a compound of Formula (I), wherein Raa is C1-6alkoxy- carbonyl wherein C1-6alkoxy is methoxy.
- Another aspect includes use of a compound of Formula (I), wherein Raa is C1-6alkyl-amino, wherein C1-6alkyl is selected from methyl, ethyl, propyl, isopropyl, butyl, sec- butyl, iso-butyl, tert-butyl, pentyl, and hexyl.
- Another aspect includes use of a compound of Formula (I), wherein Raa is C1-6alkyl-amino, wherein C1-6alkyl is methyl.
- Another aspect includes use of a compound of Formula (I), wherein Raa is halo- C1-6alkyl-amino, wherein C1-6alkyl is selected from methyl, ethyl, propyl, isopropyl, butyl, sec- butyl, iso-butyl, tert-butyl, pentyl, and hexyl partially or completely substituted with one or more halogen atoms where allowed by available valences.
- Raa is halo- C1-6alkyl-amino
- C1-6alkyl is selected from methyl, ethyl, propyl, isopropyl, butyl, sec- butyl, iso-butyl, tert-butyl, pentyl, and hexyl partially or completely substituted with one or more halogen atoms where allowed by available valences.
- Another aspect includes use of a compound of Formula (I), wherein Raa is halo- C1-6alkyl-amino, wherein C1-6alkyl is methyl substituted with three fluorine atoms.
- Another aspect includes use of a compound of Formula (I), wherein Raa is (C1-6alkyl)2-amino, wherein C1-6alkyl is selected from methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, iso-butyl, tert-butyl, pentyl, and hexyl.
- Another aspect includes use of a compound of Formula (I), wherein Raa is (C1-6alkyl)2-amino, wherein C1-6alkyl is methyl.
- Another aspect includes use of a compound of Formula (I), wherein R3a is phenyl- amino, wherein phenyl is optionally substituted with one, two, three or four independently selected R3a' substituents.
- Another aspect includes use of a compound of Formula (I), wherein R3a is phenyl- amino wherein phenyl is optionally substituted with one independently selected R3a' substituents.
- R3a is phenyl- amino wherein phenyl is optionally substituted with one independently selected R3a' substituents.
- Another aspect includes use of a compound of Formula (I), wherein Ria is heteroaryl- amino, wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S, wherein heteroaryl is optionally substituted with one, two, three or four independently selected R3a' substituents.
- Another aspect includes use of a compound of Formula (I), wherein R3a is heteroaryl- amino, wherein heteroaryl is selected from furanyl, thiophenyl, IH-pyrazolyl, IH-imidazolyl, isoxazolyl, 1,3 -thiazolyl, 1,3-oxazolyl, tetrazolyl, 1,2,3-triazolyl, 1,2,4-oxadiazolyl, 1,3,4-oxadiazolyl, 1,2,3-thiadiazolyl, pyridinyl, pyrimidinyl, pyrazinyl, pyridazinyl, benzofuranyl, and quinolinyl, wherein heteroaryl is optionally substituted with one, two, three or four independently selected R3a' substituents.
- heteroaryl is optionally substituted with one, two, three or four independently selected R3a' substituents.
- Another aspect includes use of a compound of Formula (I), wherein R3a is heteroaryl- amino, wherein heteroaryl is selected IH-pyrazolyl, pyridinyl, and pyrazinyl, wherein each instance is optionally substituted with one, two, three or four independently selected R3a' substituents.
- Another aspect includes use of a compound of Formula (I), wherein R3a is phenyl- (C1-6alkyl)-amino, wherein C1-6alkyl is selected from methyl, ethyl, propyl, butyl, pentyl, and hexyl, wherein phenyl is phenyl is optionally substituted with one, two, three, or four independently selected R3a' substituents.
- R3a is phenyl- (C1-6alkyl)-amino, wherein C1-6alkyl is selected from methyl, ethyl, propyl, butyl, pentyl, and hexyl, wherein phenyl is phenyl is optionally substituted with one, two, three, or four independently selected R3a' substituents.
- Another aspect includes use of a compound of Formula (I), wherein R3a is phenyl- (C1-6alkyl)-amino, wherein C1-6alkyl is selected from methyl, ethyl, propyl, butyl, pentyl, and hexyl, wherein phenyl is phenyl is optionally substituted with one independently selected R3a' substituents.
- Another aspect includes use of a compound of Formula (I), wherein R3a is phenyl- (C1-6alkyl)-amino, wherein C1-6alkyl is methyl.
- R3a is phenyl- (C1-6alkyl)-amino, wherein C1-6alkyl is methyl.
- Another aspect includes use of a compound of Formula (I), wherein Rs a is C1-6alkyl-thio, wherein C1-6alkyl is selected from methyl, ethyl, propyl, isopropyl, butyl, sec- butyl, iso-butyl, tert-butyl, pentyl, and hexyl.
- Another aspect includes use of a compound of Formula (I), wherein Rs a is C1-6alkyl-thio, wherein C1-6alkyl is methyl.
- Another aspect includes use of a compound of Formula (I), wherein Rsa is C1-6alkyl-sulfoxyl, wherein C1-6alkyl is selected from methyl, ethyl, propyl, isopropyl, butyl, sec- butyl, iso-butyl, tert-butyl, pentyl, and hexyl.
- Another aspect includes use of a compound of Formula (I), wherein R.3a is C1-6alkyl-sulfoxyl, wherein C1-6alkyl is methyl.
- Another aspect includes use of a compound of Formula (1), wherein Rsa is C1-6alkyl-sulfonyl, wherein C1-6alkyl is selected from methyl, ethyl, propyl, isopropyl, butyl, sec- butyl, iso-butyl, tert-butyl, pentyl, and hexyl.
- Another aspect includes use of a compound of Formula (I), wherein R3a is C1-6alkyl-sulfonyl, wherein C1-6alkyl is methyl.
- One aspect includes use of a compound of Formula (I), wherein Rsa' is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, or amino.
- Another aspect includes use of a compound of Formula (I), wherein Rsa 1 is halo or C1-6alkyl.
- Another aspect includes use of a compound of Formula (I), wherein Rsa' is cyano.
- Another aspect includes use of a compound of Formula (I), wherein Rsa' is halo selected from fluoro, chloro, bromo, and iodo.
- Another aspect includes use of a compound of Formula (I), wherein Rsa' is fluoro or chloro.
- Another aspect includes use of a compound of Formula (I), wherein Rsa' is C1-6alkyl selected from methyl, ethyl, propyl, butyl, pentyl, and hexyl.
- Another aspect includes use of a compound of Formula (I), wherein Rsa' is from methyl.
- Another aspect includes use of a compound of Formula (I), wherein Rsa’ is C1-6alkoxy selected from methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butoxy, iso-butoxy, tert- butoxy, pentoxy, and hexyloxy.
- Another aspect includes use of a compound of Formula (I), wherein Rsa’ is methoxy.
- Another aspect includes use of a compound of Formula (I), wherein R3a’ is amino.
- One aspect includes use of a compound of Formula (I), wherein R4 is hydrogen, cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, halo-C1-6alkoxy, amino, C1-6alkyl-amino, (C1-6alkyl)2-amino, C3-10cycloalkyl, phenyl, heterocyclyl, or heteroaryl, wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S, wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S, and wherein each instance of C1-6alkyl, C3-10cycloalkyl, phenyl, heterocyclyl, or heteroaryl are optionally substituted with one, two, three, or four independently selected R4a substituent
- Another aspect includes use of a compound of Formula (I), wherein R4 is hydrogen, cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkoxy, or C3-10cycloalkyl, wherein C1-6alkyl or C3-10cycloalkyl are optionally substituted with one, two, three, or four independently selected R4a substituents.
- Another aspect includes use of a compound of Formula (I), wherein R4 is hydrogen.
- Another aspect includes use of a compound of Formula (I), wherein R4 is cyano.
- Another aspect includes use of a compound of Formula (I), wherein R4 is halo selected from fluoro, chloro, bromo, and iodo.
- Another aspect includes use of a compound of Formula (I), wherein R4 is halo selected from chloro and bromo.
- Another aspect includes use of a compound of Formula (I), wherein R4 is hydroxy.
- Another aspect includes use of a compound of Formula (I), wherein R4 is C1-6alkyl selected from methyl, ethyl, propyl, butyl, pentyl, and hexyl, wherein C1-6alkyl is optionally substituted with one, two, three, or four independently selected R4a substituents.
- Another aspect includes use of a compound of Formula (I), wherein R4 is methyl optionally substituted with one, two, three, or four independently selected R4a substituents.
- Another aspect includes use of a compound of Formula (I), wherein JU is halo- C1-6alkoxy wherein C1-6alkoxy is selected from methoxy, methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butoxy, iso-butoxy, tert-butoxy, pentoxy, and hexyloxy partially or completely substituted with one or more halogen atoms where allowed by available valences.
- Another aspect includes use of a compound of Formula (I), wherein R3a is halo- C1-6alkoxy, wherein C1-6alkoxy is methoxy substituted with two fluorine atoms.
- Another aspect includes use of a compound of Formula (I), wherein JU is C3-10cycloalkyl, wherein C3-10cycloalkyl is optionally substituted with one, two, three, or four independently selected R.4a substituents.
- Another aspect includes use of a compound of Formula (I), wherein JU is C3-10cycloalkyl selected from cyclopropyl, cyclobutyl, cyclopentyl, cylcohexyl, cycloheptyl, and cyclooctyl, optionally substituted with one, two, three, or four independently selected R4a substituents.
- Another aspect includes use of a compound of Formula (I), wherein Rr is cyclopropyl, optionally substituted with one, two, three, or four independently selected R4a substituents.
- One aspect includes use of a compound of Formula (I), wherein R4a is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, or C1-6alkoxy.
- One aspect includes use of a compound of Formula (I), wherein R5 is hydrogen, cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, carbamoyl, C3-10cycloalkyl, or heterocyclyl, wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S.
- Another aspect includes use of a compound of Formula (I), wherein R5 is hydrogen, cyano, halo, or C1-6alkyl.
- Another aspect includes use of a compound of Formula (I), wherein R5 is hydrogen.
- Another aspect includes use of a compound of Formula (I), wherein R5 is cyano.
- Another aspect includes use of a compound of Formula (I), wherein R5 is halo selected from fluoro, chloro, bromo, and iodo.
- Another aspect includes use of a compound of Formula (I), wherein R5 is chloro.
- Another aspect includes use of a compound of Formula (I), wherein R5 is C1-6alkyl selected from methyl, ethyl, propyl, butyl, pentyl, and hexyl.
- Another aspect includes use of a compound of Formula (I), wherein R5 is methyl.
- One aspect includes use of a compound of Formula (I), wherein Re is hydrogen, halo, or C1-6alkyl.
- Another aspect includes use of a compound of Formula (I), wherein Re is hydrogen.
- the use of the compound of Formula (I) or a form thereof includes use of a compound selected from the group consisting of: 1791
- the form of the compound is selected from the group consisting of a salt, hydrate, solvate, and tautomer form thereof.
- the present application further provides a pharmaceutical composition
- a pharmaceutical composition comprising a compound described herein, or a pharmaceutically acceptable salt thereof, and at least one pharmaceutically acceptable carrier.
- C1-6alkyl generally refers to saturated hydrocarbon radicals having from one to eight carbon atoms in a straight or branched chain configuration, including, but not limited to, methyl, ethyl, n-propyl (also referred to as propyl or propanyl), isopropyl, n-butyl (also referred to as butyl or butanyl), isobutyl, sec-butyl, tert-butyl, n-pentyl (also referred to as pentyl or pentanyl), n-hexyl (also referred to as hexyl or hexanyl), and the like.
- C1-6alkyl includes, but is not limited to, C1-6alkyl, Ci-4alkyl and the like.
- a C1-6alkyl radical is optionally substituted with substituent species as described herein where allowed by available valences.
- hetero-C1-6alkyl generally refers to saturated hydrocarbon radicals having from one to six carbon atoms in a straight or branched chain configuration, in which one or more heteroatoms, such as an O, S or N atom, are members in the chain, including, but not limited to, but not limited to, hetero-methyl, hetero-ethyl, hetero-propyl, hetero-butyl, hetero-pentyl, hetero-hexyl and the like.
- hetero-C1-6alkyl includes, but is not limited to, hetero-C2-6alkyl, hetero-Ci-ralkyl, hetero-C2-4alkyl and the like.
- a hetero-C1-6alkyl radical is optionally substituted with substituent species as described herein where allowed by available valences.
- C2-6alkenyl generally refers to partially unsaturated hydrocarbon radicals having from two to eight carbon atoms in a straight or branched chain configuration and one or more carbon-carbon double bonds therein, including, but not limited to, ethenyl (also referred to as vinyl), allyl, propenyl and the like.
- C2-6alkenyl includes, but is not limited to, C2-6alkenyl, C2-4alkenyl and the like.
- a C2-6alkenyl radical is optionally substituted with substituent species as described herein where allowed by available valences.
- C2-6alkynyl generally refers to partially unsaturated hydrocarbon radicals having from two to eight carbon atoms in a straight or branched chain configuration and one or more carbon-carbon triple bonds therein, including, but not limited to, ethynyl (also referred to as acetylenyl), propynyl, butynyl and the like.
- C2-6alkynyl includes, but is not limited to, C2-6alkynyl, C2-4alkynyl and the like.
- a C2-6alkynyl radical is optionally substituted with substituent species as described herein where allowed by available valences.
- C1-6alkoxy generally refers to saturated hydrocarbon radicals having from one to eight carbon atoms in a straight or branched chain configuration of the formula: -O-C1-6alkyl, including, but not limited to, methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, sec-butoxy, tert-butoxy, n-pentoxy, n-hexoxy and the like.
- C1-6alkoxy includes, but is not limited to, C1-6alkoxy, Ci-4alkoxy and the like.
- a C1-6alkoxy radical is optionally substituted with substituent species as described herein where allowed by available valences.
- carboxyl refers to a radical of the formula: -COOH, -
- C1-6alkoxy-carbonyl refers to a radical of the formula: -COO- C1-6alkyl, -C(O)O-C1-6alkyl or -CO2-C1-6alkyl.
- carbamoyl refers to a radical of the formula: -C(O)NH2.
- C3-10cycloalkyl generally refers to a saturated or partially unsaturated monocyclic, bicyclic or polycyclic hydrocarbon radical, including, but not limited to, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cyclohexenyl, cycloheptyl, cyclooctyl, 1/7-indanyl, indenyl, tetrahydro-naphthalenyl and the like.
- C3-10cycloalkyl includes, but is not limited to, Cs-scycloalkyl, Cs-scycloalkyl, C3-10cycloalkyl and the like.
- a C3-10cycloalkyl radical is optionally substituted with substituent species as described herein where allowed by available valences.
- aryl generally refers to a monocyclic, bicyclic or polycyclic aromatic carbon atom ring structure radical, including, but not limited to, phenyl, naphthyl, anthracenyl, fluorenyl, azulenyl, phenanthrenyl and the like.
- An aryl radical is optionally substituted with substituent species as described herein where allowed by available valences.
- heteroaryl generally refers to a monocyclic, bicyclic or polycyclic aromatic carbon atom ring structure radical in which one or more carbon atom ring members have been replaced, where allowed by structural stability, with one or more heteroatoms, such as an O, S or N atom, including, but not limited to, furanyl, thiophenyl, pyrrolyl, pyrazolyl, imidazolyl, isoxazolyl, isothiazolyl, oxazolyl, 1,3 -thiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, tetrazolyl, pyridinyl, pyrimidinyl, pyrazinyl, pyridazinyl, triazinyl, indolyl, indazolyl, indolizinyl, isoindolyl, benzofuranyl, benzothiophenyl,
- heteroaryl radical may differ, such as in non-limiting examples where furanyl may also be referred to as furyl, thiophenyl may also be referred to as thienyl, pyridinyl may also be referred to as pyridyl, benzothiophenyl may also be referred to as benzothienyl and 1,3-benzoxazolyl may also be referred to as 1,3-benzooxazolyl.
- the term for a heteroaryl radical may also include other regioisomers, such as in non-limiting examples where the term pyrrolyl may also include 2//-pyrrolyl, 3 //-pyrrol y I and the like, the term pyrazolyl may also include l//-pyrazolyl and the like, the term imidazolyl may also include 1/Z-imidazolyl and the like, the term triazolyl may also include l//-l,2,3-triazolyl and the like, the term oxadiazolyl may also include 1,2,4-oxadiazolyl, 1,3,4-oxadiazolyl and the like, the term tetrazolyl may also include
- indolyl may also include l//-indolyl and the like
- indazolyl may also include l//-indazolyl, 2//-indazolyl and the like
- benzoimidazolyl may also include l//-benzoimidazolyl
- purinyl may also include 9 //-purinyl and the like.
- heterocyclyl generally refers to a saturated or partially unsaturated monocyclic, bicyclic or polycyclic carbon atom ring structure radical in which one or more carbon atom ring members have been replaced, where allowed by structural stability, with a heteroatom, such as an O, S or N atom, including, but not limited to, oxiranyl, oxetanyl, azetidinyl, tetrahydrofuranyl, pyrrolinyl, pyrrolidinyl, pyrazolinyl, pyrazolidinyl, imidazolinyl, imidazolidinyl, isoxazolinyl, isoxazolidinyl, isothiazolinyl, isothiazolidinyl, oxazolinyl, oxazolidinyl, thiazolinyl, thiazolidinyl, triazolinyl, triazolid
- C1-6alkyl-amino refers to a radical of the formula: -NH-C1-6alkyl.
- halo-C1-6alkyl-amino refers to a radical of the formula: -NH-C1-6alkyl, wherein C1-6alkyl is partially or completely substituted with one or more halogen atoms where allowed by available valences.
- (C1-6alkyl)2-amino refers to a radical of the formula: -N(C1-6alkyl)2.
- C1-6alkyl-carboxyl-amino refers to a radical of the formula: -NH-C(O)-.
- aryl-amino refers to a radical of the formula: -NH-aryl.
- heterocyclyl-amino refers to a radical of the formula: -NH-heterocyclyl.
- heteroaryl-amino refers to a radical of the formula: -NH-heteroaryl.
- aryl-(C1-6alkyl)-amino refers to a radical of the formula: -N(C1-6alkyl)-aryl.
- heterocyclyl-(C1-6alkyl)-amino refers to a radical of the formula: -N(C1-6alkyl)-heterocyclyl.
- heteroaryl-(C1-6alkyl)-amino refers to a radical of the formula: -N(C1-6alkyl)-heteroaryl.
- C1-6alkyl-thio refers to a radical of the formula: -S-Ci- ealkyl.
- C1-6alkyl-sulfoxyl refers to a radical of the formula: -S(O)-C1-6alkyl.
- C1-6alkyl-sulfonyl refers to a radical of the formula: -SCh-C1-6alkyl.
- halo or halogen generally refers to a halogen atom radical, including fluoro, chloro, bromo and iodo.
- halo-C1-6alkoxy refers to a radical of the formula: -O-C1-6alkyl-halo, wherein C1-6alkyl is partially or completely substituted with one or more halogen atoms where allowed by available valences.
- halo-C1-6alkyl refers to a radical of the formula: -C1-6alkyl-halo, wherein C1-6alkyl is partially or completely substituted with one or more halogen atoms where allowed by available valences.
- hydroxy refers to a radical of the formula: -OH.
- hydroxy-C1-6alkyl refers to a radical of the formula: -C1-6alkyl-OH, wherein C1-6alkyl is partially or completely substituted with one or more hydroxy radicals where allowed by available valences.
- substituted means positional variables on the atoms of a core molecule that are substituted at a designated atom position, replacing one or more hydrogens on the designated atom, provided that the designated atom’s normal valency is not exceeded, and that the substitution results in a stable compound. Combinations of substituents and/or variables are permissible only if such combinations result in stable compounds.
- any carbon as well as heteroatom with valences that appear to be unsatisfied as described or shown herein is assumed to have a sufficient number of hydrogen atom(s) to satisfy the valences described or shown.
- one or more substituents having a double bond may be described, shown or listed herein within a substituent group, wherein the structure may only show a single bond as the point of attachment to the core structure of Formula (I).
- a double bond is intended for those substituents.
- the term “and the like,” with reference to the definitions of chemical terms described herein, means that variations in chemical structures that could be expected by one skilled in the art include, without limitation, isomers (including chain, branching or positional structural isomers), hydration of ring systems (including saturation or partial unsaturation of monocyclic, bicyclic or polycyclic ring structures) and all other variations where allowed by available valences which result in a stable compound.
- each functionality appearing at any location within the disclosed compound may be independently selected, and as appropriate, independently and/or optionally substituted.
- the terms “independently selected,” or “each selected” refer to functional variables in a substituent list that may occur more than once on the structure of Formula (I), the pattern of substitution at each occurrence is independent of the pattern at any other occurrence.
- a generic substituent variable on any formula or structure for a compound described herein is understood to include the replacement of the generic substituent with species substituents that are included within the particular genus, e.g., aryl may be replaced with phenyl or naphthal enyl and the like, and that the resulting compound is to be included within the scope of the compounds described herein.
- each instance of’ or “in each instance, when present,” when used preceding a phrase such as “...C3-10cycloalkyl, C3-10cycloalkyl-Ci-4alkyl, aryl, aryl-Ci-4alkyl, heteroaryl, heteroaryl-Ci-4alkyl, heterocyclyl and heterocyclyl-Ci-4alkyl,” are intended to refer to the C3-10cycloalkyl, aryl, heteroaryl and heterocyclyl ring systems when each are present either alone or as a substituent.
- stable compound or “stable structure” mean a compound that is sufficiently robust to be isolated to a useful degree of purity from a reaction mixture and formulations thereof into an efficacious therapeutic agent.
- Compound names described herein were obtained using ACD Labs Index Name software provided by ACD Labs and/or ChemDraw Ultra software provided by CambridgeSoft®. When the compound name disclosed herein conflicts with the structure depicted, the structure shown will supercede the use of the name to define the compound intended. Nomenclature for substituent radicals defined herein may differ slightly from the chemical name from which they are derived; one skilled in the art will recognize that the definition of the substituent radical is intended to include the radical as found in the chemical name.
- the term “aberrant” refers to a deviation from the norm of, e.g., the average healthy subject or a cell(s) or tissue sample from a healthy subject.
- the term “aberrant expression,” as used herein, refers to abnormal expression (up-regulated or down-regulated resulting in an excessive or deficient amount or type thereof) of a gene product (e.g., RNA transcript or protein) by a cell, tissue sample, or subject relative to a corresponding normal, healthy cell, tissue sample or subject.
- the “aberrant expression” refers to an altered level of a gene product (e.g., RNA transcript or protein) in a cell, tissue sample, or subject relative to a corresponding normal, healthy cell, tissue sample or subject.
- aberrant amount refers to an altered level of a gene product (e.g., RNA, protein, polypeptide, or peptide) in a cell, tissue sample, or subject relative to a corresponding normal, healthy cell, tissue sample or subject.
- the amount or type of a gene product (e.g., RNA, protein, polypeptide, or peptide) in a cell, tissue sample, or subject relative to a corresponding cell or tissue sample from a healthy subject or a healthy subject, is considered aberrant if it is 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6-fold or more above or below the amount or type of the gene product in the corresponding cell or tissue sample from a healthy subject or healthy subject.
- non-endogenous REMS refers to a REMS not naturally found to be part of an RNA sequence or naturally encoded by a DNA sequence. In other words, the hand of man is required to manipulate the RNA or DNA sequence to introduce the REMS or the nucleotide sequence encoding the REMS.
- the term “substantial change” in the context of the amount or type of one or more RNA transcripts e.g. , pre-mRNA or mature mRNA transcripts), an alternative splice variant thereof or an isoform thereof, or one or more proteins thereof, each expressed as the product of one or more of genes, means that the amount or type of such products changes by a statistically significant amount such as, in a nonlimiting example, a p value less than a value selected from 0.1, 0.01, 0.001, or 0.0001.
- the terms “subject” and “subject” are used interchangeably to refer to an animal or any living organism having sensation and the power of voluntary movement, and which requires for its existence oxygen and organic food.
- Non-limiting examples include members of the human, equine, porcine, bovine, rattus, murine, canine and feline species.
- the subject is a mammal or a warm-blooded vertebrate animal.
- the subject is a non-human animal.
- the subject is a human.
- the term “functional protein” refers to a form of a protein that retains a certain biological function or the functions of a full length protein or protein isoform encoding by a gene.
- the term “produce substantially less” means that the amount or type of functional protein in the absence of a compound described herein is at least 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 70%, 75%, 80%, 85%, 90%, 95%, 98%, or 100% less than the amount or type of functional protein produced in the presence of the compound.
- form means a compound of Formula (I) having a form selected from the group consisting of a free acid, free base, salt, hydrate, solvate, racemate, enantiomer, diastereomer, stereoisomer, and tautomer form thereof.
- the form of the compound of Formula (I) is a free acid, free base or salt thereof.
- the form of the compound of Formula (I) is a salt thereof.
- the form of the compound of Formula (I) is a stereoisomer, racemate, enantiomer or diastereomer thereof.
- the form of the compound of Formula (I) is a tautomer thereof.
- the form of the compound of Formula (I) is a pharmaceutically acceptable form.
- isolated means the physical state of a compound of Formula (I) or a form thereof after being isolated and/or purified from a synthetic process (e.g., from a reaction mixture) or natural source or combination thereof according to an isolation or purification process or processes described herein or which are well known to the skilled artisan (e.g., chromatography, recrystallization and the like) in sufficient purity to be characterized by standard analytical techniques described herein or well known to the skilled artisan.
- the term “protected” means that a functional group in a compound of Formula (I) or a form thereof is in a form modified to preclude undesired side reactions at the protected site when the compound is subjected to a reaction.
- Suitable protecting groups will be recognized by those with ordinary skill in the art as well as by reference to standard textbooks such as, for example, T.W. Greene et al, Protective Groups in organic Synthesis (1991), Wiley, New York.
- Such functional groups include hydroxy, phenol, amino and carboxylic acid.
- Suitable protecting groups for hydroxy or phenol include trialkylsilyl or diarylalkylsilyl (e.g., t-butyldimethylsilyl, t-butyldiphenyl silyl or trimethylsilyl), tetrahydropyranyl, benzyl, substituted benzyl, methyl, methoxymethanol, and the like.
- Suitable protecting groups for amino, amidino and guanidino include t-butoxycarbonyl, benzyl oxy carbonyl, and the like.
- Suitable protecting groups for carboxylic acid include alkyl, aryl or arylalkyl esters.
- the protecting group may also be a polymer resin, such as a Wang resin or a 2-chlorotrityl- chloride resin.
- Protecting groups may be added or removed in accordance with standard techniques, which are well-known to those skilled in the art and as described herein. It will also be appreciated by those skilled in the art, although such protected derivatives of compounds described herein may not possess pharmacological activity as such, they may be administered to a subject and thereafter metabolized in the body to form compounds described herein which are pharmacologically active. Such derivatives may therefore be described as "prodrugs". All prodrugs of compounds described herein are included within the scope of the use described herein.
- prodrug means a form of an instant compound (e.g., a drug precursor) that is transformed in vivo to yield an active compound of Formula (I) or a form thereof.
- the transformation may occur by various mechanisms (e.g., by metabolic and/or non-metabolic chemical processes), such as, for example, by hydrolysis and/or metabolism in blood, liver and/or other organs and tissues.
- metabolic and/or non-metabolic chemical processes e.g., by hydrolysis and/or metabolism in blood, liver and/or other organs and tissues.
- a prodrug when a compound of Formula (I) or a form thereof contains a carboxylic acid functional group, a prodrug can comprise an ester formed by the replacement of the hydrogen atom of the acid group with a functional group such as alkyl and the like.
- a prodrug form when a compound of Formula (I) or a form thereof contains a hydroxyl functional group, a prodrug form can be prepared by replacing the hydrogen atom of the hydroxyl with another functional group such as alkyl, alkylcarbonyl or a phosphonate ester and the like.
- a prodrug form can be prepared by replacing one or more amine hydrogen atoms with a functional group such as alkyl or substituted carbonyl.
- Pharmaceutically acceptable prodrugs of compounds of Formula (I) or a form thereof include those compounds substituted with one or more of the following groups: carboxylic acid esters, sulfonate esters, amino acid esters, phosphonate esters and mono-, di- or triphosphate esters or alkyl substituents, where appropriate. As described herein, it is understood by a person of ordinary skill in the art that one or more of such substituents may be used to provide a compound of Formula (I) or a form thereof as a prodrug.
- One or more compounds described herein may exist in unsolvated as well as solvated forms with pharmaceutically acceptable solvents such as water, ethanol, and the like, and the description herein is intended to embrace both solvated and unsolvated forms.
- solvate means a physical association of a compound described herein with one or more solvent molecules. This physical association involves varying degrees of ionic and covalent bonding, including hydrogen bonding. In certain instances, the solvate will be capable of isolation, for example when one or more solvent molecules are incorporated in the crystal lattice of the crystalline solid. As used herein, “solvate” encompasses both solution-phase and isolatable solvates. Non-limiting examples of suitable solvates include ethanolates, methanolates, and the like.
- hydrate means a solvate wherein the solvent molecule is water.
- the compounds of Formula (I) can form salts, which are intended to be included within the scope of this description.
- Reference to a compound of Formula (I) or a form thereof herein is understood to include reference to salt forms thereof, unless otherwise indicated.
- the term "salt(s)", as employed herein, denotes acidic salts formed with inorganic and/or organic acids, as well as basic salts formed with inorganic and/or organic bases.
- a compound of Formula (1) or a form thereof contains both a basic moiety, such as, without limitation an amine moiety, and an acidic moiety, such as, but not limited to a carboxylic acid, zwitterions ("inner salts") may be formed and are included within the term “salt(s)" as used herein.
- salts of the compounds of the Formula (I) may be formed, for example, by reacting a compound of Formula (I) or a form thereof with an amount of acid or base, such as an equivalent amount, in a medium such as one in which the salt precipitates or in an aqueous medium followed by lyophilization.
- Pharmaceutically acceptable salts include one or more salts of acidic or basic groups present in compounds described herein.
- particular acid addition salts include, and are not limited to, acetate, ascorbate, benzoate, benzenesulfonate, bisulfate, bitartrate, borate, bromide, butyrate, chloride, citrate, camphorate, camphorsulfonate, ethanesulfonate, formate, fumarate, gentisinate, gluconate, glucaronate, glutamate, iodide, isonicotinate, lactate, maleate, methanesulfonate, naphthalenesulfonate, nitrate, oxalate, pamoate, pantothenate, phosphate, propionate, saccharate, salicylate, succinate, sulfate, tartrate, thiocyanate, toluenesulfonate (also known as tosy
- certain particular acid addition salts include chloride or dichloride.
- acids which are generally considered suitable for the formation of pharmaceutically useful salts from basic pharmaceutical compounds are discussed, for example, by P. Stahl et al, Camille G. (eds.) Handbook of Pharmaceutical Salts. Properties, Selection and Use. (2002) Zurich: Wiley-VCH; S. Berge et al, Journal of Pharmaceutical Sciences (VMT) 66(1) 1-19; P. Gould, International J. of Pharmaceutics (1986) 33, 201-217; Anderson et al, The Practice of Medicinal Chemistry (1996), Academic Press, New York; and in The Orange Book (Food & Drug Administration, Washington, D.C. on their website). These disclosures are incorporated herein by reference thereto.
- Suitable basic salts include, but are not limited to, aluminum, ammonium, calcium, lithium, magnesium, potassium, sodium and zinc salts.
- the compounds of Formula (I) or a form thereof may contain asymmetric or chiral centers, and, therefore, exist in different stereoisomeric forms.
- the present description is intended to include all stereoisomeric forms of the compounds of Formula (I) as well as mixtures thereof, including racemic mixtures.
- the compounds described herein may include one or more chiral centers, and as such may exist as racemic mixtures (A ⁇ S) or as substantially pure enantiomers and diastereomers.
- the compounds may also exist as substantially pure (R) or (5) enantiomers (when one chiral center is present).
- the compounds described herein are (S) isomers and may exist as enantiomerically pure compositions substantially comprising only the (S) isomer.
- the compounds described herein are (R) isomers and may exist as enantiomerically pure compositions substantially comprising only the (R) isomer.
- the compounds described herein may also exist as a (R,R), (R,S), (S,R) or (S,S) isomer, as defined by IUPAC Nomenclature Recommendations.
- the term “chiral” refers to a carbon atom bonded to four nonidentical substituents. Stereochemical definitions and conventions used herein generally follow S. P. Parker, Ed., McGraw-Hill Dictionary of Chemical Terms (1984) McGraw-Hill Book Company, New York; and Eliel, E. and Wilen, S., "Stereochemistry of Organic Compounds", John Wiley & Sons, Inc., New York, 1994. In describing an optically active compound, the prefixes D and L, or R and S, are used to denote the absolute configuration of the molecule about its chiral center(s). The substituents attached to the chiral center under consideration are ranked in accordance with the Sequence Rule of Cahn, Ingold and Prelog. (Cahn et al. Angew. Chem.
- substantially pure refers to compounds consisting substantially of a single isomer in an amount greater than or equal to 90%, in an amount greater than or equal to 92%, in an amount greater than or equal to 95%, in an amount greater than or equal to 98%, in an amount greater than or equal to 99%, or in an amount equal to 100% of the single isomer.
- a compound of Formula (I) or a form thereof is a substantially pure (S) enantiomer form present in an amount greater than or equal to 90%, in an amount greater than or equal to 92%, in an amount greater than or equal to 95%, in an amount greater than or equal to 98%, in an amount greater than or equal to 99%, or in an amount equal to 100%.
- a compound of Formula (I) or a form thereof is a substantially pure (R) enantiomer form present in an amount greater than or equal to 90%, in an amount greater than or equal to 92%, in an amount greater than or equal to 95%, in an amount greater than or equal to 98%, in an amount greater than or equal to 99%, or in an amount equal to 100%.
- a “racemate” is any mixture of isometric forms that are not “enantiomerically pure”, including mixtures such as, without limitation, in a ratio of about 50/50, about 60/40, about 70/30, or about 80/20.
- the present description embraces all geometric and positional isomers. For example, if a compound of Formula (I) or a form thereof incorporates a double bond or a fused ring, both the cis- and trans-forms, as well as mixtures, are embraced within the scope of the description.
- Diastereomeric mixtures can be separated into their individual diastereomers on the basis of their physical chemical differences by methods well known to those skilled in the art, such as, for example, by chromatography and/or fractional crystallization.
- Enantiomers can be separated by use of chiral HPLC column or other chromatographic methods known to those skilled in the art.
- Enantiomers can also be separated by converting the enantiomeric mixture into a diastereomeric mixture by reaction with an appropriate optically active compound (e.g., chiral auxiliary such as a chiral alcohol or Mosher’s acid chloride), separating the diastereomers and converting (e.g., hydrolyzing) the individual diastereomers to the corresponding pure enantiomers.
- an appropriate optically active compound e.g., chiral auxiliary such as a chiral alcohol or Mosher’s acid chloride
- separating the diastereomers converting (e.g., hydrolyzing) the individual diaste
- All stereoisomers (for example, geometric isomers, optical isomers and the like) of the present compounds including those of the salts, solvates, esters and prodrugs of the compounds as well as the salts, solvates and esters of the prodrugs), such as those which may exist due to asymmetric carbons on various substituents, including enantiomeric forms (which may exist even in the absence of asymmetric carbons), rotameric forms, atropisomers, and diastereomeric forms, are contemplated within the scope of this description, as are positional isomers (such as, for example, 4-pyridyl and 3-pyridyl).
- Individual stereoisomers of the compounds described herein may, for example, be substantially free of other isomers, or may be present in a racemic mixture, as described supra.
- isotopologue refers to isotopically-enriched compounds described herein which are identical to those recited herein, but for the fact that one or more atoms are replaced by an atom having an atomic mass or mass number different from the atomic mass or mass number usually found in nature.
- isotopes that can be incorporated into compounds described herein include isotopes of hydrogen, carbon, nitrogen, oxygen, phosphorus, fluorine and chlorine, such as 2 H, 3 H, 13 C, 14 C, 15 N, 18 O, 17 0, 31 P, 32 P, 35 S, 18 F, 35 C1 and 36 C1, respectively, each of which are also within the scope of this description.
- Certain isotopically-enriched compounds described herein are useful in compound and/or substrate tissue distribution assays. Tritiated (z.e., 3 H) and carbon-14 (z.e., 14 C) isotopes are particularly preferred for their ease of preparation and detectability. Further, substitution with heavier isotopes such as deuterium (z.e., 2 H) may afford certain therapeutic advantages resulting from greater metabolic stability (e.g., increased in vivo half-life or reduced dosage requirements) and hence may be preferred in some circumstances.
- RNA REMS comprises a U1 snRNP binding site.
- a recognition element for splicing modifier (otherwise referred to as “REMS”) that plays a role in the recognition of a compound described herein.
- the REMS has a RNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 5776 to SEQ ID NO. 11550.
- the REMS has a DNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 1 to SEQ ID NO. 5775.
- a REMS can be part of an endogenous RNA or can be introduced into an RNA sequence that does not naturally contain the REMS sequence (i.e., the introduced REMS is a non-endogenous REMS).
- a nucleotide sequence encoding a REMS can also be part of an endogenous DNA sequence, or a nucleotide sequence encoding a REMS can be introduced into a DNA sequence that does not naturally contain the nucleotide sequence encoding the introduced REMS
- the REMS is the endogenous 5’ splice site.
- the REMS is located within an exon.
- the REMS is located within an intron.
- the REMS is located within an exon-intron junction.
- described herein is a REMS that is the endogenous, wild-type 5’ splice site of a pre-mRNA. In another aspect, described herein is a REMS that is located within an endogenous, wild-type 5’ splice site of a pre-mRNA. In another aspect, described herein is a REMS that is inserted within an endogenous, wild-type 5’ splice site of a pre-mRNA. In the presence of a compound described herein, nucleotides between the REMS in the 5’ splice site and 3’ splice site of a pre-mRNA are removed and the remaining nucleotides of the pre-mRNA are spliced together.
- a REMS located within an exon in a pre- mRNA.
- the nucleotides between the REMS and the 3’ splice site of a pre-mRNA are removed and the remaining portions of the pre-mRNA are spliced together, which may result in an RNA transcript with a truncated open reading frame or internal deletions within the open reading frame, which may further result in the creation of a premature termination codon.
- a pre-mRNA transcript comprises three exons (el, e2, and e3) and two introns (il and i2), wherein a REMS is present endogenously or introduced into the 5’ splice site of the exon 2-intron 2 boundary of the RNA transcript.
- a REMS is present endogenously or introduced into the 5’ splice site of the exon 2-intron 2 boundary of the RNA transcript.
- some degree of exon 2 skipping will occur and two mRNAs will be produced, e le2e3 and ele3.
- the balance between the two mRNAs produced is shifted so that more ele2e3 and less ele3 mRNA is produced.
- a pre-mRNA transcript comprises two exons (el and e2) and one intron (il), wherein a REMS is present endogenously or introduced into the 5’splice site of the exon 1 -intron 1 boundary of the pre-mRNA transcript.
- a REMS is present endogenously or introduced into the 5’splice site of the exon 1 -intron 1 boundary of the pre-mRNA transcript.
- An mRNA elile2 and an ele2 mRNA An mRNA elile2 and an ele2 mRNA.
- the elile2 mRNA is usually unstable and degraded and, thus, usually not translated so no functional protein is produced.
- the balance between the two RNA products is shifted so that more ele2 and less elile2 is produced.
- a pre-mRNA transcript comprises a REMS inside an exon.
- the splicing outcome is driven by the distal 5’ splice site and the 5 ’splice site mediates whole exon splicing, thus producing an extended exon.
- splicing at the REMS is induced and inclusion of a shorter exon can result.
- the splicing outcome is governed by the presence/absence of an upstream 5’ splice site(s), upstream 3’ splice sites, and downstream 3’ splice site(s) and endogenous splicing control sequences
- contacting a compound of Formula (I) with a pre-mRNA transcript of gene comprising a REMS results in inclusion of an exon of the gene.
- contacting a compound of Formula (I) with a pre-mRNA transcript of gene comprising a REMS results in skipping of an exon of the gene.
- pre-mRNA is matured by capping, polyadenylating, and splicing the mRNA to produce a mature mRNA transcript.
- Exon skipping refers to a splicing event where an exon, a sequence that would normally be expressed as part of the final mature RNA after procession, is instead made absent from the final matured RNA.
- Exon inclusion refers to a splicing event where an exon is included in the final matured RNA.
- a given gene may produce a mixture of RNA isoforms, some having an included exon and some having an omitted exon, and yet in various examples a compound of Formula (I) can modulate such splicing events by way of interaction with a REMS.
- modulationg of splicing events can be measured by evaluating a population of transcripts and calculating the percent-spliced-in (PSI).
- PSI percent-spliced-in
- Exon skipping and exon inclusion can also each be confugred in various examples to result in a mature RNA transcript that undergoes decay and thus the downregulate resulting expressed protein.
- an exon can be included to disrupt the reading frame or introduce a stop codon.
- Exon inclusion or exon skipping can be measured by comparing a mature RNA transcript expressed in the presence of the compound of Formula (I) relative to a mature RNA transcript expressed in the absence of the compound, of Formula (I). Exon inclusion. Exon inclusion or exon skipping can also be measured by comparing the expressed mature RNA transcript with a gene.
- RNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 1 to SEQ ID NO. 5775, wherein a pre-RNA transcript transcribed from a gene comprising the DNA REMS nucleotide sequence comprises a RNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 5776 to SEQ ID NO. 11550, wherein, a compound of Formula (I)
- Ri is phenyl or heteroaryl, optionally substituted with one, two, three, or four, independently selected Ria substituents,
- heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S;
- Ria is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, or C1-6alkoxy;
- R3 is hydrogen, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, and C1-6alkyl-amino,
- C1-6alkyl, C2-6alkenyl, and C2-6alkynyl is optionally substituted with one, two, three, or four independently selected R3a substituents, and
- each instance of C1-6alkyl, C2-6alkenyl, and C2-6alkynyl may optionally contain a chiral carbon having an (R) or (S) configuration;
- R3a is cyano, halo, hydroxy, oxo, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, halo-C1-6alkoxy, carboxyl, amino, Ci -ealkoxy -carbonyl, C1-6alkyl-amino, halo-C1-6alkyl-amino, (C1-6alkyl)2-amino, phenyl-amino, heterocyclyl-amino, heteroaryl-amino, phenyl-(C1-6alkyl)-amino, heterocyclyl-(C1-6alkyl)-amino, heteroaryl-(C1-6alkyl)-amino, C1-6alkyl-thio, C1-6alkyl-sulfoxyl, and C1-6alkyl-sulfonyl,
- heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S,
- heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S;
- each instance of phenyl, heterocyclyl, and heteroaryl is optionally substituted with one, two, three or four independently selected Raa’ substituents;
- Raa’ is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, or amino;
- R.4 is hydrogen, cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, halo-C1-6alkoxy, amino, C1-6alkyl-amino, (C1-6alkyl)2-amino, C3-10cycloalkyl, phenyl, heterocyclyl, or heteroaryl,
- heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S,
- heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S, and
- each instance of C1-6alkyl, C3-10cycloalkyl, phenyl, heterocyclyl, or heteroaryl are optionally substituted with one, two, three, or four independently selected IUa substituents;
- R.4a is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, or C1-6alkoxy;
- R5 is hydrogen, cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, carbamoyl, C3-10cycloalkyl, or heterocyclyl,
- heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S;
- Re is hydrogen, halo, or C1-6alkyl
- RNA REMS nucleotide sequence in a cell lysate or in a cell in cell culture, whether in vivo or ex vivo, to express the mature RNA transcript, wherein the amount or type of mature RNA transcript expressed in the presence of the compound is modulated compared to the amount or type of mature RNA transcript expressed in the absence of the compound, wherein the mature RNA transcript is selected from a wildtype or non-wildtype mature RNA transcript, and wherein the gene is selected from a gene comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5.
- described herein are methods for modulating the amount or type of mature mRNA transcript produced from pre-mRNA containing a RNA REMS.
- artificial gene constructs comprising a DNA REMS or RNA REMS, which may be used in the context of, e.g., gene therapy or reporter assays.
- methods for engineering a gene to become such an artificial gene construct from an endogenous gene wherein the artificial gene construct contains a non-wildtype DNA REMS or a non-wildtype RNA REMS.
- the REMS is an endogenous 5’ splice site in a pre-mRNA.
- the REMS is a canonical endogenous 5’ splice site in a pre-mRNA. In another aspect, the REMS is a noncanonical endogenous 5’ splice site in a pre- mRNA.
- described herein are methods for modulating the amount or type of mature mRNA transcript produced from pre-mRNA containing a RNA REMS.
- artificial gene constructs comprising a DNA REMS or RNA REMS, which may be used in the context of, e.g., gene therapy or reporter assays.
- methods for engineering a gene to become such an artificial gene construct from an endogenous gene wherein the artificial gene construct contains a non-wildtype DNA REMS or a non -wildtype RNA REMS.
- RNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 1 to SEQ ID NO. 5775, wherein a pre-RNA transcript transcribed from the gene comprising the DNA REMS nucleotide sequence comprises a RNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 5776 to SEQ ID NO. 11550, wherein, a compound of Formula (I)
- RNA REMS nucleotide sequence in a cell lysate or in a cell in cell culture, whether in vivo or ex vivo, to express the mature RNA transcript, wherein the amount or type of mature RNA transcript expressed in the presence of the compound is modulated compared to the amount or type of mature RNA transcript expressed in the absence of the compound, and wherein the mature RNA transcript is selected from a wildtype or non-wildtype mature RNA transcript.
- the artificial gene construct comprising a DNA REMS or RNA REMS may be used in the context of gene therapy or reporter assays.
- the nucleotide sequence encoding the RNA REMS comprises a DNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 1 to SEQ ID NO. 5775.
- the nucleotide sequence encoding the REMS is a nucleotide sequence encoding a non-endogenous REMS, i.e., not naturally found in the DNA sequence of the artificial construct.
- a method for determining whether the splicing of the pre-mRNA of a gene is likely to be modulated by a compound of Formula (I) or a form thereof comprising searching for the presence of a REMS in the gene sequence, wherein the presence of a REMS upstream of a 3’ splice site and a branch point in the gene sequence indicates that the splicing of the pre-mRNA of the gene is likely to be modulated by the compound of Formula (I) or a form thereof, and the absence of a REMS upstream of a 3’ splice site and a branch point in the gene sequence indicates that the splicing of the pre-mRNA of the gene is unlikely to be modulated by the compound of Formula (I) or a form thereof.
- a product e.g., an mRNA transcript or protein
- searching for the presence of a REMS in the gene sequence wherein the presence of a REMS upstream of a 3’ splice site and a branch point in the gene sequence indicates that the amount or type of a product (e.g., an mRNA transcript or protein) of the gene is likely to be modulated by the compound of Formula (I) or a form thereof, and the absence of a REMS upstream of a 3’ splice site and a branch point in the gene sequence indicates that the amount or type of a product (e.g, an mRNA transcript or protein) of the gene is unlikely to be modulated by the compound of Formula (I) or a form thereof.
- the step of searching for the presence of a REMS, a 3’ splice site, and/or a branch point in the gene sequence described herein can be performed by a computer system comprising a memory storing instructions for searching the presence of the REMS, the 3’ splice site, and/or the branch point in the gene sequence, or can be performed manually.
- the splicing of a pre-mRNA containing a REMS is assessed by contacting a compound described herein with the pre-mRNA in cell cultured in tissue culture.
- the splicing of a pre-mRNA containing a REMS is assessed by contacting a compound described herein with the pre-mRNA in a cell-free extract.
- a reference compound known to modulate the splicing of a pre-mRNA containing a REMS may be used.
- One aspect described herein is a method for determining whether a compound of Formula (I) or a form thereof modulates the amount or type of one, two, three or more RNA transcripts (e.g., pre-mRNA or mRNA transcripts or isoforms thereof) of one, two, three or more genes.
- the gene is a gene comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5, or any one of the genes disclosed in a subset thereof.
- the gene is other than a gene comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5.
- a method for determining whether a compound of Formula (I) or a form thereof modulates the amount or type of an RNA transcript comprising: (a) contacting a cell or cell lysate with a compound of Formula (I) or a form thereof, and (b) determining the amount or type of the RNA transcript produced by the cell or cell lysate, wherein an alteration in the amount or type of the RNA transcript in the presence of the compound relative to the amount or type of the RNA transcript in the absence of the compound or the presence of a negative control (e.g., a vehicle control such as PBS or DMSO) indicates that the compound of Formula (I) or a form thereof modulates the amount or type of the RNA transcript.
- a negative control e.g., a vehicle control such as PBS or DMSO
- RNA transcript e.g., an mRNA transcript
- a method for determining whether a compound of Formula (1) or a form thereof modulates the amount or type of an RNA transcript comprising: (a) contacting a first cell(s) with a compound of Formula (I) or a form thereof, (b) contacting a second cell(s) with a negative control (e.g., a vehicle control, such as PBS or DMSO); and (c) determining the amount or type of the RNA transcript produced by the first cell(s) and the second cell(s); and (d) comparing the amount or type of the RNA transcript produced by the first cell(s) to the amount or type of the RNA transcript expressed by the second cell(s), wherein an alteration in the amount or type of the RNA transcript produced by the first cell(s) relative to the amount or type of the RNA transcript produced by the second cell(s) indicates that the compound of Formula (I) or a form thereof modulates the amount or type of an RNA transcript (e.g
- contacting of the cell(s) with the compound occurs in cell culture. In another aspect, contacting of the cell(s) with the compound occurs in a subject, such as a human or non-human animal subject.
- RNA transcript e.g., an mRNA transcript
- a method for determining whether a compound of Formula (I) or a form thereof modulates the splicing of an RNA transcript comprising: (a) culturing a cell(s) in the presence of a compound of Formula (I) or a form thereof; and (b) determining the amount or type of the RNA transcript splice variants produced by the cell(s), wherein an alteration in the amount or type of the RNA transcript in the presence of the compound relative to the amount or type of the RNA transcript splice variants in the absence of the compound or the presence of a negative control (e.g., a vehicle control such as PBS or DMSO) indicates that the compound of Formula (I) or a form thereof modulates the splicing of the RNA transcript.
- a negative control e.g., a vehicle control such as PBS or DMSO
- RNA transcript e.g., an mRNA transcript
- a method for determining whether a compound of Formula (I) or a form thereof modulates the splicing of an RNA transcript comprising: (a) culturing a cell(s) in the presence of a compound of Formula (I) or a form thereof; (b) isolating RNA transcript splice variants from the cell(s) after a certain period of time; and (c) determining the amount or type of the RNA transcript splice variants produced by the cell(s), wherein an alteration in the amount or type of the RNA transcript in the presence of the compound relative to the amount or type of the RNA transcript splice variants in the absence of the compound or the presence of a negative control (e.g., a vehicle control such as PBS or DMSO) indicates that the compound of Formula (1) or a form thereof modulates the splicing of the RNA transcript.
- a negative control e.g., a vehicle control such as
- RNA transcript e.g., an mRNA transcript
- a method for determining whether a compound of Formula (I) or a form thereof modulates the splicing of an RNA transcript comprising (a) culturing a first cell(s) in the presence of a compound of Formula (I) or a form thereof; (b) culturing a second cell(s) in the presence of a negative control (e.g., a vehicle control, such as PBS or DMSO); (c) isolating RNA transcript splice variants produced by the first cell(s) and isolating RNA transcript splice variants produced by the second cell(s); (d) determining the amount or type of the RNA transcript splice variants produced by the first cell(s) and the second cell(s); and (e) comparing the amount or type of the RNA transcript splice variants produced by the first cell(s) to the amount or type of the RNA transcript s
- a negative control e
- RNA transcript e.g., an mRNA transcript
- a method for determining whether a compound of Formula (I) or a form thereof modulates the amount or type of an RNA transcript comprising: (a) contacting a cell-free system with a compound of Formula (I) or a form thereof, and (b) determining the amount or type of the RNA transcript produced by the cell-free system, wherein an alteration in the amount or type of the RNA transcript in the presence of the compound relative to the amount or type of the RNA transcript in the absence of the compound or the presence of a negative control (e.g., a vehicle control such as PBS or DMSO) indicates that the compound of Formula (I) or a form thereof modulates the amount or type of the RNA transcript.
- a negative control e.g., a vehicle control such as PBS or DMSO
- RNA transcript e.g., an mRNA transcript
- a method for determining whether a compound of Formula (I) or a form thereof modulates the amount or type of an RNA transcript comprising: (a) contacting a first cell-free system with a compound of Formula (I) or a form thereof, (b) contacting a second cell-free system with a negative control (e.g., a vehicle control, such as PBS or DMSO); and (c) determining the amount or type of the RNA transcript produced by the first cell-free system and the second cell-free system; and (d) comparing the amount or type of the RNA transcript produced by the first cell- free system to the amount or type of the RNA transcript expressed by the second cell-free system, wherein an alteration in the amount or type of the RNA transcript produced by the first cell-free system relative to the amount or type of the RNA transcript produced by the second cell-free system indicates that the compound of Formula (I) or a form thereof modulates the amount or type of the RNA transcript
- the cell-free system comprises purely synthetic RNA, synthetic or recombinant (purified) enzymes, and protein factors.
- the cell-free system comprises RNA transcribed from a synthetic DNA template, synthetic or recombinant (purified) enzymes, and protein factors.
- the cell-free system comprises purely synthetic RNA and nuclear extract.
- the cell-free system comprises RNA transcribed from a synthetic DNA template and nuclear extract.
- the cell-free system comprises purely synthetic RNA and whole cell extract.
- the cell-free system comprises RNA transcribed from a synthetic DNA template and whole cell extract.
- the cell-free system additionally comprises regulatory RNAs (e.g., microRNAs).
- RNA transcript e.g., an mRNA transcript
- a method for determining whether a compound of Formula (I) or a form thereof modulates the splicing of an RNA transcript comprising: (a) contacting a cell-free system with a compound of Formula (I) or a form thereof; and (b) determining the amount or type of RNA transcript splice variants produced by the cell-free system, wherein an alteration in the amount or type of the RNA transcript splice variants in the presence of the compound relative to the amount or type of the RNA transcript splice variants in the absence of the compound or the presence of a negative control (e.g., a vehicle control such as PBS or DMSO) indicates that the compound of Formula (I) or a form thereof modulates the splicing of the RNA transcript.
- a negative control e.g., a vehicle control such as PBS or DMSO
- RNA transcript e.g., an mRNA transcript
- a method for determining whether a compound of Formula (I) or a form thereof modulates the splicing of an RNA transcript comprising: (a) contacting a first cell- free system with a compound of Formula (I) or a form thereof; (b) contacting a second cell-free system with a negative control (e.g., a vehicle control, such as PBS or DMSO); and (c) determining the amount or type of RNA transcript splice variants produced by the first cell-free system and the second cell -free system; and (d) comparing the amount or type of the RNA transcript splice variants produced by the first cell-free system to the amount or type of the RNA transcript expressed by the second cell-free system, wherein an alteration in the amount or type of the RNA transcript splice variants produced by the first cell-free system relative to the amount or type of the RNA transcript splice variants produced by the second cell
- the cell-free system comprises purely synthetic RNA, synthetic or recombinant (purified) enzymes, and protein factors.
- the cell-free system comprises RNA transcribed from a synthetic DNA template, synthetic or recombinant (purified) enzymes, and protein factors.
- the cell-free system comprises purely synthetic RNA and nuclear extract.
- the cell-free system comprises RNA transcribed from a synthetic DNA template and nuclear extract.
- the cell-free system comprises purely synthetic RNA and whole cell extract.
- the cell-free system comprises RNA transcribed from a synthetic DNA template and whole cell extract.
- the cell-free system additionally comprises regulatory RNAs (e.g., microRNAs).
- RNA transcript e.g., an mRNA transcript
- a method for determining whether a compound of Formula (I) or a form thereof modulates the amount or type of an RNA transcript comprising: (a) culturing a cell(s) in the presence of a compound of Formula (I) or a form thereof, (b) isolating the RNA transcript from the cell(s) after a certain period of time; and (c) determining the amount or type of the RNA transcript produced by the cell(s), wherein an alteration in the amount or type of the RNA transcript in the presence of the compound relative to the amount or type of the RNA transcript in the absence of the compound or the presence of a negative control (e.g., a vehicle control such as PBS or DMSO) indicates that the compound of Formula (I) or a form thereof modulates the amount or type of the RNA transcript.
- a negative control e.g., a vehicle control such as PBS or DMSO
- RNA transcript e.g., an mRNA transcript
- a method for determining whether a compound of Formula (I) or a form thereof modulates the amount or type of an RNA transcript comprising (a) culturing a first cell(s) in the presence of a compound of Formula (I) or a form thereof, (b) culturing a second cell(s) in the presence of a negative control (e.g., a vehicle control, such as PBS or DMSO); (c) isolating the RNA transcript produced by the first cell(s) and isolating the RNA transcript produced by the second cell(s); (d) determining the amount or type of the RNA transcript produced by the first cell(s) and the second cell(s); and (e) comparing the amount or type of the RNA transcript produced by the first cell(s) to the amount or type of the RNA transcript produced by the second cell(s), wherein an alteration in the amount or type of the RNA transcript produced by the first cell(s)
- the cell(s) contacted or cultured with a compound of Formula (I) or a form thereof is a primary cell(s) from a subject.
- the cell(s) contacted or cultured with a compound of Formula (I) or a form thereof is a primary cell(s) from a subject with a disease.
- the cell(s) contacted or cultured with a compound of Formula (I) or a form thereof is a primary cell(s) from a subject with a disease associated with an aberrant amount or type of an RNA transcript(s) for a particular gene(s).
- the cell(s) contacted or cultured with a compound of Formula (I) or a form thereof is a primary cell(s) from a subject with a disease associated with an aberrant amount or type of an isoform(s) of a particular gene(s).
- the cell(s) contacted or cultured with a compound of Formula (I) or a form thereof is a fibroblast (e.g., GM03813 or PNN 1-46 fibroblasts), an immune cell (e.g., a T cell, B cell, natural killer cell, macrophage), or a muscle cell.
- the cell(s) contacted or cultured with a compound of Formula (I) or a form thereof is a cancer cell.
- the cell(s) contacted or cultured with a compound of Formula (I) or a form thereof is from a cell line.
- the cell(s) contacted or cultured with a compound of Formula (I) or a form thereof is a cell line derived from a subject with a disease.
- the cell(s) contacted or cultured with a compound of Formula (I) or a form thereof is from a cell line known to have aberrant RNA transcript levels for a particular gene(s).
- the cell(s) contacted or cultured with a compound of Formula (I) or a form thereof is from a cell line derived from a subject with a disease known to have aberrant RNA transcript levels for a particular gene(s).
- the cell(s) contacted or cultured with a compound of Formula (I) or a form thereof is a cancer cell line.
- the cell(s) contacted or culured with the compound of Formula (I) or a form thereof is from a cell line derived from a subject with a disease known to have an aberrant amount or type of an RNA isoform(s) and/or protein isoform(s) of a particular gene(s).
- Non-limiting examples of cell lines include 293, 3T3, 4T1, 721, 9L, A2780, A172, A20, A253, A431, A-549, ALC, B16, B35, BCP- 1, BEAS-2B, bEnd.3, BHK, BR 293, BT2O, BT483, BxPC3, C2C12, C3H-10T1/2, C6/36, C6, Cal-27, CHO, COR-L23, COS, COV-434, CML Tl, CMT, CRL7O3O, CT26, D17, DH82, DU145, DuCaP, EL4, EM2, EM3, EMT6, FM3, H1299, H69, HB54, HB55, HCA2, HEK293, HeLa, Hepalclc7, HL-60, HMEC, Hs578T, HsS78Bst, HT1080, HT-29, HTB2, HUVEC, Jurkat, J558L, J
- the cells are from a subject.
- the cells are FD patient fibroblast cells.
- the cells are differentiated SY5Y cells.
- the cells are stimulated PBMC cells.
- a method for determining whether a compound of Formula (I) or a form thereof modulates the amount or type of an RNA transcript comprising: (a) contacting a tissue sample with a compound of Formula (I) or a form thereof; and (b) determining the amount or type of the RNA transcript produced by the tissue sample, wherein an alteration in the amount or type of the RNA transcript in the presence of the compound relative to the amount or type of the RNA transcript in the absence of the compound or the presence of a negative control (e.g., a vehicle control such as PBS or DMSO) indicates that the compound of Formula (I) or a form thereof modulates the amount or type of the RNA transcript.
- a negative control e.g., a vehicle control such as PBS or DMSO
- RNA transcript e.g., an mRNA transcript
- a method for determining whether a compound of Formula (I) or a form thereof modulates the amount or type of an RNA transcript comprising: (a) contacting a first tissue sample with a compound of Formula (I) or a form thereof, (b) contacting a second tissue sample with a negative control (e.g., a vehicle control, such as PBS or DMSO); and (c) determining the amount or type of the RNA transcript produced by the first tissue sample and the second tissue sample; and (d) comparing the amount or type of the RNA transcript produced by the first tissue sample to the amount or type of the RNA transcript produced by the second tissue sample, wherein an alteration in the amount or type of the RNA transcript produced by the first tissue sample relative to the amount or type of the RNA transcript produced by the second tissue sample indicates that the compound of Formula (1) or a form thereof modulates the amount or type of the RNA transcript.
- a negative control e.g., a vehicle control,
- tissue sample containing cells may be used in the accordance with these methods.
- the tissue sample is a blood sample, a skin sample, a muscle sample, or a tumor sample. Techniques known to one skilled in the art may be used to obtain a tissue sample from a subject. [00410] In another aspect, a dose-response assay is performed.
- the dose response assay comprises: (a) contacting a cell(s) with a concentration of a compound of Formula (I) or a form thereof; (b) determining the amount or type of the RNA transcript produced by the cell(s), wherein an alteration in the amount or type of the RNA transcript in the presence of the compound relative to the amount or type of the RNA transcript in the absence of the compound or the presence of a negative control (e.g., a vehicle control such as PBS or DMSO) indicates that the compound of Formula (I) or a form thereof modulates the amount or type of the RNA transcript; (c) repeating steps (a) and (b), wherein the only experimental variable changed is the concentration of the compound or a form thereof; and (d) comparing the amount or type of the RNA transcript produced at the different concentrations of the compound or a form thereof.
- a negative control e.g., a vehicle control such as PBS or DMSO
- the dose response assay comprises: (a) culturing a cell(s) in the presence of a compound of Formula (I) or a form thereof, (b) isolating the RNA transcript from the cell(s) after a certain period of time; (c) determining the amount or type of the RNA transcript produced by the cell(s), wherein an alteration in the amount or type of the RNA transcript in the presence of the compound relative to the amount or type of the RNA transcript in the absence of the compound or the presence of a negative control (e.g., a vehicle control such as PBS or DMSO) indicates that the compound of Formula (I) or a form thereof modulates the amount or type of the RNA transcript; (d) repeating steps (a), (b), and (c), wherein the only experimental variable changed is the concentration of the compound or a form thereof; and (e) comparing the amount or type of the RNA transcript produced at the different concentrations of the compound or a form thereof.
- a negative control e.g., a
- the dose-response assay comprises: (a) contacting each well of a microtiter plate containing cells with a different concentration of a compound of Formula (I) or a form thereof; (b) determining the amount or type of an RNA transcript produced by cells in each well; and (c) assessing the change of the amount or type of the RNA transcript at the different concentrations of the compound or form thereof.
- the dose response assay comprises: (a) contacting a cell(s) with a concentration of a compound of Formula (1) or a form thereof, wherein the cells are within the wells of a tissue culture container (e.g., a 96-well plate) at about the same density within each well, and wherein the cells are contacted with different concentrations of compound in different wells; (b) isolating the RNA from said cells in each well; (c) determining the amount or type of the RNA transcript produced by the cell(s) in each well; and (d) assessing change in the amount or type of the RNA transcript in the presence of one or more concentrations of compound relative to the amount or type of the RNA transcript in the presence of a different concentration of the compound or the absence of the compound or the presence of a negative control (e.g., a vehicle control such as PBS or DMSO).
- a negative control e.g., a vehicle control such as PBS or DMSO
- the contacting of the cell(s) with the compound occurs in cell culture. In one aspect, the contacting of the cell(s) with the compound occurs in a subject, such as a non-human animal subject.
- the cell(s) is contacted or cultured with a compound of Formula (I) or a form thereof, or a tissue sample is contacted with a compound of Formula (I) or a form thereof, or a negative control for a period of 15 minutes, 30 minutes, 45 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 5 hours, 6 hours, 8 hours, 12 hours, 18 hours, 24 hours, 48 hours, 72 hours or more.
- the cell(s) is contacted or cultured with a compound of Formula (I) or a form thereof, or a tissue sample is contacted with a compound of Formula (I) or a form thereof, or a negative control for a period of 15 minutes to 1 hour, 1 to 2 hours, 2 to 4 hours, 6 to 12 hours, 12 to 18 hours, 12 to 24 hours, 28 to 24 hours, 24 to 48 hours, 48 to 72 hours.
- the cell(s) is contacted or cultured with a certain concentration of a compound of Formula (I) or a form thereof, or a tissue sample is contacted with a certain concentration of a compound of Formula (I) or a form thereof, wherein the certain concentration is 0.0001 pM, 0.0003 pM, 0.001 pM, 0.003 pM, 0.01 pM, 0.05 pM, 1 pM, 2 pM, 5 pM, 10 pM, 15 pM, 20 pM, 25 pM, 50 pM, 75 pM, 100 pM, or 150 pM.
- the cell(s) is contacted or cultured with a certain concentration of a compound of Formula (I) or a form thereof, or a tissue sample is contacted with a certain concentration of a compound of Formula (I) or a form thereof, wherein the certain concentration is 0.0001 pM, 0.0003 pM, 0.0005 pM, 0.001 pM, 0.003 pM, 0.005 pM, 0.01 pM, 0.03 pM, 0.05 pM, 0.1 pM, 0.3 pM, 0.5 pM or 1 pM.
- the cell(s) is contacted or cultured with a certain concentration of a compound of Formula (I) or a form thereof, or a tissue sample is contacted with a certain concentration of a compound of Formula (I) or a form thereof, wherein the certain concentration is 175 pM, 200 pM, 250 pM, 275 pM, 300 pM, 350 pM, 400 pM, 450 pM, 500 pM, 550 pM 600 pM, 650 pM, 700 pM, 750 pM, 800 pM, 850 pM, 900 pM, 950 pM or 1 mM.
- the cell(s) is contacted or cultured with a certain concentration of a compound of Formula (I) or a form thereof, or a tissue sample is contacted with a certain concentration of a compound of Formula (I) or a form thereof, wherein the certain concentration is 5 nM, 10 nM, 20 nM, 30 nM, 40 nM, 50 nM, 60 nM, 70 nM, 80 nM, 90 nM, 100 nM, 150 nM, 200 nM, 250 nM, 300 nM, 350 nM, 400 nM, 450 nM, 500 nM, 550 nM, 600 nM, 650 nM, 700 nM, 750 nM, 800 nM, 850 nM, 900 nM, or 950 nM.
- the cell(s) is contacted or cultured with a certain concentration of a compound of Formula (I) or a form thereof, or a tissue sample is contacted with a certain concentration of a compound of Formula (I) or a form thereof, wherein the certain concentration is between 0.0001 pM to 0.001 pM, 0.0001 pM to 0.01 pM, 0.0003 pM to 0.001 pM, 0.0003 pM to 0.01 pM, 0.001 pM to 0.01 pM, 0.003 pM to 0.01 pM, 0.01 pM to 0.1 pM, 0.1 pM to 1 pM, 1 pM to 50 pM, 50 pM to 100 pM, 100 pM to 500 pM, 500 pM to 1 nM, 1 nM to 10 nM, 10 nM to 50 nM, 50 nM to 100 nM, 100 nM to 500 n
- RNA transcript e.g., an mRNA transcript
- a method for determining whether a compound of Formula (I) or a form thereof modulates the amount or type of an RNA transcript comprising: (a) administering a compound of Formula (I) or a form thereof to a subject (e.g., a non-human animal); and (b) determining the amount or type of the RNA transcript in a sample obtained from the subject, wherein an alteration in the amount or type of the RNA transcript measured in the sample from the subject administered the compound or form thereof relative to the amount or type of the RNA transcript in a sample from the subject prior to administration of the compound or form thereof or a sample from a different subject from the same species not administered the compound or form thereof indicates that the compound of Formula (I) or a form thereof modulates the amount or type of the RNA transcript.
- a subject e.g., a non-human animal
- RNA transcript e.g., an mRNA transcript
- a method for determining whether a compound of Formula (I) or a form thereof modulates the amount or type of an RNA transcript comprising: (a) administering a compound of Formula (I) or a form thereof to a first subject (e.g., a non-human animal); (b) administering a negative control (e.g., a pharmaceutical carrier) to a second subject (e.g., a non-human animal) of the same species as the first subject; and (c) determining the amount or type of the RNA transcript in a first tissue sample from the first subject and the amount or type of the RNA transcript in the second tissue sample from the second subject; and (d) comparing the amount or type of the RNA transcript in the first tissue sample to the amount or type of the RNA transcript in the second tissue sample, wherein an alteration in the amount or type of the RNA transcript in the first tissue sample relative to the amount or type of the RNA transcript in the second tissue sample indicates
- a compound of Formula (I) or form thereof is administered to a subject at a dose of about 0.001 mg/kg/day to about 500 mg/kg/day.
- a single dose of a compound of Formula (I) or a form thereof is administered to a subject in accordance with the methods described herein.
- 2, 3, 4, 5 or more doses of a compound of Formula (I) is administered to a subject in accordance with the methods described herein.
- the compound of Formula (I) or a form thereof is administered in a subject in a pharmaceutically acceptable carrier, excipient or diluent.
- RNA transcript e.g., an mRNA transcript
- a method for determining whether a compound of Formula (I) or a form thereof modulates the splicing of an RNA transcript comprising: (a) administering a compound of Formula (I) or a form thereof to a subject (e.g., a non-human animal); and (b) determining the amount or type of two or more RNA transcript splice variants in a sample obtained from the subject, wherein an alteration in the amount or type of the two or more RNA transcript splice variants measured in the sample from the subject administered the compound or form thereof relative to the amount or type of the two or more RNA transcript splice variants in a sample from the subject prior to administration of the compound or form thereof or a sample from a different subject from the same species not administered the compound or form thereof indicates that the compound of Formula (I) or a form thereof modulates the splicing of the RNA transcript.
- a subject e.g., a non-human
- RNA transcript e.g., an mRNA transcript
- a method for determining whether a compound of Formula (I) or a form thereof modulates the splicing of an RNA transcript comprising: (a) administering a compound of Formula (I) or a form thereof to a first subject (e.g., a non-human animal); (b) administering a negative control (e.g., a pharmaceutical carrier) to a second subject (e.g., a non- human animal) of the same species as the first subject; and (c) determining the amount or type of two or more RNA transcript splice variants in a first tissue sample from the first subject and the amount or type of two or more RNA transcript splice variants in the second tissue sample from the second subject; and (d) comparing the amount or type of the two or more RNA transcript splice variants in the first tissue sample to the amount or type of the two or more RNA transcript splice variants in the second tissue sample, wherein
- a compound of Formula (I) or form thereof is administered to a subject at a dose of about 0.001 mg/kg/day to about 500 mg/kg/day.
- a single dose of a compound of Formula (I) or a form thereof is administered to a subject in accordance with the methods described herein.
- 2, 3, 4, 5 or more doses of a compound of Formula (I) is administered to a subject in accordance with the methods described herein.
- the compound of Formula (I) or a form thereof is administered in a subject in a pharmaceutically acceptable carrier, excipient or diluent.
- the compound of Formula (I) or a form thereof that is contacted or cultured with a cell(s) or a tissue sample, or administered to a subject is a compound described herein.
- RNA transcript(s) Techniques known to one skilled in the art may be used to determine the amount or type of an RNA transcript(s).
- the amount or type of one, two, three or more RNA transcripts is measured using deep sequencing, such as ILLUMINA® RNASeq, ILLUMINA® next generation sequencing (NGS), ION TORRENTTM RNA next generation sequencing, 454TM pyrosequencing, or Sequencing by Oligo Ligation Detection (SOLIDTM).
- the amount or type of multiple RNA transcripts is measured using an exon array, such as the GENECHIP® human exon array.
- the amount or type of one, two, three or more RNA transcripts is determined by RT-PCR.
- the amount or type of one, two, three or more RNA transcripts is measured by RT-qPCR or digital color-coded barcode technology. Techniques for conducting these assays are known to one skilled in the art.
- analysis is perfomed on data derived from the assay to measure the magnitude of splicing to determine the amount of exons spliced into an mRNA transcript that is produced in the presence of the compound relative to the amount in the absence of the compound or presence of a negative control.
- the method utilized is calculation of change in Percent Spliced In (APSI).
- the method utilizes read data from RNAseq (or any other method that can distinguish mRNA splice isoforms) to calculate the ratio (percentage) between reads that either demonstrate inclusion (junctions between the upstream exon and the exon of interest) or exclusion (junction between the upstream and downstream exons, exluding the exon of interest), to demonstrate whether the presence of the compound affects the amount of exon inclusion relative to the amount of inclusion in the absence of the compound or the presence of a negative control.
- RNAseq or any other method that can distinguish mRNA splice isoforms
- APSI (%) ⁇ (a+b)/2/[(a+b)/2 + c] ⁇ c - ⁇ (a+b)/2/[(a+b)/2 + c] ⁇ u xl00 [00421]
- U represents the value for probability of iExon inclusion (a+b)/2/[(a+b)/2+c] u in the absence of the compound
- C represents the value for probability of iExon inclusion (a+b)/2/[(a+b)/2 + c] c in the presence of the compound.
- the values for “a” and “b” represent the number of reads supporting inclusion of an iExon in an RNA transcript.
- the “a” value is derived from the amount of reads for a first intronic nucleotide sequence comprising, in 5’ to 3’ order: a first exon having a 5’ splice site operably linked and upstream from a first intronic nucleotide sequence comprising a first branch point further operably linked and upstream from a first intronic 3’ splice site (upstream of the nascent iExon).
- the “b” value is derived from the amount of reads for a second intronic nucleotide sequence comprising, in 5’ to 3’ order: an iREMS sequence operably linked downstream from the first intronic 3’ splice site and upstream from a second intronic nucleotide sequence comprising a second branch point further operably linked and upstream from a second intronic 3’ splice site of a second exon.
- the value for “c” represents the number of reads supporting exclusion of an iExon.
- the value for (a+b)/2/[(a+b)/2+c] c in the presence of the splicing modifier compound will differ from the value for (a+b)/2/[(a+b)/2+c] u in the absence of the compound.
- the statistically significant value for the likelihood of iExon inclusion may be obtained according to statistical analysis methods or other probability analysis methods known to those of ordinary skill in the art.
- a statistical analysis or other probability analysis is performed on data from the assay utilized to measure an RNA transcript.
- a Fisher’s Exact Test statistical analysis is performed by comparing the total number of reads for the inclusion and exclusion of an iExon (or region) based on data from one or more assays used to measure whether the amount or type of an RNA transcript is altered in the presence of the compound relative to the amount in the absence of the compound or presence of a negative control.
- the statistical analysis results in a confidence value for those RNA transcripts with the alternation of 10%, 5%, 4%, 3%, 2%, 1%, 0.5%, 0.1%, 0.01%, 0.001% or 0.0001%.
- the confidence value is a p value of those altered RNA transcripts of is 10%, 5%, 4%, 3%, 2%, 1%, 0.5%, 0.1%, 0.01%, 0.001% or 0.0001%.
- an exact test, student t-test or p value of those RNA transcripts with the alteration is 10%, 5%, 4%, 3%, 2%, 1%, 0.5% or 0.1% and 10%, 5%, 4%, 3%, 2%, 1%, 0.5%, 0.1%, 0.01%, 0.001% or 0.0001%, respectively.
- a further analysis is perfonned to determine how the compound of Formula (I) or a form thereof is changing the amount or type of an RNA transcripts).
- a further analysis is performed to determine if an alternation in the amount or type of an RNA transcript(s) in the presence of a compound of Formula (I) or a form thereof relative the amount or type of the RNA transcript(s) in the absence of the compound or a form thereof, or the presence of a negative control is due to changes in transcription, splicing, and/or stability of the RNA transcript(s).
- Techniques known to one skilled in the art may be used to determine whether a compound of Formula (I) or a form thereof changes, e.g., the transcription, splicing and/or stability of an RNA transcript(s).
- the stability of one or more RNA transcripts is determined by serial analysis of gene expression (SAGE), differential display analysis (DD), RNA arbitrary primer (RAP)-PCR, restriction endonuclease-lytic analysis of differentially expressed sequences (READS), amplified restriction fragment-length polymorphism (ALFP), total gene expression analysis (TOGA), RT-PCR, RT-qPCR, RNA-Seq, digital color-coded barcode technology, high- density cDNA filter hybridization analysis (HDFCA), suppression subtractive hybridization (SSH), differential screening (DS), cDNA arrays, oligonucleotide chips, or tissue microarrays.
- the stability of one or more RNA transcripts is determined by Northern blot, RNase protection, or slot blot.
- the transcription in a cell(s) or tissue sample is inhibited before (e.g., 5 minutes, 10 minutes, 30 minutes, 1 hour, 2 hours, 4 hours, 6 hours, 8 hours, 12 hours, 18 hours, 24 hours, 36 hours, 48 hours, or 72 hours before) or after (e.g., 5 minutes, 10 minutes, 30 minutes, 1 hour, 2 hours, 4 hours, 6 hours, 8 hours, 12 hours, 18 hours, 24 hours, 36 hours, 48 hours, or 72 hours after) the cell or the tissue sample is contacted or cultured with an inhibitor of transcription, such as a-amanitin, DRB, flavopiridol, triptolide, or actinomycin-D.
- an inhibitor of transcription such as a-amanitin, DRB, flavopiridol, triptolide, or actinomycin-D.
- the transcription in a cell(s) or tissue sample is inhibited with an inhibitor of transcription, such as a-amanitin, DRB, flavopiridol, triptolide, or actinomycin-D, while the cell(s) or tissue sample is contacted or cultured with a compound of Formula (I) or a form thereof.
- an inhibitor of transcription such as a-amanitin, DRB, flavopiridol, triptolide, or actinomycin-D
- the level of transcription of one or more RNA transcripts is determined by nuclear run-on assay or an in vitro transcription initiation and elongation assay.
- the detection of transcription is based on measuring radioactivity or fluorescence.
- a PCR-based amplification step is used.
- the amount or type of alternatively spliced forms of the RNA transcripts of a particular gene are measured to see if there is an alteration in the amount or type of one, two or more alternatively spliced forms of the RNA transcripts of the gene.
- the amount or type of an isoform(s) encoded by a particular gene is measured to see if there is an alteration in the amount or type of the isoform(s).
- the levels of spliced forms of RNA are quantified by RT-PCR, RT-qPCR, RNA-Seq, digital color-coded barcode technology, or Northern blot.
- sequence-specific techniques may be used to detect the levels of an individual spliceoform.
- splicing is measured in vitro using nuclear extracts.
- detection is based on measuring radioactivity or fluorescence.
- RNA transcripts of a gene may be used to measure alterations in the amount or type of alternatively spliced forms of an RNA transcript of a gene and alterations in the amount or type of an isoform encoded by a gene.
- modulation of RNA transcripts is assessed as described in the Examples described herein.
- a product e.g., a precursor RNA, an mRNA, or protein
- the methods described herein to determine whether the amount or type of a product (e.g. , a precursor RNA, an mRNA, or protein) of a gene is likely to be modulated by a compound of Formula (I) or a form thereof can be also used in the methods of screening for new compounds.
- the method comprises contacting a candidate compound with an RNA transcript, wherein the RNA transcript comprises exons and one or more introns, wherein at least one intron comprises, in 5’ to 3’ order, a branch point, a 3’ splice site, and an intronic REMS.
- the method comprises contacting a candidate compound with an RNA transcript, wherein the RNA transcript comprises exons and one or more introns, wherein at least one intron comprises an intronic REMS downstream of a branch point and a 3’ splice site.
- the RNA transcript may be present in a cell or cell lysate.
- the methods described above regarding the techniques of contacting a compound with an RNA transcript, the dosage, etc., may be used in the methods of screening.
- the candidate compounds to be screened can be provided by any source.
- the candidate compounds to be screened can be from a compound library, such as a commercial compound library.
- a further analysis is performed to determine how the compound of Formula (I) or a form thereof is changing the amount or type of an RNA transcripts).
- a further analysis is performed to determine if an alternation in the amount or type of an RNA transcript(s) in the presence of a compound of Formula (I) or a form thereof relative the amount or type of the RNA transcript(s) in the absence of the compound or a form thereof, or the presence of a negative control is due to changes in transcription, splicing, and/or stability of the RNA transcript(s).
- Techniques known to one skilled in the art may be used to determine whether a compound of Formula (I) or a form thereof changes, e.g.. the transcription, splicing and/or stability of an RNA transcript(s).
- the stability of one or more RNA transcripts is determined by serial analysis of gene expression (SAGE), differential display analysis (DD), RNA arbitrarily primer (RAP)-PCR, restriction endonuclease-lytic analysis of differentially expressed sequences (READS), amplified restriction fragment-length polymorphism (ALFP), total gene expression analysis (TOGA), RT-PCR, RT-qPCR, high-density cDNA filter hybridization analysis (HDFCA), suppression subtractive hybridization (SSH), differential screening (DS), cDNA arrays, oligonucleotide chips, or tissue microarrays.
- the stability of one or more RNA transcripts is determined by Northern blots, RNase protection, or slot blots.
- the transcription in a cell(s) or tissue sample is inhibited before (e.g., 5 minutes, 10 minutes, 30 minutes, I hour, 2 hours, 4 hours, 6 hours, 8 hours, 12 hours, 18 hours, 24 hours, 36 hours, 48 hours, or 72 hours before) or after (e.g., 5 minutes, 10 minutes, 30 minutes, 1 hour, 2 hours, 4 hours, 6 hours, 8 hours, 12 hours, 18 hours, 24 hours, 36 hours, 48 hours, or 72 hours after) the cell or the tissue sample is contacted or cultured with an inhibitor of transcription, such as a-amanitin, DRB, flavopiridol, triptolide, or actinomycin-D.
- an inhibitor of transcription such as a-amanitin, DRB, flavopiridol, triptolide, or actinomycin-D.
- the transcription in a cell(s) or tissue sample is inhibited with an inhibitor of transcription, such as a-amanitin, DRB, flavopiridol, triptolide, or actinomycin-D, while the cell(s) or tissue sample is contacted or cultured with a compound of Formula (I) or a form thereof.
- an inhibitor of transcription such as a-amanitin, DRB, flavopiridol, triptolide, or actinomycin-D
- the level of transcription of one or more RNA transcripts is determined by nuclear run-on assay or an in vitro transcription initiation and elongation assay.
- the detection of transcription is based on measuring radioactivity or fluorescence.
- a PCR-based amplification step is used.
- the amount or type of alternatively spliced forms of the RNA transcripts of a particular gene are measured to see if there is an alteration in the amount or type of one, alternatively spliced forms of the RNA transcripts of the gene.
- the amount or type of an isoform(s) encoded by a particular gene is measured to see if there is an alteration in the amount or type of the isoform(s).
- the levels of spliced forms of RNA are quantified by RT-PCR, RT-qPCR, or northern blotting.
- sequence- specific techniques may be used to detect the levels of an individual spliceoform.
- splicing is measured in vitro using nuclear extracts.
- detection is based on measuring radioactivity or fluorescence. Techniques known to one skilled in the art may be used to measure alterations in the amount or type of alternatively spliced forms of an RNA transcript of a gene and alterations in the amount or type of an isoform encoded by a gene.
- a compound of Formula (I) or a form thereof is preferably administered as a component of a composition that optionally comprises a pharmaceutically acceptable carrier, excipient or diluent.
- the composition can be administered orally, or by any other convenient route, for example, by infusion or bolus injection, by absorption through epithelial or mucocutaneous linings (e.g, oral mucosa, rectal, and intestinal mucosa) and may be administered together with another biologically active agent. Administration can be systemic or local.
- Various delivery systems are known, e g., encapsulation in liposomes, microparticles, microcapsules, capsules, and can be used to administer the compound.
- Methods of administration include, but are not limited to, parenteral, intradermal, intramuscular, intraperitoneal, intravenous, subcutaneous, intranasal, epidural, oral, sublingual, intranasal, intraocular, intratumoral, intracerebral, intravaginal, transdermal, ocularly, rectally, by inhalation, or topically, particularly to the ears, nose, eyes, or skin.
- the mode of administration is left to the discretion of the practitioner. In most instances, administration will result in the release of a compound into the bloodstream, tissue or cell(s). In a specific aspect, a compound is administered orally.
- the amount of a compound of Formula (I) or a form thereof that will be effective in the treatment of a disease resulting from an aberrant amount or type of mRNA transcripts depends, e.g., on the route of administration, the disease being treated, the general health of the subject, ethnicity, age, weight, and gender of the subject, diet, time, and the severity of disease progress, and should be decided according to the judgment of the practitioner and each subject’s or subject’s circumstances.
- an “effective amount” in the context of the administration of a compound of Formula (I) or a form thereof, or composition or medicament thereof refers to an amount of a compound of Formula (I) or a form thereof to a subject which has a therapeutic effect and/or beneficial effect.
- an “effective amount” in the context of the administration of a compound of Formula (I) or a form thereof, or composition or medicament thereof to a subject results in one, of the following effects: (i) reduces or ameliorates the severity of a disease; (ii) delays onset of a disease; (iii) inhibits the progression of a disease; (iv) reduces hospitalization of a subject; (v) reduces hospitalization length for a subject; (vi) increases the survival of a subject; (vii) improves the quality of life of a subject; (viii) reduces the number of symptoms associated with a disease; (ix) reduces or ameliorates the severity of a symptom(s) associated with a disease; (x) reduces the duration of a symptom associated with a disease associated; (xi) prevents the recurrence of a symptom associated with a disease; (xii) inhibits the development or onset of a symptom of a disease; and/or (xiii) inhibit
- an effective amount of a compound of Formula (I) or a form thereof is an amount effective to restore the amount or type of a RNA transcript of a gene to the amount or type of the RNA transcript detectable in healthy subjects or cells from healthy subjects.
- an effective amount of a compound of Formula (I) or a form thereof is an amount effective to restore the amount an RNA isoform and/or protein isoform of gene to the amount or type of the RNA isoform and/or protein isoform detectable in healthy subjects or cells from healthy subjects.
- an effective amount of a compound of Formula (I) or a form thereof is an amount effective to decrease the aberrant amount or type of RNA transcript of a gene which associated with a disease.
- an effective amount of a compound of Formula (I) or a form thereof is an amount effective to decrease the amount or type of aberrant expression associated with an isoform of a gene.
- an effective amount of a compound of Formula (I) or a form thereof is an amount effective to result in a substantial change in the amount or type of an RNA transcript (e.g., mRNA transcript), alternative splice variant or isoform.
- an effective amount of a compound of Formula (I) or a form thereof is an amount effective to increase or decrease the amount or type of an RNA transcript (e.g., an mRNA transcript) of gene which is beneficial for the prevention and/or treatment of a disease.
- an effective amount of a compound of Formula (I) or a form thereof is an amount effective to increase or decrease the amount or type of an alternative splice variant of an RNA transcript of gene which is beneficial for the prevention and/or treatment of a disease.
- an effective amount of a compound of Formula (I) or a form thereof is an amount effective to increase or decrease the amount or type of an isoform of gene which is beneficial for the prevention and/or treatment of a disease.
- Non-limiting examples of effective amounts of a compound of Formula (I) or a form thereof are described herein.
- the effective amount may be the amount required to prevent and/or treat a disease associated with the aberrant amount or type of an mRNA transcript of gene in a human subject.
- the effective amount will be in a range of from about 0.001 mg/kg/day to about 500 mg/kg/day for a subject having a weight in a range of between about 1 kg to about 200 kg.
- the typical adult subject is expected to have a median weight in a range of between about 70 and about 100 kg.
- the “effective amount” of a compound of Formula (I) or a form thereof for use in the manufacture of a medicament, the preparation of a pharmaceutical kit or in a method for preventing and/or treating a disease in a human subject in need thereof is intended to include an amount in a range of from about 0.001 mg to about 35,000 mg.
- compositions described herein are formulated for administration to the subject via any drug delivery route known in the art.
- Non-limiting examples include oral, ocular, rectal, buccal, topical, nasal, ophthalmic, subcutaneous, intramuscular, intraveneous (bolus and infusion), intracerebral, transdermal, and pulmonary routes of administration.
- described herein include the use of a compound of Formula (I) or a form thereof in a pharmaceutical composition.
- a compound of Formula (I) or a form thereof in a pharmaceutical composition for preventing and/or treating a disease in a human subject in need thereof comprising administering an effective amount of a compound of Formula (I) or a form thereof in admixture with a pharmaceutically acceptable carrier, excipient or diluent.
- the human subject is a subject with a disease associated with the aberrant amount or type of an mRNA transcript(s).
- a compound of Formula (I) or a form thereof may optionally be in the form of a composition comprising the compound or a form thereof and an optional carrier, excipient or diluent.
- described herein include pharmaceutical compositions comprising an effective amount of a compound of Formula (1) or a form thereof and a pharmaceutically acceptable carrier, excipient, or diluent.
- the pharmaceutical compositions are suitable for veterinary and/or human administration.
- the pharmaceutical compositions described herein can be in any form that allows for the composition to be administered to a subject.
- the term “pharmaceutically acceptable carrier, excipient or diluent” means a carrier, excipient or diluent approved by a regulatory agency of the Federal or a state government or listed in the U.S. Pharmacopeia or other generally recognized pharmacopeia for use in animals, and more particularly in humans.
- carrier refers to a diluent, adjuvant (e.g., Freund’s adjuvant (complete and incomplete)), excipient, or vehicle with which a therapeutic agent is administered.
- Such pharmaceutical carriers can be sterile liquids, such as water and oils, including those of petroleum, animal, vegetable or synthetic origin, such as peanut oil, soybean oil, mineral oil, sesame oil and the like. Water is a specific carrier for intravenously administered pharmaceutical compositions. Saline solutions and aqueous dextrose and glycerol solutions can also be employed as liquid carriers, particularly for injectable solutions.
- compositions and dosage forms comprise one or more excipients.
- Suitable excipients are well-known to those skilled in the art of pharmacy, and non limiting examples of suitable excipients include starch, glucose, lactose, sucrose, gelatin, malt, rice, flour, chalk, silica gel, sodium stearate, glycerol monostearate, talc, sodium chloride, dried skim milk, glycerol, propylene, glycol, water, ethanol and the like.
- compositions and dosage forms comprising one or more compounds of Formula (I) or a form thereof as described herein.
- the compositions and single unit dosage forms can take the form of solutions or syrups (optionally with a flavoring agent), suspensions (optionally with a flavoring agent), emulsions, tablets (e.g., chewable tablets), pills, capsules, granules, powder (optionally for reconstitution), taste-masked or sustained-release formulations and the like.
- compositions described herein that are suitable for oral administration can be presented as discrete dosage forms, such as, but are not limited to, tablets, caplets, capsules, granules, powder, and liquids.
- dosage forms contain predetermined amounts of active ingredients, and may be prepared by methods of pharmacy well known to those skilled in the art.
- excipients that can be used in oral dosage forms described herein include, but are not limited to, binders, fillers, disintegrants, and lubricants.
- RNA transcripts of a gene in a subject comprising a REMS (for example, an endogenous REMS or a non-endogenous REMS), the methods comprising administering to the subject a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent, wherein the gene is: (a) a gene comprising a DNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 1 to SEQ ID NO.
- RNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 5776 to SEQ ID NO. 11550.
- RNA transcripts of a gene in a subject comprising a REMS (for example, an endogenous REMS or a non-endogenous REMS), the methods comprising administering to the subject a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent, wherein the gene is other than SMN2, F0XM1, APLP2, GGCT, ABHD10, STRN3, VPS29, ERGIC3, MADD, LARP 7, ARMCX6, GALC, LAMA2, PRKDC, RCC1, FADS2, DIAPH3, FN1, PARP1, COL1A1, COL1A2, COL3A1 or COL5A2
- REMS for example, an endogenous REMS or a non-endogenous REMS
- RNA transcripts of a gene in a subject comprising a REMS (for example, an endogenous REMS or a non-endogenous REMS), the methods comprising administering to the subject a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent, wherein the gene is other than SMN2, FOXM1, APLP2, GGCT, ABHD10, STRN3, VPS29, ERGIC3, MADD, LARP7 or COL1A1.
- REMS for example, an endogenous REMS or a non-endogenous REMS
- RNA transcripts of a gene in a subject comprising administering to the subject a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
- RNA transcripts of a gene other than a gene comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5, infra, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
- a compound of Formula (I) or a form thereof contacted or cultured with a cell(s), or administered to a subject is a compound described herein.
- a disease associated with the aberrant expression of a product of a gene e.g., an mRNA transcript or protein
- the pre-mRNA transcript transcribed from the gene comprises a REMS
- the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
- the gene is a gene comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5.
- the gene contains a nucleotide sequence encoding a non-endogenous REMS.
- described herein are methods for preventing and/or treating a disease associated with aberrant expression of a product of a gene (e.g., an mRNA, RNA transcript or protein), by way of nonlimiting example, comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5, infra, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
- a product of a gene e.g., an mRNA, RNA transcript or protein
- a disease associated with aberrant expression of a product of a gene e.g., an mRNA, RNA transcript or protein
- a product of a gene e.g., an mRNA, RNA transcript or protein
- the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
- RNA isoforms encoded by a gene are beneficial to the prevention and/or treatment of the disease, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
- the gene is a gene comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5.
- the gene contains a nucleotide sequence encoding the non-endogenous REMS.
- a disease in which the alteration (e.g., increase or decrease) in the expression one, two, three or more RNA isoforms encoded by a gene, by way of nonlimiting example, comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5, infra, is beneficial to the prevention and/or treatment of the disease, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
- RNA isoforms encoded by a gene not comprising a sequence of Tables 1 or 2 is beneficial to the prevention and/or treatment of the disease, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
- a change in the level of expression of one, two, three or more protein isoforms encoded by a gene is beneficial to the prevention and/or treatment of the disease, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
- the gene is a gene comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5.
- the gene contains a nucleotide sequence encoding a non-endogenous REMS.
- described herein are methods for preventing and/or treating a disease in which the alteration (e.g., increase or decrease) in the expression one, two, three or more protein isoforms encoded by a gene, by way of nonlimiting example, comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5, infra, is beneficial to the prevention and/or treatment of the disease, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
- a disease in which the alteration (e.g, increase or decrease) in the expression one, two, three or more protein isoforms encoded by a gene, other than a gene comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5, infra, is beneficial to the prevention and/or treatment of the disease, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
- the methods for preventing a disease described herein prevent the onset or development of one or symptoms of the disease. In another aspect, the methods for preventing a disease described herein prevent the recurrence of the disease or delays the recurrence of the disease.
- the methods for treating a disease described herein has one, two or more of the effects: (i) reduce or ameliorate the severity of the disease; (ii) inhibit the progression of the disease; (iii) reduce hospitalization of a subject; (iv) reduce hospitalization length for a subject; (v) increase the survival of a subject; (vi) improve the quality of life of a subject; (vii) reduce the number of symptoms associated with the disease; (viii) reduce or ameliorates the severity of a symptom(s) associated with the disease; (ix) reduce the duration of a symptom(s) associated with the disease; (x) prevent the recurrence of a symptom associated with the disease; (xi) inhibit the development or onset of a symptom of the disease; and/or (xii) inhibit of the progression of a symptom associated with the disease.
- the disease or disorder prevented and/or treated in accordance with a method described herein is a disease or disorder associated with a gene comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5.
- the disease or disorder prevented and/or treated in accordance with a method described herein is leukemia, acute myeloid leukemia, colon cancer, gastric cancer, macular degeneration, acute monocytic leukemia, breast cancer, combined methylmalonic aciduria and homocystinuria, cblC type, hepatocellular carcinoma, cone-rod dystrophy, alveolar soft part sarcoma, myeloma, skin melanoma, prostatitis, pancreatitis, pancreatic cancer, retinitis, adenocarcinoma, adenoiditis, adenoid cystic carcinoma, cataract, retinal degeneration, gastrointestinal stromal tumor, Wegener’s granulomatosis,
- the disease or disorder prevented and/or treated in accordance with a method described herein is basal cell carcinoma, goblet cell metaplasia, or a malignant glioma.
- the disease or disorder prevented and/or treated in accordance with a method described herein is a cancer of the liver, breast, lung, prostate, cervix, uterus, colon, pancreas, kidney, stomach, bladder, ovary, or brain.
- the disease prevented and/or treated in accordance with a method described herein is cancer amenable to treatment by upregulation or downregulation of a gene or isoform thereof as described herein.
- cancers that can be prevented and/or treated in accordance with a method described herein include, but are not limited to, cancer of the head, neck, eye, mouth, throat, esophagus, esophagus, chest, bone, lung, kidney, colon, rectum or other gastrointestinal tract organs, stomach, spleen, skeletal muscle, subcutaneous tissue, prostate, breast, ovaries, testicles or other reproductive organs, skin, thyroid, blood, lymph nodes, kidney, liver, pancreas, brain or central nervous system.
- cancers that can be prevented and/or treated in accordance with the methods described herein include, but are not limited to, the following: renal cancer, kidney cancer, glioblastoma multiforme, metastatic breast cancer; breast carcinoma; breast sarcoma; neurofibroma; neurofibromatosis; pediatric tumors; neuroblastoma; malignant melanoma; carcinomas of the epidermis; leukemias such as but not limited to, acute leukemia, acute lymphocytic leukemia, acute myelocytic leukemias such as myeloblastic, promyelocytic, myelomonocytic, monocytic, erythroleukemia leukemias and myelodysplastic syndrome, chronic leukemias such as but not limited to, chronic myelocytic (granulocytic) leukemia, chronic lymphocytic leukemia, hairy cell leukemia; polycythemia vera; lymphomas such as but not
- cancers include myxosarcoma, osteogenic sarcoma, endotheliosarcoma, lymphangioendotheliosarcoma, mesothelioma, synovioma, hemangioblastoma, epithelial carcinoma, cystadenocarcinoma, bronchogenic carcinoma, sweat gland carcinoma, sebaceous gland carcinoma, papillary carcinoma and papillary adenocarcinomas.
- cancers that can be prevented and/or treated in accordance with the methods described herein include, the following: pediatric solid tumor, Ewing’s sarcoma, Wilms tumor, neuroblastoma, neurofibroma, carcinoma of the epidermis, malignant melanoma, cervical carcinoma, colon carcinoma, lung carcinoma, renal carcinoma, breast carcinoma, breast sarcoma, metastatic breast cancer, HIV-related Kaposi’s sarcoma, prostate cancer, androgen-independent prostate cancer, androgen-dependent prostate cancer, neurofibromatosis, lung cancer, non-small cell lung cancer, KRAS-mutated non-small cell lung cancer, malignant melanoma, melanoma, colon cancer, KRAS-mutated colorectal cancer, glioblastoma multiforme, renal cancer, kidney cancer, bladder cancer, ovarian cancer, hepatocellular carcinoma, thyroid carcinoma, rhabdomyosarcoma, acute myeloid leukemia, and multiple my
- cancers and conditions associated therewith that are prevented and/or treated in accordance with the methods described herein are breast carcinomas, lung carcinomas, gastric carcinomas, esophageal carcinomas, colorectal carcinomas, liver carcinomas, ovarian carcinomas, thecomas, arrhenoblastomas, cervical carcinomas, endometrial carcinoma, endometrial hyperplasia, endometriosis, fibrosarcomas, choriocarcinoma, head and neck cancer, nasopharyngeal carcinoma, laryngeal carcinomas, hepatoblastoma, Kaposi’s sarcoma, melanoma, skin carcinomas, hemangioma, cavernous hemangioma, hemangioblastoma, pancreas carcinomas, retinoblastoma, astrocytoma, glioblastoma, Schwannoma, oligodendroglioma, med
- the cancer astrocytoma, an oligodendroglioma, a mixture of oligodendroglioma and an astrocytoma elements, an ependymoma, a meningioma, a pituitary adenoma, a primitive neuroectodermal tumor, a medullblastoma, a primary central nervous system (CNS) lymphoma, or a CNS germ cell tumor.
- the cancer treated in accordance with the methods described herein is an acoustic neuroma, an anaplastic astrocytoma, a glioblastoma multiforme, or a meningioma.
- the cancer treated in accordance with the methods described herein is a brain stem glioma, a craniopharyngioma, an ependyoma, a juvenile pilocytic astrocytoma, a medulloblastoma, an optic nerve glioma, primitive neuroectodermal tumor, or a rhabdoid tumor.
- cystic fibrosis cystic fibrosis, muscular dystrophy, polycystic autosomal -dominant kidney disease, cancer-induced cachexia, benign prostatic hyperplasia, rheumatoid arthritis, psoriasis, atherosclerosis, obesity, retinopathies (including diabetic retinopathy and retinopathy of prematurity), retrolental fibroplasia, neovascular glaucoma, age- related macular degeneration, exudative macular degeneration, thyroid hyperplasias (including Grave’s disease), corneal and other tissue transplantation, epidemic keratoconjunctivitis, Vitamin A deficiency, contact lens overwear, atopic keratitis, superior limbic keratitis, and pterygium keratitis sicca, viral infections, inflammation associated with viral infections, chronic inflammation, lung inflammation, nephrotic syndrome,
- non-neoplastic conditions that can be prevented and/or treated in accordance with the methods described herein include viral infections, including but not limited to, those associated with viruses belonging to Flaviviridae, flavivirus, pestivirus, hepacivirus, West Nile virus, hepatitis C virus (HCV) or human papilloma virus (HPV).
- viral infections including but not limited to, those associated with viruses belonging to Flaviviridae, flavivirus, pestivirus, hepacivirus, West Nile virus, hepatitis C virus (HCV) or human papilloma virus (HPV).
- an artificial gene construct comprising a REMS.
- an artificial gene construct comprises genomic DNA or DNA encoding exons and one, two or more introns, wherein a nucleotide sequence encoding a 5’ splice site, which is upstream of a nucleotide sequence a branch point and a nucleotide sequence encoding a 3’ splice site, is modified to introduce a nucleotide sequence encoding a REMS.
- an artificial gene construct comprises DNA encoding exons, a 5’ splice site(s), a 3’ splice site(s) and a branch point(s), wherein a nucleotide sequence encoding a 5’ splice site, which is upstream of at least one nucleotide sequence encoding a branch point and at least one nucleotide sequence encoding a 3’ splice site, is modified to introduce a nucleotide sequence encoding a REMS.
- an artificial gene construct comprises DNA encoding exons, a 3’ splice site(s) and a branch point(s), wherein a nucleotide sequence encoding an exon, which is upstream of a nucleotide sequence encoding a branch point and a 3’ splice site, is modified to introduce a nucleotide sequence encoding a REMS.
- an artificial gene construct comprises a DNA sequence that is modified to introduce a nucleotide sequence encoding a REMS.
- the DNA sequence chosen to be used in the production of an artificial gene construct contains a nucleotide sequence encoding a REMS and an additional nucleotide sequence encoding a REMS is introduced.
- the nucleotide sequence encoding a REMS is a nucleotide sequence encoding a non-endogenous REMS, i.e., not naturally found in the DNA sequence of the artificial gene construct.
- the artificial gene construct comprises other elements, such as a promoter (e.g., a constitutive, inducible or tissue specific promoter), a Poly(A) site, a transcription termination site, and a transcription binding site(s).
- the artificial gene construct comprises at least the exons of a gene encoding a therapeutic protein.
- the artificial gene construct comprises at least the exons of a gene comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5.
- the artificial gene construct comprises at least the exons of a detectable reporter gene, such as green fluorescent protein (GFP), yellow fluorescent protein (YEP), red fluorescent protein, beta galactosidase, renilla luciferase, firefly luciferase, etc.
- an artificial gene construct is produced as follows: a nucleotide sequence encoding a REMS is introduced into a nucleotide sequence encoding an existing 5’ splice site of genomic DNA or DNA, wherein the DNA encodes two or more exons and one or more introns, and wherein the nucleotide sequence encoding the existing 5’ splice site is upstream of a nucleotide sequence encoding a 3’ splice site.
- an artificial gene construct is produced as follows: a nucleotide sequence encoding a REMS is introduced upstream of a nucleotide sequence encoding a branch point and a 3’ splice site of genomic DNA or DNA, wherein the DNA encodes two or more exons and an intron(s).
- the nucleotide sequence encoding the REMS is introduced internally within a nucleotide sequence encoding an exon.
- an artificial gene construct is produced as follows: a nucleotide sequence encoding a REMS, a nucleotide sequence encoding a branch point, and a nucleotide sequence encoding a 3’ splice site are introduced into a cDNA, wherein the nucleotide sequence encoding the REMS is upstream of the branch point and 3’ splice site.
- the nucleotide sequence encoding the REMS can function as a 5’ splice site.
- the nucleotide sequence encoding the REMS is internally within an exon.
- the genomic DNA or DNA chosen for use in the production of an artificial gene construct does not contain a nucleotide sequence encoding a REMS.
- the genomic DNA or DNA chosen for use in the production of an artificial gene construct contains a REMS and an additional REMS is introduced.
- the introduction of a nucleotide sequence encoding a REMS into a DNA sequence may or may not result in an amino acid change at the protein level.
- the introduction of a nucleotide sequence encoding a REMS into a DNA sequence results in an amino acid change at the protein level. In another aspect, this amino acid change is a conservative amino acid substitution. In another aspect, the introduction of a nucleotide sequence encoding a REMS into a DNA sequence does not result in an amino acid change at the protein level.
- REMS and other elements such as a branch point or 3’ splice site into a DNA sequence
- gene editing techniques such as the CRISPR-Cas approach, Transcription Activator-Like Effector Nucleases (TALENs), or Zinc finger nucleases (ZFNs) may be used.
- an artificial gene construct comprises an RNA sequence comprising exons and one, two or more introns, wherein a 5’ splice site, which is upstream of a 3’ splice site, is modified to introduce a REMS .
- an artificial gene construct comprises an RNA sequence comprising exons, a 5’ splice site(s), a 3’ splice site(s) and a branch point(s), wherein a 5’ splice site, which is upstream of a 3’ splice site, is modified to introduce a REMS.
- an artificial gene construct comprises an RNA sequence comprising exons, a 3’ splice site(s) and a branch point(s), wherein an exon, which is upstream of a 3’ splice site, is modified to introduce a REMS.
- the REMS is non-endogenous, i.e., not naturally found in the RNA sequence of the artificial gene construct.
- the artificial gene construct comprises other elements, such as a promoter (e.g., a tissue-s.pecific promoter or constitutively expressed promoter), 5’ untranslated region, 3’ untranslated region, a binding site(s) for RNA binding proteins, a small molecule RNA sensor(s), e.g., riboswitches, stem-loop structures, and/or internal ribosome entry sites (IRES), etc.
- the artificial gene construct comprises at least the exons of a gene encoding a therapeutic protein.
- the artificial gene construct comprises at least the exons of a gene comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5.
- the RNA transcript chosen to be used in the production of an artificial gene construct does not contain a REMS.
- the RNA transcript chosen to use in the production of an artificial gene construct contains a REMS and an additional REMS is introduced.
- the artificial gene construct comprises at least the exons of a detectable reporter gene, such as green fluorescent protein (GFP), yellow fluorescent protein (YFP), red fluorescent protein, beta galactosidase, renilla luciferase, firefly luciferase, etc.
- an artificial gene construct is produced as follows: a REMS is introduced into an existing 5’ splice site of pre-mRNA, wherein the RNA comprises two or more exons and one or more introns, and wherein the existing 5’ splice site is upstream of a 3’ splice site.
- an artificial gene construct is produced as follows: a REMS is introduced upstream of a 3’ splice site of pre-mRNA, wherein the RNA comprises two or more exons and an intron(s).
- the REMS is introduced internally within an exon.
- an artificial gene construct is produced as follows: a REMS, branch point, and a 3’ splice site are introduced into an mRNA, wherein the REMS is upstream of the branch point and 3’ splice site.
- the REMS can be a 5’ splice site.
- the REMS is internally with an exon.
- the introduction of a REMS into an RNA transcript may or may not result in an amino acid change at the protein level.
- the introduction of a REMS into an RNA transcript results in an amino acid change at the protein level.
- this amino acid change is a conservative amino acid substitution.
- the introduction of a REMS into an RNA transcript does not result in an amino acid change at the protein level Techniques known to one of skill in the art may be used to introduce a REMS and other elements, such as a branch point or 3’ splice site into an RNA transcript.
- an artificial gene construct is present in a viral vector (e.g., an adeno-associated virus (AAV), self-complimentary adeno-associated virus, adenovirus, retrovirus, lentivirus (e.g., Simian immunodeficiency virus, human immunodeficiency virus, or modified human immunodeficiency virus), Newcastle disease virus (NDV), herpes virus (e.g., herpes simplex virus), alphavirus, vaccina virus, etc.), a plasmid, or other vector (e.g., non-viral vectors, such as lipoplexes, liposomes, polymerosomes, or nanoparticles).
- AAV adeno-associated virus
- adenovirus retrovirus
- lentivirus e.g., Simian immunodeficiency virus, human immunodeficiency virus, or modified human immunodeficiency virus
- Newcastle disease virus NDV
- herpes virus e.g., herpe
- the artificial gene construct is an RNA molecule modified to enable cellular uptake.
- the artificial gene construct is an RNA molecule containing pseudouridine or other modified/artificial nucleotides for enhanced cellular uptake and gene expression.
- an artificial gene construct described herein in gene therapy allows one to regulate the amount or type of a functional protein produced from the construct depending on whether or not a compound described herein is present.
- the compound is essentially a tunable switch that, depending on the amount and duration of the dose of the compound, regulates the amount or type of functional protein produced.
- an RNA transcript transcribed from an artificial gene construct that is DNA would not produce or produce substantially less functional protein in the absence of a compound described herein than the amount or type of functional protein produced in the presence of a compound described herein.
- the artificial gene construct comprises a nucleotide sequence encoding a REMS in a 5’ splice site, which is upstream of a nucleotide sequence encoding a 3’ splice site, then less splicing would occur in the absence of the compound and this would result in exon skipping which would ultimately result in less functional protein being produced.
- RNA transcript transcribed from an artificial gene construct that is DNA would not produce or would produce substantially less functional protein in the presence of a compound described herein than the amount or type of functional protein produced in the absence of a compound described herein.
- the artificial gene construct comprises a nucleotide sequence encoding a REMS in the middle of an exon
- ectopic splicing would occur in the presence of a compound described herein and this would result in reduction in the production of the functional protein.
- the normal splicing would occur, and the production of the functional protein will not be reduced. Either way, the amount or type of the functional protein produced can be titrated based on the amount of a compound used and duration of exposure to the compound.
- an artificial gene construct or vector comprising an artificial gene construct is used in cell culture.
- the amount or type of a functional protein produced from the artificial gene construct can be altered depending upon whether or not a compound described herein is contacted with the transfected cell(s).
- the artificial gene construct comprises a nucleotide sequence encoding a REMS in a 5’ splice site, which is upstream of a nucleotide sequence encoding a 3’ splice site, then less splicing would occur in the absence of the compound and this would result in exon skipping which would ultimately result in less functional protein being produced.
- the use of an artificial gene construct described herein allows one to regulate the amount or type of a functional protein produced from the construct depending on whether or not a compound described herein is present.
- a compound described herein is essentially a switch that regulates the amount or type of functional protein produced.
- an animal e.g., a non-human animal, such as a mouse, rat, fly, etc.
- an animal is engineered to contain an artificial gene construct or a vector comprising an artificial gene construct. Techniques known to one of skill in the art may be used to engineer such animals.
- the amount or type of functional protein produced by this engineered animal can be regulated by whether or not a compound described herein is administered to the animal.
- the amount or type of the functional protein produced can be titrated based on the dose and/or the duration of administration of a compound described herein to the engineered animal.
- the artificial gene construct encodes a detectable reporter gene, such as green fluorescent protein (GFP), yellow fluorescent protein (YFP), red fluorescent protein, beta galactosidase, renilla luciferase, firefly luciferase, etc.
- the engineered animal may be used to monitor development at different stages, visualize tissue function, etc.
- the engineered animal may be used to monitor development at different stages or in functional biological studies where a certain protein or protein isoform needs to be expressed only for a period of time and not constitutively, etc.
- an artificial gene construct or a vector comprising an artificial gene construct are used in gene therapy.
- an artificial gene construct described herein in gene therapy allows one to regulate the amount or type of a functional protein produced from the construct depending on whether or not a compound described herein is present.
- the compound is essentially a switch that regulates the amount or type of functional protein produced.
- an RNA transcript transcribed from an artificial gene construct that is DNA would not produce or produce substantially less functional protein in the absence of a compound described herein than the amount or type of functional protein produced in the presence of a compound described herein.
- the artificial gene construct comprises a nucleotide sequence encoding a REMS in a 5’ splice site, which is upstream of a nucleotide sequence encoding a 3’ splice site, then less splicing would occur in the absence of the compound and this would result in exon skipping which would ultimately result in less functional protein being produced.
- an exon-skipped mRNA may be produced which cannot be translated into full length, functional protein.
- a full length, functional protein may be produced.
- the amount or type of the functional protein produced can be titrated based on dose and duration of dosing of the compound.
- the protein can be turned on and off depending upon whether the compound is present, which may be beneficial for a subject to maintain muscle health.
- an artificial gene construct or a vector comprising an artificial gene construct is useful may be useful in treating and/or preventing certain conditions or diseases associated with one or more genes listed in Tables Zl-9.
- the conditions or diseases may include those described herein.
- an RNA transcript transcribed from an artificial gene construct that is DNA would not produce or would produce substantially less functional protein in the presence of a compound described herein than the amount or type of functional protein produced in the absence of a compound described herein.
- the artificial gene construct comprises a nucleotide sequence encoding a REMS in the middle of an exon, then ectopic splicing would occur in the presence of a compound described herein and this would result in reduction in the production of the functional protein.
- An artificial gene construct, a vector comprising the artificial gene construct, or an RNA molecule comprising an artificial gene construct modified to enable cellular uptake may be introduced into cells or administered directly to subjects.
- an artificial gene construct or a vector comprising the artificial gene construct is introduced into cells ex vivo or in vivo.
- an artificial gene construct or vector is introduced into a cell(s) ex vivo and the cell(s) may be administered to a subject
- Various techniques known to one of skill in the art may be used to introduce an artificial gene construct or vector comprising the artificial gene construct into a cell(s), such as electroporation, transfection, transformation, etc.
- an artificial gene construct or vector comprising the artificial gene construct is administered to a subject.
- the artificial gene construct or vector comprising the artificial gene construct may be administered to a subject by any technique known to one skilled in the art, e.g., intramuscularly, intravenously, subcutaneously, intradermally, topically, intrathecally, intraperitoneally, intratumorally, etc.
- the artificial gene construct or vector comprising the artificial gene construct is administered to a subject systemically.
- the artificial gene construct or vector comprising the artificial gene construct is administered to a subject locally.
- a REMS not naturally found in the endogenous gene, i.e., a non-endogenous REMS.
- Techniques known to one of skill in the art can be used to introduce a REMS into an endogenous gene, e.g., the CRISPR-Cas approach, TALEN, or ZFN may be used.
- a nucleotide sequence encoding an existing 5’ splice site can be replaced with a REMS or a REMS may be inserted internally within an exon.
- the introduction of a nucleotide sequence encoding a REMS into an endogenous gene may or may not result in an amino acid change at the protein level.
- the introduction of a nucleotide sequence encoding a REMS into an endogenous gene results in an amino acid change at the protein level. In another aspect, this amino acid change is a conservative amino acid substitution.
- the introduction of a nucleotide sequence encoding a REMS into an endogenous gene does not result in an amino acid change at the protein level.
- kits comprising, in a container, an artificial gene construct or a vector comprising an artificial construct.
- the kits further comprise a compound described herein, in a separate container, and/or a negative control, such as phosphate buffered saline or a compound that does not recognize REMS, in a separate container.
- the kits further comprise primers and/or antibodies, in one or more separate containers, for assessing the production of an mRNA transcript from an artificial gene construct and/or protein production therefrom.
- kits comprising, in one or more containers, the components and/or reagents necessary to produce an artificial gene construct and/or a vector comprising an artificial gene construct.
- kits comprising, in one or more containers, the components and/or reagents necessary to alter an endogenous gene so that it contains a nucleotide sequence encoding a REMS or an additional nucleotide sequence encoding a REMS (in other words, a REMS not naturally found in the endogenous gene, i.e., a non-endogenous REMS).
- the kits further comprise primers and/or antibodies, in one or more separate containers, for assessing the production of an mRNA transcript from altered endogenous gene and/or protein production therefrom.
- kits comprising, in a container, a compound described herein, and instructions for use.
- the kits further comprise a negative control, such as phosphate buffered saline or a compound that does not recognize a REMS, in a separate container.
- test compounds were obtained and prepared according to synthetic approaches described in WO/2020/ 167628.
- mRNA was enriched using oligo(dT) beads and then fragmented randomly by adding fragmentation buffer, and then cDNA was synthesized by mRNA templating and using random hexamer primer, after which a second-strand synthesis buffer (Illumina) , dNTPs, RNase H, and DNA polymerase I were added to initiate the second-strand synthesis.
- a second-strand synthesis buffer Illumina
- dNTPs dNTPs
- RNase H RNase H
- DNA polymerase I DNA polymerase I
- the double-stranded cDNA library was completed through size selection and PCR enrichment.
- RNA libraries were sequenced in a HiSeq sequencer or a NovaSeq sequencer, each available from Illumina, Inc. (San Diego, CA). RNA-seq Splicing Analysis
- splicing analysis For splicing analysis, reads were counted for different exons. For each exon, a Percent- Spliced-In (PSI) value was calculated using the percent of average read number supporting the inclusion of the exon (include both the upstream and downstream junctions) among all reads supporting either the inclusion or the skipping of an exon. A cutoff was set at 20 for the denominator of PSI calculation. PSI values for biological replicates were averaged and the PSI difference between two treatment groups (eg. +compound vs. control) was calculated. For statistical analysis, a 2x2 read counts table was made for each exon and Fisher’s Exact Test was applied. Rows were analyzed for inclusion or skipping and columns were used to compare sample groups.
- PSI Percent- Spliced-In
- Table 8 identifies genes that exhibited a PSI change (APSI) of 10% to 100% (inclusion) and aE-value ⁇ 0.001, or -10% to -100% (skipping) and a P-value ⁇ 0.001, upon treatment with a test compound.
- APSI PSI change
- Table 9 identifies 5’ splice sites that are in genes that exhibited a PSI change (APSI) of 10% to 100% (inclusion) and a P-value ⁇ 0.001, or -10% to -100% (skipping) and aP- value ⁇ 0.001, upon treatment with a test compound.
- APSI PSI change
- Table 10 identifies genes that exhibited a PSI change (APSI) of 10% to 100% (inclusion) and a E- value ⁇ 0.001 upon treatment with a test compound.
- APSI PSI change
- Table 11 identifies 5’ splice sites that are in genes that exhibited a PSI change (APSI) of 10% to 100% (inclusion) and a P-value ⁇ 0.001 upon treatment with a test ompound.
- Table 12 identifies genes that exhibited a PSI change (APSI) of -10% to -100% (skipping) and a T’-value ⁇ 0.001, upon treatment with a test compound.
- Table 13 identifies 5’ splice sites that are in genes that exhibited a PSI change (APSI) of -10% to -100% (skipping) and a T’-value ⁇ 0.001, upon treatment with a test compound.
- Table 14 identifies genes that exhibited a PSI change (APSI) of +50% to +100% (inclusion) and a T’-value ⁇ 0.001, or -50% to -100% (skipping) and T’-value ⁇ 0.001, upon treatment with a test compound.
- Table 15 identifies 5’ splice sites that are in genes that exhibited a PSI change (APSI) of +50% to +100% (inclusion) and a T’-value ⁇ 0.001, or -50% to -100% (skipping) and T’- value ⁇ 0.001, upon treatment with a test compound.
- PSI PSI change
- the regulated exon were annotated with the estimated consequence of the splicing event based on the following: 1), the splicing-induced change results in modulation of resulting protein isoform but no decay effect on the mRNA (annotated as “Protein Isoform”), which is determined based on an exon size dividable by 3 and containing no stop codon in-frame with the upstream annotated exon; 2), the splicing-induced change results in inclusion of an exon causing non-sense mediated decay of the mRNA (annotated as “NMD”), which is determined based on (a) an exon with basal (DMSO treatment condition) PSI level ⁇ 10% and the exon is not dividable by 3 and so is expected to cause frameshift when included, or (b) the exon contains at least one stop codon in-frame with the upstream annotated exon; 3) the splicing-induced change results in skipping of an exon causing non-sense mediated
- CDS coding sequence
- RNAseq experiments showed that compounds of Formula (I) induced exon inclusion with a PSI change (APSI) of +10% to +100% and /’-value ⁇ 0.001 or induced exon skipping with a APSI of -10% to -100% and T’-value ⁇ 0.001 in 8224 genes as shown in Table 8:
- Table 8 ABCD2, ABCD3, ABCD4, ABCE1, ABCF2, ABCF3, ABHD10, ABHD11, ABHD12, ABHD I4A, ABHD14A-ACY1, ABHD18, ABHD2, ABHD3, ABHD5, ABHD6, ABH, ABI2, ABI3BP, ABL1, ABL2, ABLIMI, ABR, ABRAXAS1, ABRAXAS2, ACAA1, ACACA, ACACB, ACAD1O, ACAD11, ACAD8, ACAD9, ACADM, ACADS, ACADVL, ACAP2, ACAP3, ACAT1, ACBD3, ACBD5, ACBD6, ACCS, ACD, ACER3, ACINI, ACLY, ACO1, ACO2, ACOT11, ACOT2, ACOT8, ACOT9, ACOX1, ACOX3, ACPI, ACP6, ACSF2, ACSF3, ACSL1, ACSL3, ACSL4, ACSS2, ACSS3, ACTA2, ACTL6B, ACTN1,
- GLMN GLMP, GLRB, GLRX3, GLS, GLS2, GLT1D1 , GLT8D1 , GLT8D2, GLTP, GLYCTK, GLYR1 , GMCL1, GMDS, GMDS- AS1, GMEB1, GMFB, GMFG, GMIP, GMNN, GMPPB, GMPR2, GNA12, GNA13, GNAS, GNAS-AS1, GNB1, G
- REEP3, REEP4 RELA, RELB, RELL2, REPIN1, REPSI, RER1, RERE, RERG, RET, RETREG1, RETREG3, RETSAT, REV1, REV3L, REX1BD, REXO1, REXO2, REXO5, RFC1, RFC2, RFC3, RFC5, RFESD, RFFL, RFT1, RFWD3, RFX1, RFX2, RFX3, RFX7, RFX8, RFXANK, RGL1, RGN, RGP1, RGPD5, RGPD6, RGS1O, RGS11, RGS12, RGS14, RGS19, RGS3, RGS5, RGS7, RHBDD1, RHBDD2, RHBDD3, RHBDF2, RHBDL1, RHCE, RHOBTB1, RHOBTB3, RHOC, RHOJ, RHOQ, RHOT1, RHOT2, RHOU, RIC1,
- RNAseq experiments showed that compounds of Formula (I) induced exon inclusion with a PSI change (APSI) sbof +10% to +100% and /’-value ⁇ 0.001 or induced exon skipping with a APSI of -10% to -100% and /-value ⁇ 0.001 in genes having a 5' splice site as shown in Table 9 (5775 entries):
- Table 9 (SEQ ID NO.: 43), AAAAgtaggt (SEQ ID NO.: 44), AAAAgtatac (SEQ ID NO.: 45), AAAAgtatga (SEQ ID NO.: 46), AAAAgtatgc (SEQ ID NO.: 47), AAAAgtatgt (SEQ ID NO.: 48), AAAAgtatta (SEQ ID NO.: 49), AAAAgtcagt (SEQ ID NO.: 50), AAAAgtgaga (SEQ ID NO.: 51), AAAAgtgagc (SEQ ID NO.: 52), AAAAgtgagg (SEQ ID NO.: 53), AAAAgtgagt (SEQ ID NO.: 54), AAAAgtgatt (SEQ ID NO.: 55), AAAAgtgggt (SEQ ID NO.: 56), AAAAgtggtg (SEQ ID NO.: 57), AAAAgtgtaa (SEQ ID NO.: 58), AAA
- T16 (SEQ ID NO.: 165), AAAGgtcagt (SEQ ID NO.: 166), AAAGgtcatt (SEQ ID NO.: 167), AAAGgtccac (SEQ ID NO.: 168), AAAGgtccag (SEQ ID NO.: 169), AAAGgtcctg (SEQ ID NO.: 170), AAAGgtcctt (SEQ ID NO.: 171), AAAGgtcggt (SEQ ID NO.: 172), AAAGgtctaa (SEQ ID NO.: 173), AAAGgtctct (SEQ ID NO.: 174), AAAGgtctga (SEQ ID NO.: 175), AAAGgtctgg (SEQ ID NO.: 176), AAAGgtctgt (SEQ ID NO.: 177), AAAGgtcttc (SEQ ID NO.: 178), AAAGgtcttt (SEQ ID NO.: 179
- AACAgtatgt SEQ ID NO. : 312), AACAgtgaga (SEQ ID NO. : 313), AACAgtgagc (SEQ ID NO.: 314), AACAgtgagt (SEQ ID NO : 315), AACAgtggtg (SEQ ID NO.: 316), AACCgtaagt (SEQ ID NO.: 317), AACCgtatgt (SEQ ID NO.: 318), AACCgtgagc (SEQ ID NO.: 319), AACCgtgagt (SEQ ID NO.: 320), AACGgcaagt (SEQ ID NO.: 321), AACGgtaaa (SEQ ID NO.: 322), AACGgtaaat (SEQ ID NO.: 323), AACGgtaacc (SEQ ID NO.: 324), AACGgtaact (SEQ ID NO.: 325), AA
- AGAGgttctt (SEQ ID NO.: 1185), AGAGgttgag (SEQ ID NO.: 1186), AGAGgttgcc (SEQ ID NO.: 1187), AGAGgttggc (SEQ ID NO.: 1188), AGAGgttggg (SEQ ID NO.: 1189), AGAGgttggt (SEQ ID NO. : 1190), AGAGgttgtg (SEQ ID NO.
- CTTGgtaaga SEQ ID NO. : 3104
- CTTGgtaagc SEQ ID NO.: 3105
- CTTGgtaagg SEQ ID NO.: 3106
- CTTGgtaagt SEQ ID NO.: 3107
- CTTGgtaata SEQ ID NO.: 3108
- CTTGgtaatg SEQ ID NO.: 3109
- CTTGgtaatt SEQ ID NO.: 3110
- CTTGgtacag SEQ ID NO. : 3111
- CTTGgtacgt SEQ ID NO. : 3112
- CTTGgtagat SEQ ID NO.: 3113
- CTTGgtaggg SEQ ID NO.
- CTTGgtaggt SEQ ID NO. : 3115
- CTTGgtatac SEQ ID NO. : 3116
- CTTGgtatat SEQ ID NO. : 3117
- CTTGgtatcc SEQ ID NO. : 3118
- CTTGgtatga SEQ ID NO.
- CTTGgtatgc (SEQ ID NO.: 3120), CTTGgtatgg (SEQ ID NO.: 3121), CTTGgtatgt (SEQ ID NO.: 3122), CTTGgtattc (SEQ ID NO.: 3123), CTTGgtattt (SEQ ID NO.: 3124), CTTGgtcagc (SEQ ID NO.: 3125), CTTGgtcgtc (SEQ ID NO.: 3126), CTTGgtctgc (SEQ ID NO.: 3127), CTTGgtgaga (SEQ ID NO.: 3128), CTTGgtgagc (SEQ ID NO.: 3129), CTTGgtgagg (SEQ ID NO.: 3130), CTTGgtgagt (SEQ ID NO.: 3131), CTTGgtgatt (SEQ ID NO.: 3132), CTTGgtgcgt (SEQ ID NO.: 3133), CTTGgtggga (SEQ ID NO.:
- CTTGgttagt (SEQ ID NO. : 3141), CTTGgttggt (SEQ ID NO. : 3142), CTTGgtttgt (SEQ ID NO. : 3143), CTTTatatcc (SEQ ID NO. : 3144), CTTTgtaaga (SEQ ID NO. : 3145), CTTTgtaagg (SEQ ID NO.: 3146), CTTTgtaagt (SEQ ID NO.: 3147), CTTTgtaggt (SEQ ID NO.: 3148), CTTTgtatgt (SEQ ID NO.: 3149), CTTTgtctcc (SEQ ID NO.: 3150), CTTTgtgaga (SEQ ID NO.
- GTGTgtgagt (SEQ ID NO. : 4311), GTGTgtgtgt (SEQ ID NO.: 4312), GTTAgtaagt (SEQ ID NO.: 4313), GTTAgtatgt (SEQ ID NO.: 4314), GTTAtggtga (SEQ ID NO.: 4315), GTTAttgtat (SEQ ID NO.: 4316), GTTCagatgt (SEQ ID NO.: 4317), GTTCatgagg (SEQ ID NO.: 4318), GTTCgtaagt (SEQ ID NO.: 4319), GTTCttccag (SEQ ID NO.: 4320), GTTGgcaagt (SEQ ID NO.: 4321), GTTGgtaaa (SEQ ID NO.: 4322), GTTGgtaaag (SEQ ID NO.: 4323), GTTGgtaaat (SEQ ID NO.: 4324), GTTGgtaaga (SEQ ID NO.:
- RNA sequences corresponding to the 5' splice sites in Table 9 are provided as follows (5775 entries) in Table 10:
- AAAAguaaaa (SEQ ID NO.: 5801), AAAAguaaac (SEQ ID NO.: 5802), AAAAguaaag (SEQ ID NO.: 5803), AAAAguaaau (SEQ ID NO.: 5804), AAAAguaacg (SEQ ID NO.: 5805), AAAAguaacu (SEQ ID NO.: 5806), AAAAguaaga (SEQ ID NO.: 5807), AAAAguaagc (SEQ ID NO.: 5808), AAAAguaagg (SEQ ID NO.: 5809), AAAAguaagu (SEQ ID NO.: 5810), AAAAguaaua (SEQ ID NO.: 5811), AAAAguaauc (SEQ ID NO.: 5812), AAAAguaauu (SEQ ID NO.: 5813), AAAAguacac (SEQ ID NO.: 5814), AAAAguacau
- AAAUgcacgc SEQ ID NO. : 6032
- AAAUgcaggu SEQ ID NO.: 6033
- AAAUguaaau SEQ ID NO.: 6034
- AAAUguaaca SEQ ID NO.: 6035
- AAAUguaacg SEQ ID NO.: 6036
- AAAUguaaga SEQ ID NO.: 6037
- AAAUguaagc SEQ ID NO.: 6038
- AAAUguaagg SEQ ID NO.: 6039
- AAAUguaagu SEQ ID NO.: 6040
- AAAUguaaua SEQ ID NO.: 6041
- AAAUguaauc SEQ ID NO.: 6042
- AAAUguaaug SEQ ID NO.: 6043
- AAAUguaauu SEQ ID NO.: 6044
- AAAUguacag SEQ ID NO.: 6045
- AAAUguacau SEQ ID NO.: 6046
- AAAUguacca SEQ ID NO.:
- AUCGgugggu SEQ ID NO. : 7311
- AUCGguuagu SEQ ID NO. : 7312
- AUCUggugag SEQ ID NO.: 7313
- AUCUguaaga SEQ ID NO.: 7314
- AUCUguaagc SEQ ID NO.: 7315
- AUCUguaagg SEQ ID NO. : 7316
- AUCUguaagu SEQ ID NO.
- CCCAgagacu SEQ ID NO. : 8232
- CCCAgcuaag SEQ ID NO.: 8233
- CCCAgguaac SEQ ID NO.: 8234
- CCCAgguaau SEQ ID NO.: 8235
- CCCAgguaga SEQ ID NO.: 8236
- CCCAguaaau SEQ ID NO.: 8237
- CCCAguaaga SEQ ID NO.: 8238
- CCCAguaagc SEQ ID NO.: 8239
- CCCAguaagg SEQ ID NO.: 8240
- CCCAguaagu SEQ ID NO.: 8241
- CCCAguacga SEQ ID NO.: 8242
- CCCAguacgu SEQ ID NO.: 8243
- CCCAguaggu SEQ ID NO.: 8244
- CCCAguaucc SEQ ID NO.: 8245
- 11162 UGGAgugugu (SEQ ID NO.: 11163), UGGAguuagc (SEQ ID NO.: 11164), UGGAuauccu (SEQ ID NO : 11165), UGGAuuuuuau (SEQ ID NO : 11166), UGGCgcaggu (SEQ ID NO.: 11167), UGGCguaaga (SEQ ID NO.: 11168), UGGCguaagu (SEQ ID NO.: 11169), UGGCguacgu (SEQ ID NO.: 11170), UGGCguaucc (SEQ ID NO.: 11171), UGGCgugagu (SEQ ID NO.
- RNAseq experiments showed that compounds of Formula (I) induced exon inclusion with a PSI change (APSI) of +10% to +100% and E-value ⁇ 0.001 in 4232 genes as shown in Table 11 :
- NFIC NFIC
- NFRKB NFX1, NFYC, NGLY1, NHLRC3, NIDI, NIF3L1, NIN, NINE, NIPA1, NISCH, NITI, NKAPD1, NKIRAS1, NKIRAS2, NKTR, NLE1, NLGN1, NLK, NLRC3, NLRC5, NME6, NME7, NMNAT1, NMRAL1, NMRK1, NNT, NNT-AS1, NOC2L, NOCT, NOLIO, NOL4, NOL4L, NOL8, N0M02, NOP16, NOP58, NOTCH2NL, NOTCH3, N0X5, NPAS2, NPFFR2, NPHP4, NPIPA1, NPIPB5, NPLOC4, NPM1, NPNT, NPRL2, NPRL3, NQO2, NR1D2, NR1H3, NR2C2, NR6A1, NRCAM, NRDC, NREP, NRF1, NRG1, NRG2, NRG3, NRG4,
- RNAseq experiments showed that compounds of Formula (I) induced exon skipping with a APSI of -10% to -100% and P-value ⁇ 0.001 in 7305 genes as shown in Table 12: [00521] Table 12
- GTF2B GTF2F1, GTF2H1, GTF2H2, GTF2H2B, GTF2H2C, GTF2H2C 2, GTF2H3, GTF2I, GTF2IP1, GTF2IP20, GTF2IP23, GTF2IP4, GTF2IRD1, GTF2IRD2, GTF2IRD2B, GTF3A, GTF3C2, GTF3C3, GTF3C4, GTF3C5, GTPBP1, GTPBP10, GTSE1, GUCA1A, GUCD1, GUF1, GUK1, GULP1, GUSB, GUSBP1, GUSBP11, GVQW2, GYG1, GYG2, GYSI, GZF1, H2AFV, H6PD,
- LOC145694 LOC150776, LOC155060, LOC283683, LOC283788, LOC284581, LOC339862, LOC389765, LOC389831, LOC389906, LOC392232, LOC399815, LOC400464, LOC400927, LOC400927-CSNK1E, LOC440434, LOC441242, LOC441601, LOC441666, LOC642846, LOC643339, LOC645513, LOC648987, LOC653080, LOC727751, LOC728613, LOC728730, LOC729218, LOC729732, LOC729970, LONP2, LONRF3, LOXL2, LOXL3, LPAR1, LPAR3, LPCAT1, LPCAT2, LPCAT3, LPCAT4, LPGAT1, LPIN1, LPP, LRBA, LRCH3, LRIG1,
- NECAP2 NEDD1, NEDD4, NEDD4L, NEDD9, NEIL2, NEIL3, NEK1, NEK10, NEK11, NEKA, NEK7, NEK9, NELFA, NELFCD, NEMF, NEMP I, NENF, NE01, NEPRO, NET1, NETO2, NEURL1B, NEURL4, NEXN, NF1, NF2, NFASC, NFAT5, NFATC2IP, NFATC3, NFATC4, NFE2L1, NFIB, NFIC, NFIX, NFKB1, NFRKB, NFS1, NFU1, NFX1, NFYB, NFYC, NGDN, NGLY1, NHEJ1, NHSL1, NICN1, NID2, NIF3L1, NIFK, NIN, NIP7, NIPA1, NIPA2, NIPBL, NIPSNAP
- RNASE RNASEH1-AS1, RNASEH2B, RNASEK, RNASEK-C17orf49, RNASET2, RND3, RNF10, RNF103-CHMP3, RNF111, RNF114, RNF115, RNF121, RNF123, RNF126, RNF13, RNF130, RNF135, RNF138, RNF14, RNF146, RNF150, RNF157, RNF167, RNF168, RNF170, RNF175, RNF181, RNF185, RNF19A, RNF2, RNF212, RNF213, RNF214, RNF215, RNF216, RNF216P1, RNF219, RNF25, RNF34, RNF38, RNF8, RNFT1, RNGTT, RNLS, RNMT, RNPEP, RNU5D-1, RNU5E-1,
- TSPAN9 TSP0AP1-AS1, TSR1, TSR3, TSSC2, TSTD2, TSTD3, TTBK1, TTBK2, TTC12,
- TTC13 TTC17, TTC21B, TTC23, TTC26, TTC27, TTC28-AS1, TTC3, TTC31, TTC33,
- TTC37 TTC39A, TTC39B, TTC39C, TTC4, TTC5, TTC7A, TTC7B, TTC8, TTF1, TTF2,
- RNAseq experiments showed that compounds of Formula (I) induced exon inclusion with a PSI change (APSI) of +50% to +100% and P-value ⁇ 0.001 or induced exon skipping with a APSI of -50% to -100% and L-value ⁇ 0.001 in 2629 genes as shown in Table 13:
- GSAP GSK3B, GSTCD, GTF2H1, GTF2H2, GTF2H2B, GTF2I, GTF2IP1, GTF2IP20, GTF2IP4, GTF2IRD1, GTF3C2, GTPBP2, GUCD1, GUF1, GUSBP1, GUSBP11, GVQW2, HACD1, HACE1, HACL1, HADHB, HAGHL, HDAC1, HDAC8, HDX, HEATR3, HEATR5A, HEATR5B, HECTD4, HECW1, HEMK1, HERC1, HERC2, HERC2P3, HERC2P9, HERC3, HERC4, HERC5, HERC6, HERPUD2, HEXDC, HFM1, HGF, HGSNAT, HHAT, HIBADH, HIBCH, HIRA, HIVEP1, HIVEP3, HMGN5, HNRNPA1, HNRNPUL1, HOGA1, HOOK3, HOXA9,
- RNAseq experiments showed that compounds of Formula (I) induced exon inclusion with a PSI change (APSI) of +50% to +100% and T’-value ⁇ 0.001 or induced exon skipping with a APSI of -50% to -100% and / ⁇ value ⁇ 0.001 in genes having a 5' splice site as shown in Table 14 (2088 entries):
- AAAGgtaaag SEQ ID NO.: 99
- AAAGgtaaat SEQ ID NO.: 100
- AAAGgtaaca SEQ ID NO.: 101
- AAAGgtaacc SEQ ID NO.: 102
- AAAGgtaact SEQ ID NO.: 104
- AAAGgtaaga SEQ ID NO.: 105
- AAAGgtaagc SEQ ID NO.: 106
- AAAGgtaagg SEQ ID NO.: 107
- AAAGgtaagt SEQ ID NO.: 108
- AAAGgtaata SEQ ID NO.: 109
- AAAGgtaatc SEQ ID NO.: 110
- AAAGgtaatg SEQ ID NO.: 111
- AAAGgtaatt SEQ ID NO.: 112
- AAAGgtacaa SEQ ID NO.
- AAAGgtacag SEQ ID NO. : 115
- AAAGgtacat SEQ ID NO. : 116
- AAAGgtacca SEQ ID NO.: 117
- AAAGgtaccc SEQ ID NO.: 118
- AAAGgtaccg SEQ ID NO.: 119
- AAAGgtacct SEQ ID NO.: 120
- AAAGgtacga SEQ ID NO.: 121
- AAAGgtacgt SEQ ID NO.: 124
- AAAGgtacta SEQ ID NO.: 125
- AAAGgtactc SEQ ID NO.: 126
- AAAGgtactg SEQ ID NO.: 127
- AAAGgtactt SEQ ID NO.: 128)
- AAAGgtagag SEQ ID NO : 131
- AAAGgtagat SEQ ID NO.: 132
- AAAGgtagcc SEQ ID NO : 134
- RNA sequences corresponding to the 5' splice sites in Table 12 are provided as shown in Table 15 (2088 entries):
- CCAGguaugc SEQ ID NO.: 8113
- CCAGguaugg SEQ ID NO.: 8114
- CCAGguaugu SEQ ID NO.: 8115
- CCAGguauua SEQ ID NO. : 8116
- CCAGguauuc SEQ ID NO. : 8117
- CCAGguauug SEQ ID NO. : 8118
- CCAGguauuu SEQ ID NO.: 8119
- CCAGgucagc SEQ ID NO.: 8121
- CCAGgucagg SEQ ID NO.: 8122
- CCAGgucagu SEQ ID NO.
- CCGAgugagu SEQ ID NO. : 8312
- CCGCgugagu SEQ ID NO.: 8315
- CCGGguaaaa SEQ ID NO.: 8319
- CCGGguaagu SEQ ID NO.: 8326
- CCGGguaauu SEQ ID NO.: 8328
- CCGGguagga SEQ ID NO.: 8332
- CCGGguaugg SEQ ID NO.: 8337
- CCGGguaugu SEQ ID NO.: 8338
- CCGGgugaga SEQ ID NO.: 8341
- CCGGgugagc SEQ ID NO.: 8342
- CCGGgugagg SEQ ID NO.: 8343
- CCGGgugagu SEQ ID NO.
- CCGGgugugu SEQ ID NO. : 8348
- CCGUguaagu SEQ ID NO. : 8351
- CCGUgugagu SEQ ID NO.: 8353
- CCUAguaaga SEQ ID NO.: 8355
- CCUAguaagu SEQ ID NO.: 8357
- CCUCguaagu SEQ ID NO.: 8364
- CCUCgugagu SEQ ID NO.: 8367
- CCUCgugggu SEQ ID NO.: 8368
- CCUGgcaagu SEQ ID NO.: 8370
- CCUGgccaac SEQ ID NO.: 8371
- CCUGguaaag SEQ ID NO.: 8373
- CCUGguaaau SEQ ID NO.: 8374
- CCUGguaacc SEQ ID NO.: 8376
- CCUGguaaga SEQ ID NO.: 8378
- Table 16 demonstrates the effect of various representative compounds (Cpd) described herein to induce a > Log2 fold change (L2FC) in the amount of mature mRNA for a wildtype gene (Gene) after treatment in various cell lines (Cell) tested at various concentrations (Cone).
- a Log2 fold change of 1.0 represents a doubling in expression of the mature mRNA transcript produced in the presence of the compound. Positive values correspond to upregulation of gene expression while negative values correspond to down regulation of gene expression.
- the compounds of Formula (I) induce a two fold change, or more, in gene expression (a Log2 fold change of 1 .0 or above, or -1 .0 or below) together with a change in Percent Spliced In (APSI) of 10% to 100%, or -10% to -100%, at a p value (pVal) of ⁇ 0.001 for the indicated genes.
- APSI Percent Spliced In
- TSTD2, TSTD3, TTBK2 TTC12, TTC13, TTC17, TTC27, TTC28, TTC28-AS1, TTC3,
- TUBGCP6 TUT1, TVP23C, TVP23C-CDRT4, TW1ST2, TXK, TXN, TXNDC11, TXNDC16,
- TXNDC9 TXNIP
- TXNL4B TXNL4B
- TYMP TYSND1, U2AF1L4, UACA, UBA2, UBA6, UBAC2
- the compounds of Table 17 induce a two fold change, or more, in gene expression (a Log2 fold change of 1.0 or above, or -1.0 or below) together with a change in Percent Spliced In (APSI) of 50% to 100%, or -50% to -100%, at a p value (pVal) of ⁇ 0.001 for the indicated genes.
- APSI Percent Spliced In
- AAAS AAAS, AACS, AARS2, AASS, ABCA1 IP, ABCC4, ABCD3, ABCD4, ABHD12, ABHD6, ABLIM1, ACAA1, ACACA, ACAP3, ACCS, ACD, ACER3, ACSF3, ACSS2, ACTR1B, ACYP1, ADA, AD AL, ADAM22, ADAMTS6, ADAMTS9, AD API, ADCY7, ADGRB2, ADK, AFF3, AFMID, AG04, AGRN, AGTPBP1, AHI1, AHRR, AKAP13, AKAP6, AKAP9, AKIP1, ALDH1L2, ALDH4A1, ALG13, ALG9, ALKBH3, AMN1, AMOT, ANAPC10, ANK2, ANKMY2, ANKRD12, ANKRD36, ANKRD37, ANKZF1, ANLN, AP2A2, APOOL, ARFGAP2, ARHGAP31, ARHGEF10, ARHGEF12, ARHGEF39,
- APSI Percent Spliced In
- the cell lines tested included Familial Dysautonomia patient fibroblasts (FDPF), HEK293, stimulated PBMC (sPBMC), differentiated SY5Y (diffSY5Y), SHSY5Y, M0LM13 and HT1080.
- FDPF Familial Dysautonomia patient fibroblasts
- sPBMC stimulated PBMC
- DiffSY5Y differentiated SY5Y
- SHSY5Y SHSY5Y
- M0LM13 M0LM13
- HT1080 HT1080
- RNAseq experiments showed that Compound 18 induced exon inclusion with a PSI change (APSI) of +50% to +100% and P-value ⁇ 0.001 in 158 genes as shown in Table 19:
- RNAseq experiments showed that Compound 18 induced exon inclusion associated with nonsense mediated decay with a PSI change (APSI) of +50% to +100% and P- value ⁇ 0.001with a PSI change (APSI) of +50% to +100% and P-value ⁇ 0.001in 24 genes as shown in Table 21:
- RNAseq experiments showed that Compound 18 induced exon inclusion associated with nonsense mediated decay with a PSI change (APSI) of +50% to +100% and P- value ⁇ 0.001 with a PSI change (APSI) of +50% to +100% and P-value ⁇ 0.001 in genes having a 5' splice site as shown in Table 22 (23 entries):
- RNAseq experiments showed that Compound 18 induced exon skipping with a PSI change (APSI) of -50% to -100% and P-value ⁇ 0.001 in 661 genes as shown in Table 23:
- RNAseq experiments showed that Compound 18 induced exon skipping with a
- PSI change (APSI) of -50% to -100% and P-value ⁇ 0.001 in genes having a 5' splice site as shown in Table 24 (641 entries):
- RNAseq experiments showed that Compound 18 induced exon skipping associated with nonsense mediated decay with a PSI change (APSI) of -50% to -100% and P- value ⁇ 0.001 in 267 genes: [00554] Table 25
- RNAseq experiments showed that Compound 18 induced exon skipping associated with nonsense mediated decay with a PST change (APSI) of -50% to -100% and P- value ⁇ 0.001 in genes having a 5' splice site as follows (234 entries):
- RNAseq experiments showed that Compound 18 modulated expression of various genes by a factor of 2 or more.
- the following table identifies genes from Table 5 which resulted in a log 2 fold change (L2FC) of 1 or above (increased expression), or -1 or below (decreased expression), upon treatment with Compound 18:
- Table 27 (AARS2, -1.6, M0LM13, 1.2 ⁇ M), (AARS2, -1.1, stimulated PBMC, 1.2 gM), (AARS2, -1.2, HEK293, 5 ⁇ M), (AARS2, -1, SHSY5Y, 5 ⁇ M), (AASS, 1, stimulated PBMC, 0.6 ⁇ M), (AASS,
- APSI Percent Spliced In
- the cell lines tested included Familial Dysautonomia patient fibroblasts (FDPF), HEK293, stimulated PBMC (sPBMC), differentiated SY5Y (diffSY5Y), SHSY5Y, M0LM13 and HT1080.
- FDPF Familial Dysautonomia patient fibroblasts
- sPBMC stimulated PBMC
- DiffSY5Y differentiated SY5Y
- SHSY5Y SHSY5Y
- M0LM13 M0LM13
- HT1080 HT1080
- RNAseq experiments showed that Compound 3 induced exon skipping with a PSI change (APSI) of -50% to -100% and P-value ⁇ 0.001 in 1 gene:
- RNAseq experiments showed that Compound 3 induced skipping with a PSI change (APSI) of -50% to -100% and P-value ⁇ 0.001 in genes having a 5' splice site as follows (1 entry):
- RNAseq experiments showed that Compound 3 modulated expression of various genes by a factor of 2 or more.
- the following table identifies genes from Table 5 which resulted in a log 2 fold change (L2FC) of 1 or above (increased expression), or -1 or below (decreased expression), upon treatment with Compound 3:
- APSI Percent Spliced In
- the cell lines tested included Familial Dysautonomia patient fibroblasts (FDPF), HEK293, stimulated PBMC (sPBMC), differentiated SY5Y (diffSY5Y), SHSY5Y, M0LM13 and HT1080.
- FDPF Familial Dysautonomia patient fibroblasts
- sPBMC stimulated PBMC
- DiffSY5Y differentiated SY5Y
- SHSY5Y SHSY5Y
- M0LM13 M0LM13
- HT1080 HT1080
- RNAseq experiments showed that Compound 26 induced exon skipping with a PSI change (APSI) of -50% to -100% and P-value ⁇ 0.001 in 3 genes:
- RNAseq experiments showed that Compound 26 induced exon skipping with a PSI change (APSI) of -50% to -100% and P-value ⁇ 0.001 in genes having a 5' splice site as follows (3 entries):
- RNAseq experiments showed that Compound 26 induced exon skipping associated with nonsense mediated decay with a PSI change (APSI) of -50% to -100% and P- value ⁇ 0.001 in 1 gene:
- RNAseq experiments showed that Compound 26 induced exon skipping associated with nonsense mediated decay with a PSI change (APSI) of -50% to -100% and P- value ⁇ 0.001 in genes having a 5' splice site as follows (1 entry):
- RNAseq experiments showed that Compound 26 induced exon inclusion with a
- RNAseq experiments showed that Compound 26 induced exon inclusion with a PSI change (APSI) of +50% to +100% and P-value ⁇ 0.001 in genes having a 5' splice site as follows (1 entry):
- RNAseq experiments showed that Compound 26 modulated expression of various genes by a factor of 2 or more.
- the following table identifies genes from Table 5 which resulted in a log 2 fold change (L2FC) of 1 or above (increased expression), or -1 or below (decreased expression), upon treatment with Compound 26:
- APSI Percent Spliced In
- the cell lines tested included Familial Dysautonomia patient fibroblasts (FDPF), HEK293, stimulated PBMC (sPBMC), differentiated SY5Y (diffSY5Y), SHSY5Y, M0LM13 and HT1080.
- FDPF Familial Dysautonomia patient fibroblasts
- sPBMC stimulated PBMC
- DiffSY5Y differentiated SY5Y
- SHSY5Y SHSY5Y
- M0LM13 M0LM13
- HT1080 HT1080
- RNAseq experiments showed that Compound 28 induced exon inclusion with a PSI change (APSI) of +50% to +100% and P-value ⁇ 0.001 in 123 genes:
- RNAseq experiments showed that Compound 28 induced exon inclusion with a PSI change (APSI) of +50% to +100% and P-value ⁇ 0.001 in genes having a 5' splice site as follows (150 entries):
- RNAseq experiments showed that Compound 28 induced exon inclusion associated with nonsense mediated decay with a PSI change (APSI) of +50% to +100% and P- value ⁇ 0.001 in 13 genes:
- RNAseq experiments showed that Compound 28 induced exon inclusion associated with nonsense mediated decay with a PSI change (APSI) of +50% to +100% and P- value ⁇ 0.001in genes having a 5' splice site as follows (13 entries):
- RNAseq experiments showed that Compound 28 induced exon skipping with a
- RNAseq experiments showed that Compound 28 induced exon skipping with a
- PSI change (APSI) of -50% to -100% and P-value ⁇ 0.001 in genes having a 5' splice site as follows (502 entries):
- RNAseq experiments showed that Compound 28 induced exon skipping associated with nonsense mediated decay with a PSI change (APSI) of -50% to -100% and P- value ⁇ 0.001 in 169 genes:
- RNAseq experiments showed that Compound 28 induced exon skipping associated with nonsense mediated decay with a PST change (APSI) of -50% to -100% and P- value ⁇ 0.001 in genes having a 5' splice site as follows (165 entries):
- RNAseq experiments showed that Compound 28 modulated expression of various genes by a factor of 2 or more.
- the following table identifies genes from Table 5 which resulted in a log 2 fold change (L2FC) of 1 or above (increased expression), or 1 or below (decreased expression), upon treatment with Compound 28:
- APSI Percent Spliced In
- the cell lines tested included Familial Dysautonomia patient fibroblasts (FDPF), HEK293, stimulated PBMC (sPBMC), differentiated SY5Y (diffSY5Y), SHSY5Y, M0LM13 and HT1080.
- FDPF Familial Dysautonomia patient fibroblasts
- sPBMC stimulated PBMC
- DiffSY5Y differentiated SY5Y
- SHSY5Y SHSY5Y
- M0LM13 M0LM13
- HT1080 HT1080
- RNAseq experiments showed that Compound 52 induced exon inclusion with a PSI change (APSI) of +50% to +100% and P-value ⁇ 0.001 in 263 genes:
- RNAseq experiments showed that Compound 52 induced exon inclusion with a
- PSI change (APSI) of +50% to +100% and P-value ⁇ 0.001 in genes having a 5' splice site as follows (257 entries):
- RNAseq experiments showed that Compound 52 induced exon inclusion associated with nonsense mediated decay with a PSI change (APSI) of +50% to +100% and P- value ⁇ 0.001in 77 genes:
- RNAseq experiments showed that Compound 52 induced exon inclusion associated with nonsense mediated decay with a PSI change (APSI) of +50% to +100% and P- value ⁇ 0.001in genes having a 5' splice site as follows (74 entries):
- RNAseq experiments showed that Compound 52 induced exon skipping with a PSI change (APSI) of -50% to -100% and P-value ⁇ 0.001 in 1118 genes:
- RNAseq experiments showed that Compound 52 induced exon skipping associated with nonsense mediated decay with a PSI change (APSI) of -50% to -100% and P- value ⁇ 0.001 in 583 genes: [00622] Table 57
- RNAseq experiments showed that Compound 52 induced exon skipping associated with nonsense mediated decay with a PSI change (APSI) of -50% to -100% and P-value ⁇ 0.001 in genes having a 5' splice site as follows (565 entries):
- RNAseq experiments showed that Compound 52 modulated expression of various genes by a factor of 2 or more.
- the following table identifies genes from Table 5 which resulted in a log 2 fold change (L2FC) of 1 or above (increased expression), or -1 or below (decreased expression), upon treatment with Compound 52:
- APSI Percent Spliced In
- the cell lines tested included Familial Dysautonomia patient fibroblasts (FDPF), HEK293, stimulated PBMC (sPBMC), differentiated SY5Y (diffSY5Y), SHSY5Y, M0LM13 and HT1080.
- FDPF Familial Dysautonomia patient fibroblasts
- sPBMC stimulated PBMC
- DiffSY5Y differentiated SY5Y
- SHSY5Y SHSY5Y
- M0LM13 M0LM13
- HT1080 HT1080
- RNAseq experiments showed that Compound 57 induced exon inclusion with a PSI change (APSI) of +50% to +100% and P-value ⁇ 0.001 in 106 genes:
- RNAseq experiments showed that Compound 57 induced exon inclusion with a PSI change (APSI) of +50% to +100% and P-value ⁇ 0.001 in genes having a 5' splice site as follows (161 entries):
- RNAseq experiments showed that Compound 57 induced exon inclusion associated with nonsense mediated decay with a PSI change (APSI) of +50% to +100% and P- value ⁇ 0.001in 12 genes:
- RNAseq experiments showed that Compound 57 induced exon inclusion associated with nonsense mediated decay with a PSI change (APSI) of +50% to +100% and P- value ⁇ 0.001in genes having a 5' splice site as follows (12 entries):
- RNAseq experiments showed that Compound 57 induced exon skipping with a
- RNAseq experiments showed that Compound 57 induced exon skipping with a
- PSI change (APSI) of -50% to -100% and P-value ⁇ 0.001 in genes having a 5' splice site as follows (425 entries):
- Table 66 ACAAgtgagt, ACACgtaagc, ACACgtaagt, ACACgtgagt, ACAGgtaac, ACAGgtaaat, ACAGgtaaga, ACAGgtaagc, ACAGgtaata, ACAGgtaatg, ACAGgtaccc, ACAGgtaccg, ACAGgtacct, ACAGgtacgt, ACAGgtactg, ACAGgtatga, ACAGgtatgt, ACAGgtattc, ACAGgtattt, ACAGgtgaga, ACAGgtgagg, ACAGgtgagt, ACAGgtgcgt, ACAGgtgtgt, ACAGgttgca, ACATgtaagc, ACATgtaagt, ACATgtaatg, ACATgtgagt, ACCAgtgag
- RNAseq experiments showed that Compound 57 induced exon skipping associated with nonsense mediated decay with a PSI change (APSI) of -50% to -100% and P- value ⁇ 0.001 in 155 genes:
- RNAseq experiments showed that Compound 57 induced exon skipping associated with nonsense mediated decay with a PSI change (APSI) of -50% to -100% and P- value ⁇ 0.001 in genes having a 5' splice site as follows (141 entries):
- RNAseq experiments showed that Compound 57 modulated expression of various genes by a factor of 2 or more.
- the following table identifies genes from Table 5 which resulted in a log 2 fold change (L2FC) of 1 or above (increased expression), or -1 or below (decreased expression), upon treatment with Compound 57:
Abstract
A method for modulating an amount or type of a mature RNA transcript, comprising contacting a compound of Formula (I) with a pre-mRNA transcript transcribed from a gene, wherein the gene comprises a DNA REMS sequence and the pre-mRNA transcript transcribed from the gene comprises a RNA REMS sequence.
Description
METHODS FOR MODULATING RNA SPLICING
[0001] This application claims priority to U.S. Provisional Application Serial No. 63/956,616, filed August 9, 2022, the disclosure of which is hereby incorporated by reference in its entirety.
SEQUENCE LISTING
[0002] This application contains a Sequence Listing created on August 8, 2023, named P1699-US_SL.txt and 9,454 kilobytes in size, which has been submitted electronically in ASCII format and is hereby incorporated by reference in its entirety.
INTRODUCTION
[0003] In one aspect, described herein is a DNA nucleotide sequence or an RNA nucleotide sequence comprising a DNA or RNA recognition element for splicing modifier (a DNA REMS or RNA REMS) recognized by a compound described herein.
[0004] In another aspect, described herein are methods for modulating an amount or type of gene product using a compound described herein, wherein the precursor RNA (pre-mRNA) transcript transcribed from the gene comprises a RNA REMS.
[0005] In another aspect, described herein are methods for modulating the amount or type of RNA transcript or protein product encoded by a gene, wherein a pre-mRNA transcript transcribed from the gene comprises a RNA REMS, by utilizing a compound described herein. [0006] In another aspect, described herein is a plurality of artificial gene constructs, comprising a DNA REMS or RNA REMS and uses thereof, for use in a method for modulating an amount or type of a pre-mRNA transcript or protein encoded by a gene transfected with an artificial gene construct, by utilizing a compound described herein.
BACKGROUND
[0007] A number of diseases are associated with aberrant expression of a gene product (e.g., an RNA transcript or protein) of a gene. An aberrant amount or type of RNA transcript may lead to disease due to corresponding changes in protein expression. Changes in the amount or type of a particular RNA transcript may be the result of several factors. For example, changes in the
amount or type of an RNA transcript may be due to an aberrant level of transcription of a particular gene, such as by the perturbation of a transcription factor or a portion of the transcription process, resulting in a change in the expression level of a particular RNA transcript. In another example, changes in the splicing of particular RNA transcripts, such as by perturbation of a particular splicing process or mutations in the gene that may lead to modified splicing can change the levels of a particular RNA transcript. In another example, changes to the stability of a particular RNA transcript or to components that maintain RNA transcript stability, such as the process of poly-A tail incorporation or an effect on certain factors or proteins that bind to and stabilize RNA transcripts, may lead to changes in the levels of a particular RNA transcript. In another example, changes in the level of translation of a particular RNA transcript can affect the amount or type of those transcripts, affecting or upregulating RNA transcript decay processes. Finally, aberrant RNA transport or RNA sequestration may lead to changes in functional levels of RNA transcripts, and may have an effect on the stability, further processing, or translation of the RNA transcripts.
[0008] Often, diseases associated with changes to the amount or type of RNA transcript may be treated with a focus on the aberrant protein expression. However, if the processes responsible for changing the amount or type of aberrant RNA, such as components of the splicing process, associated translation factors or associated stability factors, could be targeted by treatment with a small molecule, it may be possible to restore protein expression levels and avoid the expression of an aberrant RNA transcript or associated protein. Accordingly, there remains a need for methods of modulating the amount or type of aberrant RNA encoded by a gene to prevent or treat diseases associated with expression of aberrant RNA transcripts or associated proteins.
SUMMARY
[0009] In one aspect, described herein is a method for modulating an amount or type of a mature RNA transcript expressed, comprising contacting a compound of Formula (I), or form thereof, with a pre-mRNA transcript transcribed from a gene, wherein the gene comprises a DNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 1 to SEQ ID NO. 5775, as shown in Table 1, and the pre-mRNA transcript transcribed from the gene comprises a RNA
REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 5776 to SEQ ID
[0010] having Ri, Rs, Ri, R5, and Re as defined herein, wherein the compound is contacted with the RNA REMS nucleotide sequence in a cell lysate or in a cell in cell culture, whether in vivo or ex vivo, to express the mature RNA transcript, wherein the amount or type of mature RNA transcript expressed in the presence of the compound is modulated compared to the amount or type of mature RNA transcript expressed in the absence of the compound, and wherein the mature RNA transcript is selected from a wildtype or non-wildtype mature RNA transcript.
[0011] In another aspect, described herein are methods for modulating the amount or type of mature mRNA transcript produced from pre-mRNA containing a RNA REMS. In another aspect, described herein are artificial gene constructs comprising a DNA REMS or RNA REMS, which may be used in the context of, e.g., gene therapy or reporter assays. In another aspect, described herein are methods for engineering a gene to become such an artificial gene construct from an endogenous gene, wherein the artificial gene construct contains a non-wildtype DNA REMS or a non-wildtype RNA REMS. In another aspect, the REMS is an endogenous 5’ splice site in a pre-mRNA. In another aspect, the REMS is a canonical endogenous 5’ splice site in a pre-mRNA. In another aspect, the REMS is a noncanonical endogenous 5’ splice site in a pre- mRNA.
[0012] In one aspect, described herein is a method for modulating an amount or type of a mature RNA transcript expressed, comprising contacting a pre-mRNA transcript with a compound of Formula (I), or form thereof, wherein the pre-mRNA transcript is (a) transcribed from a gene comprising a DNA REMS nucleotide sequence sele cted from the group consisting of SEQ ID NO. 1 to SEQ ID NO. 5775, (b) transcribed from a gene selected from Table 5, and/or (c) comprises an RNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 5776 to SEQ ID NO. 11550, wherein the compound of Formula (I) has a structure having
Ri, R3, R4, R5, and Re as defined herein, wherein the compound is contacted with the RNA REMS nucleotide sequence in a cell lysate or in a cell in cell culture, whether in vivo or ex vivo, to express the mature RNA transcript, wherein the amount or type of mature RNA transcript expressed in the presence of the compound is modulated compared to the amount or type of mature RNA transcript expressed in the absence of the compound, and wherein the mature RNA transcript is selected from a wildtype or non-wildtype mature RNA transcript.
[0013] In one aspect, described herein is an artificial gene construct, which comprises (a) DNA encoding exons, a 3' splice site(s) and a branch point(s), wherein a nucleotide sequence encoding an exon, which is upstream of a nucleotide sequence encoding a branch point and a nucleotide sequence encoding a 3' splice site, (b) DNA encoding exons and one, two or more introns, wherein a nucleotide sequence encoding a 5' splice site, which is upstream of a nucleotide sequence encoding a branch point and a nucleotide sequence encoding a 3' splice site; or (c) DNA encoding exons, a 5' splice site(s), a 3' splice site(s) and a branch point(s), wherein a nucleotide sequence encoding a 5' splice site, which is upstream of a nucleotide sequence encoding a 3' splice site; and wherein the artificial gene construct is modified to introduce a nucleotide sequence encoding a non-endogenous REMS comprising a sequence selected from the group consisting of SEQ ID NO. 1 to SEQ ID NO. 5775
[0014] In one aspect, described herein is a method of regulating the amount or type of a protein produced by a gene, comprising contacting a compound of Formula (I), or form thereof, with a pre-mRNA transcript transcribed from a gene, wherein the gene comprises a DNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 1 to SEQ ID NO. 5775, and the pre-mRNA transcript transcribed from the gene comprises a RNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 5776 to SEQ ID NO. 11550, wherein, the compound of Formula (I) has the structure having Ri, R3, R4, R5, and Re as defined herein, wherein the compound is contacted with the RNA REMS nucleotide sequence in a cell lysate or in a cell in cell culture, whether in vivo or ex vivo, to express the mature RNA transcript, wherein the amount or type of mature RNA transcript expressed in the presence of the compound is modulated compared to the amount or type of mature RNA transcript expressed in the absence of the compound, and wherein the mature RNA transcript is selected from a wildtype or non-wildtype mature RNA transcript.
DETAILED DESCRIPTION
[0015] In one aspect, described herein is a method for modulating an amount or type of a mature RNA transcript expressed, comprising contacting a compound of Formula (I), or form thereof, with a pre-mRNA transcript transcribed from a gene, wherein the gene comprises a DNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 1 to SEQ ID NO. 5775, and the pre-mRNA transcript transcribed from the gene comprises a RNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 5776 to SEQ ID NO. 11550, wherein, the compound of Formula (I) has the structure:
[0016] wherein:
[0017] Ri is phenyl or heteroaryl, optionally substituted with one, two, three, or four, independently selected Ria substituents,
[0018] wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S;
[0019] R1a is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, or C1-6alkoxy;
[0020] R3 is hydrogen, C1-6alkyl, C2-salkenyl, C2-6alkynyl, and C1-6alkyl-amino, wherein C1-6alkyl, C2-6alkenyl, and C2-6alkynyl is optionally substituted with one, two, three, or four independently selected Ria substituents, and
[0021] wherein each instance of C1-6alkyl, C2-6alkenyl, and C2-6alkynyl may optionally contain a chiral carbon having an (R) or (S) configuration;
[0022] R3a is cyano, halo, hydroxy, oxo, C1-6alkyl, halo-C1-6alkyl, Ci-oalkoxy, halo-C1-6alkoxy, carboxyl, amino, C1-6alkoxy-carbonyl, C1-6alkyl-amino, halo-C1-6alkyl-amino, ( C1-6alkyl)2-amino, phenyl-amino, heterocyclyl-amino, heteroaryl-amino, phenyl-(C1-6alkyl)-amino, heterocyclyl-(C1-6alkyl)-amino, heteroaryl-(C1-6alkyl)-amino, C1-6alkyl-thio, C1-6alkyl-sulfoxyl, and C1-6alkyl-sulfonyl,
[0023] wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S,
[0024] wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S;
[0025] wherein each instance of phenyl, heterocyclyl, and heteroaryl is optionally substituted with one, two, three or four independently selected Rsa’ substituents;
[0026] Raa’ is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, or amino;
[0027] Rr is hydrogen, cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, halo-C1-6alkoxy, amino, C1-6alkyl-amino, (C1-6alkyl)2-amino, C3-10cycloalkyl, phenyl, heterocyclyl, or heteroaryl,
[0028] wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S,
[0029] wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S, and
[0030] wherein each instance of C1-6alkyl, C3-10cycloalkyl, phenyl, heterocyclyl, or heteroaryl are optionally substituted with one, two, three, or four independently selected R4a substituents; [0031] R4a is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, or C1-6alkoxy;
[0032] R5 is hydrogen, cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, carbamoyl, C3-10cycloalkyl, or heterocyclyl,
[0033] wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S; and
[0034] Re is hydrogen, halo, or C1-6alkyl;
[0035] wherein the form of the compound is selected from the group consisting of a salt, hydrate, solvate, and tautomer form thereof,
[0036] wherein the compound is contacted with the RNA REMS nucleotide sequence in a cell lysate or in a cell in cell culture, whether in vivo or ex vivo, to express the mature RNA transcript, wherein the amount or type of mature RNA transcript expressed in the presence of the compound is modulated compared to the amount or type of mature RNA transcript expressed in the absence of the compound, and wherein the mature RNA transcript is selected from a wildtype or non-wildtype mature RNA transcript.
[0037] In one aspect, described herein is a method for modulating an amount or type of a mature RNA transcript expressed, comprising contacting a pre-mRNA transcript with a compound of Formula (I), or form thereof, wherein the pre-mRNA transcript is (a) transcribed from a gene comprising a DNA REMS nucleotide sequence sele cted from the group consisting of SEQ ID NO. 1 to SEQ ID NO. 5775, (b) transcribed from a gene selected from Table 5, and/or (c) comprises an RNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 5776 to SEQ ID NO. 11550, wherein the compound of Formula (I) has the structure:
[0038] wherein:
[0039] Ri is phenyl or heteroaryl, optionally substituted with one, two, three, or four, independently selected Ria substituents,
[0040] wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S;
[0041] Ria is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, or C1-6alkoxy;
[0042] R3 is hydrogen, C1-6alkyl, C2-salkenyl, C2-6alkynyl, and C1-6alkyl-amino,
[0043] wherein C1-6alkyl, C2-6alkenyl, and C2-6alkynyl is optionally substituted with one, two, three, or four independently selected Ria substituents, and
[0044] wherein each instance of C1-6alkyl, C2-6alkenyl, and C2-6alkynyl may optionally contain a chiral carbon having an (R) or (S) configuration;
[0045] Ria is cyano, halo, hydroxy, oxo, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, halo-C1-6alkoxy, carboxyl, amino, C1-6alkoxy-carbonyl, C1-6alkyl-amino, halo-C1-6alkyl-amino, (C1-6alkyl)2-amino, phenyl-amino, heterocyclyl-amino, heteroaryl-amino, phenyl-(C1-6alkyl)-amino, heterocyclyl-(C1-6alkyl)-amino, heteroaryl-(C1-6alkyl)-amino, C1-6alkyl-thio, C1-6alkyl-sulfoxyl, and C1-6alkyl-sulfonyl,
[0046] wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S,
[0047] wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S;
[0048] wherein each instance of phenyl, heterocyclyl, and heteroaryl is optionally substituted with one, two, three or four independently selected Raa’ substituents;
[0049] Rja’ is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, or amino;
[0050] Rr is hydrogen, cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, halo-C1-6alkoxy, amino, C1-6alkyl-amino, (C1-6alkyl)2-amino, C3-10cycloalkyl, phenyl, heterocyclyl, or heteroaryl,
[0051] wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S,
[0052] wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S, and
[0053] wherein each instance of C1-6alkyl, C3-10cycloalkyl, phenyl, heterocyclyl, or heteroaryl are optionally substituted with one, two, three, or four independently selected R4a substituents; [0054] R4a is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, or C1-6alkoxy;
[0055] R5 is hydrogen, cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, carbamoyl, C3-10cycloalkyl, or heterocyclyl,
[0056] wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S; and
[0057] Re is hydrogen, halo, or C1-6alkyl;
[0058] wherein the form of the compound is selected from the group consisting of a salt, hydrate, solvate, and tautomer form thereof,
[0059] wherein the compound is contacted with the RNA REMS nucleotide sequence in a cell lysate or in a cell in cell culture, whether in vivo or ex vivo, to express the mature RNA transcript, wherein the amount or type of mature RNA transcript expressed in the presence of the compound is modulated compared to the amount or type of mature RNA transcript expressed in the absence of the compound, and wherein the mature RNA transcript is selected from a wildtype or non-wildtype mature RNA transcript.
[0060] In another aspect, described herein are methods for modulating the amount or type of mature mRNA transcript produced from pre-mRNA containing a RNA REMS. In another
aspect, described herein are artificial gene constructs comprising a DNA REMS or RNA REMS, which may be used in the context of, e.g., gene therapy or reporter assays. In another aspect, described herein are methods for engineering a gene to become such an artificial gene construct from an endogenous gene, wherein the artificial gene construct contains a non-wildtype DNA REMS or a non-wildtype RNA REMS. In another aspect, the REMS is an endogenous 5’ splice site in a pre-mRNA. In another aspect, the REMS is a canonical endogenous 5’ splice site in a pre-mRNA. In another aspect, the REMS is a noncanonical endogenous 5’ splice site in a pre- mRNA.
[0061] In another aspect, described herein are methods for modulating the amount or type of mature mRNA transcript produced from pre-mRNA containing a RNA REMS. In another aspect, described herein are artificial gene constructs comprising a DNA REMS or RNA REMS, which may be used in the context of, e.g., gene therapy or reporter assays. In another aspect, described herein are methods for engineering a gene to become such an artificial gene construct from an endogenous gene, wherein the artificial gene construct contains a non-wildtype DNA REMS or a non -wildtype RNA REMS.
[0062] In one aspect, described herein are methods for modulating the amount or type of one or more mRNA transcripts or proteins thereof expressed as the product of one or more genes, wherein the pre-mRNA transcripts transcribed by the one or more genes comprise a REMS, the methods comprising contacting a cell with a compound of Formula (I)
[0063] or a form thereof, wherein Ri, R3, R4, R5, and Re are defined herein.
[0064] In another aspect, the pre-mRNA transcript is transcribed from a gene comprising a DNA REMs sequence set forth in Table la, wherein the nucleotide sequence ANNNrrrrrr comprises N exonic nucleotides selected from A, C, G or T, and r intronic nucleotides selected from a, c, g or t); Table lb, wherein the nucleotide sequence CNNNrrrrrr comprises N exonic nucleotides selected from A, C, G or T, and r intronic nucleotides selected from a, c, g or t);
Table 1c, wherein the nucleotide sequence GNNNrrrrrr comprises N exonic nucleotides selected from A, C, G or T, and r intronic nucleotides selected from a, c, g or t); and, Table Id, wherein the nucleotide sequence TNNNrrrrrr comprises N exonic nucleotides selected from A, C, G or T, and r intronic nucleotides selected from a, c, g or t). In another aspect, references to Table 1 are inclusive of Tables la-ld unless specified otherwise.
[0069] In another aspect, the pre-mRNA transcript is transcribed from a gene comprising a RNA REMs sequence set forth in Table 2a, wherein the nucleotide sequence ANNNrrrrrr comprises N exonic nucleotides selected from A, C, G or U, and r intronic nucleotides selected from a, c, g or u); Table 2b, wherein the nucleotide sequence CNNNrrrrrr comprises N exonic nucleotides
selected from A, C, G or U, and r intronic nucleotides selected from a, c, g or u); Table 2c, wherein the nucleotide sequence GNNNrrrrrr comprises N exonic nucleotides selected from A, C, G or U, and r intronic nucleotides selected from a, c, g or u); and, Table 2d, wherein the nucleotide sequence TNNNrrrrrr comprises N exonic nucleotides selected from A, C, G or U, and r intronic nucleotides selected from a, c, g or u). In another aspect, references to Table 2 are inclusive of Tables 2a-2d unless specified otherwise.
[0074] In another aspect, the pre-mRNA transcript is transcribed from a gene comprising a DNA REMs sequence set forth in Table 3a, wherein the nucleotide sequence ANNNrrrrrr comprises N exonic nucleotides selected from A, C, G or T, and r intronic nucleotides selected from a, c, g or t); Table 3b, wherein the nucleotide sequence CNNNrrrrrr comprises N exonic nucleotides
selected from A, C, G or T, and r intronic nucleotides selected from a, c, g or t); Table 3c, wherein the nucleotide sequence GNNNrrrrrr comprises N exonic nucleotides selected from A, C, G or T, and r intronic nucleotides selected from a, c, g or t); and, Table 3d, wherein the nucleotide sequence TNNNrrrrrr comprises N exonic nucleotides selected from A, C, G or T, and r intronic nucleotides selected from a, c, g or t). In another aspect, references to Table 3 are inclusive of Tables 3a-3d unless specified otherwise.
[0079] In another aspect, the pre-mRNA transcript is transcribed from a gene comprising a RNA REMs sequence set forth in Table 4a, wherein the nucleotide sequence ANNNrrrrrr comprises N exonic nucleotides selected from A, C, G or U, and r intronic nucleotides selected from a, c, g or u); Table 4b, wherein the nucleotide sequence CNNNrrrrrr comprises N exonic nucleotides selected from A, C, G or U, and r intronic nucleotides selected from a, c, g or u); Table 4c, wherein the nucleotide sequence GNNNrrrrrr comprises N exonic nucleotides selected from A, C, G or U, and r intronic nucleotides selected from a, c, g or u); and, Table 4d, wherein the nucleotide sequence TNNNrrrrrr comprises N exonic nucleotides selected from A, C, G or U, and r intronic nucleotides selected from a, c, g or u). Tn another aspect, references to Table 4 are inclusive of Tables 4a-4d unless specified otherwise.
[0084] In various aspects, a pre-mRNA transcript comprises a REMs sequence transcribed from a gene is selected from a DNA REMs sequence set forth in Table 1 and Table 3 and comprises a REMs sequence expressed from a gene selected from a RNA REMs sequence set forth in Table 2 and Table 4; and, wherein the gene transcribed or expressed is selected from the group consisting of genes in Table 5.
I l l
AFDN, AFF1, AFF3, AFF4, AFG1L, AFG3L1P, AFG3L2, AFMID, AGA, AGAP1, AGAP3, AGAP6, AGAP9, AGBL3, AGBL4, AGFG2, AGGF1, AGK, AGL, AG02, AG03, AG04, AGPAT3, AGPAT4, AGPAT5, AGPS, AGRN, AGTPBP1, AGTR1, AGTRAP, AHCTF1, AHCYL2, AHDC1, AHI1, AHNAK, AHRR, AHSA2P, AIDA, AIFM1, AIFM2, AIG1, AIMP1, AIMP2, AIP, AK2, AK3, AK4, AK8, AK9, AKAP1, AKAP10, AKAP11, AKAP12, AKAP13, AKAP2, AKAP6, AKAP7, AKAP8, AKAP9, AKIP1, AKNA, AKR1A1, AKR1E2, AKR7A2, AKT1, AKT1S1, AKT2, AKT3, AKTIP, ALAD, ALAS1, ALCAM, ALDH16A1, ALDH18A1, ALDH1L2, ALDH2, ALDH3A2, ALDH3B1, ALDH4A1, ALDH5A1, ALDH7A1, ALDOA, ALDOC, ALG1, ALG11, ALG13, ALG14, ALG1L, ALG2, ALG3, ALG5, ALG8, ALG9, ALK, ALKAL2, ALKBH1, ALKBH2, ALKBH3, ALKBH5, ALKBH6, ALKBH8, ALLC, ALMS I, ALOX12-AS1, ALPK1, ALPK2, ALS2, AMACR, AMBRA1, AMDHD2, AMHR2, AMMECRI, AMMECR1L, AMN1, AMOT, AMOTL1, AMPD2, AMPH, AMT, AMY2B, AMZ2, AMZ2P1, ANAPC1, ANAPC10, ANAPC15, ANAPC4, ANAPC7, ANGEL1, ANGEL2, ANGPT1, ANK2, ANK3, ANKEF1, ANKFY1, ANKH, ANKHD1, ANKHD1-EIF4EBP3, ANKIB1, ANKLE2, ANKMY1, ANKMY2, ANKRA2, ANKRD10, ANKRD11, ANKRD12, ANKRD13A, ANKRD13C, ANKRD13D, ANKRD17, ANKRD26, ANKRD27, ANKRD28, ANKRD33B, ANKRD35, ANKRD36, ANKRD37, ANKRD39, ANKRD44, ANKRD45, ANKRD46, ANKRD49, ANKRD54, ANKRD6, ANKS1A, ANKS3, ANKS6, ANKZF1, ANLN, ANO 10, ANO4, ANO5, ANO6, ANO8, ANP32A, ANXA11, ANXA2, ANXA4, ANXA6, ANXA7, AOAH, AOX1, AP1AR, AP1B1, AP1G1, AP1M1, AP1S2, AP1S3, AP2A1, AP2A2, AP2B1, AP2M1, AP3B1, AP3B2, AP3D1, AP3M1, AP3M2, AP3S1, AP3S2, AP4B1, AP4E1, AP4M1, AP5M1, AP5S1, APAF1, APBA1, APBA2, APBA3, APBB2, APC, APCDD1L-AS1, APEH, APEX2, APH1A, APH1B, API5, APIP, APLP1, APLP2, APOBEC3D, APOBEC3F, APOBEC3H, APOCI, APOL1, APOL2, APOL3, APOLD1, APOO, APOOL, APOPT 1, APP, APPBP2, APPL1, APPL2, APTR, APTX, AQR, ARAF, ARAP1, ARAP2, ARCN1, AREL1, ARFGAP1, ARFGAP2, ARFGAP3, ARFGEF1, ARFGEF2, ARFIP1, ARFIP2, ARFRP1, ARHGAP1, ARHGAP10, ARHGAP11A, ARHGAP12, ARHGAP17, ARHGAP19, ARHGAP19-SLIT1, ARHGAP21, ARHGAP22, ARHGAP23, ARHGAP24, ARHGAP26, ARHGAP27P1, ARHGAP27P1-BPTFP1-KPNA2P3, ARHGAP28, ARHGAP29, ARHGAP30, ARHGAP31, ARHGAP32, ARHGAP33, ARHGAP36, ARHGAP39, ARHGAP42, ARHGAP45, ARHGAP5, ARHGAP8, ARHGDIA, ARHGEF1, ARHGEF10, ARHGEF10L, ARHGEF11, ARHGEF12, ARHGEF18, ARHGEF2, ARHGEF25, ARHGEF26, ARHGEF28, ARHGEF3, ARHGEF33, ARHGEF39, ARHGEF4, ARHGEF40, ARHGEF6, ARHGEF7, ARHGEF9, ARID1B, ARID2, ARID4A, ARID4B, ARID5A, ARID5B, ARIHI, ARIH2, ARL13B, ARL14EP, ARL15, ARL16, ARL17A, ARL17B, ARL2, ARL2-SNX15, ARL3, ARL5B, ARL6, ARL6IP6, ARL8A, ARMCI, ARMC10, ARMC2, ARMC4, ARMC4P1, ARMC6, ARMC7, ARMC8, ARMC9, ARMCX1, ARMCX2, ARMCX3, ARMCX5, ARMCX5- GPRASP2, ARMCX6, ARMH1, ARMH3, ARMT1, ARNT, ARNT2, ARNTL, ARNTL2, ARPC3, ARPC5L, ARRB1, ARRB2, ARRDC1, ARRDC2, ARRDC3, ARSB, ARSD, ARSJ, ARSK, ART5, ARV1, ARVCF, AS3MT, ASAH2B, ASAP1, ASAP2, ASAP3, ASB1, ASB13, ASB16-AS1, ASB3, ASB6, ASCC1, ASCC2, ASCC3, ASDURF, ASH1L, ASH2L, ASIC1, ASIC3, ASL, ASNS, ASNSD1, ASPDH, ASPH, ASPM, ASPSCR1, ASTE1, ASTN2, ASXL1, ASXL3, ATAD1, ATAD2, ATAD2B, ATAD3A, ATAD3B, ATAD5, ATCAY, ATE1, ATE1- AS1, ATF2, ATF6, ATF7, ATF7IP2, ATG10, ATG13, ATG16L1, ATG16L2, ATG2B, ATG3, ATG4A, ATG4B, ATG4C, ATG4D, ATG5, ATG7, ATG9A, ATL1, ATL2, ATL3, ATM,
ATN1, AT0X1, ATP10A, ATP10D, ATP11A, ATP11B, ATP11C, ATP13A2, ATP13A3, ATP1A1-AS1, ATP1B3, ATP23, ATP2A3, ATP2B1, ATP2B4, ATP2C1, ATP5F1C, ATP5ME, ATP5MF, ATP5MF-PTCD1, ATP5PB, ATP5PD, ATP5PF, ATP5PO, ATP5S, ATP6AP1L, ATP6V0A1, ATP6V0A2, ATP6V0C, ATP6V0D1, ATP6V0E1, ATP6V1A, ATP6V1C2, ATP6V1D, ATP6V1E1, ATP6V1H, ATP7A, ATP7B, ATP8B4, ATP9A, ATP9B, ATPAF1, ATPAF2, ATR, ATRIP, ATRIP-TREX1, ATRN, ATRNL1, ATRX, ATXN1, ATXN10, ATXN1L, ATXN2, ATXN2L, ATXN3, ATXN7, ATXN7L1, ATXN7L2, ATXN7L3, AUH, AUP1, AURKA, AURKB, AUTS2, AVEN, AVL9, AXIN1, AZI2, AZINI, AZIN1-AS1, AZIN2, B2M, B3GALNT1, B3GALNT2, B3GLCT, B3GNTL1, B4GALNT1, B4GALNT4, B4GALT4, B4GALT5, B4GALT6, B4GALT7, B9D1, B9D2, BAALC, BAB AMI, BABAM2, BACE1, BACH1, BACH2, BAG4, BAHCC1, BATAP2, BAIAP2L1, BAK1, BANP, BAP1, BARD1, BARX2, BAX, BAZ1A, BAZ1B, BAZ2A, BAZ2B, BBC3, BBIP1, BBOF1, BBOX1- AS1, BBS4, BBS5, BBS9, BBX, BCAR1, BCAR3, BCAS3, BCAS4, BCAT1, BCAT2, BCCIP, BCHE, BCKDHB, BCL11A, BCL2, BCL2L1, BCL2L11, BCL2L12, BCL2L13, BCL2L2- PABPN1, BCL7A, BCL7B, BCL7C, BCL9, BCL9L, BCLAF1, BCLAF3, BCOR, BCORL1, BCRP2, BCS1L, BDH1, BDH2, BDKRB2, BDNF-AS, BDP1, BEAN1, BECN1, BEGA1N, BEND5, BEND6, BEND7, BEX4, BFAR, BFSP1, BICC1, BICD1, BICDL1, BICRA, BICRAL, BID, BINI, BIN3, BIRC2, BIRC5, BIRC6, BISPR, BIVM, BIVM-ERCC5, BLM, BLMH, BLNK, BLOC1S5, BLOC1S5-TXNDC5, BLOC1S6, BLVRA, BLZF1, BMF, BMP2, BMP2K, BMP7, BMPR1B, BMPR2, BMS1P14, BMS1P20, BNC2, BNIP1, BNIP2, BOC, BOD1, BOD1L1, BOK, BOLA1, BOLA2, BOLA2-SMG1P6, BOLA2B, BOLA3, BOP1, BORA, BORCS8, BORCS8-MEF2B, BPNT1, BPTF, BRAF, BRAP, BRAT1, BRCA1, BRCA2, BRCC3, BRD1, BRD3, BRD7, BRD8, BRF1, BRF2, BRINP3, BRIP1, BRMS1L, BROX, BRPF1, BRPF3, BRSK2, BRWD1, BRWD3, BSCL2, BSDC1, BSPRY, BTAF1, BTBD19, BTBD2, BTBD3, BTBD7, BTBD9, BTD, BTF3L4, BTG3, BTK, BTLA, BTN2A1, BTN3A2, BTN3A3, BTNL9, BTRC, BUB1, BUD13, BUD23, BVES-AS1, BZW2, C10orfl43, Cl lorfl, Cl lorf24, Cl lorf49, Cl lorf54, Cllorf65, Cllorf74, CllorfBO, Cllorf95, C12orfl0, C12orf29, C12orf4, C12orf49, C12orf73, C12orf75, C12orf76, C14orfl44, C14orf39, C14orf93, C15orf38- AP3S2, C15orf40, C15orf41, C16orf45, C16orf46, C16orf58, C16orf74, C16orf87, C17orf49, C17orf75, C17orf80, C18orf21, C18orf54, C19orfl2, C19orf24, C19orf25, C19orf44, C19orf47, C19orf48, C19orf54, C19orf57, CID, C1GALT1, C1QTNF2, C1QTNF3-AMACR, C1QTNF6, Clorfl09, Clorfl l2, Clorfl23, Clorfl31, Clorfl59, Clorf21, Clorf35, Clorf43, Clorf50, Clorf52, Clorf54, C20orfl94, C20orfl96, C20orfl97, C20orf27, C20orf96, C2 lorf33, C21orf59-TCP10L, C21orf91, C22orf39, C2CD2L, C2CD3, C2CD5, C2orfl5, C2orf27A, C2orf42, C2orf48, C2orf74, C2orf76, C3orfl8, C3orf33, C3orf52, C3orf62, C3orf67, C4orf33, C5, C5AR1, C5orf22, C5or£30, C5orf42, C5orf51, C5orf63, C5orf66, C6orfl06, C6orf203, C6orf62, C6orf89, C6orf99, C7orf26, C7orf31, C7orf50, C7orf55-LUC7L2, C8orf31, C8orf34, C8orf37, C8orf44, C8orf44-SGK3, C8orf58, C8orf59, C8orf88, C9orfi, C9orf78, C9orf85, CAM, CA5B, CA5BP1, CAAP1, CAB39, CAB39L, CABIN1, CABYR, CACFD1, CACNA1A, CACNA1C, CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, CACNB1, CACNB3, CACNB4, CACNG7, CAD, CADM2, CADM4, CADPS2, CALCOCO1, CALCRL, CALD1, CALHM I, CALHM2, CALML4, CALU, CAMK1, CAMKID, CAMK2A, CAMK2D, CAMK2G, CAMK4, CAMKK1, CAMKK2, CAMKMT, CAMLG, CAMSAP 1, CAMSAP2, CAMSAP3, CAMTAI, CAMTA2, CANT1, CAP2, CAPN1, CAPN10, CAPN15, CAPN7, CAPRIN2, CAPS2, CARD11, CARD19, CARD6, CARD8, CARF, CARMI, CARMIL2,
CARNS1, CARS, CARS2, CASC3, CASC4, CASD1, CASK, CASKIN1, CASP1, CASP10, CASP2, CASP3, CASP7, CASP8, CASP8AP2, CASP9, CAST, CASTOR1, CASTOR3, CATSPER1, CATSPER3, CATSPERZ, CAVIN4, CBFA2T2, CBFA2T3, CBFB, CBL, CBLB, CBLL1, CBR4, CBS, CBWD1, CBWD2, CBWD3, CBWD6, CBX2, CBX4, CBX5, CBY1, CC2D2A, CCAR1, CCAR2, CCDC102B, CCDC106, CCDC112, CCDC115, CCDC125, CCDC126, CCDC127, CCDC130, CCDC134, CCDC136, CCDC137, CCDC138, CCDC14, CCDC144NL-AS1, CCDC149, CCDC150, CCDC152, CCDC159, CCDC163, CCDC169, CCDC169-SOHLH2, CCDC171, CCDC18, CCDC18-AS1, CCDC181, CCDC183, CCDC183- AS1, CCDC186, CCDC188, CCDC189, CCDC191, CCDC192, CCDC25, CCDC26, CCDC28B, CCDC32, CCDC36, CCDC40, CCDC43, CCDC57, CCDC58, CCDC61, CCDC66, CCDC7, CCDC74B, CCDC77, CCDC78, CCDC82, CCDC84, CCDC85A, CCDC85C, CCDC88A, CCDC88C, CCDC9, CCDC90B, CCDC91, CCDC92, CCDC93, CCL4L1, CCL4L2, CCM2, CCNB1, CCNC, CCND3, CCNDBP1, CCNE2, CCNF, CCNI, CCNJ, CCNJL, CCNK, CCNL1, CCNL2, CCNQ, CCNT1, CCNT2, CCNY, CCNYL1, CCNYL2, CCP110, CCR6, CCSER1, CCSER2, CCT3, CCT6A, CCT6P1, CCZ1P-OR7E38P, CD109, CD151, CD164, CD200, CD22, CD226, CD24, CD244, CD27-AS1, CD276, CD2AP, CD300LF, CD320, CD33, CD36, CD3D, CD40, CD44, CD46, CD47, CD53, CD55, CD58, CD59, CD68, CD70, CD8B, CD99L2, CDADC1, CDC123, CDC14A, CDC14B, CDC16, CDC23, CDC25A, CDC25B, CDC25C, CDC27, CDC40, CDC42, CDC42BPA, CDC42BPB, CDC42SE1, CDC42SE2, CDC45, CDC5L, CDC6, CDC7, CDCA3, CDCA4, CDCA7, CDCA7L, CDH23, CDH24, CDIPT, CDK10, CDK11A, CDK11B, CDK14, CDK15, CDK16, CDK19, CDK2, CDK20, CDK2AP1, CDK5, CDK5RAP1, CDK5RAP2, CDK6, CDK7, CDK8, CDKAL1, CDKL3, CDKN2B-AS1, CDKN3, CDO1, CDON, CDPF1, CDR2, CDRT4, CDS1, CDV3, CDYL, CEACAM1, CEACAM21, CEBPZ, CEBPZOS, CECR2, CELF1, CELF2, CELF3, CELSR2, CELSR3, CENPA, CENPC, CENPE, CENPH, CENPI, CENPK, CENPL, CENPM, CENPN, CENPO, CENPP, CENPQ, CENPS, CENPS-CORT, CENPT, CENPU, CENPV, CENPX, CEP104, CEP112, CEP126, CEP128, CEP131, CEP135, CEP162, CEP164, CEP170, CEP192, CEP250, CEP290, CEP295, CEP35O, CEP41, CEP44, CEP55, CEP57, CEP57L1, CEP63, CEP68, CEP70, CEP72, CEP76, CEP78, CEP83, CEP85, CEP85L, CEP89, CEP95, CEP97, CEPT1, CERCAM, CERS4, CERS5, CERS6, CES2, CES3, CES4A, CFAP206, CFAP298, CFAP299, CFAP300, CFAP36, CFAP44, CFAP58, CFLAR, CGAS, CGGBP1, CGRRF1, CHAC2, CHAF1A, CHAF1B, CHCHD5, CHCHD6, CHD1, CHD1L, CHD2, CHD3, CHD4, CHD6, CHD8, CHD9, CHEK1, CHEK2, CHFR, CHI3L1, CHID1, CHKA, CHM, CHMP1A, CHMP3, CHMP7, CHN1, CHN2, CHORDCI, CHP1, CHPF2, CHRAC1, CHRM2, CHRNA3, CHRNA5, CHRNB4, CHST10, CHST9, CHSY1, CHTF8, CHTOP, CHURC1, CHURC1-FNTB, C1AO1, CIAPIN1, CIART, CIB2, CIITA, CILP2, CINP, CIP2A, CIPC, CIR1, CIT, CIZ1, CKAP2L, CKAP5, CKLF, CKLF-CMTM1, CKMT1A, CLASP1, CLASP2, CLASRP, CLBA1, CLCC1, CLCN2, CLCN3, CLCN5, CLCN6, CLDN12, CLDND1, CLEC16A, CLEC2D, CLEC4A, CLEC5A, CLEC7A, CLGN, CLHC1, CLINT 1, CLIP1, CLIP2, CLIP3, CLIP4, CLK1, CLK2, CLK3, CLK4, CLMP, CLN3, CLN5, CLN6, CLNS1A, CLOCK, CLPB, CLSPN, CLSTN1, CLSTN3, CLTA, CLTCL1, CLUAP1, CLUHP3, CMAHP, CMAS, CMC1, CMC2, CMC4, CMIP, CMKLR1, CMSS1, CMTM1, CMTM3, CMTM7, CMTM8, CMTR1, CMTR2, CNEP1R1, CNIH1, CNIH2, CNIH3, CNIH4, CNKSR2, CNNM1, CNNM2, CNNM3, CNOT1, CNOTIO, CNOT11, CNOT2, CNOT4, CNOT6, CNOT8, CNOT9, CNPY2, CNPY3, CNPY3- GNMT, CNPY4, CNR2, CNST, CNTFR, CNTLN, CNTN1, CNTN3, CNTN4, CNTNAP1,
CNTNAP3, CNTRL, C0A1, COASY, COBL, COBLL1, COCH, COG1, COG2, COG3, COG4, COG5, COG6, COIL, COL13A1, COL1A2-AS1, COL23A1, COL24A1, COL25A1, COL26A1, COL27A1, COL4A1, COL4A3BP, COL4A5, COL4A6, COL6A2, COL6A3, COL9A3, COLECI 1, COLQ, C0MMD1, COMMDIO, C0MMD2, C0MMD3-BMI1, C0MMD4, C0MMD6, C0MMD9, COMTD1, COP1, COP A, COPB2, COPE, COPG1, COPRS, COPS3, COPS7A, COPS7B, COPS8, COPZ2, COQIOB, COQ2, COQ3, COQ4, COQ5, COQ6, COQ7, COQ8A, COQ8B, COQ9, CORO1B, COROIC, CORO7, CORO7-PAM16, COXIO, COXIO- AS1, COX15, COX16, COX17, COX20, CPB2, CPEB1, CPEB2, CPEB3, CPEB4, CPED1, CPNE1, CPNE2, CPNE3, CPNE5, CPNE7, CPOX, CPPED1, CPQ, CPS1, CPSF1, CPSF2, CPSF4, CPSF6, CPSF7, CPT1A, CPT1C, CPT2, CPVL, CPXM1, CRACR2A, CRACR2B, CRAMP 1, CRAT, CRB1 , CRBN, CRCP, CREB1 , CREB3L4, CREB5, CREBBP, CREBRF, CREBZF, CRELD1, CRELD2, CREM, CRIM1, CRIP2, CRLS1, CRMP1, CRNDE, CROCC, CROCCP2, CROT, CRTC1, CRTC3, CRYBB2P1, CRYBG3, CRYL1, CRYZ, CRYZL1, CRYZL2P, CRYZL2P-SEC16B, CS, CSAD, CSAG3, CSDE1, CSE1L, CSGALNACT2, CSMD2, CSNK1D, CSNK1G1, CSNK1G3, CSNK2A1, CSNK2A2, CSPP1, CSRNP2, CSRNP3, CSRP3, CSTF2, CSTF3, CTBP1, CTBP2, CTBS, CTCF, CEDNEP1, CEDP1, CTDSP2, CTDSPL, CTDSPL2, CTIF, CTNNA2, CTNNAL1, CTNNBIP1, CTNNBL1, CTNND1, CTNS, CTPS2, CTSA, CTSC, CTSF, CTSL, CTTN, CTTNBP2NL, CTU2, CUBN, CUEDC1, CUL1, CUL3, CUL4B, CUL5, CUL7, CUL9, CUTALP, CUTC, CUX1, CUX2, CWC22, CWC25, CWC27, CWF19L1, CWF19L2, CXADR, CXXC1, CXorf38, CXorf57, CXorf65, CYB561, CYB561D1, CYB561D2, CYB5D2, CYB5R1, CYB5R2, CYB5R4, CYB5RL, CYBA, CYBC1, CYFIP1, CYFIP2, CYLD, CYP20A1, CYP27B1, CYP27C1, CYP2S1, CYP2U1, CYP39A1, CYP4V2, CYREN, CYTH1, CYTH2, CYTH3, CYTOR, CZ1P- ASNS, D2HGDH, DAAM1, DAB2, DAB2IP, DACH1, DAG1, DAGLB, DAP3, DAPK1, DAPK3, DARS, DARS2, DAZAP1, DAZAP2, DBF4, DBF4B, DBH, DBNL, DBR1, DBT, DCAF1, DCAF10, DCAF11, DCAF13, DCAF16, DCAF17, DCAF5, DCAF6, DCAF8, DCAKD, DCBLD1, DCBLD2, DCLK2, DCLRE1C, DCP1A, DCP1B, DCP2, DCPS, DCST1, DCST1-AS1, DCTD, DCTN1, DCTN2, DCTN4, DCTN5, DCUN1D2, DCUN1D4, DCUN1D5, DCXR, DDAH1, DDB2, DDC, DDHD1, DDHD2, DDIAS, DDN, DDR2, DDT, DDX1, DDX11, DDX12P, DDX17, DDX19A, DDX19B, DDX20, DDX27, DDX31, DDX41, DDX42, DDX46, DDX49, DDX50, DDX52, DDX55, DDX59, DDX60, DDX60L, DEAF1, DECR1, DECR2, DEDD, DEDD2, DEF8, DEK, DELEI, DENND1A, DENND1B, DENND1C, DENND2C, DENND3, DENND4A, DENND4B, DENND4C, DENND5A, DENND5B, DENND6A, DENR, DEPDC1, DEPDC1B, DEPDC5, DEPTOR, DERA, DERL1, DESI1, DES12, DET1, DEXI, DFFA, DFFB, DGCR2, DGCR5, DGCR6L, DGKA, DGKE, DGKH, DGKI, DGKQ, DGKZ, DGLUCY, DGUOK, DHDDS, DHFR, DHH, DHODH, DHPS, DHRS12, DHRS4, DHRS4L1, DHRS4L2, DHRS7, DHRS7B, DHTKD1, DHX29, DHX30, DHX32, DHX33, DHX34, DHX35, DHX36, DHX37, DHX38, DHX57, DIABLO, DIAPH1, DIAPH2, DIAPH3, DICER1, DICER1-AS1, DIDOI, DIEXF, DIMT1, DIP2A, DIP2B, DIP2C, DIRAS1, DIRC2, DIRC3, DIS3, DIS3L, DIS3L2, DISCI, DISP1, DLAT, DLC1, DLD, DLEU1, DLEU2, DLEU2L, DLG1, DLG3, DLG4, DLG5, DLGAP4, DLGAP4-AS1, DLGAP5, DLST, DLX1, DMAC2, DMAP1, DMC1, DMD, DMKN, DMPK, DMRTA2, DMTF1, DMTN, DMXL1, DMXL2, DNA2, DNAAF2, DNAAF4, DNAAF4-CCPG1, DNAAF5, DNAH10, DNAH14, DNAJB12, DNAIB14, DNAJB4, DNAIB5, DNAIB6, DNAIC1, DNAIC10, DNAJC13, DNAJC17, DNAJC19, DNAJC2, DNAIC21, DNAJC22, DNAIC24, DNAJC25,
DNAJC25-GNG10, DNAJC27-AS1, DNAJC4, DNAJC5, DNAJC6, DNAJC8, DNAL1, DNALI1, DNASE 1L2, DNASE2, DNM1, DNM1L, DNM2, DNM3, DNMBP, DNMT1, DNMT3A, DNMT3B, DNPEP, DNTTIP1, DNTTIP2, D0C2A, D0C2B, D0CK1, DOCK11, DOCK2, DOCK4, DOCK5, DOCK6, DOCK7, DOCK9, DOK1, DOK2, DOK3, DOK6, DOLPP1, DONSON, DOPEY1, DOT1L, DPCD, DPF1, DPF3, DPH1, DPH2, DPH3, DPH5, DPH6, DPH7, DPMI, DPP4, DPP7, DPP8, DPP9, DPY19L1, DPY19L2, DPY19L2P1, DPY19L3, DPY19L4, DPY30, DPYD, DPYSL2, DPYSL3, DPYSL4, DPYSL5, DQX1, DRAM1, DRAM2, DRG2, DRGX, DROSHA, DSCC1, DSE, DSN1, DSP, DST, DSTYK, DTD2, DTL, DTNA, DTNB, DTNBP1, DTWD1, DTX2, DTX2P1-UPK3BP1-PMS2P11, DTYMK, DUBR, DUS1L, DUS2, DUS4L, DUSP11, DUSP16, DUSP22, DUXAP10, DUXAP8, DVL1, DVL3, DYM, DYNC1H1 , DYNC1T2, DYNC1LH , DYNC1LT2, DYNC2H1, DYNC2LI1, DYNLRB1, DYRK1A, DYRK2, DYRK3, DYRK4, DYSF, DZIP1, DZIP1L, DZIP3, E2F3, E2F6, E2F7, E4F1, EAF1, EBAG9, EBF1, EBF3, EBF4, EBLN3P, EBP, EBPL, ECHDC1, ECHDC2, ECU, ECI2, ECM1, ECSIT, ECT2, EDA2R, EDC3, EDEM2, EDEM3, EDIL3, EDRF1, EEA1, EED, EEF1AKMT1, EEF1AKMT2, EEF1D, EEF1E1-BLOC1S5, EEF2K, EEF2KMT, EEFSEC, EFCAB11, EFCAB13, EFCAB14, EFCAB2, EFCAB5, EFCAB7, EFEMP1, EFHD2, EFL1, EFNA1, EFNA3, EFNA4, EFNA5, EFNB3, EFR3A, EFS, EFTUD2, EGFL7, EGLN1, EHBP1, EHBP1L1, EHHADH, EHMT1, EI24, EIF1AD, EIF1AX, EIF2A, EIF2AK1, EIF2AK2, EIF2AK4, EIF2B3, EIF2B5, EIF2D, EIF2S2, EIF2S3, EIF3C, EIF3CL, EIF3H, EIF3I, EIF3J, EIF3K, EIF3M, EIF4A2, EIF4B, EIF4E, EIF4E2, EIF4E3, EIF4G1, EIF4G3, EIF4H, EIF6, EIPR1, ELAC2, ELAVL1, ELAVL2, ELAVL4, ELF2, ELF4, ELFN2, ELK1, ELK3, ELL, ELL2, ELMO1, ELMO2, ELMOD1, ELMOD2, ELMOD3, ELN, ELOC, ELOVL1, ELOVL2, ELOVL4, ELOVL7, ELP1, ELP2, ELP3, ELP5, ELP6, EMB, EMBP1, EMC1, EMC 10, EMC2, EMC3-AS1, EMC4, EMC8, EMG1, EMIDI, EML1, EML2, EML3, EML4, EML5, EML6, EMP3, EMSY, EMX2, ENAH, ENCI, ENDOG, ENDOV, ENKD1, ENO2, ENOSF1, ENOXI, ENOX2, ENPP1, ENTPD1-AS1, ENTPD3-AS1, ENTPD4, ENTPD5, ENTPD6, EOGT, EP300, EP400, EP400P1, EPAS1, EPB41, EPB41L1, EPB41L2, EPB41L3, EPB41L4A, EPB41L4A-AS1, EPB41L5, EPCI, EPDR1, EPG5, EPGN, EPHA1- AS1, EPHA2, EPHA3, EPHA6, EPHA8, EPHB2, EPHB4, EPHX1, EPHX4, EPM2A, EPN1, EPN2, EPRS, EPS15, EPS15L1, EPS8, EPSTI1, ERBB2, ERB IN, ERC1, ERC2, ERCC1, ERCC2, ERCC6L2, ERCC8, ERG28, ERGIC1, ERGIC2, ERGIC3, ERI1, ERI2, ERI3, ERICH1, ERICH2, ERLEC1, ERLIN1, ERLIN2, ERMAP, ERMARD, ERO1A, ERP44, ERVK13-1, ESCO1, ESCO2, ESD, ESF1, ESPL1, ESPNL, ESRRB, ESRRG, ESYT1, ESYT2, ETAA1, ETFA, ETFB, ETFDH, ETFRF1, ETHE1, ETV1, ETV3, ETV4, ETV6, ETV7, EVA1A, EVC, EV15, EWSR1, EXD2, EXD3, EXO1, EXO5, EXOCI, EXOC2, EXOC3, EXOC4, EXOC5, EXOC6, EXOC6B, EXOC7, EXOG, EXOSC1, EXOSC2, EXOSC3, EXOSC7, EXOSC8, EXOSC9, EXT2, EXTL2, EXTL3, EYA1, EYA3, EYA4, EZH1, EZH2, F3, F8, FAAH, FAAH2, FAAP20, FAAP24, FADS1, FADS2, FAF1, FAF2, FAH, FAHD2A, FAHD2B, FAHD2CP, FAIM, FAM102A, FAM103A1, FAM104A, FAM105A, FAM107B, FAM1 10B, FAM111 A, FAM114A1, FAM114A2, FAM117A, FAM117B, FAM118A, FAM118B, FAM120A, FAM120AOS, FAM120B, FAM122B, FAM122C, FAM126A, FAM126B, FAM129A, FAM129B, FAM131A, FAM133B, FAM133DP, FAM135A, FAM13A, FAM13B, FAM149B1, FAM151B, FAM155A, FAM155B, FAM157A, FAM157B, FAM160A1, FAM160A2, FAM160B2, FAM161A, FAM162A, FAM163A, FAM168A, FAM169A, FAM171A1, FAM172A, FAM173A, FAM173B, FAM174A, FAM177A1,
FAM184A, FAM185A, FAM189A2, FAM189B, FAM193A, FAM193B, FAM199X, FAM19A5, FAM204A, FAM206A, FAM207A, FAM208A, FAM208B, FAM20B, FAM210A, FAM212B-AS1, FAM214A, FAM214B, FAM216A, FAM217B, FAM219B, FAM221A, FAM222B, FAM228B, FAM229B, FAM234A, FAM241B, FAM24B, FAM24B-CUZD1, FAM35A, FAM3A, FAM3C, FAM45A, FAM45BP, FAM47E-STBD1, FAM49A, FAM49B, FAM53B, FAM57A, FAM66A, FAM69B, FAM72A, FAM72C, FAM72D, FAM76A, FAM76B, FAM78B, FAM81A, FAM83D, FAM86C1, FAM86C2P, FAM89B, FAM91A1, FAM92A, FAM96A, FAM98B, FAM98C, FAN1, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCG, FANCI, FANCL, FANCM, FANK1, FAR1, FARP1, FARP2, FARS2, FARSB, FASN, FASTK, FASTKD1, FAT1, FAT3, FAXC, FAXDC2, FBF1, FBH1, FBLIM1, FBLN7, FBN1, FBN2, FBRS, FBRSL1 , FBXL12, FBXL13, FBXL17, FBXL20, FBXL21 , FBXL3, FBXL4, FBXL5, FBXL6, FBXL7, FBXL8, FBX011, FBXO16, FBXO17, FBXO21, FBXO22, FBXO25, FBXO31, FBXO33, FBXO34, FBXO38, FBXO4, FBXO41, FBXO42, FBXO44, FBXO46, FBXO5, FBXO7, FBXO9, FBXW11, FBXW4, FBXW7, FBXW8, FBXW9, FCF1, FCGR1A, FCGRT, FCHO1, FCHO2, FCHSD1, FCHSD2, FCRLA, FDFT1, FDX1, FDX1L, FDXR, FECH, FENDRR, FER, FER1L4, FERMT2, FES, FEZ1, FEZ2, FGD2, FGD4, FGD5-AS1, FGF12, FGF13, FGF5, FGFR1, FGFR1OP, FGFR1OP2, FGFR2, FGFR3, FGFR4, FGGY, FHAD1, FHIT, FHL2, FHOD1, FHOD3, FIBP, FIG4, FIGNL1, FIP1L1, FIS1, FIZ1, FKBP10, FKBP14, FKBP15, FKBP1B, FKBP2, FKBP5, FKBP7, FKBP9, FKRP, FKTN, FLAD1, FLCN, FLII, FLJ32255, FLNA, FLNB, FLOT2, FLRT3, FLT1, FLT4, FLVCR1, FLVCR2, FLYWCH1, FLYWCH2, FMN2, FMNL2, FMNL3, FMRI, FN1, FN3K, FN3KRP, FNBP1, FNBP1L, FNBP4, FNDC3A, FNDC3B, FNIP1, FNIP2, FNTA, FNTB, FOCAD, FOLR1, FOPNL, FOXD3-AS1, FOXJ3, FOXK2, F0XM1, FOXN2, FOXN3, FOXO3, FOXP1, FOXP2, FOXP3, FOXP4, FOXRED1, FOXRED2, FPGT, FPGT-TNNI3K, FRA10AC1, FRAS1, FRG1, FRG1-DT, FRG1BP, FRG1CP, FRG1DP, FRG1HP, FRG1JP, FRMD3, FRMD4A, FRMD6, FRMD8, FRMPD4, FRS2, FRY, FRYL, FRZB, FSD1, FSD1L, FSTL1, FSTL5, FTO, FTSJ1, FTX, FUBP1, FUBP3, FUCA2, FUK, FUNDCI, FURIN, FUT10, FUT8, FUZ, FXR1, FXR2, FXYD5, FXYD6, FXYD6-FXYD2, FYN, FZD3, FZD6, FZR1, G2E3, G6PC3, GAA, GABI, GAB2, GABPA, GABPB1, GABPB2, GABRA3, GABRB3, GADD45A, GAK, GAL3ST4, GALE, GALK1, GALK2, GALNS, GALNT10, GALNT11, GALNT13, GALNT18, GALNT2, GALNT3, GALNT6, GALNT7, GALT, GANAB, GANC, GAPVD1, GAREM1, GARNL3, GART, GAS2L1, GAS2L3, GAS5, GAS6, GAS7, GAS8, GATA2, GATA2-AS1, GATA3, GATA4, GATAD2A, GATAD2B, GATB, GATD1, GATD3A, GBA, GBA2, GBAP1, GBF1, GBP IP 1, GBP5, GCA, GCAT, GCC2, GCDH, GCFC2, GCH1, GCLC, GCN1, GCNT1, GCNT2, GCOM1, GCSH, GDAP1, GDAP1L1, GDAP2, GDPD5, GEM1N2, GEMIN4, GEMIN7, GEMIN8, GEN1, GET4, GFI1, GFM1, GFM2, GFOD2, GFPT1, GFPT2, GFRA2, GGA1, GGA3, GGACT, GGCT, GGCX, GGPS1, GGT5, GID4, GID8, GIGYF1, GIGYF2, GIN1, GINM1, GINS1, GINS3, GIPC1, GUI, GIT2, GK, GK5, GKAP1, GLB1, GLCCI1, GLCE, GLDC, GLE1, GLG1, GLI2, GLIPR2, GLMN, GLMP, GLRB, GLRX3, GLS, GLS2, GLT1D1, GLT8D1, GLT8D2, GLTP, GLYCTK, GLYR1, GMCL1, GMDS, GMDS- AS1, GMEB1, GMFB, GMFG, GMIP, GMNN, GMPPB, GMPR2, GNA12, GNA13, GNAS, GNAS-AS1, GNB1, GNB1L, GNB4, GNB5, GNE, GNG2, GNG4, GNG7, GNL2, GNPAT, GNPDA1, GNPDA2, GNPNAT1, GNPTG, GNS, GOLGA2, GOLGA2P10, GOLGA2P5, GOLGA2P7, GOLGA3, GOLGA4, GOLGA6L10, GOLGA6L17P, GOLGA6L9, GOLGB1, GOLIM4, GOLPH3L, GOLT1B, GON4L, GOPC, GORAB, GORASP1, GORASP2, GOSR1,
G0SR2, GPAA1, GPALPP1, GPAT4, GPATCH11, GPATCH2, GPATCH2L, GPATCH4, GPATCH8, GPBP1, GPBP1L1, GPC5, GPC6, GPCPD1, GPD1L, GPHN, GPI, GPKOW, GPN1, GPN3, GPR107, GPR108, GPR137, GPR137B, GPR137C, GPR141, GPR155, GPR160, GPR161, GPR171, GPR173, GPR176, GPR180, GPR63, GPR75-ASB3, GPR85, GPR89A, GPR89B, GPRASP1, GPRASP2, GPRC5D-AS1, GPS1, GPS2, GPSM1, GPSM2, GPX7, GPX8, GRAMD1A, GRAMD2B, GRAMD4, GRB10, GREB1L, GREM2, GRHL1, GRHPR, GRIA3, GRIK2, GRIK5, GRIN2D, GRIN3B, GRIP API, GRK2, GRK3, GRK4, GRK5, GRK6, GRM7, GRM8, GRPEL2, GRTP1, GSl-124K5.i l, GSAP, GSK3B, GSKIP, GSN, GSPT1, GSR, GSS, GSTA4, GSTCD, GSTK1, GSTM2, GSTM4, GSTT1, GSTT2B, GSTT4, GSTZ1, GTDC1, GTF2A2, GTF2B, GTF2F1, GTF2H1, GTF2H2, GTF2H2B, GTF2H2C, GTF2H2C 2, GTF2H3, GTF21, GTF2TP1, GTF2IP20, GTF2TP23, GTF2TP4, GTF2IRD1, GTF2IRD2, GTF2IRD2B, GTF3A, GTF3C2, GTF3C3, GTF3C4, GTF3C5, GTPBP1, GTPBP1O, GTPBP2, GTPBP8, GTSE1, GUCA1A, GUCD1, GUF1, GUK1, GULP1, GUSB, GUSBP1, GUSBP11, GVQW2, GYG1, GYG2, GYSI, GZF1, H2AFV, H6PD, HABP4, HACD1, HACD4, HACE1, HACL1, HADH, HADHB, HAGH, HAGHL, HAGLR, HAND2-AS1, HAPLN1, HARS, HARS2, HAT1, HAUS1, HAUS2, HAUS3, HAUS4, HAUS5, HAUS6, HAUS7, HAUS8, HAX1, HBS1L, HCFC1, HCFC1R1, HCFC2, HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC7, HDAC8, HDAC9, HDDC2, HDGFL2, HDGFL3, HDHD2, HDHD5, HDLBP, HDX, HEATR1, HEATR3, HEATR5A, HEATR5B, HEATR6, HEBP2, HECTD1, HECTD4, HECW1, HECW2, HELLS, HELZ, HEMK1, HENMT1, HERC1, HERC2, HERC2P2, HERC2P3, HERC2P9, HERC3, HERC4, HERC5, HERC6, HERPUD1, HERPUD2, HES4, HEXA, HEXB, HEXDC, HEXIM2, HFM1, HGF, HGH1, HGS, HGSNAT, HHAT, HIBADH, HIBCH, HIF1A, HIF1AN, HIKESHI, HINFP, HINT3, HIP1, HIPK1, HIPK3, HIRA, HIRIP3, HIST1H2BD, HIVEP1, HIVEP2, HIVEP3, HJURP, HK1, HKR1, HLA-A, HLA-C, HLA-DRB1, HLA-DRB4, HLA-F, HLCS, HLTF, HM13, HMBOX1, HMBS, HMCES, HMCN1, HMG20B, HMGA1, HMGCL, HMGCR, HMGCS1, HMGN1, HMGN3, HMGN4, HMGN5, HMGXB3, HMGXB4, HMMR, HNRNPA1, HNRNPA1L2, HNRNPA2B1, HNRNPA3, HNRNPAB, HNRNPC, HNRNPD, HNRNPDL, HNRNPH1, HNRNPK, HNRNPL, HNRNPLL, HNRNPM, HNRNPR, HNRNPUL1, HOGA1, HOMER2, HOOK1, HOOK3, HOXA1 1-AS, HOXA3, HOXA5, HOXA6, HOXA9, HOXB3, HOXB6, HOXB7, HOXB8, HOXC4, HOXC5, HOXDIO, HP1BP3, HPCAL1, HPF1, HPS1, HPS3, HPS4, HPS5, HPSE, HR, HRAS, HRASLS, HRAT17, HRH1, HRH2, HS2ST1, HS3ST3A1, HS6ST1, HS6ST2, HSCB, HSD11B1L, HSD17B12, HSD17B14, HSD17B4, HSD17B7P2, HSDL2, HSF1, HSF2, HSF2BP, HSF4, HSP90AA1, HSPA12A, HSPA14, HSPA4, HSPB11, HSPBAP1, HSPBP1, HSPE1-MOB4, HTD2, HTRA2, HTT, HUWE1, HYAL3, HY1, HYOU1, 1AH1, 1ARS, 1BTK, ICA1, ICA1L, ICE1, ICK, ICMT, IDE, IDH1, IDH3A, IDH3B, IDH3G, IDI1, IDNK, IDS, IFFO1, IFI27L1, IFI27L2, IFI44L, IFITM1, IFNAR1, IFNAR2, IFNGR2, IFRD1, IFT122, IFT140, IFT172, IFT20, IFT22, IFT27, IFT43, IFT52, IFT57, IFT80, IFT81, IFT88, IGBP1, IGDCC4, IGF2BP2, IGF2BP3, IGFBP6, IGFLR1, IGLON5, IGSF1, IGSF3, IK, IKBIP, IKBKB, IKBKE, IKBKG, IKZF1, IKZF4, IKZF5, IL10RA, IL11RA, IL12RB2, IL13RA1, IL15, IL15RA, IL17RA, IL17RB, IL17RC, IL17RE, IL18BP, IL18RAP, IL21R, IL27, IL2RA, IL2RG, IL32, IL4R, IL6R, IL6ST, IL7R, ILDR2, ILF3, ILK, ILKAP, ILVBL, IMMP1L, IMMP2L, IMMT, IMPA1, IMPA2, IMPDH1, INCENP, INF2, ING3, ING4, ING5, INIP, INMT -MIND Y4, INO80C, INO80E, INPPI, INPP4A, INPP5A, INPP5B, INPP5E, INPP5F, INPP5K, INPPL1, INSIGI, INSR, INTS1O, INTS11, INTS12, INTS13, INTS14, INTS2, INTS3, INTS4, INTS4P1,
INTS4P2, INTS7, INTS8, INTS9, INTU, INVS, IP6K1, IP6K2, IPCEF1, IP011, IPO11- LRRC70, IPO4, IPO5P1, IPO7, IPO8, IPO9, IPP, IPPK, IQCB1, IQCC, IQCE, IQCG, IQCH, IQCH-AS1, IQCJ-SCHIP1, IQCK, IQGAP3, IQSEC1, IRAKI, IRAK1BP1, IRAK2, IRAK3, IRAK4, IREB2, IRF2, IRF3, IRF6, ISCA1, ISL1, ISLR2, ISOC2, IST1, ISY1, ISYNA1, ITCH, ITFG1, ITFG2, ITGA1, ITGA10, ITGA3, ITGA7, ITGA8, ITGA9, ITGA9-AS1, ITGAE, ITGAM, ITGAV, ITGAX, ITGB1BP1, ITGB3BP, ITGB5, ITIH5, ITM2A, ITM2C, ITPA, ITPK1, ITPR1, ITPR2, ITSN1, ITSN2, IVD, IVNS1ABP, IZUM04, IADE1, JADE2, JADE3, JAK1, JAK3, JAKMIP2, IAM2, JARID2, JCAD, JKAMP, JMJD1C, JMJD7, JMJD7- PLA2G4B, JMJD8, IOSD2, JPT2, JPX, JTB, KANK1, KANK2, KANSL1, KANSL1L, KANSL2, KANSL3, KARS, KAT2A, KAT5, KAT6A, KAT6B, KAT7, KAT8, KATNA1, KATNAL1, KATNAL2, KATNBL1, KAZN, KBTBD2, KBTBD3, KBTBD8, KCMF1, KCNAB2, KCNAB3, KCNG1, KCNH2, KCNK2, KCNK4, KCNMA1, KCNMB4, KCNN4, KCNQ1, KCNQ5, KCNQ5-IT1, KCNS3, KCNT2, KCTD14, KCTD15, KCTD17, KCTD20, KCTD3, KCTD9, KDELC1, KDELC2, KDM1A, KDM1B, KDM2A, KDM2B, KDM3A, KDM3B, KDM4A, KDM4B, KDM4C, KDM4D, KDM5A, KDM5B, KDM5C, KDM5D, KDM6A, KDM7A, KDM8, KEAP1, KHDC1, KHDRBS3, KHK, KHSRP, K1AA0040, KIAA0100, KIAA0232, KIAA0319L, KIAA0355, KIAA0368, KIAA0391, KIAA0556, KIAA0586, KIAA0753, KIAA0825, KIAA0895, KIAA0895L, KIAA1109, KIAA1147, KIAA1191, KIAA1211, KIAA1217, KIAA1324, KIAA1324L, KIAA1328, KIAA1468, KIAA1522, KIAA1549, KIAA1551, KIAA1586, KIAA1671, KIAA1841, KIAA1958, KIAA2026, KIDINS220, KIF11, KIF13A, KIF13B, KIF14, KIF15, KIF16B, KIF18B, KIF1A, KIF1B, KIF1C, KIF21A, KIF21B, KIF23, KIF24, KIF26B, KIF27, KIF2A, KIF2C, KIF3A, KIF4A, KIF5C, KIF9, KIF9-AS1, KIFAP3, KIFC1, KIN, KIRREL1, KIRREL3, KITLG, KIZ, KLC1, KLC4, KLF12, KLF8, KLHDC10, KLHDC3, KLHDC4, KLHDC8B, KLHL12, KLHL13, KLHL17, KLHL18, KLHL2, KLHL20, KLHL22, KLHL24, KLHL5, KLHL7, KLHL8, KLRB1, KLRC4-KLRK1, KLRD1, KLRG1, KLRG2, KLRK1, KMT2A, KMT2B, KMT2C, KMT2D, KMT2E, KMT5A, KMT5B, KMT5C, KNL1, KNOP1, KNSTRN, KNTC1, KPNA4, KPNA5, KPNA6, KPTN, KRBA1, KRBOX4, KREMEN1, KRI1, KRIT1, KRT8, KSR1, KTN1, KYAT1, KYAT3, L1CAM, L2HGDH, L3HYPDH, L3MBTL2, L3MBTL3, LACTB, LAMA2, LAMA3, LAMA5, LAMB2, LAMC3, LAMP2, LAMP5, LAMTOR4, LARGE1, LARP1, LARP1B, LARP4, LARP4B, LARP7, LARS, LARS2, LAS1L, LASPI, LAT, LAT2, LATS1, LATS2, LBHD1, LBR, LBX2, LCAT, LCLAT1, LCMT1, LCOR, LCORL, LDAH, LDB2, LDHC, LDLR, LDLRAD3, LDLRAD4, LDLRAP1, LEF1, LEMD2, LEMD3, LENEP, LENG8, LEPR, LEPROT, LEPROTL1, LETM1, LETM2, LETMD1, LGALS8, LGALS9, LGMN, EGR4, LGR5, LHFPL2, LHPP, LIAS, L1FR, L1G1, L1G3, LILRA2, LILRB3, LIMCH1, LIME1, LIMK2, LIMS2, LIN37, LIN52, LIN54, LIN7A, LIN9, LINC-PINT, LINC00240, LINC00265, LINC00327, LINC00337, LINC00426, LINC00467, LINC00473, LINC00475, LINC00476, LINC00491, LINC00578, LINC00607, LINC00623, LINC00624, LINC00630, LINC00632, LINC00649, LINC00665, LINC00667, LINC00673, LINC00674, LINC00680, LINC00680-GUSBP4, LINC00693, LINC00869, LINC00886, LINC00888, LINC00893, LINC00899, LINC00926, LINC00937, LINC00941, LINC00958, LINC00960, LINC00963, LINC01000, LINC01029, LINC01033, LINC01060, LINC01085, LINC01088, LINC01117, LINC01128, LINC01169, LINC01184, LINC01224, LINC01234, LINC01237, LINC01250, LINC01278, LINC01296, LINC01358, LINC01410, LINC01456, LINC01515, LINC01547, LINC01572, LINC01578, LINC01605, LINC01684, LINC01876,
LINC01881, LINC01894, LINC01934, LINC02062, LINC02202, LINC02210-CRHR1, LINC02246, LINC02328, LINC02446, LINC02476, LINC02511, LINC02542, LINCR-0002, LINGO 1, LINGO2, LINS1, LIPA, LIPE, LIPE-AS1, LIPT1, LIX1L, LLGL2, LMAN2L, LMBR1, LMBR1L, LMBRD1, LMBRD2, LMCD1, LMLN, LMO7, LMTK3, LNPK, LNX2, LOC100128253, LOC100128594, LOC100128885, LOC100130027, LOC100130691, LOC100130987, LOC100132111, LOC100133091, LOC100133315, LOC100134868, LOC100233156, LOC100287497, LOC100287944, LOC100288203, LOC100288637, LOC100288778, LOC100288798, LOC100420587, LOC100505501, LOC100505874, LOC100505938, LOC100506023, LOC100506207, LOC100506282, LOC100506476, LOC100506844, LOC100506990, LOC100507002, LOC100507053, LOC100507065, LOC100507291, LOC100507377, LOC100507412, LOC100507557, LOC100630923, LOC100996693, LOC100996724, LOC101060091, LOC101448202, LOC101927021, LOC101927027, LOC101927043, LOC101927056, LOC101927151, LOC101927359, LOC101927815, LOC101927827, LOC101928100, LOC101928323, LOC101928516, LOC101928605, LOC101928673, LOC101929066, LOC101929140, LOC101929147, LOC101929231, LOC101929709, LOC101929710, LOC101929767, LOC101930071, LOC102606465, LOC102723360, LOC102723780, LOC102724219, LOC102724297, LOC102724532, LOC102724593, LOC102724843, LOC102724951, LOC102725126, LOC103091866, LOC105369147, LOC105369980, LOC105370401, LOC105372273, LOC105378853, LOC107984035, LOC107984974, LOCI 10117498-PIK3R3, LOC145694, LOC148413, LOC150776, LOC155060, LOC283683, LOC283788, LOC284581, LOC339862, LOC389765, LOC389831, LOC389906, LOC392232, LOC399815, LOC400464, LOC400927, LOC400927-CSNK1E, LOC440434, LOC441242, LOC441601, LOC441666, LOC642846, LOC642852, LOC643339, LOC645166, LOC645513, LOC648987, LOC653080, LOC654342, LOC727751, LOC728613, LOC728730, LOC729218, LOC729732, LOC729970, LONP2, LONRF1, LONRF3, LOXL2, LOXL3, LPAR1, LPAR2, LPAR3, LPCAT1, LPCAT2, LPCAT3, LPCAT4, LPGAT1, LPIN1, LPP, LPXN, LRBA, LRCH3, LRCH4, LRIF1, LRIG1, LRIG2, LRIG3, LRMDA, LRMP, LRP1, LRP11, LRP12, LRP2, LRP5, LRP8, LRPPRC, LRR1, LRRC14, LRRC17, LRRC23, LRRC28, LRRC34, LRRC37A2, LRRC37B, LRRC40, LRRC42, LRRC45, LRRC49, LRRC4B, LRRC58, LRRC6, LRRC69, LRRC73, LRRC75A-AS1, LRRC75B, LRRC8A, LRRC8B, LRRC8D, LRRCC1, LRRFIP1, LRRFIP2, LRRK1, LRRK2, LRRN3, LRSAM1, LRTOMT, LSG1, LSM1, LSM12, LSM14A, LSM14B, LSM5, LSR, LSS, LTA4H, LTB4R, LTBP1, LTBP3, LTBP4, LTN1, LUC7L, LUC7L3, LUZP1, LY75, LY75- CD302, LY96, LYAR, LYPD1, LYPD6B, LYPLA1, LYPLAL1, LYRM1, LYRM4-AS1, LYRM7, LYSMD1, LYSMD4, LYST, LZ1C, LZTFL1, MACF1, MACROD1, MACROD2, MAD1L1, MADD, MAEA, MAFG, MAFG-AS1, MAGEA12, MAGEA2, MAGEA2B, MAGI1, MAGI2, MAGI2-AS3, MAGI3, MAGOH, MAGOHB, MAGT1, MAIP1, MAK16, MALL, MALSU1, MALT1, MAMDC4, MAML1, MAML3, MAMLD1, MAN1A2, MAN1C1, MAN2B2, MAN2C1, MANBA, MANBAL, MANEAL, MAP1LC3B, MAP2, MAP2K1, MAP2K4, MAP2K5, MAP2K6, MAP2K7, MAP3K10, MAP3K15, MAP3K2, MAP3K20, MAP3K21, MAP3K3, MAP3K4, MAP3K5, MAP3K7, MAP3K8, MAP3K9, MAP4, MAP4K1, MAP4K2, MAP4K3, MAP4K4, MAP4K5, MAP6, MAP6D1, MAP7D1, MAP9, MAPK10, MAPK1 1, MAPK12, MAPK13, MAPK14, MAPK3, MAPK6, MAPK7, MAPK8, MAPK8IP3, MAPK9, MAPKAP1, MAPKAPK3, MAPKAPK5, MAPKAPK5-AS1, MAPKBP1, MAPT, MARC1, MARCH1, MARCH3, MARCH5, MARCH6, MARCH7, MARCH8, MARF1,
MARK !, MARK2, MARKS, MARK4, MARVELD2, MAST1, MAST2, MAST3, MAST4, MASTL, MAT2B, MATK, MATR3, MAVS, MAX, MAZ, MBD1, MBD3, MBD4, MBD5, MB IP, MBNL1, MBNL2, MBNL3, MB0AT1, MBOAT2, MBOAT7, MBTD1, MBTPS1, MBTPS2, MCAM, MCAT, MCCC1, MCCC2, MCF2L, MCM3AP, MCM3AP-AS1, MCM4, MCM8, MCM9, MCMBP, MCOLN1, MCOLN3, MCPH1, MCPH1-AS1, MCRIP1, MCRIP2, MCRS1, MCTP1, MCTP2, MCTS1, MCU, MCUB, MCUR1, MDFI, MDM1, MDM2, MDM4, MDN1, MDP1, MEI, ME2, MEAF6, MECOM, MECP2, MECR, MED1, MED11, MED 12, MED12L, MED13, MED13L, MED14, MED15, MED16, MED17, MED19, MED20, MED23, MED24, MED25, MED27, MED30, MED31, MED6, MED8, MEF2A, MEF2B, MEF2C, MEF2C-AS1, MEG3, MEG8, MEGF11, MEGF6, MEGF8, MEGF9, MEI1, MEIS1, MEIS2, MEIS3, MELK, MELTF, MEM01, MEN1, MERTK, MET, MET API, METAP ID, METRN, METTL1, METTL13, METTL14, METTL15, METTL16, METTL21A, METTL22, METTL23, METTL25, METTL26, METTL2A, METTL2B, METTL4, METTL5, METTL6, METTL8, METTL9, MEX3B, MFF, MFGE8, MFHAS1, MFN1, MFN2, MFNG, MFSD10, MFSD11, MFSD12, MFSD13A, MFSD14B, MFSD14C, MFSD6, MFSD8, MFSD9, MGA, MGARP, MGAT1, MGAT3, MGAT4B, MGAT4C, MGAT5, MGEA5, MGME1, MGMT, MGP, MGRN1, MGST1, MGST2, MGST3, MIA-RAB4B, MIA2, MIA3, MIAT, MIATNB, MIB1, MIB2, MIC AL 1 , MICAL2, MICAL3, MICALL1, MICALL2, MICB, MICU2, MIDI, MID2, MIER1, MIER2, MIER3, MIF4GD, MIGA1, MIIP, MINDY1, MINDY2, MINDY3, MINDY4, MINK1, MINOS1, MINOS1-NBL1, MIOS, MIPEP, MIPEPP3, MIPOL1, MIR100HG, MIR1268A, MIR22HG, MIR31HG, MIR4435-2HG, MIR5095, MIR5096, MIR548G, MIR548H3, MIR548H4, MIR548N, MIR570HG, MIR646HG, MIR9-3HG, MIR924HG, MIR99AHG, MIRLET7BHG, MIS 12, MIS18BP1, MITD1, MITF, MKI67, MKKS, MKL1, MKL2, MKLN1, MKNK1, MKNK2, MKRN1, MKRN2, MKS1, MLC1, MLF1, MLH1, MLH3, MLLT1, MLLT10, MLLT3, MLPH, MLST8, MLXIP, MLXIPL, MMAB, MMD, MMGT1, MMP16, MMP19, MMP23B, MMP24-AS 1 -EDEM2, MMP24OS, MMP25-AS1, MMS19, MMS22L, MNAT1, MND1, MOB1B, MOB3A, MOCOS, MOCS1, MOCS2, MOK, MON1A, M0N2, MORC2, MORC3, MORF4L1, MORF4L2, MORN I, MORN3, MOSMO, MOSPD1, MOSPD2, MOSPD3, MOVIO, MOV10L1, MPDU1, MPDZ, MPHOSPH6, MPHOSPH8, MPHOSPH9, MPI, MPND, MPP2, MPP3, MPP4, MPP5, MPP6, MPPE1, MPPED2, MPRIP, MPST, MPV17, MPZL1, MPZL3, MR1, MRAS, MRC1, MRC2, MRE11, MREG, MRFAP1, MRNIP, MROH1, MROH6, MRPL13, MRPL17, MRPL18, MRPL2, MRPL21, MRPL22, MRPL24, MRPL33, MRPL38, MRPL43, MRPL45, MRPL47, MRPL48, MRPL52, MRPL55, MRPL9, MRPS10, MRPS18A, MRPS18C, MRPS25, MRPS28, MRPS30-DT, MRPS31, MRPS31P5, MRPS36, MRPS5, MRRF, MRS2, MRV11, MS4A14, MS4A3, MS4A6A, MS4A7, MSANTD2, MSANTD3-TMEFF1, MSANTD4, MSC-AS1, MSH2, MSH3, MSI1, MSL1, MSL3, MSRA, MSTO1, MSTO2P, MTA1, MT A3, MTCH2, MTCL1, MTCP1, MTDH, MTERF2, MTERF3, MTERF4, MTF2, MTFP1, MTFR1, MTFR2, MTG2, MTHFD2, MTHFD2L, MTHFS, MTHFSD, MTIF2, MTIF3, MTM1, MTMR1, MTMR10, MTMR12, MTMR14, MTMR2, MTMR3, MTMR6, MTMR7, MTMR8, MTO1, MTOR, MTR, MTREX, MTRF1, MTRF1L, MTRNR2L2, MTRR, MTSS1L, MTUS1, MTX1, MTX2, MTX3, MUM1, MUTYH, MVB12A, MVB12B, MVD, MVK, MX1, MXD3, MXI1, MXRA7, MYBL1, MYBL2, MYCBP2, MYEF2, MYH10, MYH14, MYHAS, MYL6B, MYLIP, MYLK, MYLK- AS1, MYNN, MYOIO, MYO18A, MY019, MYO1B, MYO1C, MYOID, MYO1E, MYO5A, MYO5B, MYO5C, MY06, MYO9A, MYO9B, MYOF, MY0M2, MYSM1, MYT1, N4BP1,
N4BP2, N4BP2L1, N4BP2L2, N6AMT1, NAA15, NAA16, NAA25, NAA35, NAA40, NAA50, NAA60, NAAA, NAALAD2, NAB1, NAB2, NABP1, NACC2, NADK, NADK2, NADSYN1, NAE1, NAF1, NAGA, NAGK, NAGPA, NAIP, NAMPT, NANS, NAP1L1, NAP1L4, NAPA, NAPB, NAPG, NAPSA, NARF, NARFL, NARS2, NASP, NAT6, NAVI, NAV2, NAV3, NAXD, NAXE, NBAS, NBDY, NBEA, NBEAL1, NBEAL2, NBL1, NBN, NBPF1, NBPF10, NBPF11, NBPF12, NBPF14, NBPF15, NBPF19, NBPF20, NBPF25P, NBPF26, NBPF3, NBPF8, NBPF9, NBR1, NBR2, NCALD, NCAM1, NCAPD3, NCAPG, NCAPG2, NCBP3, NCF4, NCK2, NCKAP1, NCKAP5, NCKAP5L, NCKIPSD, NCOA1, NCOA2, NCOA6, NCOA7, NCOR1, NCOR2, NCS1, NCSTN, NDC1, NDE1, NDEL1, NDFIP2, NDOR1, NDRG1, NDRG2, NDRG3, NDRG4, NDST1, NDUFA10, NDUFA12, NDUFA3, NDUFA4L2, NDUFA6-AS1, NDUFA8, NDUFAF1, NDUFAF2, NDUFAF5, NDUFAF6, NDUFAF7, NDUFAF8, NDUFB5, NDUFB6, NDUFC1, NDUFC2-KCTD14, NDUFS1, NDUFS2, NDUFS8, NDUFV1, NDUFV2, NDUFV3, NEBL, NECAB3, NECAP2, NEDD1, NEDD4, NEDD4L, NEDD9, NEIL2, NEIL3, NEK1, NEK 10, NEK11, NEK4, NEK7, NEK9, NELFA, NELFCD, NEMF, NEMP1, NENF, NEO1, NEPRO, NET1, NETO2, NEURL1B, NEURL4, NEXN, NF1, NF2, NFASC, NFAT5, NFATC2, NFATC21P, NFATC3, NFATC4, NFE2E1, NFIB, NFIC, NFIX, NFKB1, NFRKB, NFS1, NFU1, NFX1, NFYB, NFYC, NGDN, NGLY1, NHEJ1, NHLRC3, NHSL1, NICN1, NIDI, NID2, NIF3L1, NIFK, NIN, NINE, NIP7, NIPA1, NIPA2, NIPBL, NIPSNAP1, NIPSNAP2, NISCH, NITI, NIT2, NKAIN1, NKAPD1, NKIRAS1, NKIRAS2, NKTR, NLE1, NLGN1, NLGN2, NLK, NLN, NLRC3, NLRC5, NLRP3, NLRX1, NMD3, NME1-NME2, NME3, NME6, NME7, NMNAT1, NMRAL1, NMRK1, NMT1, NMT2, NMU, NNT, NNT-AS1, NOA1, NOC2L, NOC4L, NOCT, NODI, NOLIO, NOLI 1, NOL12, NOL3, NOL4, NOL4L, NOL8, NOL9, NOLC1, NOMO2, NOP16, NOP58, NOS1AP, NOTCH 1, NOTCH2, NOTCH2NL, NOTCH3, NOVAI, NOX4, NOX5, NPAS1, NPAS2, NPC1, NPEPPS, NPFFR2, NPHP1, NPHP3, NPHP4, NPIPA1, NPIPB5, NPL, NPLOC4, NPM1, NPM3, NPNT, NPR1, NPR2, NPRL2, NPRL3, NQO1, NQO2, NR1D2, NR1H3, NR2C1, NR2C2, NR2F1-AS1, NR3C1, NR4A1, NR6A1, NRBF2, NRCAM, NRDC, NRDE2, NREP, NRF1, NRG1, NRG2, NRG3, NRG4, NRIP1, NRN1, NRP1, NRSN2, NRXN3, NSD1, NSD2, NSD3, NSDHL, NSF, NSFL1C, NSFP1, NSG1, NSL1, NSMAF, NSMCE1, NSMCE2, NSMCE4A, NSMF, NSRP1, NSUN2, NSUN3, NSUN4, NSUN5P1, NSUN5P2, NSUN6, NT5C, NT5C1A, NT5C2, NT5C3A, NT5C3B, NT5DC2, NT5M, NTAN1, NTHL1, NTM, NTMT1, NTNG1, NTPCR, NTRK1, NTRK2, NTRK3, NUB1, NUBP1, NUBPL, NUCB2, NUDCD2, NUDT1, NUDT14, NUDT17, NUDT19, NUDT2, NUDT22, NUDT3, NUDT7, NUF2, NUFIP1, NUFIP2, NUMA1, NUMB, NUP107, NUP133, NUP153, NUP155, NUP188, NUP210, NUP214, NUP37, NUP43, NUP50, NUP50-AS1, NUP54, NUP58, NUP62CL, NUP85, NUP88, NUP93, NUP98, NUPL2, NUS1, NUTF2, NUTM2A-AS1, NUTM2B-AS1, NVL, NXN, NXPE3, NXT2, OARD1, OAZ1, OAZ3, OBSCN, OBSL1, OCA2, OCEL1, OCIAD1, OCIAD2, OCRL, ODAM, ODF2, ODF2L, ODF3B, ODR4, OFD1, OGDH, OGDHL, OGFOD2, OGFOD3, OGFRL1, OGGI, OGT, OIP5, OLA1, OLFM2, OLMALINC, OLR1, OMA1, OPA1, OPCML, OPHN1, OPLAH, OPN3, OPTN, OR2A1-AS1, ORAI2, ORAI3, ORAOV1, ORC1, ORC2, ORC3, ORC4, ORC5, ORC6, ORMDL1, ORMDL2, OS9, OSBP2, OSBPL1A, OSBPL3, OSBPL6, OSBPL7, OSBPL8, OSBPL9, OSCP1, OSER1, OSER1-AS1, OSGEPL1, OSGIN2, OSMR-AS1, OSTC, OSTF1, OTOGL, OTUD5, OTUD6B, OTULIN, OXAIL, OXCT1, OXNAD1, OXR1, OXSR1, P2RX4, P2RX7, P2RY10, P2RY6, P3H1, P3H3, P3H4, P4HA1, P4HA2, PAAF1, PABPC4, PABPN1, PACRGL, PACS1, PACS2,
PAFAH2, PAG1, PAICS, PAIP1, PAK1, PAK1IP1, PAK2, PAK3, PAK4, PALB2, PALLD, PALM, PALM2, PALM2-AKAP2, PAM, PAM16, PAMR1, PAN2, PAN3, PANK1, PANK2, PANKA, PANXI, PAOX, PAPD4, PAPD5, PAPD7, PAPOLA, PAPOLG, PAQR3, PAQR5, PAQR7, PAQR8, PARD3, PARD6G, PARG, PARGP1, PARE, PARM1, PARN, PARP11, PARP15, PARP2, PARP4, PARP6, PARP8, PARP9, PARPBP, PARVB, PASK, PATJ, PATL1, PATZ1, PAX3, PAX5, PAX6, PAX8-AS1, PAXIP1, PAXX, PBDC1, PBRM1, PBX1, PBX3, PBXIP1, PC, PCBD2, PCBP1-AS1, PCBP2, PCBP3, PCBP4, PCCA, PCCB, PCDH7, PCDH9, PCDHAC1, PCED1A, PCED1B, PCGF1, PCGF2, PCGF3, PCGF5, PCGF6, PCID2, PCK2, PCLO, PCM1, PCMTD1, PCMTD2, PCNP, PCNT, PCNX1, PCNX2, PCNX3, PCNX4, PCSK4, PCSK6, PCSK7, PCTP, PCYT1A, PCYT2, PDCD11, PDCD2, PDCD2L, PDCD4, PDCD6, PDCD6TPP2, PDCD7, PDE10A, PDE1 C, PDE3A, PDE3B, PDE4B, PDE4D, PDE4DIP, PDE6B, PDE6D, PDE7A, PDE8A, PDE9A, PDF, PDGFC, PDGFD, PDGFRB, PDHA1, PDHX, PDIA5, PDIK1L, PDK1, PDK3, PDLIM2, PDLIM3, PDLIM4, PDLIM5, PDPK1, PDPR, PDS5A, PDS5B, PDSS1, PDSS2, PDXDC1, PDXDC2P-NPIPB14P, PDXK, PDZD11, PDZD2, PDZD8, PDZK1, PEAK1, PEAR1, PEF1, PELI1, PELI2, PELI3, PELO, PEMT, PER3, PET100, PEX1, PEX11A, PEX1 IB, PEX11G, PEX14, PEX16, PEX19, PEX2, PEX26, PEX3, PEX5, PEX6, PEX7, PFAS, PFDN1, PFKFB3, PFKL, PFKM, PGAM5, PGAP1, PGAP2, PGAP3, PGF, PGGT1B, PGLS, PGM2, PGM2L1, PGM3, PGS1, PHACTR2, PHACTR3, PHACTR4, PHC1, PHC2, PHC3, PHETA1, PHETA2, PHEX, PHF10, PHF11, PHF12, PHF14, PHF19, PHF20, PHF20L1, PHF21A, PHF21B, PHF3, PHF6, PHF7, PHF8, PHKA1, PHKA2, PHKB, PHKG2, PHLDB1, PHLDB2, PHLPP2, PHOSPHO2-KLHL23, PHRF1, PHTF1, PHTF2, PHYH, PHYHD1, PHYKPL, PI4K2A, PI4K2B, PI4KA, PI4KB, PIAS1, PIAS2, PIAS3, PIBF1, PICALM, PICK1, PIEZO1, PIGA, PIGB, PIGF, PIGG, PIGH, PIGK, PIGL, PIGN, PIGO, PIGP, PIGQ, PIGT, PIGU, PIGX, PIK3AP1, PIK3C2A, PIK3C3, PIK3CB, PIK3CD, PIK3R2, PIK3R3, PIKFYVE, PIN1, PINX1, PIP4K2A, PIP4K2B, PIP4K2C, PIP4P1, PIP4P2, PIP5K1A, PIP5K1C, PIR, PITHD1, PITPNA, PITPNC1, PITPNM2, PITPNM3, PIWIL4, PKD1, PKD1P1, PKD1P3-NPIPA1, PKD1P4-NPIPA8, PKD1P6-NPIPP1, PKD2, PKDCC, PKIA, PKIB, PKIG, PKN2, PKNOX1, PKNOX2, PKP4, PLA2G12A, PLA2G15, PLA2G4A, PLA2G4B, PLA2G6, PLA2G7, PLA2R1, PLAA, PLAC1, PLAC8, PLAGL1, PLAT, PLB1, PLBD2, PLCB1, PLCB3, PLCB4, PLCD4, PLCG2, PLCL1, PLD1, PLD3, PLEC, PLEK2, PLEKHA1, PLEKHA2, PLEKHA4, PLEKHA5, PLEKHA6, PLEKHA7, PLEKHA8, PLEKHB1, PLEKHB2, PLEKHG2, PLEKHG3, PLEKHG4, PLEKHH3, PLEKHJ1, PLEKHM1P1, PLEKHM2, PLEKHM3, PLGRKT, PLK3, PLK4, PLOD1, PLOD2, PLPP4, PLPP5, PLPPR2, PLRG1, PLS1, PLSCR1, PLSCR4, PLXNA4, PLXNB1, PLXNB2, PLXNC1, PLXND1, PM20D2, PMEL, PMF1, PMM1, PMM2, PMS1, PMS2, PMS2P1, PMS2P4, PMS2P5, PMVK, PNISR, PNKP, PNLDC1, PNN, PNO1, PNPLA6, PNPLA8, PNPO, PNPT1, POC1A, POC1B, POC5, PODXL2, POFUT1, POFUT2, POGK, POGLUT1, POGZ, POLA1, POLA2, POLB, POLD2, POLDIP3, POLE, POLE2, POLG, POLG2, POLI, POLK, POLL, POLM, POLN, POLQ, POLR1A, POLR1B, POLR1D, POLR2B, POLR2D, POLR2F, POLR2J, POLR2J3, POLR2J4, POLR3A, POLR3B, POLR3C, POLR3E, POLR3F, POLR3G, POLR3GL, POLR3H, POLRMT, P0M121, POM121C, POMGNT1, POMT1, POMT2, POP1, POP4, POP5, POPDC3, PORCN, POTI, POT1-AS1, POU2F1, POU2F2, POU6F1, PPA1, PPA2, PPAN- P2RY11, PPARA, PPARD, PPARG, PPARGC1B, PPCDC, PPCS, PPDPF, PPFIA1, PPFIA3, PPFIA4, PPFIBP1, PPHLN1, PPIA, PPID, PPIE, PPIEL, PPIF, PPIH, PPIL2, PPIL3, PPIP5K1P1-CATSPER2, PPIP5K2, PPM1A, PPM1B, PPM1D, PPM1E, PPM1H, PPM1K,
PPM1M, PPOX, PPP1CB, PPP1CC, PPP1R12A, PPP1R12B, PPP1R12C, PPP1R13B, PPP1R16A, PPP1R16B, PPP1R1C, PPP1R2, PPP1R21, PPP1R35, PPP1R36, PPP1R37, PPP1R7, PPP1R8, PPP2CA, PPP2R1B, PPP2R2A, PPP2R2B, PPP2R2C, PPP2R2D, PPP2R3C, PPP2R5A, PPP2R5B, PPP2R5C, PPP2R5D, PPP2R5E, PPP3CB, PPP3CC, PPP3R1, PPP4C, PPP4R1, PPP4R2, PPP4R3A, PPP4R3B, PPP4R4, PPP5C, PPP5D1, PPP6C, PPP6R1, PPP6R2, PPP6R3, PPRC1, PPWD1, PQBP1, PQLC1, PQLC2, PQLC2L, PQLC3, PRADC1, PRAF2, PRAG1, PRC1, PRCC, PRDM15, PRDM16, PRDM2, PRDM4, PRDM5, PRDM6, PRDM8, PREB, PRELID2, PRELID3A, PRELID3B, PREP, PREPL, PRH1, PRH1-PRR4, PRH1- TAS2R14, PRICKLEI, PRIM I, PRIM2, PRIMPOL, PRKAA1, PRKAA2, PRKAB1, PRKAB2, PRKAG1, PRKAG2, PRKAR1B, PRKAR2A, PRKAR2B, PRKCA, PRKCB, PRKCE, PRKCH, PRKCT, PRKCQ, PRKCSH, PRKCZ, PRKD1, PRKD2, PRKD3, PRKDC, PRKG1 , PRKRA, PRKRIP1, PRKX, PRKY, PRMT1, PRMT2, PRMT3, PRMT5, PRMT7, PRMT9, PROCAI, PROK2, PROS1, PROSERI, PROSER2, PROSER3, PRPF18, PRPF3, PRPF38A, PRPF38B, PRPF39, PRPF4, PRPF40A, PRPF40B, PRPF4B, PRPF6, PRPF8, PRPSAP1, PRPSAP2, PRR12, PRR13, PRR14, PRR14L, PRR16, PRR5, PRR5-ARHGAP8, PRR5L, PRRC2B, PRRC2C, PRRG1, PRRG4, PRRT4, PRSS12, PRSS16, PRTFDC1, PRTG, PRUNE1, PSAT1, PSD, PSD3, PSEN1, PSEN2, PSIP1, PSMA1, PSMA3-AS1, PSMA4, PSMA6, PSMB1, PSMB3, PSMB5, PSMC5, PSMC6, PSMD10, PSMD11, PSMD13, PSMD4, PSMD5, PSMD9, PSME2, PSME4, PSMG1, PSMG2, PSPC1, PSPH, PSRC1, PSTK, PSTPIP1, PSTPIP2, PTAR1, PTBP1, PTBP3, PTCD1, PTCD2, PTCD3, PTCHI, PTCHD4, PTDSS2, PTEN, PTER, PTGER3, PTGES3, PTGES3L, PTGES3L-AARSD1, PTGFRN, PTGIS, PTGR1, PTGR2, PTGS1, PTK2, PTK2B, PTK7, PTOV1, PTP4A2, PTP4A3, PTPA, PTPDC1, PTPMT1, PTPN1, PTPN12, PTPN13, PTPN18, PTPN2, PTPN21, PTPN22, PTPN23, PTPN3, PTPN4, PTPN9, PTPRA, PTPRC, PTPRD, PTPRE, PTPRF, PTPRG, PTPRG-AS1, PTPRK, PTPRN, PTPRS, PTPRU, PTRH1, PTS, PUF60, PUM1, PUM2, PUM3, PURPL, PUS1, PUS10, PUS7, PUSL1, PVR, PVRIG2P, PVT1, PWWP2A, PXDC1, PXDN, PXK, PXMP2, PXN, PXN-AS1, PXYLP1, PYCR1, PYCR2, PYCR3, PYGB, PYM1, PYROXD1, PYROXD2, QDPR, QKI, QPCTL, QPRT, QRICH1, QRSL1, QSER1, QSOX2, QTRT1, QTRT2, R3HCC1L, R3HDM1, R3HDM2, R3HDM4, RAB11FIP1, RAB11FIP2, RAB11FIP3, RAB11FIP5, RABI 3, RABI 5, RABI 8, RAB21, RAB22A, RAB23, RAB24, RAB27A, RAB27B, RAB28, RAB29, RAB30, RAB34, RAB35, RAB36, RAB38, RAB3GAP1, RAB3GAP2, RAB3IP, RAB40B, RAB40C, RAB44, RAB4A, RAB4B, RAB4B-EGLN2, RAB5A, RAB5B, RAB6A, RAB8B, RAB9A, RABAC1, RABEP1, RABEPK, RABGAP1, RABGAP1L, RABGEF1, RABGGTB, RABL2A, RABL2B, RABL3, RABL6, RAC1, RAC3, RACGAP1, RADI, RAD17, RAD18, RAD50, RAD51, RAD51 API, RAD51B, RAD51C, RAD51D, RAD51L3-RFFL, RAD52, RAD54B, RAD54L, RAD54L2, RAD9A, RADIL, RAFI, RAH, RAI14, RALA, RALB, RALGAPA1, RALGAPA1P1, RALGAPA2, RALGAPB, RALGDS, RALGPS1, RALGPS2, RALY, RANBP10, RANBP17, RANBP2, RANBP3, RANGAP1, RANGRF, RAP1A, RAP IB, RAP1GAP2, RAP1GDS1, RAP2C, RAP2C-AS1, RAPGEF1, RAPGEF2, RAPGEF6, RAPGEFL1, RAPH1, RARA, RARS2, RASA1, RASA3, RASAL2, RASAL3, RASEF, RASGRF2, RASGRP1, RASGRP3, RASL10B, RASSF1, RASSF2, RASSF3, RASSF4, RASSF8, RASSF8-AS1, RAVER2, RBI, RB1CC1, RBAK, RBAK-RBAKDN, RBBP5, RBBP6, RBBP7, RBBP8, RBBP9, RBCK1, RBFA, RBFOX2, RBL1, RBL2, RBM10, RBM11, RBM12B, RBM14-RBM4, RBM15-AS1, RBM18, RBM19, RBM20, RBM22, RBM23, RBM25, RBM26, RBM26-AS1, RBM27, RBM28, RBM33, RBM34, RBM38, RBM39, RBM4,
RBM41, RBM42, RBM47, RBM48, RBM5, RBM6, RBM7, RBMS I , RBMS2, RBMS3, RBMXL1, RBPJ, RBPMS, RBSN, RBX1, RC3H1, RC3H2, RCAN3, RCBTB1, RCBTB2, RCC1, RCC1L, RCC2, RCCD1, RCE1, RCHY1, RCL1, RCN3, RC0R2, RC0R3, RD3, RDH11, RDH13, RDM1, RECK, RECQL, RECQL4, RECQL5, REEP3, REEP4, RELA, RELB, RELL2, REPIN1, REPSI, RER1, RERE, RERG, RET, RETREG1, RETREG3, RETSAT, REV1, REV3L, REX1BD, REX01, REXO2, REXO5, RFC1, RFC2, RFC3, RFC5, RFESD, RFFL, RFT1, RFWD3, RFX1, RFX2, RFX3, RFX7, RFX8, RFXANK, RGL1, RGN, RGP1, RGPD5, RGPD6, RGS10, RGS11, RGS12, RGS14, RGS19, RGS3, RGS5, RGS7, RHBDD1, RHBDD2, RHBDD3, RHBDF2, RHBDL1, RHCE, RHOBTB1, RHOBTB3, RHOC, RHOJ, RHOQ, RHOT1, RHOT2, RHOU, RIC1, RIC8B, RICTOR, RIDA, RIF1, RILPL1, RILPL2, RIMBP2, RTMS1 , RTMS2, RTMS3, RTN1 , RTN3, RINT1 , RTOK1 , RTOK2, RIOK3, RTOX2, RIPK1, RIPK2, RIPOR1, RIPPL Y2, RITA1, RLF, RLIM, RMCI, RMDN1, RMDN2, RMDN3, RMI1, RMND1, RMND5A, RMND5B, RNASE4, RNASEH1-AS1, RNASEH2B, RNASEK, RNASEK-C17orf49, RNASET2, RND3, RNF10, RNF103-CHMP3, RNF111, RNF114, RNF115, RNF121, RNF123, RNF126, RNF13, RNF130, RNF135, RNF138, RNF14, RNF146, RNF150, RNF152, RNF157, RNF165, RNF166, RNF167, RNF168, RNF170, RNF175, RNF181, RNF185, RNF19A, RNF2, RNF212, RNF213, RNF214, RNF215, RNF216, RNF216P1, RNF217, RNF219, RNF220, RNF24, RNF25, RNF34, RNF38, RNF4, RNF44, RNF8, RNFT1, RNFT2, RNGTT, RNLS, RNMT, RNPC3, RNPEP, RNU5D-1, RNU5E-1, ROBO1, ROBO2, ROBO3, ROCK1, ROCK2, ROGDI, ROR2, RORA-AS1, RP9P, RPA2, RPAIN, RPAP2, RPAP3, RPE, RPF2, RPGR, RPGRIP I L, RPH3AL, RPIA, RPL17, RPL17- C18orf32, RPL18A, RPL22, RPL23AP53, RPL23AP7, RPL23AP82, RPL27A, RPL29, RPL32P3, RPL34-AS1, RPL36A-HNRNPH2, RPL39, RPL41, RPL7L1, RPN2, RPP25L, RPP30, RPP38, RPP40, RPRD1A, RPRD1B, RPRD2, RPS10, RPS10-NUDT3, RPS17, RPS24, RPS26, RPS27, RPS6KA1, RPS6KA2, RPS6KA3, RPS6KA4, RPS6KA6, RPS6KB1, RPS6KB2, RPS6KC1, RPS6KL1, RPSAP52, RPSAP58, RPTOR, RPUSD1, RPUSD3, RRAGB, RRAGD, RRBP1, RRH, RRM1, RRM2B, RRN3, RRN3P2, RRN3P3, RRNAD1, RRP1, RRP12, RRP1B, RRP7BP, RRP8, RSAD1, RSF1, RSG1, RSPRY1, RSRC1, RSRC2, RSRP1, RSU1, RTCA, RTEL1, RTEL1-TNFRSF6B, RTKN, RTKN2, RTN1, RTN2, RTN3, RTN4, RTRAF, RTTN, RUBCN, RUBCNL, RUFY1, RUFY2, RUFY3, RUNX1, RUNX1T1, RUNX2, RUSC1, RUVBL2, RWDD1, RWDD2B, RWDD3, RWDD4, RXFP1, RXYLT1, RYK, S100A13, S100A16, SIOOB, S1OOPBP, SAAL1, SAC3D1, SACS, SAMD11, SAMD12, SAMD14, SAMD3, SAMD4A, SAMD4B, SAMD9, SAMD9L, SAMHD1, SAP 130, SAP25, SAP30BP, SAP30L, SAPCD2, SAR1A, SAR1B, SARAF, SARDH, SARS2, SART1, SART3, SASS6, SAT1, SAT2, SATB1-AS1, SAV1, SBDSP1, SBF1, SBF2, SBF2-AS1, SBNO1, SCAF1, SCAF11, SCAF8, SCAI, SCAMPI, SCAMP2, SCAMP3, SCAMP4, SCAMP5, SCAP, SCAPER, SCARB1, SCARB2, SCARF2, SCFD1, SCFD2, SCG3, SCG5, SCGB1B2P, SCHIP1, SCLT1, SCLY, SCMH1, SCML2, SCML4, SCN8A, SCN9A, SCNM1, SCOC, SCOC-AS1, SCPEP1, SCRIB, SCRN1, SCRN3, SCUBE2, SCYL1, SCYL2, SDC2, SDCBP2-AS1, SDCCAG3, SDCCAG8, SDE2, SDF2, SDHA, SDHAF2, SDHAF3, SDHAF4, SDHAP1, SDHAP2, SDHC, SDHD, SDR39U1, SDSL, SEC11C, SEC13, SEC14L1, SEC14L2, SEC16A, SEC22A, SEC22B, SEC22C, SEC24A, SEC24B, SEC24C, SEC31A, SEC31B, SEC61A2, SEC62, SECISBP2, SECISBP2L, SEH1L, SEL1L, SELENBP1, SELENOH, SELENOI, SELENOK, SEMI, SEMA3A, SEMA3C, SEMA3F, SEMA4A, SEMA4B, SEMA4C, SEMA4D, SEMA4F, SEMA5A, SEMA6C, SEMA6D, SEMA7A, SENP1, SENP2, SENP3,
SENP3-EIF4A1, SENP5, SENP6, SENP7, SEPHS1, SEPSECS, SEPT10, SEPT2, SEPT3, SEPT7, SEPT7P2, SEPT8, SEPT9, SERAC1, SERF2, SERGEF, SERINC5, SERP2, SERPINA1, SERTAD3, SERTAD4, SERTAD4-AS1, SESN1, SESTD1, SETD2, SETD3, SETD4, SETD5, SETD9, SETDB1, SETDB2, SETDB2-PHF11, SETMAR, SETX, SEZ6L, SEZ6L2, SF1, SF3A2, SF3A3, SF3B3, SF3B6, SFI1, SFMBT1, SFMBT2, SFSWAP, SFT2D1, SFT2D2, SFTA3, SFXN1, SFXN2, SFXN4, SFXN5, SGCB, SGCE, SGCG, SGF29, SGIP1, SGK3, SGK494, SGMS1, SGO1, SGO2, SGPL1, SGSM1, SGSM2, SGSM3, SGTB, SH2B1, SH2D4A, SH3BGR, SH3BP1, SH3BP2, SH3BP5, SH3D19, SH3GL1, SH3GL3, SH3GLB1, SH3GLB2, SH3KBP1, SH3PXD2A, SH3PXD2B, SH3YL1, SHANK1, SHANK3, SHARPIN, SHC1, SHC2, SHCBP1, SHF, SHISA4, SHISA5, SHKBP1, SHMT1, SHOC2, SHOX2, SHPK, SHPRH, SHQ1 , SHROOM2, SHTN1 , SIDT1 , STDT2, STGTRR, SIGLEC1, STGLEC7, SIGMAR1, SIK2, SIK3, SIKE1, SIL1, SIM1, SIM2, SIMC1, SIN3A, SIN3B, SINHCAF, SIPA1, SIPA1L1, SIPA1L2, SIPA1L3, SIRPB1, SIRT2, SIRT3, SIRT5, SIRT6, SIRT7, SIVA1, SIX5, SKA1, SKA2, SKA3, SKAP2, SKP2, SLAIN1, SLAIN2, SLAMF7, SLC10A7, SLC11A1, SLC12A2, SLC12A4, SLC12A6, SLC12A7, SLC12A9, SLC15A4, SLC16A10, SLC16A4, SLC16A7, SLC17A5, SEC18A1, SLC1A1, SEC1A3, SLC1A4, SEC22A15, SLC22A16, SLC22A17, SLC22A18, SLC22A23, SLC22A4, SLC23A2, SLC24A1, SLC25A1, SLC25A10, SLC25A11, SLC25A12, SLC25A13, SLC25A14, SLC25A15, SLC25A17, SLC25A19, SLC25A20, SLC25A21, SLC25A23, SLC25A25, SLC25A26, SLC25A29, SLC25A30, SLC25A32, SLC25A33, SLC25A36, SLC25A37, SLC25A38, SLC25A39, SLC25A40, SLC25A42, SLC25A43, SLC25A44, SLC25A46, SLC25A53, SLC26A10, SLC26A11, SLC26A6, SLC26A7, SLC27A4, SLC27A5, SLC29A1, SLC29A2, SLC29A3, SLC29A4, SLC2A11, SLC2A13, SLC2A14, SLC2A6, SLC2A8, SLC2A9, SLC30A4, SLC30A5, SLC30A6, SLC30A9, SLC33A1, SLC35A1, SLC35A2, SLC35A3, SLC35A5, SLC35B1, SLC35B3, SLC35B4, SLC35C2, SLC35D2, SLC35E2A, SLC35E2B, SLC35E3, SLC35F2, SLC35F5, SLC35F6, SLC35G1, SLC36A1, SLC36A4, SLC37A1, SLC37A2, SLC37A3, SLC37A4, SLC38A1, SLC38A10, SLC38A2, SLC38A3, SLC38A6, SLC38A7, SLC38A9, SLC39A11, SLC39A13, SLC39A14, SLC39A4, SLC39A8, SLC39A9, SLC3A2, SLC41A1, SLC41A2, SLC41A3, SLC43A1, SLC43A2, SLC44A1, SLC44A2, SLC44A5, SLC46A1, SLC47A1, SLC49A3, SLC4A10, SLC4A2, SLC4A5, SLC4A7, SLC4A8, SLC50A1, SLC5A4-AS1, SLC5A6, SLC6A11, SLC6A12, SLC6A2, SLC6A6, SLC6A8, SLC6A9, SLC7A11, SLC7A2, SLC7A6, SLC7A8, SLC8A1, SLC8A1-AS1, SLC9A1, SLC9A5, SLC9A7, SLC9A8, SLC9B2, SLCO2A1, SLCO4A1, SLF1, SLFN11, SLFN12L, SLFN13, SLFN5, SLIT1, SLIT2, SLIT3, SLMAP, SLMO2-ATP5E, SLTM, SLU7, SLX4, SLX4IP, SMA4, SMAD2, SMAD3, SMAD4, SMAD5, SMAD6, SMAD9, SMAP1, SMAP2, SMARCA1, SMARCA4, SM ARC ADI, SMARCAL1, SMARCC1, SMARCC2, SMARCD1, SMARCD3, SMARCE1, SMC1A, SMC2, SMC3, SMC4, SMC5, SMC6, SMCHD1, SMCO4, SMG1, SMG1P1, SMG1P2, SMG1P3, SMG5, SMG6, SMG7, SMILR, SMIM13, SMIM14, SMIM19, SMIM20, SMIM7. SMIM8, SMN1, SMOC1, SMOX, SMPD4, SMPDL3A, SMS, SMTN, SMU1, SMUG1, SMURF1, SMURF2, SMURF2P1-LRRC37BP1, SMYD2, SMYD3, SMYD4, SNAI3-AS1, SNAP23, SNAP25, SNAP47, SNAPCI, SNAPC3, SNAPC4, SNAPC5, SNAPIN, SNCA, SNCAIP, SNED1, SNF8, SNHG1, SNHG11, SNHG12, SNHG14, SNHG15, SNHG16, SNHG17, SNHG20, SNHG21, SNHG4, SNHG5, SNHG6, SNHG8, SNRK, SNRNP27, SNRNP48, SNRPA1, SNRPC, SNRPD2, SNRPE, SNRPG, SNRPN, SNTB1, SNTB2, SNUPN, SNX1, SNX11, SNX13, SNX14, SNX15, SNX16, SNX17, SNX2, SNX22, SNX24, SNX25,
SNX27, SNX29, SNX30, SNX4, SNX5, SNX6, SNX7, S0AT1, SOBP, SOCS4, SOCS6, SOD2, SOGA1, SOGA3, SOHLH2, SON, SORBS1, SORBS2, SORBS3, SORCS1, SORL1, SOS1, SOS2, SOX15, SOX6, SP100, SP110, SP140L, SP2, SP3, SP4, SPACA9, SPAG1, SPAG16, SPAG4, SPAG5, SPAG6, SPAG9, SPART, SPAST, SPATA13, SPATA17, SPATA18, SPATA20, SPATA2L, SPAT A33, SPATA5, SPATA5L1, SPATA6, SPATA7, SPATS2, SPATS2L, SPC25, SPDL1, SPDYC, SPECC1, SPECC1L, SPECC1L-ADORA2A, SPEG, SPEN, SPG11, SPG21, SPG7, SPHK2, SPIB, SPICE1, SPIDR, SPIN1, SPINT1, SPIRE1, SPNS1, SPNS3, SPOP, SPOUT1, SPP1, SPPL2A, SPPL2B, SPPL3, SPRED1, SPRED2, SPRTN, SPRY2, SPRY4-AS1, SPRYD3, SPRYD7, SPSB4, SPTAN1, SPTBN1, SPTBN2, SPTBN4, SPTLC1, SPTLC2, SQLE, SQOR, SQSTM1, SRA1, SRBD1, SRC, SRCAP, SRCIN1, SRD5A1 , SRD5A3, SREBF1, SREBF2, SREK1 , SREK1IP1, SRGAP1, SRGAP2, SRM, SRP14-AS1, SRP19, SRP54, SRP54-AS1, SRP72, SRP9, SRPK1, SRPK2, SRPX, SRRM1, SRRM2, SRSF11, SRSF12, SRSF2, SRSF4, SRSF5, SRSF7, SRSF9, SS18, SS18L1, SSBP2, SSBP3, SSBP4, SSC5D, SSFA2, SSH1, SSH2, SSR1, SSSCA1, SSX2IP, STB, ST14, ST20, ST20-MTHFS, ST3GAL1, ST3GAL2, ST3GAL3, ST3GAL4, ST3GAL6, ST5, ST6GAL1, ST6GALNAC3, ST6GALNAC4, ST6GALNAC6, ST7, ST7-OT4, ST7L, ST8S1A5, STAC, STAC3, STAG1, STAG2, STAG3L1, STAG3L4, STAG3L5P, STAG3L5P-PVRIG2P-PILRB, STAM, STAMBP, STAMBPL1, STAP2, START) 10, STARD13, STARD3NL, STARD4, STARD5, STARD7, STARD8, STARD9, STAT1, STAT2, STAT5A, STAT5B, STAU1, STAU2, STEAP1B, STEAP2, STEAP3, STIL, STIM1, STIM2, STIMATE, STIP1, STK10, STK11IP, STK16, STK17A, STK25, STK26, STK3, STK32C, STK33, STK36, STK38, STK38L, STK39, STK4, STK40, STN1, STON1, STON1-GTF2A1L, STON2, STOX2, STPG1, STRA6, STRADA, STRADB, STRBP, STRIP1, STRIP2, STRN, STRN3, STRN4, STT3A, STT3B, STX10, STX12, STX16, STX16-NPEPL1, STX18, STX18-AS1, STX2, STX3, STX4, STX5, STX6, STX8, STXBP2, STXBP3, STXBP4, STXBP5, STXBP5-AS1, STXBP5L, STYX, STYXL1, SUB1, SUCLA2, SUCLG2, SUCLG2-AS1, SUCO, SUDS3, SUFU, SUGCT, SUGP1, SUGP2, SUGT1, SULF1, SULF2, SULT1C4, SUMF1, SUMF2, SUM01, SUN1, SUN2, SUOX, SUPT20H, SUPT3H, SUPT5H, SUPT7L, SUPV3L1, SURF1, SURF2, SURF4, SUSD1, SUSD3, SUSD6, SUV39H2, SUZ12, SUZ12P1, SVEP1, SVIL, SVIL-AS1, SWT1, SYCE2, SYCP2L, SYDE1, SYDE2, SYK, SYNC, SYNCRIP, SYNE1, SYNE2, SYNE4, SYNGR2, SYNJ1, SYNJ2, SYNJ2BP, SYNJ2BP-COX16, SYNPO2, SYNRG, SYP, SYS1-DBNDD2, SYT1, SYT11, SYT14, SYT9, SYTL1, SYTL2, SYTL3, SYVN1, SZRD1, SZT2, TAB2, TAB3, TACC1, TADA1, TADA2A, TADA3, TAF1, TAF11, TAF13, TAF15, TAFIA, TAF1B, TAF1C, TAF1D, TAF2, TAF3, TAF4, TAF4B, TAF5, TAF5L, TAF6, TAF6L, TAF8, TAF9B, TANCI, TANC2, TANGO2, TANGO6, TANK, TAOK1, TAOK2, TAOK3, TAPT1, TARBP1, TARBP2, TARS, TARS2, TARSL2, TAS2R31, TASP1, TATDN1, TATDN3, TAZ, TBC1D1, TBC1D10A, TBC1D12, TBC1D13, TBC1D14, TBC1D15, TBC1D16, TBC1D17, TBC1D19, TBC1D20, TBC1D22A, TBC1D22B, TBC1D23, TBC1D24, TBC1D25, TBC1D2B, TBC1D30, TBC1D31, TBC1D32, TBC1D4, TBC1D5, TBC1D7, TBC1D7-LOC100130357, TBC1D8, TBC1D8B, TBC1D9, TBC1D9B, TBCCD1, TBCD, TBCEL, TBCK, TBK1, TBKBP1, TBL1X, TBL1XR1, TBL3, TBPL1, TBRG1, TBRG4, TBX1, TBX15, TBX2-AS1, TBX6, TBXA2R, TBXAS1, TC2N, TCAF1, TCAIM, TCEA1, TCEA2, TCEAL1, TCEAL3, TCEAL8, TCEAL9, TCERG1, TCF12, TCF20, TCF25, TCF3, TCF4, TCF7, TCF7L1, TCF7L2, TCFL5, TCOF1, TCP11L1, TCP11L2, TCTEX1D2, TCTN1, TCTN3, TDG, TDP1, TDP2, TDRD3, TDRKH, TEAD1, TEAD2, TEAD4, TECPR1, TECPR2, TEDC1, TEDC2, TEFM, TEKT4P2, TELO2,
TENM1, TENM2, TENM3, TENM4, TEPSIN, TERFI, TERF2, TES, TESK2, TESMIN, TET1, TET2, TET2-AS1, TEX 10, TEX 14, TEX15, TEX261, TEX264, TEX30, TEX41, TEX9, TFAM, TFAP2B, TFAP4, TFB1M, TFB2M, TFCP2, TFDP1, TFDP2, TFE3, TFEB, TFEC, TFIP11, TFPI, TFR2, TFRC, TGDS, TGFBR1, TGFBR2, TGFBR3, TGIF2, TGIF2-C20orf24, TGS1, THADA, THAP1, THAP12, THAP3, THAP5, THAP6, THAP9, THAP9-AS1, THBS3, THBS4, THEM4, THEM6, THEMIS, THEMIS2, THOC1, THOC2, THOC5, THOC6, THOC7, THRAP3, THRB, THSD4, THSD7A, THTPA, THUMPD2, THUMPD3, THYN1, TIA1, TIAL1, TIAM1, TIFA, TIGAR, TIGD6, TIMELESS, TIMM17B, TIMM21, TIMM23, TIMM23B, TIMM50, TIMM8B, TIMM9, TIMMDC1, TINF2, TIPIN, TIPRL, TIRAP, TJAP1, TJP1, TKFC, TLCD2, TLDC1, TLE1, TLE4, TLK1, TLK2, TLL2, TLN1, TLX2, TM2D1, TM2D3, TM7SF2, TM7SF3, TM9SF1, TM9SF3, TM9SF4, TMA16, TMBTM4, TMC6, TMCC1, TMCO3, TMCO4, TMCO6, TMED3, TMED7-TICAM2, TMED8, TMEFF2, TMEM104, TMEM106A, TMEM106B, TMEM106C, TMEM107, TMEM108, TMEM11, TMEM1 10-MUSTN1, TMEM116, TMEM117, TMEM120A, TMEM120B, TMEM126A, TMEM126B, TMEM128, TMEM131, TMEM131L, TMEM134, TMEM135, TMEM136, TMEM138, TMEM141, TMEM143, TMEM144, TMEM145, TMEM14B, TMEM14C, TMEM150A, TMEM150B, TMEM159, TMEM161A, TMEM161B, TMEM161B-AS1, TMEM164, TMEM167A, TMEM167B, TMEM168, TMEM175, TMEM181, TMEM182, TMEM183B, TMEM184B, TMEM185A, TMEM187, TMEM192, TMEM198B, TMEM200A, TMEM206, TMEM209, TMEM214, TMEM218, TMEM219, TMEM220, TMEM222, TMEM231, TMEM234, TMEM237, TMEM241, TMEM245, TMEM248, TMEM249, TMEM254, TMEM255A, TMEM255B, TMEM259, TMEM260, TMEM263, TMEM266, TMEM267, TMEM268, TMEM30A, TMEM33, TMEM38B, TMEM39A, TMEM39B, TMEM41B, TMEM42, TMEM44, TMEM45A, TMEM50A, TMEM50B, TMEM51, TMEM53, TMEM56-RWDD3, TMEM62, TMEM63A, TMEM63B, TMEM65, TMEM67, TMEM68, TMEM70, TMEM71, TMEM87A, TMEM87B, TMEM94, TMEM98, TMEM9B, TMOD1, TMOD2, TMOD3, TMOD4, TMPO, TMSB15B, TMTC1, TMTC2, TMTC3, TMTC4, TMUB1, TMUB2, TMX1, TMX2, TMX2-CTNND1, TMX3, TNC, TNFAIP1, TNFAIP8, TNFAIP8L2- SCNM1, TNFRSF10A, TNFRSF11A, TNFRSF12A, TNFRSF19, TNFRSF1A, TNFRSF6B, TNFSF12, TNFSF12-TNFSF13, TNFSF13, TNIK, TNIP1, TNIP2, TNIP3, TNK2, TNKS, TNKS2, TNNT1, TNPO1, TNPO3, TNR, TNRC18, TNRC6A, TNRC6B, TNRC6C, TNS1, TOBI, TOE1, TOGARAMI, TOLLIP, TOMI, TOM1L1, TOM1L2, TOMM34, TOMM40, TOMM40L, TOMM70, TOPI, TOP1MT, TOP2A, TOP2B, TOP3A, TOP3B, TOPBP 1, TOR1AIP2, TOR1B, TOR2A, TOR3A, TP53BP2, TP53I11, TP53I3, TP53TG1, TP73, TP73- AS1, TPCN1, TPCN2, TPD52, TPD52L1, TPD52L2, TPGS2, TPK1, TPM1, TPM2, TPM3, TPM3P9, TPMT, TPP2, TPR, TPRA1, TPRG1L, TPST1, TPST2, TPT1-AS1, TPTE2P5, TPTE2P6, TPTEP1, TPX2, TRA2A, TRABD2A, TRAF2, TRAF3, TRAF3IP1, TRAF3IP2, TRAF3IP2-AS1, TRAFD1, TRAIP, TRAK1, TRAK2, TRAM1, TRAM2, TRANK1, TRAPPC10, TRAPPC11, TRAPPC12, TRAPPC13, TRAPPC2, TRAPPC2L, TRAPPC3, TRAPPC4, TRAPPC6A, TRAPPC6B, TRAPPC8, TRAPPC9, TRDMT1, TRERF1, TRIM I 6, TRIM16L, TRIM2, TRIM23, TRIM24, TRIM26, TRIM28, TRIM3, TRIM32, TRIM33, TRIM35, TRIM36, TRIM37, TRIM41, TRIM44, TRIM59-IFT80, TRIM65, TRIM68, TRIM73, TRIM9, TRIO, TRIP 10, TRIP 12, TRIP 13, TRIP4, TRIP6, TRIQK, TRIT1, TRMO, TRMT1, TRMT10A, TRMT10B, TRMT11, TRMT1L, TRMT2A, TRMT2B, TRMT6, TRMT61A, TRMT61B, TRMU, TRNAU1AP, TRNT1, TRO, TROVE2, TRPC1, TRPC4, TRPC4AP,
TRPM2, TRPM4, TRPM7, TRPS1, TRPT1, TRPV1, TRPV2, TRRAP, TRUB1, TSC22D1, TSC22D2, TSC22D4, TSEN15, TSEN2, TSEN54, TSFM, TSG101, T
TSHZ2, TSKS, TSNARE1, TSNAX, TSNAXIP1, TSPAN12, TSPAN13, TSPAN TSPAN17, TSPAN18, TSPAN31, TSPAN4, TSPAN5, TSPAN9, TSP0AP1-AS1
TSSC2, TSSC4, TSTD2, TSTD3, TTBK1, TTBK2, TTC12, TTC13, TTC17, TT TTC23, TTC26, TTC27 , TTC28, TTC28-AS1, TTC3, TTC31, TTC33, TTC37, T
TTC39A, TTC39B, TTC39C, TTC4, TTC5, TTC7A, TTC7B, TTC8, TTC9C, TT TTI1, TTI2, TTK, TTL, TTLL11, TTLL12, TTLL3, TTLL4, TTLL5, TTLL7, TT TTP AL, TTTY14, TTYH2, TTYH3, TUB, TUBB6, TUBD1, TUBE!, TUBG2, T TUBGCP3, TUBGCP4, TUBGCP5, TUBGCP6, TUFT1, TUG1, TULP3, TULP4 TVP23A, TVP23C, TVP23C-CDRT4, TWF1 , TWF2, TWIST2, TWNK, TXK, T TXLNG, TXLNGY, TXN, TXNDC11, TXNDC15, TXNDC16, TXNDC9, TXNI TXNL4B, TXNRD1, TXNRD3, TXNRD3NB, TYK2, TYMP, TYR03, TYSND1 TYW1B, TYW3, TYW5, U2AF1, U2AF1L4, U2AF1L5, U2AF2, U2SURP, UA UBA2, UBA3, UBA5, UBA6, UBA6-AS1, UBA7, UBAC2, UBAP1, UBAP2, U UBE2A, UBE2B, UBE2D1, UBE2D2, UBE2D3, UBE2D4, UBE2E3, UBE2F, U UBE2G1, UBE2G2, UBE2H, UBE2J1, UBE2J2, UBE2K, UBE2L3, UBE2Q1, U UBE2Q2P1, UBE2Q2P2, UBE2R2, UBE2W, UBE2Z, UBE3A, UBE3B, UBE3C UBE4A, UBE4B, UBFD1, UBIAD1, UBL7, UBL7-AS1, UBN1, UBN2, UB0X5 UBQLN1, UBQLN4, UBR1, UBR2, UBR3, UBR4, UBR5, UBR7, UBTF, UBX UBXN2A, UBXN2B, UBXN4, UBXN6, UBXN7, UBXN8, UCHL1, UCHL5, U UFC1, UFD1, UFM1, UFSP2, UGCG, UGDH, UGGT2, UGP2, UGT8, UHRF1, UHRF1BP1L, UHRF2, UIMC1, ULK2, ULK3, ULK4, ULK4P1, ULK4P2, ULK UNCI 19, UNC119B, UNC13A, UNC13B, UNC45A, UNC50, UNC5B, UNC5C, UNKL, UPF2, UPF3A, UPF3B, UPP1, UPRT, UQCC1, UQCC2, UQCRH, URB URGCP, URGCP-MRPS24, URI1, URM1, UROS, USB1, USE1, USF2, USO1, USP12, USP13, USP14, USP15, USP16, USP19, USP2-AS1, USP21, USP22, US USP28, USP3, USP30, USP31, USP32, USP33, USP34, USP37, USP38, USP39, USP42, USP43, USP45, USP46, USP47, USP48, USP49, USP53, USP54, USP6N USP9X, USP9Y, USPL1, UTP15, UTP18, UTP23, UTP4, UTP6, UTRN, UTS2R UVRAG, UXS1, UXT, VAC14, VAMP3, VAMP4, VAMP5, VANGL1, VAPB, VASH1-AS1, VASH2, VAV1, VAV2, VAV3, VC AN, VCL, VCP, VDAC1, VD VDR, VEGFA, VEGFB, VEGFC, VEPH1, VEZF1, VEZT, VGF, VGLL4, VHL, VIRMA, VIT, VKORC1, VKORC1L1, VLDLR, VLDLR-AS1, VMP1, VOPP1, VPS13B, VPS13C, VPS13D, VPS26A, VPS26B, VPS26C, VPS28, VPS29, VPS VPS35, VPS35L, VPS36, VPS37A, VPS37B, VPS41, VPS4B, VPS50, VPS53, V VPS8, VPS9D1-AS1, VRK1, VRK3, VSIG10, VSNL1, VSTM2L, VTI1A, VTI1 WAC, WAPL, WARS, WARS2, WASF1, WASF3, WASH3P, WASHC2A, WA WASHC3, WASHC4, WASHC5, WBP2, WBP4, WDFY1, WDFY2, WDFY3, W WDFY4, WDHD1, WDPCP, WDR1, WDR11, WDR12, WDR18, WDR19, WDR
WDR25, WDR27, WDR33, WDR34, WDR35, WDR36, WDR37, WDR4, WDR WDR44, WDR45, WDR48, WDR53, WDR54, WDR59, WDR60, WDR61, WDR WDR7, WDR70, WDR73, WDR75, WDR77, WDR81, WDR82, WDR83, WDR WDR92, WDSUB1, WDTC1, WDYHV1, WHAMM, WHAMMP2, WIPF1, WIP WISP1, WIZ, WLS, WNK1, WNK2, WNK4, WNT3, WRAP73, WRB-SH3BGR
WRNIP1, WSB1, WSB2, WSCD1, WTAP, WWC1, WWC2, WWC3, WWOX, WWP1, WWP2, XAF1, XG, XGY2, XIAP, XIST, XK, XKR6, XPA, XPNPEP1, XPNPEP3, XPO1, XPO4, XPO5, XPO6, XPO7, XPOT, XPR1, XRCC1, XRCC2, XRCC3, XRCC4, XRN1, XRN2, XRRA1, XXYLT1, XYLB, YAF2, YAP1, YARS2, YBEY, YDJC, YEATS2, YEATS4, YES1, YIF1A, YIPF1, YIPF2, YIPF4, YIPF6, YJEFN3, YKT6, YME1L1, YPEL3, YPEL4, YPEL5, YTHDC2, YTHDF1, YTHDF2, YTHDF3, YWHAZ, YY1AP1, ZASP, ZBED3, ZBED3-AS1, ZBED6, ZBED8, ZBTB1, ZBTB14, ZBTB18, ZBTB20, ZBTB21, ZBTB24, ZBTB25, ZBTB38, ZBTB43, ZBTB44, ZBTB47, ZBTB48, ZBTB49, ZBTB5, ZBTB7B, ZBTB8A, ZBTB8OS, ZC2HC1A, ZC3H10, ZC3H11A, ZC3H13, ZC3H14, ZC3H18, ZC3H3, ZC3H4, ZC3H7A, ZC3H7B, ZC3H8, ZC3HC1, ZCCHC10, ZCCHC11, ZCCHC4, ZCCHC6, ZCCHC7, ZCCHC8, ZCCHC9, ZCWPW1, ZCWPW2, ZDBF2, ZDHHC13, ZDHHC14, ZDHHC16, ZDHHC17, ZDHHC18, ZDHHC2, ZDHHC20, ZDHHC21, ZDHHC3, ZDHHC4, ZDHHC6, ZDHHC7, ZDHHC8, ZDHHC9, ZEB1, ZEB2, ZER1, ZFAND1, ZFAND3, ZFAND4, ZFAND5, ZFAND6, ZFAS1, ZFAT, ZFC3H1, ZFP1, ZFP14, ZFP30, ZFP41, ZFP62, ZFP64, ZFP69B, ZFP91, ZFP91-CNTF, ZFPM1, ZFPM2-AS1, ZFR, ZFR2, ZFX, ZFY, ZFYVE1, ZFYVE16, ZFYVE19, ZFYVE21, ZFYVE27, ZFYVE28, ZFYVE9, ZGRF1, ZHX1-C8orf76, ZHX2, ZHX3, ZIK1, ZIM2, ZKSCAN1, ZKSCAN3, ZKSCAN5, ZKSCAN7, ZKSCAN8, ZMAT2, ZMAT3, ZMAT4, ZMAT5, ZMIZ1, ZMIZ2, ZMPSTE24, ZMYM2, ZMYM4, ZMYM5, ZMYM6, ZMYND1 1, ZMYND19, ZMYND8, ZNF10, ZNF100, ZNF106, ZNF107, ZNF112, ZNF121, ZNF124, ZNF131, ZNF133, ZNF134, ZNF136, ZNF138, ZNF140, ZNF141, ZNF142, ZNF143, ZNF146, ZNF148, ZNF160, ZNF177, ZNF180, ZNF189, ZNF195, ZNF197, ZNF202, ZNF207, ZNF211, ZNF212, ZNF213, ZNF215, ZNF225, ZNF227, ZNF23, ZNF232, ZNF236, ZNF236- DT, ZNF239, ZNF248, ZNF25, ZNF250, ZNF251, ZNF252P, ZNF253, ZNF254, ZNF257, ZNF26, ZNF260, ZNF263, ZNF266, ZNF267, ZNF268, ZNF273, ZNF274, ZNF276, ZNF277, ZNF28, ZNF280D, ZNF283, ZNF286A, ZNF292, ZNF3, ZNF30, ZNF300, ZNF302, ZNF316, ZNF317, ZNF319, ZNF320, ZNF322, ZNF326, ZNF329, ZNF330, ZNF337-AS1, ZNF33A, ZNF33B, ZNF343, ZNF345, ZNF346, ZNF35, ZNF350, ZNF354A, ZNF354B, ZNF354C, ZNF365, ZNF367, ZNF37A, ZNF37BP, ZNF383, ZNF384, ZNF385B, ZNF385D, ZNF391, ZNF394, ZNF395, ZNF397, ZNF398, ZNF407, ZNF410, ZNF415, ZNF416, ZNF419, ZNF420, ZNF423, ZNF426, ZNF429, ZNF43, ZNF430, ZNF431, ZNF433, ZNF433-AS1, ZNF438, ZNF439, ZNF44, ZNF445, ZNF446, ZNF45, ZNF451, ZNF461, ZNF462, ZNF480, ZNF484, ZNF485, ZNF487, ZNF490, ZNF493, ZNF496, ZNF502, ZNF506, ZNF507, ZNF510, ZNF512, ZNF516, ZNF518A, ZNF518B, ZNF519, ZNF521, ZNF528, ZNF529, ZNF529-AS1, ZNF53O, ZNF532, ZNF542P, ZNF544, ZNF548, ZNF554, ZNF558, ZNF559, ZNF559-ZNF177, ZNF56, ZNF561, ZNF561-AS1, ZNF562, ZNF566, ZNF567, ZNF568, ZNF569, ZNF571, ZNF580, ZNF581, ZNF583, ZNF584, ZNF585A, ZNF585B, ZNF589, ZNF592, ZNF594, ZNF595, ZNF598, ZNF600, ZNF607, ZNF608, ZNF611, ZNF613, ZNF614, ZNF615, ZNF616, ZNF618, ZNF619, ZNF620, ZNF623, ZNF626, ZNF638, ZNF639, ZNF641, ZNF644, ZNF652, ZNF654, ZNF655, ZNF660-ZNF197, ZNF664, ZNF664-RFLNA, ZNF667, ZNF670, ZNF670-ZNF695, ZNF674, ZNF678, ZNF680, ZNF681, ZNF682, ZNF687, ZNF69, ZNF691, ZNF692, ZNF695, ZNF696, ZNF7, ZNF702P, ZNF706, ZNF707, ZNF708, ZNF71, ZNF711, ZNF714, ZNF718, ZNF720, ZNF721, ZNF736, ZNF737, ZNF74, ZNF740, ZNF75A, ZNF75D, ZNF76, ZNF761, ZNF765-ZNF761, ZNF766, ZNF770, ZNF772, ZNF773, ZNF775, ZNF776, ZNF778, ZNF780A, ZNF780B, ZNF781, ZNF782, ZNF783, ZNF786, ZNF789, ZNF79, ZNF790, ZNF790-AS1, ZNF8, ZNF808, ZNF81, ZNF813, ZNF815P, ZNF816, ZNF821, ZNF826P,
[0086] In various aspects, the pre-mRNA transcript comprising a REMs sequence is selected from a DNA REMs sequence set forth in Table 3 and a RNA REMs sequence set forth in Table 4; and, wherein the gene transcribed or expressed is selected from the group consisting of genes in Table 6.
[0087] Table 6: Selected Genes Expressing a REMs Sequence
C19orf25, C19orf47, C19orf48, C19orf54, C19orf57, C1QTNF3-AMACR, C1QTNF6, Clorfl09, Clorf54, C2CD2L, C2CD3, C2CD5, C2orf48, C2orf76, C3orf67, C4orfi3, C5, C5orf42, C5orf63, C5orf66, C6orE>9, C8orf31, C8orf44-SGK3, C9orf3, C9orf85, CA5BP1, CACNA2D1, CACNA2D3, CACNB1, CACNB4, CADM2, CALCRL, CAMK1, CAMK2A, CAMK4, CAMSAP1, CAMSAP3, CAMTAI, CAP2, CAPN15, CAPRIN2, CAPS2, CARE, CASD1, CASP8, CASP9, CATSPER1, CATSPER3, CBLL1, CBY1, CCAR1, CCDC102B, CCDC112, CCDC125, CCDC127, CCDC14, CCDC169, CCDC169-SOHLH2, CCDC171, CCDC18, CCDC183, CCDC183-AS1, CCDC188, CCDC191, CCDC192, CCDC25, CCDC26, CCDC32, CCDC40, CCDC57, CCDC58, CCDC66, CCDC7, CCDC78, CCDC82, CCDC85C, CCDC88A, CCDC88C, CCDC9, CCDC91, CCND3, CCNI, CCNQ, CCNT2, CCNYL1, CCNYL2, CD 164, CD24, CD2AP, CD36, CD ADC 1 , CDC14A, CDC16, CDC25C, CDC42BPA, CDC42SE2, CDH24, CDK11B, CDK19, CDK5RAP1, CDK7, CD01, CDON, CDS1, CDYL, CEACAM1, CEBPZOS, CELSR2, CELSR3, CENPE, CENPH, CENPI, CENPM, CENPO, CENPT, CEP 112, CEP 128, CEP 131, CEP 164, CEP 170, CEP 192, CEP290, CEP295, CEP350, CEP41, CEP44, CEP63, CEP70, CEP72, CEP76, CEP78, CEP83, CEP85, CEP85L, CEP97, CERCAM, CERS4, CERS5, CES2, CES4A, CFAP206, CFAP299, CFAP44, CFAP58, CGRRF1, CHD1, CHD1L, CHD6, CHD9, CHEK1, CHEK2, CHFR, CHM, CHN1, CHRNA3, CHST10, CHST9, CIP2A, CIT, CIZ1, CKAP2L, CKMT1A, CLASP 1, CLCC1, CLDND1, CLEC16A, CLEC5A, CLIP2, CLK2, CLN3, CLSPN, CLTCL1, CMSS1, CMTM7, CMTR1, CNEP1R1, CNIH3, CNNM1, CNNM2, CNOT1, CNOTIO, CNOT2, CNOT6, CNTN1, CNTNAP1, CNTNAP3, CNTRL, COL1A2-AS1, COL23A1, COL24A1, COL25A1, COL26A1, COL4A5, COP1, COQ3, COQ6, COQ8A, CPEB3, CPNE5, CPSF7, CPT2, CPXM1, CRACR2A, CRB1, CRBN, CREB3L4, CRELD1, CRLS1, CRNDE, CROCC, CRTC3, CRYBG3, CRYL1, CRYZ, CSNK1G1, CSNK1G3, CSPP1, CSRNP2, CSRNP3, CSTF3, CTBP2, CTDP1, CTIF, CTNNBL1, CTNS, CTSF, CUBN, CUEDC1, CUL7, CUTC, CWF19L1, CXorf38, CYB561D2, CYB5RL, CYBC1, CYP20A1, CYP2U1, CYP39A1, CYTOR, CZ1P-ASNS, D2HGDH, DAAM1, DAPK1, DAZAP2, DBF4, DBF4B, DBT, DCAF10, DCAF11, DCAF17, DCBLD2, DCLRE1C, DCP1B, DCST1-AS1, DCUN1D2, DCUN1D4, DDC, DDIAS, DDX11, DDX12P, DDX19B, DDX60, DEAF1, DECR2, DEF8, DENND1A, DENND2C, DENND3, DENND4B, DENND4C, DENND5A, DENND5B, DENND6A, DEPDC1B, DESI1, DFFB, DGKA, DGKI, DGKZ, DHDDS, DHPS, DHRS12, DHRS4L2, DHTKD1, DHX33, DHX35, DHX37, DHX57, DIAPH2, DICER 1, DICER 1 -AS 1, DIMT1, DIP2A, DISP1, DLEU1, DLEU2, DLG1, DLGAP4-AS1, DLST, DMC1, DMD, DMPK, DMTF1, DMXL1, DMXL2, DNA2, DNAAF4, DNAAF4-CCPG1, DNAAF5, DNAH10, DNAH14, DNAJB12, DNAJC19, DNAJC21, DNAJC4, DNM1L, DNM3, DNMT3A, DNPEP, DOC2B, DOCK11, DOCK7, DONSON, DOPEY1, DOT1L, DPCD, DPF1, DPH3, DPH5, DPY19L2, DPY19L3, DPY19L4, DPYD, DPYSL5, DRAM2, DROSHA, DSE, DST, DSTYK, DTD2, DTNA, DTNB, DTNBP1, DUS2, DUSP11, DUSP22, DUXAP10, DUXAP8, DYM, DYNC1LI2, DYNC2LI1, DYRK3, DYSF, DZIP3, E2F6, EBF1, EBF4, EBPL, EDEM3, EEF1AKMT2, EFCAB13, EFS, EIF1AX, EIF2AK2, EIF2AK4, EIF4E2, ELF2, ELMO2, ELMOD1, ELMOD3, ELN, ELOVL2, ELOVL7, ELP2, EMB, EMC2, EMC3-AS1, EMIDI, EML4, EML6, EMSY, ENDOV, ENOXI, ENTPD1-AS1, ENTPD5, ENTPD6, EOGT, EP300, EP400P1, EPB41, EPB41L1, EPB41L4A, EPB41L5, EPG5, EPHA6, EPHX4, EPN2, EPS8, ERC1, ERGIC1, ERI1, ERICH1, ERLIN1, ERMAP, ERMARD, ERO1A, ERVK13-1, ESD, ETFDH, ETHE1, EVC, EVI5, EXD2, EXD3, EXOCI, EXOC3, EXOC6, EYA1, EYA4, F8,
FAHD2A, FAM105A, FAM111 A, FAM114A2, FAM118B, FAM120B, FAM122C, FAM133B, FAM133DP, FAM135A, FAM13A, FAM13B, FAM151B, FAM157A, FAM157B, FAM160A1, FAM169A, FAM171A1, FAM172A, FAM173B, FAM184A, FAM189B, FAM193B, FAM206A, FAM207A, FAM208A, FAM208B, FAM212B-AS1, FAM219B, FAM35A, FAM3A, FAM3C, FAM45A, FAM45BP, FAM53B, FAM66A, FAM78B, FAM81A, FAM92A, FANCA, FANCD2, FANCE, FANCI, FANCL, FANCM, FANK1, FARP2, FAT1, FAT3, FBRSL1, FBXL13, FBX016, FBXO22, FBXO38, FBXO44, FBX09, FBXW11, FBXW8, FBXW9, FCF1, FDX1, FER, FER1L4, FGF12, FGGY, FHAD1, FH0D3, FIG4, FIP1L1, FKBPI5, FKTN, FMRI, FNIP1, F0XJ3, F0XN3, F0XP2, F0XRED1, FPGT-TNNI3K, FRAS1, FRG1-DT, FRG1BP, FRG1CP, FRG1HP, FRG1JP, FRMD4A, FRMPD4, FRYL, FSD1L, FSTL5, FTX, FUBP1, FUK, FUT10, FXR2, FYN, FZD3, G2E3, G6PC3, GAB2, GABPA, GALNT13, GALNT18, GALNT6, GALT, GAPVD1, GARNL3, GAS2L1, GAS2L3, GATA2-AS1, GATB, GBA2, GBAP1, GBF1, GCA, GCH1, GCNT2, GDPD5, GEMIN2, GEMIN8, GEN1, GFM2, GGA1, GGCX, GGT5, GIGYF2, GINS1, GINS3, GIT1, GIT2, GLB1, GLMN, GLS, GLS2, GLYR1, GMDS-AS1, GMIP, GMPR2, GNAS-AS1, GNG7, GNPTG, GOLGA2, GOLGA2P10, GOLGA3, GOLGA4, GOLGA6L10, GOLGA6L17P, GOLGA6L9, GOLT1B, GON4L, GOSR2, GPATCH2, GPATCH2L, GPBP1, GPCPD1, GPR107, GPR137, GPR137C, GPR155, GPR173, GPR176, GPR180, GPR85, GPR89A, GPRASP1, GREB1L, GRIN2D, GRIN3B, GRIP API, GRK3, GRK4, GRM7, GRTP1, GSl-124K5.il, GSAP, GSK3B, GSTCD, GTF2H1, GTF2H2, GTF2H2B, GTF2I, GTF2IP1, GTF2IP20, GTF2IP4, GTF2IRD1, GTF3C2, GTPBP2, GUCD1, GUF1, GUSBP1, GUSBP11, GVQW2, HACD1, HACE1, HACL1, HADHB, HAGHL, HDAC1, HDAC8, HDX, HEATR3, HEATR5A, HEATR5B, HECTD4, HECW1, HEMK1, HERC1, HERC2, HERC2P3, HERC2P9, HERC3, HERC4, HERC5, HERC6, HERPUD2, HEXDC, HFM1, HGF, HGSNAT, HHAT, HIBADH, HIBCH, HIRA, HIVEP1, HIVEP3, HMGN5, HNRNPA1, HNRNPUL1, HOGA1, HOOK3, HOXA9, HOXB8, HOXC4, HPS1, HPS3, HPS4, HR, HRAT17, HSCB, HSD17B14, HSD17B4, HSD17B7P2, HSF2BP, HSPA12A, HTD2, HTT, HYAL3, ICA1, ICA1L, IDE, IDH3G, IFI27L1, IFNAR2, IFT122, IFT140, IFTI72, IFT80, IFT88, IGDCC4, IGF2BP2, IKBKB, IKZF5, IL11RA, IL15, IL17RB, IL17RC, IL17RE, IL18RAP, IL4R, IMMP1L, IMMP2L, ING3, ING4, INMT-MINDY4, INO80C, INPP5E, INPP5F, INPP5K, INPPL1, INTS13, INTS4P2, INTS8, INTU, IPO11, IPO8, IQCB1, IQCE, IQCG, IQCH, IQCH-AS1, IQCK, IQSEC1, IRAK2, IRAK3, IRF3, IST1, ITGA10, ITGA3, ITGAE, ITGAM, ITPR1, ITSN1, IVD, JADE2, JAK3, JARID2, JMJD1C, JPX, KANK1, KANSL1L, KAT6B, KAT7, KATNAL1, KATNAL2, KATNBL1, KAZN, KCNG1, KCNQ1, KCNQ5, KCNT2, KCTD14, KCTD20, KCTD9, KDM1B, KDM4B, KDM4C, KDM4D, KDM6A, KDM7A, K1AA0100, K1AA0319L, KIAA0556, KIAA0825, KIAA0895L, KIAA1324, KIAA1468, KIAA1671, KIAA1841, KIAA2026, KIDINS220, KIF13A, KIF13B, KIF14, KIF21A, KIF24, KIF27, KIF3A, KIF9, KITLG, KLC1, KLHDC4, KLHL2, KLHL20, KLHL22, KLRD1, KLRG1, KLRG2, KMT2B, KMT5C, KNL1, KREMEN1, KYAT3, L1CAM, L3MBTL2, LAMA3, LAMP5, LARP1B, LARS, LAS1L, LAT, LBHD1, LBX2, LCMT1, LCORL, LDLRAD3, LDLRAD4, LENEP, LEPR, LEPROTL1, LETMD1, LGALS9, LGR4, LGR5, LIG1, LIMCH1, LIN52, LIN54, LINC- PINT, LINC00240, LINC00265, LINC00337, LINC00426, LINC00473, LINC00578, LINC00607, LINC00624, LINC00630, LINC00888, LINC01060, LINC01085, LINC01088, LINC01169, LINC01237, LINC01250, LINC01358, LINC01572, LINC01684, LINC01876, LINC01881, LINC01894, LINC01934, LINC02062, LINC02511, LINC02542, LINGO1,
LING02, LIPE-AS1, LMBR1, LMBR1L, LMBRD1, LM07, LOC100128253, LOC100128885, LQC100130027, LOC100133091, LOC100133315, LOC100233156, LOC100287944, LOC100288637, LOC100288778, LOC100288798, LOC100420587, LOC100505938, LOC100506023, LOC100506207, LOC100506476, LOC100506844, LOC100506990, LOC100507291, LOC100507377, LOC100507557, LOC100996724, LOC101060091, LOC101448202, LOC101927027, LOC101927043, LOC101927056, LOC101927359, LOC101928605, LOC101928673, LOC101929140, LOC101929709, LOC101929710, LOC102606465, LOC102724532, LOC102724593, LOC105372273, LOC107984974,
LOCI 10117498-PIK3R3, LOC145694, LOC150776, LOC283683, LOC284581, LOC339862, LOC389765, LOC389906, LOC399815, LOC400464, LOC400927, LOC400927-CSNK1E, LOC441242, LOC642852, LOC645166, LOC653080, LOC727751, LOC728730, LOC729732, LOC729970, L0NP2, L0XL2, LPAR1, LPAR2, LPCAT2, LPCAT4, LPIN1, LPP, LRCH3, LRIG1, LRIG3, LRMDA, LRP1, LRP2, LRP8, LRRC28, LRRC34, LRRC37A2, LRRC37B, LRRC40, LRRC58, LRRC6, LRRCC1, LRRFIP2, LRSAM1, LRTOMT, LSM12, LSS, LTB4R, LTBP1, LTBP4, LY75, LY75-CD302, LYPLAL1, LYRM7, LYSMD4, LYST, LZTFL1, MACF1, MACROD2, MAD1L1, MADD, MAGEA2B, MAG12, MAG12-AS3, MAG13, MAML3, MANBAL, MANUAL, MAP1LC3B, MAP2, MAP2K4, MAP2K5, MAP2K6, MAP3K20, MAP3K21, MAP3K3, MAP3K5, MAP4K2, MAP4K3, MAPK10, MAPK11, MAPK13, MAPK7, MAPK8, MAPKAPK5, MARCH !, MARCH6, MARF1, MARK ! , MAST4, MBD5, MB IP, MBNL2, MBOAT2, MBTD1, MCCC2, MCOLN1, MCOLN3, MCRS1, MCTP1, MCTP2, MDM1, MDM2, MDN1, MECR, MED1, MED12, MED12L, MED15, MED23, MED25, MED27, MEF2A, MEF2C-AS1, MEG3, MEGF8, MEIS1, MELTF, MEMO1, MERTK, METTL14, METTL21A, METTL22, METTL8, MFF, MFGE8, MFSD12, MFSD14B, MFSD8, MFSD9, MGA, MGAT4C, MGAT5, MGEA5, MIA3, MIATNB, MICAL1, MICAL2, MICALL1, MICB, MIDI, MIF4GD, MIGA1, MINDY2, MINDY3, MINDY4, MINK1, MIPEPP3, MIPOL1, MIR1268A, MIR548G, MIR548N, MIR570HG, MIR924HG, MIR99AHG, MITD1, MITF, MKI67, MKL1, MKL2, MKNK1, MKS1, MLC1, MLF1, MLH1, MLXIP, MMAB, MMP16, MMP24-AS 1 -EDEM2, MMS19, MMS22L, MNAT1, MND1, MOCS1, MOK, MORN3, MOSPD1, MOSPD2, MPDZ, MPHOSPH9, MPND, MPP3, MRAS, MRC1, MRNIP, MROH1, MROH6, MRPL43, MRPS30-DT, MRRF, MRVI1, MS4A3, MS4A7, MSC- AS1, MSI1, MSTO1, MTCH2, MTERF4, MTHFD2L, MTHFSD, MTMR1, MTMR3, MTMR6, MTMR7, MTMR8, MTR, MTRR, MUTYH, MVB12B, MYBL1, MYBL2, MYH14, MYHAS, MYLK, MY018A, MYO1B, MY05A, MYO5B, MYO5C, MY09A, MY0M2, MYSM1, N4BP2, N4BP2L2, NAA25, NAA40, NAALAD2, NADK, NAGK, NAGPA, NAPG, NARS2, NAV2, NAXD, NBAS, NBEA, NBEAE1, NBEAE2, NBN, NBPF1, NBPF10, NBPF11, NBPF12, NBPF14, NBPF19, NBPF20, NBPF25P, NBPF26, NBPF3, NBPF8, NBPF9, NCALD, NCKAP5, NCOA1, NCOA2, NCOA6, NCOR2, NCSTN, NDC1, NDOR1, NDRG2, NDRG3, NDUFA10, NDUFA6-AS1, NDUFAF5, NDUFAF6, NDUFB6, NDUFC2-KCTD14, NECAB3, NEDD4L, NEIL3, NEK1, NEK 10, NEK11, NEK4, NF2, NFATC2, NFATC2IP, NFIX, NFKB1, NFRKB, NHLRC3, NIFK, NIPA2, NIPBL, NKAIN1, NKTR, NLGN1, NLRC5, NMNAT1, NODI, NOLIO, NOL4L, NOMO2, NOS1AP, NOTCH 1, NOTCH2, NOTCH3, NOX4, NPIPA1, NPNT, NPRL3, NR2C1, NR6A1, NRCAM, NRDC, NRF1, NRG3, NRG4, NSD1, NSD3, NSF, NSFP1, NSUN6, NT5C2, NTPCR, NTRK1, NTRK3, NUB1, NUBP1, NUBPL, NUDT17, NUDT22, NUMB, NUP153, NUP188, NUP43, NUP54, NUP58, NUP85, NUP98, NUPL2, NUTM2B-AS1, NXN, OARD1, OAZ1, OBSCN, OCA2, OCRL, ODAM, ODF2, ODF2L,
0FD1, OGGI, OGT, OIP5, OLFM2, OLMALINC, 0MA1, OPA1, OPHN1, OR2A1-AS1, ORAOV1, OSBP2, OSBPL6, OSBPL7, OSBPL8, OSBPL9, OSGEPL1, OSGIN2, OSMR-AS1, OSTF1, OTOGL, OTUD5, OTULIN, OXCT1, 0XNAD1, P2RX4, P4HA2, PAAF1, PACRGL, PALED, PALM2, PALM2-AKAP2, PAN3, PANK2, PANK4, PAOX, PAPD4, PAPD5, PAPD7, PAPOLA, P APOLG, PAQR3, PAQR7, PARG, PARL, PARP2, PARP4, PARP8, PARPBP, PARVB, PATL1, PAXX, PBRM1, PBX3, PC, PCBD2, PCBP1-AS1, PCBP3, PCCB, PCDH9, PCED1B, PCGF6, PCID2, PCLO, PCM1, PCMTD2, PCNT, PCNX2, PCNX3, PCSK4, PCSK6, PDCD2L, PDCD6IPP2, PDE10A, PDE3B, PDE4D, PDE4DIP, PDE6B, PDE7A, PDE8A, PDIA5, PDK3, PDLIM2, PDLIM4, PDPK1, PDSS1, PDXDC2P-NPIPB14P, PDZD11, PDZK1, PEAK1, PEAR1, PELI3, PET100, PEX11A, PEX26, PEX6, PEX7, PFDN1, PFKFB3, PGAP1, PGAP3, PGGT1B, PGS1 , PHACTR4, PHETA1, PHEX, PHF12, PHF6, PHKA1, PHKA2, PHKG2, PHLDB1, PHLPP2, PHOSPHO2-KLHL23, PI4KA, PIC ALM, PICK1, PIGB, PIGG, PIGK, PIGL, PIGN, PIGQ, PIGT, PIK3C2A, PIK3C3, PIK3CB, PIKFYVE, PIP4K2C, PIP5K1A, PITPNA, PITPNC1, PITPNM2, PKD1, PKD1P1, PKD1P4-NPIPA8, PKDCC, PKIB, PKNOX2, PKP4, PLA2G12A, PLA2G4A, PLA2G4B, PLA2G6, PLAC1, PLAGL1, PLAT, PLB1, PLBD2, PLCB4, PLCG2, PLCL1, PLD1, PLEKHA1, PLEKHA4, PLEKHA5, PLEKHA6, PLEKHA7, PLEKHG2, PLEKHG4, PLEKHM3, PLPP4, PLPP5, PLRG1, PMS1, PMS2, PMS2P1, PMS2P5, PNPLA6, POC1A, POC1B, POFUT1, POLA1, POLA2, POLE2, POLK, POLL, POLM, POLN, POLQ, POLR1A, POLR2F, POLR2J3, POLR2J4, POLR3C, POLR3F, POLR3G, POLR3GL, POLR3H, P0M121, POMT1, POT1-AS1, POU2F1, PPCDC, PPFIA1, PPIEL, PPIL2, PPIP5K1P1-CATSPER2, PPM1K, PPM1M, PPP1R12A, PPP1R12B, PPP1R13B, PPP1R16A, PPP1R1C, PPP1R21, PPP1R35, PPP1R36, PPP2R3C, PPP4C, PPP4R3B, PPP4R4, PPP5D1, PPP6R2, PPRC1, PRDM4, PREB, PRELID3A, PREPL, PRH1, PRH1-PRR4, PRH1-TAS2R14, PRICKLEI, PRIM2, PRIMPOL, PRKAA2, PRKAB2, PRKAG1, PRKAG2, PRKCZ, PRKD2, PRKRA, PRMT2, PRMT3, PRMT9, PROK2, PROSERI, PRPF39, PRPF40A, PRPF40B, PRPF4B, PRR14, PRR16, PRR5L, PRRC2B, PRRC2C, PRRG1, PRRT4, PRSS16, PRUNE1, PSD3, PSEN2, PSMD9, PSME4, PSTPIP1, PSTPIP2, PTAR1, PTBP3, PTCHI, PTER, PTGIS, PTK2, PTPN13, PTPN18, PTPN2, PTPN21, PTPN23, PTPN4, PTPRA, PTPRD, PTPRE, PTPRG-AS1, PTPRK, PTPRS, PUM2, PURPL, PUS7, PVR, PVT1, PXDC1, PXDN, PXN, PYCR3, PYM1, PYROXD1, PYROXD2, QPCTL, QRICH1, QTRT2, R3HCC1L, R3HDM1, R3HDM2, RAB15, RAB22A, RAB23, RAB28, RAB36, RAB3GAP1, RAB3GAP2, RAB3IP, RAB4B, RABGAP1L, RABGEF1, RABL2B, RABL6, RAC1, RACGAP1, RAD18, RAD51AP1, RAD51B, RAD51C, RAD51L3-RFFL, RADIL, RAFI, RALGAPA1, RALGAPA1P1, RALGPS1, RALGPS2, RANBP17, RAP1GAP2, RAP1GDS1, RAP2C-AS1, RAPGEF6, RARA, RASGRF2, RASGRP3, RASSF4, RBBP5, RBBP6, RBCK1, RBFOX2, RBL1, RBM15-AS1, RBM20, RBM23, RBM26-AS1, RBM33, RBM38, RBM41, RBM47, RBM5, RBM6, RBM7, RBMXL1, RBPMS, RBSN, RCAN3, RCBTB2, RCHY1, RDH13, RECK, REPSI, RERE, RERG, RETREG1, REV1, REV3L, REXO5, RFC3, RFFL, RFX3, RFX8, RGL1, RGP1, RGS11, RGS12, RGS5, RGS7, RHBDF2, RHCE, RHOBTB1, RHOQ, RHOT1, RIC1, RICTOR, RIF1, RIMBP2, RIMS1, RIMS2, RINT1, RLF, RNASE4, RNASET2, RNF111, RNF123, RNF165, RNF170, RNF212, RNF214, RNF216P1, RNF25, RNF44, RNFT1, RNLS, RNU5D-1, RNU5E-1, ROBO1, ROBO3, ROGDI, RORA-AS1, RP9P, RPAIN, RPAP2, RPAP3, RPE, RPGRIP1L, RPH3AL, RPL23AP7, RPL23AP82, RPL34-AS1, RPP40, RPS6KC1, RPSAP58, RPUSD1, RRN3P3, RRNAD1, RRP7BP, RSRP1, RTEL1, RTEL1-TNFRSF6B, RTKN, RTN2, RTTN, RUFY2, RUNX1T1,
RWDD4, S100B, SAMD12, SAMD3, SAP13O, SARDH, SATB1-AS1, SBF2, SCAI, SCAMPI, SCAMP5, SCAPER, SCARB1, SCFD1, SCG3, SCGB1B2P, SCMH1, SCML2, SCN9A, SCYL1, SDCBP2-AS1, SDCCAG3, SDCCAG8, SDHAF3, SDHAP1, SEC16A, SEC24C, SEC31B, SEC61A2, SECISBP2L, SEMA3F, SEMA4A, SEMA4C, SEMA4F, SENP1, SENP2, SENP3, SENP3-EIF4A1, SENP6, SENP7, SEPT 10, SEPT7, SEPT7P2, SERAC 1, SERF2, SESN1, SETD2, SETD5, SETDB1, SEZ6L2, SFI1, SFMBT1, SFT2D2, SFXN2, SFXN4, SGCB, SGF29, SGIP1, SGMS1, SGPL1, SGSM3, SH2B1, SH3D19, SHC1, SHMT1, SHTN1, SK3, SIM2, SIPA1L1, SLAIN 1, SLC12A6, SLC12A9, SLC22A15, SLC22A23, SLC23A2, SLC24A1, SLC25A12, SLC25A14, SLC25A17, SLC25A19, SLC25A21, SLC25A30, SLC25A32, SLC25A39, SLC25A40, SLC25A43, SLC25A53, SLC26A10, SLC29A4, SLC2A11, SLC2A8, SLC2A9, SLC30A5, SLC30A6, SLC33A1, SLC35A1, SLC35A3, SLC35B3, SLC35D2, SLC35E2B, SLC35F2, SLC35F5, SLC37A2, SLC37A3, SLC38A6, SLC38A7, SLC38A9, SLC39A4, SLC3A2, SLC41A3, SLC43A1, SLC47A1, SLC4A5, SLC4A7, SLC7A6, SLC9A5, SLC9B2, SLCO4A1, SLF1, SLIT1, SLIT3, SLMAP, SMA4, SMAD3, SMAD5, SMAD9, SMARCC2, SMARCD1, SMC1A, SMC5, SMCHD1, SMCO4, SMG1, SMG1P2, SMG1P3, SMG5, SMG6, SM1LR, SM1M14, SMPD4, SMURF1, SMURF2, SMYD3, SNAI3-AS1, SNAPC5, SNCAIP, SNHG12, SNHG14, SNHG15, SNHG17, SNRK, SNRPE, SNX14, SNX24, SNX25, SNX29, SNX5, SOHLH2, S0RBS1, SORL1, S0S1, S0S2, SPAG4, SPATA13, SPATA33, SPATA6, SPECC1, SPEN, SPG11, SPG7, SPIB, SPICE1, SPPL2A, SPPL2B, SPRY4-AS1, SPRYD3, SPTAN1, SQOR, SRBD1, SRCIN1, SREK1IP1, SRP14-AS1, SRP19, SRP54-AS1, SRPK2, SRPX, SRSF7, SSI 8, SSBP2, SSBP3, SSH1, SSX2IP, ST3GAL2, ST3GAL6, ST6GAL1, ST6GALNAC3, ST6GALNAC4, ST7L, STAC, STAG1, STAG3L5P-PVRIG2P-PILRB, STAP2, STARD13, STARD5, STAT1, STAT5B, STEAP1B, STIM2, STK10, STK26, STK38, STK38L, STK40, STPG1, STRADA, STRADB, STRBP, STRIP2, STRN3, STX16, STX18, STX18-AS1, STX2, STXBP3, STXBP5L, SUCLG2- AS1, SUCO, SULF1, SULF2, SULT1C4, SUMF1, SUN1, SUPT20H, SUPT3H, SUSD1, SUV39H2, SUZ12P1, SWT1, SYCP2L, SYNE2, SYNE4, SYP, SYT1, SYT14, SYT9, SYTL3, TADA2A, TAF13, TAF1D, TAF3, TAF6L, TANGO2, TAOK1, TAOK2, TARBP1, TARSL2, TASP1, TBC1D1, TBC1D12, TBC1D14, TBC1D17, TBC1D19, TBC1D22A, TBC1D23, TBC1D25, TBC1D32, TBC1D4, TBC1D5, TBCD, TBCEL, TBCK, TBL3, TBX15, TBX2-AS1, TBXAS1, TCEAL1, TCF7L1, TCTN1, TDG, TDP1, TEAD1, TEDC1, TENM4, TERF2, TESK2, TET1, TET2, TET2-AS1, TEX15, TEX9, TFB1M, TFCP2, TFDP2, TFE3, TFEC, TGFBR1, THADA, THBS4, THOC1, THOC2, THOC6, THRB, THSD7A, THUMPD3, TIA1, TIMM21, TIMM23, TIMM23B, TINF2, TIRAP, TJAP1, TJP1, TKFC, TLE1, TLE4, TLK2, TLL2, TM2D3, TM9SF1, TM9SF4, TMC6, TMCC1, TMCO3, TMCO4, TMEFF2, TMEM106C, TMEM116, TMEM117, TMEM120A, TMEM120B, TMEM131L, TMEM135, TMEM144, TMEM150A, TMEM161A, TMEM161B, TMEM161B-AS1, TMEM181, TMEM182, TMEM184B, TMEM185A, TMEM206, TMEM214, TMEM218, TMEM220, TMEM222, TMEM234, TMEM237, TMEM241, TMEM255B, TMEM260, TMEM39A, TMEM39B, TMEM41B, TMEM45A, TMEM56-RWDD3, TMEM62, TMEM63B, TMEM65, TMEM67, TMEM71, TMEM87A, TMEM94, TMOD2, TMTC1, TMTC2, TMTC3, TMX2, TMX3, TNFRSF12A, TNFRSF1A, TNIP1, TNIP3, TNKS2, TNRC6A, TNRC6C, TOMI, TOM1L1, TOM1L2, TOPI, TOP2B, TOPBP1, TOR1B, TPD52L2, TPK1, TPM3, TPP2, TPRA1, TPT1-AS1, TPTE2P5, TPTEP1, TRABD2A, TRAF3, TRAIP, TRAK2, TRAPPC10, TRAPPC13, TRAPPC8, TRIM16, TRIM16L, TRIM23, TRIM3, TRIM33, TRIM35, TRIM36,
[0088] In one aspect, described herein are methods for modulating the amount or type of a pre-mRNA transcript of a gene, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the method comprising contacting a cell or cell lysate with a compound of Formula (I) or a form thereof, wherein the gene is not disclosed in International Patent Application No. PCT/US2016/013553 (International Publication No. WO2016/115434). In another aspect, described herein are methods for modulating the amount or type of a pre-mRNA transcript of a gene, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the method comprising contacting a cell or cell lysate with a compound of Formula (I) or a form thereof, wherein the gene is not disclosed in International Patent Application No.
PCT/US2020/017430 (International Publication No. WO2020/167628). In another aspect, described herein are methods for modulating the amount or type of a pre-mRNA transcript of a gene, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the method comprising contacting a cell or cell lysate with a compound of Formula (I) or a form thereof, wherein the gene is not disclosed in International Patent Application No. PCT/US2021/012103 (International Publication No. WO2021/138678).
[0089] In one aspect, described herein are methods for modulating the amount or type of one, two, three or more RNA transcripts of a gene, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the method comprising contacting a cell with a compound of Formula (I) or a form thereof. In another aspect, a cell or cell lysate is contacted with the compound of Formula (1) or a form thereof, where the cell may be in cell culture, in vitro, in vivo or ex vivo. In another aspect, the cell is contacted with the compound of Formula (I) or a form thereof in a subject (e.g., a non-human animal subject or a human subject).
[0090] In one aspect, described herein are methods for modulating the amount or type of one, two, three or more RNA transcripts of a gene, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent. In another aspect, described herein are methods for modulating the amount or type of one, two, three or more RNA transcripts of a gene, by way of nonlimiting example, comprising a REMS sequence or a gene described herein, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent. In another aspect, a compound of Formula (I) is a compound selected from a compound described herein.
[0091] In one aspect, described herein are methods for modulating the amount or type of one, two, three or more RNA transcripts of a gene comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of
Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent. In another aspect, a compound of Formula (I) is a compound selected from a compound described herein.
[0092] In one aspect, described herein are methods for modulating the amount or type of one, two, three or more RNA transcripts of a gene, other than a gene comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent. In another aspect, a compound of Formula (I) is a compound selected from a compound described herein.
[0093] In one aspect, described herein are methods for preventing and/or treating a disease associated with the aberrant expression of a product of a gene (e.g., an mRNA transcript or protein), wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent. In another aspect, a compound of Formula (I) is a compound selected from a compound described herein. described herein are methods for preventing and/or treating a disease associated with aberrant expression of a product of a gene (e.g., an mRNA, RNA transcript or protein), by way of nonlimiting example, comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent. In another aspect, described herein are methods for preventing and/or treating a disease associated with aberrant expression of a product of a gene (e.g., an mRNA, RNA transcript or protein), other than a gene comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical
composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
[0094] In one aspect, described herein are methods for preventing and/or treating a disease associated with aberrant expression of a product of a gene (e.g., an mRNA, RNA transcript or protein), by way of nonlimiting example, wherein the gene is not disclosed in International Patent Application No. PCT/US2016/013553 (International Publication No. WO2016/115434), and wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent. In another aspect, described herein are methods for preventing and/or treating a disease associated with aberrant expression of a product of a gene (e.g., an mRNA, RNA transcript or protein), other than a gene comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent. In another aspect, a compound of Formula (I) is a compound selected from a compound described herein.
[0095] In another aspect, described herein are methods for preventing and/or treating a disease in which a change in the level of expression of one, two, three or more RNA isoforms encoded by a gene is beneficial to the prevention and/or treatment of the disease, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
[0096] In one aspect, described herein are methods for preventing and/or treating a disease in which the alteration (e.g., increase or decrease) in the expression one, two, three or more RNA isoforms encoded by a gene, by way of nonlimiting example, comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5, is beneficial to the prevention and/or treatment of the disease, the methods comprising administering to a subject in need thereof a compound of
Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent. [0097] In another aspect, described herein are methods for preventing and/or treating a disease in which the alteration (e.g., increase or decrease) in the expression one, two, three or more RNA isoforms encoded by a gene, not disclosed in Tables W-Z, infra, is beneficial to the prevention and/or treatment of the disease, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
[0098] In one aspect, described herein are methods for preventing and/or treating a disease in which the alteration (e.g., increase or decrease) in the expression one, two, three or more RNA isoforms encoded by a gene, wherein the gene is not disclosed in International Patent Application No. PCT/US2016/013553 (International Publication No. WO2016/115434), and is beneficial to the prevention and/or treatment of the disease, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent. In another aspect, described herein are methods for preventing and/or treating a disease in which the alteration (e.g., increase or decrease) in the expression one, two, three or more RNA isoforms encoded by a gene, other than a gene comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5, is beneficial to the prevention and/or treatment of the disease, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent. In another aspect, a compound of Formula (I) is a compound selected from a compound described herein.
[0099] In one aspect, described herein are methods for preventing and/or treating a disease in which a change in the level of expression of one, two, three or more protein isoforms encoded by a gene is beneficial to the prevention and/or treatment of the disease, wherein the pre-mRNA
transcript transcribed from the gene comprises a REMS, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent. In another aspect, described herein are methods for preventing and/or treating a disease in which the alteration (e.g., increase or decrease) in the expression one, two, three or more protein isoforms encoded by a gene comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5, is beneficial to the prevention and/or treatment of the disease, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent. In another aspect, a compound of Formula (1) is a compound selected from a compound described herein.
[00100] In another aspect, described herein are methods for preventing and/or treating a disease in which the alteration (e.g., increase or decrease) in the expression one, two, three or more protein isoforms encoded by a gene, not disclosed in Tables W-Z, infra, is beneficial to the prevention and/or treatment of the disease, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent. In another aspect, described herein are methods for preventing and/or treating a disease in which the alteration (e.g., increase or decrease) in the expression one, two, three or more protein isoforms encoded by a gene, wherein the gene is not disclosed in International Patent Application No. PCT/US2016/013553 (International Publication No. WO2016/115434), and is beneficial to the prevention and/or treatment of the disease, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent. In another aspect, described herein are methods for preventing and/or treating a disease in which the alteration (e.g., increase or decrease) in the expression one, two, three or more protein isoforms encoded by a gene other than a gene
comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5, is beneficial to the prevention and/or treatment of the disease, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent. In another aspect, a compound of Formula (I) is a compound selected from a compound described herein.
[00101] In another aspect, described herein are artificial gene constructs. In one aspect, described herein is an artificial gene construct comprising DNA encoding exons, a 3’ splice site(s) and a branch point(s), wherein a nucleotide sequence encoding an exon, which is upstream of a nucleotide sequence encoding a branch point and a nucleotide sequence encoding a 3’ splice site, is modified to introduce a nucleotide sequence encoding a REMS. In another aspect, described herein is an artificial gene construct comprising DNA encoding exons and one, two or more introns, wherein a nucleotide sequence encoding a 5’ splice site, which is upstream of a nucleotide sequence encoding a branch point and a nucleotide sequence encoding a 3’ splice site, is modified to introduce a nucleotide sequence encoding a REMS. In another aspect, described herein is an artificial gene construct comprising DNA encoding exons, a 5’ splice site(s), a 3’ splice site(s) and a branch point(s), wherein a nucleotide sequence encoding a 5’ splice site, which is upstream of a nucleotide sequence encoding a 3’ splice site, is modified to introduce a nucleotide sequence encoding a REMS. In another aspect, the artificial gene construct encodes a therapeutic protein. In another aspect, the artificial gene construct encodes a detectable reporter protein. In another aspect, the nucleotide sequence encoding an endogenous RNA REMS comprises a DNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 1 to SEQ ID NO. 5775. In another aspect, the nucleotide sequence encloding the RNA REMS is selected from the group consisting of SEQ ID NO. 5776 to SEQ ID NO. 11550. In another aspect, the nucleotide sequence encoding the RNA REMS is a nucleotide sequence encoding a non-endogenous DNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 1 to SEQ ID NO. 5775, i.e., not naturally found in the DNA sequence of the artificial construct.
[00102] In one aspect, described herein is a vector comprising the artificial gene construct described herein. In another aspect, described herein is a cell comprising an artificial gene construct described herein or a vector comprising an artificial gene construct described herein. [00103] In one aspect, described herein is a method of modulating the amount or type of a functional protein produced by a cell containing an artificial gene construct described herein. In another aspect, described herein is a method of modulating the amount or type of a functional protein produced by a cell containing an artificial gene construct described herein, the method comprising contacting the cell with a compound of Formula (I) or a form thereof. In another aspect, the artificial gene construct encodes a therapeutic protein. In another aspect, the artificial gene construct encodes a detectable reporter protein.
[00104] In one aspect, described herein is a method of modulating the amount or type of a functional protein produced by a subject, wherein the subject is or was administered an artificial gene construct described herein. In another aspect, described herein is method of regulating the amount or type of a functional protein produced by a subject, the mehod comprising: (a) administering an artificial gene construct or a vector comprising the artificial gene construct described herein to the subject; and (b) administering a compound of Formula (I) or a form thereof to the subject. In another aspect, described herein is a method of regulating the amount or type of a functional protein produced by a subject, the method comprising administering a compound of Formula (I) or a form thereof to a subject carrying a gene containing a nucleotide sequence encoding a REMS. In another aspect, described herein is a method of regulating the amount or type of a functional protein produced by a subject, the method comprising administering a compound of Formula (I) to the subject, wherein the subject was previously administered an artificial gene construct described herein. In another aspect, the artificial gene construct encodes a therapeutic protein. In another aspect, the artificial gene construct encodes a detectable reporter protein. In another aspect, the subject is a non-human. In another aspect, the subject is a human.
[00105] In one aspect, described herein is a method for modulating the amount or type of an RNA transcript produced from pre-mRNA containing a non-endogenous recognition element for splicing modifier (REMS), the method comprising contacting the pre-mRNA with a compound of Formula (I) or a form thereof, wherein the non-endogenous RNA REMS nucleotide sequence
selected from the group consisting of SEQ ID NO. 5776 to SEQ ID NO. 11550, and the compound is a compound of Formula (I)
[00106] or a form thereof, wherein Ri, R3, R4, R5, and Re are defined herein.
COMPOUNDS
[00107] One aspect of the present description relates to a use of a compound comprising, a compound of Formula (I):
[00108] or a form thereof, wherein
[00109] Ri is phenyl or heteroaryl, optionally substituted with one, two, three, or four, independently selected Ria substituents,
[00110] wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S;
[00111] Ria is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, or C1-6alkoxy;
[00112] R3 is hydrogen, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, and C1-6alkyl-amino,
[00113] wherein C1-6alkyl, C2-6alkenyl, and C2-6alkynyl is optionally substituted with one, two, three, or four independently selected R3a substituents, and
[00114] wherein each instance of C1-6alkyl, C2-6alkenyl, and C2-6alkynyl may optionally contain a chiral carbon having an (R) or (S) configuration;
[00115] Rsa is cyano, halo, hydroxy, oxo, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, halo- C1-6alkoxy, carboxyl, amino, C1-6alkoxy-carbonyl, C1-6alkyl-amino, halo-C1-6alkyl-amino, (C1-6alkyl)2-amino, phenyl-amino, heterocyclyl-amino, heteroaryl-amino, phenyl-(C1-6alkyl)- amino, heterocyclyl-(C1-6alkyl)-amino, heteroaryl-(C1-6alkyl)-amino, C1-6alkyl-thio, C1-6alkyl-sulfoxyl, and C1-6alkyl-sulfonyl,
[00116] wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S,
[00117] wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S;
[00118] wherein each instance of phenyl, heterocyclyl, and heteroaryl is optionally substituted with one, two, three or four independently selected Rsa' substituents;
[00119] Rsa’ is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, or amino; [00120] Rr is hydrogen, cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, halo-C1-6alkoxy, amino, C1-6alkyl-amino, (C1-6alkyl)2-amino, C3-10cycloalkyl, phenyl, heterocyclyl, or heteroaryl,
[00121] wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S,
[00122] wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S, and
[00123] wherein each instance of C1-6alkyl, C3-10cycloalkyl, phenyl, heterocyclyl, or heteroaryl are optionally substituted with one, two, three, or four independently selected R4a substituents;
[00124] R4a is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, or C1-6alkoxy;
[00125] R5 is hydrogen, cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, carbamoyl, C3-10cycloalkyl, or heterocyclyl,
[00126] wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S; and
[00127] Re is hydrogen, halo, or C1-6alkyl;
[00128] wherein the form of the compound is selected from the group consisting of a salt, hydrate, solvate, and tautomer form thereof.
[00129] One aspect includes use of a compound of Formula (I), wherein Ri is phenyl or heteroaryl, optionally substituted with one, two, three, or four, independently selected Ria substituents, wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S.
[00130] Another aspect includes use of a compound of Formula (I), wherein Ri is phenyl, optionally substituted with one, two, three, or four, independently selected Ria substituents. [00131] Another aspect includes use of a compound of Formula (I), wherein Ri is phenyl, optionally substituted with one Ria substituent.
[00132] Another aspect includes use of a compound of Formula (I), wherein Ri is heteroaryl, optionally substituted with one, two, three, or four, independently selected Ria substituents, wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S.
[00133] Another aspect includes use of a compound of Formula (I), wherein Ri is heteroaryl, optionally substituted with one Ria substituent, wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S.
[00134] Another aspect includes use of a compound of Formula (I), wherein Ri is heteroaryl selected from furanyl, thiophenyl, IH-pyrazolyl, IH-imidazolyl, isoxazolyl, 1,3 -thiazolyl, 1,3- oxazolyl, tetrazolyl, 1,2,3-triazolyl, 1,2,4-oxadiazolyl, 1,3,4-oxadiazolyl, 1,2,3-thiadiazolyl, pyridinyl, pyrimidinyl, pyrazinyl, pyridazinyl, Another aspect , and quinolinyl, wherein heteroaryl is optionally substituted with one, two, three, or four, independently Ria substituents. [00135] Another aspect includes use of a compound of Formula (I), wherein Ri is heteroaryl selected from furanyl, thiophenyl, 1,3 -thiazolyl, and pyridinyl, wherein heteroaryl is optionally substituted with one, two, three, or four, independently Ria substituents.
[00136] Another aspect includes use of a compound of Formula (I), wherein Ri is heteroaryl selected from furan-2-yl, furan-3-yl, thi ophen-2 -yl, thi ophen-3 -yl, IH-pyrazol-l-yl, lH-pyrazol-3-yl, lH-pyrazol-4-yl, lH-pyrazol-5-yl, IH-imidazol-l-yl, lH-imidazol-4-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, l,3-thiazol-2-yl, l,3-thiazol-4-yl, l,3-thiazol-5-yl, l,3-oxazol-2-yl, l,3-oxazol-4-yl, l,3-oxazol-5-yl, l,2,4-oxadiazol-3-yl, l,3,4-oxadiazol-2-yl, tetrazol-5-yl, 1,2, 3 -triazol -4-yl, l,2,3-triazol-5-yl, l,2,3-thiadiazol-4-yl, l,2,3-thiadiazol-5-yl,
pyri din-2 -yl, pyri din-3 -yl, pyridin-4-yl, pyrimidin-4-yl, pyrazin-2-yl, pyridazin-3-yl, pyridazin-4- yl, benzofuran-2-yl, benzofuran-5-yl, and quinoline-4-yl, wherein, heteroaryl is optionally substituted with one, two, three, or four, independently Ria substituents.
[00137] Another aspect includes use of a compound of Formula (I), wherein Ri is heteroaryl selected from furan-2-yl, thiophen-2-yl, l,3-thiazol-2-yl, and pyridin-4-yl, wherein heteroaryl is optionally substituted with one, two, three, or four, independently Ria substituents.
[00138] One aspect includes use of a compound of Formula (I), wherein Ria is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, or C1-6alkoxy.
[00139] Another aspect includes use of a compound of Formula (I), wherein Ria is halo.
[00140] Another aspect includes use of a compound of Formula (I), wherein Ria is halo selected from fluoro, chloro, bromo, and iodo.
[00141] Another aspect includes use of a compound of Formula (I), wherein Ria is fluoro.
[00142] One aspect includes use of a compound of Formula (I), wherein R3 is hydrogen, C1-6alkyl, C1-6alkenyl, C1-6alkynyl, or C1-6alkyl-amino,
[00143] wherein each instance of C1-6alkyl, C2-6alkenyl, and C2-6alkynyl is optionally substituted with one, two, three, or four independently selected Rsa substituents, and [00144] wherein each instance of C1-6alkyl, C2-6alkenyl, and C2-6alkynyl may optionally contain a chiral carbon having an (R) or (S) configuration.
[00145] Another aspect includes use of a compound of Formula (I), wherein R3 is hydrogen, C1-6alkyl, C2-6alkenyl, or C2-6alkynyl, optionally substituted with one, two, three, or four, independently selected R3a substituents, wherein C1-6alkyl, C2-6alkenyl, or C2-6alkynyl may optionally contain a chiral carbon having an (R) or (S) configuration.
[00146] Another aspect includes use of a compound of Formula (I), wherein R3 is hydrogen. [00147] Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl, optionally substituted with one, two, three, or four, independently selected Rsa substituents, and wherein, C1-6alkyl optionally contains a chiral carbon having an (R) or (S) configuration.
[00148] Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl, optionally substituted with one, two, three, or four independently selected R3a substituents.
[00149] Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl selected from methyl, ethyl, propyl, butyl, pentyl, and hexyl, optionally substituted with one, two, three, or four independently selected Ria substituents.
[00150] Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl selected from methyl, ethyl, propyl, butyl, and pentyl, optionally substituted with one, two, three, or four independently selected R3a substituents.
[00151] Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C1-6alkyl optionally contains a chiral carbon having an (R) configuration.
[00152] Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl selected from methyl, ethyl, propyl, butyl, pentyl, and hexyl, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C1-6alkyl optionally contains a chiral carbon having an (R) configuration.
[00153] Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl selected from methyl, ethyl, propyl, butyl, and pentyl, optionally substituted with one, two, three, or four independently selected Rsa substituents, and wherein C1-6alkyl optionally contains a chiral carbon having an (R) configuration.
[00154] Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C1-6alkyl optionally contains a chiral carbon having an (S) configuration.
[00155] Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl selected from methyl, ethyl, propyl, butyl, pentyl, and hexyl, optionally substituted with one, two, three, or four independently selected Ria substituents, and wherein C1-6alkyl optionally contains a chiral carbon having an (S) configuration.
[00156] Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl selected from methyl, ethyl, propyl, butyl, and pentyl, optionally substituted with one, two, three, or four independently selected Rsa substituents, and wherein C1-6alkyl optionally contains a chiral carbon having an (S) configuration.
[00157] Another aspect includes use of a compound of Formula (I), wherein R3 is C2-6alkenyl, optionally substituted with one, two, three, or four, independently selected Ria substituents, and wherein, C2-6alkenyl optionally contains a chiral carbon having an (R) or (S) configuration.
[00158] Another aspect includes use of a compound of Formula (I), wherein R3 is C2-6alkenyl selected from ethenyl, propenyl, butenyl, pentenyl, hexenyl, and heptenyl, optionally substituted with one, two, three, or four independently selected R3a substituents.
[00159] Another aspect includes use of a compound of Formula (I), wherein R3 is butenyl, optionally substituted with one, two, three, or four independently selected R3a substituents.
[00160] Another aspect includes use of a compound of Formula (I), wherein R3 is C2-6alkenyl selected from ethenyl, propenyl, butenyl, pentenyl, hexenyl, and heptenyl, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C2-6alkenyl optionally contains a chiral carbon having an (R) configuration.
[00161] Another aspect includes use of a compound of Formula (I), wherein R3 is butenyl, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C2-6alkenyl optionally contains a chiral carbon having an (R) configuration.
[00162] Another aspect includes use of a compound of Formula (I), wherein R3 is C2-6alkynyl, optionally substituted with one, two, three, or four, independently selected Ria substituents, and wherein, C2-6alkynyl optionally contains a chiral carbon having an (R) or (S) configuration.
[00163] Another aspect includes use of a compound of Formula (I), wherein R3 is C2-6alkenyl selected from ethenyl, propenyl, butenyl, pentenyl, hexenyl, and heptenyl, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C2-6alkenyl optionally contains a chiral carbon having an (S) configuration.
[00164] Another aspect includes use of a compound of Formula (I), wherein R3 is butenyl, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C2-6alkenyl optionally contains a chiral carbon having an (S) configuration.
[00165] Another aspect includes use of a compound of Formula (I), wherein R3 is C2-6alkynyl selected from ethynyl, propynyl, butynyl, pentynyl, hexynyl, and heptynyl, optionally substituted with one, two, three, or four independently selected R3a substituents.
[00166] Another aspect includes use of a compound of Formula (I), wherein R3 is butynyl, optionally substituted with one, two, three, or four independently selected R3a substituents.
[00167] Another aspect includes use of a compound of Formula (I), wherein R3 is C2-6alkynyl selected from ethynyl, propynyl, butynyl, pentynyl, hexynyl, and heptynyl, optionally substituted with one, two, three, or four independently selected Rsa substituents, and wherein C2-6alkynyl optionally contains a chiral carbon having an (R) configuration.
[00168] Another aspect includes use of a compound of Formula (I), wherein R3 is butynyl, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C2-6alkynyl optionally contains a chiral carbon having an (R) configuration.
[00169] Another aspect includes use of a compound of Formula (I), wherein R3 is C2-6alkynyl selected from ethynyl, propynyl, butynyl, pentynyl, hexynyl, and heptynyl, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C2-6alkynyl optionally contains a chiral carbon having an (S) configuration.
[00170] Another aspect includes use of a compound of Formula (I), wherein R3 is butynyl, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C?-r>alkynyl optionally contains a chiral carbon having an (8) configuration.
[00171] Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl-amino, optionally substituted with one, two, three, or four, independently selected R3a substituents, and wherein, C1-6alkyl optionally contains a chiral carbon having an (R) or (8) configuration.
[00172] Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl-amino, optionally substituted with one, two, three, or four independently selected R3a substituents.
[00173] Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl-amino, wherein Ci-calkyl is selected from methyl, ethyl, propyl, isopropyl, butyl, sec- butyl, isobutyl, and tert-butyl, optionally substituted with one, two, three, or four independently selected R3a substituents.
[00174] Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl-amino, wherein C1-6alkyl is propyl, optionally substituted with one, two, three, or four independently selected R3a substituents.
[00175] Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl-amino, optionally substituted with one, two, three, or four independently selected R3a
substituents, and wherein C1-6alkyl optionally contains a chiral carbon having an (R) configuration.
[00176] Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl-amino, wherein C1-6alkyl is selected from methyl, ethyl, propyl, isopropyl, butyl, sec- butyl, isobutyl, and tert-butyl, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C1-6alkyl optionally contains a chiral carbon having an (R) configuration.
[00177] Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl-amino, wherein C1-6alkyl is propyl, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C1-6alkyl optionally contains a chiral carbon having an (R) configuration.
[00178] Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl-amino, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C1-6alkyl optionally contains a chiral carbon having an (S) configuration.
[00179] Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl-amino, wherein C1-6alkyl is selected from methyl, ethyl, propyl, isopropyl, butyl, sec- butyl, isobutyl, and tert-butyl, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C1-6alkyl optionally contains a chiral carbon having an (S) configuration.
[00180] Another aspect includes use of a compound of Formula (I), wherein R3 is C1-6alkyl-amino, wherein C1-6alkyl is propyl, optionally substituted with one, two, three, or four independently selected R3a substituents, and wherein C1-6alkyl optionally contains a chiral carbon having an (S) configuration.
[00181] Another aspect includes use of a compound of Formula (I), wherein R3 is Ci-iocycloalkyl selected from cyclopropyl, cyclobutyl, cyclopentyl, cylcohexyl, cycloheptyl, and cyclooctyl, optionally substituted with one, two, three or four independently selected R3a substituents.
[00182] Another aspect includes use of a compound of Formula (I), wherein R3 is cyclopropyl or cyclopentyl, optionally substituted with one, two, three or four independently selected Rja substituents.
[00183] Another aspect includes use of a compound of Formula (I), wherein R3 is heterocyclyl, optionally substituted with one, two, three, or four, independently selected R3a substituents, wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S, and wherein heterocyclyl optionally contains a chiral carbon having an (R) or (S) configuration.
[00184] Another aspect includes use of a compound of Formula (I), wherein R3 is heterocyclyl selected from azetidinyl, oxetanyl, pyrazolidinyl, tetrahydrofuranyl, oxazolidinyl, thiazolidinyl, isothiazolidinyl, pyrrolidinyl, piperidinyl, piperazinyl, 2H-pyranyl, tetrahydropyranyl, morpholinyl, 1,3-oxazinanyl, and azepanyl, optionally substituted with one, two, three, or four independently selected R3a substituents.
[00185] Another aspect includes use of a compound of Formula (I), wherein R3 is azetidinyl, optionally substituted with one, two, three, or four independently selected R3a substituents.
[00186] Another aspect includes use of a compound of Formula (I), wherein R3 is heterocyclyl selected from azetidin-2-yl, azeti din-3 -yl, oxetan-2-yl, oxetan-3-yl, pyrazolidine-l-yl, pyrazolidine-2-yl, pyrazolidine-3-yl, pyrazolidine-4-yl, pyrazolidine-5-yl, tetrahydrofuran- 1-yl, tetrahydrofuran-2-yl, oxazolidin-2-yl, oxazolidin-4-yl, oxazolidine-5-yl, thiazolidin-2-yl, thiazolidin-4-yl, thiazolidin-5-yl, isothiazolidin-3-yl, isothiazolidin-4-yl, isothiazolidin-5-yl, pyrrolidin-2-yl, pyrrolidin-3-yl, piperidin-l-yl, piperidin-2-yl, piperidin-3-yl, piperidin-4-yl, piperazin- 1-yl, piperazin-2-yl, piperazin-3 -yl, 2H-pyran-2-yl, 2H-pyran-3-yl, 2H-pyran-4-yl, 2H-pyran-5-yl, 2H-pyran-6-yl, tetrahydropyran-2-yl, tetrahydropyran-3-yl, tetrahydropyran-4-yl, morpholin-2-yl, morpholin-3-yl, morpholin-4-yl, l,3-oxazinan-2-yl, l,3-oxazinan-3-yl, l,3-oxazinan-4-yl, azepan-l-yl, azepan-2-yl, azepan-3-yl, and azepan-4-yl, optionally substituted with one, two, three, or four independently selected R3a substituents.
[00187] Another aspect includes use of a compound of Formula (I), wherein R3 is azeti din-3 -yl, optionally substituted with one, two, three, or four independently selected R3a substituents.
[00188] One aspect includes use of a compound of Formula (I), wherein Rsa is cyano, halo, hydroxy, oxo, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, halo-C1-6alkoxy, carboxyl, amino, C1-6alkoxy-carbonyl, C1-6alkyl-amino, halo-C1-6alkyl-amino, (C1-6alkyl)2-amino, phenyl-amino, heterocyclyl-amino, heteroaryl-amino, phenyl-(C1-6alkyl)-amino, heterocyclyl-(C1-6alkyl)-amino, heteroaryl-(C1-6alkyl)-amino, C1-6alkyl-thio, C1-6alkyl-sulfoxyl, or C1-6alkyl-sulfonyl wherein each instance of Ca-iocycloalkyl, phenyl, heterocyclyl and heteroaryl is optionally substituted with one, two, three or four independently selected Raa’ substituents.
[00189] Another aspect includes use of a compound of Formula (I), wherein Raa is cyano, halo, hydroxy, oxo, C1-6alkyl, C1-6alkoxy, halo-C1-6alkoxy, carboxyl, amino, C1-6alkoxy- carbonyl, C1-6alkyl-amino, halo-C1-6alkyl-amino, (C1-6alkyl)2-amino, phenyl-amino, heteroaryl- amino, phenyl-(C1-6alkyl)-amino, heterocyclyl-(C1-6alkyl)-amino, heteroaryl-(C1-6alkyl)-amino, C1-6alkyl-thio, C1-6alkyl-sulfoxyl, or C1-6alkyl-sulfonyl, wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S, wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S, and wherein each instance of Cs-iocycloalkyl, phenyl, heterocyclyl and heteroaryl is optionally substituted with one, two, three or four independently selected Ra;i' substituents.
[00190] Another aspect includes use of a compound of Formula (I), wherein Raa is cyano.
[00191] Another aspect includes use of a compound of Formula (I), wherein Raa is halo selected from fluoro, chloro, bromo, and iodo.
[00192] Another aspect includes use of a compound of Formula (I), wherein Raa is fluoro.
[00193] Another aspect includes use of a compound of Formula (I), wherein Raa is hydroxy.
[00194] Another aspect includes use of a compound of Formula (I), wherein Raa is oxo.
[00195] Another aspect includes use of a compound of Formula (I), wherein Raa is C1-6alkyl selected from C1-6alkyl selected from methyl, ethyl, propyl, butyl, pentyl, and hexyl.
[00196] Another aspect includes use of a compound of Formula (I), wherein Raa is C1-6alkyl selected from methyl and isopropyl.
[00197] Another aspect includes use of a compound of Formula (I), wherein Raa is C1-6alkoxy selected from methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butoxy, iso-butoxy, tert- butoxy, pentoxy, and hexyloxy.
[00198] Another aspect includes use of a compound of Formula (I), wherein Raa methoxy.
[00199] Another aspect includes use of a compound of Formula (I), wherein Raa is halo- C1-6alkoxy wherein C1-6alkoxy is selected from methoxy, methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butoxy, iso-butoxy, tert-butoxy, pentoxy, and hexyloxy partially or completely substituted with one or more halogen atoms where allowed by available valences.
[00200] Another aspect includes use of a compound of Formula (I), wherein Raa is halo- C1-6alkoxy, wherein C1-6alkoxy is methoxy substituted with three fluorine atoms.
[00201] Another aspect includes use of a compound of Formula (I), wherein Raa is carboxyl.
[00202] Another aspect includes use of a compound of Formula (I), wherein Raa is amino.
[00203] Another aspect includes use of a compound of Formula (I), wherein Raa is C1-6alkoxy- carbonyl wherein C1-6alkoxy is selected from methoxy, methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butoxy, iso-butoxy, tert-butoxy, pentoxy, and hexyloxy.
[00204] Another aspect includes use of a compound of Formula (I), wherein Raa is C1-6alkoxy- carbonyl wherein C1-6alkoxy is methoxy.
[00205] Another aspect includes use of a compound of Formula (I), wherein Raa is C1-6alkyl-amino, wherein C1-6alkyl is selected from methyl, ethyl, propyl, isopropyl, butyl, sec- butyl, iso-butyl, tert-butyl, pentyl, and hexyl.
[00206] Another aspect includes use of a compound of Formula (I), wherein Raa is C1-6alkyl-amino, wherein C1-6alkyl is methyl.
[00207] Another aspect includes use of a compound of Formula (I), wherein Raa is halo- C1-6alkyl-amino, wherein C1-6alkyl is selected from methyl, ethyl, propyl, isopropyl, butyl, sec- butyl, iso-butyl, tert-butyl, pentyl, and hexyl partially or completely substituted with one or more halogen atoms where allowed by available valences.
[00208] Another aspect includes use of a compound of Formula (I), wherein Raa is halo- C1-6alkyl-amino, wherein C1-6alkyl is methyl substituted with three fluorine atoms.
[00209] Another aspect includes use of a compound of Formula (I), wherein Raa is (C1-6alkyl)2-amino, wherein C1-6alkyl is selected from methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, iso-butyl, tert-butyl, pentyl, and hexyl.
[00210] Another aspect includes use of a compound of Formula (I), wherein Raa is (C1-6alkyl)2-amino, wherein C1-6alkyl is methyl.
[00211] Another aspect includes use of a compound of Formula (I), wherein R3a is phenyl- amino, wherein phenyl is optionally substituted with one, two, three or four independently selected R3a' substituents.
[00212] Another aspect includes use of a compound of Formula (I), wherein R3a is phenyl- amino wherein phenyl is optionally substituted with one independently selected R3a' substituents. [00213] Another aspect includes use of a compound of Formula (I), wherein Ria is heteroaryl- amino, wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S, wherein heteroaryl is optionally substituted with one, two, three or four independently selected R3a' substituents.
[00214] Another aspect includes use of a compound of Formula (I), wherein R3a is heteroaryl- amino, wherein heteroaryl is selected from furanyl, thiophenyl, IH-pyrazolyl, IH-imidazolyl, isoxazolyl, 1,3 -thiazolyl, 1,3-oxazolyl, tetrazolyl, 1,2,3-triazolyl, 1,2,4-oxadiazolyl, 1,3,4-oxadiazolyl, 1,2,3-thiadiazolyl, pyridinyl, pyrimidinyl, pyrazinyl, pyridazinyl, benzofuranyl, and quinolinyl, wherein heteroaryl is optionally substituted with one, two, three or four independently selected R3a' substituents.
[00215] Another aspect includes use of a compound of Formula (I), wherein R3a is heteroaryl- amino, wherein heteroaryl is selected IH-pyrazolyl, pyridinyl, and pyrazinyl, wherein each instance is optionally substituted with one, two, three or four independently selected R3a' substituents.
[00216] Another aspect includes use of a compound of Formula (I), wherein R3a is phenyl- (C1-6alkyl)-amino, wherein C1-6alkyl is selected from methyl, ethyl, propyl, butyl, pentyl, and hexyl, wherein phenyl is phenyl is optionally substituted with one, two, three, or four independently selected R3a' substituents.
[00217] Another aspect includes use of a compound of Formula (I), wherein R3a is phenyl- (C1-6alkyl)-amino, wherein C1-6alkyl is selected from methyl, ethyl, propyl, butyl, pentyl, and hexyl, wherein phenyl is phenyl is optionally substituted with one independently selected R3a' substituents.
[00218] Another aspect includes use of a compound of Formula (I), wherein R3a is phenyl- (C1-6alkyl)-amino, wherein C1-6alkyl is methyl.
[00219] Another aspect includes use of a compound of Formula (I), wherein Rsa is C1-6alkyl-thio, wherein C1-6alkyl is selected from methyl, ethyl, propyl, isopropyl, butyl, sec- butyl, iso-butyl, tert-butyl, pentyl, and hexyl.
[00220] Another aspect includes use of a compound of Formula (I), wherein Rsa is C1-6alkyl-thio, wherein C1-6alkyl is methyl.
[00221] Another aspect includes use of a compound of Formula (I), wherein Rsa is C1-6alkyl-sulfoxyl, wherein C1-6alkyl is selected from methyl, ethyl, propyl, isopropyl, butyl, sec- butyl, iso-butyl, tert-butyl, pentyl, and hexyl.
[00222] Another aspect includes use of a compound of Formula (I), wherein R.3a is C1-6alkyl-sulfoxyl, wherein C1-6alkyl is methyl.
[00223] Another aspect includes use of a compound of Formula (1), wherein Rsa is C1-6alkyl-sulfonyl, wherein C1-6alkyl is selected from methyl, ethyl, propyl, isopropyl, butyl, sec- butyl, iso-butyl, tert-butyl, pentyl, and hexyl.
[00224] Another aspect includes use of a compound of Formula (I), wherein R3a is C1-6alkyl-sulfonyl, wherein C1-6alkyl is methyl.
[00225] One aspect includes use of a compound of Formula (I), wherein Rsa' is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, or amino.
[00226] Another aspect includes use of a compound of Formula (I), wherein Rsa1 is halo or C1-6alkyl.
[00227] Another aspect includes use of a compound of Formula (I), wherein Rsa' is cyano.
[00228] Another aspect includes use of a compound of Formula (I), wherein Rsa' is halo selected from fluoro, chloro, bromo, and iodo.
[00229] Another aspect includes use of a compound of Formula (I), wherein Rsa' is fluoro or chloro.
[00230] Another aspect includes use of a compound of Formula (I), wherein Rsa' is C1-6alkyl selected from methyl, ethyl, propyl, butyl, pentyl, and hexyl.
[00231] Another aspect includes use of a compound of Formula (I), wherein Rsa' is from methyl.
[00232] Another aspect includes use of a compound of Formula (I), wherein Rsa’ is C1-6alkoxy selected from methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butoxy, iso-butoxy, tert- butoxy, pentoxy, and hexyloxy.
[00233] Another aspect includes use of a compound of Formula (I), wherein Rsa’ is methoxy.
[00234] Another aspect includes use of a compound of Formula (I), wherein R3a’ is amino.
[00235] One aspect includes use of a compound of Formula (I), wherein R4 is hydrogen, cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, halo-C1-6alkoxy, amino, C1-6alkyl-amino, (C1-6alkyl)2-amino, C3-10cycloalkyl, phenyl, heterocyclyl, or heteroaryl, wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S, wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S, and wherein each instance of C1-6alkyl, C3-10cycloalkyl, phenyl, heterocyclyl, or heteroaryl are optionally substituted with one, two, three, or four independently selected R4a substituents.
[00236] Another aspect includes use of a compound of Formula (I), wherein R4 is hydrogen, cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkoxy, or C3-10cycloalkyl, wherein C1-6alkyl or C3-10cycloalkyl are optionally substituted with one, two, three, or four independently selected R4a substituents.
[00237] Another aspect includes use of a compound of Formula (I), wherein R4 is hydrogen.
[00238] Another aspect includes use of a compound of Formula (I), wherein R4 is cyano.
[00239] Another aspect includes use of a compound of Formula (I), wherein R4 is halo selected from fluoro, chloro, bromo, and iodo.
[00240] Another aspect includes use of a compound of Formula (I), wherein R4 is halo selected from chloro and bromo.
[00241] Another aspect includes use of a compound of Formula (I), wherein R4 is hydroxy.
[00242] Another aspect includes use of a compound of Formula (I), wherein R4 is C1-6alkyl selected from methyl, ethyl, propyl, butyl, pentyl, and hexyl, wherein C1-6alkyl is optionally substituted with one, two, three, or four independently selected R4a substituents.
[00243] Another aspect includes use of a compound of Formula (I), wherein R4 is methyl optionally substituted with one, two, three, or four independently selected R4a substituents.
[00244] Another aspect includes use of a compound of Formula (I), wherein JU is halo- C1-6alkoxy wherein C1-6alkoxy is selected from methoxy, methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butoxy, iso-butoxy, tert-butoxy, pentoxy, and hexyloxy partially or completely substituted with one or more halogen atoms where allowed by available valences.
[00245] Another aspect includes use of a compound of Formula (I), wherein R3a is halo- C1-6alkoxy, wherein C1-6alkoxy is methoxy substituted with two fluorine atoms.
[00246] Another aspect includes use of a compound of Formula (I), wherein JU is C3-10cycloalkyl, wherein C3-10cycloalkyl is optionally substituted with one, two, three, or four independently selected R.4a substituents.
[00247] Another aspect includes use of a compound of Formula (I), wherein JU is C3-10cycloalkyl selected from cyclopropyl, cyclobutyl, cyclopentyl, cylcohexyl, cycloheptyl, and cyclooctyl, optionally substituted with one, two, three, or four independently selected R4a substituents.
[00248] Another aspect includes use of a compound of Formula (I), wherein Rr is cyclopropyl, optionally substituted with one, two, three, or four independently selected R4a substituents.
[00249] One aspect includes use of a compound of Formula (I), wherein R4a is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, or C1-6alkoxy.
[00250] One aspect includes use of a compound of Formula (I), wherein R5 is hydrogen, cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, carbamoyl, C3-10cycloalkyl, or heterocyclyl, wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S.
[00251] Another aspect includes use of a compound of Formula (I), wherein R5 is hydrogen, cyano, halo, or C1-6alkyl.
[00252] Another aspect includes use of a compound of Formula (I), wherein R5 is hydrogen.
[00253] Another aspect includes use of a compound of Formula (I), wherein R5 is cyano.
[00254] Another aspect includes use of a compound of Formula (I), wherein R5 is halo selected from fluoro, chloro, bromo, and iodo.
[00255] Another aspect includes use of a compound of Formula (I), wherein R5 is chloro.
[00256] Another aspect includes use of a compound of Formula (I), wherein R5 is C1-6alkyl selected from methyl, ethyl, propyl, butyl, pentyl, and hexyl.
[00257] Another aspect includes use of a compound of Formula (I), wherein R5 is methyl.
[00258] One aspect includes use of a compound of Formula (I), wherein Re is hydrogen, halo, or C1-6alkyl.
[00259] Another aspect includes use of a compound of Formula (I), wherein Re is hydrogen.
[00260] In one aspect, described herein the use of the compound of Formula (I) or a form thereof includes use of a compound selected from the group consisting of:
1791
[00261] wherein the form of the compound is selected from the group consisting of a salt, hydrate, solvate, and tautomer form thereof.
[00262] In another aspect, described herein use of the compound of Formula (I) or a form thereof (wherein compound number (#x) indicates that the salt form was isolated) includes a compound selected from the group consisting of:
[00263] wherein the form of the compound is selected from the group consisting of a salt, hydrate, solvate, and tautomer form thereof.
[00264] In another aspect, described herein use of the compound of Formula (I) or a form thereof includes a compound salt selected from the group consisting of:
[00265] wherein the form of the compound is selected from the group consisting of a salt, hydrate, solvate, and tautomer.
[00266] The present application further provides a pharmaceutical composition comprising a compound described herein, or a pharmaceutically acceptable salt thereof, and at least one pharmaceutically acceptable carrier.
[00267] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Methods and materials are described herein for use in the present invention; other, suitable methods and materials known in the art can also be used.
[00268] The materials, methods, and examples are illustrative only and not intended to be limiting. All publications, patent applications, patents, sequences, database entries, and other references mentioned herein are incorporated by reference in their entirety. In case of conflict, the present specification, including definitions, will control.
CHEMICAL DEFINITIONS
[00269] The chemical terms used above and throughout the description herein, unless specifically defined otherwise, shall be understood by one of ordinary skill in the art to have the following indicated meanings.
[00270] As used herein, the term “C1-6alkyl” generally refers to saturated hydrocarbon radicals having from one to eight carbon atoms in a straight or branched chain configuration, including, but not limited to, methyl, ethyl, n-propyl (also referred to as propyl or propanyl), isopropyl, n-butyl (also referred to as butyl or butanyl), isobutyl, sec-butyl, tert-butyl, n-pentyl (also referred to as pentyl or pentanyl), n-hexyl (also referred to as hexyl or hexanyl), and the like. In another aspect, C1-6alkyl includes, but is not limited to, C1-6alkyl, Ci-4alkyl and the like. A C1-6alkyl radical is optionally substituted with substituent species as described herein where allowed by available valences.
[00271] As used herein, the term “hetero-C1-6alkyl” generally refers to saturated hydrocarbon radicals having from one to six carbon atoms in a straight or branched chain configuration, in which one or more heteroatoms, such as an O, S or N atom, are members in the chain, including, but not limited to, but not limited to, hetero-methyl, hetero-ethyl, hetero-propyl, hetero-butyl, hetero-pentyl, hetero-hexyl and the like. In another aspect, hetero-C1-6alkyl includes, but is not limited to, hetero-C2-6alkyl, hetero-Ci-ralkyl, hetero-C2-4alkyl and the like. A hetero-C1-6alkyl radical is optionally substituted with substituent species as described herein where allowed by available valences.
[00272] As used herein, the term “C2-6alkenyl” generally refers to partially unsaturated hydrocarbon radicals having from two to eight carbon atoms in a straight or branched chain configuration and one or more carbon-carbon double bonds therein, including, but not limited to, ethenyl (also referred to as vinyl), allyl, propenyl and the like. In another aspect, C2-6alkenyl includes, but is not limited to, C2-6alkenyl, C2-4alkenyl and the like. A C2-6alkenyl radical is optionally substituted with substituent species as described herein where allowed by available valences.
[00273] As used herein, the term “C2-6alkynyl” generally refers to partially unsaturated hydrocarbon radicals having from two to eight carbon atoms in a straight or branched chain configuration and one or more carbon-carbon triple bonds therein, including, but not limited to,
ethynyl (also referred to as acetylenyl), propynyl, butynyl and the like. In another aspect, C2-6alkynyl includes, but is not limited to, C2-6alkynyl, C2-4alkynyl and the like. A C2-6alkynyl radical is optionally substituted with substituent species as described herein where allowed by available valences.
[00274] As used herein, the term “C1-6alkoxy” generally refers to saturated hydrocarbon radicals having from one to eight carbon atoms in a straight or branched chain configuration of the formula: -O-C1-6alkyl, including, but not limited to, methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, sec-butoxy, tert-butoxy, n-pentoxy, n-hexoxy and the like. In another aspect, C1-6alkoxy includes, but is not limited to, C1-6alkoxy, Ci-4alkoxy and the like. A C1-6alkoxy radical is optionally substituted with substituent species as described herein where allowed by available valences.
[00275] As used herein, the term "oxo" refers to a radical of the formula: =0.
[00276] As used herein, the term "carboxyl" refers to a radical of the formula: -COOH, -
C(O)OH or -CO2H.
[00277] As used herein, the term "C1-6alkoxy-carbonyl " refers to a radical of the formula: -COO- C1-6alkyl, -C(O)O-C1-6alkyl or -CO2-C1-6alkyl.
[00278] As used herein, the term "carbamoyl" refers to a radical of the formula: -C(O)NH2.
[00279] As used herein, the term “C3-10cycloalkyl” generally refers to a saturated or partially unsaturated monocyclic, bicyclic or polycyclic hydrocarbon radical, including, but not limited to, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cyclohexenyl, cycloheptyl, cyclooctyl, 1/7-indanyl, indenyl, tetrahydro-naphthalenyl and the like. In another aspect, C3-10cycloalkyl includes, but is not limited to, Cs-scycloalkyl, Cs-scycloalkyl, C3-10cycloalkyl and the like. A C3-10cycloalkyl radical is optionally substituted with substituent species as described herein where allowed by available valences.
[00280] As used herein, the term “aryl” generally refers to a monocyclic, bicyclic or polycyclic aromatic carbon atom ring structure radical, including, but not limited to, phenyl, naphthyl, anthracenyl, fluorenyl, azulenyl, phenanthrenyl and the like. An aryl radical is optionally substituted with substituent species as described herein where allowed by available valences.
[00281] As used herein, the term “heteroaryl” generally refers to a monocyclic, bicyclic or polycyclic aromatic carbon atom ring structure radical in which one or more carbon atom ring members have been replaced, where allowed by structural stability, with one or more heteroatoms, such as an O, S or N atom, including, but not limited to, furanyl, thiophenyl, pyrrolyl, pyrazolyl, imidazolyl, isoxazolyl, isothiazolyl, oxazolyl, 1,3 -thiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, tetrazolyl, pyridinyl, pyrimidinyl, pyrazinyl, pyridazinyl, triazinyl, indolyl, indazolyl, indolizinyl, isoindolyl, benzofuranyl, benzothiophenyl, benzoimidazolyl, 1,3-benzothiazolyl, 1,3-benzoxazolyl, purinyl, quinolinyl, isoquinolinyl, quinazolinyl, quinoxalinyl and the like. A heteroaryl radical is optionally substituted on a carbon or nitrogen atom ring member with substituent species as described herein where allowed by available valences.
[00282] In another aspect, the nomenclature for a heteroaryl radical may differ, such as in non-limiting examples where furanyl may also be referred to as furyl, thiophenyl may also be referred to as thienyl, pyridinyl may also be referred to as pyridyl, benzothiophenyl may also be referred to as benzothienyl and 1,3-benzoxazolyl may also be referred to as 1,3-benzooxazolyl. [00283] In another aspect, the term for a heteroaryl radical may also include other regioisomers, such as in non-limiting examples where the term pyrrolyl may also include 2//-pyrrolyl, 3 //-pyrrol y I and the like, the term pyrazolyl may also include l//-pyrazolyl and the like, the term imidazolyl may also include 1/Z-imidazolyl and the like, the term triazolyl may also include l//-l,2,3-triazolyl and the like, the term oxadiazolyl may also include 1,2,4-oxadiazolyl, 1,3,4-oxadiazolyl and the like, the term tetrazolyl may also include
I //-tetrazolyl, 2//-tetrazolyl and the like, the term indolyl may also include l//-indolyl and the like, the term indazolyl may also include l//-indazolyl, 2//-indazolyl and the like, the term benzoimidazolyl may also include l//-benzoimidazolyl and the term purinyl may also include 9 //-purinyl and the like.
[00284] As used herein, the term “heterocyclyl” generally refers to a saturated or partially unsaturated monocyclic, bicyclic or polycyclic carbon atom ring structure radical in which one or more carbon atom ring members have been replaced, where allowed by structural stability, with a heteroatom, such as an O, S or N atom, including, but not limited to, oxiranyl, oxetanyl, azetidinyl, tetrahydrofuranyl, pyrrolinyl, pyrrolidinyl, pyrazolinyl, pyrazolidinyl, imidazolinyl,
imidazolidinyl, isoxazolinyl, isoxazolidinyl, isothiazolinyl, isothiazolidinyl, oxazolinyl, oxazolidinyl, thiazolinyl, thiazolidinyl, triazolinyl, triazolidinyl, oxadiazolinyl, oxadiazolidinyl, thiadiazolinyl, thiadiazolidinyl, tetrazolinyl, tetrazolidinyl, pyranyl, di hydro-2//- pyranyl, tetrahydropyranyl, thiopyranyl, 1,3-dioxanyl, 1,3-oxazinanyl, 1,2,5,6-tetrahydropyridinyl, 1,2,3,6-tetrahydropyridinyl, piperidinyl, piperazinyl, morpholinyl, thiomorpholinyl, 1,4-diazepanyl, 1,3 -benzodi oxolyl, 1,4-benzodioxanyl and the like. A heterocyclyl radical is optionally substituted on a carbon or nitrogen atom ring member with substituent species as described herein where allowed by available valences.
[00285] As used herein, the term “C1-6alkyl-amino” refers to a radical of the formula: -NH-C1-6alkyl.
[00286] As used herein, the term “halo-C1-6alkyl-amino” refers to a radical of the formula: -NH-C1-6alkyl, wherein C1-6alkyl is partially or completely substituted with one or more halogen atoms where allowed by available valences.
[00287] As used herein, the term “(C1-6alkyl)2-amino” refers to a radical of the formula: -N(C1-6alkyl)2.
[00288] As used herein, the term “C1-6alkyl-carboxyl-amino” refers to a radical of the formula: -NH-C(O)-.
[00289] As used herein, the term “aryl-amino” refers to a radical of the formula: -NH-aryl.
[00290] As used herein, the term “heterocyclyl-amino” refers to a radical of the formula: -NH-heterocyclyl.
[00291] As used herein, the term “heteroaryl-amino” refers to a radical of the formula: -NH-heteroaryl.
[00292] As used herein, the term “aryl-(C1-6alkyl)-amino” refers to a radical of the formula: -N(C1-6alkyl)-aryl.
[00293] As used herein, the term “heterocyclyl-(C1-6alkyl)-amino” refers to a radical of the formula: -N(C1-6alkyl)-heterocyclyl.
[00294] As used herein, the term “heteroaryl-(C1-6alkyl)-amino” refers to a radical of the formula: -N(C1-6alkyl)-heteroaryl.
[00295] As used herein, the term “C1-6alkyl-thio” refers to a radical of the formula: -S-Ci- ealkyl.
[00296] As used herein, the term "C1-6alkyl-sulfoxyl" refers to a radical of the formula: -S(O)-C1-6alkyl.
[00297] As used herein, the term "C1-6alkyl-sulfonyl" refers to a radical of the formula: -SCh-C1-6alkyl.
[00298] As used herein, the term “halo” or “halogen” generally refers to a halogen atom radical, including fluoro, chloro, bromo and iodo.
[00299] As used herein, the term “halo-C1-6alkoxy” refers to a radical of the formula: -O-C1-6alkyl-halo, wherein C1-6alkyl is partially or completely substituted with one or more halogen atoms where allowed by available valences.
[00300] As used herein, the term “halo-C1-6alkyl” refers to a radical of the formula: -C1-6alkyl-halo, wherein C1-6alkyl is partially or completely substituted with one or more halogen atoms where allowed by available valences.
[00301] As used herein, the term “hydroxy” refers to a radical of the formula: -OH.
[00302] As used herein, the term “hydroxy-C1-6alkyl” refers to a radical of the formula: -C1-6alkyl-OH, wherein C1-6alkyl is partially or completely substituted with one or more hydroxy radicals where allowed by available valences.
[00303] As used herein, the term “substituent” means positional variables on the atoms of a core molecule that are substituted at a designated atom position, replacing one or more hydrogens on the designated atom, provided that the designated atom’s normal valency is not exceeded, and that the substitution results in a stable compound. Combinations of substituents and/or variables are permissible only if such combinations result in stable compounds. A person of ordinary skill in the art should note that any carbon as well as heteroatom with valences that appear to be unsatisfied as described or shown herein is assumed to have a sufficient number of hydrogen atom(s) to satisfy the valences described or shown. In certain instances, one or more substituents having a double bond (e g , “oxo” or “=O”) as the point of attachment may be described, shown or listed herein within a substituent group, wherein the structure may only show a single bond as the point of attachment to the core structure of Formula (I). A person of ordinary skill in the art would understand that, while only a single bond is shown, a double bond is intended for those substituents.
[00304] As used herein, the term “and the like,” with reference to the definitions of chemical terms described herein, means that variations in chemical structures that could be expected by one skilled in the art include, without limitation, isomers (including chain, branching or positional structural isomers), hydration of ring systems (including saturation or partial unsaturation of monocyclic, bicyclic or polycyclic ring structures) and all other variations where allowed by available valences which result in a stable compound.
[00305] For the purposes of this description, where one or more substituent variables for a compound of Formula (I) or a form thereof encompass functionalities incorporated into a compound of Formula (I), each functionality appearing at any location within the disclosed compound may be independently selected, and as appropriate, independently and/or optionally substituted.
[00306] As used herein, the terms “independently selected,” or “each selected” refer to functional variables in a substituent list that may occur more than once on the structure of Formula (I), the pattern of substitution at each occurrence is independent of the pattern at any other occurrence. Further, the use of a generic substituent variable on any formula or structure for a compound described herein is understood to include the replacement of the generic substituent with species substituents that are included within the particular genus, e.g., aryl may be replaced with phenyl or naphthal enyl and the like, and that the resulting compound is to be included within the scope of the compounds described herein.
[00307] As used herein, the terms “each instance of’ or “in each instance, when present,” when used preceding a phrase such as “...C3-10cycloalkyl, C3-10cycloalkyl-Ci-4alkyl, aryl, aryl-Ci-4alkyl, heteroaryl, heteroaryl-Ci-4alkyl, heterocyclyl and heterocyclyl-Ci-4alkyl,” are intended to refer to the C3-10cycloalkyl, aryl, heteroaryl and heterocyclyl ring systems when each are present either alone or as a substituent.
[00308] As used herein, the term “optionally substituted” means optional substitution with the specified substituent variables, groups, radicals or moieties.
[00309] As used herein, the terms “stable compound’ or “stable structure” mean a compound that is sufficiently robust to be isolated to a useful degree of purity from a reaction mixture and formulations thereof into an efficacious therapeutic agent.
[00310] Compound names described herein were obtained using ACD Labs Index Name software provided by ACD Labs and/or ChemDraw Ultra software provided by CambridgeSoft®. When the compound name disclosed herein conflicts with the structure depicted, the structure shown will supercede the use of the name to define the compound intended. Nomenclature for substituent radicals defined herein may differ slightly from the chemical name from which they are derived; one skilled in the art will recognize that the definition of the substituent radical is intended to include the radical as found in the chemical name.
[00311] As used herein the term “aberrant” refers to a deviation from the norm of, e.g., the average healthy subject or a cell(s) or tissue sample from a healthy subject. The term “aberrant expression,” as used herein, refers to abnormal expression (up-regulated or down-regulated resulting in an excessive or deficient amount or type thereof) of a gene product (e.g., RNA transcript or protein) by a cell, tissue sample, or subject relative to a corresponding normal, healthy cell, tissue sample or subject. In a specific aspect, the “aberrant expression” refers to an altered level of a gene product (e.g., RNA transcript or protein) in a cell, tissue sample, or subject relative to a corresponding normal, healthy cell, tissue sample or subject. The term “aberrant amount” as used herein refers to an altered level of a gene product (e.g., RNA, protein, polypeptide, or peptide) in a cell, tissue sample, or subject relative to a corresponding normal, healthy cell, tissue sample or subject. In another aspect, the amount or type of a gene product (e.g., RNA, protein, polypeptide, or peptide) in a cell, tissue sample, or subject relative to a corresponding cell or tissue sample from a healthy subject or a healthy subject, is considered aberrant if it is 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6-fold or more above or below the amount or type of the gene product in the corresponding cell or tissue sample from a healthy subject or healthy subject.
[00312] As used herein, the phrase “non-endogenous REMS” refers to a REMS not naturally found to be part of an RNA sequence or naturally encoded by a DNA sequence. In other words, the hand of man is required to manipulate the RNA or DNA sequence to introduce the REMS or the nucleotide sequence encoding the REMS.
[00313] As used herein, the term “substantial change” in the context of the amount or type of one or more RNA transcripts (e.g. , pre-mRNA or mature mRNA transcripts), an alternative splice variant thereof or an isoform thereof, or one or more proteins thereof, each expressed as
the product of one or more of genes, means that the amount or type of such products changes by a statistically significant amount such as, in a nonlimiting example, a p value less than a value selected from 0.1, 0.01, 0.001, or 0.0001.
[00314] As used herein, the terms “subject” and “subject” are used interchangeably to refer to an animal or any living organism having sensation and the power of voluntary movement, and which requires for its existence oxygen and organic food. Non-limiting examples include members of the human, equine, porcine, bovine, rattus, murine, canine and feline species. In another aspect, the subject is a mammal or a warm-blooded vertebrate animal. In another aspect, the subject is a non-human animal. In another aspect, the subject is a human.
[00315] As used herein, the term “functional protein” refers to a form of a protein that retains a certain biological function or the functions of a full length protein or protein isoform encoding by a gene.
[00316] As used herein, in the context of a functional protein produced from an artificial construct, the term “produce substantially less” means that the amount or type of functional protein in the absence of a compound described herein is at least 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 70%, 75%, 80%, 85%, 90%, 95%, 98%, or 100% less than the amount or type of functional protein produced in the presence of the compound.
COMPOUND FORMS
[00317] As used herein, the term “form” means a compound of Formula (I) having a form selected from the group consisting of a free acid, free base, salt, hydrate, solvate, racemate, enantiomer, diastereomer, stereoisomer, and tautomer form thereof.
[00318] In another aspect, described herein, the form of the compound of Formula (I) is a free acid, free base or salt thereof.
[00319] In another aspect, described herein, the form of the compound of Formula (I) is a salt thereof.
[00320] In another aspect, described herein, the form of the compound of Formula (I) is a stereoisomer, racemate, enantiomer or diastereomer thereof.
[00321] In another aspect, described herein, the form of the compound of Formula (I) is a tautomer thereof.
[00322] In another aspect, described herein, the form of the compound of Formula (I) is a pharmaceutically acceptable form.
[00323] In another aspect, described herein, the compound of Formula (I) or a form thereof is isolated for use.
[00324] As used herein, the term “isolated” means the physical state of a compound of Formula (I) or a form thereof after being isolated and/or purified from a synthetic process (e.g., from a reaction mixture) or natural source or combination thereof according to an isolation or purification process or processes described herein or which are well known to the skilled artisan (e.g., chromatography, recrystallization and the like) in sufficient purity to be characterized by standard analytical techniques described herein or well known to the skilled artisan.
[00325] As used herein, the term “protected” means that a functional group in a compound of Formula (I) or a form thereof is in a form modified to preclude undesired side reactions at the protected site when the compound is subjected to a reaction. Suitable protecting groups will be recognized by those with ordinary skill in the art as well as by reference to standard textbooks such as, for example, T.W. Greene et al, Protective Groups in organic Synthesis (1991), Wiley, New York. Such functional groups include hydroxy, phenol, amino and carboxylic acid.
Suitable protecting groups for hydroxy or phenol include trialkylsilyl or diarylalkylsilyl (e.g., t-butyldimethylsilyl, t-butyldiphenyl silyl or trimethylsilyl), tetrahydropyranyl, benzyl, substituted benzyl, methyl, methoxymethanol, and the like. Suitable protecting groups for amino, amidino and guanidino include t-butoxycarbonyl, benzyl oxy carbonyl, and the like. Suitable protecting groups for carboxylic acid include alkyl, aryl or arylalkyl esters. In certain instances, the protecting group may also be a polymer resin, such as a Wang resin or a 2-chlorotrityl- chloride resin. Protecting groups may be added or removed in accordance with standard techniques, which are well-known to those skilled in the art and as described herein. It will also be appreciated by those skilled in the art, although such protected derivatives of compounds described herein may not possess pharmacological activity as such, they may be administered to a subject and thereafter metabolized in the body to form compounds described herein which are pharmacologically active. Such derivatives may therefore be described as "prodrugs". All prodrugs of compounds described herein are included within the scope of the use described herein.
[00326] As used herein, the term “prodrug” means a form of an instant compound (e.g., a drug precursor) that is transformed in vivo to yield an active compound of Formula (I) or a form thereof. The transformation may occur by various mechanisms (e.g., by metabolic and/or non-metabolic chemical processes), such as, for example, by hydrolysis and/or metabolism in blood, liver and/or other organs and tissues. A discussion of the use of prodrugs is provided by T. Higuchi and W. Stella, “Pro-drugs as Novel Delivery Systems,” Vol. 14 of the A C S. Symposium Series, and in Bioreversible Carriers in Drug Design, ed. Edward B. Roche, American Pharmaceutical Association and Pergamon Press, 1987.
[00327] In one example, when a compound of Formula (I) or a form thereof contains a carboxylic acid functional group, a prodrug can comprise an ester formed by the replacement of the hydrogen atom of the acid group with a functional group such as alkyl and the like. In another example, when a compound of Formula (I) or a form thereof contains a hydroxyl functional group, a prodrug form can be prepared by replacing the hydrogen atom of the hydroxyl with another functional group such as alkyl, alkylcarbonyl or a phosphonate ester and the like. In another example, when a compound of Formula (I) or a form thereof contains an amine functional group, a prodrug form can be prepared by replacing one or more amine hydrogen atoms with a functional group such as alkyl or substituted carbonyl. Pharmaceutically acceptable prodrugs of compounds of Formula (I) or a form thereof include those compounds substituted with one or more of the following groups: carboxylic acid esters, sulfonate esters, amino acid esters, phosphonate esters and mono-, di- or triphosphate esters or alkyl substituents, where appropriate. As described herein, it is understood by a person of ordinary skill in the art that one or more of such substituents may be used to provide a compound of Formula (I) or a form thereof as a prodrug.
[00328] One or more compounds described herein may exist in unsolvated as well as solvated forms with pharmaceutically acceptable solvents such as water, ethanol, and the like, and the description herein is intended to embrace both solvated and unsolvated forms.
[00329] As used herein, the term “solvate” means a physical association of a compound described herein with one or more solvent molecules. This physical association involves varying degrees of ionic and covalent bonding, including hydrogen bonding. In certain instances, the solvate will be capable of isolation, for example when one or more solvent molecules are
incorporated in the crystal lattice of the crystalline solid. As used herein, “solvate” encompasses both solution-phase and isolatable solvates. Non-limiting examples of suitable solvates include ethanolates, methanolates, and the like.
[00330] As used herein, the term “hydrate” means a solvate wherein the solvent molecule is water.
[00331] The compounds of Formula (I) can form salts, which are intended to be included within the scope of this description. Reference to a compound of Formula (I) or a form thereof herein is understood to include reference to salt forms thereof, unless otherwise indicated. The term "salt(s)", as employed herein, denotes acidic salts formed with inorganic and/or organic acids, as well as basic salts formed with inorganic and/or organic bases. In addition, when a compound of Formula (1) or a form thereof contains both a basic moiety, such as, without limitation an amine moiety, and an acidic moiety, such as, but not limited to a carboxylic acid, zwitterions ("inner salts") may be formed and are included within the term "salt(s)" as used herein.
[00332] The term "pharmaceutically acceptable salt(s)", as used herein, means those salts of compounds described herein that are safe and effective (/.e., non-toxic, physiologically acceptable) for use in mammals and that possess biological activity, although other salts are also useful. Salts of the compounds of the Formula (I) may be formed, for example, by reacting a compound of Formula (I) or a form thereof with an amount of acid or base, such as an equivalent amount, in a medium such as one in which the salt precipitates or in an aqueous medium followed by lyophilization.
[00333] Pharmaceutically acceptable salts include one or more salts of acidic or basic groups present in compounds described herein. In another aspect, particular acid addition salts include, and are not limited to, acetate, ascorbate, benzoate, benzenesulfonate, bisulfate, bitartrate, borate, bromide, butyrate, chloride, citrate, camphorate, camphorsulfonate, ethanesulfonate, formate, fumarate, gentisinate, gluconate, glucaronate, glutamate, iodide, isonicotinate, lactate, maleate, methanesulfonate, naphthalenesulfonate, nitrate, oxalate, pamoate, pantothenate, phosphate, propionate, saccharate, salicylate, succinate, sulfate, tartrate, thiocyanate, toluenesulfonate (also known as tosylate), trifluoroacetate salts and the like. In another aspect, certain particular acid addition salts include chloride or dichloride.
[00334] Additionally, acids which are generally considered suitable for the formation of pharmaceutically useful salts from basic pharmaceutical compounds are discussed, for example, by P. Stahl et al, Camille G. (eds.) Handbook of Pharmaceutical Salts. Properties, Selection and Use. (2002) Zurich: Wiley-VCH; S. Berge et al, Journal of Pharmaceutical Sciences (VMT) 66(1) 1-19; P. Gould, International J. of Pharmaceutics (1986) 33, 201-217; Anderson et al, The Practice of Medicinal Chemistry (1996), Academic Press, New York; and in The Orange Book (Food & Drug Administration, Washington, D.C. on their website). These disclosures are incorporated herein by reference thereto.
[00335] Suitable basic salts include, but are not limited to, aluminum, ammonium, calcium, lithium, magnesium, potassium, sodium and zinc salts.
[00336] All such acid salts and base salts are intended to be included within the scope of pharmaceutically acceptable salts as described herein. In addition, all such acid and base salts are considered equivalent to the free forms of the corresponding compounds for purposes of this description.
[00337] Compounds of Formula (I) and forms thereof, may further exist in a tautomeric form. All such tautomeric forms are contemplated and intended to be included within the scope of the compounds of Formula (I) or a form thereof as described herein.
[00338] The compounds of Formula (I) or a form thereof may contain asymmetric or chiral centers, and, therefore, exist in different stereoisomeric forms. The present description is intended to include all stereoisomeric forms of the compounds of Formula (I) as well as mixtures thereof, including racemic mixtures.
[00339] The compounds described herein may include one or more chiral centers, and as such may exist as racemic mixtures (A\S) or as substantially pure enantiomers and diastereomers. The compounds may also exist as substantially pure (R) or (5) enantiomers (when one chiral center is present). In one particular aspect, the compounds described herein are (S) isomers and may exist as enantiomerically pure compositions substantially comprising only the (S) isomer. In another particular aspect, the compounds described herein are (R) isomers and may exist as enantiomerically pure compositions substantially comprising only the (R) isomer. As one of skill in the art will recognize, when more than one chiral center is present, the compounds described
herein may also exist as a (R,R), (R,S), (S,R) or (S,S) isomer, as defined by IUPAC Nomenclature Recommendations.
[00340] As used herein, the term “chiral” refers to a carbon atom bonded to four nonidentical substituents. Stereochemical definitions and conventions used herein generally follow S. P. Parker, Ed., McGraw-Hill Dictionary of Chemical Terms (1984) McGraw-Hill Book Company, New York; and Eliel, E. and Wilen, S., "Stereochemistry of Organic Compounds", John Wiley & Sons, Inc., New York, 1994. In describing an optically active compound, the prefixes D and L, or R and S, are used to denote the absolute configuration of the molecule about its chiral center(s). The substituents attached to the chiral center under consideration are ranked in accordance with the Sequence Rule of Cahn, Ingold and Prelog. (Cahn et al. Angew. Chem.
Inter. Edit. 1966, 5, 385; errata 511).
[00341] As used herein, the term “substantially pure” refers to compounds consisting substantially of a single isomer in an amount greater than or equal to 90%, in an amount greater than or equal to 92%, in an amount greater than or equal to 95%, in an amount greater than or equal to 98%, in an amount greater than or equal to 99%, or in an amount equal to 100% of the single isomer.
[00342] In one aspect of the description, a compound of Formula (I) or a form thereof is a substantially pure (S) enantiomer form present in an amount greater than or equal to 90%, in an amount greater than or equal to 92%, in an amount greater than or equal to 95%, in an amount greater than or equal to 98%, in an amount greater than or equal to 99%, or in an amount equal to 100%.
[00343] In one aspect of the description, a compound of Formula (I) or a form thereof is a substantially pure (R) enantiomer form present in an amount greater than or equal to 90%, in an amount greater than or equal to 92%, in an amount greater than or equal to 95%, in an amount greater than or equal to 98%, in an amount greater than or equal to 99%, or in an amount equal to 100%.
[00344] As used herein, a “racemate” is any mixture of isometric forms that are not “enantiomerically pure”, including mixtures such as, without limitation, in a ratio of about 50/50, about 60/40, about 70/30, or about 80/20.
[00345] In addition, the present description embraces all geometric and positional isomers. For example, if a compound of Formula (I) or a form thereof incorporates a double bond or a fused ring, both the cis- and trans-forms, as well as mixtures, are embraced within the scope of the description. Diastereomeric mixtures can be separated into their individual diastereomers on the basis of their physical chemical differences by methods well known to those skilled in the art, such as, for example, by chromatography and/or fractional crystallization. Enantiomers can be separated by use of chiral HPLC column or other chromatographic methods known to those skilled in the art. Enantiomers can also be separated by converting the enantiomeric mixture into a diastereomeric mixture by reaction with an appropriate optically active compound (e.g., chiral auxiliary such as a chiral alcohol or Mosher’s acid chloride), separating the diastereomers and converting (e.g., hydrolyzing) the individual diastereomers to the corresponding pure enantiomers. Also, some of the compounds of Formula (I) may be atropisomers (e.g., substituted biaryls) and are considered as part of this description.
[00346] All stereoisomers (for example, geometric isomers, optical isomers and the like) of the present compounds (including those of the salts, solvates, esters and prodrugs of the compounds as well as the salts, solvates and esters of the prodrugs), such as those which may exist due to asymmetric carbons on various substituents, including enantiomeric forms (which may exist even in the absence of asymmetric carbons), rotameric forms, atropisomers, and diastereomeric forms, are contemplated within the scope of this description, as are positional isomers (such as, for example, 4-pyridyl and 3-pyridyl). Individual stereoisomers of the compounds described herein may, for example, be substantially free of other isomers, or may be present in a racemic mixture, as described supra.
[00347] The use of the terms "salt", "solvate", “ester”, "prodrug" and the like, is intended to equally apply to the salt, solvate, ester and prodrug of enantiomers, stereoisomers, rotamers, tautomers, positional isomers, racemates or isotopologues of the instant compounds.
[00348] The term "isotopologue" refers to isotopically-enriched compounds described herein which are identical to those recited herein, but for the fact that one or more atoms are replaced by an atom having an atomic mass or mass number different from the atomic mass or mass number usually found in nature. Examples of isotopes that can be incorporated into compounds described herein include isotopes of hydrogen, carbon, nitrogen, oxygen, phosphorus, fluorine
and chlorine, such as 2H, 3H, 13C, 14C, 15N, 18O, 170, 31P, 32P, 35 S, 18F, 35C1 and 36C1, respectively, each of which are also within the scope of this description.
[00349] Certain isotopically-enriched compounds described herein (e.g., those labeled with 3H and 14C) are useful in compound and/or substrate tissue distribution assays. Tritiated (z.e., 3H) and carbon-14 (z.e., 14C) isotopes are particularly preferred for their ease of preparation and detectability. Further, substitution with heavier isotopes such as deuterium (z.e., 2H) may afford certain therapeutic advantages resulting from greater metabolic stability (e.g., increased in vivo half-life or reduced dosage requirements) and hence may be preferred in some circumstances.
RECOGNITION ELEMENT FOR SPLICING MODIFIER (REMS)
[00350] Without being bound by theory or mechanism of action, it is believed that compounds described herein increase the affinity of the interaction between a U1 snRNP and a RNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 5776 to SEQ ID NO.
11550. This belief is based, in part, on the knowledge that the RNA REMS comprises a U1 snRNP binding site.
[00351] In one aspect, described herein is a recognition element for splicing modifier (otherwise referred to as “REMS”) that plays a role in the recognition of a compound described herein. In another aspect, the REMS has a RNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 5776 to SEQ ID NO. 11550. In another aspect, the REMS has a DNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 1 to SEQ ID NO. 5775.
[00352] A REMS can be part of an endogenous RNA or can be introduced into an RNA sequence that does not naturally contain the REMS sequence (i.e., the introduced REMS is a non-endogenous REMS). A nucleotide sequence encoding a REMS can also be part of an endogenous DNA sequence, or a nucleotide sequence encoding a REMS can be introduced into a DNA sequence that does not naturally contain the nucleotide sequence encoding the introduced REMS
[00353] In one aspect, the REMS is the endogenous 5’ splice site. In another aspect, the REMS is located within an exon. In another aspect, the REMS is located within an intron. In another aspect, the REMS is located within an exon-intron junction. Without being bound by
theory or mechanism, it is believed that compounds described herein increase the affinity of the interaction between U1 snRNP and the nucleotides of an RNA REMS. This belief is based, in part, on the recognition that the RNA REMS comprises a U1 snRNP binding site.
[00354] In one aspect, described herein is a REMS that is the endogenous, wild-type 5’ splice site of a pre-mRNA. In another aspect, described herein is a REMS that is located within an endogenous, wild-type 5’ splice site of a pre-mRNA. In another aspect, described herein is a REMS that is inserted within an endogenous, wild-type 5’ splice site of a pre-mRNA. In the presence of a compound described herein, nucleotides between the REMS in the 5’ splice site and 3’ splice site of a pre-mRNA are removed and the remaining nucleotides of the pre-mRNA are spliced together. In one aspect, described herein is a REMS located within an exon in a pre- mRNA. In the presence of a compound described herein, the nucleotides between the REMS and the 3’ splice site of a pre-mRNA (except for certain exonic nucleotides) are removed and the remaining portions of the pre-mRNA are spliced together, which may result in an RNA transcript with a truncated open reading frame or internal deletions within the open reading frame, which may further result in the creation of a premature termination codon.
[00355] In one aspect, a pre-mRNA transcript comprises three exons (el, e2, and e3) and two introns (il and i2), wherein a REMS is present endogenously or introduced into the 5’ splice site of the exon 2-intron 2 boundary of the RNA transcript. In the absence of a compound described herein, some degree of exon 2 skipping will occur and two mRNAs will be produced, e le2e3 and ele3. When a compound described herein is added, the balance between the two mRNAs produced is shifted so that more ele2e3 and less ele3 mRNA is produced.
[00356] In another aspect, a pre-mRNA transcript comprises two exons (el and e2) and one intron (il), wherein a REMS is present endogenously or introduced into the 5’splice site of the exon 1 -intron 1 boundary of the pre-mRNA transcript. In the absence of a compound described herein, some degree of inhibition of splicing altogether will occur and two RNA products will be produced. An mRNA elile2 and an ele2 mRNA. The elile2 mRNA is usually unstable and degraded and, thus, usually not translated so no functional protein is produced. When a compound described herein is added, the balance between the two RNA products is shifted so that more ele2 and less elile2 is produced.
[00357] In another aspect, a pre-mRNA transcript comprises a REMS inside an exon. In this situation, in the absence of a compound described herein, the splicing outcome is driven by the distal 5’ splice site and the 5 ’splice site mediates whole exon splicing, thus producing an extended exon. However, when a compound described herein is present, splicing at the REMS is induced and inclusion of a shorter exon can result.
[00358] In another aspect, when a REMS is introduced into an RNA sequence, the splicing outcome is governed by the presence/absence of an upstream 5’ splice site(s), upstream 3’ splice sites, and downstream 3’ splice site(s) and endogenous splicing control sequences
[00359] In another aspect, contacting a compound of Formula (I) with a pre-mRNA transcript of gene comprising a REMS results in inclusion of an exon of the gene.
[00360] In another aspect, contacting a compound of Formula (I) with a pre-mRNA transcript of gene comprising a REMS results in skipping of an exon of the gene.
[00361] During mRNA processing pre-mRNA is matured by capping, polyadenylating, and splicing the mRNA to produce a mature mRNA transcript. Exon skipping refers to a splicing event where an exon, a sequence that would normally be expressed as part of the final mature RNA after procession, is instead made absent from the final matured RNA. Exon inclusion refers to a splicing event where an exon is included in the final matured RNA. For example, a given gene may produce a mixture of RNA isoforms, some having an included exon and some having an omitted exon, and yet in various examples a compound of Formula (I) can modulate such splicing events by way of interaction with a REMS. Such modulationg of splicing events can be measured by evaluating a population of transcripts and calculating the percent-spliced-in (PSI). [00362] Exon skipping and exon inclusion can each be confugred in various examples to result in functional mature RNA transcripts and result in a functional protein. For example, an exon can be skipped in order to restore a disrupted reading frame and yet still result in a largely functional protein. Exon skipping and exon inclusion can also each be confugred in various examples to result in a mature RNA transcript that undergoes decay and thus the downregulate resulting expressed protein. For example, an exon can be included to disrupt the reading frame or introduce a stop codon.
[00363] Exon inclusion or exon skipping can be measured by comparing a mature RNA transcript expressed in the presence of the compound of Formula (I) relative to a mature RNA
transcript expressed in the absence of the compound, of Formula (I). Exon inclusion. Exon inclusion or exon skipping can also be measured by comparing the expressed mature RNA transcript with a gene.
USE OF THE COMPOUNDS
[00364] In one aspect, described herein is a method for modulating the amount or type of a mature RNA transcript expressed, comprising a DNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 1 to SEQ ID NO. 5775, wherein a pre-RNA transcript transcribed from a gene comprising the DNA REMS nucleotide sequence comprises a RNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 5776 to SEQ ID NO. 11550, wherein, a compound of Formula (I)
[00365] or a form thereof, wherein:
[00366] Ri is phenyl or heteroaryl, optionally substituted with one, two, three, or four, independently selected Ria substituents,
[00367] wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S;
[00368] Ria is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, or C1-6alkoxy;
[00369] R3 is hydrogen, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, and C1-6alkyl-amino,
[00370] wherein C1-6alkyl, C2-6alkenyl, and C2-6alkynyl is optionally substituted with one, two, three, or four independently selected R3a substituents, and
[00371] wherein each instance of C1-6alkyl, C2-6alkenyl, and C2-6alkynyl may optionally contain a chiral carbon having an (R) or (S) configuration;
[00372] R3a is cyano, halo, hydroxy, oxo, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, halo-C1-6alkoxy, carboxyl, amino, Ci -ealkoxy -carbonyl, C1-6alkyl-amino, halo-C1-6alkyl-amino,
(C1-6alkyl)2-amino, phenyl-amino, heterocyclyl-amino, heteroaryl-amino, phenyl-(C1-6alkyl)-amino, heterocyclyl-(C1-6alkyl)-amino, heteroaryl-(C1-6alkyl)-amino, C1-6alkyl-thio, C1-6alkyl-sulfoxyl, and C1-6alkyl-sulfonyl,
[00373] wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S,
[00374] wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S;
[00375] wherein each instance of phenyl, heterocyclyl, and heteroaryl is optionally substituted with one, two, three or four independently selected Raa’ substituents;
[00376] Raa’ is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, or amino;
[00377] R.4 is hydrogen, cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, halo-C1-6alkoxy, amino, C1-6alkyl-amino, (C1-6alkyl)2-amino, C3-10cycloalkyl, phenyl, heterocyclyl, or heteroaryl,
[00378] wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S,
[00379] wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S, and
[00380] wherein each instance of C1-6alkyl, C3-10cycloalkyl, phenyl, heterocyclyl, or heteroaryl are optionally substituted with one, two, three, or four independently selected IUa substituents;
[00381] R.4a is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, or C1-6alkoxy;
[00382] R5 is hydrogen, cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, carbamoyl, C3-10cycloalkyl, or heterocyclyl,
[00383] wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S; and
[00384] Re is hydrogen, halo, or C1-6alkyl;
[00385] wherein the form of the compound is selected from the group consisting of a salt, hydrate, solvate, and tautomer form thereof,
[00386] is contacted with the RNA REMS nucleotide sequence in a cell lysate or in a cell in cell culture, whether in vivo or ex vivo, to express the mature RNA transcript, wherein the
amount or type of mature RNA transcript expressed in the presence of the compound is modulated compared to the amount or type of mature RNA transcript expressed in the absence of the compound, wherein the mature RNA transcript is selected from a wildtype or non-wildtype mature RNA transcript, and wherein the gene is selected from a gene comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5.
[00387] In another aspect, described herein are methods for modulating the amount or type of mature mRNA transcript produced from pre-mRNA containing a RNA REMS. In another aspect, described herein are artificial gene constructs comprising a DNA REMS or RNA REMS, which may be used in the context of, e.g., gene therapy or reporter assays. In another aspect, described herein are methods for engineering a gene to become such an artificial gene construct from an endogenous gene, wherein the artificial gene construct contains a non-wildtype DNA REMS or a non-wildtype RNA REMS. In another aspect, the REMS is an endogenous 5’ splice site in a pre-mRNA. In another aspect, the REMS is a canonical endogenous 5’ splice site in a pre-mRNA. In another aspect, the REMS is a noncanonical endogenous 5’ splice site in a pre- mRNA.
[00388] In another aspect, described herein are methods for modulating the amount or type of mature mRNA transcript produced from pre-mRNA containing a RNA REMS. In another aspect, described herein are artificial gene constructs comprising a DNA REMS or RNA REMS, which may be used in the context of, e.g., gene therapy or reporter assays. In another aspect, described herein are methods for engineering a gene to become such an artificial gene construct from an endogenous gene, wherein the artificial gene construct contains a non-wildtype DNA REMS or a non -wildtype RNA REMS.
[00389] In another aspect, described herein is a method for modulating the amount or type of a mature RNA transcript expressed, comprising an artificial gene construct containing a DNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 1 to SEQ ID NO. 5775, wherein a pre-RNA transcript transcribed from the gene comprising the DNA REMS nucleotide sequence comprises a RNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 5776 to SEQ ID NO. 11550, wherein, a compound of Formula (I)
[003901 or a form thereof, is contacted with the RNA REMS nucleotide sequence in a cell lysate or in a cell in cell culture, whether in vivo or ex vivo, to express the mature RNA transcript, wherein the amount or type of mature RNA transcript expressed in the presence of the compound is modulated compared to the amount or type of mature RNA transcript expressed in the absence of the compound, and wherein the mature RNA transcript is selected from a wildtype or non-wildtype mature RNA transcript.
[00391] In another aspect, the artificial gene construct comprising a DNA REMS or RNA REMS may be used in the context of gene therapy or reporter assays.
[00392] In another aspect, the nucleotide sequence encoding the RNA REMS comprises a DNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 1 to SEQ ID NO. 5775. In another aspect, the nucleotide sequence encoding the REMS is a nucleotide sequence encoding a non-endogenous REMS, i.e., not naturally found in the DNA sequence of the artificial construct.
METHODS FOR DETERMINING WHICH GENES MAY BE MODULATED BY THE COMPOUNDS
[00393] In another aspect, described herein are methods for determining whether the splicing of the pre-mRNA of a gene is likely to be modulated by a compound of Formula (I) or a form thereof, comprising searching for the presence of a REMS in the gene sequence, wherein the presence of a REMS upstream of a 3’ splice site and a branch point in the gene sequence indicates that the splicing of the pre-mRNA of the gene is likely to be modulated by the compound of Formula (I) or a form thereof, and the absence of a REMS upstream of a 3’ splice site and a branch point in the gene sequence indicates that the splicing of the pre-mRNA of the gene is unlikely to be modulated by the compound of Formula (I) or a form thereof.
[00394] In another aspect, described herein are methods for determining whether the amount or type of a product (e.g., an mRNA transcript or protein) of a gene is likely to be modulated by a compound of Formula (I) or a form thereof, comprising searching for the presence of a REMS in the gene sequence, wherein the presence of a REMS upstream of a 3’ splice site and a branch point in the gene sequence indicates that the amount or type of a product (e.g., an mRNA transcript or protein) of the gene is likely to be modulated by the compound of Formula (I) or a form thereof, and the absence of a REMS upstream of a 3’ splice site and a branch point in the gene sequence indicates that the amount or type of a product (e.g, an mRNA transcript or protein) of the gene is unlikely to be modulated by the compound of Formula (I) or a form thereof.
[00395] The step of searching for the presence of a REMS, a 3’ splice site, and/or a branch point in the gene sequence described herein can be performed by a computer system comprising a memory storing instructions for searching the presence of the REMS, the 3’ splice site, and/or the branch point in the gene sequence, or can be performed manually.
[00396] In another aspect, the splicing of a pre-mRNA containing a REMS is assessed by contacting a compound described herein with the pre-mRNA in cell cultured in tissue culture. In another aspect, the splicing of a pre-mRNA containing a REMS is assessed by contacting a compound described herein with the pre-mRNA in a cell-free extract. In another aspect, a reference compound known to modulate the splicing of a pre-mRNA containing a REMS may be used.
METHODS FOR DETERMINING WHICH COMPOUNDS OF FORMULA (I) MODULATE THE EXPRESSION OF CERTAIN GENES
[00397] One aspect described herein is a method for determining whether a compound of Formula (I) or a form thereof modulates the amount or type of one, two, three or more RNA transcripts (e.g., pre-mRNA or mRNA transcripts or isoforms thereof) of one, two, three or more genes. In another aspect, the gene is a gene comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5, or any one of the genes disclosed in a subset thereof. In another aspect, the gene is other than a gene comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5.
[00398] In one aspect, described herein is a method for determining whether a compound of Formula (I) or a form thereof modulates the amount or type of an RNA transcript, comprising: (a) contacting a cell or cell lysate with a compound of Formula (I) or a form thereof, and (b) determining the amount or type of the RNA transcript produced by the cell or cell lysate, wherein an alteration in the amount or type of the RNA transcript in the presence of the compound relative to the amount or type of the RNA transcript in the absence of the compound or the presence of a negative control (e.g., a vehicle control such as PBS or DMSO) indicates that the compound of Formula (I) or a form thereof modulates the amount or type of the RNA transcript.
[00399] In another aspect, described herein is a method for determining whether a compound of Formula (1) or a form thereof modulates the amount or type of an RNA transcript (e.g., an mRNA transcript), comprising: (a) contacting a first cell(s) with a compound of Formula (I) or a form thereof, (b) contacting a second cell(s) with a negative control (e.g., a vehicle control, such as PBS or DMSO); and (c) determining the amount or type of the RNA transcript produced by the first cell(s) and the second cell(s); and (d) comparing the amount or type of the RNA transcript produced by the first cell(s) to the amount or type of the RNA transcript expressed by the second cell(s), wherein an alteration in the amount or type of the RNA transcript produced by the first cell(s) relative to the amount or type of the RNA transcript produced by the second cell(s) indicates that the compound of Formula (I) or a form thereof modulates the amount or type of the RNA transcript.
[00400] In another aspect, contacting of the cell(s) with the compound occurs in cell culture. In another aspect, contacting of the cell(s) with the compound occurs in a subject, such as a human or non-human animal subject.
[00401] In another aspect, described herein is a method for determining whether a compound of Formula (I) or a form thereof modulates the splicing of an RNA transcript (e.g., an mRNA transcript), comprising: (a) culturing a cell(s) in the presence of a compound of Formula (I) or a form thereof; and (b) determining the amount or type of the RNA transcript splice variants produced by the cell(s), wherein an alteration in the amount or type of the RNA transcript in the presence of the compound relative to the amount or type of the RNA transcript splice variants in the absence of the compound or the presence of a negative control (e.g., a vehicle control such as
PBS or DMSO) indicates that the compound of Formula (I) or a form thereof modulates the splicing of the RNA transcript.
[00402] In another aspect, described herein is a method for determining whether a compound of Formula (I) or a form thereof modulates the splicing of an RNA transcript (e.g., an mRNA transcript), comprising: (a) culturing a cell(s) in the presence of a compound of Formula (I) or a form thereof; (b) isolating RNA transcript splice variants from the cell(s) after a certain period of time; and (c) determining the amount or type of the RNA transcript splice variants produced by the cell(s), wherein an alteration in the amount or type of the RNA transcript in the presence of the compound relative to the amount or type of the RNA transcript splice variants in the absence of the compound or the presence of a negative control (e.g., a vehicle control such as PBS or DMSO) indicates that the compound of Formula (1) or a form thereof modulates the splicing of the RNA transcript.
[00403] In another aspect, described herein is a method for determining whether a compound of Formula (I) or a form thereof modulates the splicing of an RNA transcript (e.g., an mRNA transcript), comprising (a) culturing a first cell(s) in the presence of a compound of Formula (I) or a form thereof; (b) culturing a second cell(s) in the presence of a negative control (e.g., a vehicle control, such as PBS or DMSO); (c) isolating RNA transcript splice variants produced by the first cell(s) and isolating RNA transcript splice variants produced by the second cell(s); (d) determining the amount or type of the RNA transcript splice variants produced by the first cell(s) and the second cell(s); and (e) comparing the amount or type of the RNA transcript splice variants produced by the first cell(s) to the amount or type of the RNA transcript splice variants produced by the second cell(s), wherein an alteration in the amount or type of the RNA transcript splice variants produced by the first cell(s) relative to the amount or type of the RNA transcript splice variants produced by the second cell(s) indicates that the compound of Formula (I) or a form thereof modulates the aplicing of the RNA transcript.
[00404] In another aspect, described herein is a method for determining whether a compound of Formula (I) or a form thereof modulates the amount or type of an RNA transcript (e.g., an mRNA transcript), comprising: (a) contacting a cell-free system with a compound of Formula (I) or a form thereof, and (b) determining the amount or type of the RNA transcript produced by the cell-free system, wherein an alteration in the amount or type of the RNA transcript in the
presence of the compound relative to the amount or type of the RNA transcript in the absence of the compound or the presence of a negative control (e.g., a vehicle control such as PBS or DMSO) indicates that the compound of Formula (I) or a form thereof modulates the amount or type of the RNA transcript. In another aspect, described herein is a method for determining whether a compound of Formula (I) or a form thereof modulates the amount or type of an RNA transcript (e.g., an mRNA transcript), comprising: (a) contacting a first cell-free system with a compound of Formula (I) or a form thereof, (b) contacting a second cell-free system with a negative control (e.g., a vehicle control, such as PBS or DMSO); and (c) determining the amount or type of the RNA transcript produced by the first cell-free system and the second cell-free system; and (d) comparing the amount or type of the RNA transcript produced by the first cell- free system to the amount or type of the RNA transcript expressed by the second cell-free system, wherein an alteration in the amount or type of the RNA transcript produced by the first cell-free system relative to the amount or type of the RNA transcript produced by the second cell-free system indicates that the compound of Formula (I) or a form thereof modulates the amount or type of the RNA transcript. In another aspect, the cell-free system comprises purely synthetic RNA, synthetic or recombinant (purified) enzymes, and protein factors. In another aspect, the cell-free system comprises RNA transcribed from a synthetic DNA template, synthetic or recombinant (purified) enzymes, and protein factors. In another aspect, the cell-free system comprises purely synthetic RNA and nuclear extract. In another aspect, the cell-free system comprises RNA transcribed from a synthetic DNA template and nuclear extract. In another aspect, the cell-free system comprises purely synthetic RNA and whole cell extract. In another aspect, the cell-free system comprises RNA transcribed from a synthetic DNA template and whole cell extract. In another aspect, the cell-free system additionally comprises regulatory RNAs (e.g., microRNAs).
[00405] In another aspect, described herein is a method for determining whether a compound of Formula (I) or a form thereof modulates the splicing of an RNA transcript (e.g., an mRNA transcript), comprising: (a) contacting a cell-free system with a compound of Formula (I) or a form thereof; and (b) determining the amount or type of RNA transcript splice variants produced by the cell-free system, wherein an alteration in the amount or type of the RNA transcript splice variants in the presence of the compound relative to the amount or type of the RNA transcript
splice variants in the absence of the compound or the presence of a negative control (e.g., a vehicle control such as PBS or DMSO) indicates that the compound of Formula (I) or a form thereof modulates the splicing of the RNA transcript. In another aspect, described herein is a method for determining whether a compound of Formula (I) or a form thereof modulates the splicing of an RNA transcript (e.g., an mRNA transcript), comprising: (a) contacting a first cell- free system with a compound of Formula (I) or a form thereof; (b) contacting a second cell-free system with a negative control (e.g., a vehicle control, such as PBS or DMSO); and (c) determining the amount or type of RNA transcript splice variants produced by the first cell-free system and the second cell -free system; and (d) comparing the amount or type of the RNA transcript splice variants produced by the first cell-free system to the amount or type of the RNA transcript expressed by the second cell-free system, wherein an alteration in the amount or type of the RNA transcript splice variants produced by the first cell-free system relative to the amount or type of the RNA transcript splice variants produced by the second cell-free system indicates that the compound of Formula (I) or a form thereof modulates the splicing of the RNA transcript. In certain aspects, the cell-free system comprises purely synthetic RNA, synthetic or recombinant (purified) enzymes, and protein factors. In another aspect, the cell-free system comprises RNA transcribed from a synthetic DNA template, synthetic or recombinant (purified) enzymes, and protein factors. In another aspect, the cell-free system comprises purely synthetic RNA and nuclear extract. In another aspect, the cell-free system comprises RNA transcribed from a synthetic DNA template and nuclear extract. In another aspect, the cell-free system comprises purely synthetic RNA and whole cell extract. In another aspect, the cell-free system comprises RNA transcribed from a synthetic DNA template and whole cell extract. In certain aspects, the cell-free system additionally comprises regulatory RNAs (e.g., microRNAs).
[00406] In another aspect, described herein is a method for determining whether a compound of Formula (I) or a form thereof modulates the amount or type of an RNA transcript (e.g., an mRNA transcript), comprising: (a) culturing a cell(s) in the presence of a compound of Formula (I) or a form thereof, (b) isolating the RNA transcript from the cell(s) after a certain period of time; and (c) determining the amount or type of the RNA transcript produced by the cell(s), wherein an alteration in the amount or type of the RNA transcript in the presence of the compound relative to the amount or type of the RNA transcript in the absence of the compound
or the presence of a negative control (e.g., a vehicle control such as PBS or DMSO) indicates that the compound of Formula (I) or a form thereof modulates the amount or type of the RNA transcript. In another aspect, described herein is a method for determining whether a compound of Formula (I) or a form thereof modulates the amount or type of an RNA transcript (e.g., an mRNA transcript), comprising (a) culturing a first cell(s) in the presence of a compound of Formula (I) or a form thereof, (b) culturing a second cell(s) in the presence of a negative control (e.g., a vehicle control, such as PBS or DMSO); (c) isolating the RNA transcript produced by the first cell(s) and isolating the RNA transcript produced by the second cell(s); (d) determining the amount or type of the RNA transcript produced by the first cell(s) and the second cell(s); and (e) comparing the amount or type of the RNA transcript produced by the first cell(s) to the amount or type of the RNA transcript produced by the second cell(s), wherein an alteration in the amount or type of the RNA transcript produced by the first cell(s) relative to the amount or type of the RNA transcript produced by the second cell(s) indicates that the compound of Formula (I) or a form thereof modulates the amount or type of the RNA transcript.
[00407] In certain aspects, the cell(s) contacted or cultured with a compound of Formula (I) or a form thereof is a primary cell(s) from a subject. In another aspect, the cell(s) contacted or cultured with a compound of Formula (I) or a form thereof is a primary cell(s) from a subject with a disease. In another aspect, the cell(s) contacted or cultured with a compound of Formula (I) or a form thereof is a primary cell(s) from a subject with a disease associated with an aberrant amount or type of an RNA transcript(s) for a particular gene(s). In another aspect, the cell(s) contacted or cultured with a compound of Formula (I) or a form thereof is a primary cell(s) from a subject with a disease associated with an aberrant amount or type of an isoform(s) of a particular gene(s). In another aspect, the cell(s) contacted or cultured with a compound of Formula (I) or a form thereof is a fibroblast (e.g., GM03813 or PNN 1-46 fibroblasts), an immune cell (e.g., a T cell, B cell, natural killer cell, macrophage), or a muscle cell. In another aspect, the cell(s) contacted or cultured with a compound of Formula (I) or a form thereof is a cancer cell.
[00408] In another aspect, the cell(s) contacted or cultured with a compound of Formula (I) or a form thereof is from a cell line. In another aspect, the cell(s) contacted or cultured with a compound of Formula (I) or a form thereof is a cell line derived from a subject with a disease. In
certain aspects, the cell(s) contacted or cultured with a compound of Formula (I) or a form thereof is from a cell line known to have aberrant RNA transcript levels for a particular gene(s). In specific aspects, the cell(s) contacted or cultured with a compound of Formula (I) or a form thereof is from a cell line derived from a subject with a disease known to have aberrant RNA transcript levels for a particular gene(s). In certain aspects, the cell(s) contacted or cultured with a compound of Formula (I) or a form thereof is a cancer cell line. In some specific aspects, the cell(s) contacted or culured with the compound of Formula (I) or a form thereof is from a cell line derived from a subject with a disease known to have an aberrant amount or type of an RNA isoform(s) and/or protein isoform(s) of a particular gene(s). Non-limiting examples of cell lines include 293, 3T3, 4T1, 721, 9L, A2780, A172, A20, A253, A431, A-549, ALC, B16, B35, BCP- 1, BEAS-2B, bEnd.3, BHK, BR 293, BT2O, BT483, BxPC3, C2C12, C3H-10T1/2, C6/36, C6, Cal-27, CHO, COR-L23, COS, COV-434, CML Tl, CMT, CRL7O3O, CT26, D17, DH82, DU145, DuCaP, EL4, EM2, EM3, EMT6, FM3, H1299, H69, HB54, HB55, HCA2, HEK293, HeLa, Hepalclc7, HL-60, HMEC, Hs578T, HsS78Bst, HT1080, HT-29, HTB2, HUVEC, Jurkat, J558L, JY, K562, Ku812, KCL22, KG1, KY01, LNCap, Ma-Mel, MC-38, MCF-7, MCF-10A, MDA-MB-231, MDA-MB-468, MDA-MB-435, MDCK, MG63, MOR/0.2R, M0LM13, MONO-MAC 6, MRC5, MTD-1A, NCI-H69, NIH-3T3, NALM-1, NSO, NW-145, OPCN, OPCT, PBMC, PNT-1A, PNT-2, Raji, RBL, RenCa, RIN-5F, RMA, Saos-2, Sf21, Sf9, SHSY5Y, SiHa, SKBR3, SKOV-3, T2, T-47D, T84, THP1, U373, U87, U937, VCaP, Vero, VERY, W138, WM39, WT-49, X63, YAC-1, and YAR cells. In another aspect, the cells are from a subject. In another aspect, the cells are FD patient fibroblast cells. In another aspect, the cells are differentiated SY5Y cells. In another aspect, the cells are stimulated PBMC cells. [00409] In one aspect, provided herein is a method for determining whether a compound of Formula (I) or a form thereof modulates the amount or type of an RNA transcript (e.g., an mRNA transcript), comprising: (a) contacting a tissue sample with a compound of Formula (I) or a form thereof; and (b) determining the amount or type of the RNA transcript produced by the tissue sample, wherein an alteration in the amount or type of the RNA transcript in the presence of the compound relative to the amount or type of the RNA transcript in the absence of the compound or the presence of a negative control (e.g., a vehicle control such as PBS or DMSO) indicates that the compound of Formula (I) or a form thereof modulates the amount or type of the
RNA transcript. In another aspect, provided herein is a method for determining whether a compound of Formula (I) or a form thereof modulates the amount or type of an RNA transcript (e.g., an mRNA transcript), comprising: (a) contacting a first tissue sample with a compound of Formula (I) or a form thereof, (b) contacting a second tissue sample with a negative control (e.g., a vehicle control, such as PBS or DMSO); and (c) determining the amount or type of the RNA transcript produced by the first tissue sample and the second tissue sample; and (d) comparing the amount or type of the RNA transcript produced by the first tissue sample to the amount or type of the RNA transcript produced by the second tissue sample, wherein an alteration in the amount or type of the RNA transcript produced by the first tissue sample relative to the amount or type of the RNA transcript produced by the second tissue sample indicates that the compound of Formula (1) or a form thereof modulates the amount or type of the RNA transcript. Any tissue sample containing cells may be used in the accordance with these methods. In another aspect, the tissue sample is a blood sample, a skin sample, a muscle sample, or a tumor sample. Techniques known to one skilled in the art may be used to obtain a tissue sample from a subject. [00410] In another aspect, a dose-response assay is performed. In another aspect, the dose response assay comprises: (a) contacting a cell(s) with a concentration of a compound of Formula (I) or a form thereof; (b) determining the amount or type of the RNA transcript produced by the cell(s), wherein an alteration in the amount or type of the RNA transcript in the presence of the compound relative to the amount or type of the RNA transcript in the absence of the compound or the presence of a negative control (e.g., a vehicle control such as PBS or DMSO) indicates that the compound of Formula (I) or a form thereof modulates the amount or type of the RNA transcript; (c) repeating steps (a) and (b), wherein the only experimental variable changed is the concentration of the compound or a form thereof; and (d) comparing the amount or type of the RNA transcript produced at the different concentrations of the compound or a form thereof. In another aspect, the dose response assay comprises: (a) culturing a cell(s) in the presence of a compound of Formula (I) or a form thereof, (b) isolating the RNA transcript from the cell(s) after a certain period of time; (c) determining the amount or type of the RNA transcript produced by the cell(s), wherein an alteration in the amount or type of the RNA transcript in the presence of the compound relative to the amount or type of the RNA transcript in the absence of the compound or the presence of a negative control (e.g., a vehicle control such
as PBS or DMSO) indicates that the compound of Formula (I) or a form thereof modulates the amount or type of the RNA transcript; (d) repeating steps (a), (b), and (c), wherein the only experimental variable changed is the concentration of the compound or a form thereof; and (e) comparing the amount or type of the RNA transcript produced at the different concentrations of the compound or a form thereof. In another aspect, the dose-response assay comprises: (a) contacting each well of a microtiter plate containing cells with a different concentration of a compound of Formula (I) or a form thereof; (b) determining the amount or type of an RNA transcript produced by cells in each well; and (c) assessing the change of the amount or type of the RNA transcript at the different concentrations of the compound or form thereof.
[00411] In one aspect, described herein, the dose response assay comprises: (a) contacting a cell(s) with a concentration of a compound of Formula (1) or a form thereof, wherein the cells are within the wells of a tissue culture container (e.g., a 96-well plate) at about the same density within each well, and wherein the cells are contacted with different concentrations of compound in different wells; (b) isolating the RNA from said cells in each well; (c) determining the amount or type of the RNA transcript produced by the cell(s) in each well; and (d) assessing change in the amount or type of the RNA transcript in the presence of one or more concentrations of compound relative to the amount or type of the RNA transcript in the presence of a different concentration of the compound or the absence of the compound or the presence of a negative control (e.g., a vehicle control such as PBS or DMSO).
[00412] In another aspect, the contacting of the cell(s) with the compound occurs in cell culture. In one aspect, the contacting of the cell(s) with the compound occurs in a subject, such as a non-human animal subject.
[00413] In one aspect, described herein, the cell(s) is contacted or cultured with a compound of Formula (I) or a form thereof, or a tissue sample is contacted with a compound of Formula (I) or a form thereof, or a negative control for a period of 15 minutes, 30 minutes, 45 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 5 hours, 6 hours, 8 hours, 12 hours, 18 hours, 24 hours, 48 hours, 72 hours or more. In another aspect, described herein, the cell(s) is contacted or cultured with a compound of Formula (I) or a form thereof, or a tissue sample is contacted with a compound of Formula (I) or a form thereof, or a negative control for a period of 15 minutes to 1 hour, 1 to 2
hours, 2 to 4 hours, 6 to 12 hours, 12 to 18 hours, 12 to 24 hours, 28 to 24 hours, 24 to 48 hours, 48 to 72 hours.
[00414] In another aspect, described herein, the cell(s) is contacted or cultured with a certain concentration of a compound of Formula (I) or a form thereof, or a tissue sample is contacted with a certain concentration of a compound of Formula (I) or a form thereof, wherein the certain concentration is 0.0001 pM, 0.0003 pM, 0.001 pM, 0.003 pM, 0.01 pM, 0.05 pM, 1 pM, 2 pM, 5 pM, 10 pM, 15 pM, 20 pM, 25 pM, 50 pM, 75 pM, 100 pM, or 150 pM. In another aspect, described herein, the cell(s) is contacted or cultured with a certain concentration of a compound of Formula (I) or a form thereof, or a tissue sample is contacted with a certain concentration of a compound of Formula (I) or a form thereof, wherein the certain concentration is 0.0001 pM, 0.0003 pM, 0.0005 pM, 0.001 pM, 0.003 pM, 0.005 pM, 0.01 pM, 0.03 pM, 0.05 pM, 0.1 pM, 0.3 pM, 0.5 pM or 1 pM. In another aspect, described herein, the cell(s) is contacted or cultured with a certain concentration of a compound of Formula (I) or a form thereof, or a tissue sample is contacted with a certain concentration of a compound of Formula (I) or a form thereof, wherein the certain concentration is 175 pM, 200 pM, 250 pM, 275 pM, 300 pM, 350 pM, 400 pM, 450 pM, 500 pM, 550 pM 600 pM, 650 pM, 700 pM, 750 pM, 800 pM, 850 pM, 900 pM, 950 pM or 1 mM. In another aspect, described herein, the cell(s) is contacted or cultured with a certain concentration of a compound of Formula (I) or a form thereof, or a tissue sample is contacted with a certain concentration of a compound of Formula (I) or a form thereof, wherein the certain concentration is 5 nM, 10 nM, 20 nM, 30 nM, 40 nM, 50 nM, 60 nM, 70 nM, 80 nM, 90 nM, 100 nM, 150 nM, 200 nM, 250 nM, 300 nM, 350 nM, 400 nM, 450 nM, 500 nM, 550 nM, 600 nM, 650 nM, 700 nM, 750 nM, 800 nM, 850 nM, 900 nM, or 950 nM. In another aspect, described herein, the cell(s) is contacted or cultured with a certain concentration of a compound of Formula (I) or a form thereof, or a tissue sample is contacted with a certain concentration of a compound of Formula (I) or a form thereof, wherein the certain concentration is between 0.0001 pM to 0.001 pM, 0.0001 pM to 0.01 pM, 0.0003 pM to 0.001 pM, 0.0003 pM to 0.01 pM, 0.001 pM to 0.01 pM, 0.003 pM to 0.01 pM, 0.01 pM to 0.1 pM, 0.1 pM to 1 pM, 1 pM to 50 pM, 50 pM to 100 pM, 100 pM to 500 pM, 500 pM to 1 nM, 1 nM to 10 nM, 10 nM to 50 nM, 50 nM to 100 nM, 100 nM to 500 nM, 500 nM to 1000 nM.
[00415] In another aspect, provided herein is a method for determining whether a compound of Formula (I) or a form thereof modulates the amount or type of an RNA transcript (e.g., an mRNA transcript), comprising: (a) administering a compound of Formula (I) or a form thereof to a subject (e.g., a non-human animal); and (b) determining the amount or type of the RNA transcript in a sample obtained from the subject, wherein an alteration in the amount or type of the RNA transcript measured in the sample from the subject administered the compound or form thereof relative to the amount or type of the RNA transcript in a sample from the subject prior to administration of the compound or form thereof or a sample from a different subject from the same species not administered the compound or form thereof indicates that the compound of Formula (I) or a form thereof modulates the amount or type of the RNA transcript. In another aspect, provided herein is a method for determining whether a compound of Formula (I) or a form thereof modulates the amount or type of an RNA transcript (e.g., an mRNA transcript), comprising: (a) administering a compound of Formula (I) or a form thereof to a first subject (e.g., a non-human animal); (b) administering a negative control (e.g., a pharmaceutical carrier) to a second subject (e.g., a non-human animal) of the same species as the first subject; and (c) determining the amount or type of the RNA transcript in a first tissue sample from the first subject and the amount or type of the RNA transcript in the second tissue sample from the second subject; and (d) comparing the amount or type of the RNA transcript in the first tissue sample to the amount or type of the RNA transcript in the second tissue sample, wherein an alteration in the amount or type of the RNA transcript in the first tissue sample relative to the amount or type of the RNA transcript in the second tissue sample indicates that the compound of Formula (I) or a form thereof modulates the amount or type of the RNA transcript. In another aspect, a compound of Formula (I) or form thereof is administered to a subject at a dose of about 0.001 mg/kg/day to about 500 mg/kg/day. In another aspect, a single dose of a compound of Formula (I) or a form thereof is administered to a subject in accordance with the methods described herein. In another aspect, 2, 3, 4, 5 or more doses of a compound of Formula (I) is administered to a subject in accordance with the methods described herein. In another aspect, the compound of Formula (I) or a form thereof is administered in a subject in a pharmaceutically acceptable carrier, excipient or diluent.
[00416] In another aspect, provided herein is a method for determining whether a compound of Formula (I) or a form thereof modulates the splicing of an RNA transcript (e.g., an mRNA transcript), comprising: (a) administering a compound of Formula (I) or a form thereof to a subject (e.g., a non-human animal); and (b) determining the amount or type of two or more RNA transcript splice variants in a sample obtained from the subject, wherein an alteration in the amount or type of the two or more RNA transcript splice variants measured in the sample from the subject administered the compound or form thereof relative to the amount or type of the two or more RNA transcript splice variants in a sample from the subject prior to administration of the compound or form thereof or a sample from a different subject from the same species not administered the compound or form thereof indicates that the compound of Formula (I) or a form thereof modulates the splicing of the RNA transcript. In another aspect, provided herein is a method for determining whether a compound of Formula (I) or a form thereof modulates the splicing of an RNA transcript (e.g., an mRNA transcript), comprising: (a) administering a compound of Formula (I) or a form thereof to a first subject (e.g., a non-human animal); (b) administering a negative control (e.g., a pharmaceutical carrier) to a second subject (e.g., a non- human animal) of the same species as the first subject; and (c) determining the amount or type of two or more RNA transcript splice variants in a first tissue sample from the first subject and the amount or type of two or more RNA transcript splice variants in the second tissue sample from the second subject; and (d) comparing the amount or type of the two or more RNA transcript splice variants in the first tissue sample to the amount or type of the two or more RNA transcript splice variants in the second tissue sample, wherein an alteration in the amount or type of the two or more RNA transcript splice variants in the first tissue sample relative to the amount or type of the two or more RNA transcript splice variants in the second tissue sample indicates that the compound of Formula (I) or a form thereof modulates the splicing of the RNA transcript. In another aspect, a compound of Formula (I) or form thereof is administered to a subject at a dose of about 0.001 mg/kg/day to about 500 mg/kg/day. In another aspect, a single dose of a compound of Formula (I) or a form thereof is administered to a subject in accordance with the methods described herein. In another aspect, 2, 3, 4, 5 or more doses of a compound of Formula (I) is administered to a subject in accordance with the methods described herein. In another aspect, the compound of Formula (I) or a form thereof is administered in a subject in a
pharmaceutically acceptable carrier, excipient or diluent. In another aspect, the compound of Formula (I) or a form thereof that is contacted or cultured with a cell(s) or a tissue sample, or administered to a subject is a compound described herein.
[00417] Techniques known to one skilled in the art may be used to determine the amount or type of an RNA transcript(s). In one aspect, the amount or type of one, two, three or more RNA transcripts is measured using deep sequencing, such as ILLUMINA® RNASeq, ILLUMINA® next generation sequencing (NGS), ION TORRENT™ RNA next generation sequencing, 454™ pyrosequencing, or Sequencing by Oligo Ligation Detection (SOLID™). In another aspect, the amount or type of multiple RNA transcripts is measured using an exon array, such as the GENECHIP® human exon array. In another aspect, the amount or type of one, two, three or more RNA transcripts is determined by RT-PCR. In another aspect, the amount or type of one, two, three or more RNA transcripts is measured by RT-qPCR or digital color-coded barcode technology. Techniques for conducting these assays are known to one skilled in the art.
[00418] In another aspect, analysis is perfomed on data derived from the assay to measure the magnitude of splicing to determine the amount of exons spliced into an mRNA transcript that is produced in the presence of the compound relative to the amount in the absence of the compound or presence of a negative control. In another aspect, the method utilized is calculation of change in Percent Spliced In (APSI). The method utilizes read data from RNAseq (or any other method that can distinguish mRNA splice isoforms) to calculate the ratio (percentage) between reads that either demonstrate inclusion (junctions between the upstream exon and the exon of interest) or exclusion (junction between the upstream and downstream exons, exluding the exon of interest), to demonstrate whether the presence of the compound affects the amount of exon inclusion relative to the amount of inclusion in the absence of the compound or the presence of a negative control.
[00419] The change in Percent Spliced In (APSI) value is derived from the formula: [00420] APSI (%) = {(a+b)/2/[(a+b)/2 + c] }c-{(a+b)/2/[(a+b)/2 + c]}uxl00 [00421] Where “U” represents the value for probability of iExon inclusion (a+b)/2/[(a+b)/2+c]u in the absence of the compound; and, where “C” represents the value for probability of iExon inclusion (a+b)/2/[(a+b)/2 + c]c in the presence of the compound. The values for “a” and “b” represent the number of reads supporting inclusion of an iExon in an RNA
transcript. In other words, the “a” value is derived from the amount of reads for a first intronic nucleotide sequence comprising, in 5’ to 3’ order: a first exon having a 5’ splice site operably linked and upstream from a first intronic nucleotide sequence comprising a first branch point further operably linked and upstream from a first intronic 3’ splice site (upstream of the nascent iExon). The “b” value is derived from the amount of reads for a second intronic nucleotide sequence comprising, in 5’ to 3’ order: an iREMS sequence operably linked downstream from the first intronic 3’ splice site and upstream from a second intronic nucleotide sequence comprising a second branch point further operably linked and upstream from a second intronic 3’ splice site of a second exon. The value for “c” represents the number of reads supporting exclusion of an iExon. Accordingly, when a compound enables the splicing machinery to recognize a nascent iExon, the value for (a+b)/2/[(a+b)/2+c]c in the presence of the splicing modifier compound will differ from the value for (a+b)/2/[(a+b)/2+c]u in the absence of the compound. The statistically significant value for the likelihood of iExon inclusion may be obtained according to statistical analysis methods or other probability analysis methods known to those of ordinary skill in the art.
[00422] In one aspect, a statistical analysis or other probability analysis is performed on data from the assay utilized to measure an RNA transcript. In another aspect, for example, a Fisher’s Exact Test statistical analysis is performed by comparing the total number of reads for the inclusion and exclusion of an iExon (or region) based on data from one or more assays used to measure whether the amount or type of an RNA transcript is altered in the presence of the compound relative to the amount in the absence of the compound or presence of a negative control. In another aspect, the statistical analysis results in a confidence value for those RNA transcripts with the alternation of 10%, 5%, 4%, 3%, 2%, 1%, 0.5%, 0.1%, 0.01%, 0.001% or 0.0001%. In another aspect, the confidence value is a p value of those altered RNA transcripts of is 10%, 5%, 4%, 3%, 2%, 1%, 0.5%, 0.1%, 0.01%, 0.001% or 0.0001%. In another aspect, an exact test, student t-test or p value of those RNA transcripts with the alteration is 10%, 5%, 4%, 3%, 2%, 1%, 0.5% or 0.1% and 10%, 5%, 4%, 3%, 2%, 1%, 0.5%, 0.1%, 0.01%, 0.001% or 0.0001%, respectively.
[00423] In one aspect, a further analysis is perfonned to determine how the compound of Formula (I) or a form thereof is changing the amount or type of an RNA transcripts). In another
aspect, a further analysis is performed to determine if an alternation in the amount or type of an RNA transcript(s) in the presence of a compound of Formula (I) or a form thereof relative the amount or type of the RNA transcript(s) in the absence of the compound or a form thereof, or the presence of a negative control is due to changes in transcription, splicing, and/or stability of the RNA transcript(s). Techniques known to one skilled in the art may be used to determine whether a compound of Formula (I) or a form thereof changes, e.g., the transcription, splicing and/or stability of an RNA transcript(s).
[00424] In another aspect, the stability of one or more RNA transcripts is determined by serial analysis of gene expression (SAGE), differential display analysis (DD), RNA arbitrary primer (RAP)-PCR, restriction endonuclease-lytic analysis of differentially expressed sequences (READS), amplified restriction fragment-length polymorphism (ALFP), total gene expression analysis (TOGA), RT-PCR, RT-qPCR, RNA-Seq, digital color-coded barcode technology, high- density cDNA filter hybridization analysis (HDFCA), suppression subtractive hybridization (SSH), differential screening (DS), cDNA arrays, oligonucleotide chips, or tissue microarrays. In another aspect, the stability of one or more RNA transcripts is determined by Northern blot, RNase protection, or slot blot.
[00425] In another aspect, the transcription in a cell(s) or tissue sample is inhibited before (e.g., 5 minutes, 10 minutes, 30 minutes, 1 hour, 2 hours, 4 hours, 6 hours, 8 hours, 12 hours, 18 hours, 24 hours, 36 hours, 48 hours, or 72 hours before) or after (e.g., 5 minutes, 10 minutes, 30 minutes, 1 hour, 2 hours, 4 hours, 6 hours, 8 hours, 12 hours, 18 hours, 24 hours, 36 hours, 48 hours, or 72 hours after) the cell or the tissue sample is contacted or cultured with an inhibitor of transcription, such as a-amanitin, DRB, flavopiridol, triptolide, or actinomycin-D. In another aspect, the transcription in a cell(s) or tissue sample is inhibited with an inhibitor of transcription, such as a-amanitin, DRB, flavopiridol, triptolide, or actinomycin-D, while the cell(s) or tissue sample is contacted or cultured with a compound of Formula (I) or a form thereof.
[00426] In another aspect, the level of transcription of one or more RNA transcripts is determined by nuclear run-on assay or an in vitro transcription initiation and elongation assay. In another aspect, the detection of transcription is based on measuring radioactivity or fluorescence. In another aspect, a PCR-based amplification step is used.
[00427] In another aspect, the amount or type of alternatively spliced forms of the RNA transcripts of a particular gene are measured to see if there is an alteration in the amount or type of one, two or more alternatively spliced forms of the RNA transcripts of the gene. In another aspect, the amount or type of an isoform(s) encoded by a particular gene is measured to see if there is an alteration in the amount or type of the isoform(s). In another aspect, the levels of spliced forms of RNA are quantified by RT-PCR, RT-qPCR, RNA-Seq, digital color-coded barcode technology, or Northern blot. In another aspect, sequence-specific techniques may be used to detect the levels of an individual spliceoform. In another aspect, splicing is measured in vitro using nuclear extracts. In another aspect, detection is based on measuring radioactivity or fluorescence. Techniques known to one skilled in the art may be used to measure alterations in the amount or type of alternatively spliced forms of an RNA transcript of a gene and alterations in the amount or type of an isoform encoded by a gene. In another aspect, modulation of RNA transcripts is assessed as described in the Examples described herein.
[00428] Also provided herein are methods of screening for new compounds that can be used to modulate the amount or type of a product (e.g., a precursor RNA, an mRNA, or protein) expressed by a gene comprising an intronic REMS in its DNA or RNA sequence. The methods described herein to determine whether the amount or type of a product (e.g. , a precursor RNA, an mRNA, or protein) of a gene is likely to be modulated by a compound of Formula (I) or a form thereof can be also used in the methods of screening for new compounds. In another aspect, the method comprises contacting a candidate compound with an RNA transcript, wherein the RNA transcript comprises exons and one or more introns, wherein at least one intron comprises, in 5’ to 3’ order, a branch point, a 3’ splice site, and an intronic REMS. In another aspect, the method comprises contacting a candidate compound with an RNA transcript, wherein the RNA transcript comprises exons and one or more introns, wherein at least one intron comprises an intronic REMS downstream of a branch point and a 3’ splice site. The RNA transcript may be present in a cell or cell lysate. The methods described above regarding the techniques of contacting a compound with an RNA transcript, the dosage, etc., may be used in the methods of screening. The candidate compounds to be screened can be provided by any source. For example, the candidate compounds to be screened can be from a compound library, such as a commercial compound library.
[00429] In certain aspects, a further analysis is performed to determine how the compound of Formula (I) or a form thereof is changing the amount or type of an RNA transcripts). In specific aspects, a further analysis is performed to determine if an alternation in the amount or type of an RNA transcript(s) in the presence of a compound of Formula (I) or a form thereof relative the amount or type of the RNA transcript(s) in the absence of the compound or a form thereof, or the presence of a negative control is due to changes in transcription, splicing, and/or stability of the RNA transcript(s). Techniques known to one skilled in the art may be used to determine whether a compound of Formula (I) or a form thereof changes, e.g.. the transcription, splicing and/or stability of an RNA transcript(s).
[00430] In certain aspects, the stability of one or more RNA transcripts is determined by serial analysis of gene expression (SAGE), differential display analysis (DD), RNA arbitrarily primer (RAP)-PCR, restriction endonuclease-lytic analysis of differentially expressed sequences (READS), amplified restriction fragment-length polymorphism (ALFP), total gene expression analysis (TOGA), RT-PCR, RT-qPCR, high-density cDNA filter hybridization analysis (HDFCA), suppression subtractive hybridization (SSH), differential screening (DS), cDNA arrays, oligonucleotide chips, or tissue microarrays. In another aspect, the stability of one or more RNA transcripts is determined by Northern blots, RNase protection, or slot blots.
[00431] In another aspect, the transcription in a cell(s) or tissue sample is inhibited before (e.g., 5 minutes, 10 minutes, 30 minutes, I hour, 2 hours, 4 hours, 6 hours, 8 hours, 12 hours, 18 hours, 24 hours, 36 hours, 48 hours, or 72 hours before) or after (e.g., 5 minutes, 10 minutes, 30 minutes, 1 hour, 2 hours, 4 hours, 6 hours, 8 hours, 12 hours, 18 hours, 24 hours, 36 hours, 48 hours, or 72 hours after) the cell or the tissue sample is contacted or cultured with an inhibitor of transcription, such as a-amanitin, DRB, flavopiridol, triptolide, or actinomycin-D. In another aspect, the transcription in a cell(s) or tissue sample is inhibited with an inhibitor of transcription, such as a-amanitin, DRB, flavopiridol, triptolide, or actinomycin-D, while the cell(s) or tissue sample is contacted or cultured with a compound of Formula (I) or a form thereof.
[00432] In another aspect, the level of transcription of one or more RNA transcripts is determined by nuclear run-on assay or an in vitro transcription initiation and elongation assay. In another aspect, the detection of transcription is based on measuring radioactivity or fluorescence. In another aspect, a PCR-based amplification step is used.
Hl
[00433] In specific aspects, the amount or type of alternatively spliced forms of the RNA transcripts of a particular gene are measured to see if there is an alteration in the amount or type of one, alternatively spliced forms of the RNA transcripts of the gene. In another aspect, the amount or type of an isoform(s) encoded by a particular gene is measured to see if there is an alteration in the amount or type of the isoform(s). In another aspect, the levels of spliced forms of RNA are quantified by RT-PCR, RT-qPCR, or northern blotting. In another aspect, sequence- specific techniques may be used to detect the levels of an individual spliceoform. In another aspect, splicing is measured in vitro using nuclear extracts. In another aspect, detection is based on measuring radioactivity or fluorescence. Techniques known to one skilled in the art may be used to measure alterations in the amount or type of alternatively spliced forms of an RNA transcript of a gene and alterations in the amount or type of an isoform encoded by a gene.
PHARMACEUTICAL COMPOSITIONS AND MODES OF ADMINISTRATION
[00434] When administered to a subject, a compound of Formula (I) or a form thereof is preferably administered as a component of a composition that optionally comprises a pharmaceutically acceptable carrier, excipient or diluent. The composition can be administered orally, or by any other convenient route, for example, by infusion or bolus injection, by absorption through epithelial or mucocutaneous linings (e.g, oral mucosa, rectal, and intestinal mucosa) and may be administered together with another biologically active agent. Administration can be systemic or local. Various delivery systems are known, e g., encapsulation in liposomes, microparticles, microcapsules, capsules, and can be used to administer the compound.
[00435] Methods of administration include, but are not limited to, parenteral, intradermal, intramuscular, intraperitoneal, intravenous, subcutaneous, intranasal, epidural, oral, sublingual, intranasal, intraocular, intratumoral, intracerebral, intravaginal, transdermal, ocularly, rectally, by inhalation, or topically, particularly to the ears, nose, eyes, or skin. The mode of administration is left to the discretion of the practitioner. In most instances, administration will result in the release of a compound into the bloodstream, tissue or cell(s). In a specific aspect, a compound is administered orally.
[00436] The amount of a compound of Formula (I) or a form thereof that will be effective in the treatment of a disease resulting from an aberrant amount or type of mRNA transcripts depends, e.g., on the route of administration, the disease being treated, the general health of the subject, ethnicity, age, weight, and gender of the subject, diet, time, and the severity of disease progress, and should be decided according to the judgment of the practitioner and each subject’s or subject’s circumstances.
[00437] In specific aspects, an “effective amount” in the context of the administration of a compound of Formula (I) or a form thereof, or composition or medicament thereof refers to an amount of a compound of Formula (I) or a form thereof to a subject which has a therapeutic effect and/or beneficial effect. In certain specific aspects, an “effective amount” in the context of the administration of a compound of Formula (I) or a form thereof, or composition or medicament thereof to a subject results in one, of the following effects: (i) reduces or ameliorates the severity of a disease; (ii) delays onset of a disease; (iii) inhibits the progression of a disease; (iv) reduces hospitalization of a subject; (v) reduces hospitalization length for a subject; (vi) increases the survival of a subject; (vii) improves the quality of life of a subject; (viii) reduces the number of symptoms associated with a disease; (ix) reduces or ameliorates the severity of a symptom(s) associated with a disease; (x) reduces the duration of a symptom associated with a disease associated; (xi) prevents the recurrence of a symptom associated with a disease; (xii) inhibits the development or onset of a symptom of a disease; and/or (xiii) inhibits of the progression of a symptom associated with a disease. In certain aspects, an effective amount of a compound of Formula (I) or a form thereof is an amount effective to restore the amount or type of a RNA transcript of a gene to the amount or type of the RNA transcript detectable in healthy subjects or cells from healthy subjects. In another aspect, an effective amount of a compound of Formula (I) or a form thereof is an amount effective to restore the amount an RNA isoform and/or protein isoform of gene to the amount or type of the RNA isoform and/or protein isoform detectable in healthy subjects or cells from healthy subjects.
[00438] In another aspect, an effective amount of a compound of Formula (I) or a form thereof is an amount effective to decrease the aberrant amount or type of RNA transcript of a gene which associated with a disease. In another aspect, an effective amount of a compound of Formula (I) or a form thereof is an amount effective to decrease the amount or type of aberrant
expression associated with an isoform of a gene. In another aspect, an effective amount of a compound of Formula (I) or a form thereof is an amount effective to result in a substantial change in the amount or type of an RNA transcript (e.g., mRNA transcript), alternative splice variant or isoform.
[00439] In another aspect, an effective amount of a compound of Formula (I) or a form thereof is an amount effective to increase or decrease the amount or type of an RNA transcript (e.g., an mRNA transcript) of gene which is beneficial for the prevention and/or treatment of a disease. In certain In another aspect, an effective amount of a compound of Formula (I) or a form thereof is an amount effective to increase or decrease the amount or type of an alternative splice variant of an RNA transcript of gene which is beneficial for the prevention and/or treatment of a disease. In another aspect, an effective amount of a compound of Formula (I) or a form thereof is an amount effective to increase or decrease the amount or type of an isoform of gene which is beneficial for the prevention and/or treatment of a disease. Non-limiting examples of effective amounts of a compound of Formula (I) or a form thereof are described herein.
[00440] For example, the effective amount may be the amount required to prevent and/or treat a disease associated with the aberrant amount or type of an mRNA transcript of gene in a human subject.
[00441] In general, the effective amount will be in a range of from about 0.001 mg/kg/day to about 500 mg/kg/day for a subject having a weight in a range of between about 1 kg to about 200 kg. The typical adult subject is expected to have a median weight in a range of between about 70 and about 100 kg.
[00442] Within the scope of the present description, the “effective amount” of a compound of Formula (I) or a form thereof for use in the manufacture of a medicament, the preparation of a pharmaceutical kit or in a method for preventing and/or treating a disease in a human subject in need thereof, is intended to include an amount in a range of from about 0.001 mg to about 35,000 mg.
[00443] The compositions described herein are formulated for administration to the subject via any drug delivery route known in the art. Non-limiting examples include oral, ocular, rectal, buccal, topical, nasal, ophthalmic, subcutaneous, intramuscular, intraveneous (bolus and infusion), intracerebral, transdermal, and pulmonary routes of administration.
[00444] In another aspect, described herein include the use of a compound of Formula (I) or a form thereof in a pharmaceutical composition. In a specific aspect, described herein is the use of a compound of Formula (I) or a form thereof in a pharmaceutical composition for preventing and/or treating a disease in a human subject in need thereof comprising administering an effective amount of a compound of Formula (I) or a form thereof in admixture with a pharmaceutically acceptable carrier, excipient or diluent.In a specific aspect, the human subject is a subject with a disease associated with the aberrant amount or type of an mRNA transcript(s). [00445] A compound of Formula (I) or a form thereof may optionally be in the form of a composition comprising the compound or a form thereof and an optional carrier, excipient or diluent. In another aspect, described herein include pharmaceutical compositions comprising an effective amount of a compound of Formula (1) or a form thereof and a pharmaceutically acceptable carrier, excipient, or diluent. In a specific aspect, the pharmaceutical compositions are suitable for veterinary and/or human administration. The pharmaceutical compositions described herein can be in any form that allows for the composition to be administered to a subject.
[00446] In a specific aspect and in this context, the term “pharmaceutically acceptable carrier, excipient or diluent” means a carrier, excipient or diluent approved by a regulatory agency of the Federal or a state government or listed in the U.S. Pharmacopeia or other generally recognized pharmacopeia for use in animals, and more particularly in humans. The term “carrier” refers to a diluent, adjuvant (e.g., Freund’s adjuvant (complete and incomplete)), excipient, or vehicle with which a therapeutic agent is administered. Such pharmaceutical carriers can be sterile liquids, such as water and oils, including those of petroleum, animal, vegetable or synthetic origin, such as peanut oil, soybean oil, mineral oil, sesame oil and the like. Water is a specific carrier for intravenously administered pharmaceutical compositions. Saline solutions and aqueous dextrose and glycerol solutions can also be employed as liquid carriers, particularly for injectable solutions.
[00447] Typical compositions and dosage forms comprise one or more excipients. Suitable excipients are well-known to those skilled in the art of pharmacy, and non limiting examples of suitable excipients include starch, glucose, lactose, sucrose, gelatin, malt, rice, flour, chalk, silica gel, sodium stearate, glycerol monostearate, talc, sodium chloride, dried skim milk, glycerol,
propylene, glycol, water, ethanol and the like. Whether a particular excipient is suitable for incorporation into a pharmaceutical composition or dosage form depends on a variety of factors well known in the art including, but not limited to, the way in which the dosage form will be administered to a subject and the specific active ingredients in the dosage form. Further described herein are anhydrous pharmaceutical compositions and dosage forms comprising one or more compounds of Formula (I) or a form thereof as described herein. The compositions and single unit dosage forms can take the form of solutions or syrups (optionally with a flavoring agent), suspensions (optionally with a flavoring agent), emulsions, tablets (e.g., chewable tablets), pills, capsules, granules, powder (optionally for reconstitution), taste-masked or sustained-release formulations and the like.
[00448] Pharmaceutical compositions described herein that are suitable for oral administration can be presented as discrete dosage forms, such as, but are not limited to, tablets, caplets, capsules, granules, powder, and liquids. Such dosage forms contain predetermined amounts of active ingredients, and may be prepared by methods of pharmacy well known to those skilled in the art.
[00449] Examples of excipients that can be used in oral dosage forms described herein include, but are not limited to, binders, fillers, disintegrants, and lubricants.
[00450] In a particular aspect, described herein are methods for modulating the amount or type of one, two, three or more RNA transcripts of a gene in a subject, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS (for example, an endogenous REMS or a non-endogenous REMS), the methods comprising administering to the subject a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent, wherein the gene is: (a) a gene comprising a DNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 1 to SEQ ID NO. 5775, (b) a gene selected from Table 5, and/or (c) a gene that transcribes to a pre-mRNA comprising an RNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 5776 to SEQ ID NO. 11550.
[00451] In another particular aspect, described herein are methods for modulating the amount or type of one, two, three or more RNA transcripts of a gene in a subject, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS (for example, an endogenous REMS or a
non-endogenous REMS), the methods comprising administering to the subject a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent, wherein the gene is other than SMN2, F0XM1, APLP2, GGCT, ABHD10, STRN3, VPS29, ERGIC3, MADD, LARP 7, ARMCX6, GALC, LAMA2, PRKDC, RCC1, FADS2, DIAPH3, FN1, PARP1, COL1A1, COL1A2, COL3A1 or COL5A2
[00452] In another particular aspect, described herein are methods for modulating the amount or type of one, two, three or more RNA transcripts of a gene in a subject, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS (for example, an endogenous REMS or a non-endogenous REMS), the methods comprising administering to the subject a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent, wherein the gene is other than SMN2, FOXM1, APLP2, GGCT, ABHD10, STRN3, VPS29, ERGIC3, MADD, LARP7 or COL1A1.
[00453] In another particular aspect, described herein are methods for modulating the amount or type of one, two, three or more RNA transcripts of a gene in a subject, wherein the pre-mRNA transcript transcribed from the gene comprises a non-endogenous REMS, the methods comprising administering to the subject a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
[00454] In another aspect, described herein are methods for modulating the amount or type of one, two, three or more RNA transcripts of a gene other than a gene comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5, infra, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
[00455] In another aspect, a compound of Formula (I) or a form thereof contacted or cultured with a cell(s), or administered to a subject is a compound described herein.
METHODS OF PREVENTING AND/OR TREATING DISEASES
[00456] In another aspect, described herein are methods for preventing and/or treating a disease associated with the aberrant expression of a product of a gene (e.g., an mRNA transcript or protein), wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
[00457] In certain aspects, the gene is a gene comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5. In certain aspects, the gene contains a nucleotide sequence encoding a non-endogenous REMS. In one aspect, described herein are methods for preventing and/or treating a disease associated with aberrant expression of a product of a gene (e.g., an mRNA, RNA transcript or protein), by way of nonlimiting example, comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5, infra, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
[00458] In another aspect, described herein are methods for preventing and/or treating a disease associated with aberrant expression of a product of a gene (e.g., an mRNA, RNA transcript or protein), not comprising a sequence of Tables 1 or 2, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
[00459] In another aspect, described herein are methods for preventing and/or treating a disease in which a change in the level of expression of one, two, three or more RNA isoforms encoded by a gene is beneficial to the prevention and/or treatment of the disease, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
[00460] In certain aspects, the gene is a gene comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5. In certain aspects, the gene contains a nucleotide sequence encoding the non-endogenous REMS. In one aspect, described herein are methods for preventing and/or treating a disease in which the alteration (e.g., increase or decrease) in the expression one, two, three or more RNA isoforms encoded by a gene, by way of nonlimiting example, comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5, infra, is beneficial to the prevention and/or treatment of the disease, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent. In another aspect, described herein are methods for preventing and/or treating a disease in which the alteration (e.g., increase or decrease) in the expression one, two, three or more RNA isoforms encoded by a gene, not comprising a sequence of Tables 1 or 2 is beneficial to the prevention and/or treatment of the disease, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
[00461] In another aspect, described herein are methods for preventing and/or treating a disease in which a change in the level of expression of one, two, three or more protein isoforms encoded by a gene is beneficial to the prevention and/or treatment of the disease, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
[00462] In certain aspects, the gene is a gene comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5. In certain aspects, the gene contains a nucleotide sequence encoding a non-endogenous REMS. In one aspect, described herein are methods for preventing and/or treating a disease in which the alteration (e.g., increase or decrease) in the expression one, two, three or more protein isoforms encoded by a gene, by way of nonlimiting example, comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5, infra, is beneficial to the prevention
and/or treatment of the disease, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
[00463] In another aspect, described herein are methods for preventing and/or treating a disease in which the alteration (e.g, increase or decrease) in the expression one, two, three or more protein isoforms encoded by a gene, other than a gene comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5, infra, is beneficial to the prevention and/or treatment of the disease, wherein the pre-mRNA transcript transcribed from the gene comprises a REMS, the methods comprising administering to a subject in need thereof a compound of Formula (I) or a form thereof, or a pharmaceutical composition comprising a compound of Formula (I) or a form thereof and a pharmaceutically acceptable carrier, excipient or diluent.
[00464] In a specific aspect, the methods for preventing a disease described herein prevent the onset or development of one or symptoms of the disease. In another aspect, the methods for preventing a disease described herein prevent the recurrence of the disease or delays the recurrence of the disease. In another aspect, the methods for treating a disease described herein has one, two or more of the effects: (i) reduce or ameliorate the severity of the disease; (ii) inhibit the progression of the disease; (iii) reduce hospitalization of a subject; (iv) reduce hospitalization length for a subject; (v) increase the survival of a subject; (vi) improve the quality of life of a subject; (vii) reduce the number of symptoms associated with the disease; (viii) reduce or ameliorates the severity of a symptom(s) associated with the disease; (ix) reduce the duration of a symptom(s) associated with the disease; (x) prevent the recurrence of a symptom associated with the disease; (xi) inhibit the development or onset of a symptom of the disease; and/or (xii) inhibit of the progression of a symptom associated with the disease.
[00465] In certain aspects, the disease or disorder prevented and/or treated in accordance with a method described herein is a disease or disorder associated with a gene comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5. In specific aspects, the disease or disorder prevented and/or treated in accordance with a method described herein is leukemia, acute myeloid leukemia, colon cancer, gastric cancer, macular degeneration, acute monocytic leukemia, breast cancer, combined methylmalonic aciduria and homocystinuria, cblC type,
hepatocellular carcinoma, cone-rod dystrophy, alveolar soft part sarcoma, myeloma, skin melanoma, prostatitis, pancreatitis, pancreatic cancer, retinitis, adenocarcinoma, adenoiditis, adenoid cystic carcinoma, cataract, retinal degeneration, gastrointestinal stromal tumor, Wegener’s granulomatosis, sarcoma, myopathy, prostate adenocarcinoma, Alzheimer’s disease, hyperprolinemia, acne, tuberculosis, succinic semialdehyde dehydrogenase deficiency, esophagitis, mental retardation, esophageal adenocarcinoma, glycine encephalopathy, Crohn’s disease, spina bifida, tuberculosis, autosomal recessive disease, schizophrenia, neural tube defects, lung cancer, myelodysplastic syndromes, amyotropic lateral sclerosis, neuronitis, germ cell tumors, Parkinson’s disease, talipes equinovarus, dystrophinopathies, Hodgkin’s lymphoma, ovarian cancer, non-Hodgkin’s lymphoma, multiple myeloma, chronic myeloid leukemia, ischemia, acute lymphoblastic leukemia, renal cell carcinoma, transitional cell carcinoma, colorectal cancer, chronic lymphocytic leukemia, anaplastic large cell lymphoma, kidney cancer, cerebritis, bladder related disorders, breast cancer, cervical cancer, cleft lip, cleft palate, cervicitis, spasticity, lipoma, scleroderma, Gitelman syndrome, poliomyelitis, paralysis, Aagenaes syndrome, or oculomotor nerve paralysis. In specific aspects, the disease or disorder prevented and/or treated in accordance with a method described herein is basal cell carcinoma, goblet cell metaplasia, or a malignant glioma. In other specific aspects, the disease or disorder prevented and/or treated in accordance with a method described herein is a cancer of the liver, breast, lung, prostate, cervix, uterus, colon, pancreas, kidney, stomach, bladder, ovary, or brain. [00466] In certain aspects, the disease prevented and/or treated in accordance with a method described herein is cancer amenable to treatment by upregulation or downregulation of a gene or isoform thereof as described herein. In specific aspects, cancers that can be prevented and/or treated in accordance with a method described herein include, but are not limited to, cancer of the head, neck, eye, mouth, throat, esophagus, esophagus, chest, bone, lung, kidney, colon, rectum or other gastrointestinal tract organs, stomach, spleen, skeletal muscle, subcutaneous tissue, prostate, breast, ovaries, testicles or other reproductive organs, skin, thyroid, blood, lymph nodes, kidney, liver, pancreas, brain or central nervous system.
[00467] Specific examples of cancers that can be prevented and/or treated in accordance with the methods described herein include, but are not limited to, the following: renal cancer, kidney cancer, glioblastoma multiforme, metastatic breast cancer; breast carcinoma; breast sarcoma;
neurofibroma; neurofibromatosis; pediatric tumors; neuroblastoma; malignant melanoma; carcinomas of the epidermis; leukemias such as but not limited to, acute leukemia, acute lymphocytic leukemia, acute myelocytic leukemias such as myeloblastic, promyelocytic, myelomonocytic, monocytic, erythroleukemia leukemias and myelodysplastic syndrome, chronic leukemias such as but not limited to, chronic myelocytic (granulocytic) leukemia, chronic lymphocytic leukemia, hairy cell leukemia; polycythemia vera; lymphomas such as but not limited to Hodgkin’s disease, non-Hodgkin’s disease; multiple myelomas such as but not limited to smoldering multiple myeloma, nonsecretory myeloma, osteosclerotic myeloma, plasma cell leukemia, solitary plasmacytoma and extramedullary plasmacytoma; Waldenstrom’s macroglobulinemia; monoclonal gammopathy of undetermined significance; benign monoclonal gammopathy; heavy chain disease; bone cancer and connective tissue sarcomas such as but not limited to bone sarcoma, myeloma bone disease, multiple myeloma, cholesteatoma-induced bone osteosarcoma, Paget’s disease of bone, osteosarcoma, chondrosarcoma, Ewing’s sarcoma, malignant giant cell tumor, fibrosarcoma of bone, chordoma, periosteal sarcoma, soft-tissue sarcomas, angiosarcoma (hemangiosarcoma), fibrosarcoma, Kaposi’s sarcoma, leiomyosarcoma, liposarcoma, lymphangiosarcoma, neurilemmoma, rhabdomyosarcoma, and synovial sarcoma; brain tumors such as but not limited to, glioma, astrocytoma, brain stem glioma, ependymoma, oligodendroglioma, nonglial tumor, acoustic neurinoma, craniopharyngioma, medulloblastoma, meningioma, pineocytoma, pineoblastoma, and primary brain lymphoma; breast cancer including but not limited to adenocarcinoma, lobular (small cell) carcinoma, intraductal carcinoma, medullary breast cancer, mucinous breast cancer, tubular breast cancer, papillary breast cancer, Paget’s disease (including juvenile Paget’s disease) and inflammatory breast cancer; adrenal cancer such as but not limited to pheochromocytom and adrenocortical carcinoma; thyroid cancer such as but not limited to papillary or follicular thyroid cancer, medullary thyroid cancer and anaplastic thyroid cancer; pancreatic cancer such as but not limited to, insulinoma, gastrinoma, glucagonoma, vipoma, somatostatin-secreting tumor, and carcinoid or islet cell tumor; pituitary cancers such as but limited to Cushing’s disease, prolactin-secreting tumor, acromegaly, and diabetes insipius; eye cancers such as but not limited to ocular melanoma such as iris melanoma, choroidal melanoma, and cilliary body melanoma, and retinoblastoma; vaginal cancers such as squamous cell carcinoma, adenocarcinoma, and melanoma; vulvar cancer such
as squamous cell carcinoma, melanoma, adenocarcinoma, basal cell carcinoma, sarcoma, and Paget’s disease; cervical cancers such as but not limited to, squamous cell carcinoma, and adenocarcinoma; uterine cancers such as but not limited to endometrial carcinoma and uterine sarcoma; ovarian cancers such as but not limited to, ovarian epithelial carcinoma, borderline tumor, germ cell tumor, and stromal tumor; cervical carcinoma; esophageal cancers such as but not limited to, squamous cancer, adenocarcinoma, adenoid cyctic carcinoma, mucoepidermoid carcinoma, adenosquamous carcinoma, sarcoma, melanoma, plasmacytoma, verrucous carcinoma, and oat cell (small cell) carcinoma; stomach cancers such as but not limited to, adenocarcinoma, fungating (polypoid), ulcerating, superficial spreading, diffusely spreading, malignant lymphoma, liposarcoma, fibrosarcoma, and carcinosarcoma; colon cancers; KRAS- mutated colorectal cancer; colon carcinoma; rectal cancers; liver cancers such as but not limited to hepatocellular carcinoma and hepatoblastoma, gallbladder cancers such as adenocarcinoma; cholangiocarcinomas such as but not limited to papillary, nodular, and diffuse; lung cancers such as KRAS-mutated non-small cell lung cancer, non-small cell lung cancer, squamous cell carcinoma (epidermoid carcinoma), adenocarcinoma, large-cell carcinoma and small-cell lung cancer; lung carcinoma; testicular cancers such as but not limited to germinal tumor, seminoma, anaplastic, classic (typical), spermatocytic, nonseminoma, embryonal carcinoma, teratoma carcinoma, choriocarcinoma (yolk-sac tumor), prostate cancers such as but not limited to, androgen-independent prostate cancer, androgen-dependent prostate cancer, adenocarcinoma, leiomyosarcoma, and rhabdomyosarcoma; penal cancers; oral cancers such as but not limited to squamous cell carcinoma; basal cancers; salivary gland cancers such as but not limited to adenocarcinoma, mucoepidermoid carcinoma, and adenoidcystic carcinoma; pharynx cancers such as but not limited to squamous cell cancer, and verrucous; skin cancers such as but not limited to, basal cell carcinoma, squamous cell carcinoma and melanoma, superficial spreading melanoma, nodular melanoma, lentigo malignant melanoma, acral lentiginous melanoma; kidney cancers such as but not limited to renal cell cancer, adenocarcinoma, hypernephroma, fibrosarcoma, transitional cell cancer (renal pelvis and/or uterer); renal carcinoma; Wilms’ tumor; bladder cancers such as but not limited to transitional cell carcinoma, squamous cell cancer, adenocarcinoma, carcinosarcoma. In addition, cancers include myxosarcoma, osteogenic sarcoma, endotheliosarcoma, lymphangioendotheliosarcoma, mesothelioma, synovioma,
hemangioblastoma, epithelial carcinoma, cystadenocarcinoma, bronchogenic carcinoma, sweat gland carcinoma, sebaceous gland carcinoma, papillary carcinoma and papillary adenocarcinomas.
[00468] In another aspect, cancers that can be prevented and/or treated in accordance with the methods described herein include, the following: pediatric solid tumor, Ewing’s sarcoma, Wilms tumor, neuroblastoma, neurofibroma, carcinoma of the epidermis, malignant melanoma, cervical carcinoma, colon carcinoma, lung carcinoma, renal carcinoma, breast carcinoma, breast sarcoma, metastatic breast cancer, HIV-related Kaposi’s sarcoma, prostate cancer, androgen-independent prostate cancer, androgen-dependent prostate cancer, neurofibromatosis, lung cancer, non-small cell lung cancer, KRAS-mutated non-small cell lung cancer, malignant melanoma, melanoma, colon cancer, KRAS-mutated colorectal cancer, glioblastoma multiforme, renal cancer, kidney cancer, bladder cancer, ovarian cancer, hepatocellular carcinoma, thyroid carcinoma, rhabdomyosarcoma, acute myeloid leukemia, and multiple myeloma.
[00469] In another aspect, cancers and conditions associated therewith that are prevented and/or treated in accordance with the methods described herein are breast carcinomas, lung carcinomas, gastric carcinomas, esophageal carcinomas, colorectal carcinomas, liver carcinomas, ovarian carcinomas, thecomas, arrhenoblastomas, cervical carcinomas, endometrial carcinoma, endometrial hyperplasia, endometriosis, fibrosarcomas, choriocarcinoma, head and neck cancer, nasopharyngeal carcinoma, laryngeal carcinomas, hepatoblastoma, Kaposi’s sarcoma, melanoma, skin carcinomas, hemangioma, cavernous hemangioma, hemangioblastoma, pancreas carcinomas, retinoblastoma, astrocytoma, glioblastoma, Schwannoma, oligodendroglioma, medulloblastoma, neuroblastomas, rhabdomyosarcoma, osteogenic sarcoma, leiomyosarcomas, urinary tract carcinomas, thyroid carcinomas, Wilm’s tumor, renal cell carcinoma, prostate carcinoma, abnormal vascular proliferation associated with phakomatoses, edema (such as that associated with brain tumors), or Meigs’ syndrome. In specific aspect, the cancer astrocytoma, an oligodendroglioma, a mixture of oligodendroglioma and an astrocytoma elements, an ependymoma, a meningioma, a pituitary adenoma, a primitive neuroectodermal tumor, a medullblastoma, a primary central nervous system (CNS) lymphoma, or a CNS germ cell tumor. In specific aspects, the cancer treated in accordance with the methods described herein is an acoustic neuroma, an anaplastic astrocytoma, a glioblastoma multiforme, or a meningioma. In
other specific aspects, the cancer treated in accordance with the methods described herein is a brain stem glioma, a craniopharyngioma, an ependyoma, a juvenile pilocytic astrocytoma, a medulloblastoma, an optic nerve glioma, primitive neuroectodermal tumor, or a rhabdoid tumor. [00470] Specific examples of conditions that can be prevented and/or treated in accordance with the methods described herein include cystic fibrosis, muscular dystrophy, polycystic autosomal -dominant kidney disease, cancer-induced cachexia, benign prostatic hyperplasia, rheumatoid arthritis, psoriasis, atherosclerosis, obesity, retinopathies (including diabetic retinopathy and retinopathy of prematurity), retrolental fibroplasia, neovascular glaucoma, age- related macular degeneration, exudative macular degeneration, thyroid hyperplasias (including Grave’s disease), corneal and other tissue transplantation, epidemic keratoconjunctivitis, Vitamin A deficiency, contact lens overwear, atopic keratitis, superior limbic keratitis, and pterygium keratitis sicca, viral infections, inflammation associated with viral infections, chronic inflammation, lung inflammation, nephrotic syndrome, preeclampsia, ascites, pericardial effusion (such as that associated with pericarditis), pleural effusion, Sjogren’s syndrome, acne rosacea, phylectenulosis, syphilis, lipid degeneration, chemical burns, bacterial ulcers, fungal ulcers, Herpes simplex infection, Herpes zoster infections, protozoan infections, Mooren’s ulcer, Terrien’s marginal degeneration, marginal keratolysis, systemic lupus, polyarteritis, trauma, Wegener’s sarcoidosis, Paget’s disease, scleritis, Stevens-Johnson’s disease, pemphigoid, radial keratotomy, Eales’ disease, Behcet’s disease, sickle cell anemia, pseudoxanthoma elasticum, Stargardt’s disease, pars planitis, chronic retinal detachment, vein occlusion, artery occlusion, carotid obstructive disease, chronic uveitis/vitritis, ocular histoplasmosis, Mycobacteria infections, Lyme’s disease, Best’s disease, myopia, optic pits, hyperviscosity syndromes, toxoplasmosis, sarcoidosis, trauma, post-laser complications, diseases associated with rubeosis (neovascularization of the iris and of the angle), and diseases caused by the abnormal proliferation of fibrovascular or fibrous tissue, including all forms of prolific vitreoretinopathy. Certain examples of non-neoplastic conditions that can be prevented and/or treated in accordance with the methods described herein include viral infections, including but not limited to, those associated with viruses belonging to Flaviviridae, flavivirus, pestivirus, hepacivirus, West Nile virus, hepatitis C virus (HCV) or human papilloma virus (HPV).
ARTIFICIAL GENE CONSTRUCTS
[00471] In one aspect, described herein are artificial gene constructs comprising a REMS. In one aspect, an artificial gene construct comprises genomic DNA or DNA encoding exons and one, two or more introns, wherein a nucleotide sequence encoding a 5’ splice site, which is upstream of a nucleotide sequence a branch point and a nucleotide sequence encoding a 3’ splice site, is modified to introduce a nucleotide sequence encoding a REMS. In another aspect, an artificial gene construct comprises DNA encoding exons, a 5’ splice site(s), a 3’ splice site(s) and a branch point(s), wherein a nucleotide sequence encoding a 5’ splice site, which is upstream of at least one nucleotide sequence encoding a branch point and at least one nucleotide sequence encoding a 3’ splice site, is modified to introduce a nucleotide sequence encoding a REMS. In another aspect, an artificial gene construct comprises DNA encoding exons, a 3’ splice site(s) and a branch point(s), wherein a nucleotide sequence encoding an exon, which is upstream of a nucleotide sequence encoding a branch point and a 3’ splice site, is modified to introduce a nucleotide sequence encoding a REMS. In another aspect, an artificial gene construct comprises a DNA sequence that is modified to introduce a nucleotide sequence encoding a REMS. In another aspect, the DNA sequence chosen to be used in the production of an artificial gene construct contains a nucleotide sequence encoding a REMS and an additional nucleotide sequence encoding a REMS is introduced. In another aspect, the nucleotide sequence encoding a REMS is a nucleotide sequence encoding a non-endogenous REMS, i.e., not naturally found in the DNA sequence of the artificial gene construct. In another aspect, the artificial gene construct comprises other elements, such as a promoter (e.g., a constitutive, inducible or tissue specific promoter), a Poly(A) site, a transcription termination site, and a transcription binding site(s). In another aspect, the artificial gene construct comprises at least the exons of a gene encoding a therapeutic protein. In another aspect, the artificial gene construct comprises at least the exons of a gene comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5. In another aspect, the artificial gene construct comprises at least the exons of a detectable reporter gene, such as green fluorescent protein (GFP), yellow fluorescent protein (YEP), red fluorescent protein, beta galactosidase, renilla luciferase, firefly luciferase, etc.
[00472] In another aspect, an artificial gene construct is produced as follows: a nucleotide sequence encoding a REMS is introduced into a nucleotide sequence encoding an existing 5’
splice site of genomic DNA or DNA, wherein the DNA encodes two or more exons and one or more introns, and wherein the nucleotide sequence encoding the existing 5’ splice site is upstream of a nucleotide sequence encoding a 3’ splice site. In another aspect, an artificial gene construct is produced as follows: a nucleotide sequence encoding a REMS is introduced upstream of a nucleotide sequence encoding a branch point and a 3’ splice site of genomic DNA or DNA, wherein the DNA encodes two or more exons and an intron(s). In a specific aspect, the nucleotide sequence encoding the REMS is introduced internally within a nucleotide sequence encoding an exon. In another aspect, an artificial gene construct is produced as follows: a nucleotide sequence encoding a REMS, a nucleotide sequence encoding a branch point, and a nucleotide sequence encoding a 3’ splice site are introduced into a cDNA, wherein the nucleotide sequence encoding the REMS is upstream of the branch point and 3’ splice site. The nucleotide sequence encoding the REMS can function as a 5’ splice site. In another aspect, the nucleotide sequence encoding the REMS is internally within an exon. In another aspect, the genomic DNA or DNA chosen for use in the production of an artificial gene construct does not contain a nucleotide sequence encoding a REMS. In another aspect, the genomic DNA or DNA chosen for use in the production of an artificial gene construct contains a REMS and an additional REMS is introduced. In introducing a nucleotide sequence encoding a REMS into a DNA sequence, care should be taken so as not to disrupt an open reading frame or introduce a stop codon. The introduction of a nucleotide sequence encoding a REMS into a DNA sequence may or may not result in an amino acid change at the protein level. In another aspect, the introduction of a nucleotide sequence encoding a REMS into a DNA sequence results in an amino acid change at the protein level. In another aspect, this amino acid change is a conservative amino acid substitution. In another aspect, the introduction of a nucleotide sequence encoding a REMS into a DNA sequence does not result in an amino acid change at the protein level. Techniques known to one of skill in the art may be used to introduce a REMS and other elements, such as a branch point or 3’ splice site into a DNA sequence, e.g., gene editing techniques such as the CRISPR-Cas approach, Transcription Activator-Like Effector Nucleases (TALENs), or Zinc finger nucleases (ZFNs) may be used.
[00473] In another aspect, an artificial gene construct comprises an RNA sequence comprising exons and one, two or more introns, wherein a 5’ splice site, which is upstream of a 3’ splice site,
is modified to introduce a REMS . In another aspect, an artificial gene construct comprises an RNA sequence comprising exons, a 5’ splice site(s), a 3’ splice site(s) and a branch point(s), wherein a 5’ splice site, which is upstream of a 3’ splice site, is modified to introduce a REMS. In another aspect, an artificial gene construct comprises an RNA sequence comprising exons, a 3’ splice site(s) and a branch point(s), wherein an exon, which is upstream of a 3’ splice site, is modified to introduce a REMS. In specific aspects, the REMS is non-endogenous, i.e., not naturally found in the RNA sequence of the artificial gene construct. In another aspect, the artificial gene construct comprises other elements, such as a promoter (e.g., a tissue-s.pecific promoter or constitutively expressed promoter), 5’ untranslated region, 3’ untranslated region, a binding site(s) for RNA binding proteins, a small molecule RNA sensor(s), e.g., riboswitches, stem-loop structures, and/or internal ribosome entry sites (IRES), etc. In another aspect, the artificial gene construct comprises at least the exons of a gene encoding a therapeutic protein. In another aspect, the artificial gene construct comprises at least the exons of a gene comprising a sequence of Tables 1 or 2 and a gene disclosed in Table 5. In another aspect, the RNA transcript chosen to be used in the production of an artificial gene construct does not contain a REMS. In another aspect, the RNA transcript chosen to use in the production of an artificial gene construct contains a REMS and an additional REMS is introduced. In another aspect, the artificial gene construct comprises at least the exons of a detectable reporter gene, such as green fluorescent protein (GFP), yellow fluorescent protein (YFP), red fluorescent protein, beta galactosidase, renilla luciferase, firefly luciferase, etc.
[00474] In another aspect, an artificial gene construct is produced as follows: a REMS is introduced into an existing 5’ splice site of pre-mRNA, wherein the RNA comprises two or more exons and one or more introns, and wherein the existing 5’ splice site is upstream of a 3’ splice site. In another aspect, an artificial gene construct is produced as follows: a REMS is introduced upstream of a 3’ splice site of pre-mRNA, wherein the RNA comprises two or more exons and an intron(s). In another aspect, the REMS is introduced internally within an exon. In another aspect, an artificial gene construct is produced as follows: a REMS, branch point, and a 3’ splice site are introduced into an mRNA, wherein the REMS is upstream of the branch point and 3’ splice site. The REMS can be a 5’ splice site. In another aspect, the REMS is internally with an exon. In introducing a REMS into an RNA sequence, care should be taken so as not to disrupt
an open reading frame or introduce a stop codon. The introduction of a REMS into an RNA transcript may or may not result in an amino acid change at the protein level. In another aspect, the introduction of a REMS into an RNA transcript results in an amino acid change at the protein level. In another aspect, this amino acid change is a conservative amino acid substitution. In another aspect, the introduction of a REMS into an RNA transcript does not result in an amino acid change at the protein level Techniques known to one of skill in the art may be used to introduce a REMS and other elements, such as a branch point or 3’ splice site into an RNA transcript.
[00475] In another aspect, an artificial gene construct is present in a viral vector (e.g., an adeno-associated virus (AAV), self-complimentary adeno-associated virus, adenovirus, retrovirus, lentivirus (e.g., Simian immunodeficiency virus, human immunodeficiency virus, or modified human immunodeficiency virus), Newcastle disease virus (NDV), herpes virus (e.g., herpes simplex virus), alphavirus, vaccina virus, etc.), a plasmid, or other vector (e.g., non-viral vectors, such as lipoplexes, liposomes, polymerosomes, or nanoparticles).
[00476] In some aspects the artificial gene construct is an RNA molecule modified to enable cellular uptake. In another aspect, the artificial gene construct is an RNA molecule containing pseudouridine or other modified/artificial nucleotides for enhanced cellular uptake and gene expression.
[00477] The use of an artificial gene construct described herein in gene therapy allows one to regulate the amount or type of a functional protein produced from the construct depending on whether or not a compound described herein is present. The compound is essentially a tunable switch that, depending on the amount and duration of the dose of the compound, regulates the amount or type of functional protein produced.
[00478] In another aspect, an RNA transcript transcribed from an artificial gene construct that is DNA would not produce or produce substantially less functional protein in the absence of a compound described herein than the amount or type of functional protein produced in the presence of a compound described herein. For example, if the artificial gene construct comprises a nucleotide sequence encoding a REMS in a 5’ splice site, which is upstream of a nucleotide sequence encoding a 3’ splice site, then less splicing would occur in the absence of the compound and this would result in exon skipping which would ultimately result in less
functional protein being produced. For the purposes of illustration only, in various examples if there is a pre-mRNA for a given protein containing a REMS-controlled exon which exhibits exon inclusion upon treatment with a compound described herein, in the absence of the compound an exon-skipped mRNA may be produced which cannot be translated into full length, functional protein. However, in the presence of a compound described herein in said illustrative example, a full length, functional protein may be produced. For the purposes of illustration only, in various examples if there is a pre-mRNA for a given protein containing a REMS-controlled exon which exhibits exon skipping upon treatment with a compound described herein, in the absence of the compound an exon-included mRNA may be produced which cannot be translated into full length, functional protein. However, in the presence of a compound described herein in said illustrative example, a full length, functional protein may be produced. In another aspect, an RNA transcript transcribed from an artificial gene construct that is DNA would not produce or would produce substantially less functional protein in the presence of a compound described herein than the amount or type of functional protein produced in the absence of a compound described herein. For example, if the artificial gene construct comprises a nucleotide sequence encoding a REMS in the middle of an exon, then ectopic splicing would occur in the presence of a compound described herein and this would result in reduction in the production of the functional protein. However, in the absence of a compound described herein, the normal splicing would occur, and the production of the functional protein will not be reduced. Either way, the amount or type of the functional protein produced can be titrated based on the amount of a compound used and duration of exposure to the compound.
[00479] In another aspect, an artificial gene construct or vector comprising an artificial gene construct is used in cell culture. For example, in a cell(s) transfected with an artificial gene construct or transduced with a vector comprising an artificial gene construct, the amount or type of a functional protein produced from the artificial gene construct can be altered depending upon whether or not a compound described herein is contacted with the transfected cell(s). For example, if the artificial gene construct comprises a nucleotide sequence encoding a REMS in a 5’ splice site, which is upstream of a nucleotide sequence encoding a 3’ splice site, then less splicing would occur in the absence of the compound and this would result in exon skipping which would ultimately result in less functional protein being produced. Thus, the use of an
artificial gene construct described herein allows one to regulate the amount or type of a functional protein produced from the construct depending on whether or not a compound described herein is present. In other words, a compound described herein is essentially a switch that regulates the amount or type of functional protein produced. This regulation of the production of functional protein could be useful, e.g., when trying to assess the role of certain genes or the effects of certain agents on pathways. The amount or type of the functional protein produced can be modified based on the amount of a compound described herein that is contacted with the transfected cell and/or how long the compound is contacted with the transfected cell. [00480] In another aspect, an animal (e.g., a non-human animal, such as a mouse, rat, fly, etc.) is engineered to contain an artificial gene construct or a vector comprising an artificial gene construct. Techniques known to one of skill in the art may be used to engineer such animals.
The amount or type of functional protein produced by this engineered animal can be regulated by whether or not a compound described herein is administered to the animal. The amount or type of the functional protein produced can be titrated based on the dose and/or the duration of administration of a compound described herein to the engineered animal. In another aspect, the artificial gene construct encodes a detectable reporter gene, such as green fluorescent protein (GFP), yellow fluorescent protein (YFP), red fluorescent protein, beta galactosidase, renilla luciferase, firefly luciferase, etc. In accordance with this aspect, the engineered animal may be used to monitor development at different stages, visualize tissue function, etc. In accordance with this aspect, the engineered animal may be used to monitor development at different stages or in functional biological studies where a certain protein or protein isoform needs to be expressed only for a period of time and not constitutively, etc. In another aspect, an artificial gene construct or a vector comprising an artificial gene construct are used in gene therapy.
GENE THERAPY
[00481] In another aspect, described herein are artificial gene constructs or vectors comprising an artificial gene construct for use in gene therapy. The use of an artificial gene construct described herein in gene therapy allows one to regulate the amount or type of a functional protein produced from the construct depending on whether or not a compound described herein is
present. The compound is essentially a switch that regulates the amount or type of functional protein produced.
[00482] In another aspect, an RNA transcript transcribed from an artificial gene construct that is DNA would not produce or produce substantially less functional protein in the absence of a compound described herein than the amount or type of functional protein produced in the presence of a compound described herein. For example, if the artificial gene construct comprises a nucleotide sequence encoding a REMS in a 5’ splice site, which is upstream of a nucleotide sequence encoding a 3’ splice site, then less splicing would occur in the absence of the compound and this would result in exon skipping which would ultimately result in less functional protein being produced. In an example for illustration only, if there is an pre-mRNA containing a REMS-controlled exon exhibiting inclusion, then in the absence of a compound described herein an exon-skipped mRNA may be produced which cannot be translated into full length, functional protein. However, in the presence of a compound described herein in such illustrative example, a full length, functional protein may be produced. The amount or type of the functional protein produced can be titrated based on dose and duration of dosing of the compound. In this illustrative example, the protein can be turned on and off depending upon whether the compound is present, which may be beneficial for a subject to maintain muscle health. Thus, the use of an artificial gene construct or a vector comprising an artificial gene construct is useful may be useful in treating and/or preventing certain conditions or diseases associated with one or more genes listed in Tables Zl-9. The conditions or diseases may include those described herein. In another aspect, an RNA transcript transcribed from an artificial gene construct that is DNA would not produce or would produce substantially less functional protein in the presence of a compound described herein than the amount or type of functional protein produced in the absence of a compound described herein. For example, if the artificial gene construct comprises a nucleotide sequence encoding a REMS in the middle of an exon, then ectopic splicing would occur in the presence of a compound described herein and this would result in reduction in the production of the functional protein. However, in the absence of a compound described herein, the normal splicing would occur, and the production of the functional protein will not be reduced. The amount or type of the functional protein produced can be titrated based on dose and duration of dosing of the compound.
[00483] An artificial gene construct, a vector comprising the artificial gene construct, or an RNA molecule comprising an artificial gene construct modified to enable cellular uptake may be introduced into cells or administered directly to subjects. In one aspect, an artificial gene construct or a vector comprising the artificial gene construct is introduced into cells ex vivo or in vivo. In a specific aspect, an artificial gene construct or vector is introduced into a cell(s) ex vivo and the cell(s) may be administered to a subject Various techniques known to one of skill in the art may be used to introduce an artificial gene construct or vector comprising the artificial gene construct into a cell(s), such as electroporation, transfection, transformation, etc. In another aspect, an artificial gene construct or vector comprising the artificial gene construct is administered to a subject. The artificial gene construct or vector comprising the artificial gene construct may be administered to a subject by any technique known to one skilled in the art, e.g., intramuscularly, intravenously, subcutaneously, intradermally, topically, intrathecally, intraperitoneally, intratumorally, etc. In another aspect, the artificial gene construct or vector comprising the artificial gene construct is administered to a subject systemically. In another aspect, the artificial gene construct or vector comprising the artificial gene construct is administered to a subject locally.
ALTERING ENDOGENOUS GENES
[00484] In another aspect, described herein are method for altering an endogenous gene such that it contains a nucleotide sequence encoding a REMS, or contains an additional nucleotide sequence encoding a REMS (in other words, a REMS not naturally found in the endogenous gene, i.e., a non-endogenous REMS). Techniques known to one of skill in the art can be used to introduce a REMS into an endogenous gene, e.g., the CRISPR-Cas approach, TALEN, or ZFN may be used. In another aspect, a nucleotide sequence encoding an existing 5’ splice site can be replaced with a REMS or a REMS may be inserted internally within an exon. In introducing a nucleotide sequence encoding a REMS into an endogenous gene, care should be taken so as not to disrupt an open reading frame or introduce a stop codon. The introduction of a nucleotide sequence encoding a REMS into an endogenous gene may or may not result in an amino acid change at the protein level. In another aspect, the introduction of a nucleotide sequence encoding a REMS into an endogenous gene results in an amino acid change at the protein level.
In another aspect, this amino acid change is a conservative amino acid substitution. In another aspect, the introduction of a nucleotide sequence encoding a REMS into an endogenous gene does not result in an amino acid change at the protein level.
KITS
[00485] In one aspect, described herein are kits comprising, in a container, an artificial gene construct or a vector comprising an artificial construct. In another aspect, the kits further comprise a compound described herein, in a separate container, and/or a negative control, such as phosphate buffered saline or a compound that does not recognize REMS, in a separate container. In another aspect, the kits further comprise primers and/or antibodies, in one or more separate containers, for assessing the production of an mRNA transcript from an artificial gene construct and/or protein production therefrom.
[00486] In another aspect, described herein are kits comprising, in one or more containers, the components and/or reagents necessary to produce an artificial gene construct and/or a vector comprising an artificial gene construct. In another aspect, described herein are kits comprising, in one or more containers, the components and/or reagents necessary to alter an endogenous gene so that it contains a nucleotide sequence encoding a REMS or an additional nucleotide sequence encoding a REMS (in other words, a REMS not naturally found in the endogenous gene, i.e., a non-endogenous REMS). In another aspect, the kits further comprise primers and/or antibodies, in one or more separate containers, for assessing the production of an mRNA transcript from altered endogenous gene and/or protein production therefrom.
[00487] In another aspect, described herein are kits comprising, in a container, a compound described herein, and instructions for use. In another aspect, the kits further comprise a negative control, such as phosphate buffered saline or a compound that does not recognize a REMS, in a separate container.
EXPERIMENTAL EXAMPLES
[00488] To describe in more detail and assist in understanding the present description, the following non-limiting biological examples are offered to more fully illustrate the scope of the description and are not to be construed as specifically limiting the scope thereof. Various
examples below illustrate the existence of a recognition element for splicing modifier (REMS) that can recognize a compound described herein, and the binding of such a compound to the REMS on a pre-mRNA permits or enhances splicing and/or expression of the pre-mRNA, and suggests the usefulness of the REMS in combination with a compound described herein for modulating RNA splicing, and for modulating the type and amount of a gene product.
MATERIALS AND METHODS
Test Compounds
[00489] Various compounds according to Formula (I) were selected for RNA seq analysis.
The following test compounds were obtained and prepared according to synthetic approaches described in WO/2020/ 167628.
Compound treatment, RNA-seq library preparation and sequencing
[00491] Cells were plated and incubated for 4 hours in a cell culture incubator (37 °C, 5% CO2, 100% relative humidity). Cells were then treated with a test compound at a given concentration (in 0.1% DMSO), or vehicle control (DMSO) for 24 hours. The following cell lines were tested: familial dysautonomia (FD) patient fibroblast, HEK293, stimulated peripheral blood mononuclear cell (PBMC), differentiated SHSY5Y (diffSY5Y), SHSY5Y, M0LM13, and HT1080.
[00492] Total RNA was used for stranded RNA library preparation and sequencing. mRNA was enriched using oligo(dT) beads and then fragmented randomly by adding fragmentation buffer, and then cDNA was synthesized by mRNA templating and using random hexamer primer, after which a second-strand synthesis buffer (Illumina) , dNTPs, RNase H, and DNA polymerase I were added to initiate the second-strand synthesis. After a series of terminal repair, A-ligation, and sequencing adaptor ligation, the double-stranded cDNA library was completed through size selection and PCR enrichment. RNA libraries were sequenced in a HiSeq sequencer or a NovaSeq sequencer, each available from Illumina, Inc. (San Diego, CA).
RNA-seq Splicing Analysis
[00493] The reads were mapped to human genome (hgl9) using STAR (version 2.5.1, Dobin 2013). Only uniquely mapped reads (with mapping quality score or MAPQ >10) with <5nt/100nt mismatches and properly paired reads were used.
Analysis of Exon Inclusion and Exon Skipping
[00494] For splicing analysis, reads were counted for different exons. For each exon, a Percent- Spliced-In (PSI) value was calculated using the percent of average read number supporting the inclusion of the exon (include both the upstream and downstream junctions) among all reads supporting either the inclusion or the skipping of an exon. A cutoff was set at 20 for the denominator of PSI calculation. PSI values for biological replicates were averaged and the PSI difference between two treatment groups (eg. +compound vs. control) was calculated. For statistical analysis, a 2x2 read counts table was made for each exon and Fisher’s Exact Test was applied. Rows were analyzed for inclusion or skipping and columns were used to compare sample groups. For /’-values of biological replicates, all pairs of test and control samples were compared and the final E-value calculated was the geometric mean of all /^-values from each pair. PSI change (APSI) and statistical E- value were used together to identify genes, exons, and splice sights, that exhibited exon inclusion (Inc) or exon skipping (Skp) upon treatment with a compound of Formula (I).
[00495] Table 8 identifies genes that exhibited a PSI change (APSI) of 10% to 100% (inclusion) and aE-value <0.001, or -10% to -100% (skipping) and a P-value <0.001, upon treatment with a test compound.
[00496] Table 9 identifies 5’ splice sites that are in genes that exhibited a PSI change (APSI) of 10% to 100% (inclusion) and a P-value <0.001, or -10% to -100% (skipping) and aP- value <0.001, upon treatment with a test compound.
[00497] Table 10 identifies genes that exhibited a PSI change (APSI) of 10% to 100% (inclusion) and a E- value <0.001 upon treatment with a test compound.
[00498] Table 11 identifies 5’ splice sites that are in genes that exhibited a PSI change (APSI) of 10% to 100% (inclusion) and a P-value <0.001 upon treatment with a test ompound.
[00499] Table 12 identifies genes that exhibited a PSI change (APSI) of -10% to -100% (skipping) and a T’-value <0.001, upon treatment with a test compound.
[00500] Table 13 identifies 5’ splice sites that are in genes that exhibited a PSI change (APSI) of -10% to -100% (skipping) and a T’-value <0.001, upon treatment with a test compound. [00501] Table 14 identifies genes that exhibited a PSI change (APSI) of +50% to +100% (inclusion) and a T’-value <0.001, or -50% to -100% (skipping) and T’-value <0.001, upon treatment with a test compound.
[00502] Table 15 identifies 5’ splice sites that are in genes that exhibited a PSI change (APSI) of +50% to +100% (inclusion) and a T’-value <0.001, or -50% to -100% (skipping) and T’- value <0.001, upon treatment with a test compound.
[00503] Further tables, discussed below, show results that were obtained for specific test compounds and having a PSI change (APSI) of +50% to +100% (inclusion) and a T’-value <0.001, or -50% to -100% (skipping) and T’-value <0.001. See, Tables 19-92.
[00504] Such results demonstrate that the compounds of the present disclosure can be used to modulate RNA expression, including the type of expression and the resulting isoforms thereby expressed.
Annotation of Estimated Consequence of Splicing Events
[00505] The regulated exon were annotated with the estimated consequence of the splicing event based on the following: 1), the splicing-induced change results in modulation of resulting protein isoform but no decay effect on the mRNA (annotated as “Protein Isoform”), which is determined based on an exon size dividable by 3 and containing no stop codon in-frame with the upstream annotated exon; 2), the splicing-induced change results in inclusion of an exon causing non-sense mediated decay of the mRNA (annotated as “NMD”), which is determined based on (a) an exon with basal (DMSO treatment condition) PSI level <10% and the exon is not dividable by 3 and so is expected to cause frameshift when included, or (b) the exon contains at least one stop codon in-frame with the upstream annotated exon; 3) the splicing-induced change results in skipping of an exon causing non-sense mediated decay of mRNA (annotated as “NMD”), which is determined based on an skipped exon that is not dividable by 3 and so is expected to cause frameshift when included. All other exons were annotated as “unknown”.
[00506] An effect of a compound described herein has been demonstrated to induce exon inclusion or skipping events that may cause a shift in the Open Reading Frame (i.e., a “frameshift”), thus creating a premature stop codon and resulting in nonsense mediated decay of the mRNA.
[00507] Such results further demonstrate that the compounds of the present disclosure will impart a functional effect, for example, in terms of resulting isoforms, decay effects, and thus subsequent downstream effects on functional protein encoded by the subject gene sequences.
Gene Expression Analysis
[00508] For gene expression analysis, the number of read in the coding sequence (CDS) region of protein-coding genes and exonic region of non-coding genes were counted and analyzed using DESeq2 (Love 2014).
[00509] The results provided in Table 16 show gene expression analysis for those genes having an exon with a PSI change (APSI) of + 10% to +100% and /’-value <0.001, or -10% to - 100% and /’-value <0.00, together with a log2 fold change (L2FC) in gene expression of 1.0 and above, or -1.0 and below.
[00510] The results provided in Table 17 show gene expression analysis for those genes having an exon with a PSI change (APSI) of +50% to +100% and /’-value <0.001, or -50% to - 100% and /’-value <0.00, together with a log2 fold change (L2FC) in gene expression of 1.0 and above, or -1.0 and below.
Results and Discussion
Splicing modification of genes by a compound of Formula (I)
Genes exhibiting APSI >+10 and <-10
[00511] RNAseq experiments showed that compounds of Formula (I) induced exon inclusion with a PSI change (APSI) of +10% to +100% and /’-value <0.001 or induced exon skipping with a APSI of -10% to -100% and T’-value <0.001 in 8224 genes as shown in Table 8:
[00512] Table 8
ABCD2, ABCD3, ABCD4, ABCE1, ABCF2, ABCF3, ABHD10, ABHD11, ABHD12, ABHD I4A, ABHD14A-ACY1, ABHD18, ABHD2, ABHD3, ABHD5, ABHD6, ABH, ABI2, ABI3BP, ABL1, ABL2, ABLIMI, ABR, ABRAXAS1, ABRAXAS2, ACAA1, ACACA, ACACB, ACAD1O, ACAD11, ACAD8, ACAD9, ACADM, ACADS, ACADVL, ACAP2, ACAP3, ACAT1, ACBD3, ACBD5, ACBD6, ACCS, ACD, ACER3, ACINI, ACLY, ACO1, ACO2, ACOT11, ACOT2, ACOT8, ACOT9, ACOX1, ACOX3, ACPI, ACP6, ACSF2, ACSF3, ACSL1, ACSL3, ACSL4, ACSS2, ACSS3, ACTA2, ACTL6B, ACTN1, ACTN4, ACTR10, ACTR1A, ACTR1B, ACTR3, ACTR3B, ACTR3C, ACTR6, ACTR8, ACVR1, ACVR1B, ACVR2A, ACVRL1, ACY1, ACYP1, ACYP2, ADA, AD AL, ADAM10, ADAMI 1, ADAM 15, ADAM 17, ADAM 19, ADAM22, ADAM23, ADAM9, ADAMTS12, ADAMTS14, ADAMTS17, ADAMTS19, ADAMTS2, ADAMTS4, ADAMTS6, ADAMTS7, ADAMTS9, ADAMTS9-AS2, ADAMTSL1, ADAMTSL4, ADAMTSL5, AD API, ADAP2, ADAR, AD ARBI, ADAT1, ADAT2, ADCK1, ADCK2, ADCK5, ADCY1, ADCY3, ADCY6, ADCY7, ADCYAP1R1, ADD1, ADD2, ADD3, ADGRA2, ADGRA3, ADGRB1, ADGRB2, ADGRD1, ADGRE2, ADGRE5, ADGRG2, ADGRG5, ADGRL1, ADGRL2, ADGRL3, ADGRV1, AD1POR2, ADK, ADM5, ADNP, ADPGK, ADPRH, ADRM1, ADSL, AFAP1, AFAP1L1, AFDN, AFF1, AFF3, AFF4, AFG1L, AFG3L1P, AFG3L2, AFMID, AGA, AGAP1, AGAP3, AGAP6, AGAP9, AGBL3, AGBL4, AGFG2, AGGF1, AGK, AGL, AGO2, AGO3, AGO4, AGPAT3, AGPAT4, AGPAT5, AGPS, AGRN, AGTPBP1, AGTR1, AGTRAP, AHCTF1, AHCYL2, AHDC1, AHI1, AHNAK, AHRR, AHSA2P, AIDA, AIFM1, AIFM2, AIG1, AIMP1, AIMP2, AIP, AK2, AK3, AK4, AK8, AK9, AKAP1, AKAP10, AKAP11, AKAP12, AKAP13, AKAP2, AKAP6, AKAP7, AKAP8, AKAP9, AKIP1, AKNA, AKR1A1, AKR1E2, AKR7A2, AKT1, AKT1S1, AKT2, AKT3, AKTIP, ALAD, ALAS1, ALCAM, ALDH16A1, ALDH18A1, ALDH1L2, ALDH2, ALDH3A2, ALDH3B1, ALDH4A1, ALDH5A1, ALDH7A1, ALDOA, ALDOC, ALG1, ALG11, ALG13, ALG14, ALG1L, ALG2, ALG3, ALG5, ALG8, ALG9, ALL, ALKAL2, ALKBH1, ALKBH2, ALKBH3, ALKBH5, ALKBH6, ALKBH8, ALLC, ALMS1, ALOX12-AS1, ALPK1, ALPK2, ALS2, AMACR, AMBRA1, AMDHD2, AMHR2, AMMECR1, AMMECR1L, AMN1, AMOT, AMOTL1, AMPD2, AMPH, AMT, AMY2B, AMZ2, AMZ2P1, ANAPC1, ANAPC10, ANAPC15, ANAPC4, ANAPC7, ANGEL1, ANGEL2, ANGPT1, ANK2, ANK3, ANKEF1, ANKFY1, ANKH, ANKHD1, ANKHD1-EIF4EBP3, ANKIB1, ANKLE2, ANKMY1, ANKMY2, ANKRA2, ANKRD10, ANKRD11, ANKRD12, ANKRD13A, ANKRD13C, ANKRD13D, ANKRD17, ANKRD26, ANKRD27, ANKRD28, ANKRD33B, ANKRD35, ANKRD36, ANKRD37, ANKRD39, ANKRD44, ANKRD45, ANKRD46, ANKRD49, ANKRD54, ANKRD6, ANKS1A, ANKS3, ANKS6, ANKZF1, ANLN, ANOIO, ANO4, ANO5, ANO6, ANO8, ANP32A, ANXA11, ANXA2, ANXA4, ANXA6, ANXA7, AOAH, AOX1, AP1AR, AP1B1, AP1G1, AP1M1, AP1S2, AP1S3, AP2A1, AP2A2, AP2B1, AP2M1, AP3B1, AP3B2, AP3D1, AP3M1, AP3M2, AP3S1, AP3S2, AP4B1, AP4E1, AP4M1, AP5M1, AP5S1, APAF1, APBA1, APBA2, APBA3, APBB2, APC, APCDD1L-AS1, APEH, APEX2, APH1A, APH1B, API5, APIP, APLP1, APLP2, APOBEC3D, APOBEC3F, APOBEC3H, APOCI, APOL1, APOL2, APOL3, APOLD1, APOO, APOOL, APOPT 1, APP, APPBP2, APPL1, APPL2, APTR, APTX, AQR, ARAF, ARAP1, ARAP2, ARCN1, AREL1, ARFGAP1, ARFGAP2, ARFGAP3, ARFGEF1, ARFGEF2, ARFIP1, ARFIP2, ARFRP1, ARHGAP1, ARHGAP10, ARHGAP11A, ARHGAP12, ARHGAP17, ARHGAP19, ARHGAP19-SLIT1, ARHGAP21, ARHGAP22, ARHGAP23, ARHGAP24, ARHGAP26, ARHGAP27P1, ARHGAP27P1-BPTFP1-KPNA2P3, ARHGAP28, ARHGAP29, ARHGAP30,
ARHGAP31, ARHGAP32, ARHGAP33, ARHGAP36, ARHGAP39, ARHGAP42, ARHGAP45, ARHGAP5, ARHGAP8, ARHGDIA, ARHGEF1, ARHGEF10, ARHGEF1OL, ARHGEF11, ARHGEF12, ARHGEF18, ARHGEF2, ARHGEF25, ARHGEF26, ARHGEF28, ARHGEF3, ARHGEF33, ARHGEF39, ARHGEF4, ARHGEF40, ARHGEF6, ARHGEF7, ARHGEF9, ARID1B, ARID2, ARID4A, ARID4B, ARID5A, ARID5B, ARIHI, ARIH2, ARL13B, ARL14EP, ARL15, ARL16, ARL17A, ARL17B, ARL2, ARL2-SNX15, ARL3, ARL5B, ARL6, ARL6IP6, ARL8A, ARMCI, ARMC10, ARMC2, ARMC4, ARMC4P1, ARMC6, ARMC7, ARMC8, ARMC9, ARMCX1, ARMCX2, ARMCX3, ARMCX5, ARMCX5- GPRASP2, ARMCX6, ARMH1, ARMH3, ARMT1, ARNT, ARNT2, ARNTL, ARNTL2, ARPC3, ARPC5L, ARRB1, ARRB2, ARRDC1, ARRDC2, ARRDC3, ARSB, ARSD, ARSJ, ARSK, ART5, ARV1, ARVCF, AS3MT, ASAH2B, ASAP1, ASAP2, ASAP3, ASB1, ASB13, ASB16-AS1, ASB3, ASB6, ASCC1, ASCC2, ASCC3, ASDURF, ASH1L, ASH2L, ASIC1, ASIC3, ASL, ASNS, ASNSD1, ASPDH, ASPH, ASPM, ASPSCR1, ASTE1, ASTN2, ASXL1, ASXL3, ATAD1, ATAD2, ATAD2B, ATAD3A, ATAD3B, ATAD5, ATCAY, ATE1, ATE1- AS1, ATF2, ATF6, ATF7, ATF7IP2, ATG1O, ATG13, ATG16L1, ATG16L2, ATG2B, ATG3, ATG4A, ATG4B, ATG4C, ATG4D, ATG5, ATG7, ATG9A, ATL1, ATL2, ATL3, ATM, ATN1, ATOX1, ATP10A, ATP1OD, ATP11A, ATP11B, ATP11C, ATP13A2, ATP13A3, ATP1A1-AS1, ATP1B3, ATP23, ATP2A3, ATP2B1, ATP2B4, ATP2C1, ATP5F1C, ATP5ME, ATP5MF, ATP5MF-PTCD1, ATP5PB, ATP5PD, ATP5PF, ATP5PO, ATP5S, ATP6AP1L, ATP6V0A1, ATP6V0A2, ATP6V0C, ATP6V0D1, ATP6V0E1, ATP6V1A, ATP6V1C2, ATP6V1D, ATP6V1E1, ATP6V1H, ATP7A, ATP7B, ATP8B4, ATP9A, ATP9B, ATPAF1, ATPAF2, ATR, ATRIP, ATRIP-TREX1, ATRN, ATRNL1, ATRX, ATXN1, ATXN10, ATXN1L, ATXN2, ATXN2L, ATXN3, ATXN7, ATXN7L1, ATXN7L2, ATXN7L3, AUH, AUP1, AURKA, AURKB, AUTS2, AVEN, AVL9, AXIN1, AZI2, AZINI, AZIN1-AS1, AZIN2, B2M, B3GALNT1, B3GALNT2, B3GLCT, B3GNTL1, B4GALNT1, B4GALNT4, B4GALT4, B4GALT5, B4GALT6, B4GALT7, B9D1, B9D2, BAALC, BAB AMI, BABAM2, BACE1, BACH1, BACH2, BAG4, BAHCC1, BAIAP2, BAIAP2L1, BAK1, BANP, BAP1, BARD1, BARX2, BAX, BAZ1A, BAZ1B, BAZ2A, BAZ2B, BBC3, BBIP1, BBOF1, BBOX1- AS1, BBS4, BBS5, BBS9, BBX, BCAR1, BCAR3, BCAS3, BCAS4, BCAT1, BCAT2, BCCIP, BCHE, BCKDHB, BCL11A, BCL2, BCL2L1, BCL2L11, BCL2L12, BCL2L13, BCL2L2- PABPN1, BCL7A, BCL7B, BCL7C, BCL9, BCL9L, BCLAF1, BCLAF3, BCOR, BCORL1, BCRP2, BCS1L, BDH1, BDH2, BDKRB2, BDNF-AS, BDP1, BEAN1, BECN1, BEGAIN, BEND5, BEND6, BEND7, BEX4, BFAR, BFSP1, BICC1, BICD1, BICDL1, BICRA, BICRAL, BID, BINI, BIN3, BIRC2, BIRC5, BIRC6, BISPR, BIVM, BIVM-ERCC5, BLM, BLMH, BLNK, BEOC1S5, BLOC1S5-TXNDC5, BLOC1S6, BLVRA, BLZF1, BMF, BMP2, BMP2K, BMP7, BMPR1B, BMPR2, BMS1P14, BMS1P20, BNC2, BNIP1, BNIP2, BOC, BOD1, BOD1L1, BOK, BOLA1, BOLA2, BOLA2-SMG1P6, BOLA2B, BOLA3, BOP1, BORA, BORCS8, BORCS8-MEF2B, BPNT1, BPTF, BRAE, BRAP, BRAT1, BRCA1, BRCA2, BRCC3, BRD1, BRD3, BRD7, BRD8, BRF1, BRF2, BRINP3, BRIP1, BRMS1L, BROX, BRPF1, BRPF3, BRSK2, BRWD1, BRWD3, BSCL2, BSDC1, BSPRY, BTAF1, BTBD19, BTBD2, BTBD3, BTBD7, BTBD9, BTD, BTF3L4, BTG3, BTK, BTLA, BTN2A1, BTN3A2, BTN3A3, BTNL9, BTRC, BUB1, BUD13, BUD23, BVES-AS1, BZW2, C10orfl43, Cllorfl, Cllorf24, Cl lorf49, Cl lorf54, Cllorf65, Cllorf74, Cllorf80, Cllorf95, C12orfl0, C12orf29, C12orf4, C12orf49, C12orf73, C12orf75, C12orf76, C14orfl44, C14orD9, C14orf93, C15orfi8- AP3S2, C15orf40, C15orf41, C16orf45, C16orf46, C16orf58, C16orf74, C16orf87, C17orf49,
C17orf75, C17orf80, C18orf21, C18orf54, C19orfl2, C19orf24, C19orf25, C19orf44, C19orf47, C19orf48, C19orf54, C19orf57, CID, C1GALT1, C1QTNF2, C1QTNF3-AMACR, C1QTNF6, Clorfl09, Clorfl l2, Clorfl23, Clorfl31, Clorfl59, Clorf21, Clorf35, Clorf43, Clorf50, Clorf52, Clorf54, C20orfl94, C20orfl96, C20orfl97, C20orf27, C20orf96, C21orf33, C21orf59-TCP10L, C21orf91, C22orf39, C2CD2L, C2CD3, C2CD5, C2orfl5, C2orf27A, C2orf42, C2orf48, C2orf74, C2orf76, C3orfl8, C3orf33, C3orf52, C3orf62, C3orf67, C4orf33, C5, C5AR1, C5orf22, C5orf30, C5orf42, C5orf51, C5orf63, C5orf66, C6orfl06, C6orf203, C6orf62, C6orf89, C6orf99, C7orf26, C7orf31, C7orf50, C7orf55-LUC7L2, C8orf31, C8orfi4, C8orf37, C8orf44, C8orf44-SGK3, C8orf58, C8orf59, C8orf88, C9orf3, C9orf78, C9orf85, CAM, CA5B, CA5BP1, CAAP1, CAB39, CAB39L, CABIN1, CAB YR, CACFD1, CACNA1A, CACNA1C, CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, CACNB1, CACNB3, CACNB4, CACNG7, CAD, CADM2, CADM4, CADPS2, CALC0C01, CALCRL, CALD1, CALHM1, CALHM2, CALML4, CALU, CAMK1, CAMKID, CAMK2A, CAMK2D, CAMK2G, CAMK4, CAMKK1, CAMKK2, CAMKMT, CAMLG, CAMSAP 1, CAMSAP2, CAMSAP3, CAMTAI, CAMTA2, CANT1, CAP2, CAPN1, CAPN10, CAPN15, CAPN7, CAPRIN2, CAPS2, CARD11, CARD19, CARD6, CARD8, CARF, CARMI, CARM1L2, CARNS1, CARS, CARS2, CASC3, CASC4, CASD1, CASK, CASKIN1, CASP1, CASP10, CASP2, CASP3, CASP7, CASP8, CASP8AP2, CASP9, CAST, CASTOR1, CASTOR3, CATSPER1, CATSPER3, CATSPERZ, CAVIN4, CBFA2T2, CBFA2T3, CBFB, CBL, CBLB, CBLL1, CBR4, CBS, CBWD1, CBWD2, CBWD3, CBWD6, CBX2, CBX4, CBX5, CBY1, CC2D2A, CCAR1, CCAR2, CCDC102B, CCDC106, CCDC112, CCDC115, CCDC125, CCDC126, CCDC127, CCDC130, CCDC134, CCDC136, CCDC137, CCDC138, CCDCU, CCDCM4NL-AS1, CCDCM9, CCDC150, CCDC152, CCDC159, CCDC163, CCDC169, CCDC169-SOHLH2, CCDC171, CCDC18, CCDC18-AS1, CCDC181, CCDC183, CCDC183- AS1, CCDC186, CCDC188, CCDC189, CCDC191, CCDC192, CCDC25, CCDC26, CCDC28B, CCDC32, CCDC36, CCDC40, CCDC43, CCDC57, CCDC58, CCDC61, CCDC66, CCDC7, CCDC74B, CCDC77, CCDC78, CCDC82, CCDC84, CCDC85A, CCDC85C, CCDC88A, CCDC88C, CCDC9, CCDC90B, CCDC91, CCDC92, CCDC93, CCL4L1, CCL4L2, CCM2, CCNB1, CCNC, CCND3, CCNDBP1, CCNE2, CCNF, CCNI, CCNJ, CCNJL, CCNK, CCNL1, CCNL2, CCNQ, CCNT1, CCNT2, CCNY, CCNYL1, CCNYL2, CCP110, CCR6, CCSER1, CCSER2, CCT3, CCT6A, CCT6P1, CCZ1P-OR7E38P, CD109, CD151, CD164, CD200, CD22, CD226, CD24, CD244, CD27-AS1, CD276, CD2AP, CD300LF, CD320, CD33, CD36, CD3D, CD40, CD44, CD46, CD47, CD53, CD55, CD58, CD59, CD68, CD70, CD8B, CD99L2, CDADC1, CDC123, CDCMA, CDCMB, CDC16, CDC23, CDC25A, CDC25B, CDC25C, CDC27, CDC40, CDC42, CDC42BPA, CDC42BPB, CDC42SE1, CDC42SE2, CDC45, CDC5L, CDC6, CDC7, CDCA3, CDCA4, CDCA7, CDCA7L, CDH23, CDH24, CDIPT, CDK10, CDK11A, CDK11B, CDKM, CDK15, CDK16, CDK19, CDK2, CDK20, CDK2AP1, CDK5, CDK5RAP1, CDK5RAP2, CDK6, CDK7, CDK8, CDKAL1, CDKL3, CDKN2B-AS1, CDKN3, CDO1, CDON, CDPF1, CDR2, CDRT4, CDS1, CDV3, CDYL, CEACAM1, CEACAM21, CEBPZ, CEBPZOS, CECR2, CELF1, CELF2, CELF3, CELSR2, CELSR3, CENPA, CENPC, CENPE, CENPH, CENPI, CENPK, CENPL, CENPM, CENPN, CENPO, CENPP, CENPQ, CENPS, CENPS-CORT, CENPT, CENPU, CENPV, CENPX, CEP104, CEP112, CEP126, CEP128, CEP131, CEP135, CEP162, CEP164, CEP170, CEP192, CEP250, CEP290, CEP295, CEP35O, CEP41, CEP44, CEP55, CEP57, CEP57L1, CEP63, CEP68, CEP70, CEP72, CEP76, CEP78, CEP83, CEP85, CEP85L, CEP89, CEP95, CEP97, CEPT1,
CERCAM, CERS4, CERS5, CERS6, CES2, CES3, CES4A, CFAP206, CFAP298, CFAP299, CFAP300, CFAP36, CFAP44, CFAP58, CFLAR, CGAS, CGGBP1, CGRRF1, CHAC2, CHAF1A, CHAF1B, CHCHD5, CHCHD6, CHD1, CHD1L, CHD2, CHD3, CHD4, CHD6, CHD8, CHD9, CHEK1, CHEK2, CHFR, CHI3L1, CHID1, CHKA, CHM, CHMP1A, CHMP3, CHMP7, CHN1, CHN2, CHORDCI, CHP1, CHPF2, CHRAC1, CHRM2, CHRNA3, CHRNA5, CHRNB4, CHST10, CHST9, CHSY1, CHTF8, CHTOP, CHURC1, CHURC1-FNTB, CIAO1, CIAPIN1, CIART, CIB2, CIITA, CILP2, CINP, CIP2A, CIPC, CIR1, CIT, CIZ1, CKAP2L, CKAP5, CKLF, CKLF-CMTM1, CKMT1A, CLASP1, CLASP2, CLASRP, CLBA1, CLCC1, CLCN2, CLCN3, CLCN5, CLCN6, CLDN12, CLDNDI, CLECI6A, CLEC2D, CLEC4A, CLEC5A, CLEC7A, CLGN, CLHC1, CLINT1, CLIP1, CLIP2, CLIP3, CLIP4, CLK1, CLK2, CLK3, CLK4, CLMP, CLN3, CLN5, CLN6, CLNS1A, CLOCK, CLPB, CLSPN, CLSTN1, CLSTN3, CLTA, CLTCL1, CLUAP1, CLUHP3, CMAHP, CMAS, CMC1, CMC2, CMC4, CMIP, CMKLR1, CMSS1, CMTM1, CMTM3, CMTM7, CMTM8, CMTR1, CMTR2, CNEP1R1, CNIH1, CNIH2, CNIH3, CNIH4, CNKSR2, CNNM1, CNNM2, CNNM3, CNOT1, CNOTIO, CNOT11, CNOT2, CNOT4, CNOT6, CNOT8, CNOT9, CNPY2, CNPY3, CNPY3- GNMT, CNPY4, CNR2, CNST, CNTFR, CNTLN, CNTN1, CNTN3, CNTN4, CNTNAP1, CNTNAP3, CNTRL, COA1, COASY, COBL, COBLL1, COCH, COG1, COG2, COG3, COG4, COG5, COG6, COIL, COL13A1, COL1A2-AS1, COL23A1, COL24A1, COL25A1, COL26A1, COL27A1, COL4A1, COL4A3BP, COL4A5, COL4A6, COL6A2, COL6A3, COL9A3, COLEC11, COLQ, C0MMD1, COMMDIO, C0MMD2, C0MMD3-BMI1, C0MMD4, C0MMD6, C0MMD9, COMTD1, COP1, COP A, COPB2, COPE, COPG1, COPRS, COPS3, COPS7A, COPS7B, COPS8, COPZ2, COQIOB, COQ2, COQ3, COQ4, COQ5, COQ6, COQ7, COQ8A, COQ8B, COQ9, CORO1B, COROIC, CORO7, CORO7-PAM16, COXIO, COXIO- AS1, COX15, COX16, COX17, COX20, CPB2, CPEB1, CPEB2, CPEB3, CPEB4, CPED1, CPNE1, CPNE2, CPNE3, CPNE5, CPNE7, CPOX, CPPED1, CPQ, CPS1, CPSF1, CPSF2, CPSF4, CPSF6, CPSF7, CPT1A, CPT1C, CPT2, CPVL, CPXM1, CRACR2A, CRACR2B, CRAMP 1, CRAT, CRB1, CRBN, CRCP, CREB1, CREB3L4, CREB5, CREBBP, CREBRF, CREBZF, CRELDI, CRELD2, CREM, CRIM I, CRIP2, CRLS1, CRMPI, CRNDE, CROCC, CROCCP2, CROT, CRTC1, CRTC3, CRYBB2P1, CRYBG3, CRYL1, CRYZ, CRYZL1, CRYZL2P, CRYZL2P-SEC16B, CS, CSAD, CSAG3, CSDE1, CSE1L, CSGALNACT2, CSMD2, CSNK1D, CSNK1G1, CSNK1G3, CSNK2A1, CSNK2A2, CSPP1, CSRNP2, CSRNP3, CSRP3, CSTF2, CSTF3, CTBP1, CTBP2, CTBS, CTCF, CTDNEP1, CTDP1, CTDSP2, CTDSPL, CTDSPL2, CTIF, CTNNA2, CTNNAL1, CTNNBIP1, CTNNBL1, CTNND1, CTNS, CTPS2, CTSA, CTSC, CTSF, CTSL, CTTN, CTTNBP2NL, CTU2, CUBN, CUEDC1, CUL1, CUL3, CUL4B, CUL5, CUL7, CUE9, CUTALP, CUTC, CUX1, CUX2, CWC22, CWC25, CWC27, CWF19L1, CWF19L2, CXADR, CXXC1, CXorf38, CXorf57, CXorf65, CYB561, CYB561D1, CYB561D2, CYB5D2, CYB5R1, CYB5R2, CYB5R4, CYB5RL, CYBA, CYBC1, CYFIP1, CYFIP2, CYLD, CYP20A1, CYP27B1, CYP27C1, CYP2S1, CYP2U1, CYP39A1, CYP4V2, CYREN, CYTH1, CYTH2, CYTH3, CYTOR, CZ1P- ASNS, D2HGDH, DAAM1, DAB2, DAB2IP, DACH1, DAG1, DAGLB, DAP3, DAPK1, DAPK3, DARS, DARS2, DAZAP1, DAZAP2, DBF4, DBF4B, DBH, DBNL, DBR1, DBT, DCAF1, DCAF10, DCAF11, DCAF13, DCAF16, DCAF17, DCAF5, DCAF6, DCAF8, DCAKD, DCBLD1, DCBLD2, DCLK2, DCLRE1C, DCP1A, DCP1B, DCP2, DCPS, DCST1, DCST1-AS1, DCTD, DCTN1, DCTN2, DCTN4, DCTN5, DCUN1D2, DCUN1D4, DCUN1D5, DCXR, DDAH1, DDB2, DDC, DDHD1, DDHD2, DDIAS, DDN, DDR2, DDT, DDX1,
DDX11, DDX12P, DDX17, DDX19A, DDX19B, DDX20, DDX27, DDX31, DDX41, DDX42, DDX46, DDX49, DDX50, DDX52, DDX55, DDX59, DDX60, DDX60L, DEAF1, DECR1, DECR2, DEDD, DEDD2, DEF8, DEK, DELEI, DENND1A, DENND1B, DENND1C, DENND2C, DENND3, DENND4A, DENND4B, DENND4C, DENND5A, DENND5B, DENND6A, DENR, DEPDC1, DEPDC1B, DEPDC5, DEPTOR, DERA, DERL1, DESI1, DESI2, DET1, DEXI, DFFA, DFFB, DGCR2, DGCR5, DGCR6L, DGKA, DGKE, DGKH, DGKI, DGKQ, DGKZ, DGLUCY, DGUOK, DHDDS, DHFR, DHH, DHODH, DHPS, DHRS12, DHRS4, DHRS4L1, DHRS4L2, DHRS7, DHRS7B, DHTKD1, DHX29, DHX30, DHX32, DHX33, DHX34, DHX35, DHX36, DHX37, DHX38, DHX57, DIABLO, DIAPH1, DIAPH2, DIAPH3, DICER1, DICER1-AS1, DIDOI, DIEXF, DIMT1, DIP2A, DIP2B, DIP2C, DIRAS1 , DTRC2, DIRC3, DTS3, DTS3L, DTS3L2, DISCI , DTSP1 , DL AT, DLC1, DLD, DLEU1 , DLEU2, DLEU2L, DLG1, DLG3, DLG4, DLG5, DLGAP4, DLGAP4-AS1, DLGAP5, DLST, DLX1, DMAC2, DMAP1, DMC1, DMD, DMKN, DMPK, DMRTA2, DMTF1, DMTN, DMXL1, DMXL2, DNA2, DNAAF2, DNAAF4, DNAAF4-CCPG1, DNAAF5, DNAH10, DNAH14, DNAJB12, DNAJB14, DNAJB4, DNAJB5, DNAJB6, DNAJC1, DNAIC10, DNAJC13, DNAJC17, DNAJC19, DNAJC2, DNAIC21, DNAJC22, DNAIC24, DNAJC25, DNAJC25-GNG10, DNAJC27-AS1, DNAJC4, DNAJC5, DNAIC6, DNAJC8, DNAL1, DNALI1, DNASE 1L2, DNASE2, DNM1, DNM1L, DNM2, DNM3, DNMBP, DNMT1, DNMT3A, DNMT3B, DNPEP, DNTTIP1, DNTTIP2, DOC2A, DOC2B, DOCK1, DOCK11, DOCK2, DOCK4, DOCK5, DOCK6, DOCK7, DOCK9, DOK1, DOK2, DOK3, DOK6, DOLPP1, DONSON, DOPEY1, DOT1L, DPCD, DPF1, DPF3, DPH1, DPH2, DPH3, DPH5, DPH6, DPH7, DPMI, DPP4, DPP7, DPP8, DPP9, DPY19L1, DPY19L2, DPY19L2P1, DPY19L3, DPY19L4, DPY30, DPYD, DPYSL2, DPYSL3, DPYSL4, DPYSL5, DQX1, DRAM1, DRAM2, DRG2, DRGX, DROSHA, DSCC1, DSE, DSN1, DSP, DST, DSTYK, DTD2, DTL, DTNA, DTNB, DTNBP1, DTWD1, DTX2, DTX2P1-UPK3BP1-PMS2P11, DTYMK, DUBR, DUS1L, DUS2, DUS4L, DUSP11, DUSP16, DUSP22, DUXAP10, DUXAP8, DVL1, DVL3, DYM, DYNC1H1, DYNC1I2, DYNC1LI1, DYNC1LI2, DYNC2H1, DYNC2LI1, DYNLRB1, DYRK1A, DYRK2, DYRK3, DYRK4, DYSF, DZIP1, DZIP1L, DZIP3, E2F3, E2F6, E2F7, E4F1, EAF1, EBAG9, EBF1, EBF3, EBF4, EBLN3P, EBP, EBPL, ECHDC1, ECHDC2, ECU, ECI2, ECM1, ECSIT, ECT2, EDA2R, EDC3, EDEM2, EDEM3, EDIL3, EDRF1, EEA1, EED, EEF1AKMT1, EEF1AKMT2, EEF1D, EEF1E1-BLOC1S5, EEF2K, EEF2KMT, EEFSEC, EFCAB11, EFCAB13, EFCAB14, EFCAB2, EFCAB5, EFCAB7, EFEMP1, EFHD2, EFL1, EFNA1, EFNA3, EFNA4, EFNA5, EFNB3, EFR3A, EFS, EFTUD2, EGFL7, EGLN1, EHBP1, EHBP1L1, EHHADH, EHMT1, EI24, EIF1AD, EIF1AX, EIF2A, EIF2AK1, EIF2AK2, EIF2AK4, EIF2B3, EIF2B5, EIF2D, E1F2S2, EIF2S3, EIF3C, EIF3CL, EIF3H, EIF3I, EIF3J, EIF3K, EIF3M, EIF4A2, EIF4B, EIF4E, EIF4E2, EIF4E3, EIF4G1, EIF4G3, EIF4H, EIF6, EIPR1, ELAC2, ELAVL1, ELAVL2, ELAVL4, ELF2, ELF4, ELFN2, ELK1, ELK3, ELL, ELL2, ELMO1, ELMO2, ELMOD1, ELMOD2, ELMOD3, ELN, ELOC, ELOVL1, ELOVL2, ELOVL4, ELOVL7, ELP1, ELP2, ELP3, ELP5, ELP6, EMB, EMBP1, EMC1, EMC 10, EMC2, EMC3-AS1, EMC4, EMC8, EMG1, EMIDI, EML1, EML2, EML3, EML4, EML5, EML6, EMP3, EMSY, EMX2, ENAH, ENCI, ENDOG, ENDOV, ENKD1, ENO2, ENOSF1, ENOXI, ENOX2, ENPP1, ENTPD1-AS1, ENTPD3-AS1, ENTPD4, ENTPD5, ENTPD6, EOGT, EP300, EP400, EP400P1, EPAS1, EPB41, EPB41L1, EPB41L2, EPB41L3, EPB41L4A, EPB41L4A-AS1, EPB41L5, EPCI, EPDR1, EPG5, EPGN, EPHA1- AS1, EPHA2, EPHA3, EPHA6, EPHA8, EPHB2, EPHB4, EPHX1, EPHX4, EPM2A, EPN1,
EPN2, EPRS, EPS15, EPS15L1, EPS8, EPSTI1, ERBB2, ERB IN, ERC1, ERC2, ERCC1, ERCC2, ERCC6L2, ERCC8, ERG28, ERGIC1, ERGIC2, ERGIC3, ERI1, ERI2, ERI3, ERICH1, ERICH2, ERLEC1, ERLIN1, ERLIN2, ERMAP, ERMARD, ER01A, ERP44, ERVK13-1, ESCO1, ESCO2, ESD, ESF1, ESPL1, ESPNL, ESRRB, ESRRG, ESYT1, ESYT2, ETAA1, ETFA, ETFB, ETFDH, ETFRF1, ETHE1, ETV1, ETV3, ETV4, ETV6, ETV7, EVA1A, EVC, EVI5, EWSR1, EXD2, EXD3, EX01, EXO5, EXOCI, EXOC2, EXOC3, EXOC4, EXOC5, EXOC6, EXOC6B, EXOC7, EXOG, EXOSC1, EXOSC2, EXOSC3, EXOSC7, EXOSC8, EXOSC9, EXT2, EXTL2, EXTL3, EYA1, EYA3, EYA4, EZH1, EZH2, F3, F8, FAAH, FAAH2, FAAP20, FAAP24, FADS1, FADS2, FAF1, FAF2, FAH, FAHD2A, FAHD2B, FAHD2CP, FAIM, FAM102A, FAM103A1, FAM104A, FAM105A, FAM107B, F AMI 1 OB, FAM11 1 A, F AMI 14A1 , FAM114A2, F AMI 17A, F AMI 17B, FAM118 A, FAM118B, FAM120A, FAM120AOS, FAM120B, FAM122B, FAM122C, FAM126A, FAM126B, FAM129A, FAM129B, FAM131A, FAM133B, FAM133DP, FAM135A, FAM13A, FAM13B, FAM149B1, FAM151B, FAM155A, FAM155B, FAM157A, FAM157B, FAM160A1, FAM160A2, FAM160B2, FAM161A, FAM162A, FAM163A, FAM168A, FAM169A, FAM171A1, FAM172A, FAM173A, FAM173B, FAM174A, FAM177A1, FAM184A, FAM185A, FAM189A2, FAM189B, FAM193A, FAM193B, FAM199X, FAM19A5, FAM204A, FAM206A, FAM207A, FAM208A, FAM208B, FAM20B, FAM210A, FAM212B-AS1, FAM214A, FAM214B, FAM216A, FAM217B, FAM219B, FAM221A, FAM222B, FAM228B, FAM229B, FAM234A, FAM241B, FAM24B, FAM24B-CUZD1, FAM35A, FAM3A, FAM3C, FAM45A, FAM45BP, FAM47E-STBD1, FAM49A, FAM49B, FAM53B, FAM57A, FAM66A, FAM69B, FAM72A, FAM72C, FAM72D, FAM76A, FAM76B, FAM78B, FAM81A, FAM83D, FAM86C1, FAM86C2P, FAM89B, FAM91A1, FAM92A, FAM96A, FAM98B, FAM98C, FAN1, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCG, FANCI, FANCL, FANCM, FANK1, FAR1, FARP1, FARP2, FARS2, FARSB, FASN, FASTK, FASTKD1, FAT1, FAT3, FAXC, FAXDC2, FBF1, FBH1, FBLIM1, FBLN7, FBN1, FBN2, FBRS, FBRSL1, FBXL12, FBXL13, FBXL17, FBXL20, FBXL21, FBXL3, FBXL4, FBXL5, FBXL6, FBXL7, FBXL8, FBXO11, FBXO16, FBXO17, FBXO21, FBXO22, FBXO25, FBXO31, FBXO33, FBXO34, FBXO38, FBXO4, FBXO41, FBXO42, FBXO44, FBXO46, FBXO5, FBXO7, FBXO9, FBXW11, FBXW4, FBXW7, FBXW8, FBXW9, FCF1, FCGR1A, FCGRT, FCHO1, FCHO2, FCHSD1, FCHSD2, FCRLA, FDFT1, FDX1, FDX1L, FDXR, FECH, FENDRR, FER, FER1L4, FERMT2, FES, FEZ1, FEZ2, FGD2, FGD4, FGD5-AS1, FGF12, FGF13, FGF5, FGFR1, FGFR1OP, FGFR1OP2, FGFR2, FGFR3, FGFR4, FGGY, FHAD1, FHIT, FHL2, FHOD1, FHOD3, FIBP, FIG4, FIGNL1, FIP1L1, FIS1, F1Z1, FKBP10, FKBP14, FKBP15, FKBP1B, FKBP2, FKBP5, FKBP7, FKBP9, FKRP, FKTN, FLAD1, FLCN, FLII, FLJ32255, FLNA, FLNB, FLOT2, FLRT3, FLT1, FLT4, FLVCR1, FLVCR2, FLYWCH1, FLYWCH2, FMN2, FMNL2, FMNL3, FMRI, FN1, FN3K, FN3KRP, FNBP1, FNBP1L, FNBP4, FNDC3A, FNDC3B, FNIP1, FNIP2, FNTA, FNTB, FOCAD, FOLR1, FOPNL, FOXD3-AS1, FOXJ3, FOXK2, F0XM1, FOXN2, FOXN3, FOXO3, FOXP1, FOXP2, FOXP3, FOXP4, FOXRED1, FOXRED2, FPGT, FPGT-TNNI3K, FRA10AC1, FRAS1, FRG1, FRG1-DT, FRG1BP, FRG1CP, FRG1DP, FRG1HP, FRG1JP, FRMD3, FRMD4A, FRMD6, FRMD8, FRMPD4, FRS2, FRY, FRYL, FRZB, FSD1, FSD1L, FSTL1, FSTL5, FTO, FTSJ1, FTX, FUBP1, FUBP3, FUCA2, FUK, FUNDCI, FURIN, FUT10, FUT8, FUZ, FXR1, FXR2, FXYD5, FXYD6, FXYD6-FXYD2, FYN, FZD3, FZD6, FZR1, G2E3, G6PC3, GAA, GABI, GAB2, GABPA, GABPB1, GABPB2, GABRA3, GABRB3, GADD45A,
GAK, GAL3ST4, GALE, GALK1, GALK2, GALNS, GALNT10, GALNT11, GALNT13, GALNT18, GALNT2, GALNT3, GALNT6, GALNT7, GALT, GANAB, GANC, GAPVD1, GAREM1, GARNL3, GART, GAS2L1, GAS2L3, GAS5, GAS6, GAS7, GAS8, GATA2, GATA2-AS1, GATA3, GATA4, GATAD2A, GATAD2B, GATB, GATD1, GATD3A, GBA, GBA2, GBAP1, GBF1, GBP IP 1, GBP5, GCA, GCAT, GCC2, GCDH, GCFC2, GCH1, GCLC, GCN1, GCNT1, GCNT2, GCOM1, GCSH, GDAP1, GDAP1L1, GDAP2, GDPD5, GEMIN2, GEMIN4, GEMIN7. GEMIN8, GEN1, GET4, GFI1, GFM1, GFM2, GFOD2, GFPT1, GFPT2, GFRA2, GGA1, GGA3, GGACT, GGCT, GGCX, GGPS1, GGT5, GID4, GID8, GIGYF1, GIGYF2, GIN1, GINM1, GINS1, GINS3, GIPC1, GIT1, GIT2, GK, GK5, GKAP1, GLB1, GLCCI1, GLCE, GLDC, GLE1, GLG1, GLI2, GLIPR2, GLMN, GLMP, GLRB, GLRX3, GLS, GLS2, GLT1D1 , GLT8D1 , GLT8D2, GLTP, GLYCTK, GLYR1 , GMCL1, GMDS, GMDS- AS1, GMEB1, GMFB, GMFG, GMIP, GMNN, GMPPB, GMPR2, GNA12, GNA13, GNAS, GNAS-AS1, GNB1, GNB1L, GNB4, GNB5, GNE, GNG2, GNG4, GNG7, GNL2, GNPAT, GNPDA1, GNPDA2, GNPNAT1, GNPTG, GNS, GOLGA2, GOLGA2P10, GOLGA2P5, GOLGA2P7, GOLGA3, GOLGA4, GOLGA6L10, GOLGA6L17P, GOLGA6L9, GOLGB1, GOLIM4, GOLPH3L, GOLT1B, GON4L, GOPC, GORAB, GORASP1, GORASP2, GOSR1, GOSR2, GPAA1, GPALPP1, GPAT4, GPATCH11, GPATCH2, GPATCH2L, GPATCH4, GPATCH8, GPBP1, GPBP1L1, GPC5, GPC6, GPCPD1, GPD1L, GPHN, GPI, GPKOW, GPN1, GPN3, GPR107, GPR108, GPR137, GPR137B, GPR137C, GPR141, GPR155, GPR160, GPR161, GPR171, GPR173, GPR176, GPR180, GPR63, GPR75-ASB3, GPR85, GPR89A, GPR89B, GPRASP1, GPRASP2, GPRC5D-AS1, GPS1, GPS2, GPSM1, GPSM2, GPX7, GPX8, GRAMD1A, GRAMD2B, GRAMD4, GRB10, GREB1L, GREM2, GRHL1, GRHPR, GRIA3, GRIK2, GRIK5, GRIN2D, GRIN3B, GRIP API, GRK2, GRK3, GRK4, GRK5, GRK6, GRM7, GRM8, GRPEL2, GRTP1, GSl-124K5.i l, GSAP, GSK3B, GSKIP, GSN, GSPT1, GSR, GSS, GSTA4, GSTCD, GSTK1, GSTM2, GSTM4, GSTT1, GSTT2B, GSTT4, GSTZ1, GTDC1, GTF2A2, GTF2B, GTF2F1, GTF2H1, GTF2H2, GTF2H2B, GTF2H2C, GTF2H2C 2, GTF2H3, GTF2I, GTF2IP1, GTF2IP20, GTF2IP23, GTF2IP4, GTF2IRD1, GTF2IRD2, GTF2IRD2B, GTF3A, GTF3C2, GTF3C3, GTF3C4, GTF3C5, GTPBP1, GTPBP10, GTPBP2, GTPBP8, GTSE1, GUCA1A, GUCD1, GUF1, GUK1, GULP1, GUSB, GUSBP1, GUSBP11, GVQW2, GYG1, GYG2, GYSI, GZF1, H2AFV, H6PD, HABP4, HACD1, HACD4, HACE1, HACL1, HADH, HADHB, HAGH, HAGHL, HAGLR, HAND2-AS1, HAPLN1, HARS, HARS2, HAT1, HAUS1, HAUS2, HAUS3, HAUS4, HAUS5, HAUS6, HAUS7, HAUS8, HAX1, HBS1L, HCFC1, HCFC1R1, HCFC2, HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC7, HDAC8, HDAC9, HDDC2, HDGFL2, HDGFL3, HDHD2, ELDHD5, HDLBP, HDX, HEATR1, ELEATR3, HEATR5A, HEATR5B, HEATR6, HEBP2, HECTD1, HECTD4, HECW1, HECW2, HELLS, HELZ, HEMK1, HENMT1, HERC1, HERC2, HERC2P2, HERC2P3, HERC2P9, HERC3, HERC4, HERC5, HERC6, HERPUD1, HERPUD2, HES4, HEXA, HEXB, HEXDC, HEXIM2, HFM1, HGF, HGH1, HGS, HGSNAT, HHAT, HIBADH, HIBCH, HIF1A, HIF1AN, HIKESHI, HINFP, HINT3, HIP1, HIPK1, HIPK3, HIRA, HIRIP3, HIST1H2BD, HIVEP1, HIVEP2, HIVEP3, HJURP, HK1, HKR1, HLA-A, HLA-C, HLA-DRB1, HLA-DRB4, HLA-F, HLCS, HLTF, HM13, HMBOX1, HMBS, HMCES, HMCN1, HMG20B, HMGA1, HMGCL, HMGCR, HMGCS1, HMGN1, HMGN3, HMGN4, HMGN5, HMGXB3, HMGXB4, HMMR, HNRNPA1, HNRNPA1L2, HNRNPA2B1, HNRNPA3, HNRNPAB, HNRNPC, HNRNPD, HNRNPDL, HNRNPH1, HNRNPK, HNRNPL, HNRNPLL, HNRNPM, HNRNPR, HNRNPUL1, HOGA1, HOMER2, HOOK1, HOOK3,
H0XA1 1-AS, HOXA3, HOXA5, HOXA6, HOXA9, HOXB3, HOXB6, HOXB7, HOXB8, HOXC4, HOXC5, HOXDIO, HP1BP3, HPCAL1, HPF1, HPS1, HPS3, HPS4, HPS5, HPSE, HR, HRAS, HRASLS, HRAT17, HRH1, HRH2, HS2ST1, HS3ST3A1, HS6ST1, HS6ST2, HSCB, HSD11B1L, HSD17B12, HSD17B14, HSD17B4, HSD17B7P2, HSDL2, HSF1, HSF2, HSF2BP, HSF4, HSP90AA1, HSPA12A, HSPA14, HSPA4, HSPB11, HSPBAP1, HSPBP1, HSPE1-MOB4, HTD2, HTRA2, HTT, HUWE1, HYAL3, HYI, HYOU1, IAH1, IARS, IBTK, ICA1, ICA1L, ICE1, ICK, ICMT, IDE, IDH1, IDH3A, IDH3B, IDH3G, IDI1, IDNK, IDS, IFFO1, IFI27L1, IFI27L2, IFI44L, IFITM1, IFNAR1, IFNAR2, IFNGR2, IFRD1, IFT122, IFT140, IFT172, IFT20, IFT22, IFT27, IFT43, IFT52, IFT57, IFT80, IFT8I, IFT88, IGBPI, IGDCC4, IGF2BP2, IGF2BP3, IGFBP6, IGFLR1, IGLON5, IGSF1, IGSF3, IK, IKBIP, IKBKB, IKBKE, IKBKG, IKZF1, TKZF4, TKZF5, IL10RA, IL11RA, TL12RB2, IL13RA1, TL15, IL15RA, IL17RA, IL17RB, IL17RC, IL17RE, IL18BP, IL18RAP, IL21R, IL27, IL2RA, IL2RG, IL32, IL4R, IL6R, IL6ST, IL7R, ILDR2, ILF3, ILK, ILKAP, ILVBL, IMMP1L, IMMP2L, IMMT, IMPA1, IMPA2, IMPDH1, INCENP, INF2, ING3, ING4, ING5, INIP, INMT -MIND Y4, INO80C, INO80E, INPPI, INPP4A, INPP5A, INPP5B, INPP5E, INPP5F, INPP5K, INPPL1, 1NS1G1, 1NSR, INTS10, 1NTS11, 1NTS12, 1NTS13, INTS14, INTS2, INTS3, 1NTS4, INTS4P1, INTS4P2, INTS7, INTS8, INTS9, INTU, INVS, IP6K1, IP6K2, IPCEF1, IPO11, IPO11- LRRC70, IPO4, IPO5P1, IPO7, IPO8, IPO9, IPP, IPPK, IQCB1, IQCC, IQCE, IQCG, IQCH, IQCH-AS1, IQCJ-SCHIP1, IQCK, IQGAP3, IQSEC1, IRAKI, IRAK1BP1, IRAK2, IRAK3, IRAK4, IREB2, IRF2, IRF3, IRF6, ISCA1, ISL1, ISLR2, ISOC2, IST1, ISY1, ISYNA1, ITCH, ITFG1, ITFG2, ITGA1, ITGA10, ITGA3, ITGA7, ITGA8, ITGA9, ITGA9-AS1, ITGAE, ITGAM, ITGAV, ITGAX, ITGB1BP1, ITGB3BP, ITGB5, ITIH5, ITM2A, ITM2C, ITPA, ITPK1, ITPR1, ITPR2, ITSN1, ITSN2, IVD, IVNS1ABP, IZUMO4, JADE1, JADE2, JADE3, JAK1, JAK3, JAKMIP2, JAM2, JARID2, JCAD, JKAMP, JMJD1C, JMJD7, JMJD7- PLA2G4B, JMJD8, JOSD2, JPT2, JPX, JTB, KANK1, KANK2, KANSL1, KANSL1L, KANSL2, KANSL3, KARS, KAT2A, KAT5, KAT6A, KAT6B, KAT7, KAT8, KATNA1, KATNAL1, KATNAL2, KATNBL1, KAZN, KBTBD2, KBTBD3, KBTBD8, KCMF1, KCNAB2, KCNAB3, KCNGI, KCNH2, KCNK2, KCNK4, KCNMAI, KCNMB4, KCNN4, KCNQ1, KCNQ5, KCNQ5-IT1, KCNS3, KCNT2, KCTD14, KCTD15, KCTD17, KCTD20, KCTD3, KCTD9, KDELC1, KDELC2, KDM1A, KDM1B, KDM2A, KDM2B, KDM3A, KDM3B, KDM4A, KDM4B, KDM4C, KDM4D, KDM5A, KDM5B, KDM5C, KDM5D, KDM6A, KDM7A, KDM8, KEAP1, KHDC1, KHDRBS3, KHK, KHSRP, KIAA0040, KIAA0100, KIAA0232, KIAA0319L, KIAA0355, KIAA0368, KIAA0391, KIAA0556, KIAA0586, KIAA0753, KIAA0825, KIAA0895, KIAA0895L, KIAA1109, KIAA1147, K1AA1191, KIAA1211, KIAA1217, KIAA1324, KIAA1324L, K1AA1328, K1AA1468, KIAA1522, KIAA1549, KIAA1551, KIAA1586, KIAA1671, KIAA1841, KIAA1958, KIAA2026, KIDINS220, KIF11, KIF13A, KIF13B, KIF14, KIF15, KIF16B, KIF18B, KIF1A, KIF1B, KIF1C, KIF21A, KIF21B, KIF23, KIF24, KIF26B, KIF27, KIF2A, KIF2C, KIF3A, KIF4A, KIF5C, KIF9, KIF9-AS1, KIFAP3, KIFC1, KIN, KIRREL1, KIRREL3, KITLG, KIZ, KLC1, KLC4, KLF12, KLF8, KLHDC10, KLHDC3, KLHDC4, KLHDC8B, KLHL12, KLHL13, KLHL17, KLHL18, KLHL2, KLHL20, KLHL22, KLHL24, KLHL5, KLHL7, KLHL8, KLRB1, KLRC4-KLRK1, KLRD1, KLRG1, KLRG2, KLRK1, KMT2A, KMT2B, KMT2C, KMT2D, KMT2E, KMT5A, KMT5B, KMT5C, KNL1, KNOP1, KNSTRN, KNTC1, KPNA4, KPNA5, KPNA6, KPTN, KRBA1, KRBOX4, KREMEN1, KRI1, KRIT1, KRT8, KSR1, KTN1, KYAT1, KYAT3, L1CAM, L2HGDH, L3HYPDH, L3MBTL2, L3MBTL3,
LACTB, LAMA2, LAMA3, LAMA5, LAMB2, LAMC3, LAMP2, LAMP5, LAMT0R4, LARGE1, LARP1, LARP1B, LARP4, LARP4B, LARP7, LARS, LARS2, LAS1L, LASPI, LAT, LAT2, LATS1, LATS2, LBHD1, LBR, LBX2, LCAT, LCLAT1, LCMT1, LCOR, LCORL, LDAH, LDB2, LDHC, LDLR, LDLRAD3, LDLRAD4, LDLRAP1, LEF1, LEMD2, LEMD3, LENEP, LENG8, LEPR, LEPROT, LEPROTL1, LETM1, LETM2, LETMD1, LGALS8, LGALS9, LGMN, LGR4, LGR5, LHFPL2, LHPP, LIAS, LIFR, LIG1, LIG3, LILRA2, LILRB3, LIMCH1, LIME1, LIMK2, LIMS2, LIN37, LIN52, LIN54, LIN7A, LIN9, LINC-PINT, LINC00240, LINC00265, LINC00327, LINC00337, LINC00426, LINC00467, LINC00473, LINC00475, LINC00476, LINC00491, LINC00578, LINC00607, LINC00623, LINC00624, LINC00630, LINC00632, LINC00649, LINC00665, LINC00667, LINC00673, LINC00674, LINC00680, LINC00680-GUSBP4, LINC00693, LINC00869, LINC00886, LINC00888, LINC00893, LINC00899, LINC00926, LINC00937, LINC00941, LINC00958, LINC00960, LINC00963, LINC01000, LINC01029, LINC01033, LINC01060, LINC01085, LINCO I 088, LINCOI 117, LINC01128, LINCO I 169, LINC01184, LINC01224, LINC01234, LINC01237, LINC01250, LINC01278, LINC01296, LINC01358, LINC01410, LINC01456, L1NC01515, L1NC01547, L1NC01572, L1NC01578, L1NC01605, L1NC01684, L1NC01876, LINC01881, LINC01894, LINC01934, LINC02062, LINC02202, LINC02210-CRHR1, LINC02246, LINC02328, LINC02446, LINC02476, LINC02511, LINC02542, LINCR-0002, LINGO 1, LINGO2, LINS1, LIPA, LIPE, LIPE-AS1, LIPT1, LIX1L, LLGL2, LMAN2L, LMBR1, LMBR1L, LMBRD1, LMBRD2, LMCD1, LMLN, LMO7, LMTK3, LNPK, LNX2, LOC100128253, LOC100128594, LOC100128885, LOC100130027, LOC100130691, LOC100130987, LOC100132111, LOC100133091, LOC100133315, LOC100134868, LOC100233156, LOC100287497, LOC100287944, LOC100288203, LOC100288637, LOC100288778, LOC100288798, LOC100420587, LOC100505501, LOC100505874, LOC100505938, LOC100506023, LOC100506207, LOC100506282, LOC100506476, LOC100506844, LOC100506990, LOC100507002, LOC100507053, LOC100507065, LOC100507291, LOC100507377, LOC100507412, LOC100507557, LOC100630923, LOC I 00996693, LOCI 00996724, LOC 101060091, LOC 101448202, LOCI 01927021, LOC101927027, LOC101927043, LOC101927056, LOC101927151, LOC101927359, LOC101927815, LOC101927827, LOC101928100, LOC101928323, LOC101928516, LOC101928605, LOC101928673, LOC101929066, LOC101929140, LOC101929147, LOC101929231, LOC101929709, LOC101929710, LOC101929767, LOC101930071, LOC102606465, LOC102723360, LOC102723780, LOC102724219, LOC102724297, LOC102724532, LOC102724593, LOC102724843, LOC102724951, LOC102725126, LOC103091866, LOC105369147, LOC105369980, LOC105370401, LOC105372273, LOC105378853, LOC107984035, LOC107984974, LOCI 10117498-PIK3R3, LOC145694, LOC1484L3, LOC150776, LOC155060, LOC283683, LOC283788, LOC284581, LOC339862, LOC389765, LOC389831, LOC389906, LOC392232, LOC399815, LOC400464, LOC400927, LOC400927-CSNK1E, LOC440434, LOC441242, LOC441601, LOC441666, LOC642846, LOC642852, LOC643339, LOC645166, LOC645513, LOC648987, LOC653080, LOC654342, LOC727751, LOC728613, LOC728730, LOC729218, LOC729732, LOC729970, LONP2, LONRF1, LONRF3, LOXL2, LOXL3, LPAR1, LPAR2, LPAR3, LPCAT1, LPCAT2, LPCAT3, LPCAT4, LPGAT1, LPIN1, LPP, LPXN, LRBA, LRCH3, LRCH4, LRIF1, LRIG1, LRIG2, LRIG3, LRMDA, LRMP, LRP1, LRP11, LRP12, LRP2, LRP5, LRP8, LRPPRC, LRR1, LRRC14, LRRC17, LRRC23, LRRC28, LRRC34, LRRC37A2, LRRC37B, LRRC40, LRRC42,
LRRC45, LRRC49, LRRC4B, LRRC58, LRRC6, LRRC69, LRRC73, LRRC75A-AS1, LRRC75B, LRRC8A, LRRC8B, LRRC8D, LRRCC1, LRRFIP1, LRRFIP2, LRRK1, LRRK2, LRRN3, LRSAM1, LRTOMT, LSG1, LSM1, LSM12, LSM14A, LSM14B, LSM5, LSR, LSS, LTA4H, LTB4R, LTBP1, LTBP3, LTBP4, LTN1, LUC7L, LUC7L3, LUZP1, LY75, LY75- CD302, LY96, LYAR, LYPD1, LYPD6B, LYPLA1, LYPLAL1, LYRM1, LYRM4-AS1, LYRM7, LYSMD1, LYSMD4, LYST, LZIC, LZTFL1, MACF1, MACROD1, MACROD2, MAD1L1, MADD, MAEA, MAFG, MAFG-AS1, MAGEA12, MAGEA2, MAGEA2B, MAGI1, MAGI2, MAGI2-AS3, MAGI3, MAGOH, MAGOHB, MAGT1, MAIP1, MAK16, MALL, MALSU1, MALT1, MAMDC4, MAML1, MAML3, MAMLD1, MAN1A2, MAN1C1, MAN2B2, MAN2C1, MANBA, MANBAL, MANEAL, MAP1LC3B, MAP2, MAP2K1, MAP2K4, MAP2K5, MAP2K6, MAP2K7, MAP3K10, MAP3K15, MAP3K2, MAP3K20, MAP3K21, MAP3K3, MAP3K4, MAP3K5, MAP3K7, MAP3K8, MAP3K9, MAP4, MAP4K1, MAP4K2, MAP4K3, MAP4K4, MAP4K5, MAP6, MAP6D1, MAP7D1, MAP9, MAPK10, MAPK1 1, MAPK12, MAPK13, MAPK14, MAPK3, MAPK6, MAPK7, MAPK8, MAPK8IP3, MAPK9, MAPKAP1, MAPKAPK3, MAPKAPK5, MAPKAPK5-AS1, MAPKBP1, MAPT, MARC1, MARCH1, MARCH3, MARCH5, MARCH6, MARCH7, MARCH8, MARF1, MARK1, MARK2, MARK3, MARK4, MARVELD2, MAST1, MAST2, MAST3, MAST4, MASTL, MAT2B, MATK, MATR3, MAVS, MAX, MAZ, MBD1, MBD3, MBD4, MBD5, MB IP, MBNL1, MBNL2, MBNL3, MBOAT1, MBOAT2, MBOAT7, MBTD1, MBTPS1, MBTPS2, MCAM, MCAT, MCCC1, MCCC2, MCF2L, MCM3AP, MCM3AP-AS1, MCM4, MCM8, MCM9, MCMBP, MCOLN1, MCOLN3, MCPH1, MCPH1-AS1, MCRIP1, MCRIP2, MCRS1, MCTP1, MCTP2, MCTS1, MCU, MCUB, MCUR1, MDFI, MDM1, MDM2, MDM4, MDN1, MDP1, MEI, ME2, MEAF6, MECOM, MECP2, MECR, MED1, MED11, MED 12, MED12L, MED13, MED13L, MED14, MED15, MED16, MED17, MED19, MED20, MED23, MED24, MED25, MED27, MED30, MED31, MED6, MED8, MEF2A, MEF2B, MEF2C, MEF2C-AS1, MEG3, MEG8, MEGF11, MEGF6, MEGF8, MEGF9, MEI1, MEIS1, MEIS2, MEIS3, MELK, MELTF, MEM01, MEN1, MERTK, MET, METAP1, METAP1D, METRN, METTL1, METTL13, METTL14, METTL15, METTL16, METTL21A, METTL22, METTL23, METTL25, METTL26, METTL2A, METTL2B, METTL4, METTL5, METTL6, METTL8, METTL9, MEX3B, MFF, MFGE8, MFHAS1, MFN1, MFN2, MFNG, MFSD10, MFSD11, MFSD12, MFSD13A, MFSD14B, MFSD14C, MFSD6, MFSD8, MFSD9, MGA, MGARP, MGAT1, MGAT3, MGAT4B, MGAT4C, MGAT5, MGEA5, MGME1, MGMT, MGP, MGRN1, MGST1, MGST2, MGST3, MIA-RAB4B, MIA2, MIA3, MIAT, MIATNB, MIB I, MIB2, MIC ALL MICAL2, MICAL3, MICALL1, MICALL2, MICB, MICU2, MIDI, MID2, M1ER1, M1ER2, MIER3, MIF4GD, MIGA1, MIIP, M1NDY1, M1NDY2, M1NDY3, M1NDY4, MINK1, MINOS1, MINOS1-NBL1, MIOS, MIPEP, MIPEPP3, MIPOL1, MIR100HG, MIR1268A, MIR22HG, MIR31HG, MIR4435-2HG, MIR5095, MIR5096, MIR548G, MIR548H3, MIR548H4, MIR548N, MIR570HG, MIR646HG, MIR9-3HG, MIR924HG, MIR99AHG, MIRLET7BHG, MIS 12, MIS18BP1, MITD1, MITF, MKI67, MKKS, MKL1, MKL2, MKLN1, MKNK1, MKNK2, MKRN1, MKRN2, MKS1, MLC1, MLF1, MLH1, MLH3, MLLT1, MLLT10, MLLT3, MLPH, MLST8, MLXIP, MLXIPL, MMAB, MMD, MMGT1, MMP16, MMP19, MMP23B, MMP24-AS1-EDEM2, MMP24OS, MMP25-AS1, MMS19, MMS22L, MNAT1, MND1, MOB1B, MOB3A, MOCOS, MOCS1, MOCS2, MOK, MON1A, M0N2, MORC2, MORC3, MORF4L1, MORF4L2, MORN I, MORN3, MOSMO, MOSPD1, MOSPD2, MOSPD3, MOVIO, MOV10L1, MPDU1, MPDZ, MPHOSPH6, MPHOSPH8,
MPH0SPH9, MPI, MPND, MPP2, MPP3, MPP4, MPP5, MPP6, MPPE1, MPPED2, MPRIP, MPST, MPV17, MPZL1, MPZL3, MR1, MRAS, MRC1, MRC2, MRE11, MR EG, MRFAP I, MRNIP, MR0H1, MROH6, MRPL13, MRPL17, MRPL18, MRPL2, MRPL21, MRPL22, MRPL24, MRPL33, MRPL38, MRPL43, MRPL45, MRPL47, MRPL48, MRPL52, MRPL55, MRPL9, MRPS10, MRPS18A, MRPS18C, MRPS25, MRPS28, MRPS30-DT, MRPS31, MRPS31P5, MRPS36, MRPS5, MRRF, MRS2, MRVI1, MS4A14, MS4A3, MS4A6A, MS4A7, MSANTD2, MSANTD3-TMEFF1, MSANTD4, MSC-AS1, MSH2, MSH3, MSI1, MSL1, MSL3, MSRA, MSTO1, MSTO2P, MTA1, MT A3, MTCH2, MTCL1, MTCP1, MTDH, MTERF2, MTERF3, MTERF4, MTF2, MTFP1, MTFR1, MTFR2, MTG2, MTHFD2, MTHFD2L, MTHFS, MTHFSD, MTIF2, MTIF3, MTM1, MTMR1, MTMR10, MTMR12, MTMR14, MTMR2, MTMR3, MTMR6, MTMR7, MTMR8, MTO1, MTOR, MTR, MTREX, MTRF1, MTRF1L, MTRNR2L2, MTRR, MTSS1L, MTUS1, MTX1, MTX2, MTX3, MUM1, MUTYH, MVB12A, MVB12B, MVD, MVK, MX1, MXD3, MXI1, MXRA7, MYBL1, MYBL2, MYCBP2, MYEF2, MYH10, MYH14, MYHAS, MYL6B, MYLIP, MYLK, MYLK- AS1, MYNN, MYOIO, MYO18A, MYO19, MYO1B, MYO1C, MYOID, MYO1E, MYO5A, MYO5B, MYO5C, MYO6, MYO9A, MYO9B, MYOF, MYOM2, MYSM1, MYT1, N4BP1, N4BP2, N4BP2L1, N4BP2L2, N6AMT1, NAA15, NAA16, NAA25, NAA35, NAA40, NAA50, NAA60, NAAA, NAALAD2, NAB1, NAB2, NABP1, NACC2, NADK, NADK2, NADSYN1, NAE1, NAF1, NAGA, NAGK, NAGPA, NAIP, NAMPT, NANS, NAP1L1, NAP1L4, NAPA, NAPB, NAPG, NAPSA, NARF, NARFL, NARS2, NASP, NAT6, NAVI, NAV2, NAV3, NAXD, NAXE, NBAS, NBDY, NBEA, NBEAL1, NBEAL2, NBL1, NBN, NBPF1, NBPF10, NBPF11, NBPF12, NBPF14, NBPF15, NBPF19, NBPF20, NBPF25P, NBPF26, NBPF3, NBPF8, NBPF9, NBR1, NBR2, NCALD, NCAM1, NCAPD3, NCAPG, NCAPG2, NCBP3, NCF4, NCK2, NCKAP1, NCKAP5, NCKAP5L, NCKIPSD, NCOA1, NCOA2, NCOA6, NCOA7, NCOR1, NCOR2, NCS1, NCSTN, NDC1, NDE1, NDEL1, NDFIP2, NDOR1, NDRG1, NDRG2, NDRG3, NDRG4, NDST1, NDUFA10, NDUFA12, NDUFA3, NDUFA4L2, NDUFA6-AS1, NDUFA8, NDUFAF1, NDUFAF2, NDUFAF5, NDUFAF6, NDUFAF7, NDUFAF8, NDUFB5, NDUFB6, NDUFC1, NDUFC2-KCTD14, NDUFS1, NDUFS2, NDUFS8, NDUFV1, NDUFV2, NDUFV3, NEBL, NECAB3, NECAP2, NEDD1, NEDD4, NEDD4L, NEDD9, NEIL2, NEIL3, NEK1, NEK10, NEK11, NEK4, NEK7, NEK9, NELFA, NELFCD, NEMF, NEMP1, NENF, NEO1, NEPRO, NET1, NETO2, NEURL1B, NEURL4, NEXN, NF1, NF2, NFASC, NFAT5, NFATC2, NFATC2IP, NFATC3, NFATC4, NFE2L1, NFIB, NFIC, NFIX, NFKB1, NFRKB, NFS1, NFU1, NFX1, NFYB, NFYC, NGDN, NGLY1, NHEJ1, NHLRC3, NHSL1, NICN1, NIDI, NID2, NIF3L1, NIFK, NIN, NINE, NIP7, NIPA1, N1PA2, NIPBL, N1PSNAP1, NIPSNAP2, NISCH, NITI, NIT2, NKAIN1, NKAPD1, NKIRAS1, NKIRAS2, NKTR, NLE1, NLGN1, NLGN2, NLK, NLN, NLRC3, NLRC5, NLRP3, NLRX1, NMD3, NME1-NME2, NME3, NME6, NME7, NMNAT1, NMRAL1, NMRK1, NMT1, NMT2, NMU, NNT, NNT-AS1, NOA1, NOC2L, NOC4L, NOCT, NODI, NOLIO, NOLI 1, NOL12, NOL3, NOL4, NOL4L, NOL8, NOL9, NOLC1, N0M02, NOP16, NOP58, NOS1AP, NOTCH 1, NOTCH2, NOTCH2NL, NOTCH3, NOVAI, NOX4, NOX5, NPAS1, NPAS2, NPC1, NPEPPS, NPFFR2, NPHP1, NPHP3, NPHP4, NPIPA1, NPIPB5, NPL, NPLOC4, NPM1, NPM3, NPNT, NPR1, NPR2, NPRL2, NPRL3, NQO1, NQO2, NR1D2, NR1H3, NR2C1, NR2C2, NR2F1-AS1, NR3C1, NR4A1, NR6A1, NRBF2, NRCAM, NRDC, NRDE2, NREP, NRF1, NRG1, NRG2, NRG3, NRG4, NRIP1, NRN1, NRP1, NRSN2, NRXN3, NSD1, NSD2, NSD3, NSDHL, NSF, NSFL1C, NSFP1, NSG1, NSL1, NSMAF, NSMCE1,
NSMCE2, NSMCE4A, NSMF, NSRP1, NSUN2, NSUN3, NSUN4, NSUN5P1, NSUN5P2, NSUN6, NT5C, NT5C1A, NT5C2, NT5C3A, NT5C3B, NT5DC2, NT5M, NTAN1, NTHL1, NTM, NTMT1, NTNG1, NTPCR, NTRK1, NTRK2, NTRK3, NUB1, NUBP1, NUBPL, NUCB2, NUDCD2, NUDT1, NUDT14, NUDT17, NUDT19, NUDT2, NUDT22, NUDT3, NUDT7, NUF2, NUFIP1, NUFIP2, NUMA1, NUMB, NUP107, NUP133, NUP153, NUP155, NUP188, NUP210, NUP214, NUP37, NUP43, NUP50, NUP50-AS1, NUP54, NUP58, NUP62CL, NUP85, NUP88, NUP93, NUP98, NUPL2, NUS1, NUTF2, NUTM2A-AS1, NUTM2B-AS1, NVL, NXN, NXPE3, NXT2, 0ARD1, OAZ1, OAZ3, OBSCN, OBSL1, OCA2, OCEL1, OCIAD1, OCIAD2, OCRL, ODAM, ODF2, ODF2L, ODF3B, ODR4, OFD1, OGDH, OGDHL, OGFOD2, OGFOD3, OGFRL1, OGGI, OGT, OIP5, OLA1, OLFM2, OLMALINC, OLR1, 0MA1 , OPA1 , OPCML, OPHN1 , OPLAH, OPN3, OPTN, OR2A1-AS1, ORAT2, ORAI3, ORAOV1, ORC1, ORC2, ORC3, ORC4, ORC5, ORC6, 0RMDL1, 0RMDL2, OS9, OSBP2, OSBPL1A, OSBPL3, OSBPL6, OSBPL7, OSBPL8, OSBPL9, OSCP1, OSER1, OSER1-AS1, OSGEPL1, OSGIN2, OSMR-AS1, OSTC, OSTF1, OTOGL, OTUD5, OTUD6B, OTULIN, OXAIL, OXCT1, 0XNAD1, 0XR1, OXSR1, P2RX4, P2RX7, P2RY10, P2RY6, P3H1, P3H3, P3H4, P4HA1, P4HA2, PAAF1, PABPC4, PABPN1, PACRGL, PACS1, PACS2, PAFAH2, PAG1, PAICS, PAIP1, PAK1, PAK1IP1, PAK2, PAK3, PAK4, PALB2, PALLD, PALM, PALM2, PALM2-AKAP2, PAM, PAM16, PAMR1, PAN2, PAN3, PANK1, PANK2, PANKA, PANXI, PAOX, PAPD4, PAPD5, PAPD7, PAPOLA, PAPOLG, PAQR3, PAQR5, PAQR7, PAQR8, PARD3, PARD6G, PARG, PARGP1, PARL, PARM1, PARN, PARP11, PARP15, PARP2, PARP4, PARP6, PARP8, PARP9, PARPBP, PARVB, PASK, PATJ, PATL1, PATZ1, PAX3, PAX5, PAX6, PAX8-AS1, PAXIP1, PAXX, PBDC1, PBRM1, PBX1, PBX3, PBXIP1, PC, PCBD2, PCBP1-AS1, PCBP2, PCBP3, PCBP4, PCCA, PCCB, PCDH7, PCDH9, PCDHAC1, PCED1A, PCED1B, PCGF1, PCGF2, PCGF3, PCGF5, PCGF6, PCID2, PCK2, PCLO, PCM1, PCMTD1, PCMTD2, PCNP, PCNT, PCNX1, PCNX2, PCNX3, PCNX4, PCSK4, PCSK6, PCSK7, PCTP, PCYT1A, PCYT2, PDCD11, PDCD2, PDCD2L, PDCD4, PDCD6, PDCD6IPP2, PDCD7, PDE10A, PDE1C, PDE3A, PDE3B, PDE4B, PDE4D, PDE4DIP, PDE6B, PDE6D, PDE7A, PDE8A, PDE9A, PDF, PDGFC, PDGFD, PDGFRB, PDHA1, PDHX, PDIA5, PDIK1L, PDK1, PDK3, PDLIM2, PDLIM3, PDLIM4, PDLIM5, PDPK1, PDPR, PDS5A, PDS5B, PDSS1, PDSS2, PDXDC1, PDXDC2P-NPIPB14P, PDXK, PDZD11, PDZD2, PDZD8, PDZK1, PEAK1, PEAR1, PEF1, PELI1, PELI2, PELI3, PELO, PEMT, PER3, PET100, PEX1, PEX11A, PEX1 IB, PEX11G, PEX14, PEX16, PEX19, PEX2, PEX26, PEX3, PEX5, PEX6, PEX7, PFAS, PFDN1, PFKFB3, PFKL, PFKM, PGAM5, PGAP1, PGAP2, PGAP3, PGF, PGGT1B, PGLS, PGM2, PGM2L1, PGM3, PGS1, PHACTR2, PHACTR3, PHACTR4, PHC1, PHC2, PHC3, PHETA1, PHEFA2, PHEX, PHF10, PHF11, PHF12, PHF14, PHF19, PHF20, PHF20L1, PHF21A, PHF21B, PHF3, PHF6, PHF7, PHF8, PHKA1, PHKA2, PHKB, PHKG2, PHLDB1, PHLDB2, PHLPP2, PHOSPHO2-KLHL23, PHRF1, PHTF1, PHTF2, PHYH, PHYHD1, PHYKPL, PI4K2A, PI4K2B, PI4KA, PI4KB, PIAS1, PIAS2, PIAS3, PIBF1, PICALM, PICK1, PIEZO1, PIGA, PIGB, PIGF, PIGG, PIGH, PIGK, PIGL, PIGN, PIGO, PIGP, PIGQ, PIGT, PIGU, PIGX, PIK3AP1, PIK3C2A, PIK3C3, PIK3CB, PIK3CD, PIK3R2, PIK3R3, PIKFYVE, PIN1, PINX1, PIP4K2A, PIP4K2B, PIP4K2C, PIP4P1, PIP4P2, PIP5K1A, PIP5K1C, PIR, PITHD1, PITPNA, PITPNC1, PITPNM2, PITPNM3, PIWIL4, PKD1, PKD1P1, PKD1P3-NPIPA1, PKD1P4-NPIPA8, PKD1P6-NPIPP1, PKD2, PKDCC, PKIA, PKIB, PKIG, PKN2, PKNOX1, PKNOX2, PKP4, PLA2G12A, PLA2G15, PLA2G4A, PLA2G4B, PLA2G6, PLA2G7, PLA2R1, PLAA, PLAC1, PLAC8,
PLAGL1, PLAT, PLB1, PLBD2, PLCB1, PLCB3, PLCB4, PLCD4, PLCG2, PLCL1, PLD1, PLD3, PLEC, PLEK2, PLEKHA1, PLEKHA2, PLEKHA4, PLEKHA5, PLEKHA6, PLEKHA7, PLEKHA8, PLEKHB1, PLEKHB2, PLEKHG2, PLEKHG3, PLEKHG4, PLEKHH3, PLEKHJ1, PLEKHM1P1, PLEKHM2, PLEKHM3, PLGRKT, PLK3, PLK4, PL0D1, PLOD2, PLPP4, PLPP5, PLPPR2, PLRG1, PLS1, PLSCR1, PLSCR4, PLXNA4, PLXNB1, PLXNB2, PLXNC1, PLXND1, PM20D2, PMEL, PMF1, PMM1, PMM2, PMS1, PMS2, PMS2P1, PMS2P4, PMS2P5, PMVK, PNISR, PNKP, PNLDC1, PNN, PNO1, PNPLA6, PNPLA8, PNPO, PNPT1, POC1A, POC1B, POC5, PODXL2, POFUT1, POFUT2, POGK, POGLUT1, POGZ, POLA1, POLA2, POLB, POLD2, POLDIP3, POLE, POLE2, POLG, POLG2, POLI, POLK, POLL, POLM, POLN, POLQ, POLR1A, POLR1B, POLR1D, POLR2B, POLR2D, POLR2F, POLR2J, POLR2J3, POLR2J4, POLR3A, POLR3B, POLR3C, POLR3E, POLR3F, POLR3G, POLR3GL, POLR3H, POLRMT, P0M121, POM121C, POMGNT1, POMT1, POMT2, POP1, POP4, POP5, POPDC3, PORCN, POTI, POT1-AS1, POU2F1, POU2F2, POU6F1, PPA1, PPA2, PPAN- P2RY11, PPARA, PPARD, PPARG, PPARGC1B, PPCDC, PPCS, PPDPF, PPFIA1, PPFIA3, PPFIA4, PPFIBP1, PPHLN1, PPIA, PPID, PPIE, PPIEL, PPIF, PPIH, PPIL2, PPIL3, PPIP5K1P1-CATSPER2, PP1P5K2, PPM1A, PPM1B, PPM1D, PPM1E, PPM1H, PPM1K, PPM1M, PPOX, PPP1CB, PPP1CC, PPP1R12A, PPP1R12B, PPP1R12C, PPP1R13B, PPP1R16A, PPP1R16B, PPP1R1C, PPP1R2, PPP1R21, PPP1R35, PPP1R36, PPP1R37, PPP1R7, PPP1R8, PPP2CA, PPP2R1B, PPP2R2A, PPP2R2B, PPP2R2C, PPP2R2D, PPP2R3C, PPP2R5A, PPP2R5B, PPP2R5C, PPP2R5D, PPP2R5E, PPP3CB, PPP3CC, PPP3R1, PPP4C, PPP4R1, PPP4R2, PPP4R3A, PPP4R3B, PPP4R4, PPP5C, PPP5D1, PPP6C, PPP6R1, PPP6R2, PPP6R3, PPRC1, PPWD1, PQBP1, PQLC1, PQLC2, PQLC2L, PQLC3, PRADC1, PRAF2, PRAG1, PRC1, PRCC, PRDM15, PRDM16, PRDM2, PRDM4, PRDM5, PRDM6, PRDM8, PREB, PRELID2, PRELID3A, PRELID3B, PREP, PREPL, PRH1, PRH1-PRR4, PRH1- TAS2R14, PRICKLEI, PRIM1, PRIM2, PRIMPOL, PRKAA1, PRKAA2, PRKAB1, PRKAB2, PRKAG1, PRKAG2, PRKAR1B, PRKAR2A, PRKAR2B, PRKCA, PRKCB, PRKCE, PRKCH, PRKCI, PRKCQ, PRKCSH, PRKCZ, PRKD1, PRKD2, PRKD3, PRKDC, PRKG1, PRKRA, PRKRIPI, PRKX, PRKY, PRMT1, PRMT2, PRMT3, PRMT5, PRMT7, PRMT9, PROCAI, PROK2, PROS1, PROSERI, PROSER2, PROSER3, PRPF18, PRPF3, PRPF38A, PRPF38B, PRPF39, PRPF4, PRPF40A, PRPF40B, PRPF4B, PRPF6, PRPF8, PRPSAP1, PRPSAP2, PRR12, PRR13, PRR14, PRR14L, PRR16, PRR5, PRR5-ARHGAP8, PRR5L, PRRC2B, PRRC2C, PRRG1, PRRG4, PRRT4, PRSS12, PRSS16, PRTFDC1, PRTG, PRUNE1, PSAT1, PSD, PSD3, PSEN1, PSEN2, PSIP1, PSMA1, PSMA3-AS1, PSMA4, PSMA6, PSMB1, PSMB3, PSMB5, PSMC5, PSMC6, PSMD10, PSMD11, PSMD13, PSMD4, PSMD5, PSMD9, PSME2, PSME4, PSMG1, PSMG2, PSPC1, PSPH, PSRC1, PSTK, PSTPIP1, PSTPIP2, PTAR1, PTBP1, PTBP3, PTCD1, PTCD2, PTCD3, PTCHI, PTCHD4, PTDSS2, PTEN, PTER, PTGER3, PTGES3, PTGES3L, PTGES3L-AARSD1, PTGFRN, PTGIS, PTGR1, PTGR2, PTGS1, PTK2, PTK2B, PTK7, PTOV1, PTP4A2, PTP4A3, PTPA, PTPDC1, PTPMT1, PTPN1, PTPN12, PTPN13, PTPN18, PTPN2, PTPN21, PTPN22, PTPN23, PTPN3, PTPN4, PTPN9, PTPRA, PTPRC, PTPRD, PTPRE, PTPRF, PTPRG, PTPRG-AS1, PTPRK, PTPRN, PTPRS, PTPRU, PTRH1, PTS, PUF60, PUM1, PUM2, PUM3, PURPL, PUS1, PUS10, PUS7, PUSL1, PVR, PVRIG2P, PVT1, PWWP2A, PXDC1, PXDN, PXK, PXMP2, PXN, PXN-AS1, PXYLP1, PYCR1, PYCR2, PYCR3, PYGB, PYM1, PYROXD1, PYROXD2, QDPR, QKI, QPCTL, QPRT, QRICH1, QRSL1, QSER1, QSOX2, QTRT1, QTRT2, R3HCC1L, R3HDM1, R3HDM2, R3HDM4, RAB11FIP1, RAB11FIP2, RAB11FIP3, RAB11FIP5, RABI 3, RABI 5, RABI 8,
RAB21, RAB22A, RAB23, RAB24, RAB27A, RAB27B, RAB28, RAB29, RAB30, RAB34, RAB35, RAB36, RAB38, RAB3GAP1, RAB3GAP2, RAB3IP, RAB40B, RAB40C, RAB44, RAB4A, RAB4B, RAB4B-EGLN2, RAB5A, RAB5B, RAB6A, RAB8B, RAB9A, RABAC1, RABEP1, RABEPK, RABGAP1, RABGAP1L, RABGEF1, RABGGTB, RABL2A, RABL2B, RABL3, RABL6, RAC1, RAC3, RACGAP1, RADI, RAD17, RAD18, RAD50, RAD51, RAD51 API, RAD51B, RAD51C, RAD51D, RAD51L3-RFFL, RAD52, RAD54B, RAD54L, RAD54L2, RAD9A, RADIL, RAFI, RAI1, RAI14, RALA, RALB, RALGAPA1, RALGAPA1P1, RALGAPA2, RALGAPB, RALGDS, RALGPS1, RALGPS2, RALY, RANBP10, RANBP17, RANBP2, RANBP3, RANGAP1, RANGRF, RAP1A, RAP IB, RAP1GAP2, RAP1GDS1, RAP2C, RAP2C-AS1, RAPGEF1, RAPGEF2, RAPGEF6, RAPGEFL1 , RAPH1 , RARA, RARS2, RASA1, RASA3, RASAL2, RASAL3, RASEF, RASGRF2, RASGRP1, RASGRP3, RASL1OB, RASSF1, RASSF2, RASSF3, RASSF4, RASSF8, RASSF8-AS1, RAVER2, RBI, RB1CC1, RBAK, RBAK-RBAKDN, RBBP5, RBBP6, RBBP7, RBBP8, RBBP9, RBCK1, RBFA, RBFOX2, RBL1, RBL2, RBM10, RBM11, RBM12B, RBM14-RBM4, RBM15-AS1, RBM18, RBM19, RBM20, RBM22. RBM23, RBM25, RBM26, RBM26-AS1, RBM27, RBM28, RBM33, RBM34, RBM38, RBM39, RBM4, RBM41, RBM42, RBM47, RBM48, RBM5, RBM6, RBM7, RBMS1, RBMS2, RBMS3, RBMXL1, RBPJ, RBPMS, RBSN, RBX1, RC3H1, RC3H2, RCAN3, RCBTB1, RCBTB2, RCC1, RCC1L, RCC2, RCCD1, RCE1, RCHY1, RCL1, RCN3, RCOR2, RCOR3, RD3, RDH11, RDH13, RDM! , RECK, RECQL, RECQL4, RECQL5, REEP3, REEP4, RELA, RELB, RELL2, REPIN1, REPSI, RER1, RERE, RERG, RET, RETREG1, RETREG3, RETSAT, REV1, REV3L, REX1BD, REXO1, REXO2, REXO5, RFC1, RFC2, RFC3, RFC5, RFESD, RFFL, RFT1, RFWD3, RFX1, RFX2, RFX3, RFX7, RFX8, RFXANK, RGL1, RGN, RGP1, RGPD5, RGPD6, RGS1O, RGS11, RGS12, RGS14, RGS19, RGS3, RGS5, RGS7, RHBDD1, RHBDD2, RHBDD3, RHBDF2, RHBDL1, RHCE, RHOBTB1, RHOBTB3, RHOC, RHOJ, RHOQ, RHOT1, RHOT2, RHOU, RIC1, RIC8B, RICTOR, RIDA, RIF1, RILPL1, RILPL2, RIMBP2, RIMS1, RIMS2, RIMS3, RIN1, RIN3, RINT1, RIOK1, RIOK2, RIOK3, RIOX2, RIPK1, RIPK2, RIPOR1, RIPPL Y2, RITAI, RLF, RLIM, RMCI, RMDN1, RMDN2, RMDN3, RMI1, RMND1, RMND5A, RMND5B, RNASE4, RNASEH1-AS1, RNASEH2B, RNASEK, RNASEK-C17orf49, RNASET2, RND3, RNF10, RNF103-CHMP3, RNF111, RNF114, RNF115, RNF121, RNF123, RNF126, RNF13, RNF130, RNF135, RNF138, RNF14, RNF146, RNF150, RNF152, RNF157, RNF165, RNF166, RNF167, RNF168, RNF170, RNF175, RNF181, RNF185, RNF19A, RNF2, RNF212, RNF213, RNF214, RNF215, RNF216, RNF216P1, RNF217, RNF219, RNF220, RNF24, RNF25, RNF34, RNF38, RNF4, RNF44, RNF8, RNFT1, RNFT2, RNGTT, RNLS, RNMT, RNPC3, RNPEP, RNU5D-1, RNU5E-1, ROBO1, ROBO2, ROBO3, ROCK1, ROCK2, ROGDI, ROR2, RORA-AS1, RP9P, RPA2, RPAIN, RPAP2, RPAP3, RPE, RPF2, RPGR, RPGRIP1L, RPH3AL, RPIA, RPL17, RPL17- C18orf32, RPL18A, RPL22, RPL23AP53, RPL23AP7, RPL23AP82, RPL27A, RPL29, RPL32P3, RPL34-AS1, RPL36A-HNRNPH2, RPL39, RPL41, RPL7L1, RPN2, RPP25L, RPP30, RPP38, RPP40, RPRD1A, RPRD1B, RPRD2, RPS1O, RPS10-NUDT3, RPS17, RPS24, RPS26, RPS27, RPS6KA1, RPS6KA2, RPS6KA3, RPS6KA4, RPS6KA6, RPS6KB1, RPS6KB2, RPS6KC1, RPS6KL1, RPSAP52, RPSAP58, RPTOR, RPUSD1, RPUSD3, RRAGB, RRAGD, RRBP1, RRH, RRM1, RRM2B, RRN3, RRN3P2, RRN3P3, RRNAD1, RRP1, RRP12, RRP1B, RRP7BP, RRP8, RSAD1, RSF1, RSG1, RSPRY1, RSRC1, RSRC2, RSRP1, RSU1, RTCA, RTEL1, RTEL1-TNFRSF6B, RTKN, RTKN2, RTN1, RTN2, RTN3, RTN4,
RTRAF, RTTN, RUBCN, RUBCNL, RUFY1, RUFY2, RUFY3, RUNX1, RUNX1T1, RUNX2, RUSC1, RUVBL2, RWDD1, RWDD2B, RWDD3, RWDD4, RXFP1, RXYLT1, RYK, S100A13, S100A16, SIOOB, S100PBP, SAAL1, SAC3D1, SACS, SAMD11, SAMD12, SAMD14, SAMD3, SAMD4A, SAMD4B, SAMD9, SAMD9L, SAMHD1, SAP130, SAP25, SAP30BP, SAP30L, SAPCD2, SAR1A, SAR1B, SARAF, SARDH, SARS2, SART1, SART3, SASS6, SAT1, SAT2, SATB1-AS1, SAV1, SBDSP1, SBF1, SBF2, SBF2-AS1, SBNO1, SCAF1, SCAF11, SCAF8, SCAI, SCAMPI, SCAMP2, SCAMP3, SCAMP4, SCAMP5, SCAP, SCAPER, SCARB1, SCARB2, SCARF2, SCFD1, SCFD2, SCG3, SCG5, SCGB1B2P, SCHIP1, SCLT1, SCLY, SCMH1, SCML2, SCML4, SCN8A, SCN9A, SCNM1, SCOC, SCOC-AS1, SCPEP1, SCRIB, SCRN1, SCRN3, SCUBE2, SCYL1, SCYL2, SDC2, SDCBP2-AS1, SDCCAG3, SDCCAG8, SDE2, SDF2, SDHA, SDHAF2, SDHAF3, SDHAF4, SDHAP1 , SDHAP2, SDHC, SDHD, SDR39U1, SDSL, SEC11C, SEC13, SEC14L1, SEC14L2, SEC16A, SEC22A, SEC22B, SEC22C, SEC24A, SEC24B, SEC24C, SEC31A, SEC31B, SEC61A2, SEC62, SECISBP2, SECISBP2L, SEH1L, SEL1L, SELENBP1, SELENOH, SELENOI, SELENOK, SEMI, SEMA3A, SEMA3C, SEMA3F, SEMA4A, SEMA4B, SEMA4C, SEMA4D, SEMA4F, SEMA5A, SEMA6C, SEMA6D, SEMA7A, SENP1, SENP2, SENP3, SENP3-EIF4A1, SENP5, SENP6, SENP7, SEPHS1, SEPSECS, SEPT10, SEPT2, SEPT3, SEPT7, SEPT7P2, SEPT8, SEPT9, SERAC1, SERF2, SERGEF, SERINGA, SERP2, SERPINA1, SERTAD3, SERTAD4, SERTAD4-AS1, SESN1, SESTD1, SETD2, SETD3, SETD4, SETD5, SETD9, SETDB1, SETDB2, SETDB2-PHF11, SETMAR, SETX, SEZ6L, SEZ6L2, SF1, SF3A2, SF3A3, SF3B3, SF3B6, SFI1, SFMBT1, SFMBT2, SFSWAP, SFT2D1, SFT2D2, SFTA3, SFXN1, SFXN2, SFXN4, SFXN5, SGCB, SGCE, SGCG, SGF29, SGIP1, SGK3, SGK494, SGMS1, SGO1, SGO2, SGPL1, SGSM1, SGSM2, SGSM3, SGTB, SH2B1, SH2D4A, SH3BGR, SH3BP1, SH3BP2, SH3BP5, SH3D19, SH3GL1, SH3GL3, SH3GLB1, SH3GLB2, SH3KBP1, SH3PXD2A, SH3PXD2B, SH3YL1, SHANK1, SHANK3, SHARPIN, SHC1, SHC2, SHCBP1, SHF, SHISA4, SHISA5, SHKBP1, SHMT1, SHOC2, SHOX2, SHPK, SHPRH, SHQ1, SHROOM2, SHTN1, SIDT1, SIDT2, SIGIRR, SIGLEC1, SIGLEC7, SIGMAR1, SIK2, SIK3, SIKE1, SIL1, SIM1, SIM2, SIMC1, SIN3A, SIN3B, SINHCAF, SIPA1, SIPA1L1, SIPA1L2, SIPA1L3, SIRPB1, SIRT2, SIRT3, SIRT5, SIRT6, SIRT7, SIVA1, SIX5, SKA1, SKA2, SKA3, SKAP2, SKP2, SLAIN1, SLAIN2, SLAMF7, SLC10A7, SLC11A1, SLC12A2, SLC12A4, SLC12A6, SLC12A7, SLC12A9, SLC15A4, SLC16A10, SLC16A4, SLC16A7, SLC17A5, SLC18A1, SLC1A1, SLC1A3, SLC1A4, SLC22A15, SLC22A16, SLC22A17, SLC22A18, SLC22A23, SLC22A4, SLC23A2, SLC24A1, SLC25A1, SLC25A10, SLC25A11, SLC25A12, SLC25A13, SLC25A14, SLC25A15, SLC25A17, SLC25A19, SLC25A20, SLC25A21, SLC25A23, SLC25A25, SLC25A26, SLC25A29, SLC25A30, SLC25A32, SLC25A33, SLC25A36, SLC25A37, SLC25A38, SLC25A39, SLC25A40, SLC25A42, SLC25A43, SLC25A44, SLC25A46, SLC25A53, SLC26A10, SLC26A11, SLC26A6, SLC26A7, SLC27A4, SLC27A5, SLC29A1, SLC29A2, SLC29A3, SLC29A4, SLC2A11, SLC2A13, SLC2A14, SLC2A6, SLC2A8, SLC2A9, SLC30A4, SLC30A5, SLC30A6, SLC30A9, SLC33A1, SLC35A1, SLC35A2, SLC35A3, SLC35A5, SLC35B1, SLC35B3, SLC35B4, SLC35C2, SLC35D2, SLC35E2A, SLC35E2B, SLC35E3, SLC35F2, SLC35F5, SLC35F6, SLC35G1, SLC36A1, SLC36A4, SLC37A1, SLC37A2, SLC37A3, SLC37A4, SLC38A1, SLC38A10, SLC38A2, SLC38A3, SLC38A6, SLC38A7, SLC38A9, SLC39A11, SLC39A13, SLC39A14, SLC39A4, SLC39A8, SLC39A9, SLC3A2, SLC41A1, SLC41A2, SLC41A3, SLC43A1, SLC43A2, SLC44A1, SLC44A2, SLC44A5,
SLC46A1, SLC47A1, SLC49A3, SLC4A10, SLC4A2, SLC4A5, SLC4A7, SLC4A8, SLC50A1, SLC5A4-AS1, SLC5A6, SLC6A11, SLC6A12, SLC6A2, SLC6A6, SLC6A8, SLC6A9, SLC7A11, SLC7A2, SLC7A6, SLC7A8, SLC8A1, SLC8A1-AS1, SLC9A1, SLC9A5, SLC9A7, SLC9A8, SLC9B2, SLC02A1, SLC04A1, SLF1, SLFN11, SLFN12L, SLFN13, SLFN5, SLIT1, SLIT2, SLIT3, SLMAP, SLMO2-ATP5E, SLTM, SLU7, SLX4, SLX4IP, SMA4, SMAD2, SMAD3, SMAD4, SMAD5, SMAD6, SMAD9, SMAP I, SMAP2, SMARCA1, SMARCA4, SM ARC ADI, SMARCAL1, SMARCC1, SMARCC2, SMARCD1, SMARCD3, SMARCE1, SMC1A, SMC2, SMC3, SMC4, SMC5, SMC6, SMCHD1, SMC04, SMG1, SMG1P1, SMG1P2, SMG1P3, SMG5, SMG6, SMG7, SMILR, SMIM13, SMIM14, SMIM19, SMIM20, SMIM7. SMIM8, SMN1, SM0C1, SMOX, SMPD4, SMPDL3A, SMS, SMTN, SMU1, SMUG1 , SMURF1 , SMURF2, SMURF2P1-LRRC37BP1, SMYD2, SMYD3, SMYD4, SNAI3-AS1, SNAP23, SNAP25, SNAP47, SNAPCI, SNAPC3, SNAPC4, SNAPC5, SNAPIN, SNCA, SNCAIP, SNED1, SNF8, SNHG1, SNHG11, SNHG12, SNHG14, SNHG15, SNHG16, SNHG17, SNHG20, SNHG21, SNHG4, SNHG5, SNHG6, SNHG8, SNRK, SNRNP27, SNRNP48, SNRPA1, SNRPC, SNRPD2, SNRPE, SNRPG, SNRPN, SNTB1, SNTB2, SNUPN, SNX1, SNX11, SNX13, SNX14, SNX15, SNX16, SNX17, SNX2, SNX22, SNX24, SNX25, SNX27, SNX29, SNX30, SNX4, SNX5, SNX6, SNX7, SOAT1, SOBP, SOCS4, SOCS6, SOD2, SOGA1, SOGA3, SOHLH2, SON, SORBS1, SORBS2, SORBS3, SORCS1, SORL1, SOS1, SOS2, SOX15, SOX6, SP100, SP110, SP140L, SP2, SP3, SP4, SPACA9, SPAG1, SPAG16, SPAG4, SPAG5, SPAG6, SPAG9, SPART, SPAST, SPATA13, SPATA17, SPATA18, SPATA20, SPATA2L, SPAT A33, SPATA5, SPATA5L1, SPATA6, SPATA7, SPATS2, SPATS2L, SPC25, SPDL1, SPDYC, SPECC1, SPECC1L, SPECC1L-ADORA2A, SPEG, SPEN, SPG11, SPG21, SPG7, SPHK2, SPIB, SPICE1, SPIDR, SPIN1, SPINT1, SPIRE1, SPNS1, SPNS3, SPOP, SPOUT1, SPP1, SPPL2A, SPPL2B, SPPL3, SPRED1, SPRED2, SPRTN, SPRY2, SPRY4-AS1, SPRYD3, SPRYD7, SPSB4, SPTAN1, SPTBN1, SPTBN2, SPTBN4, SPTLC1, SPTLC2, SQLE, SQOR, SQSTM1, SRA1, SRBD1, SRC, SRCAP, SRCIN1, SRD5A1, SRD5A3, SREBF1, SREBF2, SREK1, SREK1IP1, SRGAP1, SRGAP2, SRM, SRP14-AS1, SRP19, SRP54, SRP54-AS1, SRP72, SRP9, SRPK1, SRPK2, SRPX, SRRM1, SRRM2, SRSF11, SRSF12, SRSF2, SRSF4, SRSF5, SRSF7, SRSF9, SS18, SS18L1, SSBP2, SSBP3, SSBP4, SSC5D, SSFA2, SSH1, SSH2, SSR1, SSSCA1, SSX2IP, STB, STM, ST20, ST20-MTHFS, ST3GAL1, ST3GAL2, ST3GAL3, ST3GAL4, ST3GAL6, ST5, ST6GAL1, ST6GALNAC3, ST6GALNAC4, ST6GALNAC6, ST7, ST7-OT4, ST7L, ST8SIA5, STAC, STAC3, STAG1, STAG2, STAG3L1, STAG3L4, STAG3L5P, STAG3L5P-PVRIG2P-PILRB, STAM, STAMBP, STAMBPL1, STAP2, STARD10, STARD13, STARD3NL, STARD4, STARD5, STARD7, STARD8, STARD9, STAT1, STAT2, STAT5A, STAT5B, STAU1, STAU2, STEAP1B, STEAP2, STEAP3, STIL, STIM1, STIM2, STIMATE, STIP1, STK10, STK11IP, STK16, STK17A, STK25, STK26, STK3, STK32C, STK33, STK36, STK38, STK38L, STK39, STK4, STK40, STN1, STON1, STON1-GTF2A1L, STON2, STOX2, STPG1, STRA6, STRADA, STRADB, STRBP, STRIP1, STRIP2, STRN, STRN3, STRN4, STT3A, STT3B, STX10, STX12, STX16, STX16-NPEPL1, STX18, STX18-AS1, STX2, STX3, STX4, STX5, STX6, STX8, STXBP2, STXBP3, STXBP4, STXBP5, STXBP5-AS1, STXBP5L, STYX, STYXL1, SUB1, SUCLA2, SUCLG2, SUCLG2-AS1, SUCO, SUDS3, SUFU, SUGCT, SUGP1, SUGP2, SUGT1, SULF1, SULF2, SULT1C4, SUMF1, SUMF2, SUM01, SUN1, SUN2, SUOX, SUPT20H, SUPT3H, SUPT5H, SUPT7L, SUPV3L1, SURF1, SURF2, SURF4, SUSD1, SUSD3, SUSD6, SUV39H2, SUZ12, SUZ12P1, SVEP1, SVIL, SVIL-AS1, SWT1, SYCE2,
SYCP2L, SYDE1, SYDE2, SYK, SYNC, SYNCRIP, SYNE1, SYNE2, SYNE4, SYNGR2, SYNJ1, SYNJ2, SYNJ2BP, SYNJ2BP-COX16, SYNP02, SYNRG, SYP, SYS1-DBNDD2, SYT1, SYT11, SYT14, SYT9, SYTL1, SYTL2, SYTL3, SYVN1, SZRD1, SZT2, TAB2, TAB3, TACC1, TADA1, TADA2A, TADA3, TAF1, TAF11, TAF13, TAF15, TAFIA, TAF1B, TAF1C, TAF1D, TAF2, TAF3, TAF4, TAF4B, TAF5, TAF5L, TAF6, TAF6L, TAF8, TAF9B, TANCI, TANC2, TANG02, TANG06, TANK, TA0K1, TAOK2, TAOK3, TAPT1, TARBP 1, TARBP2, TARS, TARS2, TARSL2, TAS2R31, TASP1, TATDN1, TATDN3, TAZ, TBC1D1, TBC1D10A, TBC1D12, TBC1D13, TBC1D14, TBC1D15, TBC1D16, TBC1D17, TBC1D19, TBC1D20, TBC1D22A, TBC1D22B, TBC1D23, TBC1D24, TBC1D25, TBC1D2B, TBC1D30, TBC1D31, TBC1D32, TBC1D4, TBC1D5, TBC1D7, TBC1D7-LOC100130357, TBC1D8, TBC1D8B, TBC1D9, TBC1D9B, TBCCD1, TBCD, TBCEL, TBCK, TBK1, TBKBP1, TBL1X, TBL1XR1, TBL3, TBPL1, TBRG1, TBRG4, TBX1, TBX15, TBX2-AS1, TBX6, TBXA2R, TBXAS1, TC2N, TCAF1, TCAIM, TCEA1, TCEA2, TCEAL1, TCEAL3, TCEAL8, TCEAL9, TCERG1, TCF12, TCF20, TCF25, TCF3, TCF4, TCF7, TCF7L1, TCF7L2, TCFL5, TCOF1, TCP11L1, TCP11L2, TCTEX1D2, TCTN1, TCTN3, TDG, TDP1, TDP2, TDRD3, TDRKH, TEAD1, TEAD2, TEAD4, TECPR1, TECPR2, TEDC1, TEDC2, TEFM, TEKT4P2, TELO2, TENM1, TENM2, TENM3, TENM4, TEPSIN, TERFI, TERF2, TES, TESK2, TESMIN, TET1, TET2, TET2-AS1, TEX 10, TEX 14, TEX15, TEX261, TEX264, TEX30, TEX41, TEX9, TFAM, TFAP2B, TFAP4, TFB1M, TFB2M, TFCP2, TFDP1, TFDP2, TFE3, TFEB, TFEC, TFIP11, TFPI, TFR2, TFRC, TGDS, TGFBR1, TGFBR2, TGFBR3, TGIF2, TGIF2-C20orf24, TGS1, THADA, THAP1, THAP12, THAP3, THAP5, THAP6, THAP9, THAP9-AS1, THBS3, THBS4, THEM4, THEM6, THEMIS, THEMIS2, THOC1, THOC2, THOC5, THOC6, THOC7, THRAP3, THRB, THSD4, THSD7A, THTPA, THUMPD2, THUMPD3, THYN1, TIA1, TIAL1, TIAM1, TIFA, TIGAR, TIGD6, TIMELESS, TIMM17B, TIMM21, TIMM23, TIMM23B, TIMM50, TIMM8B, TIMM9, TIMMDC I, TINF2, TIPIN, TIPRL, TIRAP, TIAP1, TJP1, TKFC, TLCD2, TLDC1, TLE1, TLE4, TLK1, TLK2, TLL2, TLN1, TLX2, TM2D1, TM2D3, TM7SF2, TM7SF3, TM9SF1, TM9SF3, TM9SF4, TMA16, TMBIM4, TMC6, TMCC1, TMCO3, TMCO4, TMCO6, TMED3, TMED7-TICAM2, TMED8, TMEFF2, TMEM104, TMEM106A, TMEM106B, TMEM106C, TMEM107, TMEM108, TMEM11, TMEM110-MUSTN1, TMEM116, TMEM117, TMEM120A, TMEM120B, TMEM126A, TMEM126B, TMEM128, TMEM131, TMEM131L, TMEM134, TMEM135, TMEM136, TMEM138, TMEM141, TMEM143, TMEM144, TMEM145, TMEM14B, TMEM14C, TMEM150A, TMEM150B, TMEM159, TMEM161A, TMEM161B, TMEM161B-AS1, TMEM164, TMEM167A, TMEM167B, TMEM168, TMEM175, TMEM181, TMEM182, TMEM183B, TMEM184B, TMEM185A, TMEM187, TMEM192, TMEM198B, TMEM200A, TMEM206, TMEM209, TMEM214, TMEM218, TMEM219, TMEM220, TMEM222, TMEM231, TMEM234, TMEM237, TMEM241, TMEM245, TMEM248, TMEM249, TMEM254, TMEM255A, TMEM255B, TMEM259, TMEM260, TMEM263, TMEM266, TMEM267, TMEM268, TMEM30A, TMEM33, TMEM38B, TMEM39A, TMEM39B, TMEM41B, TMEM42, TMEM44, TMEM45A, TMEM50A, TMEM50B, TMEM51, TMEM53, TMEM56-RWDD3, TMEM62, TMEM63A, TMEM63B, TMEM65, TMEM67, TMEM68, TMEM70, TMEM71, TMEM87A, TMEM87B, TMEM94, TMEM98, TMEM9B, TMOD1, TMOD2, TMOD3, TMOD4, TMPO, TMSB15B, TMTC1, TMTC2, TMTC3, TMTC4, TMUB1, TMUB2, TMX1, TMX2, TMX2-CTNND1, TMX3, TNC, TNFAIP1, TNFAIP8, TNFAIP8L2- SCNM1, TNFRSF10A, TNFRSF11A, TNFRSF12A, TNFRSF19, TNFRSF1A, TNFRSF6B,
TNFSF12, TNFSF12-TNFSF13, TNFSF13, TNIK, TNIP1, TNIP2, TNIP3, TNK2, TNKS, TNKS2, TNNT1, TNP01, TNPO3, TNR, TNRC18, TNRC6A, TNRC6B, TNRC6C, TNS1, TOBI, TOE1, TOGARAMI, TOLLIP, TOMI, TOM1L1, TOM1L2, TOMM34, TOMM40, TOMM40L, TOMM70, TOPI, TOP1MT, TOP2A, TOP2B, TOP3A, TOP3B, TOPBP 1, TOR1AIP2, TOR1B, TOR2A, TOR3A, TP53BP2, TP53I11, TP53I3, TP53TG1, TP73, TP73- AS1, TPCN1, TPCN2, TPD52, TPD52L1, TPD52L2, TPGS2, TPK1, TPM1, TPM2, TPM3, TPM3P9, TPMT, TPP2, TPR, TPRA1, TPRG1L, TPST1, TPST2, TPT1-AS1, TPTE2P5, TPTE2P6, TPTEP1, TPX2, TRA2A, TRABD2A, TRAF2, TRAF3, TRAF3IP1, TRAF3IP2, TRAF3IP2-AS1, TRAFD1, TRAIP, TRAK1, TRAK2, TRAM1, TRAM2, TRANK1, TRAPPC10, TRAPPCI 1, TRAPPC12, TRAPPC13, TRAPPC2, TRAPPC2L, TRAPPC3, TRAPPC4, TRAPPC6A, TRAPPC6B, TRAPPC8, TRAPPC9, TRDMT1 , TRERF1 , TRIM16, TRIM16L, TRIM2, TRIM23, TRIM24, TRIM26, TRIM28, TRIM3, TRIM32, TRIM33, TRIM35, TRIM36, TRIM37, TRIM4 I, TRIM44, TRIM59-IFT80, TRIM65, TRIM68, TRIM73, TRIM9, TRIO, TRIP 10, TRIP 12, TRIP 13, TRIP4, TRIP6, TRIQK, TRIT1, TRMO, TRMT1, TRMT10A, TRMT10B, TRMT11, TRMT1L, TRMT2A, TRMT2B, TRMT6, TRMT61A, TRMT61B, TRMU, TRNAU1AP, TRNT1, TRO, TROVE2, TRPC1, TRPC4, TRPC4AP, TRPM2, TRPM4, TRPM7, TRPS1, TRPT1, TRPV1, TRPV2, TRRAP, TRUB1, TSACC, TSC2, TSC22D1, TSC22D2, TSC22D4, TSEN15, TSEN2, TSEN54, TSFM, TSG101, TSGA10, TSHZ2, TSKS, TSNARE1, TSNAX, TSNAXIP1, TSPAN12, TSPAN13, TSPAN14, TSPAN15, TSPAN17, TSPAN18, TSPAN31, TSPAN4, TSPAN5, TSPAN9, TSPOAP1-AS1, TSR1, TSR3, TSSC2, TSSC4, TSTD2, TSTD3, TTBK1, TTBK2, TTC12, TTC13, TTC17, TTC19, TTC21B, TTC23, TTC26, TTC27, TTC28, TTC28-AS1, TTC3, TTC31, TTC33, TTC37, TTC38, TTC39A, TTC39B, TTC39C, TTC4, TTC5, TTC7A, TTC7B, TTC8, TTC9C, TTF1, TTF2, TTI1, TTI2, TTK, TTL, TTLL11, TTLL12, TTLL3, TTLL4, TTLL5, TTLL7, TTN-AS1, TTP AL, TTTY14, TTYH2, TTYH3, TUB, TUBB6, TUBD1, TUBE1, TUBG2, TUBGCP2, TUBGCP3, TUBGCP4, TUBGCP5, TUBGCP6, TUFT1, TUG1, TULP3, TULP4, TUT1, TVP23A, TVP23C, TVP23C-CDRT4, TWF1, TWF2, TWIST2, TWNK, TXK, TXLNA, TXLNG, TXLNGY, TXN, TXNDC11, TXNDC15, TXNDC16, TXNDC9, TXNIP, TXNL4A, TXNL4B, TXNRD1, TXNRD3, TXNRD3NB, TYK2, TYMP, TYRO3, TYSND1, TYW1, TYW1B, TYW3, TYW5, U2AF1, U2AF1L4, U2AF1L5, U2AF2, U2SURP, UACA, UAP1, UBA2, UBA3, UBA5, UBA6, UBA6-AS1, UBA7, UBAC2, UBAP1, UBAP2, UBAP2L, UBC, UBE2A, UBE2B, UBE2D1, UBE2D2, UBE2D3, UBE2D4, UBE2E3, UBE2F, UBE2F-SCLY, UBE2G1, UBE2G2, UBE2H, UBE2I1, UBE2J2, UBE2K, UBE2L3, UBE2Q1, UBE2Q2, UBE2Q2P1, UBE2Q2P2, UBE2R2, UBE2W, UBE2Z, UBE3A, UBE3B, UBE3C, UBE3D, UBE4A, UBE4B, UBFD1, UB1AD1, UBL7, UBL7-AS1, UBN1, UBN2, UBOX5, UBP1, UBQLN1, UBQLN4, UBR1, UBR2, UBR3, UBR4, UBR5, UBR7, UBTF, UBXN1, UBXN11, UBXN2A, UBXN2B, UBXN4, UBXN6, UBXN7, UBXN8, UCHL1, UCHL5, UCP2, UEVLD, UFC1, UFD1, UFM1, UFSP2, UGCG, UGDH, UGGT2, UGP2, UGT8, UHRF1, UHRF1BP1, UHRF1BP1L, UHRF2, UIMC1, ULK2, ULK3, ULK4, ULK4P1, ULK4P2, ULK4P3, UM AD I , UNCI 19, UNC119B, UNC13A, UNC13B, UNC45A, UNC50, UNC5B, UNC5C, UNG, UNK, UNKL, UPF2, UPF3A, UPF3B, UPP1, UPRT, UQCC1, UQCC2, UQCRH, URB1, URB2, URGCP, URGCP-MRPS24, URI1, URM1, UROS, USB1, USE1, USF2, USO1, USP1, USP10, USP12, USP13, USP14, USP15, USP16, USP19, USP2-AS1, USP21, USP22, USP24, USP25, USP28, USP3, USP30, USP31, USP32, USP33, USP34, USP37, USP38, USP39, USP4, USP40, USP42, USP43, USP45, USP46, USP47, USP48, USP49, USP53, USP54, USP6NL, USP8,
USP9X, USP9Y, USPL1, UTP15, UTP18, UTP23, UTP4, UTP6, UTRN, UTS2R, UTY, UVRAG, UXS1, UXT, VAC14, VAMP3, VAMP4, VAMP5, VANGL1, VAPB, VASH1, VASH1-AS1, VASH2, VAV1, VAV2, VAV3, VC AN, VCL, VCP, VDAC1, VDAC2, VDAC3, VDR, VEGFA, VEGFB, VEGFC, VEPH1, VEZF1, VEZT, VGF, VGLL4, VHL, VIPAS39, VIRMA, VIT, VK0RC1, VKORC1L1, VLDLR, VLDLR-AS1, VMP1, VOPP1, VPS 13 A, VPS13B, VPS13C, VPS13D, VPS26A, VPS26B, VPS26C, VPS28, VPS29, VPS33A, VPS33B, VPS35, VPS35L, VPS36, VPS37A, VPS37B, VPS41, VPS4B, VPS50, VPS53, VPS54, VPS72, VPS8, VPS9D1-AS1, VRK1, VRK3, VSIG10, VSNL1, VSTM2L, VTI1A, VTI1B, VWA8, WAC, WAPL, WARS, WARS2, WASF1, WASF3, WASH3P, WASHC2A, WASHC2C, WASHC3, WASHC4, WASHC5, WBP2, WBP4, WDFY1, WDFY2, WDFY3, WDFY3-AS2, WDFY4, WDHD 1 , WDPCP, WDR1 , WDR1 1 , WDR12, WDR18, WDR19, WDR20, WDR24, WDR25, WDR27, WDR33, WDR34, WDR35, WDR36, WDR37, WDR4, WDR41, WDR43, WDR44, WDR45, WDR48, WDR53, WDR54, WDR59, WDR60, WDR61, WDR62, WDR66, WDR7, WDR70, WDR73, WDR75, WDR77, WDR81, WDR82, WDR83, WDR89, WDR90, WDR92, WDSUB1, WDTC1, WDYHV1, WHAMM, WHAMMP2, WIPF1, WIPF2, WIPI2, W1SP1, W1Z, WLS, WNK1, WNK2, WNK4, WNT3, WRAP73, WRB-SH3BGR, WRN, WRNIP1, WSB1, WSB2, WSCD1, WTAP, WWC1, WWC2, WWC3, WWOX, WWP1, WWP2, XAF1, XG, XGY2, XIAP, XIST, XK, XKR6, XPA, XPNPEP1, XPNPEP3, XPO1, XPO4, XPO5, XPO6, XPO7, XPOT, XPR1, XRCC1, XRCC2, XRCC3, XRCC4, XRN1, XRN2, XRRA1, XXYLT1, XYLB, YAF2, YAP1, YARS2, YBEY, YDJC, YEATS2, YEATS4, YES1, YIF1A, YIPF1, YIPF2, YIPF4, YIPF6, YJEFN3, YKT6, YME1L1, YPEL3, YPEL4, YPEL5, YTHDC2, YTHDF1, YTHDF2, YTHDF3, YWHAZ, YY1AP1, ZASP, ZBED3, ZBED3-AS1, ZBED6, ZBED8, ZBTB1, ZBTB14, ZBTB18, ZBTB20, ZBTB21, ZBTB24, ZBTB25, ZBTB38, ZBTB43, ZBTB44, ZBTB47, ZBTB48, ZBTB49, ZBTB5, ZBTB7B, ZBTB8A, ZBTB8OS, ZC2HC1A, ZC3H10, ZC3H11A, ZC3H13, ZC3H14, ZC3H18, ZC3H3, ZC3H4, ZC3H7A, ZC3H7B, ZC3H8, ZC3HC1, ZCCHC10, ZCCHC11, ZCCHC4, ZCCHC6, ZCCHC7, ZCCHC8, ZCCHC9, ZCWPW1, ZCWPW2, ZDBF2, ZDHHC13, ZDHHC14, ZDHHC16, ZDHHC17, ZDHHC18, ZDHHC2, ZDHHC20, ZDHHC21, ZDHHC3, ZDHHC4, ZDHHC6, ZDHHC7, ZDHHC8, ZDHHC9, ZEB1, ZEB2, ZER1, ZFAND1, ZFAND3, ZFAND4, ZFAND5, ZFAND6, ZFAS1, ZFAT, ZFC3H1, ZFP1, ZFP14, ZFP3O, ZFP41, ZFP62, ZFP64, ZFP69B, ZFP91, ZFP91-CNTF, ZFPM1, ZFPM2-AS1, ZFR, ZFR2, ZFX, ZFY, ZFYVE1, ZFYVE16, ZFYVE19, ZFYVE21, ZFYVE27, ZFYVE28, ZFYVE9, ZGRF1, ZHX1-C8orf76, ZHX2, ZHX3, ZIK1, ZIM2, ZKSCAN1, ZKSCAN3, ZKSCAN5, ZKSCAN7, ZKSCAN8, ZMAT2, ZMAT3, ZMAT4, ZMAT5, ZMIZ1, ZMIZ2, ZMPSTE24, ZMYM2, ZMYM4, ZMYM5, ZMYM6, ZMYND11, ZMYND19, ZMYND8, ZNF10, ZNF100, ZNF106, ZNF107, ZNF112, ZNF121, ZNF124, ZNF131, ZNF133, ZNF134, ZNF136, ZNF138, ZNF140, ZNF141, ZNF142, ZNF143, ZNF146, ZNF148, ZNF160, ZNF177, ZNF180, ZNF189, ZNF195, ZNF197, ZNF202, ZNF207, ZNF211, ZNF212, ZNF213, ZNF215, ZNF225, ZNF227, ZNF23, ZNF232, ZNF236, ZNF236- DT, ZNF239, ZNF248, ZNF25, ZNF250, ZNF251, ZNF252P, ZNF253, ZNF254, ZNF257, ZNF26, ZNF260, ZNF263, ZNF266, ZNF267, ZNF268, ZNF273, ZNF274, ZNF276, ZNF277, ZNF28, ZNF280D, ZNF283, ZNF286A, ZNF292, ZNF3, ZNF30, ZNF300, ZNF302, ZNF316, ZNF317, ZNF319, ZNF320, ZNF322, ZNF326, ZNF329, ZNF330, ZNF337-AS1, ZNF33A, ZNF33B, ZNF343, ZNF345, ZNF346, ZNF35, ZNF350, ZNF354A, ZNF354B, ZNF354C, ZNF365, ZNF367, ZNF37A, ZNF37BP, ZNF383, ZNF384, ZNF385B, ZNF385D, ZNF391, ZNF394, ZNF395, ZNF397, ZNF398, ZNF407, ZNF410, ZNF415, ZNF416, ZNF419, ZNF420,
[00513] RNAseq experiments showed that compounds of Formula (I) induced exon inclusion with a PSI change (APSI) sbof +10% to +100% and /’-value <0.001 or induced exon skipping with a APSI of -10% to -100% and /-value <0.001 in genes having a 5' splice site as shown in Table 9 (5775 entries):
[00514] Table 9
(SEQ ID NO.: 43), AAAAgtaggt (SEQ ID NO.: 44), AAAAgtatac (SEQ ID NO.: 45), AAAAgtatga (SEQ ID NO.: 46), AAAAgtatgc (SEQ ID NO.: 47), AAAAgtatgt (SEQ ID NO.: 48), AAAAgtatta (SEQ ID NO.: 49), AAAAgtcagt (SEQ ID NO.: 50), AAAAgtgaga (SEQ ID NO.: 51), AAAAgtgagc (SEQ ID NO.: 52), AAAAgtgagg (SEQ ID NO.: 53), AAAAgtgagt (SEQ ID NO.: 54), AAAAgtgatt (SEQ ID NO.: 55), AAAAgtgggt (SEQ ID NO.: 56), AAAAgtggtg (SEQ ID NO.: 57), AAAAgtgtaa (SEQ ID NO.: 58), AAAAgtgtgt (SEQ ID NO.: 59), AAAAgttagt (SEQ ID NO.: 60), AAAAgttggt (SEQ ID NO.: 61), AAAAtgaaga (SEQ ID NO.: 62), AAAAtggaac (SEQ ID NO.: 63), AAACgaactg (SEQ ID NO.: 64), AAACgcaggt (SEQ ID NO.: 65), AAACgcagta (SEQ ID NO.: 66), AAACgccagc (SEQ ID NO.: 67), AAACgtaaat (SEQ ID NO.: 68), AAACgtaaca (SEQ ID NO : 69), AAACgtaaga (SEQ ID NO.: 70), AAACgtaagc (SEQ ID NO.: 71), AAACgtaagg (SEQ ID NO : 72), AAACgtaagt (SEQ ID NO.: 73), AAACgtacgt (SEQ ID NO.: 74), AAACgtatcc (SEQ ID NO.: 75), AAACgtatgt (SEQ ID NO.: 76), AAACgtgagc (SEQ ID NO.: 77), AAACgtgagt (SEQ ID NO.: 78), AAACgtgggt (SEQ ID NO.: 79), AAACgtggta (SEQ ID NO.: 80), AAACtggtag (SEQ ID NO.: 81), AAAGgcaaaa (SEQ ID NO.: 82), AAAGgcaaag (SEQ ID NO.: 83), AAAGgcaaga (SEQ ID NO.: 84), AAAGgcaagc (SEQ ID NO.: 85), AAAGgcaagg (SEQ ID NO.: 86), AAAGgcaagt (SEQ ID NO.: 87), AAAGgcaatt (SEQ ID NO.: 88), AAAGgcagat (SEQ ID NO.: 89), AAAGgcagga (SEQ ID NO.: 90), AAAGgcaggt (SEQ ID NO.: 91), AAAGgcatgc (SEQ ID NO.: 92), AAAGgccagt (SEQ ID NO.: 93), AAAGgcgagt (SEQ ID NO.: 94), AAAGggaagt (SEQ ID NO.: 95), AAAGggagct (SEQ ID NO.: 96), AAAGgtaaaa (SEQ ID NO.: 97), AAAGgtaaac (SEQ ID NO.: 98), AAAGgtaaag (SEQ ID NO.: 99), AAAGgtaaat (SEQ ID NO.: 100), AAAGgtaaca (SEQ ID NO.: 101), AAAGgtaacc (SEQ ID NO.: 102), AAAGgtaacg (SEQ ID NO.: 103), AAAGgtaact (SEQ ID NO.: 104), AAAGgtaaga (SEQ ID NO.: 105), AAAGgtaagc (SEQ ID NO.: 106), AAAGgtaagg (SEQ ID NO.: 107), AAAGgtaagt (SEQ ID NO.: 108), AAAGgtaata (SEQ ID NO.: 109), AAAGgtaatc (SEQ ID NO.: 110), AAAGgtaatg (SEQ ID NO.: 111), AAAGgtaatt (SEQ ID NO.: 112), AAAGgtacaa (SEQ ID NO.: 113), AAAGgtacac (SEQ ID NO.: 114), AAAGgtacag (SEQ ID NO.: 115), AAAGgtacat (SEQ ID NO.: 116), AAAGgtacca (SEQ ID NO.: 117), AAAGgtaccc (SEQ ID NO.: 118), AAAGgtaccg (SEQ ID NO.: 119), AAAGgtacct (SEQ ID NO.: 120), AAAGgtacga (SEQ ID NO.: 121), AAAGgtacgc (SEQ ID NO.: 122), AAAGgtacgg (SEQ ID NO.: 123), AAAGgtacgt (SEQ ID NO.: 124), AAAGgtacta (SEQ ID NO.: 125), AAAGgtactc (SEQ ID NO.: 126), AAAGgtactg (SEQ ID NO.: 127), AAAGgtactt (SEQ ID NO.: 128), AAAGgtagaa (SEQ ID NO.: 129), AAAGgtagac (SEQ ID NO.: 130), AAAGgtagag (SEQ ID NO.: 131), AAAGgtagat (SEQ ID NO.: 132), AAAGgtagca (SEQ ID NO.: 133), AAAGgtagcc (SEQ ID NO.: 134), AAAGgtagcg (SEQ ID NO.: 135), AAAGgtagct (SEQ ID NO.: 136), AAAGgtagga (SEQ ID NO.: 137), AAAGgtaggc (SEQ ID NO.: 138), AAAGgtaggg (SEQ ID NO.: 139), AAAGgtaggt (SEQ ID NO.: 140), AAAGgtagta (SEQ ID NO.: 141), AAAGgtagtg (SEQ ID NO.: 142), AAAGgtagtt (SEQ ID NO.: 143), AAAGgtataa (SEQ ID NO.: 144), AAAGgtatac (SEQ ID NO.: 145), AAAGgtatag (SEQ ID NO.: 146), AAAGgtatat (SEQ ID NO.: 147), AAAGgtatca (SEQ ID NO.: 148), AAAGgtatcc (SEQ ID NO.: 149), AAAGgtatct (SEQ ID NO.: 150), AAAGgtatga (SEQ ID NO.: 151), AAAGgtatgc (SEQ ID NO.: 152), AAAGgtatgg (SEQ ID NO.: 153), AAAGgtatgt (SEQ ID NO.: 154), AAAGgtatta (SEQ ID NO.: 155), AAAGgtattc (SEQ ID NO.: 156), AAAGgtattg (SEQ ID NO.: 157), AAAGgtattt (SEQ ID NO.: 158), AAAGgtcaac (SEQ ID NO.: 159), AAAGgtcaag (SEQ ID NO.: 160), AAAGgtcaca (SEQ ID NO.: 161), AAAGgtcacc (SEQ ID NO.: 162), AAAGgtcaga (SEQ ID NO.: 163), AAAGgtcagc (SEQ ID NO.: 164), AAAGgtcagg
T16
(SEQ ID NO.: 165), AAAGgtcagt (SEQ ID NO.: 166), AAAGgtcatt (SEQ ID NO.: 167), AAAGgtccac (SEQ ID NO.: 168), AAAGgtccag (SEQ ID NO.: 169), AAAGgtcctg (SEQ ID NO.: 170), AAAGgtcctt (SEQ ID NO.: 171), AAAGgtcggt (SEQ ID NO.: 172), AAAGgtctaa (SEQ ID NO.: 173), AAAGgtctct (SEQ ID NO.: 174), AAAGgtctga (SEQ ID NO.: 175), AAAGgtctgg (SEQ ID NO.: 176), AAAGgtctgt (SEQ ID NO.: 177), AAAGgtcttc (SEQ ID NO.: 178), AAAGgtcttt (SEQ ID NO.: 179), AAAGgtgaaa (SEQ ID NO.: 180), AAAGgtgaac (SEQ ID NO.: 181), AAAGgtgaag (SEQ ID NO.: 182), AAAGgtgaat (SEQ ID NO.: 183), AAAGgtgacc (SEQ ID NO.: 184), AAAGgtgact (SEQ ID NO.: 185), AAAGgtgaga (SEQ ID NO.: 186), AAAGgtgagc (SEQ ID NO.: 187), AAAGgtgagg (SEQ ID NO.: 188), AAAGgtgagt (SEQ ID NO.: 189), AAAGgtgata (SEQ ID NO.: 190), AAAGgtgatc (SEQ ID NO.: 191), AAAGgtgatg (SEQ ID NO.: 192), AAAGgtgatt (SEQ ID NO.: 193), AAAGgtgcaa (SEQ ID NO.: 194), AAAGgtgcac (SEQ ID NO.: 195), AAAGgtgcag (SEQ ID NO.: 196), AAAGgtgcca (SEQ ID NO.: 197), AAAGgtgccg (SEQ ID NO.: 198), AAAGgtgcct (SEQ ID NO.: 199), AAAGgtgcgt (SEQ ID NO.: 200), AAAGgtgcta (SEQ ID NO.: 201), AAAGgtgctg (SEQ ID NO.: 202), AAAGgtggag (SEQ ID NO.: 203), AAAGgtggat (SEQ ID NO.: 204), AAAGgtggcg (SEQ ID NO.: 205), AAAGgtggga (SEQ ID NO.: 206), AAAGgtgggc (SEQ ID NO.: 207), AAAGgtgggg (SEQ ID NO.: 208), AAAGgtgggt (SEQ ID NO.: 209), AAAGgtggta (SEQ ID NO.: 210), AAAGgtggtg (SEQ ID NO.: 211), AAAGgtgtat (SEQ ID NO : 212), AAAGgtgtga (SEQ ID NO.: 213), AAAGgtgtgc (SEQ ID NO.: 214), AAAGgtgtgg (SEQ ID NO.: 215), AAAGgtgtgt (SEQ ID NO.: 216), AAAGgtgtta (SEQ ID NO.: 217), AAAGgtgttg (SEQ ID NO.: 218), AAAGgttaaa (SEQ ID NO.: 219), AAAGgttaag (SEQ ID NO.: 220), AAAGgttaga (SEQ ID NO.: 221), AAAGgttagc (SEQ ID NO.: 222), AAAGgttagg (SEQ ID NO.: 223), AAAGgttagt (SEQ ID NO.: 224), AAAGgttatg (SEQ ID NO.: 225), AAAGgttcag (SEQ ID NO : 226), AAAGgttcat (SEQ ID NO.: 227), AAAGgttcca (SEQ ID NO.: 228), AAAGgttcga (SEQ ID NO.: 229), AAAGgttcgt (SEQ ID NO.: 230), AAAGgttcta (SEQ ID NO.: 231), AAAGgttctt (SEQ ID NO.: 232), AAAGgttgag (SEQ ID NO.: 233), AAAGgttgat (SEQ ID NO.: 234), AAAGgttgca (SEQ ID NO.: 235), AAAGgttgcc (SEQ ID NO.: 236), AAAGgttgct (SEQ ID NO.: 237), AAAGgttgga (SEQ ID NO.: 238), AAAGgttggc (SEQ ID NO.: 239), AAAGgttggg (SEQ ID NO.: 240), AAAGgttggt (SEQ ID NO.: 241), AAAGgttgtc (SEQ ID NO.: 242), AAAGgttgtg (SEQ ID NO.: 243), AAAGgttgtt (SEQ ID NO.: 244), AAAGgtttac (SEQ ID NO.: 245), AAAGgtttca (SEQ ID NO.: 246), AAAGgtttga (SEQ ID NO.: 247), AAAGgtttgc (SEQ ID NO.: 248), AAAGgtttgg (SEQ ID NO.: 249), AAAGgtttgt (SEQ ID NO.: 250), AAAGgtttta (SEQ ID NO.: 251), AAAGgttttc (SEQ ID NO.: 252), AAAGgttttg (SEQ ID NO.: 253), AAAGgttttt (SEQ ID NO.: 254), AAATctgatt (SEQ ID NO.: 255), AAATgcaagt (SEQ ID NO.: 256), AAATgcacgc (SEQ ID NO.: 257), AAATgcaggt (SEQ ID NO.: 258), AAATgtaaat (SEQ ID NO.: 259), AAATgtaaca (SEQ ID NO.: 260), AAATgtaacg (SEQ ID NO.: 261), AAATgtaaga (SEQ ID NO.: 262), AAATgtaagc (SEQ ID NO.: 263), AAATgtaagg (SEQ ID NO.: 264), AAATgtaagt (SEQ ID NO.: 265), AAATgtaata (SEQ ID NO.: 266), AAATgtaatc (SEQ ID NO.: 267), AAATgtaatg (SEQ ID NO.: 268), AAATgtaatt (SEQ ID NO.: 269), AAATgtacag (SEQ ID NO.: 270), AAATgtacat (SEQ ID NO.: 271), AAATgtacca (SEQ ID NO.: 272), AAATgtacgg (SEQ ID NO.: 273), AAATgtacgt (SEQ ID NO.: 274), AAATgtaggt (SEQ ID NO.: 275), AAATgtagta (SEQ ID NO.: 276), AAATgtatat (SEQ ID NO.: 277), AAATgtatgt (SEQ ID NO.: 278), AAATgtattg (SEQ ID NO.: 279), AAATgtcagc (SEQ ID NO.: 280), AAATgtcagg (SEQ ID NO.: 281), AAATgtcagt (SEQ ID NO.: 282), AAATgtgaga (SEQ ID NO.: 283), AAATgtgagc (SEQ ID NO.: 284), AAATgtgagg (SEQ ID NO.: 285), AAATgtgagt (SEQ ID NO.: 286),
AAATgtgcgc (SEQ ID NO.: 287), AAATgtgcgt (SEQ ID NO.: 288), AAATgtgggc (SEQ ID NO.: 289), AAATgtgggt (SEQ ID NO.: 290), AAATgtggta (SEQ ID NO.: 291), AAATgtggtt (SEQ ID NO.: 292), AAATgtgtaa (SEQ ID NO.: 293), AAATgtgtgt (SEQ ID NO.: 294), AAATgttggc (SEQ ID NO.: 295), AAATttaagt (SEQ ID NO.: 296), AACAgcaagt (SEQ ID NO.: 297), AACAggtaaa (SEQ ID NO.: 298), AACAggtaga (SEQ ID NO.: 299), AACAggtata (SEQ ID NO.: 300), AACAggttta (SEQ ID NO.: 301), AACAgtaaat (SEQ ID NO.: 302), AACAgtaaga (SEQ ID NO.: 303), AACAgtaagc (SEQ ID NO.: 304), AACAgtaagg (SEQ ID NO.: 305), AACAgtaagt (SEQ ID NO.: 306), AACAgtacga (SEQ ID NO.: 307), AACAgtacgt (SEQ ID NO.: 308), AACAgtaggt (SEQ ID NO.: 309), AACAgtatcc (SEQ ID NO.: 310), AACAgtatga (SEQ ID NO. : 311), AACAgtatgt (SEQ ID NO. : 312), AACAgtgaga (SEQ ID NO. : 313), AACAgtgagc (SEQ ID NO.: 314), AACAgtgagt (SEQ ID NO : 315), AACAgtggtg (SEQ ID NO.: 316), AACCgtaagt (SEQ ID NO.: 317), AACCgtatgt (SEQ ID NO.: 318), AACCgtgagc (SEQ ID NO.: 319), AACCgtgagt (SEQ ID NO.: 320), AACGgcaagt (SEQ ID NO.: 321), AACGgtaaaa (SEQ ID NO.: 322), AACGgtaaat (SEQ ID NO.: 323), AACGgtaacc (SEQ ID NO.: 324), AACGgtaact (SEQ ID NO.: 325), AACGgtaaga (SEQ ID NO.: 326), AACGgtaagc (SEQ ID NO.: 327), AACGgtaagg (SEQ ID NO.: 328), AACGgtaagt (SEQ ID NO.: 329), AACGgtaatc (SEQ ID NO.: 330), AACGgtaatg (SEQ ID NO.: 331), AACGgtaatt (SEQ ID NO.: 332), AACGgtaccc (SEQ ID NO : 333), AACGgtacga (SEQ ID NO.: 334), AACGgtacgt (SEQ ID NO.: 335), AACGgtagga (SEQ ID NO : 336), AACGgtaggt (SEQ ID NO.: 337), AACGgtatag (SEQ ID NO.: 338), AACGgtatat (SEQ ID NO.: 339), AACGgtatct (SEQ ID NO.: 340), AACGgtatgc (SEQ ID NO.: 341), AACGgtatgg (SEQ ID NO.: 342), AACGgtatgt (SEQ ID NO.: 343), AACGgtcagc (SEQ ID NO.: 344), AACGgtcagt (SEQ ID NO.: 345), AACGgtgaag (SEQ ID NO.: 346), AACGgtgaga (SEQ ID NO.: 347), AACGgtgagc (SEQ ID NO.: 348), AACGgtgagg (SEQ ID NO : 349), AACGgtgagt (SEQ ID NO.: 350), AACGgtgcct (SEQ ID NO.: 351), AACGgtgcgg (SEQ ID NO.: 352), AACGgtggaa (SEQ ID NO.: 353), AACGgtgggg (SEQ ID NO.: 354), AACGgtgggt (SEQ ID NO.: 355), AACGgtgtaa (SEQ ID NO.: 356), AACGgttagt (SEQ ID NO.: 357), AACTgtaaat (SEQ ID NO.: 358), AACTgtaaga (SEQ ID NO.: 359), AACTgtaagc (SEQ ID NO.: 360), AACTgtaagg (SEQ ID NO.: 361), AACTgtaagt (SEQ ID NO.: 362), AACTgtacgt (SEQ ID NO.: 363), AACTgtaggt (SEQ ID NO.: 364), AACTgtatcc (SEQ ID NO.: 365), AACTgtatgt (SEQ ID NO.: 366), AACTgtcagg (SEQ ID NO.: 367), AACTgtgaga (SEQ ID NO.: 368), AACTgtgagc (SEQ ID NO.: 369), AACTgtgagg (SEQ ID NO.: 370), AACTgtgagt (SEQ ID NO.: 371), AACTgtggtg (SEQ ID NO.: 372), AACTgtgtga (SEQ ID NO.: 373), AACTttgtgg (SEQ ID NO.: 374), AAGAaaggta (SEQ ID NO.: 375), AAGAccctgg (SEQ ID NO.: 376), AAGAgtaaga (SEQ ID NO.: 377), AAGAgtaagc (SEQ ID NO.: 378), AAGAgtaagg (SEQ ID NO.: 379), AAGAgtaagt (SEQ ID NO.: 380), AAGAgtacgt (SEQ ID NO.: 381), AAGAgtaggt (SEQ ID NO.: 382), AAGAgtagta (SEQ ID NO.: 383), AAGAgtatcc (SEQ ID NO 384), AAGAgtatgt (SEQ ID NO.: 385), AAGAgtgagc (SEQ ID NO.: 386), AAGAgtgagg (SEQ ID NO.: 387), AAGAgtgagt (SEQ ID NO.: 388), AAGAgtgcgt (SEQ ID NO.: 389), AAGAgtgggt (SEQ ID NO.: 390), AAGAgtggta (SEQ ID NO.: 391), AAGAgtggtg (SEQ ID NO.: 392), AAGAgttaag (SEQ ID NO.: 393), AAGAtgctca (SEQ ID NO.: 394), AAGCgcagca (SEQ ID NO.: 395), AAGCgtaagc (SEQ ID NO.: 396), AAGCgtaagg (SEQ ID NO.: 397), AAGCgtaagt (SEQ ID NO.: 398), AAGCgtgagt (SEQ ID NO.: 399), AAGCgttagt (SEQ ID NO.: 400), AAGGaagcgg (SEQ ID NO.: 401), AAGGagagaa (SEQ ID NO.: 402), AAGGgcaagt (SEQ ID NO.: 403), AAGGgctggt (SEQ ID NO.: 404), AAGGgtaaaa (SEQ ID NO.: 405), AAGGgtaaac (SEQ ID NO.: 406), AAGGgtaaag (SEQ ID NO.: 407),
AAGGgtaaat (SEQ ID NO.: 408), AAGGgtaaca (SEQ ID NO.: 409), AAGGgtaacc (SEQ ID NO.: 410), AAGGgtaact (SEQ ID NO.: 411), AAGGgtaaga (SEQ ID NO.: 412), AAGGgtaagc (SEQ ID NO.: 413), AAGGgtaagg (SEQ ID NO.: 414), AAGGgtaagt (SEQ ID NO.: 415), AAGGgtaata (SEQ ID NO.: 416), AAGGgtaatc (SEQ ID NO.: 417), AAGGgtaatg (SEQ ID NO.: 418), AAGGgtaatt (SEQ ID NO.: 419), AAGGgtacag (SEQ ID NO.: 420), AAGGgtacct (SEQ ID NO.: 421), AAGGgtacgt (SEQ ID NO.: 422), AAGGgtagca (SEQ ID NO.: 423), AAGGgtagga (SEQ ID NO : 424), AAGGgtaggc (SEQ ID NO.: 425), AAGGgtaggg (SEQ ID NO.: 426), AAGGgtaggt (SEQ ID NO.: 427), AAGGgtagta (SEQ ID NO.: 428), AAGGgtagtt (SEQ ID NO.: 429), AAGGgtatag (SEQ ID NO.: 430), AAGGgtatat (SEQ ID NO.: 431), AAGGgtatct (SEQ ID NO.: 432), AAGGgtatga (SEQ ID NO.: 433), AAGGgtatgc (SEQ ID NO.: 434), AAGGgtatgt (SEQ ID NO.: 435), AAGGgtattg (SEQ ID NO.: 436), AAGGgtattt (SEQ ID NO.: 437), AAGGgtcaga (SEQ ID NO.: 438), AAGGgtcagt (SEQ ID NO.: 439), AAGGgtgaga (SEQ ID NO.: 440), AAGGgtgagc (SEQ ID NO.: 441), AAGGgtgagg (SEQ ID NO.: 442), AAGGgtgagt (SEQ ID NO.: 443), AAGGgtgatg (SEQ ID NO.: 444), AAGGgtgcgt (SEQ ID NO.: 445), AAGGgtgggt (SEQ ID NO.: 446), AAGGgtggtg (SEQ ID NO.: 447), AAGGgtgtgt (SEQ ID NO.: 448), AAGGgttaag (SEQ ID NO.: 449), AAGGgttagt (SEQ ID NO.: 450), AAGTgctggt (SEQ ID NO.: 451), AAGTgtaaga (SEQ ID NO.: 452), AAGTgtaagc (SEQ ID NO.: 453), AAGTgtaagg (SEQ ID NO.: 454), AAGTgtaagt (SEQ ID NO.: 455), AAGTgtacgt (SEQ ID NO.: 456), AAGTgtatcc (SEQ ID NO.: 457), AAGTgtatga (SEQ ID NO.: 458), AAGTgtatgc (SEQ ID NO.: 459), AAGTgtatgg (SEQ ID NO.: 460), AAGTgtatgt (SEQ ID NO.: 461), AAGTgtgagc (SEQ ID NO.: 462), AAGTgtgagg (SEQ ID NO.: 463), AAGTgtgagt (SEQ ID NO.: 464), AAGTgtgtaa (SEQ ID NO.: 465), AAGTgttagt (SEQ ID NO.: 466), AAGTtgctgg (SEQ ID NO.: 467), AATAggtaat (SEQ ID NO.: 468), AATAggtagt (SEQ ID NO.: 469), AATAgtaaat (SEQ ID NO.: 470), AATAgtaaga (SEQ ID NO.: 471), AATAgtaagc (SEQ ID NO.: 472), AATAgtaagt (SEQ ID NO.: 473), AATAgtagga (SEQ ID NO.: 474), AATAgtaggt (SEQ ID NO.: 475), AATAgtagtg (SEQ ID NO.: 476), AATAgtatcc (SEQ ID NO.: 477), AATAgtatga (SEQ ID NO.: 478), AATAgtatgg (SEQ ID NO.: 479), AATAgtatgt (SEQ ID NO.: 480), AATAgtgagt (SEQ ID NO.: 481), AATAgttaag (SEQ ID NO.: 482), AATAtaaggt (SEQ ID NO.: 483), AATAtgccag (SEQ ID NO.: 484), AATCatgtat (SEQ ID NO.: 485), AATCcaacat (SEQ ID NO.: 486), AATCctggta (SEQ ID NO.: 487), AATCgcagtg (SEQ ID NO.: 488), AATCgtaaga (SEQ ID NO.: 489), AATCgtaagc (SEQ ID NO.: 490), AATCgtaagt (SEQ ID NO.: 491), AATCgtatgt (SEQ ID NO.: 492), AATCgtgagt (SEQ ID NO.: 493), AATCtgactg (SEQ ID NO.: 494), AATCtggaag (SEQ ID NO.: 495), AATGcaaata (SEQ ID NO.: 496), AATGgagtga (SEQ ID NO.: 497), AATGgcaagt (SEQ ID NO.: 498), AATGgcacga (SEQ ID NO.: 499), AATGgcaggt (SEQ ID NO.: 500), AATGgcgagt (SEQ ID NO.: 501), AATGgcgtaa (SEQ ID NO.: 502), AATGgtaaaa (SEQ ID NO.: 503), AATGgtaaac (SEQ ID NO.: 504), AATGgtaaag (SEQ ID NO.: 505), AATGgtaaat (SEQ ID NO.: 506), AATGgtaaca (SEQ ID NO : 507), AATGgtaacg (SEQ ID NO.: 508), AATGgtaact (SEQ ID NO.: 509), AATGgtaaga (SEQ ID NO.: 510), AATGgtaagc (SEQ ID NO.: 511), AATGgtaagg (SEQ ID NO.: 512), AATGgtaagt (SEQ ID NO.: 513), AATGgtaata (SEQ ID NO.: 514), AATGgtaatc (SEQ ID NO.: 515), AATGgtaatg (SEQ ID NO.: 516), AATGgtaatt (SEQ ID NO.: 517), AATGgtacac (SEQ ID NO.: 518), AATGgtacat (SEQ ID NO.: 519), AATGgtacga (SEQ ID NO.: 520), AATGgtacgc (SEQ ID NO.: 521), AATGgtacgg (SEQ ID NO.: 522), AATGgtacgt (SEQ ID NO.: 523), AATGgtacta (SEQ ID NO.: 524), AATGgtactc (SEQ ID NO.: 525), AATGgtactt (SEQ ID NO.: 526), AATGgtagaa (SEQ ID NO.: 527), AATGgtagat (SEQ ID NO.: 528), AATGgtagct (SEQ ID NO.:
529), AATGgtagga (SEQ ID NO.: 530), AATGgtaggc (SEQ ID NO.: 531), AATGgtaggg (SEQ ID NO.: 532), AATGgtaggt (SEQ ID NO.: 533), AATGgtagta (SEQ ID NO.: 534), AATGgtataa (SEQ ID NO.: 535), AATGgtatag (SEQ ID NO : 536), AATGgtatat (SEQ ID NO.: 537), AATGgtatca (SEQ ID NO.: 538), AATGgtatcc (SEQ ID NO.: 539), AATGgtatct (SEQ ID NO : 540), AATGgtatga (SEQ ID NO.: 541), AATGgtatgc (SEQ ID NO.: 542), AATGgtatgg (SEQ ID NO.: 543), AATGgtatgt (SEQ ID NO.: 544), AATGgtattc (SEQ ID NO.: 545), AATGgtattg (SEQ ID NO.: 546), AATGgtattt (SEQ ID NO.: 547), AATGgtcagt (SEQ ID NO.: 548), AATGgtctct (SEQ ID NO.: 549), AATGgtgaat (SEQ ID NO.: 550), AATGgtgaga (SEQ ID NO.: 551), AATGgtgagc (SEQ ID NO.: 552), AATGgtgagg (SEQ ID NO.: 553), AATGgtgagt (SEQ ID NO.: 554), AATGgtgcaa (SEQ ID NO.: 555), AATGgtgcga (SEQ ID NO.: 556), AATGgtgcgt (SEQ ID NO 557), AATGgtgggc (SEQ ID NO.: 558), AATGgtgggt (SEQ ID NO.: 559), AATGgtgtgt (SEQ ID NO.: 560), AATGgttagt (SEQ ID NO.: 561), AATGgttatg (SEQ ID NO.: 562), AATGgttggt (SEQ ID NO.: 563), AATGgtttga (SEQ ID NO.: 564), AATGgtttgg (SEQ ID NO.: 565), AATGgtttgt (SEQ ID NO.: 566), AATTgtaaat (SEQ ID NO.: 567), AATTgtaaga (SEQ ID NO.: 568), AATTgtaagc (SEQ ID NO.: 569), AATTgtaagg (SEQ ID NO.: 570), AATTgtaagt (SEQ ID NO.: 571), AATTgtacga (SEQ ID NO.: 572), AATTgtatgt (SEQ ID NO.: 573), AATTgtgagg (SEQ ID NO.: 574), AATTgtgagt (SEQ ID NO.: 575), AATTgttcag (SEQ ID NO.: 576), AATTttgcaa (SEQ ID NO.: 577), ACAAagggat (SEQ ID NO.: 578), ACAAagtaag (SEQ ID NO.: 579), ACAAagtgag (SEQ ID NO.: 580), ACAAgaagtc (SEQ ID NO.: 581), ACAAgcaagt (SEQ ID NO.: 582), ACAAggtaag (SEQ ID NO.: 583), ACAAggtaat (SEQ ID NO.: 584), ACAAgtaaac (SEQ ID NO.: 585), ACAAgtaaat (SEQ ID NO.: 586), ACAAgtaaga (SEQ ID NO.: 587), ACAAgtaagc (SEQ ID NO.: 588), ACAAgtaagg (SEQ ID NO.: 589), ACAAgtaagt (SEQ ID NO.: 590), ACAAgtaata (SEQ ID NO.: 591), ACAAgtaatc (SEQ ID NO.: 592), ACAAgtaatt (SEQ ID NO.: 593), ACAAgtacat (SEQ ID NO.: 594), ACAAgtacgc (SEQ ID NO.: 595), ACAAgtacgg (SEQ ID NO.: 596), ACAAgtacgt (SEQ ID NO.: 597), ACAAgtaggc (SEQ ID NO.: 598), ACAAgtaggg (SEQ ID NO.: 599), ACAAgtaggt (SEQ ID NO.: 600), ACAAgtatct (SEQ ID NO.: 601), ACAAgtatga (SEQ ID NO.: 602), ACAAgtatgc (SEQ ID NO.: 603), ACAAgtatgg (SEQ ID NO.: 604), ACAAgtatgt (SEQ ID NO.: 605), ACAAgtattg (SEQ ID NO.: 606), ACAAgtcagt (SEQ ID NO.: 607), ACAAgtgaga (SEQ ID NO.: 608), ACAAgtgagc (SEQ ID NO.: 609), ACAAgtgagg (SEQ ID NO.: 610), ACAAgtgagt (SEQ ID NO.: 611), ACAAgtgcgt (SEQ ID NO.: 612), ACAAgtgggc (SEQ ID NO.: 613), ACAAgtgggt (SEQ ID NO.: 614), ACAAgtgtgt (SEQ ID NO.: 615), ACAAgttaag (SEQ ID NO.: 616), ACAAgttaga (SEQ ID NO.: 617), ACAAgttagt (SEQ ID NO.: 618), ACAAtggaaa (SEQ ID NO.: 619), ACACacacac (SEQ ID NO.: 620), ACACcagggt (SEQ ID NO.: 621), ACACgcaagt (SEQ ID NO.: 622), ACACgtaaga (SEQ ID NO.: 623), ACACgtaagc (SEQ ID NO.: 624), ACACgtaagg (SEQ ID NO.: 625), ACACgtaagt (SEQ ID NO.: 626), ACACgtacgt (SEQ ID NO.: 627), ACACgtaggt (SEQ ID NO.: 628), ACACgtatgt (SEQ ID NO.: 629), ACACgtcagt (SEQ ID NO.: 630), ACACgtgaga (SEQ ID NO.: 631), ACACgtgagc (SEQ ID NO.: 632), ACACgtgagg (SEQ ID NO.: 633), ACACgtgagt (SEQ ID NO.: 634), ACACgtgcgt (SEQ ID NO.: 635), ACACgtgggt (SEQ ID NO.: 636), ACACgttagt (SEQ ID NO.: 637), ACAGaggttg (SEQ ID NO.: 638), ACAGagtaag (SEQ ID NO.: 639), ACAGatatcc (SEQ ID NO.: 640), ACAGgcaaca (SEQ ID NO.: 641), ACAGgcaact (SEQ ID NO.: 642), ACAGgcaaga (SEQ ID NO.: 643), ACAGgcaagc (SEQ ID NO.: 644), ACAGgcaagg (SEQ ID NO.: 645), ACAGgcaagt (SEQ ID NO.: 646), ACAGgcacag (SEQ ID NO.: 647), ACAGgcacgc (SEQ ID NO.: 648), ACAGgcacgt (SEQ ID NO.: 649), ACAGgcaggc (SEQ ID NO.: 650),
ACAGgcaggt (SEQ ID NO.: 651), ACAGgcatca (SEQ ID NO.: 652), ACAGgcatga (SEQ ID NO.: 653), ACAGgcatgc (SEQ ID NO.: 654), ACAGgcatgt (SEQ ID NO.: 655), ACAGgcgaga (SEQ ID NO.: 656), ACAGgcgagt (SEQ ID NO.: 657), ACAGgcgcct (SEQ ID NO.: 658), ACAGgcgcgt (SEQ ID NO.: 659), ACAGgctagt (SEQ ID NO.: 660), ACAGgtaaaa (SEQ ID NO.: 661), ACAGgtaaac (SEQ ID NO.: 662), ACAGgtaaag (SEQ ID NO.: 663), ACAGgtaaat (SEQ ID NO.: 664), ACAGgtaaca (SEQ ID NO.: 665), ACAGgtaacc (SEQ ID NO.: 666), ACAGgtaacg (SEQ ID NO.: 667), ACAGgtaact (SEQ ID NO.: 668), ACAGgtaaga (SEQ ID NO.: 669), ACAGgtaagc (SEQ ID NO.: 670), ACAGgtaagg (SEQ ID NO.: 671), ACAGgtaagt (SEQ ID NO.: 672), ACAGgtaata (SEQ ID NO : 673), ACAGgtaatc (SEQ ID NO.: 674), ACAGgtaatg (SEQ ID NO.: 675), ACAGgtaatt (SEQ ID NO.: 676), ACAGgtacaa (SEQ ID NO.: 677), ACAGgtacac (SEQ ID NO : 678), ACAGgtacag (SEQ ID NO.: 679), ACAGgtacat (SEQ ID NO.: 680), ACAGgtacca (SEQ ID NO.: 681), ACAGgtaccc (SEQ ID NO.: 682), ACAGgtaccg (SEQ ID NO.: 683), ACAGgtacct (SEQ ID NO.: 684), ACAGgtacga (SEQ ID NO.: 685), ACAGgtacgc (SEQ ID NO.: 686), ACAGgtacgg (SEQ ID NO.: 687), ACAGgtacgt (SEQ ID NO.: 688), ACAGgtacta (SEQ ID NO.: 689), ACAGgtactc (SEQ ID NO.: 690), ACAGgtactg (SEQ ID NO.: 691), ACAGgtactt (SEQ ID NO.: 692), ACAGgtagaa (SEQ ID NO.: 693), ACAGgtagac (SEQ ID NO.: 694), ACAGgtagag (SEQ ID NO.: 695), ACAGgtagat (SEQ ID NO.: 696), ACAGgtagca (SEQ ID NO.: 697), ACAGgtagcg (SEQ ID NO.: 698), ACAGgtagct (SEQ ID NO.: 699), ACAGgtagga (SEQ ID NO.: 700), ACAGgtaggc (SEQ ID NO.: 701), ACAGgtaggg (SEQ ID NO.: 702), ACAGgtaggt (SEQ ID NO.: 703), ACAGgtagta (SEQ ID NO.: 704), ACAGgtagtc (SEQ ID NO.: 705), ACAGgtagtg (SEQ ID NO.: 706), ACAGgtagtt (SEQ ID NO.: 707), ACAGgtataa (SEQ ID NO.: 708), ACAGgtatac (SEQ ID NO.: 709), ACAGgtatag (SEQ ID NO.: 710), ACAGgtatat (SEQ ID NO.: 711), ACAGgtatca (SEQ ID NO.: 712), ACAGgtatcc (SEQ ID NO.: 713), ACAGgtatcg (SEQ ID NO.: 714), ACAGgtatct (SEQ ID NO.: 715), ACAGgtatga (SEQ ID NO.: 716), ACAGgtatgc (SEQ ID NO.: 717), ACAGgtatgg (SEQ ID NO.: 718), ACAGgtatgt (SEQ ID NO.: 719), ACAGgtatta (SEQ ID NO.: 720), ACAGgtattc (SEQ ID NO.: 721), ACAGgtattg (SEQ ID NO.: 722), ACAGgtattt (SEQ ID NO.: 723), ACAGgtcaag (SEQ ID NO.: 724), ACAGgtcact (SEQ ID NO.: 725), ACAGgtcaga (SEQ ID NO.: 726), ACAGgtcagc (SEQ ID NO.: 727), ACAGgtcagg (SEQ ID NO.: 728), ACAGgtcagt (SEQ ID NO.: 729), ACAGgtcgct (SEQ ID NO.: 730), ACAGgtcgga (SEQ ID NO.: 731), ACAGgtcggg (SEQ ID NO.: 732), ACAGgtcggt (SEQ ID NO.: 733), ACAGgtctct (SEQ ID NO.: 734), ACAGgtctgg (SEQ ID NO.: 735), ACAGgtctgt (SEQ ID NO.: 736), ACAGgtgaaa (SEQ ID NO.: 737), ACAGgtgaac (SEQ ID NO.: 738), ACAGgtgaag (SEQ ID NO.: 739), ACAGgtgaat (SEQ ID NO.: 740), ACAGgtgaca (SEQ ID NO.: 741), ACAGgtgacc (SEQ ID NO.: 742), ACAGgtgacg (SEQ ID NO.: 743), ACAGgtgact (SEQ ID NO.: 744), ACAGgtgaga (SEQ ID NO.: 745), ACAGgtgagc (SEQ ID NO.: 746), ACAGgtgagg (SEQ ID NO.: 747), ACAGgtgagt (SEQ ID NO.: 748), ACAGgtgata (SEQ ID NO.: 749), ACAGgtgatg (SEQ ID NO.: 750), ACAGgtgatt (SEQ ID NO.: 751), ACAGgtgcaa (SEQ ID NO.: 752), ACAGgtgcac (SEQ ID NO.: 753), ACAGgtgcag (SEQ ID NO.: 754), ACAGgtgcat (SEQ ID NO.: 755), ACAGgtgcca (SEQ ID NO.: 756), ACAGgtgccc (SEQ ID NO.: 757), ACAGgtgccg (SEQ ID NO.: 758), ACAGgtgcct (SEQ ID NO.: 759), ACAGgtgcga (SEQ ID NO.: 760), ACAGgtgcgc (SEQ ID NO.: 761), ACAGgtgcgg (SEQ ID NO.: 762), ACAGgtgcgt (SEQ ID NO.: 763), ACAGgtgcta (SEQ ID NO.: 764), ACAGgtgctc (SEQ ID NO.: 765), ACAGgtgctg (SEQ ID NO.: 766), ACAGgtgctt (SEQ ID NO.: 767), ACAGgtggag (SEQ ID NO.: 768), ACAGgtggcc (SEQ ID NO.: 769), ACAGgtggcg (SEQ ID NO.: 770), ACAGgtggga (SEQ ID
NO.: 771), ACAGgtgggc (SEQ ID NO.: 772), ACAGgtgggg (SEQ ID NO.: 773), ACAGgtgggt (SEQ ID NO.: 774), ACAGgtggtg (SEQ ID NO.: 775), ACAGgtggtt (SEQ ID NO.: 776), ACAGgtgtac (SEQ ID NO.: 777), ACAGgtgtag (SEQ ID NO.: 778), ACAGgtgtca (SEQ ID NO.: 779), ACAGgtgtct (SEQ ID NO.: 780), ACAGgtgtga (SEQ ID NO.: 781), ACAGgtgtgc (SEQ ID NO.: 782), ACAGgtgtgg (SEQ ID NO.: 783), ACAGgtgtgt (SEQ ID NO.: 784), ACAGgtgttt (SEQ ID NO.: 785), ACAGgttaag (SEQ ID NO.: 786), ACAGgttaat (SEQ ID NO.: 787), ACAGgttaga (SEQ ID NO.: 788), ACAGgttagc (SEQ ID NO.: 789), ACAGgttagg (SEQ ID NO.: 790), ACAGgttagt (SEQ ID NO.: 791), ACAGgttatg (SEQ ID NO.: 792), ACAGgttccc (SEQ ID NO.: 793), ACAGgttcct (SEQ ID NO.: 794), ACAGgttcga (SEQ ID NO.: 795), ACAGgttcgc (SEQ ID NO.: 796), ACAGgttcgg (SEQ ID NO.: 797), ACAGgttcgt (SEQ ID NO.: 798), ACAGgttctc (SEQ ID NO.: 799), ACAGgttctt (SEQ ID NO : 800), ACAGgttgca (SEQ ID NO.: 801), ACAGgttgcg (SEQ ID NO.: 802), ACAGgttgct (SEQ ID NO.: 803), ACAGgttgga (SEQ ID NO.: 804), ACAGgttggg (SEQ ID NO.: 805), ACAGgttggt (SEQ ID NO.: 806), ACAGgttgtc (SEQ ID NO.: 807), ACAGgttgtt (SEQ ID NO.: 808), ACAGgtttag (SEQ ID NO.: 809), ACAGgtttcc (SEQ ID NO.: 810), ACAGgtttga (SEQ ID NO.: 811), ACAGgtttgc (SEQ ID NO.: 812), ACAGgtttgg (SEQ ID NO.: 813), ACAGgtttgt (SEQ ID NO.: 814), ACAGgtttta (SEQ ID NO.: 815), ACAGgttttt (SEQ ID NO.: 816), ACAGtcagtg (SEQ ID NO.: 817), ACAGtggtaa (SEQ ID NO 818), ACAGtgtagc (SEQ ID NO 819), ACATccatta (SEQ ID NO.: 820), ACATgtaaga (SEQ ID NO.: 821), ACATgtaagc (SEQ ID NO.: 822), ACATgtaagg (SEQ ID NO.: 823), ACATgtaagt (SEQ ID NO.: 824), ACATgtaatg (SEQ ID NO.: 825), ACATgtacat (SEQ ID NO.: 826), ACATgtacgg (SEQ ID NO.: 827), ACATgtaggt (SEQ ID NO.: 828), ACATgtatgg (SEQ ID NO.: 829), ACATgtatgt (SEQ ID NO.: 830), ACATgtgaga (SEQ ID NO.: 831), ACATgtgagc (SEQ ID NO.: 832), ACATgtgagt (SEQ ID NO.: 833), ACATgtgatt (SEQ ID NO.: 834), ACATtgcatc (SEQ ID NO.: 835), ACCAggtatc (SEQ ID NO.: 836), ACCAggtgaa (SEQ ID NO.: 837), ACCAggttgg (SEQ ID NO.: 838), ACCAgtaaga (SEQ ID NO.: 839), ACCAgtaagc (SEQ ID NO.: 840), ACCAgtaagt (SEQ ID NO.: 841), ACCAgtacgt (SEQ ID NO.: 842), ACCAgtaggt (SEQ ID NO.: 843), ACCAgtatgg (SEQ ID NO.: 844), ACCAgtatgt (SEQ ID NO.: 845), ACCAgtgaga (SEQ ID NO.: 846), ACCAgtgagc (SEQ ID NO.: 847), ACCAgtgagg (SEQ ID NO.: 848), ACCAgtgagt (SEQ ID NO.: 849), ACCAgtggag (SEQ ID NO.: 850), ACCAgttgag (SEQ ID NO.: 851), ACCCaagggt (SEQ ID NO.: 852), ACCCgtaagt (SEQ ID NO.: 853), ACCCgtacgt (SEQ ID NO.: 854), ACCCgtatct (SEQ ID NO.: 855), ACCCgtgaga (SEQ ID NO.: 856), ACCCgtgagt (SEQ ID NO.: 857), ACCCgtggta (SEQ ID NO.: 858), ACCCgtgtga (SEQ ID NO.: 859), ACCGgtaaca (SEQ ID NO.: 860), ACCGgtaaga (SEQ ID NO.: 861), ACCGgtaagc (SEQ ID NO.: 862), ACCGgtaagg (SEQ ID NO.: 863), ACCGgtaagt (SEQ ID NO.: 864), ACCGgtaatt (SEQ ID NO.: 865), ACCGgtacgg (SEQ ID NO.: 866), ACCGgtagct (SEQ ID NO.: 867), ACCGgtaggg (SEQ ID NO.: 868), ACCGgtaggt (SEQ ID NO.: 869), ACCGgtatga (SEQ ID NO.: 870), ACCGgtatgg (SEQ ID NO.: 871), ACCGgtatgt (SEQ ID NO.: 872), ACCGgtattt (SEQ ID NO.: 873), ACCGgtcagg (SEQ ID NO.: 874), ACCGgtcagt (SEQ ID NO.: 875), ACCGgtctgc (SEQ ID NO.: 876), ACCGgtgaga (SEQ ID NO.: 877), ACCGgtgagc (SEQ ID NO.: 878), ACCGgtgagg (SEQ ID NO.: 879), ACCGgtgagt (SEQ ID NO.: 880), ACCGgtgcgt (SEQ ID NO.: 881), ACCGgtgggt (SEQ ID NO.: 882), ACCGgtgtgt (SEQ ID NO.: 883), ACCGgttagt (SEQ ID NO.: 884), ACCGgtttgt (SEQ ID NO.: 885), ACCTgtaaga (SEQ ID NO.: 886), ACCTgtaagc (SEQ ID NO.: 887), ACCTgtaagg (SEQ ID NO.: 888), ACCTgtaagt (SEQ ID NO.: 889), ACCTgtaggt (SEQ ID NO.: 890), ACCTgtatcc (SEQ ID NO.: 891), ACCTgtatgg (SEQ ID NO.: 892), ACCTgtatgt (SEQ ID NO.: 893), ACCTgtgaat (SEQ ID NO.:
894), ACCTgtgagc (SEQ ID NO.: 895), ACCTgtgagg (SEQ ID NO.: 896), ACCTgtgagt (SEQ ID NO.: 897), ACCTgtgcgt (SEQ ID NO.: 898), ACCTgttcgc (SEQ ID NO.: 899), ACGAggtaaa (SEQ ID NO.: 900), ACGAgtaaga (SEQ ID NO.: 901), ACGAgtaagt (SEQ ID NO.: 902), ACGAgtacgt (SEQ ID NO.: 903), ACGAgtgagc (SEQ ID NO.: 904), ACGAgtgagt (SEQ ID NO.: 905), ACGAgttagt (SEQ ID NO.: 906), ACGCgtaaga (SEQ ID NO.: 907), ACGCgtaagc (SEQ ID NO.: 908), ACGCgtaggt (SEQ ID NO.: 909), ACGGgcaagg (SEQ ID NO.: 910), ACGGgcaagt (SEQ ID NO.: 911), ACGGgcaggt (SEQ ID NO.: 912), ACGGgtaaac (SEQ ID NO.: 913), ACGGgtaaat (SEQ ID NO.: 914), ACGGgtaaga (SEQ ID NO.: 915), ACGGgtaagc (SEQ ID NO.: 916), ACGGgtaagg (SEQ ID NO.: 917), ACGGgtaagt (SEQ ID NO.: 918), ACGGgtaata (SEQ ID NO.: 919), ACGGgtaatt (SEQ ID NO.: 920), ACGGgtacat (SEQ ID NO.: 921), ACGGgtacgc (SEQ ID NO.: 922), ACGGgtacgg (SEQ ID NO.: 923), ACGGgtacta (SEQ ID NO.: 924), ACGGgtaggt (SEQ ID NO.: 925), ACGGgtataa (SEQ ID NO.: 926), ACGGgtatga (SEQ ID NO.: 927), ACGGgtatgc (SEQ ID NO.: 928), ACGGgtatgt (SEQ ID NO.: 929), ACGGgtcagt (SEQ ID NO.: 930), ACGGgtgacg (SEQ ID NO.: 931), ACGGgtgaga (SEQ ID NO.: 932), ACGGgtgagc (SEQ ID NO.: 933), ACGGgtgagg (SEQ ID NO.: 934), ACGGgtgagt (SEQ ID NO.: 935), ACGGgtgatc (SEQ ID NO.: 936), ACGGgtgcgc (SEQ ID NO.: 937), ACGGgtgggt (SEQ ID NO.: 938), ACGGgtttgt (SEQ ID NO.: 939), ACGTgtaagg (SEQ ID NO.: 940), ACGTgtaagt (SEQ ID NO.: 941), ACGTgtacgt (SEQ ID NO.: 942), ACGTgtgagc (SEQ ID NO.: 943), ACGTgtgagt (SEQ ID NO.: 944), ACGTgttagt (SEQ ID NO.: 945), ACTAgtaaga (SEQ ID NO.: 946), ACTAgtaagg (SEQ ID NO.: 947), ACTAgtaagt (SEQ ID NO.: 948), ACTAgtacgt (SEQ ID NO.: 949), ACTAgtgagc (SEQ ID NO.: 950), ACTAgtgagt (SEQ ID NO.: 951), ACTCatatcc (SEQ ID NO.: 952), ACTCgtaagt (SEQ ID NO.: 953), ACTCgtatgt (SEQ ID NO.: 954), ACTCgtgagt (SEQ ID NO.: 955), ACTGagtccc (SEQ ID NO.: 956), ACTGgaactg (SEQ ID NO.: 957), ACTGgcaaga (SEQ ID NO.: 958), ACTGgcaggt (SEQ ID NO.: 959), ACTGgtaaaa (SEQ ID NO.: 960), ACTGgtaaag (SEQ ID NO.: 961), ACTGgtaaat (SEQ ID NO.: 962), ACTGgtaaca (SEQ ID NO.: 963), ACTGgtaacc (SEQ ID NO.: 964), ACTGgtaact (SEQ ID NO.: 965), ACTGgtaaga (SEQ ID NO.: 966), ACTGgtaagc (SEQ ID NO.: 967), ACTGgtaagg (SEQ ID NO.: 968), ACTGgtaagt (SEQ ID NO.: 969), ACTGgtaata (SEQ ID NO.: 970), ACTGgtaatc (SEQ ID NO.: 971), ACTGgtaatg (SEQ ID NO.: 972), ACTGgtaatt (SEQ ID NO.: 973), ACTGgtacag (SEQ ID NO.: 974), ACTGgtacct (SEQ ID NO.: 975), ACTGgtacga (SEQ ID NO.: 976), ACTGgtacgt (SEQ ID NO.: 977), ACTGgtagag (SEQ ID NO.: 978), ACTGgtagcc (SEQ ID NO.: 979), ACTGgtagct (SEQ ID NO.: 980), ACTGgtagga (SEQ ID NO.: 981), ACTGgtaggg (SEQ ID NO.: 982), ACTGgtaggt (SEQ ID NO.: 983), ACTGgtatga (SEQ ID NO.: 984), ACTGgtatgg (SEQ ID NO.: 985), ACTGgtatgt (SEQ ID NO.: 986), ACTGgtatta (SEQ ID NO.: 987), ACTGgtattt (SEQ ID NO.: 988), ACTGgtcagt (SEQ ID NO.: 989), ACTGgtgaat (SEQ ID NO.: 990), ACTGgtgacg (SEQ ID NO.: 991), ACTGgtgaga (SEQ ID NO.: 992), ACTGgtgagc (SEQ ID NO.: 993), ACTGgtgagg (SEQ ID NO.: 994), ACTGgtgagt (SEQ ID NO.: 995), ACTGgtgatg (SEQ ID NO.: 996), ACTGgtgatt (SEQ ID NO.: 997), ACTGgtgccg (SEQ ID NO.: 998), ACTGgtgcgt (SEQ ID NO.: 999), ACTGgtgggc (SEQ ID NO.: 1000), ACTGgtgggt (SEQ ID NO.: 1001), ACTGgtgtgc (SEQ ID NO.: 1002), ACTGgtgtgt (SEQ ID NO.: 1003), ACTGgttagt (SEQ ID NO.: 1004), ACTGgtttgt (SEQ ID NO.: 1005), ACTTatgtga (SEQ ID NO.: 1006), ACTTgtaaga (SEQ ID NO.: 1007), ACTTgtaagt (SEQ ID NO.: 1008), ACTTgtacgc (SEQ ID NO.: 1009), ACTTgtacgt (SEQ ID NO.: 1010), ACTTgtagga (SEQ ID NO.: 1011), ACTTgtaggt (SEQ ID NO.: 1012), ACTTgtagtt (SEQ ID NO.: 1013), ACTTgtatcc (SEQ ID NO.: 1014), ACTTgtgagt (SEQ ID NO.: 1015), ACTTgtgtga (SEQ ID NO.: 1016),
ACTTgttggt (SEQ ID NO.: 1017), AGAAaaggat (SEQ ID NO.: 1018), AGAAaggtac (SEQ ID NO.: 1019), AGAAaggtga (SEQ ID NO.: 1020), AGAAatatcc (SEQ ID NO.: 1021), AGAAgagaag (SEQ ID NO.: 1022), AGAAgctggg (SEQ ID NO.: 1023), AGAAgtaaat (SEQ ID NO.: 1024), AGAAgtaacc (SEQ ID NO.: 1025), AGAAgtaaga (SEQ ID NO.: 1026), AGAAgtaagc (SEQ ID NO.: 1027), AGAAgtaagg (SEQ ID NO.: 1028), AGAAgtaagt (SEQ ID NO.: 1029), AGAAgtaatg (SEQ ID NO.: 1030), AGAAgtaatt (SEQ ID NO.: 1031), AGAAgtacga (SEQ ID NO.: 1032), AGAAgtacgc (SEQ ID NO.: 1033), AGAAgtaggt (SEQ ID NO.: 1034), AGAAgtatat (SEQ ID NO.: 1035), AGAAgtatcc (SEQ ID NO.: 1036), AGAAgtatga (SEQ ID NO.: 1037), AGAAgtatgg (SEQ ID NO.: 1038), AGAAgtatgt (SEQ ID NO.: 1039), AGAAgtcagt (SEQ ID NO.: 1040), AGAAgtgact (SEQ ID NO.: 1041), AGAAgtgaga (SEQ ID NO.: 1042), AGAAgtgagc (SEQ ID NO.: 1043), AGAAgtgagg (SEQ ID NO.: 1044), AGAAgtgagt (SEQ ID NO.: 1045), AGAAgtgcgt (SEQ ID NO.: 1046), AGAAgtgggt (SEQ ID NO.: 1047), AGAAgtgtgt (SEQ ID NO.: 1048), AGAAgttagt (SEQ ID NO.: 1049), AGAAgtttgt (SEQ ID NO.: 1050), AGACagcgcg (SEQ ID NO.: 1051), AGACgccaga (SEQ ID NO.: 1052), AGACgtaaag (SEQ ID NO.: 1053), AGACgtaaga (SEQ ID NO.: 1054), AGACgtaagt (SEQ ID NO.: 1055), AGACgtatgt (SEQ ID NO.: 1056), AGACgtgaga (SEQ ID NO.: 1057), AGACgtgagc (SEQ ID NO.: 1058), AGACgtgagg (SEQ ID NO.: 1059), AGACgtgagt (SEQ ID NO.: 1060), AGAGagggta (SEQ ID NO.: 1061), AGAGgcaaga (SEQ ID NO.: 1062), AGAGgcaagt (SEQ ID NO.: 1063), AGAGgcacct (SEQ ID NO.: 1064), AGAGgcaggt (SEQ ID NO.: 1065), AGAGgcatgt (SEQ ID NO.: 1066), AGAGgccagt (SEQ ID NO.: 1067), AGAGgcctct (SEQ ID NO.: 1068), AGAGgcgtga (SEQ ID NO.: 1069), AGAGgcttca (SEQ ID NO.: 1070), AGAGgtaaaa (SEQ ID NO.: 1071), AGAGgtaaac (SEQ ID NO.: 1072), AGAGgtaaag (SEQ ID NO.: 1073), AGAGgtaaat (SEQ ID NO.: 1074), AGAGgtaaca (SEQ ID NO.: 1075), AGAGgtaacc (SEQ ID NO.: 1076), AGAGgtaacg (SEQ ID NO.: 1077), AGAGgtaact (SEQ ID NO.: 1078), AGAGgtaaga (SEQ ID NO.: 1079), AGAGgtaagc (SEQ ID NO.: 1080), AGAGgtaagg (SEQ ID NO.: 1081), AGAGgtaagt (SEQ ID NO.: 1082), AGAGgtaata (SEQ ID NO.: 1083), AGAGgtaatc (SEQ ID NO.: 1084), AGAGgtaatg (SEQ ID NO.: 1085), AGAGgtaatt (SEQ ID NO.: 1086), AGAGgtacaa (SEQ ID NO.: 1087), AGAGgtacac (SEQ ID NO.: 1088), AGAGgtacag (SEQ ID NO.: 1089), AGAGgtacat (SEQ ID NO.: 1090), AGAGgtacca (SEQ ID NO.: 1091), AGAGgtaccc (SEQ ID NO.: 1092), AGAGgtaccg (SEQ ID NO.: 1093), AGAGgtacct (SEQ ID NO.: 1094), AGAGgtacgt (SEQ ID NO.: 1095), AGAGgtacta (SEQ ID NO.: 1096), AGAGgtactc (SEQ ID NO.: 1097), AGAGgtactg (SEQ ID NO.: 1098), AGAGgtactt (SEQ ID NO.: 1099), AGAGgtagaa (SEQ ID NO.: 1100), AGAGgtagac (SEQ ID NO.: 1101), AGAGgtagat (SEQ ID NO.: 1102), AGAGgtagca (SEQ ID NO.: 1103), AGAGgtagcc (SEQ ID NO.: 1104), AGAGgtagcg (SEQ ID NO.: 1105), AGAGgtagct (SEQ ID NO.: 1106), AGAGgtagga (SEQ ID NO.: 1107), AGAGgtaggc (SEQ ID NO : 1108), AGAGgtaggg (SEQ ID NO.: 1109), AGAGgtaggt (SEQ ID NO.: 1110), AGAGgtagta (SEQ ID NO.: 1111), AGAGgtagtg (SEQ ID NO.: 1112), AGAGgtagtt (SEQ ID NO.: 1113), AGAGgtataa (SEQ ID NO.: 1114), AGAGgtatac (SEQ ID NO.: 1115), AGAGgtatag (SEQ ID NO.: 1116), AGAGgtatat (SEQ ID NO.: 1117), AGAGgtatca (SEQ ID NO. : 1118), AGAGgtatcc (SEQ ID NO.: 1119), AGAGgtatga (SEQ ID NO. : 1120), AGAGgtatgc (SEQ ID NO. : 1121), AGAGgtatgg (SEQ ID NO. : 1122), AGAGgtatgt (SEQ ID NO.: 1123), AGAGgtatta (SEQ ID NO.: 1124), AGAGgtattc (SEQ ID NO.: 1125), AGAGgtattg (SEQ ID NO. : 1126), AGAGgtattt (SEQ ID NO. : 1127), AGAGgtcaga (SEQ ID NO. : 1128), AGAGgtcagc (SEQ ID NO.: 1129), AGAGgtcagg (SEQ ID NO.: 1130), AGAGgtcagt (SEQ ID
NO.: 1131), AGAGgtcatt (SEQ ID NO.: 1132), AGAGgtccgt (SEQ ID NO.: 1133), AGAGgtcgtg (SEQ ID NO.: 1134), AGAGgtctat (SEQ ID NO. : 1135), AGAGgtctga (SEQ ID NO.: 1136), AGAGgtctgc (SEQ ID NO.: 1137), AGAGgtctgt (SEQ ID NO.: 1138), AGAGgtcttg (SEQ ID NO.: 1139), AGAGgtgaaa (SEQ ID NO.: 1140), AGAGgtgaac (SEQ ID NO.: 1141), AGAGgtgaag (SEQ ID NO : 1142), AGAGgtgaat (SEQ ID NO.: 1143), AGAGgtgaca (SEQ ID NO.: 1144), AGAGgtgacc (SEQ ID NO.: 1145), AGAGgtgacg (SEQ ID NO.: 1146), AGAGgtgact (SEQ ID NO.: 1147), AGAGgtgaga (SEQ ID NO.: 1148), AGAGgtgagc (SEQ ID NO.: 1149), AGAGgtgagg (SEQ ID NO.: 1150), AGAGgtgagt (SEQ ID NO.: 1151), AGAGgtgata (SEQ ID NO.: 1152), AGAGgtgatc (SEQ ID NO.: 1153), AGAGgtgatg (SEQ ID NO.: 1154), AGAGgtgatt (SEQ ID NO.: 1155), AGAGgtgcat (SEQ ID NO.: 1156), AGAGgtgccc (SEQ ID NO : 1 157), AGAGgtgcga (SEQ ID NO : 1158), AGAGgtgcgg (SEQ ID NO.: 1159), AGAGgtgcta (SEQ ID NO.: 1160), AGAGgtgctc (SEQ ID NO.: 1161), AGAGgtgctg (SEQ ID NO : 1162), AGAGgtgctt (SEQ ID NO. : 1163), AGAGgtggag (SEQ ID NO.: 1164), AGAGgtggct (SEQ ID NO.: 1165), AGAGgtggga (SEQ ID NO.: 1166), AGAGgtgggc (SEQ ID NO.: 1167), AGAGgtgggg (SEQ ID NO.: 1168), AGAGgtgggt (SEQ ID NO.: 1169), AGAGgtggta (SEQ ID NO.: 1170), AGAGgtggtg (SEQ ID NO.: 1171), AGAGgtggtt (SEQ ID NO. : 1172), AGAGgtgtga (SEQ ID NO. : 1173), AGAGgtgtgc (SEQ ID NO : 1174), AGAGgtgtgg (SEQ ID NO : 1175), AGAGgtgtgt (SEQ ID NO : 1176), AGAGgttaag (SEQ ID NO.: 1177), AGAGgttact (SEQ ID NO.: 1178), AGAGgttaga (SEQ ID NO.: 1179), AGAGgttagt (SEQ ID NO.: 1180), AGAGgttata (SEQ ID NO.: 1181), AGAGgttcaa (SEQ ID NO. : 1182), AGAGgttcgg (SEQ ID NO. : 1183), AGAGgttcgt (SEQ ID NO. : 1184), AGAGgttctt (SEQ ID NO.: 1185), AGAGgttgag (SEQ ID NO.: 1186), AGAGgttgcc (SEQ ID NO.: 1187), AGAGgttggc (SEQ ID NO.: 1188), AGAGgttggg (SEQ ID NO.: 1189), AGAGgttggt (SEQ ID NO. : 1190), AGAGgttgtg (SEQ ID NO. : 1191), AGAGgtttat (SEQ ID NO.: 1192), AGAGgtttcc (SEQ ID NO.: 1193), AGAGgtttgc (SEQ ID NO.: 1194), AGAGgtttgg (SEQ ID NO. : 1195), AGAGgtttgt (SEQ ID NO. : 1196), AGAGtggtaa (SEQ ID NO. : 1197), AGATatctct (SEQ ID NO.: 1198), AGATatctga (SEQ ID NO.: 1199), AGATctacca (SEQ ID NO.: 1200), AGATgaacat (SEQ ID NO.: 1201), AGATgtaaaa (SEQ ID NO.: 1202), AGATgtaaat (SEQ ID NO.: 1203), AGATgtaaga (SEQ ID NO.: 1204), AGATgtaagc (SEQ ID NO.: 1205), AGATgtaagg (SEQ ID NO.: 1206), AGATgtaagt (SEQ ID NO.: 1207), AGATgtaatg (SEQ ID NO.: 1208), AGATgtaatt (SEQ ID NO.: 1209), AGATgtacgt (SEQ ID NO.: 1210), AGATgtaggt (SEQ ID NO.: 1211), AGATgtataa (SEQ ID NO.: 1212), AGATgtatag (SEQ ID NO.: 1213), AGATgtatcc (SEQ ID NO.: 1214), AGATgtatga (SEQ ID NO.: 1215), AGATgtatgt (SEQ ID NO.: 1216), AGATgtgaca (SEQ ID NO.: 1217), AGATgtgaga (SEQ ID NO.: 1218), AGATgtgagc (SEQ ID NO.: 1219), AGATgtgagt (SEQ ID NO.: 1220), AGATgtgggt (SEQ ID NO.: 1221), AGATgtggta (SEQ ID NO.: 1222), AGATgtgtgt (SEQ ID NO.: 1223), AGCAggaaaa (SEQ ID NO : 1224), AGCAggtaaa (SEQ ID NO.: 1225), AGCAggtaag (SEQ ID NO.: 1226), AGCAggtcag (SEQ ID NO.: 1227), AGCAggtgag (SEQ ID NO.: 1228), AGCAgtaaga (SEQ ID NO.: 1229), AGCAgtaagc (SEQ ID NO.: 1230), AGCAgtaagg (SEQ ID NO.: 1231), AGCAgtaagt (SEQ ID NO.: 1232), AGCAgtacgt (SEQ ID NO.: 1233), AGCAgtaggt (SEQ ID NO.: 1234), AGCAgtatcc (SEQ ID NO.: 1235), AGCAgtatgt (SEQ ID NO.: 1236), AGCAgtgaga (SEQ ID NO.: 1237), AGCAgtgagg (SEQ ID NO.: 1238), AGCAgtgagt (SEQ ID NO.: 1239), AGCAgtgggg (SEQ ID NO.: 1240), AGCAgtgtga (SEQ ID NO.: 1241), AGCAgttaag (SEQ ID NO.: 1242), AGCCcaggga (SEQ ID NO.: 1243), AGCCgtaagt (SEQ ID NO.: 1244), AGCCgtacgt (SEQ ID NO.: 1245), AGCCgtatgt (SEQ ID
NO.: 1246), AGCCgtgagt (SEQ ID NO.: 1247), AGCCgtgtgt (SEQ ID NO.: 1248), AGCGgcagca (SEQ ID NO.: 1249), AGCGgcaggt (SEQ ID NO.: 1250), AGCGgtaaat (SEQ ID NO.: 1251), AGCGgtaact (SEQ ID NO.: 1252), AGCGgtaaga (SEQ ID NO.: 1253), AGCGgtaagc (SEQ ID NO.: 1254), AGCGgtaagg (SEQ ID NO.: 1255), AGCGgtaagt (SEQ ID NO.: 1256), AGCGgtaatc (SEQ ID NO.: 1257), AGCGgtaatt (SEQ ID NO.: 1258), AGCGgtacgg (SEQ ID NO.: 1259), AGCGgtactt (SEQ ID NO.: 1260), AGCGgtaggt (SEQ ID NO.: 1261), AGCGgtagta (SEQ ID NO.: 1262), AGCGgtatga (SEQ ID NO.: 1263), AGCGgtatgg (SEQ ID NO.: 1264), AGCGgtatgt (SEQ ID NO.: 1265), AGCGgtcagt (SEQ ID NO.: 1266), AGCGgtgaag (SEQ ID NO.: 1267), AGCGgtgaat (SEQ ID NO.: 1268), AGCGgtgaga (SEQ ID NO.: 1269), AGCGgtgagc (SEQ ID NO.: 1270), AGCGgtgagg (SEQ ID NO.: 1271), AGCGgtgagt (SEQ ID NO.: 1272), AGCGgtgcgt (SEQ ID NO : 1273), AGCGgtgggt (SEQ ID NO.: 1274), AGCGgtgtgt (SEQ ID NO.: 1275), AGCTatatcc (SEQ ID NO.: 1276), AGCTatttac (SEQ ID NO.: 1277), AGCTcaggtg (SEQ ID NO.: 1278), AGCTgtaaga (SEQ ID NO.: 1279), AGCTgtaagc (SEQ ID NO.: 1280), AGCTgtaagg (SEQ ID NO.: 1281), AGCTgtaagt (SEQ ID NO.: 1282), AGCTgtacgt (SEQ ID NO.: 1283), AGCTgtaggt (SEQ ID NO.: 1284), AGCTgtatgt (SEQ ID NO.: 1285), AGCTgtgaga (SEQ ID NO.: 1286), AGCTgtgagc (SEQ ID NO.: 1287), AGCTgtgagt (SEQ ID NO.: 1288), AGCTgtggga (SEQ ID NO.: 1289), AGCTgtggta (SEQ ID NO.: 1290), AGGAaaagta (SEQ ID NO.: 1291), AGGAaaggta (SEQ ID NO.: 1292), AGGAaagtaa (SEQ ID NO.: 1293), AGGAgccttg (SEQ ID NO.: 1294), AGGAgtaaga (SEQ ID NO.: 1295), AGGAgtaagg (SEQ ID NO.: 1296), AGGAgtaagt (SEQ ID NO.: 1297), AGGAgtaggt (SEQ ID NO.: 1298), AGGAgtatgt (SEQ ID NO.: 1299), AGGAgtgagg (SEQ ID NO.: 1300), AGGAgtgagt (SEQ ID NO.: 1301), AGGCgtaaga (SEQ ID NO.: 1302), AGGCgtaagt (SEQ ID NO.: 1303), AGGCgtaatg (SEQ ID NO.: 1304), AGGCgtgagt (SEQ ID NO.: 1305), AGGGcgggtc (SEQ ID NO.: 1306), AGGGgcaagt (SEQ ID NO.: 1307), AGGGgccagg (SEQ ID NO.: 1308), AGGGgtaaaa (SEQ ID NO.: 1309), AGGGgtaaag (SEQ ID NO.: 1310), AGGGgtaaat (SEQ ID NO.: 1311), AGGGgtaaca (SEQ ID NO.: 1312), AGGGgtaaga (SEQ ID NO.: 1313), AGGGgtaagc (SEQ ID NO.: 1314), AGGGgtaagg (SEQ ID NO.: 1315), AGGGgtaagt (SEQ ID NO.: 1316), AGGGgtaata (SEQ ID NO.: 1317), AGGGgtaatg (SEQ ID NO.: 1318), AGGGgtaatt (SEQ ID NO.: 1319), AGGGgtacga (SEQ ID NO.: 1320), AGGGgtacgt (SEQ ID NO.: 1321), AGGGgtagga (SEQ ID NO.: 1322), AGGGgtaggt (SEQ ID NO.: 1323), AGGGgtatac (SEQ ID NO.: 1324), AGGGgtatga (SEQ ID NO.: 1325), AGGGgtatgg (SEQ ID NO.: 1326), AGGGgtatgt (SEQ ID NO.: 1327), AGGGgtcagt (SEQ ID NO.: 1328), AGGGgtctgt (SEQ ID NO.: 1329), AGGGgtgaga (SEQ ID NO.: 1330), AGGGgtgagc (SEQ ID NO.: 1331), AGGGgtgagg (SEQ ID NO.: 1332), AGGGgtgagt (SEQ ID NO.: 1333), AGGGgtgggt (SEQ ID NO.: 1334), AGGTgtaagg (SEQ ID NO.: 1335), AGGTgtaagt (SEQ ID NO.: 1336), AGGTgtaggt (SEQ ID NO.: 1337), AGGTgtgagt (SEQ ID NO.: 1338), AGGTgttgct (SEQ ID NO.: 1339), AGGTgtggt (SEQ ID NO.: 1340), AGTAgtaagt (SEQ ID NO.: 1341), AGTAgtacgt (SEQ ID NO.: 1342), AGTAgtgagt (SEQ ID NO.: 1343), AGTAgttagt (SEQ ID NO.: 1344), AGTAttggta (SEQ ID NO.: 1345), AGTCagacag (SEQ ID NO.: 1346), AGTCgggctc (SEQ ID NO.: 1347), AGTCgtaagt (SEQ ID NO.: 1348), AGTCgtatcc (SEQ ID NO.: 1349), AGTCgtgagt (SEQ ID NO.: 1350), AGTCtctgca (SEQ ID NO.: 1351), AGTGagtaag (SEQ ID NO.: 1352), AGTGgtaaaa (SEQ ID NO.: 1353), AGTGgtaaag (SEQ ID NO.: 1354), AGTGgtaaat (SEQ ID NO.: 1355), AGTGgtaacc (SEQ ID NO.: 1356), AGTGgtaaga (SEQ ID NO.: 1357), AGTGgtaagc (SEQ ID NO.: 1358), AGTGgtaagg (SEQ ID NO.: 1359), AGTGgtaagt (SEQ ID NO.: 1360), AGTGgtaatc (SEQ ID
NO.: 1361), AGTGgtaatg (SEQ ID NO.: 1362), AGTGgtaatt (SEQ ID NO.: 1363), AGTGgtacgt (SEQ ID NO.: 1364), AGTGgtagga (SEQ ID NO.: 1365), AGTGgtaggt (SEQ ID NO.: 1366), AGTGgtataa (SEQ ID NO.: 1367), AGTGgtatac (SEQ ID NO.: 1368), AGTGgtatca (SEQ ID NO.: 1369), AGTGgtatga (SEQ ID NO.: 1370), AGTGgtatgt (SEQ ID NO.: 1371), AGTGgtcagt (SEQ ID NO.: 1372), AGTGgtgact (SEQ ID NO.: 1373), AGTGgtgaga (SEQ ID NO.: 1374), AGTGgtgagc (SEQ ID NO.: 1375), AGTGgtgagg (SEQ ID NO.: 1376), AGTGgtgagt (SEQ ID NO.: 1377), AGTGgtgggt (SEQ ID NO.: 1378), AGTGgttggt (SEQ ID NO.: 1379), AGTGgtttgt (SEQ ID NO.: 1380), AGTGtcctgg (SEQ ID NO.: 1381), AGTTcacggg (SEQ ID NO.: 1382), AGTTgcacgt (SEQ ID NO.: 1383), AGTTgtaagc (SEQ ID NO.: 1384), AGTTgtaagt (SEQ ID NO.: 1385), AGTTgtagat (SEQ ID NO.: 1386), AGTTgtaggt (SEQ ID NO.: 1387), AGTTgtgagt (SEQ ID NO.: 1388), ATAAagaaga (SEQ ID NO.: 1389), ATAActggtg (SEQ ID NO.: 1390), ATAAgtaacc (SEQ ID NO.: 1391), ATAAgtaaga (SEQ ID NO.: 1392), ATAAgtaagc (SEQ ID NO.: 1393), ATAAgtaagt (SEQ ID NO.: 1394), ATAAgtaatg (SEQ ID NO.: 1395), ATAAgtacat (SEQ ID NO.: 1396), ATAAgtactg (SEQ ID NO.: 1397), ATAAgtaggt (SEQ ID NO.: 1398), ATAAgtatga (SEQ ID NO.: 1399), ATAAgtatgc (SEQ ID NO.: 1400), ATAAgtatgt (SEQ ID NO.: 1401), ATAAgtattg (SEQ ID NO.: 1402), ATAAgtgaga (SEQ ID NO.: 1403), ATAAgtgagc (SEQ ID NO.: 1404), ATAAgtgagt (SEQ ID NO.: 1405), ATAAgtgtgt (SEQ ID NO.: 1406), ATACctggtc (SEQ ID NO.: 1407), ATACgtaagg (SEQ ID NO.: 1408), ATACgtaagt (SEQ ID NO.: 1409), ATACgtgagt (SEQ ID NO.: 1410), ATAGcgaaga (SEQ ID NO.: 1411), ATAGgcaagc (SEQ ID NO.: 1412), ATAGgcaagt (SEQ ID NO.: 1413), ATAGgcatgt (SEQ ID NO.: 1414), ATAGgcgagt (SEQ ID NO.: 1415), ATAGgtaaaa (SEQ ID NO.: 1416), ATAGgtaaac (SEQ ID NO.: 1417), ATAGgtaaag (SEQ ID NO.: 1418), ATAGgtaaat (SEQ ID NO.: 1419), ATAGgtaaca (SEQ ID NO.: 1420), ATAGgtaact (SEQ ID NO.: 1421), ATAGgtaaga (SEQ ID NO.: 1422), ATAGgtaagc (SEQ ID NO.: 1423), ATAGgtaagg (SEQ ID NO.: 1424), ATAGgtaagt (SEQ ID NO.: 1425), ATAGgtaata (SEQ ID NO.: 1426), ATAGgtaatc (SEQ ID NO.: 1427), ATAGgtaatg (SEQ ID NO.: 1428), ATAGgtaatt (SEQ ID NO.: 1429), ATAGgtacag (SEQ ID NO.: 1430), ATAGgtacat (SEQ ID NO.: 1431), ATAGgtacca (SEQ ID NO.: 1432), ATAGgtacgt (SEQ ID NO.: 1433), ATAGgtactc (SEQ ID NO.: 1434), ATAGgtactg (SEQ ID NO.: 1435), ATAGgtactt (SEQ ID NO.: 1436), ATAGgtagat (SEQ ID NO.: 1437), ATAGgtagga (SEQ ID NO.: 1438), ATAGgtaggc (SEQ ID NO.: 1439), ATAGgtaggg (SEQ ID NO.: 1440), ATAGgtaggt (SEQ ID NO.: 1441), ATAGgtagtc (SEQ ID NO.: 1442), ATAGgtagtt (SEQ ID NO.: 1443), ATAGgtatag (SEQ ID NO.: 1444), ATAGgtatat (SEQ ID NO.: 1445), ATAGgtatga (SEQ ID NO.: 1446), ATAGgtatgc (SEQ ID NO.: 1447), ATAGgtatgg (SEQ ID NO.: 1448), ATAGgtatgt (SEQ ID NO.: 1449), ATAGgtattg (SEQ ID NO.: 1450), ATAGgtattt (SEQ ID NO.: 1451), ATAGgtcagt (SEQ ID NO.: 1452), ATAGgtctgc (SEQ ID NO.: 1453), ATAGgtgaaa (SEQ ID NO.: 1454), ATAGgtgaat (SEQ ID NO.: 1455), ATAGgtgaca (SEQ ID NO.: 1456), ATAGgtgaga (SEQ ID NO.: 1457), ATAGgtgagc (SEQ ID NO.: 1458), ATAGgtgagg (SEQ ID NO.: 1459), ATAGgtgagt (SEQ ID NO.: 1460), ATAGgtgata (SEQ ID NO.: 1461), ATAGgtgatg (SEQ ID NO.: 1462), ATAGgtgcgt (SEQ ID NO.: 1463), ATAGgtgctc (SEQ ID NO.: 1464), ATAGgtgggt (SEQ ID NO.: 1465), ATAGgtgtga (SEQ ID NO.: 1466), ATAGgtgtgt (SEQ ID NO.: 1467), ATAGgtgttg (SEQ ID NO.: 1468), ATAGgttagg (SEQ ID NO.: 1469), ATAGgttagt (SEQ ID NO.: 1470), ATAGgttcgt (SEQ ID NO.: 1471), ATAGgttggc (SEQ ID NO.: 1472), ATAGgttggt (SEQ ID NO.: 1473), ATAGgtttgt (SEQ ID NO.: 1474), ATAGgttttc (SEQ ID NO.: 1475), ATAGtgatct (SEQ ID NO.: 1476), ATATataaga (SEQ ID NO.: 1477), ATATatcctg (SEQ ID NO.: 1478), ATATctggtg (SEQ ID NO.: 1479), ATATgcaggt
(SEQ ID NO.: 1480), ATATggtaca (SEQ ID NO.: 1481), ATATgtaaaa (SEQ ID NO.: 1482), ATATgtaaga (SEQ ID NO.: 1483), ATATgtaagt (SEQ ID NO.: 1484), ATATgtacgt (SEQ ID NO.: 1485), ATATgtaggt (SEQ ID NO.: 1486), ATATgtagta (SEQ ID NO.: 1487), ATATgtatcc (SEQ ID NO.: 1488), ATATgtatgt (SEQ ID NO.: 1489), ATATgtgagc (SEQ ID NO.: 1490), ATATgtgagt (SEQ ID NO.: 1491), ATATgttggt (SEQ ID NO.: 1492), ATCAaggaac (SEQ ID NO.: 1493), ATCAatatcc (SEQ ID NO.: 1494), ATCAgtaaga (SEQ ID NO.: 1495), ATCAgtaagg (SEQ ID NO.: 1496), ATCAgtaagt (SEQ ID NO.: 1497), ATCAgtaatc (SEQ ID NO.: 1498), ATCAgtatgt (SEQ ID NO.: 1499), ATCAgtgaga (SEQ ID NO.: 1500), ATCAgtgagt (SEQ ID NO.: 1501), ATCAgtgcgt (SEQ ID NO.: 1502), ATCAgttaag (SEQ ID NO.: 1503), ATCAgttaat (SEQ ID NO.: 1504), ATCCagaaac (SEQ ID NO.: 1505), ATCCataagt (SEQ ID NO.: 1506), ATCCcttagg (SEQ ID NO.: 1507), ATCCgtaagt (SEQ ID NO : 1508), ATCCgtgagc (SEQ ID NO.: 1509), ATCCgtgagt (SEQ ID NO.: 1510), ATCGgcaagt (SEQ ID NO.: 1511), ATCGgtaaag (SEQ ID NO.: 1512), ATCGgtaaat (SEQ ID NO.: 1513), ATCGgtaaga (SEQ ID NO.: 1514), ATCGgtaagc (SEQ ID NO.: 1515), ATCGgtaagg (SEQ ID NO.: 1516), ATCGgtaagt (SEQ ID NO.: 1517), ATCGgtaata (SEQ ID NO.: 1518), ATCGgtaatc (SEQ ID NO.: 1519), ATCGgtaatg (SEQ ID NO.: 1520), ATCGgtacaa (SEQ ID NO.: 1521), ATCGgtacgg (SEQ ID NO.: 1522), ATCGgtaggt (SEQ ID NO.: 1523), ATCGgtataa (SEQ ID NO.: 1524), ATCGgtatgg (SEQ ID NO.: 1525), ATCGgtatgt (SEQ ID NO.: 1526), ATCGgtattt (SEQ ID NO.: 1527), ATCGgtcaat (SEQ ID NO.: 1528), ATCGgtcagt (SEQ ID NO.: 1529), ATCGgtgaga (SEQ ID NO.: 1530), ATCGgtgagc (SEQ ID NO.: 1531), ATCGgtgagg (SEQ ID NO.: 1532), ATCGgtgagt (SEQ ID NO.: 1533), ATCGgtgcgg (SEQ ID NO.: 1534), ATCGgtgcgt (SEQ ID NO.: 1535), ATCGgtgggt (SEQ ID NO.: 1536), ATCGgttagt (SEQ ID NO.: 1537), ATCTggtgag (SEQ ID NO.: 1538), ATCTgtaaga (SEQ ID NO.: 1539), ATCTgtaagc (SEQ ID NO.: 1540), ATCTgtaagg (SEQ ID NO.: 1541), ATCTgtaagt (SEQ ID NO.: 1542), ATCTgtatcc (SEQ ID NO.: 1543), ATCTgtatgt (SEQ ID NO.: 1544), ATCTgtgaga (SEQ ID NO.: 1545), ATCTgtgagc (SEQ ID NO.: 1546), ATCTgtgagt (SEQ ID NO.: 1547), ATCTgtggtg (SEQ ID NO.: 1548), ATGAaaaggt (SEQ ID NO.: 1549), ATGAggtgag (SEQ ID NO.: 1550), ATGAggtttg (SEQ ID NO.: 1551), ATGAgtaaga (SEQ ID NO.: 1552), ATGAgtaagt (SEQ ID NO.: 1553), ATGAgtactt (SEQ ID NO.: 1554), ATGAgtaggt (SEQ ID NO.: 1555), ATGAgtatga (SEQ ID NO.: 1556), ATGAgtatgc (SEQ ID NO.: 1557), ATGAgtatgt (SEQ ID NO.: 1558), ATGAgtgagt (SEQ ID NO.: 1559), ATGAgtgtga (SEQ ID NO.: 1560), ATGAtatcct (SEQ ID NO.: 1561), ATGAtgagga (SEQ ID NO.: 1562), ATGAtttgaa (SEQ ID NO.: 1563), ATGCgtaaga (SEQ ID NO.: 1564), ATGCgtaagt (SEQ ID NO.: 1565), ATGCgtgagt (SEQ ID NO.: 1566), ATGCgtgcca (SEQ ID NO.: 1567), ATGGgcaagg (SEQ ID NO.: 1568), ATGGgcaagt (SEQ ID NO.: 1569), ATGGgcaggt (SEQ ID NO.: 1570), ATGGgtaaaa (SEQ ID NO.: 1571), ATGGgtaaac (SEQ ID NO.: 1572), ATGGgtaaag (SEQ ID NO.: 1573), ATGGgtaaat (SEQ ID NO : 1574), ATGGgtaact (SEQ ID NO.: 1575), ATGGgtaaga (SEQ ID NO : 1576), ATGGgtaagc (SEQ ID NO.: 1577), ATGGgtaagg (SEQ ID NO.: 1578), ATGGgtaagt (SEQ ID NO.: 1579), ATGGgtaata (SEQ ID NO.: 1580), ATGGgtaatc (SEQ ID NO.: 1581), ATGGgtaatg (SEQ ID NO.: 1582), ATGGgtaatt (SEQ ID NO.: 1583), ATGGgtacga (SEQ ID NO.: 1584), ATGGgtacgg (SEQ ID NO.: 1585), ATGGgtacgt (SEQ ID NO.: 1586), ATGGgtactt (SEQ ID NO.: 1587), ATGGgtagga (SEQ ID NO.: 1588), ATGGgtaggc (SEQ ID NO.: 1589), ATGGgtaggg (SEQ ID NO.: 1590), ATGGgtaggt (SEQ ID NO.: 1591), ATGGgtatga (SEQ ID NO.: 1592), ATGGgtatgc (SEQ ID NO.: 1593), ATGGgtatgg (SEQ ID NO.: 1594), ATGGgtatgt (SEQ ID NO.: 1595), ATGGgtattt (SEQ ID NO.: 1596), ATGGgtcagt (SEQ ID NO.: 1597),
ATGGgtctgc (SEQ ID NO.: 1598), ATGGgtgaat (SEQ ID NO.: 1599), ATGGgtgaga (SEQ ID NO.: 1600), ATGGgtgagc (SEQ ID NO.: 1601), ATGGgtgagg (SEQ ID NO.: 1602), ATGGgtgagt (SEQ ID NO.: 1603), ATGGgtgggt (SEQ ID NO.: 1604), ATGGgtgtgt (SEQ ID NO.: 1605), ATGGgttaat (SEQ ID NO.: 1606), ATGGgttagt (SEQ ID NO.: 1607), ATGGgttcag (SEQ ID NO.: 1608), ATGGgttggt (SEQ ID NO.: 1609), ATGGgtttgt (SEQ ID NO.: 1610), ATGGtggtga (SEQ ID NO.: 1611), ATGTactcat (SEQ ID NO.: 1612), ATGTgcaagt (SEQ ID NO.: 1613), ATGTgtaaga (SEQ ID NO.: 1614), ATGTgtaagc (SEQ ID NO.: 1615), ATGTgtaagt (SEQ ID NO.: 1616), ATGTgtatgt (SEQ ID NO.: 1617), ATGTgtgagt (SEQ ID NO.: 1618), ATGTgtggtg (SEQ ID NO.: 1619), ATGTgtgtga (SEQ ID NO.: 1620), ATGTtggtgg (SEQ ID NO.: 1621), ATTAatatcc (SEQ ID NO.: 1622), ATTAgtaagt (SEQ ID NO.: 1623), ATTAgtaggt (SEQ ID NO. : 1624), ATT Agtatgt (SEQ ID NO. : 1625), ATTAgtgagt (SEQ ID NO. : 1626), ATTAttccaa (SEQ ID NO.: 1627), ATTCgtaagt (SEQ ID NO.: 1628), ATTCgtgagt (SEQ ID NO.: 1629), ATTGgatatc (SEQ ID NO.: 1630), ATTGgcaaga (SEQ ID NO.: 1631), ATTGgcaagt (SEQ ID NO.: 1632), ATTGgcacgt (SEQ ID NO.: 1633), ATTGgcatgc (SEQ ID NO.: 1634), ATTGgtaaaa (SEQ ID NO.: 1635), ATTGgtaaag (SEQ ID NO.: 1636), ATTGgtaaat (SEQ ID NO.: 1637), ATTGgtaaga (SEQ ID NO.: 1638), ATTGgtaagc (SEQ ID NO.: 1639), ATTGgtaagg (SEQ ID NO.: 1640), ATTGgtaagt (SEQ ID NO.: 1641), ATTGgtaata (SEQ ID NO.: 1642), ATTGgtaatc (SEQ ID NO.: 1643), ATTGgtaatt (SEQ ID NO.: 1644), ATTGgtacga (SEQ ID NO.: 1645), ATTGgtacgt (SEQ ID NO.: 1646), ATTGgtactt (SEQ ID NO.: 1647), ATTGgtagga (SEQ ID NO.: 1648), ATTGgtaggc (SEQ ID NO.: 1649), ATTGgtaggg (SEQ ID NO.: 1650), ATTGgtaggt (SEQ ID NO.: 1651), ATTGgtagta (SEQ ID NO.: 1652), ATTGgtagtt (SEQ ID NO.: 1653), ATTGgtatga (SEQ ID NO.: 1654), ATTGgtatgc (SEQ ID NO.: 1655), ATTGgtatgt (SEQ ID NO.: 1656), ATTGgtatta (SEQ ID NO.: 1657), ATTGgtattg (SEQ ID NO.: 1658), ATTGgtcagt (SEQ ID NO.: 1659), ATTGgtctgt (SEQ ID NO.: 1660), ATTGgtgaga (SEQ ID NO.: 1661), ATTGgtgagc (SEQ ID NO.: 1662), ATTGgtgagg (SEQ ID NO.: 1663), ATTGgtgagt (SEQ ID NO.: 1664), ATTGgtgatg (SEQ ID NO.: 1665), ATTGgtgcga (SEQ ID NO.: 1666), ATTGgtgcgt (SEQ ID NO.: 1667), ATTGgtgggt (SEQ ID NO.: 1668), ATTGgtggta (SEQ ID NO.: 1669), ATTGgtgtga (SEQ ID NO.: 1670), ATTGgttagt (SEQ ID NO.: 1671), ATTGgttcgt (SEQ ID NO.: 1672), ATTTatctca (SEQ ID NO.: 1673), ATTTgatgtg (SEQ ID NO.: 1674), ATTTgcaggt (SEQ ID NO.: 1675), ATTTggtgag (SEQ ID NO.: 1676), ATTTgtaaga (SEQ ID NO.: 1677), ATTTgtaagc (SEQ ID NO.: 1678), ATTTgtaagt (SEQ ID NO.: 1679), ATTTgtacgt (SEQ ID NO.: 1680), ATTTgtatcc (SEQ ID NO.: 1681), ATTTgtatgt (SEQ ID NO.: 1682), ATTTgtgagt (SEQ ID NO.: 1683), CAAAaacagg (SEQ ID NO.: 1684), CAAAaaggca (SEQ ID NO.: 1685), CAAAaaggta (SEQ ID NO.: 1686), CAAAaaggtg (SEQ ID NO.: 1687), CAAAaggtca (SEQ ID NO.: 1688), CAAAggtaag (SEQ ID NO.: 1689), CAAAgtaaag (SEQ ID NO.: 1690), CAAAgtaaat (SEQ ID NO.: 1691), CAAAgtaaga (SEQ ID NO.: 1692), CAAAgtaagc (SEQ ID NO.: 1693), CAAAgtaagg (SEQ ID NO.: 1694), CAAAgtaagt (SEQ ID NO.: 1695), CAAAgtaata (SEQ ID NO.: 1696), CAAAgtaatc (SEQ ID NO.: 1697), CAAAgtaatt (SEQ ID NO.: 1698), CAAAgtacaa (SEQ ID NO.: 1699), CAAAgtacgg (SEQ ID NO.: 1700), CAAAgtacgt (SEQ ID NO.: 1701), CAAAgtactg (SEQ ID NO.: 1702), CAAAgtagga (SEQ ID NO.: 1703), CAAAgtaggt (SEQ ID NO.: 1704), CAAAgtataa (SEQ ID NO.: 1705), CAAAgtatct (SEQ ID NO.: 1706), CAAAgtatgg (SEQ ID NO.: 1707), CAAAgtatgt (SEQ ID NO.: 1708), CAAAgtattg (SEQ ID NO.: 1709), CAAAgtcagt (SEQ ID NO.: 1710), CAAAgtcccc (SEQ ID NO.: 1711), CAAAgtctgt (SEQ ID NO.: 1712), CAAAgtgaga (SEQ ID NO.: 1713), CAAAgtgagc (SEQ ID NO.: 1714), CAAAgtgagt (SEQ ID NO.: 1715), CAAAgtgggt (SEQ ID
NO.: 1716), CAAAgttagc (SEQ ID NO.: 1717), CAAAgttagt (SEQ ID NO.: 1718), CAACataagt (SEQ ID NO.: 1719), CAACatcaac (SEQ ID NO.: 1720), CAACctggta (SEQ ID NO.: 1721), CAACgtaagc (SEQ ID NO.: 1722), CAACgtaagg (SEQ ID NO.: 1723), CAACgtaagt (SEQ ID NO.: 1724), CAACgtatgt (SEQ ID NO.: 1725), CAACgtgagc (SEQ ID NO.: 1726), CAACgtgagg (SEQ ID NO.: 1727), CAACgtgagt (SEQ ID NO.: 1728), CAAGagactg (SEQ ID NO.: 1729), CAAGatatcc (SEQ ID NO.: 1730), CAAGgcaact (SEQ ID NO.: 1731), CAAGgcaaga (SEQ ID NO.: 1732), CAAGgcaagc (SEQ ID NO.: 1733), CAAGgcaagg (SEQ ID NO.: 1734), CAAGgcaagt (SEQ ID NO.: 1735), CAAGgcacag (SEQ ID NO.: 1736), CAAGgcacgt (SEQ ID NO.: 1737), CAAGgcaggt (SEQ ID NO.: 1738), CAAGgcatgt (SEQ ID NO.: 1739), CAAGgccagt (SEQ ID NO.: 1740), CAAGgcccaa (SEQ ID NO.: 1741), C A AGgcgagc (SEQ ID NO. : 1742), C A AGgcgagg (SEQ ID NO. : 1743), C A AGgcgggc (SEQ ID NO.: 1744), CAAGgctaca (SEQ ID NO.: 1745), CAAGgctagt (SEQ ID NO.: 1746), CAAGgctggt (SEQ ID NO.: 1747), CAAGgtaaaa (SEQ ID NO.: 1748), CAAGgtaaac (SEQ ID NO.: 1749), CAAGgtaaag (SEQ ID NO.: 1750), CAAGgtaaat (SEQ ID NO.: 1751), CAAGgtaaca (SEQ ID NO.: 1752), CAAGgtaacc (SEQ ID NO.: 1753), CAAGgtaacg (SEQ ID NO.: 1754), CAAGgtaact (SEQ ID NO.: 1755), CAAGgtaaga (SEQ ID NO.: 1756), CAAGgtaagc (SEQ ID NO.: 1757), CAAGgtaagg (SEQ ID NO.: 1758), CAAGgtaagt (SEQ ID NO.: 1759), CAAGgtaata (SEQ ID NO.: 1760), CAAGgtaatc (SEQ ID NO.: 1761), CAAGgtaatg (SEQ ID NO.: 1762), CAAGgtaatt (SEQ ID NO.: 1763), CAAGgtacaa (SEQ ID NO.: 1764), CAAGgtacac (SEQ ID NO.: 1765), CAAGgtacag (SEQ ID NO.: 1766), CAAGgtacat (SEQ ID NO.: 1767), CAAGgtacca (SEQ ID NO.: 1768), CAAGgtaccc (SEQ ID NO.: 1769), CAAGgtaccg (SEQ ID NO.: 1770), CAAGgtacct (SEQ ID NO.: 1771), CAAGgtacga (SEQ ID NO.: 1772), CAAGgtacgg (SEQ ID NO.: 1773), CAAGgtacgt (SEQ ID NO.: 1774), CAAGgtacta (SEQ ID NO.: 1775), CAAGgtactc (SEQ ID NO.: 1776), CAAGgtactg (SEQ ID NO.: 1777), CAAGgtactt (SEQ ID NO.: 1778), CAAGgtagaa (SEQ ID NO.: 1779), CAAGgtagac (SEQ ID NO.: 1780), CAAGgtagag (SEQ ID NO.: 1781), CAAGgtagat (SEQ ID NO.: 1782), CAAGgtagca (SEQ ID NO.: 1783), CAAGgtagct (SEQ ID NO.: 1784), CAAGgtagga (SEQ ID NO.: 1785), CAAGgtaggc (SEQ ID NO.: 1786), CAAGgtaggg (SEQ ID NO.: 1787), CAAGgtaggt (SEQ ID NO.: 1788), CAAGgtagta (SEQ ID NO.: 1789), CAAGgtagtc (SEQ ID NO.: 1790), CAAGgtagtg (SEQ ID NO.: 1791), CAAGgtagtt (SEQ ID NO.: 1792), CAAGgtataa (SEQ ID NO.: 1793), CAAGgtatac (SEQ ID NO.: 1794), CAAGgtatag (SEQ ID NO.: 1795), CAAGgtatat (SEQ ID NO.: 1796), CAAGgtatca (SEQ ID NO.: 1797), CAAGgtatcc (SEQ ID NO.: 1798), CAAGgtatct (SEQ ID NO.: 1799), CAAGgtatga (SEQ ID NO.: 1800), CAAGgtatgc (SEQ ID NO.: 1801), CAAGgtatgg (SEQ ID NO.: 1802), CAAGgtatgt (SEQ ID NO.: 1803), CAAGgtatta (SEQ ID NO.: 1804), CAAGgtattc (SEQ ID NO.: 1805), CAAGgtattg (SEQ ID NO.: 1806), CAAGgtattt (SEQ ID NO.: 1807), CAAGgtcaaa (SEQ ID NO.: 1808), CAAGgtcaat (SEQ ID NO.: 1809), CAAGgtcact (SEQ ID NO.: 1810), CAAGgtcaga (SEQ ID NO.: 1811), CAAGgtcagc (SEQ ID NO.: 1812), CAAGgtcagg (SEQ ID NO.: 1813), CAAGgtcagt (SEQ ID NO.: 1814), CAAGgtcata (SEQ ID NO.: 1815), CAAGgtcatg (SEQ ID NO.: 1816), CAAGgtcatt (SEQ ID NO.: 1817), CAAGgtccct (SEQ ID NO.: 1818), CAAGgtccta (SEQ ID NO.: 1819), CAAGgtcctg (SEQ ID NO.: 1820), CAAGgtcgaa (SEQ ID NO.: 1821), CAAGgtcgag (SEQ ID NO.: 1822), CAAGgtcgga (SEQ ID NO.: 1823), CAAGgtcgtg (SEQ ID NO.: 1824), CAAGgtctac (SEQ ID NO.: 1825), CAAGgtctat (SEQ ID NO.: 1826), CAAGgtctct (SEQ ID NO.: 1827), CAAGgtctga (SEQ ID NO.: 1828), CAAGgtctgg (SEQ ID NO.: 1829), CAAGgtctgt (SEQ ID NO.: 1830), CAAGgtcttc (SEQ ID NO.: 1831),
CAAGgtgaaa (SEQ ID NO.: 1832), CAAGgtgaag (SEQ ID NO.: 1833), CAAGgtgaat (SEQ ID NO.: 1834), CAAGgtgaca (SEQ ID NO.: 1835), CAAGgtgacc (SEQ ID NO.: 1836), CAAGgtgacg (SEQ ID NO.: 1837), CAAGgtgact (SEQ ID NO.: 1838), CAAGgtgaga (SEQ ID NO.: 1839), CAAGgtgagc (SEQ ID NO.: 1840), CAAGgtgagg (SEQ ID NO.: 1841), CAAGgtgagt (SEQ ID NO.: 1842), CAAGgtgata (SEQ ID NO.: 1843), CAAGgtgatc (SEQ ID NO.: 1844), CAAGgtgatg (SEQ ID NO.: 1845), CAAGgtgatt (SEQ ID NO.: 1846), CAAGgtgcac (SEQ ID NO.: 1847), CAAGgtgcag (SEQ ID NO.: 1848), CAAGgtgcat (SEQ ID NO.: 1849), CAAGgtgcca (SEQ ID NO.: 1850), CAAGgtgccc (SEQ ID NO.: 1851), CAAGgtgcct (SEQ ID NO.: 1852), CAAGgtgcga (SEQ ID NO.: 1853), CAAGgtgcgc (SEQ ID NO.: 1854), CAAGgtgcgt (SEQ ID NO.: 1855), CAAGgtgctc (SEQ ID NO.: 1856), CAAGgtgctg (SEQ ID NO.: 1857), CAAGgtgctt (SEQ ID NO.: 1858), CAAGgtggag (SEQ ID NO.: 1859), CAAGgtggct (SEQ ID NO.: 1860), CAAGgtggga (SEQ ID NO.: 1861), CAAGgtgggc (SEQ ID NO.: 1862), CAAGgtgggg (SEQ ID NO.: 1863), CAAGgtgggt (SEQ ID NO.: 1864), CAAGgtggta (SEQ ID NO.: 1865), CAAGgtggtt (SEQ ID NO.: 1866), CAAGgtgtac (SEQ ID NO.: 1867), CAAGgtgtag (SEQ ID NO.: 1868), CAAGgtgtat (SEQ ID NO.: 1869), CAAGgtgtct (SEQ ID NO.: 1870), CAAGgtgtgc (SEQ ID NO.: 1871), CAAGgtgtgg (SEQ ID NO.: 1872), CAAGgtgtgt (SEQ ID NO.: 1873), CAAGgtgttc (SEQ ID NO.: 1874), CAAGgtgttg (SEQ ID NO.: 1875), CAAGgttaaa (SEQ ID NO.: 1876), CAAGgttaac (SEQ ID NO.: 1877), CAAGgttact (SEQ ID NO.: 1878), CAAGgttaga (SEQ ID NO.: 1879), CAAGgttagc (SEQ ID NO.: 1880), CAAGgttagg (SEQ ID NO.: 1881), CAAGgttagt (SEQ ID NO.: 1882), CAAGgttata (SEQ ID NO.: 1883), CAAGgttatc (SEQ ID NO.: 1884), CAAGgttatt (SEQ ID NO.: 1885), CAAGgttcga (SEQ ID NO.: 1886), CAAGgttcgt (SEQ ID NO.: 1887), CAAGgttcta (SEQ ID NO.: 1888), CAAGgttctc (SEQ ID NO.: 1889), CAAGgttgag (SEQ ID NO.: 1890), CAAGgttgga (SEQ ID NO.: 1891), CAAGgttggc (SEQ ID NO.: 1892), CAAGgttggg (SEQ ID NO.: 1893), CAAGgttggt (SEQ ID NO.: 1894), CAAGgttgta (SEQ ID NO.: 1895), CAAGgtttaa (SEQ ID NO.: 1896), CAAGgtttcc (SEQ ID NO.: 1897), CAAGgtttct (SEQ ID NO.: 1898), CAAGgtttga (SEQ ID NO.: 1899), CAAGgtttgc (SEQ ID NO.: 1900), CAAGgtttgg (SEQ ID NO.: 1901), CAAGgtttgt (SEQ ID NO.: 1902), CAAGgttttt (SEQ ID NO.: 1903), CAATatcctt (SEQ ID NO.: 1904), CAATctaagt (SEQ ID NO.: 1905), CAATgcaagt (SEQ ID NO.: 1906), CAATgctggg (SEQ ID NO.: 1907), CAATgtaacc (SEQ ID NO.: 1908), CAATgtaaga (SEQ ID NO.: 1909), CAATgtaagc (SEQ ID NO.: 1910), CAATgtaagg (SEQ ID NO.: 1911), CAATgtaagt (SEQ ID NO.: 1912), CAATgtacat (SEQ ID NO.: 1913), CAATgtacgt (SEQ ID NO.: 1914), CAATgtaggg (SEQ ID NO.: 1915), CAATgtaggt (SEQ ID NO.: 1916), CAATgtagtg (SEQ ID NO.: 1917), CAATgtatgt (SEQ ID NO.: 1918), CAATgtgagg (SEQ ID NO.: 1919), CAATgtgagt (SEQ ID NO.: 1920), CAATgtgcgt (SEQ ID NO.: 1921), CAATgtgggt (SEQ ID NO.: 1922), CAATgtgtgt (SEQ ID NO.: 1923), CACAggtaaa (SEQ ID NO.: 1924), CACAggttag (SEQ ID NO.: 1925), CACAgtaacg (SEQ ID NO.: 1926), CACAgtaaga (SEQ ID NO 1927), CACAgtaagc (SEQ ID NO.: 1928), CACAgtaagg (SEQ ID NO.: 1929), CACAgtaagt (SEQ ID NO.: 1930), CACAgtaatg (SEQ ID NO. : 1931), CACAgtacga (SEQ ID NO. : 1932), CACAgtacgt (SEQ ID NO.: 1933), CACAgtaggt (SEQ ID NO.: 1934), CACAgtgaga (SEQ ID NO.: 1935), CACAgtgagg (SEQ ID NO.: 1936), CACAgtgagt (SEQ ID NO.: 1937), CACAgtgggt (SEQ ID NO.: 1938), CACAgtgtga (SEQ ID NO.: 1939), CACAgttagt (SEQ ID NO.: 1940), CACAgttgag (SEQ ID NO.: 1941), CACAgtttgt (SEQ ID NO.: 1942), CACCcagcct (SEQ ID NO.: 1943), CACCgtaagt (SEQ ID NO.: 1944), CACCgtacgc (SEQ ID NO.: 1945), CACCgtgagt (SEQ ID NO.: 1946), CACCgtgcgt (SEQ ID NO.: 1947), CACCgtgtga (SEQ ID NO.: 1948),
CACGagggtg (SEQ ID NO.: 1949), CACGgcaagc (SEQ ID NO.: 1950), CACGgcaagt (SEQ ID NO.: 1951), CACGgcgtga (SEQ ID NO.: 1952), CACGgtaaaa (SEQ ID NO.: 1953), CACGgtaaac (SEQ ID NO.: 1954), CACGgtaaag (SEQ ID NO.: 1955), CACGgtaaat (SEQ ID NO.: 1956), CACGgtaaca (SEQ ID NO.: 1957), CACGgtaacc (SEQ ID NO.: 1958), CACGgtaact (SEQ ID NO.: 1959), CACGgtaaga (SEQ ID NO.: 1960), CACGgtaagc (SEQ ID NO.: 1961), CACGgtaagg (SEQ ID NO.: 1962), CACGgtaagt (SEQ ID NO.: 1963), CACGgtaatc (SEQ ID NO.: 1964), CACGgtaatg (SEQ ID NO.: 1965), CACGgtaatt (SEQ ID NO.: 1966), CACGgtacaa (SEQ ID NO.: 1967), CACGgtacag (SEQ ID NO.: 1968), CACGgtacat (SEQ ID NO.: 1969), CACGgtacct (SEQ ID NO.: 1970), CACGgtacga (SEQ ID NO.: 1971), CACGgtacgc (SEQ ID NO.: 1972), CACGgtacgt (SEQ ID NO.: 1973), CACGgtactc (SEQ ID NO.: 1974), CACGgtactg (SEQ ID NO.: 1975), CACGgtagat (SEQ ID NO.: 1976), CACGgtagga (SEQ ID NO.: 1977), CACGgtaggc (SEQ ID NO.: 1978), CACGgtaggg (SEQ ID NO.: 1979), CACGgtaggt (SEQ ID NO.: 1980), CACGgtatac (SEQ ID NO.: 1981), CACGgtatcc (SEQ ID NO.: 1982), CACGgtatgg (SEQ ID NO.: 1983), CACGgtatgt (SEQ ID NO.: 1984), CACGgtcagt (SEQ ID NO.: 1985), CACGgtgaga (SEQ ID NO.: 1986), CACGgtgagc (SEQ ID NO.: 1987), CACGgtgagg (SEQ ID NO.: 1988), CACGgtgagt (SEQ ID NO.: 1989), CACGgtgatt (SEQ ID NO.: 1990), CACGgtgccc (SEQ ID NO.: 1991), CACGgtgcgc (SEQ ID NO.: 1992), CACGgtgggc (SEQ ID NO.: 1993), CACGgtgggt (SEQ ID NO 1994), CACGgtgtgt (SEQ ID NO.: 1995), CACGgttagt (SEQ ID NO.: 1996), CACTgcacgt (SEQ ID NO.: 1997), CACTgtaagc (SEQ ID NO.: 1998), CACTgtaagg (SEQ ID NO.: 1999), CACTgtaagt (SEQ ID NO.: 2000), CACTgtaatg (SEQ ID NO.: 2001), CACTgtacgt (SEQ ID NO.: 2002), CACTgtatcc (SEQ ID NO.: 2003), CACTgtatga (SEQ ID NO.: 2004), CACTgtgagc (SEQ ID NO.: 2005), CACTgtgagt (SEQ ID NO.: 2006), CACTgtgcgt (SEQ ID NO.: 2007), CACTgtggta (SEQ ID NO.: 2008), CAGAacttct (SEQ ID NO.: 2009), CAGAagggag (SEQ ID NO.: 2010), CAGAggtaaa (SEQ ID NO.: 2011), CAGAggtaca (SEQ ID NO.: 2012), CAGAgtaaaa (SEQ ID NO.: 2013), CAGAgtaact (SEQ ID NO.: 2014), CAGAgtaaga (SEQ ID NO.: 2015), CAGAgtaagc (SEQ ID NO.: 2016), CAGAgtaagg (SEQ ID NO.: 2017), CAGAgtaagt (SEQ ID NO.: 2018), CAGAgtacgt (SEQ ID NO.: 2019), CAGAgtaggg (SEQ ID NO.: 2020), CAGAgtaggt (SEQ ID NO.: 2021), CAGAgtatcc (SEQ ID NO.: 2022), CAGAgtatga (SEQ ID NO.: 2023), CAGAgtatgt (SEQ ID NO.: 2024), CAGAgtcagg (SEQ ID NO.: 2025), CAGAgtgaga (SEQ ID NO.: 2026), CAGAgtgagg (SEQ ID NO.: 2027), CAGAgtgagt (SEQ ID NO.: 2028), CAGAgtgcgt (SEQ ID NO.: 2029), CAGAgtgggt (SEQ ID NO.: 2030), CAGCagcaca (SEQ ID NO.: 2031), CAGCagcacc (SEQ ID NO.: 2032), CAGCgtaaga (SEQ ID NO.: 2033), CAGCgtaagc (SEQ ID NO.: 2034), CAGCgtaagg (SEQ ID NO.: 2035), CAGCgtaagt (SEQ ID NO.: 2036), CAGCgtatgt (SEQ ID NO.: 2037), CAGCgtgagt (SEQ ID NO.: 2038), CAGCtgggcg (SEQ ID NO.: 2039), CAGGctggtg (SEQ ID NO.: 2040), CAGGgcaagt (SEQ ID NO.: 2041), CAGGgcaggc (SEQ ID NO.: 2042), CAGGgtaaaa (SEQ ID NO.: 2043), CAGGgtaaag (SEQ ID NO.: 2044), CAGGgtaaat (SEQ ID NO.: 2045), CAGGgtaacg (SEQ ID NO.: 2046), CAGGgtaact (SEQ ID NO.: 2047), CAGGgtaaga (SEQ ID NO.: 2048), CAGGgtaagc (SEQ ID NO.: 2049), CAGGgtaagg (SEQ ID NO.: 2050), CAGGgtaagt (SEQ ID NO.: 2051), CAGGgtaatc (SEQ ID NO.: 2052), CAGGgtaatg (SEQ ID NO.: 2053), CAGGgtaatt (SEQ ID NO.: 2054), CAGGgtacag (SEQ ID NO.: 2055), CAGGgtacat (SEQ ID NO.: 2056), CAGGgtacct (SEQ ID NO.: 2057), CAGGgtacgt (SEQ ID NO.: 2058), CAGGgtactg (SEQ ID NO.: 2059), CAGGgtactt (SEQ ID NO.: 2060), CAGGgtagag (SEQ ID NO.: 2061), CAGGgtagga (SEQ ID NO.: 2062), CAGGgtaggg (SEQ ID NO.: 2063),
CAGGgtaggt (SEQ ID NO.: 2064), CAGGgtagta (SEQ ID NO.: 2065), CAGGgtagtt (SEQ ID NO.: 2066), CAGGgtataa (SEQ ID NO.: 2067), CAGGgtatac (SEQ ID NO.: 2068), CAGGgtatag (SEQ ID NO.: 2069), CAGGgtatga (SEQ ID NO.: 2070), CAGGgtatgc (SEQ ID NO.: 2071), CAGGgtatgg (SEQ ID NO.: 2072), CAGGgtatgt (SEQ ID NO.: 2073), CAGGgtcacg (SEQ ID NO.: 2074), CAGGgtcaga (SEQ ID NO.: 2075), CAGGgtcagc (SEQ ID NO.: 2076), CAGGgtcagg (SEQ ID NO.: 2077), CAGGgtcagt (SEQ ID NO.: 2078), CAGGgtccgt (SEQ ID NO.: 2079), CAGGgtctgt (SEQ ID NO.: 2080), CAGGgtgaca (SEQ ID NO.: 2081), CAGGgtgaga (SEQ ID NO.: 2082), CAGGgtgagc (SEQ ID NO.: 2083), CAGGgtgagg (SEQ ID NO.: 2084), CAGGgtgagt (SEQ ID NO.: 2085), CAGGgtgcgt (SEQ ID NO.: 2086), CAGGgtgggc (SEQ ID NO.: 2087), CAGGgtgggt (SEQ ID NO.: 2088), CAGGgtgtgc (SEQ ID NO.: 2089), CAGGgtgtgt (SEQ ID NO.: 2090), CAGGgttagt (SEQ ID NO.: 2091), CAGGgttcgt (SEQ ID NO.: 2092), CAGGgttcta (SEQ ID NO.: 2093), CAGGgttggt (SEQ ID NO.: 2094), CAGGgtttgt (SEQ ID NO.: 2095), CAGTgaacag (SEQ ID NO.: 2096), CAGTgtaagc (SEQ ID NO.: 2097), CAGTgtaagg (SEQ ID NO.: 2098), CAGTgtaagt (SEQ ID NO.: 2099), CAGTgtacgg (SEQ ID NO.: 2100), CAGTgtaggt (SEQ ID NO.: 2101), CAGTgtatcc (SEQ ID NO.: 2102), CAGTgtatga (SEQ ID NO.: 2103), CAGTgtatgt (SEQ ID NO.: 2104), CAGTgtccaa (SEQ ID NO.: 2105), CAGTgtcggt (SEQ ID NO.: 2106), CAGTgtgaga (SEQ ID NO.: 2107), CAGTgtgagc (SEQ ID NO.: 2108), CAGTgtgagt (SEQ ID NO.: 2109), CAGTgtgggt (SEQ ID NO.: 2110), CAGTgtgtgt (SEQ ID NO.: 2111), CAGTgttagt (SEQ ID NO.: 2112), CATAaactgt (SEQ ID NO.: 2113), CATAggtcag (SEQ ID NO.: 2114), CATAggtgag (SEQ ID NO.: 2115), CATAgtaaag (SEQ ID NO.: 2116), CATAgtaaga (SEQ ID NO. : 2117), CATAgtaagc (SEQ ID NO.: 2118), CATAgtaagg (SEQ ID NO.: 2119), CATAgtaagt (SEQ ID NO.: 2120), CATAgtacgt (SEQ ID NO.: 2121), CATAgtaggt (SEQ ID NO.: 2122), CATAgtatgc (SEQ ID NO.: 2123), CATAgtatgt (SEQ ID NO.: 2124), CATAgtgaga (SEQ ID NO.: 2125), CATAgtgagt (SEQ ID NO.: 2126), CATAgtgctt (SEQ ID NO.: 2127), CATCatatcc (SEQ ID NO.: 2128), CATCgccatg (SEQ ID NO.: 2129), CATCgtaaga (SEQ ID NO.: 2130), CATCgtaagt (SEQ ID NO.: 2131), CATCgtatgt (SEQ ID NO.: 2132), CATCgtgaga (SEQ ID NO.: 2133), CATCgtgagc (SEQ ID NO.: 2134), CATCgtgagt (SEQ ID NO.: 2135), CATCgtgtga (SEQ ID NO.: 2136), CATGatgttt (SEQ ID NO.: 2137), CATGgccact (SEQ ID NO.: 2138), CATGgcgagt (SEQ ID NO.: 2139), CATGggagag (SEQ ID NO.: 2140), CATGgtaaaa (SEQ ID NO.: 2141), CATGgtaaac (SEQ ID NO.: 2142), CATGgtaaag (SEQ ID NO.: 2143), CATGgtaaat (SEQ ID NO.: 2144), CATGgtaaca (SEQ ID NO.: 2145), CATGgtaacg (SEQ ID NO.: 2146), CATGgtaact (SEQ ID NO.: 2147), CATGgtaaga (SEQ ID NO.: 2148), CATGgtaagc (SEQ ID NO.: 2149), CATGgtaagg (SEQ ID NO.: 2150), CATGgtaagt (SEQ ID NO.: 2151), CATGgtaata (SEQ ID NO.: 2152), CATGgtaatg (SEQ ID NO.: 2153), CATGgtaatt (SEQ ID NO.: 2154), CATGgtacag (SEQ ID NO.: 2155), CATGgtacga (SEQ ID NO.: 2156), CATGgtacgg (SEQ ID NO.: 2157), CATGgtacgt (SEQ ID NO.: 2158), CATGgtactg (SEQ ID NO.: 2159), CATGgtactt (SEQ ID NO.: 2160), CATGgtagca (SEQ ID NO.: 2161), CATGgtagga (SEQ ID NO.: 2162), CATGgtaggc (SEQ ID NO.: 2163), CATGgtaggg (SEQ ID NO.: 2164), CATGgtaggt (SEQ ID NO.: 2165), CATGgtagta (SEQ ID NO.: 2166), CATGgtatag (SEQ ID NO.: 2167), CATGgtatcc (SEQ ID NO.: 2168), CATGgtatga (SEQ ID NO.: 2169), CATGgtatgc (SEQ ID NO.: 2170), CATGgtatgg (SEQ ID NO.: 2171), CATGgtatgt (SEQ ID NO.: 2172), CATGgtattg (SEQ ID NO.: 2173), CATGgtattt (SEQ ID NO.: 2174), CATGgtcagt (SEQ ID NO.: 2175), CATGgtctgt (SEQ ID NO.: 2176), CATGgtgaaa (SEQ ID NO.: 2177), CATGgtgaat (SEQ ID NO.: 2178), CATGgtgact (SEQ ID NO.: 2179), CATGgtgaga (SEQ ID NO.: 2180), CATGgtgagc (SEQ ID NO.: 2181), CATGgtgagg (SEQ ID
NO.: 2182), CATGgtgagt (SEQ ID NO.: 2183), CATGgtgatt (SEQ ID NO.: 2184), CATGgtgcgg (SEQ ID NO.: 2185), CATGgtgcgt (SEQ ID NO.: 2186), CATGgtgggc (SEQ ID NO.: 2187), CATGgtgggg (SEQ ID NO.: 2188), CATGgtgggt (SEQ ID NO.: 2189), CATGgtggtg (SEQ ID NO.: 2190), CATGgtgtgg (SEQ ID NO.: 2191), CATGgtgtgt (SEQ ID NO.: 2192), CATGgttact (SEQ ID NO.: 2193), CATGgttagt (SEQ ID NO.: 2194), CATGgttcac (SEQ ID NO.: 2195), CATGgttggt (SEQ ID NO.: 2196), CATGgtttga (SEQ ID NO.: 2197), CATGgtttgc (SEQ ID NO.: 2198), CATTagtgag (SEQ ID NO.: 2199), CATTgtaaga (SEQ ID NO.: 2200), CATTgtaagc (SEQ ID NO.: 2201), CATTgtaagg (SEQ ID NO.: 2202), CATTgtaagt (SEQ ID NO.: 2203), CATTgtaggt (SEQ ID NO.: 2204), CATTgtatcc (SEQ ID NO.: 2205), CATTgtatgt (SEQ ID NO.: 2206), CATTgtgaga (SEQ ID NO.: 2207), CATTgtgagc (SEQ ID NO.: 2208), CATTgtgagt (SEQ ID NO.: 2209), CATTgttagt (SEQ ID NO.: 2210), CATTtggtaa (SEQ ID NO 221 1), CCAAaaaggt (SEQ ID NO.: 2212), CCAAatgcaa (SEQ ID NO.: 2213), CCAAgccccg (SEQ ID NO.: 2214), CCAAggaaaa (SEQ ID NO.: 2215), CCAAggtaca (SEQ ID NO.: 2216), CCAAggtatg (SEQ ID NO.: 2217), CCAAggtgag (SEQ ID NO.: 2218), CCAAgtaaat (SEQ ID NO.: 2219), CCAAgtaacg (SEQ ID NO.: 2220), CCAAgtaact (SEQ ID NO.: 2221), CCAAgtaaga (SEQ ID NO.: 2222), CCAAgtaagc (SEQ ID NO.: 2223), CCAAgtaagg (SEQ ID NO.: 2224), CCAAgtaagt (SEQ ID NO.: 2225), CCAAgtaata (SEQ ID NO.: 2226), CCAAgtaatc (SEQ ID NO.: 2227), CCAAgtaatg (SEQ ID NO.: 2228), CCAAgtaatt (SEQ ID NO : 2229), CCAAgtacgg (SEQ ID NO. : 2230), CCAAgtacgt (SEQ ID NO. : 2231), CCAAgtactg (SEQ ID NO.: 2232), CCAAgtactt (SEQ ID NO.: 2233), CCAAgtagct (SEQ ID NO.: 2234), CCAAgtagga (SEQ ID NO.: 2235), CCAAgtaggc (SEQ ID NO.: 2236), CCAAgtaggt (SEQ ID NO.: 2237), CCAAgtatgg (SEQ ID NO.: 2238), CCAAgtatgt (SEQ ID NO.: 2239), CCAAgtcagt (SEQ ID NO.: 2240), CCAAgtgact (SEQ ID NO.: 2241), CCAAgtgaga (SEQ ID NO.: 2242), CCAAgtgagc (SEQ ID NO.: 2243), CCAAgtgagg (SEQ ID NO.: 2244), CCAAgtgagt (SEQ ID NO.: 2245), CCAAgtgggt (SEQ ID NO.: 2246), CCAAgtgtgt (SEQ ID NO.: 2247), CCAAgttagt (SEQ ID NO.: 2248), CCACgtaaga (SEQ ID NO.: 2249), CCACgtaagc (SEQ ID NO.: 2250), CCACgtaagg (SEQ ID NO.: 2251), CCACgtaagt (SEQ ID NO.: 2252), CCACgtacgt (SEQ ID NO.: 2253), CCACgtaggt (SEQ ID NO.: 2254), CCACgtatga (SEQ ID NO.: 2255), CCACgtatgt (SEQ ID NO.: 2256), CCACgtgagc (SEQ ID NO.: 2257), CCACgtgagg (SEQ ID NO.: 2258), CCACgtgagt (SEQ ID NO.: 2259), CCACgtgcgt (SEQ ID NO.: 2260), CCAGatatgt (SEQ ID NO.: 2261), CCAGccctca (SEQ ID NO.: 2262), CCAGctggag (SEQ ID NO.: 2263), CCAGgcaaga (SEQ ID NO.: 2264), CCAGgcaagc (SEQ ID NO.: 2265), CCAGgcaagg (SEQ ID NO.: 2266), CCAGgcaagt (SEQ ID NO.: 2267), CCAGgcacgc (SEQ ID NO.: 2268), CCAGgcacgg (SEQ ID NO.: 2269), CCAGgcagct (SEQ ID NO.: 2270), CCAGgcaggt (SEQ ID NO.: 2271), CCAGgcagta (SEQ ID NO.: 2272), CCAGgcatgt (SEQ ID NO.: 2273), CCAGgccagt (SEQ ID NO.: 2274), CCAGgcgagt (SEQ ID NO.: 2275), CCAGgcggcc (SEQ ID NO.: 2276), CCAGgctatg (SEQ ID NO.: 2277), CCAGgctggt (SEQ ID NO.: 2278), CCAGggaagg (SEQ ID NO.: 2279), CCAGggtaag (SEQ ID NO.: 2280), CCAGggtaat (SEQ ID NO.: 2281), CCAGgtaaaa (SEQ ID NO.: 2282), CCAGgtaaac (SEQ ID NO.: 2283), CCAGgtaaag (SEQ ID NO.: 2284), CCAGgtaaat (SEQ ID NO.: 2285), CCAGgtaaca (SEQ ID NO.: 2286), CCAGgtaacc (SEQ ID NO.: 2287), CCAGgtaacg (SEQ ID NO.: 2288), CCAGgtaact (SEQ ID NO.: 2289), CCAGgtaaga (SEQ ID NO.: 2290), CCAGgtaagc (SEQ ID NO.: 2291), CCAGgtaagg (SEQ ID NO.: 2292), CCAGgtaagt (SEQ ID NO.: 2293), CCAGgtaata (SEQ ID NO.: 2294), CCAGgtaatc (SEQ ID NO.: 2295), CCAGgtaatg (SEQ ID NO.: 2296), CCAGgtaatt (SEQ ID NO.: 2297), CCAGgtacaa (SEQ ID NO.: 2298), CCAGgtacac
(SEQ ID NO.: 2299), CCAGgtacag (SEQ ID NO.: 2300), CCAGgtacat (SEQ ID NO.: 2301), CCAGgtacca (SEQ ID NO.: 2302), CCAGgtaccc (SEQ ID NO.: 2303), CCAGgtaccg (SEQ ID NO.: 2304), CCAGgtacct (SEQ ID NO.: 2305), CCAGgtacga (SEQ ID NO.: 2306), CCAGgtacgc (SEQ ID NO.: 2307), CCAGgtacgg (SEQ ID NO.: 2308), CCAGgtacgt (SEQ ID NO.: 2309), CCAGgtacta (SEQ ID NO. : 2310), CCAGgtactc (SEQ ID NO. : 2311), CCAGgtactg (SEQ ID NO.: 2312), CCAGgtactt (SEQ ID NO.: 2313), CCAGgtagaa (SEQ ID NO.: 2314), CCAGgtagac (SEQ ID NO.: 2315), CCAGgtagag (SEQ ID NO.: 2316), CCAGgtagat (SEQ ID NO.: 2317), CCAGgtagca (SEQ ID NO.: 2318), CCAGgtagcc (SEQ ID NO.: 2319), CCAGgtagcg (SEQ ID NO.: 2320), CCAGgtagct (SEQ ID NO.: 2321), CCAGgtagga (SEQ ID NO.: 2322), CCAGgtaggc (SEQ ID NO.: 2323), CCAGgtaggg (SEQ ID NO.: 2324), CCAGgtaggt (SEQ ID NO 2325), CCAGgtagta (SEQ ID NO.: 2326), CCAGgtagtc (SEQ ID NO.: 2327), CCAGgtagtg (SEQ ID NO.: 2328), CCAGgtagtt (SEQ ID NO.: 2329), CCAGgtataa (SEQ ID NO.: 2330), CCAGgtatac (SEQ ID NO.: 2331), CCAGgtatag (SEQ ID NO.: 2332), CCAGgtatat (SEQ ID NO.: 2333), CCAGgtatca (SEQ ID NO.: 2334), CCAGgtatcc (SEQ ID NO.: 2335), CCAGgtatct (SEQ ID NO.: 2336), CCAGgtatga (SEQ ID NO.: 2337), CCAGgtatgc (SEQ ID NO.: 2338), CCAGgtatgg (SEQ ID NO.: 2339), CCAGgtatgt (SEQ ID NO.: 2340), CCAGgtatta (SEQ ID NO.: 2341), CCAGgtattc (SEQ ID NO.: 2342), CCAGgtattg (SEQ ID NO.: 2343), CCAGgtattt (SEQ ID NO.: 2344), CCAGgtcaga (SEQ ID NO.: 2345), CCAGgtcagc (SEQ ID NO.: 2346), CCAGgtcagg (SEQ ID NO.: 2347), CCAGgtcagt (SEQ ID NO.: 2348), CCAGgtcatc (SEQ ID NO.: 2349), CCAGgtccac (SEQ ID NO.: 2350), CCAGgtccct (SEQ ID NO.: 2351), CCAGgtccgt (SEQ ID NO.: 2352), CCAGgtccta (SEQ ID NO.: 2353), CCAGgtcctc (SEQ ID NO.: 2354), CCAGgtcggc (SEQ ID NO : 2355), CCAGgtcggt (SEQ ID NO.: 2356), CCAGgtcgtc (SEQ ID NO.: 2357), CCAGgtctac (SEQ ID NO.: 2358), CCAGgtctca (SEQ ID NO.: 2359), CCAGgtctcg (SEQ ID NO.: 2360), CCAGgtctga (SEQ ID NO.: 2361), CCAGgtctgg (SEQ ID NO.: 2362), CCAGgtctgt (SEQ ID NO.: 2363), CCAGgtcttt (SEQ ID NO.: 2364), CCAGgtgaaa (SEQ ID NO.: 2365), CCAGgtgaac (SEQ ID NO.: 2366), CCAGgtgaag (SEQ ID NO.: 2367), CCAGgtgaat (SEQ ID NO.: 2368), CCAGgtgaca (SEQ ID NO.: 2369), CCAGgtgacc (SEQ ID NO.: 2370), CCAGgtgacg (SEQ ID NO.: 2371), CCAGgtgact (SEQ ID NO.: 2372), CCAGgtgaga (SEQ ID NO.: 2373), CCAGgtgagc (SEQ ID NO.: 2374), CCAGgtgagg (SEQ ID NO.: 2375), CCAGgtgagt (SEQ ID NO.: 2376), CCAGgtgata (SEQ ID NO.: 2377), CCAGgtgatc (SEQ ID NO.: 2378), CCAGgtgatg (SEQ ID NO.: 2379), CCAGgtgatt (SEQ ID NO.: 2380), CCAGgtgcac (SEQ ID NO.: 2381), CCAGgtgcag (SEQ ID NO.: 2382), CCAGgtgcat (SEQ ID NO.: 2383), CCAGgtgcca (SEQ ID NO.: 2384), CCAGgtgccc (SEQ ID NO.: 2385), CCAGgtgccg (SEQ ID NO.: 2386), CCAGgtgcct (SEQ ID NO.: 2387), CCAGgtgcga (SEQ ID NO.: 2388), CCAGgtgcgc (SEQ ID NO.: 2389), CCAGgtgcgg (SEQ ID NO.: 2390), CCAGgtgcgt (SEQ ID NO.: 2391), CCAGgtgctc (SEQ ID NO.: 2392), CCAGgtgctg (SEQ ID NO : 2393), CCAGgtgctt (SEQ ID NO : 2394), CCAGgtggag (SEQ ID NO : 2395), CCAGgtggat (SEQ ID NO.: 2396), CCAGgtggca (SEQ ID NO.: 2397), CCAGgtggct (SEQ ID NO.: 2398), CCAGgtggga (SEQ ID NO.: 2399), CCAGgtgggc (SEQ ID NO.: 2400), CCAGgtgggg (SEQ ID NO.: 2401), CCAGgtgggt (SEQ ID NO.: 2402), CCAGgtggtg (SEQ ID NO.: 2403), CCAGgtgtcc (SEQ ID NO.: 2404), CCAGgtgtcg (SEQ ID NO.: 2405), CCAGgtgtct (SEQ ID NO.: 2406), CCAGgtgtga (SEQ ID NO.: 2407), CCAGgtgtgc (SEQ ID NO.: 2408), CCAGgtgtgg (SEQ ID NO.: 2409), CCAGgtgtgt (SEQ ID NO.: 2410), CCAGgttacg (SEQ ID NO.: 2411), CCAGgttaga (SEQ ID NO.: 2412), CCAGgttagc (SEQ ID NO.: 2413), CCAGgttagg (SEQ ID NO.: 2414), CCAGgttagt (SEQ ID NO.: 2415), CCAGgttata (SEQ ID NO.: 2416),
CCAGgttatc (SEQ ID NO.: 2417), CCAGgttcaa (SEQ ID NO.: 2418), CCAGgttcac (SEQ ID NO.: 2419), CCAGgttcga (SEQ ID NO.: 2420), CCAGgttcgc (SEQ ID NO.: 2421), CCAGgttcgg (SEQ ID NO.: 2422), CCAGgttcgt (SEQ ID NO.: 2423), CCAGgttcta (SEQ ID NO.: 2424), CCAGgttctg (SEQ ID NO.: 2425), CCAGgttctt (SEQ ID NO.: 2426), CCAGgttgag (SEQ ID NO.: 2427), CCAGgttgct (SEQ ID NO.: 2428), CCAGgttgga (SEQ ID NO.: 2429), CCAGgttggc (SEQ ID NO. : 2430), CCAGgttggg (SEQ ID NO.: 2431), CCAGgttggt (SEQ ID NO. : 2432), CCAGgttgta (SEQ ID NO.: 2433), CCAGgttgtg (SEQ ID NO.: 2434), CCAGgtttat (SEQ ID NO.: 2435), CCAGgtttga (SEQ ID NO.: 2436), CCAGgtttgc (SEQ ID NO.: 2437), CCAGgtttgt (SEQ ID NO.: 2438), CCAGgtttta (SEQ ID NO.: 2439), CCAGgttttc (SEQ ID NO.: 2440), CCAGgttttg (SEQ ID NO.: 2441), CCAGgttttt (SEQ ID NO.: 2442), CCATgtaaac (SEQ ID NO.: 2443), CCATgtaaga (SEQ ID NO.: 2444), CCATgtaagc (SEQ ID NO.: 2445), CCATgtaagg (SEQ ID NO.: 2446), CCATgtaagt (SEQ ID NO.: 2447), CCATgtacgc (SEQ ID NO.: 2448), CCATgtacgt (SEQ ID NO.: 2449), CCATgtatcc (SEQ ID NO.: 2450), CCATgtatgt (SEQ ID NO.: 2451), CCATgtgaga (SEQ ID NO.: 2452), CCATgtgagc (SEQ ID NO.: 2453), CCATgtgagt (SEQ ID NO.: 2454), CCATgtgcgt (SEQ ID NO.: 2455), CCATgttagt (SEQ ID NO.: 2456), CCCAgagact (SEQ ID NO.: 2457), CCCAgctaag (SEQ ID NO.: 2458), CCCAggtaac (SEQ ID NO.: 2459), CCCAggtaat (SEQ ID NO.: 2460), CCCAggtaga (SEQ ID NO.: 2461), CCCAgtaaat (SEQ ID NO : 2462), CCCAgtaaga (SEQ ID NO.: 2463), CCCAgtaagc (SEQ ID NO.: 2464), CCCAgtaagg (SEQ ID NO.: 2465), CCCAgtaagt (SEQ ID NO.: 2466), CCCAgtacga (SEQ ID NO.: 2467), CCCAgtacgt (SEQ ID NO.: 2468), CCCAgtaggt (SEQ ID NO.: 2469), CCCAgtatcc (SEQ ID NO.: 2470), CCCAgtatgt (SEQ ID NO.: 2471), CCCAgtgagt (SEQ ID NO.: 2472), CCCAgtggtg (SEQ ID NO.: 2473), CCCCaggtga (SEQ ID NO.: 2474), CCCCgatttg (SEQ ID NO.: 2475), CCCCgtaagc (SEQ ID NO.: 2476), CCCCgtaagg (SEQ ID NO.: 2477), CCCCgtaagt (SEQ ID NO.: 2478), CCCCgtatga (SEQ ID NO.: 2479), CCCCgtgagt (SEQ ID NO.: 2480), CCCCgtgcgt (SEQ ID NO.: 2481), CCCCgtgggt (SEQ ID NO.: 2482), CCCGgcacgt (SEQ ID NO.: 2483), CCCGgctggt (SEQ ID NO.: 2484), CCCGgtaaat (SEQ ID NO.: 2485), CCCGgtaaga (SEQ ID NO.: 2486), CCCGgtaagc (SEQ ID NO.: 2487), CCCGgtaagg (SEQ ID NO.: 2488), CCCGgtaagt (SEQ ID NO.: 2489), CCCGgtaatc (SEQ ID NO.: 2490), CCCGgtaatg (SEQ ID NO.: 2491), CCCGgtaatt (SEQ ID NO.: 2492), CCCGgtacat (SEQ ID NO.: 2493), CCCGgtaccc (SEQ ID NO.: 2494), CCCGgtacgg (SEQ ID NO.: 2495), CCCGgtacgt (SEQ ID NO.: 2496), CCCGgtaggg (SEQ ID NO.: 2497), CCCGgtaggt (SEQ ID NO.: 2498), CCCGgtataa (SEQ ID NO.: 2499), CCCGgtatga (SEQ ID NO.: 2500), CCCGgtatgg (SEQ ID NO.: 2501), CCCGgtatgt (SEQ ID NO.: 2502), CCCGgtattg (SEQ ID NO.: 2503), CCCGgtcagt (SEQ ID NO.: 2504), CCCGgtgaga (SEQ ID NO.: 2505), CCCGgtgagc (SEQ ID NO.: 2506), CCCGgtgagg (SEQ ID NO.: 2507), CCCGgtgagt (SEQ ID NO.: 2508), CCCGgtgcgc (SEQ ID NO.: 2509), CCCGgtgcgg (SEQ ID NO.: 2510), CCCGgtgcgt (SEQ ID NO.: 2511), CCCGgtgggc (SEQ ID NO : 2512), CCCGgtgggt (SEQ ID NO : 2513), CCCGgtgtgt (SEQ ID NO.: 2514), CCCGgttaat (SEQ ID NO.: 2515), CCCGgttaga (SEQ ID NO.: 2516), CCCGgtttga (SEQ ID NO.: 2517), CCCTctggaa (SEQ ID NO.: 2518), CCCTgtaagt (SEQ ID NO.: 2519), CCCTgtacga (SEQ ID NO.: 2520), CCCTgtaggt (SEQ ID NO.: 2521), CCCTgtatgt (SEQ ID NO.: 2522), CCCTgtgaat (SEQ ID NO.: 2523), CCCTgtgagc (SEQ ID NO.: 2524), CCCTgtgagg (SEQ ID NO.: 2525), CCCTgtgagt (SEQ ID NO.: 2526), CCCTgtgcgt (SEQ ID NO.: 2527), CCCTttgtcc (SEQ ID NO.: 2528), CCGAgaagtt (SEQ ID NO.: 2529), CCGAgtaagc (SEQ ID NO.: 2530), CCGAgtaagg (SEQ ID NO.: 2531), CCGAgtaagt (SEQ ID NO.: 2532), CCGAgtacgg (SEQ ID NO.: 2533), CCGAgtaggc (SEQ ID NO.: 2534),
CCGAgtaggt (SEQ ID NO.: 2535), CCGAgtgagc (SEQ ID NO.: 2536), CCGAgtgagt (SEQ ID NO.: 2537), CCGCatttcc (SEQ ID NO.: 2538), CCGCgtaagc (SEQ ID NO.: 2539), CCGCgtgagt (SEQ ID NO.: 2540), CCGCtgcggc (SEQ ID NO.: 2541), CCGGgcaagt (SEQ ID NO.: 2542), CCGGgcgagt (SEQ ID NO.: 2543), CCGGgtaaaa (SEQ ID NO.: 2544), CCGGgtaaat (SEQ ID NO.: 2545), CCGGgtaacc (SEQ ID NO.: 2546), CCGGgtaact (SEQ ID NO.: 2547), CCGGgtaaga (SEQ ID NO.: 2548), CCGGgtaagc (SEQ ID NO.: 2549), CCGGgtaagg (SEQ ID NO.: 2550), CCGGgtaagt (SEQ ID NO.: 2551), CCGGgtaata (SEQ ID NO.: 2552), CCGGgtaatt (SEQ ID NO.: 2553), CCGGgtacca (SEQ ID NO.: 2554), CCGGgtacgt (SEQ ID NO.: 2555), CCGGgtagct (SEQ ID NO.: 2556), CCGGgtagga (SEQ ID NO.: 2557), CCGGgtaggc (SEQ ID NO.: 2558), CCGGgtaggt (SEQ ID NO.: 2559), CCGGgtatga (SEQ ID NO.: 2560), CCGGgtatgc (SEQ ID NO : 2561), CCGGgtatgg (SEQ ID NO : 2562), CCGGgtatgt (SEQ ID NO : 2563), CCGGgtcaga (SEQ ID NO.: 2564), CCGGgtcagt (SEQ ID NO.: 2565), CCGGgtgaga (SEQ ID NO.: 2566), CCGGgtgagc (SEQ ID NO.: 2567), CCGGgtgagg (SEQ ID NO.: 2568), CCGGgtgagt (SEQ ID NO.: 2569), CCGGgtgcat (SEQ ID NO.: 2570), CCGGgtgcgg (SEQ ID NO.: 2571), CCGGgtgcgt (SEQ ID NO.: 2572), CCGGgtgtgt (SEQ ID NO.: 2573), CCGGgttcac (SEQ ID NO.: 2574), CCGTgctcat (SEQ ID NO.: 2575), CCGTgtaagt (SEQ ID NO.: 2576), CCGTgtctgg (SEQ ID NO.: 2577), CCGTgtgagt (SEQ ID NO.: 2578), CCTAgcagga (SEQ ID NO.: 2579), CCTAgtaaga (SEQ ID NO.: 2580), CCTAgtaagc (SEQ ID NO : 2581), CCTAgtaagt (SEQ ID NO.: 2582), CCTAgtaatg (SEQ ID NO.: 2583), CCTAgtaggt (SEQ ID NO.: 2584), CCTAgtgagc (SEQ ID NO.: 2585), CCTAgtgagt (SEQ ID NO.: 2586), CCTCaaaagt (SEQ ID NO.: 2587), CCTCgctgag (SEQ ID NO.: 2588), CCTCgtaagt (SEQ ID NO.: 2589), CCTCgtatcc (SEQ ID NO.: 2590), CCTCgtgagc (SEQ ID NO.: 2591), CCTCgtgagt (SEQ ID NO.: 2592), CCTCgtgggt (SEQ ID NO.: 2593), CCTGgaaggt (SEQ ID NO.: 2594), CCTGgcaagt (SEQ ID NO.: 2595), CCTGgccaac (SEQ ID NO.: 2596), CCTGgtaaac (SEQ ID NO.: 2597), CCTGgtaaag (SEQ ID NO.: 2598), CCTGgtaaat (SEQ ID NO.: 2599), CCTGgtaaca (SEQ ID NO.: 2600), CCTGgtaacc (SEQ ID NO.: 2601), CCTGgtaact (SEQ ID NO.: 2602), CCTGgtaaga (SEQ ID NO.: 2603), CCTGgtaagc (SEQ ID NO.: 2604), CCTGgtaagg (SEQ ID NO.: 2605), CCTGgtaagt (SEQ ID NO.: 2606), CCTGgtaata (SEQ ID NO.: 2607), CCTGgtaatc (SEQ ID NO.: 2608), CCTGgtaatg (SEQ ID NO.: 2609), CCTGgtaatt (SEQ ID NO.: 2610), CCTGgtacga (SEQ ID NO.: 2611), CCTGgtacgc (SEQ ID NO.: 2612), CCTGgtacgg (SEQ ID NO.: 2613), CCTGgtacgt (SEQ ID NO.: 2614), CCTGgtactg (SEQ ID NO.: 2615), CCTGgtactt (SEQ ID NO.: 2616), CCTGgtagag (SEQ ID NO.: 2617), CCTGgtagct (SEQ ID NO.: 2618), CCTGgtagga (SEQ ID NO.: 2619), CCTGgtaggg (SEQ ID NO.: 2620), CCTGgtaggt (SEQ ID NO.: 2621), CCTGgtagtt (SEQ ID NO.: 2622), CCTGgtatct (SEQ ID NO.: 2623), CCTGgtatga (SEQ ID NO.: 2624), CCTGgtatgc (SEQ ID NO.: 2625), CCTGgtatgg (SEQ ID NO.: 2626), CCTGgtatgt (SEQ ID NO.: 2627), CCTGgtattc (SEQ ID NO.: 2628), CCTGgtattg (SEQ ID NO.: 2629), CCTGgtattt (SEQ ID NO.: 2630), CCTGgtcagg (SEQ ID NO.: 2631), CCTGgtcagt (SEQ ID NO.: 2632), CCTGgtgaag (SEQ ID NO.: 2633), CCTGgtgaat (SEQ ID NO.: 2634), CCTGgtgaga (SEQ ID NO.: 2635), CCTGgtgagc (SEQ ID NO.: 2636), CCTGgtgagg (SEQ ID NO.: 2637), CCTGgtgagt (SEQ ID NO.: 2638), CCTGgtgcga (SEQ ID NO.: 2639), CCTGgtgcgt (SEQ ID NO.: 2640), CCTGgtgggc (SEQ ID NO.: 2641), CCTGgtgggt (SEQ ID NO.: 2642), CCTGgtgtat (SEQ ID NO.: 2643), CCTGgtgtgt (SEQ ID NO.: 2644), CCTGgttagt (SEQ ID NO.: 2645), CCTGgttgta (SEQ ID NO.: 2646), CCTGgtttgt (SEQ ID NO.: 2647), CCTTgtaagc (SEQ ID NO.: 2648), CCTTgtaagg (SEQ ID NO.: 2649), CCTTgtaagt (SEQ ID NO.: 2650), CCTTgtacag (SEQ ID NO.: 2651), CCTTgtacgt (SEQ ID NO.: 2652), CCTTgtaggt (SEQ ID NO.: 2653),
CCTTgtatcc (SEQ ID NO.: 2654), CCTTgtgagc (SEQ ID NO.: 2655), CCTTgtgagt (SEQ ID NO.: 2656), CCTTtggtgt (SEQ ID NO.: 2657), CGAAaggtaa (SEQ ID NO.: 2658), CGAAgtaagg (SEQ ID NO.: 2659), CGAAgtaagt (SEQ ID NO.: 2660), CGAAgtacgc (SEQ ID NO.: 2661), CGAAgtaggt (SEQ ID NO.: 2662), CGAAgtgaga (SEQ ID NO.: 2663), CGAAgtgagt (SEQ ID NO.: 2664), CGAAtgtgag (SEQ ID NO.: 2665), CGACgtaagg (SEQ ID NO.: 2666), CGACgtaagt (SEQ ID NO.: 2667), CGACgtgagg (SEQ ID NO.: 2668), CGACgtgagt (SEQ ID NO.: 2669), CGAGagatag (SEQ ID NO.: 2670), CGAGgcaagt (SEQ ID NO.: 2671), CGAGgcacgt (SEQ ID NO.: 2672), CGAGgcaggt (SEQ ID NO.: 2673), CGAGgcgagt (SEQ ID NO.: 2674), CGAGgtaaaa (SEQ ID NO.: 2675), CGAGgtaaac (SEQ ID NO.: 2676), CGAGgtaaag (SEQ ID NO.: 2677), CGAGgtaaat (SEQ ID NO.: 2678), CGAGgtaacc (SEQ ID NO.: 2679), CGAGgtaacg (SEQ ID NO.: 2680), CGAGgtaact (SEQ ID NO.: 2681), CGAGgtaaga (SEQ ID NO.: 2682), CGAGgtaagc (SEQ ID NO.: 2683), CGAGgtaagg (SEQ ID NO.: 2684), CGAGgtaagt (SEQ ID NO.: 2685), CGAGgtaata (SEQ ID NO.: 2686), CGAGgtaatc (SEQ ID NO.: 2687), CGAGgtaatg (SEQ ID NO.: 2688), CGAGgtaatt (SEQ ID NO.: 2689), CGAGgtacaa (SEQ ID NO.: 2690), CGAGgtacag (SEQ ID NO.: 2691), CGAGgtacca (SEQ ID NO.: 2692), CGAGgtaccc (SEQ ID NO.: 2693), CGAGgtaccg (SEQ ID NO.: 2694), CGAGgtacct (SEQ ID NO.: 2695), CGAGgtacga (SEQ ID NO.: 2696), CGAGgtacgg (SEQ ID NO.: 2697), CGAGgtacgt (SEQ ID NO 2698), CGAGgtactg (SEQ ID NO.: 2699), CGAGgtactt (SEQ ID NO.: 2700), CGAGgtagaa (SEQ ID NO.: 2701), CGAGgtagag (SEQ ID NO.: 2702), CGAGgtagcc (SEQ ID NO.: 2703), CGAGgtagct (SEQ ID NO.: 2704), CGAGgtaggc (SEQ ID NO.: 2705), CGAGgtaggg (SEQ ID NO.: 2706), CGAGgtaggt (SEQ ID NO.: 2707), CGAGgtagta (SEQ ID NO.: 2708), CGAGgtagtt (SEQ ID NO.: 2709), CGAGgtataa (SEQ ID NO.: 2710), CGAGgtatac (SEQ ID NO.: 2711), CGAGgtatag (SEQ ID NO.: 2712), CGAGgtatat (SEQ ID NO.: 2713), CGAGgtatca (SEQ ID NO.: 2714), CGAGgtatcc (SEQ ID NO.: 2715), CGAGgtatcg (SEQ ID NO.: 2716), CGAGgtatga (SEQ ID NO.: 2717), CGAGgtatgc (SEQ ID NO.: 2718), CGAGgtatgg (SEQ ID NO.: 2719), CGAGgtatgt (SEQ ID NO.: 2720), CGAGgtattc (SEQ ID NO.: 2721), CGAGgtattg (SEQ ID NO.: 2722), CGAGgtattt (SEQ ID NO.: 2723), CGAGgtcaca (SEQ ID NO.: 2724), CGAGgtcagg (SEQ ID NO.: 2725), CGAGgtcagt (SEQ ID NO.: 2726), CGAGgtccgc (SEQ ID NO.: 2727), CGAGgtcctg (SEQ ID NO.: 2728), CGAGgtctgt (SEQ ID NO.: 2729), CGAGgtgaac (SEQ ID NO.: 2730), CGAGgtgaag (SEQ ID NO.: 2731), CGAGgtgacc (SEQ ID NO.: 2732), CGAGgtgact (SEQ ID NO.: 2733), CGAGgtgaga (SEQ ID NO.: 2734), CGAGgtgagc (SEQ ID NO.: 2735), CGAGgtgagg (SEQ ID NO.: 2736), CGAGgtgagt (SEQ ID NO.: 2737), CGAGgtgatc (SEQ ID NO.: 2738), CGAGgtgatg (SEQ ID NO.: 2739), CGAGgtgcat (SEQ ID NO.: 2740), CGAGgtgcgt (SEQ ID NO.: 2741), CGAGgtgcta (SEQ ID NO.: 2742), CGAGgtgctg (SEQ ID NO.: 2743), CGAGgtgctt (SEQ ID NO.: 2744), CGAGgtggag (SEQ ID NO.: 2745), CGAGgtgggc (SEQ ID NO.: 2746), CGAGgtgggg (SEQ ID NO.: 2747), CGAGgtgggt (SEQ ID NO.: 2748), CGAGgtgtgc (SEQ ID NO.: 2749), CGAGgttaat (SEQ ID NO.: 2750), CGAGgttagg (SEQ ID NO.: 2751), CGAGgttagt (SEQ ID NO.: 2752), CGAGgttcac (SEQ ID NO.: 2753), CGAGgttggc (SEQ ID NO.: 2754), CGAGgttggt (SEQ ID NO.: 2755), CGAGgtttgg (SEQ ID NO.: 2756), CGAGgtttgt (SEQ ID NO.: 2757), CGATgtaagg (SEQ ID NO.: 2758), CGATgtaagt (SEQ ID NO.: 2759), CGATgtacaa (SEQ ID NO.: 2760), CGATgtacag (SEQ ID NO.: 2761), CGATgtatga (SEQ ID NO.: 2762), CGATgtatgg (SEQ ID NO.: 2763), CGATgtgagc (SEQ ID NO.: 2764), CGATgtgagt (SEQ ID NO.: 2765), CGCAcgatca (SEQ ID NO.: 2766), CGCAgtaagt (SEQ ID NO.: 2767), CGCAgtgagc (SEQ ID NO.: 2768),
CGCAgtgagt (SEQ ID NO.: 2769), CGCCatggcc (SEQ ID NO.: 2770), CGCCgtaagt (SEQ ID NO.: 2771), CGCCgtgagt (SEQ ID NO.: 2772), CGCGgtaaga (SEQ ID NO.: 2773), CGCGgtaagc (SEQ ID NO.: 2774), CGCGgtaagg (SEQ ID NO.: 2775), CGCGgtaatc (SEQ ID NO.: 2776), CGCGgtacag (SEQ ID NO.: 2777), CGCGgtacgg (SEQ ID NO.: 2778), CGCGgtaggt (SEQ ID NO.: 2779), CGCGgtatgt (SEQ ID NO.: 2780), CGCGgtgagc (SEQ ID NO.: 2781), CGCGgtgagg (SEQ ID NO.: 2782), CGCGgtgagt (SEQ ID NO.: 2783), CGCGgtgggt (SEQ ID NO.: 2784), CGCGgtgtgt (SEQ ID NO.: 2785), CGCTggggga (SEQ ID NO.: 2786), CGCTgtaagc (SEQ ID NO.: 2787), CGCTgtaagt (SEQ ID NO.: 2788), CGCTgtcagt (SEQ ID NO.: 2789), CGCTgtgagg (SEQ ID NO.: 2790), CGCTgtgagt (SEQ ID NO.: 2791), CGGAaagtta (SEQ ID NO.: 2792), CGGCggagcc (SEQ ID NO.: 2793), CGGCgtaagt (SEQ ID NO.: 2794), CGGCgtgagt (SEQ ID NO.: 2795), CGGGgtaaga (SEQ ID NO.: 2796), CGGGgtaagc (SEQ ID NO.: 2797), CGGGgtaagg (SEQ ID NO.: 2798), CGGGgtaagt (SEQ ID NO.: 2799), CGGGgtaatg (SEQ ID NO.: 2800), CGGGgtacgg (SEQ ID NO.: 2801), CGGGgtacgt (SEQ ID NO.: 2802), CGGGgtactg (SEQ ID NO.: 2803), CGGGgtaggc (SEQ ID NO.: 2804), CGGGgtaggt (SEQ ID NO.: 2805), CGGGgtgaga (SEQ ID NO.: 2806), CGGGgtgagc (SEQ ID NO.: 2807), CGGGgtgagg (SEQ ID NO.: 2808), CGGGgtgagt (SEQ ID NO.: 2809), CGGTgtaagc (SEQ ID NO.: 2810), CGGTgtaagt (SEQ ID NO.: 2811), CGTAgtaagt (SEQ ID NO.: 2812), CGTAgtatgt (SEQ ID NO.: 2813), CGTCgtaagt (SEQ ID NO.: 2814), CGTGgtaaaa (SEQ ID NO.: 2815), CGTGgtaaga (SEQ ID NO.: 2816), CGTGgtaagc (SEQ ID NO.: 2817), CGTGgtaagg (SEQ ID NO.: 2818), CGTGgtaagt (SEQ ID NO.: 2819), CGTGgtacaa (SEQ ID NO.: 2820), CGTGgtaccc (SEQ ID NO.: 2821), CGTGgtacga (SEQ ID NO.: 2822), CGTGgtacgt (SEQ ID NO.: 2823), CGTGgtaggt (SEQ ID NO.: 2824), CGTGgtatgc (SEQ ID NO.: 2825), CGTGgtatgt (SEQ ID NO.: 2826), CGTGgtcagt (SEQ ID NO.: 2827), CGTGgtgagc (SEQ ID NO.: 2828), CGTGgtgagg (SEQ ID NO.: 2829), CGTGgtgagt (SEQ ID NO.: 2830), CGTGgtgcgc (SEQ ID NO.: 2831), CGTGgtgcgg (SEQ ID NO.: 2832), CGTGgtgcgt (SEQ ID NO.: 2833), CGTGgtgggt (SEQ ID NO.: 2834), CGTTgtaagt (SEQ ID NO.: 2835), CGTTgttagt (SEQ ID NO.: 2836), CTAAagtaat (SEQ ID NO.: 2837), CTAAccggcg (SEQ ID NO.: 2838), CTAAgtaaga (SEQ ID NO.: 2839), CTAAgtaagc (SEQ ID NO.: 2840), CTAAgtaagt (SEQ ID NO.: 2841), CTAAgtacgt (SEQ ID NO.: 2842), CTAAgtaggt (SEQ ID NO.: 2843), CTAAgtatgg (SEQ ID NO.: 2844), CTAAgtatgt (SEQ ID NO.: 2845), CTAAgtattt (SEQ ID NO.: 2846), CTAAgtcagt (SEQ ID NO.: 2847), CTAAgtgagc (SEQ ID NO.: 2848), CTAAgtgagt (SEQ ID NO.: 2849), CTAAgttaag (SEQ ID NO.: 2850), CTAAgttaca (SEQ ID NO.: 2851), CTACgtaagc (SEQ ID NO.: 2852), CTACgtaagt (SEQ ID NO.: 2853), CTACgtgagc (SEQ ID NO.: 2854), CTACgtgagt (SEQ ID NO.: 2855), CTAGgcaagt (SEQ ID NO.: 2856), CTAGgtaaaa (SEQ ID NO.: 2857), CTAGgtaaac (SEQ ID NO.: 2858), CTAGgtaaag (SEQ ID NO.: 2859), CTAGgtaaat (SEQ ID NO.: 2860), CTAGgtaacc (SEQ ID NO.: 2861), CTAGgtaact (SEQ ID NO.: 2862), CTAGgtaaga (SEQ ID NO.: 2863), CTAGgtaagc (SEQ ID NO 2864), CTAGgtaagg (SEQ ID NO.: 2865), CTAGgtaagt (SEQ ID NO.: 2866), CTAGgtaata (SEQ ID NO.: 2867), CTAGgtaatc (SEQ ID NO.: 2868), CTAGgtaatg (SEQ ID NO.: 2869), CTAGgtaatt (SEQ ID NO.: 2870), CTAGgtacaa (SEQ ID NO.: 2871), CTAGgtacag (SEQ ID NO.: 2872), CTAGgtacat (SEQ ID NO.: 2873), CTAGgtaccc (SEQ ID NO.: 2874), CTAGgtacgg (SEQ ID NO.: 2875), CTAGgtacgt (SEQ ID NO.: 2876), CTAGgtactg (SEQ ID NO.: 2877), CTAGgtactt (SEQ ID NO.: 2878), CTAGgtagaa (SEQ ID NO.: 2879), CTAGgtagag (SEQ ID NO.: 2880), CTAGgtagca (SEQ ID NO.: 2881), CTAGgtagcc (SEQ ID NO.: 2882), CTAGgtagga (SEQ ID NO.: 2883), CTAGgtaggc (SEQ ID NO.: 2884), CTAGgtaggg (SEQ ID NO.: 2885),
CTAGgtaggt (SEQ ID NO.: 2886), CTAGgtagta (SEQ ID NO.: 2887), CTAGgtatat (SEQ ID NO.: 2888), CTAGgtatca (SEQ ID NO.: 2889), CTAGgtatct (SEQ ID NO.: 2890), CTAGgtatga (SEQ ID NO.: 2891), CTAGgtatgc (SEQ ID NO.: 2892), CTAGgtatgg (SEQ ID NO.: 2893), CTAGgtatgt (SEQ ID NO.: 2894), CTAGgtatta (SEQ ID NO.: 2895), CTAGgtattg (SEQ ID NO.: 2896), CTAGgtattt (SEQ ID NO.: 2897), CTAGgtcaag (SEQ ID NO.: 2898), CTAGgtcagc (SEQ ID NO.: 2899), CTAGgtcagt (SEQ ID NO.: 2900), CTAGgtctat (SEQ ID NO.: 2901), CTAGgtctgg (SEQ ID NO.: 2902), CTAGgtgaat (SEQ ID NO.: 2903), CTAGgtgaga (SEQ ID NO.: 2904), CTAGgtgagc (SEQ ID NO.: 2905), CTAGgtgagg (SEQ ID NO.: 2906), CTAGgtgagt (SEQ ID NO.: 2907), CTAGgtgatg (SEQ ID NO.: 2908), CTAGgtgatt (SEQ ID NO.: 2909), CTAGgtgggg (SEQ ID NO.: 2910), CTAGgtgggt (SEQ ID NO.: 2911), CTAGgtgtgt (SEQ ID NO. : 2912), CTAGgttagt (SEQ ID NO. : 2913), CTAGgttcaa (SEQ ID NO.: 2914), CTAGgttggt (SEQ ID NO.: 2915), CTAGgtttga (SEQ ID NO.: 2916), CTAGgtttgc (SEQ ID NO.: 2917), CTAGgtttgg (SEQ ID NO.: 2918), CTAGgtttgt (SEQ ID NO.: 2919), CTATatatcc (SEQ ID NO.: 2920), CTATatggta (SEQ ID NO.: 2921), CTATgataag (SEQ ID NO.: 2922), CTATgcaagt (SEQ ID NO.: 2923), CTATgtaact (SEQ ID NO.: 2924), CTATgtaaga (SEQ ID NO.: 2925), CTATgtaagt (SEQ ID NO.: 2926), CTATgtaatg (SEQ ID NO.: 2927), CTATgtacgt (SEQ ID NO.: 2928), CTATgtatcc (SEQ ID NO.: 2929), CTATgtatgt (SEQ ID NO.: 2930), CTATgtgagc (SEQ ID NO.: 2931), CTATgtgagt (SEQ ID NO.: 2932), CTATgtgcgc (SEQ ID NO.: 2933), CTCAggtaaa (SEQ ID NO.: 2934), CTCAgtaaga (SEQ ID NO.: 2935), CTCAgtaagc (SEQ ID NO.: 2936), CTCAgtaagg (SEQ ID NO.: 2937), CTCAgtaagt (SEQ ID NO.: 2938), CTCAgtaggt (SEQ ID NO.: 2939), CTCAgtcagt (SEQ ID NO.: 2940), CTCAgtgagt (SEQ ID NO.: 2941), CTCAgtggtg (SEQ ID NO.: 2942), CTCAgttaaa (SEQ ID NO.: 2943), CTCAgttgta (SEQ ID NO.: 2944), CTCCagcccc (SEQ ID NO.: 2945), CTCCgaggga (SEQ ID NO.: 2946), CTCCgtaagc (SEQ ID NO.: 2947), CTCCgtaagt (SEQ ID NO.: 2948), CTCCgtaggt (SEQ ID NO.: 2949), CTCCgtatgt (SEQ ID NO.: 2950), CTCCgtgagt (SEQ ID NO.: 2951), CTCCgtggta (SEQ ID NO.: 2952), CTCGggtaat (SEQ ID NO.: 2953), CTCGgtaact (SEQ ID NO.: 2954), CTCGgtaaga (SEQ ID NO.: 2955), CTCGgtaagc (SEQ ID NO.: 2956), CTCGgtaagg (SEQ ID NO.: 2957), CTCGgtaagt (SEQ ID NO.: 2958), CTCGgtaata (SEQ ID NO.: 2959), CTCGgtaatg (SEQ ID NO.: 2960), CTCGgtacaa (SEQ ID NO.: 2961), CTCGgtacag (SEQ ID NO.: 2962), CTCGgtacca (SEQ ID NO.: 2963), CTCGgtaccc (SEQ ID NO.: 2964), CTCGgtacga (SEQ ID NO.: 2965), CTCGgtacgg (SEQ ID NO.: 2966), CTCGgtacgt (SEQ ID NO.: 2967), CTCGgtaggt (SEQ ID NO.: 2968), CTCGgtatac (SEQ ID NO.: 2969), CTCGgtatgg (SEQ ID NO.: 2970), CTCGgtatgt (SEQ ID NO.: 2971), CTCGgtattg (SEQ ID NO.: 2972), CTCGgtattt (SEQ ID NO.: 2973), CTCGgtcaga (SEQ ID NO.: 2974), CTCGgtcagt (SEQ ID NO.: 2975), CTCGgtctgt (SEQ ID NO.: 2976), CTCGgtgaat (SEQ ID NO.: 2977), CTCGgtgaga (SEQ ID NO.: 2978), CTCGgtgagc (SEQ ID NO.: 2979), CTCGgtgagg (SEQ ID NO.: 2980), CTCGgtgagt (SEQ ID NO.: 2981), CTCGgtgcgt (SEQ ID NO.: 2982), CTCGgtgggc (SEQ ID NO.: 2983), CTCGgtgggg (SEQ ID NO.: 2984), CTCGgtgggt (SEQ ID NO.: 2985), CTCGgtgtgt (SEQ ID NO.: 2986), CTCGgttagc (SEQ ID NO.: 2987), CTCGgttagt (SEQ ID NO.: 2988), CTCTgcaagt (SEQ ID NO.: 2989), CTCTggcagc (SEQ ID NO.: 2990), CTCTgtaaga (SEQ ID NO.: 2991), CTCTgtaagc (SEQ ID NO.: 2992), CTCTgtaagg (SEQ ID NO.: 2993), CTCTgtaagt (SEQ ID NO.: 2994), CTCTgtaatt (SEQ ID NO.: 2995), CTCTgtaggt (SEQ ID NO.: 2996), CTCTgtatgt (SEQ ID NO.: 2997), CTCTgtgagg (SEQ ID NO.: 2998), CTCTgtgagt (SEQ ID NO.: 2999), CTCTgtgcgt (SEQ ID NO.: 3000), CTCTgtgtgt (SEQ ID NO.: 3001), CTGAgtaaga (SEQ ID NO.: 3002), CTGAgtaagc (SEQ ID NO.: 3003), CTGAgtaagg (SEQ ID NO.: 3004),
CTGAgtaagt (SEQ ID NO.: 3005), CTGAgtaatt (SEQ ID NO.: 3006), CTGAgtaggt (SEQ ID NO.: 3007), CTGAgtatcc (SEQ ID NO.: 3008), CTGAgtatgt (SEQ ID NO.: 3009), CTGAgtctgt (SEQ ID NO.: 3010), CTGAgtgagc (SEQ ID NO.: 3011), CTGAgtgagg (SEQ ID NO.: 3012), CTGAgtgagt (SEQ ID NO.: 3013), CTGAgttagg (SEQ ID NO.: 3014), CTGCacagca (SEQ ID NO.: 3015), CTGCaggggg (SEQ ID NO.: 3016), CTGCgcagca (SEQ ID NO.: 3017), CTGCgtacgt (SEQ ID NO.: 3018), CTGCgtgagt (SEQ ID NO.: 3019), CTGCgtgggt (SEQ ID NO.: 3020), CTGGaccagc (SEQ ID NO.: 3021), CTGGatgtat (SEQ ID NO.: 3022), CTGGcaattg (SEQ ID NO.: 3023), CTGGgcaagt (SEQ ID NO.: 3024), CTGGgtaaaa (SEQ ID NO.: 3025), CTGGgtaaag (SEQ ID NO.: 3026), CTGGgtaaat (SEQ ID NO.: 3027), CTGGgtaaca (SEQ ID NO.: 3028), CTGGgtaacc (SEQ ID NO.: 3029), CTGGgtaact (SEQ ID NO.: 3030), CTGGgtaaga (SEQ ID NO.: 3031), CTGGgtaagc (SEQ ID NO.: 3032), CTGGgtaagg (SEQ ID NO.: 3033), CTGGgtaagt (SEQ ID NO.: 3034), CTGGgtaata (SEQ ID NO.: 3035), CTGGgtaatg (SEQ ID NO.: 3036), CTGGgtaatt (SEQ ID NO.: 3037), CTGGgtacaa (SEQ ID NO.: 3038), CTGGgtaccc (SEQ ID NO.: 3039), CTGGgtacgg (SEQ ID NO.: 3040), CTGGgtacgt (SEQ ID NO.: 3041), CTGGgtactg (SEQ ID NO.: 3042), CTGGgtagga (SEQ ID NO.: 3043), CTGGgtaggc (SEQ ID NO.: 3044), CTGGgtaggg (SEQ ID NO.: 3045), CTGGgtaggt (SEQ ID NO.: 3046), CTGGgtatca (SEQ ID NO.: 3047), CTGGgtatga (SEQ ID NO.: 3048), CTGGgtatgc (SEQ ID NO.: 3049), CTGGgtatgg (SEQ ID NO.: 3050), CTGGgtatgt (SEQ ID NO.: 3051), CTGGgtatta (SEQ ID NO.: 3052), CTGGgtattg (SEQ ID NO.: 3053), CTGGgtcagt (SEQ ID NO.: 3054), CTGGgtcctg (SEQ ID NO.: 3055), CTGGgtctgc (SEQ ID NO.: 3056), CTGGgtctgt (SEQ ID NO.: 3057), CTGGgtgaat (SEQ ID NO.: 3058), CTGGgtgact (SEQ ID NO.: 3059), CTGGgtgaga (SEQ ID NO.: 3060), CTGGgtgagc (SEQ ID NO.: 3061), CTGGgtgagg (SEQ ID NO.: 3062), CTGGgtgagt (SEQ ID NO.: 3063), CTGGgtgatt (SEQ ID NO.: 3064), CTGGgtgcgg (SEQ ID NO.: 3065), CTGGgtgggt (SEQ ID NO.: 3066), CTGGgtgtga (SEQ ID NO.: 3067), CTGGgttaag (SEQ ID NO.: 3068), CTGGgttaca (SEQ ID NO.: 3069), CTGGgttagt (SEQ ID NO.: 3070), CTGGgttcaa (SEQ ID NO.: 3071), CTGGgttgga (SEQ ID NO.: 3072), CTGGgttgta (SEQ ID NO.: 3073), CTGGgtttga (SEQ ID NO.: 3074), CTGGtcaaga (SEQ ID NO.: 3075), CTGGttatca (SEQ ID NO.: 3076), CTGTcggcat (SEQ ID NO.: 3077), CTGTgccgcc (SEQ ID NO.: 3078), CTGTgctgtc (SEQ ID NO.: 3079), CTGTgtaaat (SEQ ID NO.: 3080), CTGTgtaaga (SEQ ID NO.: 3081), CTGTgtaagg (SEQ ID NO.: 3082), CTGTgtaagt (SEQ ID NO.: 3083), CTGTgtacgt (SEQ ID NO.: 3084), CTGTgtactg (SEQ ID NO.: 3085), CTGTgtaggt (SEQ ID NO.: 3086), CTGTgtatgg (SEQ ID NO.: 3087), CTGTgtatgt (SEQ ID NO.: 3088), CTGTgtgaga (SEQ ID NO.: 3089), CTGTgtgagt (SEQ ID NO.: 3090), CTTAggtaag (SEQ ID NO.: 3091), CTTAgtaaat (SEQ ID NO.: 3092), CTTAgtaagt (SEQ ID NO.: 3093), CTTAgtatgt (SEQ ID NO.: 3094), CTTAgtgagt (SEQ ID NO.: 3095), CTTCgtaagt (SEQ ID NO.: 3096), CTTCgtgagt (SEQ ID NO.: 3097), CTTCttggta (SEQ ID NO.: 3098), CTTGatttta (SEQ ID NO.: 3099), CTTGgtaaaa (SEQ ID NO.: 3100), CTTGgtaaag (SEQ ID NO.: 3101), CTTGgtaaat (SEQ ID NO : 3102), CTTGgtaacc (SEQ ID NO. : 3103), CTTGgtaaga (SEQ ID NO. : 3104), CTTGgtaagc (SEQ ID NO.: 3105), CTTGgtaagg (SEQ ID NO.: 3106), CTTGgtaagt (SEQ ID NO.: 3107), CTTGgtaata (SEQ ID NO.: 3108), CTTGgtaatg (SEQ ID NO.: 3109), CTTGgtaatt (SEQ ID NO.: 3110), CTTGgtacag (SEQ ID NO. : 3111), CTTGgtacgt (SEQ ID NO. : 3112), CTTGgtagat (SEQ ID NO.: 3113), CTTGgtaggg (SEQ ID NO. : 3114), CTTGgtaggt (SEQ ID NO. : 3115), CTTGgtatac (SEQ ID NO. : 3116), CTTGgtatat (SEQ ID NO. : 3117), CTTGgtatcc (SEQ ID NO. : 3118), CTTGgtatga (SEQ ID NO. : 3119), CTTGgtatgc (SEQ ID NO.: 3120), CTTGgtatgg (SEQ ID NO.: 3121), CTTGgtatgt (SEQ ID NO.: 3122), CTTGgtattc (SEQ ID NO.: 3123), CTTGgtattt
(SEQ ID NO.: 3124), CTTGgtcagc (SEQ ID NO.: 3125), CTTGgtcgtc (SEQ ID NO.: 3126), CTTGgtctgc (SEQ ID NO.: 3127), CTTGgtgaga (SEQ ID NO.: 3128), CTTGgtgagc (SEQ ID NO.: 3129), CTTGgtgagg (SEQ ID NO.: 3130), CTTGgtgagt (SEQ ID NO.: 3131), CTTGgtgatt (SEQ ID NO.: 3132), CTTGgtgcgt (SEQ ID NO.: 3133), CTTGgtggga (SEQ ID NO.: 3134), CTTGgtgggt (SEQ ID NO.: 3135), CTTGgtgtga (SEQ ID NO.: 3136), CTTGgtgtgc (SEQ ID NO.: 3137), CTTGgtgtgg (SEQ ID NO.: 3138), CTTGgtgtgt (SEQ ID NO.: 3139), CTTGgttaga (SEQ ID NO. : 3140), CTTGgttagt (SEQ ID NO. : 3141), CTTGgttggt (SEQ ID NO. : 3142), CTTGgtttgt (SEQ ID NO. : 3143), CTTTatatcc (SEQ ID NO. : 3144), CTTTgtaaga (SEQ ID NO. : 3145), CTTTgtaagg (SEQ ID NO.: 3146), CTTTgtaagt (SEQ ID NO.: 3147), CTTTgtaggt (SEQ ID NO.: 3148), CTTTgtatgt (SEQ ID NO.: 3149), CTTTgtctcc (SEQ ID NO.: 3150), CTTTgtgaga (SEQ ID NO. : 3151 ), CTTTgtgagc (SEQ ID NO. : 3152), CTTTgtgagt (SEQ ID NO.: 3153), CTTTgtgatt (SEQ ID NO.: 3154), CTTTgtgtgt (SEQ ID NO.: 3155), CTTTtggtga (SEQ ID NO.: 3156), GAAAaaggta (SEQ ID NO.: 3157), GAAAaggtat (SEQ ID NO.: 3158), GAAAagtaag (SEQ ID NO.: 3159), GAAAagtgag (SEQ ID NO.: 3160), GAAAgcaagc (SEQ ID NO.: 3161), GAAAggtaac (SEQ ID NO.: 3162), GAAAggtaat (SEQ ID NO.: 3163), GAAAggtagt (SEQ ID NO.: 3164), GAAAgtaaaa (SEQ ID NO.: 3165), GAAAgtaaat (SEQ ID NO.: 3166), GAAAgtaaga (SEQ ID NO.: 3167), GAAAgtaagc (SEQ ID NO.: 3168), GAAAgtaagg (SEQ ID NO : 3169), GAAAgtaagt (SEQ ID NO.: 3170), GAAAgtaatc (SEQ ID NO.: 3171), GAAAgtaatt (SEQ ID NO.: 3172), GAAAgtacag (SEQ ID NO.: 3173), GAAAgtacta (SEQ ID NO.: 3174), GAAAgtagca (SEQ ID NO.: 3175), GAAAgtaggt (SEQ ID NO.: 3176), GAAAgtatgt (SEQ ID NO.: 3177), GAAAgtcagt (SEQ ID NO.: 3178), GAAAgtgaga (SEQ ID NO.: 3179), GAAAgtgagc (SEQ ID NO.: 3180), GAAAgtgagg (SEQ ID NO.: 3181), GAAAgtgagt (SEQ ID NO.: 3182), GAAAgtggag (SEQ ID NO.: 3183), GAAAgtgtga (SEQ ID NO.: 3184), GAAAgttagt (SEQ ID NO.: 3185), GAACgtaaga (SEQ ID NO.: 3186), GAACgtaagc (SEQ ID NO.: 3187), GAACgtaagt (SEQ ID NO.: 3188), GAACgtatgt (SEQ ID NO.: 3189), GAACgtgagc (SEQ ID NO.: 3190), GAACgtgagg (SEQ ID NO.: 3191), GAACgtgagt (SEQ ID NO.: 3192), GAACgtgtga (SEQ ID NO.: 3193), GAAGaggaag (SEQ ID NO.: 3194), GAAGatatcc (SEQ ID NO.: 3195), GAAGcagatt (SEQ ID NO.: 3196), GAAGctgact (SEQ ID NO.: 3197), GAAGgcaaag (SEQ ID NO.: 3198), GAAGgcaaga (SEQ ID NO. : 3199), GAAGgcaagc (SEQ ID NO. : 3200), GAAGgcaagg (SEQ ID NO.: 3201), GAAGgcaagt (SEQ ID NO.: 3202), GAAGgcacgt (SEQ ID NO.: 3203), GAAGgcaggt (SEQ ID NO.: 3204), GAAGgcatga (SEQ ID NO.: 3205), GAAGgcatgt (SEQ ID NO.: 3206), GAAGgccagc (SEQ ID NO.: 3207), GAAGgccagt (SEQ ID NO.: 3208), GAAGgcttac (SEQ ID NO.: 3209), GAAGggaggt (SEQ ID NO.: 3210), GAAGggtgag (SEQ ID NO.: 3211), GAAGgtaaaa (SEQ ID NO.: 3212), GAAGgtaaac (SEQ ID NO.: 3213), GAAGgtaaag (SEQ ID NO.: 3214), GAAGgtaaat (SEQ ID NO.: 3215), GAAGgtaaca (SEQ ID NO : 3216), GAAGgtaacc (SEQ ID NO : 3217), GAAGgtaacg (SEQ ID NO : 3218), GAAGgtaact (SEQ ID NO.: 3219), GAAGgtaaga (SEQ ID NO.: 3220), GAAGgtaagc (SEQ ID NO.: 3221), GAAGgtaagg (SEQ ID NO.: 3222), GAAGgtaagt (SEQ ID NO.: 3223), GAAGgtaata (SEQ ID NO.: 3224), GAAGgtaatc (SEQ ID NO.: 3225), GAAGgtaatg (SEQ ID NO.: 3226), GAAGgtaatt (SEQ ID NO.: 3227), GAAGgtacaa (SEQ ID NO.: 3228), GAAGgtacac (SEQ ID NO.: 3229), GAAGgtacag (SEQ ID NO.: 3230), GAAGgtacat (SEQ ID NO.: 3231), GAAGgtacca (SEQ ID NO.: 3232), GAAGgtaccc (SEQ ID NO.: 3233), GAAGgtaccg (SEQ ID NO.: 3234), GAAGgtacct (SEQ ID NO.: 3235), GAAGgtacga (SEQ ID NO.: 3236), GAAGgtacgg (SEQ ID NO.: 3237), GAAGgtacgt (SEQ ID NO.: 3238),
GAAGgtacta (SEQ ID NO.: 3239), GAAGgtactc (SEQ ID NO.: 3240), GAAGgtactg (SEQ ID NO.: 3241), GAAGgtactt (SEQ ID NO.: 3242), GAAGgtagaa (SEQ ID NO.: 3243), GAAGgtagac (SEQ ID NO.: 3244), GAAGgtagag (SEQ ID NO.: 3245), GAAGgtagat (SEQ ID NO.: 3246), GAAGgtagca (SEQ ID NO.: 3247), GAAGgtagcc (SEQ ID NO.: 3248), GAAGgtagcg (SEQ ID NO.: 3249), GAAGgtagct (SEQ ID NO.: 3250), GAAGgtagga (SEQ ID NO.: 3251), GAAGgtaggc (SEQ ID NO.: 3252), GAAGgtaggg (SEQ ID NO.: 3253), GAAGgtaggt (SEQ ID NO.: 3254), GAAGgtagta (SEQ ID NO.: 3255), GAAGgtagtg (SEQ ID NO.: 3256), GAAGgtagtt (SEQ ID NO.: 3257), GAAGgtataa (SEQ ID NO.: 3258), GAAGgtatac (SEQ ID NO.: 3259), GAAGgtatag (SEQ ID NO.: 3260), GAAGgtatat (SEQ ID NO.: 3261), GAAGgtatca (SEQ ID NO.: 3262), GAAGgtatcc (SEQ ID NO.: 3263), GAAGgtatcg (SEQ ID NO.: 3264), GAAGgtatct (SEQ ID NO.: 3265), GAAGgtatga (SEQ ID NO.: 3266), GAAGgtatgc (SEQ ID NO.: 3267), GAAGgtatgg (SEQ ID NO.: 3268), GAAGgtatgt (SEQ ID NO.: 3269), GAAGgtatta (SEQ ID NO.: 3270), GAAGgtattc (SEQ ID NO.: 3271), GAAGgtattg (SEQ ID NO.: 3272), GAAGgtattt (SEQ ID NO.: 3273), GAAGgtcaga (SEQ ID NO.: 3274), GAAGgtcagc (SEQ ID NO.: 3275), GAAGgtcagg (SEQ ID NO.: 3276), GAAGgtcagt (SEQ ID NO.: 3277), GAAGgtcata (SEQ ID NO.: 3278), GAAGgtccag (SEQ ID NO.: 3279), GAAGgtcccg (SEQ ID NO.: 3280), GAAGgtctaa (SEQ ID NO.: 3281), GAAGgtctat (SEQ ID NO.: 3282), GAAGgtctgc (SEQ ID NO 3283), GAAGgtctgg (SEQ ID NO.: 3284), GAAGgtctgt (SEQ ID NO.: 3285), GAAGgtcttc (SEQ ID NO.: 3286), GAAGgtgaaa (SEQ ID NO.: 3287), GAAGgtgaac (SEQ ID NO.: 3288), GAAGgtgaag (SEQ ID NO.: 3289), GAAGgtgaat (SEQ ID NO.: 3290), GAAGgtgaca (SEQ ID NO.: 3291), GAAGgtgacc (SEQ ID NO.: 3292), GAAGgtgact (SEQ ID NO.: 3293), GAAGgtgaga (SEQ ID NO.: 3294), GAAGgtgagc (SEQ ID NO.: 3295), GAAGgtgagg (SEQ ID NO.: 3296), GAAGgtgagt (SEQ ID NO.: 3297), GAAGgtgata (SEQ ID NO.: 3298), GAAGgtgatc (SEQ ID NO.: 3299), GAAGgtgatg (SEQ ID NO.: 3300), GAAGgtgatt (SEQ ID NO.: 3301), GAAGgtgcac (SEQ ID NO.: 3302), GAAGgtgcag (SEQ ID NO.: 3303), GAAGgtgcca (SEQ ID NO.: 3304), GAAGgtgccc (SEQ ID NO.: 3305), GAAGgtgccg (SEQ ID NO.: 3306), GAAGgtgcct (SEQ ID NO.: 3307), GAAGgtgcgc (SEQ ID NO.: 3308), GAAGgtgcgg (SEQ ID NO.: 3309), GAAGgtgcgt (SEQ ID NO.: 3310), GAAGgtgcta (SEQ ID NO. : 3311), GAAGgtgctc (SEQ ID NO.: 3312), GAAGgtgctg (SEQ ID NO.: 3313), GAAGgtgctt (SEQ ID NO.: 3314), GAAGgtggaa (SEQ ID NO.: 3315), GAAGgtggag (SEQ ID NO.: 3316), GAAGgtggat (SEQ ID NO.: 3317), GAAGgtggcc (SEQ ID NO.: 3318), GAAGgtggga (SEQ ID NO.: 3319), GAAGgtgggc (SEQ ID NO.: 3320), GAAGgtgggg (SEQ ID NO.: 3321), GAAGgtgggt (SEQ ID NO.: 3322), GAAGgtggta (SEQ ID NO.: 3323), GAAGgtggtg (SEQ ID NO.: 3324), GAAGgtggtt (SEQ ID NO.: 3325), GAAGgtgtaa (SEQ ID NO.: 3326), GAAGgtgtca (SEQ ID NO.: 3327), GAAGgtgtga (SEQ ID NO.: 3328), GAAGgtgtgc (SEQ ID NO.: 3329), GAAGgtgtgg (SEQ ID NO.: 3330), GAAGgtgtgt (SEQ ID NO.: 3331), GAAGgtgtt (SEQ ID NO.: 3332), GAAGgttaaa (SEQ ID NO.: 3333), GAAGgttaag (SEQ ID NO.: 3334), GAAGgttaat (SEQ ID NO.: 3335), GAAGgttaga (SEQ ID NO.: 3336), GAAGgttagc (SEQ ID NO.: 3337), GAAGgttagg (SEQ ID NO.: 3338), GAAGgttagt (SEQ ID NO.: 3339), GAAGgttatc (SEQ ID NO.: 3340), GAAGgttatt (SEQ ID NO.: 3341), GAAGgttcag (SEQ ID NO.: 3342), GAAGgttcga (SEQ ID NO.: 3343), GAAGgttgag (SEQ ID NO.: 3344), GAAGgttggc (SEQ ID NO.: 3345), GAAGgttggt (SEQ ID NO.: 3346), GAAGgttgta (SEQ ID NO.: 3347), GAAGgttgtc (SEQ ID NO.: 3348), GAAGgtttgc (SEQ ID NO.: 3349), GAAGgtttgg (SEQ ID NO.: 3350), GAAGgtttgt (SEQ ID NO.: 3351), GAAGgtttta (SEQ ID NO.: 3352), GAAGtaaatc (SEQ ID NO.: 3353),
GAAGttaagt (SEQ ID NO.: 3354), GAATgaaaat (SEQ ID NO.: 3355), GAATgcaagg (SEQ ID NO.: 3356), GAATgtaaat (SEQ ID NO.: 3357), GAATgtaaga (SEQ ID NO.: 3358), GAATgtaagc (SEQ ID NO.: 3359), GAATgtaagg (SEQ ID NO.: 3360), GAATgtaagt (SEQ ID NO.: 3361), GAATgtaatg (SEQ ID NO.: 3362), GAATgtaatt (SEQ ID NO.: 3363), GAATgtacac (SEQ ID NO.: 3364), GAATgtatgt (SEQ ID NO.: 3365), GAATgtattt (SEQ ID NO.: 3366), GAATgtgaga (SEQ ID NO.: 3367), GAATgtgagc (SEQ ID NO.: 3368), GAATgtgagg (SEQ ID NO.: 3369), GAATgtgagt (SEQ ID NO.: 3370), GAATgtgcgc (SEQ ID NO.: 3371), GAATgtgcgt (SEQ ID NO.: 3372), GAATgtggct (SEQ ID NO.: 3373), GAATgtggtg (SEQ ID NO.: 3374), GAATtgtaag (SEQ ID NO.: 3375), GACAaaggta (SEQ ID NO.: 3376), GACAaggaaa (SEQ ID NO.: 3377), GACAgtaaga (SEQ ID NO.: 3378), GACAgtaagc (SEQ ID NO.: 3379), GACAgtaagg (SEQ ID NO.: 3380), GACAgtaagt (SEQ ID NO.: 3381), GACAgtaatt (SEQ ID NO.: 3382), GACAgtagct (SEQ ID NO.: 3383), GACAgtaggt (SEQ ID NO.: 3384), GACAgtatgt (SEQ ID NO.: 3385), GACAgtattt (SEQ ID NO.: 3386), GACAgtgaga (SEQ ID NO.: 3387), GACAgtgagc (SEQ ID NO.: 3388), GACAgtgagt (SEQ ID NO.: 3389), GACAgtggtg (SEQ ID NO.: 3390), GACAgttaag (SEQ ID NO.: 3391), GACAgttggt (SEQ ID NO.: 3392), GACCaggata (SEQ ID NO.: 3393), GACCatatcc (SEQ ID NO.: 3394), GACCggtatc (SEQ ID NO.: 3395), GACCgtaagt (SEQ ID NO.: 3396), GACCgtatcc (SEQ ID NO.: 3397), GACCgtatgt (SEQ ID NO.: 3398), GACCgtgagt (SEQ ID NO.: 3399), GACCgtgggt (SEQ ID NO.: 3400), GACGgtaaag (SEQ ID NO.: 3401), GACGgtaaat (SEQ ID NO.: 3402), GACGgtaaga (SEQ ID NO.: 3403), GACGgtaagc (SEQ ID NO.: 3404), GACGgtaagt (SEQ ID NO.: 3405), GACGgtaata (SEQ ID NO.: 3406), GACGgtaatg (SEQ ID NO.: 3407), GACGgtaatt (SEQ ID NO.: 3408), GACGgtagga (SEQ ID NO.: 3409), GACGgtaggt (SEQ ID NO.: 3410), GACGgtatga (SEQ ID NO.: 3411), GACGgtatgg (SEQ ID NO.: 3412), GACGgtatgt (SEQ ID NO.: 3413), GACGgtgaga (SEQ ID NO.: 3414), GACGgtgagc (SEQ ID NO.: 3415), GACGgtgagg (SEQ ID NO : 3416), GACGgtgagt (SEQ ID NO.: 3417), GACGgtgcgt (SEQ ID NO.: 3418), GACGgtgggc (SEQ ID NO.: 3419), GACGgtgggt (SEQ ID NO.: 3420), GACGgtgtgt (SEQ ID NO.: 3421), GACGgttagt (SEQ ID NO.: 3422), GACGgttggt (SEQ ID NO.: 3423), GACGtaaaac (SEQ ID NO.: 3424), GACTacttca (SEQ ID NO.: 3425), GACTgcaggt (SEQ ID NO.: 3426), GACTgtaaga (SEQ ID NO.: 3427), GACTgtaagc (SEQ ID NO.: 3428), GACTgtaagt (SEQ ID NO.: 3429), GACTgtacgt (SEQ ID NO.: 3430), GACTgtaggt (SEQ ID NO.: 3431), GACTgtatcc (SEQ ID NO.: 3432), GACTgtatgt (SEQ ID NO.: 3433), GACTgtgaga (SEQ ID NO.: 3434), GACTgtgagg (SEQ ID NO.: 3435), GACTgtgagt (SEQ ID NO.: 3436), GACTgtgggg (SEQ ID NO.: 3437), GACTgtgggt (SEQ ID NO.: 3438), GACTgtggta (SEQ ID NO.: 3439), GACTgtggtt (SEQ ID NO.: 3440), GAGAagatat (SEQ ID NO.: 3441), GAGAagctaa (SEQ ID NO.: 3442), GAGAatatcc (SEQ ID NO.: 3443), GAGAgaataa (SEQ ID NO.: 3444), GAGAgcacga (SEQ ID NO.: 3445), GAGAgtaact (SEQ ID NO.: 3446), GAGAgtaaga (SEQ ID NO.: 3447), GAGAgtaagc (SEQ ID NO.: 3448), GAGAgtaagg (SEQ ID NO.: 3449), GAGAgtaagt (SEQ ID NO.: 3450), GAGAgtacaa (SEQ ID NO.: 3451), GAGAgtaggt (SEQ ID NO.: 3452), GAGAgtgagg (SEQ ID NO.: 3453), GAGAgtgagt (SEQ ID NO.: 3454), GAGAgtgatt (SEQ ID NO.: 3455), GAGAgtggta (SEQ ID NO.: 3456), GAGAgtgtaa (SEQ ID NO.: 3457), GAGAgttggt (SEQ ID NO.: 3458), GAGAgtttgt (SEQ ID NO.: 3459), GAGAtgctgc (SEQ ID NO.: 3460), GAGCgtaagc (SEQ ID NO.: 3461), GAGCgtaagt (SEQ ID NO.: 3462), GAGCgtacgt (SEQ ID NO.: 3463), GAGCgtaggt (SEQ ID NO.: 3464), GAGCgtatgt (SEQ ID NO.: 3465), GAGCgtgagc (SEQ ID NO.: 3466), GAGCgtgagt (SEQ ID NO.: 3467), GAGCgtgtga (SEQ ID NO.: 3468), GAGGagatgc (SEQ ID NO.: 3469), GAGGagtgtg (SEQ ID
NO.: 3470), GAGGgaagga (SEQ ID NO.: 3471), GAGGgaagtg (SEQ ID NO.: 3472), GAGGgcaagt (SEQ ID NO.: 3473), GAGGggatag (SEQ ID NO.: 3474), GAGGgtaaaa (SEQ ID NO.: 3475), GAGGgtaaac (SEQ ID NO.: 3476), GAGGgtaaag (SEQ ID NO.: 3477), GAGGgtaaat (SEQ ID NO.: 3478), GAGGgtaaga (SEQ ID NO.: 3479), GAGGgtaagc (SEQ ID NO.: 3480), GAGGgtaagg (SEQ ID NO.: 3481), GAGGgtaagt (SEQ ID NO.: 3482), GAGGgtaata (SEQ ID NO.: 3483), GAGGgtaatg (SEQ ID NO.: 3484), GAGGgtaatt (SEQ ID NO.: 3485), GAGGgtacag (SEQ ID NO.: 3486), GAGGgtacct (SEQ ID NO.: 3487), GAGGgtacgt (SEQ ID NO.: 3488), GAGGgtagga (SEQ ID NO.: 3489), GAGGgtaggt (SEQ ID NO.: 3490), GAGGgtatac (SEQ ID NO.: 3491), GAGGgtatga (SEQ ID NO.: 3492), GAGGgtatgc (SEQ ID NO.: 3493), GAGGgtatgg (SEQ ID NO.: 3494), GAGGgtatgt (SEQ ID NO.: 3495), GAGGgtattc (SEQ ID NO.: 3496), GAGGgtcagt (SEQ ID NO.: 3497), GAGGgtgaga (SEQ ID NO.: 3498), GAGGgtgagc (SEQ ID NO.: 3499), GAGGgtgagg (SEQ ID NO.: 3500), GAGGgtgagt (SEQ ID NO.: 3501), GAGGgtgctc (SEQ ID NO.: 3502), GAGGgtgggc (SEQ ID NO.: 3503), GAGGgtgggt (SEQ ID NO.: 3504), GAGGgtgtgt (SEQ ID NO.: 3505), GAGGgttagc (SEQ ID NO.: 3506), GAGGgttgta (SEQ ID NO.: 3507), GAGGgtttgt (SEQ ID NO.: 3508), GAGGttacag (SEQ ID NO.: 3509), GAGTgtaaga (SEQ ID NO.: 3510), GAGTgtaagt (SEQ ID NO.: 3511), GAGTgtaggt (SEQ ID NO.: 3512), GAGTgtatgt (SEQ ID NO.: 3513), GAGTgtgagc (SEQ ID NO.: 3514), GAGTgtgagt (SEQ ID NO.: 3515), GATActcgta (SEQ ID NO.: 3516), GATAgtaagt (SEQ ID NO.: 3517), GATAgtactg (SEQ ID NO.: 3518), GATAgtgagt (SEQ ID NO.: 3519), GATCgtaaga (SEQ ID NO.: 3520), GATCgtaagt (SEQ ID NO.: 3521), GATCgtatcc (SEQ ID NO.: 3522), GATCgtgagc (SEQ ID NO.: 3523), GATCgtgagt (SEQ ID NO.: 3524), GATGagggaa (SEQ ID NO.: 3525), GATGatgagg (SEQ ID NO.: 3526), GATGcaggaa (SEQ ID NO.: 3527), GATGgcaagt (SEQ ID NO.: 3528), GATGgcaatc (SEQ ID NO.: 3529), GATGgcacgg (SEQ ID NO.: 3530), GATGgcatgt (SEQ ID NO.: 3531), GATGggtagg (SEQ ID NO.: 3532), GATGgtaaaa (SEQ ID NO.: 3533), GATGgtaaac (SEQ ID NO.: 3534), GATGgtaaag (SEQ ID NO.: 3535), GATGgtaaat (SEQ ID NO.: 3536), GATGgtaaca (SEQ ID NO.: 3537), GATGgtaact (SEQ ID NO.: 3538), GATGgtaaga (SEQ ID NO.: 3539), GATGgtaagc (SEQ ID NO.: 3540), GATGgtaagg (SEQ ID NO.: 3541), GATGgtaagt (SEQ ID NO.: 3542), GATGgtaata (SEQ ID NO.: 3543), GATGgtaatg (SEQ ID NO.: 3544), GATGgtaatt (SEQ ID NO.: 3545), GATGgtacat (SEQ ID NO.: 3546), GATGgtaccc (SEQ ID NO.: 3547), GATGgtacga (SEQ ID NO.: 3548), GATGgtagga (SEQ ID NO.: 3549), GATGgtaggc (SEQ ID NO.: 3550), GATGgtaggg (SEQ ID NO.: 3551), GATGgtaggt (SEQ ID NO.: 3552), GATGgtatag (SEQ ID NO.: 3553), GATGgtatga (SEQ ID NO.: 3554), GATGgtatgg (SEQ ID NO.: 3555), GATGgtatgt (SEQ ID NO.: 3556), GATGgtcagt (SEQ ID NO.: 3557), GATGgtccgt (SEQ ID NO.: 3558), GATGgtcggt (SEQ ID NO.: 3559), GATGgtgaat (SEQ ID NO.: 3560), GATGgtgaga (SEQ ID NO.: 3561), GATGgtgagc (SEQ ID NO.: 3562), GATGgtgagg (SEQ ID NO.: 3563), GATGgtgagt (SEQ ID NO.: 3564), GATGgtgcgg (SEQ ID NO.: 3565), GATGgtgcgt (SEQ ID NO.: 3566), GATGgtgctc (SEQ ID NO.: 3567), GATGgtggac (SEQ ID NO.: 3568), GATGgtggga (SEQ ID NO.: 3569), GATGgtgggc (SEQ ID NO.: 3570), GATGgtgggg (SEQ ID NO.: 3571), GATGgtggtg (SEQ ID NO.: 3572), GATGgtgtgc (SEQ ID NO.: 3573), GATGgtgtgt (SEQ ID NO.: 3574), GATGgttagt (SEQ ID NO.: 3575), GATGgtttgt (SEQ ID NO.: 3576), GATGtgggtt (SEQ ID NO.: 3577), GATTgtaagg (SEQ ID NO.: 3578), GATTgtaagt (SEQ ID NO.: 3579), GATTgtaggt (SEQ ID NO.: 3580), GATTgtatcc (SEQ ID NO.: 3581), GATTgtatgt (SEQ ID NO.: 3582), GATTgtgaga (SEQ ID NO.: 3583), GATTgtgagt (SEQ ID NO.: 3584), GATTgtgtga (SEQ ID NO.: 3585),
GATTgttagt (SEQ ID NO.: 3586), GATTtgcatg (SEQ ID NO.: 3587), GATTtgtaag (SEQ ID NO.: 3588), GCAAaacagg (SEQ ID NO.: 3589), GCAAaggtaa (SEQ ID NO.: 3590), GCAAgcaagt (SEQ ID NO.: 3591), GCAAggtaag (SEQ ID NO.: 3592), GCAAgtaaat (SEQ ID NO.: 3593), GCAAgtaaga (SEQ ID NO.: 3594), GCAAgtaagc (SEQ ID NO.: 3595), GCAAgtaagg (SEQ ID NO.: 3596), GCAAgtaagt (SEQ ID NO.: 3597), GCAAgtacaa (SEQ ID NO.: 3598), GCAAgtacgg (SEQ ID NO.: 3599), GCAAgtacgt (SEQ ID NO.: 3600), GCAAgtacta (SEQ ID NO.: 3601), GCAAgtaggc (SEQ ID NO.: 3602), GCAAgtaggt (SEQ ID NO.: 3603), GCAAgtatga (SEQ ID NO.: 3604), GCAAgtatgc (SEQ ID NO.: 3605), GCAAgtatgg (SEQ ID NO.: 3606), GCAAgtatgt (SEQ ID NO.: 3607), GCAAgtcagt (SEQ ID NO.: 3608), GCAAgtgagc (SEQ ID NO.: 3609), GCAAgtgagg (SEQ ID NO.: 3610), GCAAgtgagt (SEQ ID NO.: 361 1), GCAAgtgggg (SEQ ID NO.: 3612), GCAAgtgggt (SEQ ID NO.: 3613), GCAAgttagt (SEQ ID NO.: 3614), GCACgcaagt (SEQ ID NO.: 3615), GCACgtaagc (SEQ ID NO.: 3616), GCACgtaagt (SEQ ID NO.: 3617), GCACgtaggt (SEQ ID NO.: 3618), GCACgtatgt (SEQ ID NO.: 3619), GCACgtgagc (SEQ ID NO.: 3620), GCACgtgagt (SEQ ID NO.: 3621), GCACgtgcgt (SEQ ID NO.: 3622), GCAGaggaaa (SEQ ID NO.: 3623), GCAGataagt (SEQ ID NO.: 3624), GCAGcagaag (SEQ ID NO.: 3625), GCAGgaaagt (SEQ ID NO.: 3626), GCAGgcaaga (SEQ ID NO.: 3627), GCAGgcaagc (SEQ ID NO.: 3628), GCAGgcaagg (SEQ ID NO.: 3629), GCAGgcaagt (SEQ ID NO.: 3630), GCAGgcacag (SEQ ID NO.: 3631), GCAGgcaggg (SEQ ID NO.: 3632), GCAGgcaggt (SEQ ID NO.: 3633), GCAGgcatat (SEQ ID NO.: 3634), GCAGgcatgt (SEQ ID NO.: 3635), GCAGgccctg (SEQ ID NO.: 3636), GCAGgcgaga (SEQ ID NO.: 3637), GCAGgcgagt (SEQ ID NO.: 3638), GCAGgcgggg (SEQ ID NO.: 3639), GCAGgctcgc (SEQ ID NO.: 3640), GCAGgtaaaa (SEQ ID NO.: 3641), GCAGgtaaac (SEQ ID NO.: 3642), GCAGgtaaag (SEQ ID NO.: 3643), GCAGgtaaat (SEQ ID NO.: 3644), GCAGgtaaca (SEQ ID NO.: 3645), GCAGgtaacc (SEQ ID NO.: 3646), GCAGgtaacg (SEQ ID NO.: 3647), GCAGgtaact (SEQ ID NO.: 3648), GCAGgtaaga (SEQ ID NO.: 3649), GCAGgtaagc (SEQ ID NO.: 3650), GCAGgtaagg (SEQ ID NO.: 3651), GCAGgtaagt (SEQ ID NO.: 3652), GCAGgtaata (SEQ ID NO.: 3653), GCAGgtaatc (SEQ ID NO.: 3654), GCAGgtaatg (SEQ ID NO.: 3655), GCAGgtaatt (SEQ ID NO.: 3656), GCAGgtacaa (SEQ ID NO.: 3657), GCAGgtacac (SEQ ID NO.: 3658), GCAGgtacag (SEQ ID NO.: 3659), GCAGgtacat (SEQ ID NO.: 3660), GCAGgtacca (SEQ ID NO.: 3661), GCAGgtaccc (SEQ ID NO.: 3662), GCAGgtaccg (SEQ ID NO.: 3663), GCAGgtacct (SEQ ID NO.: 3664), GCAGgtacga (SEQ ID NO.: 3665), GCAGgtacgc (SEQ ID NO.: 3666), GCAGgtacgg (SEQ ID NO.: 3667), GCAGgtacgt (SEQ ID NO.: 3668), GCAGgtacta (SEQ ID NO.: 3669), GCAGgtactc (SEQ ID NO.: 3670), GCAGgtactg (SEQ ID NO.: 3671), GCAGgtactt (SEQ ID NO.: 3672), GCAGgtagaa (SEQ ID NO.: 3673), GCAGgtagac (SEQ ID NO.: 3674), GCAGgtagag (SEQ ID NO.: 3675), GCAGgtagcc (SEQ ID NO.: 3676), GCAGgtagcg (SEQ ID NO.: 3677), GCAGgtagct (SEQ ID NO.: 3678), GCAGgtagga (SEQ ID NO.: 3679), GCAGgtaggc (SEQ ID NO.: 3680), GCAGgtaggg (SEQ ID NO.: 3681), GCAGgtaggt (SEQ ID NO.: 3682), GCAGgtagta (SEQ ID NO.: 3683), GCAGgtagtc (SEQ ID NO.: 3684), GCAGgtagtg (SEQ ID NO.: 3685), GCAGgtagtt (SEQ ID NO.: 3686), GCAGgtataa (SEQ ID NO.: 3687), GCAGgtatac (SEQ ID NO.: 3688), GCAGgtatag (SEQ ID NO.: 3689), GCAGgtatat (SEQ ID NO.: 3690), GCAGgtatca (SEQ ID NO.: 3691), GCAGgtatcc (SEQ ID NO.: 3692), GCAGgtatcg (SEQ ID NO.: 3693), GCAGgtatct (SEQ ID NO.: 3694), GCAGgtatga (SEQ ID NO.: 3695), GCAGgtatgc (SEQ ID NO.: 3696), GCAGgtatgg (SEQ ID NO.: 3697), GCAGgtatgt (SEQ ID NO.: 3698), GCAGgtatta (SEQ ID NO.: 3699), GCAGgtattc (SEQ ID NO.: 3700),
GCAGgtattg (SEQ ID NO.: 3701), GCAGgtattt (SEQ ID NO.: 3702), GCAGgtcaac (SEQ ID NO.: 3703), GCAGgtcaat (SEQ ID NO.: 3704), GCAGgtcaga (SEQ ID NO.: 3705), GCAGgtcagc (SEQ ID NO.: 3706), GCAGgtcagg (SEQ ID NO.: 3707), GCAGgtcagt (SEQ ID NO.: 3708), GCAGgtcatt (SEQ ID NO.: 3709), GCAGgtccaa (SEQ ID NO.: 3710), GCAGgtccag (SEQ ID NO.: 3711), GCAGgtccca (SEQ ID NO.: 3712), GCAGgtcccg (SEQ ID NO.: 3713), GCAGgtccgc (SEQ ID NO.: 3714), GCAGgtccgt (SEQ ID NO.: 3715), GCAGgtcggg (SEQ ID NO.: 3716), GCAGgtcgtt (SEQ ID NO.: 3717), GCAGgtctga (SEQ ID NO.: 3718), GCAGgtctgc (SEQ ID NO.: 3719), GCAGgtctgt (SEQ ID NO.: 3720), GCAGgtgaaa (SEQ ID NO.: 3721), GCAGgtgaac (SEQ ID NO.: 3722), GCAGgtgaag (SEQ ID NO.: 3723), GCAGgtgaat (SEQ ID NO.: 3724), GCAGgtgaca (SEQ ID NO.: 3725), GCAGgtgacc (SEQ ID NO.: 3726), GCAGgtgacg (SEQ ID NO.: 3727), GCAGgtgact (SEQ ID NO.: 3728), GCAGgtgaga (SEQ ID NO.: 3729), GCAGgtgagc (SEQ ID NO.: 3730), GCAGgtgagg (SEQ ID NO : 3731), GCAGgtgagt (SEQ ID NO.: 3732), GCAGgtgata (SEQ ID NO.: 3733), GCAGgtgatc (SEQ ID NO.: 3734), GCAGgtgatg (SEQ ID NO.: 3735), GCAGgtgatt (SEQ ID NO.: 3736), GCAGgtgcaa (SEQ ID NO.: 3737), GCAGgtgcag (SEQ ID NO.: 3738), GCAGgtgcat (SEQ ID NO.: 3739), GCAGgtgcca (SEQ ID NO.: 3740), GCAGgtgccc (SEQ ID NO.: 3741), GCAGgtgcct (SEQ ID NO.: 3742), GCAGgtgcga (SEQ ID NO.: 3743), GCAGgtgcgc (SEQ ID NO : 3744), GCAGgtgcgg (SEQ ID NO : 3745), GCAGgtgcgt (SEQ ID NO.: 3746), GCAGgtgcta (SEQ ID NO.: 3747), GCAGgtgctc (SEQ ID NO.: 3748), GCAGgtgctg (SEQ ID NO.: 3749), GCAGgtgctt (SEQ ID NO.: 3750), GCAGgtggag (SEQ ID NO.: 3751), GCAGgtggat (SEQ ID NO.: 3752), GCAGgtggga (SEQ ID NO.: 3753), GCAGgtgggc (SEQ ID NO.: 3754), GCAGgtgggg (SEQ ID NO.: 3755), GCAGgtgggt (SEQ ID NO.: 3756), GCAGgtggtg (SEQ ID NO.: 3757), GCAGgtggtt (SEQ ID NO.: 3758), GCAGgtgtat (SEQ ID NO.: 3759), GCAGgtgtct (SEQ ID NO.: 3760), GCAGgtgtga (SEQ ID NO.: 3761), GCAGgtgtgc (SEQ ID NO.: 3762), GCAGgtgtgg (SEQ ID NO.: 3763), GCAGgtgtgt (SEQ ID NO.: 3764), GCAGgtgtta (SEQ ID NO.: 3765), GCAGgttaat (SEQ ID NO.: 3766), GCAGgttaga (SEQ ID NO.: 3767), GCAGgttagc (SEQ ID NO.: 3768), GCAGgttagg (SEQ ID NO.: 3769), GCAGgttagt (SEQ ID NO.: 3770), GCAGgttata (SEQ ID NO.: 3771), GCAGgttcag (SEQ ID NO.: 3772), GCAGgttcat (SEQ ID NO.: 3773), GCAGgttcgt (SEQ ID NO.: 3774), GCAGgttctg (SEQ ID NO.: 3775), GCAGgttctt (SEQ ID NO.: 3776), GCAGgttgct (SEQ ID NO.: 3777), GCAGgttgga (SEQ ID NO.: 3778), GCAGgttggt (SEQ ID NO.: 3779), GCAGgttgtc (SEQ ID NO.: 3780), GCAGgttgtg (SEQ ID NO.: 3781), GCAGgtttat (SEQ ID NO.: 3782), GCAGgtttgc (SEQ ID NO.: 3783), GCAGgtttgg (SEQ ID NO.: 3784), GCAGgtttgt (SEQ ID NO.: 3785), GCAGtggtga (SEQ ID NO.: 3786), GCATgcaagt (SEQ ID NO.: 3787), GCATggtaaa (SEQ ID NO.: 3788), GCATgtaaga (SEQ ID NO.: 3789), GCATgtaagt (SEQ ID NO.: 3790), GCATgtaatg (SEQ ID NO.: 3791), GCATgtaatt (SEQ ID NO.: 3792), GCATgtaggt (SEQ ID NO.: 3793), GCATgtatcc (SEQ ID NO.: 3794), GCATgtatgt (SEQ ID NO.: 3795), GCATgtgagc (SEQ ID NO.: 3796), GCATgtgagt (SEQ ID NO.: 3797), GCATgtgcca (SEQ ID NO.: 3798), GCATgtgggt (SEQ ID NO.: 3799), GCATgtgtgt (SEQ ID NO.: 3800), GCATtcttca (SEQ ID NO.: 3801), GCCAgtaaga (SEQ ID NO.: 3802), GCCAgtaagg (SEQ ID NO.: 3803), GCCAgtaagt (SEQ ID NO.: 3804), GCCAgtaggt (SEQ ID NO.: 3805), GCCAgtgagg (SEQ ID NO.: 3806), GCCAgtgagt (SEQ ID NO.: 3807), GCCCaggcac (SEQ ID NO.: 3808), GCCCgggcat (SEQ ID NO.: 3809), GCCCgtaagc (SEQ ID NO.: 3810), GCCCgtaagt (SEQ ID NO.: 3811), GCCCgtatga (SEQ ID NO.: 3812), GCCCgtatgt (SEQ ID NO.: 3813), GCCCgtgagt (SEQ ID NO.: 3814), GCCGgcaagt (SEQ ID NO.: 3815), GCCGgggtga (SEQ ID NO.: 3816),
GCCGggtggg (SEQ ID NO.: 3817), GCCGgtaaag (SEQ ID NO.: 3818), GCCGgtaaat (SEQ ID NO.: 3819), GCCGgtaaga (SEQ ID NO.: 3820), GCCGgtaagc (SEQ ID NO.: 3821), GCCGgtaagg (SEQ ID NO.: 3822), GCCGgtaagt (SEQ ID NO.: 3823), GCCGgtaata (SEQ ID NO.: 3824), GCCGgtaatc (SEQ ID NO.: 3825), GCCGgtaatg (SEQ ID NO.: 3826), GCCGgtacgg (SEQ ID NO.: 3827), GCCGgtacgt (SEQ ID NO.: 3828), GCCGgtactg (SEQ ID NO.: 3829), GCCGgtagga (SEQ ID NO.: 3830), GCCGgtaggc (SEQ ID NO.: 3831), GCCGgtaggt (SEQ ID NO.: 3832), GCCGgtatgt (SEQ ID NO.: 3833), GCCGgtcagc (SEQ ID NO.: 3834), GCCGgtcagt (SEQ ID NO.: 3835), GCCGgtctgt (SEQ ID NO.: 3836), GCCGgtgaga (SEQ ID NO.: 3837), GCCGgtgagc (SEQ ID NO.: 3838), GCCGgtgagg (SEQ ID NO.: 3839), GCCGgtgagt (SEQ ID NO.: 3840), GCCGgtgcgt (SEQ ID NO.: 3841), GCCGgtgggt (SEQ ID NO.: 3842), GCCGgttagt (SEQ ID NO.: 3843), GCCTgtaaga (SEQ ID NO : 3844), GCCTgtaagt (SEQ ID NO.: 3845), GCCTgtaggt (SEQ ID NO.: 3846), GCCTgtatcc (SEQ ID NO.: 3847), GCCTgtatgt (SEQ ID NO.: 3848), GCCTgtgaga (SEQ ID NO.: 3849), GCCTgtgagg (SEQ ID NO.: 3850), GCCTgtgagt (SEQ ID NO.: 3851), GCCTgtgggt (SEQ ID NO.: 3852), GCGAgtaagg (SEQ ID NO.: 3853), GCGAgtaagt (SEQ ID NO.: 3854), GCGAgtacgt (SEQ ID NO.: 3855), GCGAgtatgt (SEQ ID NO.: 3856), GCGAgtcagt (SEQ ID NO.: 3857), GCGAgtcggt (SEQ ID NO.: 3858), GCGAgtgagc (SEQ ID NO.: 3859), GCGAgtgagt (SEQ ID NO.: 3860), GCGCgggtac (SEQ ID NO : 3861), GCGCgggtga (SEQ ID NO : 3862), GCGCgtgagc (SEQ ID NO.: 3863), GCGCgtgagt (SEQ ID NO.: 3864), GCGGgtaaaa (SEQ ID NO.: 3865), GCGGgtaaac (SEQ ID NO.: 3866), GCGGgtaaga (SEQ ID NO.: 3867), GCGGgtaagc (SEQ ID NO.: 3868), GCGGgtaagg (SEQ ID NO.: 3869), GCGGgtaagt (SEQ ID NO.: 3870), GCGGgtacga (SEQ ID NO.: 3871), GCGGgtacgg (SEQ ID NO.: 3872), GCGGgtactc (SEQ ID NO.: 3873), GCGGgtactt (SEQ ID NO.: 3874), GCGGgtagag (SEQ ID NO.: 3875), GCGGgtaggc (SEQ ID NO.: 3876), GCGGgtaggg (SEQ ID NO.: 3877), GCGGgtaggt (SEQ ID NO.: 3878), GCGGgtatgg (SEQ ID NO.: 3879), GCGGgtatgt (SEQ ID NO.: 3880), GCGGgtgaga (SEQ ID NO.: 3881), GCGGgtgagc (SEQ ID NO.: 3882), GCGGgtgagg (SEQ ID NO.: 3883), GCGGgtgagt (SEQ ID NO.: 3884), GCGGgtgcag (SEQ ID NO.: 3885), GCGGgtgcgt (SEQ ID NO.: 3886), GCGGgtgtgc (SEQ ID NO.: 3887), GCGGgttggt (SEQ ID NO.: 3888), GCGGgtttgt (SEQ ID NO.: 3889), GCGTgtaagg (SEQ ID NO.: 3890), GCGTgtaagt (SEQ ID NO.: 3891), GCGTgtgagc (SEQ ID NO.: 3892), GCGTgtgagt (SEQ ID NO.: 3893), GCTAagttaa (SEQ ID NO.: 3894), GCTAgcaagt (SEQ ID NO.: 3895), GCTAgtaagc (SEQ ID NO.: 3896), GCTAgtaagt (SEQ ID NO.: 3897), GCTAgtatgt (SEQ ID NO.: 3898), GCTAgtgagt (SEQ ID NO.: 3899), GCTAgtgcgt (SEQ ID NO.: 3900), GCTAtggaat (SEQ ID NO.: 3901), GCTAtgggcc (SEQ ID NO.: 3902), GCTCgtaagt (SEQ ID NO.: 3903), GCTCgtgagg (SEQ ID NO.: 3904), GCTCtcttgt (SEQ ID NO.: 3905), GCTGatatcc (SEQ ID NO.: 3906), GCTGgcaagt (SEQ ID NO.: 3907), GCTGgcaggt (SEQ ID NO.: 3908), GCTGggaaca (SEQ ID NO.: 3909), GCTGgtaaaa (SEQ ID NO 3910), GCTGgtaaac (SEQ ID NO.: 3911), GCTGgtaaag (SEQ ID NO.: 3912), GCTGgtaaat (SEQ ID NO.: 3913), GCTGgtaacc (SEQ ID NO.: 3914), GCTGgtaaga (SEQ ID NO.: 3915), GCTGgtaagc (SEQ ID NO.: 3916), GCTGgtaagg (SEQ ID NO.: 3917), GCTGgtaagt (SEQ ID NO.: 3918), GCTGgtaata (SEQ ID NO.: 3919), GCTGgtaatg (SEQ ID NO.: 3920), GCTGgtacct (SEQ ID NO.: 3921), GCTGgtacga (SEQ ID NO.: 3922), GCTGgtacgg (SEQ ID NO.: 3923), GCTGgtacgt (SEQ ID NO.: 3924), GCTGgtacta (SEQ ID NO.: 3925), GCTGgtactc (SEQ ID NO.: 3926), GCTGgtagct (SEQ ID NO.: 3927), GCTGgtagga (SEQ ID NO.: 3928), GCTGgtaggc (SEQ ID NO.: 3929), GCTGgtaggg (SEQ ID NO.: 3930), GCTGgtaggt (SEQ ID NO.: 3931), GCTGgtatct (SEQ ID NO.: 3932), GCTGgtatga (SEQ ID
NO.: 3933), GCTGgtatgc (SEQ ID NO.: 3934), GCTGgtatgg (SEQ ID NO.: 3935), GCTGgtatgt (SEQ ID NO.: 3936), GCTGgtatta (SEQ ID NO.: 3937), GCTGgtcagc (SEQ ID NO.: 3938), GCTGgtcagt (SEQ ID NO.: 3939), GCTGgtctgt (SEQ ID NO.: 3940), GCTGgtgaga (SEQ ID NO.: 3941), GCTGgtgagc (SEQ ID NO.: 3942), GCTGgtgagg (SEQ ID NO.: 3943), GCTGgtgagt (SEQ ID NO.: 3944), GCTGgtgata (SEQ ID NO.: 3945), GCTGgtgatg (SEQ ID NO.: 3946), GCTGgtgcgg (SEQ ID NO.: 3947), GCTGgtgcgt (SEQ ID NO.: 3948), GCTGgtgggt (SEQ ID NO.: 3949), GCTGgtgtgc (SEQ ID NO.: 3950), GCTGgtgtgt (SEQ ID NO.: 3951), GCTGgttagt (SEQ ID NO.: 3952), GCTTcaacag (SEQ ID NO.: 3953), GCTTcaggaa (SEQ ID NO.: 3954), GCTTgtaaga (SEQ ID NO.: 3955), GCTTgtaagg (SEQ ID NO.: 3956), GCTTgtaagt (SEQ ID NO.: 3957), GCTTgtacgt (SEQ ID NO.: 3958), GCTTgtagga (SEQ ID NO.: 3959), GCTTgtatcc (SEQ ID NO.: 3960), GCTTgtatgt (SEQ ID NO.: 3961), GCTTgtgagt (SEQ ID NO.: 3962), GCTTgtgctt (SEQ ID NO.: 3963), GCTTtggtaa (SEQ ID NO.: 3964), GGAAaaggta (SEQ ID NO.: 3965), GGAAcaggaa (SEQ ID NO.: 3966), GGAAcgggtg (SEQ ID NO.: 3967), GGAActccgg (SEQ ID NO.: 3968), GGAAggtagt (SEQ ID NO.: 3969), GGAAggtcag (SEQ ID NO.: 3970), GGAAggtgtc (SEQ ID NO.: 3971), GGAAgtaact (SEQ ID NO.: 3972), GGAAgtaaga (SEQ ID NO.: 3973), GGAAgtaagc (SEQ ID NO.: 3974), GGAAgtaagg (SEQ ID NO.: 3975), GGAAgtaagt (SEQ ID NO.: 3976), GGAAgtaatc (SEQ ID NO.: 3977), GGAAgtaatg (SEQ ID NO 3978), GGAAgtagga (SEQ ID NO.: 3979), GGAAgtaggt (SEQ ID NO.: 3980), GGAAgtatgc (SEQ ID NO.: 3981), GGAAgtatgt (SEQ ID NO.: 3982), GGAAgtgagc (SEQ ID NO.: 3983), GGAAgtgagg (SEQ ID NO.: 3984), GGAAgtgagt (SEQ ID NO.: 3985), GGAAgttagt (SEQ ID NO.: 3986), GGACgtaaga (SEQ ID NO.: 3987), GGACgtaagt (SEQ ID NO.: 3988), GGACgtatgt (SEQ ID NO.: 3989), GGACgtgagt (SEQ ID NO.: 3990), GGACgtgtgt (SEQ ID NO.: 3991), GGAGctcagg (SEQ ID NO.: 3992), GGAGgaaagt (SEQ ID NO.: 3993), GGAGgcaagc (SEQ ID NO.: 3994), GGAGgcaagg (SEQ ID NO.: 3995), GGAGgcaagt (SEQ ID NO.: 3996), GGAGgcaggt (SEQ ID NO.: 3997), GGAGgccatg (SEQ ID NO.: 3998), GGAGgcctct (SEQ ID NO.: 3999), GGAGgcgagt (SEQ ID NO.: 4000), GGAGgctgcc (SEQ ID NO.: 4001), GGAGgtaaaa (SEQ ID NO.: 4002), GGAGgtaaac (SEQ ID NO.: 4003), GGAGgtaaag (SEQ ID NO.: 4004), GGAGgtaaat (SEQ ID NO.: 4005), GGAGgtaaca (SEQ ID NO.: 4006), GGAGgtaacc (SEQ ID NO.: 4007), GGAGgtaacg (SEQ ID NO.: 4008), GGAGgtaact (SEQ ID NO.: 4009), GGAGgtaaga (SEQ ID NO.: 4010), GGAGgtaagc (SEQ ID NO.: 4011), GGAGgtaagg (SEQ ID NO.: 4012), GGAGgtaagt (SEQ ID NO.: 4013), GGAGgtaata (SEQ ID NO.: 4014), GGAGgtaatc (SEQ ID NO.: 4015), GGAGgtaatg (SEQ ID NO.: 4016), GGAGgtaatt (SEQ ID NO.: 4017), GGAGgtacaa (SEQ ID NO.: 4018), GGAGgtacag (SEQ ID NO.: 4019), GGAGgtacat (SEQ ID NO.: 4020), GGAGgtaccc (SEQ ID NO.: 4021), GGAGgtaccg (SEQ ID NO.: 4022), GGAGgtacct (SEQ ID NO.: 4023), GGAGgtacga (SEQ ID NO.: 4024), GGAGgtacgc (SEQ ID NO.: 4025), GGAGgtacgg (SEQ ID NO.: 4026), GGAGgtacgt (SEQ ID NO.: 4027), GGAGgtactc (SEQ ID NO.: 4028), GGAGgtactg (SEQ ID NO.: 4029), GGAGgtactt (SEQ ID NO.: 4030), GGAGgtagaa (SEQ ID NO.: 4031), GGAGgtagag (SEQ ID NO.: 4032), GGAGgtagca (SEQ ID NO.: 4033), GGAGgtagga (SEQ ID NO.: 4034), GGAGgtaggc (SEQ ID NO.: 4035), GGAGgtaggg (SEQ ID NO.: 4036), GGAGgtaggt (SEQ ID NO.: 4037), GGAGgtagta (SEQ ID NO.: 4038), GGAGgtagtc (SEQ ID NO.: 4039), GGAGgtagtg (SEQ ID NO.: 4040), GGAGgtatac (SEQ ID NO.: 4041), GGAGgtatag (SEQ ID NO.: 4042), GGAGgtatat (SEQ ID NO.: 4043), GGAGgtatca (SEQ ID NO.: 4044), GGAGgtatct (SEQ ID NO.: 4045), GGAGgtatga (SEQ ID NO.: 4046), GGAGgtatgc (SEQ ID NO.: 4047), GGAGgtatgg (SEQ ID
NO.: 4048), GGAGgtatgt (SEQ ID NO.: 4049), GGAGgtatta (SEQ ID NO.: 4050), GGAGgtattc (SEQ ID NO.: 4051), GGAGgtattg (SEQ ID NO.: 4052), GGAGgtattt (SEQ ID NO.: 4053), GGAGgtcaga (SEQ ID NO.: 4054), GGAGgtcagc (SEQ ID NO.: 4055), GGAGgtcagg (SEQ ID NO.: 4056), GGAGgtcagt (SEQ ID NO.: 4057), GGAGgtccac (SEQ ID NO.: 4058), GGAGgtcctg (SEQ ID NO.: 4059), GGAGgtcgag (SEQ ID NO.: 4060), GGAGgtcgtc (SEQ ID NO.: 4061), GGAGgtctgc (SEQ ID NO.: 4062), GGAGgtctgg (SEQ ID NO.: 4063), GGAGgtctgt (SEQ ID NO.: 4064), GGAGgtcttg (SEQ ID NO.: 4065), GGAGgtgaag (SEQ ID NO.: 4066), GGAGgtgaat (SEQ ID NO.: 4067), GGAGgtgaca (SEQ ID NO.: 4068), GGAGgtgacc (SEQ ID NO.: 4069), GGAGgtgacg (SEQ ID NO.: 4070), GGAGgtgact (SEQ ID NO.: 4071), GGAGgtgaga (SEQ ID NO.: 4072), GGAGgtgagc (SEQ ID NO.: 4073), GGAGgtgagg (SEQ ID NO.: 4074), GGAGgtgagt (SEQ ID NO.: 4075), GGAGgtgatg (SEQ ID NO.: 4076), GGAGgtgatt (SEQ ID NO.: 4077), GGAGgtgcct (SEQ ID NO.: 4078), GGAGgtgcgc (SEQ ID NO.: 4079), GGAGgtgcgg (SEQ ID NO.: 4080), GGAGgtgcgt (SEQ ID NO.: 4081), GGAGgtgctc (SEQ ID NO.: 4082), GGAGgtgctg (SEQ ID NO.: 4083), GGAGgtgctt (SEQ ID NO.: 4084), GGAGgtggag (SEQ ID NO.: 4085), GGAGgtggcc (SEQ ID NO.: 4086), GGAGgtggcg (SEQ ID NO.: 4087), GGAGgtggga (SEQ ID NO.: 4088), GGAGgtgggc (SEQ ID NO.: 4089), GGAGgtgggg (SEQ ID NO.: 4090), GGAGgtgggt (SEQ ID NO.: 4091), GGAGgtggta (SEQ ID NO.: 4092), GGAGgtggtt (SEQ ID NO.: 4093), GGAGgtgtgc (SEQ ID NO.: 4094), GGAGgtgtgg (SEQ ID NO.: 4095), GGAGgtgtgt (SEQ ID NO.: 4096), GGAGgtgttg (SEQ ID NO.: 4097), GGAGgttaaa (SEQ ID NO.: 4098), GGAGgttaga (SEQ ID NO.: 4099), GGAGgttagg (SEQ ID NO.: 4100), GGAGgttagt (SEQ ID NO.: 4101), GGAGgttatc (SEQ ID NO.: 4102), GGAGgttcac (SEQ ID NO.: 4103), GGAGgttcgt (SEQ ID NO.: 4104), GGAGgttgat (SEQ ID NO.: 4105), GGAGgttgcg (SEQ ID NO.: 4106), GGAGgttgct (SEQ ID NO.: 4107), GGAGgttgga (SEQ ID NO.: 4108), GGAGgttggc (SEQ ID NO.: 4109), GGAGgttggt (SEQ ID NO.: 4110), GGAGgtttgc (SEQ ID NO.: 4111), GGAGgtttgt (SEQ ID NO. : 4112), GGAGtgtaat (SEQ ID NO. : 4113), GGAGttgggt (SEQ ID NO. : 4114), GGATatcctt (SEQ ID NO. : 4115), GGATatgtaa (SEQ ID NO.: 4116), GGATgtaaga (SEQ ID NO.: 4117), GGATgtaagc (SEQ ID NO.: 4118), GGATgtaagg (SEQ ID NO.: 4119), GGATgtaagt (SEQ ID NO.: 4120), GGATgtatcc (SEQ ID NO.: 4121), GGATgtatct (SEQ ID NO.: 4122), GGATgtcagt (SEQ ID NO.: 4123), GGATgtgagc (SEQ ID NO.: 4124), GGATgtgagt (SEQ ID NO.: 4125), GGATgtgcgt (SEQ ID NO.: 4126), GGATgtgtgt (SEQ ID NO.: 4127), GGATgttagc (SEQ ID NO.: 4128), GGCAgcagag (SEQ ID NO.: 4129), GGCAggtaag (SEQ ID NO.: 4130), GGCAgtaaga (SEQ ID NO.: 4131), GGCAgtaagc (SEQ ID NO.: 4132), GGCAgtaagt (SEQ ID NO.: 4133), GGCAgtgagt (SEQ ID NO.: 4134), GGCCacccgg (SEQ ID NO.: 4135), GGCCggccgc (SEQ ID NO.: 4136), GGCCgtaaga (SEQ ID NO.: 4137), GGCCgtacag (SEQ ID NO.: 4138), GGCCgtcagg (SEQ ID NO.: 4139), GGCCgtgagt (SEQ ID NO 4140), GGCCgtgcgt (SEQ ID NO.: 4141), GGCGggccac (SEQ ID NO.: 4142), GGCGgtaaag (SEQ ID NO.: 4143), GGCGgtaaga (SEQ ID NO.: 4144), GGCGgtaagc (SEQ ID NO.: 4145), GGCGgtaagt (SEQ ID NO.: 4146), GGCGgtaggt (SEQ ID NO.: 4147), GGCGgtcaca (SEQ ID NO.: 4148), GGCGgtgaag (SEQ ID NO.: 4149), GGCGgtgaga (SEQ ID NO.: 4150), GGCGgtgagc (SEQ ID NO.: 4151), GGCGgtgagg (SEQ ID NO.: 4152), GGCGgtgagt (SEQ ID NO.: 4153), GGCGgtgggt (SEQ ID NO.: 4154), GGCTgcccca (SEQ ID NO.: 4155), GGCTgtaagg (SEQ ID NO.: 4156), GGCTgtaagt (SEQ ID NO.: 4157), GGCTgtaata (SEQ ID NO.: 4158), GGCTgtacaa (SEQ ID NO.: 4159), GGCTgtacag (SEQ ID NO.: 4160), GGCTgtaggt (SEQ ID NO.: 4161), GGCTgtgagt (SEQ ID NO.: 4162),
GGCTgtgcgt (SEQ ID NO.: 4163), GGCTtttcaa (SEQ ID NO.: 4164), GGGAagatat (SEQ ID NO.: 4165), GGGAgtaagg (SEQ ID NO.: 4166), GGGAgtaagt (SEQ ID NO.: 4167), GGGAgtacgt (SEQ ID NO.: 4168), GGGAgtatgt (SEQ ID NO.: 4169), GGGAgtgagc (SEQ ID NO.: 4170), GGGAgtgagt (SEQ ID NO.: 4171), GGGCattggt (SEQ ID NO.: 4172), GGGCgctggg (SEQ ID NO.: 4173), GGGCgtaagt (SEQ ID NO.: 4174), GGGCgtatct (SEQ ID NO.: 4175), GGGCgtgaaa (SEQ ID NO.: 4176), GGGCgtgagt (SEQ ID NO.: 4177), GGGGctatgg (SEQ ID NO.: 4178), GGGGgcaagt (SEQ ID NO.: 4179), GGGGgtaaga (SEQ ID NO.: 4180), GGGGgtaagc (SEQ ID NO.: 4181), GGGGgtaagg (SEQ ID NO.: 4182), GGGGgtaagt (SEQ ID NO.: 4183), GGGGgtacgg (SEQ ID NO.: 4184), GGGGgtaggc (SEQ ID NO.: 4185), GGGGgtatgg (SEQ ID NO.: 4186), GGGGgtgagc (SEQ ID NO.: 4187), GGGGgtgagg (SEQ ID NO.: 4188), GGGGgtgagt (SEQ ID NO.: 4189), GGGGgtgggt (SEQ ID NO.: 4190), GGGGgtgtgt (SEQ ID NO.: 4191), GGGGgttagt (SEQ ID NO.: 4192), GGGTgccatc (SEQ ID NO.: 4193), GGGTgtaagt (SEQ ID NO.: 4194), GGTAgtaagt (SEQ ID NO.: 4195), GGTGcaaggt (SEQ ID NO.: 4196), GGTGctaaga (SEQ ID NO.: 4197), GGTGgtaaga (SEQ ID NO.: 4198), GGTGgtaagc (SEQ ID NO.: 4199), GGTGgtaagg (SEQ ID NO.: 4200), GGTGgtaagt (SEQ ID NO.: 4201), GGTGgtacat (SEQ ID NO.: 4202), GGTGgtacgg (SEQ ID NO.: 4203), GGTGgtagga (SEQ ID NO.: 4204), GGTGgtatat (SEQ ID NO.: 4205), GGTGgtatgg (SEQ ID NO.: 4206), GGTGgtatgt (SEQ ID NO.: 4207), GGTGgtattt (SEQ ID NO.: 4208), GGTGgtcagc (SEQ ID NO.: 4209), GGTGgtcctc (SEQ ID NO.: 4210), GGTGgtgaga (SEQ ID NO.: 4211), GGTGgtgagg (SEQ ID NO.: 4212), GGTGgtgagt (SEQ ID NO.: 4213), GGTGgttcat (SEQ ID NO.: 4214), GGTTgcactc (SEQ ID NO.: 4215), GGTTgtaaga (SEQ ID NO.: 4216), GGTTgtaagt (SEQ ID NO.: 4217), GGTTgtgagt (SEQ ID NO.: 4218), GTAGgcaagt (SEQ ID NO.: 4219), GTAGgtaaaa (SEQ ID NO.: 4220), GTAGgtaaag (SEQ ID NO.: 4221), GTAGgtaaat (SEQ ID NO.: 4222), GTAGgtaaga (SEQ ID NO.: 4223), GTAGgtaagc (SEQ ID NO.: 4224), GTAGgtaagg (SEQ ID NO.: 4225), GTAGgtaagt (SEQ ID NO.: 4226), GTAGgtaatg (SEQ ID NO.: 4227), GTAGgtaatt (SEQ ID NO.: 4228), GTAGgtacag (SEQ ID NO.: 4229), GTAGgtaggt (SEQ ID NO.: 4230), GTAGgtatga (SEQ ID NO.: 4231), GTAGgtatgc (SEQ ID NO.: 4232), GTAGgtatgg (SEQ ID NO.: 4233), GTAGgtatgt (SEQ ID NO.: 4234), GTAGgtccgg (SEQ ID NO.: 4235), GTAGgtgaga (SEQ ID NO.: 4236), GTAGgtgagc (SEQ ID NO.: 4237), GTAGgtgagt (SEQ ID NO.: 4238), GTAGgtgcgg (SEQ ID NO.: 4239), GTAGgtgggt (SEQ ID NO.: 4240), GTAGgtggtg (SEQ ID NO.: 4241), GTAGgttgcc (SEQ ID NO.: 4242), GTAGgttgcg (SEQ ID NO.: 4243), GTAGgttgga (SEQ ID NO.: 4244), GTATgtaagt (SEQ ID NO.: 4245), GTATgtaggt (SEQ ID NO.: 4246), GTATgtatgt (SEQ ID NO.: 4247), GTCAaaggtg (SEQ ID NO.: 4248), GTCAacggct (SEQ ID NO.: 4249), GTCAgggcca (SEQ ID NO.: 4250), GTCAggtgag (SEQ ID NO.: 4251), GTCAgtaagt (SEQ ID NO.: 4252), GTCAgtcagt (SEQ ID NO.: 4253), GTCAgtgagt (SEQ ID NO.: 4254), GTCCcagggc (SEQ ID NO.: 4255), GTCCctggag (SEQ ID NO.: 4256), GTCCgtaagc (SEQ ID NO.: 4257), GTCCgtaagt (SEQ ID NO.: 4258), GTCCgtgagt (SEQ ID NO.: 4259), GTCGgtaaga (SEQ ID NO.: 4260), GTCGgtaagc (SEQ ID NO.: 4261), GTCGgtaagg (SEQ ID NO.: 4262), GTCGgtaagt (SEQ ID NO.: 4263), GTCGgtaatg (SEQ ID NO.: 4264), GTCGgtacgt (SEQ ID NO.: 4265), GTCGgtagga (SEQ ID NO.: 4266), GTCGgtaggt (SEQ ID NO.: 4267), GTCGgtatct (SEQ ID NO.: 4268), GTCGgtatga (SEQ ID NO.: 4269), GTCGgtcagt (SEQ ID NO.: 4270), GTCGgtgagg (SEQ ID NO.: 4271), GTCGgtgagt (SEQ ID NO.: 4272), GTCGgtggga (SEQ ID NO.: 4273), GTCTcccctg (SEQ ID NO.: 4274), GTCTgaagag (SEQ ID NO.: 4275), GTCTgtaagc (SEQ ID NO.: 4276), GTCTgtaagg (SEQ ID NO.: 4277), GTCTgtaagt (SEQ ID NO.: 4278), GTCTgtaggt
(SEQ ID NO.: 4279), GTCTgtgagt (SEQ ID NO.: 4280), GTGAgtaagt (SEQ ID NO.: 4281), GTGAgtgagt (SEQ ID NO.: 4282), GTGCgtgagt (SEQ ID NO.: 4283), GTGGgcaagt (SEQ ID NO.: 4284), GTGGggagga (SEQ ID NO.: 4285), GTGGgtaaga (SEQ ID NO.: 4286), GTGGgtaagc (SEQ ID NO.: 4287), GTGGgtaagg (SEQ ID NO.: 4288), GTGGgtaagt (SEQ ID NO.: 4289), GTGGgtacga (SEQ ID NO.: 4290), GTGGgtacgg (SEQ ID NO.: 4291), GTGGgtacgt (SEQ ID NO.: 4292), GTGGgtaggc (SEQ ID NO.: 4293), GTGGgtaggt (SEQ ID NO.: 4294), GTGGgtatgg (SEQ ID NO.: 4295), GTGGgtatgt (SEQ ID NO.: 4296), GTGGgtcagt (SEQ ID NO.: 4297), GTGGgtctgt (SEQ ID NO.: 4298), GTGGgtgaga (SEQ ID NO.: 4299), GTGGgtgagc (SEQ ID NO.: 4300), GTGGgtgagg (SEQ ID NO.: 4301), GTGGgtgagt (SEQ ID NO.: 4302), GTGGgtgcga (SEQ ID NO.: 4303), GTGGgtgggt (SEQ ID NO.: 4304), GTGGgtgtgt (SEQ ID NO.: 4305), GTGGtttcaa (SEQ ID NO.: 4306), GTGTctccca (SEQ ID NO.: 4307), GTGTgtaaga (SEQ ID NO.: 4308), GTGTgtaagg (SEQ ID NO.: 4309), GTGTgtaagt (SEQ ID NO. : 4310), GTGTgtgagt (SEQ ID NO. : 4311), GTGTgtgtgt (SEQ ID NO.: 4312), GTTAgtaagt (SEQ ID NO.: 4313), GTTAgtatgt (SEQ ID NO.: 4314), GTTAtggtga (SEQ ID NO.: 4315), GTTAttgtat (SEQ ID NO.: 4316), GTTCagatgt (SEQ ID NO.: 4317), GTTCatgagg (SEQ ID NO.: 4318), GTTCgtaagt (SEQ ID NO.: 4319), GTTCttccag (SEQ ID NO.: 4320), GTTGgcaagt (SEQ ID NO.: 4321), GTTGgtaaaa (SEQ ID NO.: 4322), GTTGgtaaag (SEQ ID NO.: 4323), GTTGgtaaat (SEQ ID NO.: 4324), GTTGgtaaga (SEQ ID NO : 4325), GTTGgtaagc (SEQ ID NO.: 4326), GTTGgtaagt (SEQ ID NO.: 4327), GTTGgtaatc (SEQ ID NO.: 4328), GTTGgtaatg (SEQ ID NO.: 4329), GTTGgtaatt (SEQ ID NO.: 4330), GTTGgtacag (SEQ ID NO.: 4331), GTTGgtacgg (SEQ ID NO.: 4332), GTTGgtacgt (SEQ ID NO.: 4333), GTTGgtaggt (SEQ ID NO.: 4334), GTTGgtatga (SEQ ID NO.: 4335), GTTGgtatgg (SEQ ID NO.: 4336), GTTGgtatgt (SEQ ID NO.: 4337), GTTGgtcagt (SEQ ID NO.: 4338), GTTGgtgaga (SEQ ID NO.: 4339), GTTGgtgagc (SEQ ID NO.: 4340), GTTGgtgagt (SEQ ID NO.: 4341), GTTGgtgcgc (SEQ ID NO.: 4342), GTTGgtgcgg (SEQ ID NO.: 4343), GTTGgtgcgt (SEQ ID NO.: 4344), GTTGgtgtgg (SEQ ID NO.: 4345), GTTGgttagt (SEQ ID NO.: 4346), GTTTgtaagc (SEQ ID NO.: 4347), GTTTgtaagt (SEQ ID NO.: 4348), GTTTgtgagt (SEQ ID NO.: 4349), GTTTtggtga (SEQ ID NO.: 4350), TAAAaggtaa (SEQ ID NO.: 4351), TAAAaggtac (SEQ ID NO.: 4352), TAAAagtaag (SEQ ID NO.: 4353), TAAAggtttg (SEQ ID NO.: 4354), TAAAgtaaaa (SEQ ID NO.: 4355), TAAAgtaaat (SEQ ID NO.: 4356), TAAAgtaaga (SEQ ID NO.: 4357), TAAAgtaagc (SEQ ID NO.: 4358), TAAAgtaagg (SEQ ID NO.: 4359), TAAAgtaagt (SEQ ID NO.: 4360), TAAAgtaatt (SEQ ID NO.: 4361), TAAAgtacgt (SEQ ID NO.: 4362), TAAAgtagag (SEQ ID NO.: 4363), TAAAgtaggt (SEQ ID NO.: 4364), TAAAgtatat (SEQ ID NO.: 4365), TAAAgtatcc (SEQ ID NO.: 4366), TAAAgtatga (SEQ ID NO.: 4367), TAAAgtatgg (SEQ ID NO.: 4368), TAAAgtatgt (SEQ ID NO.: 4369), TAAAgtgagt (SEQ ID NO.: 4370), TAAAgtgggt (SEQ ID NO.: 4371), TAAAgtggtg (SEQ ID NO.: 4372), TAAAgtgtgt (SEQ ID NO.: 4373), TAAAgttagt (SEQ ID NO.: 4374), TAAAgtgtt (SEQ ID NO 4375), TAAAttgtga (SEQ ID NO.: 4376), TAACctaagg (SEQ ID NO.: 4377), TAACgtaagc (SEQ ID NO.: 4378), TAACgtaagt (SEQ ID NO.: 4379), TAACgtatgt (SEQ ID NO.: 4380), TAACgtgagc (SEQ ID NO.: 4381), TAACgtgagt (SEQ ID NO.: 4382), TAACgtgcgt (SEQ ID NO.: 4383), TAACgtgtga (SEQ ID NO.: 4384), TAAGaagatt (SEQ ID NO.: 4385), TAAGataagt (SEQ ID NO.: 4386), TAAGgcaagg (SEQ ID NO.: 4387), TAAGgcaagt (SEQ ID NO.: 4388), TAAGgcaata (SEQ ID NO.: 4389), TAAGgcagag (SEQ ID NO.: 4390), TAAGgcgagt (SEQ ID NO.: 4391), TAAGggatat (SEQ ID NO.: 4392), TAAGgtaaaa (SEQ ID NO.: 4393), TAAGgtaaac (SEQ ID NO.: 4394), TAAGgtaaag (SEQ ID NO.: 4395), TAAGgtaaat (SEQ ID
NO.: 4396), TAAGgtaaca (SEQ ID NO.: 4397), TAAGgtaacc (SEQ ID NO.: 4398), TAAGgtaacg (SEQ ID NO.: 4399), TAAGgtaact (SEQ ID NO.: 4400), TAAGgtaaga (SEQ ID NO.: 4401), TAAGgtaagc (SEQ ID NO.: 4402), TAAGgtaagg (SEQ ID NO.: 4403), TAAGgtaagt (SEQ ID NO.: 4404), TAAGgtaata (SEQ ID NO.: 4405), TAAGgtaatc (SEQ ID NO.: 4406), TAAGgtaatg (SEQ ID NO.: 4407), TAAGgtaatt (SEQ ID NO.: 4408), TAAGgtacaa (SEQ ID NO.: 4409), TAAGgtacac (SEQ ID NO.: 4410), TAAGgtacag (SEQ ID NO.: 4411), TAAGgtacat (SEQ ID NO.: 4412), TAAGgtacca (SEQ ID NO.: 4413), TAAGgtaccc (SEQ ID NO.: 4414), TAAGgtaccg (SEQ ID NO.: 4415), TAAGgtacct (SEQ ID NO.: 4416), TAAGgtacgg (SEQ ID NO.: 4417), TAAGgtacgt (SEQ ID NO.: 4418), TAAGgtacta (SEQ ID NO.: 4419), TAAGgtactc (SEQ ID NO.: 4420), TAAGgtactg (SEQ ID NO.: 4421), TAAGgtactt (SEQ ID NO.: 4422), TAAGgtagaa (SEQ ID NO.: 4423), TAAGgtagag (SEQ ID NO.: 4424), TAAGgtagat (SEQ ID NO.: 4425), TAAGgtagca (SEQ ID NO.: 4426), TAAGgtagcc (SEQ ID NO.: 4427), TAAGgtagct (SEQ ID NO.: 4428), TAAGgtagga (SEQ ID NO.: 4429), TAAGgtaggc (SEQ ID NO.: 4430), TAAGgtaggg (SEQ ID NO.: 4431), TAAGgtaggt (SEQ ID NO.: 4432), TAAGgtagta (SEQ ID NO.: 4433), TAAGgtagtg (SEQ ID NO.: 4434), TAAGgtagtt (SEQ ID NO.: 4435), TAAGgtataa (SEQ ID NO.: 4436), TAAGgtatac (SEQ ID NO.: 4437), TAAGgtatag (SEQ ID NO.: 4438), TAAGgtatat (SEQ ID NO.: 4439), TAAGgtatca (SEQ ID NO.: 4440), TAAGgtatcc (SEQ ID NO.: 4441), TAAGgtatct (SEQ ID NO.: 4442), TAAGgtatga (SEQ ID NO.: 4443), TAAGgtatgc (SEQ ID NO.: 4444), TAAGgtatgg (SEQ ID NO.: 4445), TAAGgtatgt (SEQ ID NO.: 4446), TAAGgtatta (SEQ ID NO.: 4447), TAAGgtattc (SEQ ID NO.: 4448), TAAGgtattg (SEQ ID NO.: 4449), TAAGgtattt (SEQ ID NO.: 4450), TAAGgtcaat (SEQ ID NO.: 4451), TAAGgtcaga (SEQ ID NO.: 4452), TAAGgtcagc (SEQ ID NO.: 4453), TAAGgtcagt (SEQ ID NO.: 4454), TAAGgtcata (SEQ ID NO.: 4455), TAAGgtcatt (SEQ ID NO.: 4456), TAAGgtccta (SEQ ID NO.: 4457), TAAGgtcggc (SEQ ID NO.: 4458), TAAGgtcggt (SEQ ID NO.: 4459), TAAGgtctca (SEQ ID NO.: 4460), TAAGgtctcg (SEQ ID NO.: 4461), TAAGgtctgt (SEQ ID NO.: 4462), TAAGgtctta (SEQ ID NO.: 4463), TAAGgtgaaa (SEQ ID NO.: 4464), TAAGgtgaag (SEQ ID NO.: 4465), TAAGgtgaat (SEQ ID NO.: 4466), TAAGgtgacc (SEQ ID NO.: 4467), TAAGgtgact (SEQ ID NO.: 4468), TAAGgtgaga (SEQ ID NO.: 4469), TAAGgtgagc (SEQ ID NO.: 4470), TAAGgtgagg (SEQ ID NO.: 4471), TAAGgtgagt (SEQ ID NO.: 4472), TAAGgtgata (SEQ ID NO.: 4473), TAAGgtgatc (SEQ ID NO.: 4474), TAAGgtgatt (SEQ ID NO.: 4475), TAAGgtgcac (SEQ ID NO.: 4476), TAAGgtgcca (SEQ ID NO.: 4477), TAAGgtgcct (SEQ ID NO.: 4478), TAAGgtgcgc (SEQ ID NO.: 4479), TAAGgtgcgt (SEQ ID NO.: 4480), TAAGgtgctg (SEQ ID NO.: 4481), TAAGgtgctt (SEQ ID NO.: 4482), TAAGgtggat (SEQ ID NO.: 4483), TAAGgtggga (SEQ ID NO.: 4484), TAAGgtgggc (SEQ ID NO.: 4485), TAAGgtgggt (SEQ ID NO.: 4486), TAAGgtgtga (SEQ ID NO.: 4487), TAAGgtgtgg (SEQ ID NO.: 4488), TAAGgtgtgt (SEQ ID NO.: 4489), TAAGgtgttc (SEQ ID NO.: 4490), TAAGgttaaa (SEQ ID NO 4491), TAAGgttaga (SEQ ID NO.: 4492), TAAGgttagc (SEQ ID NO.: 4493), TAAGgttagg (SEQ ID NO.: 4494), TAAGgttagt (SEQ ID NO.: 4495), TAAGgttata (SEQ ID NO.: 4496), TAAGgttatt (SEQ ID NO.: 4497), TAAGgttcta (SEQ ID NO.: 4498), TAAGgttctc (SEQ ID NO.: 4499), TAAGgttgaa (SEQ ID NO.: 4500), TAAGgttgct (SEQ ID NO.: 4501), TAAGgttggt (SEQ ID NO.: 4502), TAAGgttgtg (SEQ ID NO.: 4503), TAAGgtttcc (SEQ ID NO.: 4504), TAAGgtttcg (SEQ ID NO.: 4505), TAAGgtttct (SEQ ID NO.: 4506), TAAGgtttga (SEQ ID NO.: 4507), TAAGgtttgt (SEQ ID NO.: 4508), TAAGgttttt (SEQ ID NO.: 4509), TAAGtaactc (SEQ ID NO.: 4510), TAATgcaagt (SEQ ID NO.: 4511), TAATgtaaat (SEQ ID NO.: 4512), TAATgtaaga (SEQ ID NO.: 4513), TAATgtaagc
(SEQ ID NO.: 4514), TAATgtaagt (SEQ ID NO.: 4515), TAATgtacgg (SEQ ID NO.: 4516), TAATgtaggt (SEQ ID NO.: 4517), TAATgtatga (SEQ ID NO.: 4518), TAATgtgaga (SEQ ID NO.: 4519), TAATgtgagc (SEQ ID NO.: 4520), TAATgtgagt (SEQ ID NO.: 4521), TAATgtgggt (SEQ ID NO.: 4522), TAATgtgtgc (SEQ ID NO.: 4523), TACAgctctg (SEQ ID NO.: 4524), TACAggtaag (SEQ ID NO.: 4525), TACAggtgag (SEQ ID NO.: 4526), TACAggttgc (SEQ ID NO.: 4527), TACAgtaaga (SEQ ID NO.: 4528), TACAgtaagg (SEQ ID NO.: 4529), TACAgtaagt (SEQ ID NO.: 4530), TACAgtacgt (SEQ ID NO.: 4531), TACAgtagga (SEQ ID NO.: 4532), TACAgtaggc (SEQ ID NO.: 4533), TACAgtaggt (SEQ ID NO.: 4534), TACAgtatcc (SEQ ID NO.: 4535), TACAgtatgt (SEQ ID NO.: 4536), TACAgtgaat (SEQ ID NO.: 4537), TACAgtgaga (SEQ ID NO.: 4538), TACAgtgagt (SEQ ID NO.: 4539), TACAgttaag (SEQ ID NO.: 4540), TACAgttagt (SEQ ID NO.: 4541), TACAtatctc (SEQ ID NO.: 4542), TACAttgaac (SEQ ID NO.: 4543), TACCaaaggg (SEQ ID NO.: 4544), TACCgggaag (SEQ ID NO.: 4545), TACCgtaagt (SEQ ID NO.: 4546), TACCgtatgg (SEQ ID NO.: 4547), TACCgtgaga (SEQ ID NO.: 4548), TACCgtgagg (SEQ ID NO.: 4549), TACCgtgagt (SEQ ID NO.: 4550), TACGgtaaaa (SEQ ID NO.: 4551), TACGgtaaag (SEQ ID NO.: 4552), TACGgtaaat (SEQ ID NO.: 4553), TACGgtaaga (SEQ ID NO.: 4554), TACGgtaagc (SEQ ID NO.: 4555), TACGgtaagg (SEQ ID NO.: 4556), TACGgtaagt (SEQ ID NO.: 4557), TACGgtaata (SEQ ID NO.: 4558), TACGgtaatt (SEQ ID NO.: 4559), TACGgtacgt (SEQ ID NO.: 4560), TACGgtactc (SEQ ID NO.: 4561), TACGgtactt (SEQ ID NO.: 4562), TACGgtagga (SEQ ID NO.: 4563), TACGgtaggc (SEQ ID NO.: 4564), TACGgtaggt (SEQ ID NO.: 4565), TACGgtatgt (SEQ ID NO.: 4566), TACGgtattg (SEQ ID NO.: 4567), TACGgtattt (SEQ ID NO.: 4568), TACGgtcagt (SEQ ID NO.: 4569), TACGgtgaag (SEQ ID NO.: 4570), TACGgtgagt (SEQ ID NO.: 4571), TACGgtgggt (SEQ ID NO.: 4572), TACGgtgtgt (SEQ ID NO.: 4573), TACTccaagc (SEQ ID NO.: 4574), TACTgtaaga (SEQ ID NO.: 4575), TACTgtaagc (SEQ ID NO.: 4576), TACTgtaagg (SEQ ID NO.: 4577), TACTgtaagt (SEQ ID NO.: 4578), TACTgtacgt (SEQ ID NO.: 4579), TACTgtactt (SEQ ID NO.: 4580), TACTgtaggt (SEQ ID NO.: 4581), TACTgtatcc (SEQ ID NO.: 4582), TACTgtatgt (SEQ ID NO.: 4583), TACTgtgagt (SEQ ID NO.: 4584), TACTgtggta (SEQ ID NO.: 4585), TAGAaaggta (SEQ ID NO.: 4586), TAGActgatc (SEQ ID NO.: 4587), TAGAggtaag (SEQ ID NO.: 4588), TAGAgtaagc (SEQ ID NO.: 4589), TAGAgtaagt (SEQ ID NO.: 4590), TAGAgtaggt (SEQ ID NO.: 4591), TAGAgtatgt (SEQ ID NO.: 4592), TAGAgtatta (SEQ ID NO.: 4593), TAGAgtgagc (SEQ ID NO.: 4594), TAGAgtgagt (SEQ ID NO.: 4595), TAGAgttgta (SEQ ID NO.: 4596), TAGCgtaagt (SEQ ID NO.: 4597), TAGCtctgct (SEQ ID NO.: 4598), TAGGaaagtg (SEQ ID NO.: 4599), TAGGgtaaaa (SEQ ID NO.: 4600), TAGGgtaaat (SEQ ID NO.: 4601), TAGGgtaaga (SEQ ID NO.: 4602), TAGGgtaagc (SEQ ID NO.: 4603), TAGGgtaagt (SEQ ID NO.: 4604), TAGGgtaatg (SEQ ID NO.: 4605), TAGGgtaatt (SEQ ID NO.: 4606), TAGGgtagga (SEQ ID NO.: 4607), TAGGgtaggg (SEQ ID NO.: 4608), TAGGgtaggt (SEQ ID NO 4609), TAGGgtatgt (SEQ ID NO.: 4610), TAGGgtgaga (SEQ ID NO.: 4611), TAGGgtgagc (SEQ ID NO.: 4612), TAGGgtgagt (SEQ ID NO.: 4613), TAGGgttcgt (SEQ ID NO.: 4614), TAGGgttggt (SEQ ID NO.: 4615), TAGTgtaagc (SEQ ID NO.: 4616), TAGTgtaagg (SEQ ID NO.: 4617), TAGTgtaagt (SEQ ID NO.: 4618), TAGTgtacgt (SEQ ID NO.: 4619), TAGTgtaggt (SEQ ID NO.: 4620), TAGTgtatga (SEQ ID NO.: 4621), TAGTgtatgt (SEQ ID NO.: 4622), TAGTgtgagt (SEQ ID NO.: 4623), TATAaaggta (SEQ ID NO.: 4624), TATAagttaa (SEQ ID NO.: 4625), TATAgcaggt (SEQ ID NO.: 4626), TATAgtaaga (SEQ ID NO.: 4627), TATAgtaagc (SEQ ID NO.: 4628), TATAgtaagg (SEQ ID NO.: 4629), TATAgtaagt (SEQ ID NO.: 4630), TATAgtaggt (SEQ ID NO.: 4631), TATAtaaggt (SEQ ID NO.: 4632),
TATAtattct (SEQ ID NO.: 4633), TATCactgtt (SEQ ID NO.: 4634), TATCagtgag (SEQ ID NO.: 4635), TATCgcgtga (SEQ ID NO.: 4636), TATCgtaaga (SEQ ID NO.: 4637), TATCgtaagt (SEQ ID NO.: 4638), TATCgtaggt (SEQ ID NO.: 4639), TATCgtgaga (SEQ ID NO.: 4640), TATCgtgagt (SEQ ID NO.: 4641), TATGgcaagt (SEQ ID NO.: 4642), TATGgccagt (SEQ ID NO.: 4643), TATGgtaaaa (SEQ ID NO.: 4644), TATGgtaaag (SEQ ID NO.: 4645), TATGgtaaat (SEQ ID NO.: 4646), TATGgtaacc (SEQ ID NO.: 4647), TATGgtaacg (SEQ ID NO.: 4648), TATGgtaact (SEQ ID NO.: 4649), TATGgtaaga (SEQ ID NO.: 4650), TATGgtaagc (SEQ ID NO.: 4651), TATGgtaagg (SEQ ID NO.: 4652), TATGgtaagt (SEQ ID NO.: 4653), TATGgtaata (SEQ ID NO.: 4654), TATGgtaatc (SEQ ID NO.: 4655), TATGgtaatg (SEQ ID NO.: 4656), TATGgtaatt (SEQ ID NO.: 4657), TATGgtacac (SEQ ID NO.: 4658), TATGgtacga (SEQ ID NO.: 4659), TATGgtacgc (SEQ ID NO.: 4660), TATGgtacgt (SEQ ID NO.: 4661), TATGgtactt (SEQ ID NO.: 4662), TATGgtagat (SEQ ID NO.: 4663), TATGgtagcc (SEQ ID NO.: 4664), TATGgtagga (SEQ ID NO.: 4665), TATGgtaggc (SEQ ID NO.: 4666), TATGgtaggt (SEQ ID NO.: 4667), TATGgtatag (SEQ ID NO.: 4668), TATGgtatct (SEQ ID NO.: 4669), TATGgtatga (SEQ ID NO.: 4670), TATGgtatgg (SEQ ID NO.: 4671), TATGgtatgt (SEQ ID NO.: 4672), TATGgtatta (SEQ ID NO.: 4673), TATGgtattg (SEQ ID NO.: 4674), TATGgtcaga (SEQ ID NO.: 4675), TATGgtcagc (SEQ ID NO.: 4676), TATGgtcagt (SEQ ID NO.: 4677), TATGgtgaag (SEQ ID NO.: 4678), TATGgtgaat (SEQ ID NO.: 4679), TATGgtgaga (SEQ ID NO.: 4680), TATGgtgagc (SEQ ID NO.: 4681), TATGgtgagg (SEQ ID NO.: 4682), TATGgtgagt (SEQ ID NO.: 4683), TATGgtgggt (SEQ ID NO.: 4684), TATGgtggtg (SEQ ID NO.: 4685), TATGgtgtga (SEQ ID NO.: 4686), TATGgttagt (SEQ ID NO.: 4687), TATGgttgtt (SEQ ID NO.: 4688), TATTatatcc (SEQ ID NO.: 4689), TATTgtaagc (SEQ ID NO.: 4690), TATTgtaagt (SEQ ID NO.: 4691), TATTgtaata (SEQ ID NO.: 4692), TATTgtatcc (SEQ ID NO.: 4693), TATTgtatgg (SEQ ID NO.: 4694), TATTgtatgt (SEQ ID NO.: 4695), TATTgtatta (SEQ ID NO.: 4696), TATTgtgagc (SEQ ID NO.: 4697), TATTgtgagt (SEQ ID NO.: 4698), TATTtggatt (SEQ ID NO.: 4699), TCAAagaaga (SEQ ID NO.: 4700), TCAAaggtaa (SEQ ID NO.: 4701), TCAAatatcc (SEQ ID NO.: 4702), TCAAgcaggt (SEQ ID NO.: 4703), TCAAggaaaa (SEQ ID NO.: 4704), TCAAgtaaaa (SEQ ID NO.: 4705), TCAAgtaaac (SEQ ID NO.: 4706), TCAAgtaaat (SEQ ID NO.: 4707), TCAAgtaaga (SEQ ID NO.: 4708), TCAAgtaagc (SEQ ID NO.: 4709), TCAAgtaagg (SEQ ID NO.: 4710), TCAAgtaagt (SEQ ID NO.: 4711), TCAAgtaata (SEQ ID NO.: 4712), TCAAgtaatc (SEQ ID NO.: 4713), TCAAgtaatt (SEQ ID NO.: 4714), TCAAgtacat (SEQ ID NO.: 4715), TCAAgtacgc (SEQ ID NO.: 4716), TCAAgtacgt (SEQ ID NO.: 4717), TCAAgtacta (SEQ ID NO.: 4718), TCAAgtagaa (SEQ ID NO.: 4719), TCAAgtaggc (SEQ ID NO.: 4720), TCAAgtaggt (SEQ ID NO.: 4721), TCAAgtatga (SEQ ID NO.: 4722), TCAAgtatgc (SEQ ID NO.: 4723), TCAAgtatgg (SEQ ID NO.: 4724), TCAAgtatgt (SEQ ID NO.: 4725), TCAAgtcagt (SEQ ID NO.: 4726), TCAAgtgact (SEQ ID NO.: 4727), TCAAgtgaga (SEQ ID NO.: 4728), TCAAgtgagc (SEQ ID NO.: 4729), TCAAgtgagg (SEQ ID NO 4730), TCAAgtgagt (SEQ ID NO.: 4731), TCAAgtgatt (SEQ ID NO.: 4732), TCAAgtgggt (SEQ ID NO.: 4733), TCAAgtgtgt (SEQ ID NO.: 4734), TCAAgttagt (SEQ ID NO.: 4735), TCAAgttggt (SEQ ID NO.: 4736), TCACgcaggt (SEQ ID NO.: 4737), TCACgtaaga (SEQ ID NO.: 4738), TCACgtaagc (SEQ ID NO.: 4739), TCACgtaagt (SEQ ID NO.: 4740), TCACgtacgg (SEQ ID NO.: 4741), TCACgtatgt (SEQ ID NO.: 4742), TCACgtgagc (SEQ ID NO.: 4743), TCACgtgagt (SEQ ID NO.: 4744), TCACgtgcgt (SEQ ID NO.: 4745), TCACtagagt (SEQ ID NO.: 4746), TCACtcagag (SEQ ID NO.: 4747), TCAGaggaaa (SEQ ID NO.: 4748), TCAGataagt (SEQ ID NO.: 4749), TCAGatatcc (SEQ ID NO.: 4750), TCAGgcaaat (SEQ ID NO.: 4751),
TCAGgcaaga (SEQ ID NO.: 4752), TCAGgcaagg (SEQ ID NO.: 4753), TCAGgcaagt (SEQ ID NO.: 4754), TCAGgcaatg (SEQ ID NO.: 4755), TCAGgcaccc (SEQ ID NO.: 4756), TCAGgcagga (SEQ ID NO.: 4757), TCAGgcaggc (SEQ ID NO.: 4758), TCAGgcaggt (SEQ ID NO.: 4759), TCAGgcatat (SEQ ID NO.: 4760), TCAGgcatgt (SEQ ID NO.: 4761), TCAGgccagt (SEQ ID NO.: 4762), TCAGgcgagt (SEQ ID NO.: 4763), TCAGgcttgt (SEQ ID NO.: 4764), TCAGgtaaaa (SEQ ID NO.: 4765), TCAGgtaaac (SEQ ID NO.: 4766), TCAGgtaaag (SEQ ID NO.: 4767), TCAGgtaaat (SEQ ID NO.: 4768), TCAGgtaaca (SEQ ID NO.: 4769), TCAGgtaacc (SEQ ID NO.: 4770), TCAGgtaacg (SEQ ID NO.: 4771), TCAGgtaact (SEQ ID NO.: 4772), TCAGgtaaga (SEQ ID NO.: 4773), TCAGgtaagc (SEQ ID NO.: 4774), TCAGgtaagg (SEQ ID NO.: 4775), TCAGgtaagt (SEQ ID NO.: 4776), TCAGgtaata (SEQ ID NO.: 4777), TCAGgtaatc (SEQ ID NO.: 4778), TCAGgtaatg (SEQ ID NO 4779), TCAGgtaatt (SEQ ID NO.: 4780), TCAGgtacaa (SEQ ID NO.: 4781), TCAGgtacac (SEQ ID NO.: 4782), TCAGgtacag (SEQ ID NO.: 4783), TCAGgtacat (SEQ ID NO.: 4784), TCAGgtacca (SEQ ID NO.: 4785), TCAGgtaccc (SEQ ID NO.: 4786), TCAGgtacct (SEQ ID NO.: 4787), TCAGgtacga (SEQ ID NO.: 4788), TCAGgtacgc (SEQ ID NO.: 4789), TCAGgtacgg (SEQ ID NO.: 4790), TCAGgtacgt (SEQ ID NO.: 4791), TCAGgtacta (SEQ ID NO.: 4792), TCAGgtactc (SEQ ID NO.: 4793), TCAGgtactg (SEQ ID NO.: 4794), TCAGgtactt (SEQ ID NO.: 4795), TCAGgtagaa (SEQ ID NO.: 4796), TCAGgtagac (SEQ ID NO.: 4797), TCAGgtagag (SEQ ID NO.: 4798), TCAGgtagat (SEQ ID NO.: 4799), TCAGgtagca (SEQ ID NO.: 4800), TCAGgtagcc (SEQ ID NO.: 4801), TCAGgtagcg (SEQ ID NO.: 4802), TCAGgtagct (SEQ ID NO.: 4803), TCAGgtagga (SEQ ID NO.: 4804), TCAGgtaggc (SEQ ID NO.: 4805), TCAGgtaggg (SEQ ID NO.: 4806), TCAGgtaggt (SEQ ID NO.: 4807), TCAGgtagtc (SEQ ID NO.: 4808), TCAGgtagtg (SEQ ID NO.: 4809), TCAGgtagtt (SEQ ID NO.: 4810), TCAGgtataa (SEQ ID NO.: 4811), TCAGgtatac (SEQ ID NO.: 4812), TCAGgtatag (SEQ ID NO.: 4813), TCAGgtatat (SEQ ID NO.: 4814), TCAGgtatca (SEQ ID NO.: 4815), TCAGgtatcc (SEQ ID NO.: 4816), TCAGgtatct (SEQ ID NO.: 4817), TCAGgtatga (SEQ ID NO.: 4818), TCAGgtatgc (SEQ ID NO.: 4819), TCAGgtatgg (SEQ ID NO.: 4820), TCAGgtatgt (SEQ ID NO.: 4821), TCAGgtatta (SEQ ID NO.: 4822), TCAGgtattc (SEQ ID NO.: 4823), TCAGgtattg (SEQ ID NO.: 4824), TCAGgtattt (SEQ ID NO.: 4825), TCAGgtcaaa (SEQ ID NO.: 4826), TCAGgtcaga (SEQ ID NO.: 4827), TCAGgtcagc (SEQ ID NO.: 4828), TCAGgtcagg (SEQ ID NO.: 4829), TCAGgtcagt (SEQ ID NO.: 4830), TCAGgtccga (SEQ ID NO.: 4831), TCAGgtccgt (SEQ ID NO.: 4832), TCAGgtcctc (SEQ ID NO.: 4833), TCAGgtcctg (SEQ ID NO.: 4834), TCAGgtcggc (SEQ ID NO.: 4835), TCAGgtcggt (SEQ ID NO.: 4836), TCAGgtcgta (SEQ ID NO.: 4837), TCAGgtctcc (SEQ ID NO.: 4838), TCAGgtctgc (SEQ ID NO.: 4839), TCAGgtctgg (SEQ ID NO.: 4840), TCAGgtctgt (SEQ ID NO.: 4841), TCAGgtcttc (SEQ ID NO.: 4842), TCAGgtcttt (SEQ ID NO.: 4843), TCAGgtgaaa (SEQ ID NO.: 4844), TCAGgtgaac (SEQ ID NO.: 4845), TCAGgtgaag (SEQ ID NO.: 4846), TCAGgtgaat (SEQ ID NO.: 4847), TCAGgtgaca (SEQ ID NO.: 4848), TCAGgtgacc (SEQ ID NO.: 4849), TCAGgtgact (SEQ ID NO.: 4850), TCAGgtgaga (SEQ ID NO.: 4851), TCAGgtgagc (SEQ ID NO.: 4852), TCAGgtgagg (SEQ ID NO.: 4853), TCAGgtgagt (SEQ ID NO.: 4854), TCAGgtgata (SEQ ID NO.: 4855), TCAGgtgatc (SEQ ID NO.: 4856), TCAGgtgatg (SEQ ID NO.: 4857), TCAGgtgatt (SEQ ID NO.: 4858), TCAGgtgcaa (SEQ ID NO.: 4859), TCAGgtgcac (SEQ ID NO.: 4860), TCAGgtgcag (SEQ ID NO.: 4861), TCAGgtgcca (SEQ ID NO.: 4862), TCAGgtgccg (SEQ ID NO.: 4863), TCAGgtgcct (SEQ ID NO.: 4864), TCAGgtgcga (SEQ ID NO.: 4865), TCAGgtgcgg (SEQ ID NO.: 4866), TCAGgtgcgt (SEQ ID NO.: 4867), TCAGgtgcta (SEQ ID NO.: 4868), TCAGgtgctg (SEQ ID NO.: 4869), TCAGgtgctt
(SEQ ID NO.: 4870), TCAGgtggat (SEQ ID NO.: 4871), TCAGgtggcg (SEQ ID NO.: 4872), TCAGgtggga (SEQ ID NO.: 4873), TCAGgtgggc (SEQ ID NO.: 4874), TCAGgtgggg (SEQ ID NO.: 4875), TCAGgtgggt (SEQ ID NO.: 4876), TCAGgtggtc (SEQ ID NO.: 4877), TCAGgtggtg (SEQ ID NO.: 4878), TCAGgtgtaa (SEQ ID NO.: 4879), TCAGgtgtca (SEQ ID NO.: 4880), TCAGgtgtcg (SEQ ID NO.: 4881), TCAGgtgtga (SEQ ID NO.: 4882), TCAGgtgtgc (SEQ ID NO.: 4883), TCAGgtgtgg (SEQ ID NO.: 4884), TCAGgtgtgt (SEQ ID NO.: 4885), TCAGgtgttt (SEQ ID NO.: 4886), TCAGgttaaa (SEQ ID NO.: 4887), TCAGgttaat (SEQ ID NO.: 4888), TCAGgttaga (SEQ ID NO.: 4889), TCAGgttagc (SEQ ID NO.: 4890), TCAGgttagg (SEQ ID NO.: 4891), TCAGgttagt (SEQ ID NO.: 4892), TCAGgttcaa (SEQ ID NO.: 4893), TCAGgttcgc (SEQ ID NO.: 4894), TCAGgttcgt (SEQ ID NO.: 4895), TCAGgttgaa (SEQ ID NO.: 4896), TCAGgttgac (SEQ ID NO.: 4897), TCAGgttgat (SEQ ID NO.: 4898), TCAGgttgca (SEQ ID NO.: 4899), TCAGgttgcc (SEQ ID NO.: 4900), TCAGgttgct (SEQ ID NO.: 4901), TCAGgttgga (SEQ ID NO.: 4902), TCAGgttggc (SEQ ID NO.: 4903), TCAGgttggg (SEQ ID NO.: 4904), TCAGgttggt (SEQ ID NO.: 4905), TCAGgttgta (SEQ ID NO.: 4906), TCAGgtttag (SEQ ID NO.: 4907), TCAGgtttcg (SEQ ID NO.: 4908), TCAGgtttct (SEQ ID NO.: 4909), TCAGgtttga (SEQ ID NO.: 4910), TCAGgtttgc (SEQ ID NO.: 4911), TCAGgtttgg (SEQ ID NO.: 4912), TCAGgtttgt (SEQ ID NO.: 4913), TCAGgttttt (SEQ ID NO.: 4914), TCAGtgtgaa (SEQ ID NO.: 4915), TCATattggt (SEQ ID NO : 4916), TCATgcaagt (SEQ ID NO 4917), TCATgcaggt (SEQ ID NO.: 4918), TCATgtaaaa (SEQ ID NO.: 4919), TCATgtaaat (SEQ ID NO.: 4920), TCATgtaaga (SEQ ID NO.: 4921), TCATgtaagg (SEQ ID NO.: 4922), TCATgtaagt (SEQ ID NO.: 4923), TCATgtaata (SEQ ID NO.: 4924), TCATgtaatt (SEQ ID NO.: 4925), TCATgtacat (SEQ ID NO.: 4926), TCATgtacgt (SEQ ID NO.: 4927), TCATgtagga (SEQ ID NO.: 4928), TCATgtaggt (SEQ ID NO.: 4929), TCATgtatgt (SEQ ID NO.: 4930), TCATgtgaga (SEQ ID NO.: 4931), TCATgtgagc (SEQ ID NO.: 4932), TCATgtgagt (SEQ ID NO.: 4933), TCATgtgcgt (SEQ ID NO.: 4934), TCCAgagcat (SEQ ID NO.: 4935), TCCAgcaggt (SEQ ID NO.: 4936), TCCAgtaaga (SEQ ID NO.: 4937), TCCAgtaagc (SEQ ID NO.: 4938), TCCAgtaagg (SEQ ID NO.: 4939), TCCAgtaagt (SEQ ID NO.: 4940), TCCAgtaggt (SEQ ID NO.: 4941), TCCAgtatgt (SEQ ID NO.: 4942), TCCAgtgaga (SEQ ID NO.: 4943), TCCAgtgagg (SEQ ID NO.: 4944), TCCAgtgagt (SEQ ID NO.: 4945), TCCAgtgtga (SEQ ID NO.: 4946), TCCCcagctg (SEQ ID NO.: 4947), TCCCgtaagt (SEQ ID NO.: 4948), TCCCgtatcc (SEQ ID NO.: 4949), TCCCgtgaga (SEQ ID NO.: 4950), TCCCgtgagt (SEQ ID NO.: 4951), TCCCgtgcgt (SEQ ID NO.: 4952), TCCGgtaaac (SEQ ID NO.: 4953), TCCGgtaacc (SEQ ID NO.: 4954), TCCGgtaact (SEQ ID NO.: 4955), TCCGgtaaga (SEQ ID NO.: 4956), TCCGgtaagc (SEQ ID NO.: 4957), TCCGgtaagg (SEQ ID NO.: 4958), TCCGgtaagt (SEQ ID NO.: 4959), TCCGgtaata (SEQ ID NO.: 4960), TCCGgtaatg (SEQ ID NO.: 4961), TCCGgtacga (SEQ ID NO.: 4962), TCCGgtacgc (SEQ ID NO.: 4963), TCCGgtactt (SEQ ID NO.: 4964), TCCGgtaggt (SEQ ID NO.: 4965), TCCGgtatat (SEQ ID NO : 4966), TCCGgtatcc (SEQ ID NO : 4967), TCCGgtatgt (SEQ ID NO.: 4968), TCCGgtgaga (SEQ ID NO.: 4969), TCCGgtgagc (SEQ ID NO.: 4970), TCCGgtgagg (SEQ ID NO.: 4971), TCCGgtgagt (SEQ ID NO.: 4972), TCCGgtgcgt (SEQ ID NO.: 4973), TCCGgtgggc (SEQ ID NO.: 4974), TCCGgtgggt (SEQ ID NO.: 4975), TCCGgtgtgt (SEQ ID NO.: 4976), TCCTacttca (SEQ ID NO.: 4977), TCCTgcagga (SEQ ID NO.: 4978), TCCTgcaggt (SEQ ID NO.: 4979), TCCTggagga (SEQ ID NO.: 4980), TCCTggtgag (SEQ ID NO.: 4981), TCCTgtaaga (SEQ ID NO.: 4982), TCCTgtaagc (SEQ ID NO.: 4983), TCCTgtaagg (SEQ ID NO.: 4984), TCCTgtaagt (SEQ ID NO.: 4985), TCCTgtacgt (SEQ ID NO.: 4986), TCCTgtaggc (SEQ ID NO.: 4987), TCCTgtaggt (SEQ ID NO.: 4988), TCCTgtatga (SEQ ID
NO.: 4989), TCCTgtatgt (SEQ ID NO.: 4990), TCCTgtgaga (SEQ ID NO.: 4991), TCCTgtgagc (SEQ ID NO.: 4992), TCCTgtgagt (SEQ ID NO.: 4993), TCCTgtgtga (SEQ ID NO.: 4994), TCCTgttatc (SEQ ID NO.: 4995), TCCTtgctcg (SEQ ID NO.: 4996), TCCTtggagg (SEQ ID NO.: 4997), TCGActggac (SEQ ID NO.: 4998), TCGAgtaagc (SEQ ID NO.: 4999), TCGAgtaagt (SEQ ID NO.: 5000), TCGAgtaata (SEQ ID NO.: 5001), TCGAgtacgg (SEQ ID NO.: 5002), TCGAgtacgt (SEQ ID NO.: 5003), TCGAgtatgg (SEQ ID NO.: 5004), TCGAgtcagt (SEQ ID NO.: 5005), TCGAgtgagt (SEQ ID NO.: 5006), TCGAgtgtga (SEQ ID NO.: 5007), TCGAgtgtgt (SEQ ID NO.: 5008), TCGAgtttgt (SEQ ID NO.: 5009), TCGCgtatgt (SEQ ID NO.: 5010), TCGCgtgagg (SEQ ID NO.: 5011), TCGCgtgagt (SEQ ID NO.: 5012), TCGGgcaagt (SEQ ID NO.: 5013), TCGGgtaaag (SEQ ID NO.: 5014), TCGGgtaaat (SEQ ID NO.: 5015), TCGGgtaaca (SEQ ID NO 5016), TCGGgtaacg (SEQ ID NO : 5017), TCGGgtaaga (SEQ ID NO.: 5018), TCGGgtaagc (SEQ ID NO.: 5019), TCGGgtaagg (SEQ ID NO.: 5020), TCGGgtaagt (SEQ ID NO.: 5021), TCGGgtaatg (SEQ ID NO.: 5022), TCGGgtaatt (SEQ ID NO.: 5023), TCGGgtaccc (SEQ ID NO.: 5024), TCGGgtacgt (SEQ ID NO.: 5025), TCGGgtagat (SEQ ID NO.: 5026), TCGGgtaggg (SEQ ID NO.: 5027), TCGGgtaggt (SEQ ID NO.: 5028), TCGGgtatgg (SEQ ID NO.: 5029), TCGGgtatgt (SEQ ID NO.: 5030), TCGGgtattt (SEQ ID NO.: 5031), TCGGgtctgt (SEQ ID NO.: 5032), TCGGgtgaat (SEQ ID NO.: 5033), TCGGgtgaga (SEQ ID NO.: 5034), TCGGgtgagc (SEQ ID NO.: 5035), TCGGgtgagg (SEQ ID NO.: 5036), TCGGgtgagt (SEQ ID NO.: 5037), TCGGgtgcga (SEQ ID NO.: 5038), TCGGgtgcgc (SEQ ID NO.: 5039), TCGGgtgtgt (SEQ ID NO.: 5040), TCGGgttagc (SEQ ID NO.: 5041), TCGGgttagt (SEQ ID NO.: 5042), TCGGgttggt (SEQ ID NO.: 5043), TCGTggtatg (SEQ ID NO.: 5044), TCGTgtaagt (SEQ ID NO.: 5045), TCGTgtatga (SEQ ID NO.: 5046), TCGTgtgagt (SEQ ID NO.: 5047), TCGTgtggtg (SEQ ID NO.: 5048), TCTAagttta (SEQ ID NO.: 5049), TCTAgcaagt (SEQ ID NO.: 5050), TCTAgtaaga (SEQ ID NO.: 5051), TCTAgtaagc (SEQ ID NO.: 5052), TCTAgtaagt (SEQ ID NO.: 5053), TCTAgtatcc (SEQ ID NO.: 5054), TCTAgtatgt (SEQ ID NO.: 5055), TCTAgtgagt (SEQ ID NO.: 5056), TCTCaagagg (SEQ ID NO.: 5057), TCTCcagagg (SEQ ID NO.: 5058), TCTCgggaga (SEQ ID NO.: 5059), TCTCgtaagt (SEQ ID NO.: 5060), TCTCgtaggt (SEQ ID NO.: 5061), TCTCgtatga (SEQ ID NO.: 5062), TCTCgtgagt (SEQ ID NO.: 5063), TCTGatatcc (SEQ ID NO.: 5064), TCTGgcaagt (SEQ ID NO.: 5065), TCTGggtaag (SEQ ID NO.: 5066), TCTGgtaaaa (SEQ ID NO.: 5067), TCTGgtaaag (SEQ ID NO.: 5068), TCTGgtaaat (SEQ ID NO.: 5069), TCTGgtaaca (SEQ ID NO.: 5070), TCTGgtaacc (SEQ ID NO.: 5071), TCTGgtaact (SEQ ID NO.: 5072), TCTGgtaaga (SEQ ID NO.: 5073), TCTGgtaagc (SEQ ID NO.: 5074), TCTGgtaagg (SEQ ID NO.: 5075), TCTGgtaagt (SEQ ID NO.: 5076), TCTGgtaata (SEQ ID NO.: 5077), TCTGgtaatg (SEQ ID NO.: 5078), TCTGgtaatt (SEQ ID NO.: 5079), TCTGgtacag (SEQ ID NO.: 5080), TCTGgtacat (SEQ ID NO.: 5081), TCTGgtaccc (SEQ ID NO.: 5082), TCTGgtacga (SEQ ID NO.: 5083), TCTGgtacgt (SEQ ID NO.: 5084), TCTGgtacta (SEQ ID NO.: 5085), TCTGgtactg (SEQ ID NO 5086), TCTGgtagaa (SEQ ID NO.: 5087), TCTGgtagga (SEQ ID NO.: 5088), TCTGgtaggc (SEQ ID NO.: 5089), TCTGgtaggg (SEQ ID NO.: 5090), TCTGgtaggt (SEQ ID NO.: 5091), TCTGgtatag (SEQ ID NO.: 5092), TCTGgtatat (SEQ ID NO.: 5093), TCTGgtatca (SEQ ID NO.: 5094), TCTGgtatga (SEQ ID NO.: 5095), TCTGgtatgc (SEQ ID NO.: 5096), TCTGgtatgg (SEQ ID NO.: 5097), TCTGgtatgt (SEQ ID NO.: 5098), TCTGgtattt (SEQ ID NO.: 5099), TCTGgtcagt (SEQ ID NO.: 5100), TCTGgtctgt (SEQ ID NO.: 5101), TCTGgtgaat (SEQ ID NO.: 5102), TCTGgtgact (SEQ ID NO.: 5103), TCTGgtgaga (SEQ ID NO.: 5104), TCTGgtgagc (SEQ ID NO.: 5105), TCTGgtgagg (SEQ ID NO.: 5106), TCTGgtgagt (SEQ ID NO.: 5107), TCTGgtgcgt (SEQ ID
NO.: 5108), TCTGgtgctc (SEQ ID NO.: 5109), TCTGgtgggt (SEQ ID NO.: 5110), TCTGgtgtgt (SEQ ID NO.: 5111), TCTGgttagt (SEQ ID NO. : 5112), TCTGgttggt (SEQ ID NO.: 5113), TCTGgtttgt (SEQ ID NO. : 5114), TCTTaagaca (SEQ ID NO. : 5115), TCTTgtaaga (SEQ ID NO.: 5116), TCTTgtaagc (SEQ ID NO.: 5117), TCTTgtaagt (SEQ ID NO.: 5118), TCTTgtacgt (SEQ ID NO.: 5119), TCTTgtatgt (SEQ ID NO.: 5120), TCTTgtgagg (SEQ ID NO.: 5121), TCTTgtgagt (SEQ ID NO.: 5122), TCTTgtgggt (SEQ ID NO.: 5123), TCTTtggtaa (SEQ ID NO.: 5124), TCTTtgttga (SEQ ID NO.: 5125), TGAAaaggta (SEQ ID NO.: 5126), TGAAaggtaa (SEQ ID NO.: 5127), TGAAggtagg (SEQ ID NO.: 5128), TGAAgtaaag (SEQ ID NO.: 5129), TGAAgtaaat (SEQ ID NO.: 5130), TGAAgtaact (SEQ ID NO.: 5131), TGAAgtaaga (SEQ ID NO.: 5132), TGAAgtaagc (SEQ ID NO.: 5133), TGAAgtaagg (SEQ ID NO.: 5134), TGAAgtaagt (SEQ ID NO.: 5135), TGAAgtaatc (SEQ ID NO.: 5136), TGAAgtaatt (SEQ ID NO.: 5137), TGAAgtaccc (SEQ ID NO.: 5138), TGAAgtacct (SEQ ID NO.: 5139), TGAAgtacgg (SEQ ID NO.: 5140), TGAAgtagga (SEQ ID NO.: 5141), TGAAgtaggt (SEQ ID NO.: 5142), TGAAgtatgc (SEQ ID NO.: 5143), TGAAgtatgt (SEQ ID NO.: 5144), TGAAgtcagt (SEQ ID NO.: 5145), TGAAgtccgt (SEQ ID NO.: 5146), TGAAgtgagc (SEQ ID NO.: 5147), TGAAgtgagt (SEQ ID NO.: 5148), TGAAgtgctt (SEQ ID NO.: 5149), TGAAgtgggt (SEQ ID NO.: 5150), TGAAgttggt (SEQ ID NO.: 5151), TGAAttaagt (SEQ ID NO.: 5152), TGACcaagcc (SEQ ID NO : 5153), TGACgtaagg (SEQ ID NO : 5154), TGACgtaagt (SEQ ID NO : 5155), TGACgtacgt (SEQ ID NO.: 5156), TGACgtgagc (SEQ ID NO.: 5157), TGACgtgagt (SEQ ID NO.: 5158), TGACgtgcgt (SEQ ID NO.: 5159), TGACttaatt (SEQ ID NO.: 5160), TGAGcaattt (SEQ ID NO.: 5161), TGAGcccctg (SEQ ID NO.: 5162), TGAGgcaaga (SEQ ID NO.: 5163), TGAGgcaagc (SEQ ID NO.: 5164), TGAGgcaagt (SEQ ID NO.: 5165), TGAGgcacgg (SEQ ID NO.: 5166), TGAGgcaggt (SEQ ID NO.: 5167), TGAGgcatgt (SEQ ID NO.: 5168), TGAGggccag (SEQ ID NO.: 5169), TGAGgtaaaa (SEQ ID NO.: 5170), TGAGgtaaac (SEQ ID NO.: 5171), TGAGgtaaag (SEQ ID NO.: 5172), TGAGgtaaat (SEQ ID NO.: 5173), TGAGgtaaca (SEQ ID NO.: 5174), TGAGgtaacc (SEQ ID NO.: 5175), TGAGgtaacg (SEQ ID NO.: 5176), TGAGgtaact (SEQ ID NO.: 5177), TGAGgtaaga (SEQ ID NO.: 5178), TGAGgtaagc (SEQ ID NO.: 5179), TGAGgtaagg (SEQ ID NO.: 5180), TGAGgtaagt (SEQ ID NO.: 5181), TGAGgtaata (SEQ ID NO.: 5182), TGAGgtaatc (SEQ ID NO.: 5183), TGAGgtaatg (SEQ ID NO.: 5184), TGAGgtaatt (SEQ ID NO.: 5185), TGAGgtacaa (SEQ ID NO.: 5186), TGAGgtacac (SEQ ID NO.: 5187), TGAGgtacag (SEQ ID NO.: 5188), TGAGgtacat (SEQ ID NO.: 5189), TGAGgtacca (SEQ ID NO.: 5190), TGAGgtaccg (SEQ ID NO.: 5191), TGAGgtacct (SEQ ID NO.: 5192), TGAGgtacgc (SEQ ID NO.: 5193), TGAGgtacgg (SEQ ID NO.: 5194), TGAGgtacgt (SEQ ID NO.: 5195), TGAGgtacta (SEQ ID NO.: 5196), TGAGgtactc (SEQ ID NO.: 5197), TGAGgtactg (SEQ ID NO.: 5198), TGAGgtactt (SEQ ID NO.: 5199), TGAGgtagag (SEQ ID NO.: 5200), TGAGgtagat (SEQ ID NO.: 5201), TGAGgtagcc (SEQ ID NO.: 5202), TGAGgtagct (SEQ ID NO.: 5203), TGAGgtagga (SEQ ID NO.: 5204), TGAGgtaggc (SEQ ID NO.: 5205), TGAGgtaggg (SEQ ID NO.: 5206), TGAGgtaggt (SEQ ID NO.: 5207), TGAGgtagta (SEQ ID NO.: 5208), TGAGgtagtg (SEQ ID NO.: 5209), TGAGgtagtt (SEQ ID NO.: 5210), TGAGgtataa (SEQ ID NO.: 5211), TGAGgtatac (SEQ ID NO.: 5212), TGAGgtatag (SEQ ID NO.: 5213), TGAGgtatat (SEQ ID NO.: 5214), TGAGgtatca (SEQ ID NO.: 5215), TGAGgtatct (SEQ ID NO.: 5216), TGAGgtatga (SEQ ID NO.: 5217), TGAGgtatgc (SEQ ID NO.: 5218), TGAGgtatgg (SEQ ID NO.: 5219), TGAGgtatgt (SEQ ID NO.: 5220), TGAGgtatta (SEQ ID NO.: 5221), TGAGgtattc (SEQ ID NO.: 5222), TGAGgtattg (SEQ ID NO.: 5223), TGAGgtattt (SEQ ID NO.: 5224), TGAGgtcaga (SEQ ID NO.: 5225), TGAGgtcagc
(SEQ ID NO.: 5226), TGAGgtcagg (SEQ ID NO : 5227), TGAGgtcagt (SEQ ID NO.: 5228), TGAGgtcatt (SEQ ID NO.: 5229), TGAGgtccgt (SEQ ID NO.: 5230), TGAGgtcgag (SEQ ID NO.: 5231), TGAGgtcggg (SEQ ID NO.: 5232), TGAGgtctga (SEQ ID NO.: 5233), TGAGgtctgg (SEQ ID NO.: 5234), TGAGgtctgt (SEQ ID NO.: 5235), TGAGgtcttt (SEQ ID NO.: 5236), TGAGgtgaaa (SEQ ID NO.: 5237), TGAGgtgaac (SEQ ID NO.: 5238), TGAGgtgaag (SEQ ID NO.: 5239), TGAGgtgaat (SEQ ID NO.: 5240), TGAGgtgaca (SEQ ID NO.: 5241), TGAGgtgacg (SEQ ID NO.: 5242), TGAGgtgact (SEQ ID NO.: 5243), TGAGgtgaga (SEQ ID NO.: 5244), TGAGgtgagc (SEQ ID NO.: 5245), TGAGgtgagg (SEQ ID NO.: 5246), TGAGgtgagt (SEQ ID NO.: 5247), TGAGgtgata (SEQ ID NO.: 5248), TGAGgtgatc (SEQ ID NO.: 5249), TGAGgtgatg (SEQ ID NO.: 5250), TGAGgtgatt (SEQ ID NO.: 5251), TGAGgtgcat (SEQ ID NO : 5252), TGAGgtgcga (SEQ ID NO : 5253), TGAGgtgcgc (SEQ ID NO.: 5254), TGAGgtgcgg (SEQ ID NO.: 5255), TGAGgtgcgt (SEQ ID NO.: 5256), TGAGgtgctg (SEQ ID NO.: 5257), TGAGgtggga (SEQ ID NO.: 5258), TGAGgtgggc (SEQ ID NO.: 5259), TGAGgtgggg (SEQ ID NO.: 5260), TGAGgtgggt (SEQ ID NO.: 5261), TGAGgtggta (SEQ ID NO.: 5262), TGAGgtgtca (SEQ ID NO.: 5263), TGAGgtgtct (SEQ ID NO.: 5264), TGAGgtgtga (SEQ ID NO.: 5265), TGAGgtgtgg (SEQ ID NO.: 5266), TGAGgtgtgt (SEQ ID NO.: 5267), TGAGgtgttc (SEQ ID NO.: 5268), TGAGgttacg (SEQ ID NO.: 5269), TGAGgttaga (SEQ ID NO.: 5270), TGAGgttagc (SEQ ID NO.: 5271), TGAGgttagg (SEQ ID NO.: 5272), TGAGgttagt (SEQ ID NO.: 5273), TGAGgttcgg (SEQ ID NO.: 5274), TGAGgttgag (SEQ ID NO.: 5275), TGAGgttgcc (SEQ ID NO.: 5276), TGAGgttgga (SEQ ID NO.: 5277), TGAGgttggg (SEQ ID NO.: 5278), TGAGgttggt (SEQ ID NO.: 5279), TGAGgttgta (SEQ ID NO.: 5280), TGAGgttgtg (SEQ ID NO.: 5281), TGAGgttgtt (SEQ ID NO.: 5282), TGAGgtttaa (SEQ ID NO.: 5283), TGAGgtttat (SEQ ID NO.: 5284), TGAGgtttga (SEQ ID NO.: 5285), TGAGgtttgc (SEQ ID NO.: 5286), TGAGgtttgg (SEQ ID NO.: 5287), TGAGgtttgt (SEQ ID NO.: 5288), TGAGtgaggt (SEQ ID NO.: 5289), TGATatcctt (SEQ ID NO.: 5290), TGATgtaaga (SEQ ID NO.: 5291), TGATgtaagc (SEQ ID NO.: 5292), TGATgtaagg (SEQ ID NO.: 5293), TGATgtaagt (SEQ ID NO.: 5294), TGATgtaatt (SEQ ID NO.: 5295), TGATgtacga (SEQ ID NO.: 5296), TGATgtacgg (SEQ ID NO.: 5297), TGATgtaggt (SEQ ID NO.: 5298), TGATgtatcc (SEQ ID NO.: 5299), TGATgtatgc (SEQ ID NO.: 5300), TGATgtatgg (SEQ ID NO.: 5301), TGATgtatgt (SEQ ID NO.: 5302), TGATgtgaga (SEQ ID NO.: 5303), TGATgtgagc (SEQ ID NO.: 5304), TGATgtgagg (SEQ ID NO.: 5305), TGATgtgagt (SEQ ID NO.: 5306), TGATgttagt (SEQ ID NO.: 5307), TGATtgtgga (SEQ ID NO.: 5308), TGCAgcaggt (SEQ ID NO.: 5309), TGCAggtaag (SEQ ID NO.: 5310), TGCAggtatt (SEQ ID NO.: 5311), TGCAgtaaga (SEQ ID NO.: 5312), TGCAgtaagg (SEQ ID NO.: 5313), TGCAgtaagt (SEQ ID NO.: 5314), TGCAgtacgg (SEQ ID NO.: 5315), TGCAgtaggt (SEQ ID NO.: 5316), TGCAgtatcc (SEQ ID NO.: 5317), TGCAgtatgt (SEQ ID NO.: 5318), TGCAgtcagt (SEQ ID NO.: 5319), TGCAgtgaga (SEQ ID NO.: 5320), TGCAgtgagc (SEQ ID NO.: 5321), TGCAgtgagg (SEQ ID NO.: 5322), TGCAgtgagt (SEQ ID NO.: 5323), TGCAgtggta (SEQ ID NO.: 5324), TGCAgttaag (SEQ ID NO.: 5325), TGCAgttacg (SEQ ID NO.: 5326), TGCAgttcag (SEQ ID NO.: 5327), TGCCgtaagc (SEQ ID NO.: 5328), TGCCgtaagt (SEQ ID NO.: 5329), TGCCgtaggt (SEQ ID NO.: 5330), TGCCgtatcc (SEQ ID NO.: 5331), TGCCgtatgt (SEQ ID NO.: 5332), TGCCgtgaga (SEQ ID NO.: 5333), TGCCgtgagt (SEQ ID NO.: 5334), TGCGgtaaat (SEQ ID NO.: 5335), TGCGgtaaca (SEQ ID NO.: 5336), TGCGgtaaga (SEQ ID NO.: 5337), TGCGgtaagc (SEQ ID NO.: 5338), TGCGgtaagg (SEQ ID NO.: 5339), TGCGgtaagt (SEQ ID NO.: 5340), TGCGgtaatg (SEQ ID NO.: 5341), TGCGgtacag (SEQ ID NO.: 5342), TGCGgtaccg (SEQ ID NO.: 5343),
TGCGgtacgc (SEQ ID NO.: 5344), TGCGgtacgt (SEQ ID NO.: 5345), TGCGgtactc (SEQ ID NO.: 5346), TGCGgtaggg (SEQ ID NO.: 5347), TGCGgtaggt (SEQ ID NO.: 5348), TGCGgtatgg (SEQ ID NO.: 5349), TGCGgtatgt (SEQ ID NO.: 5350), TGCGgtcagt (SEQ ID NO.: 5351), TGCGgtgaga (SEQ ID NO.: 5352), TGCGgtgagc (SEQ ID NO.: 5353), TGCGgtgagg (SEQ ID NO.: 5354), TGCGgtgagt (SEQ ID NO.: 5355), TGCGgtgatg (SEQ ID NO.: 5356), TGCGgtgcgg (SEQ ID NO.: 5357), TGCGgtgcgt (SEQ ID NO.: 5358), TGCGgttggt (SEQ ID NO.: 5359), TGCGtatttt (SEQ ID NO.: 5360), TGCTcaagtc (SEQ ID NO.: 5361), TGCTcttccc (SEQ ID NO.: 5362), TGCTgcaggt (SEQ ID NO.: 5363), TGCTgtaaga (SEQ ID NO.: 5364), TGCTgtaagc (SEQ ID NO.: 5365), TGCTgtaagt (SEQ ID NO.: 5366), TGCTgtacgc (SEQ ID NO.: 5367), TGCTgtaggt (SEQ ID NO.: 5368), TGCTgtatcc (SEQ ID NO.: 5369), TGCTgtatgg (SEQ ID NO.: 5370), TGCTgtatgt (SEQ ID NO.: 5371), TGCTgtcagt (SEQ ID NO.: 5372), TGCTgtgaga (SEQ ID NO.: 5373), TGCTgtgagc (SEQ ID NO.: 5374), TGCTgtgagg (SEQ ID NO.: 5375), TGCTgtgagt (SEQ ID NO.: 5376), TGGAatccac (SEQ ID NO.: 5377), TGGAgtaaga (SEQ ID NO.: 5378), TGGAgtaagc (SEQ ID NO.: 5379), TGGAgtaagg (SEQ ID NO.: 5380), TGGAgtaagt (SEQ ID NO.: 5381), TGGAgtacgt (SEQ ID NO.: 5382), TGGAgtaggg (SEQ ID NO.: 5383), TGGAgtaggt (SEQ ID NO.: 5384), TGGAgtgagc (SEQ ID NO.: 5385), TGGAgtgagg (SEQ ID NO.: 5386), TGGAgtgagt (SEQ ID NO.: 5387), TGGAgtgtgt (SEQ ID NO : 5388), TGGAgttagc (SEQ ID NO : 5389), TGGAtatcct (SEQ ID NO.: 5390), TGGAttttat (SEQ ID NO.: 5391), TGGCgcaggt (SEQ ID NO.: 5392), TGGCgtaaga (SEQ ID NO.: 5393), TGGCgtaagt (SEQ ID NO.: 5394), TGGCgtacgt (SEQ ID NO.: 5395), TGGCgtatcc (SEQ ID NO.: 5396), TGGCgtgagt (SEQ ID NO.: 5397), TGGGaacgag (SEQ ID NO : 5398), TGGGataaag (SEQ ID NO.: 5399), TGGGcaggct (SEQ ID NO.: 5400), TGGGgtaaaa (SEQ ID NO.: 5401), TGGGgtaaat (SEQ ID NO.: 5402), TGGGgtaaga (SEQ ID NO.: 5403), TGGGgtaagc (SEQ ID NO.: 5404), TGGGgtaagg (SEQ ID NO.: 5405), TGGGgtaagt (SEQ ID NO.: 5406), TGGGgtaata (SEQ ID NO.: 5407), TGGGgtaatg (SEQ ID NO.: 5408), TGGGgtaatt (SEQ ID NO.: 5409), TGGGgtacct (SEQ ID NO.: 5410), TGGGgtacgt (SEQ ID NO.: 5411), TGGGgtaggc (SEQ ID NO.: 5412), TGGGgtaggg (SEQ ID NO.: 5413), TGGGgtaggt (SEQ ID NO.: 5414), TGGGgtatca (SEQ ID NO.: 5415), TGGGgtatcc (SEQ ID NO.: 5416), TGGGgtatct (SEQ ID NO.: 5417), TGGGgtatgg (SEQ ID NO.: 5418), TGGGgtatgt (SEQ ID NO.: 5419), TGGGgtattg (SEQ ID NO.: 5420), TGGGgtcagt (SEQ ID NO.: 5421), TGGGgtgact (SEQ ID NO.: 5422), TGGGgtgaga (SEQ ID NO.: 5423), TGGGgtgagc (SEQ ID NO.: 5424), TGGGgtgagg (SEQ ID NO.: 5425), TGGGgtgagt (SEQ ID NO.: 5426), TGGGgtgggt (SEQ ID NO.: 5427), TGGGgtgtaa (SEQ ID NO.: 5428), TGGGgtgtgt (SEQ ID NO.: 5429), TGGGgttagt (SEQ ID NO.: 5430), TGGGgttgtg (SEQ ID NO.: 5431), TGGTgtaaga (SEQ ID NO.: 5432), TGGTgtaagc (SEQ ID NO.: 5433), TGGTgtaagt (SEQ ID NO.: 5434), TGGTgtaata (SEQ ID NO.: 5435), TGGTgtacgt (SEQ ID NO.: 5436), TGGTgtaggt (SEQ ID NO.: 5437), TGGTgtcagt (SEQ ID NO.: 5438), TGGTgtgagc (SEQ ID NO.: 5439), TGGTgtgagt (SEQ ID NO.: 5440), TGGTtatcat (SEQ ID NO.: 5441), TGTAcgatga (SEQ ID NO.: 5442), TGTAgtaagg (SEQ ID NO.: 5443), TGTAgtaagt (SEQ ID NO.: 5444), TGTAgtccca (SEQ ID NO.: 5445), TGTAgtgagt (SEQ ID NO.: 5446), TGTAgttgtg (SEQ ID NO.: 5447), TGTCaaaaag (SEQ ID NO.: 5448), TGTCctccaa (SEQ ID NO.: 5449), TGTCctggct (SEQ ID NO.: 5450), TGTCgtaagt (SEQ ID NO.: 5451), TGTCgtaggt (SEQ ID NO.: 5452), TGTCgtgagt (SEQ ID NO.: 5453), TGTGatgtac (SEQ ID NO.: 5454), TGTGgtaaaa (SEQ ID NO.: 5455), TGTGgtaaag (SEQ ID NO.: 5456), TGTGgtaaat (SEQ ID NO.: 5457), TGTGgtaaca (SEQ ID NO.: 5458), TGTGgtaaga (SEQ ID NO.: 5459), TGTGgtaagc (SEQ ID NO.: 5460),
TGTGgtaagg (SEQ ID NO.: 5461), TGTGgtaagt (SEQ ID NO.: 5462), TGTGgtaata (SEQ ID NO.: 5463), TGTGgtaatg (SEQ ID NO.: 5464), TGTGgtaatt (SEQ ID NO.: 5465), TGTGgtacat (SEQ ID NO.: 5466), TGTGgtacgg (SEQ ID NO.: 5467), TGTGgtacta (SEQ ID NO.: 5468), TGTGgtagag (SEQ ID NO.: 5469), TGTGgtagga (SEQ ID NO.: 5470), TGTGgtaggg (SEQ ID NO.: 5471), TGTGgtaggt (SEQ ID NO.: 5472), TGTGgtatga (SEQ ID NO.: 5473), TGTGgtatgc (SEQ ID NO.: 5474), TGTGgtatgg (SEQ ID NO.: 5475), TGTGgtatgt (SEQ ID NO.: 5476), TGTGgtattt (SEQ ID NO.: 5477), TGTGgtcagt (SEQ ID NO.: 5478), TGTGgtgaga (SEQ ID NO.: 5479), TGTGgtgagc (SEQ ID NO.: 5480), TGTGgtgagg (SEQ ID NO.: 5481), TGTGgtgagt (SEQ ID NO.: 5482), TGTGgtgatt (SEQ ID NO.: 5483), TGTGgtgggt (SEQ ID NO.: 5484), TGTGgtgtga (SEQ ID NO.: 5485), TGTGgtgtgt (SEQ ID NO.: 5486), TGTGgttagt (SEQ ID NO.: 5487), TGTGgtttgt (SEQ ID NO.: 5488), TGTGtggtga (SEQ ID NO.: 5489), TGTTacggta (SEQ ID NO.: 5490), TGTTgtaagt (SEQ ID NO.: 5491), TGTTgtaggt (SEQ ID NO.: 5492), TGTTgtatcc (SEQ ID NO.: 5493), TGTTgtgagt (SEQ ID NO.: 5494), TGTTgttgag (SEQ ID NO.: 5495), TTAAatatcc (SEQ ID NO.: 5496), TTAAggtgag (SEQ ID NO.: 5497), TTAAgtaaaa (SEQ ID NO.: 5498), TTAAgtaaat (SEQ ID NO.: 5499), TTAAgtaaga (SEQ ID NO.: 5500), TTAAgtaagg (SEQ ID NO.: 5501), TTAAgtaagt (SEQ ID NO.: 5502), TTAAgtaatt (SEQ ID NO.: 5503), TTAAgtaggt (SEQ ID NO.: 5504), TTAAgtatgc (SEQ ID NO.: 5505), TTAAgtatgg (SEQ ID NO.: 5506), TTAAgtatgt (SEQ ID NO.: 5507), TTAAgtcagt (SEQ ID NO.: 5508), TTAAgtgagc (SEQ ID NO.: 5509), TTAAgtgagt (SEQ ID NO.: 5510), TTAAgtgggt (SEQ ID NO.: 5511), TTAAgttagt (SEQ ID NO.: 5512), TTACgtaagt (SEQ ID NO.: 5513), TTACgtgagt (SEQ ID NO.: 5514), TTAGgcaagt (SEQ ID NO.: 5515), TTAGgcacgg (SEQ ID NO.: 5516), TTAGgcacgt (SEQ ID NO.: 5517), TTAGgtaaaa (SEQ ID NO.: 5518), TTAGgtaaac (SEQ ID NO.: 5519), TTAGgtaaag (SEQ ID NO.: 5520), TTAGgtaaat (SEQ ID NO.: 5521), TTAGgtaaca (SEQ ID NO.: 5522), TTAGgtaacc (SEQ ID NO.: 5523), TTAGgtaacg (SEQ ID NO.: 5524), TTAGgtaact (SEQ ID NO.: 5525), TTAGgtaaga (SEQ ID NO.: 5526), TTAGgtaagc (SEQ ID NO.: 5527), TTAGgtaagg (SEQ ID NO.: 5528), TTAGgtaagt (SEQ ID NO.: 5529), TTAGgtaata (SEQ ID NO.: 5530), TTAGgtaatg (SEQ ID NO.: 5531), TTAGgtaatt (SEQ ID NO.: 5532), TTAGgtacat (SEQ ID NO.: 5533), TTAGgtacct (SEQ ID NO.: 5534), TTAGgtacgt (SEQ ID NO.: 5535), TTAGgtacta (SEQ ID NO.: 5536), TTAGgtactt (SEQ ID NO.: 5537), TTAGgtagag (SEQ ID NO.: 5538), TTAGgtagat (SEQ ID NO.: 5539), TTAGgtagga (SEQ ID NO.: 5540), TTAGgtaggg (SEQ ID NO.: 5541), TTAGgtaggt (SEQ ID NO.: 5542), TTAGgtataa (SEQ ID NO.: 5543), TTAGgtatag (SEQ ID NO.: 5544), TTAGgtatat (SEQ ID NO.: 5545), TTAGgtatcc (SEQ ID NO.: 5546), TTAGgtatga (SEQ ID NO.: 5547), TTAGgtatgc (SEQ ID NO.: 5548), TTAGgtatgg (SEQ ID NO.: 5549), TTAGgtatgt (SEQ ID NO.: 5550), TTAGgtatta (SEQ ID NO.: 5551), TTAGgtattc (SEQ ID NO.: 5552), TTAGgtattg (SEQ ID NO.: 5553), TTAGgtattt (SEQ ID NO.: 5554), TTAGgtcagg (SEQ ID NO.: 5555), TTAGgtcagt (SEQ ID NO.: 5556), TTAGgtctct (SEQ ID NO : 5557), TTAGgtcttc (SEQ ID NO.: 5558), TTAGgtgaag (SEQ ID NO.: 5559), TTAGgtgaat (SEQ ID NO.: 5560), TTAGgtgaga (SEQ ID NO.: 5561), TTAGgtgagc (SEQ ID NO.: 5562), TTAGgtgagg (SEQ ID NO.: 5563), TTAGgtgagt (SEQ ID NO.: 5564), TTAGgtgatc (SEQ ID NO.: 5565), TTAGgtgcct (SEQ ID NO.: 5566), TTAGgtgcgt (SEQ ID NO.: 5567), TTAGgtgggg (SEQ ID NO.: 5568), TTAGgtgggt (SEQ ID NO.: 5569), TTAGgtgtgt (SEQ ID NO.: 5570), TTAGgttaga (SEQ ID NO.: 5571), TTAGgttgaa (SEQ ID NO.: 5572), TTAGgttggt (SEQ ID NO.: 5573), TTAGgttgtg (SEQ ID NO.: 5574), TTAGgtttgt (SEQ ID NO.: 5575), TTATatatca (SEQ ID NO.: 5576), TTATgcaagt (SEQ ID NO.: 5577), TTATgtaaga (SEQ ID NO.: 5578), TTATgtaagc (SEQ ID NO.: 5579), TTATgtaagg (SEQ ID
NO.: 5580), TTATgtaagt (SEQ ID NO.: 5581), TTATgtaata (SEQ ID NO.: 5582), TTATgtacgt (SEQ ID NO.: 5583), TTATgtatgt (SEQ ID NO.: 5584), TTATgtgagt (SEQ ID NO.: 5585), TTCAatatcc (SEQ ID NO.: 5586), TTCAggtaag (SEQ ID NO.: 5587), TTCAggtatg (SEQ ID NO.: 5588), TTCAgtaaga (SEQ ID NO.: 5589), TTCAgtaagt (SEQ ID NO.: 5590), TTCAgtacgt (SEQ ID NO.: 5591), TTCAgtaggt (SEQ ID NO.: 5592), TTCAgtatcc (SEQ ID NO.: 5593), TTCAgtctgt (SEQ ID NO.: 5594), TTCAgtgagc (SEQ ID NO.: 5595), TTCAgtgagt (SEQ ID NO.: 5596), TTCAgtgggt (SEQ ID NO.: 5597), TTCAgttaag (SEQ ID NO.: 5598), TTCAgttagt (SEQ ID NO.: 5599), TTCCatatcc (SEQ ID NO.: 5600), TTCCgtaagt (SEQ ID NO.: 5601), TTCCgtatcc (SEQ ID NO.: 5602), TTCCgtgagt (SEQ ID NO.: 5603), TTCGgcaagt (SEQ ID NO.: 5604), TTCGgtaaaa (SEQ ID NO.: 5605), TTCGgtaaga (SEQ ID NO.: 5606), TTCGgtaagg (SEQ ID NO.: 5607), TTCGgtaagt (SEQ ID NO.: 5608), TTCGgtaatc (SEQ ID NO.: 5609), TTCGgtaatg (SEQ ID NO.: 5610), TTCGgtacag (SEQ ID NO.: 5611), TTCGgtagga (SEQ ID NO.: 5612), TTCGgtaggt (SEQ ID NO.: 5613), TTCGgtatgt (SEQ ID NO.: 5614), TTCGgtattt (SEQ ID NO.: 5615), TTCGgtctgt (SEQ ID NO.: 5616), TTCGgtgaga (SEQ ID NO.: 5617), TTCGgtgagc (SEQ ID NO.: 5618), TTCGgtgagg (SEQ ID NO.: 5619), TTCGgtgagt (SEQ ID NO.: 5620), TTCGgtgggc (SEQ ID NO.: 5621), TTCGgtgggt (SEQ ID NO.: 5622), TTCGgttagt (SEQ ID NO.: 5623), TTCTgtaaga (SEQ ID NO.: 5624), TTCTgtaagc (SEQ ID NO.: 5625), TTCTgtaagg (SEQ ID NO.: 5626), TTCTgtaagt (SEQ ID NO.: 5627), TTCTgtacct (SEQ ID NO.: 5628), TTCTgtacgt (SEQ ID NO.: 5629), TTCTgtactg (SEQ ID NO.: 5630), TTCTgtaggt (SEQ ID NO.: 5631), TTCTgtatcc (SEQ ID NO.: 5632), TTCTgtatgt (SEQ ID NO.: 5633), TTCTgtgaga (SEQ ID NO.: 5634), TTCTgtgagc (SEQ ID NO.: 5635), TTCTgtgagt (SEQ ID NO.: 5636), TTCTgtgcgt (SEQ ID NO.: 5637), TTCTgttcag (SEQ ID NO.: 5638), TTCTtccctt (SEQ ID NO.: 5639), TTGAatatcc (SEQ ID NO.: 5640), TTGAggtaag (SEQ ID NO.: 5641), TTGAggtagg (SEQ ID NO.: 5642), TTGAgtaagc (SEQ ID NO.: 5643), TTGAgtaagg (SEQ ID NO.: 5644), TTGAgtaagt (SEQ ID NO.: 5645), TTGAgtatgt (SEQ ID NO.: 5646), TTGAgtgaga (SEQ ID NO.: 5647), TTGAgtgagc (SEQ ID NO.: 5648), TTGAgtgagt (SEQ ID NO.: 5649), TTGAgtgggt (SEQ ID NO.: 5650), TTGAtggtaa (SEQ ID NO.: 5651), TTGCgtaagg (SEQ ID NO.: 5652), TTGCgtaagt (SEQ ID NO.: 5653), TTGCgtacgt (SEQ ID NO.: 5654), TTGCgtatgt (SEQ ID NO.: 5655), TTGCgtgagt (SEQ ID NO.: 5656), TTGCgtgggt (SEQ ID NO.: 5657), TTGCtgagac (SEQ ID NO.: 5658), TTGGatatcc (SEQ ID NO.: 5659), TTGGgcaagt (SEQ ID NO.: 5660), TTGGgcgagt (SEQ ID NO.: 5661), TTGGggaagg (SEQ ID NO.: 5662), TTGGgtaaaa (SEQ ID NO.: 5663), TTGGgtaaag (SEQ ID NO.: 5664), TTGGgtaaat (SEQ ID NO.: 5665), TTGGgtaact (SEQ ID NO.: 5666), TTGGgtaaga (SEQ ID NO.: 5667), TTGGgtaagc (SEQ ID NO.: 5668), TTGGgtaagg (SEQ ID NO.: 5669), TTGGgtaagt (SEQ ID NO.: 5670), TTGGgtaata (SEQ ID NO.: 5671), TTGGgtaatg (SEQ ID NO.: 5672), TTGGgtaatt (SEQ ID NO.: 5673), TTGGgtacgt (SEQ ID NO.: 5674), TTGGgtacta (SEQ ID NO.: 5675), TTGGgtactg (SEQ ID NO.: 5676), TTGGgtagga (SEQ ID NO.: 5677), TTGGgtaggc (SEQ ID NO 5678), TTGGgtaggg (SEQ ID NO.: 5679), TTGGgtaggt (SEQ ID NO.: 5680), TTGGgtatga (SEQ ID NO.: 5681), TTGGgtatgg (SEQ ID NO.: 5682), TTGGgtatgt (SEQ ID NO.: 5683), TTGGgtattc (SEQ ID NO.: 5684), TTGGgtctgt (SEQ ID NO.: 5685), TTGGgtgaat (SEQ ID NO.: 5686), TTGGgtgact (SEQ ID NO.: 5687), TTGGgtgaga (SEQ ID NO.: 5688), TTGGgtgagc (SEQ ID NO.: 5689), TTGGgtgagg (SEQ ID NO.: 5690), TTGGgtgagt (SEQ ID NO.: 5691), TTGGgtgatt (SEQ ID NO.: 5692), TTGGgtgggt (SEQ ID NO.: 5693), TTGGgttggt (SEQ ID NO.: 5694), TTGGgtttgg (SEQ ID NO.: 5695), TTGTgtaaga (SEQ ID NO.: 5696), TTGTgtaagc (SEQ ID NO.: 5697), TTGTgtaagt (SEQ ID NO.: 5698), TTGTgtacgt (SEQ ID NO.: 5699), TTGTgtaggt
[00515] RNA sequences corresponding to the 5' splice sites in Table 9 are provided as follows (5775 entries) in Table 10:
[00516] Table 10
AAAAguaaaa (SEQ ID NO.: 5801), AAAAguaaac (SEQ ID NO.: 5802), AAAAguaaag (SEQ ID NO.: 5803), AAAAguaaau (SEQ ID NO.: 5804), AAAAguaacg (SEQ ID NO.: 5805), AAAAguaacu (SEQ ID NO.: 5806), AAAAguaaga (SEQ ID NO.: 5807), AAAAguaagc (SEQ ID NO.: 5808), AAAAguaagg (SEQ ID NO.: 5809), AAAAguaagu (SEQ ID NO.: 5810), AAAAguaaua (SEQ ID NO.: 5811), AAAAguaauc (SEQ ID NO.: 5812), AAAAguaauu (SEQ ID NO.: 5813), AAAAguacac (SEQ ID NO.: 5814), AAAAguacau (SEQ ID NO.: 5815), AAAAguacga (SEQ ID NO.: 5816), AAAAguacgu (SEQ ID NO.: 5817), AAAAguacuu (SEQ ID NO.: 5818), AAAAguaggu (SEQ ID NO.: 5819), AAAAguauac (SEQ ID NO.: 5820), AAAAguauga (SEQ ID NO.: 5821), AAAAguaugc (SEQ ID NO.: 5822), AAAAguaugu (SEQ ID NO.: 5823), AAAAguauua (SEQ ID NO.: 5824), AAAAgucagu (SEQ ID NO.: 5825), AAAAgugaga (SEQ ID NO.: 5826), AAAAgugagc (SEQ ID NO.: 5827), AAAAgugagg (SEQ ID NO.: 5828), AAAAgugagu (SEQ ID NO.: 5829), AAAAgugauu (SEQ ID NO.: 5830), AAAAgugggu (SEQ ID NO.: 5831), AAAAguggug (SEQ ID NO.: 5832), AAAAguguaa (SEQ ID NO.: 5833), AAAAgugugu (SEQ ID NO.: 5834), AAAAguuagu (SEQ ID NO.: 5835), AAAAguuggu (SEQ ID NO.: 5836), AAAAugaaga (SEQ ID NO.: 5837), AAAAuggaac (SEQ ID NO.: 5838), AAACgaacug (SEQ ID NO.: 5839), AAACgcaggu (SEQ ID NO.: 5840), AAACgcagua (SEQ ID NO.: 5841), AAACgccagc (SEQ ID NO.: 5842), AAACguaaau (SEQ ID NO.: 5843), AAACguaaca (SEQ ID NO : 5844), AAACguaaga (SEQ ID NO.: 5845), AAACguaagc (SEQ ID NO.: 5846), AAACguaagg (SEQ ID NO.: 5847), AAACguaagu (SEQ ID NO.: 5848), AAACguacgu (SEQ ID NO.: 5849), AAACguaucc (SEQ ID NO.: 5850), AAACguaugu (SEQ ID NO.: 5851), AAACgugagc (SEQ ID NO.: 5852), AAACgugagu (SEQ ID NO.: 5853), AAACgugggu (SEQ ID NO.: 5854), AAACguggua (SEQ ID NO.: 5855), AAACugguag (SEQ ID NO.: 5856), AAAGgcaaaa (SEQ ID NO.: 5857), AAAGgcaaag (SEQ ID NO.: 5858), AAAGgcaaga (SEQ ID NO.: 5859), AAAGgcaagc (SEQ ID NO.: 5860), AAAGgcaagg (SEQ ID NO.: 5861), AAAGgcaagu (SEQ ID NO.: 5862), AAAGgcaauu (SEQ ID NO.: 5863), AAAGgcagau (SEQ ID NO.: 5864), AAAGgcagga (SEQ ID NO.: 5865), AAAGgcaggu (SEQ ID NO.: 5866), AAAGgcaugc (SEQ ID NO.: 5867), AAAGgccagu (SEQ ID NO.: 5868), AAAGgcgagu (SEQ ID NO.: 5869), AAAGggaagu (SEQ ID NO.: 5870), AAAGggagcu (SEQ ID NO.: 5871), AAAGguaaaa (SEQ ID NO.: 5872), AAAGguaaac (SEQ ID NO.: 5873), AAAGguaaag (SEQ ID NO.: 5874), AAAGguaaau (SEQ ID NO.: 5875), AAAGguaaca (SEQ ID NO.: 5876), AAAGguaacc (SEQ ID NO.: 5877), AAAGguaacg (SEQ ID NO.: 5878), AAAGguaacu (SEQ ID NO.: 5879), AAAGguaaga (SEQ ID NO.: 5880), AAAGguaagc (SEQ ID NO.: 5881), AAAGguaagg (SEQ ID NO.: 5882), AAAGguaagu (SEQ ID NO.: 5883), AAAGguaaua (SEQ ID NO.: 5884), AAAGguaauc (SEQ ID NO.: 5885), AAAGguaaug (SEQ ID NO.: 5886), AAAGguaauu (SEQ ID NO.: 5887), AAAGguacaa (SEQ ID NO.: 5888), AAAGguacac (SEQ ID NO.: 5889), AAAGguacag (SEQ ID NO.: 5890), AAAGguacau (SEQ ID NO.: 5891), AAAGguacca (SEQ ID NO.: 5892), AAAGguaccc (SEQ ID NO.: 5893), AAAGguaccg (SEQ ID NO.: 5894), AAAGguaccu (SEQ ID NO.: 5895), AAAGguacga (SEQ ID NO.: 5896), AAAGguacgc (SEQ ID NO.: 5897), AAAGguacgg (SEQ ID NO.: 5898), AAAGguacgu (SEQ ID NO.: 5899), AAAGguacua (SEQ ID NO.: 5900), AAAGguacuc (SEQ ID NO.: 5901), AAAGguacug (SEQ ID NO.: 5902), AAAGguacuu (SEQ ID NO.: 5903), AAAGguagaa (SEQ ID NO.: 5904), AAAGguagac (SEQ ID NO.: 5905), AAAGguagag (SEQ ID NO.: 5906), AAAGguagau (SEQ ID NO.: 5907), AAAGguagca (SEQ ID NO.: 5908), AAAGguagcc (SEQ ID NO.: 5909), AAAGguagcg (SEQ ID NO.: 5910), AAAGguagcu (SEQ ID NO.: 5911), AAAGguagga (SEQ ID NO.: 5912), AAAGguaggc (SEQ
ID NO.: 5913), AAAGguaggg (SEQ ID NO.: 5914), AAAGguaggu (SEQ ID NO.: 5915), AAAGguagua (SEQ ID NO.: 5916), AAAGguagug (SEQ ID NO.: 5917), AAAGguaguu (SEQ ID NO.: 5918), AAAGguauaa (SEQ ID NO.: 5919), AAAGguauac (SEQ ID NO.: 5920), AAAGguauag (SEQ ID NO.: 5921), AAAGguauau (SEQ ID NO.: 5922), AAAGguauca (SEQ ID NO.: 5923), AAAGguaucc (SEQ ID NO.: 5924), AAAGguaucu (SEQ ID NO.: 5925), AAAGguauga (SEQ ID NO.: 5926), AAAGguaugc (SEQ ID NO.: 5927), AAAGguaugg (SEQ ID NO.: 5928), AAAGguaugu (SEQ ID NO.: 5929), AAAGguauua (SEQ ID NO.: 5930), AAAGguauuc (SEQ ID NO.: 5931), AAAGguauug (SEQ ID NO.: 5932), AAAGguauuu (SEQ ID NO.: 5933), AAAGgucaac (SEQ ID NO.: 5934), AAAGgucaag (SEQ ID NO.: 5935), AAAGgucaca (SEQ ID NO.: 5936), AAAGgucacc (SEQ ID NO.: 5937), AAAGgucaga (SEQ ID NO.: 5938), AAAGgucagc (SEQ ID NO.: 5939), AAAGgucagg (SEQ ID NO.: 5940), AAAGgucagu (SEQ ID NO.: 5941), AAAGgucauu (SEQ ID NO.: 5942), AAAGguccac (SEQ ID NO.: 5943), AAAGguccag (SEQ ID NO.: 5944), AAAGguccug (SEQ ID NO.: 5945), AAAGguccuu (SEQ ID NO.: 5946), AAAGgucggu (SEQ ID NO.: 5947), AAAGgucuaa (SEQ ID NO.: 5948), AAAGgucucu (SEQ ID NO.: 5949), AAAGgucuga (SEQ ID NO.: 5950), AAAGgucugg (SEQ ID NO.: 5951), AAAGgucugu (SEQ ID NO.: 5952), AAAGgucuuc (SEQ ID NO.: 5953), AAAGgucuuu (SEQ ID NO.: 5954), AAAGgugaaa (SEQ ID NO.: 5955), AAAGgugaac (SEQ ID NO.: 5956), AAAGgugaag (SEQ ID NO 5957), AAAGgugaau (SEQ ID NO.: 5958), AAAGgugacc (SEQ ID NO.: 5959), AAAGgugacu (SEQ ID NO.: 5960), AAAGgugaga (SEQ ID NO.: 5961), AAAGgugagc (SEQ ID NO.: 5962), AAAGgugagg (SEQ ID NO.: 5963), AAAGgugagu (SEQ ID NO.: 5964), AAAGgugaua (SEQ ID NO.: 5965), AAAGgugauc (SEQ ID NO.: 5966), AAAGgugaug (SEQ ID NO.: 5967), AAAGgugauu (SEQ ID NO.: 5968), AAAGgugcaa (SEQ ID NO.: 5969), AAAGgugcac (SEQ ID NO.: 5970), AAAGgugcag (SEQ ID NO.: 5971), AAAGgugcca (SEQ ID NO.: 5972), AAAGgugccg (SEQ ID NO.: 5973), AAAGgugccu (SEQ ID NO.: 5974), AAAGgugcgu (SEQ ID NO.: 5975), AAAGgugcua (SEQ ID NO.: 5976), AAAGgugcug (SEQ ID NO.: 5977), AAAGguggag (SEQ ID NO.: 5978), AAAGguggau (SEQ ID NO.: 5979), AAAGguggcg (SEQ ID NO.: 5980), AAAGguggga (SEQ ID NO.: 5981), AAAGgugggc (SEQ ID NO.: 5982), AAAGgugggg (SEQ ID NO.: 5983), AAAGgugggu (SEQ ID NO.: 5984), AAAGguggua (SEQ ID NO.: 5985), AAAGguggug (SEQ ID NO.: 5986), AAAGguguau (SEQ ID NO.: 5987), AAAGguguga (SEQ ID NO.: 5988), AAAGgugugc (SEQ ID NO.: 5989), AAAGgugugg (SEQ ID NO.: 5990), AAAGgugugu (SEQ ID NO.: 5991), AAAGguguua (SEQ ID NO.: 5992), AAAGguguug (SEQ ID NO.: 5993), AAAGguuaaa (SEQ ID NO.: 5994), AAAGguuaag (SEQ ID NO.: 5995), AAAGguuaga (SEQ ID NO.: 5996), AAAGguuagc (SEQ ID NO.: 5997), AAAGguuagg (SEQ ID NO.: 5998), AAAGguuagu (SEQ ID NO.: 5999), AAAGguuaug (SEQ ID NO.: 6000), AAAGguucag (SEQ ID NO.: 6001), AAAGguucau (SEQ ID NO.: 6002), AAAGguucca (SEQ ID NO.: 6003), AAAGguucga (SEQ ID NO.: 6004), AAAGguucgu (SEQ ID NO.: 6005), AAAGguucua (SEQ ID NO.: 6006), AAAGguucuu (SEQ ID NO.: 6007), AAAGguugag (SEQ ID NO.: 6008), AAAGguugau (SEQ ID NO.: 6009), AAAGguugca (SEQ ID NO.: 6010), AAAGguugcc (SEQ ID NO.: 6011), AAAGguugcu (SEQ ID NO.: 6012), AAAGguugga (SEQ ID NO.: 6013), AAAGguuggc (SEQ ID NO.: 6014), AAAGguuggg (SEQ ID NO.: 6015), AAAGguuggu (SEQ ID NO.: 6016), AAAGguuguc (SEQ ID NO.: 6017), AAAGguugug (SEQ ID NO.: 6018), AAAGguuguu (SEQ ID NO.: 6019), AAAGguuuac (SEQ ID NO.: 6020), AAAGguuuca (SEQ ID NO.: 6021), AAAGguuuga (SEQ ID NO.: 6022), AAAGguuugc (SEQ ID NO.: 6023), AAAGguuugg (SEQ ID NO.: 6024), AAAGguuugu (SEQ ID NO.: 6025),
AAAGguuuua (SEQ ID NO.: 6026), AAAGguuuuc (SEQ ID NO.: 6027), AAAGguuuug (SEQ ID NO.: 6028), AAAGguuuuu (SEQ ID NO.: 6029), AAAUcugauu (SEQ ID NO.: 6030), AAAUgcaagu (SEQ ID NO. : 6031), AAAUgcacgc (SEQ ID NO. : 6032), AAAUgcaggu (SEQ ID NO.: 6033), AAAUguaaau (SEQ ID NO.: 6034), AAAUguaaca (SEQ ID NO.: 6035), AAAUguaacg (SEQ ID NO.: 6036), AAAUguaaga (SEQ ID NO.: 6037), AAAUguaagc (SEQ ID NO.: 6038), AAAUguaagg (SEQ ID NO.: 6039), AAAUguaagu (SEQ ID NO.: 6040), AAAUguaaua (SEQ ID NO.: 6041), AAAUguaauc (SEQ ID NO.: 6042), AAAUguaaug (SEQ ID NO.: 6043), AAAUguaauu (SEQ ID NO.: 6044), AAAUguacag (SEQ ID NO.: 6045), AAAUguacau (SEQ ID NO.: 6046), AAAUguacca (SEQ ID NO.: 6047), AAAUguacgg (SEQ ID NO.: 6048), AAAUguacgu (SEQ ID NO.: 6049), AAAUguaggu (SEQ ID NO.: 6050), AAAUguagua (SEQ ID NO.: 6051), AAAUguauau (SEQ ID NO.: 6052), AAAUguaugu (SEQ ID NO.: 6053), AAAUguauug (SEQ ID NO.: 6054), AAAUgucagc (SEQ ID NO.: 6055), AAAUgucagg (SEQ ID NO.: 6056), AAAUgucagu (SEQ ID NO.: 6057), AAAUgugaga (SEQ ID NO.: 6058), AAAUgugagc (SEQ ID NO.: 6059), AAAUgugagg (SEQ ID NO.: 6060), AAAUgugagu (SEQ ID NO.: 6061), AAAUgugcgc (SEQ ID NO.: 6062), AAAUgugcgu (SEQ ID NO.: 6063), AAAUgugggc (SEQ ID NO.: 6064), AAAUgugggu (SEQ ID NO.: 6065), AAAUguggua (SEQ ID NO.: 6066), AAAUgugguu (SEQ ID NO.: 6067), AAAUguguaa (SEQ ID NO.: 6068), AAAUgugugu (SEQ ID NO.: 6069), AAAUguuggc (SEQ ID NO 6070), AAAUuuaagu (SEQ ID NO.: 6071), AACAgcaagu (SEQ ID NO.: 6072), AACAgguaaa (SEQ ID NO.: 6073), AACAgguaga (SEQ ID NO.: 6074), AACAgguaua (SEQ ID NO.: 6075), AACAgguuua (SEQ ID NO.: 6076), AACAguaaau (SEQ ID NO.: 6077), AACAguaaga (SEQ ID NO.: 6078), AACAguaagc (SEQ ID NO.: 6079), AACAguaagg (SEQ ID NO.: 6080), AACAguaagu (SEQ ID NO.: 6081), AACAguacga (SEQ ID NO.: 6082), AACAguacgu (SEQ ID NO.: 6083), AACAguaggu (SEQ ID NO.: 6084), AACAguaucc (SEQ ID NO.: 6085), AACAguauga (SEQ ID NO.: 6086), AACAguaugu (SEQ ID NO.: 6087), AACAgugaga (SEQ ID NO.: 6088), AACAgugagc (SEQ ID NO.: 6089), AACAgugagu (SEQ ID NO.: 6090), AACAguggug (SEQ ID NO.: 6091), AACCguaagu (SEQ ID NO.: 6092), AACCguaugu (SEQ ID NO.: 6093), AACCgugagc (SEQ ID NO.: 6094), AACCgugagu (SEQ ID NO.: 6095), AACGgcaagu (SEQ ID NO.: 6096), AACGguaaaa (SEQ ID NO.: 6097), AACGguaaau (SEQ ID NO.: 6098), AACGguaacc (SEQ ID NO.: 6099), AACGguaacu (SEQ ID NO.: 6100), AACGguaaga (SEQ ID NO.: 6101), AACGguaagc (SEQ ID NO.: 6102), AACGguaagg (SEQ ID NO.: 6103), AACGguaagu (SEQ ID NO.: 6104), AACGguaauc (SEQ ID NO.: 6105), AACGguaaug (SEQ ID NO.: 6106), AACGguaauu (SEQ ID NO.: 6107), AACGguaccc (SEQ ID NO.: 6108), AACGguacga (SEQ ID NO.: 6109), AACGguacgu (SEQ ID NO.: 6110), AACGguagga (SEQ ID NO.: 6111), AACGguaggu (SEQ ID NO.: 6112), AACGguauag (SEQ ID NO.: 6113), AACGguauau (SEQ ID NO.: 6114), AACGguaucu (SEQ ID NO.: 6115), AACGguaugc (SEQ ID NO : 6116), AACGguaugg (SEQ ID NO 6117), AACGguaugu (SEQ ID NO.: 6118), AACGgucagc (SEQ ID NO.: 6119), AACGgucagu (SEQ ID NO.: 6120), AACGgugaag (SEQ ID NO.: 6121), AACGgugaga (SEQ ID NO.: 6122), AACGgugagc (SEQ ID NO.: 6123), AACGgugagg (SEQ ID NO.: 6124), AACGgugagu (SEQ ID NO.: 6125), AACGgugccu (SEQ ID NO.: 6126), AACGgugcgg (SEQ ID NO.: 6127), AACGguggaa (SEQ ID NO.: 6128), AACGgugggg (SEQ ID NO.: 6129), AACGgugggu (SEQ ID NO.: 6130), AACGguguaa (SEQ ID NO.: 6131), AACGguuagu (SEQ ID NO.: 6132), AACUguaaau (SEQ ID NO.: 6133), AACUguaaga (SEQ ID NO.: 6134), AACUguaagc (SEQ ID NO.: 6135), AACUguaagg (SEQ ID NO.: 6136), AACUguaagu (SEQ ID NO.: 6137), AACUguacgu (SEQ
ID NO.: 6138), AACUguaggu (SEQ ID NO.: 6139), AACUguaucc (SEQ ID NO.: 6140), AACUguaugu (SEQ ID NO.: 6141), AACUgucagg (SEQ ID NO.: 6142), AACUgugaga (SEQ ID NO.: 6143), AACUgugagc (SEQ ID NO.: 6144), AACUgugagg (SEQ ID NO.: 6145), AACUgugagu (SEQ ID NO.: 6146), AACUguggug (SEQ ID NO.: 6147), AACUguguga (SEQ ID NO.: 6148), AACUuugugg (SEQ ID NO.: 6149), AAGAaaggua (SEQ ID NO.: 6150), AAGAcccugg (SEQ ID NO.: 6151), AAGAguaaga (SEQ ID NO.: 6152), AAGAguaagc (SEQ ID NO.: 6153), AAGAguaagg (SEQ ID NO.: 6154), AAGAguaagu (SEQ ID NO.: 6155), AAGAguacgu (SEQ ID NO.: 6156), AAGAguaggu (SEQ ID NO.: 6157), AAGAguagua (SEQ ID NO.: 6158), AAGAguaucc (SEQ ID NO.: 6159), AAGAguaugu (SEQ ID NO.: 6160), AAGAgugagc (SEQ ID NO.: 6161), AAGAgugagg (SEQ ID NO.: 6162), AAGAgugagu (SEQ ID NO.: 6163), AAGAgugcgu (SEQ ID NO.: 6164), AAGAgugggu (SEQ ID NO 6165), AAGAguggua (SEQ ID NO.: 6166), AAGAguggug (SEQ ID NO.: 6167), AAGAguuaag (SEQ ID NO.: 6168), AAGAugcuca (SEQ ID NO.: 6169), AAGCgcagca (SEQ ID NO.: 6170), AAGCguaagc (SEQ ID NO.: 6171), AAGCguaagg (SEQ ID NO.: 6172), AAGCguaagu (SEQ ID NO.: 6173), AAGCgugagu (SEQ ID NO.: 6174), AAGCguuagu (SEQ ID NO.: 6175), AAGGaagcgg (SEQ ID NO.: 6176), AAGGagagaa (SEQ ID NO.: 6177), AAGGgcaagu (SEQ ID NO.: 6178), AAGGgcuggu (SEQ ID NO.: 6179), AAGGguaaaa (SEQ ID NO.: 6180), AAGGguaaac (SEQ ID NO.: 6181), AAGGguaaag (SEQ ID NO.: 6182), AAGGguaaau (SEQ ID NO.: 6183), AAGGguaaca (SEQ ID NO.: 6184), AAGGguaacc (SEQ ID NO.: 6185), AAGGguaacu (SEQ ID NO.: 6186), AAGGguaaga (SEQ ID NO.: 6187), AAGGguaagc (SEQ ID NO.: 6188), AAGGguaagg (SEQ ID NO.: 6189), AAGGguaagu (SEQ ID NO.: 6190), AAGGguaaua (SEQ ID NO.: 6191), AAGGguaauc (SEQ ID NO.: 6192), AAGGguaaug (SEQ ID NO.: 6193), AAGGguaauu (SEQ ID NO.: 6194), AAGGguacag (SEQ ID NO.: 6195), AAGGguaccu (SEQ ID NO.: 6196), AAGGguacgu (SEQ ID NO.: 6197), AAGGguagca (SEQ ID NO.: 6198), AAGGguagga (SEQ ID NO.: 6199), AAGGguaggc (SEQ ID NO.: 6200), AAGGguaggg (SEQ ID NO.: 6201), AAGGguaggu (SEQ ID NO.: 6202), AAGGguagua (SEQ ID NO.: 6203), AAGGguaguu (SEQ ID NO.: 6204), AAGGguauag (SEQ ID NO.: 6205), AAGGguauau (SEQ ID NO.: 6206), AAGGguaucu (SEQ ID NO.: 6207), AAGGguauga (SEQ ID NO.: 6208), AAGGguaugc (SEQ ID NO.: 6209), AAGGguaugu (SEQ ID NO.: 6210), AAGGguauug (SEQ ID NO.: 6211), AAGGguauuu (SEQ ID NO.: 6212), AAGGgucaga (SEQ ID NO.: 6213), AAGGgucagu (SEQ ID NO.: 6214), AAGGgugaga (SEQ ID NO.: 6215), AAGGgugagc (SEQ ID NO.: 6216), AAGGgugagg (SEQ ID NO.: 6217), AAGGgugagu (SEQ ID NO.: 6218), AAGGgugaug (SEQ ID NO.: 6219), AAGGgugcgu (SEQ ID NO.: 6220), AAGGgugggu (SEQ ID NO.: 6221), AAGGguggug (SEQ ID NO.: 6222), AAGGgugugu (SEQ ID NO.: 6223), AAGGguuaag (SEQ ID NO.: 6224), AAGGguuagu (SEQ ID NO.: 6225), AAGUgcuggu (SEQ ID NO.: 6226), AAGUguaaga (SEQ ID NO.: 6227), AAGUguaagc (SEQ ID NO.: 6228), AAGUguaagg (SEQ ID NO.: 6229), AAGUguaagu (SEQ ID NO.: 6230), AAGUguacgu (SEQ ID NO.: 6231), AAGUguaucc (SEQ ID NO.: 6232), AAGUguauga (SEQ ID NO.: 6233), AAGUguaugc (SEQ ID NO.: 6234), AAGUguaugg (SEQ ID NO.: 6235), AAGUguaugu (SEQ ID NO.: 6236), AAGUgugagc (SEQ ID NO.: 6237), AAGUgugagg (SEQ ID NO.: 6238), AAGUgugagu (SEQ ID NO.: 6239), AAGUguguaa (SEQ ID NO.: 6240), AAGUguuagu (SEQ ID NO.: 6241), AAGUugcugg (SEQ ID NO.: 6242), AAUAgguaau (SEQ ID NO.: 6243), AAUAgguagu (SEQ ID NO.: 6244), AAUAguaaau (SEQ ID NO.: 6245), AAUAguaaga (SEQ ID NO.: 6246), AAUAguaagc (SEQ ID NO.: 6247), AAUAguaagu (SEQ ID NO.: 6248), AAUAguagga (SEQ ID NO.: 6249), AAUAguaggu (SEQ ID NO.: 6250),
AAUAguagug (SEQ ID NO.: 6251), AAUAguaucc (SEQ ID NO.: 6252), AAUAguauga (SEQ ID NO.: 6253), AAUAguaugg (SEQ ID NO.: 6254), AAUAguaugu (SEQ ID NO.: 6255), AAUAgugagu (SEQ ID NO.: 6256), AAUAguuaag (SEQ ID NO.: 6257), AAUAuaaggu (SEQ ID NO.: 6258), AAUAugccag (SEQ ID NO.: 6259), AAUCauguau (SEQ ID NO.: 6260), AAUCcaacau (SEQ ID NO.: 6261), AAUCcuggua (SEQ ID NO.: 6262), AAUCgcagug (SEQ ID NO.: 6263), AAUCguaaga (SEQ ID NO.: 6264), AAUCguaagc (SEQ ID NO.: 6265), AAUCguaagu (SEQ ID NO.: 6266), AAUCguaugu (SEQ ID NO.: 6267), AAUCgugagu (SEQ ID NO.: 6268), AAUCugacug (SEQ ID NO.: 6269), AAUCuggaag (SEQ ID NO.: 6270), AAUGcaaaua (SEQ ID NO.: 6271), AAUGgaguga (SEQ ID NO.: 6272), AAUGgcaagu (SEQ ID NO.: 6273), AAUGgcacga (SEQ ID NO.: 6274), AAUGgcaggu (SEQ ID NO.: 6275), AAUGgcgagu (SEQ ID NO.: 6276), AAUGgcguaa (SEQ ID NO 6277), AAUGguaaaa (SEQ ID NO.: 6278), AAUGguaaac (SEQ ID NO.: 6279), AAUGguaaag (SEQ ID NO.: 6280), AAUGguaaau (SEQ ID NO.: 6281), AAUGguaaca (SEQ ID NO.: 6282), AAUGguaacg (SEQ ID NO.: 6283), AAUGguaacu (SEQ ID NO.: 6284), AAUGguaaga (SEQ ID NO.: 6285), AAUGguaagc (SEQ ID NO.: 6286), AAUGguaagg (SEQ ID NO.: 6287), AAUGguaagu (SEQ ID NO.: 6288), AAUGguaaua (SEQ ID NO.: 6289), AAUGguaauc (SEQ ID NO.: 6290), AAUGguaaug (SEQ ID NO.: 6291), AAUGguaauu (SEQ ID NO.: 6292), AAUGguacac (SEQ ID NO.: 6293), AAUGguacau (SEQ ID NO.: 6294), AAUGguacga (SEQ ID NO.: 6295), AAUGguacgc (SEQ ID NO.: 6296), AAUGguacgg (SEQ ID NO.: 6297), AAUGguacgu (SEQ ID NO.: 6298), AAUGguacua (SEQ ID NO.: 6299), AAUGguacuc (SEQ ID NO.: 6300), AAUGguacuu (SEQ ID NO.: 6301), AAUGguagaa (SEQ ID NO.: 6302), AAUGguagau (SEQ ID NO.: 6303), AAUGguagcu (SEQ ID NO.: 6304), AAUGguagga (SEQ ID NO.: 6305), AAUGguaggc (SEQ ID NO.: 6306), AAUGguaggg (SEQ ID NO.: 6307), AAUGguaggu (SEQ ID NO.: 6308), AAUGguagua (SEQ ID NO.: 6309), AAUGguauaa (SEQ ID NO.: 6310), AAUGguauag (SEQ ID NO. : 6311), AAUGguauau (SEQ ID NO.: 6312), AAUGguauca (SEQ ID NO.: 6313), AAUGguaucc (SEQ ID NO.: 6314), AAUGguaucu (SEQ ID NO.: 6315), AAUGguauga (SEQ ID NO.: 6316), AAUGguaugc (SEQ ID NO.: 6317), AAUGguaugg (SEQ ID NO. : 6318), AAUGguaugu (SEQ ID NO. : 6319), AAUGguauuc (SEQ ID NO. : 6320), AAUGguauug (SEQ ID NO.: 6321), AAUGguauuu (SEQ ID NO.: 6322), AAUGgucagu (SEQ ID NO.: 6323), AAUGgucucu (SEQ ID NO.: 6324), AAUGgugaau (SEQ ID NO.: 6325), AAUGgugaga (SEQ ID NO.: 6326), AAUGgugagc (SEQ ID NO.: 6327), AAUGgugagg (SEQ ID NO.: 6328), AAUGgugagu (SEQ ID NO.: 6329), AAUGgugcaa (SEQ ID NO.: 6330), AAUGgugcga (SEQ ID NO.: 6331), AAUGgugcgu (SEQ ID NO.: 6332), AAUGgugggc (SEQ ID NO.: 6333), AAUGgugggu (SEQ ID NO.: 6334), AAUGgugugu (SEQ ID NO.: 6335), AAUGguuagu (SEQ ID NO.: 6336), AAUGguuaug (SEQ ID NO.: 6337), AAUGguuggu (SEQ ID NO.: 6338), AAUGguuuga (SEQ ID NO.: 6339), AAUGguuugg (SEQ ID NO.: 6340), AAUGguuugu (SEQ ID NO.: 6341), AAUUguaaau (SEQ ID NO.: 6342), AAUUguaaga (SEQ ID NO.: 6343), AAUUguaagc (SEQ ID NO.: 6344), AAUUguaagg (SEQ ID NO.: 6345), AAUUguaagu (SEQ ID NO.: 6346), AAUUguacga (SEQ ID NO.: 6347), AAUUguaugu (SEQ ID NO.: 6348), AAUUgugagg (SEQ ID NO.: 6349), AAUUgugagu (SEQ ID NO.: 6350), AAUUguucag (SEQ ID NO.: 6351), AAUUuugcaa (SEQ ID NO.: 6352), ACAAagggau (SEQ ID NO.: 6353), ACAAaguaag (SEQ ID NO.: 6354), ACAAagugag (SEQ ID NO.: 6355), ACAAgaaguc (SEQ ID NO.: 6356), ACAAgcaagu (SEQ ID NO.: 6357), ACAAgguaag (SEQ ID NO.: 6358), ACAAgguaau (SEQ ID NO.: 6359), ACAAguaaac (SEQ ID NO.: 6360), ACAAguaaau (SEQ ID NO.: 6361), ACAAguaaga (SEQ ID NO.: 6362), ACAAguaagc (SEQ ID
NO.: 6363), ACAAguaagg (SEQ ID NO.: 6364), ACAAguaagu (SEQ ID NO.: 6365), ACAAguaaua (SEQ ID NO.: 6366), ACAAguaauc (SEQ ID NO.: 6367), ACAAguaauu (SEQ ID NO.: 6368), ACAAguacau (SEQ ID NO.: 6369), ACAAguacgc (SEQ ID NO.: 6370), ACAAguacgg (SEQ ID NO.: 6371), ACAAguacgu (SEQ ID NO.: 6372), ACAAguaggc (SEQ ID NO.: 6373), ACAAguaggg (SEQ ID NO.: 6374), ACAAguaggu (SEQ ID NO.: 6375), ACAAguaucu (SEQ ID NO.: 6376), ACAAguauga (SEQ ID NO.: 6377), ACAAguaugc (SEQ ID NO.: 6378), ACAAguaugg (SEQ ID NO.: 6379), ACAAguaugu (SEQ ID NO.: 6380), ACAAguauug (SEQ ID NO.: 6381), ACAAgucagu (SEQ ID NO.: 6382), ACAAgugaga (SEQ ID NO.: 6383), ACAAgugagc (SEQ ID NO.: 6384), ACAAgugagg (SEQ ID NO.: 6385), ACAAgugagu (SEQ ID NO.: 6386), ACAAgugcgu (SEQ ID NO.: 6387), ACAAgugggc (SEQ ID NO.: 6388), ACAAgugggu (SEQ ID NO.: 6389), ACAAgugugu (SEQ ID NO.: 6390), ACAAguuaag (SEQ ID NO.: 6391), ACAAguuaga (SEQ ID NO.: 6392), ACAAguuagu (SEQ ID NO.: 6393), ACAAuggaaa (SEQ ID NO.: 6394), ACACacacac (SEQ ID NO.: 6395), ACACcagggu (SEQ ID NO.: 6396), ACACgcaagu (SEQ ID NO.: 6397), ACACguaaga (SEQ ID NO.: 6398), ACACguaagc (SEQ ID NO.: 6399), ACACguaagg (SEQ ID NO.: 6400), ACACguaagu (SEQ ID NO.: 6401), ACACguacgu (SEQ ID NO.: 6402), ACACguaggu (SEQ ID NO.: 6403), ACACguaugu (SEQ ID NO.: 6404), ACACgucagu (SEQ ID NO.: 6405), ACACgugaga (SEQ ID NO.: 6406), ACACgugagc (SEQ ID NO.: 6407), ACACgugagg (SEQ ID NO.: 6408), ACACgugagu (SEQ ID NO.: 6409), ACACgugcgu (SEQ ID NO.: 6410), ACACgugggu (SEQ ID NO.: 6411), ACACguuagu (SEQ ID NO.: 6412), ACAGagguug (SEQ ID NO.: 6413), ACAGaguaag (SEQ ID NO.: 6414), ACAGauaucc (SEQ ID NO.: 6415), ACAGgcaaca (SEQ ID NO.: 6416), ACAGgcaacu (SEQ ID NO.: 6417), ACAGgcaaga (SEQ ID NO.: 6418), ACAGgcaagc (SEQ ID NO.: 6419), ACAGgcaagg (SEQ ID NO.: 6420), ACAGgcaagu (SEQ ID NO.: 6421), ACAGgcacag (SEQ ID NO.: 6422), ACAGgcacgc (SEQ ID NO.: 6423), ACAGgcacgu (SEQ ID NO.: 6424), ACAGgcaggc (SEQ ID NO.: 6425), ACAGgcaggu (SEQ ID NO.: 6426), ACAGgcauca (SEQ ID NO.: 6427), ACAGgcauga (SEQ ID NO.: 6428), ACAGgcaugc (SEQ ID NO.: 6429), ACAGgcaugu (SEQ ID NO.: 6430), ACAGgcgaga (SEQ ID NO.: 6431), ACAGgcgagu (SEQ ID NO.: 6432), ACAGgcgccu (SEQ ID NO.: 6433), ACAGgcgcgu (SEQ ID NO.: 6434), ACAGgcuagu (SEQ ID NO.: 6435), ACAGguaaaa (SEQ ID NO.: 6436), ACAGguaaac (SEQ ID NO.: 6437), ACAGguaaag (SEQ ID NO.: 6438), ACAGguaaau (SEQ ID NO.: 6439), ACAGguaaca (SEQ ID NO.: 6440), ACAGguaacc (SEQ ID NO.: 6441), ACAGguaacg (SEQ ID NO.: 6442), ACAGguaacu (SEQ ID NO.: 6443), ACAGguaaga (SEQ ID NO.: 6444), ACAGguaagc (SEQ ID NO.: 6445), ACAGguaagg (SEQ ID NO.: 6446), ACAGguaagu (SEQ ID NO.: 6447), ACAGguaaua (SEQ ID NO.: 6448), ACAGguaauc (SEQ ID NO.: 6449), ACAGguaaug (SEQ ID NO.: 6450), ACAGguaauu (SEQ ID NO.: 6451), ACAGguacaa (SEQ ID NO.: 6452), ACAGguacac (SEQ ID NO.: 6453), ACAGguacag (SEQ ID NO.: 6454), ACAGguacau (SEQ ID NO.: 6455), ACAGguacca (SEQ ID NO.: 6456), ACAGguaccc (SEQ ID NO.: 6457), ACAGguaccg (SEQ ID NO.: 6458), ACAGguaccu (SEQ ID NO.: 6459), ACAGguacga (SEQ ID NO.: 6460), ACAGguacgc (SEQ ID NO.: 6461), ACAGguacgg (SEQ ID NO.: 6462), ACAGguacgu (SEQ ID NO.: 6463), ACAGguacua (SEQ ID NO.: 6464), ACAGguacuc (SEQ ID NO.: 6465), ACAGguacug (SEQ ID NO.: 6466), ACAGguacuu (SEQ ID NO.: 6467), ACAGguagaa (SEQ ID NO.: 6468), ACAGguagac (SEQ ID NO.: 6469), ACAGguagag (SEQ ID NO.: 6470), ACAGguagau (SEQ ID NO.: 6471), ACAGguagca (SEQ ID NO.: 6472), ACAGguagcg (SEQ ID NO.: 6473), ACAGguagcu (SEQ ID NO.: 6474), ACAGguagga (SEQ ID NO.: 6475),
ACAGguaggc (SEQ ID NO.: 6476), ACAGguaggg (SEQ ID NO.: 6477), ACAGguaggu (SEQ ID NO.: 6478), ACAGguagua (SEQ ID NO.: 6479), ACAGguaguc (SEQ ID NO.: 6480), ACAGguagug (SEQ ID NO.: 6481), ACAGguaguu (SEQ ID NO.: 6482), ACAGguauaa (SEQ ID NO.: 6483), ACAGguauac (SEQ ID NO.: 6484), ACAGguauag (SEQ ID NO.: 6485), ACAGguauau (SEQ ID NO.: 6486), ACAGguauca (SEQ ID NO.: 6487), ACAGguaucc (SEQ ID NO.: 6488), ACAGguaucg (SEQ ID NO.: 6489), ACAGguaucu (SEQ ID NO.: 6490), ACAGguauga (SEQ ID NO.: 6491), ACAGguaugc (SEQ ID NO.: 6492), ACAGguaugg (SEQ ID NO.: 6493), ACAGguaugu (SEQ ID NO.: 6494), ACAGguauua (SEQ ID NO.: 6495), ACAGguauuc (SEQ ID NO.: 6496), ACAGguauug (SEQ ID NO.: 6497), ACAGguauuu (SEQ ID NO.: 6498), ACAGgucaag (SEQ ID NO.: 6499), ACAGgucacu (SEQ ID NO.: 6500), ACAGgucaga (SEQ ID NO.: 6501), ACAGgucagc (SEQ ID NO.: 6502), ACAGgucagg (SEQ ID NO.: 6503), ACAGgucagu (SEQ ID NO.: 6504), ACAGgucgcu (SEQ ID NO.: 6505), ACAGgucgga (SEQ ID NO.: 6506), ACAGgucggg (SEQ ID NO.: 6507), ACAGgucggu (SEQ ID NO.: 6508), ACAGgucucu (SEQ ID NO.: 6509), ACAGgucugg (SEQ ID NO.: 6510), ACAGgucugu (SEQ ID NO.: 6511), ACAGgugaaa (SEQ ID NO.: 6512), ACAGgugaac (SEQ ID NO.: 6513), ACAGgugaag (SEQ ID NO.: 6514), ACAGgugaau (SEQ ID NO.: 6515), ACAGgugaca (SEQ ID NO.: 6516), ACAGgugacc (SEQ ID NO.: 6517), ACAGgugacg (SEQ ID NO.: 6518), ACAGgugacu (SEQ ID NO.: 6519), ACAGgugaga (SEQ ID NO.: 6520), ACAGgugagc (SEQ ID NO.: 6521), ACAGgugagg (SEQ ID NO.: 6522), ACAGgugagu (SEQ ID NO.: 6523), ACAGgugaua (SEQ ID NO.: 6524), ACAGgugaug (SEQ ID NO.: 6525), ACAGgugauu (SEQ ID NO.: 6526), ACAGgugcaa (SEQ ID NO.: 6527), ACAGgugcac (SEQ ID NO.: 6528), ACAGgugcag (SEQ ID NO.: 6529), ACAGgugcau (SEQ ID NO.: 6530), ACAGgugcca (SEQ ID NO.: 6531), ACAGgugccc (SEQ ID NO.: 6532), ACAGgugccg (SEQ ID NO.: 6533), ACAGgugccu (SEQ ID NO.: 6534), ACAGgugcga (SEQ ID NO.: 6535), ACAGgugcgc (SEQ ID NO.: 6536), ACAGgugcgg (SEQ ID NO.: 6537), ACAGgugcgu (SEQ ID NO.: 6538), ACAGgugcua (SEQ ID NO.: 6539), ACAGgugcuc (SEQ ID NO.: 6540), ACAGgugcug (SEQ ID NO.: 6541), ACAGgugcuu (SEQ ID NO.: 6542), ACAGguggag (SEQ ID NO.: 6543), ACAGguggcc (SEQ ID NO.: 6544), ACAGguggcg (SEQ ID NO.: 6545), ACAGguggga (SEQ ID NO.: 6546), ACAGgugggc (SEQ ID NO.: 6547), ACAGgugggg (SEQ ID NO.: 6548), ACAGgugggu (SEQ ID NO.: 6549), ACAGguggug (SEQ ID NO.: 6550), ACAGgugguu (SEQ ID NO.: 6551), ACAGguguac (SEQ ID NO.: 6552), ACAGguguag (SEQ ID NO.: 6553), ACAGguguca (SEQ ID NO.: 6554), ACAGgugucu (SEQ ID NO.: 6555), ACAGguguga (SEQ ID NO.: 6556), ACAGgugugc (SEQ ID NO.: 6557), ACAGgugugg (SEQ ID NO.: 6558), ACAGgugugu (SEQ ID NO.: 6559), ACAGguguuu (SEQ ID NO.: 6560), ACAGguuaag (SEQ ID NO.: 6561), ACAGguuaau (SEQ ID NO.: 6562), ACAGguuaga (SEQ ID NO.: 6563), ACAGguuagc (SEQ ID NO.: 6564), ACAGguuagg (SEQ ID NO.: 6565), ACAGguuagu (SEQ ID NO.: 6566), ACAGguuaug (SEQ ID NO.: 6567), ACAGguuccc (SEQ ID NO.: 6568), ACAGguuccu (SEQ ID NO.: 6569), ACAGguucga (SEQ ID NO.: 6570), ACAGguucgc (SEQ ID NO.: 6571), ACAGguucgg (SEQ ID NO.: 6572), ACAGguucgu (SEQ ID NO.: 6573), ACAGguucuc (SEQ ID NO.: 6574), ACAGguucuu (SEQ ID NO.: 6575), ACAGguugca (SEQ ID NO.: 6576), ACAGguugcg (SEQ ID NO.: 6577), ACAGguugcu (SEQ ID NO.: 6578), ACAGguugga (SEQ ID NO.: 6579), ACAGguuggg (SEQ ID NO.: 6580), ACAGguuggu (SEQ ID NO.: 6581), ACAGguuguc (SEQ ID NO.: 6582), ACAGguuguu (SEQ ID NO.: 6583), ACAGguuuag (SEQ ID NO.: 6584), ACAGguuucc (SEQ ID NO.: 6585), ACAGguuuga (SEQ ID NO.: 6586), ACAGguuugc (SEQ ID NO.: 6587), ACAGguuugg (SEQ
ID NO.: 6588), ACAGguuugu (SEQ ID NO.: 6589), ACAGguuuua (SEQ ID NO.: 6590), ACAGguuuuu (SEQ ID NO.: 6591), ACAGucagug (SEQ ID NO.: 6592), ACAGugguaa (SEQ ID NO.: 6593), ACAGuguagc (SEQ ID NO.: 6594), ACAUccauua (SEQ ID NO.: 6595), ACAUguaaga (SEQ ID NO.: 6596), ACAUguaagc (SEQ ID NO.: 6597), ACAUguaagg (SEQ ID NO.: 6598), ACAUguaagu (SEQ ID NO.: 6599), ACAUguaaug (SEQ ID NO.: 6600), ACAUguacau (SEQ ID NO.: 6601), ACAUguacgg (SEQ ID NO.: 6602), ACAUguaggu (SEQ ID NO.: 6603), ACAUguaugg (SEQ ID NO.: 6604), ACAUguaugu (SEQ ID NO.: 6605), ACAUgugaga (SEQ ID NO.: 6606), ACAUgugagc (SEQ ID NO.: 6607), ACAUgugagu (SEQ ID NO.: 6608), ACAUgugauu (SEQ ID NO.: 6609), ACAUugcauc (SEQ ID NO.: 6610), ACCAgguauc (SEQ ID NO.: 6611), ACCAggugaa (SEQ ID NO.: 6612), ACCAgguugg (SEQ ID NO.: 6613), ACCAguaaga (SEQ ID NO.: 6614), ACCAguaagc (SEQ ID NO.: 6615), ACCAguaagu (SEQ ID NO.: 6616), ACCAguacgu (SEQ ID NO.: 6617), ACCAguaggu (SEQ ID NO.: 6618), ACCAguaugg (SEQ ID NO.: 6619), ACCAguaugu (SEQ ID NO.: 6620), ACCAgugaga (SEQ ID NO.: 6621), ACCAgugagc (SEQ ID NO.: 6622), ACCAgugagg (SEQ ID NO.: 6623), ACCAgugagu (SEQ ID NO.: 6624), ACCAguggag (SEQ ID NO.: 6625), ACCAguugag (SEQ ID NO.: 6626), ACCCaagggu (SEQ ID NO.: 6627), ACCCguaagu (SEQ ID NO.: 6628), ACCCguacgu (SEQ ID NO.: 6629), ACCCguaucu (SEQ ID NO.: 6630), ACCCgugaga (SEQ ID NO.: 6631), ACCCgugagu (SEQ ID NO.: 6632), ACCCguggua (SEQ ID NO.: 6633), ACCCguguga (SEQ ID NO.: 6634), ACCGguaaca (SEQ ID NO.: 6635), ACCGguaaga (SEQ ID NO.: 6636), ACCGguaagc (SEQ ID NO.: 6637), ACCGguaagg (SEQ ID NO.: 6638), ACCGguaagu (SEQ ID NO.: 6639), ACCGguaauu (SEQ ID NO.: 6640), ACCGguacgg (SEQ ID NO.: 6641), ACCGguagcu (SEQ ID NO.: 6642), ACCGguaggg (SEQ ID NO.: 6643), ACCGguaggu (SEQ ID NO.: 6644), ACCGguauga (SEQ ID NO.: 6645), ACCGguaugg (SEQ ID NO.: 6646), ACCGguaugu (SEQ ID NO.: 6647), ACCGguauuu (SEQ ID NO.: 6648), ACCGgucagg (SEQ ID NO.: 6649), ACCGgucagu (SEQ ID NO.: 6650), ACCGgucugc (SEQ ID NO.: 6651), ACCGgugaga (SEQ ID NO.: 6652), ACCGgugagc (SEQ ID NO.: 6653), ACCGgugagg (SEQ ID NO.: 6654), ACCGgugagu (SEQ ID NO.: 6655), ACCGgugcgu (SEQ ID NO.: 6656), ACCGgugggu (SEQ ID NO.: 6657), ACCGgugugu (SEQ ID NO.: 6658), ACCGguuagu (SEQ ID NO.: 6659), ACCGguuugu (SEQ ID NO.: 6660), ACCUguaaga (SEQ ID NO.: 6661), ACCUguaagc (SEQ ID NO.: 6662), ACCUguaagg (SEQ ID NO.: 6663), ACCUguaagu (SEQ ID NO.: 6664), ACCUguaggu (SEQ ID NO.: 6665), ACCUguaucc (SEQ ID NO.: 6666), ACCUguaugg (SEQ ID NO.: 6667), ACCUguaugu (SEQ ID NO.: 6668), ACCUgugaau (SEQ ID NO.: 6669), ACCUgugagc (SEQ ID NO.: 6670), ACCUgugagg (SEQ ID NO.: 6671), ACCUgugagu (SEQ ID NO.: 6672), ACCUgugcgu (SEQ ID NO.: 6673), ACCUguucgc (SEQ ID NO.: 6674), ACGAgguaaa (SEQ ID NO.: 6675), ACGAguaaga (SEQ ID NO.: 6676), ACGAguaagu (SEQ ID NO.: 6677), ACGAguacgu (SEQ ID NO.: 6678), ACGAgugagc (SEQ ID NO.: 6679), ACGAgugagu (SEQ ID NO.: 6680), ACGAguuagu (SEQ ID NO.: 6681), ACGCguaaga (SEQ ID NO.: 6682), ACGCguaagc (SEQ ID NO.: 6683), ACGCguaggu (SEQ ID NO.: 6684), ACGGgcaagg (SEQ ID NO.: 6685), ACGGgcaagu (SEQ ID NO.: 6686), ACGGgcaggu (SEQ ID NO.: 6687), ACGGguaaac (SEQ ID NO.: 6688), ACGGguaaau (SEQ ID NO.: 6689), ACGGguaaga (SEQ ID NO.: 6690), ACGGguaagc (SEQ ID NO.: 6691), ACGGguaagg (SEQ ID NO.: 6692), ACGGguaagu (SEQ ID NO.: 6693), ACGGguaaua (SEQ ID NO.: 6694), ACGGguaauu (SEQ ID NO.: 6695), ACGGguacau (SEQ ID NO.: 6696), ACGGguacgc (SEQ ID NO.: 6697), ACGGguacgg (SEQ ID NO.: 6698), ACGGguacua (SEQ ID NO.: 6699), ACGGguaggu (SEQ ID NO.: 6700),
ACGGguauaa (SEQ ID NO.: 6701), ACGGguauga (SEQ ID NO.: 6702), ACGGguaugc (SEQ ID NO.: 6703), ACGGguaugu (SEQ ID NO.: 6704), ACGGgucagu (SEQ ID NO.: 6705), ACGGgugacg (SEQ ID NO.: 6706), ACGGgugaga (SEQ ID NO.: 6707), ACGGgugagc (SEQ ID NO.: 6708), ACGGgugagg (SEQ ID NO.: 6709), ACGGgugagu (SEQ ID NO.: 6710), ACGGgugauc (SEQ ID NO.: 6711), ACGGgugcgc (SEQ ID NO.: 6712), ACGGgugggu (SEQ ID NO.: 6713), ACGGguuugu (SEQ ID NO.: 6714), ACGUguaagg (SEQ ID NO.: 6715), ACGUguaagu (SEQ ID NO.: 6716), ACGUguacgu (SEQ ID NO.: 6717), ACGUgugagc (SEQ ID NO.: 6718), ACGUgugagu (SEQ ID NO.: 6719), ACGUguuagu (SEQ ID NO.: 6720), ACUAguaaga (SEQ ID NO.: 6721), ACUAguaagg (SEQ ID NO.: 6722), ACUAguaagu (SEQ ID NO.: 6723), ACUAguacgu (SEQ ID NO.: 6724), ACUAgugagc (SEQ ID NO.: 6725), ACUAgugagu (SEQ ID NO.: 6726), ACUCauaucc (SEQ ID NO.: 6727), ACUCguaagu (SEQ ID NO.: 6728), ACUCguaugu (SEQ ID NO.: 6729), ACUCgugagu (SEQ ID NO.: 6730), ACUGaguccc (SEQ ID NO.: 6731), ACUGgaacug (SEQ ID NO.: 6732), ACUGgcaaga (SEQ ID NO.: 6733), ACUGgcaggu (SEQ ID NO.: 6734), ACUGguaaaa (SEQ ID NO.: 6735), ACUGguaaag (SEQ ID NO.: 6736), ACUGguaaau (SEQ ID NO.: 6737), ACUGguaaca (SEQ ID NO.: 6738), ACUGguaacc (SEQ ID NO.: 6739), ACUGguaacu (SEQ ID NO.: 6740), ACUGguaaga (SEQ ID NO.: 6741), ACUGguaagc (SEQ ID NO.: 6742), ACUGguaagg (SEQ ID NO.: 6743), ACUGguaagu (SEQ ID NO.: 6744), ACUGguaaua (SEQ ID NO.: 6745), ACUGguaauc (SEQ ID NO.: 6746), ACUGguaaug (SEQ ID NO.: 6747), ACUGguaauu (SEQ ID NO.: 6748), ACUGguacag (SEQ ID NO.: 6749), ACUGguaccu (SEQ ID NO.: 6750), ACUGguacga (SEQ ID NO.: 6751), ACUGguacgu (SEQ ID NO.: 6752), ACUGguagag (SEQ ID NO.: 6753), ACUGguagcc (SEQ ID NO.: 6754), ACUGguagcu (SEQ ID NO.: 6755), ACUGguagga (SEQ ID NO.: 6756), ACUGguaggg (SEQ ID NO.: 6757), ACUGguaggu (SEQ ID NO.: 6758), ACUGguauga (SEQ ID NO.: 6759), ACUGguaugg (SEQ ID NO.: 6760), ACUGguaugu (SEQ ID NO.: 6761), ACUGguauua (SEQ ID NO.: 6762), ACUGguauuu (SEQ ID NO.: 6763), ACUGgucagu (SEQ ID NO.: 6764), ACUGgugaau (SEQ ID NO.: 6765), ACUGgugacg (SEQ ID NO.: 6766), ACUGgugaga (SEQ ID NO.: 6767), ACUGgugagc (SEQ ID NO.: 6768), ACUGgugagg (SEQ ID NO.: 6769), ACUGgugagu (SEQ ID NO.: 6770), ACUGgugaug (SEQ ID NO.: 6771), ACUGgugauu (SEQ ID NO.: 6772), ACUGgugccg (SEQ ID NO.: 6773), ACUGgugcgu (SEQ ID NO.: 6774), ACUGgugggc (SEQ ID NO.: 6775), ACUGgugggu (SEQ ID NO.: 6776), ACUGgugugc (SEQ ID NO.: 6777), ACUGgugugu (SEQ ID NO.: 6778), ACUGguuagu (SEQ ID NO.: 6779), ACUGguuugu (SEQ ID NO.: 6780), ACUUauguga (SEQ ID NO.: 6781), ACUUguaaga (SEQ ID NO.: 6782), ACUUguaagu (SEQ ID NO.: 6783), ACUUguacgc (SEQ ID NO.: 6784), ACUUguacgu (SEQ ID NO.: 6785), ACUUguagga (SEQ ID NO.: 6786), ACUUguaggu (SEQ ID NO.: 6787), ACUUguaguu (SEQ ID NO.: 6788), ACUUguaucc (SEQ ID NO.: 6789), ACUUgugagu (SEQ ID NO.: 6790), ACUUguguga (SEQ ID NO.: 6791), ACUUguuggu (SEQ ID NO.: 6792), AGAAaaggau (SEQ ID NO.: 6793), AGAAagguac (SEQ ID NO.: 6794), AGAAagguga (SEQ ID NO.: 6795), AGAAauaucc (SEQ ID NO.: 6796), AGAAgagaag (SEQ ID NO.: 6797), AGAAgcuggg (SEQ ID NO.: 6798), AGAAguaaau (SEQ ID NO.: 6799), AGAAguaacc (SEQ ID NO.: 6800), AGAAguaaga (SEQ ID NO.: 6801), AGAAguaagc (SEQ ID NO.: 6802), AGAAguaagg (SEQ ID NO.: 6803), AGAAguaagu (SEQ ID NO.: 6804), AGAAguaaug (SEQ ID NO.: 6805), AGAAguaauu (SEQ ID NO.: 6806), AGAAguacga (SEQ ID NO.: 6807), AGAAguacgc (SEQ ID NO.: 6808), AGAAguaggu (SEQ ID NO.: 6809), AGAAguauau (SEQ ID NO.: 6810), AGAAguaucc (SEQ ID NO.: 6811), AGAAguauga (SEQ ID NO.: 6812), AGAAguaugg (SEQ
ID NO.: 6813), AGAAguaugu (SEQ ID NO.: 6814), AGAAgucagu (SEQ ID NO.: 6815), AGAAgugacu (SEQ ID NO.: 6816), AGAAgugaga (SEQ ID NO.: 6817), AGAAgugagc (SEQ ID NO.: 6818), AGAAgugagg (SEQ ID NO.: 6819), AGAAgugagu (SEQ ID NO.: 6820), AGAAgugcgu (SEQ ID NO.: 6821), AGAAgugggu (SEQ ID NO.: 6822), AGAAgugugu (SEQ ID NO.: 6823), AGAAguuagu (SEQ ID NO.: 6824), AGAAguuugu (SEQ ID NO.: 6825), AGACagcgcg (SEQ ID NO.: 6826), AGACgccaga (SEQ ID NO.: 6827), AGACguaaag (SEQ ID NO.: 6828), AGACguaaga (SEQ ID NO.: 6829), AGACguaagu (SEQ ID NO.: 6830), AGACguaugu (SEQ ID NO.: 6831), AGACgugaga (SEQ ID NO.: 6832), AGACgugagc (SEQ ID NO.: 6833), AGACgugagg (SEQ ID NO.: 6834), AGACgugagu (SEQ ID NO.: 6835), AGAGagggua (SEQ ID NO.: 6836), AGAGgcaaga (SEQ ID NO.: 6837), AGAGgcaagu (SEQ ID NO.: 6838), AGAGgcaccu (SEQ ID NO.: 6839), AGAGgcaggu (SEQ ID NO.: 6840), AGAGgcaugu (SEQ ID NO.: 6841), AGAGgccagu (SEQ ID NO.: 6842), AGAGgccucu (SEQ ID NO.: 6843), AGAGgcguga (SEQ ID NO.: 6844), AGAGgcuuca (SEQ ID NO.: 6845), AGAGguaaaa (SEQ ID NO.: 6846), AGAGguaaac (SEQ ID NO.: 6847), AGAGguaaag (SEQ ID NO.: 6848), AGAGguaaau (SEQ ID NO.: 6849), AGAGguaaca (SEQ ID NO.: 6850), AGAGguaacc (SEQ ID NO.: 6851), AGAGguaacg (SEQ ID NO.: 6852), AGAGguaacu (SEQ ID NO.: 6853), AGAGguaaga (SEQ ID NO.: 6854), AGAGguaagc (SEQ ID NO.: 6855), AGAGguaagg (SEQ ID NO.: 6856), AGAGguaagu (SEQ ID NO.: 6857), AGAGguaaua (SEQ ID NO.: 6858), AGAGguaauc (SEQ ID NO.: 6859), AGAGguaaug (SEQ ID NO.: 6860), AGAGguaauu (SEQ ID NO.: 6861), AGAGguacaa (SEQ ID NO.: 6862), AGAGguacac (SEQ ID NO.: 6863), AGAGguacag (SEQ ID NO.: 6864), AGAGguacau (SEQ ID NO.: 6865), AGAGguacca (SEQ ID NO.: 6866), AGAGguaccc (SEQ ID NO.: 6867), AGAGguaccg (SEQ ID NO.: 6868), AGAGguaccu (SEQ ID NO.: 6869), AGAGguacgu (SEQ ID NO.: 6870), AGAGguacua (SEQ ID NO.: 6871), AGAGguacuc (SEQ ID NO.: 6872), AGAGguacug (SEQ ID NO.: 6873), AGAGguacuu (SEQ ID NO.: 6874), AGAGguagaa (SEQ ID NO.: 6875), AGAGguagac (SEQ ID NO.: 6876), AGAGguagau (SEQ ID NO.: 6877), AGAGguagca (SEQ ID NO.: 6878), AGAGguagcc (SEQ ID NO.: 6879), AGAGguagcg (SEQ ID NO.: 6880), AGAGguagcu (SEQ ID NO.: 6881), AGAGguagga (SEQ ID NO.: 6882), AGAGguaggc (SEQ ID NO.: 6883), AGAGguaggg (SEQ ID NO.: 6884), AGAGguaggu (SEQ ID NO.: 6885), AGAGguagua (SEQ ID NO.: 6886), AGAGguagug (SEQ ID NO.: 6887), AGAGguaguu (SEQ ID NO.: 6888), AGAGguauaa (SEQ ID NO.: 6889), AGAGguauac (SEQ ID NO.: 6890), AGAGguauag (SEQ ID NO.: 6891), AGAGguauau (SEQ ID NO.: 6892), AGAGguauca (SEQ ID NO.: 6893), AGAGguaucc (SEQ ID NO.: 6894), AGAGguauga (SEQ ID NO.: 6895), AGAGguaugc (SEQ ID NO.: 6896), AGAGguaugg (SEQ ID NO.: 6897), AGAGguaugu (SEQ ID NO.: 6898), AGAGguauua (SEQ ID NO.: 6899), AGAGguauuc (SEQ ID NO.: 6900), AGAGguauug (SEQ ID NO.: 6901), AGAGguauuu (SEQ ID NO.: 6902), AGAGgucaga (SEQ ID NO.: 6903), AGAGgucagc (SEQ ID NO.: 6904), AGAGgucagg (SEQ ID NO.: 6905), AGAGgucagu (SEQ ID NO.: 6906), AGAGgucauu (SEQ ID NO.: 6907), AGAGguccgu (SEQ ID NO.: 6908), AGAGgucgug (SEQ ID NO.: 6909), AGAGgucuau (SEQ ID NO.: 6910), AGAGgucuga (SEQ ID NO.: 6911), AGAGgucugc (SEQ ID NO.: 6912), AGAGgucugu (SEQ ID NO.: 6913), AGAGgucuug (SEQ ID NO.: 6914), AGAGgugaaa (SEQ ID NO.: 6915), AGAGgugaac (SEQ ID NO.: 6916), AGAGgugaag (SEQ ID NO.: 6917), AGAGgugaau (SEQ ID NO.: 6918), AGAGgugaca (SEQ ID NO.: 6919), AGAGgugacc (SEQ ID NO.: 6920), AGAGgugacg (SEQ ID NO.: 6921), AGAGgugacu (SEQ ID NO.: 6922), AGAGgugaga (SEQ ID NO.: 6923), AGAGgugagc (SEQ ID NO.: 6924), AGAGgugagg (SEQ ID NO.: 6925),
AGAGgugagu (SEQ ID NO.: 6926), AGAGgugaua (SEQ ID NO.: 6927), AGAGgugauc (SEQ ID NO.: 6928), AGAGgugaug (SEQ ID NO.: 6929), AGAGgugauu (SEQ ID NO.: 6930), AGAGgugcau (SEQ ID NO.: 6931), AGAGgugccc (SEQ ID NO.: 6932), AGAGgugcga (SEQ ID NO.: 6933), AGAGgugcgg (SEQ ID NO.: 6934), AGAGgugcua (SEQ ID NO.: 6935), AGAGgugcuc (SEQ ID NO.: 6936), AGAGgugcug (SEQ ID NO.: 6937), AGAGgugcuu (SEQ ID NO.: 6938), AGAGguggag (SEQ ID NO.: 6939), AGAGguggcu (SEQ ID NO.: 6940), AGAGguggga (SEQ ID NO.: 6941), AGAGgugggc (SEQ ID NO.: 6942), AGAGgugggg (SEQ ID NO.: 6943), AGAGgugggu (SEQ ID NO.: 6944), AGAGguggua (SEQ ID NO.: 6945), AGAGguggug (SEQ ID NO.: 6946), AGAGgugguu (SEQ ID NO.: 6947), AGAGguguga (SEQ ID NO.: 6948), AGAGgugugc (SEQ ID NO.: 6949), AGAGgugugg (SEQ ID NO.: 6950), AGAGgugugu (SEQ ID NO.: 6951), AGAGguuaag (SEQ ID NO.: 6952), AGAGguuacu (SEQ ID NO.: 6953), AGAGguuaga (SEQ ID NO.: 6954), AGAGguuagu (SEQ ID NO.: 6955), AGAGguuaua (SEQ ID NO.: 6956), AGAGguucaa (SEQ ID NO.: 6957), AGAGguucgg (SEQ ID NO.: 6958), AGAGguucgu (SEQ ID NO.: 6959), AGAGguucuu (SEQ ID NO.: 6960), AGAGguugag (SEQ ID NO.: 6961), AGAGguugcc (SEQ ID NO.: 6962), AGAGguuggc (SEQ ID NO.: 6963), AGAGguuggg (SEQ ID NO.: 6964), AGAGguuggu (SEQ ID NO.: 6965), AGAGguugug (SEQ ID NO.: 6966), AGAGguuuau (SEQ ID NO.: 6967), AGAGguuucc (SEQ ID NO.: 6968), AGAGguuugc (SEQ ID NO.: 6969), AGAGguuugg (SEQ ID NO 6970), AGAGguuugu (SEQ ID NO.: 6971), AGAGugguaa (SEQ ID NO.: 6972), AGAUaucucu (SEQ ID NO.: 6973), AGAUaucuga (SEQ ID NO.: 6974), AGAUcuacca (SEQ ID NO.: 6975), AGAUgaacau (SEQ ID NO.: 6976), AGAUguaaaa (SEQ ID NO.: 6977), AGAUguaaau (SEQ ID NO.: 6978), AGAUguaaga (SEQ ID NO.: 6979), AGAUguaagc (SEQ ID NO.: 6980), AGAUguaagg (SEQ ID NO.: 6981), AGAUguaagu (SEQ ID NO.: 6982), AGAUguaaug (SEQ ID NO.: 6983), AGAUguaauu (SEQ ID NO.: 6984), AGAUguacgu (SEQ ID NO.: 6985), AGAUguaggu (SEQ ID NO.: 6986), AGAUguauaa (SEQ ID NO.: 6987), AGAUguauag (SEQ ID NO.: 6988), AGAUguaucc (SEQ ID NO.: 6989), AGAUguauga (SEQ ID NO.: 6990), AGAUguaugu (SEQ ID NO.: 6991), AGAUgugaca (SEQ ID NO.: 6992), AGAUgugaga (SEQ ID NO.: 6993), AGAUgugagc (SEQ ID NO.: 6994), AGAUgugagu (SEQ ID NO.: 6995), AGAUgugggu (SEQ ID NO.: 6996), AGAUguggua (SEQ ID NO.: 6997), AGAUgugugu (SEQ ID NO.: 6998), AGCAggaaaa (SEQ ID NO.: 6999), AGCAgguaaa (SEQ ID NO.: 7000), AGCAgguaag (SEQ ID NO.: 7001), AGCAggucag (SEQ ID NO.: 7002), AGCAggugag (SEQ ID NO.: 7003), AGCAguaaga (SEQ ID NO.: 7004), AGCAguaagc (SEQ ID NO.: 7005), AGCAguaagg (SEQ ID NO.: 7006), AGCAguaagu (SEQ ID NO.: 7007), AGCAguacgu (SEQ ID NO.: 7008), AGCAguaggu (SEQ ID NO.: 7009), AGCAguaucc (SEQ ID NO.: 7010), AGCAguaugu (SEQ ID NO.: 7011), AGCAgugaga (SEQ ID NO.: 7012), AGCAgugagg (SEQ ID NO.: 7013), AGCAgugagu (SEQ ID NO.: 7014), AGCAgugggg (SEQ ID NO.: 7015), AGCAguguga (SEQ ID NO.: 7016), AGCAguuaag (SEQ ID NO 7017), AGCCcaggga (SEQ ID NO.: 7018), AGCCguaagu (SEQ ID NO.: 7019), AGCCguacgu (SEQ ID NO.: 7020), AGCCguaugu (SEQ ID NO.: 7021), AGCCgugagu (SEQ ID NO.: 7022), AGCCgugugu (SEQ ID NO.: 7023), AGCGgcagca (SEQ ID NO.: 7024), AGCGgcaggu (SEQ ID NO.: 7025), AGCGguaaau (SEQ ID NO.: 7026), AGCGguaacu (SEQ ID NO.: 7027), AGCGguaaga (SEQ ID NO.: 7028), AGCGguaagc (SEQ ID NO.: 7029), AGCGguaagg (SEQ ID NO.: 7030), AGCGguaagu (SEQ ID NO. : 7031), AGCGguaauc (SEQ ID NO. : 7032), AGCGguaauu (SEQ ID NO.: 7033), AGCGguacgg (SEQ ID NO.: 7034), AGCGguacuu (SEQ ID NO.: 7035), AGCGguaggu (SEQ ID NO.: 7036), AGCGguagua (SEQ ID NO.: 7037), AGCGguauga (SEQ
ID NO.: 7038), AGCGguaugg (SEQ ID NO.: 7039), AGCGguaugu (SEQ ID NO.: 7040), AGCGgucagu (SEQ ID NO.: 7041), AGCGgugaag (SEQ ID NO.: 7042), AGCGgugaau (SEQ ID NO.: 7043), AGCGgugaga (SEQ ID NO.: 7044), AGCGgugagc (SEQ ID NO.: 7045), AGCGgugagg (SEQ ID NO.: 7046), AGCGgugagu (SEQ ID NO.: 7047), AGCGgugcgu (SEQ ID NO.: 7048), AGCGgugggu (SEQ ID NO.: 7049), AGCGgugugu (SEQ ID NO.: 7050), AGCUauaucc (SEQ ID NO.: 7051), AGCUauuuac (SEQ ID NO.: 7052), AGCUcaggug (SEQ ID NO.: 7053), AGCUguaaga (SEQ ID NO.: 7054), AGCUguaagc (SEQ ID NO.: 7055), AGCUguaagg (SEQ ID NO.: 7056), AGCUguaagu (SEQ ID NO.: 7057), AGCUguacgu (SEQ ID NO.: 7058), AGCUguaggu (SEQ ID NO.: 7059), AGCUguaugu (SEQ ID NO.: 7060), AGCUgugaga (SEQ ID NO.: 7061), AGCUgugagc (SEQ ID NO.: 7062), AGCUgugagu (SEQ ID NO.: 7063), AGCUguggga (SEQ ID NO.: 7064), AGCUguggua (SEQ ID NO.: 7065), AGGAaaagua (SEQ ID NO.: 7066), AGGAaaggua (SEQ ID NO.: 7067), AGGAaaguaa (SEQ ID NO.: 7068), AGGAgccuug (SEQ ID NO.: 7069), AGGAguaaga (SEQ ID NO.: 7070), AGGAguaagg (SEQ ID NO.: 7071), AGGAguaagu (SEQ ID NO.: 7072), AGGAguaggu (SEQ ID NO.: 7073), AGGAguaugu (SEQ ID NO.: 7074), AGGAgugagg (SEQ ID NO.: 7075), AGGAgugagu (SEQ ID NO.: 7076), AGGCguaaga (SEQ ID NO.: 7077), AGGCguaagu (SEQ ID NO.: 7078), AGGCguaaug (SEQ ID NO.: 7079), AGGCgugagu (SEQ ID NO.: 7080), AGGGcggguc (SEQ ID NO.: 7081), AGGGgcaagu (SEQ ID NO 7082), AGGGgccagg (SEQ ID NO.: 7083), AGGGguaaaa (SEQ ID NO.: 7084), AGGGguaaag (SEQ ID NO.: 7085), AGGGguaaau (SEQ ID NO.: 7086), AGGGguaaca (SEQ ID NO.: 7087), AGGGguaaga (SEQ ID NO.: 7088), AGGGguaagc (SEQ ID NO.: 7089), AGGGguaagg (SEQ ID NO.: 7090), AGGGguaagu (SEQ ID NO.: 7091), AGGGguaaua (SEQ ID NO.: 7092), AGGGguaaug (SEQ ID NO.: 7093), AGGGguaauu (SEQ ID NO.: 7094), AGGGguacga (SEQ ID NO.: 7095), AGGGguacgu (SEQ ID NO.: 7096), AGGGguagga (SEQ ID NO.: 7097), AGGGguaggu (SEQ ID NO.: 7098), AGGGguauac (SEQ ID NO.: 7099), AGGGguauga (SEQ ID NO.: 7100), AGGGguaugg (SEQ ID NO.: 7101), AGGGguaugu (SEQ ID NO.: 7102), AGGGgucagu (SEQ ID NO.: 7103), AGGGgucugu (SEQ ID NO.: 7104), AGGGgugaga (SEQ ID NO.: 7105), AGGGgugagc (SEQ ID NO.: 7106), AGGGgugagg (SEQ ID NO.: 7107), AGGGgugagu (SEQ ID NO.: 7108), AGGGgugggu (SEQ ID NO.: 7109), AGGUguaagg (SEQ ID NO.: 7110), AGGUguaagu (SEQ ID NO. : 7111), AGGUguaggu (SEQ ID NO.: 7112), AGGUgugagu (SEQ ID NO. : 7113), AGGUguugcu (SEQ ID NO. : 7114), AGGUguuggu (SEQ ID NO. : 7115), AGUAguaagu (SEQ ID NO. : 7116), AGUAguacgu (SEQ ID NO.: 7117), AGUAgugagu (SEQ ID NO.: 7118), AGUAguuagu (SEQ ID NO.: 7119), AGUAuuggua (SEQ ID NO.: 7120), AGUCagacag (SEQ ID NO.: 7121), AGUCgggcuc (SEQ ID NO.: 7122), AGUCguaagu (SEQ ID NO.: 7123), AGUCguaucc (SEQ ID NO.: 7124), AGUCgugagu (SEQ ID NO.: 7125), AGUCucugca (SEQ ID NO.: 7126), AGUGaguaag (SEQ ID NO.: 7127), AGUGguaaaa (SEQ ID NO.: 7128), AGUGguaaag (SEQ ID NO.: 7129), AGUGguaaau (SEQ ID NO.: 7130), AGUGguaacc (SEQ ID NO.: 7131), AGUGguaaga (SEQ ID NO.: 7132), AGUGguaagc (SEQ ID NO.: 7133), AGUGguaagg (SEQ ID NO.: 7134), AGUGguaagu (SEQ ID NO.: 7135), AGUGguaauc (SEQ ID NO.: 7136), AGUGguaaug (SEQ ID NO.: 7137), AGUGguaauu (SEQ ID NO.: 7138), AGUGguacgu (SEQ ID NO.: 7139), AGUGguagga (SEQ ID NO.: 7140), AGUGguaggu (SEQ ID NO.: 7141), AGUGguauaa (SEQ ID NO.: 7142), AGUGguauac (SEQ ID NO.: 7143), AGUGguauca (SEQ ID NO.: 7144), AGUGguauga (SEQ ID NO.: 7145), AGUGguaugu (SEQ ID NO.: 7146), AGUGgucagu (SEQ ID NO.: 7147), AGUGgugacu (SEQ ID NO.: 7148), AGUGgugaga (SEQ ID NO.: 7149), AGUGgugagc (SEQ ID NO.: 7150),
AGUGgugagg (SEQ ID NO.: 7151), AGUGgugagu (SEQ ID NO.: 7152), AGUGgugggu (SEQ ID NO.: 7153), AGUGguuggu (SEQ ID NO.: 7154), AGUGguuugu (SEQ ID NO.: 7155), AGUGuccugg (SEQ ID NO.: 7156), AGUUcacggg (SEQ ID NO.: 7157), AGUUgcacgu (SEQ ID NO.: 7158), AGUUguaagc (SEQ ID NO.: 7159), AGUUguaagu (SEQ ID NO.: 7160), AGUUguagau (SEQ ID NO.: 7161), AGUUguaggu (SEQ ID NO.: 7162), AGUUgugagu (SEQ ID NO.: 7163), AUAAagaaga (SEQ ID NO.: 7164), AUAAcuggug (SEQ ID NO.: 7165), AUAAguaacc (SEQ ID NO.: 7166), AUAAguaaga (SEQ ID NO.: 7167), AUAAguaagc (SEQ ID NO.: 7168), AUAAguaagu (SEQ ID NO.: 7169), AUAAguaaug (SEQ ID NO.: 7170), AUAAguacau (SEQ ID NO.: 7171), AUAAguacug (SEQ ID NO.: 7172), AUAAguaggu (SEQ ID NO.: 7173), AUAAguauga (SEQ ID NO.: 7174), AUAAguaugc (SEQ ID NO.: 7175), AUAAguaugu (SEQ ID NO.: 7176), AUAAguauug (SEQ ID NO.: 7177), AUAAgugaga (SEQ ID NO.: 7178), AUAAgugagc (SEQ ID NO.: 7179), AUAAgugagu (SEQ ID NO.: 7180), AUAAgugugu (SEQ ID NO.: 7181), AUACcugguc (SEQ ID NO.: 7182), AUACguaagg (SEQ ID NO.: 7183), AUACguaagu (SEQ ID NO.: 7184), AUACgugagu (SEQ ID NO.: 7185), AUAGcgaaga (SEQ ID NO.: 7186), AUAGgcaagc (SEQ ID NO.: 7187), AUAGgcaagu (SEQ ID NO.: 7188), AUAGgcaugu (SEQ ID NO.: 7189), AUAGgcgagu (SEQ ID NO.: 7190), AUAGguaaaa (SEQ ID NO.: 7191), AUAGguaaac (SEQ ID NO.: 7192), AUAGguaaag (SEQ ID NO.: 7193), AUAGguaaau (SEQ ID NO.: 7194), AUAGguaaca (SEQ ID NO.: 7195), AUAGguaacu (SEQ ID NO.: 7196), AUAGguaaga (SEQ ID NO.: 7197), AUAGguaagc (SEQ ID NO.: 7198), AUAGguaagg (SEQ ID NO.: 7199), AUAGguaagu (SEQ ID NO.: 7200), AUAGguaaua (SEQ ID NO.: 7201), AUAGguaauc (SEQ ID NO.: 7202), AUAGguaaug (SEQ ID NO.: 7203), AUAGguaauu (SEQ ID NO.: 7204), AUAGguacag (SEQ ID NO.: 7205), AUAGguacau (SEQ ID NO.: 7206), AUAGguacca (SEQ ID NO.: 7207), AUAGguacgu (SEQ ID NO.: 7208), AUAGguacuc (SEQ ID NO.: 7209), AUAGguacug (SEQ ID NO.: 7210), AUAGguacuu (SEQ ID NO.: 7211), AUAGguagau (SEQ ID NO.: 7212), AUAGguagga (SEQ ID NO.: 7213), AUAGguaggc (SEQ ID NO.: 7214), AUAGguaggg (SEQ ID NO.: 7215), AUAGguaggu (SEQ ID NO.: 7216), AUAGguaguc (SEQ ID NO.: 7217), AUAGguaguu (SEQ ID NO.: 7218), AUAGguauag (SEQ ID NO.: 7219), AUAGguauau (SEQ ID NO.: 7220), AUAGguauga (SEQ ID NO.: 7221), AUAGguaugc (SEQ ID NO.: 7222), AUAGguaugg (SEQ ID NO.: 7223), AUAGguaugu (SEQ ID NO.: 7224), AUAGguauug (SEQ ID NO.: 7225), AUAGguauuu (SEQ ID NO.: 7226), AUAGgucagu (SEQ ID NO.: 7227), AUAGgucugc (SEQ ID NO.: 7228), AUAGgugaaa (SEQ ID NO.: 7229), AUAGgugaau (SEQ ID NO.: 7230), AUAGgugaca (SEQ ID NO.: 7231), AUAGgugaga (SEQ ID NO.: 7232), AUAGgugagc (SEQ ID NO.: 7233), AUAGgugagg (SEQ ID NO.: 7234), AUAGgugagu (SEQ ID NO.: 7235), AUAGgugaua (SEQ ID NO.: 7236), AUAGgugaug (SEQ ID NO.: 7237), AUAGgugcgu (SEQ ID NO.: 7238), AUAGgugcuc (SEQ ID NO.: 7239), AUAGgugggu (SEQ ID NO.: 7240), AUAGguguga (SEQ ID NO.: 7241), AUAGgugugu (SEQ ID NO.: 7242), AUAGguguug (SEQ ID NO.: 7243), AUAGguuagg (SEQ ID NO.: 7244), AUAGguuagu (SEQ ID NO.: 7245), AUAGguucgu (SEQ ID NO.: 7246), AUAGguuggc (SEQ ID NO.: 7247), AUAGguuggu (SEQ ID NO.: 7248), AUAGguuugu (SEQ ID NO.: 7249), AUAGguuuuc (SEQ ID NO.: 7250), AUAGugaucu (SEQ ID NO.: 7251), AUAUauaaga (SEQ ID NO.: 7252), AUAUauccug (SEQ ID NO.: 7253), AUAUcuggug (SEQ ID NO.: 7254), AUAUgcaggu (SEQ ID NO.: 7255), AUAUgguaca (SEQ ID NO.: 7256), AUAUguaaaa (SEQ ID NO.: 7257), AUAUguaaga (SEQ ID NO.: 7258), AUAUguaagu (SEQ ID NO.: 7259), AUAUguacgu (SEQ ID NO.: 7260), AUAUguaggu (SEQ ID NO.: 7261), AUAUguagua (SEQ ID NO.: 7262), AUAUguaucc (SEQ
ID NO.: 7263), AUAUguaugu (SEQ ID NO.: 7264), AUAUgugagc (SEQ ID NO.: 7265), AUAUgugagu (SEQ ID NO.: 7266), AUAUguuggu (SEQ ID NO.: 7267), AUCAaggaac (SEQ ID NO.: 7268), AUCAauaucc (SEQ ID NO.: 7269), AUCAguaaga (SEQ ID NO.: 7270), AUCAguaagg (SEQ ID NO.: 7271), AUCAguaagu (SEQ ID NO.: 7272), AUCAguaauc (SEQ ID NO.: 7273), AUCAguaugu (SEQ ID NO.: 7274), AUCAgugaga (SEQ ID NO.: 7275), AUCAgugagu (SEQ ID NO.: 7276), AUCAgugcgu (SEQ ID NO.: 7277), AUCAguuaag (SEQ ID NO.: 7278), AUCAguuaau (SEQ ID NO.: 7279), AUCCagaaac (SEQ ID NO.: 7280), AUCCauaagu (SEQ ID NO.: 7281), AUCCcuuagg (SEQ ID NO.: 7282), AUCCguaagu (SEQ ID NO.: 7283), AUCCgugagc (SEQ ID NO.: 7284), AUCCgugagu (SEQ ID NO.: 7285), AUCGgcaagu (SEQ ID NO.: 7286), AUCGguaaag (SEQ ID NO.: 7287), AUCGguaaau (SEQ ID NO.: 7288), AUCGguaaga (SEQ ID NO.: 7289), AUCGguaagc (SEQ ID NO.: 7290), AUCGguaagg (SEQ ID NO.: 7291), AUCGguaagu (SEQ ID NO.: 7292), AUCGguaaua (SEQ ID NO.: 7293), AUCGguaauc (SEQ ID NO.: 7294), AUCGguaaug (SEQ ID NO.: 7295), AUCGguacaa (SEQ ID NO.: 7296), AUCGguacgg (SEQ ID NO.: 7297), AUCGguaggu (SEQ ID NO.: 7298), AUCGguauaa (SEQ ID NO.: 7299), AUCGguaugg (SEQ ID NO.: 7300), AUCGguaugu (SEQ ID NO.: 7301), AUCGguauuu (SEQ ID NO.: 7302), AUCGgucaau (SEQ ID NO.: 7303), AUCGgucagu (SEQ ID NO.: 7304), AUCGgugaga (SEQ ID NO.: 7305), AUCGgugagc (SEQ ID NO.: 7306), AUCGgugagg (SEQ ID NO 7307), AUCGgugagu (SEQ ID NO.: 7308), AUCGgugcgg (SEQ ID NO.: 7309), AUCGgugcgu (SEQ ID NO. : 7310), AUCGgugggu (SEQ ID NO. : 7311), AUCGguuagu (SEQ ID NO. : 7312), AUCUggugag (SEQ ID NO.: 7313), AUCUguaaga (SEQ ID NO.: 7314), AUCUguaagc (SEQ ID NO.: 7315), AUCUguaagg (SEQ ID NO. : 7316), AUCUguaagu (SEQ ID NO. : 7317), AUCUguaucc (SEQ ID NO.: 7318), AUCUguaugu (SEQ ID NO.: 7319), AUCUgugaga (SEQ ID NO.: 7320), AUCUgugagc (SEQ ID NO.: 7321), AUCUgugagu (SEQ ID NO.: 7322), AUCUguggug (SEQ ID NO.: 7323), AUGAaaaggu (SEQ ID NO.: 7324), AUGAggugag (SEQ ID NO.: 7325), AUGAgguuug (SEQ ID NO.: 7326), AUGAguaaga (SEQ ID NO.: 7327), AUGAguaagu (SEQ ID NO.: 7328), AUGAguacuu (SEQ ID NO.: 7329), AUGAguaggu (SEQ ID NO.: 7330), AUGAguauga (SEQ ID NO.: 7331), AUGAguaugc (SEQ ID NO.: 7332), AUGAguaugu (SEQ ID NO.: 7333), AUGAgugagu (SEQ ID NO.: 7334), AUGAguguga (SEQ ID NO.: 7335), AUGAuauccu (SEQ ID NO.: 7336), AUGAugagga (SEQ ID NO.: 7337), AUGAuuugaa (SEQ ID NO.: 7338), AUGCguaaga (SEQ ID NO.: 7339), AUGCguaagu (SEQ ID NO.: 7340), AUGCgugagu (SEQ ID NO.: 7341), AUGCgugcca (SEQ ID NO.: 7342), AUGGgcaagg (SEQ ID NO.: 7343), AUGGgcaagu (SEQ ID NO.: 7344), AUGGgcaggu (SEQ ID NO.: 7345), AUGGguaaaa (SEQ ID NO.: 7346), AUGGguaaac (SEQ ID NO.: 7347), AUGGguaaag (SEQ ID NO.: 7348), AUGGguaaau (SEQ ID NO.: 7349), AUGGguaacu (SEQ ID NO.: 7350), AUGGguaaga (SEQ ID NO.: 7351), AUGGguaagc (SEQ ID NO.: 7352), AUGGguaagg (SEQ ID NO.: 7353), AUGGguaagu (SEQ ID NO.: 7354), AUGGguaaua (SEQ ID NO.: 7355), AUGGguaauc (SEQ ID NO.: 7356), AUGGguaaug (SEQ ID NO.: 7357), AUGGguaauu (SEQ ID NO.: 7358), AUGGguacga (SEQ ID NO.: 7359), AUGGguacgg (SEQ ID NO.: 7360), AUGGguacgu (SEQ ID NO.: 7361), AUGGguacuu (SEQ ID NO.: 7362), AUGGguagga (SEQ ID NO.: 7363), AUGGguaggc (SEQ ID NO.: 7364), AUGGguaggg (SEQ ID NO.: 7365), AUGGguaggu (SEQ ID NO.: 7366), AUGGguauga (SEQ ID NO.: 7367), AUGGguaugc (SEQ ID NO.: 7368), AUGGguaugg (SEQ ID NO.: 7369), AUGGguaugu (SEQ ID NO.: 7370), AUGGguauuu (SEQ ID NO.: 7371), AUGGgucagu (SEQ ID NO.: 7372), AUGGgucugc (SEQ ID NO.: 7373), AUGGgugaau (SEQ ID NO.: 7374), AUGGgugaga (SEQ ID NO.: 7375),
AUGGgugagc (SEQ ID NO.: 7376), AUGGgugagg (SEQ ID NO.: 7377), AUGGgugagu (SEQ ID NO.: 7378), AUGGgugggu (SEQ ID NO.: 7379), AUGGgugugu (SEQ ID NO.: 7380), AUGGguuaau (SEQ ID NO.: 7381), AUGGguuagu (SEQ ID NO.: 7382), AUGGguucag (SEQ ID NO.: 7383), AUGGguuggu (SEQ ID NO.: 7384), AUGGguuugu (SEQ ID NO.: 7385), AUGGugguga (SEQ ID NO.: 7386), AUGUacucau (SEQ ID NO.: 7387), AUGUgcaagu (SEQ ID NO.: 7388), AUGUguaaga (SEQ ID NO.: 7389), AUGUguaagc (SEQ ID NO.: 7390), AUGUguaagu (SEQ ID NO.: 7391), AUGUguaugu (SEQ ID NO.: 7392), AUGUgugagu (SEQ ID NO.: 7393), AUGUguggug (SEQ ID NO.: 7394), AUGUguguga (SEQ ID NO.: 7395), AUGUuggugg (SEQ ID NO.: 7396), AUUAauaucc (SEQ ID NO.: 7397), AUUAguaagu (SEQ ID NO.: 7398), AUUAguaggu (SEQ ID NO.: 7399), AUUAguaugu (SEQ ID NO.: 7400), AUUAgugagu (SEQ ID NO.: 7401), AUUAuuccaa (SEQ ID NO 7402), AUUCguaagu (SEQ ID NO.: 7403), AUUCgugagu (SEQ ID NO.: 7404), AUUGgauauc (SEQ ID NO.: 7405), AUUGgcaaga (SEQ ID NO.: 7406), AUUGgcaagu (SEQ ID NO.: 7407), AUUGgcacgu (SEQ ID NO.: 7408), AUUGgcaugc (SEQ ID NO.: 7409), AUUGguaaaa (SEQ ID NO.: 7410), AUUGguaaag (SEQ ID NO.: 7411), AUUGguaaau (SEQ ID NO.: 7412), AUUGguaaga (SEQ ID NO.: 7413), AUUGguaagc (SEQ ID NO.: 7414), AUUGguaagg (SEQ ID NO.: 7415), AUUGguaagu (SEQ ID NO.: 7416), AUUGguaaua (SEQ ID NO.: 7417), AUUGguaauc (SEQ ID NO.: 7418), AUUGguaauu (SEQ ID NO.: 7419), AUUGguacga (SEQ ID NO.: 7420), AUUGguacgu (SEQ ID NO.: 7421), AUUGguacuu (SEQ ID NO.: 7422), AUUGguagga (SEQ ID NO.: 7423), AUUGguaggc (SEQ ID NO.: 7424), AUUGguaggg (SEQ ID NO.: 7425), AUUGguaggu (SEQ ID NO.: 7426), AUUGguagua (SEQ ID NO.: 7427), AUUGguaguu (SEQ ID NO.: 7428), AUUGguauga (SEQ ID NO.: 7429), AUUGguaugc (SEQ ID NO.: 7430), AUUGguaugu (SEQ ID NO.: 7431), AUUGguauua (SEQ ID NO.: 7432), AUUGguauug (SEQ ID NO.: 7433), AUUGgucagu (SEQ ID NO.: 7434), AUUGgucugu (SEQ ID NO.: 7435), AUUGgugaga (SEQ ID NO.: 7436), AUUGgugagc (SEQ ID NO.: 7437), AUUGgugagg (SEQ ID NO.: 7438), AUUGgugagu (SEQ ID NO.: 7439), AUUGgugaug (SEQ ID NO.: 7440), AUUGgugcga (SEQ ID NO.: 7441), AUUGgugcgu (SEQ ID NO.: 7442), AUUGgugggu (SEQ ID NO.: 7443), AUUGguggua (SEQ ID NO.: 7444), AUUGguguga (SEQ ID NO.: 7445), AUUGguuagu (SEQ ID NO.: 7446), AUUGguucgu (SEQ ID NO.: 7447), AUUUaucuca (SEQ ID NO.: 7448), AUUUgaugug (SEQ ID NO.: 7449), AUUUgcaggu (SEQ ID NO.: 7450), AUUUggugag (SEQ ID NO.: 7451), AUUUguaaga (SEQ ID NO.: 7452), AUUUguaagc (SEQ ID NO.: 7453), AUUUguaagu (SEQ ID NO.: 7454), AUUUguacgu (SEQ ID NO.: 7455), AUUUguaucc (SEQ ID NO.: 7456), AUUUguaugu (SEQ ID NO.: 7457), AUUUgugagu (SEQ ID NO.: 7458), CAAAaacagg (SEQ ID NO.: 7459), CAAAaaggca (SEQ ID NO.: 7460), CAAAaaggua (SEQ ID NO.: 7461), CAAAaaggug (SEQ ID NO.: 7462), CAAAagguca (SEQ ID NO.: 7463), CAAAgguaag (SEQ ID NO.: 7464), CAAAguaaag (SEQ ID NO.: 7465), CAAAguaaau (SEQ ID NO.: 7466), CAAAguaaga (SEQ ID NO.: 7467), CAAAguaagc (SEQ ID NO.: 7468), CAAAguaagg (SEQ ID NO.: 7469), CAAAguaagu (SEQ ID NO.: 7470), CAAAguaaua (SEQ ID NO.: 7471), CAAAguaauc (SEQ ID NO.: 7472), CAAAguaauu (SEQ ID NO.: 7473), CAAAguacaa (SEQ ID NO.: 7474), CAAAguacgg (SEQ ID NO.: 7475), CAAAguacgu (SEQ ID NO.: 7476), CAAAguacug (SEQ ID NO.: 7477), CAAAguagga (SEQ ID NO.: 7478), CAAAguaggu (SEQ ID NO.: 7479), CAAAguauaa (SEQ ID NO.: 7480), CAAAguaucu (SEQ ID NO.: 7481), CAAAguaugg (SEQ ID NO.: 7482), CAAAguaugu (SEQ ID NO.: 7483), CAAAguauug (SEQ ID NO.: 7484), CAAAgucagu (SEQ ID NO.: 7485), CAAAgucccc (SEQ ID NO.: 7486), CAAAgucugu (SEQ ID NO.: 7487), CAAAgugaga (SEQ
ID NO.: 7488), CAAAgugagc (SEQ ID NO.: 7489), CAAAgugagu (SEQ ID NO.: 7490), CAAAgugggu (SEQ ID NO.: 7491), CAAAguuagc (SEQ ID NO.: 7492), CAAAguuagu (SEQ ID NO.: 7493), CAACauaagu (SEQ ID NO.: 7494), CAACaucaac (SEQ ID NO.: 7495), CAACcuggua (SEQ ID NO.: 7496), CAACguaagc (SEQ ID NO.: 7497), CAACguaagg (SEQ ID NO.: 7498), CAACguaagu (SEQ ID NO.: 7499), CAACguaugu (SEQ ID NO.: 7500), CAACgugagc (SEQ ID NO.: 7501), CAACgugagg (SEQ ID NO.: 7502), CAACgugagu (SEQ ID NO.: 7503), CAAGagacug (SEQ ID NO.: 7504), CAAGauaucc (SEQ ID NO.: 7505), CAAGgcaacu (SEQ ID NO.: 7506), CAAGgcaaga (SEQ ID NO.: 7507), CAAGgcaagc (SEQ ID NO.: 7508), CAAGgcaagg (SEQ ID NO.: 7509), CAAGgcaagu (SEQ ID NO.: 7510), CAAGgcacag (SEQ ID NO.: 7511), CAAGgcacgu (SEQ ID NO.: 7512), CAAGgcaggu (SEQ ID NO.: 7513), CAAGgcaugu (SEQ ID NO : 7514), CAAGgccagu (SEQ ID NO : 7515), CAAGgcccaa (SEQ ID NO.: 7516), CAAGgcgagc (SEQ ID NO.: 7517), CAAGgcgagg (SEQ ID NO.: 7518), CAAGgcgggc (SEQ ID NO.: 7519), CAAGgcuaca (SEQ ID NO.: 7520), CAAGgcuagu (SEQ ID NO.: 7521), CAAGgcuggu (SEQ ID NO.: 7522), CAAGguaaaa (SEQ ID NO.: 7523), CAAGguaaac (SEQ ID NO.: 7524), CAAGguaaag (SEQ ID NO.: 7525), CAAGguaaau (SEQ ID NO.: 7526), CAAGguaaca (SEQ ID NO.: 7527), CAAGguaacc (SEQ ID NO.: 7528), CAAGguaacg (SEQ ID NO.: 7529), CAAGguaacu (SEQ ID NO.: 7530), CAAGguaaga (SEQ ID NO.: 7531), CAAGguaagc (SEQ ID NO.: 7532), CAAGguaagg (SEQ ID NO.: 7533), CAAGguaagu (SEQ ID NO.: 7534), CAAGguaaua (SEQ ID NO.: 7535), CAAGguaauc (SEQ ID NO.: 7536), CAAGguaaug (SEQ ID NO.: 7537), CAAGguaauu (SEQ ID NO.: 7538), CAAGguacaa (SEQ ID NO.: 7539), CAAGguacac (SEQ ID NO.: 7540), CAAGguacag (SEQ ID NO.: 7541), CAAGguacau (SEQ ID NO.: 7542), CAAGguacca (SEQ ID NO.: 7543), CAAGguaccc (SEQ ID NO.: 7544), CAAGguaccg (SEQ ID NO.: 7545), CAAGguaccu (SEQ ID NO.: 7546), CAAGguacga (SEQ ID NO.: 7547), CAAGguacgg (SEQ ID NO.: 7548), CAAGguacgu (SEQ ID NO.: 7549), CAAGguacua (SEQ ID NO.: 7550), CAAGguacuc (SEQ ID NO.: 7551), CAAGguacug (SEQ ID NO.: 7552), CAAGguacuu (SEQ ID NO.: 7553), CAAGguagaa (SEQ ID NO.: 7554), CAAGguagac (SEQ ID NO.: 7555), CAAGguagag (SEQ ID NO.: 7556), CAAGguagau (SEQ ID NO.: 7557), CAAGguagca (SEQ ID NO.: 7558), CAAGguagcu (SEQ ID NO.: 7559), CAAGguagga (SEQ ID NO.: 7560), CAAGguaggc (SEQ ID NO.: 7561), CAAGguaggg (SEQ ID NO.: 7562), CAAGguaggu (SEQ ID NO.: 7563), CAAGguagua (SEQ ID NO.: 7564), CAAGguaguc (SEQ ID NO.: 7565), CAAGguagug (SEQ ID NO.: 7566), CAAGguaguu (SEQ ID NO.: 7567), CAAGguauaa (SEQ ID NO.: 7568), CAAGguauac (SEQ ID NO.: 7569), CAAGguauag (SEQ ID NO.: 7570), CAAGguauau (SEQ ID NO.: 7571), CAAGguauca (SEQ ID NO.: 7572), CAAGguaucc (SEQ ID NO.: 7573), CAAGguaucu (SEQ ID NO.: 7574), CAAGguauga (SEQ ID NO.: 7575), CAAGguaugc (SEQ ID NO.: 7576), CAAGguaugg (SEQ ID NO.: 7577), CAAGguaugu (SEQ ID NO.: 7578), CAAGguauua (SEQ ID NO.: 7579), CAAGguauuc (SEQ ID NO.: 7580), CAAGguauug (SEQ ID NO.: 7581), CAAGguauuu (SEQ ID NO.: 7582), CAAGgucaaa (SEQ ID NO.: 7583), CAAGgucaau (SEQ ID NO.: 7584), CAAGgucacu (SEQ ID NO.: 7585), CAAGgucaga (SEQ ID NO.: 7586), CAAGgucagc (SEQ ID NO.: 7587), CAAGgucagg (SEQ ID NO.: 7588), CAAGgucagu (SEQ ID NO.: 7589), CAAGgucaua (SEQ ID NO.: 7590), CAAGgucaug (SEQ ID NO.: 7591), CAAGgucauu (SEQ ID NO.: 7592), CAAGgucccu (SEQ ID NO.: 7593), CAAGguccua (SEQ ID NO.: 7594), CAAGguccug (SEQ ID NO.: 7595), CAAGgucgaa (SEQ ID NO.: 7596), CAAGgucgag (SEQ ID NO.: 7597), CAAGgucgga (SEQ ID NO.: 7598), CAAGgucgug (SEQ ID NO.: 7599), CAAGgucuac (SEQ ID NO.: 7600),
CAAGgucuau (SEQ ID NO.: 7601), CAAGgucucu (SEQ ID NO.: 7602), CAAGgucuga (SEQ ID NO.: 7603), CAAGgucugg (SEQ ID NO.: 7604), CAAGgucugu (SEQ ID NO.: 7605), CAAGgucuuc (SEQ ID NO.: 7606), CAAGgugaaa (SEQ ID NO.: 7607), CAAGgugaag (SEQ ID NO.: 7608), CAAGgugaau (SEQ ID NO.: 7609), CAAGgugaca (SEQ ID NO.: 7610), CAAGgugacc (SEQ ID NO.: 7611), CAAGgugacg (SEQ ID NO.: 7612), CAAGgugacu (SEQ ID NO.: 7613), CAAGgugaga (SEQ ID NO.: 7614), CAAGgugagc (SEQ ID NO.: 7615), CAAGgugagg (SEQ ID NO.: 7616), CAAGgugagu (SEQ ID NO.: 7617), CAAGgugaua (SEQ ID NO.: 7618), CAAGgugauc (SEQ ID NO.: 7619), CAAGgugaug (SEQ ID NO.: 7620), CAAGgugauu (SEQ ID NO.: 7621), CAAGgugcac (SEQ ID NO.: 7622), CAAGgugcag (SEQ ID NO.: 7623), CAAGgugcau (SEQ ID NO.: 7624), CAAGgugcca (SEQ ID NO.: 7625), CAAGgugccc (SEQ ID NO.: 7626), CAAGgugccu (SEQ ID NO.: 7627), CAAGgugcga (SEQ ID NO.: 7628), CAAGgugcgc (SEQ ID NO.: 7629), CAAGgugcgu (SEQ ID NO.: 7630), CAAGgugcuc (SEQ ID NO.: 7631), CAAGgugcug (SEQ ID NO.: 7632), CAAGgugcuu (SEQ ID NO.: 7633), CAAGguggag (SEQ ID NO.: 7634), CAAGguggcu (SEQ ID NO.: 7635), CAAGguggga (SEQ ID NO.: 7636), CAAGgugggc (SEQ ID NO.: 7637), CAAGgugggg (SEQ ID NO.: 7638), CAAGgugggu (SEQ ID NO.: 7639), CAAGguggua (SEQ ID NO.: 7640), CAAGgugguu (SEQ ID NO.: 7641), CAAGguguac (SEQ ID NO.: 7642), CAAGguguag (SEQ ID NO.: 7643), CAAGguguau (SEQ ID NO.: 7644), CAAGgugucu (SEQ ID NO.: 7645), CAAGgugugc (SEQ ID NO.: 7646), CAAGgugugg (SEQ ID NO.: 7647), CAAGgugugu (SEQ ID NO.: 7648), CAAGguguuc (SEQ ID NO.: 7649), CAAGguguug (SEQ ID NO.: 7650), CAAGguuaaa (SEQ ID NO.: 7651), CAAGguuaac (SEQ ID NO.: 7652), CAAGguuacu (SEQ ID NO.: 7653), CAAGguuaga (SEQ ID NO.: 7654), CAAGguuagc (SEQ ID NO.: 7655), CAAGguuagg (SEQ ID NO.: 7656), CAAGguuagu (SEQ ID NO.: 7657), CAAGguuaua (SEQ ID NO.: 7658), CAAGguuauc (SEQ ID NO.: 7659), CAAGguuauu (SEQ ID NO.: 7660), CAAGguucga (SEQ ID NO.: 7661), CAAGguucgu (SEQ ID NO.: 7662), CAAGguucua (SEQ ID NO.: 7663), CAAGguucuc (SEQ ID NO.: 7664), CAAGguugag (SEQ ID NO.: 7665), CAAGguugga (SEQ ID NO.: 7666), CAAGguuggc (SEQ ID NO.: 7667), CAAGguuggg (SEQ ID NO.: 7668), CAAGguuggu (SEQ ID NO.: 7669), CAAGguugua (SEQ ID NO.: 7670), CAAGguuuaa (SEQ ID NO.: 7671), CAAGguuucc (SEQ ID NO.: 7672), CAAGguuucu (SEQ ID NO.: 7673), CAAGguuuga (SEQ ID NO.: 7674), CAAGguuugc (SEQ ID NO.: 7675), CAAGguuugg (SEQ ID NO.: 7676), CAAGguuugu (SEQ ID NO.: 7677), CAAGguuuuu (SEQ ID NO.: 7678), CAAUauccuu (SEQ ID NO.: 7679), CAAUcuaagu (SEQ ID NO.: 7680), CAAUgcaagu (SEQ ID NO.: 7681), CAAUgcuggg (SEQ ID NO.: 7682), CAAUguaacc (SEQ ID NO.: 7683), CAAUguaaga (SEQ ID NO.: 7684), CAAUguaagc (SEQ ID NO.: 7685), CAAUguaagg (SEQ ID NO.: 7686), CAAUguaagu (SEQ ID NO.: 7687), CAAUguacau (SEQ ID NO.: 7688), CAAUguacgu (SEQ ID NO.: 7689), CAAUguaggg (SEQ ID NO.: 7690), CAAUguaggu (SEQ ID NO.: 7691), CAAUguagug (SEQ ID NO.: 7692), CAAUguaugu (SEQ ID NO.: 7693), CAAUgugagg (SEQ ID NO.: 7694), CAAUgugagu (SEQ ID NO.: 7695), CAAUgugcgu (SEQ ID NO.: 7696), CAAUgugggu (SEQ ID NO.: 7697), CAAUgugugu (SEQ ID NO.: 7698), CACAgguaaa (SEQ ID NO.: 7699), CACAgguuag (SEQ ID NO.: 7700), CACAguaacg (SEQ ID NO.: 7701), CACAguaaga (SEQ ID NO.: 7702), CACAguaagc (SEQ ID NO.: 7703), CACAguaagg (SEQ ID NO.: 7704), CACAguaagu (SEQ ID NO.: 7705), CACAguaaug (SEQ ID NO.: 7706), CACAguacga (SEQ ID NO.: 7707), CACAguacgu (SEQ ID NO.: 7708), CACAguaggu (SEQ ID NO.: 7709), CACAgugaga (SEQ ID NO.: 7710), CACAgugagg (SEQ ID NO.: 7711), CACAgugagu (SEQ ID NO.: 7712), CACAgugggu (SEQ
ID NO.: 7713), CACAguguga (SEQ ID NO.: 7714), CACAguuagu (SEQ ID NO.: 7715), CACAguugag (SEQ ID NO.: 7716), CACAguuugu (SEQ ID NO.: 7717), CACCcagccu (SEQ ID NO.: 7718), CACCguaagu (SEQ ID NO.: 7719), CACCguacgc (SEQ ID NO.: 7720), CACCgugagu (SEQ ID NO.: 7721), CACCgugcgu (SEQ ID NO.: 7722), CACCguguga (SEQ ID NO.: 7723), CACGagggug (SEQ ID NO.: 7724), CACGgcaagc (SEQ ID NO.: 7725), CACGgcaagu (SEQ ID NO.: 7726), CACGgcguga (SEQ ID NO.: 7727), CACGguaaaa (SEQ ID NO.: 7728), CACGguaaac (SEQ ID NO.: 7729), CACGguaaag (SEQ ID NO.: 7730), CACGguaaau (SEQ ID NO.: 7731), CACGguaaca (SEQ ID NO.: 7732), CACGguaacc (SEQ ID NO.: 7733), CACGguaacu (SEQ ID NO.: 7734), CACGguaaga (SEQ ID NO.: 7735), CACGguaagc (SEQ ID NO.: 7736), CACGguaagg (SEQ ID NO.: 7737), CACGguaagu (SEQ ID NO.: 7738), CACGguaauc (SEQ ID NO : 7739), CACGguaaug (SEQ ID NO.: 7740), CACGguaauu (SEQ ID NO.: 7741), CACGguacaa (SEQ ID NO.: 7742), CACGguacag (SEQ ID NO.: 7743), CACGguacau (SEQ ID NO.: 7744), CACGguaccu (SEQ ID NO.: 7745), CACGguacga (SEQ ID NO.: 7746), CACGguacgc (SEQ ID NO.: 7747), CACGguacgu (SEQ ID NO.: 7748), CACGguacuc (SEQ ID NO.: 7749), CACGguacug (SEQ ID NO.: 7750), CACGguagau (SEQ ID NO.: 7751), CACGguagga (SEQ ID NO.: 7752), CACGguaggc (SEQ ID NO.: 7753), CACGguaggg (SEQ ID NO.: 7754), CACGguaggu (SEQ ID NO.: 7755), CACGguauac (SEQ ID NO.: 7756), CACGguaucc (SEQ ID NO.: 7757), CACGguaugg (SEQ ID NO.: 7758), CACGguaugu (SEQ ID NO.: 7759), CACGgucagu (SEQ ID NO.: 7760), CACGgugaga (SEQ ID NO.: 7761), CACGgugagc (SEQ ID NO.: 7762), CACGgugagg (SEQ ID NO.: 7763), CACGgugagu (SEQ ID NO.: 7764), CACGgugauu (SEQ ID NO.: 7765), CACGgugccc (SEQ ID NO.: 7766), CACGgugcgc (SEQ ID NO.: 7767), CACGgugggc (SEQ ID NO.: 7768), CACGgugggu (SEQ ID NO.: 7769), CACGgugugu (SEQ ID NO.: 7770), CACGguuagu (SEQ ID NO.: 7771), CACUgcacgu (SEQ ID NO.: 7772), CACUguaagc (SEQ ID NO.: 7773), CACUguaagg (SEQ ID NO.: 7774), CACUguaagu (SEQ ID NO.: 7775), CACUguaaug (SEQ ID NO.: 7776), CACUguacgu (SEQ ID NO.: 7777), CACUguaucc (SEQ ID NO.: 7778), CACUguauga (SEQ ID NO.: 7779), CACUgugagc (SEQ ID NO.: 7780), CACUgugagu (SEQ ID NO.: 7781), CACUgugcgu (SEQ ID NO.: 7782), CACUguggua (SEQ ID NO.: 7783), CAGAacuucu (SEQ ID NO.: 7784), CAGAagggag (SEQ ID NO.: 7785), CAGAgguaaa (SEQ ID NO.: 7786), CAGAgguaca (SEQ ID NO.: 7787), CAGAguaaaa (SEQ ID NO.: 7788), CAGAguaacu (SEQ ID NO.: 7789), CAGAguaaga (SEQ ID NO.: 7790), CAGAguaagc (SEQ ID NO.: 7791), CAGAguaagg (SEQ ID NO.: 7792), CAGAguaagu (SEQ ID NO.: 7793), CAGAguacgu (SEQ ID NO.: 7794), CAGAguaggg (SEQ ID NO.: 7795), CAGAguaggu (SEQ ID NO.: 7796), CAGAguaucc (SEQ ID NO.: 7797), CAGAguauga (SEQ ID NO.: 7798), CAGAguaugu (SEQ ID NO.: 7799), CAGAgucagg (SEQ ID NO.: 7800), CAGAgugaga (SEQ ID NO.: 7801), CAGAgugagg (SEQ ID NO.: 7802), CAGAgugagu (SEQ ID NO.: 7803), CAGAgugcgu (SEQ ID NO.: 7804), CAGAgugggu (SEQ ID NO.: 7805), CAGCagcaca (SEQ ID NO.: 7806), CAGCagcacc (SEQ ID NO.: 7807), CAGCguaaga (SEQ ID NO.: 7808), CAGCguaagc (SEQ ID NO.: 7809), CAGCguaagg (SEQ ID NO.: 7810), CAGCguaagu (SEQ ID NO. : 7811), CAGCguaugu (SEQ ID NO. : 7812), CAGCgugagu (SEQ ID NO.: 7813), CAGCugggcg (SEQ ID NO.: 7814), CAGGcuggug (SEQ ID NO.: 7815), CAGGgcaagu (SEQ ID NO.: 7816), CAGGgcaggc (SEQ ID NO.: 7817), CAGGguaaaa (SEQ ID NO.: 7818), CAGGguaaag (SEQ ID NO.: 7819), CAGGguaaau (SEQ ID NO.: 7820), CAGGguaacg (SEQ ID NO.: 7821), CAGGguaacu (SEQ ID NO.: 7822), CAGGguaaga (SEQ ID NO.: 7823), CAGGguaagc (SEQ ID NO.: 7824), CAGGguaagg (SEQ ID NO.: 7825),
CAGGguaagu (SEQ ID NO.: 7826), CAGGguaauc (SEQ ID NO.: 7827), CAGGguaaug (SEQ ID NO.: 7828), CAGGguaauu (SEQ ID NO.: 7829), CAGGguacag (SEQ ID NO.: 7830), CAGGguacau (SEQ ID NO.: 7831), CAGGguaccu (SEQ ID NO.: 7832), CAGGguacgu (SEQ ID NO.: 7833), CAGGguacug (SEQ ID NO.: 7834), CAGGguacuu (SEQ ID NO.: 7835), CAGGguagag (SEQ ID NO.: 7836), CAGGguagga (SEQ ID NO.: 7837), CAGGguaggg (SEQ ID NO.: 7838), CAGGguaggu (SEQ ID NO.: 7839), CAGGguagua (SEQ ID NO.: 7840), CAGGguaguu (SEQ ID NO.: 7841), CAGGguauaa (SEQ ID NO.: 7842), CAGGguauac (SEQ ID NO.: 7843), CAGGguauag (SEQ ID NO.: 7844), CAGGguauga (SEQ ID NO.: 7845), CAGGguaugc (SEQ ID NO.: 7846), CAGGguaugg (SEQ ID NO.: 7847), CAGGguaugu (SEQ ID NO.: 7848), CAGGgucacg (SEQ ID NO.: 7849), CAGGgucaga (SEQ ID NO.: 7850), CAGGgucagc (SEQ ID NO.: 7851), CAGGgucagg (SEQ ID NO.: 7852), CAGGgucagu (SEQ ID NO.: 7853), CAGGguccgu (SEQ ID NO.: 7854), CAGGgucugu (SEQ ID NO.: 7855), CAGGgugaca (SEQ ID NO.: 7856), CAGGgugaga (SEQ ID NO.: 7857), CAGGgugagc (SEQ ID NO.: 7858), CAGGgugagg (SEQ ID NO.: 7859), CAGGgugagu (SEQ ID NO.: 7860), CAGGgugcgu (SEQ ID NO.: 7861), CAGGgugggc (SEQ ID NO.: 7862), CAGGgugggu (SEQ ID NO.: 7863), CAGGgugugc (SEQ ID NO.: 7864), CAGGgugugu (SEQ ID NO.: 7865), CAGGguuagu (SEQ ID NO.: 7866), CAGGguucgu (SEQ ID NO.: 7867), CAGGguucua (SEQ ID NO.: 7868), CAGGguuggu (SEQ ID NO.: 7869), CAGGguuugu (SEQ ID NO.: 7870), CAGUgaacag (SEQ ID NO.: 7871), CAGUguaagc (SEQ ID NO.: 7872), CAGUguaagg (SEQ ID NO.: 7873), CAGUguaagu (SEQ ID NO.: 7874), CAGUguacgg (SEQ ID NO.: 7875), CAGUguaggu (SEQ ID NO.: 7876), CAGUguaucc (SEQ ID NO.: 7877), CAGUguauga (SEQ ID NO.: 7878), CAGUguaugu (SEQ ID NO.: 7879), CAGUguccaa (SEQ ID NO.: 7880), CAGUgucggu (SEQ ID NO.: 7881), CAGUgugaga (SEQ ID NO.: 7882), CAGUgugagc (SEQ ID NO.: 7883), CAGUgugagu (SEQ ID NO.: 7884), CAGUgugggu (SEQ ID NO.: 7885), CAGUgugugu (SEQ ID NO.: 7886), CAGUguuagu (SEQ ID NO.: 7887), CAUAaacugu (SEQ ID NO.: 7888), CAUAggucag (SEQ ID NO.: 7889), CAUAggugag (SEQ ID NO.: 7890), CAUAguaaag (SEQ ID NO.: 7891), CAUAguaaga (SEQ ID NO.: 7892), CAUAguaagc (SEQ ID NO.: 7893), CAUAguaagg (SEQ ID NO.: 7894), CAUAguaagu (SEQ ID NO.: 7895), CAUAguacgu (SEQ ID NO.: 7896), CAUAguaggu (SEQ ID NO.: 7897), CAUAguaugc (SEQ ID NO.: 7898), CAUAguaugu (SEQ ID NO.: 7899), CAUAgugaga (SEQ ID NO.: 7900), CAUAgugagu (SEQ ID NO.: 7901), CAUAgugcuu (SEQ ID NO.: 7902), CAUCauaucc (SEQ ID NO.: 7903), CAUCgccaug (SEQ ID NO.: 7904), CAUCguaaga (SEQ ID NO.: 7905), CAUCguaagu (SEQ ID NO.: 7906), CAUCguaugu (SEQ ID NO.: 7907), CAUCgugaga (SEQ ID NO.: 7908), CAUCgugagc (SEQ ID NO.: 7909), CAUCgugagu (SEQ ID NO.: 7910), CAUCguguga (SEQ ID NO.: 7911), CAUGauguuu (SEQ ID NO.: 7912), CAUGgccacu (SEQ ID NO.: 7913), CAUGgcgagu (SEQ ID NO.: 7914), CAUGggagag (SEQ ID NO.: 7915), CAUGguaaaa (SEQ ID NO.: 7916), CAUGguaaac (SEQ ID NO.: 7917), CAUGguaaag (SEQ ID NO.: 7918), CAUGguaaau (SEQ ID NO.: 7919), CAUGguaaca (SEQ ID NO.: 7920), CAUGguaacg (SEQ ID NO.: 7921), CAUGguaacu (SEQ ID NO.: 7922), CAUGguaaga (SEQ ID NO.: 7923), CAUGguaagc (SEQ ID NO.: 7924), CAUGguaagg (SEQ ID NO.: 7925), CAUGguaagu (SEQ ID NO.: 7926), CAUGguaaua (SEQ ID NO.: 7927), CAUGguaaug (SEQ ID NO.: 7928), CAUGguaauu (SEQ ID NO.: 7929), CAUGguacag (SEQ ID NO.: 7930), CAUGguacga (SEQ ID NO.: 7931), CAUGguacgg (SEQ ID NO.: 7932), CAUGguacgu (SEQ ID NO.: 7933), CAUGguacug (SEQ ID NO.: 7934), CAUGguacuu (SEQ ID NO.: 7935), CAUGguagca (SEQ ID NO.: 7936), CAUGguagga (SEQ ID NO.: 7937), CAUGguaggc (SEQ
ID NO.: 7938), CAUGguaggg (SEQ ID NO.: 7939), CAUGguaggu (SEQ ID NO.: 7940), CAUGguagua (SEQ ID NO.: 7941), CAUGguauag (SEQ ID NO.: 7942), CAUGguaucc (SEQ ID NO.: 7943), CAUGguauga (SEQ ID NO.: 7944), CAUGguaugc (SEQ ID NO.: 7945), CAUGguaugg (SEQ ID NO.: 7946), CAUGguaugu (SEQ ID NO.: 7947), CAUGguauug (SEQ ID NO.: 7948), CAUGguauuu (SEQ ID NO.: 7949), CAUGgucagu (SEQ ID NO.: 7950), CAUGgucugu (SEQ ID NO.: 7951), CAUGgugaaa (SEQ ID NO.: 7952), CAUGgugaau (SEQ ID NO.: 7953), CAUGgugacu (SEQ ID NO.: 7954), CAUGgugaga (SEQ ID NO.: 7955), CAUGgugagc (SEQ ID NO.: 7956), CAUGgugagg (SEQ ID NO.: 7957), CAUGgugagu (SEQ ID NO.: 7958), CAUGgugauu (SEQ ID NO.: 7959), CAUGgugcgg (SEQ ID NO.: 7960), CAUGgugcgu (SEQ ID NO.: 7961), CAUGgugggc (SEQ ID NO.: 7962), CAUGgugggg (SEQ ID NO.: 7963), CAUGgugggu (SEQ ID NO.: 7964), CAUGguggug (SEQ ID NO.: 7965), CAUGgugugg (SEQ ID NO.: 7966), CAUGgugugu (SEQ ID NO.: 7967), CAUGguuacu (SEQ ID NO.: 7968), CAUGguuagu (SEQ ID NO.: 7969), CAUGguucac (SEQ ID NO.: 7970), CAUGguuggu (SEQ ID NO.: 7971), CAUGguuuga (SEQ ID NO.: 7972), CAUGguuugc (SEQ ID NO.: 7973), CAUUagugag (SEQ ID NO.: 7974), CAUUguaaga (SEQ ID NO.: 7975), CAUUguaagc (SEQ ID NO.: 7976), CAUUguaagg (SEQ ID NO.: 7977), CAUUguaagu (SEQ ID NO.: 7978), CAUUguaggu (SEQ ID NO.: 7979), CAUUguaucc (SEQ ID NO.: 7980), CAUUguaugu (SEQ ID NO.: 7981), CAUUgugaga (SEQ ID NO 7982), CAUUgugagc (SEQ ID NO.: 7983), CAUUgugagu (SEQ ID NO.: 7984), CAUUguuagu (SEQ ID NO.: 7985), CAUUugguaa (SEQ ID NO.: 7986), CCAAaaaggu (SEQ ID NO.: 7987), CCAAaugcaa (SEQ ID NO.: 7988), CCAAgccccg (SEQ ID NO.: 7989), CCAAggaaaa (SEQ ID NO.: 7990), CCAAgguaca (SEQ ID NO.: 7991), CCAAgguaug (SEQ ID NO.: 7992), CCAAggugag (SEQ ID NO.: 7993), CCAAguaaau (SEQ ID NO.: 7994), CCAAguaacg (SEQ ID NO.: 7995), CCAAguaacu (SEQ ID NO.: 7996), CCAAguaaga (SEQ ID NO.: 7997), CCAAguaagc (SEQ ID NO.: 7998), CCAAguaagg (SEQ ID NO.: 7999), CCAAguaagu (SEQ ID NO.: 8000), CCAAguaaua (SEQ ID NO.: 8001), CCAAguaauc (SEQ ID NO.: 8002), CCAAguaaug (SEQ ID NO.: 8003), CCAAguaauu (SEQ ID NO.: 8004), CCAAguacgg (SEQ ID NO.: 8005), CCAAguacgu (SEQ ID NO.: 8006), CCAAguacug (SEQ ID NO.: 8007), CCAAguacuu (SEQ ID NO.: 8008), CCAAguagcu (SEQ ID NO.: 8009), CCAAguagga (SEQ ID NO.: 8010), CCAAguaggc (SEQ ID NO.: 8011), CCAAguaggu (SEQ ID NO. : 8012), CCAAguaugg (SEQ ID NO.: 8013), CCAAguaugu (SEQ ID NO.: 8014), CCAAgucagu (SEQ ID NO.: 8015), CCAAgugacu (SEQ ID NO.: 8016), CCAAgugaga (SEQ ID NO.: 8017), CCAAgugagc (SEQ ID NO.: 8018), CCAAgugagg (SEQ ID NO.: 8019), CCAAgugagu (SEQ ID NO.: 8020), CCAAgugggu (SEQ ID NO.: 8021), CCAAgugugu (SEQ ID NO.: 8022), CCAAguuagu (SEQ ID NO.: 8023), CCACguaaga (SEQ ID NO.: 8024), CCACguaagc (SEQ ID NO.: 8025), CCACguaagg (SEQ ID NO.: 8026), CCACguaagu (SEQ ID NO.: 8027), CCACguacgu (SEQ ID NO.: 8028), CCACguaggu (SEQ ID NO.: 8029), CCACguauga (SEQ ID NO.: 8030), CCACguaugu (SEQ ID NO.: 8031), CCACgugagc (SEQ ID NO.: 8032), CCACgugagg (SEQ ID NO.: 8033), CCACgugagu (SEQ ID NO.: 8034), CCACgugcgu (SEQ ID NO.: 8035), CCAGauaugu (SEQ ID NO.: 8036), CCAGcccuca (SEQ ID NO.: 8037), CCAGcuggag (SEQ ID NO.: 8038), CCAGgcaaga (SEQ ID NO.: 8039), CCAGgcaagc (SEQ ID NO.: 8040), CCAGgcaagg (SEQ ID NO.: 8041), CCAGgcaagu (SEQ ID NO.: 8042), CCAGgcacgc (SEQ ID NO.: 8043), CCAGgcacgg (SEQ ID NO.: 8044), CCAGgcagcu (SEQ ID NO.: 8045), CCAGgcaggu (SEQ ID NO.: 8046), CCAGgcagua (SEQ ID NO.: 8047), CCAGgcaugu (SEQ ID NO.: 8048), CCAGgccagu (SEQ ID NO.: 8049), CCAGgcgagu (SEQ ID NO.: 8050),
CCAGgcggcc (SEQ ID NO.: 8051), CCAGgcuaug (SEQ ID NO.: 8052), CCAGgcuggu (SEQ ID NO.: 8053), CCAGggaagg (SEQ ID NO.: 8054), CCAGgguaag (SEQ ID NO.: 8055), CCAGgguaau (SEQ ID NO.: 8056), CCAGguaaaa (SEQ ID NO.: 8057), CCAGguaaac (SEQ ID NO.: 8058), CCAGguaaag (SEQ ID NO.: 8059), CCAGguaaau (SEQ ID NO.: 8060), CCAGguaaca (SEQ ID NO.: 8061), CCAGguaacc (SEQ ID NO.: 8062), CCAGguaacg (SEQ ID NO.: 8063), CCAGguaacu (SEQ ID NO.: 8064), CCAGguaaga (SEQ ID NO.: 8065), CCAGguaagc (SEQ ID NO.: 8066), CCAGguaagg (SEQ ID NO.: 8067), CCAGguaagu (SEQ ID NO.: 8068), CCAGguaaua (SEQ ID NO.: 8069), CCAGguaauc (SEQ ID NO.: 8070), CCAGguaaug (SEQ ID NO.: 8071), CCAGguaauu (SEQ ID NO.: 8072), CCAGguacaa (SEQ ID NO.: 8073), CCAGguacac (SEQ ID NO.: 8074), CCAGguacag (SEQ ID NO.: 8075), CCAGguacau (SEQ ID NO.: 8076), CCAGguacca (SEQ ID NO.: 8077), CCAGguaccc (SEQ ID NO.: 8078), CCAGguaccg (SEQ ID NO.: 8079), CCAGguaccu (SEQ ID NO.: 8080), CCAGguacga (SEQ ID NO.: 8081), CCAGguacgc (SEQ ID NO.: 8082), CCAGguacgg (SEQ ID NO.: 8083), CCAGguacgu (SEQ ID NO.: 8084), CCAGguacua (SEQ ID NO.: 8085), CCAGguacuc (SEQ ID NO.: 8086), CCAGguacug (SEQ ID NO.: 8087), CCAGguacuu (SEQ ID NO.: 8088), CCAGguagaa (SEQ ID NO.: 8089), CCAGguagac (SEQ ID NO.: 8090), CCAGguagag (SEQ ID NO.: 8091), CCAGguagau (SEQ ID NO.: 8092), CCAGguagca (SEQ ID NO.: 8093), CCAGguagcc (SEQ ID NO : 8094), CCAGguagcg (SEQ ID NO.: 8095), CCAGguagcu (SEQ ID NO.: 8096), CCAGguagga (SEQ ID NO.: 8097), CCAGguaggc (SEQ ID NO.: 8098), CCAGguaggg (SEQ ID NO.: 8099), CCAGguaggu (SEQ ID NO.: 8100), CCAGguagua (SEQ ID NO.: 8101), CCAGguaguc (SEQ ID NO.: 8102), CCAGguagug (SEQ ID NO.: 8103), CCAGguaguu (SEQ ID NO.: 8104), CCAGguauaa (SEQ ID NO.: 8105), CCAGguauac (SEQ ID NO.: 8106), CCAGguauag (SEQ ID NO.: 8107), CCAGguauau (SEQ ID NO.: 8108), CCAGguauca (SEQ ID NO.: 8109), CCAGguaucc (SEQ ID NO.: 8110), CCAGguaucu (SEQ ID NO.: 8111), CCAGguauga (SEQ ID NO.: 8112), CCAGguaugc (SEQ ID NO.: 8113), CCAGguaugg (SEQ ID NO.: 8114), CCAGguaugu (SEQ ID NO.: 8115), CCAGguauua (SEQ ID NO.: 8116), CCAGguauuc (SEQ ID NO.: 8117), CCAGguauug (SEQ ID NO.: 8118), CCAGguauuu (SEQ ID NO.: 8119), CCAGgucaga (SEQ ID NO.: 8120), CCAGgucagc (SEQ ID NO.: 8121), CCAGgucagg (SEQ ID NO.: 8122), CCAGgucagu (SEQ ID NO.: 8123), CCAGgucauc (SEQ ID NO.: 8124), CCAGguccac (SEQ ID NO.: 8125), CCAGgucccu (SEQ ID NO.: 8126), CCAGguccgu (SEQ ID NO.: 8127), CCAGguccua (SEQ ID NO.: 8128), CCAGguccuc (SEQ ID NO.: 8129), CCAGgucggc (SEQ ID NO.: 8130), CCAGgucggu (SEQ ID NO.: 8131), CCAGgucguc (SEQ ID NO.: 8132), CCAGgucuac (SEQ ID NO.: 8133), CCAGgucuca (SEQ ID NO.: 8134), CCAGgucucg (SEQ ID NO.: 8135), CCAGgucuga (SEQ ID NO.: 8136), CCAGgucugg (SEQ ID NO.: 8137), CCAGgucugu (SEQ ID NO.: 8138), CCAGgucuuu (SEQ ID NO.: 8139), CCAGgugaaa (SEQ ID NO.: 8140), CCAGgugaac (SEQ ID NO.: 8141), CCAGgugaag (SEQ ID NO.: 8142), CCAGgugaau (SEQ ID NO.: 8143), CCAGgugaca (SEQ ID NO.: 8144), CCAGgugacc (SEQ ID NO.: 8145), CCAGgugacg (SEQ ID NO.: 8146), CCAGgugacu (SEQ ID NO.: 8147), CCAGgugaga (SEQ ID NO.: 8148), CCAGgugagc (SEQ ID NO.: 8149), CCAGgugagg (SEQ ID NO.: 8150), CCAGgugagu (SEQ ID NO.: 8151), CCAGgugaua (SEQ ID NO.: 8152), CCAGgugauc (SEQ ID NO.: 8153), CCAGgugaug (SEQ ID NO.: 8154), CCAGgugauu (SEQ ID NO.: 8155), CCAGgugcac (SEQ ID NO.: 8156), CCAGgugcag (SEQ ID NO.: 8157), CCAGgugcau (SEQ ID NO.: 8158), CCAGgugcca (SEQ ID NO.: 8159), CCAGgugccc (SEQ ID NO.: 8160), CCAGgugccg (SEQ ID NO.: 8161), CCAGgugccu (SEQ ID NO.: 8162), CCAGgugcga (SEQ ID
NO.: 8163), CCAGgugcgc (SEQ ID NO.: 8164), CCAGgugcgg (SEQ ID NO.: 8165), CCAGgugcgu (SEQ ID NO.: 8166), CCAGgugcuc (SEQ ID NO.: 8167), CCAGgugcug (SEQ ID NO.: 8168), CCAGgugcuu (SEQ ID NO.: 8169), CCAGguggag (SEQ ID NO.: 8170), CCAGguggau (SEQ ID NO.: 8171), CCAGguggca (SEQ ID NO.: 8172), CCAGguggcu (SEQ ID NO.: 8173), CCAGguggga (SEQ ID NO.: 8174), CCAGgugggc (SEQ ID NO.: 8175), CCAGgugggg (SEQ ID NO.: 8176), CCAGgugggu (SEQ ID NO.: 8177), CCAGguggug (SEQ ID NO.: 8178), CCAGgugucc (SEQ ID NO.: 8179), CCAGgugucg (SEQ ID NO.: 8180), CCAGgugucu (SEQ ID NO.: 8181), CCAGguguga (SEQ ID NO.: 8182), CCAGgugugc (SEQ ID NO.: 8183), CCAGgugugg (SEQ ID NO.: 8184), CCAGgugugu (SEQ ID NO.: 8185), CCAGguuacg (SEQ ID NO.: 8186), CCAGguuaga (SEQ ID NO.: 8187), CCAGguuagc (SEQ ID NO.: 8188), CCAGguuagg (SEQ ID NO.: 8189), CCAGguuagu (SEQ ID NO.: 8190), CCAGguuaua (SEQ ID NO.: 8191), CCAGguuauc (SEQ ID NO.: 8192), CCAGguucaa (SEQ ID NO.: 8193), CCAGguucac (SEQ ID NO.: 8194), CCAGguucga (SEQ ID NO.: 8195), CCAGguucgc (SEQ ID NO.: 8196), CCAGguucgg (SEQ ID NO.: 8197), CCAGguucgu (SEQ ID NO.: 8198), CCAGguucua (SEQ ID NO.: 8199), CCAGguucug (SEQ ID NO.: 8200), CCAGguucuu (SEQ ID NO.: 8201), CCAGguugag (SEQ ID NO.: 8202), CCAGguugcu (SEQ ID NO.: 8203), CCAGguugga (SEQ ID NO.: 8204), CCAGguuggc (SEQ ID NO.: 8205), CCAGguuggg (SEQ ID NO.: 8206), CCAGguuggu (SEQ ID NO.: 8207), CCAGguugua (SEQ ID NO.: 8208), CCAGguugug (SEQ ID NO.: 8209), CCAGguuuau (SEQ ID NO.: 8210), CCAGguuuga (SEQ ID NO.: 8211), CCAGguuugc (SEQ ID NO.: 8212), CCAGguuugu (SEQ ID NO.: 8213), CCAGguuuua (SEQ ID NO.: 8214), CCAGguuuuc (SEQ ID NO.: 8215), CCAGguuuug (SEQ ID NO.: 8216), CCAGguuuuu (SEQ ID NO.: 8217), CCAUguaaac (SEQ ID NO.: 8218), CCAUguaaga (SEQ ID NO.: 8219), CCAUguaagc (SEQ ID NO.: 8220), CCAUguaagg (SEQ ID NO.: 8221), CCAUguaagu (SEQ ID NO.: 8222), CCAUguacgc (SEQ ID NO.: 8223), CCAUguacgu (SEQ ID NO.: 8224), CCAUguaucc (SEQ ID NO.: 8225), CCAUguaugu (SEQ ID NO.: 8226), CCAUgugaga (SEQ ID NO.: 8227), CCAUgugagc (SEQ ID NO.: 8228), CCAUgugagu (SEQ ID NO.: 8229), CCAUgugcgu (SEQ ID NO.: 8230), CCAUguuagu (SEQ ID NO. : 8231), CCCAgagacu (SEQ ID NO. : 8232), CCCAgcuaag (SEQ ID NO.: 8233), CCCAgguaac (SEQ ID NO.: 8234), CCCAgguaau (SEQ ID NO.: 8235), CCCAgguaga (SEQ ID NO.: 8236), CCCAguaaau (SEQ ID NO.: 8237), CCCAguaaga (SEQ ID NO.: 8238), CCCAguaagc (SEQ ID NO.: 8239), CCCAguaagg (SEQ ID NO.: 8240), CCCAguaagu (SEQ ID NO.: 8241), CCCAguacga (SEQ ID NO.: 8242), CCCAguacgu (SEQ ID NO.: 8243), CCCAguaggu (SEQ ID NO.: 8244), CCCAguaucc (SEQ ID NO.: 8245), CCCAguaugu (SEQ ID NO.: 8246), CCCAgugagu (SEQ ID NO.: 8247), CCCAguggug (SEQ ID NO.: 8248), CCCCagguga (SEQ ID NO.: 8249), CCCCgauuug (SEQ ID NO.: 8250), CCCCguaagc (SEQ ID NO.: 8251), CCCCguaagg (SEQ ID NO.: 8252), CCCCguaagu (SEQ ID NO.: 8253), CCCCguauga (SEQ ID NO.: 8254), CCCCgugagu (SEQ ID NO.: 8255), CCCCgugcgu (SEQ ID NO.: 8256), CCCCgugggu (SEQ ID NO.: 8257), CCCGgcacgu (SEQ ID NO.: 8258), CCCGgcuggu (SEQ ID NO.: 8259), CCCGguaaau (SEQ ID NO.: 8260), CCCGguaaga (SEQ ID NO.: 8261), CCCGguaagc (SEQ ID NO.: 8262), CCCGguaagg (SEQ ID NO.: 8263), CCCGguaagu (SEQ ID NO.: 8264), CCCGguaauc (SEQ ID NO.: 8265), CCCGguaaug (SEQ ID NO.: 8266), CCCGguaauu (SEQ ID NO.: 8267), CCCGguacau (SEQ ID NO.: 8268), CCCGguaccc (SEQ ID NO.: 8269), CCCGguacgg (SEQ ID NO.: 8270), CCCGguacgu (SEQ ID NO.: 8271), CCCGguaggg (SEQ ID NO.: 8272), CCCGguaggu (SEQ ID NO.: 8273), CCCGguauaa (SEQ ID NO.: 8274), CCCGguauga (SEQ ID NO.: 8275),
CCCGguaugg (SEQ ID NO.: 8276), CCCGguaugu (SEQ ID NO.: 8277), CCCGguauug (SEQ ID NO.: 8278), CCCGgucagu (SEQ ID NO.: 8279), CCCGgugaga (SEQ ID NO.: 8280), CCCGgugagc (SEQ ID NO.: 8281), CCCGgugagg (SEQ ID NO.: 8282), CCCGgugagu (SEQ ID NO.: 8283), CCCGgugcgc (SEQ ID NO.: 8284), CCCGgugcgg (SEQ ID NO.: 8285), CCCGgugcgu (SEQ ID NO.: 8286), CCCGgugggc (SEQ ID NO.: 8287), CCCGgugggu (SEQ ID NO.: 8288), CCCGgugugu (SEQ ID NO.: 8289), CCCGguuaau (SEQ ID NO.: 8290), CCCGguuaga (SEQ ID NO.: 8291), CCCGguuuga (SEQ ID NO.: 8292), CCCUcuggaa (SEQ ID NO.: 8293), CCCUguaagu (SEQ ID NO.: 8294), CCCUguacga (SEQ ID NO.: 8295), CCCUguaggu (SEQ ID NO.: 8296), CCCUguaugu (SEQ ID NO.: 8297), CCCUgugaau (SEQ ID NO.: 8298), CCCUgugagc (SEQ ID NO.: 8299), CCCUgugagg (SEQ ID NO.: 8300), CCCUgugagu (SEQ ID NO.: 8301), CCCUgugcgu (SEQ ID NO.: 8302), CCCUuugucc (SEQ ID NO.: 8303), CCGAgaaguu (SEQ ID NO.: 8304), CCGAguaagc (SEQ ID NO.: 8305), CCGAguaagg (SEQ ID NO.: 8306), CCGAguaagu (SEQ ID NO.: 8307), CCGAguacgg (SEQ ID NO.: 8308), CCGAguaggc (SEQ ID NO.: 8309), CCGAguaggu (SEQ ID NO.: 8310), CCGAgugagc (SEQ ID NO. : 8311), CCGAgugagu (SEQ ID NO. : 8312), CCGCauuucc (SEQ ID NO.: 8313), CCGCguaagc (SEQ ID NO.: 8314), CCGCgugagu (SEQ ID NO.: 8315), CCGCugcggc (SEQ ID NO.: 8316), CCGGgcaagu (SEQ ID NO.: 8317), CCGGgcgagu (SEQ ID NO.: 8318), CCGGguaaaa (SEQ ID NO.: 8319), CCGGguaaau (SEQ ID NO.: 8320), CCGGguaacc (SEQ ID NO.: 8321), CCGGguaacu (SEQ ID NO.: 8322), CCGGguaaga (SEQ ID NO.: 8323), CCGGguaagc (SEQ ID NO.: 8324), CCGGguaagg (SEQ ID NO.: 8325), CCGGguaagu (SEQ ID NO.: 8326), CCGGguaaua (SEQ ID NO.: 8327), CCGGguaauu (SEQ ID NO.: 8328), CCGGguacca (SEQ ID NO.: 8329), CCGGguacgu (SEQ ID NO.: 8330), CCGGguagcu (SEQ ID NO.: 8331), CCGGguagga (SEQ ID NO.: 8332), CCGGguaggc (SEQ ID NO.: 8333), CCGGguaggu (SEQ ID NO.: 8334), CCGGguauga (SEQ ID NO.: 8335), CCGGguaugc (SEQ ID NO.: 8336), CCGGguaugg (SEQ ID NO.: 8337), CCGGguaugu (SEQ ID NO.: 8338), CCGGgucaga (SEQ ID NO.: 8339), CCGGgucagu (SEQ ID NO.: 8340), CCGGgugaga (SEQ ID NO.: 8341), CCGGgugagc (SEQ ID NO.: 8342), CCGGgugagg (SEQ ID NO.: 8343), CCGGgugagu (SEQ ID NO.: 8344), CCGGgugcau (SEQ ID NO.: 8345), CCGGgugcgg (SEQ ID NO.: 8346), CCGGgugcgu (SEQ ID NO.: 8347), CCGGgugugu (SEQ ID NO.: 8348), CCGGguucac (SEQ ID NO.: 8349), CCGUgcucau (SEQ ID NO : 8350), CCGUguaagu (SEQ ID NO.: 8351), CCGUgucugg (SEQ ID NO.: 8352), CCGUgugagu (SEQ ID NO.: 8353), CCUAgcagga (SEQ ID NO.: 8354), CCUAguaaga (SEQ ID NO.: 8355), CCUAguaagc (SEQ ID NO.: 8356), CCUAguaagu (SEQ ID NO.: 8357), CCUAguaaug (SEQ ID NO.: 8358), CCUAguaggu (SEQ ID NO.: 8359), CCUAgugagc (SEQ ID NO.: 8360), CCUAgugagu (SEQ ID NO.: 8361), CCUCaaaagu (SEQ ID NO.: 8362), CCUCgcugag (SEQ ID NO.: 8363), CCUCguaagu (SEQ ID NO.: 8364), CCUCguaucc (SEQ ID NO.: 8365), CCUCgugagc (SEQ ID NO.: 8366), CCUCgugagu (SEQ ID NO.: 8367), CCUCgugggu (SEQ ID NO.: 8368), CCUGgaaggu (SEQ ID NO.: 8369), CCUGgcaagu (SEQ ID NO.: 8370), CCUGgccaac (SEQ ID NO.: 8371), CCUGguaaac (SEQ ID NO.: 8372), CCUGguaaag (SEQ ID NO.: 8373), CCUGguaaau (SEQ ID NO.: 8374), CCUGguaaca (SEQ ID NO.: 8375), CCUGguaacc (SEQ ID NO.: 8376), CCUGguaacu (SEQ ID NO.: 8377), CCUGguaaga (SEQ ID NO.: 8378), CCUGguaagc (SEQ ID NO.: 8379), CCUGguaagg (SEQ ID NO.: 8380), CCUGguaagu (SEQ ID NO.: 8381), CCUGguaaua (SEQ ID NO.: 8382), CCUGguaauc (SEQ ID NO.: 8383), CCUGguaaug (SEQ ID NO.: 8384), CCUGguaauu (SEQ ID NO.: 8385), CCUGguacga (SEQ ID NO.: 8386), CCUGguacgc (SEQ ID NO.: 8387), CCUGguacgg (SEQ ID
NO.: 8388), CCUGguacgu (SEQ ID NO.: 8389), CCUGguacug (SEQ ID NO.: 8390), CCUGguacuu (SEQ ID NO.: 8391), CCUGguagag (SEQ ID NO.: 8392), CCUGguagcu (SEQ ID NO.: 8393), CCUGguagga (SEQ ID NO.: 8394), CCUGguaggg (SEQ ID NO.: 8395), CCUGguaggu (SEQ ID NO.: 8396), CCUGguaguu (SEQ ID NO.: 8397), CCUGguaucu (SEQ ID NO.: 8398), CCUGguauga (SEQ ID NO.: 8399), CCUGguaugc (SEQ ID NO.: 8400), CCUGguaugg (SEQ ID NO.: 8401), CCUGguaugu (SEQ ID NO.: 8402), CCUGguauuc (SEQ ID NO.: 8403), CCUGguauug (SEQ ID NO.: 8404), CCUGguauuu (SEQ ID NO.: 8405), CCUGgucagg (SEQ ID NO.: 8406), CCUGgucagu (SEQ ID NO.: 8407), CCUGgugaag (SEQ ID NO.: 8408), CCUGgugaau (SEQ ID NO.: 8409), CCUGgugaga (SEQ ID NO.: 8410), CCUGgugagc (SEQ ID NO.: 8411), CCUGgugagg (SEQ ID NO.: 8412), CCUGgugagu (SEQ ID NO : 8413), CCUGgugcga (SEQ ID NO : 8414), CCUGgugcgu (SEQ ID NO. : 8415), CCUGgugggc (SEQ ID NO.: 8416), CCUGgugggu (SEQ ID NO.: 8417), CCUGguguau (SEQ ID NO.: 8418), CCUGgugugu (SEQ ID NO.: 8419), CCUGguuagu (SEQ ID NO.: 8420), CCUGguugua (SEQ ID NO.: 8421), CCUGguuugu (SEQ ID NO.: 8422), CCUUguaagc (SEQ ID NO.: 8423), CCUUguaagg (SEQ ID NO.: 8424), CCUUguaagu (SEQ ID NO.: 8425), CCUUguacag (SEQ ID NO.: 8426), CCUUguacgu (SEQ ID NO.: 8427), CCUUguaggu (SEQ ID NO.: 8428), CCUUguaucc (SEQ ID NO.: 8429), CCUUgugagc (SEQ ID NO.: 8430), CCUUgugagu (SEQ ID NO. : 8431), CCUUuggugu (SEQ ID NO. : 8432), CGAAagguaa (SEQ ID NO.: 8433), CGAAguaagg (SEQ ID NO.: 8434), CGAAguaagu (SEQ ID NO.: 8435), CGAAguacgc (SEQ ID NO.: 8436), CGAAguaggu (SEQ ID NO.: 8437), CGAAgugaga (SEQ ID NO.: 8438), CGAAgugagu (SEQ ID NO.: 8439), CGAAugugag (SEQ ID NO.: 8440), CGACguaagg (SEQ ID NO.: 8441), CGACguaagu (SEQ ID NO.: 8442), CGACgugagg (SEQ ID NO.: 8443), CGACgugagu (SEQ ID NO.: 8444), CGAGagauag (SEQ ID NO.: 8445), CGAGgcaagu (SEQ ID NO.: 8446), CGAGgcacgu (SEQ ID NO.: 8447), CGAGgcaggu (SEQ ID NO.: 8448), CGAGgcgagu (SEQ ID NO.: 8449), CGAGguaaaa (SEQ ID NO.: 8450), CGAGguaaac (SEQ ID NO.: 8451), CGAGguaaag (SEQ ID NO.: 8452), CGAGguaaau (SEQ ID NO.: 8453), CGAGguaacc (SEQ ID NO.: 8454), CGAGguaacg (SEQ ID NO.: 8455), CGAGguaacu (SEQ ID NO.: 8456), CGAGguaaga (SEQ ID NO.: 8457), CGAGguaagc (SEQ ID NO.: 8458), CGAGguaagg (SEQ ID NO.: 8459), CGAGguaagu (SEQ ID NO.: 8460), CGAGguaaua (SEQ ID NO.: 8461), CGAGguaauc (SEQ ID NO.: 8462), CGAGguaaug (SEQ ID NO.: 8463), CGAGguaauu (SEQ ID NO.: 8464), CGAGguacaa (SEQ ID NO.: 8465), CGAGguacag (SEQ ID NO.: 8466), CGAGguacca (SEQ ID NO.: 8467), CGAGguaccc (SEQ ID NO.: 8468), CGAGguaccg (SEQ ID NO.: 8469), CGAGguaccu (SEQ ID NO.: 8470), CGAGguacga (SEQ ID NO.: 8471), CGAGguacgg (SEQ ID NO.: 8472), CGAGguacgu (SEQ ID NO.: 8473), CGAGguacug (SEQ ID NO.: 8474), CGAGguacuu (SEQ ID NO.: 8475), CGAGguagaa (SEQ ID NO.: 8476), CGAGguagag (SEQ ID NO.: 8477), CGAGguagcc (SEQ ID NO.: 8478), CGAGguagcu (SEQ ID NO.: 8479), CGAGguaggc (SEQ ID NO.: 8480), CGAGguaggg (SEQ ID NO.: 8481), CGAGguaggu (SEQ ID NO.: 8482), CGAGguagua (SEQ ID NO.: 8483), CGAGguaguu (SEQ ID NO.: 8484), CGAGguauaa (SEQ ID NO.: 8485), CGAGguauac (SEQ ID NO.: 8486), CGAGguauag (SEQ ID NO.: 8487), CGAGguauau (SEQ ID NO.: 8488), CGAGguauca (SEQ ID NO.: 8489), CGAGguaucc (SEQ ID NO.: 8490), CGAGguaucg (SEQ ID NO.: 8491), CGAGguauga (SEQ ID NO.: 8492), CGAGguaugc (SEQ ID NO.: 8493), CGAGguaugg (SEQ ID NO.: 8494), CGAGguaugu (SEQ ID NO.: 8495), CGAGguauuc (SEQ ID NO.: 8496), CGAGguauug (SEQ ID NO.: 8497), CGAGguauuu (SEQ ID NO.: 8498), CGAGgucaca (SEQ ID NO.: 8499), CGAGgucagg (SEQ ID NO.: 8500),
CGAGgucagu (SEQ ID NO.: 8501), CGAGguccgc (SEQ ID NO.: 8502), CGAGguccug (SEQ ID NO.: 8503), CGAGgucugu (SEQ ID NO.: 8504), CGAGgugaac (SEQ ID NO.: 8505), CGAGgugaag (SEQ ID NO.: 8506), CGAGgugacc (SEQ ID NO.: 8507), CGAGgugacu (SEQ ID NO.: 8508), CGAGgugaga (SEQ ID NO.: 8509), CGAGgugagc (SEQ ID NO.: 8510), CGAGgugagg (SEQ ID NO.: 8511), CGAGgugagu (SEQ ID NO.: 8512), CGAGgugauc (SEQ ID NO.: 8513), CGAGgugaug (SEQ ID NO.: 8514), CGAGgugcau (SEQ ID NO.: 8515), CGAGgugcgu (SEQ ID NO.: 8516), CGAGgugcua (SEQ ID NO.: 8517), CGAGgugcug (SEQ ID NO.: 8518), CGAGgugcuu (SEQ ID NO.: 8519), CGAGguggag (SEQ ID NO.: 8520), CGAGgugggc (SEQ ID NO.: 8521), CGAGgugggg (SEQ ID NO.: 8522), CGAGgugggu (SEQ ID NO.: 8523), CGAGgugugc (SEQ ID NO.: 8524), CGAGguuaau (SEQ ID NO.: 8525), CGAGguuagg (SEQ ID NO.: 8526), CGAGguuagu (SEQ ID NO.: 8527), CGAGguucac (SEQ ID NO.: 8528), CGAGguuggc (SEQ ID NO.: 8529), CGAGguuggu (SEQ ID NO.: 8530), CGAGguuugg (SEQ ID NO.: 8531), CGAGguuugu (SEQ ID NO.: 8532), CGAUguaagg (SEQ ID NO.: 8533), CGAUguaagu (SEQ ID NO.: 8534), CGAUguacaa (SEQ ID NO.: 8535), CGAUguacag (SEQ ID NO.: 8536), CGAUguauga (SEQ ID NO.: 8537), CGAUguaugg (SEQ ID NO.: 8538), CGAUgugagc (SEQ ID NO.: 8539), CGAUgugagu (SEQ ID NO.: 8540), CGCAcgauca (SEQ ID NO.: 8541), CGCAguaagu (SEQ ID NO.: 8542), CGCAgugagc (SEQ ID NO.: 8543), CGCAgugagu (SEQ ID NO.: 8544), CGCCauggcc (SEQ ID NO.: 8545), CGCCguaagu (SEQ ID NO.: 8546), CGCCgugagu (SEQ ID NO.: 8547), CGCGguaaga (SEQ ID NO.: 8548), CGCGguaagc (SEQ ID NO.: 8549), CGCGguaagg (SEQ ID NO.: 8550), CGCGguaauc (SEQ ID NO.: 8551), CGCGguacag (SEQ ID NO.: 8552), CGCGguacgg (SEQ ID NO.: 8553), CGCGguaggu (SEQ ID NO.: 8554), CGCGguaugu (SEQ ID NO.: 8555), CGCGgugagc (SEQ ID NO.: 8556), CGCGgugagg (SEQ ID NO.: 8557), CGCGgugagu (SEQ ID NO.: 8558), CGCGgugggu (SEQ ID NO.: 8559), CGCGgugugu (SEQ ID NO.: 8560), CGCUggggga (SEQ ID NO.: 8561), CGCUguaagc (SEQ ID NO.: 8562), CGCUguaagu (SEQ ID NO.: 8563), CGCUgucagu (SEQ ID NO.: 8564), CGCUgugagg (SEQ ID NO.: 8565), CGCUgugagu (SEQ ID NO.: 8566), CGGAaaguua (SEQ ID NO.: 8567), CGGCggagcc (SEQ ID NO.: 8568), CGGCguaagu (SEQ ID NO.: 8569), CGGCgugagu (SEQ ID NO.: 8570), CGGGguaaga (SEQ ID NO.: 8571), CGGGguaagc (SEQ ID NO.: 8572), CGGGguaagg (SEQ ID NO.: 8573), CGGGguaagu (SEQ ID NO.: 8574), CGGGguaaug (SEQ ID NO.: 8575), CGGGguacgg (SEQ ID NO.: 8576), CGGGguacgu (SEQ ID NO.: 8577), CGGGguacug (SEQ ID NO.: 8578), CGGGguaggc (SEQ ID NO.: 8579), CGGGguaggu (SEQ ID NO.: 8580), CGGGgugaga (SEQ ID NO.: 8581), CGGGgugagc (SEQ ID NO.: 8582), CGGGgugagg (SEQ ID NO.: 8583), CGGGgugagu (SEQ ID NO.: 8584), CGGUguaagc (SEQ ID NO.: 8585), CGGUguaagu (SEQ ID NO.: 8586), CGUAguaagu (SEQ ID NO.: 8587), CGUAguaugu (SEQ ID NO.: 8588), CGUCguaagu (SEQ ID NO.: 8589), CGUGguaaaa (SEQ ID NO.: 8590), CGUGguaaga (SEQ ID NO.: 8591), CGUGguaagc (SEQ ID NO.: 8592), CGUGguaagg (SEQ ID NO.: 8593), CGUGguaagu (SEQ ID NO.: 8594), CGUGguacaa (SEQ ID NO.: 8595), CGUGguaccc (SEQ ID NO.: 8596), CGUGguacga (SEQ ID NO.: 8597), CGUGguacgu (SEQ ID NO.: 8598), CGUGguaggu (SEQ ID NO.: 8599), CGUGguaugc (SEQ ID NO.: 8600), CGUGguaugu (SEQ ID NO.: 8601), CGUGgucagu (SEQ ID NO.: 8602), CGUGgugagc (SEQ ID NO.: 8603), CGUGgugagg (SEQ ID NO.: 8604), CGUGgugagu (SEQ ID NO.: 8605), CGUGgugcgc (SEQ ID NO.: 8606), CGUGgugcgg (SEQ ID NO.: 8607), CGUGgugcgu (SEQ ID NO.: 8608), CGUGgugggu (SEQ ID NO.: 8609), CGUUguaagu (SEQ ID NO.: 8610), CGUUguuagu (SEQ ID NO.: 8611), CUAAaguaau (SEQ ID NO.: 8612), CUAAccggcg (SEQ
ID NO.: 8613), CUAAguaaga (SEQ ID NO.: 8614), CUAAguaagc (SEQ ID NO.: 8615), CUAAguaagu (SEQ ID NO.: 8616), CUAAguacgu (SEQ ID NO.: 8617), CUAAguaggu (SEQ ID NO.: 8618), CUAAguaugg (SEQ ID NO.: 8619), CUAAguaugu (SEQ ID NO.: 8620), CUAAguauuu (SEQ ID NO.: 8621), CUAAgucagu (SEQ ID NO.: 8622), CUAAgugagc (SEQ ID NO.: 8623), CUAAgugagu (SEQ ID NO.: 8624), CUAAguuaag (SEQ ID NO.: 8625), CUAAguuaca (SEQ ID NO.: 8626), CUACguaagc (SEQ ID NO.: 8627), CUACguaagu (SEQ ID NO.: 8628), CUACgugagc (SEQ ID NO.: 8629), CUACgugagu (SEQ ID NO.: 8630), CUAGgcaagu (SEQ ID NO.: 8631), CUAGguaaaa (SEQ ID NO.: 8632), CUAGguaaac (SEQ ID NO.: 8633), CUAGguaaag (SEQ ID NO.: 8634), CUAGguaaau (SEQ ID NO.: 8635), CUAGguaacc (SEQ ID NO.: 8636), CUAGguaacu (SEQ ID NO.: 8637), CUAGguaaga (SEQ ID NO.: 8638), CUAGguaagc (SEQ ID NO.: 8639), CUAGguaagg (SEQ ID NO.: 8640), CUAGguaagu (SEQ ID NO.: 8641), CUAGguaaua (SEQ ID NO.: 8642), CUAGguaauc (SEQ ID NO.: 8643), CUAGguaaug (SEQ ID NO.: 8644), CUAGguaauu (SEQ ID NO.: 8645), CUAGguacaa (SEQ ID NO.: 8646), CUAGguacag (SEQ ID NO.: 8647), CUAGguacau (SEQ ID NO.: 8648), CUAGguaccc (SEQ ID NO.: 8649), CUAGguacgg (SEQ ID NO.: 8650), CUAGguacgu (SEQ ID NO.: 8651), CUAGguacug (SEQ ID NO.: 8652), CUAGguacuu (SEQ ID NO.: 8653), CUAGguagaa (SEQ ID NO.: 8654), CUAGguagag (SEQ ID NO.: 8655), CUAGguagca (SEQ ID NO.: 8656), CUAGguagcc (SEQ ID NO.: 8657), CUAGguagga (SEQ ID NO.: 8658), CUAGguaggc (SEQ ID NO.: 8659), CUAGguaggg (SEQ ID NO.: 8660), CUAGguaggu (SEQ ID NO.: 8661), CUAGguagua (SEQ ID NO.: 8662), CUAGguauau (SEQ ID NO.: 8663), CUAGguauca (SEQ ID NO.: 8664), CUAGguaucu (SEQ ID NO.: 8665), CUAGguauga (SEQ ID NO.: 8666), CUAGguaugc (SEQ ID NO.: 8667), CUAGguaugg (SEQ ID NO.: 8668), CUAGguaugu (SEQ ID NO.: 8669), CUAGguauua (SEQ ID NO.: 8670), CUAGguauug (SEQ ID NO.: 8671), CUAGguauuu (SEQ ID NO.: 8672), CUAGgucaag (SEQ ID NO.: 8673), CUAGgucagc (SEQ ID NO.: 8674), CUAGgucagu (SEQ ID NO.: 8675), CUAGgucuau (SEQ ID NO.: 8676), CUAGgucugg (SEQ ID NO.: 8677), CUAGgugaau (SEQ ID NO.: 8678), CUAGgugaga (SEQ ID NO.: 8679), CUAGgugagc (SEQ ID NO.: 8680), CUAGgugagg (SEQ ID NO.: 8681), CUAGgugagu (SEQ ID NO.: 8682), CUAGgugaug (SEQ ID NO.: 8683), CUAGgugauu (SEQ ID NO.: 8684), CUAGgugggg (SEQ ID NO.: 8685), CUAGgugggu (SEQ ID NO.: 8686), CUAGgugugu (SEQ ID NO.: 8687), CUAGguuagu (SEQ ID NO.: 8688), CUAGguucaa (SEQ ID NO.: 8689), CUAGguuggu (SEQ ID NO.: 8690), CUAGguuuga (SEQ ID NO.: 8691), CUAGguuugc (SEQ ID NO.: 8692), CUAGguuugg (SEQ ID NO.: 8693), CUAGguuugu (SEQ ID NO.: 8694), CUAUauaucc (SEQ ID NO.: 8695), CUAUauggua (SEQ ID NO.: 8696), CUAUgauaag (SEQ ID NO.: 8697), CUAUgcaagu (SEQ ID NO.: 8698), CUAUguaacu (SEQ ID NO.: 8699), CUAUguaaga (SEQ ID NO.: 8700), CUAUguaagu (SEQ ID NO.: 8701), CUAUguaaug (SEQ ID NO.: 8702), CUAUguacgu (SEQ ID NO.: 8703), CUAUguaucc (SEQ ID NO.: 8704), CUAUguaugu (SEQ ID NO.: 8705), CUAUgugagc (SEQ ID NO.: 8706), CUAUgugagu (SEQ ID NO.: 8707), CUAUgugcgc (SEQ ID NO.: 8708), CUCAgguaaa (SEQ ID NO.: 8709), CUCAguaaga (SEQ ID NO.: 8710), CUCAguaagc (SEQ ID NO.: 8711), CUCAguaagg (SEQ ID NO.: 8712), CUCAguaagu (SEQ ID NO.: 8713), CUCAguaggu (SEQ ID NO.: 8714), CUCAgucagu (SEQ ID NO.: 8715), CUCAgugagu (SEQ ID NO.: 8716), CUCAguggug (SEQ ID NO.: 8717), CUCAguuaaa (SEQ ID NO.: 8718), CUCAguugua (SEQ ID NO.: 8719), CUCCagcccc (SEQ ID NO.: 8720), CUCCgaggga (SEQ ID NO.: 8721), CUCCguaagc (SEQ ID NO.: 8722), CUCCguaagu (SEQ ID NO.: 8723), CUCCguaggu (SEQ ID NO.: 8724), CUCCguaugu (SEQ ID NO.: 8725),
CUCCgugagu (SEQ ID NO.: 8726), CUCCguggua (SEQ ID NO.: 8727), CUCGgguaau (SEQ ID NO.: 8728), CUCGguaacu (SEQ ID NO.: 8729), CUCGguaaga (SEQ ID NO.: 8730), CUCGguaagc (SEQ ID NO.: 8731), CUCGguaagg (SEQ ID NO.: 8732), CUCGguaagu (SEQ ID NO.: 8733), CUCGguaaua (SEQ ID NO.: 8734), CUCGguaaug (SEQ ID NO.: 8735), CUCGguacaa (SEQ ID NO.: 8736), CUCGguacag (SEQ ID NO.: 8737), CUCGguacca (SEQ ID NO.: 8738), CUCGguaccc (SEQ ID NO.: 8739), CUCGguacga (SEQ ID NO.: 8740), CUCGguacgg (SEQ ID NO.: 8741), CUCGguacgu (SEQ ID NO.: 8742), CUCGguaggu (SEQ ID NO.: 8743), CUCGguauac (SEQ ID NO.: 8744), CUCGguaugg (SEQ ID NO.: 8745), CUCGguaugu (SEQ ID NO.: 8746), CUCGguauug (SEQ ID NO.: 8747), CUCGguauuu (SEQ ID NO.: 8748), CUCGgucaga (SEQ ID NO.: 8749), CUCGgucagu (SEQ ID NO.: 8750), CUCGgucugu (SEQ ID NO.: 8751), CUCGgugaau (SEQ ID NO.: 8752), CUCGgugaga (SEQ ID NO.: 8753), CUCGgugagc (SEQ ID NO.: 8754), CUCGgugagg (SEQ ID NO.: 8755), CUCGgugagu (SEQ ID NO.: 8756), CUCGgugcgu (SEQ ID NO.: 8757), CUCGgugggc (SEQ ID NO.: 8758), CUCGgugggg (SEQ ID NO.: 8759), CUCGgugggu (SEQ ID NO.: 8760), CUCGgugugu (SEQ ID NO.: 8761), CUCGguuagc (SEQ ID NO.: 8762), CUCGguuagu (SEQ ID NO.: 8763), CUCUgcaagu (SEQ ID NO.: 8764), CUCUggcagc (SEQ ID NO.: 8765), CUCUguaaga (SEQ ID NO.: 8766), CUCUguaagc (SEQ ID NO.: 8767), CUCUguaagg (SEQ ID NO.: 8768), CUCUguaagu (SEQ ID NO.: 8769), CUCUguaauu (SEQ ID NO.: 8770), CUCUguaggu (SEQ ID NO.: 8771), CUCUguaugu (SEQ ID NO.: 8772), CUCUgugagg (SEQ ID NO.: 8773), CUCUgugagu (SEQ ID NO.: 8774), CUCUgugcgu (SEQ ID NO.: 8775), CUCUgugugu (SEQ ID NO.: 8776), CUGAguaaga (SEQ ID NO.: 8777), CUGAguaagc (SEQ ID NO.: 8778), CUGAguaagg (SEQ ID NO.: 8779), CUGAguaagu (SEQ ID NO.: 8780), CUGAguaauu (SEQ ID N/O.: 8781), CUGAguaggu (SEQ ID NO.: 8782), CUGAguaucc (SEQ ID NO.: 8783), CUGAguaugu (SEQ ID NO.: 8784), CUGAgucugu (SEQ ID NO.: 8785), CUGAgugagc (SEQ ID NO.: 8786), CUGAgugagg (SEQ ID NO.: 8787), CUGAgugagu (SEQ ID NO.: 8788), CUGAguuagg (SEQ ID NO.: 8789), CUGCacagca (SEQ ID NO.: 8790), CUGCaggggg (SEQ ID NO.: 8791), CUGCgcagca (SEQ ID NO.: 8792), CUGCguacgu (SEQ ID NO.: 8793), CUGCgugagu (SEQ ID NO.: 8794), CUGCgugggu (SEQ ID NO.: 8795), CUGGaccagc (SEQ ID NO.: 8796), CUGGauguau (SEQ ID NO.: 8797), CUGGcaauug (SEQ ID NO.: 8798), CUGGgcaagu (SEQ ID NO.: 8799), CUGGguaaaa (SEQ ID NO.: 8800), CUGGguaaag (SEQ ID NO.: 8801), CUGGguaaau (SEQ ID NO.: 8802), CUGGguaaca (SEQ ID NO.: 8803), CUGGguaacc (SEQ ID NO.: 8804), CUGGguaacu (SEQ ID NO.: 8805), CUGGguaaga (SEQ ID NO.: 8806), CUGGguaagc (SEQ ID NO.: 8807), CUGGguaagg (SEQ ID NO.: 8808), CUGGguaagu (SEQ ID NO.: 8809), CUGGguaaua (SEQ ID NO.: 8810), CUGGguaaug (SEQ ID NO.: 8811), CUGGguaauu (SEQ ID NO.: 8812), CUGGguacaa (SEQ ID NO.: 8813), CUGGguaccc (SEQ ID NO : 8814), CUGGguacgg (SEQ ID NO.: 8815), CUGGguacgu (SEQ ID NO.: 8816), CUGGguacug (SEQ ID NO.: 8817), CUGGguagga (SEQ ID NO.: 8818), CUGGguaggc (SEQ ID NO.: 8819), CUGGguaggg (SEQ ID NO.: 8820), CUGGguaggu (SEQ ID NO.: 8821), CUGGguauca (SEQ ID NO.: 8822), CUGGguauga (SEQ ID NO.: 8823), CUGGguaugc (SEQ ID NO.: 8824), CUGGguaugg (SEQ ID NO.: 8825), CUGGguaugu (SEQ ID NO.: 8826), CUGGguauua (SEQ ID NO.: 8827), CUGGguauug (SEQ ID NO.: 8828), CUGGgucagu (SEQ ID NO.: 8829), CUGGguccug (SEQ ID NO.: 8830), CUGGgucugc (SEQ ID NO.: 8831), CUGGgucugu (SEQ ID NO.: 8832), CUGGgugaau (SEQ ID NO.: 8833), CUGGgugacu (SEQ ID NO.: 8834), CUGGgugaga (SEQ ID NO.: 8835), CUGGgugagc (SEQ ID NO.: 8836), CUGGgugagg (SEQ ID NO.: 8837), CUGGgugagu (SEQ
ID NO.: 8838), CUGGgugauu (SEQ ID NO.: 8839), CUGGgugcgg (SEQ ID NO.: 8840), CUGGgugggu (SEQ ID NO.: 8841), CUGGguguga (SEQ ID NO.: 8842), CUGGguuaag (SEQ ID NO.: 8843), CUGGguuaca (SEQ ID NO.: 8844), CUGGguuagu (SEQ ID NO.: 8845), CUGGguucaa (SEQ ID NO.: 8846), CUGGguugga (SEQ ID NO.: 8847), CUGGguugua (SEQ ID NO.: 8848), CUGGguuuga (SEQ ID NO.: 8849), CUGGucaaga (SEQ ID NO.: 8850), CUGGuuauca (SEQ ID NO.: 8851), CUGUcggcau (SEQ ID NO.: 8852), CUGUgccgcc (SEQ ID NO.: 8853), CUGUgcuguc (SEQ ID NO.: 8854), CUGUguaaau (SEQ ID NO.: 8855), CUGUguaaga (SEQ ID NO.: 8856), CUGUguaagg (SEQ ID NO.: 8857), CUGUguaagu (SEQ ID NO.: 8858), CUGUguacgu (SEQ ID NO.: 8859), CUGUguacug (SEQ ID NO.: 8860), CUGUguaggu (SEQ ID NO.: 8861), CUGUguaugg (SEQ ID NO.: 8862), CUGUguaugu (SEQ ID NO.: 8863), CUGUgugaga (SEQ ID NO.: 8864), CUGUgugagu (SEQ ID NO.: 8865), CUUAgguaag (SEQ ID NO.: 8866), CUUAguaaau (SEQ ID NO.: 8867), CUUAguaagu (SEQ ID NO.: 8868), CUUAguaugu (SEQ ID NO.: 8869), CUUAgugagu (SEQ ID NO.: 8870), CUUCguaagu (SEQ ID NO.: 8871), CUUCgugagu (SEQ ID NO.: 8872), CUUCuuggua (SEQ ID NO.: 8873), CUUGauuuua (SEQ ID NO.: 8874), CUUGguaaaa (SEQ ID NO.: 8875), CUUGguaaag (SEQ ID NO.: 8876), CUUGguaaau (SEQ ID NO.: 8877), CUUGguaacc (SEQ ID NO.: 8878), CUUGguaaga (SEQ ID NO.: 8879), CUUGguaagc (SEQ ID NO.: 8880), CUUGguaagg (SEQ ID NO.: 8881), CUUGguaagu (SEQ ID NO.: 8882), CUUGguaaua (SEQ ID NO.: 8883), CUUGguaaug (SEQ ID NO.: 8884), CUUGguaauu (SEQ ID NO.: 8885), CUUGguacag (SEQ ID NO.: 8886), CUUGguacgu (SEQ ID NO.: 8887), CUUGguagau (SEQ ID NO.: 8888), CUUGguaggg (SEQ ID NO.: 8889), CUUGguaggu (SEQ ID NO.: 8890), CUUGguauac (SEQ ID NO.: 8891), CUUGguauau (SEQ ID NO.: 8892), CUUGguaucc (SEQ ID NO.: 8893), CUUGguauga (SEQ ID NO.: 8894), CUUGguaugc (SEQ ID NO.: 8895), CUUGguaugg (SEQ ID NO.: 8896), CUUGguaugu (SEQ ID NO.: 8897), CUUGguauuc (SEQ ID NO.: 8898), CUUGguauuu (SEQ ID NO.: 8899), CUUGgucagc (SEQ ID NO.: 8900), CUUGgucguc (SEQ ID NO.: 8901), CUUGgucugc (SEQ ID NO.: 8902), CUUGgugaga (SEQ ID NO.: 8903), CUUGgugagc (SEQ ID NO.: 8904), CUUGgugagg (SEQ ID NO.: 8905), CUUGgugagu (SEQ ID NO.: 8906), CUUGgugauu (SEQ ID NO.: 8907), CUUGgugcgu (SEQ ID NO.: 8908), CUUGguggga (SEQ ID NO.: 8909), CUUGgugggu (SEQ ID NO.: 8910), CUUGguguga (SEQ ID NO.: 8911), CUUGgugugc (SEQ ID NO.: 8912), CUUGgugugg (SEQ ID NO.: 8913), CUUGgugugu (SEQ ID NO.: 8914), CUUGguuaga (SEQ ID NO.: 8915), CUUGguuagu (SEQ ID NO.: 8916), CUUGguuggu (SEQ ID NO.: 8917), CUUGguuugu (SEQ ID NO.: 8918), CUUUauaucc (SEQ ID NO.: 8919), CUUUguaaga (SEQ ID NO.: 8920), CUUUguaagg (SEQ ID NO.: 8921), CUUUguaagu (SEQ ID NO.: 8922), CUUUguaggu (SEQ ID NO.: 8923), CUUUguaugu (SEQ ID NO.: 8924), CUUUgucucc (SEQ ID NO.: 8925), CUUUgugaga (SEQ ID NO.: 8926), CUUUgugagc (SEQ ID NO.: 8927), CUUUgugagu (SEQ ID NO.: 8928), CUUUgugauu (SEQ ID NO.: 8929), CUUUgugugu (SEQ ID NO.: 8930), CUUUugguga (SEQ ID NO. : 8931), GAAAaaggua (SEQ ID NO. : 8932), GAAAagguau (SEQ ID NO.: 8933), GAAAaguaag (SEQ ID NO.: 8934), GAAAagugag (SEQ ID NO.: 8935), GAAAgcaagc (SEQ ID NO.: 8936), GAAAgguaac (SEQ ID NO.: 8937), GAAAgguaau (SEQ ID NO.: 8938), GAAAgguagu (SEQ ID NO.: 8939), GAAAguaaaa (SEQ ID NO.: 8940), GAAAguaaau (SEQ ID NO.: 8941), GAAAguaaga (SEQ ID NO.: 8942), GAAAguaagc (SEQ ID NO.: 8943), GAAAguaagg (SEQ ID NO.: 8944), GAAAguaagu (SEQ ID NO.: 8945), GAAAguaauc (SEQ ID NO.: 8946), GAAAguaauu (SEQ ID NO.: 8947), GAAAguacag (SEQ ID NO.: 8948), GAAAguacua (SEQ ID NO.: 8949), GAAAguagca (SEQ ID NO.: 8950),
GAAAguaggu (SEQ ID NO.: 8951), GAAAguaugu (SEQ ID NO.: 8952), GAAAgucagu (SEQ ID NO.: 8953), GAAAgugaga (SEQ ID NO.: 8954), GAAAgugagc (SEQ ID NO.: 8955), GAAAgugagg (SEQ ID NO.: 8956), GAAAgugagu (SEQ ID NO.: 8957), GAAAguggag (SEQ ID NO.: 8958), GAAAguguga (SEQ ID NO.: 8959), GAAAguuagu (SEQ ID NO.: 8960), GAACguaaga (SEQ ID NO.: 8961), GAACguaagc (SEQ ID NO.: 8962), GAACguaagu (SEQ ID NO.: 8963), GAACguaugu (SEQ ID NO.: 8964), GAACgugagc (SEQ ID NO.: 8965), GAACgugagg (SEQ ID NO.: 8966), GAACgugagu (SEQ ID NO.: 8967), GAACguguga (SEQ ID NO.: 8968), GAAGaggaag (SEQ ID NO.: 8969), GAAGauaucc (SEQ ID NO.: 8970), GAAGcagauu (SEQ ID NO.: 8971), GAAGcugacu (SEQ ID NO.: 8972), GAAGgcaaag (SEQ ID NO.: 8973), GAAGgcaaga (SEQ ID NO.: 8974), GAAGgcaagc (SEQ ID NO.: 8975), GAAGgcaagg (SEQ ID NO.: 8976), GAAGgcaagu (SEQ ID NO.: 8977), GAAGgcacgu (SEQ ID NO.: 8978), GAAGgcaggu (SEQ ID NO.: 8979), GAAGgcauga (SEQ ID NO.: 8980), GAAGgcaugu (SEQ ID NO.: 8981), GAAGgccagc (SEQ ID NO.: 8982), GAAGgccagu (SEQ ID NO.: 8983), GAAGgcuuac (SEQ ID NO.: 8984), GAAGggaggu (SEQ ID NO.: 8985), GAAGggugag (SEQ ID NO.: 8986), GAAGguaaaa (SEQ ID NO.: 8987), GAAGguaaac (SEQ ID NO.: 8988), GAAGguaaag (SEQ ID NO.: 8989), GAAGguaaau (SEQ ID NO.: 8990), GAAGguaaca (SEQ ID NO.: 8991), GAAGguaacc (SEQ ID NO.: 8992), GAAGguaacg (SEQ ID NO.: 8993), GAAGguaacu (SEQ ID NO.: 8994), GAAGguaaga (SEQ ID NO.: 8995), GAAGguaagc (SEQ ID NO.: 8996), GAAGguaagg (SEQ ID NO.: 8997), GAAGguaagu (SEQ ID NO.: 8998), GAAGguaaua (SEQ ID NO.: 8999), GAAGguaauc (SEQ ID NO.: 9000), GAAGguaaug (SEQ ID NO.: 9001), GAAGguaauu (SEQ ID NO.: 9002), GAAGguacaa (SEQ ID NO.: 9003), GAAGguacac (SEQ ID NO.: 9004), GAAGguacag (SEQ ID NO.: 9005), GAAGguacau (SEQ ID NO.: 9006), GAAGguacca (SEQ ID NO.: 9007), GAAGguaccc (SEQ ID NO.: 9008), GAAGguaccg (SEQ ID NO.: 9009), GAAGguaccu (SEQ ID NO.: 9010), GAAGguacga (SEQ ID NO.: 9011), GAAGguacgg (SEQ ID NO.: 9012), GAAGguacgu (SEQ ID NO.: 9013), GAAGguacua (SEQ ID NO.: 9014), GAAGguacuc (SEQ ID NO.: 9015), GAAGguacug (SEQ ID NO.: 9016), GAAGguacuu (SEQ ID NO.: 9017), GAAGguagaa (SEQ ID NO.: 9018), GAAGguagac (SEQ ID NO.: 9019), GAAGguagag (SEQ ID NO.: 9020), GAAGguagau (SEQ ID NO.: 9021), GAAGguagca (SEQ ID NO.: 9022), GAAGguagcc (SEQ ID NO.: 9023), GAAGguagcg (SEQ ID NO.: 9024), GAAGguagcu (SEQ ID NO.: 9025), GAAGguagga (SEQ ID NO.: 9026), GAAGguaggc (SEQ ID NO.: 9027), GAAGguaggg (SEQ ID NO.: 9028), GAAGguaggu (SEQ ID NO.: 9029), GAAGguagua (SEQ ID NO.: 9030), GAAGguagug (SEQ ID NO.: 9031), GAAGguaguu (SEQ ID NO.: 9032), GAAGguauaa (SEQ ID NO.: 9033), GAAGguauac (SEQ ID NO.: 9034), GAAGguauag (SEQ ID NO.: 9035), GAAGguauau (SEQ ID NO.: 9036), GAAGguauca (SEQ ID NO.: 9037), GAAGguaucc (SEQ ID NO.: 9038), GAAGguaucg (SEQ ID NO.: 9039), GAAGguaucu (SEQ ID NO.: 9040), GAAGguauga (SEQ ID NO.: 9041), GAAGguaugc (SEQ ID NO.: 9042), GAAGguaugg (SEQ ID NO.: 9043), GAAGguaugu (SEQ ID NO.: 9044), GAAGguauua (SEQ ID NO.: 9045), GAAGguauuc (SEQ ID NO.: 9046), GAAGguauug (SEQ ID NO.: 9047), GAAGguauuu (SEQ ID NO.: 9048), GAAGgucaga (SEQ ID NO.: 9049), GAAGgucagc (SEQ ID NO.: 9050), GAAGgucagg (SEQ ID NO.: 9051), GAAGgucagu (SEQ ID NO.: 9052), GAAGgucaua (SEQ ID NO.: 9053), GAAGguccag (SEQ ID NO.: 9054), GAAGgucccg (SEQ ID NO.: 9055), GAAGgucuaa (SEQ ID NO.: 9056), GAAGgucuau (SEQ ID NO.: 9057), GAAGgucugc (SEQ ID NO.: 9058), GAAGgucugg (SEQ ID NO.: 9059), GAAGgucugu (SEQ ID NO.: 9060), GAAGgucuuc (SEQ ID NO.: 9061), GAAGgugaaa (SEQ ID NO.: 9062), GAAGgugaac (SEQ
ID NO.: 9063), GAAGgugaag (SEQ ID NO.: 9064), GAAGgugaau (SEQ ID NO.: 9065), GAAGgugaca (SEQ ID NO.: 9066), GAAGgugacc (SEQ ID NO.: 9067), GAAGgugacu (SEQ ID NO.: 9068), GAAGgugaga (SEQ ID NO.: 9069), GAAGgugagc (SEQ ID NO.: 9070), GAAGgugagg (SEQ ID NO.: 9071), GAAGgugagu (SEQ ID NO.: 9072), GAAGgugaua (SEQ ID NO.: 9073), GAAGgugauc (SEQ ID NO.: 9074), GAAGgugaug (SEQ ID NO.: 9075), GAAGgugauu (SEQ ID NO.: 9076), GAAGgugcac (SEQ ID NO.: 9077), GAAGgugcag (SEQ ID NO.: 9078), GAAGgugcca (SEQ ID NO.: 9079), GAAGgugccc (SEQ ID NO.: 9080), GAAGgugccg (SEQ ID NO.: 9081), GAAGgugccu (SEQ ID NO.: 9082), GAAGgugcgc (SEQ ID NO.: 9083), GAAGgugcgg (SEQ ID NO.: 9084), GAAGgugcgu (SEQ ID NO.: 9085), GAAGgugcua (SEQ ID NO.: 9086), GAAGgugcuc (SEQ ID NO.: 9087), GAAGgugcug (SEQ ID NO.: 9088), GAAGgugcuu (SEQ ID NO.: 9089), GAAGguggaa (SEQ ID NO.: 9090), GAAGguggag (SEQ ID NO.: 9091), GAAGguggau (SEQ ID NO.: 9092), GAAGguggcc (SEQ ID NO.: 9093), GAAGguggga (SEQ ID NO.: 9094), GAAGgugggc (SEQ ID NO.: 9095), GAAGgugggg (SEQ ID NO.: 9096), GAAGgugggu (SEQ ID NO.: 9097), GAAGguggua (SEQ ID NO.: 9098), GAAGguggug (SEQ ID NO.: 9099), GAAGgugguu (SEQ ID NO.: 9100), GAAGguguaa (SEQ ID NO.: 9101), GAAGguguca (SEQ ID NO.: 9102), GAAGguguga (SEQ ID NO.: 9103), GAAGgugugc (SEQ ID NO.: 9104), GAAGgugugg (SEQ ID NO.: 9105), GAAGgugugu (SEQ ID NO.: 9106), GAAGguguuu (SEQ ID NO : 9107), GAAGguuaaa (SEQ ID NO.: 9108), GAAGguuaag (SEQ ID NO.: 9109), GAAGguuaau (SEQ ID NO.: 9110), GAAGguuaga (SEQ ID NO. : 9111), GAAGguuagc (SEQ ID NO.: 9112), GAAGguuagg (SEQ ID NO. : 9113), GAAGguuagu (SEQ ID NO. : 9114), GAAGguuauc (SEQ ID NO. : 9115), GAAGguuauu (SEQ ID NO.: 9116), GAAGguucag (SEQ ID NO.: 9117), GAAGguucga (SEQ ID NO.: 9118), GAAGguugag (SEQ ID NO.: 9119), GAAGguuggc (SEQ ID NO.: 9120), GAAGguuggu (SEQ ID NO.: 9121), GAAGguugua (SEQ ID NO.: 9122), GAAGguuguc (SEQ ID NO.: 9123), GAAGguuugc (SEQ ID NO.: 9124), GAAGguuugg (SEQ ID NO.: 9125), GAAGguuugu (SEQ ID NO.: 9126), GAAGguuuua (SEQ ID NO.: 9127), GAAGuaaauc (SEQ ID NO.: 9128), GAAGuuaagu (SEQ ID NO.: 9129), GAAUgaaaau (SEQ ID NO.: 9130), GAAUgcaagg (SEQ ID NO. : 9131), GAAUguaaau (SEQ ID NO. : 9132), GAAUguaaga (SEQ ID NO.: 9133), GAAUguaagc (SEQ ID NO.: 9134), GAAUguaagg (SEQ ID NO.: 9135), GAAUguaagu (SEQ ID NO.: 9136), GAAUguaaug (SEQ ID NO.: 9137), GAAUguaauu (SEQ ID NO.: 9138), GAAUguacac (SEQ ID NO.: 9139), GAAUguaugu (SEQ ID NO.: 9140), GAAUguauuu (SEQ ID NO.: 9141), GAAUgugaga (SEQ ID NO.: 9142), GAAUgugagc (SEQ ID NO.: 9143), GAAUgugagg (SEQ ID NO.: 9144), GAAUgugagu (SEQ ID NO.: 9145), GAAUgugcgc (SEQ ID NO.: 9146), GAAUgugcgu (SEQ ID NO.: 9147), GAAUguggcu (SEQ ID NO.: 9148), GAAUguggug (SEQ ID NO.: 9149), GAAUuguaag (SEQ ID NO.: 9150), GACAaaggua (SEQ ID NO.: 9151), GACAaggaaa (SEQ ID NO.: 9152), GACAguaaga (SEQ ID NO.: 9153), GACAguaagc (SEQ ID NO.: 9154), GACAguaagg (SEQ ID NO.: 9155), GACAguaagu (SEQ ID NO.: 9156), GACAguaauu (SEQ ID NO.: 9157), GACAguagcu (SEQ ID NO.: 9158), GACAguaggu (SEQ ID NO.: 9159), GACAguaugu (SEQ ID NO.: 9160), GACAguauuu (SEQ ID NO.: 9161), GACAgugaga (SEQ ID NO.: 9162), GACAgugagc (SEQ ID NO.: 9163), GACAgugagu (SEQ ID NO.: 9164), GACAguggug (SEQ ID NO.: 9165), GACAguuaag (SEQ ID NO.: 9166), GACAguuggu (SEQ ID NO.: 9167), GACCaggaua (SEQ ID NO.: 9168), GACCauaucc (SEQ ID NO.: 9169), GACCgguauc (SEQ ID NO.: 9170), GACCguaagu (SEQ ID NO.: 9171), GACCguaucc (SEQ ID NO.: 9172), GACCguaugu (SEQ ID NO.: 9173), GACCgugagu (SEQ ID NO.: 9174), GACCgugggu (SEQ ID NO.: 9175),
GACGguaaag (SEQ ID NO.: 9176), GACGguaaau (SEQ ID NO.: 9177), GACGguaaga (SEQ ID NO.: 9178), GACGguaagc (SEQ ID NO.: 9179), GACGguaagu (SEQ ID NO.: 9180), GACGguaaua (SEQ ID NO.: 9181), GACGguaaug (SEQ ID NO.: 9182), GACGguaauu (SEQ ID NO.: 9183), GACGguagga (SEQ ID NO.: 9184), GACGguaggu (SEQ ID NO.: 9185), GACGguauga (SEQ ID NO.: 9186), GACGguaugg (SEQ ID NO.: 9187), GACGguaugu (SEQ ID NO.: 9188), GACGgugaga (SEQ ID NO.: 9189), GACGgugagc (SEQ ID NO.: 9190), GACGgugagg (SEQ ID NO.: 9191), GACGgugagu (SEQ ID NO.: 9192), GACGgugcgu (SEQ ID NO.: 9193), GACGgugggc (SEQ ID NO.: 9194), GACGgugggu (SEQ ID NO.: 9195), GACGgugugu (SEQ ID NO.: 9196), GACGguuagu (SEQ ID NO.: 9197), GACGguuggu (SEQ ID NO.: 9198), GACGuaaaac (SEQ ID NO.: 9199), GACUacuuca (SEQ ID NO.: 9200), GACUgcaggu (SEQ ID NO.: 9201), GACUguaaga (SEQ ID NO.: 9202), GACUguaagc (SEQ ID NO.: 9203), GACUguaagu (SEQ ID NO.: 9204), GACUguacgu (SEQ ID NO.: 9205), GACUguaggu (SEQ ID NO.: 9206), GACUguaucc (SEQ ID NO.: 9207), GACUguaugu (SEQ ID NO.: 9208), GACUgugaga (SEQ ID NO.: 9209), GACUgugagg (SEQ ID NO.: 9210), GACUgugagu (SEQ ID NO.: 9211), GACUgugggg (SEQ ID NO.: 9212), GACUgugggu (SEQ ID NO.: 9213), GACUguggua (SEQ ID NO.: 9214), GACUgugguu (SEQ ID NO.: 9215), GAGAagauau (SEQ ID NO.: 9216), GAGAagcuaa (SEQ ID NO.: 9217), GAGAauaucc (SEQ ID NO.: 9218), GAGAgaauaa (SEQ ID NO.: 9219), GAGAgcacga (SEQ ID NO.: 9220), GAGAguaacu (SEQ ID NO.: 9221), GAGAguaaga (SEQ ID NO.: 9222), GAGAguaagc (SEQ ID NO.: 9223), GAGAguaagg (SEQ ID NO.: 9224), GAGAguaagu (SEQ ID NO.: 9225), GAGAguacaa (SEQ ID NO.: 9226), GAGAguaggu (SEQ ID NO.: 9227), GAGAgugagg (SEQ ID NO.: 9228), GAGAgugagu (SEQ ID NO.: 9229), GAGAgugauu (SEQ ID NO.: 9230), GAGAguggua (SEQ ID NO.: 9231), GAGAguguaa (SEQ ID NO.: 9232), GAGAguuggu (SEQ ID NO.: 9233), GAGAguuugu (SEQ ID NO.: 9234), GAGAugcugc (SEQ ID NO.: 9235), GAGCguaagc (SEQ ID NO.: 9236), GAGCguaagu (SEQ ID NO.: 9237), GAGCguacgu (SEQ ID NO.: 9238), GAGCguaggu (SEQ ID NO.: 9239), GAGCguaugu (SEQ ID NO.: 9240), GAGCgugagc (SEQ ID NO.: 9241), GAGCgugagu (SEQ ID NO.: 9242), GAGCguguga (SEQ ID NO.: 9243), GAGGagaugc (SEQ ID NO.: 9244), GAGGagugug (SEQ ID NO.: 9245), GAGGgaagga (SEQ ID NO.: 9246), GAGGgaagug (SEQ ID NO.: 9247), GAGGgcaagu (SEQ ID NO.: 9248), GAGGggauag (SEQ ID NO.: 9249), GAGGguaaaa (SEQ ID NO.: 9250), GAGGguaaac (SEQ ID NO.: 9251), GAGGguaaag (SEQ ID NO.: 9252), GAGGguaaau (SEQ ID NO.: 9253), GAGGguaaga (SEQ ID NO.: 9254), GAGGguaagc (SEQ ID NO.: 9255), GAGGguaagg (SEQ ID NO.: 9256), GAGGguaagu (SEQ ID NO.: 9257), GAGGguaaua (SEQ ID NO.: 9258), GAGGguaaug (SEQ ID NO.: 9259), GAGGguaauu (SEQ ID NO.: 9260), GAGGguacag (SEQ ID NO.: 9261), GAGGguaccu (SEQ ID NO.: 9262), GAGGguacgu (SEQ ID NO.: 9263), GAGGguagga (SEQ ID NO.: 9264), GAGGguaggu (SEQ ID NO.: 9265), GAGGguauac (SEQ ID NO.: 9266), GAGGguauga (SEQ ID NO 9267), GAGGguaugc (SEQ ID NO.: 9268), GAGGguaugg (SEQ ID NO.: 9269), GAGGguaugu (SEQ ID NO.: 9270), GAGGguauuc (SEQ ID NO.: 9271), GAGGgucagu (SEQ ID NO.: 9272), GAGGgugaga (SEQ ID NO.: 9273), GAGGgugagc (SEQ ID NO.: 9274), GAGGgugagg (SEQ ID NO.: 9275), GAGGgugagu (SEQ ID NO.: 9276), GAGGgugcuc (SEQ ID NO.: 9277), GAGGgugggc (SEQ ID NO.: 9278), GAGGgugggu (SEQ ID NO.: 9279), GAGGgugugu (SEQ ID NO.: 9280), GAGGguuagc (SEQ ID NO.: 9281), GAGGguugua (SEQ ID NO.: 9282), GAGGguuugu (SEQ ID NO.: 9283), GAGGuuacag (SEQ ID NO.: 9284), GAGUguaaga (SEQ ID NO.: 9285), GAGUguaagu (SEQ ID NO.: 9286), GAGUguaggu (SEQ ID NO.: 9287), GAGUguaugu (SEQ
ID NO.: 9288), GAGUgugagc (SEQ ID NO.: 9289), GAGUgugagu (SEQ ID NO.: 9290), GAUAcucgua (SEQ ID NO.: 9291), GAUAguaagu (SEQ ID NO.: 9292), GAUAguacug (SEQ ID NO.: 9293), GAUAgugagu (SEQ ID NO.: 9294), GAUCguaaga (SEQ ID NO.: 9295), GAUCguaagu (SEQ ID NO.: 9296), GAUCguaucc (SEQ ID NO.: 9297), GAUCgugagc (SEQ ID NO.: 9298), GAUCgugagu (SEQ ID NO.: 9299), GAUGagggaa (SEQ ID NO.: 9300), GAUGaugagg (SEQ ID NO.: 9301), GAUGcaggaa (SEQ ID NO.: 9302), GAUGgcaagu (SEQ ID NO.: 9303), GAUGgcaauc (SEQ ID NO.: 9304), GAUGgcacgg (SEQ ID NO.: 9305), GAUGgcaugu (SEQ ID NO.: 9306), GAUGgguagg (SEQ ID NO.: 9307), GAUGguaaaa (SEQ ID NO.: 9308), GAUGguaaac (SEQ ID NO.: 9309), GAUGguaaag (SEQ ID NO.: 9310), GAUGguaaau (SEQ ID NO. : 9311), GAUGguaaca (SEQ ID NO. : 9312), GAUGguaacu (SEQ ID NO. : 9313), GAUGguaaga (SEQ ID NO. : 9314), GAUGguaagc (SEQ ID NO. : 9315), GAUGguaagg (SEQ ID NO.: 9316), GAUGguaagu (SEQ ID NO.: 9317), GAUGguaaua (SEQ ID NO. : 9318), GAUGguaaug (SEQ ID NO. : 9319), GAUGguaauu (SEQ ID NO. : 9320), GAUGguacau (SEQ ID NO.: 9321), GAUGguaccc (SEQ ID NO.: 9322), GAUGguacga (SEQ ID NO.: 9323), GAUGguagga (SEQ ID NO.: 9324), GAUGguaggc (SEQ ID NO.: 9325), GAUGguaggg (SEQ ID NO.: 9326), GAUGguaggu (SEQ ID NO.: 9327), GAUGguauag (SEQ ID NO.: 9328), GAUGguauga (SEQ ID NO.: 9329), GAUGguaugg (SEQ ID NO.: 9330), GAUGguaugu (SEQ ID NO.: 9331), GAUGgucagu (SEQ ID NO.: 9332), GAUGguccgu (SEQ ID NO.: 9333), GAUGgucggu (SEQ ID NO.: 9334), GAUGgugaau (SEQ ID NO.: 9335), GAUGgugaga (SEQ ID NO.: 9336), GAUGgugagc (SEQ ID NO.: 9337), GAUGgugagg (SEQ ID NO.: 9338), GAUGgugagu (SEQ ID NO.: 9339), GAUGgugcgg (SEQ ID NO.: 9340), GAUGgugcgu (SEQ ID NO.: 9341), GAUGgugcuc (SEQ ID NO.: 9342), GAUGguggac (SEQ ID NO.: 9343), GAUGguggga (SEQ ID NO.: 9344), GAUGgugggc (SEQ ID NO.: 9345), GAUGgugggg (SEQ ID NO.: 9346), GAUGguggug (SEQ ID NO.: 9347), GAUGgugugc (SEQ ID NO.: 9348), GAUGgugugu (SEQ ID NO.: 9349), GAUGguuagu (SEQ ID NO.: 9350), GAUGguuugu (SEQ ID NO.: 9351), GAUGuggguu (SEQ ID NO.: 9352), GAUUguaagg (SEQ ID NO.: 9353), GAUUguaagu (SEQ ID NO.: 9354), GAUUguaggu (SEQ ID NO.: 9355), GAUUguaucc (SEQ ID NO.: 9356), GAUUguaugu (SEQ ID NO.: 9357), GAUUgugaga (SEQ ID NO.: 9358), GAUUgugagu (SEQ ID NO.: 9359), GAUUguguga (SEQ ID NO.: 9360), GAUUguuagu (SEQ ID NO.: 9361), GAUUugcaug (SEQ ID NO.: 9362), GAUUuguaag (SEQ ID NO.: 9363), GCAAaacagg (SEQ ID NO.: 9364), GCAAagguaa (SEQ ID NO.: 9365), GCAAgcaagu (SEQ ID NO.: 9366), GCAAgguaag (SEQ ID NO.: 9367), GCAAguaaau (SEQ ID NO.: 9368), GCAAguaaga (SEQ ID NO.: 9369), GCAAguaagc (SEQ ID NO.: 9370), GCAAguaagg (SEQ ID NO.: 9371), GCAAguaagu (SEQ ID NO.: 9372), GCAAguacaa (SEQ ID NO.: 9373), GCAAguacgg (SEQ ID NO.: 9374), GCAAguacgu (SEQ ID NO.: 9375), GCAAguacua (SEQ ID NO.: 9376), GCAAguaggc (SEQ ID NO.: 9377), GCAAguaggu (SEQ ID NO.: 9378), GCAAguauga (SEQ ID NO.: 9379), GCAAguaugc (SEQ ID NO.: 9380), GCAAguaugg (SEQ ID NO.: 9381), GCAAguaugu (SEQ ID NO.: 9382), GCAAgucagu (SEQ ID NO.: 9383), GCAAgugagc (SEQ ID NO.: 9384), GCAAgugagg (SEQ ID NO.: 9385), GCAAgugagu (SEQ ID NO.: 9386), GCAAgugggg (SEQ ID NO.: 9387), GCAAgugggu (SEQ ID NO.: 9388), GCAAguuagu (SEQ ID NO.: 9389), GCACgcaagu (SEQ ID NO.: 9390), GCACguaagc (SEQ ID NO.: 9391), GCACguaagu (SEQ ID NO.: 9392), GCACguaggu (SEQ ID NO.: 9393), GCACguaugu (SEQ ID NO.: 9394), GCACgugagc (SEQ ID NO.: 9395), GCACgugagu (SEQ ID NO.: 9396), GCACgugcgu (SEQ ID NO.: 9397), GCAGaggaaa (SEQ ID NO.: 9398), GCAGauaagu (SEQ ID NO.: 9399), GCAGcagaag (SEQ ID NO.: 9400),
GCAGgaaagu (SEQ ID NO.: 9401), GCAGgcaaga (SEQ ID NO.: 9402), GCAGgcaagc (SEQ ID NO.: 9403), GCAGgcaagg (SEQ ID NO.: 9404), GCAGgcaagu (SEQ ID NO.: 9405), GCAGgcacag (SEQ ID NO.: 9406), GCAGgcaggg (SEQ ID NO.: 9407), GCAGgcaggu (SEQ ID NO.: 9408), GCAGgcauau (SEQ ID NO.: 9409), GCAGgcaugu (SEQ ID NO.: 9410), GCAGgcccug (SEQ ID NO.: 9411), GCAGgcgaga (SEQ ID NO.: 9412), GCAGgcgagu (SEQ ID NO.: 9413), GCAGgcgggg (SEQ ID NO.: 9414), GCAGgcucgc (SEQ ID NO.: 9415), GCAGguaaaa (SEQ ID NO.: 9416), GCAGguaaac (SEQ ID NO.: 9417), GCAGguaaag (SEQ ID NO.: 9418), GCAGguaaau (SEQ ID NO.: 9419), GCAGguaaca (SEQ ID NO.: 9420), GCAGguaacc (SEQ ID NO.: 9421), GCAGguaacg (SEQ ID NO.: 9422), GCAGguaacu (SEQ ID NO.: 9423), GCAGguaaga (SEQ ID NO.: 9424), GCAGguaagc (SEQ ID NO.: 9425), GCAGguaagg (SEQ ID NO.: 9426), GCAGguaagu (SEQ ID NO.: 9427), GCAGguaaua (SEQ ID NO.: 9428), GCAGguaauc (SEQ ID NO.: 9429), GCAGguaaug (SEQ ID NO.: 9430), GCAGguaauu (SEQ ID NO. : 9431), GCAGguacaa (SEQ ID NO. : 9432), GCAGguacac (SEQ ID NO.: 9433), GCAGguacag (SEQ ID NO.: 9434), GCAGguacau (SEQ ID NO.: 9435), GCAGguacca (SEQ ID NO.: 9436), GCAGguaccc (SEQ ID NO.: 9437), GCAGguaccg (SEQ ID NO.: 9438), GCAGguaccu (SEQ ID NO.: 9439), GCAGguacga (SEQ ID NO.: 9440), GCAGguacgc (SEQ ID NO.: 9441), GCAGguacgg (SEQ ID NO.: 9442), GCAGguacgu (SEQ ID NO.: 9443), GCAGguacua (SEQ ID NO.: 9444), GCAGguacuc (SEQ ID NO.: 9445), GCAGguacug (SEQ ID NO.: 9446), GCAGguacuu (SEQ ID NO.: 9447), GCAGguagaa (SEQ ID NO.: 9448), GCAGguagac (SEQ ID NO.: 9449), GCAGguagag (SEQ ID NO.: 9450), GCAGguagcc (SEQ ID NO.: 9451), GCAGguagcg (SEQ ID NO.: 9452), GCAGguagcu (SEQ ID NO.: 9453), GCAGguagga (SEQ ID NO.: 9454), GCAGguaggc (SEQ ID NO.: 9455), GCAGguaggg (SEQ ID NO.: 9456), GCAGguaggu (SEQ ID NO.: 9457), GCAGguagua (SEQ ID NO.: 9458), GCAGguaguc (SEQ ID NO.: 9459), GCAGguagug (SEQ ID NO.: 9460), GCAGguaguu (SEQ ID NO.: 9461), GCAGguauaa (SEQ ID NO.: 9462), GCAGguauac (SEQ ID NO.: 9463), GCAGguauag (SEQ ID NO.: 9464), GCAGguauau (SEQ ID NO.: 9465), GCAGguauca (SEQ ID NO.: 9466), GCAGguaucc (SEQ ID NO.: 9467), GCAGguaucg (SEQ ID NO.: 9468), GCAGguaucu (SEQ ID NO.: 9469), GCAGguauga (SEQ ID NO.: 9470), GCAGguaugc (SEQ ID NO.: 9471), GCAGguaugg (SEQ ID NO.: 9472), GCAGguaugu (SEQ ID NO.: 9473), GCAGguauua (SEQ ID NO.: 9474), GCAGguauuc (SEQ ID NO.: 9475), GCAGguauug (SEQ ID NO.: 9476), GCAGguauuu (SEQ ID NO.: 9477), GCAGgucaac (SEQ ID NO.: 9478), GCAGgucaau (SEQ ID NO.: 9479), GCAGgucaga (SEQ ID NO.: 9480), GCAGgucagc (SEQ ID NO.: 9481), GCAGgucagg (SEQ ID NO.: 9482), GCAGgucagu (SEQ ID NO.: 9483), GCAGgucauu (SEQ ID NO.: 9484), GCAGguccaa (SEQ ID NO.: 9485), GCAGguccag (SEQ ID NO.: 9486), GCAGguccca (SEQ ID NO.: 9487), GCAGgucccg (SEQ ID NO.: 9488), GCAGguccgc (SEQ ID NO.: 9489), GCAGguccgu (SEQ ID NO.: 9490), GCAGgucggg (SEQ ID NO.: 9491), GCAGgucguu (SEQ ID NO.: 9492), GCAGgucuga (SEQ ID NO.: 9493), GCAGgucugc (SEQ ID NO.: 9494), GCAGgucugu (SEQ ID NO.: 9495), GCAGgugaaa (SEQ ID NO.: 9496), GCAGgugaac (SEQ ID NO.: 9497), GCAGgugaag (SEQ ID NO.: 9498), GCAGgugaau (SEQ ID NO.: 9499), GCAGgugaca (SEQ ID NO.: 9500), GCAGgugacc (SEQ ID NO.: 9501), GCAGgugacg (SEQ ID NO.: 9502), GCAGgugacu (SEQ ID NO.: 9503), GCAGgugaga (SEQ ID NO.: 9504), GCAGgugagc (SEQ ID NO.: 9505), GCAGgugagg (SEQ ID NO.: 9506), GCAGgugagu (SEQ ID NO.: 9507), GCAGgugaua (SEQ ID NO.: 9508), GCAGgugauc (SEQ ID NO.: 9509), GCAGgugaug (SEQ ID NO.: 9510), GCAGgugauu (SEQ ID NO.: 9511), GCAGgugcaa (SEQ ID NO.: 9512), GCAGgugcag (SEQ
ID NO.: 9513), GCAGgugcau (SEQ ID NO.: 9514), GCAGgugcca (SEQ ID NO. : 9515), GCAGgugccc (SEQ ID NO.: 9516), GCAGgugccu (SEQ ID NO.: 9517), GCAGgugcga (SEQ ID NO.: 9518), GCAGgugcgc (SEQ ID NO.: 9519), GCAGgugcgg (SEQ ID NO.: 9520), GCAGgugcgu (SEQ ID NO.: 9521), GCAGgugcua (SEQ ID NO.: 9522), GCAGgugcuc (SEQ ID NO.: 9523), GCAGgugcug (SEQ ID NO.: 9524), GCAGgugcuu (SEQ ID NO.: 9525), GCAGguggag (SEQ ID NO.: 9526), GCAGguggau (SEQ ID NO.: 9527), GCAGguggga (SEQ ID NO.: 9528), GCAGgugggc (SEQ ID NO.: 9529), GCAGgugggg (SEQ ID NO.: 9530), GCAGgugggu (SEQ ID NO.: 9531), GCAGguggug (SEQ ID NO.: 9532), GCAGgugguu (SEQ ID NO.: 9533), GCAGguguau (SEQ ID NO.: 9534), GCAGgugucu (SEQ ID NO.: 9535), GCAGguguga (SEQ ID NO.: 9536), GCAGgugugc (SEQ ID NO.: 9537), GCAGgugugg (SEQ ID NO.: 9538), GCAGgugugu (SEQ ID NO.: 9539), GCAGguguua (SEQ ID NO.: 9540), GCAGguuaau (SEQ ID NO.: 9541), GCAGguuaga (SEQ ID NO.: 9542), GCAGguuagc (SEQ ID NO.: 9543), GCAGguuagg (SEQ ID NO.: 9544), GCAGguuagu (SEQ ID NO.: 9545), GCAGguuaua (SEQ ID NO.: 9546), GCAGguucag (SEQ ID NO.: 9547), GCAGguucau (SEQ ID NO.: 9548), GCAGguucgu (SEQ ID NO.: 9549), GCAGguucug (SEQ ID NO.: 9550), GCAGguucuu (SEQ ID NO.: 9551), GCAGguugcu (SEQ ID NO.: 9552), GCAGguugga (SEQ ID NO.: 9553), GCAGguuggu (SEQ ID NO.: 9554), GCAGguuguc (SEQ ID NO.: 9555), GCAGguugug (SEQ ID NO.: 9556), GCAGguuuau (SEQ ID NO.: 9557), GCAGguuugc (SEQ ID NO.: 9558), GCAGguuugg (SEQ ID NO.: 9559), GCAGguuugu (SEQ ID NO.: 9560), GCAGugguga (SEQ ID NO.: 9561), GCAUgcaagu (SEQ ID NO.: 9562), GCAUgguaaa (SEQ ID NO.: 9563), GCAUguaaga (SEQ ID NO.: 9564), GCAUguaagu (SEQ ID NO.: 9565), GCAUguaaug (SEQ ID NO.: 9566), GCAUguaauu (SEQ ID NO.: 9567), GCAUguaggu (SEQ ID NO.: 9568), GCAUguaucc (SEQ ID NO.: 9569), GCAUguaugu (SEQ ID NO.: 9570), GCAUgugagc (SEQ ID NO.: 9571), GCAUgugagu (SEQ ID NO.: 9572), GCAUgugcca (SEQ ID NO.: 9573), GCAUgugggu (SEQ ID NO.: 9574), GCAUgugugu (SEQ ID NO.: 9575), GCAUucuuca (SEQ ID NO.: 9576), GCCAguaaga (SEQ ID NO.: 9577), GCCAguaagg (SEQ ID NO.: 9578), GCCAguaagu (SEQ ID NO.: 9579), GCCAguaggu (SEQ ID NO.: 9580), GCCAgugagg (SEQ ID NO.: 9581), GCCAgugagu (SEQ ID NO.: 9582), GCCCaggcac (SEQ ID NO.: 9583), GCCCgggcau (SEQ ID NO.: 9584), GCCCguaagc (SEQ ID NO.: 9585), GCCCguaagu (SEQ ID NO.: 9586), GCCCguauga (SEQ ID NO.: 9587), GCCCguaugu (SEQ ID NO.: 9588), GCCCgugagu (SEQ ID NO.: 9589), GCCGgcaagu (SEQ ID NO.: 9590), GCCGggguga (SEQ ID NO.: 9591), GCCGgguggg (SEQ ID NO.: 9592), GCCGguaaag (SEQ ID NO.: 9593), GCCGguaaau (SEQ ID NO.: 9594), GCCGguaaga (SEQ ID NO.: 9595), GCCGguaagc (SEQ ID NO.: 9596), GCCGguaagg (SEQ ID NO.: 9597), GCCGguaagu (SEQ ID NO.: 9598), GCCGguaaua (SEQ ID NO.: 9599), GCCGguaauc (SEQ ID NO.: 9600), GCCGguaaug (SEQ ID NO.: 9601), GCCGguacgg (SEQ ID NO.: 9602), GCCGguacgu (SEQ ID NO.: 9603), GCCGguacug (SEQ ID NO.: 9604), GCCGguagga (SEQ ID NO.: 9605), GCCGguaggc (SEQ ID NO.: 9606), GCCGguaggu (SEQ ID NO.: 9607), GCCGguaugu (SEQ ID NO.: 9608), GCCGgucagc (SEQ ID NO.: 9609), GCCGgucagu (SEQ ID NO.: 9610), GCCGgucugu (SEQ ID NO.: 9611), GCCGgugaga (SEQ ID NO.: 9612), GCCGgugagc (SEQ ID NO.: 9613), GCCGgugagg (SEQ ID NO.: 9614), GCCGgugagu (SEQ ID NO.: 9615), GCCGgugcgu (SEQ ID NO.: 9616), GCCGgugggu (SEQ ID NO.: 9617), GCCGguuagu (SEQ ID NO.: 9618), GCCUguaaga (SEQ ID NO.: 9619), GCCUguaagu (SEQ ID NO.: 9620), GCCUguaggu (SEQ ID NO.: 9621), GCCUguaucc (SEQ ID NO.: 9622), GCCUguaugu (SEQ ID NO.: 9623), GCCUgugaga (SEQ ID NO.: 9624), GCCUgugagg (SEQ ID NO.: 9625),
GCCUgugagu (SEQ ID NO.: 9626), GCCUgugggu (SEQ ID NO.: 9627), GCGAguaagg (SEQ ID NO.: 9628), GCGAguaagu (SEQ ID NO.: 9629), GCGAguacgu (SEQ ID NO.: 9630), GCGAguaugu (SEQ ID NO.: 9631), GCGAgucagu (SEQ ID NO.: 9632), GCGAgucggu (SEQ ID NO.: 9633), GCGAgugagc (SEQ ID NO.: 9634), GCGAgugagu (SEQ ID NO.: 9635), GCGCggguac (SEQ ID NO.: 9636), GCGCggguga (SEQ ID NO.: 9637), GCGCgugagc (SEQ ID NO.: 9638), GCGCgugagu (SEQ ID NO.: 9639), GCGGguaaaa (SEQ ID NO.: 9640), GCGGguaaac (SEQ ID NO.: 9641), GCGGguaaga (SEQ ID NO.: 9642), GCGGguaagc (SEQ ID NO.: 9643), GCGGguaagg (SEQ ID NO.: 9644), GCGGguaagu (SEQ ID NO.: 9645), GCGGguacga (SEQ ID NO.: 9646), GCGGguacgg (SEQ ID NO.: 9647), GCGGguacuc (SEQ ID NO.: 9648), GCGGguacuu (SEQ ID NO.: 9649), GCGGguagag (SEQ ID NO.: 9650), GCGGguaggc (SEQ ID NO.: 9651), GCGGguaggg (SEQ ID NO 9652), GCGGguaggu (SEQ ID NO.: 9653), GCGGguaugg (SEQ ID NO.: 9654), GCGGguaugu (SEQ ID NO.: 9655), GCGGgugaga (SEQ ID NO.: 9656), GCGGgugagc (SEQ ID NO.: 9657), GCGGgugagg (SEQ ID NO.: 9658), GCGGgugagu (SEQ ID NO.: 9659), GCGGgugcag (SEQ ID NO.: 9660), GCGGgugcgu (SEQ ID NO.: 9661), GCGGgugugc (SEQ ID NO.: 9662), GCGGguuggu (SEQ ID NO.: 9663), GCGGguuugu (SEQ ID NO.: 9664), GCGUguaagg (SEQ ID NO.: 9665), GCGUguaagu (SEQ ID NO.: 9666), GCGUgugagc (SEQ ID NO.: 9667), GCGUgugagu (SEQ ID NO.: 9668), GCUAaguuaa (SEQ ID NO.: 9669), GCUAgcaagu (SEQ ID NO.: 9670), GCUAguaagc (SEQ ID NO.: 9671), GCUAguaagu (SEQ ID NO.: 9672), GCUAguaugu (SEQ ID NO.: 9673), GCUAgugagu (SEQ ID NO.: 9674), GCUAgugcgu (SEQ ID NO.: 9675), GCUAuggaau (SEQ ID NO.: 9676), GCUAugggcc (SEQ ID NO.: 9677), GCUCguaagu (SEQ ID NO.: 9678), GCUCgugagg (SEQ ID NO.: 9679), GCUCucuugu (SEQ ID NO.: 9680), GCUGauaucc (SEQ ID NO.: 9681), GCUGgcaagu (SEQ ID NO.: 9682), GCUGgcaggu (SEQ ID NO.: 9683), GCUGggaaca (SEQ ID NO.: 9684), GCUGguaaaa (SEQ ID NO.: 9685), GCUGguaaac (SEQ ID NO.: 9686), GCUGguaaag (SEQ ID NO.: 9687), GCUGguaaau (SEQ ID NO.: 9688), GCUGguaacc (SEQ ID NO.: 9689), GCUGguaaga (SEQ ID NO.: 9690), GCUGguaagc (SEQ ID NO.: 9691), GCUGguaagg (SEQ ID NO.: 9692), GCUGguaagu (SEQ ID NO.: 9693), GCUGguaaua (SEQ ID NO.: 9694), GCUGguaaug (SEQ ID NO.: 9695), GCUGguaccu (SEQ ID NO.: 9696), GCUGguacga (SEQ ID NO.: 9697), GCUGguacgg (SEQ ID NO.: 9698), GCUGguacgu (SEQ ID NO.: 9699), GCUGguacua (SEQ ID NO.: 9700), GCUGguacuc (SEQ ID NO.: 9701), GCUGguagcu (SEQ ID NO.: 9702), GCUGguagga (SEQ ID NO.: 9703), GCUGguaggc (SEQ ID NO.: 9704), GCUGguaggg (SEQ ID NO.: 9705), GCUGguaggu (SEQ ID NO.: 9706), GCUGguaucu (SEQ ID NO.: 9707), GCUGguauga (SEQ ID NO.: 9708), GCUGguaugc (SEQ ID NO.: 9709), GCUGguaugg (SEQ ID NO.: 9710), GCUGguaugu (SEQ ID NO.: 9711), GCUGguauua (SEQ ID NO.: 9712), GCUGgucagc (SEQ ID NO.: 9713), GCUGgucagu (SEQ ID NO.: 9714), GCUGgucugu (SEQ ID NO.: 9715), GCUGgugaga (SEQ ID NO.: 9716), GCUGgugagc (SEQ ID NO.: 9717), GCUGgugagg (SEQ ID NO.: 9718), GCUGgugagu (SEQ ID NO.: 9719), GCUGgugaua (SEQ ID NO.: 9720), GCUGgugaug (SEQ ID NO.: 9721), GCUGgugcgg (SEQ ID NO.: 9722), GCUGgugcgu (SEQ ID NO.: 9723), GCUGgugggu (SEQ ID NO.: 9724), GCUGgugugc (SEQ ID NO.: 9725), GCUGgugugu (SEQ ID NO.: 9726), GCUGguuagu (SEQ ID NO.: 9727), GCUUcaacag (SEQ ID NO.: 9728), GCUUcaggaa (SEQ ID NO.: 9729), GCUUguaaga (SEQ ID NO.: 9730), GCUUguaagg (SEQ ID NO. : 9731), GCUUguaagu (SEQ ID NO. : 9732), GCUUguacgu (SEQ ID NO.: 9733), GCUUguagga (SEQ ID NO.: 9734), GCUUguaucc (SEQ ID NO.: 9735), GCUUguaugu (SEQ ID NO.: 9736), GCUUgugagu (SEQ ID NO.: 9737), GCUUgugcuu (SEQ
ID NO.: 9738), GCUUugguaa (SEQ ID NO.: 9739), GGAAaaggua (SEQ ID NO.: 9740), GGAAcaggaa (SEQ ID NO.: 9741), GGAAcgggug (SEQ ID NO.: 9742), GGAAcuccgg (SEQ ID NO.: 9743), GGAAgguagu (SEQ ID NO.: 9744), GGAAggucag (SEQ ID NO.: 9745), GGAAgguguc (SEQ ID NO.: 9746), GGAAguaacu (SEQ ID NO.: 9747), GGAAguaaga (SEQ ID NO.: 9748), GGAAguaagc (SEQ ID NO.: 9749), GGAAguaagg (SEQ ID NO.: 9750), GGAAguaagu (SEQ ID NO.: 9751), GGAAguaauc (SEQ ID NO.: 9752), GGAAguaaug (SEQ ID NO.: 9753), GGAAguagga (SEQ ID NO.: 9754), GGAAguaggu (SEQ ID NO.: 9755), GGAAguaugc (SEQ ID NO.: 9756), GGAAguaugu (SEQ ID NO.: 9757), GGAAgugagc (SEQ ID NO.: 9758), GGAAgugagg (SEQ ID NO.: 9759), GGAAgugagu (SEQ ID NO.: 9760), GGAAguuagu (SEQ ID NO.: 9761), GGACguaaga (SEQ ID NO.: 9762), GGACguaagu (SEQ ID NO.: 9763), GGACguaugu (SEQ ID NO.: 9764), GGACgugagu (SEQ ID NO.: 9765), GGACgugugu (SEQ ID NO.: 9766), GGAGcucagg (SEQ ID NO.: 9767), GGAGgaaagu (SEQ ID NO.: 9768), GGAGgcaagc (SEQ ID NO.: 9769), GGAGgcaagg (SEQ ID NO.: 9770), GGAGgcaagu (SEQ ID NO.: 9771), GGAGgcaggu (SEQ ID NO.: 9772), GGAGgccaug (SEQ ID NO.: 9773), GGAGgccucu (SEQ ID NO.: 9774), GGAGgcgagu (SEQ ID NO.: 9775), GGAGgcugcc (SEQ ID NO.: 9776), GGAGguaaaa (SEQ ID NO.: 9777), GGAGguaaac (SEQ ID NO.: 9778), GGAGguaaag (SEQ ID NO.: 9779), GGAGguaaau (SEQ ID NO.: 9780), GGAGguaaca (SEQ ID NO.: 9781), GGAGguaacc (SEQ ID NO.: 9782), GGAGguaacg (SEQ ID NO.: 9783), GGAGguaacu (SEQ ID NO.: 9784), GGAGguaaga (SEQ ID NO.: 9785), GGAGguaagc (SEQ ID NO.: 9786), GGAGguaagg (SEQ ID NO.: 9787), GGAGguaagu (SEQ ID NO.: 9788), GGAGguaaua (SEQ ID NO.: 9789), GGAGguaauc (SEQ ID NO.: 9790), GGAGguaaug (SEQ ID NO.: 9791), GGAGguaauu (SEQ ID NO.: 9792), GGAGguacaa (SEQ ID NO.: 9793), GGAGguacag (SEQ ID NO.: 9794), GGAGguacau (SEQ ID NO.: 9795), GGAGguaccc (SEQ ID NO.: 9796), GGAGguaccg (SEQ ID NO.: 9797), GGAGguaccu (SEQ ID NO.: 9798), GGAGguacga (SEQ ID NO.: 9799), GGAGguacgc (SEQ ID NO.: 9800), GGAGguacgg (SEQ ID NO.: 9801), GGAGguacgu (SEQ ID NO.: 9802), GGAGguacuc (SEQ ID NO.: 9803), GGAGguacug (SEQ ID NO.: 9804), GGAGguacuu (SEQ ID NO.: 9805), GGAGguagaa (SEQ ID NO.: 9806), GGAGguagag (SEQ ID NO.: 9807), GGAGguagca (SEQ ID NO.: 9808), GGAGguagga (SEQ ID NO.: 9809), GGAGguaggc (SEQ ID NO.: 9810), GGAGguaggg (SEQ ID NO.: 9811), GGAGguaggu (SEQ ID NO.: 9812), GGAGguagua (SEQ ID NO.: 9813), GGAGguaguc (SEQ ID NO.: 9814), GGAGguagug (SEQ ID NO.: 9815), GGAGguauac (SEQ ID NO.: 9816), GGAGguauag (SEQ ID NO.: 9817), GGAGguauau (SEQ ID NO.: 9818), GGAGguauca (SEQ ID NO.: 9819), GGAGguaucu (SEQ ID NO.: 9820), GGAGguauga (SEQ ID NO.: 9821), GGAGguaugc (SEQ ID NO.: 9822), GGAGguaugg (SEQ ID NO.: 9823), GGAGguaugu (SEQ ID NO.: 9824), GGAGguauua (SEQ ID NO.: 9825), GGAGguauuc (SEQ ID NO.: 9826), GGAGguauug (SEQ ID NO.: 9827), GGAGguauuu (SEQ ID NO.: 9828), GGAGgucaga (SEQ ID NO.: 9829), GGAGgucagc (SEQ ID NO.: 9830), GGAGgucagg (SEQ ID NO.: 9831), GGAGgucagu (SEQ ID NO.: 9832), GGAGguccac (SEQ ID NO.: 9833), GGAGguccug (SEQ ID NO.: 9834), GGAGgucgag (SEQ ID NO.: 9835), GGAGgucguc (SEQ ID NO.: 9836), GGAGgucugc (SEQ ID NO.: 9837), GGAGgucugg (SEQ ID NO.: 9838), GGAGgucugu (SEQ ID NO.: 9839), GGAGgucuug (SEQ ID NO.: 9840), GGAGgugaag (SEQ ID NO.: 9841), GGAGgugaau (SEQ ID NO.: 9842), GGAGgugaca (SEQ ID NO.: 9843), GGAGgugacc (SEQ ID NO.: 9844), GGAGgugacg (SEQ ID NO.: 9845), GGAGgugacu (SEQ ID NO.: 9846), GGAGgugaga (SEQ ID NO.: 9847), GGAGgugagc (SEQ ID NO.: 9848), GGAGgugagg (SEQ ID NO.: 9849), GGAGgugagu (SEQ ID NO.: 9850),
GGAGgugaug (SEQ ID NO.: 9851), GGAGgugauu (SEQ ID NO.: 9852), GGAGgugccu (SEQ ID NO.: 9853), GGAGgugcgc (SEQ ID NO.: 9854), GGAGgugcgg (SEQ ID NO.: 9855), GGAGgugcgu (SEQ ID NO.: 9856), GGAGgugcuc (SEQ ID NO.: 9857), GGAGgugcug (SEQ ID NO.: 9858), GGAGgugcuu (SEQ ID NO.: 9859), GGAGguggag (SEQ ID NO.: 9860), GGAGguggcc (SEQ ID NO.: 9861), GGAGguggcg (SEQ ID NO.: 9862), GGAGguggga (SEQ ID NO.: 9863), GGAGgugggc (SEQ ID NO.: 9864), GGAGgugggg (SEQ ID NO.: 9865), GGAGgugggu (SEQ ID NO.: 9866), GGAGguggua (SEQ ID NO.: 9867), GGAGgugguu (SEQ ID NO.: 9868), GGAGgugugc (SEQ ID NO.: 9869), GGAGgugugg (SEQ ID NO.: 9870), GGAGgugugu (SEQ ID NO.: 9871), GGAGguguug (SEQ ID NO.: 9872), GGAGguuaaa (SEQ ID NO.: 9873), GGAGguuaga (SEQ ID NO.: 9874), GGAGguuagg (SEQ ID NO.: 9875), GGAGguuagu (SEQ ID NO.: 9876), GGAGguuauc (SEQ ID NO.: 9877), GGAGguucac (SEQ ID NO.: 9878), GGAGguucgu (SEQ ID NO.: 9879), GGAGguugau (SEQ ID NO.: 9880), GGAGguugcg (SEQ ID NO.: 9881), GGAGguugcu (SEQ ID NO.: 9882), GGAGguugga (SEQ ID NO.: 9883), GGAGguuggc (SEQ ID NO.: 9884), GGAGguuggu (SEQ ID NO.: 9885), GGAGguuugc (SEQ ID NO.: 9886), GGAGguuugu (SEQ ID NO.: 9887), GGAGuguaau (SEQ ID NO.: 9888), GGAGuugggu (SEQ ID NO.: 9889), GGAUauccuu (SEQ ID NO.: 9890), GGAUauguaa (SEQ ID NO.: 9891), GGAUguaaga (SEQ ID NO.: 9892), GGAUguaagc (SEQ ID NO.: 9893), GGAUguaagg (SEQ ID NO.: 9894), GGAUguaagu (SEQ ID NO.: 9895), GGAUguaucc (SEQ ID NO.: 9896), GGAUguaucu (SEQ ID NO.: 9897), GGAUgucagu (SEQ ID NO.: 9898), GGAUgugagc (SEQ ID NO.: 9899), GGAUgugagu (SEQ ID NO.: 9900), GGAUgugcgu (SEQ ID NO.: 9901), GGAUgugugu (SEQ ID NO.: 9902), GGAUguuagc (SEQ ID NO.: 9903), GGCAgcagag (SEQ ID NO.: 9904), GGCAgguaag (SEQ ID NO.: 9905), GGCAguaaga (SEQ ID NO.: 9906), GGCAguaagc (SEQ ID NO.: 9907), GGCAguaagu (SEQ ID NO.: 9908), GGCAgugagu (SEQ ID NO.: 9909), GGCCacccgg (SEQ ID NO.: 9910), GGCCggccgc (SEQ ID NO.: 9911), GGCCguaaga (SEQ ID NO.: 9912), GGCCguacag (SEQ ID NO.: 9913), GGCCgucagg (SEQ ID NO.: 9914), GGCCgugagu (SEQ ID NO.: 9915), GGCCgugcgu (SEQ ID NO.: 9916), GGCGggccac (SEQ ID NO.: 9917), GGCGguaaag (SEQ ID NO.: 9918), GGCGguaaga (SEQ ID NO.: 9919), GGCGguaagc (SEQ ID NO.: 9920), GGCGguaagu (SEQ ID NO.: 9921), GGCGguaggu (SEQ ID NO.: 9922), GGCGgucaca (SEQ ID NO.: 9923), GGCGgugaag (SEQ ID NO.: 9924), GGCGgugaga (SEQ ID NO.: 9925), GGCGgugagc (SEQ ID NO.: 9926), GGCGgugagg (SEQ ID NO.: 9927), GGCGgugagu (SEQ ID NO.: 9928), GGCGgugggu (SEQ ID NO.: 9929), GGCUgcccca (SEQ ID NO.: 9930), GGCUguaagg (SEQ ID NO. : 9931), GGCUguaagu (SEQ ID NO. : 9932), GGCUguaaua (SEQ ID NO.: 9933), GGCUguacaa (SEQ ID NO.: 9934), GGCUguacag (SEQ ID NO.: 9935), GGCUguaggu (SEQ ID NO.: 9936), GGCUgugagu (SEQ ID NO.: 9937), GGCUgugcgu (SEQ ID NO.: 9938), GGCUuuucaa (SEQ ID NO.: 9939), GGGAagauau (SEQ ID NO.: 9940), GGGAguaagg (SEQ ID NO.: 9941), GGGAguaagu (SEQ ID NO.: 9942), GGGAguacgu (SEQ ID NO.: 9943), GGGAguaugu (SEQ ID NO.: 9944), GGGAgugagc (SEQ ID NO.: 9945), GGGAgugagu (SEQ ID NO.: 9946), GGGCauuggu (SEQ ID NO.: 9947), GGGCgcuggg (SEQ ID NO.: 9948), GGGCguaagu (SEQ ID NO.: 9949), GGGCguaucu (SEQ ID NO.: 9950), GGGCgugaaa (SEQ ID NO.: 9951), GGGCgugagu (SEQ ID NO.: 9952), GGGGcuaugg (SEQ ID NO.: 9953), GGGGgcaagu (SEQ ID NO.: 9954), GGGGguaaga (SEQ ID NO.: 9955), GGGGguaagc (SEQ ID NO.: 9956), GGGGguaagg (SEQ ID NO.: 9957), GGGGguaagu (SEQ ID NO.: 9958), GGGGguacgg (SEQ ID NO.: 9959), GGGGguaggc (SEQ ID NO.: 9960), GGGGguaugg (SEQ ID NO.: 9961), GGGGgugagc (SEQ ID NO.: 9962), GGGGgugagg (SEQ
ID NO.: 9963), GGGGgugagu (SEQ ID NO.: 9964), GGGGgugggu (SEQ ID NO.: 9965), GGGGgugugu (SEQ ID NO.: 9966), GGGGguuagu (SEQ ID NO.: 9967), GGGUgccauc (SEQ ID NO.: 9968), GGGUguaagu (SEQ ID NO.: 9969), GGUAguaagu (SEQ ID NO.: 9970), GGUGcaaggu (SEQ ID NO.: 9971), GGUGcuaaga (SEQ ID NO.: 9972), GGUGguaaga (SEQ ID NO.: 9973), GGUGguaagc (SEQ ID NO.: 9974), GGUGguaagg (SEQ ID NO.: 9975), GGUGguaagu (SEQ ID NO.: 9976), GGUGguacau (SEQ ID NO.: 9977), GGUGguacgg (SEQ ID NO.: 9978), GGUGguagga (SEQ ID NO.: 9979), GGUGguauau (SEQ ID NO.: 9980), GGUGguaugg (SEQ ID NO.: 9981), GGUGguaugu (SEQ ID NO.: 9982), GGUGguauuu (SEQ ID NO.: 9983), GGUGgucagc (SEQ ID NO.: 9984), GGUGguccuc (SEQ ID NO.: 9985), GGUGgugaga (SEQ ID NO.: 9986), GGUGgugagg (SEQ ID NO.: 9987), GGUGgugagu (SEQ ID NO.: 9988), GGUGguucau (SEQ ID NO.: 9989), GGUUgcacuc (SEQ ID NO.: 9990), GGUUguaaga (SEQ ID NO.: 9991), GGUUguaagu (SEQ ID NO.: 9992), GGUUgugagu (SEQ ID NO.: 9993), GUAGgcaagu (SEQ ID NO.: 9994), GUAGguaaaa (SEQ ID NO.: 9995), GUAGguaaag (SEQ ID NO.: 9996), GUAGguaaau (SEQ ID NO.: 9997), GUAGguaaga (SEQ ID NO.: 9998), GUAGguaagc (SEQ ID NO.: 9999), GUAGguaagg (SEQ ID NO.: 10000), GUAGguaagu (SEQ ID NO.: 10001), GUAGguaaug (SEQ ID NO.: 10002), GUAGguaauu (SEQ ID NO.: 10003), GUAGguacag (SEQ ID NO.: 10004), GUAGguaggu (SEQ ID NO.: 10005), GUAGguauga (SEQ ID NO.: 10006), GUAGguaugc (SEQ ID NO.: 10007), GUAGguaugg (SEQ ID NO.: 10008), GUAGguaugu (SEQ ID NO.: 10009), GUAGguccgg (SEQ ID NO.: 10010), GUAGgugaga (SEQ ID NO.: 10011), GUAGgugagc (SEQ ID NO.: 10012), GUAGgugagu (SEQ ID NO.: 10013), GUAGgugcgg (SEQ ID NO.: 10014), GUAGgugggu (SEQ ID NO.: 10015), GUAGguggug (SEQ ID NO.: 10016), GUAGguugcc (SEQ ID NO.: 10017), GUAGguugcg (SEQ ID NO.: 10018), GUAGguugga (SEQ ID NO.: 10019), GUAUguaagu (SEQ ID NO.: 10020), GUAUguaggu (SEQ ID NO.: 10021), GUAUguaugu (SEQ ID NO.: 10022), GUCAaaggug (SEQ ID NO.: 10023), GUCAacggcu (SEQ ID NO.: 10024), GUCAgggcca (SEQ ID NO.: 10025), GUCAggugag (SEQ ID NO.: 10026), GUCAguaagu (SEQ ID NO.: 10027), GUCAgucagu (SEQ ID NO.: 10028), GUCAgugagu (SEQ ID NO.: 10029), GUCCcagggc (SEQ ID NO.: 10030), GUCCcuggag (SEQ ID NO.: 10031), GUCCguaagc (SEQ ID NO.: 10032), GUCCguaagu (SEQ ID NO.: 10033), GUCCgugagu (SEQ ID NO.: 10034), GUCGguaaga (SEQ ID NO.: 10035), GUCGguaagc (SEQ ID NO.: 10036), GUCGguaagg (SEQ ID NO.: 10037), GUCGguaagu (SEQ ID NO.: 10038), GUCGguaaug (SEQ ID NO.: 10039), GUCGguacgu (SEQ ID NO.: 10040), GUCGguagga (SEQ ID NO.: 10041), GUCGguaggu (SEQ ID NO.: 10042), GUCGguaucu (SEQ ID NO.: 10043), GUCGguauga (SEQ ID NO.: 10044), GUCGgucagu (SEQ ID NO.: 10045), GUCGgugagg (SEQ ID NO.: 10046), GUCGgugagu (SEQ ID NO.: 10047), GUCGguggga (SEQ ID NO.: 10048), GUCUccccug (SEQ ID NO.: 10049), GUCUgaagag (SEQ ID NO.: 10050), GUCUguaagc (SEQ ID NO.: 10051), GUCUguaagg (SEQ ID NO.: 10052), GUCUguaagu (SEQ ID NO.: 10053), GUCUguaggu (SEQ ID NO.: 10054), GUCUgugagu (SEQ ID NO.: 10055), GUGAguaagu (SEQ ID NO.: 10056), GUGAgugagu (SEQ ID NO.: 10057), GUGCgugagu (SEQ ID NO.: 10058), GUGGgcaagu (SEQ ID NO.: 10059), GUGGggagga (SEQ ID NO.: 10060), GUGGguaaga (SEQ ID NO.: 10061), GUGGguaagc (SEQ ID NO.: 10062), GUGGguaagg (SEQ ID NO.: 10063), GUGGguaagu (SEQ ID NO.: 10064), GUGGguacga (SEQ ID NO.: 10065), GUGGguacgg (SEQ ID NO.: 10066), GUGGguacgu (SEQ ID NO.: 10067), GUGGguaggc (SEQ ID NO.: 10068), GUGGguaggu (SEQ ID NO.: 10069), GUGGguaugg (SEQ ID NO.: 10070), GUGGguaugu (SEQ ID NO.: 10071), GUGGgucagu (SEQ ID NO.: 10072), GUGGgucugu (SEQ ID NO.: 10073),
GUGGgugaga (SEQ ID NO.: 10074), GUGGgugagc (SEQ ID NO.: 10075), GUGGgugagg (SEQ ID NO.: 10076), GUGGgugagu (SEQ ID NO.: 10077), GUGGgugcga (SEQ ID NO.: 10078), GUGGgugggu (SEQ ID NO.: 10079), GUGGgugugu (SEQ ID NO.: 10080), GUGGuuucaa (SEQ ID NO.: 10081), GUGUcuccca (SEQ ID NO.: 10082), GUGUguaaga (SEQ ID NO.: 10083), GUGUguaagg (SEQ ID NO.: 10084), GUGUguaagu (SEQ ID NO.: 10085), GUGUgugagu (SEQ ID NO.: 10086), GUGUgugugu (SEQ ID NO.: 10087), GUUAguaagu (SEQ ID NO.: 10088), GUUAguaugu (SEQ ID NO.: 10089), GUUAugguga (SEQ ID NO.: 10090), GUUAuuguau (SEQ ID NO.: 10091), GUUCagaugu (SEQ ID NO.: 10092), GUUCaugagg (SEQ ID NO.: 10093), GUUCguaagu (SEQ ID NO.: 10094), GUUCuuccag (SEQ ID NO.: 10095), GUUGgcaagu (SEQ ID NO.: 10096), GUUGguaaaa (SEQ ID NO.: 10097), GUUGguaaag (SEQ ID NO. : 10098), GUUGguaaau (SEQ ID NO. : 10099), GUUGguaaga (SEQ ID NO.: 10100), GUUGguaagc (SEQ ID NO.: 10101), GUUGguaagu (SEQ ID NO.: 10102), GUUGguaauc (SEQ ID NO.: 10103), GUUGguaaug (SEQ ID NO.: 10104), GUUGguaauu (SEQ ID NO.: 10105), GUUGguacag (SEQ ID NO.: 10106), GUUGguacgg (SEQ ID NO.: 10107), GUUGguacgu (SEQ ID NO.: 10108), GUUGguaggu (SEQ ID NO.: 10109), GUUGguauga (SEQ ID NO.: 10110), GUUGguaugg (SEQ ID NO.: 10111), GUUGguaugu (SEQ ID NO.: 10112), GUUGgucagu (SEQ ID NO.: 10113), GUUGgugaga (SEQ ID NO.: 10114), GUUGgugagc (SEQ ID NO.: 10115), GUUGgugagu (SEQ ID NO.: 10116), GUUGgugcgc (SEQ ID NO.: 10117), GUUGgugcgg (SEQ ID NO.: 10118), GUUGgugcgu (SEQ ID NO.: 10119), GUUGgugugg (SEQ ID NO.: 10120), GUUGguuagu (SEQ ID NO.: 10121), GUUUguaagc (SEQ ID NO.: 10122), GUUUguaagu (SEQ ID NO.: 10123), GUUUgugagu (SEQ ID NO.: 10124), GUUUugguga (SEQ ID NO.: 10125), UAAAagguaa (SEQ ID NO.: 10126), UAAAagguac (SEQ ID NO.: 10127), UAAAaguaag (SEQ ID NO.: 10128), UAAAgguuug (SEQ ID NO.: 10129), UAAAguaaaa (SEQ ID NO.: 10130), UAAAguaaau (SEQ ID NO.: 10131), UAAAguaaga (SEQ ID NO.: 10132), UAAAguaagc (SEQ ID NO.: 10133), UAAAguaagg (SEQ ID NO.: 10134), UAAAguaagu (SEQ ID NO.: 10135), UAAAguaauu (SEQ ID NO.: 10136), UAAAguacgu (SEQ ID NO.: 10137), UAAAguagag (SEQ ID NO.: 10138), UAAAguaggu (SEQ ID NO.: 10139), UAAAguauau (SEQ ID NO.: 10140), UAAAguaucc (SEQ ID NO.: 10141), UAAAguauga (SEQ ID NO.: 10142), UAAAguaugg (SEQ ID NO.: 10143), UAAAguaugu (SEQ ID NO.: 10144), UAAAgugagu (SEQ ID NO.: 10145), UAAAgugggu (SEQ ID NO.: 10146), UAAAguggug (SEQ ID NO.: 10147), UAAAgugugu (SEQ ID NO.: 10148), UAAAguuagu (SEQ ID NO.: 10149), UAAAguuguu (SEQ ID NO.: 10150), UAAAuuguga (SEQ ID NO.: 10151), UAACcuaagg (SEQ ID NO.: 10152), UAACguaagc (SEQ ID NO.: 10153), UAACguaagu (SEQ ID NO.: 10154), UAACguaugu (SEQ ID NO.: 10155), UAACgugagc (SEQ ID NO.: 10156), UAACgugagu (SEQ ID NO.: 10157), UAACgugcgu (SEQ ID NO.: 10158), UAACguguga (SEQ ID NO.: 10159), UAAGaagauu (SEQ ID NO.: 10160), UAAGauaagu (SEQ ID NO.: 10161), UAAGgcaagg (SEQ ID NO.: 10162), UAAGgcaagu (SEQ ID NO.: 10163), UAAGgcaaua (SEQ ID NO.: 10164), UAAGgcagag (SEQ ID NO.: 10165), UAAGgcgagu (SEQ ID NO.: 10166), UAAGggauau (SEQ ID NO.: 10167), UAAGguaaaa (SEQ ID NO.: 10168), UAAGguaaac (SEQ ID NO.: 10169), UAAGguaaag (SEQ ID NO.: 10170), UAAGguaaau (SEQ ID NO.: 10171), UAAGguaaca (SEQ ID NO.: 10172), UAAGguaacc (SEQ ID NO.: 10173), UAAGguaacg (SEQ ID NO.: 10174), UAAGguaacu (SEQ ID NO.: 10175), UAAGguaaga (SEQ ID NO.: 10176), UAAGguaagc (SEQ ID NO.: 10177), UAAGguaagg (SEQ ID NO.: 10178), UAAGguaagu (SEQ ID NO.: 10179), UAAGguaaua (SEQ ID NO.: 10180), UAAGguaauc (SEQ ID NO.: 10181), UAAGguaaug (SEQ ID NO.: 10182), UAAGguaauu (SEQ
ID NO.: 10183), UAAGguacaa (SEQ ID NO.: 10184), UAAGguacac (SEQ ID NO.: 10185), UAAGguacag (SEQ ID NO.: 10186), UAAGguacau (SEQ ID NO.: 10187), UAAGguacca (SEQ ID NO.: 10188), UAAGguaccc (SEQ ID NO.: 10189), UAAGguaccg (SEQ ID NO.: 10190), UAAGguaccu (SEQ ID NO.: 10191), UAAGguacgg (SEQ ID NO.: 10192), UAAGguacgu (SEQ ID NO.: 10193), UAAGguacua (SEQ ID NO.: 10194), UAAGguacuc (SEQ ID NO.: 10195), UAAGguacug (SEQ ID NO.: 10196), UAAGguacuu (SEQ ID NO.: 10197), UAAGguagaa (SEQ ID NO.: 10198), UAAGguagag (SEQ ID NO.: 10199), UAAGguagau (SEQ ID NO.: 10200), UAAGguagca (SEQ ID NO.: 10201), UAAGguagcc (SEQ ID NO.: 10202), UAAGguagcu (SEQ ID NO.: 10203), UAAGguagga (SEQ ID NO.: 10204), UAAGguaggc (SEQ ID NO.: 10205), UAAGguaggg (SEQ ID NO.: 10206), UAAGguaggu (SEQ ID NO.: 10207), UAAGguagua (SEQ ID NO. : 10208), UA AGguagug (SEQ ID NO. : 10209), UA AGguaguu (SEQ ID NO. : 10210), UAAGguauaa (SEQ ID NO.: 10211), UAAGguauac (SEQ ID NO.: 10212), UAAGguauag (SEQ ID NO.: 10213), UAAGguauau (SEQ ID NO.: 10214), UAAGguauca (SEQ ID NO.: 10215), UAAGguaucc (SEQ ID NO.: 10216), UAAGguaucu (SEQ ID NO.: 10217), UAAGguauga (SEQ ID NO.: 10218), UAAGguaugc (SEQ ID NO.: 10219), UAAGguaugg (SEQ ID NO.: 10220), UAAGguaugu (SEQ ID NO.: 10221), UAAGguauua (SEQ ID NO.: 10222), UAAGguauuc (SEQ ID NO.: 10223), UAAGguauug (SEQ ID NO.: 10224), UAAGguauuu (SEQ ID NO.: 10225), UAAGgucaau (SEQ ID NO.: 10226), UAAGgucaga (SEQ ID NO.: 10227), UAAGgucagc (SEQ ID NO.: 10228), UAAGgucagu (SEQ ID NO.: 10229), UAAGgucaua (SEQ ID NO.: 10230), UAAGgucauu (SEQ ID NO.: 10231), UAAGguccua (SEQ ID NO.: 10232), UAAGgucggc (SEQ ID NO.: 10233), UAAGgucggu (SEQ ID NO.: 10234), UAAGgucuca (SEQ ID NO.: 10235), UAAGgucucg (SEQ ID NO.: 10236), UAAGgucugu (SEQ ID NO.: 10237), UAAGgucuua (SEQ ID NO.: 10238), UAAGgugaaa (SEQ ID NO.: 10239), UAAGgugaag (SEQ ID NO.: 10240), UAAGgugaau (SEQ ID NO.: 10241), UAAGgugacc (SEQ ID NO.: 10242), UAAGgugacu (SEQ ID NO.: 10243), UAAGgugaga (SEQ ID NO.: 10244), UAAGgugagc (SEQ ID NO.: 10245), UAAGgugagg (SEQ ID NO.: 10246), UAAGgugagu (SEQ ID NO.: 10247), UAAGgugaua (SEQ ID NO.: 10248), UAAGgugauc (SEQ ID NO.: 10249), UAAGgugauu (SEQ ID NO.: 10250), UAAGgugcac (SEQ ID NO.: 10251), UAAGgugcca (SEQ ID NO.: 10252), UAAGgugccu (SEQ ID NO.: 10253), UAAGgugcgc (SEQ ID NO.: 10254), UAAGgugcgu (SEQ ID NO.: 10255), UAAGgugcug (SEQ ID NO.: 10256), UAAGgugcuu (SEQ ID NO.: 10257), UAAGguggau (SEQ ID NO.: 10258), UAAGguggga (SEQ ID NO.: 10259), UAAGgugggc (SEQ ID NO.: 10260), UAAGgugggu (SEQ ID NO.: 10261), UAAGguguga (SEQ ID NO.: 10262), UAAGgugugg (SEQ ID NO.: 10263), UAAGgugugu (SEQ ID NO.: 10264), UAAGguguuc (SEQ ID NO.: 10265), UAAGguuaaa (SEQ ID NO.: 10266), UAAGguuaga (SEQ ID NO.: 10267), UAAGguuagc (SEQ ID NO.: 10268), UAAGguuagg (SEQ ID NO : 10269), UAAGguuagu (SEQ ID NO.: 10270), UAAGguuaua (SEQ ID NO.: 10271), UAAGguuauu (SEQ ID NO.: 10272), UAAGguucua (SEQ ID NO.: 10273), UAAGguucuc (SEQ ID NO.: 10274), UAAGguugaa (SEQ ID NO.: 10275), UAAGguugcu (SEQ ID NO : 10276), UAAGguuggu (SEQ ID NO.: 10277), UAAGguugug (SEQ ID NO.: 10278), UAAGguuucc (SEQ ID NO.: 10279), UAAGguuucg (SEQ ID NO.: 10280), UAAGguuucu (SEQ ID NO.: 10281), UAAGguuuga (SEQ ID NO.: 10282), UAAGguuugu (SEQ ID NO.: 10283), UAAGguuuuu (SEQ ID NO.: 10284), UAAGuaacuc (SEQ ID NO.: 10285), UAAUgcaagu (SEQ ID NO.: 10286), UAAUguaaau (SEQ ID NO.: 10287), UAAUguaaga (SEQ ID NO.: 10288), UAAUguaagc (SEQ ID NO.: 10289), UAAUguaagu (SEQ ID NO.: 10290), UAAUguacgg (SEQ ID NO.: 10291), UAAUguaggu
(SEQ ID NO.: 10292), UAAUguauga (SEQ ID NO.: 10293), UAAUgugaga (SEQ ID NO.: 10294), UAAUgugagc (SEQ ID NO.: 10295), UAAUgugagu (SEQ ID NO.: 10296), UAAUgugggu (SEQ ID NO.: 10297), UAAUgugugc (SEQ ID NO.: 10298), UACAgcucug (SEQ ID NO.: 10299), UACAgguaag (SEQ ID NO.: 10300), UACAggugag (SEQ ID NO.: 10301), UACAgguugc (SEQ ID NO.: 10302), UACAguaaga (SEQ ID NO.: 10303), UACAguaagg (SEQ ID NO.: 10304), UACAguaagu (SEQ ID NO.: 10305), UACAguacgu (SEQ ID NO.: 10306), UACAguagga (SEQ ID NO.: 10307), UACAguaggc (SEQ ID NO.: 10308), UACAguaggu (SEQ ID NO.: 10309), UACAguaucc (SEQ ID NO.: 10310), UACAguaugu (SEQ ID NO.: 10311), UACAgugaau (SEQ ID NO.: 10312), UACAgugaga (SEQ ID NO.: 10313), UACAgugagu (SEQ ID NO.: 10314), UACAguuaag (SEQ ID NO. : 10315), UACAguuagu (SEQ ID NO. : 10316), UACAuaucuc (SEQ ID NO. : 10317), UACAuugaac (SEQ ID NO. : 10318), UACCaaaggg (SEQ ID NO.: 10319), UACCgggaag (SEQ ID NO.: 10320), UACCguaagu (SEQ ID NO.: 10321), UACCguaugg (SEQ ID NO.: 10322), UACCgugaga (SEQ ID NO.: 10323), UACCgugagg (SEQ ID NO.: 10324), UACCgugagu (SEQ ID NO.: 10325), UACGguaaaa (SEQ ID NO.: 10326), UACGguaaag (SEQ ID NO.: 10327), UACGguaaau (SEQ ID NO.: 10328), UACGguaaga (SEQ ID NO.: 10329), UACGguaagc (SEQ ID NO.: 10330), UACGguaagg (SEQ ID NO.: 10331), UACGguaagu (SEQ ID NO.: 10332), UACGguaaua (SEQ ID NO.: 10333), UACGguaauu (SEQ ID NO.: 10334), UACGguacgu (SEQ ID NO.: 10335), UACGguacuc (SEQ ID NO.: 10336), UACGguacuu (SEQ ID NO.: 10337), UACGguagga (SEQ ID NO.: 10338), UACGguaggc (SEQ ID NO.: 10339), UACGguaggu (SEQ ID NO.: 10340), UACGguaugu (SEQ ID NO.: 10341), UACGguauug (SEQ ID NO.: 10342), UACGguauuu (SEQ ID NO.: 10343), UACGgucagu (SEQ ID NO.: 10344), UACGgugaag (SEQ ID NO.: 10345), UACGgugagu (SEQ ID NO.: 10346), UACGgugggu (SEQ ID NO.: 10347), UACGgugugu (SEQ ID NO.: 10348), UACUccaagc (SEQ ID NO.: 10349), UACUguaaga (SEQ ID NO.: 10350), UACUguaagc (SEQ ID NO.: 10351), UACUguaagg (SEQ ID NO.: 10352), UACUguaagu (SEQ ID NO.: 10353), UACUguacgu (SEQ ID NO.: 10354), UACUguacuu (SEQ ID NO.: 10355), UACUguaggu (SEQ ID NO.: 10356), UACUguaucc (SEQ ID NO.: 10357), UACUguaugu (SEQ ID NO.: 10358), UACUgugagu (SEQ ID NO.: 10359), UACUguggua (SEQ ID NO.: 10360), UAGAaaggua (SEQ ID NO.: 10361), UAGAcugauc (SEQ ID NO.: 10362), UAGAgguaag (SEQ ID NO.: 10363), UAGAguaagc (SEQ ID NO.: 10364), UAGAguaagu (SEQ ID NO.: 10365), UAGAguaggu (SEQ ID NO.: 10366), UAGAguaugu (SEQ ID NO.: 10367), UAGAguauua (SEQ ID NO.: 10368), UAGAgugagc (SEQ ID NO.: 10369), UAGAgugagu (SEQ ID NO.: 10370), UAGAguugua (SEQ ID NO.: 10371), UAGCguaagu (SEQ ID NO.: 10372), UAGCucugcu (SEQ ID NO.: 10373), UAGGaaagug (SEQ ID NO.: 10374), UAGGguaaaa (SEQ ID NO.: 10375), UAGGguaaau (SEQ ID NO.: 10376), UAGGguaaga (SEQ ID NO.: 10377), UAGGguaagc (SEQ ID NO.: 10378), UAGGguaagu (SEQ ID NO.: 10379), UAGGguaaug (SEQ ID NO.: 10380), UAGGguaauu (SEQ ID NO.: 10381), UAGGguagga (SEQ ID NO.: 10382), UAGGguaggg (SEQ ID NO.: 10383), UAGGguaggu (SEQ ID NO.: 10384), UAGGguaugu (SEQ ID NO.: 10385), UAGGgugaga (SEQ ID NO.: 10386), UAGGgugagc (SEQ ID NO.: 10387), UAGGgugagu (SEQ ID NO.: 10388), UAGGguucgu (SEQ ID NO.: 10389), UAGGguuggu (SEQ ID NO.: 10390), UAGUguaagc (SEQ ID NO.: 10391), UAGUguaagg (SEQ ID NO.: 10392), UAGUguaagu (SEQ ID NO.: 10393), UAGUguacgu (SEQ ID NO.: 10394), UAGUguaggu (SEQ ID NO.: 10395), UAGUguauga (SEQ ID NO.: 10396), UAGUguaugu (SEQ ID NO.: 10397), UAGUgugagu (SEQ ID NO.: 10398), UAUAaaggua (SEQ ID NO.: 10399), UAUAaguuaa (SEQ ID NO.: 10400), UAUAgcaggu (SEQ ID NO.: 10401),
UAUAguaaga (SEQ ID NO.: 10402), UAUAguaagc (SEQ ID NO.: 10403), UAUAguaagg (SEQ ID NO.: 10404), UAUAguaagu (SEQ ID NO.: 10405), UAUAguaggu (SEQ ID NO.: 10406), UAUAuaaggu (SEQ ID NO.: 10407), UAUAuauucu (SEQ ID NO.: 10408), UAUCacuguu (SEQ ID NO.: 10409), UAUCagugag (SEQ ID NO.: 10410), UAUCgcguga (SEQ ID NO.: 10411), UAUCguaaga (SEQ ID NO.: 10412), UAUCguaagu (SEQ ID NO.: 10413), UAUCguaggu (SEQ ID NO.: 10414), UAUCgugaga (SEQ ID NO.: 10415), UAUCgugagu (SEQ ID NO.: 10416), UAUGgcaagu (SEQ ID NO.: 10417), UAUGgccagu (SEQ ID NO.: 10418), UAUGguaaaa (SEQ ID NO.: 10419), UAUGguaaag (SEQ ID NO.: 10420), UAUGguaaau (SEQ ID NO.: 10421), UAUGguaacc (SEQ ID NO.: 10422), UAUGguaacg (SEQ ID NO.: 10423), UAUGguaacu (SEQ ID NO.: 10424), UAUGguaaga (SEQ ID NO.: 10425), UAUGguaagc (SEQ ID NO.: 10426), UAUGguaagg (SEQ ID NO.: 10427), UAUGguaagu (SEQ ID NO.: 10428), UAUGguaaua (SEQ ID NO.: 10429), UAUGguaauc (SEQ ID NO.: 10430), UAUGguaaug (SEQ ID NO.: 10431), UAUGguaauu (SEQ ID NO.: 10432), UAUGguacac (SEQ ID NO.: 10433), UAUGguacga (SEQ ID NO.: 10434), UAUGguacgc (SEQ ID NO.: 10435), UAUGguacgu (SEQ ID NO.: 10436), UAUGguacuu (SEQ ID NO.: 10437), UAUGguagau (SEQ ID NO.: 10438), UAUGguagcc (SEQ ID NO.: 10439), UAUGguagga (SEQ ID NO.: 10440), UAUGguaggc (SEQ ID NO.: 10441), UAUGguaggu (SEQ ID NO.: 10442), UAUGguauag (SEQ ID NO.: 10443), UAUGguaucu (SEQ ID NO.: 10444), UAUGguauga (SEQ ID NO.: 10445), UAUGguaugg (SEQ ID NO.: 10446), UAUGguaugu (SEQ ID NO.: 10447), UAUGguauua (SEQ ID NO.: 10448), UAUGguauug (SEQ ID NO.: 10449), UAUGgucaga (SEQ ID NO.: 10450), UAUGgucagc (SEQ ID NO.: 10451), UAUGgucagu (SEQ ID NO.: 10452), UAUGgugaag (SEQ ID NO.: 10453), UAUGgugaau (SEQ ID NO.: 10454), UAUGgugaga (SEQ ID NO.: 10455), UAUGgugagc (SEQ ID NO.: 10456), UAUGgugagg (SEQ ID NO.: 10457), UAUGgugagu (SEQ ID NO.: 10458), UAUGgugggu (SEQ ID NO.: 10459), UAUGguggug (SEQ ID NO.: 10460), UAUGguguga (SEQ ID NO.: 10461), UAUGguuagu (SEQ ID NO.: 10462), UAUGguuguu (SEQ ID NO.: 10463), UAUUauaucc (SEQ ID NO.: 10464), UAUUguaagc (SEQ ID NO.: 10465), UAUUguaagu (SEQ ID NO.: 10466), UAUUguaaua (SEQ ID NO.: 10467), UAUUguaucc (SEQ ID NO.: 10468), UAUUguaugg (SEQ ID NO.: 10469), UAUUguaugu (SEQ ID NO.: 10470), UAUUguauua (SEQ ID NO.: 10471), UAUUgugagc (SEQ ID NO.: 10472), UAUUgugagu (SEQ ID NO.: 10473), UAUUuggauu (SEQ ID NO.: 10474), UCAAagaaga (SEQ ID NO.: 10475), UCAAagguaa (SEQ ID NO.: 10476), UCAAauaucc (SEQ ID NO.: 10477), UCAAgcaggu (SEQ ID NO.: 10478), UCAAggaaaa (SEQ ID NO.: 10479), UCAAguaaaa (SEQ ID NO.: 10480), UCAAguaaac (SEQ ID NO.: 10481), UCAAguaaau (SEQ ID NO.: 10482), UCAAguaaga (SEQ ID NO.: 10483), UCAAguaagc (SEQ ID NO.: 10484), UCAAguaagg (SEQ ID NO.: 10485), UCAAguaagu (SEQ ID NO.: 10486), UCAAguaaua (SEQ ID NO.: 10487), UCAAguaauc (SEQ ID NO.: 10488), UCAAguaauu (SEQ ID NO.: 10489), UCAAguacau (SEQ ID NO.: 10490), UCAAguacgc (SEQ ID NO.: 10491), UCAAguacgu (SEQ ID NO.: 10492), UCAAguacua (SEQ ID NO.: 10493), UCAAguagaa (SEQ ID NO.: 10494), UCAAguaggc (SEQ ID NO.: 10495), UCAAguaggu (SEQ ID NO.: 10496), UCAAguauga (SEQ ID NO.: 10497), UCAAguaugc (SEQ ID NO.: 10498), UCAAguaugg (SEQ ID NO.: 10499), UCAAguaugu (SEQ ID NO.: 10500), UCAAgucagu (SEQ ID NO.: 10501), UCAAgugacu (SEQ ID NO.: 10502), UCAAgugaga (SEQ ID NO.: 10503), UCAAgugagc (SEQ ID NO.: 10504), UCAAgugagg (SEQ ID NO.: 10505), UCAAgugagu (SEQ ID NO.: 10506), UCAAgugauu (SEQ ID NO.: 10507), UCAAgugggu (SEQ ID NO.: 10508), UCAAgugugu (SEQ ID NO.: 10509), UCAAguuagu (SEQ ID NO.: 10510), UCAAguuggu (SEQ ID NO.: 10511), UCACgcaggu (SEQ ID NO.:
10512), UCACguaaga (SEQ ID NO.: 10513), UCACguaagc (SEQ ID NO.: 10514), UCACguaagu (SEQ ID NO.: 10515), UCACguacgg (SEQ ID NO.: 10516), UCACguaugu (SEQ ID NO.: 10517), UCACgugagc (SEQ ID NO.: 10518), UCACgugagu (SEQ ID NO.: 10519), UCACgugcgu (SEQ ID NO.: 10520), UCACuagagu (SEQ ID NO.: 10521), UCACucagag (SEQ ID NO.: 10522), UCAGaggaaa (SEQ ID NO.: 10523), UCAGauaagu (SEQ ID NO.: 10524), UCAGauaucc (SEQ ID NO.: 10525), UCAGgcaaau (SEQ ID NO.: 10526), UCAGgcaaga (SEQ ID NO.: 10527), UCAGgcaagg (SEQ ID NO.: 10528), UCAGgcaagu (SEQ ID NO.: 10529), UCAGgcaaug (SEQ ID NO.: 10530), UCAGgcaccc (SEQ ID NO.: 10531), UCAGgcagga (SEQ ID NO.: 10532), UCAGgcaggc (SEQ ID NO.: 10533), UCAGgcaggu (SEQ ID NO.: 10534), UCAGgcauau (SEQ ID NO.: 10535), UCAGgcaugu (SEQ ID NO.: 10536), UCAGgccagu (SEQ ID NO : 10537), UCAGgcgagu (SEQ ID NO.: 10538), UCAGgcuugu (SEQ ID NO : 10539), UCAGguaaaa (SEQ ID NO.: 10540), UCAGguaaac (SEQ ID NO.: 10541), UCAGguaaag (SEQ ID NO.: 10542), UCAGguaaau (SEQ ID NO.: 10543), UCAGguaaca (SEQ ID NO.: 10544), UCAGguaacc (SEQ ID NO.: 10545), UCAGguaacg (SEQ ID NO.: 10546), UCAGguaacu (SEQ ID NO.: 10547), UCAGguaaga (SEQ ID NO.: 10548), UCAGguaagc (SEQ ID NO.: 10549), UCAGguaagg (SEQ ID NO.: 10550), UCAGguaagu (SEQ ID NO.: 10551), UCAGguaaua (SEQ ID NO.: 10552), UCAGguaauc (SEQ ID NO.: 10553), UCAGguaaug (SEQ ID NO.: 10554), UCAGguaauu (SEQ ID NO.: 10555), UCAGguacaa (SEQ ID NO.: 10556), UCAGguacac (SEQ ID NO.: 10557), UCAGguacag (SEQ ID NO.: 10558), UCAGguacau (SEQ ID NO.: 10559), UCAGguacca (SEQ ID NO.: 10560), UCAGguaccc (SEQ ID NO.: 10561), UCAGguaccu (SEQ ID NO.: 10562), UCAGguacga (SEQ ID NO.: 10563), UCAGguacgc (SEQ ID NO.: 10564), UCAGguacgg (SEQ ID NO.: 10565), UCAGguacgu (SEQ ID NO.: 10566), UCAGguacua (SEQ ID NO.: 10567), UCAGguacuc (SEQ ID NO.: 10568), UCAGguacug (SEQ ID NO.: 10569), UCAGguacuu (SEQ ID NO.: 10570), UCAGguagaa (SEQ ID NO.: 10571), UCAGguagac (SEQ ID NO.: 10572), UCAGguagag (SEQ ID NO.: 10573), UCAGguagau (SEQ ID NO.: 10574), UCAGguagca (SEQ ID NO.: 10575), UCAGguagcc (SEQ ID NO.: 10576), UCAGguagcg (SEQ ID NO.: 10577), UCAGguagcu (SEQ ID NO.: 10578), UCAGguagga (SEQ ID NO.: 10579), UCAGguaggc (SEQ ID NO.: 10580), UCAGguaggg (SEQ ID NO.: 10581), UCAGguaggu (SEQ ID NO.: 10582), UCAGguaguc (SEQ ID NO.: 10583), UCAGguagug (SEQ ID NO.: 10584), UCAGguaguu (SEQ ID NO.: 10585), UCAGguauaa (SEQ ID NO.: 10586), UCAGguauac (SEQ ID NO.: 10587), UCAGguauag (SEQ ID NO.: 10588), UCAGguauau (SEQ ID NO.: 10589), UCAGguauca (SEQ ID NO.: 10590), UCAGguaucc (SEQ ID NO.: 10591), UCAGguaucu (SEQ ID NO.: 10592), UCAGguauga (SEQ ID NO.: 10593), UCAGguaugc (SEQ ID NO.: 10594), UCAGguaugg (SEQ ID NO.: 10595), UCAGguaugu (SEQ ID NO.: 10596), UCAGguauua (SEQ ID NO.: 10597), UCAGguauuc (SEQ ID NO.: 10598), UCAGguauug (SEQ ID NO.: 10599), UCAGguauuu (SEQ ID NO.: 10600), UCAGgucaaa (SEQ ID NO.: 10601), UCAGgucaga (SEQ ID NO.: 10602), UCAGgucagc (SEQ ID NO.: 10603), UCAGgucagg (SEQ ID NO.: 10604), UCAGgucagu (SEQ ID NO.: 10605), UCAGguccga (SEQ ID NO.: 10606), UCAGguccgu (SEQ ID NO.: 10607), UCAGguccuc (SEQ ID NO.: 10608), UCAGguccug (SEQ ID NO.: 10609), UCAGgucggc (SEQ ID NO. : 10610), UCAGgucggu (SEQ ID NO. : 10611), UCAGgucgua (SEQ ID NO.: 10612), UCAGgucucc (SEQ ID NO.: 10613), UCAGgucugc (SEQ ID NO.: 10614), UCAGgucugg (SEQ ID NO.: 10615), UCAGgucugu (SEQ ID NO.: 10616), UCAGgucuuc (SEQ ID NO.: 10617), UCAGgucuuu (SEQ ID NO.: 10618), UCAGgugaaa (SEQ ID NO.: 10619), UCAGgugaac (SEQ ID NO.: 10620), UCAGgugaag (SEQ ID NO.: 10621), UCAGgugaau (SEQ ID NO.: 10622), UCAGgugaca (SEQ ID NO.: 10623), UCAGgugacc (SEQ ID NO.: 10624),
UCAGgugacu (SEQ ID NO.: 10625), UCAGgugaga (SEQ ID NO.: 10626), UCAGgugagc (SEQ ID NO.: 10627), UCAGgugagg (SEQ ID NO.: 10628), UCAGgugagu (SEQ ID NO.: 10629), UCAGgugaua (SEQ ID NO.: 10630), UCAGgugauc (SEQ ID NO.: 10631), UCAGgugaug (SEQ ID NO.: 10632), UCAGgugauu (SEQ ID NO.: 10633), UCAGgugcaa (SEQ ID NO.: 10634), UCAGgugcac (SEQ ID NO.: 10635), UCAGgugcag (SEQ ID NO.: 10636), UCAGgugcca (SEQ ID NO.: 10637), UCAGgugccg (SEQ ID NO.: 10638), UCAGgugccu (SEQ ID NO.: 10639), UCAGgugcga (SEQ ID NO.: 10640), UCAGgugcgg (SEQ ID NO.: 10641), UCAGgugcgu (SEQ ID NO.: 10642), UCAGgugcua (SEQ ID NO.: 10643), UCAGgugcug (SEQ ID NO.: 10644), UCAGgugcuu (SEQ ID NO.: 10645), UCAGguggau (SEQ ID NO.: 10646), UCAGguggcg (SEQ ID NO.: 10647), UCAGguggga (SEQ ID NO.: 10648), UCAGgugggc (SEQ ID NO.: 10649), UCAGgugggg (SEQ ID NO.: 10650), UCAGgugggu (SEQ ID NO.: 10651), UCAGgugguc (SEQ ID NO.: 10652), UCAGguggug (SEQ ID NO.: 10653), UCAGguguaa (SEQ ID NO.: 10654), UCAGguguca (SEQ ID NO.: 10655), UCAGgugucg (SEQ ID NO.: 10656), UCAGguguga (SEQ ID NO.: 10657), UCAGgugugc (SEQ ID NO.: 10658), UCAGgugugg (SEQ ID NO.: 10659), UCAGgugugu (SEQ ID NO.: 10660), UCAGguguuu (SEQ ID NO.: 10661), UCAGguuaaa (SEQ ID NO.: 10662), UCAGguuaau (SEQ ID NO.: 10663), UCAGguuaga (SEQ ID NO.: 10664), UCAGguuagc (SEQ ID NO.: 10665), UCAGguuagg (SEQ ID NO : 10666), UCAGguuagu (SEQ ID NO.: 10667), UCAGguucaa (SEQ ID NO.: 10668), UCAGguucgc (SEQ ID NO.: 10669), UCAGguucgu (SEQ ID NO.: 10670), UCAGguugaa (SEQ ID NO.: 10671), UCAGguugac (SEQ ID NO.: 10672), UCAGguugau (SEQ ID NO.: 10673), UCAGguugca (SEQ ID NO.: 10674), UCAGguugcc (SEQ ID NO.: 10675), UCAGguugcu (SEQ ID NO.: 10676), UCAGguugga (SEQ ID NO.: 10677), UCAGguuggc (SEQ ID NO.: 10678), UCAGguuggg (SEQ ID NO.: 10679), UCAGguuggu (SEQ ID NO.: 10680), UCAGguugua (SEQ ID NO.: 10681), UCAGguuuag (SEQ ID NO.: 10682), UCAGguuucg (SEQ ID NO.: 10683), UCAGguuucu (SEQ ID NO.: 10684), UCAGguuuga (SEQ ID NO.: 10685), UCAGguuugc (SEQ ID NO.: 10686), UCAGguuugg (SEQ ID NO.: 10687), UCAGguuugu (SEQ ID NO.: 10688), UCAGguuuuu (SEQ ID NO.: 10689), UCAGugugaa (SEQ ID NO.: 10690), UCAUauuggu (SEQ ID NO.: 10691), UCAUgcaagu (SEQ ID NO.: 10692), UCAUgcaggu (SEQ ID NO.: 10693), UCAUguaaaa (SEQ ID NO.: 10694), UCAUguaaau (SEQ ID NO.: 10695), UCAUguaaga (SEQ ID NO.: 10696), UCAUguaagg (SEQ ID NO.: 10697), UCAUguaagu (SEQ ID NO.: 10698), UCAUguaaua (SEQ ID NO.: 10699), UCAUguaauu (SEQ ID NO.: 10700), UCAUguacau (SEQ ID NO.: 10701), UCAUguacgu (SEQ ID NO.: 10702), UCAUguagga (SEQ ID NO.: 10703), UCAUguaggu (SEQ ID NO.: 10704), UCAUguaugu (SEQ ID NO.: 10705), UCAUgugaga (SEQ ID NO.: 10706), UCAUgugagc (SEQ ID NO.: 10707), UCAUgugagu (SEQ ID NO.: 10708), UCAUgugcgu (SEQ ID NO.: 10709), UCCAgagcau (SEQ ID NO.: 10710), UCCAgcaggu (SEQ ID NO.: 10711), UCCAguaaga (SEQ ID NO.: 10712), UCCAguaagc (SEQ ID NO.: 10713), UCCAguaagg (SEQ ID NO : 10714), UCCAguaagu (SEQ ID NO.: 10715), UCCAguaggu (SEQ ID NO.: 10716), UCCAguaugu (SEQ ID NO.: 10717), UCCAgugaga (SEQ ID NO.: 10718), UCCAgugagg (SEQ ID NO.: 10719), UCCAgugagu (SEQ ID NO.: 10720), UCCAguguga (SEQ ID NO.: 10721), UCCCcagcug (SEQ ID NO.: 10722), UCCCguaagu (SEQ ID NO.: 10723), UCCCguaucc (SEQ ID NO.: 10724), UCCCgugaga (SEQ ID NO.: 10725), UCCCgugagu (SEQ ID NO.: 10726), UCCCgugcgu (SEQ ID NO.: 10727), UCCGguaaac (SEQ ID NO.: 10728), UCCGguaacc (SEQ ID NO.: 10729), UCCGguaacu (SEQ ID NO.: 10730), UCCGguaaga (SEQ ID NO.: 10731), UCCGguaagc (SEQ ID NO.: 10732), UCCGguaagg (SEQ ID NO.: 10733), UCCGguaagu (SEQ ID NO.: 10734), UCCGguaaua (SEQ
ID NO.: 10735), UCCGguaaug (SEQ ID NO.: 10736), UCCGguacga (SEQ ID NO.: 10737), UCCGguacgc (SEQ ID NO.: 10738), UCCGguacuu (SEQ ID NO.: 10739), UCCGguaggu (SEQ ID NO.: 10740), UCCGguauau (SEQ ID NO.: 10741), UCCGguaucc (SEQ ID NO.: 10742), UCCGguaugu (SEQ ID NO.: 10743), UCCGgugaga (SEQ ID NO.: 10744), UCCGgugagc (SEQ ID NO.: 10745), UCCGgugagg (SEQ ID NO.: 10746), UCCGgugagu (SEQ ID NO.: 10747), UCCGgugcgu (SEQ ID NO.: 10748), UCCGgugggc (SEQ ID NO.: 10749), UCCGgugggu (SEQ ID NO.: 10750), UCCGgugugu (SEQ ID NO.: 10751), UCCUacuuca (SEQ ID NO.: 10752), UCCUgcagga (SEQ ID NO.: 10753), UCCUgcaggu (SEQ ID NO.: 10754), UCCUggagga (SEQ ID NO.: 10755), UCCUggugag (SEQ ID NO.: 10756), UCCUguaaga (SEQ ID NO.: 10757), UCCUguaagc (SEQ ID NO.: 10758), UCCUguaagg (SEQ ID NO.: 10759), UCCUguaagu (SEQ ID NO. : 10760), UCCUguacgu (SEQ ID NO. : 10761 ), UCCUguaggc (SEQ ID NO. : 10762), UCCUguaggu (SEQ ID NO.: 10763), UCCUguauga (SEQ ID NO.: 10764), UCCUguaugu (SEQ ID NO.: 10765), UCCUgugaga (SEQ ID NO.: 10766), UCCUgugagc (SEQ ID NO.: 10767), UCCUgugagu (SEQ ID NO.: 10768), UCCUguguga (SEQ ID NO.: 10769), UCCUguuauc (SEQ ID NO.: 10770), UCCUugcucg (SEQ ID NO.: 10771), UCCUuggagg (SEQ ID NO.: 10772), UCGAcuggac (SEQ ID NO.: 10773), UCGAguaagc (SEQ ID NO.: 10774), UCGAguaagu (SEQ ID NO.: 10775), UCGAguaaua (SEQ ID NO.: 10776), UCGAguacgg (SEQ ID NO.: 10777), UCGAguacgu (SEQ ID NO.: 10778), UCGAguaugg (SEQ ID NO.: 10779), UCGAgucagu (SEQ ID NO.: 10780), UCGAgugagu (SEQ ID NO.: 10781), UCGAguguga (SEQ ID NO.: 10782), UCGAgugugu (SEQ ID NO.: 10783), UCGAguuugu (SEQ ID NO.: 10784), UCGCguaugu (SEQ ID NO.: 10785), UCGCgugagg (SEQ ID NO.: 10786), UCGCgugagu (SEQ ID NO.: 10787), UCGGgcaagu (SEQ ID NO.: 10788), UCGGguaaag (SEQ ID NO.: 10789), UCGGguaaau (SEQ ID NO.: 10790), UCGGguaaca (SEQ ID NO.: 10791), UCGGguaacg (SEQ ID NO.: 10792), UCGGguaaga (SEQ ID NO.: 10793), UCGGguaagc (SEQ ID NO.: 10794), UCGGguaagg (SEQ ID NO.: 10795), UCGGguaagu (SEQ ID NO.: 10796), UCGGguaaug (SEQ ID NO.: 10797), UCGGguaauu (SEQ ID NO.: 10798), UCGGguaccc (SEQ ID NO.: 10799), UCGGguacgu (SEQ ID NO.: 10800), UCGGguagau (SEQ ID NO.: 10801), UCGGguaggg (SEQ ID NO.: 10802), UCGGguaggu (SEQ ID NO.: 10803), UCGGguaugg (SEQ ID NO.: 10804), UCGGguaugu (SEQ ID NO.: 10805), UCGGguauuu (SEQ ID NO.: 10806), UCGGgucugu (SEQ ID NO.: 10807), UCGGgugaau (SEQ ID NO.: 10808), UCGGgugaga (SEQ ID NO.: 10809), UCGGgugagc (SEQ ID NO.: 10810), UCGGgugagg (SEQ ID NO.: 10811), UCGGgugagu (SEQ ID NO.: 10812), UCGGgugcga (SEQ ID NO.: 10813), UCGGgugcgc (SEQ ID NO.: 10814), UCGGgugugu (SEQ ID NO.: 10815), UCGGguuagc (SEQ ID NO.: 10816), UCGGguuagu (SEQ ID NO.: 10817), UCGGguuggu (SEQ ID NO.: 10818), UCGUgguaug (SEQ ID NO.: 10819), UCGUguaagu (SEQ ID NO.: 10820), UCGUguauga (SEQ ID NO.: 10821), UCGUgugagu (SEQ ID NO.: 10822), UCGUguggug (SEQ ID NO.: 10823), UCUAaguuua (SEQ ID NO.: 10824), UCUAgcaagu (SEQ ID NO.: 10825), UCUAguaaga (SEQ ID NO.: 10826), UCUAguaagc (SEQ ID NO.: 10827), UCUAguaagu (SEQ ID NO.: 10828), UCUAguaucc (SEQ ID NO.: 10829), UCUAguaugu (SEQ ID NO.: 10830), UCUAgugagu (SEQ ID NO.: 10831), UCUCaagagg (SEQ ID NO.: 10832), UCUCcagagg (SEQ ID NO.: 10833), UCUCgggaga (SEQ ID NO.: 10834), UCUCguaagu (SEQ ID NO.: 10835), UCUCguaggu (SEQ ID NO.: 10836), UCUCguauga (SEQ ID NO.: 10837), UCUCgugagu (SEQ ID NO.: 10838), UCUGauaucc (SEQ ID NO.: 10839), UCUGgcaagu (SEQ ID NO.: 10840), UCUGgguaag (SEQ ID NO.: 10841), UCUGguaaaa (SEQ ID NO.: 10842), UCUGguaaag (SEQ ID NO.: 10843), UCUGguaaau (SEQ ID NO.: 10844), UCUGguaaca (SEQ ID NO.: 10845), UCUGguaacc (SEQ ID NO.: 10846), UCUGguaacu (SEQ
ID NO.: 10847), UCUGguaaga (SEQ ID NO.: 10848), UCUGguaagc (SEQ ID NO.: 10849), UCUGguaagg (SEQ ID NO.: 10850), UCUGguaagu (SEQ ID NO.: 10851), UCUGguaaua (SEQ ID NO.: 10852), UCUGguaaug (SEQ ID NO.: 10853), UCUGguaauu (SEQ ID NO.: 10854), UCUGguacag (SEQ ID NO.: 10855), UCUGguacau (SEQ ID NO.: 10856), UCUGguaccc (SEQ ID NO.: 10857), UCUGguacga (SEQ ID NO.: 10858), UCUGguacgu (SEQ ID NO.: 10859), UCUGguacua (SEQ ID NO.: 10860), UCUGguacug (SEQ ID NO.: 10861), UCUGguagaa (SEQ ID NO.: 10862), UCUGguagga (SEQ ID NO.: 10863), UCUGguaggc (SEQ ID NO.: 10864), UCUGguaggg (SEQ ID NO.: 10865), UCUGguaggu (SEQ ID NO.: 10866), UCUGguauag (SEQ ID NO.: 10867), UCUGguauau (SEQ ID NO.: 10868), UCUGguauca (SEQ ID NO.: 10869), UCUGguauga (SEQ ID NO.: 10870), UCUGguaugc (SEQ ID NO.: 10871), UCUGguaugg (SEQ ID NO. : 10872), UCUGguaugu (SEQ ID NO : 10873), UCUGguauuu (SEQ ID NO : 10874), UCUGgucagu (SEQ ID NO.: 10875), UCUGgucugu (SEQ ID NO.: 10876), UCUGgugaau (SEQ ID NO.: 10877), UCUGgugacu (SEQ ID NO.: 10878), UCUGgugaga (SEQ ID NO.: 10879), UCUGgugagc (SEQ ID NO.: 10880), UCUGgugagg (SEQ ID NO.: 10881), UCUGgugagu (SEQ ID NO.: 10882), UCUGgugcgu (SEQ ID NO.: 10883), UCUGgugcuc (SEQ ID NO.: 10884), UCUGgugggu (SEQ ID NO.: 10885), UCUGgugugu (SEQ ID NO.: 10886), UCUGguuagu (SEQ ID NO.: 10887), UCUGguuggu (SEQ ID NO.: 10888), UCUGguuugu (SEQ ID NO.: 10889), UCUUaagaca (SEQ ID NO.: 10890), UCUUguaaga (SEQ ID NO.: 10891), UCUUguaagc (SEQ ID NO.: 10892), UCUUguaagu (SEQ ID NO.: 10893), UCUUguacgu (SEQ ID NO.: 10894), UCUUguaugu (SEQ ID NO.: 10895), UCUUgugagg (SEQ ID NO.: 10896), UCUUgugagu (SEQ ID NO.: 10897), UCUUgugggu (SEQ ID NO.: 10898), UCUUugguaa (SEQ ID NO.: 10899), UCUUuguuga (SEQ ID NO.: 10900), UGAAaaggua (SEQ ID NO.: 10901), UGAAagguaa (SEQ ID NO.: 10902), UGAAgguagg (SEQ ID NO.: 10903), UGAAguaaag (SEQ ID NO.: 10904), UGAAguaaau (SEQ ID NO.: 10905), UGAAguaacu (SEQ ID NO.: 10906), UGAAguaaga (SEQ ID NO.: 10907), UGAAguaagc (SEQ ID NO.: 10908), UGAAguaagg (SEQ ID NO.: 10909), UGAAguaagu (SEQ ID NO.: 10910), UGAAguaauc (SEQ ID NO.: 10911), UGAAguaauu (SEQ ID NO.: 10912), UGAAguaccc (SEQ ID NO.: 10913), UGAAguaccu (SEQ ID NO.: 10914), UGAAguacgg (SEQ ID NO.: 10915), UGAAguagga (SEQ ID NO.: 10916), UGAAguaggu (SEQ ID NO.: 10917), UGAAguaugc (SEQ ID NO.: 10918), UGAAguaugu (SEQ ID NO.: 10919), UGAAgucagu (SEQ ID NO.: 10920), UGAAguccgu (SEQ ID NO.: 10921), UGAAgugagc (SEQ ID NO.: 10922), UGAAgugagu (SEQ ID NO.: 10923), UGAAgugcuu (SEQ ID NO.: 10924), UGAAgugggu (SEQ ID NO.: 10925), UGAAguuggu (SEQ ID NO.: 10926), UGAAuuaagu (SEQ ID NO.: 10927), UGACcaagcc (SEQ ID NO.: 10928), UGACguaagg (SEQ ID NO.: 10929), UGACguaagu (SEQ ID NO.: 10930), UGACguacgu (SEQ ID NO.: 10931), UGACgugagc (SEQ ID NO.: 10932), UGACgugagu (SEQ ID NO.: 10933), UGACgugcgu (SEQ ID NO.: 10934), UGACuuaauu (SEQ ID NO.: 10935), UGAGcaauuu (SEQ ID NO.: 10936), UGAGccccug (SEQ ID NO.: 10937), UGAGgcaaga (SEQ ID NO.: 10938), UGAGgcaagc (SEQ ID NO.: 10939), UGAGgcaagu (SEQ ID NO.: 10940), UGAGgcacgg (SEQ ID NO.: 10941), UGAGgcaggu (SEQ ID NO.: 10942), UGAGgcaugu (SEQ ID NO.: 10943), UGAGggccag (SEQ ID NO.: 10944), UGAGguaaaa (SEQ ID NO.: 10945), UGAGguaaac (SEQ ID NO.: 10946), UGAGguaaag (SEQ ID NO.: 10947), UGAGguaaau (SEQ ID NO.: 10948), UGAGguaaca (SEQ ID NO.: 10949), UGAGguaacc (SEQ ID NO.: 10950), UGAGguaacg (SEQ ID NO.: 10951), UGAGguaacu (SEQ ID NO.: 10952), UGAGguaaga (SEQ ID NO.: 10953), UGAGguaagc (SEQ ID NO.: 10954), UGAGguaagg (SEQ ID NO.: 10955), UGAGguaagu (SEQ ID NO.: 10956), UGAGguaaua (SEQ ID NO.: 10957), UGAGguaauc (SEQ
ID NO.: 10958), UGAGguaaug (SEQ ID NO.: 10959), UGAGguaauu (SEQ ID NO.: 10960), UGAGguacaa (SEQ ID NO.: 10961), UGAGguacac (SEQ ID NO.: 10962), UGAGguacag (SEQ ID NO.: 10963), UGAGguacau (SEQ ID NO.: 10964), UGAGguacca (SEQ ID NO.: 10965), UGAGguaccg (SEQ ID NO.: 10966), UGAGguaccu (SEQ ID NO.: 10967), UGAGguacgc (SEQ ID NO.: 10968), UGAGguacgg (SEQ ID NO.: 10969), UGAGguacgu (SEQ ID NO.: 10970), UGAGguacua (SEQ ID NO.: 10971), UGAGguacuc (SEQ ID NO.: 10972), UGAGguacug (SEQ ID NO.: 10973), UGAGguacuu (SEQ ID NO.: 10974), UGAGguagag (SEQ ID NO.: 10975), UGAGguagau (SEQ ID NO.: 10976), UGAGguagcc (SEQ ID NO.: 10977), UGAGguagcu (SEQ ID NO.: 10978), UGAGguagga (SEQ ID NO.: 10979), UGAGguaggc (SEQ ID NO.: 10980), UGAGguaggg (SEQ ID NO.: 10981), UGAGguaggu (SEQ ID NO.: 10982), UGAGguagua (SEQ ID NO. : 10983), UGAGguagug (SEQ ID NO. : 10984), UGAGguaguu (SEQ ID NO. : 10985), UGAGguauaa (SEQ ID NO.: 10986), UGAGguauac (SEQ ID NO.: 10987), UGAGguauag (SEQ ID NO.: 10988), UGAGguauau (SEQ ID NO.: 10989), UGAGguauca (SEQ ID NO.: 10990), UGAGguaucu (SEQ ID NO.: 10991), UGAGguauga (SEQ ID NO.: 10992), UGAGguaugc (SEQ ID NO.: 10993), UGAGguaugg (SEQ ID NO.: 10994), UGAGguaugu (SEQ ID NO.: 10995), UGAGguauua (SEQ ID NO.: 10996), UGAGguauuc (SEQ ID NO.: 10997), UGAGguauug (SEQ ID NO : 10998), UGAGguauuu (SEQ ID NO.: 10999), UGAGgucaga (SEQ ID NO.: 11000), UGAGgucagc (SEQ ID NO.: 11001), UGAGgucagg (SEQ ID NO.: 11002), UGAGgucagu (SEQ ID NO.: 11003), UGAGgucauu (SEQ ID NO.: 11004), UGAGguccgu (SEQ ID NO.: 11005), UGAGgucgag (SEQ ID NO.: 11006), UGAGgucggg (SEQ ID NO.: 11007), UGAGgucuga (SEQ ID NO.: 11008), UGAGgucugg (SEQ ID NO.: 11009), UGAGgucugu (SEQ ID NO.: 11010), UGAGgucuuu (SEQ ID NO.: 11011), UGAGgugaaa (SEQ ID NO. : 11012), UGAGgugaac (SEQ ID NO. : 11013), UGAGgugaag (SEQ ID NO.: 11014), UGAGgugaau (SEQ ID NO.: 11015), UGAGgugaca (SEQ ID NO.: 11016), UGAGgugacg (SEQ ID NO.: 11017), UGAGgugacu (SEQ ID NO.: 11018), UGAGgugaga (SEQ ID NO.: 11019), UGAGgugagc (SEQ ID NO.: 11020), UGAGgugagg (SEQ ID NO.: 11021), UGAGgugagu (SEQ ID NO. : 11022), UGAGgugaua (SEQ ID NO. : 11023), UGAGgugauc (SEQ ID NO.: 11024), UGAGgugaug (SEQ ID NO.: 11025), UGAGgugauu (SEQ ID NO.: 11026), UGAGgugcau (SEQ ID NO.: 11027), UGAGgugcga (SEQ ID NO.: 11028), UGAGgugcgc (SEQ ID NO.: 11029), UGAGgugcgg (SEQ ID NO.: 11030), UGAGgugcgu (SEQ ID NO.: 11031), UGAGgugcug (SEQ ID NO.: 11032), UGAGguggga (SEQ ID NO.: 11033), UGAGgugggc (SEQ ID NO.: 11034), UGAGgugggg (SEQ ID NO.: 11035), UGAGgugggu (SEQ ID NO.: 11036), UGAGguggua (SEQ ID NO.: 11037), UGAGguguca (SEQ ID NO.: 11038), UGAGgugucu (SEQ ID NO.: 11039), UGAGguguga (SEQ ID NO.: 11040), UGAGgugugg (SEQ ID NO.: 11041), UGAGgugugu (SEQ ID NO.: 11042), UGAGguguuc (SEQ ID NO.: 11043), UGAGguuacg (SEQ ID NO.: 11044), UGAGguuaga (SEQ ID NO.: 11045), UGAGguuagc (SEQ ID NO.: 11046), UGAGguuagg (SEQ ID NO.: 11047), UGAGguuagu (SEQ ID NO : 11048), UGAGguucgg (SEQ ID NO.: 11049), UGAGguugag (SEQ ID NO.: 11050), UGAGguugcc (SEQ ID NO.: 11051), UGAGguugga (SEQ ID NO.: 11052), UGAGguuggg (SEQ ID NO.: 11053), UGAGguuggu (SEQ ID NO.: 11054), UGAGguugua (SEQ ID NO.: 11055), UGAGguugug (SEQ ID NO.: 11056), UGAGguuguu (SEQ ID NO.: 11057), UGAGguuuaa (SEQ ID NO.: 11058), UGAGguuuau (SEQ ID NO.: 11059), UGAGguuuga (SEQ ID NO.: 11060), UGAGguuugc (SEQ ID NO.: 11061), UGAGguuugg (SEQ ID NO : 11062), UGAGguuugu (SEQ ID NO.: 11063), UGAGugaggu (SEQ ID NO.: 11064), UGAUauccuu (SEQ ID NO.: 11065), UGAUguaaga (SEQ
ID NO.: 11066), UGAUguaagc (SEQ ID NO.: 11067), UGAUguaagg (SEQ ID NO.: 11068), UGAUguaagu (SEQ ID NO.: 11069), UGAUguaauu (SEQ ID NO.: 11070), UGAUguacga (SEQ ID NO.: 11071), UGAUguacgg (SEQ ID NO.: 11072), UGAUguaggu (SEQ ID NO.: 11073), UGAUguaucc (SEQ ID NO. : 11074), UGAUguaugc (SEQ ID NO. : 11075), UGAUguaugg (SEQ ID NO.: 11076), UGAUguaugu (SEQ ID NO.: 11077), UGAUgugaga (SEQ ID NO.: 11078), UGAUgugagc (SEQ ID NO.: 11079), UGAUgugagg (SEQ ID NO.: 11080), UGAUgugagu (SEQ ID NO.: 11081), UGAUguuagu (SEQ ID NO.: 11082), UGAUugugga (SEQ ID NO.: 11083), UGCAgcaggu (SEQ ID NO.: 11084), UGCAgguaag (SEQ ID NO.: 11085), UGCAgguauu (SEQ ID NO. : 11086), UGCAguaaga (SEQ ID NO. : 11087), UGCAguaagg (SEQ ID NO. : 11088), UGCAguaagu (SEQ ID NO. : 11089), UGCAguacgg (SEQ ID NO. : 11090), UGCAguaggu (SEQ ID NO. : 11091 ), UGCAguaucc (SEQ ID NO. : 1 1092), UGCAguaugu (SEQ ID NO. : 11093), UGCAgucagu (SEQ ID NO. : 11094), UGCAgugaga (SEQ ID NO. : 11095), UGCAgugagc (SEQ ID NO. : 11096), UGCAgugagg (SEQ ID NO. : 11097), UGCAgugagu (SEQ ID NO.: 11098), UGCAguggua (SEQ ID NO.: 11099), UGCAguuaag (SEQ ID NO.: 11100), UGCAguuacg (SEQ ID NO. : 11101), UGCAguucag (SEQ ID NO. : 11102), UGCCguaagc (SEQ ID NO.: 11103), UGCCguaagu (SEQ ID NO.: 11104), UGCCguaggu (SEQ ID NO.: 11105), UGCCguaucc (SEQ ID NO.: 11106), UGCCguaugu (SEQ ID NO.: 11107), UGCCgugaga (SEQ ID NO. : 11108), UGCCgugagu (SEQ ID NO. : 11109), UGCGguaaau (SEQ ID NO. : 11110), UGCGguaaca (SEQ ID NO.: 11111), UGCGguaaga (SEQ ID NO : 11112), UGCGguaagc (SEQ ID NO.: 11113), UGCGguaagg (SEQ ID NO.: 11114), UGCGguaagu (SEQ ID NO.: 11115), UGCGguaaug (SEQ ID NO. : 11116), UGCGguacag (SEQ ID NO. : 11117), UGCGguaccg (SEQ ID NO.: 11118), UGCGguacgc (SEQ ID NO.: I l l 19), UGCGguacgu (SEQ ID NO.: 11120), UGCGguacuc (SEQ ID NO.: 11121), UGCGguaggg (SEQ ID NO.: 11122), UGCGguaggu (SEQ ID NO. : 11123), UGCGguaugg (SEQ ID NO.: 11124), UGCGguaugu (SEQ ID NO.: 11125), UGCGgucagu (SEQ ID NO. : 11126), UGCGgugaga (SEQ ID NO. : 11127), UGCGgugagc (SEQ ID NO.: 11128), UGCGgugagg (SEQ ID NO.: 11129), UGCGgugagu (SEQ ID NO.: 11130), UGCGgugaug (SEQ ID NO.: 11131), UGCGgugcgg (SEQ ID NO.: 11132), UGCGgugcgu (SEQ ID NO. : 11133), UGCGguuggu (SEQ ID NO.: 11134), UGCGuauuuu (SEQ ID NO.: 11135), UGCUcaaguc (SEQ ID NO.: 11136), UGCUcuuccc (SEQ ID NO.: 11137), UGCUgcaggu (SEQ ID NO.: 11138), UGCUguaaga (SEQ ID NO.: 11139), UGCUguaagc (SEQ ID NO.: 11140), UGCUguaagu (SEQ ID NO. : 11141), UGCUguacgc (SEQ ID NO. : 11142), UGCUguaggu (SEQ ID NO. : 11143), UGCUguaucc (SEQ ID NO. : 11144), UGCUguaugg (SEQ ID NO. : 11145), UGCUguaugu (SEQ ID NO. : 11146), UGCUgucagu (SEQ ID NO. : 11147), UGCUgugaga (SEQ ID NO. : 11148), UGCUgugagc (SEQ ID NO. : 11149), UGCUgugagg (SEQ ID NO. : 11150), UGCUgugagu (SEQ ID NO.: 11151), UGGAauccac (SEQ ID NO. : 11152), UGGAguaaga (SEQ ID NO. : 11153), UGGAguaagc (SEQ ID NO. : 11154), UGGAguaagg (SEQ ID NO. : 11155), UGGAguaagu (SEQ ID NO. : 11156), UGGAguacgu (SEQ ID NO. : 11157), UGGAguaggg (SEQ ID NO.: 11158), UGGAguaggu (SEQ ID NO.: 11159), UGGAgugagc (SEQ ID NO.: 11160), UGGAgugagg (SEQ ID NO . : 11161 ), UGGAgugagu (SEQ ID NO. : 11162), UGGAgugugu (SEQ ID NO.: 11163), UGGAguuagc (SEQ ID NO.: 11164), UGGAuauccu (SEQ ID NO : 11165), UGGAuuuuau (SEQ ID NO : 11166), UGGCgcaggu (SEQ ID NO.: 11167), UGGCguaaga (SEQ ID NO.: 11168), UGGCguaagu (SEQ ID NO.: 11169), UGGCguacgu (SEQ ID NO.: 11170), UGGCguaucc (SEQ ID NO.: 11171), UGGCgugagu (SEQ ID NO. : 11172), UGGGaacgag (SEQ ID NO. : 11173), UGGGauaaag (SEQ ID NO. : 11174), UGGGcaggcu (SEQ ID NO. : 11175), UGGGguaaaa (SEQ ID NO. : 11176), UGGGguaaau (SEQ
ID NO. : 11177), UGGGguaaga (SEQ ID NO. : 11178), UGGGguaagc (SEQ ID NO. : 11179), UGGGguaagg (SEQ ID NO.: 11180), UGGGguaagu (SEQ ID NO.: 11181), UGGGguaaua (SEQ ID NO. : 11182), UGGGguaaug (SEQ ID NO. : 11183), UGGGguaauu (SEQ ID NO. : 11184), UGGGguaccu (SEQ ID NO. : 11185), UGGGguacgu (SEQ ID NO. : 11186), UGGGguaggc (SEQ ID NO. : 11187), UGGGguaggg (SEQ ID NO. : 11188), UGGGguaggu (SEQ ID NO. : 11189), UGGGguauca (SEQ ID NO. : 11190), UGGGguaucc (SEQ ID NO. : 11191), UGGGguaucu (SEQ ID NO. : 11192), UGGGguaugg (SEQ ID NO. : 11193), UGGGguaugu (SEQ ID NO. : 11194), UGGGguauug (SEQ ID NO. : 11195), UGGGgucagu (SEQ ID NO. : 11196), UGGGgugacu (SEQ ID NO. : 11197), UGGGgugaga (SEQ ID NO. : 11198), UGGGgugagc (SEQ ID NO. : 11199), UGGGgugagg (SEQ ID NO : 11200), UGGGgugagu (SEQ ID NO. : 11201 ), UGGGgugggu (SEQ ID NO : 11202), UGGGguguaa (SEQ ID NO : 11203), UGGGgugugu (SEQ ID NO.: 11204), UGGGguuagu (SEQ ID NO.: 11205), UGGGguugug (SEQ ID NO.: 11206), UGGUguaaga (SEQ ID NO.: 11207), UGGUguaagc (SEQ ID NO.: 11208), UGGUguaagu (SEQ ID NO.: 11209), UGGUguaaua (SEQ ID NO.: 11210), UGGUguacgu (SEQ ID NO.: 11211), UGGUguaggu (SEQ ID NO.: 11212), UGGUgucagu (SEQ ID NO.: 11213), UGGUgugagc (SEQ ID NO.: 11214), UGGUgugagu (SEQ ID NO.: 11215), UGGUuaucau (SEQ ID NO.: 11216), UGUAcgauga (SEQ ID NO.: 11217), UGUAguaagg (SEQ ID NO.: 11218), UGUAguaagu (SEQ ID NO. : 11219), UGUAguccca (SEQ ID NO. : 11220), UGUAgugagu (SEQ ID NO.: 11221), UGUAguugug (SEQ ID NO.: 11222), UGUCaaaaag (SEQ ID NO.: 11223), UGUCcuccaa (SEQ ID NO : 11224), UGUCcuggcu (SEQ ID NO : 11225), UGUCguaagu (SEQ ID NO.: 11226), UGUCguaggu (SEQ ID NO.: 11227), UGUCgugagu (SEQ ID NO.: 11228), UGUGauguac (SEQ ID NO. : 11229), UGUGguaaaa (SEQ ID NO. : 11230), UGUGguaaag (SEQ ID NO.: 11231), UGUGguaaau (SEQ ID NO.: 11232), UGUGguaaca (SEQ ID NO.: 11233), UGUGguaaga (SEQ ID NO. : 11234), UGUGguaagc (SEQ ID NO. : 11235), UGUGguaagg (SEQ ID NO.: 11236), UGUGguaagu (SEQ ID NO.: 11237), UGUGguaaua (SEQ ID NO.: 11238), UGUGguaaug (SEQ ID NO. : 11239), UGUGguaauu (SEQ ID NO. : 11240), UGUGguacau (SEQ ID NO.: 11241), UGUGguacgg (SEQ ID NO.: 11242), UGUGguacua (SEQ ID NO.: 11243), UGUGguagag (SEQ ID NO. : 11244), UGUGguagga (SEQ ID NO. : 11245), UGUGguaggg (SEQ ID NO.: 11246), UGUGguaggu (SEQ ID NO.: 11247), UGUGguauga (SEQ ID NO.: 11248), UGUGguaugc (SEQ ID NO.: 11249), UGUGguaugg (SEQ ID NO.: 11250), UGUGguaugu (SEQ ID NO.: 11251), UGUGguauuu (SEQ ID NO.: 11252), UGUGgucagu (SEQ ID NO : 11253), UGUGgugaga (SEQ ID NO.: 11254), UGUGgugagc (SEQ ID NO.: 11255), UGUGgugagg (SEQ ID NO.: 11256), UGUGgugagu (SEQ ID NO.: 11257), UGUGgugauu (SEQ ID NO. : 11258), UGUGgugggu (SEQ ID NO. : 11259), UGUGguguga (SEQ ID NO.: 11260), UGUGgugugu (SEQ ID NO.: 11261), UGUGguuagu (SEQ ID NO.: 11262), UGUGguuugu (SEQ ID NO. : 11263), UGUGugguga (SEQ ID NO. : 11264), UGUUacggua (SEQ ID NO. : 11265), UGUUguaagu (SEQ ID NO. : 11266), UGUUguaggu (SEQ ID NO.: 11267), UGUUguaucc (SEQ ID NO.: 11268), UGUUgugagu (SEQ ID NO.: 11269), UGUUguugag (SEQ ID NO.: 11270), UUAAauaucc (SEQ ID NO.: 11271), UUAAggugag (SEQ ID NO. : 11272), UUAAguaaaa (SEQ ID NO. : 11273), UUAAguaaau (SEQ ID NO. : 11274), UUAAguaaga (SEQ ID NO. : 11275), UUAAguaagg (SEQ ID NO. : 11276), UUAAguaagu (SEQ ID NO.: 11277), UUAAguaauu (SEQ ID NO.: 11278), UUAAguaggu (SEQ ID NO.: 11279), UUAAguaugc (SEQ ID NO. : 11280), UUAAguaugg (SEQ ID NO. : 11281), UUAAguaugu (SEQ ID NO : 11282), UUAAgucagu (SEQ ID NO : 11283), UUAAgugagc (SEQ ID NO.: 11284), UUAAgugagu (SEQ ID NO.: 11285), UUAAgugggu (SEQ ID NO.: 11286),
UUAAguuagu (SEQ ID NO.: 11287), UUACguaagu (SEQ ID NO.: 11288), UUACgugagu (SEQ ID NO.: 11289), UUAGgcaagu (SEQ ID NO.: 11290), UUAGgcacgg (SEQ ID NO.: 11291), UUAGgcacgu (SEQ ID NO.: 11292), UUAGguaaaa (SEQ ID NO.: 11293), UUAGguaaac (SEQ ID NO.: 11294), UUAGguaaag (SEQ ID NO.: 11295), UUAGguaaau (SEQ ID NO.: 11296), UUAGguaaca (SEQ ID NO.: 11297), UUAGguaacc (SEQ ID NO.: 11298), UUAGguaacg (SEQ ID NO.: 11299), UUAGguaacu (SEQ ID NO.: 11300), UUAGguaaga (SEQ ID NO.: 11301), UUAGguaagc (SEQ ID NO.: 11302), UUAGguaagg (SEQ ID NO.: 11303), UUAGguaagu (SEQ ID NO.: 11304), UUAGguaaua (SEQ ID NO.: 11305), UUAGguaaug (SEQ ID NO.: 11306), UUAGguaauu (SEQ ID NO.: 11307), UUAGguacau (SEQ ID NO.: 11308), UUAGguaccu (SEQ ID NO.: 11309), UUAGguacgu (SEQ ID NO.: 11310), UUAGguacua (SEQ ID NO.: 11311), UUAGguacuu (SEQ ID NO. : 11312), UUAGguagag (SEQ ID NO. : 11313), UUAGguagau (SEQ ID NO.: 11314), UUAGguagga (SEQ ID NO.: 11315), UUAGguaggg (SEQ ID NO.: 11316), UUAGguaggu (SEQ ID NO.: 11317), UUAGguauaa (SEQ ID NO.: 11318), UUAGguauag (SEQ ID NO.: 11319), UUAGguauau (SEQ ID NO.: 11320), UUAGguaucc (SEQ ID NO.: 11321), UUAGguauga (SEQ ID NO.: 11322), UUAGguaugc (SEQ ID NO.: 11323), UUAGguaugg (SEQ ID NO.: 11324), UUAGguaugu (SEQ ID NO.: 11325), UUAGguauua (SEQ ID NO.: 11326), UUAGguauuc (SEQ ID NO.: 11327), UUAGguauug (SEQ ID NO.: 11328), UUAGguauuu (SEQ ID NO : 11329), UUAGgucagg (SEQ ID NO : 11330), UUAGgucagu (SEQ ID NO.: 11331), UUAGgucucu (SEQ ID NO.: 11332), UUAGgucuuc (SEQ ID NO.: 11333), UUAGgugaag (SEQ ID NO.: 11334), UUAGgugaau (SEQ ID NO.: 11335), UUAGgugaga (SEQ ID NO.: 11336), UUAGgugagc (SEQ ID NO.: 11337), UUAGgugagg (SEQ ID NO.: 11338), UUAGgugagu (SEQ ID NO.: 11339), UUAGgugauc (SEQ ID NO.: 11340), UUAGgugccu (SEQ ID NO.: 11341), UUAGgugcgu (SEQ ID NO.: 11342), UUAGgugggg (SEQ ID NO.: 11343), UUAGgugggu (SEQ ID NO.: 11344), UUAGgugugu (SEQ ID NO.: 11345), UUAGguuaga (SEQ ID NO.: 11346), UUAGguugaa (SEQ ID NO.: 11347), UUAGguuggu (SEQ ID NO.: 11348), UUAGguugug (SEQ ID NO.: 11349), UUAGguuugu (SEQ ID NO.: 11350), UUAUauauca (SEQ ID NO.: 11351), UUAUgcaagu (SEQ ID NO.: 11352), UUAUguaaga (SEQ ID NO.: 11353), UUAUguaagc (SEQ ID NO.: 11354), UUAUguaagg (SEQ ID NO.: 11355), UUAUguaagu (SEQ ID NO.: 11356), UUAUguaaua (SEQ ID NO.: 11357), UUAUguacgu (SEQ ID NO.: 11358), UUAUguaugu (SEQ ID NO.: 11359), UUAUgugagu (SEQ ID NO.: 11360), UUCAauaucc (SEQ ID NO.: 11361), UUCAgguaag (SEQ ID NO.: 11362), UUCAgguaug (SEQ ID NO.: 11363), UUCAguaaga (SEQ ID NO.: 11364), UUCAguaagu (SEQ ID NO.: 11365), UUCAguacgu (SEQ ID NO.: 11366), UUCAguaggu (SEQ ID NO.: 11367), UUCAguaucc (SEQ ID NO.: 11368), UUCAgucugu (SEQ ID NO.: 11369), UUCAgugagc (SEQ ID NO.: 11370), UUCAgugagu (SEQ ID NO.: 11371), UUCAgugggu (SEQ ID NO.: 11372), UUCAguuaag (SEQ ID NO.: 11373), UUCAguuagu (SEQ ID NO.: 11374), UUCCauaucc (SEQ ID NO : 11375), UUCCguaagu (SEQ ID NO.: 11376), UUCCguaucc (SEQ ID NO.: 11377), UUCCgugagu (SEQ ID NO.: 11378), UUCGgcaagu (SEQ ID NO.: 11379), UUCGguaaaa (SEQ ID NO.: 11380), UUCGguaaga (SEQ ID NO.: 11381), UUCGguaagg (SEQ ID NO.: 11382), UUCGguaagu (SEQ ID NO.: 11383), UUCGguaauc (SEQ ID NO.: 11384), UUCGguaaug (SEQ ID NO.: 11385), UUCGguacag (SEQ ID NO.: 11386), UUCGguagga (SEQ ID NO.: 11387), UUCGguaggu (SEQ ID NO.: 11388), UUCGguaugu (SEQ ID NO.: 11389), UUCGguauuu (SEQ ID NO.: 11390), UUCGgucugu (SEQ ID NO.: 11391), UUCGgugaga (SEQ ID NO.: 11392), UUCGgugagc (SEQ ID NO.: 11393), UUCGgugagg (SEQ ID NO.: 11394), UUCGgugagu (SEQ ID NO.: 11395), UUCGgugggc (SEQ ID NO.: 11396), UUCGgugggu
(SEQ ID NO.: 11397), UUCGguuagu (SEQ ID NO.: 11398), UUCUguaaga (SEQ ID NO.: 11399), UUCUguaagc (SEQ ID NO.: 11400), UUCUguaagg (SEQ ID NO.: 11401), UUCUguaagu (SEQ ID NO.: 11402), UUCUguaccu (SEQ ID NO.: 11403), UUCUguacgu (SEQ ID NO.: 11404), UUCUguacug (SEQ ID NO.: 11405), UUCUguaggu (SEQ ID NO.: 11406), UUCUguaucc (SEQ ID NO.: 11407), UUCUguaugu (SEQ ID NO.: 11408), UUCUgugaga (SEQ ID NO.: 11409), UUCUgugagc (SEQ ID NO.: 11410), UUCUgugagu (SEQ ID NO.: 11411), UUCUgugcgu (SEQ ID NO.: 11412), UUCUguucag (SEQ ID NO.: 11413), UUCUucccuu (SEQ ID NO.: 11414), UUGAauaucc (SEQ ID NO.: 11415), UUGAgguaag (SEQ ID NO.: 11416), UUGAgguagg (SEQ ID NO.: 11417), UUGAguaagc (SEQ ID NO.: 11418), UUGAguaagg (SEQ ID NO.: 11419), UUGAguaagu (SEQ ID NO.: 11420), UUGAguaugu (SEQ ID NO.: 11421), UUGAgugaga (SEQ ID NO.: 11422), UUGAgugagc (SEQ ID NO.: 11423), UUGAgugagu (SEQ ID NO. : 11424), UUGAgugggu (SEQ ID NO. : 11425), UUGAugguaa (SEQ ID NO. : 11426), UUGCguaagg (SEQ ID NO.: 11427), UUGCguaagu (SEQ ID NO.: 11428), UUGCguacgu (SEQ ID NO. : 11429), UUGCguaugu (SEQ ID NO. : 11430), UUGCgugagu (SEQ ID NO.: 11431), UUGCgugggu (SEQ ID NO.: 11432), UUGCugagac (SEQ ID NO.: 11433), UUGGauaucc (SEQ ID NO.: 11434), UUGGgcaagu (SEQ ID NO.: 11435), UUGGgcgagu (SEQ ID NO.: 11436), UUGGggaagg (SEQ ID NO.: 11437), UUGGguaaaa (SEQ ID NO.: 11438), UUGGguaaag (SEQ ID NO.: 11439), UUGGguaaau (SEQ ID NO : 11440), UUGGguaacu (SEQ ID NO.: 11441), UUGGguaaga (SEQ ID NO.: 11442), UUGGguaagc (SEQ ID NO.: 11443), UUGGguaagg (SEQ ID NO. : 11444), UUGGguaagu (SEQ ID NO. : 11445), UUGGguaaua (SEQ ID NO.: 11446), UUGGguaaug (SEQ ID NO.: 11447), UUGGguaauu (SEQ ID NO.: 11448), UUGGguacgu (SEQ ID NO. : 11449), UUGGguacua (SEQ ID NO. : 11450), UUGGguacug (SEQ ID NO.: 11451), UUGGguagga (SEQ ID NO.: 11452), UUGGguaggc (SEQ ID NO.: 11453), UUGGguaggg (SEQ ID NO.: 11454), UUGGguaggu (SEQ ID NO.: 11455), UUGGguauga (SEQ ID NO.: 11456), UUGGguaugg (SEQ ID NO.: 11457), UUGGguaugu (SEQ ID NO.: 11458), UUGGguauuc (SEQ ID NO.: 11459), UUGGgucugu (SEQ ID NO.: 11460), UUGGgugaau (SEQ ID NO.: 11461), UUGGgugacu (SEQ ID NO.: 11462), UUGGgugaga (SEQ ID NO.: 11463), UUGGgugagc (SEQ ID NO.: 11464), UUGGgugagg (SEQ ID NO.: 11465), UUGGgugagu (SEQ ID NO.: 11466), UUGGgugauu (SEQ ID NO.: 11467), UUGGgugggu (SEQ ID NO. : 11468), UUGGguuggu (SEQ ID NO. : 11469), UUGGguuugg (SEQ ID NO. : 11470), UUGUguaaga (SEQ ID NO.: 11471), UUGUguaagc (SEQ ID NO.: 11472), UUGUguaagu (SEQ ID NO.: 11473), UUGUguacgu (SEQ ID NO.: 11474), UUGUguaggu (SEQ ID NO.: 11475), UUGUguauga (SEQ ID NO.: 11476), UUGUguaugu (SEQ ID NO.: 11477), UUGUgugagc (SEQ ID NO.: 11478), UUGUgugagu (SEQ ID NO.: 11479), UUGUguuagu (SEQ ID NO.: 11480), UUUAauaucc (SEQ ID NO.: 11481), UUUAguaaga (SEQ ID NO.: 11482), UUUAguaagg (SEQ ID NO.: 11483), UUUAguaagu (SEQ ID NO.: 11484), UUUAguaucc (SEQ ID NO. : 11485), UUUAguaugu (SEQ ID NO. : 11486), UUUAgugagu (SEQ ID NO.: 11487), UUUCaaauau (SEQ ID NO.: 11488), UUUCaagagg (SEQ ID NO.: 11489), UUUCagauac (SEQ ID NO.: 11490), UUUCagcagc (SEQ ID NO.: 11491), UUUCauagga (SEQ ID NO.: 11492), UUUCauaucc (SEQ ID NO.: 11493), UUUCguaagc (SEQ ID NO. : 11494), UUUCguaagu (SEQ ID NO. : 11495), UUUCguacgu (SEQ ID NO. : 11496), UUUCguaugu (SEQ ID NO.: 11497), UUUCgugagu (SEQ ID NO.: 11498), UUUCucugug (SEQ ID NO.: 11499), UUUGgcaagu (SEQ ID NO.: 11500), UUUGgcacgu (SEQ ID NO.: 11501), UUUGguaaac (SEQ ID NO.: 11502), UUUGguaaag (SEQ ID NO.: 11503), UUUGguaaau (SEQ ID NO.: 11504), UUUGguaacu (SEQ ID NO.: 11505), UUUGguaaga (SEQ ID NO.: 11506),
[005171 RNAseq experiments showed that compounds of Formula (I) induced exon inclusion with a PSI change (APSI) of +10% to +100% and E-value <0.001 in 4232 genes as shown in Table 11 :
[00518] Table 11
[00519] AAAS, AACS, AADAT, AAK1, AAMDC, AAR2, AASDH, AASS, ABCA1, ABCA11P, ABCA3, ABCA5, ABCA7, ABCB8, ABCC10, ABCC4, ABCD4, ABHD10, ABHD11, ABHD12, ABHD14A, ABHD14A-ACY1, ABHD18, ABHD5, ABI1, ABI2, ABR, ABRAXAS1, ACAA1, ACACA, ACAD11, ACAD8, ACAP2, ACBD5, ACD, ACINI, ACLY, ACO1, ACO2, ACOT11, ACOT8, ACOT9, ACOX1, ACOX3, ACPI, ACP6, ACSL3, ACSS2, ACTA2, ACTN4, ACTR1B, ACTR3B, ACTR3C, ACVR1, ACY1, ACYP1, ACYP2, ADAMES, ADAM17, ADAM19, ADAM22, ADAMTS12, ADAMTS14, ADAMTS17, ADAMTS6, ADAMTS9, ADAMTS9-AS2, ADAP1, ADAR, ADARB1, ADAT1, ADAT2, ADCK1, ADCK5, ADCY3, ADCYAP1R1, ADD1, ADD2, ADD3, ADGRA3, ADGRB2, ADGRD1, ADGRL1, ADGRL2, ADGRL3, ADIPOR2, ADK, ADM5, ADNP, ADPGK, ADRM1, AFDN. AFF3, AFF4, AFG1L, AFM1D, AGAP1, AGAP3, AGAP9, AGBL3, AGFG2, AGO2, AGO3, AGO4, AGPAT3, AGTPBP1, AHCTF1, AHCYL2, AHDC1, AHI1, AHNAK, AHRR, AIG1, AIMP2, AK2, AK3, AKAP11, AKAP13, AKAP6, AKAP9, AKNA, AKR1A1, AKT1, AKTIP,
ALDH16A1, ALDH18A1, ALG11, ALG13, ALG14, ALG9, ALKBH2, ALKBH3, ALKBH6, ALKBH8, ALMS1, ALPK1, ALS2, AMBRA1, AMHR2, AMMECR1L, AMN1, AMOT, AMOTL1, AMPH, AMY2B, AMZ2, ANAPC1, ANAPC10, ANAPC15, ANGEL1, ANGEL2, ANGPT1, ANK2, ANK3, ANKFY1, ANKHD1, ANKHD1-EIF4EBP3, ANKMY2, ANKRD10, ANKRD11, ANKRD13A, ANKRD13C, ANKRD17, ANKRD27, ANKRD33B, ANKRD35, ANKRD36, ANKRD39, ANKRD49, ANKS1A, ANKS3, ANKS6, ANLN, ANOIO, ANO6, ANO8, ANXA11, ANXA2, ANXA4, ANXA7, AO AH, AP1G1, AP1S2, AP2A1, AP2A2, AP2B1, AP3B1, AP3D1, AP3M1, AP3S1, AP3S2, AP4B1, AP4E1, AP4M1, AP5M1, AP5S1, APAF1, APBA1, APBA2, APBB2, APC, APH1A, APLP2, APOBEC3H, APOCI, APOL2, APOOL, APP, APPBP2, APPL2, APTR, APTX, ARAF, ARAP1, AREL1, AREG AP I, ARFGAP2, ARFGEF2, ARF1P1, ARFIP2, ARHGAP10, ARHGAP12, ARHGAP17, ARHGAP19-SLIT1, ARHGAP24, ARHGAP26, ARHGAP32, ARHGAP39, ARHGAP8, ARHGDIA, ARHGEF1, ARHGEF10, ARHGEF11, ARHGEF12, ARHGEF25, ARHGEF26, ARHGEF33, ARHGEF6, ARHGEF7, ARHGEF9, ARID1B, ARID2, ARID4B, ARIH2, ARL13B, ARL14EP, ARL15, ARL16, ARL17A, ARL17B, ARL5B, ARL6, ARMC10, ARMC7, ARMC8, ARMCX2, ARMCX5, ARMCX5-GPRASP2, ARMCX6, ARMH3, ARNT, ARNTL, ARNTL2, ARRB1, ARSB, ARSK, ART5, ARV1, ARVCF, ASAP1, ASAP2, ASB3, ASB6, ASCC1, ASCC2, ASCC3, ASH1L, ASIC1, ASL, ASPH, ASPSCR1, ASTE1, ASTN2, ASXL1, ASXL3, ATAD1, ATAD2B, ATAD3A, ATE1, ATF2, ATG10, ATG13, ATG4A, ATG4B, ATG4C, ATG7, ATG9A, ATL1, ATL2, ATM, ATP10A, ATP10D, ATP11B, ATP11C, ATP13A3, ATP1A1-AS1, ATP2B4, ATP2C1, ATP5MF-PTCD1, ATP5PF, ATP5S, ATP6V0A1, ATP6V1C2, ATP7A, ATP7B, ATP9B, ATPAF1, ATPAF2, ATRIP-TREX1, ATRX, ATXN1, ATXN1L, ATXN2, ATXN7, ATXN7L2, AURKA, AVL9, AXIN1, B3GALNT1, B3GALNT2, B3GNTL1, B4GALNT1, B4GALNT4, B4GALT4, B4GALT7, BAALC, BABAM2, BACH2, BAG4, BAHCC1, BAK1, BANP, BAZ1A, BAZ2A, BAZ2B, BBIP1, BBOX1-AS1, BBS4, BBX, BCAR1, BCAR3, BCAS3, BCAS4, BCAT2, BCKDHB, BCL11A, BCL2, BCL2L1, BCL2L12, BCL2L13, BCLAF1, BCS1L, BDH2, BDKRB2, BECN1, BEGAIN, BEND7, BFAR, BFSP1, BINI, BIRC6, BIVM, BLM, BLOC1S5, BLOC1S5- TXNDC5, BLOC1S6, BLVRA, BLZF1, BMF, BMP2, BMP2K, BMPR1B, BMPR2, BMS1P20, BNC2, BNIP2, BOLA1, BOLA2, BOLA2-SMG1P6, BOLA2B, BOP1, BORA, BORCS8,
BORCS8-MEF2B, BPTF, BRAF, BRAP, BRAT1, BRCA1, BRCC3, BRD1, BRD3, BRD8, BRF1, BRIP1, BRMS1L, BROX, BRWD1, BTBD19, BTBD2, BTBD3, BTBD7, BTBD9, BTD, BTF3L4, BTG3, BTK, BTLA, BTN2A1, BTN3A2, BTN3A3, BTRC, BUD13, C10orfl43, Cllorfl, Cllorf49, Cllorf54, Cllorf65, CllorfBO, Cl lorf95, C12orfl0, C12orf29, C12orf4, C12orf49, C14orfl44, C14orf93, C15orf38-AP3S2, C15orf41, C16orf74, C16orf87, C17orf80, C18orf21, C19orf24, C19orf44, C19orf47, C19orf48, C19orf54, C19orf57, C1GALT1, C1QTNF3-AMACR, Clorfl09, Clorfll2, Clorfl59, Clorf21, Clorf50, Clorf54, C20orfl94, C20orfl96, C20orfl97, C20orP96, C22orf39, C2CD3, C2CD5, C2orf27A, C2orf42, C2orf48, C2orf74, C2orf76, C3orfl8, C3orfi3, C4orC3, C5, C5orf22, C5orf42, C5orf51, C5orf66, C6orfl06, C6orf203, C6orf62, C6orf89, C7orf26, C7orf31, C7orf50, C8orf34, C8orfi7, C8orf44-SGK3, C8orf59, C9orf3, C9orf85, CA5BP1, CAB39, CABIN1, CACNA1C, CACNA2D1, CACNA2D4, CACNB3, CADM2, CALD1, CALHM1, CALHM2, CALU, CAMK1, CAMKID, CAMK2D, CAMK2G, CAMKK1, CAMKK2, CAMKMT, CAMLG, CAMSAP1, CAMSAP2, CAMTAI, CANT1, CAPN15, CAPN7, CAPS2, CARD8, CARMI, CARS, CARS2, CASC3, CASD1, CASK, CASP10, CASP3, CASP8, CASP9, CAST, CASTOR1, CAVIN4, CBFA2T2, CBL, CBLL1, CBR4, CBWD1, CBWD2, CBWD6, CBX2, CBX5, CBY1, CC2D2A, CCDC112, CCDC115, CCDC127, CCDC136, CCDC137, CCDC138, CCDC14, CCDC144NL-AS1, CCDC150, CCDC169-SOHLH2, CCDC171, CCDC18, CCDC183, CCDC183-AS1, CCDC26, CCDC28B, CCDC32, CCDC43, CCDC57, CCDC58, CCDC61, CCDC66, CCDC7, CCDC74B, CCDC77, CCDC82, CCDC84, CCDC88A, CCDC88C, CCDC91, CCDC93, CCM2, CCND3, CCNF, CCNJ, CCNJL, CCNL1, CCNQ, CCNT1, CCP110, CCR6, CCZ1P-OR7E38P, CD109, CD151, CD200, CD24, CD27-AS1, CD276, CD2AP, CD300LF, CD3D, CD44, CDADC1, CDC14B, CDC25A, CDC25B, CDC25C, CDC27, CDC42BPA, CDC42BPB, CDC42SE2, CDC45, CDC7, CDCA3, CDCA4, CDCA7, CDCA7L, CDH23, CDH24, CDK11B, CDK16, CDK19, CDK2, CDK5, CDK5RAP1, CDK5RAP2, CDK8, CDKAL1, CDKN2B-AS1, CDKN3, CDO1, CDR2, CDRT4, CDV3, CEBPZOS, CELF3, CENPI, CENPK, CENPL, CENPN, CENPO, CENPS-CORT, CEP112, CEP126, CEP128, CEP131, CEP162, CEP164, CEP170, CEP250, CEP290, CEP41, CEP44, CEP57, CEP57L1, CEP63, CEP78, CEP83, CEP85L, CEP95, CEP97, CEPT1, CERCAM, CERS4, CERS5, CFAP299, CFAP44, CFLAR, CGRRF1, CHAF1A, CHAF1B, CHD1, CHD2,
CHD8, CHD9, CHEK1, CHEK2, CHI3L1, CHID1, CHKA, CHM, CHN1, CHORDCI, CHP1, CHPF2, CHRM2, CHRNA3, CHRNA5, CHST10, CHST9, CHSY1, CHTF8, CHURC1-FNTB, CIART, CIB2, CIITA, CIP2A, CKLF-CMTM1, CLASP 1, CLASP2, CLASRP, CLCC1, CLCN3, CLCN5, CLCN6, CLDN12, CLEC16A, CLEC7A, CLGN, CLIP1, CLIP2, CLK1, CLK2, CLN3, CLN5, CLSPN, CLSTN1, CLTCL1, CMAHP, CMC1, CMC2, CMC4, CMSS1, CMTM8, CNEP1R1, CNIH2, CNIH3, CNNM1, CNNM2, CNNM3, CNOTIO, CNOT2, CNOT4, CNPY2, CNPY3, CNR2, CNST, CNTFR, CNTN1, CNTN3, CNTN4, COA1, COBLL1, COCH, COG3, COG5, COL1A2-AS1, COL23A1, COL24A1, COL26A1, COL27A1, COL4A5, COL4A6, COL6A3, COMMDIO, C0MMD2, C0MMD3-BMI1, C0MMD4, C0MMD6, COMTD1, COP1, COPB2, COPE, COPG1, COPS7B, COPS8, COQ3, COQ4, COQ6, COQ9, CORO7, CORO7-PAM16, COX16, COX17, CPEB2, CPEB3, CPED1, CPNE1, CPNE5, CPNE7, CPPED1, CPSF1, CPSF2, CPSF6, CPSF7, CPT1C, CPT2, CRACR2A, CRACR2B, CRAMP 1, CRBN, CRCP, CREB5, CREBBP, CREBZF, CREM, CRIM1, CRLS1, CRMP1, CROCC, CROCCP2, CROT, CRTC1, CRTC3, CRYZ, CRYZL1, CS, CSAD, CSAG3, CSGALNACT2, CSNK1D, CSNK1G3, CSPP1, CSRNP3, CSTF2, CSTF3, CTBP2, CTDP1, CTDSP2, CTDSPL, CTDSPL2, CTIF, CTNNAL1, CTNNBIP1, CTNND1, CTNS, CTPS2, CTTN, CUBN, CUL3, CUL7, CUTC, CUX1, CUX2, CWF19L1, CWF19L2, CXorf57, CYB561, CYB561D1, CYB5D2, CYB5R2, CYB5RL, CYBC1, CYFIP1, CYFIP2, CYLD, CYREN, CYTH1, CYTH2, CYTOR, CZ1P-ASNS, D2HGDH, DAB2IP, DACH1, DAGLB, DAPK1, DARS2, DBF4, DBF4B, DBT, DCAF10, DCAF16, DCAF17, DCAF5, DCAF8, DCAKD, DCBLD1, DCLK2, DCLRE1C, DCP1B, DCP2, DCST1-AS1, DCTD, DCTN1, DCUN1D4, DCUN1D5, DDAH1, DDHD1, DDIAS, DDX11, DDX12P, DDX27, DDX31, DDX42, DDX55, DDX60L, DEAF1, DECR2, DEDD2, DEF8, DENND1A, DENND1B, DENND4A, DENND5A, DENND6A, DENR, DEPDC1, DEPDC5, DERA, DESI1, DEXI, DFFA, DGCR5, DGCR6L, DGKA, DGKE, DGKH, DGKI, DGKQ, DGLUCY, DGUOK, DHFR, DHRS4L1, DHRS4L2, DHTKD1, DHX30, DHX35, DIABLO, DIAPH2, DIAPH3, DICER1, DIP2B, DIRAS1, DIRC2, DIS3, DISP1, DLD, DLEU1, DLEU2, DLG1, DLG5, DLGAP4, DLGAP4-AS1, DMAC2, DMAP1, DMC1, DMKN, DMPK, DMRTA2, DMTF1, DMXL1, DNA2, DNAAF2, DNAH10, DNAH14, DNAJB14, DNAJB4, DNAJB5, DNAJC17, DNAJC19, DNAJC21, DNAJC24, DNAJC25, DNAJC25-GNG10, DNAJC5, DNAJC8,
DNASE 1L2, DNM1, DNM2, DNM3, DNMBP, DNMT1, DNMT3A, DNMT3B, DNPEP, DOC2B, DOCK11, DOCK4, DOCK7, DOCK9, DOK1, DOK6, DONSON, DOPEY1, DOT1L, DPF3, DPH1, DPH3, DPH6, DPH7, DPP9, DPY19L4, DPYD, DPYSL4, DRAM2, DRG2, DRGX, DROSHA, DSE, DSN1, DST, DTNA, DTWD1, DTX2, DTX2P1-UPK3BP1-PMS2P11, DUBR, DUS2, DUSP11, DUSP16, DUXAP8, DVL1, DYM, DYNC1I2, DYNC2H1, DYRK1A, DZIP1, DZIP3, E2F6, E2F7, E4F1, EAF1, EBF3, EBP, EBPL, ECHDC1, ECHDC2, ECU, ECI2, ECT2, EDEM2, EDEM3, EDRF1, EEA1, EED, EEF1AKMT1, EEF1AKMT2, EEF1E1- BLOC1S5, EEF2KMT, EEFSEC, EFCAB14, EFCAB2, EFCAB5, EFEMP1, EFHD2, EFL1, EFNA1, EFNA4, EFNA5, EFR3A, EGLN1, EHBP1, EHBP1L1, EHHADH, EHMT1, EIF1AD, EIF2A, EIF2D, EIF4A2, EIF4E, EIF4G3, EIF4H, EIPR1, ELAVL2, ELAVL4, ELF2, ELFN2, ELMO1, ELMO2, EEMOD3, ELOVE1, EEP1, EEP2, ELP3, EMC3-AS1, EMC4, EMIDI, EML1, EML2, EML3, EML4, EML5, EML6, EMSY, ENCI, ENDOG, ENDOV, ENKD1, ENOSF1, ENOXI, ENOX2, ENPP1, ENTPD1-AS1, ENTPD4, ENTPD5, ENTPD6, EP400, EP400P1, EPAS1, EPB41, EPB41L1, EPB41L2, EPB41L3, EPG5, EPHA2, EPHA6, EPHA8, EPHB4, EPM2A, EPN1, EPRS, EPS15, EPS15L1, ERC1, ERCC1, ERCC6L2, ERCC8, ERGIC1, ERI1, ERI3, ERICH1, ERMARD, ESCO1, ESPNL, ESYT2, ETFA, ETFDH, ETFRF1, ETV6, EVC, EVI5, EXD2, EXO1, EXOC2, EXOC3, EXOC4, EXOC6, EXOC7, EXOSC3, EXOSC8, EXT2, EXTL2, EYA1, EYA3, EYA4, EZH2, F3, F8, FADS2, FAHD2A, FAHD2CP, FAM104A, FAM107B, FAM110B, FAM114A1, FAM118A, FAM120AOS, FAM122B, FAM126A, FAM129A, FAM129B, FAM131A, FAM135A, FAM13A, FAM13B, FAM149B1, FAM151B, FAM155A, FAM155B, FAM160A1, FAM161A, FAM163A, FAM168A, FAM171A1, FAM172A, FAM173A, FAM174A, FAM185A, FAM189B, FAM193A, FAM193B, FAM19A5, FAM206A, FAM208A, FAM208B, FAM210A, FAM217B, FAM219B, FAM222B, FAM228B, FAM241B, FAM35A, FAM3A, FAM3C, FAM45A, FAM45BP, FAM49B, FAM53B, FAM57A, FAM69B, FAM72A, FAM72C, FAM86C1, FAM86C2P, FAM91A1, FAM92A, FAM96A, FAM98B, FAM98C, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCI, FANCL, FARP1, FARP2, FARS2, FASTKD1, FAT1, FAXC, FBH1, FBN2, FBRSL1, FBXL12, FBXL20, FBXL3, FBXL6, FBXL7, FBXO21, FBXO22, FBXO25, FBXO31, FBXO38, FBXO44, FBXO7, FBXW11, FBXW4, FBXW7, FBXW8, FCGRT, FCHSD1, FCHSD2, FCRLA, FECH, FENDRR, FER, FERMT2, FES, FGD2,
FGD5-AS1, FGF13, FGFR1, FGFR10P, FGFR1OP2, FGFR2, FGFR3, FGFR4, FGGY, FHIT, FHOD1, FHOD3, FIGNL1, FIP1L1, FKBP10, FKBP14, FKBP5, FKBP7, FKRP, FKTN, FLAD1, FLCN, FLJ32255, FLNA, FLNB, FLOT2, FLRT3, FLVCR1, FLYWCH1, FLYWCH2, FMNL2, FNBP1, FNBP4, FNDC3A, FNDC3B, FNIP2, FNTB, FOCAD, FOLR1, FOXD3-AS1, FOXJ3, FOXK2, FOXM1, FOXN2, FOXN3, FOXO3, FOXP1, FOXRED1, FOXRED2, FPGT- TNNI3K, FRAS1, FRG1, FRG1-DT, FRG1BP, FRG1DP, FRG1HP, FRMD3, FRMD8, FRS2, FRY, FRYL, FSD1L, FTX, FUBP3, FUCA2, FURIN, FUT10, FUT8, FUZ, FXR1, FXR2, FXYD6, FYN, FZD6, FZR1, G2E3, GAA, GAB2, GABPA, GABPB1, GABPB2, GAK, GALE, GALK2, GALNT11, GALNT13, GALNT18, GALNT3, GALNT6, GALNT7, GANAB, GAPVD1, GAS2L1, GAS2L3, GAS5, GAS8, GATA2, GATA2-AS1, GATA3, GATA4, GATD1, GBA, GBA2, GBF1, GBP1P1, GBP5, GCFC2, GCNT2, GCSH, GDPD5, GEM1N2, GEMIN4, GEMIN7, GEN1, GFM2, GFOD2, GGA1, GGA3, GGCT, GGCX, GGPS1, GID4, GID8, GIGYF2, GIN1, GINM1, GINS3, GIPC1, GIT1, GIT2, GK5, GKAP1, GLMN, GLMP, GLRB, GLS, GLT8D1, GLT8D2, GLTP, GLYCTK, GLYR1, GMDS, GMDS-AS1, GMIP, GMPR2, GNAS-AS1, GNB1, GNB1L, GNL2, GNPAT, GNPDA2, GNPNAT1, GNPTG, GOLGA2, GOLGA2P10, GOLGA3, GOLGA4, GOLGA6L10, GOLGA6L17P, GOLGA6L9, GOLIM4, GON4L, GOPC, GORASP1, GOSR2, GPATCH11, GPATCH2, GPBP1, GPBP1L1, GPC5, GPC6, GPD1L, GPHN, GPR107, GPR137, GPR141, GPR160, GPR161, GPR176, GPR180, GPR75-ASB3, GPR89A, GPR89B, GPRASP2, GPRC5D-AS1, GPS1, GPSM2, GPX7, GPX8, GRAMD1A, GRAMD4, GRB10, GRIK5, GRIN2D, GRIP API, GRK3, GRK4, GRK6, GRM7, GRM8, GSK3B, GSTCD, GSTM4, GSTT1, GSTT2B, GTDC1, GTF2H1, GTF2H2, GTF2H2C 2, GTF2H3, GTF2I, GTF2IP1, GTF2IP20, GTF2IP4, GTF2IRD1, GTF3C2, GTPBP10, GTPBP2, GTPBP8, GUCD1, GUK1, GULP1, GUSB, GUSBP1, GUSBP11, GVQW2, GYG1, HACE1, HAND2-AS1, HARS2, HAUS1, HAUS2, HAUS3, HAUS4, HAUS7, HAX1, HBS1L, HCFC2, HDAC10, HDAC11, HDAC2, HDAC3, HDAC5, HDAC8, HDAC9, HDDC2, HDHD5, HDLBP, HDX, HEATR5A, HEATR6, HEBP2, HECTD1, HECTD4, HECW1, HECW2, HELZ, HEMK1, HERC1, HERC2, HERC2P2, HERC2P9, HERC3, HERC4, HERPUD2, HEXA, HEXIM2, HGS, HHAT, HIBADH, HIKESHI, HINFP, HIP1, HIRA, HIRIP3, HIST1H2BD, HIVEP1, HIVEP3, HKR1, HLA-A, HLA-DRB1, HLA- DRB4, HLA-F, HLCS, HMBOX1, HMG20B, HMGCL, HMGCR, HMGN4, HMGXB4,
HNRNPA1, HNRNPA2B1, HNRNPA3, HNRNPDL, HNRNPL, HNRNPUL1, H0GA1, HOOK1, HOXA11-AS, HOXA9, HOXB3, HOXB6, HOXC4, HPCAL1, HPF1, HPS4, HR, HRAT17, HRH1, HRH2, HS3ST3A1, HS6ST2, HSCB, HSD17B14, HSDL2, HSF1, HSF2, HSPA14, HSPB11, HUWE1, IAH1, IBTK, ICK, ICMT, IDE, IDI1, IDNK, IFFO1, IFI27L1, IFITM1, IFNAR1, IFRD1, IFT122, IFT140, IFT22, IFT43, IFT52, IFT80, IFT88, IGDCC4, IGF2BP2, IGF2BP3, IGFBP6, IGSF1, IGSF3, IKBIP, IKBKE, IKBKG, IKZF5, IL17RB, IL17RC, IL18RAP, IL32, IL4R, IL6R, IL7R, ILF3, IMMP1L, IMMP2L, IMMT, IMPA1, IMPA2, IMPDH1, INF2, ING3, ING5, INIP, INMT-MINDY4, INO80E, INPPI, INPP4A, INPP5B, INPP5K, INPPL1, INSR, INTS12, INTS14, INTS3, INTS4, INTS4P1, INTS4P2, INTS7, INTS8, INTS9, INVS, IP6K1, IP6K2, IPO5P1, IPO8, IPO9, IPP, IQCB1, IQCC, IQCH- AS1, 1QGAP3, IQSEC1, 1RAK1BP1, 1RAK2, IRAK3, IRF2, 1RF3, ISCA1, 1SER2, ISY1, ISYNA1, ITCH, ITGA10, ITGA7, ITGA8, ITGA9-AS1, ITGAM, ITGB1BP1, ITIH5, ITM2A, ITM2C, ITPR1, ITSN1, JADE3, JAM2, JARID2, JKAMP, JMJD1C, JMID7, JMJD7- PLA2G4B, IMID8, IOSD2, IPX, KANK1, KANK2, KANSL1, KANSL2, KANSL3, KARS, KAT5, KAT6A, KAT6B, KAT7, KATNA1, KATNAL1, KATNBL1, KAZN, KBTBD2, KBTBD3, KBTBD8, KCNK4, KCNQ1, KCNQ5, KCNQ5-IT1, KCNS3, KCNT2, KCTD14, KCTD15, KCTD17, KCTD20, KCTD9, KDELC2, KDM1A, KDM1B, KDM2A, KDM2B, KDM3B, KDM4A, KDM5A, KDM5B, KDM5C, KDM5D, KDM6A, KDM8, KHDC1, KHDRBS3, KIAA0232, KIAA0319L, KIAA0355, KIAA0391, KIAA0556, KIAA0586, KIAA0753, KIAA0895, KIAA0895L, KIAA1109, KIAA1191, KIAA1211, KIAA1324L, KIAA1328, KIAA1468, KIAA1549, KIAA1551, KIAA1671, KIAA1841, KIDINS220, KIF13A, KIF13B, KIF15, KIF1B, KIF21A, KIF23, KIF24, KIF2C, KIF3A, KIF4A, KIF9, KIFC1, KITLG, KIZ, KLC1, KLF12, KLF8, KLHDC10, KLHDC4, KLHL12, KLHL13, KLHL2, KLHL20, KLHL24, KLHL7, KLHL8, KLRG1, KMT2B, KMT2E, KNOP1, KNTC1, KPNA5, KRBA1, KRBOX4, KRIT1, KRT8, KTN1, KYAT1, L2HGDH, L3HYPDH, L3MBTL2, LACTB, LAMA5, LARGE1, LARP1, LARP4, LARP4B, LARP7, LARS2, LATS1, LATS2, LCMT1, LCOR, LCORL, LDAH, LDHC, LEMD3, LENEP, LEPR, LEPROTL1, LETM2, LGALS8, LGALS9, LHFPL2, LHPP, LIAS, LIG1, LIG3, LIMCH1, LIN54, LIN9, LINC-PINT, LINC00265, LINC00426, LINC00473, LINC00475, LINC00607, LINC00624, LINC00630, LINC00632, LINC00667, LINC00674, LINC00680, LINC00893, LINC00899, LINC00926,
LINC00937, LINC00958, LINC01029, LINC01060, LINC01184, LINC01237, LINC01278, LINC01358, LINC01410, LINC0 I456, LINC01572, LINCO1578, LINC01605, LINC01684, LINC01876, LINCO1881, LINC01894, LINC01934, LINC02062, LINC02210-CRHR1, LINC02328, LINC02476, LINC02511, LINC02542, LINGO 1, LINGO2, LINS1, LIPE-AS1, LIPT1, LIX1L, LMAN2L, LMBR1, LMBR1L, LMLN, LMO7, LMTK3, LOC100128885, LOC100130027, LOC100130691, LOC100130987, LOC100133091, LOC100133315, LOC100134868, LOC100233156, LOC100287944, LOC100288637, LOC100288778, LOC100288798, LOC100420587, LOC100505938, LOC100506023, LOC100506207, LOC100506282, LOC100507291, LOC100507377, LOC100507412, LOC100630923, LOC100996724, LOC101060091, LOC101448202, LOC101927027, LOC101927043, LOC101927056, LOC101927151, LOC101927827, LOC101928100, LOC101928323, LOC101928605, LOC101928673, LOC101929066, LOC101929140, LOC101929147, LOC101929231, LOC101929710, LOC101930071, LOC102606465, LOC103091866, LOC107984035, LOC107984974, LOCI 10117498-PIK3R3, LOC148413, LOC150776, LOC283788, LOC339862, LOC389831, LOC389906, LOC399815, LOC400464, LOC400927, LOC400927-CSNK1E, LOC441242, LOC441601, LOC642846, LOC642852, LOC645166, LOC645513, LOC654342, LOC727751, LOC728613, LOC728730, LOC729218, LOC729732, LONRF1, LOXL2, LOXL3, LPAR1, LPAR2, LPCAT4, LPIN1, LPP, LPXN, LRBA, LRCH3, LRCH4, LRIF1, LRMDA, LRMP, LRP5, LRP8, LRPPRC, LRR1, LRRC17, LRRC28, LRRC37B, LRRC42, LRRC4B, LRRC69, LRRC73, LRRC75A-AS1, LRRC8B, LRRC8D, LRRFIP1, LRRFIP2, LRRN3, LRTOMT, LSM1, LSM12, LSM14A, LSM14B, LSR, LTA4H, LTBP3, LTBP4, LUC7L3, LY96, LYPD6B, LYPLA1, LYPLAL1, LYRM1, LYRM4-AS1, LYSMD1, LYSMD4, LYST, LZIC, MACF1, MACROD1, MAD1L1, MADD, MAFG, MAGEA2, MAGEA2B, MAGI1, MAGI2-AS3, MAGI3, MAGOHB, MAGT1, MAIP1, MALSU1, MALT1, MAML3, MAN1A2, MAN1C1, MAN2B2, MANBA, MANBAL, MAP2, MAP2K4, MAP2K5, MAP3K10, MAP3K20, MAP3K21, MAP3K7, MAP3K8, MAP4, MAP4K2, MAP4K3, MAP4K4, MAP6, MAP7D1, MAPK12, MAPK14, MAPK3, MAPK7, MAPK8, MAPK8IP3, MAPK9, MAPKAP1, MAPKAPK5, MAPKAPK5-AS1, MAPT, MARC1, MARCH7, MARCH8, MARK1, MARK2, MARK3, MAST1, MAST2, MAST3, MAST4, MAX, MAZ, MBD1, MBD5, MBIP, MBNL1, MBNL2, MBNL3, MBOAT1,
MB0AT2, MB0AT7, MBTD1, MCAT, MCF2L, MCM3AP, MCM3AP-AS1, MCM8, MCM9, MCMBP, MC0LN1, MCPH1, MCPH1-AS1, MCRIP2, MCRS1, MCTP1, MCU, MDM2, MDM4, MDN1, MDP1, MEI, MEAF6, MECOM, MECP2, MECR, MED12L, MED13L, MED15, MED23, MED24, MED27, MED31, MEF2A, MEF2B, MEF2C, MEF2C-AS1, MEG8, MEGF8, MEI1, MEIS3, MELK, MELTF, MEN1, MET, METAP1, METAP1D, METRN, METTL13, METTL14, METTL21A, METTL23, METTL26, METTL2A, METTL4, METTL6, MEX3B, MFF, MFGE8, MFHAS1, MFN2, MFSD14B, MFSD6, MFSD8, MGA, MGAT1, MGAT3, MGAT4C, MGME1, MIA2, MIA3, MIATNB, MICAL1, MICAL2, MICAL3, MICALL1, MIDI, MIF4GD, MINDY3, MINDY4, MINOS1, MIOS, MIPEP, MIPEPP3, MIPOL1, MIR100HG, MIR1268A, MIR22HG, MIR4435-2HG, MIR548G, MIR548H3, M1R548H4, M1R548N, MIR570HG, MIR646HG, M1R9-3HG, MIR924HG, MIR99AHG, MITD1, MITF, MKI67, MKKS, MKL1, MKL2, MKLN1, MKNK1, MKRN2, MLLT1, MLLT10, MMAB, MMP16, MMP24-AS 1 -EDEM2, MMP25-AS1, MMS19, MMS22L, MOB1B, MOCS1, MOCS2, M0N2, MORC2, MORN1, MOSMO, MOSPD1, MOVIO, MPDZ, MPHOSPH8, MPHOSPH9, MPI, MPP2, MPP3, MPP4, MPP5, MPPE1, MPPED2, MPRIP, MPST, MPZL1, MR1, MRAS, MRC2, MRE11, MREG, MRNIP, MROH1, MRPL22, MRPL43, MRPL48, MRPL52, MRPS10, MRPS30-DT, MRRF, MRS2, MRVI1, MSANTD2, MSC-AS1, MSH3, MSL3, MSRA, MTA1, MT A3, MTCH2, MTCL1, MTCP1, MTDH, MTERF2, MTERF4, MTF2, MTFR1, MTHFD2L, MTHFSD, MTIF2, MTIF3, MTMR12, MTMR14, MTMR2, MTMR3, MTO1, MTOR, MTR, MTREX, MTRNR2L2, MTRR, MTSS1L, MTX1, MTX3, MUM1, MVB12B, MVD, MVK, MXRA7, MYCBP2, MYEF2, MYH10, MYHAS, MYL6B, MYLK, MYLK-AS1, MYNN, MYOIO, MYO18A, MYO1B, MYO1C, MYOID, MYO1E, MYO5A, MYO5B, MYO9A, MYO9B, MY0M2, MYT1, N4BP2, N4BP2L1, N4BP2L2, N6AMT1, NAA25, NAAA, NAALAD2, NAB1, NABP1, NADK, NADSYN1, NAGK, NAGPA, NAP1L1, NAP1L4, NAPG, NARF, NARFL, NARS2, NAT6, NAV2, NAXD, NBDY, NBEA, NBEAL1, NBEAL2, NBPF1, NBPF10, NBPF12, NBPF15, NBPF19, NBPF20, NBPF25P, NBPF26, NBPF3, NBPF8, NBPF9, NCALD, NCAM1, NCK2, NCKAP1, NCKAP5, NCOR1, NCOR2, NDC1, NDEL1, NDRG2, NDRG3, NDRG4, NDUFAF1, NDUFAF2, NDUFAF5, NDUFAF6, NDUFAF7, NDUFAF8, NDUFC1, NDUFC2-KCTD14, NDUFS1, NEBL, NEC AB 3, NEDD1, NEDD4, NEDD4L, NEDD9, NEIL2, NEK1, NEK4, NEK7,
NELFA, NEMF, NE01, NEPRO, NETO2, NF1, NFASC, NFAT5, NFATC2, NFATC3, NFIB.
NFIC, NFRKB, NFX1, NFYC, NGLY1, NHLRC3, NIDI, NIF3L1, NIN, NINE, NIPA1, NISCH, NITI, NKAPD1, NKIRAS1, NKIRAS2, NKTR, NLE1, NLGN1, NLK, NLRC3, NLRC5, NME6, NME7, NMNAT1, NMRAL1, NMRK1, NNT, NNT-AS1, NOC2L, NOCT, NOLIO, NOL4, NOL4L, NOL8, N0M02, NOP16, NOP58, NOTCH2NL, NOTCH3, N0X5, NPAS2, NPFFR2, NPHP4, NPIPA1, NPIPB5, NPLOC4, NPM1, NPNT, NPRL2, NPRL3, NQO2, NR1D2, NR1H3, NR2C2, NR6A1, NRCAM, NRDC, NREP, NRF1, NRG1, NRG2, NRG3, NRG4, NRIP1, NRN1, NRP1, NRSN2, NRXN3, NSD2, NSD3, NSF, NSMAF, NSMCE1, NSMCE2, NSRP1, NSUN2, NSUN3, NSUN4, NSUN6, NT5C, NT5C2, NT5C3A, NT5C3B, NTMT1, NTPCR, NTRK3, NUBPL, NUCB2, NUDT1, NUDT14, NUDT19, NUDT2, NUMA1, NUMB, NUP153, NUP188, NUP214, NUP43, NUP50, NUP85, NUP88, NUP98, NUTF2, NUTM2A-AS1, NUTM2B-AS1, NVL, NXPE3, OARD1, OAZ3, OBSCN, OBSL1, OCA2, OCEL1, OCIAD2, OCRL, ODF2, ODF2L, ODF3B, ODR4, OFD1, OGDH, OGFOD3, OGGI, OLA1, OLFM2, OLMALINC, 0MA1, OPA1, OPCML, OPN3, OPTN, OR2A1-AS1, ORAI3, ORAOV1, ORC3, ORC4, OS9, OSBPL1A, OSBPL6, OSBPL8, OSBPL9, OSGEPL1, OSMR-AS1, OSTF1, OTUD5, 0XNAD1, OXSR1, P2RX7, P3H1, P3H3, P3H4, P4HA1, P4HA2, PAAF1, PABPC4, PACRGL, PAK1, PAK2, PAK3, PAK4, PALB2, PALLD, PALM, PAM, PAN2, PAN3, PANK1, PANK2, PAPD5, PAQR3, PAQR5, PAQR7, PAQR8, PARD3, PARD6G, PARG, PARGP1, PARE, PARP15, PARP4, PARP6, PARP8, PARP9, PARPBP, PARVB, PATJ, PATZ1, PAX5, PAXX, PBRM1, PBX1, PBX3, PC, PCBP1-AS1, PCBP3, PCBP4, PCCA, PCCB, PCDH9, PCGF6, PCID2, PCK2, PCLO, PCM1, PCMTD2, PCNP, PCNT, PCNX1, PCNX2, PCNX3, PCNX4, PCSK6, PCYT1A, PCYT2, PDCD6IPP2, PDE10A, PDE3A, PDE3B, PDE4D, PDE4DIP, PDE7A, PDE8A, PDGFC, PDHX, PDIK1L, PDK1, PDLIM2, PDLIM5, PDPK1, PDPR, PDS5A, PDSS2, PDXDC1, PDXDC2P-NPIPB 14P, PDXK, PDZD11, PDZD2, PDZD8, PDZK1, PEAK1, PELI1, PET100, PEX11B, PEX14, PEX16, PEX19, PEX26, PEX7, PFKFB3, PGAM5, PGAP1, PGAP2, PGLS, PHACTR4, PHC2, PHETA1, PHF12, PHF14, PHF20, PHF20L1, PHF21A, PHF21B, PHF3, PHF8, PHKA2, PHLDB1, PHLDB2, PHLPP2, PHOSPHO2-KLHL23, PHTF1, PHTF2, PHYH, PHYKPL, PI4KA, PI4KB, PIAS1, PIAS2, PIAS3, PIGA, PIGB, PIGL, PIGN, PIGO, PIGQ, PIGX, PIK3C2A, PIK3C3, PIK3CD, PIKFYVE, PIN1, PINX1, PIP4K2B, PIP4K2C, PIP5K1A,
PITPNM3, PKD1, PKD1P1, PKD1P3-NPIPA1, PKD1P4-NPIPA8, PKD1P6-NPIPP1, PKD2, PKIA, PKIB, PKIG, PKN0X2, PKP4, PLA2G6, PLAT, PLCB4, PLD1, PLD3, PLEK2, PLEKHA5, PLEKHA6, PLEKHA7, PLEKHA8, PLEKHG3, PLEKHM1P1, PLEKHM2, PLEKHM3, PLGRKT, PLK3, PL0D1, PLOD2, PLPP4, PLPP5, PLS1, PLXNB1, PLXNB2, PMM1, PMM2, PMS1, PMS2P5, PNISR, PNLDC1, PNPLA6, PNPLA8, PNPO, POC1B, POC5, POFUT2, POGK, POGLUT1, POGZ, POLA1, POLA2, POLB, POLD2, POLDIP3, POLE, POLG, POLG2, POLK, POLL, POLN, POLQ, POLR1A, POLR1B, POLR2F, POLR3B, POLR3G, POLR3GL, POLR3H, POLRMT, P0M121, POM121C, P0MGNT1, POMT1, POMT2, POP4, POP5, POTI, POU2F1, PPAN-P2RY11, PPARA, PPARD, PPARGC1B, PPCS, PPFIA1, PPFIBP1, PPHLN1, PPIL2, PPIL3, PPIP5K2, PPM1H, PPP1CB, PPP1R12A, PPP1R12B, PPP1R13B, PPP1R16A, PPP1R35, PPP1R7, PPP2R2B, PPP2R2C, PPP2R5C, PPP3CB, PPP3CC, PPP4R1, PPP4R2, PPP4R3B, PPP4R4, PPP5D1, PPP6R2, PPP6R3, PQLC1, PQLC3, PRC1, PRDM2, PRDM4, PRDM5, PREB, PRELID2, PREPL, PRH1, PRH1-PRR4, PRH1-TAS2R14, PRICKLEI, PRIM1, PRIM2, PRKAA2, PRKAB2, PRKAG1, PRKAG2, PRKAR2B, PRKCA, PRKCB, PRKCE, PRKCI, PRKCQ, PRKD1, PRKD3, PRKDC, PRKG1, PRKRA, PRKX, PRMT2, PRMT7, PROS1, PROSER2, PROSER3, PRPF38A, PRPF39, PRPF4B, PRPSAP1, PRR12, PRR5, PRR5-ARHGAP8, PRRC2B, PRRC2C, PRRG1, PRRT4, PRTFDC1, PRUNE1, PSD3, PSEN1, PSEN2, PSIP1, PSMA1, PSMA3-AS1, PSMA4, PSMB5, PSMC6, PSME2, PSMG1, PSMG2, PSPH, PSRC1, PSTPIP2, PTAR1, PTBP1, PTBP3, PTCD1, PTDSS2, PTER, PTGER3, PTGES3L, PTGES3L-AARSD1, PTGR2, PTK2, PTPDC1, PTPMT1, PTPN13, PTPN18, PTPN2, PTPN4, PTPRA, PTPRF, PTPRG-AS1, PTPRK, PTPRS, PUF60, PUM1, PUM2, PUS1, PUS10, PUSL1, PVR, PVT1, PXMP2, PXN, PXN-AS1, PYCR1, PYM1, PYROXD2, QKI, QSER1, QTRT2, R3HCC1L, R3HDM1, R3HDM2, R3HDM4, RABI 1FIP3, RABI 1FIP5, RABI 5, RAB23, RAB27A, RAB28, RAB29, RAB30, RAB38, RAB3GAP2, RAB40B, RAB44, RAB5A, RAB5B, RAB6A, RABEP1, RABGAP1, RABGAP1L, RABGEF1, RABGGTB, RABL2A, RABL2B, RABL6, RADI, RAD17, RAD50, RAD51, RAD51AP1, RAD51B, RAD51C, RAD51D, RAD51L3-RFFL, RAD52, RAD54B, RAD54L, RADIL, RAI1, RAI14, RALA, RALGAPA1, RALGAPA1P1, RALGAPA2, RALGDS, RALGPS1, RALGPS2, RALY, RANBP17, RANBP2, RANGAP1, RANGRF, RAP1A, RAP1GAP2, RAP2C-AS1, RAPGEF1, RAPH1, RARS2, RASA1, RASAL2, RASEF,
RASGRP3, RASL10B, RASSF1, RASSF8-AS1, RBAK, RBBP5, RBBP8, RBBP9, RBCK1, RBFOX2, RBM10, RBM11, RBM12B, RBM14-RBM4, RBM15-AS1, RBM18, RBM23, RBM26, RBM33, RBM39, RBM41, RBM42, RBM48, RBM6, RBMS1, RBMS3, RBPJ, RBSN, RC3H1, RC3H2, RCBTB2, RCC1, RCCD1, RCE1, RCOR2, RCOR3, RDM1, RECK, RECQL, RECQL4, RELA, RER1, RERE, RERG, RETREG1, REV1, REV3L, REXO1, REXO5, RFC1, RFC3, RFFL, RFWD3, RFX1, RFX3, RFX8, RGL1, RGPD5, RGPD6, RGS12, RGS5, RHBDD1, RHBDF2, RHOBTB3, RHOC, RHOQ, RHOT1, RHOU, RIC1, RIC8B, RICTOR, RIF1, RILPL1, RILPL2, RIMBP2, RIPPL Y2, RMDN1, RNASE4, RNASEH1-AS1, RNASEK, RNF111, RNF115, RNF121, RNF123, RNF13, RNF130, RNF138, RNF14, RNF152, RNF165, RNF166, RNF167, RNF170, RNF175, RNF185, RNF212, RNF216, RNF216P1, RNF217, RNF219, RNF220, RNF24, RNF4, RNF44, RNF8, RNFT2, RNLS, RNMT, RNPC3, RNU5E-1, ROBO3, ROGDI, ROR2, RORA-AS1, RP9P, RPAP2, RPE, RPGR, RPGRIP1L, RPH3AL, RPL17, RPL17-C18orf32, RPL23AP53, RPL23AP7, RPL23AP82, RPL27A, RPL29, RPL32P3, RPL34-AS1, RPL39, RPL41, RPP25L, RPP30, RPP38, RPP40, RPRD1A, RPRD2, RPS1O- NUDT3, RPS26, RPS27, RPS6KA2, RPS6KA3, RPS6KA6, RPS6KB2, RPS6KC1, RPS6KL1, RPTOR, RPUSD1, RRBP1, RRN3P2, RRNAD1, RSRC2, RSRP1, RTCA, RTEL1, RTEL1- TNFRSF6B, RTKN2, RTN1, RTN2, RTTN, RUFY1, RUNX1T1, RUSC1, RUVBL2, RWDD1, RWDD2B, RWDD3, RWDD4, S100A16, SIOOB, SAAL1, SAMD11, SAMD12, SAMD3, SAMD4A, SAMD4B, SAP25, SAR1A, SAR1B, SARAF, SAT2, SATB1-AS1, SBF1, SBNO1, SCAF11, SCAF8, SCAMP2, SCAMP3, SCAMP4, SCAMP5, SCAP, SCAPER, SCARB1, SCFD1, SCFD2, SCGB1B2P, SCHIP1, SCLT1, SCMH1, SCML2, SCN9A, SCOC, SCRIB, SCRN3, SDC2, SDCBP2-AS1, SDCCAG3, SDCCAG8, SDF2, SDHAF3, SDHAF4, SDHAP1, SDHAP2, SDHC, SDR39U1, SEC11C, SEC 13, SEC14L1, SEC16A, SEC22B, SEC22C, SEC24A, SEC24B, SEC24C, SEC31A, SEH1L, SELENOI, SEMI, SEMA3C, SEMA5A, SENP5, SENP7, SEPT1O, SEPT7P2, SEPT8, SEPT9, SERGEF, SERP2, SERTAD3, SERTAD4-AS1, SETD4, SETD5, SETMAR, SETX, SF1, SFI1, SFMBT1, SFSWAP, SFTA3, SFXN5, SGCE, SGF29, SGK3, SGO1, SGO2, SGSM1, SGSM2, SGSM3, SH3BP2, SH3D19, SH3GLB1, SH3PXD2A, SH3PXD2B, SH3YL1, SHARPIN, SHC1, SHF, SHISA5, SHMT1, SHOX2, SHPK, SHPRH, SHQ1, SHROOM2, SHTN1, SIDT2, SIGIRR, SIK2, SIKE1, SIL1, SIMC1, SIN3A, SIN3B, SINHCAF, SIPA1, SIPA1L1, SIPA1L3, SIRPB1, SIRT3, SIRT6,
SIRT7, SKA1, SKA3, SKP2, SLAIN1, SLAIN2, SLC10A7, SLC12A2, SLC12A9, SLC15A4, SLC16A10, SLC16A7, SLC1A3, SLC22A15, SLC22A17, SLC22A23, SLC24A1, SLC25A1, SLC25A12, SLC25AM, SLC25A15, SLC25A19, SLC25A23, SLC25A25, SLC25A26, SLC25A30, SLC25A32, SLC25A33, SLC25A36, SLC25A37, SLC25A40, SLC25A42, SLC25A44, SLC25A46, SLC25A53, SLC26A10, SLC26A7, SLC29A2, SLC29A4, SLC2A13, SLC2A6, SLC2A8, SLC30A6, SLC35A1, SLC35A3, SLC35B1, SLC35B3, SLC35C2, SLC35D2, SLC35E2B, SLC35E3, SLC35F6, SLC36A1, SLC36A4, SLC37A3, SLC37A4, SLC38A1, SLC38A10, SLC38A9, SLC39A11, SLC39A13, SLC39A4, SLC39A8, SLC3A2, SLC44A2, SLC4A10, SLC4A5, SLC4A7, SLC50A1, SLC5A4-AS1, SLC5A6, SLC6A6, SLC6A9, SLC7A6, SLC8A1-AS1, SLC9A1, SLC9B2, SLC04A1, SLFN11, SLFN12L, SLIT1, SLIT2, SLMAP, SLTM, SLU7, SLX41P, SMAD6, SMAD9, SMAP1, SMARCA1, SMARCA4, SMARCC1, SMARCC2, SMARCD3, SMC1A, SMC4, SMC6, SMCHD1, SMC04, SMG1, SMG1P1, SMG1P2, SMG5, SMG6, SMG7, SMIM19, SMIM20, SMIM8, SMN1, SM0C1, SMOX, SMPD4, SMUG1, SMURF 1, SMURF2P1-LRRC37BP1, SMYD3, SMYD4, SNAI3- AS1, SNAP23, SNAP25, SNAP47, SNAPC4, SNHG14, SNHG15, SNHG17, SNHG20, SNHG21, SNHG5, SNHG6, SNHG8, SNRNP48, SNRPD2, SNRPE, SNRPN, SNTB2, SNUPN, SNX11, SNX13, SNX14, SNX16, SNX24, SNX25, SNX29, SNX5, SNX6, SNX7, SOBP, SOCS6, SOGA3, SOHLH2, SORBS1, SORBS3, SORCS1, SOS1, SOX15, SP110, SP140L, SP2, SPAG6, SPATA13, SPATA18, SPATA33, SPATA5, SPATA5L1, SPATA7, SPATS2, SPATS2L, SPDL1, SPECC1, SPECC1L, SPECC1L-ADORA2A, SPG11, SPG21, SPG7, SPIDR, SPIN1, SPOUT1, SPPL2A, SPPL3, SPRED1, SPRED2, SPRY2, SPRY4-AS1, SPRYD7, SPTAN1, SPTBN1, SPTLC1, SQSTM1, SRBD1, SRC, SRCAP, SREBF1, SREBF2, SREK1, SRGAP1, SRPK1, SRPK2, SRRM1, SRRM2, SRSF12, SRSF2, SRSF5, SRSF7, SSBP2, SSFA2, SSH1, SSH2, STM, ST20, ST20-MTHFS, ST3GAL2, ST3GAL3, ST3GAL4, ST3GAL6, ST5, ST6GAL1, ST6GALNAC3, ST6GALNAC4, ST6GALNAC6, ST7, ST7-OT4, STAC, STAG1, STAG2, STAG3L1, STAM, STARD13, STARD3NL, STARD5, STARD8, STAT2, STAU1, STAU2, STEAP1B, STEAP2, STEAP3, STIL, STIM1, STIM2, STK11IP, STK26, STK3, STK32C, STK33, STK38L, STK39, STK4, STK40, STN1, STON1, STON1- GTF2A1L, STON2, STOX2, STPG1, STRA6, STRADA, STRBP, STRIP1, STRIP2, STRN3, STRN4, STT3A, STX16, STX16-NPEPL1, STX18-AS1, STX2, STX3, STX6, STX8, STXBP3,
STXBP4, STXBP5, STXBP5-AS1, STYX, STYXL1, SUCLG2, SUCLG2-AS1, SUCO, SUGP2, SULT1C4, SUM01, SUN1, SUPT20H, SUPT3H, SUPV3L1, SURF1, SUSD1, SUV39H2, SUZ12, SUZ12P1, SVEP1, SVIL-AS1, SWT1, SYCP2L, SYK, SYNC, SYNCRIP, SYNE2, SYNE4, SYNGR2, SYNJ1, SYNJ2, SYNJ2BP, SYNJ2BP-COX16, SYNRG, SYS1-DBNDD2, SYT1, TACC1, TAFIA, TAF1B, TAF1C, TAF1D, TAF2, TAF3, TAF4, TAF4B, TAF5L, TAF6, TANCI, TANGO6, TAOK2, TAOK3, TAPT1, TARBP1, TARS2, TARSL2, TASP1, TATDN1, TAZ, TBC1D1, TBC1D15, TBC1D16, TBC1D17, TBC1D24, TBC1D2B, TBC1D31, TBC1D32, TBC1D5, TBC1D7, TBC1D7-LOC100130357, TBC1D9B, TBCD, TBCK, TBKBP1, TBL1X, TBRG1, TBX2-AS1, TBXAS1, TCAF1, TCAIM, TCEA2, TCEAL8, TCERG1, TCF12, TCF20, TCF25, TCF3, TCF4, TCF7L2, TCFL5, TCOF1, TCTEX1D2, TCTN1, TDG, TDP1, TDRD3, TDRKH, TEAD1, TEAD2, TECPR1, TEDC1, TEDC2, TENM2, TENM3, TEPSIN, TESK2, TET2, TET2-AS1, TEX264, TEX30, TEX9, TFCP2, TFDP1, TFE3, TGFBR1, TGFBR2, TGFBR3, THADA, THAP1, THAP5, THAP9-AS1, THBS4, THEM6, THOC2, THOC5, THRB, THTPA, THUMPD2, THYN1, TIA1, TIAL1, TIAM1, TIFA, TIMM17B, TIMM23B, TIMM8B, TIMM9, TIMMDC1, TJAP1, TKFC, TLDC1, TLE1, TLE4, TLK1, TLK2, TLL2, TLN1, TM2D1, TM2D3, TM7SF2, TM7SF3, TM9SF3, TMBIM4, TMC6, TMCC1, TMCO3, TMC04, TMC06, TMED3, TMED8, TMEM104, TMEM108, TMEM116, TMEM120B, TMEM126B, TMEM128, TMEM131, TMEM134, TMEM135, TMEM136, TMEM141, TMEM144, TMEM14B, TMEM150B, TMEM161A, TMEM161B, TMEM161B- AS1, TMEM164, TMEM168, TMEM182, TMEM183B, TMEM184B, TMEM185A, TMEM187, TMEM198B, TMEM206, TMEM209, TMEM218, TMEM220, TMEM222, TMEM231, TMEM234, TMEM241, TMEM245, TMEM248, TMEM249, TMEM254, TMEM255A, TMEM260, TMEM267, TMEM268, TMEM38B, TMEM39A, TMEM42, TMEM45A, TMEM51, TMEM56-RWDD3, TMEM62, TMEM63B, TMEM68, TMEM70, TMEM87A, TMEM9B, TM0D2, TMSB15B, TMTC2, TMTC3, TMTC4, TMUB1, TNFAIP1, TNFAIP8, TNFAIP8L2-SCNM1, TNIP3, TNK2, TNKS, TNNT1, TNRC18, TNRC6A, TNRC6C, TOGARAMI, TOLLIP, T0M1L2, TOMM40, TOMM40L, TOP1MT, TOP3B, TOR1AIP2, TOR1B, TOR2A, TOR3A, TP53I11, TP53TG1, TP73, TPCN1, TPD52, TPD52L1, TPD52L2, TPGS2, TPK1, TPM1, TPM2, TPM3P9, TPP2, TPT1-AS1, TPTE2P5, TPTE2P6, TRA2A, TRAF3, TRAF3IP2-AS1, TRAFD1, TRAK1, TRAK2, TRAPPC10, TRAPPCI 1,
TRAPPC12, TRAPPC2, TRAPPC6B, TRAPPC9, TRDMT1, TRERF1, TRIM 16, TRIM16L, TRIM2, TRIM24, TRIM3, TRIM32, TRIM33, TRIM36, TRIM37, TRIM41, TRIM65, TRIO, TRIP12, TRIQK, TRIT1, TRMO, TRMT1, TRMT10B, TRMT2A, TRMT2B, TRNAU1AP, TRNT1, TROVE2, TRPC1, TRPM2, TRPM4, TRPM7, TRRAP, TSC2, TSC22D1, TSFM, TSHZ2, TSNARE1, TSNAX, TSPAN14, TSPAN4, TSPAN5, TSSC2, TSSC4, TSTD2, TTBK2, TTC13, TTC19, TTC21B, TTC23, TTC26, TTC28, TTC28-AS1, TTC3, TTC31, TTC33, TTC38, TTC39C, TTC8, TTC9C, TTI2, TTL, TTLL11, TTLL12, TTLL3, TTLL5, TTLL7, TTN-AS1, TTP AL, TTTY14, TTYH2, TUBD1, TUBE1, TUBG2, TUBGCP3, TUBGCP4, TUFT1, TUG1, TULP4, TVP23C, TVP23C-CDRT4, TWF1, TWIST2, TWNK, TXLNGY, TXNDC11, TXNDC16, TXNIP, TXNL4A, TXNL4B, TXNRD1, TXNRD3, TXNRD3NB, TYK2, TYMP, TYSND1, TYW1B, U2AF2, U2SURP, UAP1, UBA2, UBA3, UBA6-AS1, UBAC2, UBAP1, UBAP2, UBAP2L, UBC, UBE2D3, UBE2D4, UBE2E3, UBE2F, UBE2G1, UBE2G2, UBE2Q2, UBE2Q2P2, UBE2R2, UBE2W, UBE2Z, UBE3A, UBE3B, UBE3C, UBE3D, UBE4B, UBL7, UBL7-AS1, UBN1, UBOX5, UBP1, UBQLN4, UBR2, UBR3, UBR4, UBR5, UBTF, UBXN11, UBXN2A, UBXN2B, UBXN8, UCHL5, UEVLD, UFM1, UGCG, UGGT2, UHRF1BP1, UHRF1BP1L, UHRF2, UIMC1, ULK3, ULK4, ULK4P1, ULK4P2, UMAD1, UNC13B, UNC45A, UNK, UNKL, UPF2, UPF3A, UQCC1, UQCC2, URGCP, URGCP-MRPS24, URI1, USF2, USP10, USP12, USP13, USP15, USP16, USP19, USP2-AS1, USP21, USP24, USP25, USP28, USP3, USP30, USP31, USP32, USP33, USP34, USP4, USP42, USP45, USP47, USP48, USP49, USP53, USP54, USP6NL, USP8, USP9X, UTP4, UTRN, UTS2R, UTY, UVRAG, VAC14, VAMP4, VAMP5, VANGL1, VAPB, VASH1, VASH1-AS1, VAV2, VCL, VEGFA, VEZF1, VEZT, VGLL4, VHL, VIPAS39, VKORC1, VKORC1L1, VLDLR-AS1, VPS13B, VPS13C, VPS13D, VPS26B, VPS29, VPS36, VPS41, VPS4B, VPS53, VPS54, VPS8, VRK3, VTI1B, WAC, WAPL, WARS, WASF1, WASF3, WASH3P, WASHC2A, WASHC2C, WASHC3, WASHC5, WDFY2, WDFY3, WDFY4, WDR20, WDR24, WDR27, WDR35, WDR37, WDR4, WDR41, WDR45, WDR48, WDR59, WDR62, WDR89, WDR90, WDSUB1, WDTC1, WDYHV1, WIPF1, WIPI2, WIZ, WLS, WNK1, WNK2, WRAP73, WRN, WSB1, WWOX, WWP1, WWP2, XIST, XK, XKR6, XPA, XPNPEP1, XPO1, XPO4, XPR1, XRCC1, XRCC2, XRN1, XRRA1, XXYLT1, YAF2, YAP1, YARS2, YEATS4, YES1, YIF1A, YIPF1, YIPF2, YIPF6, YJEFN3, YTHDC2, YTHDF2,
YTHDF3, YWHAZ, ZASP, ZBED3, ZBED3-AS1, ZBED6, ZBED8, ZBTB18, ZBTB20, ZBTB21, ZBTB24, ZBTB25, ZBTB38, ZBTB47, ZBTB5, ZBTB7B, ZBTB8A, ZBTB80S, ZC2HC1A, ZC3H11A, ZC3H13, ZC3H14, ZC3H18, ZC3H3, ZC3H4, ZC3H7A, ZC3H8, ZC3HC1, ZCCHC10, ZCCHC11, ZCCHC4, ZCCHC7, ZCCHC9, ZDBF2, ZDHHC13, ZDHHC16, ZDHHC17, ZDHHC2, ZDHHC20, ZDHHC21, ZDHHC3, ZDHHC4, ZDHHC6, ZDHHC8, ZEB1, ZEB2, ZFAND3, ZFAND4, ZFAND5, ZFAND6, ZFAT, ZFP1, ZFP14, ZFP69B, ZFPM2-AS1, ZFY, ZFYVE16, ZFYVE19, ZFYVE21, ZFYVE27, ZFYVE9, ZHX3, ZKSCAN3, ZKSCAN5, ZMAT5, ZMIZ2, ZMYM2, ZMYM4, ZMYM5, ZMYM6, ZMYND19, ZNF1O, ZNF106, ZNF131, ZNF134, ZNF138, ZNF141, ZNF146, ZNF148, ZNF177, ZNF18O, ZNF189, ZNF195, ZNF197, ZNF202, ZNF207, ZNF212, ZNF227, ZNF23, ZNF232, ZNF236, ZNF236-DT, ZNF239, ZNF252P, ZNF254, ZNF263, ZNF266, ZNF268, ZNF273, ZNF276, ZNF292, ZNF3, ZNF302, ZNF317, ZNF337-AS1, ZNF33A, ZNF343, ZNF345, ZNF346, ZNF35, ZNF354A, ZNF354B, ZNF365, ZNF37A, ZNF37BP, ZNF383, ZNF384, ZNF385D, ZNF391, ZNF394, ZNF395, ZNF397, ZNF407, ZNF419, ZNF420, ZNF423, ZNF426, ZNF429, ZNF43, ZNF430, ZNF431, ZNF433-AS1, ZNF438, ZNF45, ZNF451, ZNF461, ZNF462, ZNF480, ZNF496, ZNF51O, ZNF512, ZNF516, ZNF518A, ZNF518B, ZNF528, ZNF529, ZNF532, ZNF542P, ZNF548, ZNF554, ZNF558, ZNF559-ZNF177, ZNF56, ZNF561, ZNF561- AS1, ZNF566, ZNF568, ZNF569, ZNF58O, ZNF583, ZNF584, ZNF585B, ZNF589, ZNF592, ZNF598, ZNF608, ZNF613, ZNF615, ZNF616, ZNF618, ZNF623, ZNF626, ZNF638, ZNF639, ZNF644, ZNF652, ZNF670, ZNF680, ZNF682, ZNF687, ZNF69, ZNF691, ZNF696, ZNF702P, ZNF706, ZNF707, ZNF708, ZNF71, ZNF711, ZNF714, ZNF718, ZNF720, ZNF721, ZNF74, ZNF740, ZNF75A, ZNF761, ZNF765-ZNF761, ZNF775, ZNF778, ZNF786, ZNF790-AS1, ZNF8O8, ZNF81, ZNF813, ZNF815P, ZNF816, ZNF821, ZNF83, ZNF85, ZNF853, ZNHIT6, ZNRF1, ZNRF3, ZRANB1, ZRANB2-AS2, ZRANB3, ZSCAN29, ZSCAN5A, ZSCAN9, ZSWIM7, ZUP1, ZXDC, ZYGI 1A, ZYGI IB, ZZZ3
[00520] RNAseq experiments showed that compounds of Formula (I) induced exon skipping with a APSI of -10% to -100% and P-value <0.001 in 7305 genes as shown in Table 12: [00521] Table 12
[00522] A1BG-AS1, AAAS, AACS, AADAT, AAED1, AAGAB, AAK1, AAMDC, AARS,
AARS2, AARSD1, AASDH, AASS, ABCA1, ABCA11P, ABCA3, ABCA5, ABCA7, ABCB1,
ABCB10, ABCB6, ABCB7, ABCB8, ABCB9, ABCC1, ABCC3, ABCC4, ABCC5, ABCD2, ABCD3, ABCD4, ABCE1, ABCF2, ABCF3, ABHD12, ABHD14A-ACY1, ABHD18, ABHD2, ABHD3, ABHD6, ABI1, ABI2, ABI3BP, ABL1, ABL2, ABLIM1, ABR, ABRAXAS1, ABRAXAS2, ACAA1, AC AC A, ACACB, ACAD 10, ACAD8, ACAD9, AC ADM, AC ADS, ACADYL, ACAP2, ACAP3, ACAT1, ACBD3, ACBD5, ACBD6, ACCS, ACD, ACER3, ACLY, ACO1, ACO2, ACOT11, ACOT2, ACOT8, ACOT9, ACOX1, ACOX3, ACPI, ACSF2, ACSF3, ACSL1, ACSL3, ACSL4, ACSS2, ACSS3, ACTL6B, ACTN1, ACTN4, ACTR10, ACTR1A, ACTR1B, ACTR3, ACTR3B, ACTR3C, ACTR6, ACTR8, ACVR1, ACVR1B, ACVR2A, ACVRL1, ACY1, ACYP1, ACYP2, ADA, AD AL, ADAM 10, ADAMI 1, ADAM 17, ADAM22, ADAM23, ADAM9, ADAMTS12, ADAMTS14, ADAMTS17, ADAMTS19, ADAMTS2, ADAMTS4, ADAMTS6, ADAMTS7, ADAMTS9, ADAMTSL1, ADAMTSL4, ADAMTSL5, AD API, ADAP2, ADAR, AD ARBI, ADAT1, ADAT2, ADCK2, ADCY1, ADCY3, ADCY6, ADCY7, ADCYAP1R1, ADD1, ADD3, ADGRA2, ADGRA3, ADGRB1, ADGRB2, ADGRE2, ADGRE5, ADGRG2, ADGRG5, ADGRL1, ADGRL2, ADGRL3, ADGRV1, ADIPOR2, ADK, ADM5, ADNP, ADPGK, ADPRH, ADRM1, ADSL, AFAP1, AFAP1L1, AFDN, AFF1, AFF3, AFG1L, AFG3L1P, AFG3L2, AFMID, AGA, AGAP1, AGAP3, AGAP6, AGAP9, AGBL3, AGBL4, AGFG2, AGGF1, AGK, AGL, AGO2, AGO3, AGO4, AGPAT3, AGPAT4, AGPAT5, AGPS, AGRN, AGTPBP1, AGTR1, AGTRAP, AHCTF1, AHCYL2, AHI1, AHNAK, AHRR, AHSA2P, AIDA, AIFM1, AIFM2, AIG1, AIMP1, AIP, AK4, AK8, AK9, AKAP1, AKAP10, AKAP11, AKAP12, AKAP13, AKAP2, AKAP7, AKAP8, AKAP9, AKIP1, AKR1A1, AKR1E2, AKR7A2, AKT1, AKT1S1, AKT2, AKT3, AKTIP, ALAD, ALAS1, ALCAM, ALDH16A1, ALDH1L2, ALDH2, ALDH3A2, ALDH3B1, ALDH4A1, ALDH5A1, ALDH7A1, ALDOA, ALDOC, ALG1, ALG11, ALG13, ALG1L, ALG2, ALG3, ALG5, ALG8, ALG9, ALK, ALKAL2, ALKBH1, ALKBH2, ALKBH3, ALKBH5, ALKBH6, ALKBH8, ALLC, ALMS1, ALOX12-AS1, ALPK1, ALPK2, ALS2, AMACR, AMBRA1, AMDHD2, AMHR2, AMMECR1, AMMECR1L, AMN1, AMOT, AMOTL1, AMPD2, AMPH, AMT, AMZ2, AMZ2P1, ANAPC1, ANAPC10, ANAPC4, ANAPC7, ANGEL 1, ANGEL2, ANGPT1, ANK2, ANK3, ANKEF1, ANKH, ANKHD1, ANKHD1-EIF4EBP3, ANKIB1, ANKLE2, ANKMY1, ANKMY2, ANKRA2, ANKRD10, ANKRD11, ANKRD12, ANKRD13A, ANKRD13C, ANKRD13D, ANKRD17, ANKRD26,
ANKRD27, ANKRD28, ANKRD33B, ANKRD36, ANKRD37, ANKRD39, ANKRD44, ANKRD45, ANKRD46, ANKRD54, ANKRD6, ANKS1A, ANKS3, ANKS6, ANKZF1, ANLN, ANO 10, ANO4, ANO5, ANO6, ANP32A, ANXA2, ANXA4, ANXA6, ANXA7, AO AH, AOX1, AP I AR, AP1B1, AP1G1, AP1M1, AP1S2, AP1S3, AP2A1, AP2A2, AP2M1, AP3B1, AP3B2, AP3M1, AP3M2, AP3S1, AP3S2, AP4B1, AP4M1, AP5M1, APAF I, APB Al, APBA2, APBA3, APBB2, APC, APCDD1L-AS1, APEH, APEX2, APH1B, API5, APIP, APLP1, APLP2, APOBEC3D, APOBEC3F, APOL1, APOL3, APOLD1, APOO, APOOL, APOPT1, APP, APPBP2, APPL1, APPL2, APTR, APTX, AQR, ARAP1, ARAP2, ARCN1, AREL1, ARFGAP1, ARFGAP2, ARFGAP3, ARFGEF1, ARFGEF2, ARFIP1, ARFRP1, ARHGAP1, ARHGAP11A, ARHGAP12, ARHGAP17, ARHGAP19, ARHGAP19-SLIT1, ARHGAP21, ARHGAP22, ARHGAP23, ARHGAP24, ARHGAP26, ARHGAP27P1, ARHGAP27P1- BPTFP1-KPNA2P3, ARHGAP28, ARHGAP29, ARHGAP30, ARHGAP31, ARHGAP32, ARHGAP33, ARHGAP36, ARHGAP39, ARHGAP42, ARHGAP45, ARHGAP5, ARHGAP8, ARHGDIA, ARHGEF1, ARHGEF10, ARHGEF10L, ARHGEF11, ARHGEF12, ARHGEF18, ARHGEF2, ARHGEF25, ARHGEF28, ARHGEF3, ARHGEF39, ARHGEF4, ARHGEF40, ARHGEF6, ARHGEF7, ARHGEF9, ARID IB, ARID2, ARID4A, ARID4B, ARID5A, ARID5B, ARIH1, ARIH2, ARL13B, ARL15, ARL17A, ARL17B, ARL2, ARL2-SNX15, ARL3, ARL5B, ARL6, ARL6IP6, ARL8A, ARMCI, ARMC10, ARMC2, ARMC4, ARMC4P1, ARMC6, ARMC8, ARMC9, ARMCX1, ARMCX2, ARMCX3, ARMCX5, ARMCX5-GPRASP2, ARMH1, ARMH3, ARMT1, ARNT, ARNT2, ARNTL, ARNTL2, ARPC3, ARPC5L, ARRB1, ARRB2, ARRDC1, ARRDC2, ARRDC3, ARSB, ARSD, ARSJ, ARSK, ARV1, ARVCF, AS3MT, ASAH2B, ASAP1, ASAP2, ASAP3, ASB1, ASB13, ASB16-AS1, ASB3, ASCC1, ASCC2, ASCC3, ASDURF, ASH1L, ASH2L, ASIC1, ASIC3, ASL, ASNS, ASNSD1, ASPDH, ASPH, ASPM, ASPSCR1, ASTN2, ASXL1, ATAD1, ATAD2, ATAD2B, ATAD3A, ATAD3B, ATAD5, ATCAY, ATE1, ATE1-AS1, ATF2, ATF6, ATF7, ATF7IP2, ATG10, ATG13, ATG16L1, ATG16L2, ATG2B, ATG3, ATG4A, ATG4B, ATG4C, ATG4D, ATG5, ATG7, ATG9A, ATL2, ATL3, ATM, ATN1, ATOX1, ATP10D, ATP11A, ATP11B, ATP11C, ATP13A2, ATP13A3, ATP1A1-AS1, ATP1B3, ATP23, ATP2A3, ATP2B1, ATP2B4, ATP2C1, ATP5F1C, ATP5ME, ATP5MF, ATP5MF-PTCD1, ATP5PB, ATP5PD, ATP5PF, ATP5PO, ATP5S, ATP6AP1L, ATP6V0A1, ATP6V0A2, ATP6V0C, ATP6V0D1, ATP6V0E1,
ATP6V1A, ATP6V1D, ATP6V1E1, ATP6V1H, ATP7A, ATP7B, ATP8B4, ATP9A, ATP9B, ATPAF1, ATPAF2, ATR, ATRIP, ATRN, ATRNL1, ATRX, ATXN1, ATXN10, ATXN2, ATXN2L, ATXN3, ATXN7, ATXN7L1, ATXN7L2, ATXN7L3, A UH, AUP1, AURKA, AURKB, AUTS2, AVEN, AVIN, AXIN1, AZI2, AZINI, AZIN1-AS1, AZIN2, B2M, B3GALNT1, B3GALNT2, B3GLCT, B3GNTL1, B4GALNT4, B4GALT4, B4GALT5, B4GALT6, B9D1, B9D2, BABAM1, BABAM2, BACE1, BACH1, BACH2, BAG4, BAIAP2, BAIAP2L1, BANP, BAP1, BARD1, BARX2, BAX, BAZ1A, BAZ1B, BAZ2A, BAZ2B, BBC3, BBOF1, BBOX1-AS1, BBS4, BBS5, BBS9, BBX, BCAR1, BCAR3, BCAS3, BCAS4, BCAT1, BCAT2, BCCIP, BCHE, BCKDHB, BCL11A, BCL2L1, BCL2L11, BCL2L12, BCL2L13, BCL2L2-PABPN1, BCL7A, BCL7B, BCL7C, BCL9, BCL9L, BCLAF1, BCLAF3, BCOR, BCORL1, BCRP2, BCS1L, BDH1, BDH2, BDNF-AS, BDP1, BEAN1, BECN1, BEGAIN, BEND5, BEND6, BEND7, BEX4, BFAR, BFSP1, BICC1, BICD1, BICDL1, BICRA, BICRAL, BID, BINI, BIN3, BIRC2, BIRC5, BIRC6, BISPR, BIVM, BIVM-ERCC5, BLM, BLMH, BLNK, BLOC1S5, BLOC1S5-TXNDC5, BLOC1S6, BLVRA, BLZF1, BMP2K, BMP7, BMPR1B, BMPR2, BMS1P14, BMS1P20, BNC2, BNIP1, BOC, BOD1, BOD1L1, BOK, BOLA1, BOLA2-SMG1P6, BOLA3, BOP1, BORA, BORCS8, BORCS8-MEF2B, BPNT1, BPTF, BRAP, BRAT1, BRCA1, BRCA2, BRCC3, BRD1, BRD7, BRD8, BRF1, BRF2, BRINP3, BRFP1, B RMS IL, BROX, BRPF1, BRPF3, BRSK2, BRWD1, BRWD3, BSCL2, BSDC1, BSPRY, BTAF1, BTBDI9, BTBD3, BTBD7, BTBD9, BTF3L4, BTG3, BTN3A2, BTNL9, BTRC, BUB1, BUD23, BVES-AS1, BZW2, C10orfl43, Cllorf24, Cl lorf49, Cllorf54, Cllorf65, Cl lorf74, CllorfBO, C12orfl0, C12orf4, C12orf49, C12orf73, C12orf75, C12orf76, C14orf39, C14orf93, C15orf38-AP3S2, C15orf40, C15orf41, C16orf45, C16orf46, C16orf58, C16orf87, C17orf49, C17orf75, C18orf21, C18orf54, C19orfl2, C19orf24, C19orf25, C19orf44, C19orf47, C19orf48, C19orf57, CID, C1QTNF2, C1QTNF3-AMACR, C1QTNF6, Clorfll2, Clorfl23, Clorfl31, Clorfl59, Clorf35, Clorf43, Clorf50, Clorf52, Clorf54, C20orfl94, C20orf27, C20orf96, C21orf33, C21orf59-TCP10L, C21orf91, C2CD2L, C2CD3, C2CD5, C2orfl5, C2orf27A, C2orf48, C2orf74, C2orf76, C3orfl8, C3orfi3, C3orf52, C3orf62, C3orf67, C4orf33, C5, C5AR1, C5orf22, C5orfi0, C5orf42, C5orf51, C5orf63, C6orfl06, C6orf89, C6orf99, C7orf26, C7orfil, C7orf55-LUC7L2, C8orf31, C8orf44, C8orf44-SGK3, C8orf58, C8orf59, C8orf88, C9orf3, C9orf78, C9orf85, CAM, CA5B, CA5BP1, CAAP1,
CAB39L, CABIN1, CABYR, CACFD1, CACNA1A, CACNA1C, CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, CACNB1, CACNB3, CACNB4, CACNG7, CAD, CADM4, CADPS2, CALC0C01, CALCRL, CALD1, CALHM I , CALML4, CALU, CAMK1, CAMKID, CAMK2A, CAMK2D, CAMK2G, CAMK4, CAMKK1, CAMKK2, CAMKMT, CAMLG, CAMSAP1, CAMSAP2, CAMSAP3, CAMTAI, CAMTA2, CANT1, CAP2, CAPN1, CAPN10, CAPN15, CAPN7, CAPRIN2, CAPS2, CARD11, CARD19, CARD6, CARD8, CARF, CARMI, CARMIL2, CARNS1, CARS, CARS2, CASC3, CASC4, CASD1, CASK, CASKIN1, CASP1, CASP2, CASP3, CASP7, CASP8, CASP8AP2, CASP9, CAST, CASTOR3, CATSPER1, CATSPER3, CATSPERZ, CBFA2T3, CBFB, CBL, CBLB, CBR4, CBS, CBWD1, CBWD2, CBWD3, CBX4, CBY1, CCAR1, CCAR2, CCDC102B, CCDC106, CCDC112, CCDC125, CCDC126, CCDC127, CCDC130, CCDC134, CCDC138, CCDC14, CCDC144NL-AS1, CCDC149, CCDC152, CCDC159, CCDC163, CCDC169, CCDC169-SOHLH2, CCDC171, CCDC18, CCDC18-AS1, CCDC181, CCDC186, CCDC188, CCDC189, CCDC191, CCDC192, CCDC25, CCDC26, CCDC32, CCDC36, CCDC40, CCDC43, CCDC57, CCDC58, CCDC61, CCDC66, CCDC7, CCDC77, CCDC78, CCDC82, CCDC85A, CCDC85C, CCDC88A, CCDC88C, CCDC9, CCDC90B, CCDC91, CCDC92, CCDC93, CCL4L1, CCL4L2, CCM2, CCNB1, CCNC, CCND3, CCNDBP1, CCNE2, CCNF, CCNI, CCNJ, CCNJL, CCNK, CCNL1, CCNL2, CCNT1, CCNT2, CCNY, CCNYL1, CCNYL2, CCP110, CCR6, CCSER1, CCSER2, CCT3, CCT6A, CCT6P1, CCZ1P-OR7E38P, CD151, CD164, CD200, CD22, CD226, CD24, CD244, CD320, CD33, CD36, CD40, CD44, CD46, CD47, CD53, CD55, CD58, CD59, CD68, CD70, CD8B, CD99L2, CDADC1, CDC123, CDC14A, CDC14B, CDC16, CDC23, CDC25A, CDC25B, CDC25C, CDC27, CDC40, CDC42, CDC42BPA, CDC42BPB, CDC42SE1, CDC42SE2, CDC45, CDC5L, CDC6, CDC7, CDCA3, CDCA7, CDCA7L, CDIPT, CDK10, CDK11A, CDK11B, CDK14, CDK15, CDK16, CDK19, CDK2, CDK20, CDK2AP1, CDK5RAP1, CDK5RAP2, CDK6, CDK7, CDK8, CDKAL1, CDKL3, CDKN2B-AS1, CDKN3, CDO1, CDON, CDPF1, CDR2, CDS1, CDV3, CDYL, CEACAM1, CEACAM21, CEBPZ, CECR2, CELF1, CELF2, CELSR2, CELSR3, CENPA, CENPC, CENPE, CENPH, CENPI, CENPK, CENPM, CENPN, CENPO, CENPP, CENPQ, CENPS, CENPS-CORT, CENPT, CENPU, CENPV, CENPX, CEP104, CEP112, CEP126, CEP128, CEP131, CEP135, CEP164, CEP170, CEP192, CEP290, CEP295, CEP350, CEP41, CEP44, CEP55, CEP57, CEP57L1,
CEP63, CEP68, CEP70, CEP72, CEP76, CEP78, CEP83, CEP85, CEP89, CEP95, CEP97, CEPT1, CERS4, CERS5, CERS6, CES2, CES3, CES4A, CFAP206, CFAP298, CFAP299, CFAP300, CFAP36, CFAP44, CFAP58, CFLAR, CGAS, CGGBP1, CGRRF1, CHAC2, CHAF1A, CHAF1B, CHCHD5, CHCHD6, CHD1L, CHD2, CHD3, CHD4, CHD6, CHD8, CHD9, CHEK1, CHEK2, CHFR, CHI3L1, CHID1, CHKA, CHM, CHMP1A, CHMP3, CHMP7, CHN1, CHN2, CHORDCI, CHP1, CHPF2, CHRAC1, CHRNA5, CHRNB4, CHST10, CHSY1, CHTOP, CHURC1, CHURC1-FNTB, CIAO1, CIAPIN1, CIB2, CILP2, CINP, CIP2A, CIPC, CIR1, CIT, CIZ1, CKAP2L, CKAP5, CKLF, CKLF-CMTM1, CKMT1A, CLASP1, CLASP2, CLASRP, CLBA1, CLCC1, CLCN2, CLCN3, CLCN5, CLCN6, CLDN12, CLDND1, CLEC16A, CLEC2D, CLEC4A, CLEC5A, CLEC7A, CLGN, CLHC1, CLINT 1, CLIP1, CLIP2, CLIP3, CL1P4, CLK1, CLK2, CLK3, CLK4, CLMP, CLN3, CLN6, CLNS1A, CLOCK, CLPB, CLSPN, CLSTN1, CLSTN3, CLTA, CLUAP1, CLUHP3, CMAS, CMC1, CMC2, CMC4, CMIP, CMKLR1, CMSS1, CMTM1, CMTM3, CMTM7, CMTR1, CMTR2, CNIH1, CNIH3, CNIH4, CNKSR2, CNNM1, CNNM2, CNNM3, CNOT1, CNOTIO, CNOT11, CNOT2, CNOT4, CNOT6, CNOT8, CNOT9, CNPY3, CNPY3-GNMT, CNPY4, CNTFR, CNTLN, CNTN1, CNTN4, CNTNAP1, CNTNAP3, CNTRL, COA1, COASY, COBL, COBLL1, COG1, COG2, COG4, COG5, COG6, COIL, COL13A1, COL1A2-AS1, COL23A1, COL24A1, COL25A1, COL26A1, COL27A1, COL4A1, COL4A3BP, COL4A5, COL4A6, COL6A2, COL9A3, COLECI 1, COLQ, C0MMD1, C0MMD3-BMII, C0MMD4, C0MMD6, C0MMD9, COP1, COP A, COPG1, COPRS, COPS3, COPS7A, COPS7B, COPS8, COPZ2, COQIOB, COQ2, COQ3, COQ4, COQ5, COQ6, COQ7, COQ8A, COQ8B, COQ9, CORO1B, COROIC, CORO7, CORO7-PAM16, COXIO, COX10-AS1, COX15, COX20, CPB2, CPEB1, CPEB2, CPEB3, CPEB4, CPNE1, CPNE2, CPNE3, CPNE5, CPOX, CPPED1, CPQ, CPS1, CPSF2, CPSF4, CPSF7, CPT1A, CPT1C, CPT2, CPVL, CPXM1, CRACR2A, CRAMP1, CRAT, CRB1, CRBN, CRCP, CREB1, CREB3L4, CREB5, CREBBP, CREBRF, CRELD1, CRELD2, CREM, CRIM1, CRIP2, CRLS1, CRMP1, CRNDE, CROCCP2, CRTC1, CRTC3, CRYBB2P1, CRYBG3, CRYL1, CRYZ, CRYZL1, CRYZL2P, CRYZL2P-SEC16B, CS, CSAD, CSDE1, CSE1L, CSGALNACT2, CSMD2, CSNK1D, CSNK1G1, CSNK1G3, CSNK2A1, CSNK2A2, CSPP1, CSRNP2, CSRNP3, CSRP3, CSTF3, CTBP1, CTBP2, CTBS, CTCF, CTDNEP1, CTDP1, CTDSP2, CTDSPL, CTDSPL2, CTIF, CTNNA2, CTNNAL1,
CTNNBIP1, CTNNBL1, CTNND1, CTNS, CTPS2, CTSA, CTSC, CTSF, CTSL, CTTN, CTTNBP2NL, CTU2, CUBN, CUEDC1, CUL1, CUL3, CUL4B, CUL5, CUL7, CUL9, CUTALP, CUTC, CUX1, CUX2, CWC22, CWC25, CWC27, CWF19L1, CWF19L2, CXADR, CXXC1, CXorf38, CXorf65, CYB561, CYB561D2, CYB5D2, CYB5R1, CYB5R2, CYB5R4, CYB5RL, CYBA, CYBC1, CYFIP2, CYP20A1, CYP27B1, CYP27C1, CYP2S1, CYP2U1, CYP39A1, CYP4V2, CYTH1, CYTH3, CZ1P-ASNS, D2HGDH, DAAM1, DAB2, DAB2IP, DAG1, DAGLB, DAP3, DAPK1, DAPK3, DARS, DARS2, DAZAP1, DAZAP2, DBF4, DBF4B, DBH, DBNL, DBR1, DBT, DCAF1, DCAF10, DCAF11, DCAF13, DCAF16, DCAF17, DCAF5, DCAF6, DCAF8, DCBLD1, DCBLD2, DCLK2, DCLRE1C, DCP1A, DCP2, DCPS, DCST1, DCTN1, DCTN2, DCTN4, DCTN5, DCUN1D2, DCUN1D4, DCUN1D5, DCXR, DDAH1, DDB2, DDC, DDHD1, DDHD2, DDIAS, DDN, DDR2, DDT, DDX1, DDX1 1, DDX12P, DDX17, DDX19A, DDX19B, DDX20, DDX27, DDX41, DDX42, DDX46, DDX49, DDX50, DDX52, DDX55, DDX59, DDX60, DEAF1, DECR1, DECR2, DEDD, DEF8, DEK, DELEI, DENND1A, DENND1B, DENND1C, DENND2C, DENND3, DENND4A, DENND4B, DENND4C, DENND5A, DENND5B, DENND6A, DENR, DEPDC1, DEPDC1B, DEPTOR, DERA, DERL1, DESI1, DESI2, DET1, DEXI, DFFB, DGCR2, DGCR6L, DGKA, DGKH, DGKI, DGKQ, DGKZ, DGLUCY, DGUOK, DHDDS, DHFR, DHH, DHODH, DHPS, DHRS12, DHRS4, DHRS4L1, DHRS4L2, DHRS7, DHRS7B, DHTKD1, DHX29, DHX30, DHX32, DHX33, DHX34, DHX35, DHX36, DHX37, DHX38, DHX57, DIABLO, DIAPHI, DIAPH2, DIAPH3, DICER1, DICER1-AS1, DIDOI, DIEXF, DIMT1, DIP2A, DIP2B, DIP2C, DIRC2, DIRC3, DIS3, DIS3L, DIS3L2, DISCI, DISP1, DLAT, DLC1, DLD, DLEU1, DLEU2, DLEU2L, DLG1, DLG3, DLG4, DLGAP4-AS1, DLGAP5, DLST, DLX1, DMAC2, DMC1, DMD, DMKN, DMPK, DMTF1, DMTN, DMXL1, DMXL2, DNA2, DNAAF2, DNAAF4, DNAAF4-CCPG1, DNAAF5, DNAH14, DNAJB12, DNAJB14, DNAJB4, DNAJB6, DNAJC1, DNAJC10, DNAJC13, DNAJC19, DNAJC2, DNAJC21, DNAJC22, DNAJC24, DNAJC25, DNAJC27-AS1, DNAJC4, DNAJC5, DNAJC6, DNAJC8, DNAL1, DNALI1, DNASE2, DNM1, DNM1L, DNM2, DNMBP, DNMT1, DNMT3A, DNTTIP1, DNTTIP2, DOC2A, DOC2B, DOCK1, DOCK11, DOCK2, DOCK5, DOCK6, DOCK7, DOCK9, DOK2, DOK3, DOK6, DOLPP1, DONSON, DOPEY1, DPCD, DPF1, DPH2, DPH5, DPH6, DPH7, DPMI, DPP4, DPP7, DPP8, DPP9, DPY19L1, DPY19L2, DPY19L2P1, DPY19L3, DPY19L4, DPY30,
DPYD, DPYSL2, DPYSL3, DPYSL4, DPYSL5, DQX1, DRAM1, DRAM2, DRG2, DROSHA, DSCC1, DSE, DSN1, DSP, DST, DSTYK, DTD2, DTL, DTNA, DTNB, DTNBP1, DTWD1, DTYMK, DUS1L, DUS2, DUS4L, DUSP11, DUSP16, DUSP22, DUXAP10, DUXAP8, DVL3, DYM, DYNC1H1, DYNC1I2, DYNC1LI1, DYNC1LI2, DYNC2H1, DYNC2LI1, DYNLRB1, DYRK1A, DYRK2, DYRK3, DYRK4, DYSF, DZIP1, DZIP1L, DZIP3, E2F3, E2F6, EAF1, EBAG9, EBF1, EBF3, EBF4, EBLN3P, EBPL, ECHDC1, ECHDC2, ECU, ECI2, ECM1, ECSIT, ECT2, EDA2R, EDC3, EDEM2, EDEM3, EDIL3, EDRF1, EEA1, EED, EEF1AKMT1, EEF1AKMT2, EEF1D, EEF1E1-BLOC1S5, EEF2K, EEF2KMT, EEFSEC, EFCAB11, EFCAB13, EFCAB14, EFCAB2, EFCAB7, EFHD2, EFL1, EFNA1, EFNA3, EFNA4, EFNB3, EFR3A, EFS, EFTUD2, EGFL7, EGLN1, EHBP1, EHBP1L1, EHHADH, EHMT1, EI24, EIF1AX, EIF2A, EIF2AK1, EIF2AK2, EIF2AK4, E1F2B3, E1F2B5, E1F2S2, EIF2S3, EIF3C, EIF3CL, EIF3H, EIF3I, EIF3J, EIF3K, EIF3M, EIF4A2, EIF4B, EIF4E, EIF4E2, EIF4E3, EIF4G1, EIF4G3, EIF4H, EIF6, EIPR1, ELAC2, ELAVL1, ELAVL2, ELAVL4, ELF2, ELF4, ELFN2, ELK1, ELK3, ELL, ELL2, ELMO1, ELMO2, ELMOD1, ELMOD2, ELMOD3, ELN, ELOC, ELOVL1, ELOVL2, ELOVL4, ELOVL7, ELP2, ELP5, ELP6, EMB, EMBP1, EMC1, EMC10, EMC2, EMC3-AS1, EMC8, EMG1, EMIDI, EML1, EML2, EML3, EML4, EML5, EMP3, EMSY, EMX2, ENAH, ENDOV, ENKD1, ENO2, ENOSF1, ENOXI, ENOX2, ENTPD1-AS1, ENTPD3-AS1, ENTPD4, ENTPD5, ENTPD6, EOGT, EP300, EP400, EP400P1, EPB41, EPB41L1, EPB41L2, EPB41L4A, EPB41L4A-AS1, EPB41L5, EPCI, EPDR1, EPG5, EPGN, EPHA1-AS1, EPHA3, EPHA6, EPHA8, EPHB2, EPHB4, EPHX1, EPHX4, EPM2A, EPN2, EPS15, EPS15L1, EPS8, EPSTI1, ERBB2, ERBIN, ERC1, ERC2, ERCC1, ERCC2, ERCC8, ERG28, ERGIC1, ERGIC2, ERGIC3, ERI1, ERI2, ERI3, ERICH1, ERICH2, ERLEC1, ERLIN1, ERLIN2, ERMAP, ERMARD, ERO1A, ERP44, ERVK13-1, ESCO1, ESCO2, ESD, ESF1, ESPL1, ESRRB, ESRRG, ESYT1, ESYT2, ETAA1, ETFB, ETHE1, ETV1, ETV3, ETV4, ETV6, ETV7, EVA1A, EVC, EVI5, EWSR1, EXD2, EXD3, EXO1, EXO5, EXOCI, EXOC2, EXOC3, EXOC4, EXOC5, EXOC6, EXOC6B, EXOC7, EXOG, EXOSC1, EXOSC2, EXOSC7, EXOSC8, EXOSC9, EXT2, EXTL2, EXTL3, EYA1, EYA3, EYA4, EZH1, EZH2, F8, FAAH, FAAH2, FAAP20, FAAP24, FADS1, FADS2, FAF1, FAF2, FAH, FAHD2A, FAHD2B, FAHD2CP, FAIM, FAM102A, FAM103A1, FAM104A, FAM105A, FAM107B, FAM1 11 A, FAM114A1, FAM114A2, FAM117A, FAM117B, FAM118A, FAM118B,
FAM120A, FAM120AOS, FAM120B, FAM122B, FAM122C, FAM126A, FAM126B, FAM129B, FAM131A, FAM133B, FAM133DP, FAM135A, FAM13A, FAM13B, FAM149B1, FAM151B, FAM157A, FAM157B, FAM160A1, FAM160A2, FAM160B2, FAM161A, FAM162A, FAM163A, FAM168A, FAM169A, FAM171A1, FAM172A, FAM173A, FAM173B, FAM177A1, FAM184A, FAM185A, FAM189A2, FAM189B, FAM193A, FAM193B, FAM199X, FAM19A5, FAM204A, FAM206A, FAM207A, FAM208A, FAM208B, FAM20B, FAM210A, FAM212B-AS1, FAM214A, FAM214B, FAM216A, FAM219B, FAM221A, FAM222B, FAM228B, FAM229B, FAM234A, FAM241B, FAM24B, FAM24B- CUZD1, FAM35A, FAM3A, FAM3C, FAM45BP, FAM47E-STBD1, FAM49A, FAM49B, FAM53B, FAM57A, FAM66A, FAM72D, FAM76A, FAM76B, FAM78B, FAM81A, FAM83D, FAM86C1, FAM86C2P, FAM89B, FAM92A, FAM98B, FAM98C, FAN1, FANCA, FANCC, FANCD2, FANCE, FANCG, FANCI, FANCL, FANCM, FANK1, FAR1, FARP1, FARP2, FARS2, FARSB, FASN, FASTK, FASTKD1, FAT1, FAT3, FAXC, FAXDC2, FBF1, FBH1, FBLIM1, FBLN7, FBN1, FBN2, FBRS, FBRSL1, FBXL12, FBXL13, FBXL17, FBXL20, FBXL21, FBXL3, FBXL4, FBXL5, FBXL8, FBX011, FBXO16, FBXO17, FBXO21, FBXO22, FBXO25, FBXO31, FBXO33, FBXO34, FBXO38, FBXO4, FBXO41, FBXO42, FBXO44, FBXO46, FBXO5, FBXO7, FBXO9, FBXW11, FBXW4, FBXW7, FBXW8, FBXW9, FCF1, FCGR1A, FCGRT, FCHO1, FCHO2, FCHSD2, FDFT1, FDX1, FDX1L, FDXR, FECH, FER, FERIL4, FERMT2, FES, FEZ1, FEZ2, FGD4, FGD5-AS1, FGF12, FGF5, FGFR1, FGFR1OP, FGFR1OP2, FGFR3, FGGY, FHAD1, FHIT, FHL2, FHOD3, FIBP, FIG4, FIGNL1, FIP1L1, FIS1, FIZ1, FKBP10, FKBP15, FKBP1B, FKBP2, FKBP5, FKBP7, FKBP9, FKTN, FLAD1, FLII, FLNA, FLNB, FLOT2, FLRT3, FLT1, FLT4, FLVCR1, FLVCR2, FMN2, FMNL2, FMNL3, FMRI, FN1, FN3K, FN3KRP, FNBP1, FNBP1L, FNBP4, FNDC3A, FNDC3B, FNIP1, FNIP2, FNTA, FOCAD, FOPNL, FOXJ3, F0XM1, FOXN2, FOXN3, FOXP1, FOXP2, FOXP3, FOXP4, FOXRED1, FPGT, FPGT-TNNI3K, FRA10AC1, FRAS1, FRG1, FRG1BP, FRG1CP, FRG1DP, FRG1HP, FRG1JP, FRMD4A, FRMD6, FRMPD4, FRS2, FRY, FRYL, FRZB, FSD1, FSD1L, FSTL1, FSTL5, FTO, FTSJ1, FTX, FUBP1, FUBP3, FUK, FUNDCI, FURIN, FUT10, FUT8, FUZ, FXR1, FXYD5, FXYD6, FXYD6-FXYD2, FYN, FZD3, FZD6, G2E3, G6PC3, GAA, GABI, GAB2, GABPA, GABPB1, GABPB2, GABRA3, GABRB3, GADD45A, GAK, GAL3ST4, GALK1, GALK2, GALNS, GALNT10, GALNT11,
GALNT13, GALNT18, GALNT2, GALNT6, GALNT7, GALT, GANC, GAPVD1, GAREM1, GARNL3, GART, GAS2L1, GAS2L3, GAS5, GAS6, GAS7, GATA2-AS1, GATA3, GATA4, GATAD2A, GATAD2B, GATB, GATD1, GATD3A, GBA, GBA2, GBAP1, GBF1, GCA, GCAT, GCC2, GCDH, GCH1, GCLC, GCN1, GCNT1, GCNT2, GCOM1, GCSH, GDAP1, GDAP1L1, GDAP2, GDPD5, GEMIN2, GEMIN8, GEN1, GET4, GFI1, GFM1, GFM2, GFOD2, GFPT1, GFPT2, GFRA2, GGA1, GGA3, GGACT, GGCX, GGT5, GID4, GIGYF1, GIGYF2, GIN1, GINS1, GINS3, GIPC1, GIT1, GIT2, GK, GKAP1, GLB1, GLCCI1, GLCE, GLDC, GLE1, GLG1, GLI2, GLIPR2, GLMN, GLRB, GLRX3, GLS, GLS2, GLT1D1, GLT8D1, GLYR1, GMCL1, GMDS, GMDS-AS1, GMEB1, GMFB, GMFG, GMIP, GMNN, GMPPB, GNA12, GNA13, GNAS, GNAS-AS1, GNB1, GNB1L, GNB4, GNB5, GNE, GNG2, GNG4, GNG7, GNPAT, GNPDA1, GNPDA2, GNPNAT1, GNPTG, GNS, GOLGA2, GOLGA2P10, GOLGA2P5, GOLGA2P7, GOLGA3, GOLGA4, GOLGA6L10, GOLGA6L17P, GOLGA6L9, GOLGB1, GOLIM4, GOLPH3L, GOLT IB, GON4L, GOPC, GORAB, GORASP2, GOSR1, GOSR2, GPAA1, GPALPP1, GPAT4, GPATCH11, GPATCH2, GPATCH2L, GPATCH4, GPATCH8, GPBP1, GPBP1L1, GPC6, GPCPD1, GPD1L, GPHN, GPI, GPKOW, GPN1, GPN3, GPR107, GPR108, GPR137, GPR137B, GPR137C, GPR141, GPR155, GPR160, GPR161, GPR171, GPR173, GPR176, GPR180, GPR63, GPR75-ASB3, GPR85, GPR89A, GPRASP1, GPRASP2, GPRC5D-AS1, GPS2, GPSM1, GPSM2, GPX8, GRAMD1A, GRAMD2B, GRB10, GREB1L, GREM2, GRHLl, GRHPR, GRIA3, GRIK2, GRIK5, GRIN2D, GRIN3B, GRIP API, GRK2, GRK3, GRK4, GRK5, GRPEL2, GRTP1, GS1- 124K5. i l, GSAP, GSK3B, GSKIP, GSN, GSPT1, GSR, GSS, GSTA4, GSTCD, GSTK1, GSTM2, GSTT1, GSTT4, GSTZ1, GTDC1, GTF2A2, GTF2B, GTF2F1, GTF2H1, GTF2H2, GTF2H2B, GTF2H2C, GTF2H2C 2, GTF2H3, GTF2I, GTF2IP1, GTF2IP20, GTF2IP23, GTF2IP4, GTF2IRD1, GTF2IRD2, GTF2IRD2B, GTF3A, GTF3C2, GTF3C3, GTF3C4, GTF3C5, GTPBP1, GTPBP10, GTSE1, GUCA1A, GUCD1, GUF1, GUK1, GULP1, GUSB, GUSBP1, GUSBP11, GVQW2, GYG1, GYG2, GYSI, GZF1, H2AFV, H6PD, HABP4, HACD1, HACD4, HACE1, HACL1, HADH, HADHB, HAGH, HAGHL, HAGLR, HAND2- AS1, HAPLN1, HARS, HARS2, HAT1, HAUS1, HAUS2, HAUS4, HAUS5, HAUS6, HAUS7, HAUS8, HAX1, HBS1L, HCFC1, HCFC1R1, HDAC1, HDAC11, HDAC3, HDAC4, HDAC5, HDAC7, HDAC8, HDAC9, HDDC2, HDGFL2, HDGFL3, HDHD2, HDHD5, HDX, HEATR1,
HEATR3, HEATR5A, HEATR5B, HEATR6, HECTD1, HECTD4, HECW1, HECW2, HELLS, HELZ, HEMK1, HENMT1, HERC1, HERC2, HERC2P3, HERC3, HERC4, HERC5, HERC6, HERPUD1, HERPUD2, HES4, HEXA, HEXB, HEXDC, HFM1, HGF, HGH1, HGS, HGSNAT, HHAT, HIBADH, HIBCH, HIF1A, HIF1AN, HIKESHI, HINFP, HINT3, HIP1, HIPK1, HIPK3, HIRA, HIRIP3, HIVEP1, HIVEP2, HIVEP3, HJURP, HK1, HKR1, HLA-C, HLA-DRB1, HLA- F, HLCS, HLTF, HM13, HMBOX1, HMBS, HMCES, HMCN1, HMG20B, HMGA1, HMGCL, HMGCR, HMGCS1, HMGN1, HMGN3, HMGN4, HMGN5, HMGXB3, HMGXB4, HMMR, HNRNPA1, HNRNPA1L2, HNRNPA2B1, HNRNPA3, HNRNPAB, HNRNPC, HNRNPD, HNRNPH1, HNRNPK, HNRNPLL, HNRNPM, HNRNPR, HNRNPUL1, HOGA1, HOMER2, HOOK3, HOXA3, HOXA5, HOXA6, HOXB7, HOXB8, HOXC4, HOXC5, HOXDIO, HP1BP3, HPCAL1, HPF1, HPS1, HPS3, HPS4, HPS5, HPSE, HR, HRAS, HRASES, HRAT17, HS2ST1, HS3ST3A1, HS6ST1, HS6ST2, HSCB, HSD11B1L, HSD17B12, HSD17B14, HSD17B4, HSD17B7P2, HSDL2, HSF2BP, HSF4, HSP90AA1, HSPA12A, HSPA14, HSPA4, HSPBAP1, HSPBP1, HSPE1-MOB4, HTD2, HTRA2, HTT, HUWE1, HYAL3, HYI, HYOU1, IAH1, IARS, IBTK, ICA1, ICA1L, ICE1, ICK, ICMT, IDE, IDH1, IDH3A, IDH3B, IDH3G, IDI1, IDNK, IDS, IFF01, IFI27L1, IFI27L2, IFI44L, IFNAR2, IFNGR2, IFRD1, IFT122, IFT140, IFT172, IFT20, IFT22, IFT27, IFT43, IFT52, IFT57, IFT80, IFT81, IFT88, IGBP1, IGF2BP2, IGF2BP3, IGFLR1, IGLON5, IGSF1, IGSF3, IK, IKBKB, IKZF1, IKZF4, IKZF5, IL10RA, IL11RA, IL12RB2, IL13RA1, IL15, IL15RA, IL17RA, IL17RB, IL17RC, IL17RE, IL18BP, IL21R, IL27, IL2RA, IL2RG, IL4R, IL6R, IL6ST, ILDR2, ILF3, ILK, ILKAP, ILVBL, IMMP1L, IMMP2L. IMMT, IMPA1, INCENP, ING3, ING4, ING5, INIP, INMT-MINDY4, INO80C, INO80E, INPP4A, INPP5A, INPP5B, INPP5E, INPP5F, INPP5K, INPPL1, INSIGI, INSR, INTS10, INTS11, INTS12, INTS13, INTS2, INTS3, INTS4, INTS7, INTS8, INTS9, INTU, INVS, IP6K2, IPCEF1, IPO11, IPO 11 -LRRC70, IPO4, IPO7, IPO8, IPP, IPPK, IQCB1, IQCE, IQCG, IQCH, IQCH-AS1, IQCI-SCHIP1, IQCK, IQGAP3, IQSEC1, IRAKI, IRAK1BP1, IRAK2, IRAK3, IRAK4, IREB2, IRF3, IRF6, ISCA1, ISL1, IS0C2, IST1, ISYNA1, ITCH, ITFG1, ITFG2, ITGA1, ITGA3, ITGA8, ITGA9, ITGA9-AS1, ITGAE, ITGAM, ITGAV, ITGAX, ITGB1BP1, ITGB3BP, ITGB5, ITIH5, ITM2C, ITPA, ITPK1, ITPR1, ITPR2, ITSN1, ITSN2, IVD, IVNS1ABP, IZUMO4, JADE1, JADE2, JAK1, IAK3, JAKMIP2, JAM2, JARID2, JCAD, JKAMP, JMJD1C, JMJD7, 1MJD7-PLA2G4B, IMJD8,
JOSD2, JPT2, JPX, JTB, KANK1, KANSL1, KANSL1L, KANSL2, KANSL3, KARS, KAT2A, KAT5, KAT6A, KAT6B, KAT7, KAT8, KATNA1, KATNAL1, KATNAL2, KATNBL1, KAZN, KBTBD8, KCMF1, KCNAB2, KCNAB3, KCNG1, KCNH2, KCNK2, KCNK4, KCNMA1, KCNMB4, KCNN4, KCNQ1, KCNQ5, KCNQ5-IT1, KCNT2, KCTD17, KCTD20, KCTD3, KCTD9, KDELC1, KDELC2, KDM1A, KDM1B, KDM2A, KDM2B, KDM3A, KDM3B, KDM4A, KDM4B, KDM4C, KDM4D, KDM5A, KDM5B, KDM5C, KDM5D, KDM6A, KDM7A, KEAP1, KHDC1, KHDRBS3, KHK, KHSRP, KIAA0040, KIAA0100, KIAA0232, KIAA0319L, KIAA0355, KIAA0368, KIAA0391, KIAA0556, KIAA0586, KIAA0753, KIAA0825, KIAA0895, KIAA1109, KIAA1147, KIAA1191, KIAA1217, KIAA1324, KIAA1324L, KIAA1328, KIAA1468, KIAA1522, KIAA1551, KIAA1586, K1AA1841, KIAA1958, KIAA2026, KID1NS220, K1F11, K1F13A, KIF13B, KIF14, K1F15, KIF16B, KIF18B, KIF1A, KIF1B, KIF1C, KIF21A, KIF21B, KIF23, KIF24, KIF26B, KIF27, KIF2A, KIF2C, KIF3A, KIF4A, KIF5C, KIF9, KIF9-AS1, KIFAP3, KIN, KIRREL1, KIRREL3, KITLG, KIZ, KLC1, KLC4, KLF12, KLHDC10, KLHDC3, KLHDC4, KLHDC8B, KLHL12, KLHL13, KLHL17, KLHL18, KLHL2, KLHL20, KLHL22, KLHL5, KLHL7, KLHL8, KLRB1, KLRC4-KLRK1, KLRD1, KLRG1, KLRG2, KLRK1, KMT2A, KMT2B, KMT2C, KMT2D, KMT2E, KMT5A, KMT5B, KMT5C, KNL1, KNOP1, KNSTRN, KNTC1, KPNA4, KPNA5, KPNA6, KPTN, KRBA1, KRBOX4, KREMEN1, KRI1, KRIT1, KSR1, KTN1, KYAT I, KYAT3, L I CAM, L2HGDH, L3MBTL2, L3MBTL3, LAMA2, LAMA3, LAMA5, LAMB2, LAMC3, LAMP2, LAMP5, LAMTOR4, LARGE1, LARP1, LARP1B, LARP4, LARP4B, LARP7, LARS, LARS2, LAS IL, LASPI, LAT, LAT2, LATS1, LATS2, LBHD1, LBR, LBX2, LCAT, LCLAT1, LCMT1, LCOR, LCORL, LDAH, LDB2, LDLR, LDLRAD3, LDLRAD4, LDLRAP1, LEF1, LEMD2, LEMD3, LENEP, LENG8, LEPR, LEPROT, LEPROTL1, LETM1, LETMD1, LGALS9, LGMN, LGR4, LGR5, LHFPL2, LHPP, LIAS, LIFR, LIG1, LILRA2, LILRB3, LIMCH1, LIME1, LIMK2, LIMS2, LIN37, LIN52, LIN54, LIN7A, LIN9, LINC-PINT, LINC00240, LINC00265, LINC00327, LINC00337, LINC00467, LINC00476, LINC00491, LINC00578, LINC00607, LINC00623, LINC00630, LINC00649, LINC00665, LINC00667, LINC00673, LINC00674, LINC00680, LINC00680- GUSBP4, LINC00693, LINC00869, LINC00886, LINC00888, LINC00941, LINC00960, LINC00963, LINC01000, LINC01033, LINC01060, LINC01085, LINC01088, LINC01117,
LINC01128, LINC01169, LINC01184, LINC01224, LINC01234, LINC01237, LINC01250, LINC01278, LINC01296, LINC0 I 358, LINC01456, LINC01515, LINC01547, LINC01572, LINC01684, LINC01876, LINC01881, LINC01934, LINC02202, LINC02246, LINC02446, LINC02542, LINCR-0002, LINGO2, LINS1, LIPA, LIPE, LIPE-AS1, LIPT1, LIX1L, LLGL2, LMAN2L, LMBR1, LMBR1L, LMBRD1, LMBRD2, LMCD1, LMLN, LMO7, LNPK, LNX2, LOC100128253, LOC100128594, LOC100128885, LGC100130691, LOC100132111, LGC100133091, LOC100133315, LOC100233156, LOC100287497, LOC100287944, LGC100288203, LOC100288637, LOC100288778, LOC100288798, LGC100420587, LGC1OO5O55O1, LGC100505874, LOC100505938, LGC100506023, LGC100506207, LGC100506476, LGC100506844, LGC100506990, LGC100507002, LGC100507053, LGC100507065, LOC100507291, LOC100507557, LGC100630923, LOC100996693, LOC101448202, LOC101927021, LOC101927027, LOC101927043, LOC101927056, LOC101927151, LOC101927359, LOC101927815, LGC101928100, LOC101928516, LOC101928605, LOC101928673, LOC101929140, LOC101929147, LOC101929709, LOC101929710, LOC101929767, LOC102606465, LOC102723360, LOC102723780, LOC102724219, LOC102724297, LOC102724532, LOC102724593, LOC102724843, LOC102724951, LOC102725126, LOC103091866, LOC105369147, LOC105369980, LOC105370401, LOC105372273, LOC105378853, LOC107984035, LOC107984974,
LOCI 10117498-PIK3R3, LOC145694, LOC150776, LOC155060, LOC283683, LOC283788, LOC284581, LOC339862, LOC389765, LOC389831, LOC389906, LOC392232, LOC399815, LOC400464, LOC400927, LOC400927-CSNK1E, LOC440434, LOC441242, LOC441601, LOC441666, LOC642846, LOC643339, LOC645513, LOC648987, LOC653080, LOC727751, LOC728613, LOC728730, LOC729218, LOC729732, LOC729970, LONP2, LONRF3, LOXL2, LOXL3, LPAR1, LPAR3, LPCAT1, LPCAT2, LPCAT3, LPCAT4, LPGAT1, LPIN1, LPP, LRBA, LRCH3, LRIG1, LRIG2, LRIG3, LRMDA, LRMP, LRP1, LRP11, LRP12, LRP2, LRP5, LRP8, LRPPRC, LRR1, LRRC14, LRRC23, LRRC28, LRRC34, LRRC37A2, LRRC37B, LRRC40, LRRC42, LRRC45, LRRC49, LRRC4B, LRRC58, LRRC6, LRRC73, LRRC75B, LRRC8A, LRRC8B, LRRC8D, LRRCC1, LRRFIP1, LRRFIP2, LRRK1, LRRK2, LRRN3, LRSAM1, LRTOMT, LSG1, LSM12, LSM14A, LSM14B, LSM5, LSR, LSS, LTA4H, LTB4R, LTBP1, LTBP3, LTBP4, LTN1, LUC7L, LUC7L3, LUZP1, LY75, LY75-CD302,
LYAR, LYPD1, LYPD6B, LYPLA1, LYPLAL1, LYRM1, LYRM7, LYSMD1, LYST, LZIC, LZTFL1, MACF1, MACROD1, MACROD2, MAD1L1, MADD, MAEA, MAFG, MAFG-AS1, MAGEA12, MAGH, MAGI2, MAGI2-AS3, MAGI3, MAGOH, MAIP1, MAK16, MALL, MALSU1, MALT1, MAMDC4, MAML1, MAMLDI, MAN2C1, MANBA, MANBAL, MANEAL, MAP1LC3B, MAP2, MAP2K1, MAP2K4, MAP2K5, MAP2K6, MAP2K7, MAP3K10, MAP3K15, MAP3K2, MAP3K3, MAP3K4, MAP3K5, MAP3K7, MAP3K9, MAP4, MAP4K1, MAP4K2, MAP4K3, MAP4K4, MAP4K5, MAP6, MAP6D1, MAP7D1, MAP9, MAPK10, MAPK11, MAPK13, MAPK14, MAPK6, MAPK7, MAPK8, MAPK9, MAPKAP1, MAPKAPK3, MAPKAPK5, MAPKAPK5-AS1, MAPKBP1, MARCH 1, MARCH3, MARCH5, MARCH6, MARCH7, MARTI, MARK1, MARK2, MARK3, MARK4, MARVELD2, MAST1, MAST2, MAST3, MAST4, MASTL, MAT2B, MATK, MATR3, MAVS, MAX, MBD1, MBD3, MBD4, MBD5, MBIP, MBNL1, MBNL2, MBOAT2, MBTD1, MBTPS1, MBTPS2, MCAM, MCAT, MCCC1, MCCC2, MCM3AP-AS1, MCM4, MCM9, MCOLN3, MCPH1, MCPH1-AS1, MCRIP1, MCRIP2, MCRS1, MCTP1, MCTP2, MCTS1, MCU, MCUB, MCUR1, MDFI, MDM1, MDM2, MDN1, MDP1, MEI, ME2, MEAF6, MECOM, MECP2, MECR, MED1, MED11, MED 12, MED12L, MED13, MED13L, MED 14, MED15, MED16, MED17, MED19, MED20, MED23, MED24, MED25, MED27, MED30, MED31, MED6, MED8, MEF2A, MEF2B, MEF2C-AS1, MEG3, MEGF11, MEGF6, MEGF8, MEGF9, MEH, MEIS1, MEIS2, MEIS3, MELK, MELTF, MEMO!, MEN1, MERTK, MET, METAP1, METAP1D, METRN, METTL1, METTL13, METTL14, METTL15, METTL16, METTL21A, METTL22, METTL23, METTL25, METTL26, METTL2A, METTL2B, METTL4, METTL5, METTL6, METTL8, METTL9, MFF, MFGE8, MFN1, MFN2, MFNG, MFSD10, MFSD11, MFSD12, MFSD13A, MFSD14B, MFSD14C, MFSD6, MFSD8, MFSD9, MGA, MGARP, MGAT4B, MGAT4C, MGAT5, MGEA5, MGME1, MGMT, MGP, MGRN1, MGST1, MGST2, MGST3, MIA-RAB4B, MIA2, MIA3, MIAT, MIATNB, MIB1, MIB2, MICAL1, MICAL2, MICAL3, MICALL1, MICALL2, MICB, MICU2, MIDI, MID2, MIER1, MIER2, MIER3, MIF4GD, MIGA1, MIIP, MINDY1, MINDY2, MINDY3, MINDY4, MINK1, MINOS1, MINOS1-NBL1, MIOS, MIPEPP3, MIPOL1, MIR100HG, MIR1268A, MIR31HG, MIR4435-2HG, MIR5095, MIR5096, MIR548G, MIR548H3, MIR548H4, MIR548N, MIR570HG, MIR924HG, MIR99AHG, MIRLET7BHG, MIS 12, MIS18BP1, MITF, MKI67,
MKKS, MKL I, MKL2, MKLN I, MKNK1, MKNK2, MKRN1, MKRN2, MKS1, MLC1, MLF1, MLH1, MLH3, MLLT10, MLLT3, MLPH, MLST8, MLXIP, MLXIPL, MMAB, MMD, MMGT1, MMP16, MMP19, MMP23B, MMP24-AS1-EDEM2, MMP24OS, MMS19, MMS22L, MNAT1, MND1, MOB1B, MOB3A, MOCOS, MOCS1, MOK, MON1A, MON2, MORC2, MORC3, MORF4L1, MORF4L2, MORN3, MOSMO, MOSPD1, MOSPD2, MOSPD3, MOV10L1, MPDU1, MPDZ, MPHOSPH6, MPHOSPH9, MPI, MPND, MPP2, MPP3, MPP4, MPP5, MPP6, MPPE1, MPPED2, MPRIP, MPV17, MPZL1, MPZL3, MR1, MRC1, MRC2, MRE11, MRFAP1, MRNIP, MROH1, MROH6, MRPL13, MRPL17, MRPL18, MRPL2, MRPL21, MRPL22, MRPL24, MRPL33, MRPL38, MRPL43, MRPL45, MRPL47, MRPL48, MRPL52, MRPL55, MRPL9, MRPS10, MRPS18A, MRPS18C, MRPS25, MRPS28, MRPS30-DT, MRPS31, MRPS31P5, MRPS36, MRPS5, MRRF, MRS2, MS4A14, MS4A3, MS4A6A, MS4A7, MSANTD2, MSANTD3-TMEFF1, MSANTD4, MSC-AS1, MSH2, MSH3, MSI1, MSL1, MSL3, MSTO1, MSTO2P, MTA1, MTA3, MTCH2, MTDH, MTERF2, MTERF3, MTERF4, MTF2, MTFP1, MTFR1, MTFR2, MTG2, MTHFD2, MTHFD2L, MTHFS, MTHFSD, MTIF2, MTIF3, MTM1, MTMR1, MTMR10, MTMR12, MTMR14, MTMR2, MTMR3, MTMR6, MTMR7, MTMR8, MTO1, MTOR, MTR, MTREX, MTRF1, MTRF1L, MTRR, MTUS1, MTX1, MTX2, MTX3, MUM1, MUTYH, MVB12A, MVB12B, MVK, MX1, MXD3, MXI I, MXRA7, MYBL1, MYBL2, MYCBP2, MYEF2, MYH10, MYH14, MYL6B, MYLIP, MYLK, MYLK-AS1, MYNN, MYO 10, MYO 18 A, MYO 19, MYO1B, MYOID, MYO1E, MYO5A, MYO5B, MYO5C, MYO6, MYO9A, MYO9B, MYOF, MYOM2, MYSM1, N4BP1, N4BP2, N4BP2L1, N4BP2L2, N6AMT1, NAA15, NAA16, NAA25, NAA35, NAA40, NAA50, NAA60, NAAA, NAALAD2, NAB1, NAB2, NACC2, NADK, NADK2, NADSYN1, NAE1, NAF1, NAGA, NAGK, NAGPA, NAIP, NAMPT, NANS, NAPA, NAPB, NAPG, NAPSA, NARS2, NASP, NAVI, NAV3, NAXD, NAXE, NBAS, NBDY, NBEA, NBEAL1, NBEAL2, NBL1, NBN, NBPF1, NBPF10, NBPF11, NBPF12, NBPF14, NBPF15, NBPF19, NBPF20, NBPF25P, NBPF26, NBPF3, NBPF8, NBPF9, NBR1, NBR2, NCALD, NCAM1, NCAPD3, NCAPG, NCAPG2, NCBP3, NCF4, NCK2, NCKAP1, NCKAP5, NCKAP5L, NCKIPSD, NCOA1, NCOA2, NCOA6, NCOA7, NCOR1, NCOR2, NCS1, NCSTN, NDC1, NDE1, NDEL1, NDFIP2, NDOR1, NDRG1, NDRG2, NDRG3, NDRG4, NDST1, NDUFA10, NDUFA12, NDUFA3, NDUFA4L2, NDUFA6-AS1,
NDUFA8, NDUFAF1, NDUFAF2, NDUFAF5, NDUFAF6, NDUFAF7, NDUFB5, NDUFB6, NDUFC1, NDUFS2, NDUFS8. NDUFVI, NDUFV2, NDUFV3, NECAB3, NECAP2, NEDD1, NEDD4, NEDD4L, NEDD9, NEIL2, NEIL3, NEK1, NEK10, NEK11, NEKA, NEK7, NEK9, NELFA, NELFCD, NEMF, NEMP I, NENF, NE01, NEPRO, NET1, NETO2, NEURL1B, NEURL4, NEXN, NF1, NF2, NFASC, NFAT5, NFATC2IP, NFATC3, NFATC4, NFE2L1, NFIB, NFIC, NFIX, NFKB1, NFRKB, NFS1, NFU1, NFX1, NFYB, NFYC, NGDN, NGLY1, NHEJ1, NHSL1, NICN1, NID2, NIF3L1, NIFK, NIN, NIP7, NIPA1, NIPA2, NIPBL, NIPSNAP1, NIPSNAP2, NISCH, NITI, NIT2, NKAIN1, NKAPD1, NKIRAS2, NKTR, NLGN2, NLN, NLRC3, NLRC5, NLRP3, NLRX1, NMD3, NME1-NME2, NME3, NME6, NME7, NMRAL1, NMRK1, NMT1, NMT2, NMU, NOA1, NOC2L, NOC4L, NODI, NOLIO, NOL11, NOL12, NOL3, NOL4E, NOL9, NOLC1, NOMO2, NOP58, NOS1AP, NOTCH1, NOTCH2, NOTCH2NL, NOTCH3, NOVAI, NOX4, NPAS1, NPAS2, NPC1, NPEPPS, NPHP1, NPHP3. NPHP4, NPIPA1, NPIPB5, NPL, NPLOC4, NPM1, NPM3, NPNT, NPR1, NPR2, NPRL2, NPRL3, NQO1, NQO2, NR1H3, NR2C1, NR2C2, NR2F1-AS1, NR3C1, NR4A1, NR6A1, NRBF2, NRCAM, NRDC, NRDE2, NRF1, NRG1, NRG4, NRIP1, NRP1, NRXN3, NSD1, NSD2, NSD3, NSDHL, NSF, NSFL1C, NSFP1, NSG1, NSL1, NSMAF, NSMCE1, NSMCE2, NSMCE4A, NSMF, NSRP1, NSUN2, NSUN3, NSUN4, NSUN5P1, NSUN5P2, NSUN6, NT5C1A, NT5C2, NT5C3A, NT5C3B, NT5DC2, NT5M, NTAN1, NTHL1, NTM, NTNG1, NTPCR, NTRK1, NTRK2, NUB1, NUBP1, NUBPL, NUCB2, NUDCD2, NUDT1, NUDT17, NUDT19, NUDT2, NUDT22, NUDT3, NUDT7, NUF2, NUFIP1, NUFIP2, NUMA1, NUMB, NUP107, NUP133, NUP153, NUP155, NUP188, NUP210, NUP214, NUP37, NUP43, NUP50, NUP50-AS1, NUP54, NUP58, NUP62CL, NUP85, NUP88, NUP93, NUP98, NUPL2, NUS1, NUTM2A-AS1, NUTM2B-AS1, NVL, NXN, NXPE3, NXT2, OARD1, OAZ1, OBSCN, OBSL1, OCIAD1, OCIAD2, OCRL, ODAM, ODF2, ODF2L, ODR4, OFD1, OGDH, OGDHL, OGFOD2, OGFOD3, OGFRL1, OGGI, OGT, OIP5, OLA1, OLFM2, OLR1, OMA1, OPA1, OPCML, OPHN1, OPLAH, OPN3, OPTN, OR2A1-AS1, ORAI2, ORAOV1, ORC1, ORC2, ORC3, ORC4, ORC 5, ORC6, ORMDL1, ORMDL2, OSBP2, OSBPL1A, OSBPL3, OSBPL6, OSBPL7, OSBPL8, OSBPL9, 0SCP1, OSER1, OSER1-AS1, OSGEPL1, OSGIN2, OSMR-AS1, OSTC, 0STF1, OTOGL, OTUD6B, OTULIN, OXAIL, OXCT1, OXNAD1, OXR1, OXSR1, P2RX4, P2RY10, P2RY6, P3H1,
P3H3, P3H4, P4HA1, P4HA2, PAAF1, PABPC4, PABPN1, PACRGL, PACS1, PACS2, PAFAH2, PAG1, PAICS, PAIP1, PAK1, PAK1IP1, PAK3, PAK4, PALB2, PALLD, PALM, PALM2, PALM2-AKAP2, PAM, PAM16, PAMR1, PAN2, PAN3, PANK1, PANK4, PANXI, PAOX, PAPD4, PAPD5, PAPD7, PAPOLA, PAPOLG, PAQR3, PAQR5, PARD3, PARD6G, PARG, PARE, PARM1, PARK, PARP11, PARP15, PARP2, PARP4, PARP6, PARP8, PARPBP, PARVB, PASK, PATJ, PATL1, PATZ1, PAX3, PAX6, PAX8-AS1, PAXIP1, PAXX, PBDC1, PBRM1, PBX1, PBX3, PBXIP1, PC, PCBD2, PCBP1-AS1, PCBP2, PCBP3, PCBP4, PCCA, PCCB, PCDH7, PCDH9, PCDHAC1, PCED1A, PCED1B, PCGF1, PCGF2, PCGF3, PCGF5, PCGF6, PCID2, PCK2, PCM1, PCMTD1, PCNP, PCNT, PCNX1, PCNX2, PCNX3, PCNX4, PCSK4, PCSK6, PCSK7, PCTP, PCYT1A, PCYT2, PDCD11, PDCD2, PDCD2L, PDCD4, PDCD6, PDCD6IPP2, PDCD7, PDE10A, PDE1C, PDE3A, PDE3B, PDE4B, PDE4DIP, PDE6B, PDE6D, PDE7A, PDE8A, PDE9A, PDF, PDGFC, PDGFD, PDGFRB, PDHA1, PDHX, PDIA5, PDIK1L, PDK1, PDK3, PDLIM2, PDLIM3, PDLIM4, PDLIM5, PDPK1, PDS5A, PDS5B, PDSS1, PDSS2, PDXDC1, PDXDC2P-NPIPB14P, PDXK, PDZD8, PEAK1, PEAR1, PEF1, PELI2, PELI3, PELO, PEMT, PER3, PET100, PEX1, PEX11A, PEX1 IB, PEX11G, PEX14, PEX16, PEX2, PEX26, PEX3, PEX5, PEX6, PEX7, PFAS, PFDN1, PFKFB3, PFKL, PFKM, PGAM5, PGAP1, PGAP2, PGAP3, PGF, PGGT1B, PGM2, PGM2L1, PGM3, PGS1, PHACTR2, PHACTR3, PHACTR4, PHC1, PHC2, PHC3, PHETA2, PHEX, PHF10, PHF11, PHF12, PHF14, PHF19, PHF20, PHF2IA, PHF3, PHF6, PHF7, PHF8, PHKA1, PHKA2, PHKB, PHKG2, PHLDB1, PHLPP2, PHOSPHO2-KLHL23, PHRF1, PHTF1, PHTF2, PHYH, PHYHD1, PHYKPL, PI4K2A, PI4K2B, PI4KA, PI4KB, PIAS1, PIAS2, PIAS3, PIBF1, PIC ALM, PICK1, PIEZO 1, PIGA, PIGB, PIGF, PIGG, PIGH, PIGK, PIGL, PIGN, PIGO, PIGP, PIGQ, PIGT, PIGU, PIK3AP1, PIK3C2A, PIK3C3, PIK3CB, PIK3CD, PIK3R2, PIK3R3, PIKFYVE, PINX1, PIP4K2A, PIP4K2B, PIP4K2C, PIP4P1, PIP4P2, PIP5K1A, PIP5K1C, PIR, PITHD1, PITPNA, PITPNC1, PITPNM2, PIWIL4, PKD1, PKD1P1, PKD1P3-NPIPA1, PKD1P4-NPIPA8, PKD1P6-NPIPP1, PKD2, PKDCC, PKIA, PKIB, PKIG, PKN2, PKNOX1, PKNOX2, PKP4, PLA2G12A, PLA2G15, PLA2G4A, PLA2G4B, PLA2G7, PLA2R1, PLAA, PLAC1, PLAC8, PLAGL1, PLAT, PLB1, PLBD2, PLCB1, PLCB3, PLCB4, PLCD4, PLCG2, PLCL1, PLD1, PLD3, PLEC, PLEKHA1, PLEKHA2, PLEKHA4, PLEKHA5, PLEKHA6, PLEKHA7, PLEKHA8, PLEKHB1, PLEKHB2, PLEKHG2, PLEKHG3, PLEKHG4,
PLEKHH3, PLEKHI1, PLEKHM2, PLEKHM3, PLK4, PLOD1, PLOD2, PLPP4, PLPP5, PLPPR2, PLRG1, PLS1, PLSCR1, PLSCR4, PLXNA4, PLXNB2, PLXNC1, PLXND1, PM20D2, PMEL, PMF1, PMM1, PMM2, PMS1, PMS2, PMS2P1, PMS2P4, PMS2P5, PMVK, PNISR, PNKP, PNN, PNO1, PNPLA8, PNPO, PNPT1, POC1A, POC1B, POC5, PODXL2, POFUT1, POGK, POGLUT1, POGZ, POLA1, POLA2, POLB, POLDIP3, POLE, POLE2, POLI, POLK, POLL, POLM, POLN, POLQ, POLR1A, POLR1B, POLR1D, POLR2B, POLR2D, POLR2J, POLR2J3, POLR2J4, POLR3A, POLR3B, POLR3C, POLR3E, POLR3F, POLR3G, POLR3GL, POLR3H, POM121, POM121C, POMT1, POMT2, POP1, POP4, POPDC3, PORCN, POTI, POT1-AS1, POU2F1, POU2F2, POU6F1, PPA1, PPA2, PPARA, PPARD, PPARG, PPARGC1B, PPCDC, PPDPF, PPFIA1, PPFIA3, PPFIA4, PPFIBP1, PPHLN1, PPIA, PPID, PPIE, PP1EL, PPIF, PPIH, PPIL2, PPIL3, PPIP5K1P1-CATSPER2, PPIP5K2, PPM1A, PPM1B, PPM1D, PPM1E, PPM1K, PPM1M, PPOX, PPP1CB, PPP1CC, PPP1R12A, PPP1R12B, PPP1R12C, PPP1R13B, PPP1R16B, PPP1R1C, PPP1R2, PPP1R21, PPP1R36, PPP1R37, PPP1R7, PPP1R8, PPP2CA, PPP2R1B, PPP2R2A, PPP2R2B, PPP2R2D, PPP2R3C, PPP2R5A, PPP2R5B, PPP2R5C, PPP2R5D, PPP2R5E, PPP3CB, PPP3CC, PPP3R1, PPP4C, PPP4R1, PPP4R2, PPP4R3A, PPP4R3B, PPP5C, PPP5D1, PPP6C, PPP6R1, PPP6R2, PPP6R3, PPRC1, PPWD1, PQBP1, PQLC1, PQLC2, PQLC2L, PRADC1, PRAF2, PRAG1, PRCC, PRDM15, PRDM16, PRDM2, PRDM4, PRDM5, PRDM6, PRDM8, PREB, PRELID2, PRELID3A, PRELID3B, PREP, PREPL, PRH1, PRH1-PRR4, PRH1-TAS2R14, PRICKLEI, PRIM1, PRIM2, PRIMPOL, PRKAA1, PRKAA2, PRKAB1, PRKAB2, PRKAG1, PRKAG2, PRKAR1B, PRKAR2A, PRKAR2B, PRKCA, PRKCH, PRKCSH, PRKCZ, PRKD2, PRKD3, PRKDC, PRKG1, PRKRA, PRKRIP1, PRKX, PRKY, PRMT1, PRMT2, PRMT3, PRMT5, PRMT7, PRMT9, PROCAI, PROK2, PROS1, PROSERI, PROSER2, PRPF18, PRPF3, PRPF38B, PRPF4, PRPF40A, PRPF40B, PRPF4B, PRPF6, PRPF8, PRPSAP2, PRR13, PRR14, PRR14L, PRR16, PRR5-ARHGAP8, PRR5L, PRRC2B, PRRC2C, PRRG1, PRRG4, PRRT4, PRSS12, PRSS16, PRTFDC1, PRTG, PRUNE1, PSAT1, PSD, PSD3, PSEN1, PSEN2, PSIP1, PSMA1, PSMA3-AS1, PSMA6, PSMB1, PSMB3, PSMC5, PSMC6, PSMD10, PSMD11, PSMD13, PSMD4, PSMD5, PSMD9, PSME2, PSME4, PSMG1, PSPC1, PSPH, PSRC1, PSTK, PSTPIP1, PSTPIP2, PT ARI, PTBP1, PTBP3, PTCD2, PTCD3, PTCHI, PTCHD4, PTDSS2, PTEN, PTER, PTGES3, PTGES3L-AARSD1, PTGFRN, PTGIS, PTGR1, PTGR2, PTGS1,
PTK2, PTK2B, PTK7, PTOV1, PTP4A2, PTP4A3, PTPA, PTPDC1, PTPMT1, PTPN1, PTPN12, PTPN13, PTPN18, PTPN2, PTPN21, PTPN22, PTPN23, PTPN3, PTPN4, PTPN9, PTPRA, PTPRC, PTPRD, PTPRE, PTPRF, PTPRG, PTPRG-AS1, PTPRK, PTPRN, PTPRS, PTPRU, PTRH1, PTS, PUF60, PUM1, PUM2, PUM3, PURPL, PUS1, PUS10, PUS7, PUSL1, PVR, PVRIG2P, PVT1, PWWP2A, PXDC1, PXDN, PXK, PXMP2, PXN, PXYLP1, PYCR2, PYCR3, PYGB, PYM1, PYROXD1, QDPR, QKI, QPCTL, QPRT, QRICH1, QRSL1, QSER1, QSOX2, QTRT1, QTRT2, R3HCC1L, R3HDM1, R3HDM2, R3HDM4, RAB11FIP1, RAB11FIP2, RAB11FIP3, RAB I 3, RAB18, RAB21, RAB22A, RAB23, RAB24, RAB27A, RAB27B, RAB28, RAB29, RAB34, RAB35, RAB36, RAB3GAP1, RAB3GAP2, RAB3IP, RAB40B, RAB40C, RAB44, RAB4A, RAB4B, RAB4B-EGLN2, RAB5B, RAB6A, RAB8B, RAB9A, RABAC1, RABEP1, RABEPK, RABGAP1, RABGAP1L, RABGEF1, RABGGTB, RABL3, RAC1, RAC3, RACGAP1, RADI, RAD17, RAD18, RAD51, RAD51AP1, RAD51B, RAD51C, RAD51D, RAD51L3-RFFL, RAD54B, RAD54L, RAD54L2, RAD9A, RAFI, RAI14, RALA, RALB, RALGAPB, RALGPS1, RALGPS2, RALY, RANBP10, RANBP17, RANBP2, RANBP3, RANGAP1, RANGRF, RAP1B, RAP1GAP2, RAP1GDS1, RAP2C, RAP2C-AS1, RAPGEF1, RAPGEF2, RAPGEF6, RAPGEFL1, RARA, RARS2, RASA1, RASA3, RASAL3, RASGRF2, RASGRP1, RASGRP3, RASSF2, RASSF3, RASSF4, RASSF8, RASSF8-AS1, RAVER2, RBI, RB1CC1, RBAK, RBAK-RBAKDN, RBBP5, RBBP6, RBBP7, RBBP8, RBBP9, RBCK1, RBFA, RBFOX2, RBL1, RBL2, RBM10, RBM11, RBM14-RBM4, RBM15-AS1, RBM I 9, RBM20, RBM22, RBM23, RBM25, RBM26, RBM26-AS1, RBM27. RBM28, RBM33, RBM34, RBM38, RBM39, RBM4, RBM41, RBM42, RBM47, RBM5, RBM6, RBM7, RBMS2, RBMS3, RBMXL1, RBPJ, RBPMS, RBSN, RBX1, RC3H2, RCAN3, RCBTB1, RCBTB2, RCC1, RCC1L, RCC2, RCCD1, RCE1, RCHY1, RCL1, RCN3, RCOR3, RD3, RDH11, RDH13, RECK, RECQL, RECQL4, RECQL5, REEP3, REEP4, RELA, RELB, RELL2, REPIN I , REPSI, RER1, RERE, RET, RETREG3, RETSAT, REV1, REX1BD, REXO2, REXO5, RFC1, RFC2, RFC3, RFC5, RFESD, RFFL, RFT1, RFWD3, RFX2, RFX3, RFX7, RFX8, RFXANK, RGL1, RGN, RGP1, RGS10, RGS11, RGS12, RGS14, RGS19, RGS3, RGS5, RGS7, RHBDDE RHBDD2, RHBDD3, RHBDF2, RHBDL1, RHCE, RHOBTB1, RHOBTB3, RHOC, RHOJ, RHOQ, RHOT1, RHOT2, RHOU, RICE RIC8B, RICTOR, RIDA, RIF1, RILPL1, R1MBP2, RJMS1, RIMS2, RIMS3, R1N I , RIN3, RINT1, RIOK1, RIOK2,
RIOK3, RIOX2, RIPK1, RIPK2, RIPOR1, RITA1, RLE, RLIM. RMCI, RMDN1, RMDN2, RMDN3, RMI1, RMND1, RMND5A, RMND5B, RNASE4, RNASEH1-AS1, RNASEH2B, RNASEK, RNASEK-C17orf49, RNASET2, RND3, RNF10, RNF103-CHMP3, RNF111, RNF114, RNF115, RNF121, RNF123, RNF126, RNF13, RNF130, RNF135, RNF138, RNF14, RNF146, RNF150, RNF157, RNF167, RNF168, RNF170, RNF175, RNF181, RNF185, RNF19A, RNF2, RNF212, RNF213, RNF214, RNF215, RNF216, RNF216P1, RNF219, RNF25, RNF34, RNF38, RNF8, RNFT1, RNGTT, RNLS, RNMT, RNPEP, RNU5D-1, RNU5E-1, ROBO1, ROBO2, ROCK1, ROCK2, ROGDI, ROR2, RORA-AS1, RP9P, RPA2, RPAIN, RPAP2, RPAP3, RPE, RPF2, RPGR, RPGRIP1L, RPH3AL, RPIA, RPL17, RPL17-C18orf32, RPL18A, RPL22, RPL23AP53, RPL23AP7, RPL23AP82, RPL27A, RPL34-AS1, RPL36A- HNRNPH2, RPL7L1, RPN2, RPP30, RPP38, RPP40, RPRD1B, RPRD2, RPS10, RPS10- NUDT3, RPS17, RPS24, RPS26, RPS27, RPS6KA1, RPS6KA3, RPS6KA4, RPS6KA6, RPS6KB1, RPS6KB2, RPS6KC1, RPS6KL1, RPSAP52, RPSAP58, RPTOR, RPUSD3, RRAGB, RRAGD, RRH, RRM1, RRM2B, RRN3, RRN3P2, RRN3P3, RRNAD1, RRP1, RRP12, RRP1B, RRP7BP, RRP8, RSAD1, RSF1, RSG1, RSPRY1, RSRC1, RSRC2, RSRP1, RSU1, RTEL1, RTEL1-TNFRSF6B, RTKN, RTKN2, RTN1, RTN2, RTN3, RTN4, RTRAF, RTTN, RUBCN, RUBCNL, RUFY1, RUFY2, RUFY3, RUNX1, RUNX2, RUSC1, RWDD1, RWDD2B, RWDD4, RXFP1, RXYLT1, RYK, S100A13, S100PBP, SAAL1, SAC3D1, SACS, SAMD11, SAMD12, SAMD14, SAMD4B, SAMD9, SAMD9L, SAMHD1, SAP130, SAP25, SAP30BP, SAP30L, SAPCD2, SARAF, SARDH, SARS2, SART1, SART3, SASS6, SAT1, SAT2, SATB1-AS1, SAV1, SBDSP1, SBF2, SBF2-AS1, SBNO1, SCAF1, SCAF11, SCAF8, SCAI, SCAMPI, SCAMP2, SCAMP3, SCAMP4, SCAMP5, SCAP, SCAPER, SCARB1, SCARB2, SCARF2, SCFD1, SCFD2, SCG3, SCG5, SCHIP1, SCLT1, SCLY, SCMH1, SCML2, SCML4, SCN8A, SCN9A, SCNM1, SCOC-AS1, SCPEP1, SCRIB, SCRN1, SCUBE2, SCYL1, SCYL2, SDC2, SDCBP2-AS1, SDCCAG3, SDCCAG8, SDE2, SDHA, SDHAF2, SDHAF3, SDHAP1, SDHC, SDHD, SDR39U1, SDSL, SEC11C, SEC14L1, SEC14L2, SEC16A, SEC22A, SEC22B, SEC22C, SEC24A, SEC24B, SEC24C, SEC31A, SEC31B, SEC61A2, SEC62, SECISBP2, SECISBP2L, SEH1L, SEL1L, SELENBP1, SELENOH, SELENOK, SEMI, SEMA3A, SEMA3F, SEMA4A, SEMA4B, SEMA4C, SEMA4D, SEMA4F, SEMA5A, SEMA6C, SEMA6D, SEMA7A, SENP1, SENP2, SENP3, SENP3-EIF4A1, SENP5, SENP6,
SENP7, SEPHS1, SEPSECS, SEPT10, SEPT2, SEPT3, SEPT7, SEPT7P2, SEPT9, SERAC1, SERF2, SERGEF, SERINC5, SERPINA1, SERTAD4, SERTAD4-AS1, SESN1, SESTD1, SETD2, SETD3, SETD4, SETD5, SETD9, SETDB1, SETDB2, SETDB2-PHF11, SETMAR, SETX, SEZ6L, SEZ6L2, SF1, SF3A2, SF3A3, SF3B3, SF3B6, SFI1, SFMBT1, SFMBT2, SFT2D1, SFT2D2, SFXN1, SFXN2, SFXN4, SFXN5, SGCB, SGCE, SGCG, SGIP1, SGK3, SGK494, SGMS1, SGO1, SGPL1, SGSM2, SGSM3, SGTB, SH2B1, SH2D4A, SH3BGR, SH3BP1, SH3BP2, SH3BP5, SH3D19, SH3GL1, SH3GL3, SH3GLB1, SH3GLB2, SH3KBP1, SH3PXD2A, SH3PXD2B, SH3YL1, SHANK1, SHANK3, SHARPIN, SHC1, SHC2, SHCBP1, SHF, SHISA4, SHISA5, SHKBP1, SHMT1, SHOC2, SHOX2, SHPK, SHPRH, SHQ1, SIDT1, SIGIRR, SIGLEC1, SIGLEC7, SIGMAR1, SIK2, SIK3, SIKE1, SIL1, SIM1, SIM2, SIMC1, S1N3A, S1PA1L1, S1PA1L2, S1PA1L3, S1RPB1, S1RT2, S1RT3, S1RT5, S1RT6, S1VA1, S1X5, SKA1, SKA2, SKA3, SKAP2, SKP2, SLAIN1, SLAIN2, SLAMF7, SLC10A7, SLC11A1, SLC12A2, SLC12A4, SLC12A6, SLC12A7, SLC12A9, SLC16A10, SLC16A4, SLC17A5, SLC18A1, SLC1A1, SLC1A3, SLC1A4, SLC22A15, SLC22A16, SLC22A18, SLC22A23, SLC22A4, SLC23A2, SLC24A1, SLC25A1, SLC25A10, SLC25A11, SLC25A12, SLC25A13, SLC25A14, SLC25A17, SLC25A19, SLC25A20, SLC25A21, SLC25A23, SLC25A26, SLC25A29, SLC25A30, SLC25A32, SLC25A33, SLC25A36, SLC25A37, SLC25A38, SLC25A39, SLC25A40, SLC25A42, SLC25A43, SLC25A44, SLC25A46, SLC25A53, SLC26A10, SLC26A11, SLC26A6, SLC27A4, SLC27A5, SLC29A1, SLC29A2, SLC29A3, SLC29A4, SLC2A11, SLC2A13, SLC2A14, SLC2A8, SLC2A9, SLC30A4, SLC30A5, SLC30A6, SLC30A9, SLC33A1, SLC35A1, SLC35A2, SLC35A3, SLC35A5, SLC35B1, SLC35B3, SLC35B4, SLC35C2, SLC35D2, SLC35E2A, SLC35E2B, SLC35F2, SLC35F5, SLC35F6, SLC35G1, SLC36A1, SLC36A4, SLC37A1, SLC37A2, SLC37A3, SLC37A4, SLC38A1, SLC38A10, SLC38A2, SLC38A3, SLC38A6, SLC38A7, SLC38A9, SLC39A11, SLC39A14, SLC39A4, SLC39A8, SLC39A9, SLC3A2, SLC41A1, SLC41A2, SLC41A3, SLC43A1, SLC43A2, SLC44A1, SLC44A2, SLC44A5, SLC46A1, SLC47A1, SLC49A3, SLC4A2, SLC4A7, SLC4A8, SLC50A1, SLC5A4-AS1, SLC6A11, SLC6A12, SLC6A2, SLC6A6, SLC6A8, SLC7A11, SLC7A2, SLC7A6, SLC7A8, SLC8A1, SLC8A1-AS1, SLC9A5, SLC9A7, SLC9A8, SLC9B2, SLCO2A1, SLCO4A1, SLF1, SLFN13, SLFN5, SLIT2, SLIT3, SLMAP, SLMO2-ATP5E, SLU7, SLX4, SLX4IP, SMA4, SMAD2, SMAD3, SMAD4, SMAD5,
SMAD9, SMAP2, SMARCA1, SMARCA4, SM ARC ADI, SM ARGAL I, SMARCC1, SMARCC2, SMARCD1, SMARCE1, SMC1A, SMC2, SMC3, SMC4, SMC5, SMC6, SMCHD1, SMC04, SMG1, SMG1P1, SMG1P2, SMG1P3, SMG5, SMG6, SMG7, SMILR, SMIM13, SMIM14, SMIM7, SMN1, SM0C1, SMPD4, SMPDL3A, SMS, SMTN, SMU1, SMUG1, SMURF 1, SMURF2, SMURF2P1-LRRC37BP1, SMYD2, SMYD3, SMYD4, SNAP23, SNAP25, SNAP47, SNAPCI, SNAPC3, SNAPC5, SNAPIN, SNCA, SNCAIP, SNED1, SNF8, SNHG1, SNHG11, SNHG12, SNHG14, SNHG15, SNHG16, SNHG17, SNHG20, SNHG21, SNHG4, SNHG5, SNHG6, SNHG8, SNRK, SNRNP27, SNRNP48, SNRPA1, SNRPC, SNRPD2, SNRPE, SNRPG, SNRPN, SNTB1, SNTB2, SNUPN, SNX1, SNX11, SNX13, SNX14, SNX15, SNX17, SNX2, SNX22, SNX24, SNX25, SNX27, SNX29, SNX30, SNX4, SNX5, SNX6, SNX7, SOAT1, SOBP, SOCS4, SOCS6, SOD2, SOGA1, SOGA3, SON, SORBS1, SORBS2, SORBS3, SORL1, SOS1, SOS2, SOX6, SP100, SP110, SP140L, SP2, SP3, SP4, SPACA9, SPAG1, SPAG16, SPAG4, SPAG5, SPAG6, SPAG9, SPART, SPAST, SPATA13, SPATA17, SPATA20, SPATA2L, SPATA33, SPATA5, SPATA6, SPATA7, SPATS2, SPATS2L, SPC25, SPDL1, SPDYC, SPECC1, SPECC1L, SPECC1L- AD0RA2A, SPEG, SPEN, SPG11, SPG21, SPG7, SPHK2, SPIB, SPICE1, SPIDR, SPIN1, SPINT1, SPIRE 1, SPNS1, SPNS3, SPOP, SPOUT 1, SPP1, SPPL2A, SPPL2B, SPPL3, SPRED2, SPRTN, SPRY4-AS1, SPRYD3, SPRYD7, SPSB4, SPTAN1, SPTBN1, SPTBN2, SPTBN4, SPTLC1, SPTLC2, SQLE, SQOR, SRA1, SRBD1, SRC, SRCAP, SRCIN1, SRD5A1, SRD5A3, SREBF2, SREK1IP1, SRGAP1, SRGAP2, SRM, SRP14-AS1, SRP19, SRP54, SRP54-AS1, SRP72, SRP9, SRPK1, SRPK2, SRPX, SRRM1, SRRM2, SRSF11, SRSF12, SRSF4, SRSF7, SRSF9, SS18, SS18L1, SSBP2, SSBP3, SSBP4, SSC5D, SSFA2, SSH1, SSH2, SSR1, SSSCA1, SSX2IP, ST13, ST I 4, ST20, ST20-MTHFS, ST3GAL1, ST3GAL2, ST3GAL3, ST3GAL4, ST3GAL6, ST5, ST6GAL1, ST6GALNAC3, ST6GALNAC4, ST7, ST7-OT4, ST7L, ST8SIA5, STAC, STAC3, STAG1, STAG2, STAG3L4, STAG3L5P, STAG3L5P- PVRIG2P-PILRB, STAM, STAMBP, STAMBPL1, STAP2, STARD10, STARD13, STARD3NL, STARD4, STARD5, STARD7, STARD9, STAT1, STAT5A, STAT5B, STAU1, STAU2, STEAP3, STIL, STIM1, STIM2, STIMATE, STIP1, STK10, STK11IP, STK16, STK17A, STK25, STK26, STK3, STK32C, STK33, STK36, STK38, STK38L, STK39, STK40, STPG1, STRADA, STRADB, STRBP, STRIP1, STRIP2, STRN, STRN3, STRN4, STT3A,
STT3B, STX10, STX12, STX16, STX16-NPEPL1, STX18, STX18-AS1, STX2, STX3, STX4, STX5, STX6, STX8, STXBP2, STXBP3, STXBP4, STXBP5, STXBP5-AS1, STXBP5L, STYX, STYXL1, SUB1, SUCLA2, SUCLG2, SUCLG2-AS1, SUCO, SUDS3, SUFU, SUGCT, SUGP1, SUGT1, SULF1, SULF2, SUMF1, SUMF2, SUMO1, SUN1, SUN2, SUOX, SUPT20H, SUPT3H, SUPT5H, SUPT7L, SUPV3L1, SURF1, SURF2, SURF4, SUSD1, SUSD3, SUSD6, SUV39H2, SUZ12, SUZ12P1, SVIL, SVIL-AS1, SWT1, SYCE2, SYCP2L, SYDE1, SYDE2, SYNCRIP, SYNE1, SYNE2, SYNE4, SYNGR2, SYNJ1, SYNJ2BP, SYNJ2BP-COX16, SYNPO2, SYNRG, SYP, SYS1-DBNDD2, SYT1, SYT11, SYT14, SYT9, SYTL1, SYTL2, SYTL3, SYVN1, SZRD1, SZT2, TAB2, TAB3, TACC1, TADA1, TADA2A, TADA3, TAF1, TAF11, TAF13, TAF15, TAFIA, TAF1C, TAF1D, TAF2, TAF4, TAF4B, TAF5, TAF5L, TAF6, TAF6L, TAF8, TAF9B, TANCI, TANC2, TANGO2, TANGO6, TANK, TAOK1, TAOK2, TAOK3, TAPT1, TARBP 1, TARBP2, TARS, TARS2, TARSL2, TAS2R31, TASP1, TATDN1, TATDN3, TAZ, TBC1D1, TBC1D10A, TBC1D12, TBC1D13, TBC1D14, TBC1D15, TBC1D16, TBC1D17, TBC1D19, TBC1D20, TBC1D22A, TBC1D22B, TBC1D23, TBC1D25, TBC1D2B, TBC1D30, TBC1D31, TBC1D32, TBC1D4, TBC1D5, TBC1D7, TBC1D7-LOC100130357, TBC1D8, TBC1D8B, TBC1D9, TBCCD1, TBCD, TBCEL, TBCK, TBK1, TBL1X, TBL1XR1, TBL3, TBPL1, TBRG1, TBRG4, TBX1, TBX15, TBX2-AS1, TBX6, TBXA2R, TBXAS1, TC2N, TCAIM, TCEA1, TCEAL1, TCEAL3, TCEAL8, TCEAL9, TCERG1, TCF12, TCF20, TCF25, TCF3, TCF4, TCF7, TCF7L1, TCF7L2, TCFL5, TCOF1, TCP11L1, TCP11L2, TCTEX1D2, TCTN1, TCTN3, TDG, TDP1, TDP2, TDRD3, TEAD1, TEAD2, TEAD4, TECPR1, TECPR2, TEDC1, TEFM, TEKT4P2, TELO2, TENM1, TENM2, TENM3, TENM4, TEPSIN, TERFI, TERF2, TES, TESK2, TESMIN, TET1, TET2, TET2-AS1, TEX10, TEX14, TEX15, TEX261, TEX30, TEX41, TEX9, TFAM, TFAP2B, TFAP4, TFB1M, TFB2M, TFCP2, TFDP1, TFDP2, TFE3, TFEB, TFEC, TFIP11, TFPI, TFR2, TFRC, TGDS, TGFBR1, TGIF2, TGIF2-C20orf24, TGS1, THADA, THAP1, THAP12, THAP3, THAP5, THAP6, THAP9, THBS3, THBS4, THEM4, THEMIS, THEMIS2, THOC1, THOC2, THOC5, THOC6, THOC7, THRAP3, THRB, THSD4, THSD7A, THUMPD3, THYN1, TIA1, TIAL1, TIGAR, TIGD6, TIMELESS, TIMM17B, TIMM21, TIMM23, TIMM23B, TIMM50, TIMM9, TIMMDC1, TINF2, TIPIN, TIPRL, TIRAP, TJAP1, TJP1, TKFC, TLCD2, TLE1, TLE4, TLK1, TLK2, TLL2, TLN1, TLX2, TM2D1, TM2D3, TM7SF3, TM9SF1, TM9SF3, TM9SF4,
TMA16, TMBIM4, TMC6, TMCC1, TMC03, TMC04, TMC06, TMED3, TMED7-TICAM2, TMEFF2, TMEM104, TMEM106A, TMEM106B, TMEM106C, TMEM107, TMEM108, TMEM11, TMEM110-MUSTN1, TMEM116, TMEM117, TMEM120A, TMEM120B, TMEM126A, TMEM126B, TMEM131, TMEM131L, TMEM135, TMEM138, TMEM141, TMEM143, TMEM144, TMEM145, TMEM14B, TMEM14C, TMEM15OA, TMEM15OB, TMEM159, TMEM161A, TMEM161B, TMEM161B-AS1, TMEM164, TMEM167A, TMEM167B, TMEM168, TMEM175, TMEM181, TMEM182, TMEM183B, TMEM185A, TMEM192, TMEM200A, TMEM206, TMEM209, TMEM214, TMEM218, TMEM219, TMEM220, TMEM222, TMEM234, TMEM237, TMEM241, TMEM245, TMEM248, TMEM254, TMEM255A, TMEM255B, TMEM259, TMEM260, TMEM263, TMEM266, TMEM267, TMEM268, TMEM3OA, TMEM33, TMEM38B, TMEM39A, TMEM39B, TMEM41B, TMEM44, TMEM45A, TMEM5OA, TMEM5OB, TMEM51, TMEM53, TMEM56- RWDD3, TMEM62, TMEM63A, TMEM63B, TMEM65, TMEM67, TMEM68, TMEM70, TMEM71, TMEM87A, TMEM87B, TMEM94, TMEM98, TMEM9B, TMOD1, TMOD2, TMOD3, TMOD4, TMPO, TMSB15B, TMTC1, TMTC2, TMTC3, TMUB1, TMUB2, TMX1, TMX2, TMX2-CTNND1, TMX3, TNC, TNFAIP8, TNFAIP8L2-SCNM1, TNFRSF10A, TNFRSF11A, TNFRSF12A, TNFRSF19, TNFRSF1A, TNFRSF6B, TNFSF12, TNFSF12- TNFSF13, TNFSF13, TNIK, TNIP1, TNIP2, TNIP3, TNK2, TNKS, TNKS2, TNNT1, TNPO1, TNPO3, TNR, TNRC18, TNRC6A, TNRC6B, TNRC6C, TNS1, TOBI, TOE1, TOGARAMI, TOLLIP, TOMI, TOM1L1, TOM1L2, TOMM34, TOMM40, TOMM40L, TOMM70, TOPI, TOP2A, TOP2B, TOP3A, TOP3B, TOPBP1, TOR1AIP2, TOR1B, TOR2A, TOR3A, TP53BP2, TP53I3, TP53TG1, TP73, TP73-AS1, TPCN2, TPD52, TPD52L1, TPD52L2, TPGS2, TPK1, TPM1, TPM2, TPM3, TPM3P9, TPMT, TPP2, TPR, TPRA1, TPRG1L, TPST1, TPST2, TPT1- AS1, TPTE2P5, TPTEP1, TPX2, TRABD2A, TRAF2, TRAF3, TRAF3IP1, TRAF3IP2, TRAF3IP2-AS1, TRAIP, TRAK1, TRAK2, TRAM1, TRAM2, TRANK1, TRAPPC10, TRAPPC12, TRAPPC13, TRAPPC2, TRAPPC2L, TRAPPC3, TRAPPC4, TRAPPC6A, TRAPPC6B, TRAPPC8, TRAPPC9, TRDMT1, TRERF1, TRIM I 6, TRIM16L, TRIM2, TRIM23, TRIM24, TRIM26, TRIM28, TRIM33, TRIM35, TRIM36, TRIM37, TRIM44, TRIM59-IFT80, TRIM65, TRIM68, TRIM73, TRIM9, TRIO, TRIP10, TRIP12, TRIP13, TRIP4, TRIP6, TRIQK, TRIT1, TRMO, TRMT1, TRMT10A, TRMT11, TRMT1L, TRMT2A,
TRMT2B, TRMT6, TRMT61A, TRMT61B, TRMU, TRNAU1AP, TRNT1, TRO, TROVE2, TRPC1, TRPC4, TRPC4AP, TRPM2, TRPM4, TRPM7, TRPS1, TRPT1, TRPV1, TRPV2, TRRAP, TRUB1, TSACC, TSC2, TSC22D1, TSC22D2, TSC22D4, TSEN15, TSEN2, TSEN54, TSFM, TSG101, TSGA10, TSHZ2, TSKS, TSNARE1, TSNAX, TSNAXIP1, TSPAN12,
TSPAN13, TSPAN14, TSPAN15, TSPAN17, TSPAN18, TSPAN31, TSPAN4, TSPAN5,
TSPAN9, TSP0AP1-AS1, TSR1, TSR3, TSSC2, TSTD2, TSTD3, TTBK1, TTBK2, TTC12,
TTC13, TTC17, TTC21B, TTC23, TTC26, TTC27, TTC28-AS1, TTC3, TTC31, TTC33,
TTC37, TTC39A, TTC39B, TTC39C, TTC4, TTC5, TTC7A, TTC7B, TTC8, TTF1, TTF2,
TTI1, TTI2, TTK, TTL, TTLL11, TTLL4, TTLL5, TTLL7, TTN-AS1, TTP AL, TTTY14, TTYH2, TTYH3, TUB, TUBB6, TUBD1, TUBE1, TUBG2, TUBGCP2, TUBGCP3, TUBGCP4, TUBGCP5, TUBGCP6, TUFT1, TULP3, TULP4, TUT1, TVP23A, TVP23C, TVP23C-CDRT4, TWF1, TWF2, TWNK, TXK, TXLNA, TXLNG, TXN, TXNDC11, TXNDC15, TXNDC16, TXNDC9, TXNL4A, TYK2, TYR03, TYSND1, TYW1, TYW1B, TYW3, TYW5, U2AF1, U2AF1L4, U2AF1L5, U2AF2, U2SURP, UACA, UAP1, UBA2, UBA3, UBA5, UBA6, UBA7, UBAC2, UBAP1, UBAP2, UBAP2L, UBE2A, UBE2B, UBE2D1, UBE2D2, UBE2D3, UBE2D4, UBE2E3, UBE2F, UBE2F-SCLY, UBE2G1, UBE2G2, UBE2H, UBE2J1, UBE2J2, UBE2K, UBE2L3, UBE2Q1, UBE2Q2, UBE2Q2P1, UBE2Q2P2, UBE2R2, UBE2W, UBE2Z, UBE3A, UBE3B, UBE3C, UBE3D, UBE4A, UBE4B, UBFD1, UBIAD1, UBL7, UBN1, UBN2, UB0X5, UBP1, UBQLN1, UBQLN4, UBR1, UBR2, UBR3, UBR4, UBR5, UBR7, UBTF, UBXN1, UBXN11, UBXN2A, UBXN2B, UBXN4, UBXN6, UBXN7, UCHL1, UCHL5, UCP2, UEVLD, UFC1, UFD1, UFM1, UFSP2, UGDH, UGGT2, UGP2, UGT8, UHRF1, UHRF1BP1, UHRF2, UIMC1, ULK2, ULK3, ULK4, ULK4P1, ULK4P2, ULK4P3, UMAD1, UNCI 19, UNC119B, UNC13A, UNC13B, UNC45A, UNC50, UNC5B, UNC5C, UNG, UNK, UPF2, UPF3A, UPF3B, UPP1, UPRT, UQCC1, UQCRH, URB1, URB2, URGCP, URGCP-MRPS24, URI1, URM1, UROS, USB1, USE1, USF2, USO1, USP1, USP10, USP12, USP13, USP14, USP15, USP16, USP19, USP2-AS1, USP21, USP22, USP24, USP25, USP28, USP3, USP30, USP31, USP32, USP33, USP34, USP37, USP38, USP39, USP4, USP40, USP42, USP43, USP45, USP46, USP47, USP48, USP49, USP53, USP54, USP6NL, USP8, USP9Y, USPL1, UTP15, UTP18, UTP23, UTP4, UTP6, UTRN, UTY, UXS1, UXT, VAC 14, VAMP3, VAMP4, VAPB, VASH2, VAV1, VAV2,
VAV3, VCAN, VCL, VCP, VDAC1, VDAC2, VDAC3, VDR, VEGFA, VEGFB, VEGFC, VEPH1, VEZT, VGF, VGLL4, VHL, VIPAS39, VIRMA, VIT, VK0RC1, VKORC1L1, VLDLR, VMP1, VOPP1, VPS13A, VPS13B, VPS13C, VPS13D, VPS26A, VPS26C, VPS28, VPS29, VPS33A, VPS33B, VPS35, VPS35L, VPS36, VPS37A, VPS37B, VPS41, VPS50, VPS53, VPS54, VPS72, VPS8, VPS9D1-AS1, VRK1, VRK3, VSIG10, VSNL1, VSTM2L, VTI1A, VTI1B, VWA8, WAC, WARS2, WASF1, WASF3, WASH3P, WASHC2A, WASHC2C, WASHC3, WASHC4, WASHC5, WBP2, WBP4, WDFY1, WDFY2, WDFY3, WDFY3-AS2, WDFY4, WDHD1, WDPCP, WDR1, WDR11, WDR12, WDR18, WDR19, WDR20, WDR25, WDR27, WDR33, WDR34, WDR35, WDR36, WDR37, WDR4, WDR41, WDR43, WDR44, WDR45, WDR48, WDR53, WDR54, WDR59, WDR60, WDR61, WDR62, WDR66, WDR7, WDR70, WDR73, WDR75, WDR77, WDR81, WDR82, WDR83, WDR89, WDR90, WDR92, WDSUB1, WHAMM, WHAMMP2, WIPF1, WIPF2, WIPI2, WISP1, WIZ, WLS, WNK1, WNK2, WNK4, WNT3, WRAP73, WRB-SH3BGR, WRN, WRNIP1, WSB1, WSB2, WSCD1, WTAP, WWC1, WWC2, WWC3, WWOX, WWP2, XAF1, XG, XGY2, XIAP, XIST, XKR6, XPA, XPNPEP1, XPNPEP3, XPO1, XPO4, XPO5, XPO6, XPO7, XPOT, XPR1, XRCC2, XRCC3, XRCC4, XRN1, XRN2, XRRA1, XXYLT1, XYLB, YAF2, YAP1, YARS2, YBEY, YDJC, YEATS2, YEATS4, YES1, YIF1A, YIPF1, YIPF2, YIPF4, YIPF6, YJEFN3, YKT6, YME1L1, YPEL3, YPEL4, YPEL5, YTHDC2, YTHDF1, YTHDF2, YTHDF3, YWHAZ, YY1AP1, ZBED3, ZBED3-AS1, ZBED6, ZBTB1, ZBTB14, ZBTB20, ZBTB21, ZBTB24, ZBTB25, ZBTB43, ZBTB44, ZBTB48, ZBTB49, ZBTB7B, ZBTB8A, ZBTB8OS, ZC2HC1A, ZC3H10, ZC3H11A, ZC3H13, ZC3H14, ZC3H18, ZC3H3, ZC3H4, ZC3H7A, ZC3H7B, ZC3HC1, ZCCHC10, ZCCHC11, ZCCHC4, ZCCHC6, ZCCHC7, ZCCHC8, ZCCHC9, ZCWPW1, ZCWPW2, ZDBF2, ZDHHC13, ZDHHC14, ZDHHC16, ZDHHC17, ZDHHC18, ZDHHC2, ZDHHC20, ZDHHC21, ZDHHC3, ZDHHC4, ZDHHC6, ZDHHC7, ZDHHC9, ZEB2, ZER1, ZFAND1, ZFAND3, ZFAND5, ZFAND6, ZFAS1, ZFAT, ZFC3H1, ZFP1, ZFP30, ZFP41, ZFP62, ZFP64, ZFP91, ZFP91-CNTF, ZFPM1, ZFPM2-AS1, ZFR, ZFR2, ZFX, ZFY, ZFYVE1, ZFYVE16, ZFYVE19, ZFYVE21, ZFYVE27, ZFYVE28, ZFYVE9, ZGRF1, ZHX1-C8orf76, ZHX2, ZHX3, ZIK1, ZIM2, ZKSCAN1, ZKSCAN3, ZKSCAN5, ZKSCAN7, ZKSCAN8, ZMAT2, ZMAT3, ZMAT4, ZMAT5, ZMIZ1, ZMIZ2, ZMPSTE24, ZMYM2, ZMYM4, ZMYM5, ZMYM6, ZMYND11, ZMYND8, ZNF10, ZNF100,
ZNF106, ZNF107, ZNF112, ZNF121, ZNF124, ZNF131, ZNF133, ZNF136, ZNF138, ZNF140, ZNF141, ZNF142, ZNF143, ZNF146, ZNF148, ZNF160, ZNF189, ZNF195, ZNF197, ZNF202, ZNF207, ZNF211, ZNF213, ZNF215, ZNF225, ZNF227, ZNF23, ZNF232, ZNF236, ZNF236- DT, ZNF239, ZNF248, ZNF25, ZNF250, ZNF251, ZNF252P, ZNF253, ZNF254, ZNF257, ZNF26, ZNF260, ZNF263, ZNF266, ZNF267, ZNF268, ZNF273, ZNF274, ZNF277, ZNF28, ZNF280D, ZNF283, ZNF286A, ZNF292, ZNF3, ZNF30, ZNF300, ZNF302, ZNF316, ZNF317, ZNF319, ZNF320, ZNF322, ZNF326, ZNF329, ZNF330, ZNF33A, ZNF33B, ZNF343, ZNF346, ZNF35, ZNF350, ZNF354A, ZNF354B, ZNF354C, ZNF365, ZNF367, ZNF37A, ZNF383, ZNF384, ZNF385B, ZNF385D, ZNF395, ZNF397, ZNF398, ZNF410, ZNF415, ZNF416, ZNF419, ZNF420, ZNF426, ZNF429, ZNF431, ZNF433, ZNF433-AS1, ZNF438, ZNF439, ZNF44, ZNF445, ZNF446, ZNF45, ZNF451, ZNF461, ZNF480, ZNF484, ZNF485, ZNF487, ZNF490, ZNF493, ZNF496, ZNF502, ZNF506, ZNF507, ZNF510, ZNF512, ZNF518A, ZNF519, ZNF521, ZNF528, ZNF529, ZNF529-AS1, ZNF530, ZNF532, ZNF544, ZNF559, ZNF559-ZNF177, ZNF561, ZNF561-AS1, ZNF562, ZNF567, ZNF568, ZNF569, ZNF571, ZNF581, ZNF584, ZNF585A, ZNF585B, ZNF589, ZNF592, ZNF594, ZNF595, ZNF600, ZNF607, ZNF611, ZNF613, ZNF614, ZNF616, ZNF618, ZNF619, ZNF620, ZNF623, ZNF626, ZNF638, ZNF639, ZNF641, ZNF644, ZNF652, ZNF654, ZNF655, ZNF660-ZNF 197, ZNF664, ZNF664-RFLNA, ZNF667, ZNF670-ZNF695, ZNF674, ZNF678, ZNF680, ZNF681, ZNF691, ZNF692, ZNF695, ZNF7, ZNF702P, ZNF707, ZNF708, ZNF71, ZNF711, ZNF714, ZNF718, ZNF720, ZNF721, ZNF736, ZNF737, ZNF74, ZNF75D, ZNF76, ZNF761, ZNF765- ZNF761, ZNF766, ZNF770, ZNF772, ZNF773, ZNF775, ZNF776, ZNF778, ZNF780A, ZNF780B, ZNF781, ZNF782, ZNF783, ZNF789, ZNF79, ZNF790, ZNF790-AS1, ZNF8, ZNF808, ZNF821, ZNF826P, ZNF827, ZNF83, ZNF837, ZNF839, ZNF846, ZNF85, ZNF853, ZNF862, ZNF883, ZNF90, ZNF91, ZNF92, ZNHIT3, ZNHIT6, ZNRF1, ZRANB1, ZRANB2- AS2, ZRANB3, ZSCAN18, ZSCAN2, ZSCAN25, ZSCAN30, ZSCAN32, ZSCAN5A, ZSWIM3, ZSWIM4, ZSWIM7, ZSWIM8, ZWILCH, ZXDC, ZYGI 1A, ZYX, ZZEF1, ZZZ3
Genes exhibiting APSI >+50 and <-50
[00523] RNAseq experiments showed that compounds of Formula (I) induced exon inclusion with a PSI change (APSI) of +50% to +100% and P-value <0.001 or induced exon skipping with a APSI of -50% to -100% and L-value <0.001 in 2629 genes as shown in Table 13:
[00524] Table 13
CCDC112, CCDC125, CCDC127, CCDC14, CCDC169, CCDC169-SOHLH2, CCDC171, CCDC18, CCDC183, CCDC183-AS1, CCDC188, CCDC191, CCDC192, CCDC25, CCDC26, CCDC32, CCDC40, CCDC57, CCDC58, CCDC66, CCDC7, CCDC78, CCDC82, CCDC85C, CCDC88A, CCDC88C, CCDC9, CCDC91, CCND3, CCNI, CCNQ, CCNT2, CCNYL1, CCNYL2, CD 164, CD24, CD2AP, CD36, CDADC1, CDC14A, CDC16, CDC25C, CDC42BPA, CDC42SE2, CDH24, CDK11B, CDK19, CDK5RAP1, CDK7, CD01, CDON, CDS1, CDYL, CEACAM1, CEBPZOS, CELSR2, CELSR3, CENPE, CENPH, CENPI, CENPM, CENPO, CENPT, CEP 112, CEP 128, CEP 131, CEP 164, CEP 170, CEP 192, CEP290, CEP295, CEP350, CEP41, CEP44, CEP63, CEP70, CEP72, CEP76, CEP78, CEP83, CEP85, CEP85L, CEP97, CERCAM, CERS4, CERS5, CES2, CES4A, CFAP206, CFAP299, CFAP44, CFAP58, CGRRF1, CHD1 , CHD1L, CHD6, CHD9, CHEK1 , CHEK2, CHFR, CHM, CHN1 , CHRNA3, CHST10, CHST9, CIP2A, CIT, CIZ1, CKAP2L, CKMT1A, CLASP 1, CLCC1, CLDND1, CLEC16A, CLEC5A, CLIP2, CLK2, CLN3, CLSPN, CLTCL1, CMSS1, CMTM7, CMTR1, CNEP1R1, CNIH3, CNNM1, CNNM2, CNOT1, CNOTIO, CNOT2, CNOT6, CNTN1, CNTNAP1, CNTNAP3, CNTRL, COL1A2-AS1, COL23A1, COL24A1, COL25A1, COL26A1, COL4A5, COP1, COQ3, COQ6, COQ8A, CPEB3, CPNE5, CPSF7, CPT2, CPXM1, CRACR2A, CRB1, CRBN, CREB3L4, CRELD1, CRLS1, CRNDE, CROCC, CRTC3, CRYBG3, CRYL1, CRYZ, CSNK1G1, CSNK1G3, CSPP1, CSRNP2, CSRNP3, CSTF3, CTBP2, CTDP1, CTIF, CTNNBL1, CTNS, CTSF, CUBN, CUEDC1, CUL7, CUTC, CWF19L1, CXorf38, CYB561D2, CYB5RL, CYBC1, CYP20A1, CYP2U1, CYP39A1, CYTOR, CZ1P-ASNS, D2HGDH, DAAM1, DAPK1, DAZAP2, DBF4, DBF4B, DBT, DCAF10, DCAF11, DCAF17, DCBLD2, DCLRE1C, DCP1B, DCST1-AS1, DCUN1D2, DCUN1D4, DDC, DDIAS, DDX11, DDX12P, DDX19B, DDX60, DEAF1, DECR2, DEF8, DENND1A, DENND2C, DENND3, DENND4B, DENND4C, DENND5A, DENND5B, DENND6A, DEPDC1B, DESI1, DFFB, DGKA, DGKI, DGKZ, DHDDS, DHPS, DHRS12, DHRS4L2, DHTKD1, DHX33, DHX35, DHX37, DHX57, DIAPH2, DICER 1, DICER 1 -AS 1, DIMT1, DIP2A, DISP1, DLEU1, DLEU2, DLG1, DLGAP4-AS1, DLST, DMC1, DMD, DMPK, DMTF1, DMXL1, DMXL2, DNA2, DNAAF4, DNAAF4-CCPG1, DNAAF5, DNAH10, DNAH14, DNAJB12, DNAJC19, DNAJC21, DNAJC4, DNM1L, DNM3, DNMT3A, DNPEP, DOC2B, DOCK11, DOCK7, DONSON, DOPEY1, DOT1L, DPCD, DPF1, DPH3, DPH5, DPY19L2, DPY19L3, DPY19L4, DPYD, DPYSL5, DRAM2, DROSHA, DSE, DST, DSTYK, DTD2, DTNA, DTNB, DTNBP1, DUS2, DUSP11, DUSP22, DUXAP10, DUXAP8, DYM, DYNC1LI2, DYNC2LI1, DYRK3, DYSF, DZIP3, E2F6, EBF1, EBF4, EBPL, EDEM3, EEF1AKMT2, EFCAB13, EFS, EIF1AX, EIF2AK2, EIF2AK4, EIF4E2, ELF2, ELMO2, ELMOD1, ELMOD3, ELN, ELOVL2, ELOVL7, ELP2, EMB, EMC2, EMC3-AS1, EMIDI, EML4, EML6, EMSY, ENDOV, ENOXI, ENTPD1-AS1, ENTPD5, ENTPD6, EOGT, EP300, EP400P1, EPB41, EPB41L1, EPB41L4A, EPB41L5, EPG5, EPHA6, EPHX4, EPN2, EPS8, ERC1, ERGIC1, ERI1, ERICH1, ERLIN1, ERMAP, ERMARD, ERO1A, ERVK13-1, ESD, ETFDH, ETHE1, EVC, EVI5, EXD2, EXD3, EXOCI, EXOC3, EXOC6, EYA1, EYA4, F8, FAHD2A, FAM105A, FAM111 A, FAM114A2, FAM118B, FAM120B, FAM122C, FAM133B, FAM133DP, FAM135A, FAM13A, FAM13B, FAM151B, FAM157A, FAM157B, FAM160A1, FAM169A, FAM171A1, FAM172A, FAM173B, FAM184A, FAM189B, FAM193B, FAM206A, FAM207A, FAM208A, FAM208B, FAM212B-AS1, FAM219B, FAM35A, FAM3A, FAM3C, FAM45A, FAM45BP, FAM53B, FAM66A, FAM78B, FAM81A, FAM92A, FANCA, FANCD2, FANCE, FANCI, FANCL, FANCM, FANK1, FARP2, FAT1, FAT3,
FBRSL1, FBXL13, FBXO16, FBXO22, FBXO38, FBXO44, FBXO9, FBXW11, FBXW8, FBXW9, FCF1, FDX1, FER, FER1L4, FGF12, FGGY, FHAD1, FHOD3, FIG4, FIP1L1, FKBP15, FKTN, FMRI, FNIP1, FOXJ3, FOXN3, FOXP2, FOXRED1, FPGT-TNNI3K, FRAS1, FRG1-DT, FRG1BP, FRG1CP, FRG1HP, FRG1JP, FRMD4A, FRMPD4, FRYL, FSD1L, FSTL5, FTX, FUBP1, FUK, FUT10, FXR2, FYN, FZD3, G2E3, G6PC3, GAB2, GABPA, GALNT13, GALNT18, GALNT6, GALT, GAPVD1, GARNL3, GAS2L1, GAS2L3, GATA2-AS1, GATB, GBA2, GBAP1, GBF1, GCA, GCH1, GCNT2, GDPD5, GEMIN2, GEMIN8, GEN1, GFM2, GGA1, GGCX, GGT5, GIGYF2, GINS1, GINS3, GIT1, GIT2, GLB1, GLMN, GLS, GLS2, GLYR1, GMDS-AS1, GMIP, GMPR2, GNAS-AS1, GNG7, GNPTG, GOLGA2, GOLGA2P10, GOLGA3, GOLGA4, GOLGA6L10, GOLGA6L17P, GOLGA6L9, GOLT1B, GON4L, GOSR2, GPATCH2, GPATCH2L, GPBP1 , GPCPD1, GPR107, GPR137, GPR137C, GPR155, GPR173, GPR176, GPR180, GPR85, GPR89A, GPRASP1, GREB1L, GRIN2D, GRIN3B, GRIP API, GRK3, GRK4, GRM7, GRTP1, GSl-124K5. i l, GSAP, GSK3B, GSTCD, GTF2H1, GTF2H2, GTF2H2B, GTF2I, GTF2IP1, GTF2IP20, GTF2IP4, GTF2IRD1, GTF3C2, GTPBP2, GUCD1, GUF1, GUSBP1, GUSBP11, GVQW2, HACD1, HACE1, HACL1, HADHB, HAGHL, HDAC1, HDAC8, HDX, HEATR3, HEATR5A, HEATR5B, HECTD4, HECW1, HEMK1, HERC1, HERC2, HERC2P3, HERC2P9, HERC3, HERC4, HERC5, HERC6, HERPUD2, HEXDC, HFM1, HGF, HGSNAT, HHAT, HIBADH, HIBCH, HIRA, HIVEP1, HIVEP3, HMGN5, HNRNPA1, HNRNPUL1, HOGA1, HOOK3, HOXA9, HOXB8, HOXC4, HPS1, HPS3, HPS4, HR, HRAT17, HSCB, HSD17B14, HSD17B4, HSD17B7P2, HSF2BP, HSPA12A, HTD2, HTT, HYAL3, ICA1, ICA1L, IDE, IDH3G, IFI27L1, IFNAR2, IFT122, IFT140, IFT172, IFT80, IFT88, IGDCC4, IGF2BP2, IKBKB, IKZF5, IL11RA, IL15, IL17RB, IL17RC, IL17RE, IL18RAP, IL4R, IMMP1L, IMMP2L, ING3, ING4, INMT-MINDY4, INO80C, INPP5E, INPP5F, INPP5K, INPPL1, INTS13, INTS4P2, INTS8, INTU, IPO11, IPO8, IQCB1, IQCE, IQCG, IQCH, IQCH-AS1, IQCK, IQSEC1, IRAK2, IRAK3, IRF3, IST1, ITGA10, ITGA3, ITGAE, ITGAM, ITPR1, ITSN1, IVD, JADE2, JAK3, JARID2, JMJD1C, JPX, KANK1, KANSL1L, KAT6B, KAT7, KATNAL1, KATNAL2, KATNBL1, KAZN, KCNG1, KCNQ1, KCNQ5, KCNT2, KCTD14, KCTD20, KCTD9, KDM1B, KDM4B, KDM4C, KDM4D, KDM6A, KDM7A, KIAA0100, KIAA0319L, KIAA0556, KIAA0825, KIAA0895L, KIAA1324, KIAA1468, KIAA1671, KIAA1841, KIAA2026, KIDINS220, KIF13A, KIF13B, KIF14, KIF21A, KIF24, KIF27, KIF3A, KIF9, KITLG, KLC1, KLHDC4, KLHL2, KLHL20, KLHL22, KLRD1, KLRG1, KLRG2, KMT2B, KMT5C, KNL1, KREMEN1, KYAT3, L1CAM, L3MBTL2, LAMA3, LAMP5, LARP1B, LARS, LAS1L, LAT, LBHD1, LBX2, LCMT1, LCORL, LDLRAD3, LDLRAD4, LENEP, LEPR, LEPROTL1, LETMD1, LGALS9, LGR4, LGR5, L1G1, L1MCH1, L1N52, L1N54, L1NC- PINT, LINC00240, LINC00265, LINC00337, LINC00426, LINC00473, LINC00578, LINC00607, LINC00624, LINC00630, LINC00888, LINC01060, LINC01085, LINC01088, LINC01169, LINC01237, LINC01250, LINC01358, LINC01572, LINC01684, LINC01876, LINC01881, LINC01894, LINC01934, LINC02062, LINC02511, LINC02542, LINGO1, LINGO2, LIPE-AS1, LMBR1, LMBR1L, LMBRD1, LMO7, LOC100128253, LOC100128885, LGC100130027, LGC100133091, LOC100133315, LOC100233156, LOC100287944, LOC100288637, LOC100288778, LOC100288798, LGC100420587, LGC100505938, LGC100506023, LGC100506207, LOC100506476, LGC100506844, LGC100506990, LGC100507291, LGC100507377, LOC100507557, LOC100996724, LGC101060091, LOC101448202, LOC101927027, LOC101927043, LOC101927056, LOC101927359,
LOC101928605, LOC101928673, LOC101929140, LOC101929709, LOC101929710, LOC102606465, LOC102724532, LOC102724593, LOC105372273, LOC107984974, LOCI 10117498-PIK3R3, LOC145694, LOC150776, LOC283683, LOC284581, LOC339862, LOC389765, LOC389906, LOC399815, LOC400464, LOC400927, LOC400927-CSNK1E, LOC441242, LOC642852, LOC645166, LOC653080, LOC727751, LOC728730, LOC729732, LOC729970, LONP2, LOXL2, LPAR1, LPAR2, LPCAT2, LPCAT4, LPIN1, LPP, LRCH3, LRIG1, LRIG3, LRMDA, LRP1, LRP2, LRP8, LRRC28, LRRC34, LRRC37A2, LRRC37B, LRRC40, LRRC58, LRRC6, LRRCC1, LRRFIP2, LRSAM1, LRTOMT, LSM12, LSS, LTB4R, LTBP1, LTBP4, LY75, LY75-CD302, LYPLAL1, LYRM7, LYSMD4, LYST, LZTFL1, MACF1, MACROD2, MAD1L1, MADD, MAGEA2B, MAGI2, MAGI2-AS3, MAGI3, MAML3, MANBAL, MANEAL, MAP1LC3B, MAP2, MAP2K4, MAP2K5, MAP2K6, MAP3K20, MAP3K21, MAP3K3, MAP3K5, MAP4K2, MAP4K3, MAPK10, MAPK11, MAPK13, MAPK7, MAPK8, MAPKAPK5, MARCH !, MARCH6, MARF I , MARK ! , MAST4, MBD5, MB IP, MBNL2, MBOAT2, MBTD1, MCCC2, MCOLN1, MCOLN3, MCRS1, MCTP1, MCTP2, MDM1, MDM2, MDN1, MECR, MED1, MED12, MED12L, MED15, MED23, MED25, MED27, MEF2A, MEF2C-AS1, MEG3, MEGF8, ME1S1, MELTF, MEMO1, MERTK, METTL14, METTL21A, METTL22, METTL8, MFF, MFGE8, MFSD12, MFSD14B, MFSD8, MFSD9, MGA, MGAT4C, MGAT5, MGEA5, MIA3, MIATNB, MICAL1, MICAL2, MICALL1, MICB, MIDI, MIF4GD, MIGA1, MINDY2, MINDY3, MINDY4, MINK1, MIPEPP3, MIPOL1, MIR1268A, MIR548G, MIR548N, MIR570HG, MIR924HG, MIR99AHG, MITD1, MITF, MKI67, MKL1, MKL2, MKNK1, MKS1, MLC1, MLF1, MLH1, MLXIP, MMAB, MMP16, MMP24-AS 1 -EDEM2, MMS19, MMS22L, MNAT1, MND1, MOCS1, MOK, MORN3, MOSPD1, MOSPD2, MPDZ, MPHOSPH9, MPND, MPP3, MRAS, MRC1, MRNIP, MROH1, MROH6, MRPL43, MRPS30-DT, MRRF, MRVI1, MS4A3, MS4A7, MSC- AS1, MSI1, MSTO1, MTCH2, MTERF4, MTHFD2L, MTHFSD, MTMR1, MTMR3, MTMR6, MTMR7, MTMR8, MTR, MTRR, MUTYH, MVB12B, MYBL1, MYBL2, MYH14, MYHAS, MYLK, MYO18A, MYO1B, MYO5A, MYO5B, MYO5C, MYO9A, MYOM2, MYSM1, N4BP2, N4BP2L2, NAA25, NAA40, NAALAD2, NADK, NAGK, NAGPA, NAPG, NARS2, NAV2, NAXD, NBAS, NBEA, NBEAL1, NBEAL2, NBN, NBPF1, NBPF10, NBPF11, NBPF12, NBPF14, NBPF19, NBPF20, NBPF25P, NBPF26, NBPF3, NBPF8, NBPF9, NCALD, NCKAP5, NCOA1, NCOA2, NCOA6, NCOR2, NCSTN, NDC1, NDOR1, NDRG2, NDRG3, NDUFA10, NDUFA6-AS1, NDUFAF5, NDUFAF6, NDUFB6, NDUFC2-KCTD14, NECAB3, NEDD4L, NEIL3, NEK1, NEK 10, NEK11, NEK4, NF2, NFATC2, NFATC2IP, NFIX, NFKB1, NFRKB, NHLRC3, NIFK, NIPA2, NIPBL, NKAIN1, NKTR, NLGN1, NLRC5, NMNAT1, NODI, NOLIO, NOL4L, NOMO2, NOS1AP, NOTCH1, NOTCH2, NOTCH3, NOX4, NP1PA1, NPNT, NPRL3, NR2C1, NR6A1, NRCAM, NRDC, NRF1, NRG3, NRG4, NSD1, NSD3, NSF, NSFP1, NSUN6, NT5C2, NTPCR, NTRK1, NTRK3, NUB1, NUBP1, NUBPL, NUDT17, NUDT22, NUMB, NUP153, NUP188, NUP43, NUP54, NUP58, NUP85, NUP98, NUPL2, NUTM2B-AS1, NXN, OARD1, OAZ1, OBSCN, OCA2, OCRL, ODAM, ODF2, ODF2L, OFD1, OGGI, OGT, OIP5, OLFM2, OLMALINC, OMA1, OPA1, OPHN1, OR2A1-AS1, ORAOV1, OSBP2, OSBPL6, OSBPL7, OSBPL8, OSBPL9, OSGEPL1, OSGIN2, OSMR-AS1, 0STF1, OTOGL, OTUD5, OTULIN, OXCT1, OXNAD1, P2RX4, P4HA2, PAAF1, PACRGL, PALLD, PALM2, PALM2-AKAP2, PAN3, PANK2, PANK4, PAOX, PAPD4, PAPD5, PAPD7, PAPOLA, PAPOLG, PAQR3, PAQR7, PARG, PARE, PARP2, PARP4, PARP8, PARPBP, PARVB, PATL1, PAXX, PBRM1, PBX3, PC, PCBD2, PCBP1-AS1, PCBP3, PCCB, PCDH9,
PCED1B, PCGF6, PCID2, PCLO, PCM1, PCMTD2, PCNT, PCNX2, PCNX3, PCSK4, PCSK6, PDCD2L, PDCD6IPP2, PDE10A, PDE3B, PDE4D, PDE4DIP, PDE6B, PDE7A, PDE8A, PDIA5, PDK3, PDLIM2, PDLIM4, PDPK1, PDSS1, PDXDC2P-NPIPB14P, PDZD11, PDZK1, PEAK1, PEAR1, PELI3, PET100, PEX11A, PEX26, PEX6, PEX7, PFDN1, PFKFB3, PGAP1, PGAP3, PGGT1B, PGS1, PHACTR4, PHETA1, PHEX, PHF12, PHF6, PHKA1, PHKA2, PHKG2, PHLDB1, PHLPP2, PHOSPHO2-KLHL23, PI4KA, PIC ALM, PICK1, PIGB, PIGG, PIGK, PIGL, PIGN, PIGQ, PIGT, PIK3C2A, PIK3C3, PIK3CB, PIKFYVE, PIP4K2C, PIP5K1A, PITPNA, PITPNC1, PITPNM2, PKD1, PKD1P1, PKD1P4-NPIPA8, PKDCC, PKIB, PKNOX2, PKP4, PLA2GI2A, PLA2G4A, PLA2G4B, PLA2G6, PLACI, PLAGLI, PLAT, PLB1, PLBD2, PLCB4, PLCG2, PLCL1, PLD1, PLEKHA1, PLEKHA4, PLEKHA5, PLEKHA6, PLEKHA7, PLEKHG2, PLEKHG4, PLEKHM3, PLPP4, PLPP5, PLRG1, PMS1, PMS2, PMS2P1, PMS2P5, PNPLA6, POC1A, POC1B, POFUT1, POLA1, POLA2, POLE2, POLK, POLL, POLM, POLN, POLQ, POLR1A, POLR2F, POLR2J3, POLR2J4, POLR3C, POLR3F, POLR3G, POLR3GL, POLR3H, P0M121, POMT1, POT1-AS1, POU2F1, PPCDC, PPFIA1, PPIEL, PPIL2, PPIP5K1P1-CATSPER2, PPM1K, PPM1M, PPP1R12A, PPP1R12B, PPP1R13B, PPP1R16A, PPP1R1C, PPP1R21, PPP1R35, PPP1R36, PPP2R3C, PPP4C, PPP4R3B, PPP4R4, PPP5D1, PPP6R2, PPRC1, PRDM4, PREB, PRELID3A, PREPL, PRH1, PRH1-PRR4, PRH1-TAS2R14, PRICKLEI, PRIM2, PRIMPOL, PRKAA2, PRKAB2, PRKAG1, PRKAG2, PRKCZ, PRKD2, PRKRA, PRMT2, PRMT3, PRMT9, PROK2, PROSERI, PRPF39, PRPF40A, PRPF40B, PRPF4B, PRR14, PRR16, PRR5L, PRRC2B, PRRC2C, PRRG1, PRRT4, PRSS16, PRUNE1, PSD3, PSEN2, PSMD9, PSME4, PSTPIP1, PSTPIP2, PTAR1, PTBP3, PTCHI, PTER, PTGIS, PTK2, PTPN13, PTPN18, PTPN2, PTPN21, PTPN23, PTPN4, PTPRA, PTPRD, PTPRE, PTPRG-AS1, PTPRK, PTPRS, PUM2, PURPL, PUS7, PVR, PVT1, PXDC1, PXDN, PXN, PYCR3, PYM1, PYROXD1, PYROXD2, QPCTL, QRICH1, QTRT2, R3HCC1L, R3HDM1, R3HDM2, RAB15, RAB22A, RAB23, RAB28, RAB36, RAB3GAP1, RAB3GAP2, RAB3IP, RAB4B, RABGAP1L, RABGEF1, RABL2B, RABL6, RAC1, RACGAP1, RAD18, RAD51AP1, RAD51B, RAD51C, RAD51L3-RFFL, RADIL, RAFI, RALGAPAI, RALGAPAIPI, RALGPSI, RALGPS2, RANBP17, RAPIGAP2, RAP1GDS1, RAP2C-AS1, RAPGEF6, RARA, RASGRF2, RASGRP3, RASSF4, RBBP5, RBBP6, RBCK1, RBFOX2, RBL1, RBM15-AS1, RBM20, RBM23, RBM26-AS1, RBM33, RBM38, RBM41, RBM47, RBM5, RBM6, RBM7, RBMXL1, RBPMS, RBSN, RCAN3, RCBTB2, RCHY1, RDH13, RECK, REPSI, RERE, RERG, RETREG1, REV1, REV3L, REXO5, RFC3, RFFL, RFX3, RFX8, RGL1, RGP1, RGS11, RGS12, RGS5, RGS7, RHBDF2, RHCE, RHOBTB1, RHOQ, RHOT1, RIC1, RICTOR, RIF1, RIMBP2, RIMS1, RIMS2, RINT1, RLF, RNASE4, RNASET2, RNF111, RNF123, RNF165, RNF170, RNF212, RNF214, RNF216P1, RNF25, RNF44, RNFT1, RNLS, RNU5D-1, RNU5E-1, ROBO1, ROBO3, ROGDI, RORA-AS1, RP9P, RPAIN, RPAP2, RPAP3, RPE, RPGRIP1L, RPH3AL, RPL23AP7, RPL23AP82, RPL34-AS1, RPP40, RPS6KC1, RPSAP58, RPUSD1, RRN3P3, RRNAD1, RRP7BP, RSRP1, RTEL1, RTEL1-TNFRSF6B, RTKN, RTN2, RTTN, RUFY2, RUNX1T1, RWDD4, SIOOB, SAMD12, SAMD3, SAP130, SARDH, SATB1-AS1, SBF2, SCAI, SCAMPI, SCAMP5, SCAPER, SCARB1, SCFD1, SCG3, SCGB1B2P, SCMH1, SCML2, SCN9A, SCYL1, SDCBP2-AS1, SDCCAG3, SDCCAG8, SDHAF3, SDHAP1, SEC16A, SEC24C, SEC31B, SEC61A2, SECISBP2L, SEMA3F, SEMA4A, SEMA4C, SEMA4F, SENP1, SENP2, SENP3, SENP3-EIF4A1, SENP6, SENP7, SEPT 10, SEPT7, SEPT7P2, SERAC 1, SERF2, SESN1, SETD2, SETD5, SETDB1, SEZ6L2, SFI1, SFMBT1, SFT2D2, SFXN2, SFXN4,
SGCB, SGF29, SGIP1, SGMS1, SGPL1, SGSM3, SH2B1, SH3D19, SHC1, SHMT1, SHTN1, SIK3, SIM2, SIPA1L1, SLAIN 1, SLC12A6, SLC12A9, SLC22A15, SLC22A23, SLC23A2, SLC24A1, SLC25A12, SLC25A14, SLC25A17, SLC25A19, SLC25A21, SLC25A30, SLC25A32, SLC25A39, SLC25A40, SLC25A43, SLC25A53, SLC26A10, SLC29A4, SLC2A11, SLC2A8, SLC2A9, SLC30A5, SLC30A6, SLC33A1, SLC35A1, SLC35A3, SLC35B3, SLC35D2, SLC35E2B, SLC35F2, SLC35F5, SLC37A2, SLC37A3, SLC38A6, SLC38A7, SLC38A9, SLC39A4, SLC3A2, SLC41A3, SLC43A1, SLC47A1, SLC4A5, SLC4A7, SLC7A6, SLC9A5, SLC9B2, SLC04A1, SLF1, SLIT1, SLIT3, SLMAP, SMA4, SMAD3, SMAD5, SMAD9, SMARCC2, SMARCD1, SMC1A, SMC5, SMCHD1, SMC04, SMG1, SMG1P2, SMG1P3, SMG5, SMG6, SMILR, SMIM14, SMPD4, SMURF1, SMURF2, SMYD3, SNAT3-AS1, SNAPC5, SNCATP, SNHG12, SNHG14, SNHG15, SNHG17, SNRK, SNRPE, SNX14, SNX24, SNX25, SNX29, SNX5, S0HLH2, S0RBS1, SORL1, SOS1, SOS2, SPAG4, SPATA13, SPATA33, SPATA6, SPECC1, SPEN, SPG11, SPG7, SPIB, SPICE1, SPPL2A, SPPL2B, SPRY4-AS1, SPRYD3, SPTAN1, SQOR, SRBD1, SRCIN1, SREK1IP1, SRP14-AS1, SRP19, SRP54-AS1, SRPK2, SRPX, SRSF7, SSI 8, SSBP2, SSBP3, SSH1, SSX21P, ST3GAL2, ST3GAL6, ST6GAL1, ST6GALNAC3, ST6GALNAC4, ST7L, STAC, STAG1, STAG3L5P-PVRIG2P-PILRB, STAP2, STARD13, STARD5, STAT1, STAT5B, STEAP1B, STIM2, STK10, STK26, STK38, STK38L, STK40, STPG1, STRADA, STRADB, STRBP, STRIP2, STRN3, STX16, STX18, STX18-AS1, STX2, STXBP3, STXBP5L, SUCLG2- AS1, SUCO, SULF1, SULF2, SULT1C4, SUMF1, SUN1, SUPT20H, SUPT3H, SUSD1, SUV39H2, SUZ12P1, SWT1, SYCP2L, SYNE2, SYNE4, SYP, SYT1, SYT14, SYT9, SYTL3, TADA2A, TAF13, TAF1D, TAF3, TAF6L, TANG02, TA0K1, TA0K2, TARBP1, TARSL2, TASP1, TBC1D1, TBC1D12, TBC1D14, TBC1D17, TBC1D19, TBC1D22A, TBC1D23, TBC1D25, TBC1D32, TBC1D4, TBC1D5, TBCD, TBCEL, TBCK, TBL3, TBX15, TBX2-AS1, TBXAS1, TCEAL1, TCF7L1, TCTN1, TDG, TDP1, TEAD1, TEDC1, TENM4, TERF2, TESK2, TET1, TET2, TET2-AS1, TEX15, TEX9, TFB1M, TFCP2, TFDP2, TFE3, TFEC, TGFBR1, THADA, THBS4, THOC1, THOC2, THOC6, THRB, THSD7A, THUMPD3, TIA1, TIMM21, TIMM23, TIMM23B, TINF2, TIRAP, TJAP1, TJP1, TKFC, TLE1, TLE4, TLK2, TLL2, TM2D3, TM9SF1, TM9SF4, TMC6, TMCC1, TMC03, TMC04, TMEFF2, TMEM106C, TMEM116, TMEM117, TMEM120A, TMEM120B, TMEM131L, TMEM135, TMEM144, TMEM150A, TMEM161A, TMEM161B, TMEM161B-AS1, TMEM181, TMEM182, TMEM184B, TMEM185A, TMEM206, TMEM214, TMEM218, TMEM220, TMEM222, TMEM234, TMEM237, TMEM241, TMEM255B, TMEM260, TMEM39A, TMEM39B, TMEM41B, TMEM45A, TMEM56-RWDD3, TMEM62, TMEM63B, TMEM65, TMEM67, TMEM71, TMEM87A, TMEM94, TM0D2, TMTC1, TMTC2, TMTC3, TMX2, TMX3, TNFRSF12A, TNFRSF1A, TNIP1, TNIP3, TNKS2, TNRC6A, TNRC6C, TOMI, T0M1L1, T0M1L2, TOPI, TOP2B, TOPBP1, TOR1B, TPD52L2, TPK1, TPM3, TPP2, TPRA1, TPT1-AS1, TPTE2P5, TPTEP1, TRABD2A, TRAF3, TRAIP, TRAK2, TRAPPC10, TRAPPC13, TRAPPC8, TRIM16, TRIM16L, TRIM23, TRIM3, TRIM33, TRIM35, TRIM36, TRIM37, TRIM59-IFT80, TRMT1, TRMT10A, TRMT11, TRMT2B, TRMT61B, TROVE2, TRPC1, TRPM2, TRPM4, TRPT1, TRPV2, TRRAP, TSFM, TSGA10, TSNARE1, TSNAXIP1, TSPAN14, TSPAN4, TSPAN5, TTBK1, TTBK2, TTC12, TTC13, TTC23, TTC26, TTC28- AS1, TTC3, TTC31, TTC39B, TTC39C, TTC7A, TTC8, TTLL11, TTLL7, TTN-AS1, TTTY14, TTYH2, TTYH3, TUB, TUBD1, TULP3, TVP23A, TXNDC11, TXNDC16, TYW1B, TYW3, UBA2, UBA3, UBA6, UBAC2, UBAP2, UBE2D1, UBE2D4, UBE2F, UBE2H, UBE2Q2,
[00525] RNAseq experiments showed that compounds of Formula (I) induced exon inclusion with a PSI change (APSI) of +50% to +100% and T’-value <0.001 or induced exon skipping with a APSI of -50% to -100% and /< value <0.001 in genes having a 5' splice site as shown in Table 14 (2088 entries):
[00526] Table 14
97), AAAGgtaaag (SEQ ID NO.: 99), AAAGgtaaat (SEQ ID NO.: 100), AAAGgtaaca (SEQ ID NO.: 101), AAAGgtaacc (SEQ ID NO.: 102), AAAGgtaact (SEQ ID NO.: 104), AAAGgtaaga (SEQ ID NO.: 105), AAAGgtaagc (SEQ ID NO.: 106), AAAGgtaagg (SEQ ID NO.: 107), AAAGgtaagt (SEQ ID NO.: 108), AAAGgtaata (SEQ ID NO.: 109), AAAGgtaatc (SEQ ID NO.: 110), AAAGgtaatg (SEQ ID NO.: 111), AAAGgtaatt (SEQ ID NO.: 112), AAAGgtacaa (SEQ ID NO. : 113), AAAGgtacag (SEQ ID NO. : 115), AAAGgtacat (SEQ ID NO. : 116), AAAGgtacca (SEQ ID NO.: 117), AAAGgtaccc (SEQ ID NO.: 118), AAAGgtaccg (SEQ ID NO.: 119), AAAGgtacct (SEQ ID NO.: 120), AAAGgtacga (SEQ ID NO.: 121), AAAGgtacgt (SEQ ID NO.: 124), AAAGgtacta (SEQ ID NO.: 125), AAAGgtactc (SEQ ID NO.: 126), AAAGgtactg (SEQ ID NO.: 127), AAAGgtactt (SEQ ID NO.: 128), AAAGgtagag (SEQ ID NO : 131), AAAGgtagat (SEQ ID NO.: 132), AAAGgtagcc (SEQ ID NO : 134), AAAGgtagga (SEQ ID NO.: 137), AAAGgtaggc (SEQ ID NO.: 138), AAAGgtaggg (SEQ ID NO.: 139), AAAGgtaggt (SEQ ID NO.: 140), AAAGgtagta (SEQ ID NO.: 141), AAAGgtagtg (SEQ ID NO.: 142), AAAGgtagtt (SEQ ID NO.: 143), AAAGgtataa (SEQ ID NO.: 144), AAAGgtatag (SEQ ID NO.: 146), AAAGgtatca (SEQ ID NO.: 148), AAAGgtatcc (SEQ ID NO.: 149), AAAGgtatct (SEQ ID NO.: 150), AAAGgtatga (SEQ ID NO.: 151), AAAGgtatgc (SEQ ID NO.: 152), AAAGgtatgg (SEQ ID NO.: 153), AAAGgtatgt (SEQ ID NO.: 154), AAAGgtatta (SEQ ID NO.: 155), AAAGgtattc (SEQ ID NO 156), AAAGgtatg (SEQ ID NO.: 157), AAAGgtattt (SEQ ID NO.: 158), AAAGgtcaac (SEQ ID NO.: 159), AAAGgtcagc (SEQ ID NO.: 164), AAAGgtcagt (SEQ ID NO.: 166), AAAGgtcatt (SEQ ID NO.: 167), AAAGgtccag (SEQ ID NO.: 169), AAAGgtctga (SEQ ID NO.: 175), AAAGgtctgt (SEQ ID NO.: 177), AAAGgtgaaa (SEQ ID NO.: 180), AAAGgtgaac (SEQ ID NO.: 181), AAAGgtgaag (SEQ ID NO.: 182), AAAGgtgaat (SEQ ID NO.: 183), AAAGgtgact (SEQ ID NO.: 185), AAAGgtgaga (SEQ ID NO.: 186), AAAGgtgagc (SEQ ID NO.: 187), AAAGgtgagg (SEQ ID NO.: 188), AAAGgtgagt (SEQ ID NO.: 189), AAAGgtgatc (SEQ ID NO.: 191), AAAGgtgatg (SEQ ID NO.: 192), AAAGgtgatt (SEQ ID NO.: 193), AAAGgtgcca (SEQ ID NO.: 197), AAAGgtgcct (SEQ ID NO.: 199), AAAGgtgggc (SEQ ID NO.: 207), AAAGgtgggt (SEQ ID NO.: 209), AAAGgtgtat (SEQ ID NO.: 212), AAAGgtgtga (SEQ ID NO.: 213), AAAGgttaga (SEQ ID NO.: 221), AAAGgttagt (SEQ ID NO.: 224), AAAGgttgcc (SEQ ID NO.: 236), AAAGgttgga (SEQ ID NO.: 238), AAAGgttggc (SEQ ID NO.: 239), AAAGgttggt (SEQ ID NO.: 241), AAAGgtttgt (SEQ ID NO.: 250), AAATctgatt (SEQ ID NO.: 255), AAATgtaaca (SEQ ID NO.: 260), AAATgtaagc (SEQ ID NO.: 263), AAATgtaagg (SEQ ID NO.: 264), AAATgtaagt (SEQ ID NO.: 265), AAATgtaata (SEQ ID NO.: 266), AAATgtacag (SEQ ID NO.: 270), AAATgtatgt (SEQ ID NO.: 278), AAATgtgagt (SEQ ID NO.: 286), AAATgtgggc (SEQ ID NO.: 289), AACAggtaga (SEQ ID NO.: 299), AACAgtaaat (SEQ ID NO.: 302), AACAgtaagt (SEQ ID NO.: 306), AACAgtaggt (SEQ ID NO.: 309), AACAgtgagt (SEQ ID NO.: 315), AACCgtaagt (SEQ ID NO.: 317), AACCgtatgt (SEQ ID NO.: 318), AACCgtgagt (SEQ ID NO.: 320), AACGgtaaga (SEQ ID NO.: 326), AACGgtaatg (SEQ ID NO.: 331), AACGgtacgt (SEQ ID NO.: 335), AACGgtatgt (SEQ ID NO.: 343), AACGgtcagt (SEQ ID NO.: 345), AACGgtgagc (SEQ ID NO.: 348), AACGgtgagg (SEQ ID NO.: 349), AACGgtgagt (SEQ ID NO.: 350), AACGgttagt (SEQ ID NO.: 357), AACTgtaaga (SEQ ID NO.: 359), AACTgtaagc (SEQ ID NO.: 360), AACTgtaagt (SEQ ID NO.: 362), AACTgtaggt (SEQ ID NO.: 364), AACTgtgaga (SEQ ID NO.: 368), AACTgtgagc (SEQ ID NO.: 369), AACTgtgagg (SEQ ID NO.: 370), AACTgtgagt (SEQ ID NO.: 371), AAGAgtaagc (SEQ ID NO.: 378), AAGAgtaagt (SEQ ID NO.: 380), AAGAgtagta (SEQ ID NO.: 383), AAGAgtatcc (SEQ ID NO.: 384), AAGAgtgagc
(SEQ ID NO.: 386), AAGAgtgagt (SEQ ID NO.: 388), AAGAgtggta (SEQ ID NO.: 391), AAGCgtaagt (SEQ ID NO.: 398), AAGCgttagt (SEQ ID NO.: 400), AAGGgctggt (SEQ ID NO.: 404), AAGGgtaaaa (SEQ ID NO.: 405), AAGGgtaaag (SEQ ID NO.: 407), AAGGgtaaga (SEQ ID NO.: 412), AAGGgtaagc (SEQ ID NO.: 413), AAGGgtaagg (SEQ ID NO.: 414), AAGGgtaagt (SEQ ID NO.: 415), AAGGgtaata (SEQ ID NO.: 416), AAGGgtaatg (SEQ ID NO.: 418), AAGGgtacag (SEQ ID NO.: 420), AAGGgtaggt (SEQ ID NO.: 427), AAGGgtatat (SEQ ID NO.: 431), AAGGgtatct (SEQ ID NO.: 432), AAGGgtcagt (SEQ ID NO.: 439), AAGGgtgaga (SEQ ID NO.: 440), AAGGgtgagc (SEQ ID NO.: 441), AAGGgtgagg (SEQ ID NO.: 442), AAGGgtgagt (SEQ ID NO.: 443), AAGGgtgcgt (SEQ ID NO.: 445), AAGGgtggtg (SEQ ID NO.: 447), AAGGgtgtgt (SEQ ID NO.: 448), AAGTgtaagc (SEQ ID NO.: 453), AAGTgtaagt (SEQ ID NO.: 455), AAGTgtacgt (SEQ ID NO.: 456), AAGTgtatgg (SEQ ID NO.: 460), AAGTgtatgt (SEQ ID NO.: 461), AAGTgtgagc (SEQ ID NO.: 462), AAGTgtgagt (SEQ ID NO.: 464), AATAggtaat (SEQ ID NO.: 468), AATAgtaagt (SEQ ID NO.: 473), AATAgtagga (SEQ ID NO.: 474), AATAgtgagt (SEQ ID NO.: 481), AATAtaaggt (SEQ ID NO.: 483), AATCatgtat (SEQ ID NO.: 485), AATCgcagtg (SEQ ID NO.: 488), AATCgtaagt (SEQ ID NO.: 491), AATCgtgagt (SEQ ID NO.: 493), AATGgtaaac (SEQ ID NO.: 504), AATGgtaaag (SEQ ID NO.: 505), AATGgtaaat (SEQ ID NO.: 506), AATGgtaagc (SEQ ID NO.: 511), AATGgtaagg (SEQ ID NO.: 512), AATGgtaagt (SEQ ID NO.: 513), AATGgtaatg (SEQ ID NO.: 516), AATGgtaatt (SEQ ID NO.: 517), AATGgtagga (SEQ ID NO.: 530), AATGgtaggt (SEQ ID NO.: 533), AATGgtagta (SEQ ID NO : 534), AATGgtatat (SEQ ID NO.: 537), AATGgtatga (SEQ ID NO.: 541), AATGgtatgt (SEQ ID NO.: 544), AATGgtattg (SEQ ID NO.: 546), AATGgtcagt (SEQ ID NO.: 548), AATGgtctct (SEQ ID NO.: 549), AATGgtgaat (SEQ ID NO.: 550), AATGgtgaga (SEQ ID NO.: 551), AATGgtgagc (SEQ ID NO.: 552), AATGgtgagg (SEQ ID NO.: 553), AATGgtgagt (SEQ ID NO.: 554), AATGgtgcga (SEQ ID NO.: 556), AATGgtgcgt (SEQ ID NO.: 557), AATGgtgggc (SEQ ID NO.: 558), AATGgtttga (SEQ ID NO.: 564), AATTgtaagt (SEQ ID NO.: 571), AATTgtacga (SEQ ID NO.: 572), AATTgtatgt (SEQ ID NO.: 573), AATTgtgagg (SEQ ID NO.: 574), AATTgtgagt (SEQ ID NO.: 575), ACAAgcaagt (SEQ ID NO.: 582), ACAAggtaat (SEQ ID NO.: 584), ACAAgtaaac (SEQ ID NO.: 585), ACAAgtaaat (SEQ ID NO.: 586), ACAAgtaaga (SEQ ID NO.: 587), ACAAgtaagc (SEQ ID NO.: 588), ACAAgtaagg (SEQ ID NO.: 589), ACAAgtaagt (SEQ ID NO.: 590), ACAAgtaatc (SEQ ID NO.: 592), ACAAgtaatt (SEQ ID NO.: 593), ACAAgtacgc (SEQ ID NO : 595), ACAAgtacgt (SEQ ID NO.: 597), ACAAgtaggc (SEQ ID NO.: 598), ACAAgtaggg (SEQ ID NO.: 599), ACAAgtaggt (SEQ ID NO.: 600), ACAAgtatct (SEQ ID NO.: 601), ACAAgtatgt (SEQ ID NO.: 605), ACAAgtgagg (SEQ ID NO.: 610), ACAAgtgagt (SEQ ID NO.: 611), ACAAgtgggt (SEQ ID NO.: 614), ACACgtaaga (SEQ ID NO.: 623), ACACgtaagc (SEQ ID NO.: 624), ACACgtaagg (SEQ ID NO.: 625), ACACgtaagt (SEQ ID NO.: 626), ACACgtgagt (SEQ ID NO.: 634), ACACgtgggt (SEQ ID NO.: 636), ACAGagtaag (SEQ ID NO.: 639), ACAGgcaagc (SEQ ID NO.: 644), ACAGgcaagt (SEQ ID NO.: 646), ACAGgcacgc (SEQ ID NO.: 648), ACAGgcacgt (SEQ ID NO.: 649), ACAGgcaggt (SEQ ID NO.: 651), ACAGgcatga (SEQ ID NO.: 653), ACAGgcatgc (SEQ ID NO.: 654), ACAGgcatgt (SEQ ID NO.: 655), ACAGgcgcgt (SEQ ID NO.: 659), ACAGgtaaaa (SEQ ID NO.: 661), ACAGgtaaac (SEQ ID NO.: 662), ACAGgtaaag (SEQ ID NO.: 663), ACAGgtaaat (SEQ ID NO.: 664), ACAGgtaaca (SEQ ID NO.: 665), ACAGgtaacc (SEQ ID NO.: 666), ACAGgtaact (SEQ ID NO.: 668), ACAGgtaaga (SEQ ID NO.: 669), ACAGgtaagc (SEQ ID NO.: 670), ACAGgtaagg (SEQ ID NO.: 671), ACAGgtaagt (SEQ ID NO.: 672), ACAGgtaata (SEQ ID NO.: 673), ACAGgtaatc
(SEQ ID NO.: 674), ACAGgtaatg (SEQ ID NO.: 675), ACAGgtaatt (SEQ ID NO.: 676), ACAGgtacaa (SEQ ID NO.: 677), ACAGgtacac (SEQ ID NO.: 678), ACAGgtacat (SEQ ID NO.: 680), ACAGgtacca (SEQ ID NO.: 681), ACAGgtaccc (SEQ ID NO.: 682), ACAGgtaccg (SEQ ID NO.: 683), ACAGgtacct (SEQ ID NO : 684), ACAGgtacgc (SEQ ID NO.: 686), ACAGgtacgg (SEQ ID NO.: 687), ACAGgtacgt (SEQ ID NO.: 688), ACAGgtacta (SEQ ID NO.: 689), ACAGgtactg (SEQ ID NO.: 691), ACAGgtactt (SEQ ID NO.: 692), ACAGgtagag (SEQ ID NO.: 695), ACAGgtagct (SEQ ID NO.: 699), ACAGgtagga (SEQ ID NO.: 700), ACAGgtaggg (SEQ ID NO.: 702), ACAGgtaggt (SEQ ID NO.: 703), ACAGgtagta (SEQ ID NO.: 704), ACAGgtagtc (SEQ ID NO.: 705), ACAGgtataa (SEQ ID NO.: 708), ACAGgtatac (SEQ ID NO.: 709), ACAGgtatag (SEQ ID NO.: 710), ACAGgtatat (SEQ ID NO : 711), ACAGgtatct (SEQ ID NO. : 715), ACAGgtatga (SEQ ID NO. : 716), ACAGgtatgc (SEQ ID NO. : 717), ACAGgtatgg (SEQ ID NO.: 718), ACAGgtatgt (SEQ ID NO.: 719), ACAGgtatta (SEQ ID NO.: 720), ACAGgtattc (SEQ ID NO.: 721), ACAGgtattg (SEQ ID NO.: 722), ACAGgtattt (SEQ ID NO.: 723), ACAGgtcagt (SEQ ID NO.: 729), ACAGgtcggt (SEQ ID NO.: 733), ACAGgtctct (SEQ ID NO.: 734), ACAGgtctgt (SEQ ID NO.: 736), ACAGgtgaaa (SEQ ID NO.: 737), ACAGgtgaac (SEQ ID NO.: 738), ACAGgtgacc (SEQ ID NO.: 742), ACAGgtgact (SEQ ID NO.: 744), ACAGgtgaga (SEQ ID NO.: 745), ACAGgtgagc (SEQ ID NO.: 746), ACAGgtgagg (SEQ ID NO : 747), ACAGgtgagt (SEQ ID NO.: 748), ACAGgtgatg (SEQ ID NO.: 750), ACAGgtgatt (SEQ ID NO.: 751), ACAGgtgcaa (SEQ ID NO.: 752), ACAGgtgccc (SEQ ID NO.: 757), ACAGgtgcct (SEQ ID NO.: 759), ACAGgtgcgc (SEQ ID NO.: 761), ACAGgtgcgg (SEQ ID NO : 762), ACAGgtgcgt (SEQ ID NO.: 763), ACAGgtggga (SEQ ID NO.: 771), ACAGgtgggc (SEQ ID NO.: 772), ACAGgtgggg (SEQ ID NO.: 773), ACAGgtgggt (SEQ ID NO.: 774), ACAGgtgtct (SEQ ID NO.: 780), ACAGgtgtga (SEQ ID NO.: 781), ACAGgtgtgc (SEQ ID NO.: 782), ACAGgtgtgt (SEQ ID NO.: 784), ACAGgttaat (SEQ ID NO.: 787), ACAGgttagc (SEQ ID NO.: 789), ACAGgttagt (SEQ ID NO.: 791), ACAGgttcgg (SEQ ID NO.: 797), ACAGgttcgt (SEQ ID NO.: 798), ACAGgttctc (SEQ ID NO.: 799), ACAGgttgca (SEQ ID NO.: 801), ACAGgttggg (SEQ ID NO.: 805), ACAGgttggt (SEQ ID NO.: 806), ACAGgtttga (SEQ ID NO.: 811), ACAGgtttgt (SEQ ID NO.: 814), ACATgtaaga (SEQ ID NO.: 821), ACATgtaagc (SEQ ID NO.: 822), ACATgtaagt (SEQ ID NO.: 824), ACATgtaatg (SEQ ID NO.: 825), ACATgtacgg (SEQ ID NO.: 827), ACATgtgagt (SEQ ID NO.: 833), ACCAggtgaa (SEQ ID NO.: 837), ACCAgtaaga (SEQ ID NO.: 839), ACCAgtaagt (SEQ ID NO.: 841), ACCAgtgagg (SEQ ID NO.: 848), ACCAgtgagt (SEQ ID NO.: 849), ACCAgttgag (SEQ ID NO.: 851), ACCCgtgaga (SEQ ID NO.: 856), ACCCgtgagt (SEQ ID NO.: 857), ACCCgtgtga (SEQ ID NO.: 859), ACCGgtaagg (SEQ ID NO.: 863), ACCGgtctgc (SEQ ID NO.: 876), ACCGgtgagc (SEQ ID NO.: 878), ACCGgtgggt (SEQ ID NO.: 882), ACCTgtaaga (SEQ ID NO.: 886), ACCTgtaagc (SEQ ID NO.: 887), ACCTgtaagt (SEQ ID NO.: 889), ACCTgtatgg (SEQ ID NO.: 892), ACCTgtgagg (SEQ ID NO.: 896), ACCTgtgagt (SEQ ID NO.: 897), ACGAgtgagt (SEQ ID NO.: 905), ACGGgtaagt (SEQ ID NO.: 918), ACGGgtacta (SEQ ID NO.: 924), ACGGgtgagg (SEQ ID NO.: 934), ACGGgtgagt (SEQ ID NO.: 935), ACGGgtttgt (SEQ ID NO.: 939), ACGTgtaagt (SEQ ID NO.: 941), ACGTgtgagc (SEQ ID NO.: 943), ACTAgtaagt (SEQ ID NO.: 948), ACTCgtaagt (SEQ ID NO.: 953), ACTGagtccc (SEQ ID NO.: 956), ACTGgcaaga (SEQ ID NO.: 958), ACTGgtaaaa (SEQ ID NO.: 960), ACTGgtaaat (SEQ ID NO.: 962), ACTGgtaaga (SEQ ID NO.: 966), ACTGgtaagc (SEQ ID NO.: 967), ACTGgtaagt (SEQ ID NO.: 969), ACTGgtagag (SEQ ID NO.: 978), ACTGgtagga (SEQ ID NO.: 981), ACTGgtaggg (SEQ ID NO.: 982), ACTGgtaggt (SEQ ID NO.: 983), ACTGgtatgt (SEQ ID NO.:
986), ACTGgtcagt (SEQ ID NO.: 989), ACTGgtgaat (SEQ ID NO.: 990), ACTGgtgaga (SEQ ID NO.: 992), ACTGgtgagc (SEQ ID NO.: 993), ACTGgtgagt (SEQ ID NO.: 995), ACTGgtgtgc (SEQ ID NO.: 1002), ACTTgtaagt (SEQ ID NO.: 1008), ACTTgtacgc (SEQ ID NO.: 1009), ACTTgtacgt (SEQ ID NO.: 1010), ACTTgtagtt (SEQ ID NO.: 1013), ACTTgtatcc (SEQ ID NO.: 1014), ACTTgtgagt (SEQ ID NO.: 1015), AGAAaggtga (SEQ ID NO.: 1020), AGAAgtaagg (SEQ ID NO.: 1028), AGAAgtaagt (SEQ ID NO.: 1029), AGAAgtaggt (SEQ ID NO.: 1034), AGAAgtgagc (SEQ ID NO.: 1043), AGAAgtgagt (SEQ ID NO.: 1045), AGAAgtgcgt (SEQ ID NO.: 1046), AGACgtaagt (SEQ ID NO.: 1055), AGACgtatgt (SEQ ID NO.: 1056), AGACgtgagc (SEQ ID NO.: 1058), AGACgtgagt (SEQ ID NO.: 1060), AGAGagggta (SEQ ID NO.: 1061), AGAGgcgtga (SEQ ID NO.: 1069), AGAGgtaaaa (SEQ ID NO.: 1071), AGAGgtaaac (SEQ ID NO.: 1072), AGAGgtaaag (SEQ ID NO.: 1073), AGAGgtaaat (SEQ ID NO.: 1074), AGAGgtaaca (SEQ ID NO.: 1075), AGAGgtaact (SEQ ID NO.: 1078), AGAGgtaaga (SEQ ID NO.: 1079), AGAGgtaagc (SEQ ID NO.: 1080), AGAGgtaagg (SEQ ID NO.: 1081), AGAGgtaagt (SEQ ID NO.: 1082), AGAGgtaata (SEQ ID NO.: 1083), AGAGgtaatg (SEQ ID NO.: 1085), AGAGgtaatt (SEQ ID NO.: 1086), AGAGgtacaa (SEQ ID NO.: 1087), AGAGgtacag (SEQ ID NO.: 1089), AGAGgtacca (SEQ ID NO.: 1091), AGAGgtaccc (SEQ ID NO.: 1092), AGAGgtaccg (SEQ ID NO.: 1093), AGAGgtacta (SEQ ID NO 1096), AGAGgtactg (SEQ ID NO.: 1098), AGAGgtagct (SEQ ID NO.: 1106), AGAGgtagga (SEQ ID NO.: 1107), AGAGgtaggc (SEQ ID NO.: 1108), AGAGgtaggg (SEQ ID NO.: 1109), AGAGgtaggt (SEQ ID NO.: 1110), AGAGgtatat (SEQ ID NO.: 1117), AGAGgtatca (SEQ ID NO.: 1118), AGAGgtatga (SEQ ID NO.: 1120), AGAGgtatgc (SEQ ID NO.: 1121), AGAGgtatgg (SEQ ID NO.: 1122), AGAGgtatgt (SEQ ID NO.: 1123), AGAGgtattg (SEQ ID NO. : 1126), AGAGgtattt (SEQ ID NO. : 1127), AGAGgtcagt (SEQ ID NO. : 1131), AGAGgtctat (SEQ ID NO. : 1135), AGAGgtctgt (SEQ ID NO. : 1138), AGAGgtgaag (SEQ ID NO : 1142), AGAGgtgaat (SEQ ID NO.: 1143), AGAGgtgaca (SEQ ID NO.: 1144), AGAGgtgaga (SEQ ID NO.: 1148), AGAGgtgagc (SEQ ID NO.: 1149), AGAGgtgagg (SEQ ID NO.: 1150), AGAGgtgagt (SEQ ID NO.: 1151), AGAGgtgatt (SEQ ID NO.: 1155), AGAGgtgggc (SEQ ID NO : 1167), AGAGgtgggg (SEQ ID NO.: 1168), AGAGgtgggt (SEQ ID NO. : 1169), AGAGgtgtgt (SEQ ID NO. : 1176), AGAGgttagt (SEQ ID NO.: 1180), AGAGgttgcc (SEQ ID NO.: 1187), AGAGgtttgc (SEQ ID NO.: 1194), AGAGgtttgt (SEQ ID NO.: 1196), AGATgtaaat (SEQ ID NO.: 1203), AGATgtaaga (SEQ ID NO.: 1204), AGATgtaagc (SEQ ID NO.: 1205), AGATgtaagg (SEQ ID NO.: 1206), AGATgtaagt (SEQ ID NO.: 1207), AGATgtaatt (SEQ ID NO.: 1209), AGATgtgagc (SEQ ID NO.: 1219), AGATgtgagt (SEQ ID NO.: 1220), AGATgtgggt (SEQ ID NO.: 1221), AGCAggtcag (SEQ ID NO.: 1227), AGCAgtaagc (SEQ ID NO.: 1230), AGCAgtaagt (SEQ ID NO.: 1232), AGCAgtatcc (SEQ ID NO.: 1235), AGCAgtatgt (SEQ ID NO.: 1236), AGCAgtgagt (SEQ ID NO.: 1239), AGCCgtaagt (SEQ ID NO.: 1244), AGCCgtatgt (SEQ ID NO.: 1246), AGCCgtgtgt (SEQ ID NO.: 1248), AGCGgtaagc (SEQ ID NO.: 1254), AGCGgtaagt (SEQ ID NO.: 1256), AGCGgtaatc (SEQ ID NO.: 1257), AGCGgtgaga (SEQ ID NO.: 1269), AGCGgtgagc (SEQ ID NO.: 1270), AGCGgtgagg (SEQ ID NO.: 1271), AGCGgtgagt (SEQ ID NO.: 1272), AGCTatttac (SEQ ID NO.: 1277), AGCTcaggtg (SEQ ID NO.: 1278), AGCTgtaagt (SEQ ID NO.: 1282), AGCTgtacgt (SEQ ID NO.: 1283), AGCTgtatgt (SEQ ID NO.: 1285), AGCTgtgagt (SEQ ID NO.: 1288), AGGAgtaagt (SEQ ID NO.: 1297), AGGCgtaagt (SEQ ID NO.: 1303), AGGGgtaagg (SEQ ID NO : 1315), AGGGgtaggt (SEQ ID NO.: 1323), AGGGgtatga (SEQ ID NO.: 1325), AGGGgtatgt (SEQ ID NO.: 1327), AGGGgtgaga (SEQ ID NO.: 1330), AGGGgtgagt (SEQ ID
NO.: 1333), AGGGgtgggt (SEQ ID NO.: 1334), AGTAgtaagt (SEQ ID NO.: 1341), AGTCgtatcc (SEQ ID NO.: 1349), AGTCgtgagt (SEQ ID NO.: 1350), AGTGgtaaaa (SEQ ID NO.: 1353), AGTGgtaaga (SEQ ID NO.: 1357), AGTGgtaagg (SEQ ID NO.: 1359), AGTGgtaagt (SEQ ID NO.: 1360), AGTGgtaatc (SEQ ID NO.: 1361), AGTGgtacgt (SEQ ID NO.: 1364), AGTGgtaggt (SEQ ID NO.: 1366), AGTGgtatga (SEQ ID NO.: 1370), AGTGgtatgt (SEQ ID NO.: 1371), AGTGgtcagt (SEQ ID NO.: 1372), AGTGgtgagc (SEQ ID NO.: 1375), AGTGgtgagg (SEQ ID NO.: 1376), AGTGgtgagt (SEQ ID NO.: 1377), AGTTgtaagt (SEQ ID NO.: 1385), AGTTgtgagt (SEQ ID NO.: 1388), ATAAagaaga (SEQ ID NO.: 1389), ATAActggtg (SEQ ID NO.: 1390), ATAAgtaaga (SEQ ID NO.: 1392), ATAAgtaagc (SEQ ID NO.: 1393), ATAAgtaagt (SEQ ID NO.: 1394), ATAAgtatgt (SEQ ID NO.: 1401), ATACgtaagt (SEQ ID NO.: 1409), ATAGgcaagt (SEQ ID NO.: 1413), ATAGgtaaaa (SEQ ID NO.: 1416), ATAGgtaaga (SEQ ID NO.: 1422), ATAGgtaagc (SEQ ID NO.: 1423), ATAGgtaagg (SEQ ID NO.: 1424), ATAGgtaagt (SEQ ID NO.: 1425), ATAGgtaatc (SEQ ID NO.: 1427), ATAGgtaatt (SEQ ID NO.: 1429), ATAGgtacat (SEQ ID NO.: 1431), ATAGgtaggc (SEQ ID NO.: 1439), ATAGgtatga (SEQ ID NO.: 1446), ATAGgtatgg (SEQ ID NO.: 1448), ATAGgtatgt (SEQ ID NO.: 1449), ATAGgtattt (SEQ ID NO.: 1451), ATAGgtcagt (SEQ ID NO.: 1452), ATAGgtgagg (SEQ ID NO.: 1459), ATAGgtgagt (SEQ ID NO.: 1460), ATAGgtgata (SEQ ID NO.: 1461), ATAGgtgctc (SEQ ID NO.: 1464), ATAGgtgggt (SEQ ID NO 1465), ATAGgtgtgt (SEQ ID NO.: 1467), ATAGgttagt (SEQ ID NO.: 1470), ATAGgttggt (SEQ ID NO.: 1473), ATAGgtttgt (SEQ ID NO.: 1474), ATATgtaagt (SEQ ID NO.: 1484), ATATgtatcc (SEQ ID NO.: 1488), ATATgtgagc (SEQ ID NO.: 1490), ATATgtgagt (SEQ ID NO.: 1491), ATCAgtaagg (SEQ ID NO.: 1496), ATCAgtaagt (SEQ ID NO.: 1497), ATCAgtgaga (SEQ ID NO.: 1500), ATCAgtgagt (SEQ ID NO.: 1501), ATCCagaaac (SEQ ID NO.: 1505), ATCCgtaagt (SEQ ID NO.: 1508), ATCCgtgagt (SEQ ID NO.: 1510), ATCGgtaaat (SEQ ID NO.: 1513), ATCGgtaagg (SEQ ID NO.: 1516), ATCGgtatgt (SEQ ID NO.: 1526), ATCGgtgagt (SEQ ID NO.: 1533), ATCTgtaaga (SEQ ID NO.: 1539), ATCTgtaagt (SEQ ID NO.: 1542), ATCTgtgaga (SEQ ID NO.: 1545), ATCTgtgagt (SEQ ID NO.: 1547), ATCTgtggtg (SEQ ID NO.: 1548), ATGAaaaggt (SEQ ID NO.: 1549), ATGAgtaaga (SEQ ID NO.: 1552), ATGAgtaagt (SEQ ID NO.: 1553), ATGAgtatga (SEQ ID NO.: 1556), ATGAgtatgt (SEQ ID NO.: 1558), ATGAgtgagt (SEQ ID NO.: 1559), ATGAgtgtga (SEQ ID NO.: 1560), ATGCgtgagt (SEQ ID NO.: 1566), ATGGgcaagt (SEQ ID NO.: 1569), ATGGgcaggt (SEQ ID NO.: 1570), ATGGgtaaaa (SEQ ID NO.: 1571), ATGGgtaaac (SEQ ID NO.: 1572), ATGGgtaaat (SEQ ID NO.: 1574), ATGGgtaaga (SEQ ID NO.: 1576), ATGGgtaagc (SEQ ID NO.: 1577), ATGGgtaagg (SEQ ID NO.: 1578), ATGGgtaagt (SEQ ID NO.: 1579), ATGGgtaatg (SEQ ID NO.: 1582), ATGGgtaggt (SEQ ID NO.: 1591), ATGGgtatga (SEQ ID NO.: 1592), ATGGgtgaat (SEQ ID NO.: 1599), ATGGgtgagc (SEQ ID NO.: 1601), ATGGgtgagg (SEQ ID NO.: 1602), ATGGgtgagt (SEQ ID NO.: 1603), ATGGgttagt (SEQ ID NO.: 1607), ATGGgtttgt (SEQ ID NO.: 1610), ATGGtggtga (SEQ ID NO.: 1611), ATGTgtaaga (SEQ ID NO.: 1614), ATGTgtaagt (SEQ ID NO.: 1616), ATGTgtgagt (SEQ ID NO.: 1618), ATGTgtggtg (SEQ ID NO.: 1619), ATTAgtaagt (SEQ ID NO.: 1623), ATTAgtgagt (SEQ ID NO.: 1626), ATTGgcacgt (SEQ ID NO.: 1633), ATTGgcatgc (SEQ ID NO.: 1634), ATTGgtaaaa (SEQ ID NO.: 1635), ATTGgtaaga (SEQ ID NO.: 1638), ATTGgtaagc (SEQ ID NO.: 1639), ATTGgtaagg (SEQ ID NO.: 1640), ATTGgtaagt (SEQ ID NO.: 1641), ATTGgtaata (SEQ ID NO.: 1642), ATTGgtaatc (SEQ ID NO.: 1643), ATTGgtacgt (SEQ ID NO.: 1646), ATTGgtaggt (SEQ ID NO.: 1651), ATTGgtagta (SEQ ID NO.: 1652), ATTGgtagtt (SEQ ID NO.: 1653), ATTGgtatgt (SEQ ID NO.: 1656), ATTGgtatta (SEQ ID NO.: 1657), ATTGgtgaga (SEQ ID
NO.: 1661), ATTGgtgagg (SEQ ID NO.: 1663), ATTGgtgagt (SEQ ID NO.: 1664), ATTGgtgtga (SEQ ID NO.: 1670), ATTTatctca (SEQ ID NO.: 1673), ATTTgtaagc (SEQ ID NO.: 1678), ATTTgtaagt (SEQ ID NO.: 1679), ATTTgtgagt (SEQ ID NO.: 1683), CAAAgtaaag (SEQ ID NO.: 1690), CAAAgtaaga (SEQ ID NO.: 1692), CAAAgtaagc (SEQ ID NO.: 1693), CAAAgtaagg (SEQ ID NO.: 1694), CAAAgtaagt (SEQ ID NO.: 1695), CAAAgtaata (SEQ ID NO.: 1696), CAAAgtaatt (SEQ ID NO.: 1698), CAAAgtacgg (SEQ ID NO.: 1700), CAAAgtactg (SEQ ID NO.: 1702), CAAAgtagga (SEQ ID NO.: 1703), CAAAgtaggt (SEQ ID NO.: 1704), CAAAgtataa (SEQ ID NO.: 1705), CAAAgtatgg (SEQ ID NO.: 1707), CAAAgtattg (SEQ ID NO.: 1709), CAAAgtgaga (SEQ ID NO.: 1713), CAAAgtgagt (SEQ ID NO.: 1715), CAACataagt (SEQ ID NO.: 1719), CAACctggta (SEQ ID NO.: 1721), CAACgtaagg (SEQ ID NO.: 1723), CAACgtaagt (SEQ ID NO. : 1724), CAACgtgagt (SEQ ID NO. : 1728), CAAGgcaagt (SEQ ID NO.: 1735), CAAGgcaggt (SEQ ID NO.: 1738), CAAGgcgggc (SEQ ID NO.: 1744), CAAGgtaaaa (SEQ ID NO.: 1748), CAAGgtaaac (SEQ ID NO.: 1749), CAAGgtaaag (SEQ ID NO.: 1750), CAAGgtaaat (SEQ ID NO.: 1751), CAAGgtaaca (SEQ ID NO.: 1752), CAAGgtaacc (SEQ ID NO.: 1753), CAAGgtaact (SEQ ID NO.: 1755), CAAGgtaaga (SEQ ID NO.: 1756), CAAGgtaagg (SEQ ID NO.: 1758), CAAGgtaagt (SEQ ID NO.: 1759), CAAGgtaata (SEQ ID NO.: 1760), CAAGgtaatg (SEQ ID NO.: 1762), CAAGgtaatt (SEQ ID NO.: 1763), CAAGgtacaa (SEQ ID NO.: 1764), CAAGgtacac (SEQ ID NO.: 1765), CAAGgtacag (SEQ ID NO.: 1766), CAAGgtacat (SEQ ID NO.: 1767), CAAGgtacca (SEQ ID NO.: 1768), CAAGgtaccg (SEQ ID NO.: 1770), CAAGgtacct (SEQ ID NO.: 1771), CAAGgtacgt (SEQ ID NO.: 1774), CAAGgtactg (SEQ ID NO.: 1777), CAAGgtagaa (SEQ ID NO.: 1779), CAAGgtagag (SEQ ID NO.: 1781), CAAGgtagat (SEQ ID NO.: 1782), CAAGgtagga (SEQ ID NO.: 1785), CAAGgtaggc (SEQ ID NO.: 1786), CAAGgtaggg (SEQ ID NO.: 1787), CAAGgtaggt (SEQ ID NO.: 1788), CAAGgtagtc (SEQ ID NO.: 1790), CAAGgtagtt (SEQ ID NO.: 1792), CAAGgtataa (SEQ ID NO.: 1793), CAAGgtatac (SEQ ID NO.: 1794), CAAGgtatag (SEQ ID NO.: 1795), CAAGgtatat (SEQ ID NO.: 1796), CAAGgtatct (SEQ ID NO.: 1799), CAAGgtatga (SEQ ID NO.: 1800), CAAGgtatgc (SEQ ID NO.: 1801), CAAGgtatgg (SEQ ID NO.: 1802), CAAGgtatgt (SEQ ID NO.: 1803), CAAGgtatta (SEQ ID NO.: 1804), CAAGgtattc (SEQ ID NO.: 1805), CAAGgtattg (SEQ ID NO.: 1806), CAAGgtattt (SEQ ID NO.: 1807), CAAGgtcaga (SEQ ID NO.: 1811), CAAGgtcagg (SEQ ID NO.: 1813), CAAGgtcagt (SEQ ID NO.: 1814), CAAGgtcctg (SEQ ID NO.: 1820), CAAGgtcgga (SEQ ID NO.: 1823), CAAGgtctct (SEQ ID NO.: 1827), CAAGgtcttc (SEQ ID NO.: 1831), CAAGgtgacc (SEQ ID NO.: 1836), CAAGgtgact (SEQ ID NO.: 1838), CAAGgtgaga (SEQ ID NO.: 1839), CAAGgtgagc (SEQ ID NO.: 1840), CAAGgtgagg (SEQ ID NO.: 1841), CAAGgtgagt (SEQ ID NO.: 1842), CAAGgtgatg (SEQ ID NO.: 1845), CAAGgtgcat (SEQ ID NO.: 1849), CAAGgtgcca (SEQ ID NO.: 1850), CAAGgtgcgt (SEQ ID NO.: 1855), CAAGgtgctg (SEQ ID NO.: 1857), CAAGgtggga (SEQ ID NO.: 1861), CAAGgtgggt (SEQ ID NO.: 1864), CAAGgtgtgg (SEQ ID NO.: 1872), CAAGgtgtgt (SEQ ID NO.: 1873), CAAGgttaga (SEQ ID NO.: 1879), CAAGgttagg (SEQ ID NO.: 1881), CAAGgttagt (SEQ ID NO.: 1882), CAAGgttatc (SEQ ID NO.: 1884), CAAGgttggt (SEQ ID NO.: 1894), CAAGgtttcc (SEQ ID NO.: 1897), CAAGgtttct (SEQ ID NO.: 1898), CAAGgtttgt (SEQ ID NO.: 1902), CAATgctggg (SEQ ID NO.: 1907), CAATgtaagt (SEQ ID NO.: 1912), CAATgtgagg (SEQ ID NO.: 1919), CAATgtgagt (SEQ ID NO.: 1920), CAATgtgcgt (SEQ ID NO.: 1921), CACAggttag (SEQ ID NO.: 1925), CACAgtaaga (SEQ ID NO.: 1927), CACAgtaagc (SEQ ID NO.: 1928), CACAgtaagt (SEQ ID NO.: 1930), CACAgtaggt (SEQ ID NO.: 1934), CACAgtgagg (SEQ ID
NO.: 1936), CACAgtgagt (SEQ ID NO.: 1937), CACAgttgag (SEQ ID NO.: 1941), CACCgtaagt (SEQ ID NO.: 1944), CACCgtgagt (SEQ ID NO.: 1946), CACCgtgcgt (SEQ ID NO.: 1947), CACGgcaagt (SEQ ID NO.: 1951), CACGgcgtga (SEQ ID NO.: 1952), CACGgtaaac (SEQ ID NO.: 1954), CACGgtaaca (SEQ ID NO.: 1957), CACGgtaaga (SEQ ID NO.: 1960), CACGgtaagg (SEQ ID NO.: 1962), CACGgtaagt (SEQ ID NO.: 1963), CACGgtacgc (SEQ ID NO.: 1972), CACGgtagga (SEQ ID NO.: 1977), CACGgtaggc (SEQ ID NO.: 1978), CACGgtgaga (SEQ ID NO.: 1986), CACGgtgagg (SEQ ID NO.: 1988), CACGgtgagt (SEQ ID NO.: 1989), CACGgtgcgc (SEQ ID NO.: 1992), CACGgtgggt (SEQ ID NO.: 1994), CACGgtgtgt (SEQ ID NO.: 1995), CACTgtaagt (SEQ ID NO.: 2000), CACTgtaatg (SEQ ID NO.: 2001), CACTgtatga (SEQ ID NO.: 2004), CACTgtgagt (SEQ ID NO.: 2006), CACTgtgcgt (SEQ ID NO : 2007), CAGAggtaca (SEQ ID NO : 2012), CAGAgtaaga (SEQ ID NO.: 2015), CAGAgtaagc (SEQ ID NO.: 2016), CAGAgtaagt (SEQ ID NO.: 2018), CAGAgtgagt (SEQ ID NO.: 2028), CAGCagcaca (SEQ ID NO.: 2031), CAGCgtaagt (SEQ ID NO.: 2036), CAGCgtgagt (SEQ ID NO.: 2038), CAGCtgggcg (SEQ ID NO.: 2039), CAGGgtaaaa (SEQ ID NO.: 2043), CAGGgtaaat (SEQ ID NO.: 2045), CAGGgtaacg (SEQ ID NO.: 2046), CAGGgtaagc (SEQ ID NO.: 2049), CAGGgtaagg (SEQ ID NO.: 2050), CAGGgtaagt (SEQ ID NO.: 2051), CAGGgtaatt (SEQ ID NO.: 2054), CAGGgtacag (SEQ ID NO.: 2055), CAGGgtaggt (SEQ ID NO.: 2064), CAGGgtatag (SEQ ID NO.: 2069), CAGGgtatgg (SEQ ID NO.: 2072), CAGGgtatgt (SEQ ID NO.: 2073), CAGGgtcagc (SEQ ID NO.: 2076), CAGGgtgaga (SEQ ID NO.: 2082), CAGGgtgagc (SEQ ID NO.: 2083), CAGGgtgagg (SEQ ID NO.: 2084), CAGGgtgagt (SEQ ID NO.: 2085), CAGGgtgggc (SEQ ID NO.: 2087), CAGTgtaagc (SEQ ID NO.: 2097), CAGTgtaagg (SEQ ID NO.: 2098), CAGTgtaagt (SEQ ID NO.: 2099), CAGTgtgagt (SEQ ID NO.: 2109), CAGTgtgggt (SEQ ID NO.: 2110), CATAgtaggt (SEQ ID NO.: 2122), CATAgtatgc (SEQ ID NO.: 2123), CATCgtgagt (SEQ ID NO.: 2135), CATCgtgtga (SEQ ID NO.: 2136), CATGgtaaca (SEQ ID NO.: 2145), CATGgtaaga (SEQ ID NO.: 2148), CATGgtaagc (SEQ ID NO.: 2149), CATGgtaagg (SEQ ID NO.: 2150), CATGgtaagt (SEQ ID NO.: 2151), CATGgtacgt (SEQ ID NO.: 2158), CATGgtaggt (SEQ ID NO.: 2165), CATGgtatgc (SEQ ID NO.: 2170), CATGgtatgg (SEQ ID NO.: 2171), CATGgtatgt (SEQ ID NO.: 2172), CATGgtgaat (SEQ ID NO.: 2178), CATGgtgaga (SEQ ID NO.: 2180), CATGgtgagc (SEQ ID NO.: 2181), CATGgtgagg (SEQ ID NO.: 2182), CATGgtgagt (SEQ ID NO.: 2183), CATGgtgcgt (SEQ ID NO.: 2186), CATGgtgggg (SEQ ID NO.: 2188), CATGgtgtgg (SEQ ID NO.: 2191), CATGgtgtgt (SEQ ID NO.: 2192), CATGgttagt (SEQ ID NO.: 2194), CATGgttggt (SEQ ID NO.: 2196), CATGgtttga (SEQ ID NO.: 2197), CATTagtgag (SEQ ID NO.: 2199), CATTgtaagt (SEQ ID NO.: 2203), CATTgtgagt (SEQ ID NO.: 2209), CATTgttagt (SEQ ID NO.: 2210), CCAAatgcaa (SEQ ID NO.: 2213), CCAAggtgag (SEQ ID NO.: 2218), CCAAgtaaat (SEQ ID NO.: 2219), CCAAgtaacg (SEQ ID NO.: 2220), CCAAgtaaga (SEQ ID NO.: 2222), CCAAgtaagc (SEQ ID NO 2223), CCAAgtaagt (SEQ ID NO.: 2225), CCAAgtaata (SEQ ID NO.: 2226), CCAAgtacgt (SEQ ID NO.: 2231), CCAAgtactg (SEQ ID NO.: 2232), CCAAgtaggc (SEQ ID NO.: 2236), CCAAgtaggt (SEQ ID NO.: 2237), CCAAgtgagc (SEQ ID NO.: 2243), CCAAgtgagt (SEQ ID NO.: 2245), CCAAgttagt (SEQ ID NO.: 2248), CCACgtaaga (SEQ ID NO.: 2249), CCACgtaagt (SEQ ID NO.: 2252), CCACgtatga (SEQ ID NO.: 2255), CCACgtgagg (SEQ ID NO.: 2258), CCACgtgagt (SEQ ID NO.: 2259), CCAGgcaaga (SEQ ID NO.: 2264), CCAGgcaagg (SEQ ID NO.: 2266), CCAGgcaagt (SEQ ID NO.: 2267), CCAGgccagt (SEQ ID NO.: 2274), CCAGgtaaaa (SEQ ID NO.: 2282), CCAGgtaaac (SEQ ID NO.: 2283), CCAGgtaaag (SEQ ID NO.: 2284), CCAGgtaaat (SEQ ID
NO.: 2285), CCAGgtaaca (SEQ ID NO.: 2286), CCAGgtaacc (SEQ ID NO.: 2287), CCAGgtaact (SEQ ID NO.: 2289), CCAGgtaaga (SEQ ID NO.: 2290), CCAGgtaagc (SEQ ID NO.: 2291), CCAGgtaagg (SEQ ID NO.: 2292), CCAGgtaagt (SEQ ID NO.: 2293), CCAGgtaatc (SEQ ID NO.: 2295), CCAGgtaatg (SEQ ID NO.: 2296), CCAGgtaatt (SEQ ID NO.: 2297), CCAGgtacaa (SEQ ID NO.: 2298), CCAGgtacac (SEQ ID NO.: 2299), CCAGgtacag (SEQ ID NO.: 2300), CCAGgtacat (SEQ ID NO.: 2301), CCAGgtaccc (SEQ ID NO.: 2303), CCAGgtacct (SEQ ID NO.: 2305), CCAGgtacga (SEQ ID NO.: 2306), CCAGgtacgc (SEQ ID NO.: 2307), CCAGgtacgt (SEQ ID NO.: 2309), CCAGgtacta (SEQ ID NO.: 2310), CCAGgtactc (SEQ ID NO.: 2311), CCAGgtactg (SEQ ID NO.: 2312), CCAGgtactt (SEQ ID NO.: 2313), CCAGgtagaa (SEQ ID NO.: 2314), CCAGgtagag (SEQ ID NO.: 2316), CCAGgtagca (SEQ ID NO.: 2318), CCAGgtagcc (SEQ ID NO 2319), CCAGgtaggg (SEQ ID NO.: 2324), CCAGgtaggt (SEQ ID NO.: 2325), CCAGgtagta (SEQ ID NO.: 2326), CCAGgtagtg (SEQ ID NO.: 2328), CCAGgtagtt (SEQ ID NO.: 2329), CCAGgtatag (SEQ ID NO.: 2332), CCAGgtatat (SEQ ID NO.: 2333), CCAGgtatca (SEQ ID NO.: 2334), CCAGgtatcc (SEQ ID NO.: 2335), CCAGgtatct (SEQ ID NO.: 2336), CCAGgtatga (SEQ ID NO.: 2337), CCAGgtatgc (SEQ ID NO.: 2338), CCAGgtatgg (SEQ ID NO.: 2339), CCAGgtatgt (SEQ ID NO.: 2340), CCAGgtatta (SEQ ID NO.: 2341), CCAGgtattc (SEQ ID NO.: 2342), CCAGgtattg (SEQ ID NO.: 2343), CCAGgtattt (SEQ ID NO.: 2344), CCAGgtcagc (SEQ ID NO.: 2346), CCAGgtcagg (SEQ ID NO.: 2347), CCAGgtcagt (SEQ ID NO.: 2348), CCAGgtcggt (SEQ ID NO.: 2356), CCAGgtctga (SEQ ID NO.: 2361), CCAGgtctgg (SEQ ID NO.: 2362), CCAGgtctgt (SEQ ID NO.: 2363), CCAGgtgaag (SEQ ID NO.: 2367), CCAGgtgacc (SEQ ID NO.: 2370), CCAGgtgact (SEQ ID NO.: 2372), CCAGgtgaga (SEQ ID NO.: 2373), CCAGgtgagc (SEQ ID NO.: 2374), CCAGgtgagg (SEQ ID NO.: 2375), CCAGgtgagt (SEQ ID NO.: 2376), CCAGgtgcgc (SEQ ID NO.: 2389), CCAGgtgcgg (SEQ ID NO.: 2390), CCAGgtggag (SEQ ID NO.: 2395), CCAGgtggga (SEQ ID NO.: 2399), CCAGgtgggc (SEQ ID NO.: 2400), CCAGgtgggg (SEQ ID NO.: 2401), CCAGgtgggt (SEQ ID NO.: 2402), CCAGgtgtcc (SEQ ID NO.: 2404), CCAGgtgtcg (SEQ ID NO.: 2405), CCAGgtgtgg (SEQ ID NO.: 2409), CCAGgtgtgt (SEQ ID NO.: 2410), CCAGgttaga (SEQ ID NO.: 2412), CCAGgttagt (SEQ ID NO.: 2415), CCAGgttcaa (SEQ ID NO.: 2418), CCAGgttctg (SEQ ID NO.: 2425), CCAGgttgct (SEQ ID NO.: 2428), CCAGgttggt (SEQ ID NO.: 2432), CCAGgtttgt (SEQ ID NO.: 2438), CCATgtaaga (SEQ ID NO.: 2444), CCATgtaagc (SEQ ID NO.: 2445), CCATgtaagt (SEQ ID NO.: 2447), CCATgtacgc (SEQ ID NO.: 2448), CCATgtatgt (SEQ ID NO.: 2451), CCATgtgagt (SEQ ID NO.: 2454), CCATgttagt (SEQ ID NO.: 2456), CCCAggtaat (SEQ ID NO.: 2460), CCCAgtaagt (SEQ ID NO.: 2466), CCCAgtacga (SEQ ID NO.: 2467), CCCAgtacgt (SEQ ID NO.: 2468), CCCAgtaggt (SEQ ID NO.: 2469), CCCAgtgagt (SEQ ID NO.: 2472), CCCAgtggtg (SEQ ID NO.: 2473), CCCCgtaagt (SEQ ID NO.: 2478), CCCCgtgagt (SEQ ID NO.: 2480), CCCCgtgcgt (SEQ ID NO : 2481), CCCGgcacgt (SEQ ID NO : 2483), CCCGgtaaga (SEQ ID NO 2486), CCCGgtacgt (SEQ ID NO.: 2496), CCCGgtaggt (SEQ ID NO.: 2498), CCCGgtataa (SEQ ID NO.: 2499), CCCGgtatgg (SEQ ID NO.: 2501), CCCGgtatgt (SEQ ID NO.: 2502), CCCGgtgagc (SEQ ID NO.: 2506), CCCGgtgagt (SEQ ID NO.: 2508), CCCGgtgcgt (SEQ ID NO.: 2511), CCCGgtgggt (SEQ ID NO.: 2513), CCCTgtaagt (SEQ ID NO.: 2519), CCCTgtgagt (SEQ ID NO.: 2526), CCCTgtgcgt (SEQ ID NO.: 2527), CCCTttgtcc (SEQ ID NO.: 2528), CCGAgtgagc (SEQ ID NO.: 2536), CCGAgtgagt (SEQ ID NO.: 2537), CCGCgtgagt (SEQ ID NO.: 2540), CCGGgtaaaa (SEQ ID NO.: 2544), CCGGgtaagt (SEQ ID NO.: 2551), CCGGgtaatt (SEQ ID NO.: 2553), CCGGgtagga (SEQ ID NO.: 2557), CCGGgtatgg (SEQ ID NO.: 2562), CCGGgtatgt
(SEQ ID NO.: 2563), CCGGgtgaga (SEQ ID NO.: 2566), CCGGgtgagc (SEQ ID NO.: 2567), CCGGgtgagg (SEQ ID NO.: 2568), CCGGgtgagt (SEQ ID NO.: 2569), CCGGgtgtgt (SEQ ID NO.: 2573), CCGTgtaagt (SEQ ID NO.: 2576), CCGTgtgagt (SEQ ID NO.: 2578), CCTAgtaaga (SEQ ID NO.: 2580), CCTAgtaagt (SEQ ID NO.: 2582), CCTCgtaagt (SEQ ID NO.: 2589), CCTCgtgagt (SEQ ID NO.: 2592), CCTCgtgggt (SEQ ID NO.: 2593), CCTGgcaagt (SEQ ID NO.: 2595), CCTGgccaac (SEQ ID NO.: 2596), CCTGgtaaag (SEQ ID NO.: 2598), CCTGgtaaat (SEQ ID NO.: 2599), CCTGgtaacc (SEQ ID NO.: 2601), CCTGgtaaga (SEQ ID NO.: 2603), CCTGgtaagc (SEQ ID NO.: 2604), CCTGgtaagg (SEQ ID NO.: 2605), CCTGgtaagt (SEQ ID NO.: 2606), CCTGgtaggt (SEQ ID NO.: 2621), CCTGgtatgc (SEQ ID NO.: 2625), CCTGgtatgg (SEQ ID NO.: 2626), CCTGgtatgt (SEQ ID NO.: 2627), CCTGgtattg (SEQ ID NO.: 2629), CCTGgtcagt (SEQ ID NO : 2632), CCTGgtgaag (SEQ ID NO : 2633), CCTGgtgaga (SEQ ID NO.: 2635), CCTGgtgagc (SEQ ID NO.: 2636), CCTGgtgagg (SEQ ID NO.: 2637), CCTGgtgagt (SEQ ID NO.: 2638), CCTGgtgcga (SEQ ID NO.: 2639), CCTGgtgcgt (SEQ ID NO.: 2640), CCTGgttagt (SEQ ID NO.: 2645), CCTTgtaagt (SEQ ID NO.: 2650), CCTTgtgagc (SEQ ID NO.: 2655), CCTTgtgagt (SEQ ID NO.: 2656), CGAAgtaagt (SEQ ID NO.: 2660), CGACgtgagt (SEQ ID NO.: 2669), CGAGagatag (SEQ ID NO.: 2670), CGAGgcaagt (SEQ ID NO.: 2671), CGAGgtaaaa (SEQ ID NO.: 2675), CGAGgtaaat (SEQ ID NO.: 2678), CGAGgtaacc (SEQ ID NO.: 2679), CGAGgtaacg (SEQ ID NO.: 2680), CGAGgtaaga (SEQ ID NO.: 2682), CGAGgtaagc (SEQ ID NO.: 2683), CGAGgtaagg (SEQ ID NO.: 2684), CGAGgtaagt (SEQ ID NO.: 2685), CGAGgtacga (SEQ ID NO.: 2696), CGAGgtacgt (SEQ ID NO.: 2698), CGAGgtactt (SEQ ID NO.: 2700), CGAGgtaggg (SEQ ID NO.: 2706), CGAGgtaggt (SEQ ID NO.: 2707), CGAGgtatgc (SEQ ID NO.: 2718), CGAGgtatgt (SEQ ID NO.: 2720), CGAGgtattt (SEQ ID NO.: 2723), CGAGgtcagg (SEQ ID NO.: 2725), CGAGgtcagt (SEQ ID NO.: 2726), CGAGgtgaag (SEQ ID NO.: 2731), CGAGgtgacc (SEQ ID NO.: 2732), CGAGgtgaga (SEQ ID NO.: 2734), CGAGgtgagc (SEQ ID NO.: 2735), CGAGgtgagg (SEQ ID NO.: 2736), CGAGgtgagt (SEQ ID NO.: 2737), CGAGgtgatc (SEQ ID NO.: 2738), CGAGgtgatg (SEQ ID NO.: 2739), CGAGgtgcat (SEQ ID NO.: 2740), CGAGgtgctt (SEQ ID NO.: 2744), CGAGgttaat (SEQ ID NO.: 2750), CGAGgttagg (SEQ ID NO.: 2751), CGATgtaagt (SEQ ID NO.: 2759), CGATgtacaa (SEQ ID NO.: 2760), CGATgtatgg (SEQ ID NO.: 2763), CGATgtgagt (SEQ ID NO.: 2765), CGCAgtaagt (SEQ ID NO.: 2767), CGCAgtgagc (SEQ ID NO.: 2768), CGCAgtgagt (SEQ ID NO.: 2769), CGCCatggcc (SEQ ID NO.: 2770), CGCCgtgagt (SEQ ID NO.: 2772), CGCGgtaaga (SEQ ID NO.: 2773), CGCGgtgagt (SEQ ID NO.: 2783), CGCGgtgggt (SEQ ID NO.: 2784), CGCTgtaagc (SEQ ID NO.: 2787), CGCTgtgagt (SEQ ID NO.: 2791), CGGGgtaagc (SEQ ID NO.: 2797), CGGGgtaagg (SEQ ID NO.: 2798), CGGGgtaggc (SEQ ID NO.: 2804), CGGGgtgagc (SEQ ID NO.: 2807), CGGGgtgagg (SEQ ID NO.: 2808), CGGGgtgagt (SEQ ID NO.: 2809), CGTAgtaagt (SEQ ID NO.: 2812), CGTGgtaaga (SEQ ID NO.: 2816), CGTGgtaagg (SEQ ID NO.: 2818), CGTGgtaagt (SEQ ID NO.: 2819), CGTGgtatgt (SEQ ID NO.: 2826), CGTGgtcagt (SEQ ID NO.: 2827), CGTGgtgagc (SEQ ID NO.: 2828), CGTGgtgagt (SEQ ID NO.: 2830), CGTGgtgggt (SEQ ID NO.: 2834), CTAAgtaagc (SEQ ID NO.: 2840), CTAAgtaagt (SEQ ID NO.: 2841), CTAAgtcagt (SEQ ID NO.: 2847), CTAAgtgagt (SEQ ID NO.: 2849), CTAAgttaag (SEQ ID NO.: 2850), CTACgtaagt (SEQ ID NO.: 2853), CTACgtgagt (SEQ ID NO.: 2855), CTAGgtaaaa (SEQ ID NO.: 2857), CTAGgtaaat (SEQ ID NO.: 2860), CTAGgtaacc (SEQ ID NO.: 2861), CTAGgtaaga (SEQ ID NO.: 2863), CTAGgtaagc (SEQ ID NO.: 2864), CTAGgtaagt (SEQ ID NO.: 2866), CTAGgtaata (SEQ ID NO.: 2867), CTAGgtaatc (SEQ ID NO.: 2868), CTAGgtaatg (SEQ ID NO.: 2869),
CTAGgtaccc (SEQ ID NO.: 2874), CTAGgtagaa (SEQ ID NO.: 2879), CTAGgtagag (SEQ ID NO.: 2880), CTAGgtatct (SEQ ID NO.: 2890), CTAGgtatgg (SEQ ID NO.: 2893), CTAGgtatgt (SEQ ID NO.: 2894), CTAGgtcagt (SEQ ID NO.: 2900), CTAGgtgaga (SEQ ID NO.: 2904), CTAGgtgagt (SEQ ID NO.: 2907), CTAGgtgatg (SEQ ID NO.: 2908), CTAGgtgggt (SEQ ID NO.: 2911), CTAGgttagt (SEQ ID NO.: 2913), CTATgcaagt (SEQ ID NO.: 2923), CTATgtaact (SEQ ID NO.: 2924), CTATgtaaga (SEQ ID NO.: 2925), CTATgtaagt (SEQ ID NO.: 2926), CTATgtgagt (SEQ ID NO.: 2932), CTATgtgcgc (SEQ ID NO.: 2933), CTCAgtaagt (SEQ ID NO.: 2938), CTCAgtgagt (SEQ ID NO.: 2941), CTCCgtatgt (SEQ ID NO.: 2950), CTCCgtgagt (SEQ ID NO.: 2951), CTCGgtaaga (SEQ ID NO.: 2955), CTCGgtaagc (SEQ ID NO.: 2956), CTCGgtaagg (SEQ ID NO.: 2957), CTCGgtaagt (SEQ ID NO.: 2958), CTCGgtacaa (SEQ ID NO.: 2961), CTCGgtattg (SEQ ID NO.: 2972), CTCGgtcagt (SEQ ID NO.: 2975), CTCGgtgaga (SEQ ID NO.: 2978), CTCGgtgagt (SEQ ID NO.: 2981), CTCGgtgggt (SEQ ID NO.: 2985), CTCTgtaaga (SEQ ID NO.: 2991), CTCTgtaagc (SEQ ID NO.: 2992), CTCTgtaagt (SEQ ID NO.: 2994), CTCTgtatgt (SEQ ID NO.: 2997), CTCTgtgagt (SEQ ID NO.: 2999), CTGAgtaagc (SEQ ID NO.: 3003), CTGAgtaagt (SEQ ID NO.: 3005), CTGAgtatcc (SEQ ID NO.: 3008), CTGAgtgagt (SEQ ID NO.: 3013), CTGCacagca (SEQ ID NO.: 3015), CTGCaggggg (SEQ ID NO.: 3016), CTGCgtgagt (SEQ ID NO.: 3019), CTGGgtaact (SEQ ID NO.: 3030), CTGGgtaaga (SEQ ID NO.: 3031), CTGGgtaagc (SEQ ID NO.: 3032), CTGGgtaagg (SEQ ID NO.: 3033), CTGGgtaagt (SEQ ID NO.: 3034), CTGGgtaata (SEQ ID NO.: 3035), CTGGgtaatt (SEQ ID NO.: 3037), CTGGgtaggc (SEQ ID NO.: 3044), CTGGgtaggt (SEQ ID NO.: 3046), CTGGgtcagt (SEQ ID NO.: 3054), CTGGgtgaga (SEQ ID NO.: 3060), CTGGgtgagc (SEQ ID NO.: 3061), CTGGgtgagg (SEQ ID NO.: 3062), CTGGgtgagt (SEQ ID NO.: 3063), CTGGttatca (SEQ ID NO.: 3076), CTGTgtaagt (SEQ ID NO.: 3083), CTGTgtgaga (SEQ ID NO.: 3089), CTGTgtgagt (SEQ ID NO.: 3090), CTTAgtaagt (SEQ ID NO.: 3093), CTTCgtaagt (SEQ ID NO.: 3096), CTTCgtgagt (SEQ ID NO.: 3097), CTTCttggta (SEQ ID NO.: 3098), CTTGatttta (SEQ ID NO.: 3099), CTTGgtaacc (SEQ ID NO.: 3103), CTTGgtaaga (SEQ ID NO.: 3104), CTTGgtaagc (SEQ ID NO.: 3105), CTTGgtaagg (SEQ ID NO.: 3106), CTTGgtaagt (SEQ ID NO.: 3107), CTTGgtacgt (SEQ ID NO.: 3112), CTTGgtaggt (SEQ ID NO.: 3115), CTTGgtatac (SEQ ID NO.: 3116), CTTGgtatgc (SEQ ID NO.: 3120), CTTGgtatgg (SEQ ID NO.: 3121), CTTGgtatgt (SEQ ID NO.: 3122), CTTGgtgagc (SEQ ID NO.: 3129), CTTGgtgagg (SEQ ID NO.: 3130), CTTGgtgagt (SEQ ID NO.: 3131), CTTGgtgggt (SEQ ID NO.: 3135), CTTTgtaagt (SEQ ID NO.: 3147), CTTTgtctcc (SEQ ID NO.: 3150), CTTTgtgagt (SEQ ID NO.: 3153), GAAAggtaat (SEQ ID NO.: 3163), GAAAgtaaga (SEQ ID NO.: 3167), GAAAgtaagg (SEQ ID NO.: 3169), GAAAgtaagt (SEQ ID NO.: 3170), GAAAgtaatt (SEQ ID NO. : 3172), GAAAgtaggt (SEQ ID NO.: 3176), GAAAgtatgt (SEQ ID NO.: 3177), GAAAgtgagt (SEQ ID NO.: 3182), GAAAgtgtga (SEQ ID NO.: 3184), GAAAgttagt (SEQ ID NO.: 3185), GAACgtatgt (SEQ ID NO. : 3189), GAACgtgagt (SEQ ID NO. : 3192), GAACgtgtga (SEQ ID NO. : 3193), GAAGgcaaag (SEQ ID NO. : 3198), GAAGgcaagg (SEQ ID NO. : 3201), GAAGgcaagt (SEQ ID NO.: 3202), GAAGgcatgt (SEQ ID NO.: 3206), GAAGggaggt (SEQ ID NO.: 3210), GAAGgtaaaa (SEQ ID NO.: 3212), GAAGgtaaac (SEQ ID NO.: 3213), GAAGgtaaag (SEQ ID NO.: 3214), GAAGgtaaat (SEQ ID NO.: 3215), GAAGgtaaca (SEQ ID NO.: 3216), GAAGgtaact (SEQ ID NO.: 3219), GAAGgtaaga (SEQ ID NO.: 3220), GAAGgtaagc (SEQ ID NO.: 3221), GAAGgtaagg (SEQ ID NO.: 3222), GAAGgtaagt (SEQ ID NO.: 3223), GAAGgtaatg (SEQ ID NO.: 3226), GAAGgtaatt (SEQ ID NO.: 3227), GAAGgtacaa (SEQ ID NO.: 3228), GAAGgtacag (SEQ ID NO.: 3230), GAAGgtacat (SEQ ID NO.: 3231),
GAAGgtactc (SEQ ID NO.: 3240), GAAGgtactg (SEQ ID NO.: 3241), GAAGgtactt (SEQ ID NO.: 3242), GAAGgtagaa (SEQ ID NO.: 3243), GAAGgtagag (SEQ ID NO.: 3245), GAAGgtagat (SEQ ID NO.: 3246), GAAGgtagcc (SEQ ID NO.: 3248), GAAGgtagct (SEQ ID NO.: 3250), GAAGgtagga (SEQ ID NO.: 3251), GAAGgtaggc (SEQ ID NO.: 3252), GAAGgtaggg (SEQ ID NO.: 3253), GAAGgtaggt (SEQ ID NO.: 3254), GAAGgtagta (SEQ ID NO.: 3255), GAAGgtagtt (SEQ ID NO.: 3257), GAAGgtatag (SEQ ID NO.: 3260), GAAGgtatat (SEQ ID NO.: 3261), GAAGgtatga (SEQ ID NO.: 3266), GAAGgtatgg (SEQ ID NO.: 3268), GAAGgtatgt (SEQ ID NO.: 3269), GAAGgtatta (SEQ ID NO.: 3270), GAAGgtattt (SEQ ID NO.: 3273), GAAGgtcaga (SEQ ID NO.: 3274), GAAGgtcagc (SEQ ID NO.: 3275), GAAGgtcagg (SEQ ID NO.: 3276), GAAGgtcagt (SEQ ID NO.: 3277), GAAGgtctgt (SEQ ID NO.: 3285), GAAGgtcttc (SEQ ID NO.: 3286), GAAGgtgaaa (SEQ ID NO.: 3287), GAAGgtgaag (SEQ ID NO.: 3289), GAAGgtgaat (SEQ ID NO.: 3290), GAAGgtgaga (SEQ ID NO.: 3294), GAAGgtgagc (SEQ ID NO.: 3295), GAAGgtgagg (SEQ ID NO.: 3296), GAAGgtgagt (SEQ ID NO.: 3297), GAAGgtgata (SEQ ID NO.: 3298), GAAGgtgatg (SEQ ID NO.: 3300), GAAGgtgatt (SEQ ID NO.: 3301), GAAGgtgcag (SEQ ID NO.: 3303), GAAGgtgctg (SEQ ID NO.: 3313), GAAGgtggaa (SEQ ID NO.: 3315), GAAGgtggga (SEQ ID NO.: 3319), GAAGgtgggc (SEQ ID NO.: 3320), GAAGgtgggt (SEQ ID NO.: 3322), GAAGgtggta (SEQ ID NO : 3323), GAAGgtgtaa (SEQ ID NO : 3326), GAAGgttagc (SEQ ID NO.: 3337), GAAGgttagt (SEQ ID NO.: 3339), GAAGgttggt (SEQ ID NO.: 3346), GAAGgttgta (SEQ ID NO.: 3347), GAAGgtttgc (SEQ ID NO.: 3349), GAAGgtttgt (SEQ ID NO.: 3351), GAATgcaagg (SEQ ID NO.: 3356), GAATgtaagg (SEQ ID NO.: 3360), GAATgtaagt (SEQ ID NO.: 3361), GAATgtatgt (SEQ ID NO.: 3365), GAATgtgagc (SEQ ID NO.: 3368), GAATgtgagg (SEQ ID NO.: 3369), GAATgtgagt (SEQ ID NO.: 3370), GAATtgtaag (SEQ ID NO.: 3375), GACAgtaagt (SEQ ID NO.: 3381), GACAgtaggt (SEQ ID NO.: 3384), GACAgtgagt (SEQ ID NO.: 3389), GACCgtaagt (SEQ ID NO.: 3396), GACCgtatgt (SEQ ID NO.: 3398), GACCgtgagt (SEQ ID NO.: 3399), GACCgtgggt (SEQ ID NO.: 3400), GACGgtaaag (SEQ ID NO.: 3401), GACGgtaagc (SEQ ID NO.: 3404), GACGgtaagt (SEQ ID NO.: 3405), GACGgtaatt (SEQ ID NO.: 3408), GACGgtagga (SEQ ID NO.: 3409), GACGgtatgg (SEQ ID NO.: 3412), GACGgtgaga (SEQ ID NO.: 3414), GACGgtgagc (SEQ ID NO.: 3415), GACGgtgagg (SEQ ID NO.: 3416), GACGgtgcgt (SEQ ID NO.: 3418), GACGgtgggc (SEQ ID NO.: 3419), GACGgtgggt (SEQ ID NO.: 3420), GACTgtaaga (SEQ ID NO.: 3427), GACTgtaagt (SEQ ID NO.: 3429), GACTgtatcc (SEQ ID NO.: 3432), GACTgtgagt (SEQ ID NO.: 3436), GACTgtgggt (SEQ ID NO.: 3438), GAGAagctaa (SEQ ID NO.: 3442), GAGAgtaaga (SEQ ID NO.: 3447), GAGAgtaagc (SEQ ID NO.: 3448), GAGAgtaagt (SEQ ID NO.: 3450), GAGAgtgagt (SEQ ID NO.: 3454), GAGAtgctgc (SEQ ID NO.: 3460), GAGCgtaagt (SEQ ID NO.: 3462), GAGCgtgtga (SEQ ID NO.: 3468), GAGGagtgtg (SEQ ID NO.: 3470), GAGGgtaaat (SEQ ID NO.: 3478), GAGGgtaaga (SEQ ID NO.: 3479), GAGGgtaagc (SEQ ID NO.: 3480), GAGGgtaatg (SEQ ID NO.: 3484), GAGGgtatac (SEQ ID NO.: 3491), GAGGgtatgt (SEQ ID NO.: 3495), GAGGgtgaga (SEQ ID NO.: 3498), GAGGgtgagg (SEQ ID NO.: 3500), GAGGgtgagt (SEQ ID NO.: 3501), GAGGgtgggc (SEQ ID NO.: 3503), GAGGgtttgt (SEQ ID NO.: 3508), GAGTgtaagt (SEQ ID NO.: 3511), GAGTgtgagc (SEQ ID NO.: 3514), GAGTgtgagt (SEQ ID NO.: 3515), GATAgtaagt (SEQ ID NO.: 3517), GATAgtactg (SEQ ID NO.: 3518), GATAgtgagt (SEQ ID NO.: 3519), GATCgtaagt (SEQ ID NO.: 3521), GATCgtgagt (SEQ ID NO.: 3524), GATGcaggaa (SEQ ID NO.: 3527), GATGgcaatc (SEQ ID NO.: 3529), GATGgcatgt (SEQ ID NO.: 3531), GATGgtaaga (SEQ ID
NO.: 3539), GATGgtaagc (SEQ ID NO.: 3540), GATGgtaagt (SEQ ID NO.: 3542), GATGgtaata (SEQ ID NO.: 3543), GATGgtaatg (SEQ ID NO.: 3544), GATGgtaatt (SEQ ID NO : 3545), GATGgtaccc (SEQ ID NO.: 3547), GATGgtaggt (SEQ ID NO.: 3552), GATGgtatga (SEQ ID NO.: 3554), GATGgtatgt (SEQ ID NO.: 3556), GATGgtcggt (SEQ ID NO.: 3559), GATGgtgaga (SEQ ID NO.: 3561), GATGgtgagc (SEQ ID NO.: 3562), GATGgtgagg (SEQ ID NO.: 3563), GATGgtgagt (SEQ ID NO.: 3564), GATGgtggga (SEQ ID NO.: 3569), GATGgtggtg (SEQ ID NO.: 3572), GATGgttagt (SEQ ID NO.: 3575), GATGtgggtt (SEQ ID NO.: 3577), GATTgtaagt (SEQ ID NO.: 3579), GATTgtgagt (SEQ ID NO.: 3584), GATTtgcatg (SEQ ID NO.: 3587), GCAAgtaagt (SEQ ID NO.: 3597), GCAAgtacgg (SEQ ID NO.: 3599), GCAAgtaggt (SEQ ID NO.: 3603), GCAAgtatga (SEQ ID NO.: 3604), GCAAgtatgc (SEQ ID NO.: 3605), GCAAgtatgg (SEQ ID NO.: 3606), GCAAgtgagt (SEQ ID NO.: 361 1), GCAGgtaagt (SEQ ID NO.: 3617), GCACgtgagt (SEQ ID NO.: 3621), GCAGgcaagt (SEQ ID NO.: 3630), GCAGgcacag (SEQ ID NO.: 3631), GCAGgtaaaa (SEQ ID NO.: 3641), GCAGgtaaac (SEQ ID NO.: 3642), GCAGgtaaag (SEQ ID NO.: 3643), GCAGgtaaat (SEQ ID NO.: 3644), GCAGgtaaca (SEQ ID NO.: 3645), GCAGgtaacc (SEQ ID NO.: 3646), GCAGgtaact (SEQ ID NO.: 3648), GCAGgtaaga (SEQ ID NO.: 3649), GCAGgtaagc (SEQ ID NO.: 3650), GCAGgtaagg (SEQ ID NO.: 3651), GCAGgtaagt (SEQ ID NO.: 3652), GCAGgtaata (SEQ ID NO.: 3653), GCAGgtaata (SEQ ID NO.: 3654), GCAGgtaatg (SEQ ID NO.: 3655), GCAGgtaata (SEQ ID NO.: 3656), GCAGgtacag (SEQ ID NO.: 3659), GCAGgtacca (SEQ ID NO.: 3661), GCAGgtacgc (SEQ ID NO.: 3666), GCAGgtactc (SEQ ID NO.: 3670), GCAGgtactg (SEQ ID NO.: 3671), GCAGgtagga (SEQ ID NO.: 3679), GCAGgtaggc (SEQ ID NO.: 3680), GCAGgtaggg (SEQ ID NO.: 3681), GCAGgtaggt (SEQ ID NO.: 3682), GCAGgtagta (SEQ ID NO.: 3683), GCAGgtagtt (SEQ ID NO.: 3686), GCAGgtataa (SEQ ID NO.: 3687), GCAGgtatca (SEQ ID NO.: 3691), GCAGgtatcc (SEQ ID NO.: 3692), GCAGgtatct (SEQ ID NO.: 3694), GCAGgtatga (SEQ ID NO.: 3695), GCAGgtatgc (SEQ ID NO.: 3696), GCAGgtatgg (SEQ ID NO.: 3697), GCAGgtatgt (SEQ ID NO.: 3698), GCAGgtatta (SEQ ID NO.: 3699), GCAGgtattg (SEQ ID NO.: 3701), GCAGgtattt (SEQ ID NO.: 3702), GCAGgtaagc (SEQ ID NO.: 3706), GCAGgtaagg (SEQ ID NO.: 3707), GCAGgtaagt (SEQ ID NO.: 3708), GCAGgtatgt (SEQ ID NO.: 3720), GCAGgtgaaa (SEQ ID NO.: 3721), GCAGgtgaag (SEQ ID NO.: 3723), GCAGgtgacc (SEQ ID NO.: 3726), GCAGgtgaga (SEQ ID NO.: 3729), GCAGgtgagc (SEQ ID NO.: 3730), GCAGgtgagg (SEQ ID NO.: 3731), GCAGgtgagt (SEQ ID NO.: 3732), GCAGgtgatg (SEQ ID NO.: 3735), GCAGgtgcga (SEQ ID NO.: 3743), GCAGgtgcgg (SEQ ID NO.: 3745), GCAGgtgcgt (SEQ ID NO.: 3746), GCAGgtggga (SEQ ID NO.: 3753), GCAGgtgggt (SEQ ID NO.: 3756), GCAGgtgtgc (SEQ ID NO.: 3762), GCAGgtgtgg (SEQ ID NO.: 3763), GCAGgtgtgt (SEQ ID NO.: 3764), GCAGgttagt (SEQ ID NO.: 3770), GCAGgttata (SEQ ID NO.: 3771), GCAGgttcag (SEQ ID NO.: 3772), GCAGgttagt (SEQ ID NO.: 3774), GCAGgttctt (SEQ ID NO.: 3776), GCATgtaaga (SEQ ID NO.: 3789), GCATgtaagt (SEQ ID NO.: 3790), GCATgtaggt (SEQ ID NO.: 3793), GCATgtatcc (SEQ ID NO.: 3794), GCATgtatgt (SEQ ID NO.: 3795), GCATgtgagc (SEQ ID NO.: 3796), GCATgtgagt (SEQ ID NO.: 3797), GCCAgtaaga (SEQ ID NO.: 3802), GCCAgtaagt (SEQ ID NO.: 3804), GCCAgtgagt (SEQ ID NO.: 3807), GCCCgtaagc (SEQ ID NO.: 3810), GCCCgtatgt (SEQ ID NO.: 3813), GCCCgtgagt (SEQ ID NO.: 3814), GCCGgtaaga (SEQ ID NO.: 3820), GCCGgtaagg (SEQ ID NO.: 3822), GCCGgtaagt (SEQ ID NO.: 3823), GCCGgtatgt (SEQ ID NO : 3833), GCCGgtgagc (SEQ ID NO.: 3838), GCCGgtgagt (SEQ ID NO.: 3840), GCCGgtgggt (SEQ ID NO.: 3842), GCCTgtaagt (SEQ ID NO.: 3845), GCCTgtgagt (SEQ ID NO.: 3851), GCGAgtgagt (SEQ ID NO.: 3860),
GCGCgtgagt (SEQ ID NO.: 3864), GCGGgtaagc (SEQ ID NO.: 3868), GCGGgtaagg (SEQ ID NO.: 3869), GCGGgtatgg (SEQ ID NO.: 3879), GCGGgtatgt (SEQ ID NO.: 3880), GCGGgtgaga (SEQ ID NO.: 3881), GCGGgtgagc (SEQ ID NO.: 3882), GCGGgtgagt (SEQ ID NO.: 3884), GCGGgtgcgt (SEQ ID NO.: 3886), GCTAagttaa (SEQ ID NO.: 3894), GCTAgtaagc (SEQ ID NO.: 3896), GCTAgtgagt (SEQ ID NO.: 3899), GCTAgtgcgt (SEQ ID NO.: 3900), GCTAtggaat (SEQ ID NO.: 3901), GCTCgtaagt (SEQ ID NO.: 3903), GCTCtcttgt (SEQ ID NO.: 3905), GCTGgtaaat (SEQ ID NO.: 3913), GCTGgtaagg (SEQ ID NO.: 3917), GCTGgtaagt (SEQ ID NO.: 3918), GCTGgtacct (SEQ ID NO.: 3921), GCTGgtaggt (SEQ ID NO.: 3931), GCTGgtatgt (SEQ ID NO.: 3936), GCTGgtcagt (SEQ ID NO.: 3939), GCTGgtgaga (SEQ ID NO.: 3941), GCTGgtgagc (SEQ ID NO.: 3942), GCTGgtgagg (SEQ ID NO.: 3943), GCTGgtgagt (SEQ ID NO.: 3944), GCTGgtgtgt (SEQ ID NO.: 3951), GCTTgtaagt (SEQ ID NO.: 3957), GCTTgtatgt (SEQ ID NO.: 3961), GCTTgtgagt (SEQ ID NO.: 3962), GCTTgtgctt (SEQ ID NO.: 3963), GGAAaaggta (SEQ ID NO.: 3965), GGAAggtcag (SEQ ID NO.: 3970), GGAAgtaaga (SEQ ID NO.: 3973), GGAAgtaagc (SEQ ID NO.: 3974), GGAAgtaagt (SEQ ID NO.: 3976), GGAAgtatgt (SEQ ID NO.: 3982), GGAAgtgagt (SEQ ID NO.: 3985), GGAAgttagt (SEQ ID NO.: 3986), GGAGctcagg (SEQ ID NO.: 3992), GGAGgcaggt (SEQ ID NO.: 3997), GGAGgccatg (SEQ ID NO.: 3998), GGAGgtaaag (SEQ ID NO.: 4004), GGAGgtaaat (SEQ ID NO.: 4005), GGAGgtaaca (SEQ ID NO.: 4006), GGAGgtaacc (SEQ ID NO.: 4007), GGAGgtaaga (SEQ ID NO.: 4010), GGAGgtaagc (SEQ ID NO.: 4011), GGAGgtaagg (SEQ ID NO.: 4012), GGAGgtaagt (SEQ ID NO.: 4013), GGAGgtaatc (SEQ ID NO.: 4015), GGAGgtaatg (SEQ ID NO.: 4016), GGAGgtaatt (SEQ ID NO.: 4017), GGAGgtaccg (SEQ ID NO.: 4022), GGAGgtacga (SEQ ID NO.: 4024), GGAGgtagga (SEQ ID NO.: 4034), GGAGgtaggg (SEQ ID NO.: 4036), GGAGgtaggt (SEQ ID NO.: 4037), GGAGgtatac (SEQ ID NO.: 4041), GGAGgtatat (SEQ ID NO.: 4043), GGAGgtatgc (SEQ ID NO.: 4047), GGAGgtatgt (SEQ ID NO.: 4049), GGAGgtatta (SEQ ID NO.: 4050), GGAGgtattt (SEQ ID NO.: 4053), GGAGgtcagg (SEQ ID NO.: 4056), GGAGgtcagt (SEQ ID NO.: 4057), GGAGgtcgag (SEQ ID NO.: 4060), GGAGgtctgc (SEQ ID NO.: 4062), GGAGgtgaga (SEQ ID NO.: 4072), GGAGgtgagc (SEQ ID NO.: 4073), GGAGgtgagg (SEQ ID NO.: 4074), GGAGgtgagt (SEQ ID NO.: 4075), GGAGgtgatg (SEQ ID NO.: 4076), GGAGgtgcct (SEQ ID NO.: 4078), GGAGgtggcg (SEQ ID NO.: 4087), GGAGgtgggc (SEQ ID NO.: 4089), GGAGgtgggt (SEQ ID NO.: 4091), GGAGgtgtgt (SEQ ID NO.: 4096), GGATatgtaa (SEQ ID NO.: 4116), GGATgtaagt (SEQ ID NO.: 4120), GGATgtatcc (SEQ ID NO.: 4121), GGATgtgagt (SEQ ID NO.: 4125), GGATgtgtgt (SEQ ID NO.: 4127), GGATgttagc (SEQ ID NO.: 4128), GGCAgtaagt (SEQ ID NO.: 4133), GGCAgtgagt (SEQ ID NO.: 4134), GGCCgtacag (SEQ ID NO.: 4138), GGCGgtaaag (SEQ ID NO.: 4143), GGCGgtaaga (SEQ ID NO.: 4144), GGCGgtaagt (SEQ ID NO.: 4146), GGCGgtaggt (SEQ ID NO.: 4147), GGCGgtgagg (SEQ ID NO.: 4152), GGCGgtgagt (SEQ ID NO : 4153), GGCTgcccca (SEQ ID NO 4155), GGCTgtaagt (SEQ ID NO.: 4157), GGCTgtgagt (SEQ ID NO.: 4162), GGGAgtaagt (SEQ ID NO.: 4167), GGGCattggt (SEQ ID NO.: 4172), GGGCgtaagt (SEQ ID NO.: 4174), GGGCgtatct (SEQ ID NO.: 4175), GGGGgtaagc (SEQ ID NO.: 4181), GGGGgtaagt (SEQ ID NO.: 4183), GGGGgtgagt (SEQ ID NO.: 4189), GGTGgtaaga (SEQ ID NO.: 4198), GGTGgtaagc (SEQ ID NO.: 4199), GGTGgtaagt (SEQ ID NO.: 4201), GGTGgtgagt (SEQ ID NO.: 4213), GGTTgtaagt (SEQ ID NO.: 4217), GTAGgtaagc (SEQ ID NO.: 4224), GTAGgtaagt (SEQ ID NO.: 4226), GTAGgtaggt (SEQ ID NO.: 4230), GTAGgtgagc (SEQ ID NO.: 4237), GTAGgtgagt (SEQ ID NO.: 4238), GTAGgtgggt (SEQ ID NO.: 4240), GTAGgttgcg (SEQ ID NO.: 4243), GTATgtaagt
(SEQ ID NO.: 4245), GTCAacggct (SEQ ID NO.: 4249), GTCAgtaagt (SEQ ID NO.: 4252), GTCAgtgagt (SEQ ID NO.: 4254), GTCCgtaagt (SEQ ID NO.: 4258), GTCGgtaagt (SEQ ID NO.: 4263), GTCGgtaatg (SEQ ID NO.: 4264), GTCGgtcagt (SEQ ID NO.: 4270), GTCGgtggga (SEQ ID NO.: 4273), GTCTgaagag (SEQ ID NO.: 4275), GTCTgtaagt (SEQ ID NO.: 4278), GTGAgtaagt (SEQ ID NO.: 4281), GTGGgtaaga (SEQ ID NO.: 4286), GTGGgtaagt (SEQ ID NO.: 4289), GTGGgtacgg (SEQ ID NO.: 4291), GTGGgtcagt (SEQ ID NO.: 4297), GTGGgtgagg (SEQ ID NO.: 4301), GTGGgtgagt (SEQ ID NO.: 4302), GTGTctccca (SEQ ID NO.: 4307), GTGTgtaagg (SEQ ID NO.: 4309), GTGTgtaagt (SEQ ID NO.: 4310), GTGTgtgagt (SEQ ID NO. : 4311), GTTAgtaagt (SEQ ID NO. : 4313), GTTAtggtga (SEQ ID NO. : 4315), GTTGgtaaga (SEQ ID NO.: 4325), GTTGgtaagc (SEQ ID NO.: 4326), GTTGgtaagt (SEQ ID NO.: 4327), GTTGgtgaga (SEQ ID NO 4339), GTTGgtgagt (SEQ ID NO.: 4341), GTTTgtaagt (SEQ ID NO.: 4348), GTTTgtgagt (SEQ ID NO.: 4349), TAAAgtaagc (SEQ ID NO.: 4358), TAAAgtaagt (SEQ ID NO.: 4360), TAAAgtgagt (SEQ ID NO.: 4370), TAAAgtgtgt (SEQ ID NO.: 4373), TAAAgttagt (SEQ ID NO.: 4374), TAACgtaagc (SEQ ID NO.: 4378), TAACgtaagt (SEQ ID NO.: 4379), TAACgtgagt (SEQ ID NO.: 4382), TAAGgtaaaa (SEQ ID NO.: 4393), TAAGgtaaac (SEQ ID NO.: 4394), TAAGgtaaag (SEQ ID NO.: 4395), TAAGgtaaat (SEQ ID NO.: 4396), TAAGgtaacc (SEQ ID NO.: 4398), TAAGgtaact (SEQ ID NO.: 4400), TAAGgtaaga (SEQ ID NO.: 4401), TAAGgtaagc (SEQ ID NO 4402), TAAGgtaagg (SEQ ID NO.: 4403), TAAGgtaagt (SEQ ID NO.: 4404), TAAGgtaata (SEQ ID NO.: 4405), TAAGgtaatt (SEQ ID NO.: 4408), TAAGgtacaa (SEQ ID NO.: 4409), TAAGgtacag (SEQ ID NO.: 4411), TAAGgtacca (SEQ ID NO.: 4413), TAAGgtactg (SEQ ID NO.: 4421), TAAGgtactt (SEQ ID NO.: 4422), TAAGgtagag (SEQ ID NO.: 4424), TAAGgtagga (SEQ ID NO.: 4429), TAAGgtaggt (SEQ ID NO.: 4432), TAAGgtatcc (SEQ ID NO.: 4441), TAAGgtatga (SEQ ID NO.: 4443), TAAGgtatgc (SEQ ID NO.: 4444), TAAGgtatgg (SEQ ID NO.: 4445), TAAGgtatgt (SEQ ID NO.: 4446), TAAGgtattt (SEQ ID NO.: 4450), TAAGgtcagt (SEQ ID NO.: 4454), TAAGgtctcg (SEQ ID NO.: 4461), TAAGgtctgt (SEQ ID NO.: 4462), TAAGgtgaaa (SEQ ID NO.: 4464), TAAGgtgaag (SEQ ID NO.: 4465), TAAGgtgaat (SEQ ID NO.: 4466), TAAGgtgagg (SEQ ID NO.: 4471), TAAGgtgagt (SEQ ID NO.: 4472), TAAGgtgcac (SEQ ID NO.: 4476), TAAGgtgcca (SEQ ID NO.: 4477), TAAGgtgcct (SEQ ID NO.: 4478), TAAGgtggat (SEQ ID NO.: 4483), TAAGgtgggc (SEQ ID NO.: 4485), TAAGgtgggt (SEQ ID NO.: 4486), TAAGgtgtgt (SEQ ID NO.: 4489), TAAGgttatt (SEQ ID NO.: 4497), TAAGgttggt (SEQ ID NO.: 4502), TAAGgtttct (SEQ ID NO.: 4506), TAAGgtttgt (SEQ ID NO.: 4508), TAATgcaagt (SEQ ID NO.: 4511), TAATgtaagt (SEQ ID NO.: 4515), TAATgtgagt (SEQ ID NO.: 4521), TACAggttgc (SEQ ID NO.: 4527), TACAgtaaga (SEQ ID NO.: 4528), TACAgtaagt (SEQ ID NO.: 4530), TACAgtaggt (SEQ ID NO.: 4534), TACAgtgagt (SEQ ID NO.: 4539), TACCaaaggg (SEQ ID NO.: 4544), TACCgtaagt (SEQ ID NO.: 4546), TACCgtgagg (SEQ ID NO.: 4549), TACGgtaaaa (SEQ ID NO.: 4551), TACGgtaagc (SEQ ID NO.: 4555), TACGgtaagg (SEQ ID NO.: 4556), TACGgtaatt (SEQ ID NO.: 4559), TACGgtacgt (SEQ ID NO.: 4560), TACGgtaggt (SEQ ID NO.: 4565), TACGgtgagt (SEQ ID NO.: 4571), TACTgtaagt (SEQ ID NO.: 4578), TACTgtatgt (SEQ ID NO.: 4583), TACTgtgagt (SEQ ID NO.: 4584), TAGAgtaagt (SEQ ID NO.: 4590), TAGAgtatta (SEQ ID NO.: 4593), TAGAgtgagt (SEQ ID NO.: 4595), TAGAgttgta (SEQ ID NO.: 4596), TAGGgtaaga (SEQ ID NO.: 4602), TAGGgtaagt (SEQ ID NO.: 4604), TAGGgtagga (SEQ ID NO.: 4607), TAGGgtaggt (SEQ ID NO.: 4609), TAGGgtgaga (SEQ ID NO.: 4611), TAGGgttggt (SEQ ID NO.: 4615), TAGTgtaagg (SEQ ID NO.: 4617), TAGTgtaagt (SEQ ID NO.: 4618), TAGTgtatgt (SEQ ID NO.: 4622), TATAtaaggt
(SEQ ID NO.: 4632), TATCgtaagt (SEQ ID NO.: 4638), TATCgtgagt (SEQ ID NO.: 4641), TATGgtaaaa (SEQ ID NO.: 4644), TATGgtaaat (SEQ ID NO.: 4646), TATGgtaact (SEQ ID NO.: 4649), TATGgtaaga (SEQ ID NO.: 4650), TATGgtaagc (SEQ ID NO.: 4651), TATGgtaagt (SEQ ID NO.: 4653), TATGgtaatg (SEQ ID NO.: 4656), TATGgtacac (SEQ ID NO.: 4658), TATGgtagga (SEQ ID NO.: 4665), TATGgtatgg (SEQ ID NO.: 4671), TATGgtcagc (SEQ ID NO.: 4676), TATGgtgaga (SEQ ID NO.: 4680), TATGgtgagc (SEQ ID NO.: 4681), TATGgtgagg (SEQ ID NO.: 4682), TATGgtgagt (SEQ ID NO.: 4683), TATGgtggtg (SEQ ID NO.: 4685), TATTgtaagc (SEQ ID NO.: 4690), TATTgtaagt (SEQ ID NO.: 4691), TATTgtatgt (SEQ ID NO.: 4695), TATTgtgagc (SEQ ID NO.: 4697), TATTgtgagt (SEQ ID NO.: 4698), TCAAgcaggt (SEQ ID NO.: 4703), TCAAgtaaaa (SEQ ID NO.: 4705), TCAAgtaaga (SEQ ID NO.: 4708), TCAAgtaagc (SEQ ID NO 4709), TCAAgtaagt (SEQ ID NO.: 4711), TCAAgtaata (SEQ ID NO.: 4712), TCAAgtacat (SEQ ID NO.: 4715), TCAAgtacta (SEQ ID NO.: 4718), TCAAgtatgt (SEQ ID NO.: 4725), TCAAgtgagc (SEQ ID NO.: 4729), TCAAgtgagg (SEQ ID NO.: 4730), TCAAgtgagt (SEQ ID NO.: 4731), TCAAgtgatt (SEQ ID NO.: 4732), TCACgtaagc (SEQ ID NO.: 4739), TCACgtaagt (SEQ ID NO.: 4740), TCACgtatgt (SEQ ID NO.: 4742), TCACgtgagt (SEQ ID NO.: 4744), TCAGgcaagt (SEQ ID NO.: 4754), TCAGgcatat (SEQ ID NO.: 4760), TCAGgcatgt (SEQ ID NO.: 4761), TCAGgtaaaa (SEQ ID NO.: 4765), TCAGgtaaac (SEQ ID NO.: 4766), TCAGgtaaag (SEQ ID NO.: 4767), TCAGgtaaat (SEQ ID NO.: 4768), TCAGgtaaca (SEQ ID NO.: 4769), TCAGgtaacc (SEQ ID NO.: 4770), TCAGgtaact (SEQ ID NO.: 4772), TCAGgtaaga (SEQ ID NO.: 4773), TCAGgtaagc (SEQ ID NO.: 4774), TCAGgtaagg (SEQ ID NO.: 4775), TCAGgtaagt (SEQ ID NO.: 4776), TCAGgtaata (SEQ ID NO.: 4777), TCAGgtaatc (SEQ ID NO.: 4778), TCAGgtaatg (SEQ ID NO.: 4779), TCAGgtaatt (SEQ ID NO.: 4780), TCAGgtacac (SEQ ID NO.: 4782), TCAGgtacag (SEQ ID NO.: 4783), TCAGgtacat (SEQ ID NO.: 4784), TCAGgtacca (SEQ ID NO.: 4785), TCAGgtacct (SEQ ID NO.: 4787), TCAGgtacgt (SEQ ID NO.: 4791), TCAGgtactc (SEQ ID NO.: 4793), TCAGgtactg (SEQ ID NO.: 4794), TCAGgtactt (SEQ ID NO.: 4795), TCAGgtagaa (SEQ ID NO.: 4796), TCAGgtagag (SEQ ID NO.: 4798), TCAGgtagat (SEQ ID NO.: 4799), TCAGgtagcc (SEQ ID NO.: 4801), TCAGgtagga (SEQ ID NO.: 4804), TCAGgtaggc (SEQ ID NO.: 4805), TCAGgtaggg (SEQ ID NO.: 4806), TCAGgtaggt (SEQ ID NO.: 4807), TCAGgtagtt (SEQ ID NO.: 4810), TCAGgtatca (SEQ ID NO.: 4815), TCAGgtatct (SEQ ID NO.: 4817), TCAGgtatga (SEQ ID NO.: 4818), TCAGgtatgc (SEQ ID NO.: 4819), TCAGgtatgg (SEQ ID NO.: 4820), TCAGgtatgt (SEQ ID NO.: 4821), TCAGgtatta (SEQ ID NO.: 4822), TCAGgtattc (SEQ ID NO.: 4823), TCAGgtattg (SEQ ID NO.: 4824), TCAGgtattt (SEQ ID NO.: 4825), TCAGgtcaga (SEQ ID NO.: 4827), TCAGgtcagt (SEQ ID NO.: 4830), TCAGgtctgc (SEQ ID NO.: 4839), TCAGgtctgt (SEQ ID NO.: 4841), TCAGgtgaag (SEQ ID NO.: 4846), TCAGgtgaat (SEQ ID NO.: 4847), TCAGgtgaga (SEQ ID NO.: 4851), TCAGgtgagc (SEQ ID NO.: 4852), TCAGgtgagg (SEQ ID NO.: 4853), TCAGgtgagt (SEQ ID NO.: 4854), TCAGgtgatc (SEQ ID NO.: 4856), TCAGgtgatg (SEQ ID NO.: 4857), TCAGgtgatt (SEQ ID NO.: 4858), TCAGgtgcca (SEQ ID NO.: 4862), TCAGgtgcga (SEQ ID NO.: 4865), TCAGgtgcgg (SEQ ID NO.: 4866), TCAGgtgcgt (SEQ ID NO.: 4867), TCAGgtgctt (SEQ ID NO.: 4870), TCAGgtgggc (SEQ ID NO.: 4874), TCAGgtgggg (SEQ ID NO.: 4875), TCAGgtgggt (SEQ ID NO.: 4876), TCAGgtggtg (SEQ ID NO.: 4878), TCAGgtgtaa (SEQ ID NO.: 4879), TCAGgtgtga (SEQ ID NO.: 4882), TCAGgtgtgc (SEQ ID NO.: 4883), TCAGgtgtgg (SEQ ID NO.: 4884), TCAGgtgtgt (SEQ ID NO.: 4885), TCAGgttagc (SEQ ID NO.: 4890), TCAGgttagt (SEQ ID NO.: 4892), TCAGgttgaa (SEQ ID NO.: 4896), TCAGgttggt (SEQ ID NO.: 4905), TCAGgtttgt (SEQ ID
NO.: 4913), TCAGgttttt (SEQ ID NO.: 4914), TCATgtaaat (SEQ ID NO.: 4920), TCATgtaaga (SEQ ID NO.: 4921), TCATgtaagt (SEQ ID NO.: 4923), TCATgtatgt (SEQ ID NO.: 4930), TCATgtgagt (SEQ ID NO.: 4933), TCCAgtaagt (SEQ ID NO.: 4940), TCCAgtgagt (SEQ ID NO.: 4945), TCCCgtgagt (SEQ ID NO.: 4951), TCCCgtgcgt (SEQ ID NO.: 4952), TCCGgtaact (SEQ ID NO.: 4955), TCCGgtactt (SEQ ID NO.: 4964), TCCGgtgagc (SEQ ID NO.: 4970), TCCGgtgagt (SEQ ID NO.: 4972), TCCGgtgggc (SEQ ID NO.: 4974), TCCGgtgggt (SEQ ID NO.: 4975), TCCTgcagga (SEQ ID NO.: 4978), TCCTggagga (SEQ ID NO.: 4980), TCCTgtaagt (SEQ ID NO.: 4985), TCCTgtaggc (SEQ ID NO.: 4987), TCCTgtatga (SEQ ID NO.: 4989), TCCTgtgaga (SEQ ID NO.: 4991), TCCTgtgagt (SEQ ID NO.: 4993), TCGAgtacgt (SEQ ID NO.: 5003), TCGAgtcagt (SEQ ID NO.: 5005), TCGCgtatgt (SEQ ID NO.: 5010), TCGCgtgagg (SEQ ID NO.: 501 1), TCGCgtgagt (SEQ ID NO.: 5012), TCGGgcaagt (SEQ ID NO.: 5013), TCGGgtaaat (SEQ ID NO.: 5015), TCGGgtacgt (SEQ ID NO.: 5025), TCGGgtaggt (SEQ ID NO.: 5028), TCGGgtatgt (SEQ ID NO.: 5030), TCGGgtgaga (SEQ ID NO.: 5034), TCGGgtgagg (SEQ ID NO.: 5036), TCGTggtatg (SEQ ID NO.: 5044), TCGTgtaagt (SEQ ID NO.: 5045), TCGTgtgagt (SEQ ID NO.: 5047), TCTAagttta (SEQ ID NO.: 5049), TCTAgcaagt (SEQ ID NO.: 5050), TCTAgtaaga (SEQ ID NO.: 5051), TCTAgtaagc (SEQ ID NO.: 5052), TCTAgtaagt (SEQ ID NO.: 5053), TCTAgtgagt (SEQ ID NO.: 5056), TCTCgtatga (SEQ ID NO.: 5062), TCTGgtaaaa (SEQ ID NO.: 5067), TCTGgtaaat (SEQ ID NO.: 5069), TCTGgtaaga (SEQ ID NO.: 5073), TCTGgtaagc (SEQ ID NO.: 5074), TCTGgtaagg (SEQ ID NO.: 5075), TCTGgtaagt (SEQ ID NO.: 5076), TCTGgtaata (SEQ ID NO.: 5077), TCTGgtacag (SEQ ID NO.: 5080), TCTGgtaggc (SEQ ID NO.: 5089), TCTGgtaggt (SEQ ID NO.: 5091), TCTGgtatga (SEQ ID NO.: 5095), TCTGgtatgc (SEQ ID NO.: 5096), TCTGgtatgt (SEQ ID NO.: 5098), TCTGgtattt (SEQ ID NO.: 5099), TCTGgtgaat (SEQ ID NO.: 5102), TCTGgtgaga (SEQ ID NO.: 5104), TCTGgtgagc (SEQ ID NO.: 5105), TCTGgtgagg (SEQ ID NO.: 5106), TCTGgtgagt (SEQ ID NO.: 5107), TCTGgtttgt (SEQ ID NO.: 5114), TCTTgtaagt (SEQ ID NO.: 5118), TCTTgtatgt (SEQ ID NO.: 5120), TCTTgtgagt (SEQ ID NO.: 5122), TGAAaaggta (SEQ ID NO.: 5126), TGAAgtaact (SEQ ID NO.: 5131), TGAAgtaagc (SEQ ID NO.: 5133), TGAAgtaagt (SEQ ID NO.: 5135), TGAAgtatgc (SEQ ID NO.: 5143), TGAAgtccgt (SEQ ID NO.: 5146), TGAGgcaagt (SEQ ID NO.: 5165), TGAGgcaggt (SEQ ID NO.: 5167), TGAGgtaaaa (SEQ ID NO.: 5170), TGAGgtaaac (SEQ ID NO.: 5171), TGAGgtaaag (SEQ ID NO.: 5172), TGAGgtaaat (SEQ ID NO.: 5173), TGAGgtaaga (SEQ ID NO.: 5178), TGAGgtaagc (SEQ ID NO.: 5179), TGAGgtaagg (SEQ ID NO.: 5180), TGAGgtaagt (SEQ ID NO.: 5181), TGAGgtaatc (SEQ ID NO.: 5183), TGAGgtaatg (SEQ ID NO.: 5184), TGAGgtaatt (SEQ ID NO.: 5185), TGAGgtaccg (SEQ ID NO.: 5191), TGAGgtacgt (SEQ ID NO.: 5195), TGAGgtagag (SEQ ID NO.: 5200), TGAGgtagga (SEQ ID NO.: 5204), TGAGgtaggc (SEQ ID NO.: 5205), TGAGgtaggt (SEQ ID NO.: 5207), TGAGgtatac (SEQ ID NO.: 5212), TGAGgtatag (SEQ ID NO.: 5213), TGAGgtatga (SEQ ID NO.: 5217), TGAGgtatgc (SEQ ID NO.: 5218), TGAGgtatgg (SEQ ID NO.: 5219), TGAGgtatgt (SEQ ID NO.: 5220), TGAGgtattc (SEQ ID NO.: 5222), TGAGgtattg (SEQ ID NO.: 5223), TGAGgtattt (SEQ ID NO.: 5224), TGAGgtcagc (SEQ ID NO.: 5226), TGAGgtcagt (SEQ ID NO.: 5228), TGAGgtgaaa (SEQ ID NO.: 5237), TGAGgtgaag (SEQ ID NO.: 5239), TGAGgtgaat (SEQ ID NO.: 5240), TGAGgtgact (SEQ ID NO.: 5243), TGAGgtgaga (SEQ ID NO.: 5244), TGAGgtgagc (SEQ ID NO.: 5245), TGAGgtgagg (SEQ ID NO.: 5246), TGAGgtgagt (SEQ ID NO.: 5247), TGAGgtgatc (SEQ ID NO.: 5249), TGAGgtgggc (SEQ ID NO.: 5259), TGAGgtgggg (SEQ ID NO.: 5260), TGAGgtgtga (SEQ ID NO.: 5265), TGAGgttaga (SEQ ID NO.: 5270), TGAGgttagg (SEQ ID
NO.: 5272), TGAGgttggt (SEQ ID NO.: 5279), TGATgtaagc (SEQ ID NO.: 5292), TGATgtaagt (SEQ ID NO.: 5294), TGATgtatgg (SEQ ID NO.: 5301), TGATgtatgt (SEQ ID NO.: 5302), TGATgtgaga (SEQ ID NO.: 5303), TGATgtgagt (SEQ ID NO.: 5306), TGATgttagt (SEQ ID NO.: 5307), TGCAgtaagt (SEQ ID NO.: 5314), TGCAgtatcc (SEQ ID NO.: 5317), TGCAgtcagt (SEQ ID NO.: 5319), TGCAgtgagt (SEQ ID NO.: 5323), TGCCgtaagt (SEQ ID NO.: 5329), TGCCgtatgt (SEQ ID NO.: 5332), TGCCgtgagt (SEQ ID NO.: 5334), TGCGgtaaca (SEQ ID NO.: 5336), TGCGgtaagc (SEQ ID NO.: 5338), TGCGgtaccg (SEQ ID NO.: 5343), TGCGgtgagc (SEQ ID NO.: 5353), TGCGgtgagg (SEQ ID NO.: 5354), TGCGgtgagt (SEQ ID NO.: 5355), TGCGtatttt (SEQ ID NO.: 5360), TGCTgtaaga (SEQ ID NO.: 5364), TGCTgtaagc (SEQ ID NO.: 5365), TGCTgtaagt (SEQ ID NO.: 5366), TGCTgtacgc (SEQ ID NO.: 5367), TGCTgtaggt (SEQ ID NO.: 5368), TGCTgtgagt (SEQ ID NO.: 5376), TGGAatccac (SEQ ID NO.: 5377), TGGAgtaagt (SEQ ID NO.: 5381), TGGAgtgagt (SEQ ID NO.: 5387), TGGCgtgagt (SEQ ID NO.: 5397), TGGGaacgag (SEQ ID NO.: 5398), TGGGgtaaga (SEQ ID NO.: 5403), TGGGgtaagg (SEQ ID NO.: 5405), TGGGgtaagt (SEQ ID NO.: 5406), TGGGgtaggg (SEQ ID NO.: 5413), TGGGgtaggt (SEQ ID NO.: 5414), TGGGgtatca (SEQ ID NO.: 5415), TGGGgtgaga (SEQ ID NO.: 5423), TGGGgtgagg (SEQ ID NO.: 5425), TGGGgtgagt (SEQ ID NO.: 5426), TGGGgttgtg (SEQ ID NO.: 5431), TGGTgtgagt (SEQ ID NO.: 5440), TGTAgtgagt (SEQ ID NO.: 5446), TGTAgttgtg (SEQ ID NO.: 5447), TGTCctccaa (SEQ ID NO.: 5449), TGTCgtaagt (SEQ ID NO.: 5451), TGTCgtgagt (SEQ ID NO.: 5453), TGTGgtaaat (SEQ ID NO.: 5457), TGTGgtaaga (SEQ ID NO.: 5459), TGTGgtaagc (SEQ ID NO.: 5460), TGTGgtaagg (SEQ ID NO.: 5461), TGTGgtaagt (SEQ ID NO.: 5462), TGTGgtaatg (SEQ ID NO.: 5464), TGTGgtaatt (SEQ ID NO.: 5465), TGTGgtagga (SEQ ID NO.: 5470), TGTGgtaggt (SEQ ID NO.: 5472), TGTGgtatgt (SEQ ID NO.: 5476), TGTGgtgagc (SEQ ID NO.: 5480), TGTGgtgagg (SEQ ID NO.: 5481), TGTGgtgagt (SEQ ID NO.: 5482), TGTGgtgggt (SEQ ID NO.: 5484), TGTGgtgtgt (SEQ ID NO.: 5486), TGTGgttagt (SEQ ID NO.: 5487), TGTTgtaagt (SEQ ID NO.: 5491), TGTTgtatcc (SEQ ID NO.: 5493), TGTTgtgagt (SEQ ID NO.: 5494), TTAAgtaagt (SEQ ID NO.: 5502), TTAAgtcagt (SEQ ID NO.: 5508), TTAAgtgagt (SEQ ID NO.: 5510), TTAAgtgggt (SEQ ID NO.: 5511), TTACgtaagt (SEQ ID NO.: 5513), TTAGgcaagt (SEQ ID NO.: 5515), TTAGgtaaaa (SEQ ID NO.: 5518), TTAGgtaaac (SEQ ID NO.: 5519), TTAGgtaaag (SEQ ID NO.: 5520), TTAGgtaact (SEQ ID NO.: 5525), TTAGgtaaga (SEQ ID NO.: 5526), TTAGgtaagc (SEQ ID NO.: 5527), TTAGgtaagg (SEQ ID NO.: 5528), TTAGgtaagt (SEQ ID NO.: 5529), TTAGgtacct (SEQ ID NO.: 5534), TTAGgtagag (SEQ ID NO.: 5538), TTAGgtaggt (SEQ ID NO.: 5542), TTAGgtatgc (SEQ ID NO.: 5548), TTAGgtatgg (SEQ ID NO.: 5549), TTAGgtatgt (SEQ ID NO.: 5550), TTAGgtatta (SEQ ID NO.: 5551), TTAGgtcagt (SEQ ID NO.: 5556), TTAGgtgaat (SEQ ID NO.: 5560), TTAGgtgaga (SEQ ID NO.: 5561), TTAGgtgagt (SEQ ID NO.: 5564), TTAGgtttgt (SEQ ID NO.: 5575), TTATgcaagt (SEQ ID NO.: 5577), TTATgtaagg (SEQ ID NO.: 5580), TTATgtaagt (SEQ ID NO.: 5581), TTATgtgagt (SEQ ID NO.: 5585), TTCAggtaag (SEQ ID NO.: 5587), TTCAgtaagt (SEQ ID NO.: 5590), TTCAgtctgt (SEQ ID NO.: 5594), TTCAgtgagt (SEQ ID NO.: 5596), TTCCgtaagt (SEQ ID NO.: 5601), TTCCgtgagt (SEQ ID NO.: 5603), TTCGgtaagt (SEQ ID NO.: 5608), TTCGgtaggt (SEQ ID NO.: 5613), TTCGgtatgt (SEQ ID NO.: 5614), TTCGgtgagc (SEQ ID NO.: 5618), TTCGgtgagg (SEQ ID NO.: 5619), TTCGgtgagt (SEQ ID NO.: 5620), TTCGgttagt (SEQ ID NO.: 5623), TTCTgtaaga (SEQ ID NO.: 5624), TTCTgtaagt (SEQ ID NO.: 5627), TTCTgtactg (SEQ ID NO.: 5630), TTCTgtgaga (SEQ ID NO.: 5634), TTCTgtgagt (SEQ ID NO.: 5636), TTGAggtagg (SEQ ID NO.: 5642), TTGAgtgagc (SEQ ID NO.: 5648), TTGAgtgagt (SEQ ID
[00527] RNA sequences corresponding to the 5' splice sites in Table 12 are provided as shown in Table 15 (2088 entries):
[00528] Table 15
ID NO.: 5892), AAAGguaccc (SEQ ID NO.: 5893), AAAGguaccg (SEQ ID NO.: 5894), AAAGguaccu (SEQ ID NO.: 5895), AAAGguacga (SEQ ID NO.: 5896), AAAGguacgu (SEQ ID NO.: 5899), AAAGguacua (SEQ ID NO.: 5900), AAAGguacuc (SEQ ID NO.: 5901), AAAGguacug (SEQ ID NO.: 5902), AAAGguacuu (SEQ ID NO.: 5903), AAAGguagag (SEQ ID NO.: 5906), AAAGguagau (SEQ ID NO.: 5907), AAAGguagcc (SEQ ID NO.: 5909), AAAGguagga (SEQ ID NO.: 5912), AAAGguaggc (SEQ ID NO.: 5913), AAAGguaggg (SEQ ID NO.: 5914), AAAGguaggu (SEQ ID NO.: 5915), AAAGguagua (SEQ ID NO.: 5916), AAAGguagug (SEQ ID NO.: 5917), AAAGguaguu (SEQ ID NO.: 5918), AAAGguauaa (SEQ ID NO.: 5919), AAAGguauag (SEQ ID NO.: 5921), AAAGguauca (SEQ ID NO.: 5923), AAAGguaucc (SEQ ID NO.: 5924), AAAGguaucu (SEQ ID NO.: 5925), AAAGguauga (SEQ ID NO.: 5926), AAAGguaugc (SEQ ID NO.: 5927), AAAGguaugg (SEQ ID NO.: 5928), AAAGguaugu (SEQ ID NO.: 5929), AAAGguauua (SEQ ID NO.: 5930), AAAGguauuc (SEQ ID NO.: 5931), AAAGguauug (SEQ ID NO.: 5932), AAAGguauuu (SEQ ID NO.: 5933), AAAGgucaac (SEQ ID NO.: 5934), AAAGgucagc (SEQ ID NO.: 5939), AAAGgucagu (SEQ ID NO.: 5941), AAAGgucauu (SEQ ID NO.: 5942), AAAGguccag (SEQ ID NO.: 5944), AAAGgucuga (SEQ ID NO.: 5950), AAAGgucugu (SEQ ID NO.: 5952), AAAGgugaaa (SEQ ID NO.: 5955), AAAGgugaac (SEQ ID NO.: 5956), AAAGgugaag (SEQ ID NO.: 5957), AAAGgugaau (SEQ ID NO.: 5958), AAAGgugacu (SEQ ID NO.: 5960), AAAGgugaga (SEQ ID NO.: 5961), AAAGgugagc (SEQ ID NO.: 5962), AAAGgugagg (SEQ ID NO.: 5963), AAAGgugagu (SEQ ID NO.: 5964), AAAGgugauc (SEQ ID NO.: 5966), AAAGgugaug (SEQ ID NO.: 5967), AAAGgugauu (SEQ ID NO.: 5968), AAAGgugcca (SEQ ID NO.: 5972), AAAGgugccu (SEQ ID NO.: 5974), AAAGgugggc (SEQ ID NO.: 5982), AAAGgugggu (SEQ ID NO.: 5984), AAAGguguau (SEQ ID NO.: 5987), AAAGguguga (SEQ ID NO.: 5988), AAAGguuaga (SEQ ID NO.: 5996), AAAGguuagu (SEQ ID NO.: 5999), AAAGguugcc (SEQ ID NO.: 6011), AAAGguugga (SEQ ID NO.: 6013), AAAGguuggc (SEQ ID NO.: 6014), AAAGguuggu (SEQ ID NO.: 6016), AAAGguuugu (SEQ ID NO.: 6025), AAAUcugauu (SEQ ID NO.: 6030), AAAUguaaca (SEQ ID NO.: 6035), AAAUguaagc (SEQ ID NO.: 6038), AAAUguaagg (SEQ ID NO.: 6039), AAAUguaagu (SEQ ID NO.: 6040), AAAUguaaua (SEQ ID NO.: 6041), AAAUguacag (SEQ ID NO.: 6045), AAAUguaugu (SEQ ID NO.: 6053), AAAUgugagu (SEQ ID NO.: 6061), AAAUgugggc (SEQ ID NO.: 6064), AACAgguaga (SEQ ID NO.: 6074), AACAguaaau (SEQ ID NO.: 6077), AACAguaagu (SEQ ID NO.: 6081), AACAguaggu (SEQ ID NO.: 6084), AACAgugagu (SEQ ID NO.: 6090), AACCguaagu (SEQ ID NO.: 6092), AACCguaugu (SEQ ID NO.: 6093), AACCgugagu (SEQ ID NO.: 6095), AACGguaaga (SEQ ID NO.: 6101), AACGguaaug (SEQ ID NO.: 6106), AACGguacgu (SEQ ID NO.: 6110), AACGguaugu (SEQ ID NO.: 6118), AACGgucagu (SEQ ID NO.: 6120), AACGgugagc (SEQ ID NO.: 6123), AACGgugagg (SEQ ID NO.: 6124), AACGgugagu (SEQ ID NO.: 6125), AACGguuagu (SEQ ID NO.: 6132), AACUguaaga (SEQ ID NO.: 6134), AACUguaagc (SEQ ID NO.: 6135), AACUguaagu (SEQ ID NO.: 6137), AACUguaggu (SEQ ID NO.: 6139), AACUgugaga (SEQ ID NO.: 6143), AACUgugagc (SEQ ID NO.: 6144), AACUgugagg (SEQ ID NO.: 6145), AACUgugagu (SEQ ID NO.: 6146), AAGAguaagc (SEQ ID NO.: 6153), AAGAguaagu (SEQ ID NO.: 6155), AAGAguagua (SEQ ID NO.: 6158), AAGAguaucc (SEQ ID NO.: 6159), AAGAgugagc (SEQ ID NO.: 6161), AAGAgugagu (SEQ ID NO.: 6163), AAGAguggua (SEQ ID NO.: 6166), AAGCguaagu (SEQ ID NO.: 6173), AAGCguuagu (SEQ ID NO.: 6175), AAGGgcuggu (SEQ ID NO.: 6179), AAGGguaaaa (SEQ ID NO.: 6180), AAGGguaaag (SEQ ID NO.: 6182), AAGGguaaga (SEQ ID NO.: 6187),
AAGGguaagc (SEQ ID NO.: 6188), AAGGguaagg (SEQ ID NO.: 6189), AAGGguaagu (SEQ ID NO.: 6190), AAGGguaaua (SEQ ID NO.: 6191), AAGGguaaug (SEQ ID NO.: 6193), AAGGguacag (SEQ ID NO.: 6195), AAGGguaggu (SEQ ID NO.: 6202), AAGGguauau (SEQ ID NO.: 6206), AAGGguaucu (SEQ ID NO.: 6207), AAGGgucagu (SEQ ID NO.: 6214), AAGGgugaga (SEQ ID NO.: 6215), AAGGgugagc (SEQ ID NO.: 6216), AAGGgugagg (SEQ ID NO.: 6217), AAGGgugagu (SEQ ID NO.: 6218), AAGGgugcgu (SEQ ID NO.: 6220), AAGGguggug (SEQ ID NO.: 6222), AAGGgugugu (SEQ ID NO.: 6223), AAGUguaagc (SEQ ID NO. : 6228), AAGUguaagu (SEQ ID NO. : 6230), AAGUguacgu (SEQ ID NO. : 6231), AAGUguaugg (SEQ ID NO.: 6235), AAGUguaugu (SEQ ID NO.: 6236), AAGUgugagc (SEQ ID NO.: 6237), AAGUgugagu (SEQ ID NO.: 6239), AAUAgguaau (SEQ ID NO.: 6243), AAUAguaagu (SEQ ID NO.: 6248), AAUAguagga (SEQ ID NO.: 6249), AAUAgugagu (SEQ ID NO.: 6256), AAUAuaaggu (SEQ ID NO.: 6258), AAUCauguau (SEQ ID NO.: 6260), AAUCgcagug (SEQ ID NO.: 6263), AAUCguaagu (SEQ ID NO.: 6266), AAUCgugagu (SEQ ID NO.: 6268), AAUGguaaac (SEQ ID NO.: 6279), AAUGguaaag (SEQ ID NO.: 6280), AAUGguaaau (SEQ ID NO.: 6281), AAUGguaagc (SEQ ID NO.: 6286), AAUGguaagg (SEQ ID NO.: 6287), AAUGguaagu (SEQ ID NO.: 6288), AAUGguaaug (SEQ ID NO.: 6291), AAUGguaauu (SEQ ID NO.: 6292), AAUGguagga (SEQ ID NO.: 6305), AAUGguaggu (SEQ ID NO. : 6308), AAUGguagua (SEQ ID NO. : 6309), AAUGguauau (SEQ ID NO. : 6312), AAUGguauga (SEQ ID NO.: 6316), AAUGguaugu (SEQ ID NO.: 6319), AAUGguauug (SEQ ID NO.: 6321), AAUGgucagu (SEQ ID NO.: 6323), AAUGgucucu (SEQ ID NO.: 6324), AAUGgugaau (SEQ ID NO.: 6325), AAUGgugaga (SEQ ID NO.: 6326), AAUGgugagc (SEQ ID NO.: 6327), AAUGgugagg (SEQ ID NO.: 6328), AAUGgugagu (SEQ ID NO.: 6329), AAUGgugcga (SEQ ID NO.: 6331), AAUGgugcgu (SEQ ID NO.: 6332), AAUGgugggc (SEQ ID NO.: 6333), AAUGguuuga (SEQ ID NO.: 6339), AAUUguaagu (SEQ ID NO.: 6346), AAUUguacga (SEQ ID NO.: 6347), AAUUguaugu (SEQ ID NO.: 6348), AAUUgugagg (SEQ ID NO.: 6349), AAUUgugagu (SEQ ID NO.: 6350), ACAAgcaagu (SEQ ID NO.: 6357), ACAAgguaau (SEQ ID NO.: 6359), ACAAguaaac (SEQ ID NO.: 6360), ACAAguaaau (SEQ ID NO.: 6361), ACAAguaaga (SEQ ID NO.: 6362), ACAAguaagc (SEQ ID NO.: 6363), ACAAguaagg (SEQ ID NO.: 6364), ACAAguaagu (SEQ ID NO.: 6365), ACAAguaauc (SEQ ID NO.: 6367), ACAAguaauu (SEQ ID NO.: 6368), ACAAguacgc (SEQ ID NO.: 6370), ACAAguacgu (SEQ ID NO.: 6372), ACAAguaggc (SEQ ID NO.: 6373), ACAAguaggg (SEQ ID NO.: 6374), ACAAguaggu (SEQ ID NO.: 6375), ACAAguaucu (SEQ ID NO.: 6376), ACAAguaugu (SEQ ID NO.: 6380), ACAAgugagg (SEQ ID NO.: 6385), ACAAgugagu (SEQ ID NO.: 6386), ACAAgugggu (SEQ ID NO.: 6389), ACACguaaga (SEQ ID NO.: 6398), ACACguaagc (SEQ ID NO.: 6399), ACACguaagg (SEQ ID NO.: 6400), ACACguaagu (SEQ ID NO.: 6401), ACACgugagu (SEQ ID NO.: 6409), ACACgugggu (SEQ ID NO.: 6411), ACAGaguaag (SEQ ID NO.: 6414), ACAGgcaagc (SEQ ID NO.: 6419), ACAGgcaagu (SEQ ID NO.: 6421), ACAGgcacgc (SEQ ID NO.: 6423), ACAGgcacgu (SEQ ID NO.: 6424), ACAGgcaggu (SEQ ID NO.: 6426), ACAGgcauga (SEQ ID NO.: 6428), ACAGgcaugc (SEQ ID NO.: 6429), ACAGgcaugu (SEQ ID NO.: 6430), ACAGgcgcgu (SEQ ID NO.: 6434), ACAGguaaaa (SEQ ID NO.: 6436), ACAGguaaac (SEQ ID NO.: 6437), ACAGguaaag (SEQ ID NO.: 6438), ACAGguaaau (SEQ ID NO.: 6439), ACAGguaaca (SEQ ID NO.: 6440), ACAGguaacc (SEQ ID NO.: 6441), ACAGguaacu (SEQ ID NO.: 6443), ACAGguaaga (SEQ ID NO.: 6444), ACAGguaagc (SEQ ID NO.: 6445), ACAGguaagg (SEQ ID NO.: 6446), ACAGguaagu (SEQ ID NO.: 6447), ACAGguaaua (SEQ ID NO.: 6448), ACAGguaauc (SEQ ID
NO.: 6449), ACAGguaaug (SEQ ID NO.: 6450), ACAGguaauu (SEQ ID NO.: 6451), ACAGguacaa (SEQ ID NO.: 6452), ACAGguacac (SEQ ID NO.: 6453), ACAGguacau (SEQ ID NO.: 6455), ACAGguacca (SEQ ID NO.: 6456), ACAGguaccc (SEQ ID NO.: 6457), ACAGguaccg (SEQ ID NO.: 6458), ACAGguaccu (SEQ ID NO.: 6459), ACAGguacgc (SEQ ID NO.: 6461), ACAGguacgg (SEQ ID NO.: 6462), ACAGguacgu (SEQ ID NO.: 6463), ACAGguacua (SEQ ID NO.: 6464), ACAGguacug (SEQ ID NO.: 6466), ACAGguacuu (SEQ ID NO.: 6467), ACAGguagag (SEQ ID NO.: 6470), ACAGguagcu (SEQ ID NO.: 6474), ACAGguagga (SEQ ID NO.: 6475), ACAGguaggg (SEQ ID NO.: 6477), ACAGguaggu (SEQ ID NO.: 6478), ACAGguagua (SEQ ID NO.: 6479), ACAGguaguc (SEQ ID NO.: 6480), ACAGguauaa (SEQ ID NO.: 6483), ACAGguauac (SEQ ID NO.: 6484), ACAGguauag (SEQ ID NO.: 6485), ACAGguauau (SEQ ID NO.: 6486), ACAGguaucu (SEQ ID NO.: 6490), ACAGguauga (SEQ ID NO.: 6491), ACAGguaugc (SEQ ID NO.: 6492), ACAGguaugg (SEQ ID NO.: 6493), ACAGguaugu (SEQ ID NO.: 6494), ACAGguauua (SEQ ID NO.: 6495), ACAGguauuc (SEQ ID NO.: 6496), ACAGguauug (SEQ ID NO.: 6497), ACAGguauuu (SEQ ID NO.: 6498), ACAGgucagu (SEQ ID NO.: 6504), ACAGgucggu (SEQ ID NO.: 6508), ACAGgucucu (SEQ ID NO.: 6509), ACAGgucugu (SEQ ID NO.: 6511), ACAGgugaaa (SEQ ID NO.: 6512), ACAGgugaac (SEQ ID NO.: 6513), ACAGgugacc (SEQ ID NO.: 6517), ACAGgugacu (SEQ ID NO.: 6519), ACAGgugaga (SEQ ID NO.: 6520), ACAGgugagc (SEQ ID NO.: 6521), ACAGgugagg (SEQ ID NO.: 6522), ACAGgugagu (SEQ ID NO.: 6523), ACAGgugaug (SEQ ID NO.: 6525), ACAGgugauu (SEQ ID NO.: 6526), ACAGgugcaa (SEQ ID NO.: 6527), ACAGgugccc (SEQ ID NO.: 6532), ACAGgugccu (SEQ ID NO.: 6534), ACAGgugcgc (SEQ ID NO.: 6536), ACAGgugcgg (SEQ ID NO.: 6537), ACAGgugcgu (SEQ ID NO.: 6538), ACAGguggga (SEQ ID NO.: 6546), ACAGgugggc (SEQ ID NO.: 6547), ACAGgugggg (SEQ ID NO.: 6548), ACAGgugggu (SEQ ID NO.: 6549), ACAGgugucu (SEQ ID NO.: 6555), ACAGguguga (SEQ ID NO.: 6556), ACAGgugugc (SEQ ID NO.: 6557), ACAGgugugu (SEQ ID NO.: 6559), ACAGguuaau (SEQ ID NO.: 6562), ACAGguuagc (SEQ ID NO.: 6564), ACAGguuagu (SEQ ID NO.: 6566), ACAGguucgg (SEQ ID NO.: 6572), ACAGguucgu (SEQ ID NO.: 6573), ACAGguucuc (SEQ ID NO.: 6574), ACAGguugca (SEQ ID NO.: 6576), ACAGguuggg (SEQ ID NO.: 6580), ACAGguuggu (SEQ ID NO.: 6581), ACAGguuuga (SEQ ID NO.: 6586), ACAGguuugu (SEQ ID NO.: 6589), ACAUguaaga (SEQ ID NO.: 6596), ACAUguaagc (SEQ ID NO.: 6597), ACAUguaagu (SEQ ID NO.: 6599), ACAUguaaug (SEQ ID NO.: 6600), ACAUguacgg (SEQ ID NO.: 6602), ACAUgugagu (SEQ ID NO.: 6608), ACCAggugaa (SEQ ID NO.: 6612), ACCAguaaga (SEQ ID NO.: 6614), ACCAguaagu (SEQ ID NO.: 6616), ACCAgugagg (SEQ ID NO.: 6623), ACCAgugagu (SEQ ID NO.: 6624), ACCAguugag (SEQ ID NO.: 6626), ACCCgugaga (SEQ ID NO.: 6631), ACCCgugagu (SEQ ID NO.: 6632), ACCCguguga (SEQ ID NO.: 6634), ACCGguaagg (SEQ ID NO.: 6638), ACCGgucugc (SEQ ID NO.: 6651), ACCGgugagc (SEQ ID NO.: 6653), ACCGgugggu (SEQ ID NO.: 6657), ACCUguaaga (SEQ ID NO.: 6661), ACCUguaagc (SEQ ID NO.: 6662), ACCUguaagu (SEQ ID NO.: 6664), ACCUguaugg (SEQ ID NO.: 6667), ACCUgugagg (SEQ ID NO.: 6671), ACCUgugagu (SEQ ID NO.: 6672), ACGAgugagu (SEQ ID NO.: 6680), ACGGguaagu (SEQ ID NO.: 6693), ACGGguacua (SEQ ID NO.: 6699), ACGGgugagg (SEQ ID NO.: 6709), ACGGgugagu (SEQ ID NO.: 6710), ACGGguuugu (SEQ ID NO.: 6714), ACGUguaagu (SEQ ID NO.: 6716), ACGUgugagc (SEQ ID NO.: 6718), ACUAguaagu (SEQ ID NO.: 6723), ACUCguaagu (SEQ ID NO.: 6728), ACUGaguccc (SEQ ID NO.: 6731), ACUGgcaaga (SEQ ID NO.: 6733), ACUGguaaaa (SEQ ID NO.: 6735),
ACUGguaaau (SEQ ID NO.: 6737), ACUGguaaga (SEQ ID NO.: 6741), ACUGguaagc (SEQ ID NO.: 6742), ACUGguaagu (SEQ ID NO.: 6744), ACUGguagag (SEQ ID NO.: 6753), ACUGguagga (SEQ ID NO.: 6756), ACUGguaggg (SEQ ID NO.: 6757), ACUGguaggu (SEQ ID NO.: 6758), ACUGguaugu (SEQ ID NO.: 6761), ACUGgucagu (SEQ ID NO.: 6764), ACUGgugaau (SEQ ID NO.: 6765), ACUGgugaga (SEQ ID NO.: 6767), ACUGgugagc (SEQ ID NO.: 6768), ACUGgugagu (SEQ ID NO.: 6770), ACUGgugugc (SEQ ID NO.: 6777), ACUUguaagu (SEQ ID NO.: 6783), ACUUguacgc (SEQ ID NO.: 6784), ACUUguacgu (SEQ ID NO.: 6785), ACUUguaguu (SEQ ID NO.: 6788), ACUUguaucc (SEQ ID NO.: 6789), ACUUgugagu (SEQ ID NO.: 6790), AGAAagguga (SEQ ID NO.: 6795), AGAAguaagg (SEQ ID NO.: 6803), AGAAguaagu (SEQ ID NO.: 6804), AGAAguaggu (SEQ ID NO.: 6809), AGAAgugagc (SEQ ID NO.: 6818), AGAAgugagu (SEQ ID NO.: 6820), AGAAgugcgu (SEQ ID NO.: 6821), AGACguaagu (SEQ ID NO.: 6830), AGACguaugu (SEQ ID NO.: 6831), AGACgugagc (SEQ ID NO.: 6833), AGACgugagu (SEQ ID NO.: 6835), AGAGagggua (SEQ ID NO.: 6836), AGAGgcguga (SEQ ID NO.: 6844), AGAGguaaaa (SEQ ID NO.: 6846), AGAGguaaac (SEQ ID NO.: 6847), AGAGguaaag (SEQ ID NO.: 6848), AGAGguaaau (SEQ ID NO.: 6849), AGAGguaaca (SEQ ID NO.: 6850), AGAGguaacu (SEQ ID NO.: 6853), AGAGguaaga (SEQ ID NO.: 6854), AGAGguaagc (SEQ ID NO.: 6855), AGAGguaagg (SEQ ID NO.: 6856), AGAGguaagu (SEQ ID NO.: 6857), AGAGguaaua (SEQ ID NO.: 6858), AGAGguaaug (SEQ ID NO.: 6860), AGAGguaauu (SEQ ID NO.: 6861), AGAGguacaa (SEQ ID NO.: 6862), AGAGguacag (SEQ ID NO.: 6864), AGAGguacca (SEQ ID NO.: 6866), AGAGguaccc (SEQ ID NO.: 6867), AGAGguaccg (SEQ ID NO.: 6868), AGAGguacua (SEQ ID NO.: 6871), AGAGguacug (SEQ ID NO.: 6873), AGAGguagcu (SEQ ID NO.: 6881), AGAGguagga (SEQ ID NO.: 6882), AGAGguaggc (SEQ ID NO.: 6883), AGAGguaggg (SEQ ID NO.: 6884), AGAGguaggu (SEQ ID NO.: 6885), AGAGguauau (SEQ ID NO.: 6892), AGAGguauca (SEQ ID NO.: 6893), AGAGguauga (SEQ ID NO.: 6895), AGAGguaugc (SEQ ID NO.: 6896), AGAGguaugg (SEQ ID NO.: 6897), AGAGguaugu (SEQ ID NO.: 6898), AGAGguauug (SEQ ID NO.: 6901), AGAGguauuu (SEQ ID NO.: 6902), AGAGgucagu (SEQ ID NO.: 6906), AGAGgucuau (SEQ ID NO.: 6910), AGAGgucugu (SEQ ID NO.: 6913), AGAGgugaag (SEQ ID NO.: 6917), AGAGgugaau (SEQ ID NO.: 6918), AGAGgugaca (SEQ ID NO.: 6919), AGAGgugaga (SEQ ID NO.: 6923), AGAGgugagc (SEQ ID NO.: 6924), AGAGgugagg (SEQ ID NO.: 6925), AGAGgugagu (SEQ ID NO.: 6926), AGAGgugauu (SEQ ID NO.: 6930), AGAGgugggc (SEQ ID NO.: 6942), AGAGgugggg (SEQ ID NO.: 6943), AGAGgugggu (SEQ ID NO.: 6944), AGAGgugugu (SEQ ID NO.: 6951), AGAGguuagu (SEQ ID NO.: 6955), AGAGguugcc (SEQ ID NO.: 6962), AGAGguuugc (SEQ ID NO.: 6969), AGAGguuugu (SEQ ID NO.: 6971), AGAUguaaau (SEQ ID NO.: 6978), AGAUguaaga (SEQ ID NO.: 6979), AGAUguaagc (SEQ ID NO.: 6980), AGAUguaagg (SEQ ID NO.: 6981), AGAUguaagu (SEQ ID NO.: 6982), AGAUguaauu (SEQ ID NO.: 6984), AGAUgugagc (SEQ ID NO.: 6994), AGAUgugagu (SEQ ID NO.: 6995), AGAUgugggu (SEQ ID NO.: 6996), AGCAggucag (SEQ ID NO.: 7002), AGCAguaagc (SEQ ID NO.: 7005), AGCAguaagu (SEQ ID NO.: 7007), AGCAguaucc (SEQ ID NO.: 7010), AGCAguaugu (SEQ ID NO.: 7011), AGCAgugagu (SEQ ID NO.: 7014), AGCCguaagu (SEQ ID NO.: 7019), AGCCguaugu (SEQ ID NO.: 7021), AGCCgugugu (SEQ ID NO.: 7023), AGCGguaagc (SEQ ID NO.: 7029), AGCGguaagu (SEQ ID NO. : 7031), AGCGguaauc (SEQ ID NO. : 7032), AGCGgugaga (SEQ ID NO.: 7044), AGCGgugagc (SEQ ID NO.: 7045), AGCGgugagg (SEQ ID NO.: 7046), AGCGgugagu (SEQ ID NO.: 7047), AGCUauuuac (SEQ ID NO.: 7052), AGCUcaggug (SEQ
ID NO.: 7053), AGCUguaagu (SEQ ID NO.: 7057), AGCUguacgu (SEQ ID NO.: 7058), AGCUguaugu (SEQ ID NO.: 7060), AGCUgugagu (SEQ ID NO.: 7063), AGGAguaagu (SEQ ID NO.: 7072), AGGCguaagu (SEQ ID NO.: 7078), AGGGguaagg (SEQ ID NO.: 7090), AGGGguaggu (SEQ ID NO.: 7098), AGGGguauga (SEQ ID NO.: 7100), AGGGguaugu (SEQ ID NO.: 7102), AGGGgugaga (SEQ ID NO.: 7105), AGGGgugagu (SEQ ID NO.: 7108), AGGGgugggu (SEQ ID NO.: 7109), AGUAguaagu (SEQ ID NO.: 7116), AGUCguaucc (SEQ ID NO.: 7124), AGUCgugagu (SEQ ID NO.: 7125), AGUGguaaaa (SEQ ID NO.: 7128), AGUGguaaga (SEQ ID NO.: 7132), AGUGguaagg (SEQ ID NO.: 7134), AGUGguaagu (SEQ ID NO.: 7135), AGUGguaauc (SEQ ID NO.: 7136), AGUGguacgu (SEQ ID NO.: 7139), AGUGguaggu (SEQ ID NO.: 7141), AGUGguauga (SEQ ID NO.: 7145), AGUGguaugu (SEQ ID NO.: 7146), AGUGgucagu (SEQ ID NO.: 7147), AGUGgugagc (SEQ ID NO.: 7150), AGUGgugagg (SEQ ID NO.: 7151), AGUGgugagu (SEQ ID NO.: 7152), AGUUguaagu (SEQ ID NO.: 7160), AGUUgugagu (SEQ ID NO.: 7163), AUAAagaaga (SEQ ID NO.: 7164), AUAAcuggug (SEQ ID NO.: 7165), AUAAguaaga (SEQ ID NO.: 7167), AUAAguaagc (SEQ ID NO.: 7168), AUAAguaagu (SEQ ID NO.: 7169), AUAAguaugu (SEQ ID NO.: 7176), AUACguaagu (SEQ ID NO.: 7184), AUAGgcaagu (SEQ ID NO.: 7188), AUAGguaaaa (SEQ ID NO.: 7191), AUAGguaaga (SEQ ID NO.: 7197), AUAGguaagc (SEQ ID NO.: 7198), AUAGguaagg (SEQ ID NO.: 7199), AUAGguaagu (SEQ ID NO.: 7200), AUAGguaauc (SEQ ID NO.: 7202), AUAGguaauu (SEQ ID NO.: 7204), AUAGguacau (SEQ ID NO.: 7206), AUAGguaggc (SEQ ID NO.: 7214), AUAGguauga (SEQ ID NO.: 7221), AUAGguaugg (SEQ ID NO.: 7223), AUAGguaugu (SEQ ID NO.: 7224), AUAGguauuu (SEQ ID NO.: 7226), AUAGgucagu (SEQ ID NO.: 7227), AUAGgugagg (SEQ ID NO.: 7234), AUAGgugagu (SEQ ID NO.: 7235), AUAGgugaua (SEQ ID NO.: 7236), AUAGgugcuc (SEQ ID NO.: 7239), AUAGgugggu (SEQ ID NO.: 7240), AUAGgugugu (SEQ ID NO.: 7242), AUAGguuagu (SEQ ID NO.: 7245), AUAGguuggu (SEQ ID NO.: 7248), AUAGguuugu (SEQ ID NO.: 7249), AUAUguaagu (SEQ ID NO.: 7259), AUAUguaucc (SEQ ID NO.: 7263), AUAUgugagc (SEQ ID NO.: 7265), AUAUgugagu (SEQ ID NO.: 7266), AUCAguaagg (SEQ ID NO.: 7271), AUCAguaagu (SEQ ID NO.: 7272), AUCAgugaga (SEQ ID NO.: 7275), AUCAgugagu (SEQ ID NO.: 7276), AUCCagaaac (SEQ ID NO.: 7280), AUCCguaagu (SEQ ID NO.: 7283), AUCCgugagu (SEQ ID NO.: 7285), AUCGguaaau (SEQ ID NO.: 7288), AUCGguaagg (SEQ ID NO.: 7291), AUCGguaugu (SEQ ID NO.: 7301), AUCGgugagu (SEQ ID NO.: 7308), AUCUguaaga (SEQ ID NO. : 7314), AUCUguaagu (SEQ ID NO. : 7317), AUCUgugaga (SEQ ID NO.: 7320), AUCUgugagu (SEQ ID NO.: 7322), AUCUguggug (SEQ ID NO.: 7323), AUGAaaaggu (SEQ ID NO.: 7324), AUGAguaaga (SEQ ID NO.: 7327), AUGAguaagu (SEQ ID NO.: 7328), AUGAguauga (SEQ ID NO.: 7331), AUGAguaugu (SEQ ID NO.: 7333), AUGAgugagu (SEQ ID NO.: 7334), AUGAguguga (SEQ ID NO.: 7335), AUGCgugagu (SEQ ID NO.: 7341), AUGGgcaagu (SEQ ID NO.: 7344), AUGGgcaggu (SEQ ID NO.: 7345), AUGGguaaaa (SEQ ID NO.: 7346), AUGGguaaac (SEQ ID NO.: 7347), AUGGguaaau (SEQ ID NO.: 7349), AUGGguaaga (SEQ ID NO.: 7351), AUGGguaagc (SEQ ID NO.: 7352), AUGGguaagg (SEQ ID NO.: 7353), AUGGguaagu (SEQ ID NO.: 7354), AUGGguaaug (SEQ ID NO.: 7357), AUGGguaggu (SEQ ID NO.: 7366), AUGGguauga (SEQ ID NO.: 7367), AUGGgugaau (SEQ ID NO.: 7374), AUGGgugagc (SEQ ID NO.: 7376), AUGGgugagg (SEQ ID NO.: 7377), AUGGgugagu (SEQ ID NO.: 7378), AUGGguuagu (SEQ ID NO.: 7382), AUGGguuugu (SEQ ID NO.: 7385), AUGGugguga (SEQ ID NO.: 7386), AUGUguaaga (SEQ ID NO.: 7389), AUGUguaagu (SEQ ID NO.: 7391), AUGUgugagu (SEQ ID NO.: 7393),
AUGUguggug (SEQ ID NO.: 7394), AUUAguaagu (SEQ ID NO.: 7398), AUUAgugagu (SEQ ID NO.: 7401), AUUGgcacgu (SEQ ID NO.: 7408), AUUGgcaugc (SEQ ID NO.: 7409), AUUGguaaaa (SEQ ID NO.: 7410), AUUGguaaga (SEQ ID NO.: 7413), AUUGguaagc (SEQ ID NO.: 7414), AUUGguaagg (SEQ ID NO.: 7415), AUUGguaagu (SEQ ID NO.: 7416), AUUGguaaua (SEQ ID NO.: 7417), AUUGguaauc (SEQ ID NO.: 7418), AUUGguacgu (SEQ ID NO.: 7421), AUUGguaggu (SEQ ID NO.: 7426), AUUGguagua (SEQ ID NO.: 7427), AUUGguaguu (SEQ ID NO.: 7428), AUUGguaugu (SEQ ID NO.: 7431), AUUGguauua (SEQ ID NO.: 7432), AUUGgugaga (SEQ ID NO.: 7436), AUUGgugagg (SEQ ID NO.: 7438), AUUGgugagu (SEQ ID NO.: 7439), AUUGguguga (SEQ ID NO.: 7445), AUUUaucuca (SEQ ID NO.: 7448), AUUUguaagc (SEQ ID NO.: 7453), AUUUguaagu (SEQ ID NO.: 7454), AUUUgugagu (SEQ ID NO.: 7458), CAAAguaaag (SEQ ID NO 7465), CAAAguaaga (SEQ ID NO.: 7467), CAAAguaagc (SEQ ID NO.: 7468), CAAAguaagg (SEQ ID NO.: 7469), CAAAguaagu (SEQ ID NO.: 7470), CAAAguaaua (SEQ ID NO.: 7471), CAAAguaauu (SEQ ID NO.: 7473), CAAAguacgg (SEQ ID NO.: 7475), CAAAguacug (SEQ ID NO.: 7477), CAAAguagga (SEQ ID NO.: 7478), CAAAguaggu (SEQ ID NO.: 7479), CAAAguauaa (SEQ ID NO.: 7480), CAAAguaugg (SEQ ID NO.: 7482), CAAAguauug (SEQ ID NO.: 7484), CAAAgugaga (SEQ ID NO.: 7488), CAAAgugagu (SEQ ID NO.: 7490), CAACauaagu (SEQ ID NO.: 7494), CAACcuggua (SEQ ID NO.: 7496), CAACguaagg (SEQ ID NO.: 7498), CAACguaagu (SEQ ID NO.: 7499), CAACgugagu (SEQ ID NO.: 7503), CAAGgcaagu (SEQ ID NO.: 7510), CAAGgcaggu (SEQ ID NO.: 7513), CAAGgcgggc (SEQ ID NO.: 7519), CAAGguaaaa (SEQ ID NO.: 7523), CAAGguaaac (SEQ ID NO.: 7524), CAAGguaaag (SEQ ID NO.: 7525), CAAGguaaau (SEQ ID NO.: 7526), CAAGguaaca (SEQ ID NO.: 7527), CAAGguaacc (SEQ ID NO.: 7528), CAAGguaacu (SEQ ID NO.: 7530), CAAGguaaga (SEQ ID NO.: 7531), CAAGguaagg (SEQ ID NO.: 7533), CAAGguaagu (SEQ ID NO.: 7534), CAAGguaaua (SEQ ID NO.: 7535), CAAGguaaug (SEQ ID NO.: 7537), CAAGguaauu (SEQ ID NO.: 7538), CAAGguacaa (SEQ ID NO.: 7539), CAAGguacac (SEQ ID NO.: 7540), CAAGguacag (SEQ ID NO.: 7541), CAAGguacau (SEQ ID NO.: 7542), CAAGguacca (SEQ ID NO.: 7543), CAAGguaccg (SEQ ID NO.: 7545), CAAGguaccu (SEQ ID NO.: 7546), CAAGguacgu (SEQ ID NO.: 7549), CAAGguacug (SEQ ID NO.: 7552), CAAGguagaa (SEQ ID NO.: 7554), CAAGguagag (SEQ ID NO.: 7556), CAAGguagau (SEQ ID NO.: 7557), CAAGguagga (SEQ ID NO.: 7560), CAAGguaggc (SEQ ID NO.: 7561), CAAGguaggg (SEQ ID NO.: 7562), CAAGguaggu (SEQ ID NO.: 7563), CAAGguaguc (SEQ ID NO.: 7565), CAAGguaguu (SEQ ID NO.: 7567), CAAGguauaa (SEQ ID NO.: 7568), CAAGguauac (SEQ ID NO.: 7569), CAAGguauag (SEQ ID NO.: 7570), CAAGguauau (SEQ ID NO.: 7571), CAAGguaucu (SEQ ID NO.: 7574), CAAGguauga (SEQ ID NO.: 7575), CAAGguaugc (SEQ ID NO.: 7576), CAAGguaugg (SEQ ID NO.: 7577), CAAGguaugu (SEQ ID NO.: 7578), CAAGguauua (SEQ ID NO.: 7579), CAAGguauuc (SEQ ID NO.: 7580), CAAGguauug (SEQ ID NO.: 7581), CAAGguauuu (SEQ ID NO.: 7582), CAAGgucaga (SEQ ID NO.: 7586), CAAGgucagg (SEQ ID NO.: 7588), CAAGgucagu (SEQ ID NO.: 7589), CAAGguccug (SEQ ID NO.: 7595), CAAGgucgga (SEQ ID NO.: 7598), CAAGgucucu (SEQ ID NO.: 7602), CAAGgucuuc (SEQ ID NO.: 7606), CAAGgugacc (SEQ ID NO.: 7611), CAAGgugacu (SEQ ID NO.: 7613), CAAGgugaga (SEQ ID NO.: 7614), CAAGgugagc (SEQ ID NO.: 7615), CAAGgugagg (SEQ ID NO.: 7616), CAAGgugagu (SEQ ID NO.: 7617), CAAGgugaug (SEQ ID NO.: 7620), CAAGgugcau (SEQ ID NO.: 7624), CAAGgugcca (SEQ ID NO.: 7625), CAAGgugcgu (SEQ ID NO.: 7630), CAAGgugcug (SEQ ID NO.: 7632), CAAGguggga (SEQ
ID NO.: 7636), CAAGgugggu (SEQ ID NO.: 7639), CAAGgugugg (SEQ ID NO.: 7647), CAAGgugugu (SEQ ID NO.: 7648), CAAGguuaga (SEQ ID NO.: 7654), CAAGguuagg (SEQ ID NO.: 7656), CAAGguuagu (SEQ ID NO.: 7657), CAAGguuauc (SEQ ID NO.: 7659), CAAGguuggu (SEQ ID NO.: 7669), CAAGguuucc (SEQ ID NO.: 7672), CAAGguuucu (SEQ ID NO.: 7673), CAAGguuugu (SEQ ID NO.: 7677), CAAUgcuggg (SEQ ID NO.: 7682), CAAUguaagu (SEQ ID NO.: 7687), CAAUgugagg (SEQ ID NO.: 7694), CAAUgugagu (SEQ ID NO.: 7695), CAAUgugcgu (SEQ ID NO.: 7696), CACAgguuag (SEQ ID NO.: 7700), CACAguaaga (SEQ ID NO.: 7702), CACAguaagc (SEQ ID NO.: 7703), CACAguaagu (SEQ ID NO.: 7705), CACAguaggu (SEQ ID NO.: 7709), CACAgugagg (SEQ ID NO.: 7711), CACAgugagu (SEQ ID NO.: 7712), CACAguugag (SEQ ID NO.: 7716), CACCguaagu (SEQ ID NO.: 7719), CACCgugagu (SEQ ID NO : 7721), CACCgugcgu (SEQ ID NO : 7722), CACGgcaagu (SEQ ID NO.: 7726), CACGgcguga (SEQ ID NO.: 7727), CACGguaaac (SEQ ID NO.: 7729), CACGguaaca (SEQ ID NO.: 7732), CACGguaaga (SEQ ID NO.: 7735), CACGguaagg (SEQ ID NO.: 7737), CACGguaagu (SEQ ID NO.: 7738), CACGguacgc (SEQ ID NO.: 7747), CACGguagga (SEQ ID NO.: 7752), CACGguaggc (SEQ ID NO.: 7753), CACGgugaga (SEQ ID NO.: 7761), CACGgugagg (SEQ ID NO.: 7763), CACGgugagu (SEQ ID NO.: 7764), CACGgugcgc (SEQ ID NO.: 7767), CACGgugggu (SEQ ID NO.: 7769), CACGgugugu (SEQ ID NO.: 7770), CACUguaagu (SEQ ID NO.: 7775), CACUguaaug (SEQ ID NO.: 7776), CACUguauga (SEQ ID NO.: 7779), CACUgugagu (SEQ ID NO.: 7781), CACUgugcgu (SEQ ID NO.: 7782), CAGAgguaca (SEQ ID NO.: 7787), CAGAguaaga (SEQ ID NO.: 7790), CAGAguaagc (SEQ ID NO.: 7791), CAGAguaagu (SEQ ID NO.: 7793), CAGAgugagu (SEQ ID NO.: 7803), CAGCagcaca (SEQ ID NO.: 7806), CAGCguaagu (SEQ ID NO.: 7811), CAGCgugagu (SEQ ID NO.: 7813), CAGCugggcg (SEQ ID NO.: 7814), CAGGguaaaa (SEQ ID NO.: 7818), CAGGguaaau (SEQ ID NO.: 7820), CAGGguaacg (SEQ ID NO.: 7821), CAGGguaagc (SEQ ID NO.: 7824), CAGGguaagg (SEQ ID NO.: 7825), CAGGguaagu (SEQ ID NO.: 7826), CAGGguaauu (SEQ ID NO.: 7829), CAGGguacag (SEQ ID NO.: 7830), CAGGguaggu (SEQ ID NO.: 7839), CAGGguauag (SEQ ID NO.: 7844), CAGGguaugg (SEQ ID NO.: 7847), CAGGguaugu (SEQ ID NO.: 7848), CAGGgucagc (SEQ ID NO.: 7851), CAGGgugaga (SEQ ID NO.: 7857), CAGGgugagc (SEQ ID NO.: 7858), CAGGgugagg (SEQ ID NO.: 7859), CAGGgugagu (SEQ ID NO.: 7860), CAGGgugggc (SEQ ID NO.: 7862), CAGUguaagc (SEQ ID NO.: 7872), CAGUguaagg (SEQ ID NO.: 7873), CAGUguaagu (SEQ ID NO.: 7874), CAGUgugagu (SEQ ID NO.: 7884), CAGUgugggu (SEQ ID NO.: 7885), CAUAguaggu (SEQ ID NO.: 7897), CAUAguaugc (SEQ ID NO.: 7898), CAUCgugagu (SEQ ID NO.: 7910), CAUCguguga (SEQ ID NO.: 7911), CAUGguaaca (SEQ ID NO.: 7920), CAUGguaaga (SEQ ID NO.: 7923), CAUGguaagc (SEQ ID NO.: 7924), CAUGguaagg (SEQ ID NO.: 7925), CAUGguaagu (SEQ ID NO.: 7926), CAUGguacgu (SEQ ID NO.: 7933), CAUGguaggu (SEQ ID NO.: 7940), CAUGguaugc (SEQ ID NO.: 7945), CAUGguaugg (SEQ ID NO.: 7946), CAUGguaugu (SEQ ID NO.: 7947), CAUGgugaau (SEQ ID NO.: 7953), CAUGgugaga (SEQ ID NO.: 7955), CAUGgugagc (SEQ ID NO.: 7956), CAUGgugagg (SEQ ID NO.: 7957), CAUGgugagu (SEQ ID NO.: 7958), CAUGgugcgu (SEQ ID NO.: 7961), CAUGgugggg (SEQ ID NO.: 7963), CAUGgugugg (SEQ ID NO.: 7966), CAUGgugugu (SEQ ID NO.: 7967), CAUGguuagu (SEQ ID NO.: 7969), CAUGguuggu (SEQ ID NO.: 7971), CAUGguuuga (SEQ ID NO.: 7972), CAUUagugag (SEQ ID NO.: 7974), CAUUguaagu (SEQ ID NO.: 7978), CAUUgugagu (SEQ ID NO.: 7984), CAUUguuagu (SEQ ID NO.: 7985), CCAAaugcaa (SEQ ID NO.: 7988), CCAAggugag (SEQ ID NO.: 7993),
CCAAguaaau (SEQ ID NO.: 7994), CCAAguaacg (SEQ ID NO.: 7995), CCAAguaaga (SEQ ID NO.: 7997), CCAAguaagc (SEQ ID NO.: 7998), CCAAguaagu (SEQ ID NO.: 8000), CCAAguaaua (SEQ ID NO.: 8001), CCAAguacgu (SEQ ID NO.: 8006), CCAAguacug (SEQ ID NO.: 8007), CCAAguaggc (SEQ ID NO.: 8011), CCAAguaggu (SEQ ID NO.: 8012), CCAAgugagc (SEQ ID NO.: 8018), CCAAgugagu (SEQ ID NO.: 8020), CCAAguuagu (SEQ ID NO.: 8023), CCACguaaga (SEQ ID NO.: 8024), CCACguaagu (SEQ ID NO.: 8027), CCACguauga (SEQ ID NO.: 8030), CCACgugagg (SEQ ID NO.: 8033), CCACgugagu (SEQ ID NO.: 8034), CCAGgcaaga (SEQ ID NO.: 8039), CCAGgcaagg (SEQ ID NO.: 8041), CCAGgcaagu (SEQ ID NO.: 8042), CCAGgccagu (SEQ ID NO.: 8049), CCAGguaaaa (SEQ ID NO.: 8057), CCAGguaaac (SEQ ID NO.: 8058), CCAGguaaag (SEQ ID NO.: 8059), CCAGguaaau (SEQ ID NO.: 8060), CCAGguaaca (SEQ ID NO.: 8061), CCAGguaacc (SEQ ID NO.: 8062), CCAGguaacu (SEQ ID NO.: 8064), CCAGguaaga (SEQ ID NO.: 8065), CCAGguaagc (SEQ ID NO.: 8066), CCAGguaagg (SEQ ID NO.: 8067), CCAGguaagu (SEQ ID NO.: 8068), CCAGguaauc (SEQ ID NO.: 8070), CCAGguaaug (SEQ ID NO.: 8071), CCAGguaauu (SEQ ID NO.: 8072), CCAGguacaa (SEQ ID NO.: 8073), CCAGguacac (SEQ ID NO.: 8074), CCAGguacag (SEQ ID NO.: 8075), CCAGguacau (SEQ ID NO.: 8076), CCAGguaccc (SEQ ID NO.: 8078), CCAGguaccu (SEQ ID NO.: 8080), CCAGguacga (SEQ ID NO.: 8081), CCAGguacgc (SEQ ID NO : 8082), CCAGguacgu (SEQ ID NO.: 8084), CCAGguacua (SEQ ID NO.: 8085), CCAGguacuc (SEQ ID NO.: 8086), CCAGguacug (SEQ ID NO.: 8087), CCAGguacuu (SEQ ID NO.: 8088), CCAGguagaa (SEQ ID NO.: 8089), CCAGguagag (SEQ ID NO.: 8091), CCAGguagca (SEQ ID NO.: 8093), CCAGguagcc (SEQ ID NO.: 8094), CCAGguaggg (SEQ ID NO.: 8099), CCAGguaggu (SEQ ID NO.: 8100), CCAGguagua (SEQ ID NO.: 8101), CCAGguagug (SEQ ID NO.: 8103), CCAGguaguu (SEQ ID NO.: 8104), CCAGguauag (SEQ ID NO.: 8107), CCAGguauau (SEQ ID NO.: 8108), CCAGguauca (SEQ ID NO.: 8109), CCAGguaucc (SEQ ID NO.: 8110), CCAGguaucu (SEQ ID NO.: 8111), CCAGguauga (SEQ ID NO. : 8112), CCAGguaugc (SEQ ID NO.: 8113), CCAGguaugg (SEQ ID NO.: 8114), CCAGguaugu (SEQ ID NO.: 8115), CCAGguauua (SEQ ID NO. : 8116), CCAGguauuc (SEQ ID NO. : 8117), CCAGguauug (SEQ ID NO. : 8118), CCAGguauuu (SEQ ID NO.: 8119), CCAGgucagc (SEQ ID NO.: 8121), CCAGgucagg (SEQ ID NO.: 8122), CCAGgucagu (SEQ ID NO. : 8123), CCAGgucggu (SEQ ID NO.: 8131), CCAGgucuga (SEQ ID NO.: 8136), CCAGgucugg (SEQ ID NO.: 8137), CCAGgucugu (SEQ ID NO.: 8138), CCAGgugaag (SEQ ID NO.: 8142), CCAGgugacc (SEQ ID NO.: 8145), CCAGgugacu (SEQ ID NO.: 8147), CCAGgugaga (SEQ ID NO.: 8148), CCAGgugagc (SEQ ID NO.: 8149), CCAGgugagg (SEQ ID NO.: 8150), CCAGgugagu (SEQ ID NO.: 8151), CCAGgugcgc (SEQ ID NO.: 8164), CCAGgugcgg (SEQ ID NO.: 8165), CCAGguggag (SEQ ID NO.: 8170), CCAGguggga (SEQ ID NO.: 8174), CCAGgugggc (SEQ ID NO.: 8175), CCAGgugggg (SEQ ID NO.: 8176), CCAGgugggu (SEQ ID NO.: 8177), CCAGgugucc (SEQ ID NO.: 8179), CCAGgugucg (SEQ ID NO.: 8180), CCAGgugugg (SEQ ID NO.: 8184), CCAGgugugu (SEQ ID NO.: 8185), CCAGguuaga (SEQ ID NO.: 8187), CCAGguuagu (SEQ ID NO.: 8190), CCAGguucaa (SEQ ID NO.: 8193), CCAGguucug (SEQ ID NO.: 8200), CCAGguugcu (SEQ ID NO.: 8203), CCAGguuggu (SEQ ID NO.: 8207), CCAGguuugu (SEQ ID NO.: 8213), CCAUguaaga (SEQ ID NO.: 8219), CCAUguaagc (SEQ ID NO.: 8220), CCAUguaagu (SEQ ID NO.: 8222), CCAUguacgc (SEQ ID NO.: 8223), CCAUguaugu (SEQ ID NO.: 8226), CCAUgugagu (SEQ ID NO.: 8229), CCAUguuagu (SEQ ID NO.: 8231), CCCAgguaau (SEQ ID NO.: 8235), CCCAguaagu (SEQ ID NO.: 8241), CCCAguacga (SEQ ID
NO.: 8242), CCCAguacgu (SEQ ID NO.: 8243), CCCAguaggu (SEQ ID NO.: 8244), CCCAgugagu (SEQ ID NO.: 8247), CCCAguggug (SEQ ID NO.: 8248), CCCCguaagu (SEQ ID NO.: 8253), CCCCgugagu (SEQ ID NO.: 8255), CCCCgugcgu (SEQ ID NO.: 8256), CCCGgcacgu (SEQ ID NO.: 8258), CCCGguaaga (SEQ ID NO.: 8261), CCCGguacgu (SEQ ID NO.: 8271), CCCGguaggu (SEQ ID NO.: 8273), CCCGguauaa (SEQ ID NO.: 8274), CCCGguaugg (SEQ ID NO.: 8276), CCCGguaugu (SEQ ID NO.: 8277), CCCGgugagc (SEQ ID NO.: 8281), CCCGgugagu (SEQ ID NO.: 8283), CCCGgugcgu (SEQ ID NO.: 8286), CCCGgugggu (SEQ ID NO.: 8288), CCCUguaagu (SEQ ID NO.: 8294), CCCUgugagu (SEQ ID NO.: 8301), CCCUgugcgu (SEQ ID NO.: 8302), CCCUuugucc (SEQ ID NO.: 8303), CCGAgugagc (SEQ ID NO. : 8311), CCGAgugagu (SEQ ID NO. : 8312), CCGCgugagu (SEQ ID NO.: 8315), CCGGguaaaa (SEQ ID NO.: 8319), CCGGguaagu (SEQ ID NO : 8326), CCGGguaauu (SEQ ID NO.: 8328), CCGGguagga (SEQ ID NO.: 8332), CCGGguaugg (SEQ ID NO.: 8337), CCGGguaugu (SEQ ID NO.: 8338), CCGGgugaga (SEQ ID NO.: 8341), CCGGgugagc (SEQ ID NO.: 8342), CCGGgugagg (SEQ ID NO.: 8343), CCGGgugagu (SEQ ID NO. : 8344), CCGGgugugu (SEQ ID NO. : 8348), CCGUguaagu (SEQ ID NO. : 8351), CCGUgugagu (SEQ ID NO.: 8353), CCUAguaaga (SEQ ID NO.: 8355), CCUAguaagu (SEQ ID NO.: 8357), CCUCguaagu (SEQ ID NO.: 8364), CCUCgugagu (SEQ ID NO.: 8367), CCUCgugggu (SEQ ID NO.: 8368), CCUGgcaagu (SEQ ID NO.: 8370), CCUGgccaac (SEQ ID NO.: 8371), CCUGguaaag (SEQ ID NO.: 8373), CCUGguaaau (SEQ ID NO.: 8374), CCUGguaacc (SEQ ID NO.: 8376), CCUGguaaga (SEQ ID NO.: 8378), CCUGguaagc (SEQ ID NO.: 8379), CCUGguaagg (SEQ ID NO.: 8380), CCUGguaagu (SEQ ID NO.: 8381), CCUGguaggu (SEQ ID NO.: 8396), CCUGguaugc (SEQ ID NO.: 8400), CCUGguaugg (SEQ ID NO.: 8401), CCUGguaugu (SEQ ID NO.: 8402), CCUGguauug (SEQ ID NO.: 8404), CCUGgucagu (SEQ ID NO.: 8407), CCUGgugaag (SEQ ID NO.: 8408), CCUGgugaga (SEQ ID NO.: 8410), CCUGgugagc (SEQ ID NO.: 8411), CCUGgugagg (SEQ ID NO.: 8412), CCUGgugagu (SEQ ID NO.: 8413), CCUGgugcga (SEQ ID NO.: 8414), CCUGgugcgu (SEQ ID NO.: 8415), CCUGguuagu (SEQ ID NO.: 8420), CCUUguaagu (SEQ ID NO.: 8425), CCUUgugagc (SEQ ID NO.: 8430), CCUUgugagu (SEQ ID NO.: 8431), CGAAguaagu (SEQ ID NO.: 8435), CGACgugagu (SEQ ID NO.: 8444), CGAGagauag (SEQ ID NO.: 8445), CGAGgcaagu (SEQ ID NO.: 8446), CGAGguaaaa (SEQ ID NO.: 8450), CGAGguaaau (SEQ ID NO.: 8453), CGAGguaacc (SEQ ID NO.: 8454), CGAGguaacg (SEQ ID NO.: 8455), CGAGguaaga (SEQ ID NO.: 8457), CGAGguaagc (SEQ ID NO.: 8458), CGAGguaagg (SEQ ID NO.: 8459), CGAGguaagu (SEQ ID NO.: 8460), CGAGguacga (SEQ ID NO.: 8471), CGAGguacgu (SEQ ID NO.: 8473), CGAGguacuu (SEQ ID NO.: 8475), CGAGguaggg (SEQ ID NO.: 8481), CGAGguaggu (SEQ ID NO.: 8482), CGAGguaugc (SEQ ID NO.: 8493), CGAGguaugu (SEQ ID NO.: 8495), CGAGguauuu (SEQ ID NO.: 8498), CGAGgucagg (SEQ ID NO.: 8500), CGAGgucagu (SEQ ID NO.: 8501), CGAGgugaag (SEQ ID NO.: 8506), CGAGgugacc (SEQ ID NO.: 8507), CGAGgugaga (SEQ ID NO.: 8509), CGAGgugagc (SEQ ID NO.: 8510), CGAGgugagg (SEQ ID NO.: 8511), CGAGgugagu (SEQ ID NO. : 8512), CGAGgugauc (SEQ ID NO.: 8513), CGAGgugaug (SEQ ID NO.: 8514), CGAGgugcau (SEQ ID NO.: 8515), CGAGgugcuu (SEQ ID NO.: 8519), CGAGguuaau (SEQ ID NO.: 8525), CGAGguuagg (SEQ ID NO.: 8526), CGAUguaagu (SEQ ID NO.: 8534), CGAUguacaa (SEQ ID NO.: 8535), CGAUguaugg (SEQ ID NO.: 8538), CGAUgugagu (SEQ ID NO.: 8540), CGCAguaagu (SEQ ID NO.: 8542), CGCAgugagc (SEQ ID NO.: 8543), CGCAgugagu (SEQ ID NO.: 8544), CGCCauggcc (SEQ ID NO.: 8545), CGCCgugagu (SEQ ID NO.: 8547),
CGCGguaaga (SEQ ID NO.: 8548), CGCGgugagu (SEQ ID NO.: 8558), CGCGgugggu (SEQ ID NO.: 8559), CGCUguaagc (SEQ ID NO.: 8562), CGCUgugagu (SEQ ID NO.: 8566), CGGGguaagc (SEQ ID NO.: 8572), CGGGguaagg (SEQ ID NO.: 8573), CGGGguaggc (SEQ ID NO.: 8579), CGGGgugagc (SEQ ID NO.: 8582), CGGGgugagg (SEQ ID NO.: 8583), CGGGgugagu (SEQ ID NO.: 8584), CGUAguaagu (SEQ ID NO.: 8587), CGUGguaaga (SEQ ID NO.: 8591), CGUGguaagg (SEQ ID NO.: 8593), CGUGguaagu (SEQ ID NO.: 8594), CGUGguaugu (SEQ ID NO.: 8601), CGUGgucagu (SEQ ID NO.: 8602), CGUGgugagc (SEQ ID NO.: 8603), CGUGgugagu (SEQ ID NO.: 8605), CGUGgugggu (SEQ ID NO.: 8609), CUAAguaagc (SEQ ID NO.: 8615), CUAAguaagu (SEQ ID NO.: 8616), CUAAgucagu (SEQ ID NO.: 8622), CUAAgugagu (SEQ ID NO.: 8624), CUAAguuaag (SEQ ID NO.: 8625), CUACguaagu (SEQ ID NO.: 8628), CUACgugagu (SEQ ID NO.: 8630), CUAGguaaaa (SEQ ID NO.: 8632), CUAGguaaau (SEQ ID NO.: 8635), CUAGguaacc (SEQ ID NO.: 8636), CUAGguaaga (SEQ ID NO.: 8638), CUAGguaagc (SEQ ID NO.: 8639), CUAGguaagu (SEQ ID NO.: 8641), CUAGguaaua (SEQ ID NO.: 8642), CUAGguaauc (SEQ ID NO.: 8643), CUAGguaaug (SEQ ID NO.: 8644), CUAGguaccc (SEQ ID NO.: 8649), CUAGguagaa (SEQ ID NO.: 8654), CUAGguagag (SEQ ID NO.: 8655), CUAGguaucu (SEQ ID NO.: 8665), CUAGguaugg (SEQ ID NO.: 8668), CUAGguaugu (SEQ ID NO.: 8669), CUAGgucagu (SEQ ID NO.: 8675), CUAGgugaga (SEQ ID NO.: 8679), CUAGgugagu (SEQ ID NO.: 8682), CUAGgugaug (SEQ ID NO.: 8683), CUAGgugggu (SEQ ID NO.: 8686), CUAGguuagu (SEQ ID NO.: 8688), CUAUgcaagu (SEQ ID NO.: 8698), CUAUguaacu (SEQ ID NO.: 8699), CUAUguaaga (SEQ ID NO.: 8700), CUAUguaagu (SEQ ID NO.: 8701), CUAUgugagu (SEQ ID NO.: 8707), CUAUgugcgc (SEQ ID NO.: 8708), CUCAguaagu (SEQ ID NO.: 8713), CUCAgugagu (SEQ ID NO.: 8716), CUCCguaugu (SEQ ID NO.: 8725), CUCCgugagu (SEQ ID NO.: 8726), CUCGguaaga (SEQ ID NO.: 8730), CUCGguaagc (SEQ ID NO.: 8731), CUCGguaagg (SEQ ID NO.: 8732), CUCGguaagu (SEQ ID NO.: 8733), CUCGguacaa (SEQ ID NO.: 8736), CUCGguauug (SEQ ID NO.: 8747), CUCGgucagu (SEQ ID NO.: 8750), CUCGgugaga (SEQ ID NO.: 8753), CUCGgugagu (SEQ ID NO.: 8756), CUCGgugggu (SEQ ID NO.: 8760), CUCUguaaga (SEQ ID NO.: 8766), CUCUguaagc (SEQ ID NO.: 8767), CUCUguaagu (SEQ ID NO.: 8769), CUCUguaugu (SEQ ID NO.: 8772), CUCUgugagu (SEQ ID NO.: 8774), CUGAguaagc (SEQ ID NO.: 8778), CUGAguaagu (SEQ ID NO.: 8780), CUGAguaucc (SEQ ID NO.: 8783), CUGAgugagu (SEQ ID NO.: 8788), CUGCacagca (SEQ ID NO.: 8790), CUGCaggggg (SEQ ID NO.: 8791), CUGCgugagu (SEQ ID NO.: 8794), CUGGguaacu (SEQ ID NO.: 8805), CUGGguaaga (SEQ ID NO.: 8806), CUGGguaagc (SEQ ID NO.: 8807), CUGGguaagg (SEQ ID NO.: 8808), CUGGguaagu (SEQ ID NO.: 8809), CUGGguaaua (SEQ ID NO.: 8810), CUGGguaauu (SEQ ID NO.: 8812), CUGGguaggc (SEQ ID NO.: 8819), CUGGguaggu (SEQ ID NO.: 8821), CUGGgucagu (SEQ ID NO.: 8829), CUGGgugaga (SEQ ID NO.: 8835), CUGGgugagc (SEQ ID NO.: 8836), CUGGgugagg (SEQ ID NO.: 8837), CUGGgugagu (SEQ ID NO.: 8838), CUGGuuauca (SEQ ID NO.: 8851), CUGUguaagu (SEQ ID NO.: 8858), CUGUgugaga (SEQ ID NO.: 8864), CUGUgugagu (SEQ ID NO.: 8865), CUUAguaagu (SEQ ID NO.: 8868), CUUCguaagu (SEQ ID NO.: 8871), CUUCgugagu (SEQ ID NO.: 8872), CUUCuuggua (SEQ ID NO.: 8873), CUUGauuuua (SEQ ID NO.: 8874), CUUGguaacc (SEQ ID NO.: 8878), CUUGguaaga (SEQ ID NO.: 8879), CUUGguaagc (SEQ ID NO.: 8880), CUUGguaagg (SEQ ID NO.: 8881), CUUGguaagu (SEQ ID NO.: 8882), CUUGguacgu (SEQ ID NO.: 8887), CUUGguaggu (SEQ ID NO.: 8890), CUUGguauac (SEQ ID NO.: 8891), CUUGguaugc (SEQ ID NO.: 8895), CUUGguaugg (SEQ
ID NO.: 8896), CUUGguaugu (SEQ ID NO.: 8897), CUUGgugagc (SEQ ID NO.: 8904), CUUGgugagg (SEQ ID NO.: 8905), CUUGgugagu (SEQ ID NO.: 8906), CUUGgugggu (SEQ ID NO.: 8910), CUUUguaagu (SEQ ID NO.: 8922), CUUUgucucc (SEQ ID NO.: 8925), CUUUgugagu (SEQ ID NO.: 8928), GAAAgguaau (SEQ ID NO.: 8938), GAAAguaaga (SEQ ID NO.: 8942), GAAAguaagg (SEQ ID NO.: 8944), GAAAguaagu (SEQ ID NO.: 8945), GAAAguaauu (SEQ ID NO.: 8947), GAAAguaggu (SEQ ID NO.: 8951), GAAAguaugu (SEQ ID NO.: 8952), GAAAgugagu (SEQ ID NO.: 8957), GAAAguguga (SEQ ID NO.: 8959), GAAAguuagu (SEQ ID NO.: 8960), GAACguaugu (SEQ ID NO.: 8964), GAACgugagu (SEQ ID NO.: 8967), GAACguguga (SEQ ID NO.: 8968), GAAGgcaaag (SEQ ID NO.: 8973), GAAGgcaagg (SEQ ID NO.: 8976), GAAGgcaagu (SEQ ID NO.: 8977), GAAGgcaugu (SEQ ID NO.: 8981), GAAGggaggu (SEQ ID NO.: 8985), GAAGguaaaa (SEQ ID NO.: 8987), GAAGguaaac (SEQ ID NO.: 8988), GAAGguaaag (SEQ ID NO.: 8989), GAAGguaaau (SEQ ID NO.: 8990), GAAGguaaca (SEQ ID NO.: 8991), GAAGguaacu (SEQ ID NO.: 8994), GAAGguaaga (SEQ ID NO.: 8995), GAAGguaagc (SEQ ID NO.: 8996), GAAGguaagg (SEQ ID NO.: 8997), GAAGguaagu (SEQ ID NO.: 8998), GAAGguaaug (SEQ ID NO.: 9001), GAAGguaauu (SEQ ID NO.: 9002), GAAGguacaa (SEQ ID NO.: 9003), GAAGguacag (SEQ ID NO.: 9005), GAAGguacau (SEQ ID NO.: 9006), GAAGguacuc (SEQ ID NO.: 9015), GAAGguacug (SEQ ID NO.: 9016), GAAGguacuu (SEQ ID NO.: 9017), GAAGguagaa (SEQ ID NO.: 9018), GAAGguagag (SEQ ID NO.: 9020), GAAGguagau (SEQ ID NO.: 9021), GAAGguagcc (SEQ ID NO.: 9023), GAAGguagcu (SEQ ID NO.: 9025), GAAGguagga (SEQ ID NO.: 9026), GAAGguaggc (SEQ ID NO.: 9027), GAAGguaggg (SEQ ID NO.: 9028), GAAGguaggu (SEQ ID NO.: 9029), GAAGguagua (SEQ ID NO.: 9030), GAAGguaguu (SEQ ID NO.: 9032), GAAGguauag (SEQ ID NO.: 9035), GAAGguauau (SEQ ID NO.: 9036), GAAGguauga (SEQ ID NO.: 9041), GAAGguaugg (SEQ ID NO.: 9043), GAAGguaugu (SEQ ID NO.: 9044), GAAGguauua (SEQ ID NO.: 9045), GAAGguauuu (SEQ ID NO.: 9048), GAAGgucaga (SEQ ID NO.: 9049), GAAGgucagc (SEQ ID NO.: 9050), GAAGgucagg (SEQ ID NO.: 9051), GAAGgucagu (SEQ ID NO.: 9052), GAAGgucugu (SEQ ID NO.: 9060), GAAGgucuuc (SEQ ID NO.: 9061), GAAGgugaaa (SEQ ID NO.: 9062), GAAGgugaag (SEQ ID NO.: 9064), GAAGgugaau (SEQ ID NO.: 9065), GAAGgugaga (SEQ ID NO.: 9069), GAAGgugagc (SEQ ID NO.: 9070), GAAGgugagg (SEQ ID NO.: 9071), GAAGgugagu (SEQ ID NO.: 9072), GAAGgugaua (SEQ ID NO.: 9073), GAAGgugaug (SEQ ID NO.: 9075), GAAGgugauu (SEQ ID NO.: 9076), GAAGgugcag (SEQ ID NO.: 9078), GAAGgugcug (SEQ ID NO.: 9088), GAAGguggaa (SEQ ID NO.: 9090), GAAGguggga (SEQ ID NO.: 9094), GAAGgugggc (SEQ ID NO.: 9095), GAAGgugggu (SEQ ID NO.: 9097), GAAGguggua (SEQ ID NO.: 9098), GAAGguguaa (SEQ ID NO.: 9101), GAAGguuagc (SEQ ID NO.: 9112), GAAGguuagu (SEQ ID NO.: 9114), GAAGguuggu (SEQ ID NO.: 9121), GAAGguugua (SEQ ID NO.: 9122), GAAGguuugc (SEQ ID NO.: 9124), GAAGguuugu (SEQ ID NO.: 9126), GAAUgcaagg (SEQ ID NO.: 9131), GAAUguaagg (SEQ ID NO.: 9135), GAAUguaagu (SEQ ID NO.: 9136), GAAUguaugu (SEQ ID NO.: 9140), GAAUgugagc (SEQ ID NO.: 9143), GAAUgugagg (SEQ ID NO.: 9144), GAAUgugagu (SEQ ID NO.: 9145), GAAUuguaag (SEQ ID NO.: 9150), GACAguaagu (SEQ ID NO.: 9156), GACAguaggu (SEQ ID NO.: 9159), GACAgugagu (SEQ ID NO.: 9164), GACCguaagu (SEQ ID NO.: 9171), GACCguaugu (SEQ ID NO.: 9173), GACCgugagu (SEQ ID NO.: 9174), GACCgugggu (SEQ ID NO.: 9175), GACGguaaag (SEQ ID NO.: 9176), GACGguaagc (SEQ ID NO.: 9179), GACGguaagu (SEQ ID NO.: 9180), GACGguaauu (SEQ ID NO.: 9183), GACGguagga (SEQ ID NO.: 9184),
GACGguaugg (SEQ ID NO.: 9187), GACGgugaga (SEQ ID NO.: 9189), GACGgugagc (SEQ ID NO.: 9190), GACGgugagg (SEQ ID NO.: 9191), GACGgugcgu (SEQ ID NO.: 9193), GACGgugggc (SEQ ID NO.: 9194), GACGgugggu (SEQ ID NO.: 9195), GACUguaaga (SEQ ID NO.: 9202), GACUguaagu (SEQ ID NO.: 9204), GACUguaucc (SEQ ID NO.: 9207), GACUgugagu (SEQ ID NO.: 9211), GACUgugggu (SEQ ID NO.: 9213), GAGAagcuaa (SEQ ID NO.: 9217), GAGAguaaga (SEQ ID NO.: 9222), GAGAguaagc (SEQ ID NO.: 9223), GAGAguaagu (SEQ ID NO.: 9225), GAGAgugagu (SEQ ID NO.: 9229), GAGAugcugc (SEQ ID NO.: 9235), GAGCguaagu (SEQ ID NO.: 9237), GAGCguguga (SEQ ID NO.: 9243), GAGGagugug (SEQ ID NO.: 9245), GAGGguaaau (SEQ ID NO.: 9253), GAGGguaaga (SEQ ID NO.: 9254), GAGGguaagc (SEQ ID NO.: 9255), GAGGguaaug (SEQ ID NO.: 9259), GAGGguauac (SEQ ID NO.: 9266), GAGGguaugu (SEQ ID NO.: 9270), GAGGgugaga (SEQ ID NO.: 9273), GAGGgugagg (SEQ ID NO.: 9275), GAGGgugagu (SEQ ID NO.: 9276), GAGGgugggc (SEQ ID NO.: 9278), GAGGguuugu (SEQ ID NO.: 9283), GAGUguaagu (SEQ ID NO.: 9286), GAGUgugagc (SEQ ID NO.: 9289), GAGUgugagu (SEQ ID NO.: 9290), GAUAguaagu (SEQ ID NO.: 9292), GAUAguacug (SEQ ID NO.: 9293), GAUAgugagu (SEQ ID NO.: 9294), GAUCguaagu (SEQ ID NO.: 9296), GAUCgugagu (SEQ ID NO.: 9299), GAUGcaggaa (SEQ ID NO.: 9302), GAUGgcaauc (SEQ ID NO.: 9304), GAUGgcaugu (SEQ ID NO.: 9306), GAUGguaaga (SEQ ID NO.: 9314), GAUGguaagc (SEQ ID NO.: 9315), GAUGguaagu (SEQ ID NO.: 9317), GAUGguaaua (SEQ ID NO.: 9318), GAUGguaaug (SEQ ID NO.: 9319), GAUGguaauu (SEQ ID NO.: 9320), GAUGguaccc (SEQ ID NO.: 9322), GAUGguaggu (SEQ ID NO.: 9327), GAUGguauga (SEQ ID NO.: 9329), GAUGguaugu (SEQ ID NO. : 9331), GAUGgucggu (SEQ ID NO. : 9334), GAUGgugaga (SEQ ID NO. : 9336), GAUGgugagc (SEQ ID NO.: 9337), GAUGgugagg (SEQ ID NO.: 9338), GAUGgugagu (SEQ ID NO.: 9339), GAUGguggga (SEQ ID NO.: 9344), GAUGguggug (SEQ ID NO.: 9347), GAUGguuagu (SEQ ID NO.: 9350), GAUGuggguu (SEQ ID NO.: 9352), GAUUguaagu (SEQ ID NO.: 9354), GAUUgugagu (SEQ ID NO.: 9359), GAUUugcaug (SEQ ID NO.: 9362), GCAAguaagu (SEQ ID NO.: 9372), GCAAguacgg (SEQ ID NO.: 9374), GCAAguaggu (SEQ ID NO.: 9378), GCAAguauga (SEQ ID NO.: 9379), GCAAguaugc (SEQ ID NO.: 9380), GCAAguaugg (SEQ ID NO.: 9381), GCAAgugagu (SEQ ID NO.: 9386), GCACguaagu (SEQ ID NO.: 9392), GCACgugagu (SEQ ID NO.: 9396), GCAGgcaagu (SEQ ID NO.: 9405), GCAGgcacag (SEQ ID NO.: 9406), GCAGguaaaa (SEQ ID NO.: 9416), GCAGguaaac (SEQ ID NO.: 9417), GCAGguaaag (SEQ ID NO.: 9418), GCAGguaaau (SEQ ID NO.: 9419), GCAGguaaca (SEQ ID NO.: 9420), GCAGguaacc (SEQ ID NO.: 9421), GCAGguaacu (SEQ ID NO.: 9423), GCAGguaaga (SEQ ID NO.: 9424), GCAGguaagc (SEQ ID NO.: 9425), GCAGguaagg (SEQ ID NO.: 9426), GCAGguaagu (SEQ ID NO.: 9427), GCAGguaaua (SEQ ID NO.: 9428), GCAGguaauc (SEQ ID NO.: 9429), GCAGguaaug (SEQ ID NO.: 9430), GCAGguaauu (SEQ ID NO. : 9431), GCAGguacag (SEQ ID NO. : 9434), GCAGguacca (SEQ ID NO.: 9436), GCAGguacgc (SEQ ID NO.: 9441), GCAGguacuc (SEQ ID NO.: 9445), GCAGguacug (SEQ ID NO.: 9446), GCAGguagga (SEQ ID NO.: 9454), GCAGguaggc (SEQ ID NO.: 9455), GCAGguaggg (SEQ ID NO.: 9456), GCAGguaggu (SEQ ID NO.: 9457), GCAGguagua (SEQ ID NO.: 9458), GCAGguaguu (SEQ ID NO.: 9461), GCAGguauaa (SEQ ID NO.: 9462), GCAGguauca (SEQ ID NO.: 9466), GCAGguaucc (SEQ ID NO.: 9467), GCAGguaucu (SEQ ID NO.: 9469), GCAGguauga (SEQ ID NO.: 9470), GCAGguaugc (SEQ ID NO.: 9471), GCAGguaugg (SEQ ID NO.: 9472), GCAGguaugu (SEQ ID NO.: 9473), GCAGguauua (SEQ ID NO.: 9474), GCAGguauug (SEQ ID NO.: 9476), GCAGguauuu (SEQ
ID NO.: 9477), GCAGgucagc (SEQ ID NO.: 9481), GCAGgucagg (SEQ ID NO.: 9482), GCAGgucagu (SEQ ID NO.: 9483), GCAGgucugu (SEQ ID NO.: 9495), GCAGgugaaa (SEQ ID NO.: 9496), GCAGgugaag (SEQ ID NO.: 9498), GCAGgugacc (SEQ ID NO.: 9501), GCAGgugaga (SEQ ID NO.: 9504), GCAGgugagc (SEQ ID NO.: 9505), GCAGgugagg (SEQ ID NO.: 9506), GCAGgugagu (SEQ ID NO.: 9507), GCAGgugaug (SEQ ID NO.: 9510), GCAGgugcga (SEQ ID NO.: 9518), GCAGgugcgg (SEQ ID NO.: 9520), GCAGgugcgu (SEQ ID NO.: 9521), GCAGguggga (SEQ ID NO.: 9528), GCAGgugggu (SEQ ID NO.: 9531), GCAGgugugc (SEQ ID NO.: 9537), GCAGgugugg (SEQ ID NO.: 9538), GCAGgugugu (SEQ ID NO.: 9539), GCAGguuagu (SEQ ID NO.: 9545), GCAGguuaua (SEQ ID NO.: 9546), GCAGguucag (SEQ ID NO.: 9547), GCAGguucgu (SEQ ID NO.: 9549), GCAGguucuu (SEQ ID NO.: 9551), GCAUguaaga (SEQ ID NO.: 9564), GCAUguaagu (SEQ ID NO.: 9565), GCAUguaggu (SEQ ID NO.: 9568), GCAUguaucc (SEQ ID NO.: 9569), GCAUguaugu (SEQ ID NO.: 9570), GCAUgugagc (SEQ ID NO.: 9571), GCAUgugagu (SEQ ID NO.: 9572), GCCAguaaga (SEQ ID NO.: 9577), GCCAguaagu (SEQ ID NO.: 9579), GCCAgugagu (SEQ ID NO.: 9582), GCCCguaagc (SEQ ID NO.: 9585), GCCCguaugu (SEQ ID NO.: 9588), GCCCgugagu (SEQ ID NO.: 9589), GCCGguaaga (SEQ ID NO.: 9595), GCCGguaagg (SEQ ID NO.: 9597), GCCGguaagu (SEQ ID NO.: 9598), GCCGguaugu (SEQ ID NO.: 9608), GCCGgugagc (SEQ ID NO.: 9613), GCCGgugagu (SEQ ID NO.: 9615), GCCGgugggu (SEQ ID NO.: 9617), GCCUguaagu (SEQ ID NO.: 9620), GCCUgugagu (SEQ ID NO.: 9626), GCGAgugagu (SEQ ID NO.: 9635), GCGCgugagu (SEQ ID NO.: 9639), GCGGguaagc (SEQ ID NO.: 9643), GCGGguaagg (SEQ ID NO.: 9644), GCGGguaugg (SEQ ID NO.: 9654), GCGGguaugu (SEQ ID NO.: 9655), GCGGgugaga (SEQ ID NO.: 9656), GCGGgugagc (SEQ ID NO.: 9657), GCGGgugagu (SEQ ID NO.: 9659), GCGGgugcgu (SEQ ID NO.: 9661), GCUAaguuaa (SEQ ID NO.: 9669), GCUAguaagc (SEQ ID NO.: 9671), GCUAgugagu (SEQ ID NO.: 9674), GCUAgugcgu (SEQ ID NO.: 9675), GCUAuggaau (SEQ ID NO.: 9676), GCUCguaagu (SEQ ID NO.: 9678), GCUCucuugu (SEQ ID NO.: 9680), GCUGguaaau (SEQ ID NO.: 9688), GCUGguaagg (SEQ ID NO.: 9692), GCUGguaagu (SEQ ID NO.: 9693), GCUGguaccu (SEQ ID NO.: 9696), GCUGguaggu (SEQ ID NO.: 9706), GCUGguaugu (SEQ ID NO.: 9711), GCUGgucagu (SEQ ID NO.: 9714), GCUGgugaga (SEQ ID NO.: 9716), GCUGgugagc (SEQ ID NO.: 9717), GCUGgugagg (SEQ ID NO.: 9718), GCUGgugagu (SEQ ID NO.: 9719), GCUGgugugu (SEQ ID NO.: 9726), GCUUguaagu (SEQ ID NO.: 9732), GCUUguaugu (SEQ ID NO.: 9736), GCUUgugagu (SEQ ID NO.: 9737), GCUUgugcuu (SEQ ID NO.: 9738), GGAAaaggua (SEQ ID NO.: 9740), GGAAggucag (SEQ ID NO.: 9745), GGAAguaaga (SEQ ID NO.: 9748), GGAAguaagc (SEQ ID NO.: 9749), GGAAguaagu (SEQ ID NO.: 9751), GGAAguaugu (SEQ ID NO.: 9757), GGAAgugagu (SEQ ID NO.: 9760), GGAAguuagu (SEQ ID NO.: 9761), GGAGcucagg (SEQ ID NO.: 9767), GGAGgcaggu (SEQ ID NO.: 9772), GGAGgccaug (SEQ ID NO.: 9773), GGAGguaaag (SEQ ID NO.: 9779), GGAGguaaau (SEQ ID NO.: 9780), GGAGguaaca (SEQ ID NO.: 9781), GGAGguaacc (SEQ ID NO.: 9782), GGAGguaaga (SEQ ID NO.: 9785), GGAGguaagc (SEQ ID NO.: 9786), GGAGguaagg (SEQ ID NO.: 9787), GGAGguaagu (SEQ ID NO.: 9788), GGAGguaauc (SEQ ID NO.: 9790), GGAGguaaug (SEQ ID NO.: 9791), GGAGguaauu (SEQ ID NO.: 9792), GGAGguaccg (SEQ ID NO.: 9797), GGAGguacga (SEQ ID NO.: 9799), GGAGguagga (SEQ ID NO.: 9809), GGAGguaggg (SEQ ID NO.: 9811), GGAGguaggu (SEQ ID NO.: 9812), GGAGguauac (SEQ ID NO.: 9816), GGAGguauau (SEQ ID NO.: 9818), GGAGguaugc (SEQ ID NO.: 9822), GGAGguaugu (SEQ ID NO.: 9824), GGAGguauua (SEQ ID NO.: 9825),
GGAGguauuu (SEQ ID NO.: 9828), GGAGgucagg (SEQ ID NO.: 9831), GGAGgucagu (SEQ ID NO.: 9832), GGAGgucgag (SEQ ID NO.: 9835), GGAGgucugc (SEQ ID NO.: 9837), GGAGgugaga (SEQ ID NO.: 9847), GGAGgugagc (SEQ ID NO.: 9848), GGAGgugagg (SEQ ID NO.: 9849), GGAGgugagu (SEQ ID NO.: 9850), GGAGgugaug (SEQ ID NO.: 9851), GGAGgugccu (SEQ ID NO.: 9853), GGAGguggcg (SEQ ID NO.: 9862), GGAGgugggc (SEQ ID NO.: 9864), GGAGgugggu (SEQ ID NO.: 9866), GGAGgugugu (SEQ ID NO.: 9871), GGAUauguaa (SEQ ID NO.: 9891), GGAUguaagu (SEQ ID NO.: 9895), GGAUguaucc (SEQ ID NO.: 9896), GGAUgugagu (SEQ ID NO.: 9900), GGAUgugugu (SEQ ID NO.: 9902), GGAUguuagc (SEQ ID NO.: 9903), GGCAguaagu (SEQ ID NO.: 9908), GGCAgugagu (SEQ ID NO.: 9909), GGCCguacag (SEQ ID NO.: 9913), GGCGguaaag (SEQ ID NO.: 9918), GGCGguaaga (SEQ ID NO.: 9919), GGCGguaagu (SEQ ID NO.: 9921), GGCGguaggu (SEQ ID NO.: 9922), GGCGgugagg (SEQ ID NO.: 9927), GGCGgugagu (SEQ ID NO.: 9928), GGCUgcccca (SEQ ID NO.: 9930), GGCUguaagu (SEQ ID NO.: 9932), GGCUgugagu (SEQ ID NO.: 9937), GGGAguaagu (SEQ ID NO.: 9942), GGGCauuggu (SEQ ID NO.: 9947), GGGCguaagu (SEQ ID NO.: 9949), GGGCguaucu (SEQ ID NO.: 9950), GGGGguaagc (SEQ ID NO.: 9956), GGGGguaagu (SEQ ID NO.: 9958), GGGGgugagu (SEQ ID NO.: 9964), GGUGguaaga (SEQ ID NO.: 9973), GGUGguaagc (SEQ ID NO.: 9974), GGUGguaagu (SEQ ID NO.: 9976), GGUGgugagu (SEQ ID NO.: 9988), GGUUguaagu (SEQ ID NO.: 9992), GUAGguaagc (SEQ ID NO.: 9999), GUAGguaagu (SEQ ID NO.: 10001), GUAGguaggu (SEQ ID NO.: 10005), GUAGgugagc (SEQ ID NO.: 10012), GUAGgugagu (SEQ ID NO.: 10013), GUAGgugggu (SEQ ID NO.: 10015), GUAGguugcg (SEQ ID NO.: 10018), GUAUguaagu (SEQ ID NO.: 10020), GUCAacggcu (SEQ ID NO.: 10024), GUCAguaagu (SEQ ID NO.: 10027), GUCAgugagu (SEQ ID NO.: 10029), GUCCguaagu (SEQ ID NO.: 10033), GUCGguaagu (SEQ ID NO.: 10038), GUCGguaaug (SEQ ID NO.: 10039), GUCGgucagu (SEQ ID NO.: 10045), GUCGguggga (SEQ ID NO.: 10048), GUCUgaagag (SEQ ID NO.: 10050), GUCUguaagu (SEQ ID NO.: 10053), GUGAguaagu (SEQ ID NO.: 10056), GUGGguaaga (SEQ ID NO.: 10061), GUGGguaagu (SEQ ID NO.: 10064), GUGGguacgg (SEQ ID NO.: 10066), GUGGgucagu (SEQ ID NO.: 10072), GUGGgugagg (SEQ ID NO.: 10076), GUGGgugagu (SEQ ID NO.: 10077), GUGUcuccca (SEQ ID NO.: 10082), GUGUguaagg (SEQ ID NO.: 10084), GUGUguaagu (SEQ ID NO.: 10085), GUGUgugagu (SEQ ID NO.: 10086), GUUAguaagu (SEQ ID NO.: 10088), GUUAugguga (SEQ ID NO.: 10090), GUUGguaaga (SEQ ID NO.: 10100), GUUGguaagc (SEQ ID NO.: 10101), GUUGguaagu (SEQ ID NO.: 10102), GUUGgugaga (SEQ ID NO.: 10114), GUUGgugagu (SEQ ID NO.: 10116), GUUUguaagu (SEQ ID NO.: 10123), GUUUgugagu (SEQ ID NO.: 10124), UAAAguaagc (SEQ ID NO.: 10133), UAAAguaagu (SEQ ID NO.: 10135), UAAAgugagu (SEQ ID NO.: 10145), UAAAgugugu (SEQ ID NO.: 10148), UAAAguuagu (SEQ ID NO.: 10149), UAACguaagc (SEQ ID NO.: 10153), UAACguaagu (SEQ ID NO.: 10154), UAACgugagu (SEQ ID NO.: 10157), UAAGguaaaa (SEQ ID NO.: 10168), UAAGguaaac (SEQ ID NO.: 10169), UAAGguaaag (SEQ ID NO.: 10170), UAAGguaaau (SEQ ID NO.: 10171), UAAGguaacc (SEQ ID NO.: 10173), UAAGguaacu (SEQ ID NO.: 10175), UAAGguaaga (SEQ ID NO.: 10176), UAAGguaagc (SEQ ID NO.: 10177), UAAGguaagg (SEQ ID NO.: 10178), UAAGguaagu (SEQ ID NO.: 10179), UAAGguaaua (SEQ ID NO.: 10180), UAAGguaauu (SEQ ID NO.: 10183), UAAGguacaa (SEQ ID NO.: 10184), UAAGguacag (SEQ ID NO.: 10186), UAAGguacca (SEQ ID NO.: 10188), UAAGguacug (SEQ ID NO.: 10196), UAAGguacuu (SEQ ID NO.: 10197), UAAGguagag (SEQ ID NO.: 10199), UAAGguagga (SEQ ID NO.: 10204), UAAGguaggu
(SEQ ID NO.: 10207), UAAGguaucc (SEQ ID NO.: 10216), UAAGguauga (SEQ ID NO.: 10218), UAAGguaugc (SEQ ID NO.: 10219), UAAGguaugg (SEQ ID NO.: 10220), UAAGguaugu (SEQ ID NO.: 10221), UAAGguauuu (SEQ ID NO.: 10225), UAAGgucagu (SEQ ID NO.: 10229), UAAGgucucg (SEQ ID NO.: 10236), UAAGgucugu (SEQ ID NO.: 10237), UAAGgugaaa (SEQ ID NO.: 10239), UAAGgugaag (SEQ ID NO.: 10240), UAAGgugaau (SEQ ID NO.: 10241), UAAGgugagg (SEQ ID NO.: 10246), UAAGgugagu (SEQ ID NO.: 10247), UAAGgugcac (SEQ ID NO.: 10251), UAAGgugcca (SEQ ID NO.: 10252), UAAGgugccu (SEQ ID NO.: 10253), UAAGguggau (SEQ ID NO.: 10258), UAAGgugggc (SEQ ID NO.: 10260), UAAGgugggu (SEQ ID NO.: 10261), UAAGgugugu (SEQ ID NO.: 10264), UAAGguuauu (SEQ ID NO.: 10272), UAAGguuggu (SEQ ID NO.: 10277), UAAGguuucu (SEQ ID NO : 10281 ), UAAGguuugu (SEQ ID NO. : 10283), UAAUgcaagu (SEQ ID NO.: 10286), UAAUguaagu (SEQ ID NO.: 10290), UAAUgugagu (SEQ ID NO.: 10296), UACAgguugc (SEQ ID NO.: 10302), UACAguaaga (SEQ ID NO.: 10303), UACAguaagu (SEQ ID NO.: 10305), UACAguaggu (SEQ ID NO.: 10309), UACAgugagu (SEQ ID NO.: 10314), UACCaaaggg (SEQ ID NO.: 10319), UACCguaagu (SEQ ID NO.: 10321), UACCgugagg (SEQ ID NO.: 10324), UACGguaaaa (SEQ ID NO.: 10326), UACGguaagc (SEQ ID NO.: 10330), UACGguaagg (SEQ ID NO.: 10331), UACGguaauu (SEQ ID NO.: 10334), UACGguacgu (SEQ ID NO.: 10335), UACGguaggu (SEQ ID NO.: 10340), UACGgugagu (SEQ ID NO.: 10346), UACUguaagu (SEQ ID NO.: 10353), UACUguaugu (SEQ ID NO.: 10358), UACUgugagu (SEQ ID NO.: 10359), UAGAguaagu (SEQ ID NO.: 10365), UAGAguauua (SEQ ID NO.: 10368), UAGAgugagu (SEQ ID NO.: 10370), UAGAguugua (SEQ ID NO.: 10371), UAGGguaaga (SEQ ID NO.: 10377), UAGGguaagu (SEQ ID NO.: 10379), UAGGguagga (SEQ ID NO.: 10382), UAGGguaggu (SEQ ID NO.: 10384), UAGGgugaga (SEQ ID NO.: 10386), UAGGguuggu (SEQ ID NO.: 10390), UAGUguaagg (SEQ ID NO.: 10392), UAGUguaagu (SEQ ID NO.: 10393), UAGUguaugu (SEQ ID NO.: 10397), UAUAuaaggu (SEQ ID NO.: 10407), UAUCguaagu (SEQ ID NO.: 10413), UAUCgugagu (SEQ ID NO.: 10416), UAUGguaaaa (SEQ ID NO.: 10419), UAUGguaaau (SEQ ID NO.: 10421), UAUGguaacu (SEQ ID NO.: 10424), UAUGguaaga (SEQ ID NO.: 10425), UAUGguaagc (SEQ ID NO.: 10426), UAUGguaagu (SEQ ID NO.: 10428), UAUGguaaug (SEQ ID NO.: 10431), UAUGguacac (SEQ ID NO.: 10433), UAUGguagga (SEQ ID NO.: 10440), UAUGguaugg (SEQ ID NO.: 10446), UAUGgucagc (SEQ ID NO.: 10451), UAUGgugaga (SEQ ID NO.: 10455), UAUGgugagc (SEQ ID NO.: 10456), UAUGgugagg (SEQ ID NO.: 10457), UAUGgugagu (SEQ ID NO.: 10458), UAUGguggug (SEQ ID NO.: 10460), UAUUguaagc (SEQ ID NO.: 10465), UAUUguaagu (SEQ ID NO.: 10466), UAUUguaugu (SEQ ID NO.: 10470), UAUUgugagc (SEQ ID NO.: 10472), UAUUgugagu (SEQ ID NO.: 10473), UCAAgcaggu (SEQ ID NO.: 10478), UCAAguaaaa (SEQ ID NO.: 10480), UCAAguaaga (SEQ ID NO.: 10483), UCAAguaagc (SEQ ID NO : 10484), UCAAguaagu (SEQ ID NO.: 10486), UCAAguaaua (SEQ ID NO : 10487), UCAAguacau (SEQ ID NO.: 10490), UCAAguacua (SEQ ID NO.: 10493), UCAAguaugu (SEQ ID NO.: 10500), UCAAgugagc (SEQ ID NO.: 10504), UCAAgugagg (SEQ ID NO.: 10505), UCAAgugagu (SEQ ID NO.: 10506), UCAAgugauu (SEQ ID NO.: 10507), UCACguaagc (SEQ ID NO.: 10514), UCACguaagu (SEQ ID NO.: 10515), UCACguaugu (SEQ ID NO.: 10517), UCACgugagu (SEQ ID NO.: 10519), UCAGgcaagu (SEQ ID NO.: 10529), UCAGgcauau (SEQ ID NO.: 10535), UCAGgcaugu (SEQ ID NO.: 10536), UCAGguaaaa (SEQ ID NO.: 10540), UCAGguaaac (SEQ ID NO.: 10541), UCAGguaaag (SEQ ID NO.: 10542), UCAGguaaau (SEQ ID NO.: 10543), UCAGguaaca (SEQ ID NO.: 10544), UCAGguaacc (SEQ ID NO.: 10545),
UCAGguaacu (SEQ ID NO.: 10547), UCAGguaaga (SEQ ID NO.: 10548), UCAGguaagc (SEQ ID NO.: 10549), UCAGguaagg (SEQ ID NO.: 10550), UCAGguaagu (SEQ ID NO.: 10551), UCAGguaaua (SEQ ID NO.: 10552), UCAGguaauc (SEQ ID NO.: 10553), UCAGguaaug (SEQ ID NO.: 10554), UCAGguaauu (SEQ ID NO.: 10555), UCAGguacac (SEQ ID NO.: 10557), UCAGguacag (SEQ ID NO.: 10558), UCAGguacau (SEQ ID NO.: 10559), UCAGguacca (SEQ ID NO.: 10560), UCAGguaccu (SEQ ID NO.: 10562), UCAGguacgu (SEQ ID NO.: 10566), UCAGguacuc (SEQ ID NO.: 10568), UCAGguacug (SEQ ID NO.: 10569), UCAGguacuu (SEQ ID NO.: 10570), UCAGguagaa (SEQ ID NO.: 10571), UCAGguagag (SEQ ID NO.: 10573), UCAGguagau (SEQ ID NO.: 10574), UCAGguagcc (SEQ ID NO.: 10576), UCAGguagga (SEQ ID NO.: 10579), UCAGguaggc (SEQ ID NO.: 10580), UCAGguaggg (SEQ ID NO.: 10581), UCAGguaggu (SEQ ID NO.: 10582), UCAGguaguu (SEQ ID NO.: 10585), UCAGguauca (SEQ ID NO.: 10590), UCAGguaucu (SEQ ID NO.: 10592), UCAGguauga (SEQ ID NO.: 10593), UCAGguaugc (SEQ ID NO.: 10594), UCAGguaugg (SEQ ID NO.: 10595), UCAGguaugu (SEQ ID NO.: 10596), UCAGguauua (SEQ ID NO.: 10597), UCAGguauuc (SEQ ID NO.: 10598), UCAGguauug (SEQ ID NO.: 10599), UCAGguauuu (SEQ ID NO.: 10600), UCAGgucaga (SEQ ID NO.: 10602), UCAGgucagu (SEQ ID NO.: 10605), UCAGgucugc (SEQ ID NO.: 10614), UCAGgucugu (SEQ ID NO.: 10616), UCAGgugaag (SEQ ID NO.: 10621), UCAGgugaau (SEQ ID NO : 10622), UCAGgugaga (SEQ ID NO.: 10626), UCAGgugagc (SEQ ID NO.: 10627), UCAGgugagg (SEQ ID NO.: 10628), UCAGgugagu (SEQ ID NO.: 10629), UCAGgugauc (SEQ ID NO.: 10631), UCAGgugaug (SEQ ID NO.: 10632), UCAGgugauu (SEQ ID NO.: 10633), UCAGgugcca (SEQ ID NO.: 10637), UCAGgugcga (SEQ ID NO.: 10640), UCAGgugcgg (SEQ ID NO.: 10641), UCAGgugcgu (SEQ ID NO.: 10642), UCAGgugcuu (SEQ ID NO.: 10645), UCAGgugggc (SEQ ID NO.: 10649), UCAGgugggg (SEQ ID NO.: 10650), UCAGgugggu (SEQ ID NO.: 10651), UCAGguggug (SEQ ID NO.: 10653), UCAGguguaa (SEQ ID NO.: 10654), UCAGguguga (SEQ ID NO.: 10657), UCAGgugugc (SEQ ID NO.: 10658), UCAGgugugg (SEQ ID NO.: 10659), UCAGgugugu (SEQ ID NO.: 10660), UCAGguuagc (SEQ ID NO.: 10665), UCAGguuagu (SEQ ID NO.: 10667), UCAGguugaa (SEQ ID NO.: 10671), UCAGguuggu (SEQ ID NO.: 10680), UCAGguuugu (SEQ ID NO.: 10688), UCAGguuuuu (SEQ ID NO.: 10689), UCAUguaaau (SEQ ID NO.: 10695), UCAUguaaga (SEQ ID NO.: 10696), UCAUguaagu (SEQ ID NO.: 10698), UCAUguaugu (SEQ ID NO.: 10705), UCAUgugagu (SEQ ID NO.: 10708), UCCAguaagu (SEQ ID NO.: 10715), UCCAgugagu (SEQ ID NO.: 10720), UCCCgugagu (SEQ ID NO.: 10726), UCCCgugcgu (SEQ ID NO.: 10727), UCCGguaacu (SEQ ID NO.: 10730), UCCGguacuu (SEQ ID NO.: 10739), UCCGgugagc (SEQ ID NO.: 10745), UCCGgugagu (SEQ ID NO.: 10747), UCCGgugggc (SEQ ID NO.: 10749), UCCGgugggu (SEQ ID NO.: 10750), UCCUgcagga (SEQ ID NO.: 10753), UCCUggagga (SEQ ID NO.: 10755), UCCUguaagu (SEQ ID NO.: 10760), UCCUguaggc (SEQ ID NO.: 10762), UCCUguauga (SEQ ID NO.: 10764), UCCUgugaga (SEQ ID NO.: 10766), UCCUgugagu (SEQ ID NO.: 10768), UCGAguacgu (SEQ ID NO.: 10778), UCGAgucagu (SEQ ID NO.: 10780), UCGCguaugu (SEQ ID NO.: 10785), UCGCgugagg (SEQ ID NO.: 10786), UCGCgugagu (SEQ ID NO.: 10787), UCGGgcaagu (SEQ ID NO.: 10788), UCGGguaaau (SEQ ID NO.: 10790), UCGGguacgu (SEQ ID NO.: 10800), UCGGguaggu (SEQ ID NO.: 10803), UCGGguaugu (SEQ ID NO.: 10805), UCGGgugaga (SEQ ID NO.: 10809), UCGGgugagg (SEQ ID NO.: 10811), UCGUgguaug (SEQ ID NO.: 10819), UCGUguaagu (SEQ ID NO.: 10820), UCGUgugagu (SEQ ID NO.: 10822), UCUAaguuua (SEQ ID NO.: 10824), UCUAgcaagu (SEQ ID NO.: 10825), UCUAguaaga (SEQ ID NO.: 10826), UCUAguaagc (SEQ ID NO.: 10827), UCUAguaagu (SEQ
ID NO.: 10828), UCUAgugagu (SEQ ID NO.: 10831), UCUCguauga (SEQ ID NO.: 10837), UCUGguaaaa (SEQ ID NO.: 10842), UCUGguaaau (SEQ ID NO.: 10844), UCUGguaaga (SEQ ID NO.: 10848), UCUGguaagc (SEQ ID NO.: 10849), UCUGguaagg (SEQ ID NO.: 10850), UCUGguaagu (SEQ ID NO.: 10851), UCUGguaaua (SEQ ID NO.: 10852), UCUGguacag (SEQ ID NO.: 10855), UCUGguaggc (SEQ ID NO.: 10864), UCUGguaggu (SEQ ID NO.: 10866), UCUGguauga (SEQ ID NO.: 10870), UCUGguaugc (SEQ ID NO.: 10871), UCUGguaugu (SEQ ID NO.: 10873), UCUGguauuu (SEQ ID NO.: 10874), UCUGgugaau (SEQ ID NO.: 10877), UCUGgugaga (SEQ ID NO.: 10879), UCUGgugagc (SEQ ID NO.: 10880), UCUGgugagg (SEQ ID NO.: 10881), UCUGgugagu (SEQ ID NO.: 10882), UCUGguuugu (SEQ ID NO.: 10889), UCUUguaagu (SEQ ID NO.: 10893), UCUUguaugu (SEQ ID NO.: 10895), UCUUgugagu (SEQ ID NO : 10897), UGAAaaggua (SEQ ID NO : 10901), UGAAguaacu (SEQ ID NO : 10906), UGAAguaagc (SEQ ID NO.: 10908), UGAAguaagu (SEQ ID NO.: 10910), UGAAguaugc (SEQ ID NO.: 10918), UGAAguccgu (SEQ ID NO.: 10921), UGAGgcaagu (SEQ ID NO.: 10940), UGAGgcaggu (SEQ ID NO.: 10942), UGAGguaaaa (SEQ ID NO.: 10945), UGAGguaaac (SEQ ID NO.: 10946), UGAGguaaag (SEQ ID NO.: 10947), UGAGguaaau (SEQ ID NO.: 10948), UGAGguaaga (SEQ ID NO.: 10953), UGAGguaagc (SEQ ID NO.: 10954), UGAGguaagg (SEQ ID NO.: 10955), UGAGguaagu (SEQ ID NO.: 10956), UGAGguaauc (SEQ ID NO.: 10958), UGAGguaaug (SEQ ID NO.: 10959), UGAGguaauu (SEQ ID NO.: 10960), UGAGguaccg (SEQ ID NO.: 10966), UGAGguacgu (SEQ ID NO.: 10970), UGAGguagag (SEQ ID NO.: 10975), UGAGguagga (SEQ ID NO.: 10979), UGAGguaggc (SEQ ID NO.: 10980), UGAGguaggu (SEQ ID NO.: 10982), UGAGguauac (SEQ ID NO.: 10987), UGAGguauag (SEQ ID NO.: 10988), UGAGguauga (SEQ ID NO.: 10992), UGAGguaugc (SEQ ID NO.: 10993), UGAGguaugg (SEQ ID NO.: 10994), UGAGguaugu (SEQ ID NO.: 10995), UGAGguauuc (SEQ ID NO.: 10997), UGAGguauug (SEQ ID NO.: 10998), UGAGguauuu (SEQ ID NO.: 10999), UGAGgucagc (SEQ ID NO.: 11001), UGAGgucagu (SEQ ID NO.: 11003), UGAGgugaaa (SEQ ID NO.: 11012), UGAGgugaag (SEQ ID NO.: 11014), UGAGgugaau (SEQ ID NO.: 11015), UGAGgugacu (SEQ ID NO.: 11018), UGAGgugaga (SEQ ID NO.: 11019), UGAGgugagc (SEQ ID NO.: 11020), UGAGgugagg (SEQ ID NO.: 11021), UGAGgugagu (SEQ ID NO.: 11022), UGAGgugauc (SEQ ID NO.: 11024), UGAGgugggc (SEQ ID NO.: 11034), UGAGgugggg (SEQ ID NO. : 11035), UGAGguguga (SEQ ID NO. : 11040), UGAGguuaga (SEQ ID NO.: 11045), UGAGguuagg (SEQ ID NO.: 11047), UGAGguuggu (SEQ ID NO.: 11054), UGAUguaagc (SEQ ID NO.: 11067), UGAUguaagu (SEQ ID NO.: 11069), UGAUguaugg (SEQ ID NO.: 11076), UGAUguaugu (SEQ ID NO.: 11077), UGAUgugaga (SEQ ID NO.: 11078), UGAUgugagu (SEQ ID NO.: 11081), UGAUguuagu (SEQ ID NO.: 11082), UGCAguaagu (SEQ ID NO.: 11089), UGCAguaucc (SEQ ID NO.: 11092), UGCAgucagu (SEQ ID NO.: 11094), UGCAgugagu (SEQ ID NO.: 11098), UGCCguaagu (SEQ ID NO : 11104), UGCCguaugu (SEQ ID NO.: 11107), UGCCgugagu (SEQ ID NO.: 11109), UGCGguaaca (SEQ ID NO.: 11111), UGCGguaagc (SEQ ID NO.: 11113), UGCGguaccg (SEQ ID NO.: 11118), UGCGgugagc (SEQ ID NO.: 11128), UGCGgugagg (SEQ ID NO.: 11129), UGCGgugagu (SEQ ID NO.: 11130), UGCGuauuuu (SEQ ID NO.: 11135), UGCUguaaga (SEQ ID NO.: 11139), UGCUguaagc (SEQ ID NO.: 11140), UGCUguaagu (SEQ ID NO. : 11141), UGCUguacgc (SEQ ID NO. : 11142), UGCUguaggu (SEQ ID NO. : 11143), UGCUgugagu (SEQ ID NO.: 11151), UGGAauccac (SEQ ID NO.: 11152), UGGAguaagu (SEQ ID NO. : 11156), UGGAgugagu (SEQ ID NO. : 11162), UGGCgugagu (SEQ ID NO. : 11172), UGGGaacgag (SEQ ID NO. : 11173), UGGGguaaga (SEQ ID NO. : 11178), UGGGguaagg (SEQ
ID NO.: 11180), UGGGguaagu (SEQ ID NO.: 11181), UGGGguaggg (SEQ ID NO.: 11188), UGGGguaggu (SEQ ID NO.: 11189), UGGGguauca (SEQ ID NO.: 11190), UGGGgugaga (SEQ ID NO.: 11198), UGGGgugagg (SEQ ID NO.: 11200), UGGGgugagu (SEQ ID NO.: 11201), UGGGguugug (SEQ ID NO.: 11206), UGGUgugagu (SEQ ID NO.: 11215), UGUAgugagu (SEQ ID NO.: 11221), UGUAguugug (SEQ ID NO.: 11222), UGUCcuccaa (SEQ ID NO.: 11224), UGUCguaagu (SEQ ID NO.: 11226), UGUCgugagu (SEQ ID NO.: 11228), UGUGguaaau (SEQ ID NO.: 11232), UGUGguaaga (SEQ ID NO.: 11234), UGUGguaagc (SEQ ID NO.: 11235), UGUGguaagg (SEQ ID NO.: 11236), UGUGguaagu (SEQ ID NO.: 11237), UGUGguaaug (SEQ ID NO. : 11239), UGUGguaauu (SEQ ID NO. : 11240), UGUGguagga (SEQ ID NO.: 11245), UGUGguaggu (SEQ ID NO.: 11247), UGUGguaugu (SEQ ID NO.: 11251), UGUGgugagc (SEQ ID NO. : 11255), UGUGgugagg (SEQ ID NO. : 11256), UGUGgugagu (SEQ ID NO. : 11257), UGUGgugggu (SEQ ID NO. : 11259), UGUGgugugu (SEQ ID NO. : 11261), UGUGguuagu (SEQ ID NO.: 11262), UGUUguaagu (SEQ ID NO.: 11266), UGUUguaucc (SEQ ID NO. : 11268), UGUUgugagu (SEQ ID NO. : 11269), UUAAguaagu (SEQ ID NO.: 11277), UUAAgucagu (SEQ ID NO.: 11283), UUAAgugagu (SEQ ID NO.: 11285), UUAAgugggu (SEQ ID NO.: 11286), UUACguaagu (SEQ ID NO.: 11288), UUAGgcaagu (SEQ ID NO.: 11290), UUAGguaaaa (SEQ ID NO.: 11293), UUAGguaaac (SEQ ID NO.: 11294), UUAGguaaag (SEQ ID NO.: 11295), UUAGguaacu (SEQ ID NO.: 11300), UUAGguaaga (SEQ ID NO.: 11301), UUAGguaagc (SEQ ID NO.: 11302), UUAGguaagg (SEQ ID NO.: 11303), UUAGguaagu (SEQ ID NO.: 11304), UUAGguaccu (SEQ ID NO.: 11309), UUAGguagag (SEQ ID NO. : 11313), UUAGguaggu (SEQ ID NO.: 11317), UUAGguaugc (SEQ ID NO.: 11323), UUAGguaugg (SEQ ID NO.: 11324), UUAGguaugu (SEQ ID NO.: 11325), UUAGguauua (SEQ ID NO.: 11326), UUAGgucagu (SEQ ID NO.: 11331), UUAGgugaau (SEQ ID NO.: 11335), UUAGgugaga (SEQ ID NO.: 11336), UUAGgugagu (SEQ ID NO.: 11339), UUAGguuugu (SEQ ID NO.: 11350), UUAUgcaagu (SEQ ID NO.: 11352), UUAUguaagg (SEQ ID NO.: 11355), UUAUguaagu (SEQ ID NO.: 11356), UUAUgugagu (SEQ ID NO.: 11360), UUCAgguaag (SEQ ID NO.: 11362), UUCAguaagu (SEQ ID NO.: 11365), UUCAgucugu (SEQ ID NO.: 11369), UUCAgugagu (SEQ ID NO.: 11371), UUCCguaagu (SEQ ID NO.: 11376), UUCCgugagu (SEQ ID NO.: 11378), UUCGguaagu (SEQ ID NO.: 11383), UUCGguaggu (SEQ ID NO.: 11388), UUCGguaugu (SEQ ID NO.: 11389), UUCGgugagc (SEQ ID NO.: 11393), UUCGgugagg (SEQ ID NO.: 11394), UUCGgugagu (SEQ ID NO.: 11395), UUCGguuagu (SEQ ID NO.: 11398), UUCUguaaga (SEQ ID NO.: 11399), UUCUguaagu (SEQ ID NO. : 11402), UUCUguacug (SEQ ID NO. : 11405), UUCUgugaga (SEQ ID NO. : 11409), UUCUgugagu (SEQ ID NO.: 11411), UUGAgguagg (SEQ ID NO.: 11417), UUGAgugagc (SEQ ID NO.: 11423), UUGAgugagu (SEQ ID NO.: 11424), UUGAgugggu (SEQ ID NO.: 11425), UUGCguaagu (SEQ ID NO.: 11428), UUGCguacgu (SEQ ID NO.: 11429), UUGCguaugu (SEQ ID NO. : 11430), UUGGauaucc (SEQ ID NO. : 11434), UUGGguaaau (SEQ ID NO.: 11440), UUGGguaaga (SEQ ID NO.: 11442), UUGGguaagc (SEQ ID NO.: 11443), UUGGguaagu (SEQ ID NO. : 11445), UUGGguaggu (SEQ ID NO. : 11455), UUGGguauga (SEQ ID NO.: 11456), UUGGguaugu (SEQ ID NO.: 11458), UUGGgugaga (SEQ ID NO.: 11463), UUGGgugagc (SEQ ID NO.: 11464), UUGGgugagg (SEQ ID NO.: 11465), UUGGgugagu (SEQ ID NO.: 11466), UUGGgugauu (SEQ ID NO.: 11467), UUGUguaagu (SEQ ID NO.: 11473), UUGUgugagu (SEQ ID NO.: 11479), UUUAguaaga (SEQ ID NO.: 11482), UUUAguaagg (SEQ ID NO.: 11483), UUUAguaagu (SEQ ID NO : 11484), UUUAgugagu (SEQ ID NO.: 11487), UUUCaaauau (SEQ ID NO.: 11488), UUUCauagga (SEQ
Detailed Table for Genes Exhibiting APSI >+50 and <-50
[00529] In one aspect, compounds described herein have been shown to induce a PSI change (APSI) of +50% to +100%, having a /< value of <0 001 or a APS! of -50% to -100% and a P-value of <0.001.
Compound Induced Change in Amount of Mature mRNA
[00530] In another aspect, Table 16 demonstrates the effect of various representative compounds (Cpd) described herein to induce a > Log2 fold change (L2FC) in the amount of mature mRNA for a wildtype gene (Gene) after treatment in various cell lines (Cell) tested at various concentrations (Cone). A Log2 fold change of 1.0 represents a doubling in expression of the mature mRNA transcript produced in the presence of the compound. Positive values correspond to upregulation of gene expression while negative values correspond to down regulation of gene expression.
[00531] The compounds of Formula (I) induce a two fold change, or more, in gene expression (a Log2 fold change of 1 .0 or above, or -1 .0 or below) together with a change in Percent Spliced In (APSI) of 10% to 100%, or -10% to -100%, at a p value (pVal) of < 0.001 for the indicated genes.
[00532] Table 16
[00533] A1BG-AS1, AAAS, AAK1, AAMDC, AARS, AARS2, AASS, ABCA1, ABCA11P, ABCA3, ABCA7, ABCB1, ABCC10, ABCC4, ABCD2, ABCD3, ABCD4, ABCE1, ABHD12, ABHD14A, ABHD14A-ACY1, ABHD6, ABLIM1, ABR, ABRAXAS1, ACAA1, ACACA,
ACACB, ACADM, ACADS, ACAP3, ACAT1, ACBD6, ACCS, ACD, ACER3, ACSF3, ACSL3, ACSS2, ACTA2, ACTL6B, ACTR1A, ACTR1B, ACVRL1, ACY1, ACYP1, ADA, AD AL, ADAM I 9, ADAM22, AD AMTS 12, ADAMTS6, ADAMTS7, ADAMTS9, ADAMTSL4, ADAMTSL5, AD API, AD ARBI, ADAT2, ADCK1, ADCK5, ADCY3, ADCY7, ADGRA2, ADGRB2, ADGRL1, ADGRL3, ADK, ADPGK, AFF3, AFMID, AGAP1, AG04, AGPAT4, AGRN, AGTPBP1, AHCYL2, AHDC1, AHI1, AHNAK, AHRR, AHSA2P, AIFM1, AIMP2, AK4, AKAP12, AKAP13, AKAP6, AKAP7, AKAP9, AKIP1, AKT1S1, ALDH1L2, ALDH3A2, ALDH4A1, ALDOC, ALG13, ALG2, ALG9, ALKBH3, ALKBH6, ALMS1, ALPK1, ALS2, AMDHD2, AMMECR1, AMN1, AMOT, AMOTL1, AMPD2, AMT, AMY2B, ANAPC10, ANGEL 1, ANK2, ANK3, ANKH, ANKHD1, ANKHD1-EIF4EBP3, ANKMY2, ANKRA2, ANKRD10, ANKRD12, ANKRD36, ANKRD37, ANKRD45, ANKRD6, ANKS1A, ANKS6, ANKZF1, ANLN, ANO8, AP1M1, AP1S2, AP2A1, AP2A2, AP3B2, AP3D1, AP3M1, AP3S2, APBA1, APBA3, APC, APEH, APH1A, APH1B, APOLD1, APOOL, ARFGAP2, ARFRP1, ARHGAP1, ARHGAP27P1-BPTFP1-KPNA2P3, ARHGAP31, ARHGAP33, ARHGEF10, ARHGEF12, ARHGEF2, ARHGEF25, ARHGEF39, ARHGEF4, ARHGEF40, ARHGEF9, ARID4A, ARID5A, ARID5B, ARMC4P1, ARMC7, ARMC9, ARMCX5, ARMCX6, ARNT2, ARNTL2, ARRDC1, ARRDC2, ARSB, ARSK, ARV1, ARVCF, AS3MT, ASAH2B, ASAP1, ASAP2, ASAP3, ASB1, ASDURF, ASIC1, ASL, ASNS, ASPDH, ASPM, ASXL3, ATAD1, ATAD5, ATF7, ATF7IP2, ATG16L2, ATG2B, ATG7, ATN1, ATOX1, ATP1A1-AS1, ATP2A3, ATP2B1, ATP5F1C, ATP5ME, ATP5MF, ATP5PO, ATP5S, ATP6AP1L, ATP6V0A1, ATP6V0A2, ATP6V0D1, ATP6V1D, ATP8B4, ATP9A, ATP9B, ATR, ATRN, ATXN1, ATXN10, ATXN3, ATXN7L2, AVEN, AZIN2, B3GALNT1, B3GNTL1, B4GALNT4, B4GALT6, B9D1, BABAM2, BACE1, BAHCC1, BAK1, BANP, BAZ2B, BBIP1, BBOF1, BBOX1-AS1, BBS4, BBX, BCAS3, BCAS4, BCKDHB, BCL11A, BCL2L13, BCL2L2-PABPN1, BCL9L, BCLAF3, BCOR, BCORL1, BCS1L, BDNF-AS, BDP1, BEGAIN, BEND6, BEND7, BFSP1, BICD1, BICDL1, BICRA, BICRAL, BID, BIRC5, BIVM, BLM, BLOC1S5, BLZF1, BMP2, BMS1P14, BOC, BOD1L1, BOLA3, BOP1, BORCS8, BORCS8-MEF2B, BPTF, BRCA2, BRCC3, BRPF1, BRPF3, BRSK2, BRWD3, BSPRY, BTBD9, BTD, BTN3A2, BTN3A3, BUB1, BUD23, C10orfl43, Cllorfl, Cllorf65, C12orf29, C12orf4, C12orf75, C12orf76, C14orf39, C15orf38-AP3S2, C15orf41, C16orf45, C17orf75,
C19orf25, C19orf54, C19orf57, CID, C1QTNF3-AMACR, C1QTNF6, Clorfl59, Clorf35, C20orfl94, C20orfl97, C21orB3, C3orfl8, C3orf52, C3orf67, C4orfi3, C5, C5AR1, C6orf203, C6orf62, C6orf89, C8orf44-SGK3, C8orf58, C8orf59, CA5B, CAB39L, CABIN1, CACNA2D1, CACNA2D2, CACNB3, CACNG7, CALD1, CALML4, CAMKID, CAMK2D, CAMK4, CAMKK1, CAMSAP1, CAMSAP2, CAMSAP3, CAPRIN2, CAPS2, CARMIL2, CARS2, CASD1, CASKIN1, CASP1, CAST0R3, CBY1, CC2D2A, CCAR1, CCDC125, CCDC126, CCDC136, CCDC14, CCDC149, CCDC150, CCDC159, CCDC163, CCDC171, CCDC18, CCDC18-AS1, CCDC188, CCDC191, CCDC25, CCDC40, CCDC57, CCDC61, CCDC74B, CCDC82, CCDC88A, CCDC88C, CCDC92, CCM2, CCNC, CCNY, CCZ1P-OR7E38P, CD276, CD44, CD68, CDC14A, CDC16, CDC25C, CDC42SE2, CDC6, CDC7, CDCA3, CDCA7, CDK11B, CDK14, CDK5RAP2, CDKL3, CDKN3, CD01, CDPF1, CDR2, CDRT4, CDYL, CEBPZOS, CELF2, CELSR2, CELSR3, CENPA, CENPC, CENPE, CENPH, CENPI, CENPM, CENPS-CORT, CENPU, CENPX, CEP112, CEP126, CEP128, CEP131, CEP135, CEP162, CEP164, CEP170, CEP192, CEP250, CEP290, CEP295, CEP350, CEP70, CEP83, CEP89, CEPT1, CERCAM, CERS5, CERS6, CES3, CFAP299, CFAP300, CFAP44, CHCHD5, CHD1L, CHD3, CHD4, CHD6, CHD8, CHD9, CHEK2, CHFR, CHM, CHPF2, CHURC1, CHURC1-FNTB, CIR1, CIT, CKLF, CKLF-CMTM1, CKMT1A, CLCC1, CLCN2, CLEC2D, CLEC5A, CLIP1, CLIP2, CLIP4, CLK4, CLMP, CLN6, CLOCK, CLSPN, CLTCL1, CMC4, CMIP, CMTM1, CNIH1, CNIH3, CNKSR2, CNNM1, CNOTIO, CNPY3, CNPY3-GNMT, CNTFR, CNTLN, CNTNAP1, CNTRL, COG5, COG6, COL23A1, COL24A1, COL25A1, COL4A1, COL4A3BP, COL4A6, COL6A2, COL6A3, COL9A3, C0MMD1, COMMDIO, C0MMD4, COMTD1, COP1, COPRS, COPS7B, COQ2, COQ3, COQ6, CORO7, COX10-AS1, COX15, COX20, CPED1, CPNE2, CPNE3, CPS1, CPT1C, CPVL, CPXM1, CRAT, CREB3L4, CREB5, CREBZF, CRELD1, CROCC, CROCCP2, CROT, CRYBB2P1, CRYBG3, CRYZ, CSAG3, CSRNP3, CSRP3, CTTN, CUL9, CUT ALP, CUTC, CUX1, CUX2, CWF19L1, CXorf38, CYB561, CYB5R4, CYB5RL, CYBA, CYLD, CYP2S1, CYP2U1, CYP4V2, CYTH1, CZ1P-ASNS, DAAM1, DACH1, DAPK1, DARS, DAZAP1, DCAF17, DCAKD, DCBLD1, DCLK2, DCP1B, DCST1-AS1, DDC, DDN, DDR2, DDT, DDX11, DDX12P, DDX19A, DDX19B, DDX46, DDX60, DEAF1, DECR2, DEDD2, DEF8, DENND1B, DENND3, DENND4A, DENND4B, DENND4C, DENND5A, DENND5B, DEPDC1B, DEPTOR, DESI1,
DET1, DEXI, DGKA, DGKI, DGKQ, DGKZ, DGLUCY, DHPS, DHRS12, DHRS4, DHRS4L2, DHX33, DHX34, DICER1, DIMT1, DIP2A, DIRAS1, DIS3L2, DISP1, DLEU1, DLEU2, DLG5, DLST, DMC1, DMTN, DMXL1, DMXL2, DNA2, DNAJB12, DNAJB14, DNAJB4, DNAJC1, DNAJC10, DNAJC17, DNAJC2, DNAJC24, DNAJC25-GNG10, DNAJC4, DNAJC6, DNAJC8, DNASE2, DNM3, DNMT1, DNMT3A, DNPEP, DOC2A, DOC2B, DOCK1, DOCK11, DOCK4, DOCK5, DOCK9, DOK3, DOPEY 1, DOT IL, DPH6, DPMI, DPP7, DPY19L2, DPY19L3, DPYSL3, DPYSL5, DRG2, DSP, DST, DTD2, DTNB, DTWD1, DUBR, DUS4L, DUSP11, DUSP16, DYM, DYNC1H1, DYNC2H1, DYNC2LI1, DZIP3, E2F7, EBAG9, EBF4, ECT2, EDEM2, EEA1, EEF2K, EEF2KMT, EFCAB2, EFHD2, EFNA1, EFNB3, EHBP1L1, EHMT1, EIF1AD, EIF4G3, EIF6, ELF4, ELL, ELMOD2, ELN, ELP1, ELP2, ELP5, EMB, EMC2, EMC3-AS1, EMG1, EMIDI, EML2, EML4, EML5, EML6, EMSY, ENCI, ENDOG, ENDOV, ENOX2, EOGT, EP300, EP400, EPAS1, EPB41L1, EPB41L2, EPB41L4A, EPG5, EPHA2, EPHA3, EPHX1, EPHX4, EPM2A, EPS8, ERBB2, ERC1, ERC2, ERGIC1, ERLIN1, ERMARD, ETFDH, ETFRF1, ETHE1, ETV4, ETV6, EXD2, EXD3, EXO5, EXOC2, EXOC3, EXOC6B, EXOSC9, EZH1, F8, FAAH2, FADS2, FAH, FAIM, FAM111 A, FAM1 14A1, FAM114A2, FAM122B, FAM126B, FAM149B1, FAM162A, FAM168A, FAM173A, FAM173B, FAM184A, FAM206A, FAM208A, FAM208B, FAM212B-AS1, FAM214A, FAM216A, FAM24B, FAM72A, FAM72C, FAM72D, FAM76B, FAM78B, FAM81A, FAM89B, FAM98C, FANCA, FANCB, FANCE, FANCI, FANCL, FANKI, FARS2, FASN, FAT1, FAT3, FBF1, FBH1, FBLIM1, FBN1, FBN2, FBXL3, FBXL4, FBXL7, FBXO17, FBXO4, FBXO44, FBXO9, FBXW4, FBXW8, FCGRT, FCHO1, FCHSD1, FDX1L, FDXR, FENDRR, FER1L4, FEZ2, FGD2, FGD4, FGF13, FGFR1OP2, FGFR2, FGFR3, FGGY, FHOD3, FIG4, FIZ1, FLAD1, FLCN, FLNA, FLRT3, FN1, FNBP1, FOXP1, FOXRED1, FOXRED2, FPGT-TNNI3K, FRAS1, FRG1DP, FRG1HP, FRMD3, FRMD4A, FRMD8, FRY, FTSJ1, FTX, FUK, FUT8, FXR2, FYN, G2E3, GAA, GABI, GADD45A, GAK, GALK1, GALK2, GALNS, GALNT2, GALNT6, GALT, GANC, GARNL3, GAS8, GATD3A, GBA2, GCA, GCC2, GCLC, GDPD5, GEMIN2, GEN1, GFM2, GGA3, GGACT, GGPS1, GGT5, GID4, GIGYF1, GIN1, GINS1, GIT1, GK, GKAP1, GLB1, GLDC, GLI2, GLIPR2, GLRB, GLS2, GLTP, GLYCTK, GMDS, GMIP, GNAS-AS1, GNG4, GNPDA2, GNPTG, GOLGA2, GOLGA2P7, GOLGA4, GOLGB1, G0LIM4, GOLT IB, GORAB, GOSR2, GPATCH8, GPC5,
GPHN, GPKOW, GPR137, GPR137B, GPR155, GPR63, GRAMD1A, GRHL1, GRIK5, GRPEL2, GSAP, GSTM2, GSTM4, GSTT1, GSTT2B, GTDC1, GTF2B, GTF2H2, GTF2I, GTF2IP1, GTF2IP20, GTF2IP4, GTF3C3, GUSBP11, H6PD, HACD1, HACL1, HADH, HAUS5, HAX1, HCFC1, HCFC1R1, HDAC10, HDAC5, HDAC9, HDHD5, HEATR5B, HECTD4, HECW1, HEMK1, HERC2, HERC2P2, HERC3, HERC6, HES4, HEXA, HEXIM2, HFM1, HGH1, HIBADH, HIBCH, HINFP, HIP1, HIST1H2BD, HIVEP1, HIVEP2, HIVEP3, HLTF, HMCN1, HMGCL, HMGCS1, HMMR, HNRNPA1L2, HOGA1, HOMER2, HOOK3, HOXA6, HOXB3, HPCAL1, HPS3, HPS5, HPSE, HRAS, HRH1, HSD11B1L, HSD17B14, HSD17B4, HSD17B7P2, HSF4, HTD2, HTT, HUWE1, HYAL3, HYI, ICA1L, ICE1, IDE, IDNK, IFFO1, IFI27L1, IFI27L2, IFITM1, IFRD1, IFT140, IFT172, IFT20, IFT27, IFT43, 1FE88, 1GF2BP3, 1GFBP6, IGSF1, IKB1P, 1KBKB, IKBKG, 1E10RA, 1E11RA, IE15, IL17RE, IL21R, IL2RG, IL32, IL6R, IL6ST, IMMP1L, IMMP2L, IMPA2, INF2, INO80C, INPPI, INPPL1, INSIGI, INTS2, INTS3, INTS4P1, INTU, INVS, IPO5P1, IPP, IQCB1, IQCE, IQCG, IQCH, IQCH-AS1, IQCK, IQGAP3, IQSEC1, IRAK1BP1, IRAK2, IRAK4, IRF6, ISOC2, ITFG2, ITGA10, ITGA3, ITGA8, ITGA9, ITGAX, ITPR1, ITPR2, ITSN1, JADE1, JADE2, JAK1, JAM2, JCAD, JMJD1C, JPX, KAT6B, KAT8, KATNAL2, KBTBD2, KBTBD3, KCNAB2, KCNAB3, KCNG1, KCNH2, KCNQ1, KCNQ5, KCNS3, KCNT2, KDM3A, KDM4D, KIAA0232, KIAA0319L, KIAA0391, KIAA0556, KIAA0753, KIAA0825, KIAA1109, KIAA1211, KIAA1217, KIAA1522, KIAA1551, KIAA1841, KIDINS220, KIF13B, KIF15, KIF16B, KIF1A, KIF21B, KIF24, KIF26B, KIF3A, KIF9, KIF9-AS1, KITLG, KIZ, KLC4, KLHDC4, KLRG1, KLRG2, KMT2A, KMT2B, KMT2D, KMT5C, KNL1, KPTN, KREMEN1, KSR1, KTN1, KYAT1, KYAT3, L3HYPDH, L3MBTL2, LAMA3, LAMA5, LAMC3, LARP1B, LARS2, LAS1L, LCAT, LCOR, LCORL, LDHC, LDLR, LEF1, LENG8, LEPR, LEPROT, LETMD1, LGR5, LHPP, LIAS, LIG1, LIMCH1, LIN52, LINC00327, LINC00467, LINC00473, LINC00476, LINC00624, LINC00632, LINC00649, LINC00665, LINC00667, LINC00673, LINC00680-GUSBP4, LINC00886, LINC00893, LINC00963, LINC01000, LINC01029, LINC01033, LINC01128, LINC01184, LINC01278, LINC01515, LINC01881, LINC02328, LINCR-0002, LINGO 1, LLGL2, LMAN2L, LMBR1L, LMBRD2, LMCD1, LMO7, LMTK3, LOC100128885, LOC100132111, LOC100133315, LOC100233156, LOC100288637, LOC100505874, LOC100506844, LOC100507002, LOC100507291,
LOC100507412, LOC100507557, LOC101927021, LOC101927027, LOC101929066, LOC101929147, LOC102606465, LOC102723360, LOC102724219, LOC102724532, LOC102724593, LOC102724843, LOC102724951, LOC105369147, LOC105378853, LOC283683, LOC284581, LOC389831, LOC399815, LOC400927, LOC441601, LOC645166, LOC645513, LOC654342, LOC728613, LOC728730, LOC729218, L0NRF1, LPCAT3, LPCAT4, LPXN, LRP1, LRP5, LRP8, LRRC28, LRRC34, LRRC37B, LRRC40, LRRC45, LRRC4B, LRRC6, LRRC69, LRRC73, LRRFIP2, LRRK1, LRSAM1, LRTOMT, LSS, LTBP3, LUC7L, LUC7L3, LY75-CD302, LYPLA1, LYPLAL1, LYRM1, LYRM4-AS1, LYST, MACF1, MACROD1, MAFG, MAGI1, MAGI2, MAGI2-AS3, MAGI3, MAGOHB, MAK 16, MAMDC4, MAML3, MAN1C1, MAN2B2, MANBA, MANBAL, MAP2, MAP2K5, MAP2K6, MAP3K2, MAP3K20, MAP3K4, MAP3K5, MAP4, MAP4K1, MAP4K5, MAP7D1, MAPK10, MAPK1 1, MAPK12, MAPK7, MAPK8IP3, MAPT, MARK4, MAST1, MAST3, MAST4, MAT2B, MATK, MBNL3, MBOAT2, MBOAT7, MCCC1, MCCC2, MCF2L, MCM3AP-AS1, MCOLN1, MCOLN3, MCTP2, MDN1, MECR, MED11, MED16, MED20, MED23, MEF2B, MEGF6, MEGF8, MEIS1, MELTF, METAP1D, METTL15, METTL21A, METTL2A, MFF, MFSD10, MFSD11, MFSD14B, MFSD14C, MGA, MGEA5, MGP, MGST2, MIA-RAB4B, MIA3, MIATNB, MIB1, MIB2, MICAL1, MICAL3, MICALL1, MICALL2, MIDI, MIGA1, MINDY1, MINDY3, MINK1, MIR4435-2HG, MIR924HG, MIR99AHG, MITD1, MKI67, MKS1, MLH1, MLXIPL, MMAB, MMGT1, MMP24-AS 1 -EDEM2, MNAT1, MOCS1, MOSPD2, MOSPD3, MOVIO, MPDZ, MPHOSPH8, MPND, MPP2, MPPE1, MPV17, MR1, MRC1, MROH6, MRPL17, MRPL33, MRPL38, MRPL43, MRPL55, MRPS25, MRPS30-DT, MRPS31, MRRF, MS4A14, MS4A6A, MS4A7, MSI1, MSL1, MSTO2P, MT A3, MTCH2, MTCL1, MTERF2, MTERF3, MTFR1, MTG2, MTHFSD, MTM1, MTO1, MTOR, MTX2, MVB12B, MVK, MXD3, MYBL2, MYH10, MYH14, MYHAS, MYL6B, MYLK, MYLK-AS1, MYOIO, MYO18A, MYO19, MYOID, MYO1E, MYO5A, MYO5B, MYO5C, MYO9B, MYOM2, N4BP2L1, N6AMT1, NAA40, NAAA, NABP1, NADSYN1, NAE1, NAGA, NAP SA, NARFL, NARS2, NAVI, NAV2, NBEAL1, NBEAL2, NBPF1, NBPF10, NBPF15, NBPF25P, NBPF9, NCAM1, NCAPG, NCKAP5L, NCKIPSD, NCOA1, NCOA2, NCOA7, NCOR1, NCOR2, NCS1, NDFIP2, NDUFA12, NDUFA3, NDUFAF1, NDUFAF7, NDUFAF8, NDUFB6, NDUFS8, NDUFV2, NDUFV3, NECAB3, NEDD9, NEIL3, NEK1, NEK11, NENE,
NEXN, NFAT5, NFATC2, NFATC2IP, NFATC4, NFIC, NFKB1, NGDN, NHLRC3, NICN1, NIDI, NID2, NIF3L1, NIN, NINE, NIPBL, NIPSNAP1, NITI, NIT2, NLE1, NLGN2, NLK, NLRX1, NMNAT1, NMRK1, NMT1, N0L12, N0L3, NOP58, N0TCH1, NOTCH2NL, NOTCH3, N0VA1, N0X4, NPHP1, NPIPB5, NPL, NPR1, NPR2, NQO1, NQO2, NR1H3, NR2C1, NR2F1-AS1, NR4A1, NRCAM, NREP, NRN1, NRXN3, NSL1, NSMCE2, NSMCE4A, NSUN2, NT5C3A, NT5M, NTNG1, NTRK1, NUBPL, NUCB2, NUDT1, NUDT17, NUDT19, NUDT2, NUDT22, NUDT3, NUDT7, NUF2, NUFIP1, NUMA1, NUP210, NUP43, NUP50-AS1, NUP54, NUP58, NUP62CL, NUPL2, NXN, OARD1, OAZ1, OBSCN, OCA2, OGDHL, OGGI, OGT, OLA1, OLFM2, OLMALINC, OPHN1, OPN3, ORAI3, ORC5, 0RMDL2, OSBPL7, OSER1-AS1, OSGEPL1, OTUD5, OTUD6B, OTULIN, OXCT1, OXNAD1, P2RX4, P3H3, P3H4, P4HA1, PAAF1, PABPN1, PACS1, PACS2, PAFAH2, PAK1, PALM, PAM16, PAN2, PAQR8, PARG, PARP11, PARP15, PARP9, PARPBP, PARVB, PAX8-AS1, PAXX, PBDC1, PBX1, PCCA, PCCB, PCDH7, PCDH9, PCDHAC1, PCID2, PCK2, PCLO, PCM1, PCNT, PCNX3, PCSK7, PCYT2, PDCD6IPP2, PDE3A, PDE4B, PDE8A, PDF, PDGFRB, PDIA5, PDK1, PDLIM2, PDSS2, PDZD11, PDZD2, PDZD8, PEAK1, PEAR1, PELI3, PEX1 IB, PEX11G, PEX2, PEX3, PEX6, PFAS, PFDN1, PGAP1, PGF, PGM2, PGS1, PHACTR3, PHC1, PHC3, PHETA2, PHF12, PHF19, PHF21A, PHF3, PHF7, PHKB, PHKG2, PHLDB1, PHLDB2, PHYKPL, PI4K2A, PIBF1, PICK1, PIEZO 1, PIGA, PIGF, PIGH, PIGN, PIGU, PIK3C2A, PIK3R2, PIKFYVE, PIP4P1, PIR, PITPNA, PITPNM2, PIWIL4, PKD1P6-NPIPP1, PKNOX2, PLA2G7, PLAC8, PLAGL1, PLB1, PLBD2, PLCB3, PLCB4, PLCD4, PLEC, PLEKHA4, PLEKHA5, PLEKHA7, PLEKHA8, PLEKHB2, PLEKHG2, PLGRKT, PLOD2, PLPP5, PLPPR2, PLXNA4, PLXNB1, PLXNB2, PLXNC1, PLXND1, PMEL, PMM1, PMS2P4, PMS2P5, PNPLA8, POC1A, POLA2, POLG2, POLM, POLN, POLQ, POLR2D, POLR2J4, POLR3A, POLR3F, POLR3GL, POMT2, POP5, PORCN, POU2F1, POU6F1, PPARG, PPARGC1B, PPCDC, PPFIA4, PPIEL, PPIL2, PPM1M, PPOX, PPP1R12B, PPP1R35, PPP1R7, PPP1R8, PPP2R3C, PPP3R1, PPP4R3A, PPP4R4, PPP6R2, PQLC2, PRAF2, PRAG1, PRDM16, PRDM5, PRDM6, PRIMPOL, PRKAA2, PRKAG1, PRKAG2, PRKCA, PRKG1, PRKRA, PRMT3, PROCAI, PROS1, PRPF38B, PRPF40B, PRPF4B, PRPSAP1, PRR12, PRR13, PRR14L, PRR5L, PRRC2B, PRRC2C, PRRG4, PRRT4, PRSS16, PRTFDC1, PRTG, PSEN2, PSIP1, PSMA3-AS1, PSMD13, PSMD4, PSMG2, PSPH, PSTK,
PSTPIP2, PTBP3, PTGES3L, PTGIS, PTK2B, PTP4A3, PTPDC1, PTPN13, PTPN18, PTPN2, PTPN21, PTPRA, PTPRF, PTPRG-AS1, PTPRK, PTPRS, PTRH1, PURPL, PUS 10, PVT1, PXDN, PXMP2, PXN-AS1, PYROXD1, QKI, QPRT, QRSL1, QSOX2, R3HCC1L, R3HDM2, RAB28, RAB29, RAB36, RAB3GAP1, RAB40B, RAB40C, RAB4B, RAB9A, RABAC1, RABGAP1L, RABGGTB, RABL2A, RABL2B, RABL6, RAC3, RADI 8, RAD50, RAD51 API, RAD51B, RAD51C, RAD51D, RAD52, RADIL, RAI1, RAI14, RALGAPA2, RALGPS1, RANBP10, RANBP17, RAP1GAP2, RAPGEFL1, RARA, RASA1, RASGRF2, RASGRP1, RASSF1, RASSF2, RASSF8-AS1, RB1CC1, RBAK, RBAK-RBAKDN, RBBP6, RBBP7, RBL2, RBM15-AS1, RBM19, RBM20, RBM25, RBM26-AS1, RBM27, RBM38, RBM39, RBM5, RBMS2, RBPMS, RBX1, RC3H1, RCL1, RCOR2, RECK, RELB, RELL2, RERE, RETREG1, RETSAT, REV1, REV3L, REX1BD, REXO1, REXO5, RFC1, RFT1, RFX1, RFX2, RFX8, RGS19, RGS5, RHBDF2, RHOT1, RIF1, RILPL1, RIMS2, RIMS3, RIN3, RINT1, RIOK3, RIPK2, RIPOR1, RIPPL Y2, RLF, RMDN3, RMND1, RNF123, RNF135, RNF150, RNF152, RNF165, RNF166, RNF170, RNF175, RNF212, RNF213, RNF214, RNF215, RNF4, RNFT1, RNFT2, RNLS, RNPC3, ROBO1, ROCK2, ROGDI, RPGRIP1L, RPL18A, RPL36A- HNRNPH2, RPL39, RPL41, RPP25L, RPP40, RPS10, RPS27, RPS6KA6, RPS6KB1, RPS6KB2, RPUSD1, RPUSD3, RRBP1, RRH, RRNAD1, RSF1, RSG1, RSRC1, RSRP1, RSU1, RTEL1, RTEL1-TNFRSF6B, RUBCN, RUNX1T1, RWDD2B, RWDD4, RXFP1, SACS, SAMD11, SAMD12, SAMD3, SAMD4B, SAMD9, SAP25, SAPCD2, SARS2, SART1, SAT1, SATB1-AS1, SBF2-AS1, SCAF1, SCAPER, SCARB1, SCARB2, SCARF2, SCFD1, SCG3, SDCCAG3, SDHAF3, SDHAF4, SDHC, SDSL, SEC14L2, SEC24A, SEC31B, SEH1L, SELENBP1, SELENOH, SEMI, SEMA3A, SEMA3F, SEMA4A, SEMA4D, SENP3, SEPSECS, SEPT8, SERTAD3, SESTD1, SETD2, SETD4, SETX, SEZ6L2, SFI1, SFMBT1, SFTA3, SFXN2, SFXN4, SGIP1, SGK3, SGSM2, SH2B1, SH3BP1, SH3KBP1, SH3PXD2B, SHANK3, SHC2, SHF, SHISA4, SHOX2, SHPRH, SIGLEC7, SIM2, SIN3B, SINHCAF, SIPA1, SIPA1L3, SIVA1, SIX5, SKAP2, SLC15A4, SLC1A1, SLC1A3, SLC22A17, SLC22A18, SLC22A23, SLC22A4, SLC24A1, SLC25A14, SLC25A20, SLC25A21, SLC25A32, SLC25A40, SLC25A53, SLC26A10, SLC26A11, SLC27A5, SLC29A2, SLC29A3, SLC29A4, SLC2A11, SLC30A4, SLC33A1, SLC35A1, SLC35A3, SLC35B3, SLC35C2, SLC35D2, SLC35E2A, SLC35F2, SLC37A3, SLC38A3, SLC38A6, SLC38A7, SLC39A11,
SLC3A2, SLC43A1, SLC44A2, SLC47A1, SLC4A7, SLC5A6, SLC6A2, SLC6A9, SLC7A11, SLC7A8, SLC9A5, SLC9A8, SLC04A1, SLFN5, SLIT1, SLIT3, SLMAP, SLMO2-ATP5E, SLTM, SLX4, SMAD6, SMAD9, SMARCA4, SMARCAD1, SMARCAL1, SMARCC2, SMC3, SMC6, SMCHD1, SMG1P2, SMILR, SMIM19, SMIM20, SMIM7, SMIM8, SMUG1, SMYD3, SNAP23, SNAP25, SNAPC5, SNCAIP, SNHG11, SNHG12, SNHG20, SNHG21, SNHG4, SNHG8, SNRNP27, SNRNP48, SNRPG, SNX13, SNX17, SNX22, SNX24, SNX25, SNX27, S0CS4, S0GA1, SORBS1, SORBS2, SORBS3, SORL1, SP100, SPACA9, SPAG1, SPAG16, SPAG4, SPATA13, SPATA18, SPATA2L, SPATA5L1, SPATA6, SPATS2L, SPC25, SPDYC, SPEN, SPG11, SPG21, SPG7, SPICE1, SPIN1, SPIRE1, SPNS1, SPTAN1, SPTBN1, SPTBN2, SQSTM1, SRC, SRCIN1, SREBF1, SREBF2, SRGAP1, SRP14-AS1, SRP72, SRP9, SRPX, SRRM1, SRSF5, SSBP2, SSC5D, SSH1, SSX21P, ST20, ST5, ST6GAL1, ST6GALNAC4, ST7L, STAC, STAC3, STAMBP, STARD3NL, STARD4, STARD5, STARD7, STARD8, STAT2, STAT5B, STEAP3, STIM2, STIMATE, STK10, STK11IP, STK33, STK38L, STON1, STON1-GTF2A1L, STON2, STOX2, STRA6, STRIP2, STRN4, STX12, STX16, STX16- NPEPL1, STXBP3, STXBP5-AS1, SUCLG2, SUCLG2-AS1, SUDS3, SUFU, SULF1, SULF2, SUMF1, SUMO1, SUPT3H, SURF1, SUSD6, SVIL, SWT1, SYCP2L, SYNE1, SYNE2, SYNGR2, SYNJ2, SYT11, SZT2, TAB3, TAF15, TAF9B, TANC2, TANGO2, TAOK1, TAOK2, TARBP2, TARSL2, TASP1, TATDN3, TAZ, TBC1D16, TBC1D17, TBC1D19, TBC1D22A, TBC1D5, TBC1D7, TBC1D7-LOC100130357, TBC1D8B, TBC1D9B, TBCK, TBRG1, TBX1, TBX15, TCAF1, TCAIM, TCEA2, TCEAL3, TCF20, TCF7, TCF7L1, TCOF1, TCTEX1D2, TCTN3, TDG, TDP1, TECPR1, TEFM, TENM1, TENM4, TESK2, TET2, TEX10, TEX14, TEX15, TEX261, TEX264, TEX9, TFB1M, TFB2M, TFCP2, TFPI, TFRC, TGIF2, THAP6, THAP9-AS1, THBS3, THBS4, THEM6, THEMIS2, THOC2, THSD4, THSD7A, TIA1, TIGD6, TIMM23, TIMM23B, TKFC, TLL2, TLN1, TM2D3, TM9SF3, TM9SF4, TMBIM4, TMCC1, TMCO4, TMED3, TMEM106B, TMEM106C, TMEM107, TMEM110- MUSTN1, TMEM116, TMEM120A, TMEM131, TMEM138, TMEM141, TMEM143, TMEM144, TMEM145, TMEM14B, TMEM14C, TMEM161B, TMEM161B-AS1, TMEM164, TMEM167A, TMEM175, TMEM183B, TMEM187, TMEM192, TMEM198B, TMEM214, TMEM218, TMEM220, TMEM222, TMEM237, TMEM249, TMEM260, TMEM263, TMEM266, TMEM267, TMEM39A, TMEM41B, TMEM44, TMEM45A, TMEM50B,
TMEM62, TMEM63A, TMEM63B, TMEM65, TMEM67, TMEM68, TMEM87B, TMEM94, TMTC1, TMX2, TMX3, TNFRSF12A, TNFRSF19, TNFRSF6B, TNIK, TNIP2, TNK2, TNKS2, TNRC18, TNRC6B, TNS1, TOBI, TOLLIP, TOM1L1, TOM1L2, TOR2A, TP53I11, TP53I3, TP53TG1, TP73, TPCN1, TPCN2, TPM2, TPR, TPT1-AS1, TRABD2A, TRAF2,
TRAF3IP2, TRAF3IP2-AS1, TRAIP, TRAK2, TRAPPC12, TRAPPC13, TRAPPC4, TRERF1, TRIM 16, TRIM2, TRIM32, TRIO, TRIP 13, TRIP6, TRIQK, TRMT1, TRMT10A, TRMT11, TRMT61B, TRNAU1AP, TRPM2, TRPM4, TRPM7, TRPT1, TRRAP, TSEN15, TSEN2, TSFM, TSGA10, TSHZ2, TSNARE1, TSPAN13, TSPAN17, TSPAN31, TSPAN5, TSR3,
TSTD2, TSTD3, TTBK2, TTC12, TTC13, TTC17, TTC27, TTC28, TTC28-AS1, TTC3,
TTC37, TTC38, TTC39C, TTC5, TTLL3, TTLL5, TTP AL, TTYH2, TTYH3, TUBE1,
TUBGCP6, TUT1, TVP23C, TVP23C-CDRT4, TW1ST2, TXK, TXN, TXNDC11, TXNDC16,
TXNDC9, TXNIP, TXNL4B, TYMP, TYSND1, U2AF1L4, UACA, UBA2, UBA6, UBAC2,
UBE2G2, UBE2K, UBE2Z, UBFD1, UBIAD1, UBL7-AS1, UBOX5, UBR3, UBR4, UBXN8, UCP2, UFC1, UGGT2, UHRF1, UHRF1BP1L, UHRF2, ULK2, ULK4, ULK4P1, ULK4P2, UNCI 19, UNC50, UNC5B, UPF2, UPP1, UQCC2, UQCRH, URGCP-MRPS24, USE1, USO1, USP16, USP25, USP49, UTRN, UXT, VASH1, VAV2, VAV3, VCAN, VDAC2, VEGFA, VGF, VHL, VKORC1L1, VPS13C, VPS29, VPS50, VPS72, VPS8, VPS9D1-AS1, WASHC2A, WASHC2C, WASHC3, WASHC4, WDFY2, WDFY3-AS2, WDPCP, WDR11, WDR24, WDR25, WDR27, WDR35, WDR4, WDR48, WDR61, WDR62, WDR70, WDR81, WDSUB1, WDYHV1, WHAMMP2, WNK1, WNK.2, WNK4, WRN, WWC1, WWC3, WWOX, XIST, XPA, XPNPEP1, XPNPEP3, XRCC1, XRCC2, XRCC4, XYLB, YAF2, YARS2, YBEY, YDIC, YEATS2, YEATS4, YIF1A, YIPF1, YPEL3, YPEL5, YTHDC2, ZASP, ZBED6, ZBED8, ZBTB20, ZBTB21, ZBTB24, ZBTB25, ZBTB47, ZBTB48, ZC3H10, ZC3H13, ZC3H4, ZC3H7A, ZC3H8, ZCCHC10, ZCCHC6, ZCWPW1, ZDHHC14, ZDHHC16, ZDHHC17, ZDHHC18, ZDHHC21, ZEB1, ZFAND3, ZFC3H1, ZFP14, ZFP30, ZFP41, ZFP62, ZFPM1, ZFYVE16, ZFYVE27, ZHX3, ZIK1, ZKSCAN3, ZKSCAN7, ZMIZ2, ZMYND19, ZMYND8, ZNF112, ZNF121, ZNF124, ZNF133, ZNF142, ZNF202, ZNF213, ZNF227, ZNF236, ZNF239, ZNF250, ZNF252P, ZNF263, ZNF268, ZNF280D, ZNF283, ZNF292, ZNF316, ZNF320,
ZNF326, ZNF329, ZNF33B, ZNF354B, ZNF383, ZNF391, ZNF395, ZNF397, ZNF398,
ZNF407, ZNF415, ZNF416, ZNF419, ZNF420, ZNF429, ZNF43, ZNF431, ZNF433-AS1,
ZNF438, ZNF44, ZNF446, ZNF462, ZNF480, ZNF484, ZNF502, ZNF516, ZNF561-AS1, ZNF568, ZNF580, ZNF584, ZNF585A, ZNF585B, ZNF589, ZNF595, ZNF600, ZNF608, ZNF613, ZNF616, ZNF619, ZNF626, ZNF638, ZNF644, ZNF670-ZNF695, ZNF682, ZNF695, ZNF702P, ZNF707, ZNF718, ZNF720, ZNF721, ZNF737, ZNF76, ZNF761, ZNF765-ZNF761, ZNF766, ZNF772, ZNF773, ZNF775, ZNF778, ZNF782, ZNF789, ZNF790, ZNF790-AS1, ZNF813, ZNF816, ZNF821, ZNF837, ZNF85, ZNF853, ZNF862, ZNF90, ZNRF1, ZRANB3, ZSCAN5A, ZSCAN9, ZSWIM3, ZSWIM4, ZSWIM7, ZSWIM8, ZWILCH
[00534] The compounds of Table 17 induce a two fold change, or more, in gene expression (a Log2 fold change of 1.0 or above, or -1.0 or below) together with a change in Percent Spliced In (APSI) of 50% to 100%, or -50% to -100%, at a p value (pVal) of < 0.001 for the indicated genes.
[00535] Table 17
[00536] AAAS, AACS, AARS2, AASS, ABCA1 IP, ABCC4, ABCD3, ABCD4, ABHD12, ABHD6, ABLIM1, ACAA1, ACACA, ACAP3, ACCS, ACD, ACER3, ACSF3, ACSS2, ACTR1B, ACYP1, ADA, AD AL, ADAM22, ADAMTS6, ADAMTS9, AD API, ADCY7, ADGRB2, ADK, AFF3, AFMID, AG04, AGRN, AGTPBP1, AHI1, AHRR, AKAP13, AKAP6, AKAP9, AKIP1, ALDH1L2, ALDH4A1, ALG13, ALG9, ALKBH3, AMN1, AMOT, ANAPC10, ANK2, ANKMY2, ANKRD12, ANKRD36, ANKRD37, ANKZF1, ANLN, AP2A2, APOOL, ARFGAP2, ARHGAP31, ARHGEF10, ARHGEF12, ARHGEF39, ARMC4P1, ARMC9, ARMCX5, ARNTL2, ARSK, ASAP1, ASAP2, ATAD5, ATF7IP2, ATG16L2, ATG7, ATP5S, ATP6AP1L, ATP6V0A1, ATP6V0A2, ATP6V0D1, ATP9A, ATP9B, ATR, ATXN3, ATXN7L2, BABAM2, BAK1, BAZ2B, BBOX1-AS1, BBS4, BBX, BCAS4, BCL11A, BCL2L13, BCL9L, BDNF-AS, BEND6, BICD1, BICRAL, BIRC5, BIVM, BLM, BLZF1, BMS1P14, BOLA3, BPTF, BRCC3, BRPF1, BRSK2, BRWD3, BTBD9, BTD, C10orfl43, Cl lorf65, C12orf4, C15orf38-AP3S2, C15orf41, C19orf25, C19orf54, C19orf57, C1QTNF3- AMACR, C1QTNF6, C3orf67, C4orf33, C5, C8orf44-SGK3, CACNA2D1, CAMK4, CAMSAP1, CAMSAP3, CAPRIN2, CAPS2, CASD1, CBY1, CCAR1, CCDC125, CCDC14, CCDC171, CCDC18, CCDC188, CCDC191, CCDC25, CCDC40, CCDC57, CCDC82, CCDC88A, CCDC88C, CDC14A, CDC16, CDC25C, CDC42SE2, CDK11B, CDO1, CDYL, CEBPZOS, CELSR2, CELSR3, CENPE, CENPH, CENPI, CENPM, CEP112, CEP128,
CEP131, CEP164, CEP170, CEP192, CEP290, CEP295, CEP35O, CEP70, CEP83, CERCAM, CERS5, CFAP299, CFAP44, CHE) IL, CHD6, CHD9, CHEK2, CHFR, CHM, CIT, CKMT1A, CLCC1, CLEC5A, CLIP2, CLSPN, CLTCL1, CNIH3, CNNM1, CNOTIO, CNTNAP1, CNTRL, COL23A1, COL24A1, COL25A1, COP1, COQ3, COQ6, CPXM1, CREB3L4, CRELD1, CROCC, CRYBG3, CRYZ, CSRNP3, CUTC, CWF19L1, CXorf38, CYB5RL, CYP2U1, CZ1P-ASNS, DAAM1, DAPK1, DCAF17, DCP1B, DCST1-AS1, DDC, DDX11, DDX12P, DDX19B, DDX60, DEAF1, DECR2, DEF8, DENND3, DENND4B, DENND4C, DENND5A, DENND5B, DEPDC1B, DESI1, DGKA, DGKI, DGKZ, DHPS, DHRS12, DHRS4L2, DHX33, DICER1, DIMT1, DIP2A, DISP1, DLEU1, DLEU2, DLST, DMC1, DMXL1, DMXL2, DNA2, DNAJB12, DNAJC4, DNM3, DNMT3A, DNPEP, DOC2B, DOCK11, DOPEY1, DOT1L, DPY19L2, DPY19L3, DPYSL5, DSL, DTNB, DUSP11, DYM, DYNC2LI1, DZIP3, EBF4, ELN, ELP2, EMB, EMC2, EMC3-AS1, EMIDI, EML4, EML6, EMSY, ENDOV, EOGT, EP300, EPB41L1, EPB41L4A, EPG5, EPHX4, EPS8, ERC1, ERGIC1, ERLIN1, ERMARD, ETFDH, ETHE1, EXD2, EXD3, EXOC3, F8, FAM111 A, FAM114A2, FAM184A, FAM206A, FAM208A, FAM208B, FAM212B-AS1, FAM78B, FAM81A, FANCA, FANCE, FANCI, FANCL, FANK1, FAT1, FAT3, FBXO44, FBXO9, FBXW8, FER1L4, FGGY, FHOD3, FIG4, FOXRED1, FPGT-TNNI3K, FRAS1, FRG1HP, FRMD4A, FTX, FUK, FXR2, FYN, G2E3, GALNT6, GALT, GARNL3, GBA2, GCA, GDPD5, GEMIN2, GEN1, GFM2, GGT5, GINS1, GIT1, GLB1, GLS2, GMIP, GNAS-AS1, GNPTG, GOLGA2, GOLGA4, GOLT1B, GOSR2, GPR137, GPR155, GSAP, GTF2H2, GTF2I, GTF2IP1, GTF2IP20, GTF2IP4, GUSBP11, HACD1, HACL1, HEATR5B, HECTD4, HECW1, HEMK1, HERC2, HERC3, HERC6, HFM1, HIBADH, HIBCH, HIVEP1, HIVEP3, H0GA1, H00K3, HPS3, HSD17B14, HSD17B4, HSD17B7P2, HTD2, HTT, HYAL3, ICA1L, IDE, IFI27L1, IFT140, IFT172, IFT88, IKBKB, IL11RA, IL15, IL17RE, IMMP1L, IMMP2L, INO80C, INPPL1, INTU, IQCB1, IQCE, IQCG, IQCH, IQCH-AS1, IQCK, IQSEC1, IRAK2, ITGA10, ITGA3, ITPR1, ITSN1, JADE2, JMJD1C, JPX, KAT6B, KATNAL2, KCNG1, KCNQ1, KCNQ5, KCNT2, KDM4D, KIAA0319L, KIAA0556, KIAA0825, KIAA1841, KIDINS220, KIF13B, KIF24, KIF3A, KIF9, KITLG, KLHDC4, KLRG1, KLRG2, KMT2B, KMT5C, KNL1, KREMEN1, KYAT3, L3MBTL2, LAMA3, LARP1B, LAS1L, LCORL, LEPR, LETMD1, LGR5, LIG1, LIMCH1, LIN52, LINC00473, LINC00624, LINC01881, LINGO1,
LMBR1L, LM07, LOC100128885, LOC100133315, LOC100233156, LOC100288637, LOC100506844, LOC100507291, LOC100507557, LOC101927027, LOC102606465, LOC102724532, LOC102724593, LOC283683, LOC284581, LOC399815, LOC400927, LOC645166, LOC728730, LPCAT4, LRP1, LRP8, LRRC28, LRRC34, LRRC37B, LRRC40, LRRC6, LRRFIP2, LRSAM1, LRTOMT, LSS, LY75-CD302, LYPLAL1, LYST, MACF1, MAGI2, MAGI2-AS3, MAGI3, MAML3, MANBAL, MAP2, MAP2K5, MAP2K6, MAP3K20, MAP3K5, MAPK10, MAPK11, MAPK7, MAST4, MBOAT2, MCCC2, MCOLN1, MCOLN3, MCTP2, MDN1, MECR, MED23, MEGF8, MEIS1, MELTF, METTL21A, MFF, MFSD14B, MGA, MGEA5, MIA3, MIATNB, MICAL I , MICALL1, MIGA1, MINDY3, MINK1, MIR924HG, MIR99AHG, MITD1, MKI67, MKS1, MLH1, MM AB, MMP24-AS 1 -EDEM2, MNAT1, MOCS1, MOSPD2, MPDZ, MPND, MRC1, MROH6, MRPL43, MRPS30-DT, MRRF, MS4A7, MSI I , MTCH2, MTHFSD, MVBI 2B, MYBL2, MYH14, MYHAS, MYLK, MYO18A, MYO5A, MYO5B, MYO5C, MY0M2, NAA40, NARS2, NAV2, NBEAL1, NBEAL2, NBPF1, NBPF10, NBPF25P, NBPF9, NCOA1, NCOA2, NCOR2, NDUFB6, NECAB3, NEIL3, NEK1, NEK11, NFATC2, NFATC2IP, NFKB1, NHLRC3, NIPBL, NMNAT1, NOTCH1, NOTCH3, NOX4, NR2C1, NRCAM, NTRK1, NUBPL, NUDT17, NUDT22, NUP43, NUP54, NUP58, NUPL2, NXN, OARD1, OAZ1, OBSCN, OCA2, OGGI, OGT, OLFM2, OLMALINC, OPHN1, OSBPL7, OSGEPL1, OTUD5, OTULIN, OXCT1, OXNAD1, P2RX4, PAAF1, PARG, PARPBP, PARVB, PAXX, PCCB, PCDH9, PCID2, PCLO, PCM1, PCNT, PCNX3, PDCD6IPP2, PDE8A, PDIA5, PDLIM2, PDZD11, PEAK1, PEAR1, PELI3, PEX6, PFDN1, PGAP1, PGS1, PHF12, PHKG2, PHLDB1, PICK1, PIGN, PIK3C2A, PIKFYVE, PITPNA, PITPNM2, PKNOX2, PLAGL1, PLB1, PLBD2, PLCB4, PLEKHA4, PLEKHA5, PLEKHA7, PLEKHG2, PLPP5, PMS2P5, POC1A, POLA2, POLM, POLN, POLQ, POLR2J4, POLR3F, POLR3GL, POU2F1, PPCDC, PPIEL, PPIL2, PPM1M, PPP1R12B, PPP1R35, PPP2R3C, PPP4R4, PPP6R2, PRIMPOL, PRKAA2, PRKAG1, PRKAG2, PRKRA, PRMT3, PRPF40B, PRPF4B, PRR5L, PRRC2B, PRRC2C, PRRT4, PRSS16, PSEN2, PSTPIP2, PTBP3, PTGIS, PTPN13, PTPN18, PTPN2, PTPN21, PTPRA, PTPRG-AS1, PTPRK, PTPRS, PURPL, PVT1, PXDN, PYROXD1, R3HCC1L, R3HDM2, RAB28, RAB36, RAB3GAP1, RAB4B, RABGAP1L, RABL2B, RABL6, RAD18, RAD51AP1, RAD51B, RAD51C, RADIL, RALGPS1, RANBP17, RAP1GAP2, RARA, RASGRF2, RBBP6, RBM15-AS1, RBM20,
RBM26-AS1, RBM38, RBM5, RBPMS, RECK, RERE, RETREG1, REV1, REV3L, REX05, RFX8, RGS5, RHBDF2, RH0T1, RIF1, RIMS2, RINT1, RLF, RNF123, RNF165, RNF170, RNF212, RNF214, RNFT1, RNLS, ROBO1, ROGDI, RPGRIP1L, RPP40, RPUSD1, RRNAD1, RSRP1, RTEL1, RTEL1-TNFRSF6B, RUNX1T1, RWDD4, SAMD12, SAMD3, SATB1-AS1, SCAPER, SCARB1, SCFD1, SCG3, SDCCAG3, SDHAF3, SEC31B, SEMA3F, SEMA4A, SENP3, SETD2, SEZ6L2, SFI1, SFMBT1, SFXN2, SFXN4, SGIP1, SH2B1, SIM2, SLC22A23, SLC24A1, SLC25A14, SLC25A21, SLC25A32, SLC25A40, SLC25A53, SLC26A10, SLC29A4, SLC2A11, SLC33A1, SLC35A1, SLC35A3, SLC35B3, SLC35D2, SLC35F2, SLC37A3, SLC38A6, SLC38A7, SLC3A2, SLC43A1, SLC47A1, SLC4A7, SLC9A5, SLCO4A1, SLIT1, SLIT3, SLMAP, SMAD9, SMARCC2, SMCHD1, SMG1P2, SMILR, SMYD3, SNAPC5, SNCAIP, SNHG12, SNX24, SNX25, SORBS1, SORE1, SPAYA13, SPATA6, SPEN, SPG11, SPG7, SPICE1, SPTAN1, SRCIN1, SRP14-AS1, SRPX, SSBP2, SSH1, SSX2IP, ST6GAL1, ST6GALNAC4, ST7L, STAC, STARD5, STAT5B, STIM2, STK10, STK38L, STRIP2, STX16, STXBP3, SUCLG2-AS1, SULF1, SULF2, SUMF1, SUPT3H, SWT1, SYCP2L, SYNE2, TANGO2, TAOK1, TAOK2, TARSL2, TASP1, TBC1D17, TBC1D19, TBC1D22A, TBC1D5, TBCK, TBX15, TCF7L1, TDG, TDP1, TENM4, TESK2, TET2, TEX15, TEX9, TFB1M, TFCP2, THBS4, THOC2, THSD7A, TIA1, TIMM23, TIMM23B, TKFC, TLL2, TM2D3, TM9SF4, TMCC1, TMCO4, TMEM106C, TMEM116, TMEM120A, TMEM144, TMEM161B, TMEM161B-AS1, TMEM214, TMEM218, TMEM220, TMEM222, TMEM237, TMEM260, TMEM39A, TMEM41B, TMEM45A, TMEM62, TMEM63B, TMEM65, TMEM67, TMEM94, TMTC1, TMX2, TMX3, TNFRSF12A, TNKS2, TOM1L1, TOM1L2, TPT1-AS1, TRABD2A, TRAIP, TRAK2, TRAPPC13, TRIM16, TRMT1, TRMT10A, TRMT11, TRMT61B, TRPM2, TRPM4, TRPT1, TRRAP, TSFM, TSGA10, TSNARE1, TSPAN5, TTBK2, TTC12, TTC13, TTC28-AS1, TTC3, TTC39C, TTYH2, TTYH3, TXNDC11, TXNDC16, UBA2, UBA6, UBAC2, UBR4, UGGT2, ULK4, UNC50, UPF2, USP16, USP25, UTRN, VAV2, VAV3, VDAC2, VEGFA, VPS13C, VPS29, VPS8, VPS9D1- AS1, WASHC2A, WASHC2C, WDFY2, WDPCP, WDR11, WDR27, WDR4, WDR48, WDR62, WDR70, WDSUB1, WNK1, WRN, WWC1, WWOX, XRCC2, XYLB, YAF2, YEATS2, YEATS4, YIPF1, YPEL3, ZBED6, ZBTB20, ZBTB25, ZBTB48, ZC3H10, ZC3H7A, ZCWPW1, ZDHHC14, ZDHHC16, ZDHHC21, ZFAND3, ZFP30, ZFYVE27, ZKSCAN3,
ZMIZ2, ZMYND19, ZMYND8, ZNF112, ZNF124, ZNF133, ZNF202, ZNF213, ZNF250, ZNF252P, ZNF263, ZNF280D, ZNF283, ZNF292, ZNF320, ZNF416, ZNF419, ZNF431, ZNF438, ZNF44, ZNF480, ZNF484, ZNF580, ZNF608, ZNF626, ZNF638, ZNF695, ZNF707, ZNF718, ZNF721, ZNF816, ZNF85, ZNF90, ZSCAN5A, ZSWIM4, ZSWIM7, ZSWIM8, ZWILCH
[00537] Results for particular test compounds are further set forth below.
Compound 18
[005381 Table 18 provides further detail of results (Cpd = Compound, Gene = Gene, Cone = Concentration, L2FC = log2 fold change) for genes exhibiting a two fold change, or more, in gene expression (a Log2 fold change of 1.0 or above, or -1.0 or below) together with a change in Percent Spliced In (APSI) of 50% to 100%, or -50% to -100%, at a p value (pVal) of < 0.001 in the presence of Compound 18.
[00539] The cell lines tested included Familial Dysautonomia patient fibroblasts (FDPF), HEK293, stimulated PBMC (sPBMC), differentiated SY5Y (diffSY5Y), SHSY5Y, M0LM13 and HT1080.
Inclusion Results (Compound 18)
[00541] RNAseq experiments showed that Compound 18 induced exon inclusion with a PSI change (APSI) of +50% to +100% and P-value <0.001 in 158 genes as shown in Table 19:
[00542] Table 19
[00543] RNAseq experiments showed that Compound 18 induced exon inclusion with a PSI change (APSI) of +50% to +100% and P-value <0.001 in genes having a 5' splice site as shown in Table 20 (215 entries):
[00545] RNAseq experiments showed that Compound 18 induced exon inclusion associated with nonsense mediated decay with a PSI change (APSI) of +50% to +100% and P- value <0.001with a PSI change (APSI) of +50% to +100% and P-value <0.001in 24 genes as shown in Table 21:
[00547] RNAseq experiments showed that Compound 18 induced exon inclusion associated with nonsense mediated decay with a PSI change (APSI) of +50% to +100% and P- value <0.001 with a PSI change (APSI) of +50% to +100% and P-value <0.001 in genes having a 5' splice site as shown in Table 22 (23 entries):
Skipping Results (Compound 18)
[00549] RNAseq experiments showed that Compound 18 induced exon skipping with a PSI change (APSI) of -50% to -100% and P-value <0.001 in 661 genes as shown in Table 23:
[00550] Table 23
C0Q6, CPNE5, CRNDE, CRYBG3, CRYL1, CRYZ, CTIF, CTSF, CYB561D2, CYP39A1, DBF4, DCAF11, DENND2C, DENND3, DENND5A, DGKA, DHRS12, DIAPH2, DIMT1, DIP2A, DISP1, DLGAP4-AS1, DLST, DMC1, DMD, DMXL1, DMXL2, DNA2, DNAAF4, DNAAF4-CCPG1, DNAH14, DNAJB12, DNM1L, D0PEY1, DPY19L2, DRAM2, DTNB, DUSP11, DUSP22, DUXAP10, DYNC1LI2, DYSF, DZIP3, EBF1, EIF4E2, EMB, EMC3-AS1, EMIDI, EML4, ENOXI, EPB41L4A, EPG5, EPS8, ERMAP, ERMARD, ERO1A, EXD3, EXOC3, F8, FAM111A, FAM172A, FAM184A, FAM207A, FAM208A, FAM3C, FANCI, FANCL, FANK1, FBRSL1, FBXL13, FBXO22, FER1L4, FGGY, FIG4, FOXRED1, FRMD4A, FSTL5, FUBP1, FUK, FUT10, FZD3, GAB2, GARNL3, GAS2L3, GGT5, GINS1, GLMN, GMDS-AS1, GMIP, GOLT IB, GRIN2D, GRK3, GRK4, GSAP, GTF2I, GTF2IP1, GUF1, GUSBP1 , GUSBP1 1 , GVQW2, HAGHL, HERC1 , HERC3, HERPUD2, HFM1 , HGSNAT, HIVEP1, HIVEP3, HMGN5, HSD17B7P2, HTD2, ICA1L, IFI27L1, IFT122, IL15, IL17RB, IL4R, IMMP2L, ING4, INMT-MINDY4, INO80C, INPP5F, INTU, IQCE, IQCH-AS1, IQCK, IQSEC1, ITGA3, ITGAM, JAK3, JMJD1C, JPX, KANSL1L, KATNBL1, KCNQ1, KCNQ5, KCNT2, KCTD9, KDM4D, KIAA0100, KIAA0319L, KIAA0556, KIAA1468, KIAA1841, K1F27, K1F3A, KIF9, KLRD1, KMT5C, LAMA3, LAMP5, LDLRAD4, LGALS9, LGR4, LGR5, LIN52, LINC00240, LINC00265, LINC00337, LINC00630, LINC01088, LINC01169, LINC01237, LINC01250, LINC01358, LINC01572, LINC01881, LIPE-AS1, LMBR1, LOC100133091, LOC100233156, LOC100287944, LOC100288637, LOC100506207, LOC100506990, LOC101927043, LOC101929140, LOC101929709, LOC107984974, LOC283683, LOC389906, LOC400927, LOC400927-CSNK1E, LOC653080, LPP, LRIG3, LRMDA, LRP1, LRRC28, LRRC34, LRRC37A2, LRRC37B, LRRC58, LSM12, LYPLAL1, MAP2, MAP2K4, MAP2K6, MAP3K5, MAP4K3, MAPK10, MAPK11, MARCH1, MARCH6, MAST4, MBD5, MBOAT2, MCTP1, MCTP2, MEMO1, METTL8, MFF, MFSD12, MGAT5, MIA3, MIATNB, MICB, MINDY4, MIPEPP3, MIR1268A, MIR548N, MIR570HG, MITF, MKS1, MLC1, MLF1, MLH1, MOCS1, MOSPD1, MOSPD2, MRC1, MROH1, MRPS30-DT, MS4A3, MS4A7, MSC-AS1, MTCH2, MTMR6, MYBL1, MYO18A, MYSM1, NAALAD2, NARS2, NAXD, NBEAL1, NBN, NBPF1, NBPF10, NBPF11, NBPF12, NBPF19, NBPF20, NBPF25P, NBPF9, NDRG3, NDUFB6, NEK1, NEK10, NFATC2IP, NFIX, N0M02, NOTCH1, NPIPA1, NPRL3, NRCAM, NRDC, NSF, NSFP1, NTRK1, NUB1, NUP54, NUPL2, NUTM2B-AS1, ODAM, OGT, OLFM2, 0MA1, OPHN1, OSBP2, OSTF1, OXNAD1, P4HA2, PACRGL, PANK4, PAPOLA, PARG, PARP2, PARPBP, PCBP3, PCDH9, PCID2, PCSK6, PDCD6IPP2, PDIA5, PDLIM2, PDLIM4, PEAR1, PEX6, PFDN1, PGAP1, PHKG2, PIC ALM, PICK1, PIK3C2A, PITPNM2, PKD1, PKIB, PKNOX2, PLA2G12A, PLA2G4B, PLBD2, PLCG2, PLD1, PLEKHA7, PMS2P1, POLR2J3, POU2F1, PPCDC, PPIEL, PPIL2, PPM1M, PPP1R21, PPP2R3C, PPP4C, PRELID3A, PRH1, PRH1-PRR4, PRH1-TAS2R14, PRIMPOL, PRKAA2, PRKAG1, PRKRA, PROK2, PRPF40B, PRR16, PRR5L, PRSS16, PSME4, PTER, PTK2, PTPN13, PTPN18, PTPN21, PTPN4, PTPRD, PTPRE, PVT1, PXDN, RAB3GAP1, RAB3IP, RABGEF1, RAC1, RACGAP1, RALGPS1, RARA, RASGRF2, RBFOX2, RBM15- AS1, RBM20, RBM5, RFX3, RGL1, RGS12, RICTOR, RNFT1, RPAIN, RPH3AL, RPSAP58, RRN3P3, RTEL1, RTEL1-TNFRSF6B, RWDD4, SAMD12, SBF2, SCAI, SCML2, SEMA4A, SEMA4F, SENP2, SENP3, SENP3-EIF4A1, SEPT7, SFT2D2, SFXN4, SGIP1, SH3D19, SIM2, SIPA1L1, SLC22A15, SLC25A12, SLC25A17, SLC25A19, SLC25A21, SLC25A40, SLC25A43, SLC26A10, SLC29A4, SLC35A1, SLC35E2B, SLC38A6, SLC43A1, SLC47A1, SLC4A7, SLC9A5, SLC9B2, SMA4, SMAD5, SMARCD1, SMG1P3, SMURF2, SNHG14,
[00551] RNAseq experiments showed that Compound 18 induced exon skipping with a
PSI change (APSI) of -50% to -100% and P-value <0.001 in genes having a 5' splice site as shown in Table 24 (641 entries):
[00552] Table 24
AGAAgtaagt, AGAAgtgagt, AGACgtaagt, AGACgtatgt, AGAGgtaact, AGAGgtaagc, AGAGgtaagg, AGAGgtaagt, AGAGgtacaa, AGAGgtacca, AGAGgtaggg, AGAGgtattt, AGAGgtgaga, AGAGgtgagg, AGAGgtgagt, AGAGgtgggc, AGAGgtgtgt, AGATgtaaat, AGATgtaagc, AGATgtaagt, AGATgtgagt, AGCCgtgtgt, AGCGgtgagt, AGCTgtaagt, AGCTgtgagt, AGGGgtgagt, AGTCgtgagt, AGTGgtgagc, AGTGgtgagg, AGTGgtgagt, AGTTgtaagt, AGTTgtgagt, ATAAgtaagc, ATAGgtaaga, ATAGgtaagt, ATAGgtacat, ATAGgtatgt, ATAGgtgagg, ATATgtaagt, ATATgtatcc, ATATgtgagt, ATCCgtaagt, ATCCgtgagt, ATCGgtaaat, ATCGgtatgt, ATCGgtgagt, ATCTgtaaga, ATCTgtaagt, ATCTgtgaga, ATCTgtgagt, ATCTgtggtg, ATGAgtaagt, ATGAgtatgt, ATGAgtgagt, ATGGgtaagg, ATGGgtaagt, ATGGgtaatg, ATGGgtgagg, ATGTgtaagt, ATGTgtgagt, ATTAgtaagt, ATTGgcacgt, ATTGgtaaaa, ATTGgtaagt, ATTGgtagtt, ATTGgtatgt, ATTGgtgtga, ATTTgtaagt, ATTTgtgagt, CAAAgtaagc, CAAAgtaggt, CAAAgtgagt, CAACgtaagt, CAAGgcaggt, CAAGgtaaaa, CAAGgtaaac, CAAGgtaaat, CAAGgtaacc, CAAGgtaatg, CAAGgtacct, CAAGgtactg, CAAGgtagga, CAAGgtatgc, CAAGgtatgt, CAAGgtattt, CAAGgtgacc, CAAGgtgact, CAAGgtgaga, CAAGgtgagt, CAAGgtgcat, CAAGgtgggt, CAAGgttggt, CAATgtaagt, CACAgtaagt, CACAgtgagt, CACCgtgagt, CACCgtgcgt, CACGgtaggc, CACGgtgagg, CACTgtaagt, CACTgtgagt, CAGAgtaagt, CAGCgtaagt, CAGGgtaacg, CAGGgtaagt, CAGGgtaatt, CAGGgtatgt, CAGGgtcagc, CAGGgtgggc, CAGTgtaagc, CATCgtgagt, CATGgtaagc, CATGgtaagt, CATGgtatgg, CATGgtatgt, CATGgtgagc, CATGgtgagg, CATGgtgagt, CATTagtgag, CATTgtaagt, CATTgtgagt, CCACgtaagt, CCACgtgagg, CCACgtgagt, CCAGgccagt, CCAGgtaaca, CCAGgtaagc, CCAGgtaagg, CCAGgtaagt, CCAGgtacat, CCAGgtaccc, CCAGgtagcc, CCAGgtaggt, CCAGgtatag, CCAGgtatct, CCAGgtatgt, CCAGgtcagc, CCAGgtctga, CCAGgtctgg, CCAGgtgaga, CCAGgtgagc, CCAGgtgagt, CCAGgtgggc, CCAGgtgggt, CCATgtaagt, CCATgtacgc, CCATgtatgt, CCATgtgagt, CCCAgtaagt, CCCAgtgagt, CCCCgtaagt, CCCCgtgagt, CCCGgtaggt, CCCGgtgcgt, CCCTgtaagt, CCCTgtgagt, CCCTttgtcc, CCGGgtatgg, CCGGgtgaga, CCGTgtaagt, CCTCgtgagt, CCTGgcaagt, CCTGgtaagt, CCTGgtatgt, CCTGgtgagg, CCTGgtgagt, CCTGgtgcga, CCTGgtgcgt, CCTTgtaagt, CCTTgtgagt, CGACgtgagt, CGAGgtaagg, CGAGgtacgt, CGAGgtatgc, CGAGgtatgt, CGAGgtgaga, CGAGgtgagg, CGAGgtgagt, CGCAgtgagc, CGCAgtgagt, CGCCgtgagt, CGCGgtgagt, CGCGgtgggt, CGCTgtaagc, CGCTgtgagt, CGGGgtgagc, CGTGgtaagt, CGTGgtgagc, CGTGgtgagt, CTAAgtgagt, CTACgtgagt, CTAGgtaagt, CTAGgtaata, CTAGgtatgg, CTAGgtgaga, CTATgcaagt, CTATgtaact, CTATgtaaga, CTATgtaagt, CTATgtgagt, CTCAgtaagt, CTCAgtgagt, CTCCgtgagt, CTCGgtaagt, CTCGgtatg, CTCTgtaaga, CTCTgtaagt, CTCTgtgagt, CTGAgtaagt, CTGAgtgagt, CTGCgtgagt, CTGGgtaagt, CTGGgtaggc, CTGGgtgagg, CTGGgtgagt, CTGTgtgagt, CTTCgtaagt, CTTGgtaaga, CTTGgtaagc, CTTGgtaagg, CTTTgtaagt, CTTTgtgagt, GAAAgtaagt, GAACgtgagt, GAACgtgtga, GAAGgtaaga, GAAGgtaagt, GAAGgtaatt, GAAGgtagct, GAAGgtagga, GAAGgtatgt, GAAGgtgaag, GAAGgtgaga, GAAGgtgagc, GAAGgtgagt, GAAGgtgata, GAAGgtgatg, GAAGgtgcag, GAAGgtgggc, GAAGgtggta, GAATgtaagt, GAATgtgagt, GACAgtaggt, GACAgtgagt, GACCgtaagt, GACCgtatgt, GACCgtgagt, GACGgtagga, GACGgtatgg, GACGgtgagc, GACGgtgggt, GACTgtaagt, GACTgtgagt, GAGAgtaaga, GAGAgtaagt, GAGAgtgagt, GAGCgtaagt, GAGGgtaatg, GAGGgtgaga, GAGGgtgagt, GAGTgtgagt, GATAgtaagt, GATAgtgagt, GATCgtaagt, GATGgtaaga, GATGgtgaga, GATGgttagt, GATTgtaagt, GCAAgtaggt, GCAAgtatgc, GCAAgtatgg, GCACgtaagt,
Skipping and NMD Results (Compound 18)
[00553] RNAseq experiments showed that Compound 18 induced exon skipping associated with nonsense mediated decay with a PSI change (APSI) of -50% to -100% and P- value <0.001 in 267 genes:
[00554] Table 25
[00555] RNAseq experiments showed that Compound 18 induced exon skipping associated with nonsense mediated decay with a PST change (APSI) of -50% to -100% and P- value <0.001 in genes having a 5' splice site as follows (234 entries):
Gene Expression Results (Compound 18)
[00557] RNAseq experiments showed that Compound 18 modulated expression of various genes by a factor of 2 or more. The following table identifies genes from Table 5 which resulted in a log 2 fold change (L2FC) of 1 or above (increased expression), or -1 or below (decreased expression), upon treatment with Compound 18:
[00558] Table 27
(AARS2, -1.6, M0LM13, 1.2 μM), (AARS2, -1.1, stimulated PBMC, 1.2 gM), (AARS2, -1.2, HEK293, 5 μM), (AARS2, -1, SHSY5Y, 5 μM), (AASS, 1, stimulated PBMC, 0.6 μM), (AASS,
1.2, stimulated PBMC, 1.2 gM), (ABCD3, -1.6, SHSY5Y, 5 μM), (ABHD12, -1.4, HEK293, 5 μM), (ABHD12, -1, SHSY5Y, 5 μM), (ABHD12, -1.4, diffSY5Y, 5 μM), (ACAA1, -1.2, HEK293, 0.6 μM), (ACAA1, -1.5, MOLM13, 0.6 μM), (ACAA1, -1.6, stimulated PBMC, 0.6 |1M), (ACAA1, -1.1, HEK293, 1.2 μM), (ACAA1, -1.5, MOLM13, 1.2 μM), (ACAA1, -1.6, stimulated PBMC, 1.2 μM), (ACAA1, -1.2, HEK293, 5 gM), (ACAA1, -1.2, SHSY5Y, 5 μM), (ACACA, -1.2, stimulated PBMC, 1.2 μM), (ADA, -1.6, MOLM13, 0.6 μM), (ADA, -1.5, stimulated PBMC, 0.6 μM), (ADA, -1.7, MOLM13, 1.2 μM), (ADA, -1.6, stimulated PBMC, 1.2 μM), (ADA, -1.1, SHSY5Y, 5 μM), (ADAL, -1.2, stimulated PBMC, 0.6 μM), (ADAL, -1.3, stimulated PBMC, 1.2 μM), (ADAM22, -1.1,HEK293, 0.6μM) , (ADAM22, -2.1, stimulated PBMC, 0.6 μM), (ADAM22, -1.1, HEK293, 1.2 gM), (ADAM22, -2.6, stimulated PBMC, 1.2 gM), (ADAM22, -1.5, HEK293, 5 μM), (AHI1, -1.3, stimulated PBMC, 0.6 μM), (AHI1, -1.1, stimulated PBMC, 1.2 μM), (AKIP1, -1, stimulated PBMC, 0.6 μM), (AKIP1, -1.1, HEK293, 5 |1M), (ALDH1L2, -2.6, HEK293, 0.6 μM), (ALDH1L2, -2.5, MOLM13, 0.6 μM), (ALDH1L2, - 2, stimulated PBMC, 0.6 gM), (ALDH1L2, -2.5, HEK293, 1.2 μM), (ALDH1L2, -2.5, MOLM13, 1.2μM) , (ALDH1L2, -3.3, HEK293, 5 μM), (ALDH1L2, -2.9, SHSY5Y, 5 μM), (ALDH4A1, -1, HEK293, 0.6 μM), (ALDH4A1, -1.4, MOLM13, 0.6μM) , (ALDH4A1, -1.3, stimulated PBMC, 0.6 μM), (ALDH4A1, -1.6, MOLM13, 1.2 μM), (ALDH4A1, -1, stimulated PBMC, 1.2 μM), (ALDH4A1, -1.5, HEK293, 5 μM), (ALG13, -1, HEK293, 1.2 μM), (ALKBH3, -1.1, MOLM13, 0.6μM) , (ALKBH3, -1, MOLM13, 1.2μM) , (AMN1, -1.1, MOLM13, 0.6μM) , (ANKMY2, -1.2, HEK293, 0.6 μM), (ANKMY2, -1.1, stimulated PBMC, 0.6 μM), (ANKMY2, -1.1, stimulated PBMC, 1.2 μM), (ANLN, -1, HEK293, 0.6 μM), (ANLN, -1.4, MOLM13, 0.6 μM), (ANLN, -1.3, stimulated PBMC, 0.6 μM), (ANLN, -1.2, HEK293, 1.2 |1M), (ANLN, -1.3, MOLM13, 1.2 μM), (ANLN, -1.3, stimulated PBMC, 1.2 gM), (ANLN, -2, SHSY5Y, 5 μM), (AP2A2, -1.2, HEK293, 0.6 μM), (AP2A2, -1.6, stimulated PBMC, 0.6 gM), (AP2A2, -1.3, HEK293, 1.2 μM), (AP2A2, -1, MOLM13, 1.2 μM), (AP2A2, -1.6, stimulated PBMC, 1.2 μM), (ARFGAP2, -1.1, HEK293, 0.6μM) , (ARFGAP2, -1.4, MOLM13, 0.6μM) , (ARFGAP2, -1.1, stimulated PBMC, 0.6 μM), (ARFGAP2, -1.4, MOLM13, 1.2 μM), (ARFGAP2, -1.1, stimulated PBMC, 1.2 μM), (ARFGAP2, -1.5, HEK293, 5 μM), (ARFGAP2, -
1.3, SHSY5Y, 5 μM), (ARHGEF10, -1.5, MOLM13, 0.6 μM), (ARHGEF10, -1.3, MOLM13, 1.2 μM), (ARMC4P1, 3.7, HEK293, 5 μM), (ARMC4P1, 4.6, SHSY5Y, 5 μM), (ARMCX5, 1, SHSY5Y, 5 gM), (ASAP2, -1.3, HEK293, 0.6 gM), (ASAP2, -1.5, stimulated PBMC, 0.6 gM), (ASAP2, -1.5, HEK293, 1.2 μM), (ASAP2, -1.4, stimulated PBMC, 1.2 μM), (ASAP2, -1, HEK293, 5 μM), (ASAP2, -1.4, SHSY5Y, 5μM) , (ATG16L2, -1.1, MOLM13, 0.6μM) , (ATG16L2, -1.2, stimulated PBMC, 0.6 μM), (ATG16L2, -1.1, stimulated PBMC, 1.2 μM), (ATG7, -1.7, HEK293, 0.6μM) , (ATG7, -1.8, MOLM13, 0.6 μM), (ATG7, -19, stimulated PBMC, 0.6μM) , (ATG7, -1.7, HEK293, 1.2μM) , (ATG7, -1.9, MOLM13, 1.2 gM), (ATG7, -2, stimulated PBMC, 1.2 μM), (ATG7, -1.4, HEK293, 5 gM), (ATG7, -1.6, SHSY5Y, 5 μM), (ATP5S, -1.4, HEK293, 0.6 μM), (ATP5S, -1.5, MOLM13, 0.6 μM), (ATP5S, -2.1, stimulated PBMC, 0.6 μM), (ATP5S, -1.4, HEK293, 1.2 μM), (ATP5S, -1.6, MOLM13, 1.2 μM), (ATP5S, -1.6, stimulated PBMC, 1.2 μM), (ATP5S, -2, HEK293, 5 μM), (ATP5S, -1.9, SHSY5Y, 5 μM), (ATP6V0A2, -1.3, HEK293, 0.6 μM), (ATP6V0A2, -1.3, MOLM13, 0.6 μM), (ATP6V0A2, - 1.6, stimulated PBMC, 0.6 gM), (ATP6V0A2, -1.3, HEK293, 1.2 μM), (ATP6V0A2, -1.2, MOLM13, 1.2 μM), (ATP6V0A2, -1.6, stimulated PBMC, 1.2 μM), (ATP6V0A2, -2, HEK293,
5 μM), (ATP9A, -1.9, HEK293, 0.6 ^M), (ATP9A, -2, HEK293, 1.2 ^M), (ATP9A, -1.8, HEK293, 5μM) , (ATP9A, -1.8, SHSY5Y, 5 μM), (ATP9A, -1.7, diffSY5Y, 5μM), (BABAM2, -1.2, HEK293, 0.6 μM), (BABAM2, -1.5, MOLM13, 0.6 μM), (BABAM2, -1.7, stimulated PBMC, 0.6 μM), (BABAM2, -1.5, HEK293, 1.2 μM), (BABAM2, -1.6, MOLM13, 1.2 μM), (BABAM2, -1.8, stimulated PBMC, 1.2 μM), (BABAM2, -1.6, HEK293, 5 μM), (BABAM2, -
1.8, SHSY5Y, 5 μM), (BABAM2, -1.7, diffSY5Y, 5 μM), (BBS4, -1.9, HEK293, 0.6 μM), (BBS4, -2.3, MOLM13, 0.6μM) , (BBS4, -2.3, stimulated PBMC, 0.6 gM), (BBS4, -2, HEK293, 1.2 μM), (BBS4, -2.2, MOLM13, 1.2 gM), (BBS4, -2.1, stimulated PBMC, 1.2 μM), (BBS4, - 2.7, HEK293, 5 gM), (BBS4, -2.2, SHSY5Y, 5μM) , (BBS4, -2, diffSY5Y, 5 gM), (BCL2L13, -
1, HEK293, 0.6 gM), (BCL2L13, -1, HEK293, 1.2 μM), (BCL2L13, -1.2, HEK293, 5 μM), (BDNF-AS, -3.9, HEK293, 0.6μM) , (BDNF-AS, -5.2, MOLM13, 0.6 μM), (BDNF-AS, -3, stimulated PBMC, 0.6 μM), (BDNF-AS, -5.6, HEK293, 1.2 μM), (BDNF-AS, -2.6, stimulated PBMC, 1.2 μM), (BLZF1, -1.3, HEK293, 0.6 μM), (BLZF1, -1.3, HEK293, 1.2 μM), (BLZF1, - 1.2, HEK293, 5 gM), (BRSK2, -1, SHSY5Y, 5μM) , (C10orfl43, -2.7, HEK293, 0.6μM) , (C10orfl43, -5, MOLM13, 0.6 μM), (C10orfl43, -2.6, stimulated PBMC, 0.6 μM), (C10orfl43, -2.6, HEK293, 1.2 μM), (C10orfl43, -3.5, MOLM13, 1.2 μM), (C10orfl43, -2.1, stimulated PBMC, 1.2 μM), (C10orfl43, -4.3, HEK293, 5 μM), (Cllorf65, -2, HEK293, 0.6 μM), (C15orf38-AP3S2, -1.2, MOLM13, 0.6 gM), (C15orf38-AP3S2, -1.2, MOLM13, 1.2 μM), (C4orf33, -1, HEK293, 1.2μM) , (CACNA2D1, -1.2, HEK293, 0.6μM) , (CACNA2D1, -1.6, HEK293, 1.2 μM), (CACNA2D1, -1.5, HEK293, 5 μM), (CACNA2D1, -1.3, SHSY5Y, 5 μM), (CACNA2D1, -1.6, diffSY5Y, 5μM) , (CAPS2, -1.3, HEK293, 1.2μM) , (CAPS2, -1.7, HEK293, 5 μM), (CAPS2, -1.8, SHSY5Y, 5 μM), (CCDC18, -1.2, SHSY5Y, 5 μM), (CCDC188, -1.5, SHSY5Y, 5 μM), (CCDC25, -1.1, HEK293, 0.6 μM), (CCDC25, -1.2, MOLM13, 0.6 μM), (CCDC25, -1.1, MOLM13, 1.2 μM), (CCDC25, -1, HEK293, 5 gM), (CDC16, -1.2, stimulated PBMC, 0.6 μM), (CDC16, -1.2, stimulated PBMC, 1.2 μM), (CDC25C, -1.1, HEK293, 5 μM), (CDYL, -1.3, MOLM13, 0.6 gM), (CDYL, -1.5, stimulated PBMC, 0.6 μM), (CDYL, -1.4, MOLM13, 1.2 μM), (CDYL, -1.4, stimulated PBMC, 1.2 μM), (CDYL, -1.2, SHSY5Y, 5 μM), (CEBPZOS, -1, stimulated PBMC, 1.2 μM), (CENPH, -1.6, HEK293, 0.6 μM), (CENPH, -1.3, M0LM13, 0.6 μM), (CENPH, -1.3, stimulated PBMC, 0.6 |1M), (CENPH, -1.7, HEK293, 1.2 μM), (CENPH, -1.3, M0LM13, 1.2 μM), (CENPH, -1.2, stimulated PBMC, 1.2 μM), (CENPH, -1.1, HEK293, 5 gM), (CENPH, -2, SHSY5Y, 5 μM), (CENPH, -2.3, diffSY5Y, 5 μM), (CENPI, -1.7, HEK293, 0.6 μM), (CENPI, -2.2, M0LM13, 0.6 nM), (CENPI, -2.5, stimulated PBMC, 0.6 μM), (CENPI, -1.7, HEK293, 1.2 μM), (CENPI, -
2, M0LM13, 1.2 μM), (CENPI, -2.3, stimulated PBMC, 1.2 μM), (CENPI, -2.1, HEK293, 5 |1M), (CENPI, -1.7, SHSY5Y, 5 gM), (CEP70, 1, stimulated PBMC, 1.2 μM), (CEP83, -1.1, HEK293, 0.6 μM), (CEP83, -1.5, stimulated PBMC, 0.6 μM), (CEP83, -1.1, stimulated PBMC, 1.2 μM), (CHD1L, -1.3, HEK293, 0.6 μM), (CHD1L, -1.8, M0LM13, 0.6 μM), (CHD1L, -1.7, stimulated PBMC, 0.6 μM), (CHD1L, -1.4, HEK293, 1.2μM) , (CHD1L, -1.9, M0LM13, 1.2 |1M), (CHD1L, -1.8, stimulated PBMC, 1.2 μM), (CHD1L, -1.5, HEK293, 5 μM), (CHD1L, -
1.9, SHSY5Y, 5μM) , (CHD1L, -1.5, diffSY5Y, 5 μM), (CHEK2, -1.6, HEK293, 0.6μM) , (CHEK2, -1.4, M0LM13, 0.6 μM), (CHEK2, -2.5, stimulated PBMC, 0.6 gM), (CHEK2, -1.6, HEK293, 1.2 μM), (CHEK2, -1.3, M0LM13, 1.2 μM), (CHEK2, -2, stimulated PBMC, 1.2 |1M), (CHEK2, -1.4, HEK293, 5 μM), (CHEK2, -1.1, SHSY5Y, 5 μM), (CLEC5A, -1.2, stimulated PBMC, 0.6 μM), (CNIH3, -1.5, HEK293, 0.6 μM), (CNIH3, -1.4, HEK293, 1.2 μM), (CNIH3, -2.2, HEK293, 5 μM), (COL23A1, -1.1, M0LM13, 0.6 gM), (COL23A1, -1.3,
M0LM13, 1.2 μM), (COL24A1, -1.6, HEK293, 0.6 μM), (COL24A1, -1.6, HEK293, 1.2 μM), (CPXM1, -1.2, HEK293, 5 μM), (CRELD1, -1.1, HEK293, 0.6 μM), (CRELD1, -1.2, MOLM13, 0.6 μM), (CRELD1, -1.4, stimulated PBMC, 0.6 μM), (CRELD1, -1.1, HEK293, 1.2 μM), (CRELD1, -1.1, stimulated PBMC, 1.2 μM), (CUTC, -1.1, MOLM13, 0.6 μM), (CUTC, -1.1, MOLM13, 1.2 μM), (CYP2U1, -1.3, HEK293, 0.6 μM), (CYP2U1, -1.1, HEK293, 1.2 μM), (CYP2U1, -1.6, HEK293, 5 μM), (DAAM1, -1.4, HEK293, 0.6 μM), (DAAM1, -1.4, MOLM13, 0.6 μM), (DAAM1, -1.6, stimulated PBMC, 0.6 μM), (DAAM1, -1.4, HEK293, 1.2 μM), (DAAM1, -1.4, MOLM13, 1.2 μM), (DAAM1, -1.5, stimulated PBMC, 1.2 μM), (DAAM1, - 1.2, SHSY5Y, 5 μM), (DDC, -2.1, SHSY5Y, 5 μM), (DDC, -2.8, diffSY5Y, 5 μM), (DEAF1, -1, MOLM13, 1.2 μM), (DEAF1, -1.3, SHSY5Y, 5 μM), (DEAF1, -1.6, diffSY5Y, 5 μM), (DECR2, -1, HEK293, 0.6 μM), (DECR2, -1.2, SHSY5Y, 5 μM), (DENND5A, -1.3, HEK293, 0.6 μM), (DENND5A, -1, MOLM13, 0.6 μM), (DENND5A, -1.3, stimulated PBMC, 0.6 μM), (DENND5A, -1.4, HEK293, 1.2 μM), (DENND5A, -1.1, MOLM13, 1.2 μM), (DENND5A, -1.4, stimulated PBMC, 1.2 μM), (DENND5A, -1.5, HEK293, 5 μM), (DENND5A, -1.3, SHSY5Y, 5 μM), (DGKA, -1.9, HEK293, 0.6 μM), (DGKA, -1.6, MOLM13, 0.6 μM), (DGKA, -2.3, stimulated PBMC, 0.6 μM), (DGKA, -1.8, HEK293, 1.2 μM), (DGKA, -1.6, MOLM13, 1.2 μM), (DGKA, -2.4, stimulated PBMC, 1.2 μM), (DGKA, -1.3, HEK293, 5 μM), (DHRS12, 1.2, HEK293, 0.6 μM), (DHRS12, 2.1, MOLM13, 0.6 μM), (DHRS12, 2, stimulated PBMC, 0.6 μM), (DHRS12, 1.4, HEK293, 1.2 μM), (DHRS12, 2, MOLM13, 1.2 μM), (DHRS12, 2, stimulated PBMC, 1.2 μM), (DHRS12, 1.8, HEK293, 5 μM), (DHRS12, 1.3, SHSY5Y, 5 μM), (DHRS4L2, -1, stimulated PBMC, 0.6 μM), (DIMT1, -2.2, HEK293, 0.6 μM), (DIMT1, -2.6, MOLM13, 0.6 μM), (DIMT1, -2.4, stimulated PBMC, 0.6 μM), (DIMT1, -2.4, HEK293, 1.2 μM), (DIMT1, -2.8, MOLM13, 1.2 μM), (DIMT1, -2.3, stimulated PBMC, 1.2 μM), (DIMT1, - 2.1, HEK293, 5 μM), (DIMT1, -2.1, SHSY5Y, 5 μM), (DIMT1, -2, diffSY5Y, 5 μM), (DLEU2, -1.1, MOLM13, 0.6 μM), (DLEU2, -1.2, MOLM13, 1.2 μM), (DLST, -1, HEK293, 0.6 μM), (DLST, -1.1, stimulated PBMC, 0.6 μM), (DLST, -1, HEK293, 1.2 μM), (DLST, -1, stimulated PBMC, 1.2 μM), (DMC1, -1.1, stimulated PBMC, 0.6 μM), (DMC1, -1.3, stimulated PBMC, 1.2 μM), (DNAJB12, -1.2, HEK293, 0.6 μM), (DNAJB12, -1.5, MOLM13, 0.6 μM), (DNAJB12, -1, stimulated PBMC, 0.6 μM), (DNAJB12, -1.3, HEK293, 1.2 μM), (DNAJB12, -1.5, MOLM13, 1.2 μM), (DNAJB12, -1, stimulated PBMC, 1.2 μM), (DNAJB12, -1.4, HEK293, 5 μM), (DNAJB12, -1.4, SHSY5Y, 5 μM), (DNAJB12, -1.6, diffSY5Y, 5 μM), (DPY19L2, -1.2, HEK293, 5 μM), (DST, 1.1, MOLM13, 0.6 μM), (DST, 1.3, MOLM13, 1.2 μM), (DTNB, -1.1, MOLM13, 0.6 μM), (DZIP3, -1.2, MOLM13, 0.6 μM), (DZIP3, -1.2, MOLM13, 1.2 μM), (DZIP3, -1.1, HEK293, 5 μM), (EMC2, -1.5, HEK293, 0.6 μM), (EMC2, -1.7, MOLM13, 0.6 μM), (EMC2, -1.6, stimulated PBMC, 0.6 μM), (EMC2, -1.6, HEK293, 1.2 μM), (EMC2, -1.5, MOLM13, 1.2 μM), (EMC2, -1.4, stimulated PBMC, 1.2 μM), (EMC2, -1.6, HEK293, 5 μM), (EMC2, -2, SHSY5Y, 5 μM), (EMC2, -1.6, diffSY5Y, 5 μM), (EMC3-AS1, -1.2, stimulated PBMC, 0.6 μM), (EMC3-AS1, -1.1, stimulated PBMC, 1.2 μM), (EMIDI, -1.4, MOLM13, 1.2 μM), (EML4, -1.1, stimulated PBMC, 0.6 μM), (EML4, -1.3, stimulated PBMC, 1.2 μM), (EML4, -1.1, SHSY5Y, 5 μM), (EOGT, -1.1, HEK293, 5 μM), (EPS8, -2.3, HEK293, 0.6 μM), (EPS8, -2, MOLM13, 0.6 μM), (EPS8, -2.8, stimulated PBMC, 0.6 μM), (EPS8, -2.2, HEK293, 1.2 μM), (EPS8, -1.7, MOLM13, 1.2 μM), (EPS8, -3, stimulated PBMC, 1.2 μM), (EPS8, -2.2, HEK293, 5 μM), (EPS8, -1.9, SHSY5Y, 5 μM), (EPS8, -1.6, diffSY5Y, 5 μM), (ERGIC1, -1.2, HEK293, 0.6 μM), (ERGIC1, -1.4, M0LM13, 0.6 μM), (ERGIC1, -1.1, stimulated PBMC, 0.6 μM), (ERGIC1, -1.4, HEK293, 1.2 μM), (ERGIC1, -1.4, M0LM13, 1.2 μM), (ERGIC1, -1.1,
stimulated PBMC, 1.2 μM), (ERGIC1, -1.2, HEK293, 5 μM), (ERGIC1, -1.2, SHSY5Y, 5 μM), (ERGIC1, -1.2, diffSY5Y, 5 μM), (ETHE1, -1.2, stimulated PBMC, 0.6 μM), (ETHE1, -1.1, MOLM13, 1.2 μM), (ETHE1, -1.2, stimulated PBMC, 1.2 μM), (ETHE1, -1.1, SHSY5Y, 5 μM), (EXOC3, -1.2, HEK293, 0.6 μM), (EXOC3, -1.5, MOLM13, 0.6 μM), (EXOC3, -1.3, stimulated PBMC, 0.6 μM), (EXOC3, -1.2, HEK293, 1.2 μM), (EXOC3, -1.5, MOLM13, 1.2 μM), (EXOC3, -1.3, stimulated PBMC, 1.2 μM), (EXOC3, -1.1, HEK293, 5 μM), (F8, -2, HEK293, 0.6 μM), (F8, -2.1, HEK293, 1.2 μM), (FAM208A, -1.1, stimulated PBMC, 0.6 μM), (FAM208A, -1.1, stimulated PBMC, 1.2 μM), (FAM208A, -1.2, HEK293, 5 μM), (FANCI, -1.6, HEK293, 0.6 μM), (FANCI, -1.5, MOLM13, 0.6 μM), (FANCI, -2.2, stimulated PBMC, 0.6 μM), (FANCI, -1.7, HEK293, 1.2 μM), (FANCI, -1.4, MOLM13, 1.2 μM), (FANCI, -2.4, stimulated PBMC, 1.2 μM), (FANCI, -1.7, HEK293, 5 μM), (FANCT, -1.7, SHSY5Y, 5 μM), (FANCI, -2, diffiSY5Y, 5 μM), (FANCL, -2.5, HEK293, 0.6 μM), (FANCL, -1.4, MOLM13, 0.6 μM), (FANCL, -2.1, stimulated PBMC, 0.6 μM), (FANCL, -2.2, HEK293, 1.2 μM), (FANCL, - 1.5, MOLM13, 1.2 μM), (FANCL, -2.3, stimulated PBMC, 1.2 μM), (FANCL, -1.9, HEK293, 5 μM), (FANCL, -2.6, SHSY5Y, 5 μM), (FANCL, -1.8, diffSY5Y, 5 μM), (FANK1, 1.5, MOLM13, 0.6 μM), (FANK1, 1.7, MOLM13, 1.2 μM), (FGGY, -2.2, HEK293, 0.6 μM), (FGGY, -2.3, MOLM13, 0.6 μM), (FGGY, -2.5, stimulated PBMC, 0.6 μM), (FGGY, -2.4, HEK293, 1.2 μM), (FGGY, -2.6, MOLM13, 1.2 μM), (FGGY, -2.1, stimulated PBMC, 1.2 μM), (FGGY, -3, HEK293, 5 μM), (FIG4, -1.1, MOLM13, 0.6 μM), (FIG4, -1.6, stimulated PBMC, 0.6 μM), (FIG4, -1.1, HEK293, 1.2 μM), (FIG4, -1.1, MOLM13, 1.2 μM), (FIG4, -1.4, stimulated PBMC, 1.2 μM), (FIG4, -1.4, HEK293, 5 μM), (FIG4, -1.1, SHSY5Y, 5 μM), (FOXRED1, -1.4, HEK293, 5 μM), (FOXRED1, -1.3, SHSY5Y, 5 μM), (FYN, 1.1, MOLM13, 0.6 μM), (FYN, 1.1, MOLM13, 1.2 μM), (GALNT6, -1.1, HEK293, 0.6 μM), (GALNT6, -1.1, MOLM13, 0.6 μM), (GALNT6, -1.1, stimulated PBMC, 0.6 μM), (GALNT6, -1.2, MOLM13, 1.2 μM), (GALNT6, -1.1, HEK293, 5 μM), (GALNT6, -1.1, SHSY5Y, 5 μM), (GEMIN2, -1.3, stimulated PBMC, 0.6 μM), (GEMIN2, -1.1, MOLM13, 1.2 μM), (GEMIN2, -1.4, HEK293, 5 μM), (GGT5, -1.5, MOLM13, 0.6 μM), (GGT5, -1.7, MOLM13, 1.2 μM), (GLB1, -1.1, HEK293, 1.2 μM), (GLB1, -1.2, HEK293, 5 μM), (GNPTG, -1.3, HEK293, 5 μM), (GPR137, 1, MOLM13, 1.2 μM), (GPR155, -1, HEK293, 1.2 μM), (GSAP, -1.1, MOLM13, 0.6 μM), (GSAP, -2.1, stimulated PBMC, 0.6 μM), (GSAP, -1, MOLM13, 1.2 μM), (GSAP, -1.8, stimulated PBMC, 1.2 μM), (GTF2I, -1.1, HEK293, 0.6 μM), (GTF2I, -1.2, MOLM13, 0.6 μM), (GTF2I, - 1.7, stimulated PBMC, 0.6 μM), (GTF2I, -1.4, HEK293, 1.2 μM), (GTF2I, -1.3, MOLM13, 1.2 μM), (GTF2I, -1.9, stimulated PBMC, 1.2 μM), (GTF2I, -2, HEK293, 5 μM), (GTF2I, -1.8, SHSY5Y, 5 μM), (GTF2I, -1.4, diffSY5Y, 5 μM), (GTF2IP1, -1.2, HEK293, 1.2 μM), (GTF21P1, -1.6, HEK293, 5 μM), (GTF21P1, -1.5, SHSY5Y, 5 μM), (GTF21P1, -1.5, diffSY5Y, 5 μM), (GTF2IP4, -1.2, HEK293, 1.2 μM), (GTF2IP4, -1.6, HEK293, 5 μM), (GTF2IP4, -1.5, SHSY5Y, 5 μM), (GTF2IP4, -1.5, diffSY5Y, 5 μM), (HACL1, -1.1, HEK293, 0.6 μM), (HACL1, -1.3, MOLM13, 0.6 μM), (HACL1, -1.1, stimulated PBMC, 0.6 μM), (HACL1, -1.2, HEK293, 1.2 μM), (HACL1, -1.1, MOLM13, 1.2 μM), (HACL1, -1.1, stimulated PBMC, 1.2 μM), (HACL1, -1.1, HEK293, 5 μM), (HACL1, -1.2, SHSY5Y, 5 μM), (HERC2, -1.3, MOLM13, 0.6 μM), (HERC2, -1.2, stimulated PBMC, 0.6 μM), (HERC2, -1.2, MOLM13, 1.2 μM), (HERC2, -1.2, stimulated PBMC, 1.2 μM), (HERC6, 1, stimulated PBMC, 1.2 μM), (HPS3, -1.4, HEK293, 5 μM), (HSD17B4, -1.6, HEK293, 0.6 μM), (HSD17B4, -1.9, MOLM13, 0.6 μM), (HSD17B4, -2.2, stimulated PBMC, 0.6 μM), (HSD17B4, -1.6, HEK293, 1.2 μM), (HSD17B4, -1.9, MOLM13, 1.2 μM), (HSD17B4, -2.2, stimulated PBMC, 1.2 μM), (HSD17B4,
-1.4, HEK293, 5 μM), (HSD17B4, -1.8, SHSY5Y, 5 μM), (HSD17B4, -1.6, diffSY5Y, 5 μM), (HSD17B7P2, 1.4, stimulated PBMC, 0.6 μM), (HSD17B7P2, 1.4, stimulated PBMC, 1.2 μM), (ICA1L, -1.2, HEK293, 5 μM), (IFI27L1, -1.7, stimulated PBMC, 0.6 μM), (IFI27L1, -1.2, stimulated PBMC, 1.2 μM), (IL11RA, -1.7, stimulated PBMC, 0.6 μM), (IL11RA, -1.4, MOLM13, 1.2 μM), (IL11RA, -1.6, stimulated PBMC, 1.2 μM), (IMMP1L, -1.2, stimulated PBMC, 1.2 μM), (IQCG, -1.2, HEK293, 0.6 μM), (IQCG, -1.2, HEK293, 1.2 μM), (IQCG, -1.4, HEK293, 5 μM), (IQCH, -1.1, HEK293, 1.2 μM), (IQSEC1, -1, stimulated PBMC, 1.2 jaM), (ITGA3, -1.1, HEK293, 5 μM), (KATNAL2, -1.1, HEK293, 0.6 μM), (KATNAL2, -2.2, MOLM13, 0.6μM) , (KATNAL2, -1.1, HEK293, 1.2μM) , (KATNAL2, -2.2, MOLM13, 1.2 |1M), (KCNQ1, -2.7, HEK293, 0.6 μM), (KCNQ1, -3.4, MOLM13, 0.6μM) , (KCNQ1, -2, stimulated PBMC, 0.6 μM), (KCNQ1, -2.1, HEK293, 1.2 JIM), (KCNQ1, -3.7, MOLM13, 1.2 |1M), (KCNQ1, -1.9, stimulated PBMC, 1.2 μM), (KCNQ5, -1.2, stimulated PBMC, 1.2 μM), (KCNT2, -1.3, HEK293, 0.6 μM), (KCNT2, -1.3, HEK293, 1.2 μM), (KIAA0556, -1.1, HEK293, 0.6 μM), (KIAA0556, -1.3, MOLM13, 0.6 μM), (KIAA0556, -1.3, stimulated PBMC, 0.6 μM), (KIAA0556, -1.1, HEK293, 1.2 μM), (KIAA0556, -1.1, MOLM13, 1.2 μM), (K1AA0556, -1.2, stimulated PBMC, 1.2 μM), (LEPR, 2.1, MOLM13, 0.6 μM), (LEPR, 1.3, stimulated PBMC, 0.6 μM), (LEPR, 2.2, MOLM13, 1.2 μM), (LEPR, 1.4, stimulated PBMC, 1.2 |1M), (LGR5, -1.5, HEK293, 5 μM), (LINC00473, 1.5, HEK293, 1.2 ^M), (LINC00473, 1.4, SHSY5Y, 5μM) , (LINC01881, 1.1, MOLM13, 1.2μM) , (LOC100133315, -1.5, MOLM13, 1.2 |1M), (LOCI 00506844, -1.7, HEK293, 0.6 μM), (LOCI 00506844, -1.8, M0LM13, 0.6 μM), (LOC100506844, -1.5, stimulated PBMC, 0.6μM) , (LOCI 00506844, -1.8, HEK293, 1.2μM) , (LOC100506844, -2, M0LM13, 1.2 μM), (LOC100506844, -1.8, stimulated PBMC, 1.2 μM), (LOC100506844, -2, HEK293, 5 μM), (LOCI 00506844, -1.8, SHSY5Y, 5 μM), (LOC100506844, -2, diffSY5Y, 5 gM), (LOC 100507557, -2.4, stimulated PBMC, 0.6 μM), (LOC100507557, -5.1, stimulated PBMC, 1.2 μM), (LOC 101927027, -1.1, HEK293, 0.6 μM), (LOCI 01927027, -1.1, HEK293, 1.2μM) , (LOC 102606465, -2.1, HEK293, 0.6μM) , (LOC102606465, -1.5, M0LM13, 0.6 μM), (LOC102606465, -1.4, stimulated PBMC, 0.6 gM), (LOCI 02606465, -1.9, HEK293, 1.2μM) , (LOC 102606465, -1.5, M0LM13, 1.2 gM), (LOC102606465, -1.1, stimulated PBMC, 1.2 μM), (LOC 102606465, -2.8, HEK293, 5 μM), (LOC102724532, -1.8, HEK293, 0.6 μM), (LOC 102724532, -2, M0LM13, 0.6 gM), (LOC102724532, -2, stimulated PBMC, 0.6 μM), (LOC 102724532, -1.6, HEK293, 1.2 μM), (LOC102724532, -2.6, M0LM13, 1.2 μM), (LOC102724532, -1.9, stimulated PBMC, 1.2 gM), (LOC102724532, -1.9, HEK293, 5μM), (LOC 102724532, -2.2, SHSY5Y, 5μM), (LRRC28, -1, stimulated PBMC, 0.6 μM), (LRRC28, -1, stimulated PBMC, 1.2 μM), (LRRC34, -1.2, M0LM13, 0.6 μM), (LRRC34, -1.2, M0LM13, 1.2 μM), (LRRC40, -1, stimulated PBMC, 0.6 gM), (LRRC40, -1.1, stimulated PBMC, 1.2 μM), (LRRC6, -1.1, M0LM13, 1.2 μM), (MAGI2- AS3, -1.2, HEK293, 5 μM), (MBOAT2, -1, HEK293, 0.6 gM), (MBOAT2, -1.6, stimulated PBMC, 0.6μM) , (MBOAT2, -1.2, HEK293, 1.2 gM), (MBOAT2, -1.6, stimulated PBMC, 1.2 gM), (MBOAT2, -1.2, HEK293, 5 μM), (MCOLN1, 1.1, M0LM13, 0.6 jaM), (MCOLN1, 1.1, M0LM13, 1.2μM), (MCTP2, -1.6, stimulated PBMC, 0.6 μM), (MCTP2, -1.8, stimulated PBMC, 1.2 μM), (MEGF8, -1, M0LM13, 0.6 μM), (MELTF, -1.3, M0LM13, 0.6 μM), (MELTF, -1.6, stimulated PBMC, 0.6 μM), (MELTF, -1.5, M0LM13, 1.2 μM), (MELTF, -1.7, stimulated PBMC, 1.2 μM), (MELTF, -2, HEK293, 5 μM), (MIATNB, -2.3, M0LM13, 0.6 gM), (MLH1, -1.6, M0LM13, 0.6 μM), (MLH1, -1.6, stimulated PBMC, 0.6 μM), (MLH1, -1.5, M0LM13, 1.2 μM), (MLH1, -1.6, stimulated PBMC, 1.2 gM), (MLH1, -1.6, HEK293, 5 μM),
(MLH1, -1.6, SHSY5Y, 5 μM), (MLH1, -1.4, diffSY5Y, 5 μM), (MOSPD2, -1.7, HEK293, 0.6 |1M), (MOSPD2, -1.5, MOLM13, 0.6 μM), (MOSPD2, -1.6, stimulated PBMC, 0.6 ^M), (MOSPD2, -1.5, HEK293, 1.2 ^M), (MOSPD2, -1.3, MOLM13, 1.2 gM), (MOSPD2, -1.5, stimulated PBMC, 1.2 μM), (MOSPD2, -1.3, HEK293, 5 μM), (MRC1, -1.1, stimulated PBMC, 0.6 μM), (MRC1, -1.3, stimulated PBMC, 1.2 μM), (MROH6, -1.2, HEK293, 0.6 μM), (MROH6, -1.8, MOLM13, 0.6 μM), (MROH6, -1.7, MOLM13, 1.2 μM), (MS4A7, -1.9, MOLM13, 0.6μM) , (MS4A7, -1.9, MOLM13, 1.2μM), (MYBL2, -1.2, diffSY5Y, 5μM) , (NARS2, -1, HEK293, 0.6 μM), (NARS2, -1, MOLM13, 0.6 μM), (NARS2, -1, stimulated PBMC, 0.6 μM), (NARS2, -1.1, MOLM13, 1.2 μM), (NARS2, -1.1, stimulated PBMC, 1.2 μM), (NARS2, -1.1, SHSY5Y, 5 μM), (NECAB3, -1.1, HEK293, 0.6 μM), (NECAB3, -1.2, HEK293, 1.2 nM), (NECAB3, -1.2, HEK293, 5 μM), (NECAB3, -1, SHSY5Y, 5 μM), (NEK1, -1.7, HEK293, 0.6 μM), (NEK1, -1.7, MOLM13, 0.6 μM), (NEK1, -1.8, stimulated PBMC, 0.6 μM), (NEK1, -1.7, HEK293, 1.2 μM) , (NEK1, -1.5, MOLM13, 1.2 μM), (NEK1, -1.8, stimulated PBMC, 1.2 μM), (NEK1, -1.5, HEK293, 5 μM) , (NEK1, -1.7, SHSY5Y, 5μM), (NFATC2IP, -
1.2, stimulated PBMC, 0.6 gM), (NFATC2IP, -1.1, stimulated PBMC, 1.2 μM), (NFATC2IP, -
1.2, HEK293, 5 gM), (NFATC21P, -1.6, SHSY5Y, 5 μM), (NTRK1, -2.6, stimulated PBMC, 0.6 |1M), (NTRK1, -2.5, stimulated PBMC, 1.2 μM), (NTRK1, -1.2, SHSY5Y, 5 μM), (NTRK1, -
2.8, diffSY5Y, 5 μM), (NUBPL, -1, stimulated PBMC, 0.6 gM), (NUP43, -1.1, stimulated PBMC, 0.6 μM), (NUP43, -1.1, stimulated PBMC, 1.2 μM), (NUP43, -1.4, HEK293, 5 μM), (NUP58, -1.1, SHSY5Y, 5 gM), (NUPL2, -1.2, HEK293, 0.6 μM), (NUPL2, -1.6, MOLM13, 0.6 nM), (NUPL2, -1.1, stimulated PBMC, 0.6 μM), (NUPL2, -1.2, HEK293, 1.2 μM), (NUPL2, -1.7, MOLM13, 1.2 μM), (NUPL2, -1, stimulated PBMC, 1.2 μM), (NUPL2, -1.3, HEK293, 5 μM), (NUPL2, -1.7, SHSY5Y, 5 μM), (NUPL2, -1.3, diffSY5Y, 5 gM), (OARD1, -1.1, stimulated PBMC, 0.6 μM), (OARD1, -1, stimulated PBMC, 1.2 μM), (OLMALINC, -4.2, HEK293, 0.6 μM), (OLMALINC, -4.6, MOLM13, 0.6 μM), (OLMALINC, -5.5, stimulated PBMC, 0.6μM) , (OLMALINC, -4.7, HEK293, 1.2 μM), (OLMALINC, -7.4, MOLM13, 1.2 |1M), (OLMALINC, -6.5, stimulated PBMC, 1.2 gM), (OLMALINC, -4.5, HEK293, 5 gM), (OLMALINC, -3.8, SHSY5Y, 5μM) , (OLMALINC, -3.5, diffSY5Y, 5 μM), (OSBPL7, -1.2, HEK293, 5 μM), (P2RX4, -1.1, HEK293, 0.6 μM), (P2RX4, -1.1, HEK293, 5 μM), (P2RX4, -
1.1, SHSY5Y, 5 μM), (PCCB, -1.3, HEK293, 0.6 μM), (PCCB, -1.1, stimulated PBMC, 0.6 |1M), (PCCB, -1.4, HEK293, 1.2 μM), (PCCB, -1.2, stimulated PBMC, 1.2 μM), (PCCB, -1.3, HEK293, 5 μM), (PCID2, -1.8, HEK293, 0.6 μM), (PCID2, -2.7, MOLM13, 0.6 μM), (PCID2, -
3.2, stimulated PBMC, 0.6 gM), (PCID2, -1.9, HEK293, 1.2 μM), (PCID2, -2.9, MOLM13, 1.2 |1M), (PCID2, -3.2, stimulated PBMC, 1.2 μM), (PCID2, -2.1, HEK293, 5 μM), (PCID2, -1.3, SHSY5Y, 5 gM), (PC1D2, -1.9, diffSY5Y, 5 gM), (PD1A5, -1.3, HEK293, 0.6 μM), (PD1A5, - 1.5, MOLM13, 0.6 μM), (PDIA5, -1.9, stimulated PBMC, 0.6 μM), (PDIA5, -1.4, HEK293, 1.2 |1M), (PDIA5, -1.5, MOLM13, 1.2 μM), (PDIA5, -1.8, stimulated PBMC, 1.2μM), (PDIA5, - 1.1, HEK293, 5 gM), (PDIA5, -1.2, SHSY5Y, 5 gM), (PEAR1, 1.1, SHSY5Y, 5μM), (PEX6, -
1.8, HEK293, 0.6 gM), (PEX6, -1.4, MOLM13, 0.6 μM), (PEX6, -1.3, stimulated PBMC, 0.6 |1M), (PEX6, -1.7, HEK293, 1.2 μM), (PEX6, -1.5, MOLM13, 1.2 gM), (PEX6, -1.3, stimulated PBMC, 1.2 μM), (PEX6, -2, HEK293, 5 μM), (PFDN1, -1.1, SHSY5Y, 5 μM), (PHKG2, -1.2, HEK293, 0.6 μM), (PHKG2, -1.4, MOLM13, 0.6 μM), (PHKG2, -1.5, stimulated PBMC, 0.6 gM), (PHKG2, -1.1, HEK293, 1.2 μM), (PHKG2, -1.6, MOLM13, 1.2 μM), (PHKG2, -1.5, stimulated PBMC, 1.2 μM), (PHKG2, -1.3, HEK293, 5 μM), (PHKG2, -1.1, SHSY5Y, 5 μM), (PLB1, -1.7, MOLM13, 0.6 μM), (PLB1, -1.7, MOLM13, 1.2μM) , (POLA2, -1.1, HEK293, 0.6
|1M), (POLA2, -1.7, MOLM13, 0.6 μM), (POLA2, -1.2, stimulated PBMC, 0.6 gM), (POLA2, -
1.1, HEK293, 1.2 gM), (POLA2, -1.7, MOLM13, 1.2 μM), (POLA2, -1.2, stimulated PBMC,
1.2 μM), (POLA2, -1.2, HEK293, 5 μM), (POLA2, -1.4, SHSY5Y, 5 μM), (POLN, -1.6, HEK293, 0.6 μM), (POLN, -2, stimulated PBMC, 0.6 μM), (POLN, -1.4, HEK293, 1.2 μM), (POLN, -2.1, MOLM13, 1.2 gM), (POLN, -2, stimulated PBMC, 1.2 μM), (POLR2J4, 1.5, HEK293, 0.6 μM), (POLR2J4, 1, M0LM13, 0.6 ^M), (POLR2J4, 2, stimulated PBMC, 0.6 |1M), (POLR2J4, 1.5, HEK293, 1.2 μM), (POLR2J4, 2, stimulated PBMC, 1.2 μM), (POLR2J4,
1.2, SHSY5Y, 5 μM), (PPIEL, -1.2, HEK293, 5 μM), (PPM1M, -1.4, HEK293, 5 μM), (PPP2R3C, -1.1, HEK293, 0.6 μM), (PPP2R3C, -1.7, MOLM13, 0.6 μM,) (PPP2R3C, -1.9, stimulated PBMC, 0.6 μM), (PPP2R3C, -1.3, HEK293, 1.2 gM), (PPP2R3C, -1.7, MOLM13,
1.2 nM), (PPP2R3C, -1.9, stimulated PBMC, 1.2 μM), (PPP2R3C, -1, HEK293, 5 μM), (PPP2R3C, -1.1, SHSY5Y, 5 μM), (PPP4R4, -1.1, HEK293, 1.2 μM), (PPP4R4, -1.1, HEK293, 5 μM), (PRKAG1, -1.1, HEK293, 0.6 μM), (PRKAG1, -1.1, HEK293, 1.2 μM), (PRKAG1, -1.4, HEK293, 5 μM), (PRKAG1, -1.2, SHSY5Y, 5 μM), (PRPF40B, -1.1, HEK293, 0.6 μM,) (PRPF40B, -1.4, MOLM13, 0.6 gM), (PRPF40B, -1.6, stimulated PBMC, 0.6 μM), (PRPF40B, - 1.4, MOLM13, 1.2 μM), (PRPF40B, -1.5, stimulated PBMC, 1.2 μM), (PRPF40B, -1.3, HEK293, 5 μM), (PRR5L, 1.2, MOLM13, 0.6 μM), (PRR5L, 1.3, MOLM13, 1.2 gM), (PTPN18, -1.1, HEK293, 0.6 μM), (PTPN18, -1, HEK293, 1.2 μM), (PTPN18, -1.1, HEK293, 5 gM), (PTPRG-AS1, -1.4, SHSY5Y, 5 μM), (PURPL, -1.1, MOLM13, 0.6 μM,) (PYROXD1, - 1.1, SHSY5Y, 5 μM), (RAB3GAP1, -1.4, SHSY5Y, 5 μM), (RAB3GAP1, -1.2, diffSY5Y, 5 |1M), (RAB4B, -1.1, HEK293, 0.6 μM,) (RABGAP1L, -1, HEK293, 1.2 μM, ()RAD51AP1, -1, MOLM13, 0.6 μM), (RAD51AP1, -1, SHSY5Y, 5 μM), (RADIL, -1, HEK293, 0.6 μM), (RADIL, -1.2, HEK293, 1.2 μM), (RADIL, -1.1, SHSY5Y, 5 μM), (RECK, -1.1, HEK293, 0.6 gM), (RECK, -1.1, HEK293, 1.2 μM), (RECK, -1.1, MOLM13, 1.2 μM), (RECK, -1.5, HEK293, 5 μM), (RFX8, 1.1, MOLM13, 1.2 piM), (RNF123, -1.1, HEK293, 0.6 μM), (RNF123, -1.3, MOLM13, 0.6 μM), (RNF123, -1.1, stimulated PBMC, 0.6 gM), (RNF123, -1.1, HEK293,
1.2 μM), (RNF123, -1.2, MOLM13, 1.2 μM), (RNF123, -1.1, stimulated PBMC, 1.2 μM), (RNF170, -1.6, HEK293, 5 μM), (RNLS, -1.3, MOLM13, 1.2 μM,) (RRNAD1, -1.3, HEK293, 0.6 μM), (RRNAD1, -1.2, MOLM13, 0.6 μM), (RRNAD1, -1.3, MOLM13, 1.2 μM), (RRNAD1, -1.3, HEK293, 5 μM), (RTEL1, -1, HEK293, 0.6 gM), (RTEL1, -1, HEK293, 1.2 gM), (RTEL1-TNFRSF6B, -1, HEK293, 1.2 μM), (RWDD4, -1.2, stimulated PBMC, 0.6 μM), (RWDD4, -1.3, stimulated PBMC, 1.2 μM), (SATB1-AS1, -1.3, MOLM13, 0.6 μM), (SATB1- AS1, -1.3, stimulated PBMC, 1.2 μM), (SEC31B, 1.1, HEK293, 1.2 gM), (SEC31B, 1.8, SHSY5Y, 5 μM), (SEMA4A, -3, HEK293, 0.6 μM), (SEMA4A, -2.3, HEK293, 1.2 μM), (SFI1, -1, stimulated PBMC, 0.6 μM), (SF11, -1.1, HEK293, 5 gM), (SLC24A1, -1.2, HEK293, 0.6 |1M), (SLC24A1, -1.2, HEK293, 1.2 μM), (SLC24A1, -1.5, HEK293, 5 μM), (SLC25A14, -1.3, SHSY5Y, 5 μM), (SLC25A32, -1.1, MOLM13, 0.6 μM), (SLC25A32, -1.1, stimulated PBMC, 0.6 nM), (SLC25A32, -1.1, MOLM13, 1.2 μM), (SLC25A32, -1.1, stimulated PBMC, 1.2 gM), (SLC25A40, -1.4, HEK293, 0.6 gM), (SLC25A40, -1.4, MOLM13, 0.6 μM), (SLC25A40, -1.9, stimulated PBMC, 0.6 μM), (SLC25A40, -1.6, HEK293, 1.2 μM), (SLC25A40, -1.3, MOLM13,
1.2 μM), (SLC25A40, -1.9, stimulated PBMC, 1.2 μM), (SLC25A40, -1.7, HEK293, 5 μM), (SLC25A40, -1.5, SHSY5Y, 5 μM), (SLC25A40, -1.8, diffSY5Y, 5 μM), (SLC25A53, -1.3, HEK293, 0.6 μM), (SLC25A53, -1.5, stimulated PBMC, 0.6 μM), (SLC25A53, -1.8, stimulated PBMC, 1.2μM), (SLC26A10, -1.1, HEK293, 0.6 μM), (SLC38A6, -1.5, HEK293, 0.6 gM), (SLC38A6, -1.2, MOLM13, 0.6 gM), (SLC38A6, -1.6, stimulated PBMC, 0.6 μM), (SLC38A6,
-1.3, HEK293, 1.2 μM), (SLC38A6, -1.2, MOLM13, 1.2 μM), (SLC38A6, -1.6, stimulated PBMC, 1.2 μM), (SLC38A6, -1.6, HEK293, 5 μM), (SLC3A2, 1.4, HEK293, 5 μM), (SLC43A1, -1.6, HEK293, 0.6 μM), (SLC43A1, -1.7, MOLM13, 0.6 μM), (SLC43A1, -2.3, stimulated PBMC, 0.6 μM), (SLC43A1, -1.9, HEK293, 1.2 μM), (SLC43A1, -1.8, MOLM13, 1.2 μM), (SLC43A1, -1.7, stimulated PBMC, 1.2 μM), (SLC43A1, -1.8, HEK293, 5 μM), (SLC47A1, -1.4, HEK293, 0.6 μM), (SLC47A1, -1.4, HEK293, 1.2 μM), (SLC47A1, -1.2, HEK293, 5 μM), (SLC4A7, -1.3, HEK293, 0.6 μM), (SLC4A7, -2.1, MOLM13, 0.6 μM), (SLC4A7, -2.3, stimulated PBMC, 0.6 μM), (SLC4A7, -1.5, HEK293, 1.2 μM), (SLC4A7, -1.9, MOLM13, 1.2 μM), (SLC4A7, -2.3, stimulated PBMC, 1.2 μM), (SLC4A7, -1.1, HEK293, 5 μM), (SLC4A7, -1.1, SHSY5Y, 5 μM), (SLIT1, -1.3, HEK293, 0.6 μM), (SLIT1, -4, MOLM13, 0.6 μM), (SLTT1, -1.6, HEK293, 1.2 μM), (SLTT1, -4.8, MOLM13, 1.2 μM), (SLTT1, -2.1, HEK293, 5 μM), (SLIT1, -1.4, SHSY5Y, 5 μM), (SLIT3, -3.6, HEK293, 0.6 μM), (SLIT3, -3.4, HEK293, 1.2 μM), (SRP14-AS1, -1.8, HEK293, 0.6 μM), (SRP14-AS1, -1.5, stimulated PBMC, 0.6 μM), (SRP14-AS1, -1.9, HEK293, 1.2 μM), (SRP14-AS1, -1.6, stimulated PBMC, 1.2 μM), (SRP14-AS1, -2, HEK293, 5 μM), (SRP14-AS1, -1.6, SHSY5Y, 5 μM), (SRP14-AS1, -3.1, diffSY5Y, 5 μM), (ST6GAL1, -1.1, HEK293, 0.6 μM), (ST6GAL1, -1.4, MOLM13, 0.6 μM), (ST6GAL1, -1.3, HEK293, 1.2 μM), (ST6GAL1, -1.3, MOLM13, 1.2 μM), (ST6GAL1, -2.6, HEK293, 5 μM), (ST7L, -1.4, MOLM13, 0.6 μM), (ST7L, -1.7, stimulated PBMC, 0.6 μM), (ST7L, -1.5, MOLM13, 1.2 μM), (ST7L, -1.9, stimulated PBMC, 1.2 μM), (ST7L, -1.4, HEK293, 5 μM), (STIM2, 1.4, diffSY5Y, 5 μM), (STRIP2, 1.6, diffSY5Y, 5 μM), (STX16, -1.2, stimulated PBMC, 0.6 μM), (STX16, -1.1, stimulated PBMC, 1.2 μM), (STXBP3, -2.3, HEK293, 0.6 μM), (STXBP3, -2.4, MOLM13, 0.6 μM), (STXBP3, -2.9, stimulated PBMC, 0.6 μM), (STXBP3, -2.6, HEK293, 1.2 μM), (STXBP3, -2.3, MOLM13, 1.2 μM), (STXBP3, -2.9, stimulated PBMC, 1.2 μM), (STXBP3, -2.9, HEK293, 5 μM), (STXBP3, -3, SHSY5Y, 5 μM), (STXBP3, -2.4, diffSY5Y, 5 μM), (TARSL2, -1.4, HEK293, 0.6 μM), (TARSL2, -1.6, MOLM13, 0.6 μM), (TARSL2, -1.4, stimulated PBMC, 0.6 μM), (TARSL2, -1.7, HEK293, 1.2 μM), (TARSL2, -1.2, MOLM13, 1.2 μM), (TARSL2, -1.4, stimulated PBMC, 1.2 μM), (TARSL2, -1.7, HEK293, 5 μM), (TBC1D19, -1.7, HEK293, 0.6 μM), (TBC1D19, -2, MOLM13, 0.6 μM), (TBC1D19, -2.4, stimulated PBMC, 0.6 μM), (TBC1D19, -2, HEK293, 1.2 μM), (TBC1D19, -1.6, MOLM13, 1.2 μM), (TBC1D19, -1.8, stimulated PBMC, 1.2 μM), (TBC1D19, -2.3, HEK293, 5 μM), (TBC1D19, -2.7, SHSY5Y, 5 μM), (TBCK, -1.8, HEK293, 0.6 μM), (TBCK, -1, MOLM13, 0.6 μM), (TBCK, -2.1, stimulated PBMC, 0.6 μM), (TBCK, -
1.6, HEK293, 1.2 μM), (TBCK, -1.1, MOLM13, 1.2 μM), (TBCK, -2.1, stimulated PBMC, 1.2 μM), (TBCK, -1.1, SHSY5Y, 5 μM), (TDP1, -1.3, HEK293, 0.6 μM), (TDP1, -1.6, MOLM13, 0.6 μM), (TDP1, -2.1, stimulated PBMC, 0.6 μM), (TDP1, -1.4, HEK293, 1.2 μM), (TDP1, -1.7, MOLM13, 1.2 μM), (TDP1, -2, stimulated PBMC, 1.2 μM), (TDP1, -1.5, HEK293, 5 μM), (TDP1, -1.5, SHSY5Y, 5 μM), (TEX9, -1.3, HEK293, 0.6 μM), (TEX9, -1.4, HEK293, 1.2 μM), (TFCP2, -1.1, HEK293, 0.6 μM), (TFCP2, -1, MOLM13, 0.6 μM), (TFCP2, -1.3, HEK293, 1.2 μM), (TFCP2, -1.1, MOLM13, 1.2 μM), (TFCP2, -1, stimulated PBMC, 1.2 μM), (TFCP2, -1.7, HEK293, 5 μM), (TFCP2, -1.3, SHSY5Y, 5 μM), (TFCP2, -1.4, diffSY5Y, 5 μM), (THBS4, -
1.7, HEK293, 0.6 μM), (THBS4, -2.1, HEK293, 1.2 μM), (THOC2, -2, stimulated PBMC, 0.6 μM), (THOC2, -1.1, HEK293, 1.2 μM), (THOC2, -2, stimulated PBMC, 1.2 μM), (THOC2, -
1.1, HEK293, 5 μM), (TIA1, -1.1, MOLM13, 0.6 μM), (TIA1, -1.2, stimulated PBMC, 0.6 μM), (TIA1, -1.1, stimulated PBMC, 1.2 μM), (TMEM106C, -1.1, HEK293, 0.6 μM), (TMEM106C, -
1.2, MOLM13, 0.6 μM), (TMEM106C, -1.2, stimulated PBMC, 0.6 μM), (TMEM106C, -1.1,
HEK293, 1.2 μM), (TMEM106C, -1.2, MOLM13, 1.2 μM), (TMEM106C, -1.1, stimulated PBMC, 1.2 μM), (TMEM106C, -1.6, HEK293, 5 μM), (TMEM106C, -1.1, SHSY5Y, 5 μM), (TMEM144, -1.1, HEK293, 0.6 μM), (TMEM144, -1.1, MOLM13, 0.6 μM), (TMEM144, -1, HEK293, 1.2 μM), (TMEM144, -1.3, MOLM13, 1.2 μM), (TMEM144, -1.6, stimulated PBMC,
1.2 μM), (TMEM144, -1.7, HEK293, 5 μM), (TMEM45A, 1.2, MOLM13, 0.6 μM), (TMEM45A, 1, MOLM13, 1.2 μM), (TMEM65, -1.4, MOLM13, 0.6 μM), (TMEM65, -1.8, stimulated PBMC, 0.6 μM), (TMEM65, -1.3, MOLM13, 1.2 μM), (TMEM65, -1.7, stimulated PBMC, 1.2 μM), (TMX2, -1.2, MOLM13, 0.6 μM), (TMX2, -1.3, MOLM13, 1.2 μM), (TMX2, -1, SHSY5Y, 5 μM), (TMX3, -1.7, HEK293, 0.6 μM), (TMX3, -1.2, MOLM13, 0.6 μM), (TMX3, -1.8, HEK293, 1.2 μM), (TMX3, -1.2, MOLM13, 1.2 μM), (TMX3, -1.6, HEK293, 5 μM), (TMX3, -1.5, SHSY5Y, 5 μM), (TMX3, -1.4, diffSY5Y, 5 μM), (TNKS2, -1.1, HEK293, 0.6 μM), (TNKS2, -1.3, MOLM13, 0.6 μM), (TNKS2, -1.1, stimulated PBMC, 0.6 μM), (TNKS2, -1.3, HEK293, 1.2 μM), (TNKS2, -1.3, MOLM13, 1.2 μM), (TNKS2, -1.2, stimulated PBMC, 1.2 μM), (TNKS2, -1.1, HEK293, 5 μM), (TNKS2, -1.3, SHSY5Y, 5 μM), (TOM1L2, - 1.1, HEK293, 5 μM), (TPT1-AS1, 1.1, SHSY5Y, 5 μM), (TRMT10A, -1.1, stimulated PBMC, 0.6 μM), (TRMT10A, -1.1, stimulated PBMC, 1.2 μM), (TRMT10A, -1.5, SHSY5Y, 5 μM), (TRMT61B, -1.3, stimulated PBMC, 0.6 μM), (TRMT61B, -1.4, stimulated PBMC, 1.2 μM), (TSNARE1, -1.2, stimulated PBMC, 0.6 μM), (TTC12, -1.7, HEK293, 0.6 μM), (TTC12, -2.3, MOLM13, 0.6 μM), (TTC12, -1.1, stimulated PBMC, 0.6 μM), (TTC12, -1.5, HEK293, 1.2 μM), (TTC12, -2, MOLM13, 1.2 μM), (TTC12, -2.7, HEK293, 5 μM), (TTC12, -1.1, SHSY5Y, 5 μM), (TTC13, 1, stimulated PBMC, 1.2 μM), (TTC28-AS1, 1.2, MOLM13, 0.6 μM), (TTC28- AS1, 1.3, MOLM13, 1.2 μM), (TTC39C, -1.2, MOLM13, 0.6 μM), (TTC39C, -1.2, stimulated PBMC, 0.6 μM), (TTC39C, -1.2, MOLM13, 1.2 μM), (TTC39C, -1.3, stimulated PBMC, 1.2 μM), (TTYH2, -1.2, HEK293, 0.6 μM), (TTYH2, -1.1, MOLM13, 0.6 μM), (TTYH2, -1.1, HEK293, 1.2 μM), (TTYH2, -1.3, MOLM13, 1.2 μM), (TTYH2, -1.5, HEK293, 5 μM), (TTYH2, -1.1, SHSY5Y, 5 μM), (TXNDC11, -1.1,HEK293, 0.6 μM), (TXNDC11, -1.2, MOLM13, 0.6 μM), (TXNDC11, -1.1, stimulated PBMC, 0.6 μM), (TXNDC11, -1, HEK293,
1.2 μM), (TXNDC11, -1.1, MOLM13, 1.2 μM), (TXNDC11, -1, HEK293, 5 μM), (TXNDC16, - 1.3, HEK293, 0.6 μM), (TXNDC16, -2, MOLM13, 0.6 μM), (TXNDC16, -1.6, stimulated PBMC, 0.6 μM), (TXNDC16, -1.5, HEK293, 1.2 μM), (TXNDC16, -2, MOLM13, 1.2 μM), (TXNDC16, -1.2, stimulated PBMC, 1.2 μM), (TXNDC16, -1.4, HEK293, 5 μM), (TXNDC16, - 1.5, SHSY5Y, 5 μM), (UBA2, -1.3, HEK293, 0.6 μM), (UBA2, -1.5, MOLM13, 0.6 μM), (UBA2, -1.6, stimulated PBMC, 0.6 μM), (UBA2, -1.5, HEK293, 1.2 μM), (UBA2, -1.5, MOLM13, 1.2 μM), (UBA2, -1.6, stimulated PBMC, 1.2 μM), (UBA2, -1.4, HEK293, 5 μM), (UBA2, -1.5, SHSY5Y, 5 μM), (UBA2, -1.2, diffSY5Y, 5 μM), (UBAC2, -1.1, HEK293, 0.6 μM), (UBAC2, -1.5, MOLM13, 0.6 μM), (UBAC2, -1.1, stimulated PBMC, 0.6 μM), (UBAC2, -1.3, HEK293, 1.2 μM), (UBAC2, -1.5, MOLM13, 1.2 μM), (UBAC2, -1.1, stimulated PBMC,
1.2 μM), (UBAC2, -1.5, HEK293, 5 μM), (UBAC2, -1.5, SHSY5Y, 5 μM), (UBAC2, -1.7, diffSY5Y, 5 μM), (UGGT2, -1.2, HEK293, 0.6 μM), (UGGT2, -1.2, MOLM13, 0.6 μM), (UGGT2, -1.7, stimulated PBMC, 0.6 μM), (UGGT2, -1.3, HEK293, 1.2 μM), (UGGT2, -1, MOLM13, 1.2 μM), (UGGT2, -1.4, diffSY5Y, 5 μM), (UNC50, -1.1, stimulated PBMC, 0.6 μM), (UNC50, -1.3, HEK293, 5 μM), (VAV3, -1.7, MOLM13, 0.6 μM), (VAV3, -1.9, stimulated PBMC, 0.6 μM), (VAV3, -1.8, MOLM13, 1.2 μM), (VAV3, -1.9, stimulated PBMC,
1.2 μM), (VAV3, -2, SHSY5Y, 5 μM), (WDFY2, -1.3, MOLM13, 0.6 μM), (WDFY2, -1.2, MOLM13, 1.2 μM), (WDR27, -1.3, MOLM13, 0.6 μM), (WDR27, -1.6, stimulated PBMC, 0.6
Compound 3
[00559] Table 28 provides further detail of results (Cpd = Compound, Gene = Gene, Cone = Concentration, L2FC = log2 fold change) for genes exhibiting a two fold change, or more, in gene expression (a Log2 fold change of 1.0 or above, or -1.0 or below) together with a change in Percent Spliced In (APSI) of 50% to 100%, or -50% to -100%, at a p value (pVal) of < 0.001 in the presence of Compound 3.
[00560] The cell lines tested included Familial Dysautonomia patient fibroblasts (FDPF), HEK293, stimulated PBMC (sPBMC), differentiated SY5Y (diffSY5Y), SHSY5Y, M0LM13 and HT1080.
[00562] RNAseq experiments showed that Compound 3 induced exon skipping with a PSI change (APSI) of -50% to -100% and P-value <0.001 in 1 gene:
[00564] RNAseq experiments showed that Compound 3 induced skipping with a PSI change (APSI) of -50% to -100% and P-value <0.001 in genes having a 5' splice site as follows (1 entry):
[00565] Table 30
Gene Expression Results (Compound 3)
[00566] RNAseq experiments showed that Compound 3 modulated expression of various genes by a factor of 2 or more. The following table identifies genes from Table 5 which resulted in a log 2 fold change (L2FC) of 1 or above (increased expression), or -1 or below (decreased expression), upon treatment with Compound 3:
[00567] Table 31
Compound 26
[00568] Table 32 provides further detail of results (Cpd = Compound, Gene = Gene, Cone = Concentration, L2FC = log2 fold change) for genes exhibiting a two fold change, or more, in gene expression (a Log2 fold change of 1.0 or above, or -1.0 or below) together with a change in Percent Spliced In (APSI) of 50% to 100%, or -50% to -100%, at a p value (pVal) of < 0.001 in the presence of Compound 26.
[00569] The cell lines tested included Familial Dysautonomia patient fibroblasts (FDPF), HEK293, stimulated PBMC (sPBMC), differentiated SY5Y (diffSY5Y), SHSY5Y, M0LM13 and HT1080.
Skipping Results (Compound 26)
[00571] RNAseq experiments showed that Compound 26 induced exon skipping with a PSI change (APSI) of -50% to -100% and P-value <0.001 in 3 genes:
[00573] RNAseq experiments showed that Compound 26 induced exon skipping with a PSI change (APSI) of -50% to -100% and P-value <0.001 in genes having a 5' splice site as follows (3 entries):
[00574] Table 34
Skipping and NMD Results (Compound 26)
[00575] RNAseq experiments showed that Compound 26 induced exon skipping associated with nonsense mediated decay with a PSI change (APSI) of -50% to -100% and P- value <0.001 in 1 gene:
[00577] RNAseq experiments showed that Compound 26 induced exon skipping associated with nonsense mediated decay with a PSI change (APSI) of -50% to -100% and P- value <0.001 in genes having a 5' splice site as follows (1 entry):
[00578] Table 36
Inclusion Results (Compound 26)
[00579] RNAseq experiments showed that Compound 26 induced exon inclusion with a
[00581] RNAseq experiments showed that Compound 26 induced exon inclusion with a PSI change (APSI) of +50% to +100% and P-value <0.001 in genes having a 5' splice site as follows (1 entry):
[00582] Table 38
Gene Expression Results (Compound 26)
[00583] RNAseq experiments showed that Compound 26 modulated expression of various genes by a factor of 2 or more. The following table identifies genes from Table 5 which resulted in a log 2 fold change (L2FC) of 1 or above (increased expression), or -1 or below (decreased expression), upon treatment with Compound 26:
Compound 28
[00585] Table 40 provides further detail of results (Cpd = Compound, Gene = Gene, Cone = Concentration, L2FC = logi fold change) for genes exhibiting a two fold change, or more, in gene expression (a Log2 fold change of 1.0 or above, or -1.0 or below) together with a change in Percent Spliced In (APSI) of 50% to 100%, or -50% to -100%, at a p value (pVal) of < 0.001 in the presence of Compound 28.
[00586] The cell lines tested included Familial Dysautonomia patient fibroblasts (FDPF), HEK293, stimulated PBMC (sPBMC), differentiated SY5Y (diffSY5Y), SHSY5Y, M0LM13 and HT1080.
Inclusion Results (Compound 28)
[00588] RNAseq experiments showed that Compound 28 induced exon inclusion with a PSI change (APSI) of +50% to +100% and P-value <0.001 in 123 genes:
[00589] Table 41
[00590] RNAseq experiments showed that Compound 28 induced exon inclusion with a PSI change (APSI) of +50% to +100% and P-value <0.001 in genes having a 5' splice site as follows (150 entries):
Inclusion and NMD Results (Compound 28)
[00592] RNAseq experiments showed that Compound 28 induced exon inclusion associated with nonsense mediated decay with a PSI change (APSI) of +50% to +100% and P- value <0.001 in 13 genes:
[00593] Table 43
[00594] RNAseq experiments showed that Compound 28 induced exon inclusion associated with nonsense mediated decay with a PSI change (APSI) of +50% to +100% and P- value <0.001in genes having a 5' splice site as follows (13 entries):
Skipping Results (Compound 28)
[00596] RNAseq experiments showed that Compound 28 induced exon skipping with a
PSI change (APSI) of -50% to -100% and P-value <0.001 in 450 genes:
[00598] RNAseq experiments showed that Compound 28 induced exon skipping with a
PSI change (APSI) of -50% to -100% and P-value <0.001 in genes having a 5' splice site as follows (502 entries):
[00599] Table 46
ACAGgttgca, ACAGgttggt, ACAGgtttga, ACAGgtttgt, ACATgtaagc, ACATgtaagt, ACATgtaatg, ACATgtgagt, ACCAgtgagt, ACCGgtgagc, ACCTgtaaga, ACCTgtaagt, ACCTgtgagt, ACGGgtgagg, ACGGgtgagt, ACTGgtaggg, ACTTgtaagt, AGAAgtgagc, AGAAgtgagt, AGACgtaagt, AGACgtgagc, AGAGgcgtga, AGAGgtaaaa, AGAGgtaaac, AGAGgtaact, AGAGgtaaga, AGAGgtaagc, AGAGgtaagt, AGAGgtaata, AGAGgtacaa, AGAGgtacag, AGAGgtacta, AGAGgtaggc, AGAGgtcagt, AGAGgtgaag, AGAGgtgaga, AGAGgtgagc, AGATgtaaga, AGCGgtgaga, AGCTgtaagt, AGCTgtgagt, AGGGgtgagt, AGTCgtgagt, AGTGgtaaaa, AGTGgtgagt, ATACgtaagt, ATATgtaagt, ATATgtgagt, ATCAgtaagt, ATCGgtgagt, ATCTgtaagt, ATCTgtgaga, ATCTgtgagt, ATGAgtaagt, ATGAgtgagt, ATGCgtgagt, ATGGgtaagc, ATGGgtaagt, ATGGgtaatg, ATGGgtaggt, ATGTgtgagt, ATTGgtaaga, ATTGgtaagt, ATTGgtgaga, ATTTgtaagt, ATTTgtgagt, CAAAgtaaga, CAAAgtaagt, CAAAgtaata, CAAAgtgagt, CAACgtaagt, CAAGgcaagt, CAAGgtaaca, CAAGgtaata, CAAGgtatat, CAAGgtatgt, CAAGgtgagg, CAAGgtgagt, CAAGgttagt, CAATgtgagt, CACAgtaaga, CACAgtaagt, CACAgtgagt, CACCgtgagt, CACGgcaagt, CACGgtaaac, CACGgtacgc, CACGgtgggt, CACTgtaagt, CACTgtgagt, CAGAgtgagt, CAGCgtaagt, CAGGgtaagc, CAGGgtaagt, CAGGgtgagg, CAGTgtgagt, CATGgtaagt, CATGgtacgt, CATGgtgcgt, CATTgtaagt, CATTgtgagt, CCAAgtaagt, CCACgtaaga, CCACgtaagt, CCACgtgagt, CCAGgtaaac, CCAGgtaaat, CCAGgtaact, CCAGgtaagc, CCAGgtaagg, CCAGgtaatg, CCAGgtaatt, CCAGgtagaa, CCAGgtagca, CCAGgtaggt, CCAGgtatgt, CCAGgtctga, CCAGgtgact, CCAGgtgagc, CCAGgtgagt, CCAGgtggga, CCAGgtgggc, CCAGgtgggg, CCAGgtgggt, CCAGgtgtgt, CCAGgttaga, CCAGgttcaa, CCAGgtttgt, CCATgtaagt, CCATgtgagt, CCCAgtgagt, CCCAgtggtg, CCCCgtgagt, CCCGgtatgt, CCCGgtgagt, CCCTgtaagt, CCCTgtgagt, CCGGgtaaaa, CCGGgtgagt, CCGTgtaagt, CCTCgtgagt, CCTGgccaac, CCTGgtaagg, CCTGgtaggt, CCTGgtatgg, CCTGgtgagc, CCTGgtgagt, CCTTgtaagt, CGAGgtaacg, CGAGgtgaag, CGATgtgagt, CGCAgtgagc, CGCTgtaagc, CGCTgtgagt, CGGGgtgagt, CGTGgtaagg, CGTGgtgagc, CGTGgtgagt, CTAAgtgagt, CTAGgtatgt, CTAGgtgaga, CTAGgttagt, CTATgtaact, CTATgtaaga, CTATgtaagt, CTCAgtaagt, CTCAgtgagt, CTCCgtgagt, CTCGgtaagt, CTCGgtattg, CTCTgtaagt, CTCTgtatgt, CTCTgtgagt, CTGAgtaagc, CTGAgtaagt, CTGAgtgagt, CTGCgtgagt, CTGGgtaagt, CTGGgtgaga, CTGGgtgagg, CTGGgtgagt, CTGTgtaagt, CTGTgtgagt, CTTCgtgagt, CTTGgtaagg, CTTGgtatgc, CTTGgtgagc, CTTTgtaagt, CTTTgtgagt, GAAGgcatgt, GAAGgtaaag, GAAGgtaaga, GAAGgtaagt, GAAGgtaatt, GAAGgtacat, GAAGgtaggc, GAAGgtaggt, GAAGgtagtt, GAAGgtatgt, GAAGgtgaga, GAAGgtgagc, GAAGgtgagg, GAAGgtgata, GAAGgttagt, GAAGgttggt, GAATgtaagt, GAATgtgagc, GACAgtgagt, GACCgtaagt, GACGgtaagt, GACGgtgagc, GACTgtaagt, GACTgtgagt, GAGGgtaaga, GAGGgtgagt, GAGGgtttgt, GAGTgtgagt, GATAgtaagt, GATAgtgagt, GATCgtaagt, GATGgtaaga, GATGgtaagt, GATGgtatgt, GATGgtgagt, GATTgtaagt, GCAAgtaagt, GCAAgtacgg, GCAAgtatga, GCAGgtaaca, GCAGgtaacc, GCAGgtaaga, GCAGgtaggc, GCAGgtaggt, GCAGgtagtt, GCAGgtatca, GCAGgtgacc, GCAGgtgaga, GCAGgtgagg, GCAGgtgagt, GCAGgtgatg, GCAGgtgcga, GCAGgtggga, GCAGgtgtgc, GCATgtaagt, GCATgtgagc, GCATgtgagt, GCCAgtaaga, GCCAgtgagt, GCCGgtaagt, GCCGgtgagt, GCCTgtaagt, GCCTgtgagt, GCTCgtaagt, GCTGgtaaat, GCTGgtaagt, GCTGgtgagt, GCTTgtatgt, GGAAgtaagc, GGAGgtaaga, GGAGgtaagc, GGAGgtattt, GGAGgtgaga, GGAGgtgagt, GGAGgtgtgt, GGATgtgagt, GGCAgtaagt, GGCAgtgagt, GGCTgtaagt, GGCTgtgagt, GGTGgtgagt, GGTTgtaagt,
Skipping and NMD Results (Compound 28)
[00600] RNAseq experiments showed that Compound 28 induced exon skipping associated with nonsense mediated decay with a PSI change (APSI) of -50% to -100% and P- value <0.001 in 169 genes:
[00602] RNAseq experiments showed that Compound 28 induced exon skipping associated with nonsense mediated decay with a PST change (APSI) of -50% to -100% and P- value <0.001 in genes having a 5' splice site as follows (165 entries):
Gene Expression Results (Compound 28)
[00604] RNAseq experiments showed that Compound 28 modulated expression of various genes by a factor of 2 or more. The following table identifies genes from Table 5 which resulted
in a log 2 fold change (L2FC) of 1 or above (increased expression), or 1 or below (decreased expression), upon treatment with Compound 28:
[00605] Table 49
fibroblast, 1 μM), (EMC2, -1.1, FD patient fibroblast, 0.01 μM), (EMC2, -2, FD patient fibroblast, 0.1 μM), (EMC2, -2.1, FD patient fibroblast, 1 μM), (EML4, -1.2, FD patient fibroblast, 1 μM), (EPS8, -1.2, FD patient fibroblast, 0.1 μM), (EPS8, -1.4, FD patient fibroblast, 1 μM), (ERLIN1, -1.1, FD patient fibroblast, 1 μM), (FAM208A, -1.3, FD patient fibroblast, 0.1 μM), (FAM208A, -1.6, FD patient fibroblast, 1 μM), (FANCA, -1.2, FD patient fibroblast, 1 μM), (FANCI, -1.3, FD patient fibroblast, 0.01 μM), (FANCI, -2.1, FD patient fibroblast, 0.1 μM), (FANCI, -2.5, FD patient fibroblast, 1 μM), (FANCL, -1.7, FD patient fibroblast, 0.1 μM), (FANCL, -2.6, FD patient fibroblast, 1 μM), (FBX09, -1, FD patient fibroblast, 0.1 μM), (FBX09, -1.2, FD patient fibroblast, 1 μM), (FGGY, -2, FD patient fibroblast, 0.1 μM), (FGGY, -1.8, FD patient fibroblast, 1 μM), (FIG4, -1.4, FD patient fibroblast, 0.1 μM), (FIG4, -1.3, FD patient fibroblast, 1 μM), (F0XRED1 ,-1.2, FD patient fibroblast, 1 μM), (G2E3, -1.3, FD patient fibroblast, 1 μM), (GALNT6, -1, FD patient fibroblast, 0.1 μM), (GALNT6, -1.1, FD patient fibroblast, 1 μM), (GEMIN2, -1.1, FD patient fibroblast, 0.1 μM), (GEMIN2, -1.5, FD patient fibroblast, 1 μM), (GEN1, -1.1, FD patient fibroblast, 1 μM), (GPR155, -1.2, FD patient fibroblast, 0.1 μM), (GPR155, -1.6, FD patient fibroblast, 1 μM), (GTF2I, -1.2, FD patient fibroblast, 0.1 μM), (GTF2I, -1.7, FD patient fibroblast, 1 μM), (GTF21P1, -1.2, FD patient fibroblast, 1 μM), (GTF2IP4, -1.2, FD patient fibroblast, 1 μM), (HACL1, -1.1, FD patient fibroblast, 0.1 μM), (HERC2, -1.2, FD patient fibroblast, 0.1 μM), (HERC2, -1.4, FD patient fibroblast, 1 μM), (HSD17B4, -1.6, FD patient fibroblast, 0.01 μM), (HSD17B4, -1.6, FD patient fibroblast, 0.1 μM), (HSD17B4, -1.6, FD patient fibroblast, 1 μM), (IDE, -1.3, FD patient fibroblast, 1 μM), (IFT172, -1.1, FD patient fibroblast, 1 μM), (IL15, 1.4, FD patient fibroblast, 0.1 μM), (IL15, 1.4, FD patient fibroblast, 1 μM), (IL17RE, -1.6, FD patient fibroblast, 1 μM), (IQCB1, -1.1, FD patient fibroblast, 1 μM), (ITGA10, -1.5, FD patient fibroblast, 0.1 μM), (ITGA10, -2.2, FD patient fibroblast, 1 μM), (KATNAL2, -1.7, FD patient fibroblast, 0.1 μM), (KATNAL2, -1.9, FD patient fibroblast, 1 μM), (KIAA0556, -1.8, FD patient fibroblast, 0.1 μM), (KIAA0556, -1.8, FD patient fibroblast, 1 μM), (KIAA1841, -1, FD patient fibroblast, 0.1 μM), (KIAA1841, -1.2, FD patient fibroblast, 1 μM), (LCORL, 1, FD patient fibroblast, 0.1 μM), (LCORL, 1.1, FD patient fibroblast, 1 μM), (LEPR, 1.1, FD patient fibroblast, 0.1 μM), (LEPR, 1.2, FD patient fibroblast, 1 μM), (LOCI 00506844, -2.3, FD patient fibroblast, 0.1 μM), (LOC100506844, -2, FD patient fibroblast, 1 μM), (LOCI 02606465, -1.1, FD patient fibroblast, 1 μM), (LOCI 02724532, -1.2, FD patient fibroblast, 0.01 μM), (LOC102724532, -1.8, FD patient fibroblast, 0.1 μM), (LOCI 02724532, -1.6, FD patient fibroblast, 1 μM), (LRRC34, -1.4, FD patient fibroblast, 0.01 μM), (LRRC34, -1.5, FD patient fibroblast, 0.1 μM), (LYST, -1.1, FD patient fibroblast, 0.1 μM), (MB0AT2, -1, FD patient fibroblast, 0.01 μM), (MB0AT2, -1.4, FD patient fibroblast, 0.1 μM), (MB0AT2, -1.5, FD patient fibroblast, 1 μM), (MCCC2, -1, FD patient fibroblast, 0.1 μM), (MCCC2, -1.2, FD patient fibroblast, 1 μM), (MLH1, -1.3, FD patient fibroblast, 0.1 μM), (MLH1, -1.5, FD patient fibroblast, 1 μM), (MMAB, -1, FD patient fibroblast, 0.1 μM), (M0SPD2, -1.5, FD patient fibroblast, 0.1 μM), (M0SPD2, -2, FD patient fibroblast, 1 μM), (NEK1, -1.6, FD patient fibroblast, 0.1 μM), (NEK1, -1.8, FD patient fibroblast, 1 μM), (NFATC2IP, -1.6, FD patient fibroblast, 0.1 μM), (NFATC2IP, -1.8, FD patient fibroblast, 1 μM), (NUP43, -1.1, FD patient fibroblast, 1 μM), (NUPL2, -1.2, FD patient fibroblast, 0.1 μM), (NUPL2, -1.2, FD patient fibroblast, 1 μM), (0ARD1, -1.4, FD patient fibroblast, 0.1 μM), (0ARD1, -1.3, FD patient fibroblast, 1 μM), (OLMALINC, -4, FD patient fibroblast, 1 μM), (OXCT1, -1.1, FD patient fibroblast, 1 μM), (PCCB, -1.2, FD patient fibroblast, 1 μM), (PCID2, -2, FD patient fibroblast, 0.1 μM), (PCID2, -2.1, FD patient
fibroblast, 1 μM), (PFDN1, -1.4, FD patient fibroblast, 0.1 μM), (PFDN1, -1.8, FD patient fibroblast, 1 μM), (PGAP1, -1.2, FD patient fibroblast, 0.01 μM), (PGAP1, -1.3, FD patient fibroblast, 0.1 μM), (PGAP1, -1.7, FD patient fibroblast, 1 μM), (PHKG2, -1.3, FD patient fibroblast, 0.1 μM), (PHKG2, -1.5, FD patient fibroblast, 1 μM), (PIK3C2A, -1.3, FD patient fibroblast, 0.1 μM), (PIK3C2A, -1.2, FD patient fibroblast, 1 μM), (P0LA2, -1.7, FD patient fibroblast, 1 μM), (POLQ, -1.2, FD patient fibroblast, 1 μM), (POLR3F, -1.1, FD patient fibroblast, 1 μM), (PPCDC, -1.1, FD patient fibroblast, 0.1 μM), (PPP2R3C, -1.2, FD patient fibroblast, 0.1 μM), (PPP2R3C, -1.1, FD patient fibroblast, 1 μM), (PRKAG1, -1, FD patient fibroblast, 0.1 μM), (PRPF40B, -1.8, FD patient fibroblast, 0.1 μM), (PRPF40B, -2, FD patient fibroblast, 1 μM), (PTGIS, -1.2, FD patient fibroblast, 0.1 μM), (RAB3GAP1, -1.3, FD patient fibroblast, 0.1 μM), (RAB3GAP1, -1.5, FD patient fibroblast, 1 μM), (RAD51 API, -1.1, FD patient fibroblast, 1 μM), (RADIL, -1, FD patient fibroblast, 0.1 μM), (RADIL, -1.6, FD patient fibroblast, 1 μM), (RINT1, -1.2, FD patient fibroblast, 1 μM), (RNF170, -1, FD patient fibroblast, 0.1 μM), (RNF170, -1, FD patient fibroblast, 1 μM), (RNFT1, -1, FD patient fibroblast, 0.01 μM), (RNFT1, -1.2, FD patient fibroblast, 0.1 μM), (RRNAD1, -1.3, FD patient fibroblast, 0.1 μM), (RRNAD1, -1.2, FD patient fibroblast, 1 μM), (SAMD12, 1.5, FD patient fibroblast, 1 μM), (SDCCAG3, -1.1, FD patient fibroblast, 1 μM), (SFI1, -1, FD patient fibroblast, 1 μM), (SGIP1, -1.5, FD patient fibroblast, 1 μM), (SLC22A23, -1.2, FD patient fibroblast, 0.1 μM), (SLC22A23, -1.3, FD patient fibroblast, 1 μM), (SLC25A32, -1, FD patient fibroblast, 0.1 μM), (SLC25A32, -1.2, FD patient fibroblast, 1 μM), (SLC25A40, -1.1, FD patient fibroblast, 0.1 μM), (SLC25A40, -1.9, FD patient fibroblast, 1 μM), (SLC38A6, -1.4, FD patient fibroblast, 0.01 μM), (SLC38A6, -1.8, FD patient fibroblast, 0.1 μM), (SLC38A6, -1.7, FD patient fibroblast, 1 μM), (SLC43A1, -1, FD patient fibroblast, 0.01 μM), (SLC43A1, -2.2, FD patient fibroblast, 0.1 μM), (SLC43A1, -2.1, FD patient fibroblast, 1 μM), (SLC4A7, -1.4, FD patient fibroblast, 0.1 μM), (SLC4A7, -1.6, FD patient fibroblast, 1 μM), (SRP14-AS1, -1.8, FD patient fibroblast, 0.01 μM), (SRP14-AS1, -3.1, FD patient fibroblast, 0.1 μM), (SRP14- AS1, -3.5, FD patient fibroblast, 1 μM), (ST7L, -1, FD patient fibroblast, 1 μM), (STARD5, -
1.4, FD patient fibroblast, 0.1 μM), (STARD5, -1.4, FD patient fibroblast, 1 μM), (STXBP3, - 1.3, FD patient fibroblast, 0.01 μM), (STXBP3, -3.6, FD patient fibroblast, 0.1 μM), (STXBP3, - 3.9, FD patient fibroblast, 1 μM), (TARSL2, -1.3, FD patient fibroblast, 0.1 μM), (TARSL2, -
1.5, FD patient fibroblast, 1 μM), (TBC1D19, -2.2, FD patient fibroblast, 0.1 μM), (TBC1D19, -
2.6, FD patient fibroblast, 1 μM), (TBCK, -2, FD patient fibroblast, 0.1 μM), (TBCK, -2.2, FD patient fibroblast, 1 μM), (TBX15, -1.7, FD patient fibroblast, 0.1 μM), (TBX15, -1.7, FD patient fibroblast, 1 μM), (TDP1, -1.1, FD patient fibroblast, 0.01 μM), (TDP1, -1.4, FD patient fibroblast, 0.1 μM), (TDP1, -1.8, FD patient fibroblast, 1 μM), (TFCP2, -1.1, FD patient fibroblast, 1 μM), (TIA1, -1.1, FD patient fibroblast, 1 μM), (TMEM220, -1.5, FD patient fibroblast, 0.1 μM), (TMEM220, -1.8, FD patient fibroblast, 1 μM), (TMEM67, -1.3, FD patient fibroblast, 0.1 μM), (TMEM67, -1.3, FD patient fibroblast, 1 μM), (TMX2, -1.1, FD patient fibroblast, 1 μM), (TMX3, -1.5, FD patient fibroblast, 0.1 μM), (TMX3, -1.6, FD patient fibroblast, 1 μM), (TNKS2, -1.3, FD patient fibroblast, 0.1 μM), (TNKS2, -1.6, FD patient fibroblast, 1 μM), (TRABD2A, 1.2, FD patient fibroblast, 0.1 μM), (TRMT61B, -1, FD patient fibroblast, 0.01 μM), (TRMT61B, -1.7, FD patient fibroblast, 0.1 μM), (TRMT61B, -1.6, FD patient fibroblast, 1 μM), (TTC12, -1.2, FD patient fibroblast, 1 μM), (TTC13, 1.1, FD patient fibroblast, 0.1 μM), (TTC13, 1.1, FD patient fibroblast, 1 μM), (TXNDC11, -1.2, FD patient fibroblast, 0.1 μM), (TXNDC11, -1.3, FD patient fibroblast, 1 μM), (TXNDC16, -1.7, FD patient
Compound 52
[00606] Table 50 provides further detail of results (Cpd = Compound, Gene = Gene, Cone = Concentration, L2FC = log2 fold change) for genes exhibiting a two fold change, or more, in gene expression (a Log2 fold change of 1.0 or above, or -1.0 or below) together with a change in Percent Spliced In (APSI) of 50% to 100%, or -50% to -100%, at a p value (pVal) of < 0.001 in the presence of Compound 52.
[00607] The cell lines tested included Familial Dysautonomia patient fibroblasts (FDPF), HEK293, stimulated PBMC (sPBMC), differentiated SY5Y (diffSY5Y), SHSY5Y, M0LM13 and HT1080.
Inclusion Results (Compound 52)
[00609] RNAseq experiments showed that Compound 52 induced exon inclusion with a PSI change (APSI) of +50% to +100% and P-value <0.001 in 263 genes:
[00611] RNAseq experiments showed that Compound 52 induced exon inclusion with a
PSI change (APSI) of +50% to +100% and P-value <0.001 in genes having a 5' splice site as follows (257 entries):
Inclusion and NMD Results (Compound 52)
[00613] RNAseq experiments showed that Compound 52 induced exon inclusion associated with nonsense mediated decay with a PSI change (APSI) of +50% to +100% and P- value <0.001in 77 genes:
[00615] RNAseq experiments showed that Compound 52 induced exon inclusion associated with nonsense mediated decay with a PSI change (APSI) of +50% to +100% and P- value <0.001in genes having a 5' splice site as follows (74 entries):
Skipping Results (Compound 52)
[00617] RNAseq experiments showed that Compound 52 induced exon skipping with a PSI change (APSI) of -50% to -100% and P-value <0.001 in 1118 genes:
[00618] Table 55
DTNBP1, DUS2, DUSP11, DUXAP8, DYM, DYNC1LI2, DYNC2LI1, DYRK3, DZIP3, E2F6, EBPL, EFS, EIF1AX, EIF2AK2, EIF2AK4, EIF4E2, ELF2, ELM02, ELN, EL0VL2, EL0VL7, ELP2, EMC2, ENTPD5, ENTPD6, EOGT, EPB41L5, EPHX4, EPN2, ERLIN1, ERMARD, ESD, ETHE1, EVI5, EXD2, EXOC3, FAHD2A, FAM105A, FAM114A2, FAM120B, FAM135A, FAM169A, FAM172A, FAM173B, FAM189B, FAM193B, FAM206A, FAM207A, FAM208A, FAM208B, FAM35A, FAM3A, FAM53B, FAM92A, FANCD2, FANCE, FANCI, FANCL, FANCM, FARP2, FAT1, FBRSL1, FBXO38, FBXO9, FBXW8, FBXW9, FCF1, FER, FHOD3, FIG4, FKBP15, FOXJ3, FOXP2, FOXRED1, FPGT-TNNI3K, FRG1BP, FRG1CP, FRG1JP, FRYL, FUBP1, G2E3, G6PC3, GALNT13, GALT, GAS2L1, GATB, GCH1, GEMIN2, GEMIN8, GFM2, GGCX, GINS1, GINS3, GLB1, GLMN, GLS, GLS2, GNPTG, GOLGA4, GOLT1B, GOSR2, GPBP1, GPR107, GPR137, GPR180, GRIP API , GRK3, GS1 - 124K5. i l, GSTCD, GTF2H2, GTF2I, GTF2IP1, GTF2IRD1, GTF3C2, GUCD1, GUF1, GUSBP1, HADHB, HAGHL, HDAC1, HDAC8, HEATR3, HEATR5A, HERC1, HERC4, HERC5, HERPUD2, HGSNAT, HIBADH, HIBCH, HIRA, HMGN5, HNRNPA1, HPS1, HPS4, HSD17B14, HSD17B4, HTD2, HTT, HYAL3, ICA1, IDE, IDH3G, IFT122, IFT172, IFT80, 1GF2BP2, 1KBKB, IKZF5, 1L11RA, 1MMP1L, 1NG4, 1NO80C, 1NPP5F, 1NPP5K, 1NTS13, INTS8, IPO11, IPO8, IQCB1, IQSEC1, IRF3, IST1, ITPR1, IVD, JARID2, JMJD1C, KAT7, KATNAL1, KATNBL1, KCNQ5, KCTD20, KCTD9, KDM1B, KDM4B, KDM4C, KDM7A, KIAA0100, KIAA0319L, KIAA1468, KIDINS220, KIF13B, KIF24, KIF3A, KITLG, KLHL2, KLRG2, KNL1, KREMEN1, KYAT3, L1CAM, LARS, LAS1L, LAT, LBX2, LCMT1, LCORL, LDLRAD3, LENEP, LEPROTL1, LETMD1, LGR4, LGR5, LIG1, LIMCH1, LIN52, LIN54, LINC00630, LINC00888, LINC01881, LMBR1, LMBR1L, LM07, LGC100506844, LOC150776, LOC389906, LONP2, LPCAT2, LRCH3, LRIG1, LRIG3, LRRC28, LRRC40, LRRC58, LRTOMT, LYRM7, LZTFL1, MADD, MANEAL, MAP2K4, MAP2K5, MAP2K6, MAP3K3, MAP3K5, MAP4K2, MAP4K3, MAPK13, MAPK8, MAPKAPK5, MARCH6, MBNL2, MBOAT2, MBTD1, MCCC2, MCRS1, MDM1, MDM2, MED1, MED15, MED25, MEGF8, MEIS1, MELTF, MEM01, MERTK, METTL14, METTL8, MFF, MFGE8, MFSD12, MFSD14B, MFSD9, MGAT4C, MGAT5, MGEA5, MICAL1, MICALL1, MIF4GD, MINDY2, MINDY3, MINK1, MIR1268A, MKL2, MKS1, MLF1, MLH1, MLXIP, MMP24-AS 1 -EDEM2, MMS19, MMS22L, MNAT1, MND1, MOCS1, MOK, MOSPD1, MOSPD2, MPHOSPH9, MRNIP, MSI1, MSTO1, MTCH2, MTMR1, MTMR3, MTMR6, MYBL2, MYH14, MY09A, MYSM1, N4BP2, NAA40, NAGK, NAPG, NAXD, NBAS, NBEA, NBN, NBPF19, NBPF20, NBPF9, NCOA1, NCOA2, NDC1, NDRG3, NDUFA10, NDUFB6, NECAB3, NEK1, NEK4, NFATC2IP, NFKB1, NFRKB, NIFK, NFPBL, NKAIN1, NKTR, NOLIO, NOTCH2, NOTCH3, NPRL3, NR2C1, NRDC, NRF1, NSD1, NSUN6, NTPCR, NUB1, NUBP1, NUBPL, NUMB, NUP153, NUP188, NUP43, NUP54, NUP58, NUP85, NUP98, NUPL2, NXN, OARD1, ODF2, OGGI, OGT, 0MA1, ORAOV1, OSBPL6, OSBPL9, OSGIN2, OSTF1, OTULIN, OXCT1, P4HA2, PAAF1, PACRGL, PANK4, PAPD4, PAQR3, PARL, PARP2, PARP4, PARPBP, PATL1, PAXX, PC, PCBD2, PCBP3, PCCB, PCGF6, PCID2, PCM1, PCNX3, PDCD2L, PDE10A, PDE3B, PDE6B, PDK3, PDLIM2, PEX11A, PEX7, PFDN1, PFKFB3, PGAP1, PGGT1B, PGS1, PHF6, PHKA1, PHKG2, PHOSPHO2-KLHL23, PI4KA, PIC ALM, PICK1, PIGB, PIGG, PIGK, PIGT, PIK3C3, PIK3CB, PITPNA, PKIB, PKP4, PLA2G12A, PLA2G4A, PLAGL1, PLAT, PLBD2, PLCB4, PLEKHA1, PLEKHA5, PLEKHA7, PLPP5, PLRG1, PMS2, PMS2P1, POC1A, POLA2, POLE2, POLK, POLR2I3, POLR3GL, POM121, POMT1, PPCDC, PPIL2, PPM1M, PPP1R12A, PPP1R21, PPP2R3C, PPP4C, PPP4R3B, PPP6R2, PPRC1, PREB,
[00619] RNAseq experiments showed that Compound 52 induced exon skipping with a PSI change (APSI) of -50% to -100% and P-value <0.001 in genes having a 5' splice site as follows (999 entries):
[00620] Table 56
AGGGgtaagg, AGGGgtatgt, AGGGgtgagt, AGTCgtgagt, AGTGgtaagt, AGTGgtaatc, AGTGgtacgt, AGTGgtaggt, AGTGgtatgt, AGTGgtgagt, AGTTgtaagt, ATAAagaaga, ATAActggtg, ATAAgtatgt, ATACgtaagt, ATAGgtaaga, ATAGgtaagc, ATAGgtaagt, ATAGgtaatc, ATAGgtatga, ATAGgtatgg, ATAGgtatgt, ATAGgtattt, ATAGgtgagg, ATAGgtgggt, ATAGgtgtgt, ATAGgttggt, ATATgtaagt, ATATgtgagt, ATCAgtaagt, ATCAgtgagt, ATCCgtgagt, ATCTgtaaga, ATCTgtaagt, ATCTgtgaga, ATCTgtgagt, ATGAaaaggt, ATGAgtaaga, ATGAgtaagt, ATGAgtatga, ATGAgtgagt, ATGAgtgtga, ATGCgtgagt, ATGGgcaagt, ATGGgtaaat, ATGGgtaaga, ATGGgtaagt, ATGGgtgagc, ATGGgtgagt, ATGGgtttgt, ATGGtggtga, ATGTgtaagt, ATGTgtgagt, ATGTgtggtg, ATTAgtaagt, ATTGgcatgc, ATTGgtaaaa, ATTGgtaaga, ATTGgtaagc, ATTGgtaagt, ATTGgtaata, ATTGgtacgt, ATTGgtatgt, ATTGgtgaga, ATTGgtgagg, ATTGgtgagt, ATTGgtgtga, ATTTatctca, ATTTgtaagt, ATTTgtgagt, CAAAgtaagc, CAAAgtaatt, CAAAgtataa, CAAAgtgagt, CAACctggta, CAACgtaagt, CAAGgtaaaa, CAAGgtaaac, CAAGgtaaag, CAAGgtaacc, CAAGgtaact, CAAGgtaaga, CAAGgtaagg, CAAGgtaatt, CAAGgtacac, CAAGgtagat, CAAGgtaggc, CAAGgtaggt, CAAGgtataa, CAAGgtatct, CAAGgtatgt, CAAGgtattc, CAAGgtattg, CAAGgtcctg, CAAGgtctct, CAAGgtgact, CAAGgtgaga, CAAGgtgagc, CAAGgtgagt, CAAGgtgctg, CAAGgtgggt, CAAGgtgtgt, CAAGgttaga, CAAGgttagt, CAAGgtttct, CAATgtaagt, CAATgtgagg, CAATgtgagt, CAATgtgcgt, CACAggttag, CACAgtaagc, CACAgtaagt, CACAgtgagt, CACAgttgag, CACCgtaagt, CACCgtgagt, CACGgcgtga, CACGgtaaca, CACGgtagga, CACGgtgagt, CACGgtgcgc, CACTgtaagt, CACTgtatga, CACTgtgagt, CACTgtgcgt, CAGAggtaca, CAGAgtaaga, CAGAgtaagt, CAGAgtgagt, CAGCgtaagt, CAGCgtgagt, CAGGgtaaaa, CAGGgtaaat, CAGGgtaagc, CAGGgtaagg, CAGGgtaagt, CAGGgtatag, CAGGgtatgt, CAGGgtgaga, CAGGgtgagc, CAGGgtgagg, CAGGgtgagt, CAGTgtaagg, CAGTgtaagt, CAGTgtgagt, CAGTgtgggt, CATCgtgagt, CATGgtaagc, CATGgtaagt, CATGgtaggt, CATGgtatgc, CATGgtatgt, CATGgtgaat, CATGgtgagc, CATGgtgagt, CATGgtgggg, CATGgtgtgg, CATGgttggt, CATGgtttga, CATTagtgag, CATTgtaagt, CATTgtgagt, CCAAatgcaa, CCAAggtgag, CCAAgtaagt, CCAAgtgagc, CCAAgtgagt, CCACgtaagt, CCACgtgagt, CCAGgcaagg, CCAGgcaagt, CCAGgtaaaa, CCAGgtaaac, CCAGgtaaag, CCAGgtaacc, CCAGgtaaga, CCAGgtaagc, CCAGgtaagg, CCAGgtaagt, CCAGgtaatc, CCAGgtacaa, CCAGgtacag, CCAGgtactc, CCAGgtactg, CCAGgtagcc, CCAGgtaggt, CCAGgtagta, CCAGgtatat, CCAGgtatca, CCAGgtatcc, CCAGgtatgc, CCAGgtatgg, CCAGgtatgt, CCAGgtattg, CCAGgtattt, CCAGgtcagt, CCAGgtctga, CCAGgtgact, CCAGgtgaga, CCAGgtgagc, CCAGgtgagg, CCAGgtgagt, CCAGgtgggc, CCAGgtgggt, CCAGgtgtcg, CCAGgtgtgt, CCAGgttctg, CCAGgttgct, CCAGgttggt, CCAGgtttgt, CCATgtaagt, CCATgtgagt, CCCAggtaat, CCCAgtacga, CCCAgtgagt, CCCCgtgcgt, CCCGgcacgt, CCCGgtaaga, CCCGgtatgg, CCCGgtgagt, CCCTgtaagt, CCCTgtgagt, CCGAgtgagt, CCGGgtaagt, CCGGgtatgt, CCGGgtgagc, CCGGgtgagt, CCGGgtgtgt, CCGTgtgagt, CCTAgtaaga, CCTAgtaagt, CCTCgtaagt, CCTCgtgagt, CCTCgtgggt, CCTGgtaaag, CCTGgtaaat, CCTGgtaaga, CCTGgtaagt, CCTGgtaggt, CCTGgtatgc, CCTGgtcagt, CCTGgtgaga, CCTGgtgagg, CCTGgtgagt, CCTTgtaagt, CCTTgtgagc, CGAAgtaagt, CGACgtgagt, CGAGgcaagt, CGAGgtaaaa, CGAGgtaaat, CGAGgtaaga, CGAGgtacgt, CGAGgtaggg, CGAGgtatgt, CGAGgtattt, CGAGgtcagt, CGAGgtgaga, CGAGgtgagt, CGAGgtgatc, CGAGgtgatg, CGAGgtgctt, CGATgtaagt, CGATgtacaa, CGATgtgagt, CGCAgtaagt, CGCAgtgagc, CGCTgtaagc, CGCTgtgagt, CGGGgtaagc, CGGGgtaggc,
CGTGgtaaga, CGTGgtaagt, CGTGgtatgt, CGTGgtgagc, CGTGgtgagt, CTAAgtcagt, CTACgtaagt, CTAGgtaaaa, CTAGgtaaat, CTAGgtaaga, CTAGgtaatc, CTAGgtagag, CTAGgtcagt, CTAGgtgatg, CTATgtaaga, CTATgtaagt, CTATgtgagt, CTATgtgcgc, CTCAgtaagt, CTCAgtgagt, CTCCgtatgt, CTCCgtgagt, CTCGgtaagc, CTCGgtaagt, CTCTgtaaga, CTCTgtaagc, CTCTgtaagt, CTCTgtgagt, CTGAgtaagc, CTGAgtatcc, CTGAgtgagt, CTGCacagca, CTGCgtgagt, CTGGgtaact, CTGGgtaaga, CTGGgtaagc, CTGGgtaagg, CTGGgtaagt, CTGGgtaata, CTGGgtcagt, CTGGgtgagc, CTGGgtgagg, CTGGgtgagt, CTGGttatca, CTGTgtaagt, CTGTgtgaga, CTGTgtgagt, CTTCgtgagt, CTTCttggta, CTTGgtaacc, CTTGgtaaga, CTTGgtaagc, CTTGgtaggt, CTTGgtatac, CTTGgtatgt, CTTGgtgagc, CTTGgtgagg, CTTGgtgagt, CTTTgtaagt, CTTTgtgagt, GAAAgtaaga, GAAAgtaggt, GAAAgtatgt, GAAAgtgagt, GAACgtatgt, GAACgtgagt, GAAGgtaaaa, GAAGgtaaac, GAAGgtaaca, GAAGgtaact, GAAGgtaaga, GAAGgtaagt, GAAGgtacag, GAAGgtactg, GAAGgtagaa, GAAGgtagat, GAAGgtaggc, GAAGgtaggg, GAAGgtatag, GAAGgtatgt, GAAGgtcaga, GAAGgtcagt, GAAGgtgaaa, GAAGgtgaag, GAAGgtgagt, GAAGgtgatg, GAAGgtgatt, GAAGgtgcag, GAAGgtgctg, GAAGgtgggt, GAAGgtgtaa, GAAGgttggt, GAAGgtttgt, GAATgcaagg, GAATgtaagg, GAATgtaagt, GAATgtatgt, GAATgtgagg, GAATgtgagt, GAATtgtaag, GACAgtaagt, GACAgtgagt, GACCgtaagt, GACCgtatgt, GACCgtgagt, GACGgtaaag, GACGgtaagc, GACGgtaat, GACGgtgagg, GACGgtgcgt, GACTgtaaga, GACTgtaagt, GACTgtgagt, GACTgtgggt, GAGAagctaa, GAGAgtaaga, GAGAgtaagt, GAGGgtaaga, GAGGgtaagc, GAGGgtatgt, GAGGgtgaga, GAGGgtgagg, GAGGgtgagt, GAGTgtaagt, GAGTgtgagt, GATAgtaagt, GATAgtactg, GATAgtgagt, GATCgtgagt, GATGcaggaa, GATGgcatgt, GATGgtaaga, GATGgtaagt, GATGgtatga, GATGgtgagg, GATGgtgagt, GATGgtggga, GATGtgggtt, GATTgtaagt, GATTgtgagt, GCAAgtaagt, GCAAgtatgg, GCAAgtgagt, GCACgtaagt, GCAGgcaagt, GCAGgcacag, GCAGgtaaaa, GCAGgtaaac, GCAGgtaaag, GCAGgtaaca, GCAGgtaacc, GCAGgtaact, GCAGgtaaga, GCAGgtaagc, GCAGgtaagg, GCAGgtaagt, GCAGgtaatg, GCAGgtaatt, GCAGgtacag, GCAGgtactg, GCAGgtaggc, GCAGgtagta, GCAGgtatga, GCAGgtatgt, GCAGgtatta, GCAGgtattt, GCAGgtcagt, GCAGgtctgt, GCAGgtgaag, GCAGgtgaga, GCAGgtgagc, GCAGgtgagg, GCAGgtgagt, GCAGgtgcgg, GCAGgtgcgt, GCAGgtgggt, GCAGgtgtgt, GCAGgttagt, GCAGgttata, GCATgtaagt, GCATgtatcc, GCATgtgagt, GCCAgtgagt, GCCCgtgagt, GCCGgtaagg, GCCGgtaagt, GCCGgtatgt, GCCGgtgagc, GCCGgtgagt, GCCGgtgggt, GCCTgtaagt, GCCTgtgagt, GCGAgtgagt, GCGCgtgagt, GCGGgtgaga, GCGGgtgagc, GCGGgtgagt, GCGGgtgcgt, GCTAgtgagt, GCTAgtgcgt, GCTAtggaat, GCTGgtaaat, GCTGgtaagg, GCTGgtaagt, GCTGgtacct, GCTGgtaggt, GCTGgtatgt, GCTGgtcagt, GCTGgtgaga, GCTGgtgagt, GCTTgtatgt, GCTTgtgagt, GCTTgtgctt, GGAAgtaagt, GGAAgtatgt, GGAGgcaggt, GGAGgtaagt, GGAGgtaatt, GGAGgtagga, GGAGgtaggt, GGAGgtatac, GGAGgtatgc, GGAGgtatgt, GGAGgtcagg, GGAGgtcagt, GGAGgtgaga, GGAGgtgagc, GGAGgtgagg, GGAGgtgagt, GGAGgtgggc, GGAGgtgggt, GGATgtaagt, GGATgtgagt, GGATgttagc, GGCAgtaagt, GGCAgtgagt, GGCGgtgagg, GGCTgtaagt, GGCTgtgagt, GGGAgtaagt, GGGCattggt, GGGCgtatct, GGGGgtaagc, GGTGgtaagt, GTAGgtaggt, GTAGgtgagt, GTAGgtgggt, GTATgtaagt, GTCAacggct, GTCAgtaagt, GTCCgtaagt, GTCTgtaagt, GTGGgtgagg, GTGGgtgagt, GTGTgtaagg, GTTAtggtga, GTTGgtaaga, GTTGgtaagt, GTTGgtgaga, GTTGgtgagt, GTTTgtaagt, GTTTgtgagt, TAAAgtaagt, TAAAgtgagt, TAAAgtgtgt, TAACgtgagt, TAAGgtaaaa, TAAGgtaact, TAAGgtaaga, TAAGgtaagg, TAAGgtaagt,
Skipping and NMD Results (Compound 52)
[00621] RNAseq experiments showed that Compound 52 induced exon skipping associated with nonsense mediated decay with a PSI change (APSI) of -50% to -100% and P- value <0.001 in 583 genes:
[00622] Table 57
[00623] RNAseq experiments showed that Compound 52 induced exon skipping associated with nonsense mediated decay with a PSI change (APSI) of -50% to -100% and P-value <0.001 in genes having a 5' splice site as follows (565 entries):
[00624] Table 58
AGAGgtgaca, AGAGgtgaga, AGAGgtgagc, AGAGgtgagt, AGATgtaaga, AGATgtaagc, AGATgtgagt, AGCAgtgagt, AGCCgtaagt, AGCCgtgtgt, AGCGgtaagt, AGCGgtgagc, AGCTgtaagt, AGCTgtatgt, AGCTgtgagt, AGGGgtaagg, AGGGgtatgt, AGTCgtgagt, AGTGgtaatc, AGTTgtaagt, ATAAgtatgt, ATACgtaagt, ATAGgtaaga, ATAGgtaagc, ATAGgtaagt, ATAGgtaatc, ATAGgtatga, ATAGgtgagg, ATAGgtgggt, ATAGgttggt, ATATgtaagt, ATATgtgagt, ATCAgtaagt, ATCCgtgagt, ATCTgtaaga, ATCTgtaagt, ATCTgtgagt, ATGAgtaaga, ATGAgtaagt, ATGAgtatga, ATGAgtgtga, ATGCgtgagt, ATGGgcaagt, ATGGgtaaat, ATGGgtaaga, ATGGgtgagt, ATGGgtttgt, ATGTgtaagt, ATGTgtgagt, ATGTgtggtg, ATTGgtaaga, ATTGgtaagt, ATTGgtaata, ATTGgtacgt, ATTGgtatgt, ATTGgtgaga, ATTGgtgagg, ATTGgtgagt, ATTGgtgtga, CAAAgtgagt, CAACgtaagt, CAAGgtaaac, CAAGgtaact, CAAGgtaaga, CAAGgtaatt, CAAGgtatgt, CAAGgtattc, CAAGgtattg, CAAGgtctct, CAAGgtgaga, CAAGgtgagc, CAAGgtgctg, CAAGgtgtgt, CAAGgttagt, CAAGgtttct, CAATgtaagt, CAATgtgagg, CACAggttag, CACAgtaagc, CACAgtaagt, CACAgtgagt, CACAgttgag, CACCgtaagt, CACCgtgagt, CACGgcgtga, CACGgtaaca, CACGgtagga, CACGgtgagt, CACTgtaagt, CACTgtgagt, CAGAgtaagt, CAGGgtaaaa, CAGGgtaaat, CAGGgtaagc, CAGGgtaagg, CAGGgtaagt, CAGGgtgaga, CAGGgtgagc, CAGGgtgagg, CAGTgtaagg, CAGTgtaagt, CAGTgtgagt, CATCgtgagt, CATGgtaagc, CATGgtaggt, CATGgtatgt, CATGgtgagt, CATGgtgggg, CATGgtttga, CATTagtgag, CATTgtaagt, CATTgtgagt, CCAAgtgagc, CCAAgtgagt, CCACgtgagt, CCAGgcaagg, CCAGgtaaaa, CCAGgtaaac, CCAGgtaaag, CCAGgtaacc, CCAGgtaaga, CCAGgtaagg, CCAGgtaagt, CCAGgtaatc, CCAGgtacag, CCAGgtactc, CCAGgtaggt, CCAGgtatca, CCAGgtatgt, CCAGgtattg, CCAGgtattt, CCAGgtcagt, CCAGgtctga, CCAGgtgaga, CCAGgtgagc, CCAGgtgggt, CCAGgtgtcg, CCAGgtgtgt, CCAGgttctg, CCAGgttgct, CCAGgttggt, CCAGgtttgt, CCATgtaagt, CCATgtgagt, CCCAgtacga, CCCAgtgagt, CCCGgtatgg, CCCTgtaagt, CCGGgtatgt, CCGGgtgagc, CCGGgtgagt, CCGGgtgtgt, CCGTgtgagt, CCTCgtaagt, CCTCgtgagt, CCTCgtgggt, CCTGgtaaat, CCTGgtaaga, CCTGgtaagt, CCTGgtatgc, CCTGgtgaga, CCTGgtgagt, CCTTgtaagt, CCTTgtgagc, CGAAgtaagt, CGACgtgagt, CGAGgtaaaa, CGAGgtaaat, CGAGgtaaga, CGAGgtacgt, CGAGgtaggg, CGAGgtcagt, CGAGgtgaga, CGAGgtgagt, CGAGgtgatc, CGAGgtgatg, CGATgtacaa, CGATgtgagt, CGCAgtaagt, CGGGgtaagc, CGGGgtaggc, CGTGgtaagt, CGTGgtgagt, CTAAgtcagt, CTAGgtaaaa, CTAGgtagag, CTAGgtcagt, CTATgtaaga, CTATgtgagt, CTCAgtgagt, CTCGgtaagt, CTCTgtaaga, CTCTgtaagc, CTCTgtaagt, CTCTgtgagt, CTGAgtaagc, CTGAgtgagt, CTGGgtaact, CTGGgtaagc, CTGGgtaagg, CTGGgtaagt, CTGGgtgagc, CTGGgtgagg, CTGGgtgagt, CTGTgtgaga, CTTCgtgagt, CTTGgtaacc, CTTGgtaagc, CTTGgtaggt, CTTGgtgagc, CTTGgtgagg, CTTGgtgagt, GAAAgtaaga, GAAAgtgagt, GAACgtatgt, GAACgtgagt, GAAGgtaaaa, GAAGgtaaac, GAAGgtaaca, GAAGgtaact, GAAGgtaaga, GAAGgtaagt, GAAGgtactg, GAAGgtagaa, GAAGgtaggc, GAAGgtaggg, GAAGgtatag, GAAGgtcaga, GAAGgtcagt, GAAGgtgggt, GAAGgtgtaa, GAAGgttggt, GAATgtaagt, GAATgtgagg, GAATgtgagt, GACAgtgagt, GACCgtgagt, GACGgtaaag, GACGgtaatt, GACTgtaagt, GACTgtgagt, GAGAgtaaga, GAGAgtaagt, GAGGgtatgt, GAGGgtgagg, GATAgtgagt, GATCgtgagt, GATGgtaaga, GATGgtaagt, GATGgtatga, GATGgtgagg, GATGgtgagt, GATGgtggga, GATTgtaagt, GCAAgtgagt, GCACgtaagt, GCAGgtaaaa, GCAGgtaaac, GCAGgtaacc, GCAGgtaact, GCAGgtaaga, GCAGgtaagc, GCAGgtaagt, GCAGgtaatt, GCAGgtacag, GCAGgtactg, GCAGgtatga, GCAGgtatgt, GCAGgtatta, GCAGgtattt, GCAGgtcagt,
Gene Expression Results (Compound 52)
[00625] RNAseq experiments showed that Compound 52 modulated expression of various genes by a factor of 2 or more. The following table identifies genes from Table 5 which resulted in a log 2 fold change (L2FC) of 1 or above (increased expression), or -1 or below (decreased expression), upon treatment with Compound 52:
[00626] Table 59
SHSY5Y, 2.5 μM), (ABHD12, -1.1, HEK293, 5 μM), (ABHD12, -1.2, SHSY5Y, 5 μM), (ABHD12, -1.3, HEK293, 5 gM), (ABHD12, -1.2, HEK293, 5 gM), (ABHD6, 2, SHSY5Y, 5 gM), (ABLIM1, 1, SHSY5Y, 5 μM), (ACAA1, -1.4, HT1080, 0.2 μM), (ACAA1, -1.4, HEK293, 0.5 μM), (ACAA1, -1.5, HEK293, 1 μM), (ACAA1, -3.6, SHSY5Y, 1 μM), (ACAA1, -2.1, SHSY5Y, 2.5 μM), (ACAA1, -1, HEK293, 5 μM), (ACAA1, -3.1, SHSY5Y, 5 μM), (ACAA1, -1.2, HEK293, 5 μM), (ACAA1, -1.1, HEK293, 5 μM), (ACACA, -1.2, SHSY5Y, 0.5 |1M), (ACACA, -1.1, HEK293, 1 μM), (ACACA, -1.3, SHSY5Y, 1 μM), (ACACA, -1.1, HEK293, 2.5 μM), (ACACA, -1.2, SHSY5Y, 2.5 μM), (ACCS, -2.3, HEK293, 0.5 gM), (ACER3, -4.7, SHSY5Y, 1 μM), (ACSF3, 1.2, SHSY5Y, 1 μM), (ACSS2, -1.4, SHSY5Y, 5 |1M), (ACTR1B, -1.2, HEK293, 0.5 ^M), (ACTR1B, -1.2, SHSY5Y, 2.5 μM), (ACYP1, -1.8, SHSY5Y, 1 μM), (ADA, -1.1, HT1080, 0.2 μM), (ADA, -1.2, HEK293, 0.5 μM), (ADA, -1.6, HEK293, 1 μM), (ADA, -4.1, SHSY5Y, 2.5 μM), (ADA, -1.2, HEK293, 5 μM), (ADA, -3.2, SHSY5Y, 5 μM), (ADA, -1.4, HEK293, 5 μM), (ADA, -1.5, HEK293, 5 μM), (ADAL, -1.2, HEK293, 5 μM), (ADAM22, -1.4, HT1080, 0.2 μM), (ADAM22, -1.2, HEK293, 0.5 μM), (ADAM22, -2.1, SHSY5Y, 0.5 μM), (ADAM22, -1.6, HEK293, 1 μM), (ADAM22, -1.5, SHSY5Y, 1 gM), (ADAM22, -1.4, HEK293, 2.5 μM,) (ADAM22, -2.4, SHSY5Y, 2.5 gM), (ADAM22, -1.3, HEK293, 5 μM), (ADAM22, -1.8, SHSY5Y, 5 μM), (ADAMTS6, -3.4, SHSY5Y, 2.5 gM), (ADAMTS9, -1.4, SHSY5Y, 0.5 μM,) (ADCY7, -1.7, HEK293, 1 μM), (ADGRB2, -1.4, HEK293, 0.5 ^M), (ADGRB2, -1.3, HEK293, 1 μM,) (ADK, -1.9, SHSY5Y, 1 gM), (AFF3, -1.3, HEK293, 2.5 gM), (AGTPBP1, 1, SHSY5Y, 5 μM), (AHI1, -1.1, HT1080, 0.2 nM), (AHI1, -1.4, HEK293, 0.5 μM), (AHI1, -1.7, SHSY5Y, 0.5 μM,) (AHI1, -1.7, HEK293, 1 μM), (AHI1, -2.3, SHSY5Y, 1 μM), (AHI1, -1.3, HEK293, 2.5 μM), (AHI1, -2.9, SHSY5Y, 2.5 μM), (AHI1, -1.7, HEK293, 5 μM), (AHI1, -2.2, SHSY5Y, 5 μM), (AHRR, 1.2, HT1080, 0.2 μM), (AKAP6, 1.2, HT1080, 0.2 μM), (AKIP1, -1.1, HT1080, 0.2 ^M), (AKIP1, - 1.3, SHSY5Y, 5 μM), (ALDH1L2, -3, HT1080, 0.2 μM), (ALDH1L2, -2.9, HEK293, 0.5 μM), (ALDH1L2, -2.2, SHSY5Y, 0.5 gM), (ALDH1L2, -2.8, HEK293, 1 μM,) (ALDH1L2, -1.7, SHSY5Y, 1 μM), (ALDH1L2, -1.8, HEK293, 2.5 μM), (ALDH1L2, -2.4, SHSY5Y, 2.5 μM), (ALDH1L2, -2.4, HEK293, 5 μM), (ALDH1L2, -2.4, SHSY5Y, 5 μM,) (ALDH1L2, -2.4, HEK293, 5 μM), (ALDH1L2, -3.1, HEK293, 5 μM), (ALDH4A1, -3.3, SHSY5Y, 0.5 μM), (ALDH4A1, -1.2, HEK293, 1 μM), (ALDH4A1, -4.2, SHSY5Y, 1 gM), (ALDH4A1, -1.1, HEK293, 5 μM), (ALDH4A1, -1.1, HEK293, 5 μM), (ALG9, 1.1, SHSY5Y, 1 μM), (ALKBH3, -1, HT1080, 0.2 μM), (AMN1, -1.3, HT1080, 0.2 μM), (AMN1, -3.1, SHSY5Y, 1 μM), (AMN1, -1.5, HEK293, 5 μM), (AMOT, -1.1, SHSY5Y, 0.5 μM), (ANAPC10, -1.7, SHSY5Y, 1 μM), (ANK2, -1.1, HEK293, 0.5 μM), (ANK2, -1.2, HEK293, 1 μM), (ANK2, -1.3, HEK293, 2.5 |1M), (ANKMY2, -1.3, HT1080, 0.2 μM,) (ANKMY2, -1.1, HEK293, 0.5 gM), (ANKMY2, - 1.2, SHSY5Y, 0.5 μM), (ANKMY2, -1.1, HEK293, 1 μM), (ANKMY2, -1.3, HEK293, 5 μM), (ANKMY2, -1.3, SHSY5Y, 5 gM), (ANKMY2, -1.1, HEK293, 5 μM), (ANKMY2, -1.1, HEK293, 5 μM), (ANKZF1, -1.2, SHSY5Y, 1 gM), (ANLN, -1.5, HT1080, 0.2 μM, ()ANLN, - 1.2, HEK293, 0.5 gM), (ANLN, -1.8, SHSY5Y, 0.5 μM), (ANLN, -1.1, HEK293, 1 μM), (ANLN, -1.4, SHSY5Y, 1 μM), (ANLN, -2.1, SHSY5Y, 2.5 μM), (ANLN, -1.6, SHSY5Y, 5 |1M), (ANLN, -1, HEK293, 5 μM), (AP2A2, -1.5, HEK293, 0.5 μM), (AP2A2, -1.5, SHSY5Y, 0.5 μM), (AP2A2, -1.7, HEK293, 1 μM), (AP2A2, -1.3, SHSY5Y, 1 μM), (AP2A2, -1.1, HEK293, 2.5 μM), (AP2A2, -1.4, SHSY5Y, 2.5 μM), (AP2A2, -1.1, HEK293, 5 μM), (AP2A2, -1.2, SHSY5Y, 5 μM), (AP2A2, -1.5, HEK293, 5 μM), (AP2A2, -1.4, HEK293, 5 μM), (APOOL, -3.1, SHSY5Y, 1 μM), (ARFGAP2, -1.2, HT1080, 0.2 ^M), (ARFGAP2, -1.7,
HEK293, 0.5 μM), (ARFGAP2, -1.1, SHSY5Y, 0.5 μM), (ARFGAP2, -1.3, HEK293, 1 μM), (ARFGAP2, -1.5, SHSY5Y, 2.5 μM), (ARFGAP2, -1.1, HEK293, 5 μM), (ARFGAP2, -1.6, SHSY5Y, 5 μM), (ARFGAP2, -1, HEK293, 5 μM), (ARFGAP2, -1, HEK293, 5 μM), (ARHGEF10, -1.7, SHSY5Y, 1 μM), (ARHGEF12, 1, SHSY5Y, 5 μM), (ARMC9, -1.3, SHSY5Y, 0.5 μM), (ARMCX5, 1.2, SHSY5Y, 1 μM), (ARNTL2, -1.1, SHSY5Y, 2.5 μM), (ARSK, 1.4, SHSY5Y, 1 μM), (ASAP1, -1.2, HEK293, 0.5 μM), (ASAP1, -2, SHSY5Y, 0.5 μM), (ASAP1, -1.3, HEK293, 1 μM), (ASAP1, -1.3, HEK293, 2.5 μM), (ASAP2, -1.2, HT1080, 0.2 μM), (ASAP2, -2.1, HEK293, 0.5 μM), (ASAP2, -2.7, SHSY5Y, 0.5 μM), (ASAP2, -2.1, HEK293, 1 μM), (ASAP2, -2.1, SHSY5Y, 1 μM), (ASAP2, -2, HEK293, 2.5 μM), (ASAP2, - 1.7, SHSY5Y, 2.5 μM), (ASAP2, -1.8, HEK293, 5 μM), (ASAP2, -1.7, SHSY5Y, 5 μM), (ASAP2, -1, HEK293, 5 μM), (ATF7TP2, 1.1, HEK293, 0.5 μM), (ATF7IP2, 1.2, HEK293, 5 μM), (ATG16L2, -1.2, HT1080, 0.2 μM), (ATG7, -1.9, HT1080, 0.2 μM), (ATG7, -1.8, HEK293, 0.5 μM), (ATG7, -1.4, SHSY5Y, 0.5 μM), (ATG7, -2, HEK293, 1 μM), (ATG7, -2, SHSY5Y, 1 μM), (ATG7, -1.8, HEK293, 2.5 μM), (ATG7, -2.8, SHSY5Y, 2.5 μM), (ATG7, -2, HEK293, 5 μM), (ATG7, -3.4, SHSY5Y, 5 μM), (ATG7, -1.6, HEK293, 5 μM), (ATG7, -1.9, HEK293, 5 μM), (ATP5S, -1.9, HT1080, 0.2 μM), (ATP5S, -1.9, HEK293, 0.5 μM), (ATP5S, - 6.2, SHSY5Y, 0.5 μM), (ATP5S, -2.4, HEK293, 1 μM), (ATP5S, -3.5, SHSY5Y, 1 μM), (ATP5S, -1.6, HEK293, 2.5 μM), (ATP5S, -8.6, SHSY5Y, 2.5 μM), (ATP5S, -2.7, HEK293, 5 μM), (ATP5S, -8.3, SHSY5Y, 5 μM), (ATP5S, -1.8, HEK293, 5 μM), (ATP5S, -1.7, HEK293, 5 μM), (ATP6AP1L, 1.3, HEK293, 5 μM), (ATP6V0A2, -1.7, HT1080, 0.2 μM), (ATP6V0A2, - 1.4, HEK293, 0.5 μM), (ATP6V0A2, -1.2, HEK293, 1 μM), (ATP6V0A2, -1.4, HEK293, 5 μM), (ATP6V0A2, -1.3, HEK293, 5 μM), (ATP9A, -2.4, HEK293, 0.5 μM), (ATP9A, -2.6, HEK293, 1 μM), (ATP9A, -8.9, SHSY5Y, 1 μM), (ATP9A, -2.3, HEK293, 2.5 μM), (ATP9A, - 9, SHSY5Y, 2.5 μM), (ATP9A, -1.8, HEK293, 5 μM), (ATP9A, -6.3, SHSY5Y, 5 μM), (ATP9A, -2.2, HEK293, 5 μM), (ATP9A, -2.3, HEK293, 5 μM), (ATP9B, -2, SHSY5Y, 2.5 μM), (ATR, -1.2, SHSY5Y, 1 μM), (ATXN7L2, -1.9, SHSY5Y, 1 μM), (BABAM2, -1.5, HT1080, 0.2 μM), (BABAM2, -1.7, HEK293, 0.5 μM), (BABAM2, -2.4, HEK293, 1 μM), (BABAM2, -4.5, SHSY5Y, 1 μM), (BABAM2, -1.7, HEK293, 2.5 μM), (BABAM2, -2.1, HEK293, 5 μM), (BABAM2, -2.5, SHSY5Y, 5 μM), (BABAM2, -1.6, HEK293, 5 μM), (BABAM2, -1.5, HEK293, 5 μM), (BAK1, -1.8, SHSY5Y, 1 μM), (BAK1, -1.5, SHSY5Y, 5 μM), (BB0X1-AS1, 1.2, HEK293, 1 μM), (BBS4, -2.2, HT1080, 0.2 μM), (BBS4, -3.3, HEK293, 0.5 μM), (BBS4, -2.9, SHSY5Y, 0.5 μM), (BBS4, -2.7, HEK293, 1 μM), (BBS4, -2.1, SHSY5Y, 1 μM), (BBS4, -1.6, HEK293, 2.5 μM), (BBS4, -3.1, SHSY5Y, 2.5 μM), (BBS4, -1.8, HEK293, 5 μM), (BBS4, -3, SHSY5Y, 5 μM), (BBS4, -2, HEK293, 5 μM), (BBS4, -1.6, HEK293, 5 μM), (BBX, 1.2, SHSY5Y, 5 μM), (BCAS4, -4.1, SHSY5Y, 1 μM), (BCAS4, -7.9, SHSY5Y, 5 μM), (BCL2L13, -1.1, HEK293, 5 μM), (BCL2L13, -1.2, HEK293, 5 μM), (BCL9L, 1.7, SHSY5Y, 5 μM), (BEND6, -2.1, SHSY5Y, 1 μM), (BICD1, 1.2, SHSY5Y, 5 μM), (BICRAL, -1.4, HEK293, 1 μM), (BICRAL, -4.4, SHSY5Y, 1 μM), (BIRC5, -1.8, SHSY5Y, 1 μM), (BIRC5, -1.6, SHSY5Y, 5 μM), (BIVM, -1.1, HEK293, 2.5 μM), (BLM, -1.2, SHSY5Y, 0.5 μM), (BLM, -1.5, SHSY5Y, 1 μM), (BLM, -1.3, SHSY5Y, 2.5 μM), (BLZF1, -2, HEK293, 0.5 μM), (BLZF1, -1.7, SHSY5Y, 0.5 μM), (BLZF1, -2.1, HEK293, 1 μM), (BLZF1, -1.1, HEK293, 2.5 μM), (BLZF1, -1.4, HEK293, 5 μM), (BLZF1, -1.9, SHSY5Y, 5 μM), (BLZF1, - 1.7, HEK293, 5 μM), (BLZF1, -1.7, HEK293, 5 μM), (BMS1P14, -3.4, SHSY5Y, 2.5 μM), (BOLA3, -1.8, SHSY5Y, 0.5 μM), (BOLA3, -1.7, SHSY5Y, 2.5 μM), (BRCC3, 1.6, SHSY5Y, 1 μM), (BRSK2, -1.7, HT1080, 0.2 μM), (BRSK2, -1.4, HEK293, 0.5 μM), (BRSK2, -1.2,
HEK293, 1 μM), (BRSK2, -5.8, SHSY5Y, 1 μM), (BRSK2, -8.1, SHSY5Y, 5 μM), (BRSK2, -1, HEK293, 5 μM), (BRWD3, -1.1, SHSY5Y, 1 μM,) (BTBD9, -8.2, SHSY5Y, 1 μM, ()BTD, 1.2, SHSY5Y, 1 μM), (C10orfl43, -3.6, HEK293, 0.5 μM), (C10orfl43, -3.9, HEK293, 1 μM), (C10orfl43, -2.4, HEK293, 5 μM), (C12orf4, -1.1, SHSY5Y, 0.5 μM), (C12orf4, -1, SHSY5Y, 2.5 μM), (C12orf4, -1.6, SHSY5Y, 5 μM), (C15orfi8-AP3S2, -1.5, SHSY5Y, 0.5 μM), (C15orf38-AP3S2, -1.5, SHSY5Y, 1 μM), (C15orf38-AP3S2, -1.7, SHSY5Y, 5 μM), (C15orf41, -7.4, SHSY5Y, 1 μM), (C19orf25, -2, SHSY5Y, 5 ^M), (C19orf54, -6.3, SHSY5Y, 0.5 μM, ) (C19orf57, -2, SHSY5Y, 5 ^M), (C1QTNF3-AMACR, -1, SHSY5Y, 2.5 μM), (C1QTNF6, -7.9, SHSY5Y, 0.5 μM), (C1QTNF6, -7.9, SHSY5Y, 1 gM), (C3orf67, -1.2, HEK293, 2.5 μM,) (C3orf67, -1.5, SHSY5Y, 2.5 μM), (C3orf67, -1.1, HEK293, 5 μM), (C4orfi3, -1, HEK293, 5 JIM), (CACNA2D1, -1.6, HT1080, 0.2 μM), (CACNA2D1, -1.7, HEK293, 0.5 μM), (CACNA2D1, -2.5, SHSY5Y, 0.5 ^M), (CACNA2D1, -2.7, HEK293, 1 gM), (CACNA2D1, - 1.9, SHSY5Y, 1 μM), (CACNA2D1, -2.1, HEK293, 2.5 μM), (CACNA2D1, -2.2, SHSY5Y, 2.5 |1M), (CACNA2D1, -2.4, HEK293, 5 gM), (CACNA2D1, -1.6, SHSY5Y, 5 ^M), (CACNA2D1, -1.7, HEK293, 5 μM), (CACNA2D1, -1.7, HEK293, 5 μM), (CAMK4, -4, SHSY5Y, 1 μM), (CAMK4, -3.6, SHSY5Y, 2.5 μM), (CAPR1N2, -1.3, HEK293, 0.5 μM, ()CAPR1N2, -2.2, SHSY5Y, 0.5 μM), (CAPRIN2, -1.3, HEK293, 2.5 μM), (CAPS2, -2.6, HEK293, 0.5 μM), (CAPS2, -2.7, HEK293, 1 gM), (CAPS2, -7.9, SHSY5Y, 2.5 gM), (CAPS2, -2.2, HEK293, 5 |1M), (CAPS2, -7.6, SHSY5Y, 5 μM,) (CASD1, -1.3, SHSY5Y, 1 μM, ()CASD1, -1.1, SHSY5Y, 2.5 μM), (CBY1, -4.8, SHSY5Y, 2.5 μM), (CCAR1, 1.1, SHSY5Y, 5 μM), (CCDC125, -1.3, HEK293, 1 μM), (CCDC14, -1.2, SHSY5Y, 1 μM), (CCDC171, 1.6, SHSY5Y, 1 μM), (CCDC188, -1.4, HT1080, 0.2 μM), (CCDC191, -1.6, HEK293, 2.5 μM), (CCDC25, -1.1, HT1080, 0.2 μM), (CCDC25, -1, SHSY5Y, 0.5 μM), (CCDC25, -1, HEK293, 1 |1M), (CCDC25, -1, HEK293, 5 gM), (CCDC25, -1.2, HEK293, 5 μM), (CCDC25, -1.2, HEK293, 5 μM), (CCDC40, -1.5, HEK293, 1 μM), (CCDC40, -3.7, SHSY5Y, 1 μM), (CCDC57, -3.5, SHSY5Y, 1 μM), (CCDC82, -1.3, SHSY5Y, 1 μM,) (CCDC88A, -1.3, HEK293, 0.5 μM), (CCDC88A, -1.5, HEK293, 1 μM), (CCDC88A, -1.2, HEK293, 2.5 μM), (CCDC88C, -1.8, HEK293, 0.5 μM), (CCDC88C, -1.3, HEK293, 1 μM,) (CDC14A, -2.7, SHSY5Y, 1 μM), (CDC16, -1, HT1080, 0.2 μM), (CDC16, -1.1, SHSY5Y, 0.5 μM), (CDC25C, -1.3, HT1080, 0.2 μM), (CDC25C, -1.1, HEK293, 0.5 ^M), (CDC25C, -1.1, HEK293, 1 gM), (CDC25C, -1.5, SHSY5Y, 1 gM), (CDC25C, -1.1, HEK293, 5 gM), (CDC25C, -2.3, SHSY5Y, 5 μM), (CDC25C, -1, HEK293, 5 gM), (CDC42SE2, -2.7, SHSY5Y, 1 μM), (CDC42SE2, -8.1, SHSY5Y, 5 gM), (CDK11B, 1.4, SHSY5Y, 5 μM), (CDO1, -1.1, SHSY5Y, 0.5 μM,) (CDYL, - 1.1, HT1080, 0.2 nM), (CDYL, -1.3, HEK293, 0.5 μM), (CDYL, -2.1, SHSY5Y, 0.5 ^M), (CDYL, -1.6, HEK293, 1 μM), (CDYL, -3.4, SHSY5Y, 1 μM,) (CDYL, -1.2, HEK293, 2.5 μM), (CDYL, -2.7, SHSY5Y, 2.5 μM), (CDYL, -2, SHSY5Y, 5 μM), (CEBPZOS, -8, SHSY5Y, 5 |1M), (CELSR2, 1, HT1080, 0.2 gM), (CELSR3, -1.1, HEK293, 0.5 gM), (CELSR3, -1.3, HEK293, 1 μM), (CENPH, -1.3, HT1080, 0.2 μM,) (CENPH, -1.6, HEK293, 0.5 μM, ()CENPH, -2, SHSY5Y, 0.5 μM), (CENPH, -2, HEK293, 1 gM), (CENPH, -1.7, SHSY5Y, 1 μM), (CENPH, -1.2, HEK293, 2.5 ^M), (CENPH, -1.9, SHSY5Y, 2.5 μM,) (CENPH, -1.5, HEK293, 5 μM), (CENPH, -2, SHSY5Y, 5 μM), (CENPH, -1.6, HEK293, 5 μM), (CENPH, -1.5, HEK293, 5 μM), (CENPI, -2.2, HT1080, 0.2 μM), (CENPI, -2.3, HEK293, 0.5 gM), (CENPI, - 1.8, SHSY5Y, 0.5 μM), (CENPI, -2.5, HEK293, 1 ^M), (CENPI, -3, SHSY5Y, 1 μM), (CENPI, -1.7, HEK293, 2.5 μM), (CENPI, -5.5, SHSY5Y, 2.5 μM), (CENPI, -1.9, HEK293, 5 μM), (CENPI, -2.9, SHSY5Y, 5 gM), (CENPI, -1.6, HEK293, 5 μM,) (CENPI, -1.6, HEK293, 5 μM, )
(CENPM, -2.8, SHSY5Y, 5 μM), (CEP112, -5.5, SHSY5Y, 1 μM), (CEP112, -E2, HEK293, 2.5 |1M), (CEP192, -1, HEK293, 1 μM,) (CEP192, -El, SHSY5Y, 1 μM), (CEP192, -1.1, SHSY5Y, 2.5 μM), (CEP295, -1.2, HEK293, 0.5 μM), (CEP295, -1.5, SHSY5Y, 0.5 ^M), (CEP295, -1.3, HEK293, 1 μM), (CEP295, -1.6, SHSY5Y, 1 μM), (CEP295, -1.1, HEK293, 2.5 μM), (CEP295, -1.6, SHSY5Y, 2.5 μM), (CEP83, -1.5, HT1080, 0.2 ^M), (CEP83, -2, HEK293, 0.5 μM), (CEP83, -2.1, HEK293, 1 μM), (CEP83, -1.8, HEK293, 2.5 μM), (CEP83, -1.5, HEK293, 5 |1M), (CERS5, -1.4, SHSY5Y, 5 μM,) (CFAP44, -1.8, HEK293, 0.5 μM, ()CFAP44, -2, HEK293, 2.5 μM), (CHD1L, -1.4, HY1080, 0.2 μM), (CHD1L, -2, HEK293, 0.5 μM), (CHD1L, -1.9, SHSY5Y, 0.5 μM), (CHD1L, -2.1, HEK293, 1 μM), (CHD1L, -2.1, SHSY5Y, 1 μM, ) (CHD1L, -1.5, HEK293, 2.5 μM), (CHD1L, -2.7, SHSY5Y, 2.5 μM), (CHD1L, -1.8, HEK293, 5 JIM), (CHD1L, -2, SHSY5Y, 5 μM), (CHD1L, -1.3, HEK293, 5 μM), (CHD1L, -1.3, HEK293, 5 gM), (CHD9, 1, SHSY5Y, 5 ^M), (CHEK2, -1.8, HT1080, 0.2 ^M), (CHEK2, -2.2, HEK293, 0.5 μM), (CHEK2, -1.6, SHSY5Y, 0.5 μM), (CHEK2, -2.1, HEK293, 1 μM), (CHEK2, -3.8, SHSY5Y, 1 gM), (CHEK2, -1.3, HEK293, 2.5 ^M), (CHEK2, -2.9, SHSY5Y, 2.5 μM,) (CHEK2, -1.8, HEK293, 5 gM), (CHEK2, -2.4, SHSY5Y, 5 μM), (CHEK2, -1.6, HEK293, 5 |1M), (CELEK2, -1.5, HEK293, 5 μM, ()CFLFR, 1.7, SHSY5Y, 1 ,μ (MCH)M, -1.3, SHSY5Y, 1 gM), (CLCC1, -1.1, SHSY5Y, 2.5 μM), (CLTCL1, -3.8, SHSY5Y, 1 μM), (CNIH3, -2.1, HT1080, 0.2 μM), (CNIH3, -2.6, HEK293, 1 ^M), (CNIH3, -2.4, HEK293, 5 μM), (CNIH3, - 1.9, HEK293, 5 gM), (CNIH3, -2, HEK293, 5 μM,) (CNOTIO, -1.1, SHSY5Y, 1 gM), (CNTNAP1, -1.4, HEK293, 1 μM), (COL24A1, -1.3, HEK293, 5 μM), (COL25A1, -1.2, HEK293, 2.5 μM), (COP1, -1.2, SHSY5Y, 1 ^M), (COQ3, -1.4, SHSY5Y, 5 μM,) (COQ6, -2.6, SHSY5Y, 5 μM), (CPXM1, -1.6, SHSY5Y, 0.5 μM), (CPXM1, -1.6, SHSY5Y, 1 μM), (CPXM1, -1.7, SHSY5Y, 2.5 μM), (CPXM1, -1.2, SHSY5Y, 5 ^M), (CPXM1, -1.2, HEK293, 5 |1M), (CREB3L4, -1.1, HEK293, 5 μM), (CRELD1, -1.7, HEK293, 0.5 μM), (CRELD1, -1.9, HEK293, 1 μM), (CRELD1, -1.6, SHSY5Y, 5 μM), (CRELD1, -1.5, HEK293, 5 μM), (CRELD1, -1.1, HEK293, 5 μM), (CRYBG3, -1.2, HEK293, 0.5 gM), (CRYBG3, -1.5, HEK293, 1 μM), (CRYBG3, -1.4, SHSY5Y, 1 ^M), (CRYBG3, -1, HEK293, 2.5 μM), (CRYZ, -1.2, HT1080, 0.2 μM), (CSRNP3, 1.3, SHSY5Y, 5 μM,) (CWF19L1, -4.1, SHSY5Y, 1 μM, ) (CXorf38, 1.5, SHSY5Y, 1 μM), (CYB5RL, -6.7, SHSY5Y, 1 μM), (CYP2U1, -1.6, HEK293, 0.5 μM), (CYP2U1, -1.5, HEK293, 1 gM), (CYP2U1, -1.6, HEK293, 5 μM), (CYP2U1, -1.4, HEK293, 5 μM), (DAAM1, -1.9, HEK293, 0.5 μM), (DAAM1, -1.5, SHSY5Y, 0.5 μM), (DAAM1, -1.6, HEK293, 1 μM), (DAAM1, -1.1, HEK293, 2.5 ^M), (DAAM1, -2, SHSY5Y, 2.5 nM), (DAAM1, -1.2, HEK293, 5 μM), (DAAM1, -1.2, SHSY5Y, 5 μM), (DAAM1, -1.6, HEK293, 5 μM), (DAAM1, -1.8, HEK293, 5 μM), (DAPK1, -1.5, HEK293, 0.5 μM), (DAPK1, -1.6, SHSY5Y, 0.5 μM), (DAPK1, -1.8, HEK293, 1 μM), (DAPK1, -1.2, SHSY5Y, 1 μM, ) (DAPK1, -1.4, HEK293, 2.5 μM), (DAPK1, -1.3, SHSY5Y, 2.5 μM), (DAPK1, -1.3, HEK293, 5 |1M), (DCAF17, -1.1, SHSY5Y, 1 μM), (DDC, -2.3, SHSY5Y, 0.5 μM), (DDC, -3.9, SHSY5Y, 1μM), (DDC, -2.1, SHSY5Y, 2.5 μM), (DDC, -1.8, SHSY5Y, 5 gM), (DDX12P, -1.4, HEK293, 1μM), (DDX12P, -1.3, HEK293, 2.5 gM), (DDX19B, -1.6, SHSY5Y, 2.5 μM), (DDX60, -2.6, SHSY5Y, 1 μM), (DEAF1, -1.3, SHSY5Y, 0.5 μM,) (DEAF1, -1.1, SHSY5Y, 5 μM), (DECR2, -1.9, SHSY5Y, 0.5 μM), (DECR2, -1.2, HEK293, 1 gM), (DECR2, -5.7, SHSY5Y, 2.5 μM), (DECR2, -3.7, SHSY5Y, 5 μM), (DEF8, 1.1, HEK293, 1 μM), (DENND3, -1.1, HEK293, 0.5 gM), (DENND3, -1.1, HEK293, 1 μM), (DENND3, -4.1, SHSY5Y, 1 μM), (DENND4B, -1.1, HEK293, 0.5 μM), (DENND4B, -1.3, SHSY5Y, 2.5 ^M), (DENND4C, -1, SHSY5Y, 0.5 μM), (DENND5A, -1.3, HT1080, 0.2 μM), (DENND5A, -2, HEK293, 0.5 ^M), (DENND5A, -2.1,
SHSY5Y, 0.5 μM), (DENND5A, -2.1, HEK293, 1 μM), (DENND5A, -2, SHSY5Y, 1 μM), (DENND5A, -1.3, HEK293, 2.5 μM), (DENND5A, -2.4, SHSY5Y, 2.5 μM), (DENND5A, -1.4, HEK293, 5 μM), (DENND5A, -2, SHSY5Y, 5 μM), (DENND5A, -1.7, HEK293, 5 μM), (DENND5A, -1.7, HEK293, 5 μM), (DENND5B, 1.3, SHSY5Y, 5 μM), (DEPDC1B, -1.1, SHSY5Y, 1 μM), (DESI1, -1.9, SHSY5Y, 5 μM), (DGKA, -2.2, HT1080, 0.2 μM), (DGKA, -
2.7, HEK293, 0.5 μM), (DGKA, -4, SHSY5Y, 0.5 μM), (DGKA, -2.2, HEK293, 1 μM), (DGKA, -2.9, SHSY5Y, 1 μM), (DGKA, -1.3, HEK293, 2.5 μM), (DGKA, -3.2, SHSY5Y, 2.5 μM), (DGKA, -1.5, HEK293, 5 μM), (DGKA, -4, SHSY5Y, 5 μM), (DGKA, -2.1, HEK293, 5 μM), (DGKA, -1.6, HEK293, 5 μM), (DGKI, -2.5, SHSY5Y, 1 μM), (DGKI, -1.3, SHSY5Y, 2.5 μM), (DHPS, -1.2, SHSY5Y, 2.5 μM), (DHRS12, 1.7, HT1080, 0.2 μM), (DHRS12, 1.1, HEK293, 0.5 μM), (DHRS12, 1.9, SHSY5Y, 0.5 μM), (DHRS12, 2.4, SHSY5Y, 2.5 μM), (DHRS4L2, -1, HT1080, 0.2 μM), (DHRS4L2, -7.7, SHSY5Y, 1 μM), (DHRS4L2, -2, HEK293, 5 μM), (DHX33, -1.3, SHSY5Y, 1 μM), (DICER1, -1.3, SHSY5Y, 0.5 μM), (DIMT1, -2.8, HT1080, 0.2 μM), (DIMT1, -3.4, HEK293, 0.5 μM), (DIMT1, -3.1, SHSY5Y, 0.5 μM), (DIMT1, -2.5, HEK293, 1 μM), (DIMT1, -2.6, SHSY5Y, 1 μM), (DIMT1, -1.5, HEK293, 2.5 μM), (D1MT1, -3.3, SHSY5Y, 2.5 μM), (DIMT1, -2.5, HEK293, 5 μM), (D1MT1, -4, SHSY5Y, 5 μM), (DIMT1, -2.1, HEK293, 5 μM), (DIMT1, -1.9, HEK293, 5 μM), (DIP2A, -2.1, SHSY5Y, 1 μM), (DISP1, 1.5, SHSY5Y, 1 μM), (DLEU1, -1.5, SHSY5Y, 1 μM), (DLEU2, -1.4, SHSY5Y, 2.5 μM), (DLST, -1.2, HT1080, 0.2 μM), (DLST, -1.1, HEK293, 0.5 μM), (DLST, -
1.2, SHSY5Y, 0.5 μM), (DLST, -1, HEK293, 1 μM), (DLST, -1.8, SHSY5Y, 2.5 μM), (DLST, -
1.3, SHSY5Y, 5 μM), (DMXL1, -1, SHSY5Y, 1 μM), (DMXL1, -1, SHSY5Y, 2.5 μM), (DMXL2, -1.3, HEK293, 0.5 μM), (DMXL2, -1.3, HEK293, 1 μM), (DNA2, -1.1, HT1080, 0.2 μM), (DNA2, -1.4, SHSY5Y, 1 μM), (DNA2, -1.2, SHSY5Y, 2.5 μM), (DNAJB12, -1.3, HT1080, 0.2 μM), (DNAJB12, -1.6, HEK293, 0.5 μM), (DNAJB12, -2.7, SHSY5Y, 0.5 μM), (DNAJB12, -1.6, HEK293, 1 μM), (DNAJB12, -1.2, SHSY5Y, 1 μM), (DNAJB12, -1.3, SHSY5Y, 2.5 μM), (DNAJB12, -1.5, SHSY5Y, 5 μM), (DNAJB12, -1.4, HEK293, 5 μM), (DNAJB12, -1.5, HEK293, 5 μM), (DNM3, -5.1, SHSY5Y, 1 μM), (DNMT3A, -1, SHSY5Y, 1 μM), (DNPEP, -1.6, SHSY5Y, 1 μM), (DNPEP, -1.2, SHSY5Y, 2.5 μM), (DOC2B, -3.3, SHSY5Y, 1 μM), (DOCK11, -1.4, HEK293, 0.5 μM), (DOCK11, -1.3, SHSY5Y, 0.5 μM), (DOCK11, -1.3, HEK293, 1 μM), (DOCK11, -1.4, HEK293, 2.5 μM), (DOCK11, -1, SHSY5Y, 2.5 μM), (DOPEY1, -1.2, SHSY5Y, 0.5 μM), (DOPEY1, -1.4, HEK293, 1 μM), (DOPEY1, -1, HEK293, 2.5 μM), (DPY19L3, 1.1, HEK293, 1 μM), (DPY19L3, 1, HEK293, 5 μM), (DTNB, - 1.2, HEK293, 0.5 μM), (DTNB, -8.6, SHSY5Y, 1 μM), (DTNB, -1.1, HEK293, 5 μM), (DTNB, -1, HEK293, 5 μM), (DUSP11, -2.9, SHSY5Y, 5 μM), (DYM, -2, SHSY5Y, 1 μM), (DYM, -
1.7, SHSY5Y, 2.5 μM), (DZ1P3, -1, HT1080, 0.2 μM), (DZ1P3, -1.1, HEK293, 0.5 μM), (DZIP3, -1.2, SHSY5Y, 0.5 μM), (DZIP3, -1.2, HEK293, 1 μM), (DZIP3, -1.3, HEK293, 2.5 μM), (DZIP3, -1.3, SHSY5Y, 2.5 μM), (DZIP3, -1.2, HEK293, 5 μM), (DZIP3, -1, SHSY5Y, 5 μM), (EBF4, -2.2, SHSY5Y, 1 μM), (ELP2, -1.1, SHSY5Y, 5 μM), (EMB, -2.6, SHSY5Y, 2.5 μM), (EMC2, -2.3, HT1080, 0.2 μM), (EMC2, -1.5, HEK293, 0.5 μM), (EMC2, -1.5, SHSY5Y, 0.5 μM), (EMC2, -1.6, HEK293, 1 μM), (EMC2, -3.2, SHSY5Y, 1 μM), (EMC2, -1.2, HEK293, 2.5 μM), (EMC2, -1.9, SHSY5Y, 2.5 μM), (EMC2, -1.3, HEK293, 5 μM), (EMC2, -2.8, SHSY5Y, 5 μM), (EMC2, -1.6, HEK293, 5 μM), (EMC2, -1.5, HEK293, 5 μM), (EMC3-AS1, - 6.6, SHSY5Y, 1 μM), (EML4, -2.5, SHSY5Y, 0.5 μM), (EML4, -2.4, SHSY5Y, 1 μM), (EML4, -2.1, SHSY5Y, 2.5 μM), (EML4, -1.4, SHSY5Y, 5 μM), (EML6, -1.1, HEK293, 0.5 μM), (EML6, -1.6, HEK293, 1 μM), (EML6, -1.7, HEK293, 2.5 μM), (EML6, -3.5, SHSY5Y, 2.5
gM), (EMSY, 1.2, SHSY5Y, 5 μM), (ENDOV, -1.7, SHSY5Y, 1 μM), (EOGT, -1.2, HEK293, 0.5 nM), (EOGT, -1.8, SHSY5Y, 0.5 μM), (EOGT, -1.3, HEK293, 1 μM,) (EOGT, -1.6, SHSY5Y, 1 μM), (EOGT, -1.1, HEK293, 2.5 μM), (EOGT, -1.2, HEK293, 5 μM), (EPB41L4A, -1.3, HEK293, 1 μM), (EPB41L4A, -1.6, HEK293, 2.5 μM), (EPG5, -1.1, HEK293, 0.5 μM), (EPG5, -1.1, HEK293, 1 gM), (EPHX4, 1.2, HEK293, 0.5 μM), (EPHX4, 1.1, HEK293, 2.5 gM), (EPS8, -2, HT1080, 0.2 μM), (EPS8, -2.8, HEK293, 0.5 μM), (EPS8, -4.4, SHSY5Y, 0.5 μM), (EPS8, -2.6, HEK293, 1 μM), (EPS8, -6.1, SHSY5Y, 1 gM), (EPS8, -1.5, HEK293, 2.5 gM), (EPS8, -4.5, SHSY5Y, 2.5 ^M), (EPS8, -2.1, HEK293, 5 μM), (EPS8, -5.8, SHSY5Y, 5 |1M), (EPS8, -2, HEK293, 5 μM,) (EPS8, -2.4, HEK293, 5 μM), (ERGIC1, -1.4, HEK293, 0.5 gM), (ERGIC1, -1.1, SHSY5Y, 0.5 gM), (ERGIC1, -1.4, HEK293, 1 μM), (ERGIC1, -1.7, SHSY5Y, 1 μM), (ERGTC1, -1.2, HEK293, 2.5 μM, ()ERGIC1, -1.1, SHSY5Y, 2.5 μM), (ERGIC1, -1.8, HEK293, 5 μM), (ERGIC1, -1.9, SHSY5Y, 5 μM), (ERGIC1, -1.4, HEK293, 5 gM), (ERGIC1, -1.8, HEK293, 5 μM), (ERLIN1, -1.1, SHSY5Y, 0.5 μM), (ERLIN1, -1.1, SHSY5Y, 2.5 μM), (ERLIN1, -1.2, SHSY5Y, 5 μM,) (ERMARD, 1.4, SHSY5Y, 1 μM, ) (ETFDH, -1.2, SHSY5Y, 1 μM), (ETFDH, -1.2, SHSY5Y, 2.5 μM), (ETHE1, -1.2, HT1080, 0.2 |1M), (ETHE1, -1.2, ELEK293, 5 μM), (EXD2, -1, HEK293, 0.5 μ,M (E)XD2, -1, HEK293, 5 gM), (EXOC3, -1.7, HT1080, 0.2 gM), (EXOC3, -1.7, HEK293, 0.5 ^M), (EXOC3, -1.4, SHSY5Y, 0.5 μM), (EXOC3, -1.7, HEK293, 1 ^M), (EXOC3, -2.1, SHSY5Y, 1 μM), (EXOC3, -2.5, SHSY5Y, 2.5 μM), (EXOC3, -1.3, SHSY5Y, 5 μM,) (F8, -2.8, HEK293, 0.5 μM, ()F8, - 2.7, HEK293, 1 gM), (F8, -1.6, HEK293, 2.5 μM), (F8, -1.4, HEK293, 5 μM), (F8, -3, HEK293, 5 nM), (F8, -1.9, HEK293, 5 μM), (FAM111A, 1.5, SHSY5Y, 5 μM,) (FAM114A2, -1.3, SHSY5Y, 2.5 μM), (FAM114A2, -1.1, SHSY5Y, 5 μM), (FAM184A, -1, HEK293, 1 μM), (FAM206A, -8.3, SHSY5Y, 1 μM), (FAM208A, -1.3, HT1080, 0.2 μM), (FAM208A, -1.1, HEK293, 0.5 μM), (FAM208A, -1.3, SHSY5Y, 0.5 μM), (FAM208A, -1.1, HEK293, 1 μM), (FAM208A, -1, HEK293, 2.5 μM), (FAM208A, -1.8, SHSY5Y, 2.5 μM), (FAM208A, -1, HEK293, 5 μM), (FAM208A, -1.6, SHSY5Y, 5 μM,) (FAM208A, -1.2, HEK293, 5 μM, ) (FAM208A, -1.2, HEK293, 5 μM), (FAM208B, 1.1, SHSY5Y, 5 ^M), (FAM212B-AS1, 1.2, HEK293, 5 μM), (FAM78B, -1.3, HT1080, 0.2 μM,) (FANCA, -1.1, HEK293, 0.5 μM, ) (FANCA, -1.2, HEK293, 1 μM), (FANCA, -1.3, SHSY5Y, 5 μM), (FANCE, -1.1, SHSY5Y, 0.5 |1M), (FANCE, -1.7, SHSY5Y, 2.5 μM), (FANCE, -1.4, SHSY5Y, 5 ^M), (FANCI, -1.9, HT1080, 0.2 μM), (FANCI, -2.2, HEK293, 0.5 μM), (FANCI, -2.6, SHSY5Y, 0.5 μM), (FANCI, -2.3, HEK293, 1 μM), (FANCI, -2.7, SHSY5Y, 1 μM), (FANCI, -1.6, HEK293, 2.5 μM), (FANCI, -2.9, SHSY5Y, 2.5 ^M), (FANCI, -1.8, HEK293, 5 gM), (FANCI, -2.2, SHSY5Y, 5 gM), (FANCI, -1.4, HEK293, 5 gM), (FANCI, -1.5, HEK293, 5 μM), (FANCL, -2.2, HT1080, 0.2 nM), (FANCE, -2.9, HEK293, 0.5 μM), (FANCE, -3.2, SHSY5Y, 0.5 μM), (FANCL, -2.6, HEK293, 1 μM), (FANCL, -3.8, SHSY5Y, 1 ^M), (FANCL, -1.3, HEK293, 2.5 μM), (FANCL, -2.8, SHSY5Y, 2.5 μM), (FANCL, -2.1, HEK293, 5 ^M), (FANCL, -2.6, SHSY5Y, 5 μM), (FANCL, -2.2, HEK293, 5 ^M), (FANCL, -2.3, HEK293, 5 μM,) (FAT1, 1, HT1080, 0.2 μM, ) (FAT1, 1.2, SHSY5Y, 5 μM), (FAT3, 1.5, HT1080, 0.2 gM), (FAT3, 1.4, SHSY5Y, 5 gM), (FBXO44, -3.2, SHSY5Y, 1 μM), (FBXO9, -1.1, HT1080, 0.2 μM,) (FBXO9, -1.4, SHSY5Y, 0.5 μM), (FBXO9, -1.3, SHSY5Y, 1 μM), (FBXO9, -2.1, SHSY5Y, 2.5 gM), (FBXO9, -1.6, SHSY5Y, 5 gM), (FGGY, -1.4, HT1080, 0.2 μM), (FGGY, -2.4, HEK293, 0.5 μM), (FGGY, - 1.9, HEK293, 2.5 gM), (FGGY, -3.8, HEK293, 5 μM), (FGGY, -2.6, HEK293, 5 gM), (FHOD3, -1.1, HEK293, 1 μM), (FIG4, -2, HT1080, 0.2 gM), (FIG4, -1.6, HEK293, 0.5 μM), (FIG4, -1.3, SHSY5Y, 0.5 gM), (FIG4, -1.7, HEK293, 1 μM,) (FIG4, -2.1, SHSY5Y, 1 μM, ()FIG4, -1.2,
HEK293, 2.5 μM), (FIG4, -2.1, SHSY5Y, 2.5 μM), (FIG4, -1.4, HEK293, 5 μM), (FIG4, -1.9, SHSY5Y, 5 gM), (FIG4, -1.4, HEK293, 5 μM), (FIG4, -1.6, HEK293, 5 μM,)(F0XRED1, -1.2, HEK293, 0.5 μM), (FOXRED1, -1.2, SHSY5Y, 0.5 gM), (FOXRED1, -1.2, HEK293, 1 μM), (FOXRED1, -2.1, SHSY5Y, 1 μM), (FOXRED1, -1.6, SHSY5Y, 2.5 μM), (FOXRED1, -1.2, HEK293, 5 μM), (FOXRED1, -1.5, SHSY5Y, 5 μM), (FPGT-TNNI3K, -3.3, SHSY5Y, 1 μM), (FRAS1, 1.2, HT1080, 0.2 gM), (FRG1HP, -7.4, SHSY5Y, 1 μM), (FRMD4A, 2.6, SHSY5Y, 5 gM), (FTX, -1.2, HT1080, 0.2 ^M), (FUK, -3.5, SHSY5Y, 1 gM), (FXR2, -1, SHSY5Y, 2.5 gM), (G2E3, -1.3, HT1080, 0.2 μM), (G2E3, -1.4, SHSY5Y, 5 μM), (GALNT6, -2, HEK293, 0.5 nM), (GALNT6, -1.7, SHSY5Y, 0.5 μM), (GALNT6, -1.1, HEK293, 1 μM), (GALNT6, -
4.7, SHSY5Y, 1 μM), (GALNT6, -1.7, SHSY5Y, 2.5 μM), (GALNT6, -1.5, SHSY5Y, 5 ^M), (GALNT6, -1.2, HEK293, 5 μM), (GALT, -2.7, SHSY5Y, 5 μM), (GARNL3, -2.3, SHSY5Y, 0.5 μM), (GARNL3, -2.1, HEK293, 1 μM), (GARNL3, -1.8, HEK293, 2.5 μM), (GBA2, -1.1, SHSY5Y, 2.5 μM), (GBA2, -1.3, SHSY5Y, 5 μM), (GCA, -3.3, HT1080, 0.2 μM), (GCA, -2.1, SHSY5Y, 1 gM), (GCA, -1.9, SHSY5Y, 5 μM), (GDPD5, -1.3, HEK293, 0.5 ^M), (GEMIN2, -
1.7, HT1080, 0.2 nM), (GEMIN2, -5.5, SHSY5Y, 0.5 gM), (GEMIN2, -1.1, HEK293, 1 μM), (GEM1N2, -7, SHSY5Y, 1 μM), (GEM1N2, -1.3, HEK293, 5 μM), (GEM1N2, -2.4, SHSY5Y, 5 |1M), (GEMIN2, -1.1, HEK293, 5 μM), (GEN1, -1.4, SHSY5Y, 5 μM), (GFM2, -1.1, SHSY5Y, 0.5 μM), (GFM2, -1.1, SHSY5Y, 2.5 μM), (GFM2, -1.6, SHSY5Y, 5 μM), (GINS1, -1.5, SHSY5Y, 5 μM), (GLB1, -1.7, SHSY5Y, 5 μM,) (GLB1, -1, HEK293, 5 μM, ()GLB1, -1.1, HEK293, 5 μM), (GLS2, 1.5, HEK293, 2.5 μM), (GMIP, -1.9, SHSY5Y, 1 μM), (GOLT1B, -3, SHSY5Y, 5 gM), (GPR155, -1.3, HT1080, 0.2 ^M), (GPR155, -1, HEK293, 0.5 μM), (GPR155, -1.4, HEK293, 5 μM), (GPR155, -1.6, HEK293, 5 μM), (GTF2H2, -1.2, SHSY5Y, 1 μM), (GTF2I, -2.3, HT1080, 0.2 μM), (GTF2I, -2.7, HEK293, 0.5 μM), (GTF2I, -2.8, SHSY5Y, 0.5 |1M), (GTF2I, -3, HEK293, 1 μM), (GTF2I, -2.3, SHSY5Y, 1 μM), (GTF2I, -1.7, HEK293, 2.5 |1M), (GTF2I, -2.7, SHSY5Y, 2.5 μM), (GTF2I, -1.7, HEK293, 5 μM), (GTF2I, -2.5, SHSY5Y, 5 nM), (GTF2I, -2, HEK293, 5 μM), (GTF2I, -2, HEK293, 5 gM), (GTF2IP1, -2.2, HEK293, 0.5 μM), (GTF2IP1, -1.8, SHSY5Y, 0.5 μM), (GTF2IP1, -2, HEK293, 1 μM), (GTF2IP1, -4.8, SHSY5Y, 1 gM), (GTF2IP1, -2.3, SHSY5Y, 2.5 μM,) (GTF2IP1, -1.7, HEK293, 5 ^M), (GTF2IP1, -1.9, HEK293, 5 μM), (GTF2IP20, -1.8, HEK293, 1 μM), (GTF2IP4, -2.2, HEK293, 0.5 μM), (GTF2IP4, -1.8, SHSY5Y, 0.5 μM), (GTF2IP4, -2, HEK293, 1 μM), (GTF2IP4, -4.8, SHSY5Y, 1 μM), (GTF2IP4, -2.3, SHSY5Y, 2.5 μM), (GTF2IP4, -1.7, HEK293, 5 ^M), (GTF2IP4, -2, HEK293, 5 μM), (GUSBP11, -1.4, HEK293, 2.5 μM), (HACD1, -2.4, SHSY5Y, 5 nM), (HACL1, -1.2, HT1080, 0.2 μM), (HACL1, -1.1, HEK293, 0.5 ^M), (HACL1, -1.9, SHSY5Y, 0.5 μM), (HACL1, -2.2, SHSY5Y, 2.5 μM), (HACL1, -1.1, HEK293, 5 μM), (HACL1, -1.3, SHSY5Y, 5 μM), (HACL1, -1.1, HEK293, 5 μM,) (HACL1, -1.1, HEK293, 5 gM), (HEATR5B, -1.2, SHSY5Y, 0.5 μM), (HEATR5B, -1.1, HEK293, 1 μM), (HEATR5B, - 2.2, SHSY5Y, 1 μM), (HEATR5B, -1.3, SHSY5Y, 2.5 μM), (HECTD4, -1, HEK293, 0.5 μM), (HECTD4, -2.1, SHSY5Y, 0.5 μM), (HECTD4, -1, HEK293, 1 μM,) (HECW1, 1.7, HT1080, 0.2 μM), (HEMK1, -1.4, SHSY5Y, 1 gM), (HEMK1, -1.4, SHSY5Y, 5 μM), (HERC2, -1.7, HEK293, 0.5 μM), (HERC2, -2.1, HEK293, 1 μM,) (HERC2, -1.6, HEK293, 2.5 μM, ()HERC2, -1, HEK293, 5 μM), (HERC3, 2, SHSY5Y, 0.5 μM), (HFM1, -3.6, HEK293, 2.5 μM), (HIBADH, -1.4, HEK293, 5 μM), (HIBCH, -1.5, SHSY5Y, 1 μM), (HIVEP3, 1, HT1080, 0.2 |1M), (HOGA1, -7.9, SHSY5Y, 1 μM), (HOGA1, -3.5, SHSY5Y, 2.5 μM), (HOGA1, -7.7, SHSY5Y, 5 μM), (HOOK3, -1.3, HEK293, 2.5 μM), (HOOK3, -1.5, SHSY5Y, 2.5 ^M), (HPS3, -1, HEK293, 5 μM), (HSD17B14, 2, SHSY5Y, 5 μM,) (HSD17B4, -1.9, HT1080, 0.2 μM, )
(HSD17B4, -1.7, HEK293, 0.5 μM), (HSD17B4, -1.9, SHSY5Y, 0.5 ^M), (HSD17B4, -1.5, HEK293, 1 μM), (HSD17B4, -1.8, SHSY5Y, 1 μM,) (HSD17B4, -1.2, HEK293, 2.5 gM), (HSD17B4, -1.7, SHSY5Y, 2.5 μM), (HSD17B4, -1.5, HEK293, 5 ^M), (HSD17B4, -1.6, SHSY5Y, 5 gM), (HSD17B4, -1.6, HEK293, 5 μM), (HSD17B4, -1.7, HEK293, 5 μM), (HTD2, -1.7, SHSY5Y, 0.5 μM), (HTD2, -1.9, SHSY5Y, 1 μM), (HTD2, -1.9, SHSY5Y, 5 gM), (HYAL3, -7.6, SHSY5Y, 2.5 μM), (ICA1L, -2.9, SHSY5Y, 1 μM), (IDE, -1, HT1080, 0.2 ^M), (IFI27L1, -6.1, SHSY5Y, 1 μM), (IFI27L1, -3.1, SHSY5Y, 5 ^M), (IFT172, -1.1, SHSY5Y, 0.5 gM), (IFT172, -1.5, SHSY5Y, 1 μM), (IFT88, -1.4, SHSY5Y, 1 μM), (IKBKB, -E4, SHSY5Y,
2.5 nM), (IL11RA, -1.7, SHSY5Y, 5 μM), (IMMP1L, -1.6, HT1080, 0.2 μM,) (IMMP1L, -1.9, SHSY5Y, 1 μM), (IMMP1L, -1.1, HEK293, 5 μM), (INO80C, -2, SHSY5Y, 1 μM), (INO80C, -
1.5, SHSY5Y, 5 μM), (TNTU, -1.6, SHSY5Y, 1 μM), (IQCB1, -1.4, SHSY5Y, 0.5 μM), (IQCB1, -E7, SHSY5Y, 1 gM), (IQCB1, -E4, SHSY5Y, 2.5 μM), (IQCB1, -1, SHSY5Y, 5 |1M), (IQCB1, -1, HEK293, 5 μM), (IQCG, -1.2, HT1080, 0.2 μM), (IQCG, -1.4, HEK293, 0.5 |1M), (IQCG, -1.4, HEK293, 1 ^M), (IQCG, -2.2, SHSY5Y, 1 μM,) (IQCG, -1.7, HEK293, 2.5 |1M), (IQCG, -1.5, HEK293, 5 ^M), (IQCG, -1.4, HEK293, 5 μM), (IQCH, -E3, HEK293, 0.5 |1M), (IQCH, -2, HEK293, 1 μM,) (IQCH, -1.7, HEK293, 2.5 μM, ()IQCH, -1.1, HEK293, 5 gM), (IQCH-AS1, -3.1, SHSY5Y, 1 μM), (IQCK, -2.8, SHSY5Y, 1 μM), (IQCK, -1.2, HEK293,
2.5 μM), (IRAK2, 1.1, HT1080, 0.2 ^M), (ITGA3, -1.2, HEK293, 0.5 μM), (ITGA3, -1.1, HEK293, 1 μM), (ITPR1, E7, HT1080, 0.2 μM,) (ITPR1, E6, SHSY5Y, 5 μM,) (IPX, -7.1, SHSY5Y, 1 μM), (KATNAL2, -1.9, SHSY5Y, 5 μM), (KATNAL2, -E4, HEK293, 5 μM), (KCNT2, -1.7, HEK293, 0.5 ^M), (KCNT2, -E5, SHSY5Y, 0.5 μM), (KCNT2, -E8, HEK293, 1 |1M), (KCNT2, -E4, SHSY5Y, 1 μM), (KCNT2, -E6, HEK293, 2.5 μM), (KCNT2, -2.1, SHSY5Y, 2.5 μM), (KCNT2, -2.3, HEK293, 5 ^M), (KCNT2, -1.1, HEK293, 5 μM), (KDM4D, -El, HT1080, 0.2 μM), (KDM4D, -7.6, SHSY5Y, 1 ^M), (KIAA0319L, -1.1, HEK293, 0.5 gM), (KIAA0319L, -1.1, SHSY5Y, 0.5 ^M), (KIAA0319L, -1.2, SHSY5Y, 1 μM), (KIAA0319L, -El, HEK293, 2.5 μM), (KIAA0319L, -1, HEK293, 5 μM,) (KIAA0319L, -1, HEK293, 5 μM), (KIAA0556, -E9, HEK293, 0.5 μM), (KIAA0556, -2.3, HEK293, 1 μM), (KIAA0556, -1.8, HEK293, 2.5 μM), (KIAA0556, -1.2, HEK293, 5 μM,) (KIAA0825, -5.6, SHSY5Y, 1 μM), (KIAA0825, -4.6, SHSY5Y, 2.5 μM), (KIAA1841, -1.1, HEK293, 1 μM), (KIDINS220, 1.1, SHSY5Y, 5 μM), (KIF3A, -1.1, HEK293, 1 μM), (KIF9, -8.2, SHSY5Y, 1 gM), (KITLG, -1.2, SHSY5Y, 2.5 μM), (KLHDC4, -E2, SHSY5Y, 5 μM), (KMT5C, -1.5, SHSY5Y, 5 μM), (KYAT3, -1, SHSY5Y, 1 μM), (KYAT3, -E3, SHSY5Y, 5 gM), (LAMA3, - 1.8, HEK293, 0.5 gM), (LAMA3, -2, HEK293, 1 μM,) (LAMA3, -1.5, HEK293, 2.5 μM), (LAMA3, -El, HEK293, 5 μM), (LARP1B, -E3, SHSY5Y, 1 μM), (LARP1B, -El, SHSY5Y,
2.5 nM), (LAS1L, -1, SHSY5Y, 0.5 μM), (LCORE, 1, SHSY5Y, 2.5 μM,) (LCORL, 1.2, SHSY5Y, 5 μM), (LEPR, E3, HT1080, 0.2 μM), (LETMD1, -E9, SHSY5Y, 5 μM), (LGR5, -
1.5, HEK293, 1 μM), (LGR5, -1.4, HEK293, 2.5 μM), (LGR5, -1.8, HEK293, 5 μM), (LGR5, -
1.5, HEK293, 5 μM), (LIG1, -1.2, HEK293, 0.5 μM,) (LIG1, -1.3, HEK293, 1 μM, ()LIMCH1, - 1.4, HEK293, 2.5 gM), (LIN52, -7.8, SHSY5Y, 1 μM), (LINC00473, E2, SHSY5Y, 1 μM), (LINC00624, 1.6, HEK293, 5 μM), (LMBR1L, -1.9, SHSY5Y, 5 μM,) (LOC100128885, -6, SHSY5Y, 1 μM), (LOCI 00233156, El, HT1080, 0.2 μM), (LOC100288637, -2, HEK293, 2.5 μM), (LOCI 00506844, -2.4, HT1080, 0.2 μM), (LOC100506844, -1.8, HEK293, 0.5 ^M), (LOC100506844, -4.5, SHSY5Y, 0.5 gM), (LOCI 00506844, -1.3, HEK293, 1 μM), (LOC100506844, -2.7, SHSY5Y, 1 gM), (LOC100506844, -1.9, SHSY5Y, 2.5 gM), (LOC100506844, -1.3, HEK293, 5 μM), (LOCI 00506844, -2.1, SHSY5Y, 5 μM,)
(LOC100506844, -2.5, HEK293, 5 μM), (LOCI 00506844, -1.7, HEK293, 5 μM), (LOCI 01927027, -1.7, HEK293, 0.5 μM), (LOCI 01927027, -4.9, SHSY5Y, 0.5 μM, ) (LOCI 01927027, -1.9, SHSY5Y, 1 gM), (LOCI 01927027, -1.1, HEK293, 5 μM), (LOCI 01927027, -1.2, HEK293, 5 μM), (LOCI 02606465, -1.9, HT1080, 0.2 μM), (LOC102606465, -2.1, HEK293, 0.5 μM), (LOCI 02606465, -1.5, HEK293, 1 μM), (LOC102606465, -5.6, SHSY5Y, 1 gM), (LOCI 02606465, -1.4, HEK293, 2.5 μM), (LOC102606465, -1.8, HEK293, 5 μM), (LOCI 02606465, -2.7, HEK293, 5 μM,) (LOC102606465, -1.8, HEK293, 5 μM), (LOCI 02724532, -2.6, HT1080, 0.2 μM), (LOCI 02724532, -1.5, HEK293, 0.5 μM), (LOCI 02724532, -8.7, SHSY5Y, 0.5 μM, ) (LOC102724532, -8.6, SHSY5Y, 2.5 gM), (LOCI 02724532, -1.8, HEK293, 5 μM), (LOCI 02724532, -5.9, SHSY5Y, 5 μM), (LOC283683, -2.4, SHSY5Y, 1 μM), (LOC284581, - 4.2, SHSY5Y, 1 μM), (LOC400927, -2.2, HEK293, 2.5 μM), (LOC645166, 1.1, HEK293, 2.5 |1M), (LPCAT4, -1.2, HEK293, 1 μM), (LPCAT4, -1, HEK293, 5 μM), (LRP1, 1.4, HT1080, 0.2 |1M), (LRP1, -1, HEK293, 1 μM), (LRP8, -1, HEK293, 0.5 gM), (LRP8, -2, SHSY5Y, 2.5 ^M), (LRRC28, -2, SHSY5Y, 1 gM), (LRRC34, -1.7, SHSY5Y, 0.5 gM), (LRRC34, -1.9, SHSY5Y, 1 nM), (LRRC34, -5.5, SHSY5Y, 2.5 μM), (LRRC34, -1.1, HEK293, 5 μM,) (LRRC37B, -6.1, SHSY5Y, 1 μM), (LRRC40, -1.3, HT1080, 0.2 μM), (LRRC40, -1.3, SHSY5Y, 0.5 μM), (LRRC40, -1.8, SHSY5Y, 1 μM), (LRRC40, -1.3, SHSY5Y, 2.5 μM), (LRRC40, -1.1, SHSY5Y, 5 μM), (LRRFIP2, -2.2, SHSY5Y, 1 μM,) (LRSAM1, -1.5, SHSY5Y, 5 μM, ) (LRTOMT, -8.8, SHSY5Y, 1 μM), (LY75-CD302, -4.5, SHSY5Y, 1 μM), (LYPLAL1, -1.1, HT1080, 0.2 μM), (LYST, -1.3, HEK293, 0.5 μM,) (LYST, -1.2, HEK293, 1 μM, ()LYST, -1.7, SHSY5Y, 1 μM), (LYST, -1.1, HEK293, 2.5 ^M), (LYST, -1.5, SHSY5Y, 2.5 μM), (MAGI2, -
5.6, SHSY5Y, 1 μM), (MAGI3, 1.5, SHSY5Y, 5 μM), (MAML3, -1.2, HEK293, 2.5 μM), (MANBAL, -1.6, SHSY5Y, 1 gM), (MAP2K5, -1.1, SHSY5Y, 1 μM), (MAP2K6, -1, HEK293, 2.5 piM), (MAP2K6, -1, HEK293, 5 ^M), (MAPK10, -2, SHSY5Y, 1 μM), (MAPK11, -4.7, SHSY5Y, 2.5 gM), (MAST4, 1.5, SHSY5Y, 5 gM), (MBOAT2, -1.2, HT1080, 0.2 ^M), (MBOAT2, -1.2, HEK293, 0.5 μM), (MBOAT2, -1, SHSY5Y, 0.5 μM), (MBOAT2, -1.3, SHSY5Y, 1 gM), (MBOAT2, -1.2, HEK293, 2.5 μM,) (MBOAT2, -1.1, SHSY5Y, 2.5 μM, ) (MBOAT2, -1.1, HEK293, 5 μM), (MCCC2, -1.5, SHSY5Y, 2.5 gM), (MCOLN1, 1.1, HT1080, 0.2 μM), (MCOLN1, 1.4, SHSY5Y, 1 μM), (MCOLN1, 1.2, HEK293, 2.5 μM), (MCOLN1, 1.1, SHSY5Y, 2.5 μM), (MCOLN1, 1.1, HEK293, 5 gM), (MCOLN3, -1.3, HEK293, 0.5 μM), (MECR, -2.7, SHSY5Y, 1 μM), (MED23, -1.1, SHSY5Y, 1 μM), (MED23, -1.3, SHSY5Y, 2.5 |1M), (MELTF, -1.6, SHSY5Y, 2.5 μM), (MELTF, -1.2, HEK293, 5 μM,) (METTL21A, -1.1, SHSY5Y, 1 μM), (MFF, -1.1, SHSY5Y, 5 μM), (MFSD14B, -1, SHSY5Y, 5 μM), (MGA, 1.2, SHSY5Y, 5 gM), (MGEA5, -1.2, SHSY5Y, 0.5 μM,) (MGEA5, -1, SHSY5Y, 1 μM, ()M1A3,
1.7, SHSY5Y, 5 μM), (MICAL1, -1.3, HEK293, 0.5 μM), (MICAL1, -2, SHSY5Y, 0.5 μM), (MICAL1, -1.1, HEK293, 1 gM), (MICAL1, -1.2, SHSY5Y, 1 μM), (MICAL1, -1.6, SHSY5Y, 2.5 nM), (MICAL1, -1.4, SHSY5Y, 5 μM), (MIGA1, -2.5, SHSY5Y, 1 μM,) (MINDY3, -2.1, SHSY5Y, 5 μM), (MIR924HG, -1.6, HEK293, 2.5 μM), (MIR924HG, -1.6, HEK293, 5 μM), (MIR99AHG, -2.9, SHSY5Y, 2.5 gM), (MITD1, -1.2, SHSY5Y, 1 ^M), (MKS1, -1.1, HEK293, 0.5 μM), (MKS1, -1, HEK293, 1 μM), (MLH1, -1.6, HT1080, 0.2 μM), (MLH1, -1.4, SHSY5Y, 0.5 μM), (MLH1, -2.8, SHSY5Y, 1 μM), (MLH1, -2.1, SHSY5Y, 2.5 μM), (MLH1, -1.5, SHSY5Y, 5 μM), (MLH1, -1.4, HEK293, 5 μM), (MLH1, -1.6, HEK293, 5 gM), (MMAB, -2, SHSY5Y, 1 μM), (MMAB, -1.2, HEK293, 5 gM), (MMAB, -1.9, SHSY5Y, 5 μM), (MMP24- AS1-EDEM2, -2.4, SHSY5Y, 1 μM), (MMP24-AS1-EDEM2, -1.2, SHSY5Y, 2.5 μM,)
(MMP24-AS1-EDEM2, -1.3, SHSY5Y, 5 μM), (MNAT1, -3.1, SHSY5Y, 1 μM), (M0CS1, 1.2, SHSY5Y, 1 gM), (MOSPD2, -2, HT1080, 0.2 μM,) (MOSPD2, -2.2, HEK293, 0.5 μM), (MOSPD2, -1.9, HEK293, 1 gM), (MOSPD2, -5.1, SHSY5Y, 1 μM), (MOSPD2, -1.5, HEK293, 2.5 μM), (MOSPD2, -1.6, HEK293, 5 μM), (MOSPD2, -1.3, HEK293, 5 μM), (MOSPD2, -1.2, HEK293, 5 μM), (MPDZ, 1.2, SHSY5Y, 5 gM), (MPND, -1.1, SHSY5Y, 1 gM), (MROH6, - 1.9, HT1080, 0.2 μM), (MROH6, -1.3, HEK293, 5 μM), (MRPL43, -1.1, SHSY5Y, 5 μM), (MRPS30-DT, 2.1, HEK293, 5 μM), (MRRF, -1.5, SHSY5Y, 5 μM,) (MSI1, -3.9, SHSY5Y, 1 gM), (MTCH2, -1.6, SHSY5Y, 5 μM), (MTHFSD, 1.2, SHSY5Y, 1 gM), (MYH14, -1.1, HEK293, 1 μM), (MYHAS, -7.8, SHSY5Y, 1 μM), (MYLK, -1.2, HEK293, 0.5 μM, ()MYLK, - 1.9, HEK293, 1 gM), (MYLK, -3.2, SHSY5Y, 1 ^M), (MYLK, -1.9, HEK293, 2.5 gM), (MYLK, -1.9, HEK293, 5 μM), (MYO5C, -1.1, HEK293, 0.5 μM), (MYO5C, -1.2, HEK293, 1 gM), (MY0M2, -1.3, HEK293, 1 gM), (MY0M2, -1.3, HEK293, 5 μM), (NAA40, -2.2, SHSY5Y, 2.5 μM), (NAA40, -2.1, SHSY5Y, 5 μM), (NARS2, -1.3, HT1080, 0.2 μM), (NBEAL1, -1.5, SHSY5Y, 1 μM), (NBPF10, -1.6, HEK293, 2.5 μM,) (NBPF25P, -1.3, HEK293, 1 μM), (NCOA1, 2, SHSY5Y, 5 μM), (NCOA2, -1.1, HEK293, 1 μM), (NCOR2, -1.1, HEK293, 0.5 μM), (NCOR2, -1.5, HEK293, 1 gM), (NCOR2, -1, HEK293, 2.5 μM,) (NDUFB6, -1.3, SHSY5Y, 1 μM), (NDUFB6, -1.2, SHSY5Y, 5 μM), (NECAB3, -1.5, HEK293, 0.5 μM), (NECAB3, -1, HEK293, 1 μM), (NECAB3, -2.5, SHSY5Y, 1 μM), (NECAB3, -1.5, SHSY5Y, 5 |1M), (NECAB3, -1, HEK293, 5 μM,) (NECAB3, -1.1, HEK293, 5 μM, ()NEIL3, -1.2, SHSY5Y, 5 μM), (NEK1, -1.9, HT1080, 0.2 gM), (NEK1, -2.1, HEK293, 0.5 μM), (NEK1, -2.7, SHSY5Y, 0.5 μM), (NEK1, -2.6, HEK293, 1 μM,) (NEK1, -2.9, SHSY5Y, 1 μM, ()NEK1, -1.5, HEK293, 2.5 μM), (NEK1, -2.5, SHSY5Y, 2.5 μM), (NEK1, -1.8, HEK293, 5 μM), (NEK1, -
1.2, SHSY5Y, 5 μM), (NEK1, -1.6, HEK293, 5 μM), (NEK1, -1.7, HEK293, 5 μM), (NEK11, -
7.3, SHSY5Y, 1 μM), (NFATC2, 1.9, HT1080, 0.2 μM), (NFATC2IP, -1.3, HT1080, 0.2 μM), (NFATC2IP, -1.3, SHSY5Y, 0.5 μM), (NFATC2IP, -5.2, SHSY5Y, 1 μM), (NFATC2IP, -1.4, SHSY5Y, 2.5 gM), (NFATC2IP, -1.5, SHSY5Y, 5 μM,) (NFKB1, -1.3, SHSY5Y, 1 μM, ) (NHLRC3, -1.2, HT1080, 0.2 μM), (NHLRC3, -2.8, SHSY5Y, 1 μM), (NHLRC3, -1.1, HEK293, 5 μM), (NMNAT1, -1.1, HEK293, 1 μM,) (NMNAT1, -4.6, SHSY5Y, 2.5 gM), (NOTCH1, -1, HEK293, 0.5 gM), (NOTCH1, -1.1, HEK293, 1 μM), (NOTCH3, 1.1, HT1080, 0.2 μM), (NOX4, -3, SHSY5Y, 2.5 μM), (NR2C1, -1.5, SHSY5Y, 1 gM), (NR2C1, -1.5, SHSY5Y, 5 μM), (NRCAM, -6.5, SHSY5Y, 1 gM), (NTRK1, -8.6, SHSY5Y, 2.5 μM), (NTRK1, -8.4, SHSY5Y, 5 μM), (NUBPL, -1, HEK293, 1 μM), (NUBPL, -1.7, SHSY5Y, 1 |1M), (NUBPL, -1.1, HEK293, 2.5 μM,) (NUBPL, -3.7, SHSY5Y, 2.5 gM), (NUBPL, -1.1, SHSY5Y, 5 μM), (NUDT17, -7.9, SHSY5Y, 0.5 μM), (NUDT17, -7.8, SHSY5Y, 1 μM), (NUDT22, -2.6, SHSY5Y, 1 μM), (NUP43, -1.3, HT1080, 0.2 μM,) (NUP43, -1.3, HEK293, 0.5 |1M), (NUP43, -1.5, SHSY5Y, 0.5 μM), (NUP43, -1.3, HEK293, 1 μM), (NUP43, -1.8, SHSY5Y, 1 μM), (NUP43, -1.1, HEK293, 2.5 μM), (NUP43, -1.7, SHSY5Y, 5 gM), (NUP54, -
1.3, SHSY5Y, 5 μM), (NUP58, -1.1, HT1080, 0.2 gM), (NUP58, -1.6, SHSY5Y, 0.5 μM, ) (NUP58, -2, SHSY5Y, 1 gM), (NUP58, -1.5, SHSY5Y, 2.5 μM), (NUP58, -1, HEK293, 5 μM), (NUP58, -1.4, SHSY5Y, 5 gM), (NUPL2, -1.7, HT1080, 0.2 μM,) (NUPL2, -1, HEK293, 0.5 |1M), (NUPL2, -1.3, SHSY5Y, 0.5 μM), (NUPL2, -1.4, SHSY5Y, 2.5 μM), (NUPL2, -1.8, SHSY5Y, 5 gM), (NUPL2, -1.2, HEK293, 5 μM), (NXN, 1.3, HT1080, 0.2 gM), (OARD1, -1.1, HEK293, 0.5 μM), (OARD1, -1.4, SHSY5Y, 1 μM), (OARD1, -1.7, SHSY5Y, 2.5 gM), (OARD1, -2.1, SHSY5Y, 5 μM), (OAZ1, -1.2, SHSY5Y, 5 ^M), (OBSCN, -1.6, HEK293, 0.5 |1M), (OGGI, -1.7, SHSY5Y, 1 μM), (OLMALINC, -4.6, HT1080, 0.2 μM,) (OLMALINC, -3.9,
HEK293, 0.5 μM), (OLMALINC, -4.9, HEK293, 1 μM), (OLMALINC, -1.5, HEK293, 2.5 μM), (OLMALINC, -2.3, HEK293, 5 μM), (OLMALINC, -4.2, HEK293, 5 μM), (OLMALINC, -4.9, HEK293, 5 μM), (OPHN1, -5.5, SHSY5Y, 1 μM), (OPHN1, -1.2, HEK293, 5 μM), (OSGEPL1, -1.5, SHSY5Y, 5 μM), (OTUD5, -1.2, HEK293, 0.5 μM), (OTUD5, -1.2, HEK293, 1 μM), (OTUD5, -1.4, SHSY5Y, 1 μM), (OTULIN, -1.6, SHSY5Y, 1 μM), (OXCT1, -1.2, HT1080, 0.2 μM), (OXCT1, -2.7, SHSY5Y, 0.5 μM), (OXCT1, -2.4, SHSY5Y, 1 μM), (OXCT1, -1, HEK293, 2.5 μM), (OXCT1, -1.3, SHSY5Y, 2.5 μM), (OXCT1, -1.1, HEK293, 5 μM), (OXCT1, -1, HEK293, 5 μM), (OXNAD1, 1.4, SHSY5Y, 1 μM), (P2RX4, -1.1, HEK293, 0.5 μM), (P2RX4, -2.8, SHSY5Y, 1 μM), (P2RX4, -1, HEK293, 5 μM), (P2RX4, -1.2, HEK293, 5 μM), (PAAF1, -1.4, SHSY5Y, 0.5 μM), (PAAF1, -2.2, SHSY5Y, 1 μM), (PAAF1, -1.4, SHSY5Y, 5 μM), (PAAF1, -1, HEK293, 5 μM), (PARG, -1.4, HEK293, 0.5 μM), (PARG, -1.1, HEK293, 1 μM), (PARG, -1.1, SHSY5Y, 2.5 μM), (PAXX, -1, SHSY5Y, 5 μM), (PCCB, -1.1, HT1080, 0.2 μM), (PCCB, -1.4, HEK293, 0.5 μM), (PCCB, -1.3, SHSY5Y, 0.5 μM), (PCCB, -
1.1, HEK293, 1 μM), (PCCB, -1.3, SHSY5Y, 1 μM), (PCCB, -1.5, HEK293, 5 μM), (PCCB, - 1.3, SHSY5Y, 5 μM), (PCCB, -1.5, HEK293, 5 μM), (PCCB, -1.6, HEK293, 5 μM), (PCDH9,
1.2, SHSY5Y, 1 μM), (PC1D2, -2.3, HT1080, 0.2 μM), (PC1D2, -2.8, HEK293, 0.5 μM), (PCID2, -2.6, SHSY5Y, 0.5 μM), (PCID2, -2.4, HEK293, 1 μM), (PCID2, -1.9, SHSY5Y, 1 μM), (PCID2, -2, HEK293, 2.5 μM), (PCID2, -3.1, SHSY5Y, 2.5 μM), (PCID2, -2.1, HEK293, 5 μM), (PCID2, -3.6, SHSY5Y, 5 μM), (PCID2, -1.9, HEK293, 5 μM), (PCID2, -1.8, HEK293, 5 μM), (PCLO, -2, HEK293, 1 μM), (PCNT, -1.1, HEK293, 1 μM), (PDCD6IPP2, -2.4, SHSY5Y, 1 μM), (PDE8A, -1.5, SHSY5Y, 2.5 μM), (PDIA5, -1.8, HEK293, 0.5 μM), (PDIA5, -1.7, HEK293, 1 μM), (PDIA5, -3, SHSY5Y, 2.5 μM), (PDIA5, -1, HEK293, 5 μM), (PDIA5, -
2.2, SHSY5Y, 5 μM), (PDIA5, -1.5, HEK293, 5 μM), (PDIA5, -1.3, HEK293, 5 μM), (PDLIM2, -2.4, SHSY5Y, 1 μM), (PDLIM2, -2.8, SHSY5Y, 5 μM), (PDZD11, -1.4, SHSY5Y, 5 μM), (PEAK1, 1.2, SHSY5Y, 5 μM), (PEAR1, -7.5, SHSY5Y, 1 μM), (PEX6, -1.5, HEK293, 0.5 μM), (PEX6, -1.6, HEK293, 1 μM), (PEX6, -1.7, SHSY5Y, 1 μM), (PEX6, -1.4, HEK293, 5 μM), (PEX6, -1.2, HEK293, 5 μM), (PFDN1, -1, HT1080, 0.2 μM), (PFDN1, -2.5, SHSY5Y, 1 μM), (PGAP1, -1.1, HT1080, 0.2 μM), (PGAP1, -1, SHSY5Y, 2.5 μM), (PHKG2, -1.2, HT1080, 0.2 μM), (PHKG2, -1.6, HEK293, 0.5 μM), (PHKG2, -2.5, SHSY5Y, 0.5 μM), (PHKG2, -1.4, HEK293, 1 μM), (PHKG2, -1.6, SHSY5Y, 1 μM), (PHKG2, -2.1, SHSY5Y, 2.5 μM), (PHKG2, -1.2, HEK293, 5 μM), (PHKG2, -3.1, SHSY5Y, 5 μM), (PIGN, -1, SHSY5Y, 5 μM), (PIK3C2A, -1.1, HEK293, 0.5 μM), (PIK3C2A, -1.1, SHSY5Y, 0.5 μM), (PIK3C2A, -1, HEK293, 1 μM), (PIK3C2A, -1, SHSY5Y, 1 μM), (PIK3C2A, -1.3, SHSY5Y, 2.5 μM), (PIKFYVE, 1, SHSY5Y, 5 μM), (PITPNA, -1.2, SHSY5Y, 1 μM), (PITPNA, -1, SHSY5Y, 2.5 μM), (P1TPNM2, -6, SHSY5Y, 1 μM), (PLAGL1, -4.5, SHSY5Y, 1 μM), (PLBD2, -1.4, HEK293, 0.5 μM), (PLBD2, -2.1, SHSY5Y, 0.5 μM), (PLBD2, -1.5, HEK293, 1 μM), (PLBD2, -2, SHSY5Y, 1 μM), (PLCB4, -1.1, HEK293, 0.5 μM), (PLCB4, -1.1, HEK293, 1 μM), (PLCB4, -1.3, HEK293, 2.5 μM), (PLPP5, -1.2, SHSY5Y, 5 μM), (PMS2P5, -8.1, SHSY5Y, 1 μM), (POC1A, -1.3, SHSY5Y, 5 μM), (POLA2, -1.4, HT1080, 0.2 μM), (POLA2, -1.3, HEK293, 0.5 μM), (POLA2, -1.2, HEK293, 1 μM), (POLA2, -1.3, SHSY5Y, 2.5 μM), (POLA2, -1.2, HEK293, 5 μM), (POLA2, -2.3, SHSY5Y, 5 μM), (POLA2, -1.1, HEK293, 5 μM), (POLA2, -1.3, HEK293, 5 μM), (POLM, -1.9, SHSY5Y, 1 μM), (POLN, -2.1, HEK293, 0.5 μM), (POLN, -1.3, HEK293, 1 μM), (POLN, -1.5, HEK293, 2.5 μM), (POLN, -1.8, HEK293, 5 μM), (POLN, -1, HEK293, 5 μM), (POLN, -1.1, HEK293, 5 μM), (POLQ, -1.2, HEK293, 0.5 μM), (POLQ, -1.1, HEK293, 1 μM), (POLQ, -1.9, SHSY5Y, 1 μM), (POLR2J4, 1.9, HT1080,
0.2 gM), (POLR2J4, 2.6, HEK293, 0.5 gM), (POLR2J4, 2.5, SHSY5Y, 0.5 gM), (POLR2J4, 2.8, HEK293, 1 gM), (POLR2J4, 2.5, SHSY5Y, 1 gM), (POLR2J4, 2.3, HEK293, 2.5 gM), (POLR2J4, 3.4, SHSY5Y, 2.5 gM), (POLR2J4, 2.2, HEK293, 5 gM), (POLR2J4, 3, SHSY5Y, 5 gM), (POLR2J4, 1.2, HEK293, 5 gM), (POLR2J4, 1.3, HEK293, 5 gM), (POLR3F, -1.6, SHSY5Y, 5 gM), (POU2F1, 1, SHSY5Y, 5 gM), (PPIEL, -1.2, HT1080, 0.2 gM), (PPIL2, -1.7, SHSY5Y, 1 gM), (PPIL2, -2, SHSY5Y, 2.5 gM), (PPP1R12B, -1.5, HEK293, 0.5 gM), (PPP1R35, -1.2, SHSY5Y, 1 gM), (PPP2R3C, -2, HT1080, 0.2 gM), (PPP2R3C, -1.2, HEK293, 0.5 gM), (PPP2R3C, -1.4, SHSY5Y, 0.5 gM), (PPP2R3C, -1.1, HEK293, 1 gM), (PPP2R3C, - 1.6, SHSY5Y, 1 gM), (PPP2R3C, -1.4, HEK293, 5 gM), (PPP2R3C, -1.7, SHSY5Y, 5 gM), (PPP2R3C, -1.1, HEK293, 5 gM), (PPP4R4, -1.8, HEK293, 0.5 gM), (PPP4R4, -1.1, HEK293, 5 gM), (PPP4R4, -1 , HEK293, 5 gM), (PPP6R2, -1.2, HEK293, 0.5 gM), (PPP6R2, -1.1 , SHSY5Y, 0.5 gM), (PPP6R2, -1.2, HEK293, 1 gM), (PPP6R2, -1.4, SHSY5Y, 1 gM), (PRIMPOL, -1.3, HEK293, 5 gM), (PRKAA2, -1.1, HT1080, 0.2 gM), (PRKAG1, -1.3, HT1080, 0.2 gM), (PRKAG1, -1.4, HEK293, 0.5 gM), (PRKAG1, -1.5, SHSY5Y, 0.5 gM), (PRKAG1, -1.3, HEK293, 1 gM), (PRKAG1, -2.5, SHSY5Y, 1 gM), (PRKAG1, -1.7, SHSY5Y, 2.5 gM), (PRKAG1, -1.3, HEK293, 5 gM), (PRKAG1, -1.8, SHSY5Y, 5 gM), (PRKAG1, -1, HEK293, 5 gM), (PRKAG1, -1.3, HEK293, 5 gM), (PRKAG2, -1, HT1080, 0.2 gM), (PRKRA, -2.5, SHSY5Y, 1 gM), (PRKRA, -1.6, SHSY5Y, 5 gM), (PRMT3, -1.3, SHSY5Y, 2.5 gM), (PRPF40B, -1.3, HT1080, 0.2 gM), (PRPF40B, -2.1, HEK293, 0.5 gM), (PRPF40B, -4.9, SHSY5Y, 0.5 gM), (PRPF40B, -2.8, HEK293, 1 gM), (PRPF40B, -1.4, SHSY5Y, 1 gM), (PRPF40B, -1.6, HEK293, 2.5 gM), (PRPF40B, -9.6, SHSY5Y, 2.5 gM), (PRPF40B, -1.5, HEK293, 5 gM), (PRPF40B, -2.3, SHSY5Y, 5 gM), (PRPF40B, -1.2, HEK293, 5 gM), (PRPF4B, -1.1, HEK293, 0.5 gM), (PRPF4B, -1.2, SHSY5Y, 0.5 gM), (PRPF4B, -1.2, HEK293, 1 gM), (PRPF4B, -1, HEK293, 2.5 gM), (PSEN2, -6.7, SHSY5Y, 1 gM), (PSEN2, -1.1, HEK293, 5 gM), (PSTPIP2, -2.2, SHSY5Y, 1 gM), (PTBP3, -1.4, SHSY5Y, 1 gM), (PTPN18, - 1.5, HEK293, 0.5 gM), (PTPN18, -1.6, HEK293, 1 gM), (PTPN18, -1.7, HEK293, 5 gM), (PTPN18, -1.5, HEK293, 5 gM), (PTPN18, -1.2, HEK293, 5 gM), (PTPN2, -1.2, SHSY5Y, 2.5 gM), (PTPN21, -1.2, HEK293, 0.5 gM), (PTPN21, -1.9, SHSY5Y, 0.5 gM), (PTPN21, -1.3, SHSY5Y, 2.5 gM), (PTPN21, -1.1, HEK293, 5 gM), (PTPRA, -1.2, HEK293, 0.5 gM), (PTPRA, -1.5, HEK293, 1 gM), (PTPRA, -1.2, HEK293, 2.5 gM), (PTPRG-AS1, -1, HT1080, 0.2 gM), (PTPRG-AS1, -1.4, HEK293, 5 gM), (PTPRK, -1.4, HEK293, 2.5 gM), (PURPL, -1.2, HT1080, 0.2 gM), (PVT1, -7.1, SHSY5Y, 1 gM), (PXDN, -1.1, HEK293, 1 gM), (PYROXD1, -
1.2, HT1080, 0.2 gM), (PYROXD1, -1.8, SHSY5Y, 1 gM), (PYROXD1, -1.6, SHSY5Y, 5 gM), (R3HCC1L, -1.2, SHSY5Y, 0.5 gM), (R3HDM2, -1.2, HEK293, 0.5 gM), (R3HDM2, -1.3, HEK293, 1 gM), (R3HDM2, -1.5, HEK293, 2.5 gM), (RAB28, -5.7, SHSY5Y, 1 gM), (RAB36, -1.7, SHSY5Y, 0.5 gM), (RAB3GAP1, -2.2, SHSY5Y, 0.5 gM), (RAB3GAP1, -2, SHSY5Y, 1 gM), (RAB3GAP1, -2.3, SHSY5Y, 2.5 gM), (RAB3GAP1, -1.1, SHSY5Y, 5 gM), (RAB4B, -
1.3, HEK293, 0.5 gM), (RAB4B, -1.2, HEK293, 1 gM), (RAB4B, -5.6, SHSY5Y, 1 gM), (RAB4B, -1.3, HEK293, 5 gM), (RAB4B, -1.4, HEK293, 5 gM), (RABGAP1L, -1.1, HEK293, 1 gM), (RABGAP1L, -1.4, HEK293, 2.5 gM), (RABGAP1L, -1.2, HEK293, 5 gM), (RABL2B, -2.6, SHSY5Y, 5 gM), (RAD18, 1.6, SHSY5Y, 1 gM), (RAD51AP1, -1, SHSY5Y, 1 gM), (RAD51AP1, -1, HEK293, 5 gM), (RAD51AP1, -1.3, SHSY5Y, 5 gM), (RAD51B, -8, SHSY5Y, 1 gM), (RAD51C, -1.2, SHSY5Y, 1 gM), (RADIL, -1.4, HEK293, 0.5 gM), (RADIL, -1.6, SHSY5Y, 0.5 gM), (RADIL, -1.5, HEK293, 1 gM), (RADIL, -1.1, HEK293, 5 gM), (RADIL, -1.6, HEK293, 5 gM), (RADIL, -1.5, HEK293, 5 gM), (RALGPS1, -7.8, SHSY5Y, 1
μM), (RALGPS1, -1.2, HEK293, 2.5 μM), (RANBP17, -6.9, SHSY5Y, 1 μM), (RANBP17, -1.6, HEK293, 2.5 μM), (RANBP17, -1.8, SHSY5Y, 5 μM), (RAP1GAP2, -1, HEK293, 0.5 μM), (RAP1GAP2, -2.1, SHSY5Y, 1 μM), (RAP1GAP2, -1.5, SHSY5Y, 2.5 μM), (RBM15-AS1, 3.7, SHSY5Y, 1 μM), (RBM20, -1.7, HEK293, 0.5 μM), (RBM20, -2.2, SHSY5Y, 0.5 μM), (RBM20, -2.5, HEK293, 1 μM), (RBM20, -2.1, SHSY5Y, 1 μM), (RBM20, -2, HEK293, 2.5 μM), (RBM20, -1.9, SHSY5Y, 2.5 μM), (RBM20, -1.2, HEK293, 5 μM), (RBM20, -1.1, HEK293, 5 μM), (RBM38, -4.5, SHSY5Y, 1 μM), (RBM5, -1.2, SHSY5Y, 2.5 μM), (RBPMS, - 1.6, SHSY5Y, 5 μM), (RECK, -1.2, HT1080, 0.2 μM), (RECK, -1.9, SHSY5Y, 0.5 μM), (RECK, -1.2, HEK293, 1 μM), (RECK, -1.5, SHSY5Y, 1 μM), (RECK, -2.2, SHSY5Y, 2.5 μM), (RECK, -1.1, HEK293, 5 μM), (RECK, -1.6, HEK293, 5 μM), (REV1, -1.4, SHSY5Y, 1 μM), (REXO5, -1.1, HEK293, 1 μM), (REXO5, -2, SHSY5Y, 1 μM), (REXO5, -1.5, HEK293, 5 μM), (RGS5, -1.1, SHSY5Y, 1 μM), (RHOT1, -1.1, HEK293, 0.5 μM), (RHOT1, -1, HEK293, 1 μM), (RIF1, 1.3, SHSY5Y, 5 μM), (RIMS2, -2, SHSY5Y, 1 μM), (RINT1, -1, SHSY5Y, 1 μM), (RINT1, -1.3, SHSY5Y, 2.5 μM), (RINT1, -1.5, SHSY5Y, 5 μM), (RLF, 1.2, SHSY5Y, 1 μM), (RLF, 1, SHSY5Y, 5 μM), (RNF123, -1.9, HEK293, 0.5 μM), (RNF123, -1.5, SHSY5Y, 0.5 μM), (RNF123, -1.8, HEK293, 1 μM), (RNF123, -2, SHSY5Y, 2.5 μM), (RNF165, 2.7, SHSY5Y, 1 μM), (RNF170, -1.3, SHSY5Y, 0.5 μM), (RNF170, -1.1, SHSY5Y, 5 μM), (RNF212, -2.8, SHSY5Y, 1 μM), (RNF212, -1.7, SHSY5Y, 5 μM), (RNFT1, -1.2, HT1080, 0.2 μM), (RNFT1, -1.5, SHSY5Y, 1 μM), (RNFT1, -2.5, SHSY5Y, 5 μM), (RNFT1, -1, HEK293, 5 μM), (ROGDI, -1.1, SHSY5Y, 5 μM), (RPGRIP1L, -1.5, SHSY5Y, 1 μM), (RPP40, 1.1, HEK293, 1 μM), (RPUSD1, -1, SHSY5Y, 5 μM), (RRNAD1, -1.2, HEK293, 0.5 μM), (RRNAD1, -2.5, SHSY5Y, 0.5 μM), (RRNAD1, -1, HEK293, 1 μM), (RRNAD1, -1.2, SHSY5Y, 1 μM), (RRNAD1, -1.9, SHSY5Y, 2.5 μM), (RRNAD1, -1.2, HEK293, 5 μM), (RRNAD1, -1.1, HEK293, 5 μM), (RSRP1, 1.5, SHSY5Y, 0.5 μM), (RSRP1, 1.4, SHSY5Y, 5 μM), (RTEL1, -2.1, HEK293, 0.5 μM), (RTEL1, -2.1, HEK293, 1 μM), (RTEL1, -2.9, SHSY5Y, 1 μM), (RTEL1, -1.1, HEK293, 2.5 μM), (RTEL1-TNFRSF6B, -2.1, HEK293, 0.5 μM), (RTEL1-TNFRSF6B, -2.1, HEK293, 1 μM), (RTEL1-TNFRSF6B, -2.9, SHSY5Y, 1 μM), (RTEL1-TNFRSF6B, -1.1, HEK293, 2.5 μM), (RUNX1T1, -1.4, HEK293, 2.5 μM), (RWDD4, - 1, HEK293, 1 μM), (RWDD4, -1.8, SHSY5Y, 1 μM), (RWDD4, -1.2, SHSY5Y, 2.5 μM), (RWDD4, -1.6, SHSY5Y, 5 μM), (SAMD3, -5.1, HT1080, 0.2 μM), (SATB1-AS1, -2.5, SHSY5Y, 1 μM), (SCAPER, -1.5, SHSY5Y, 1 μM), (SCAPER, -1.1, HEK293, 2.5 μM), (SCARB1, -1.5, SHSY5Y, 5 μM), (SCFD1, 1.1, SHSY5Y, 5 μM), (SCG3, -1.1, SHSY5Y, 0.5 μM), (SDCCAG3, -1.1, SHSY5Y, 1 μM), (SDHAF3, -8.1, SHSY5Y, 1 μM), (SEC31B, 1.3, HEK293, 5 μM), (SEMA4A, -3.3, HEK293, 5 μM), (SENP3, -1.2, SHSY5Y, 5 μM), (SFI1, -1.6, HEK293, 0.5 μM), (SF11, -1.3, HEK293, 1 μM), (SF11, -1.2, HEK293, 2.5 μM), (SF11, -1.6, SHSY5Y, 2.5 μM), (SFI1, -1.1, HEK293, 5 μM), (SFMBT1, -1, SHSY5Y, 0.5 μM), (SFMBT1, -1.1, SHSY5Y, 2.5 μM), (SFXN2, -1.7, SHSY5Y, 0.5 μM), (SFXN2, -2, SHSY5Y, 2.5 μM), (SFXN2, -2, SHSY5Y, 5 μM), (SFXN4, 1.1, HEK293, 0.5 μM), (SFXN4, 1.2, HEK293, 1 μM), (SFXN4, 1.4, SHSY5Y, 1 μM), (SLC24A1, -1.4, HEK293, 0.5 μM), (SLC24A1, -1.4, HEK293, 1 μM), (SLC24A1, -3, SHSY5Y, 1 μM), (SLC24A1, -1.1, HEK293, 2.5 μM), (SLC24A1, -4.8, SHSY5Y, 2.5 μM), (SLC24A1, -1.1, HEK293, 5 μM), (SLC24A1, -1, HEK293, 5 μM), (SLC25A14, -1.5, HEK293, 0.5 μM), (SLC25A14, -2, SHSY5Y, 0.5 μM), (SLC25A14, -1.1, HEK293, 1 μM), (SLC25A14, -1.6, SHSY5Y, 1 μM), (SLC25A14, -1.3, SHSY5Y, 2.5 μM), (SLC25A14, -1.3, HEK293, 5 μM), (SLC25A14, -1.9, SHSY5Y, 5 μM), (SLC25A14, -1.2, HEK293, 5 μM), (SLC25A14, -1.1, HEK293, 5 μM), (SLC25A21, 1.3, HEK293, 1 μM),
(SLC25A32, -1.3, SHSY5Y, 0.5 μM), (SLC25A32, -1, SHSY5Y, 1 μM), (SLC25A32, -1, HEK293, 5 μM), (SLC25A32, -1.2, SHSY5Y, 5 gM), (SLC25A40, -1.7, HT1080, 0.2 μM), (SLC25A40, -1.8, HEK293, 0.5 gM), (SLC25A40, -2.8, SHSY5Y, 0.5 μM), (SLC25A40, -2.1, HEK293, 1 μM), (SLC25A40, -2.3, SHSY5Y, 1 gM), (SLC25A40, -1.6, HEK293, 2.5 μM), (SLC25A40, -1.9, SHSY5Y, 2.5 μM), (SLC25A40, -2.2, HEK293, 5 μM), (SLC25A40, -3.6, SHSY5Y, 5 μM), (SLC25A40, -1.2, HEK293, 5 gM), (SLC25A40, -1.4, HEK293, 5 gM), (SLC26A10, -1.3, HEK293, 5 μM), (SLC2A11, -7.4, SHSY5Y, 5 μM,) (SLC33A1, -1.1, SHSY5Y, 5 μM), (SLC35A1, -1.5, SHSY5Y, 5 μM), (SLC35A3, -2.7, SHSY5Y, 2.5 μM), (SLC35B3, -1.3, SHSY5Y, 5 μM), (SLC35D2, -1.1, SHSY5Y, 5 gM), (SLC35F2, -1.7, SHSY5Y, 2.5 μM), (SLC37A3, -1, SHSY5Y, 0.5 μM), (SLC37A3, -1, SHSY5Y, 2.5 μM), (SLC37A3, -1.3, SHSY5Y, 5 μM), (SLC38A6, -1.9, HT1080, 0.2 μM), (SLC38A6, -1.9, HEK293, 0.5 μM), (SLC38A6, -3.8, SHSY5Y, 0.5 μM), (SLC38A6, -2, HEK293, 1 μM), (SLC38A6, -1.2, HEK293, 2.5 μM), (SLC38A6, -6.3, SHSY5Y, 2.5 gM), (SLC38A6, -2, HEK293, 5 μM), (SLC38A6, -1.9, HEK293, 5 gM), (SLC38A6, -1.3, HEK293, 5 μM, ) (SLC3A2, 1, HEK293, 1 gM), (SLC3A2, 1.1, HEK293, 2.5 μM), (SLC3A2, 1.2, HEK293, 5 |1M), (SLC43A1, -1.3, HT1080, 0.2 μM,) (SLC43A1, -1.6, HEK293, 0.5 μM, ()SLC43A1, -1.5, HEK293, 1 μM), (SLC43A1, -8.2, SHSY5Y, 1 μM), (SLC43A1, -5.8, SHSY5Y, 2.5 gM), (SLC43A1, -1.5, HEK293, 5 μM), (SLC43A1, -3.6, SHSY5Y, 5 μM), (SLC43A1, -1.8, HEK293, 5 μM), (SLC43A1, -1.1, HEK293, 5 gM), (SLC47A1, -1.3, HEK293, 0.5 μM, ) (SLC47A1, -1.6, HEK293, 1 μM), (SLC47A1, -1.7, HEK293, 5 μM), (SLC47A1, -1.3, HEK293, 5 nM), (SLC47A1, -1.4, HEK293, 5 μM), (SLC4A7, -1.7, HT1080, 0.2 μM,) (SLC4A7, -2.6, HEK293, 0.5 μM), (SLC4A7, -3.4, SHSY5Y, 0.5 μM), (SLC4A7, -2.5, HEK293, 1 μM), (SLC4A7, -2.2, SHSY5Y, 1 μM), (SLC4A7, -2.1, HEK293, 2.5 μM), (SLC4A7, -2.4, SHSY5Y, 2.5 μM), (SLC4A7, -1.9, HEK293, 5 μM), (SLC4A7, -3, SHSY5Y, 5 μM), (SLC4A7, -1.8, HEK293, 5 μM), (SLC4A7, -1.7, HEK293, 5 μM), (SLC9A5, -5.6, SHSY5Y, 1 μM), (SLCO4A1, -3.2, SHSY5Y, 1 μM), (SLIT1, -2.2, HEK293, 1 ^M), (SLIT1, -1.6, HEK293, 5 |1M), (SLIT1, -1.1, HEK293, 5 μM), (SLIT3, -3.1, HEK293, 5 μM), (SLIT3, -3, HEK293, 5 |1M), (SLMAP, -1.2, HT1080, 0.2 μM,) (SLMAP, -1.1, HEK293, 1 μM, ()SLMAP, -1.1, SHSY5Y, 2.5 μM), (SMAD9, 1.2, SHSY5Y, 5 μM), (SMCHD1, -1.6, SHSY5Y, 0.5 μM), (SMCHD1, -1.1, HEK293, 1 μM), (SMCHD1, -1.6, SHSY5Y, 2.5 gM), (SMG1P2, -1.7, HEK293, 1 μM), (SMG1P2, -1.4, HEK293, 2.5 μM), (SMILR, -4.7, HT1080, 0.2 ^M), (SMYD3, 1.1, HT1080, 0.2 μM), (SMYD3, -1.7, SHSY5Y, 1 μM), (SNAPC5, -3.5, SHSY5Y, 1 |1M), (SNCAIP, 1.2, HEK293, 5 μM,) (SNHG12, -1.3, HEK293, 0.5 ^M), (SNHG12, -1.3, HEK293, 1 μM), (SNX25, 1.1, SHSY5Y, 5 μM), (SORBS1, 1.3, HT1080, 0.2 μM), (SPATA6, - 2, HEK293, 5 μM), (SPG11, -1.6, SHSY5Y, 1 gM), (SP1CE1, -1.1, SHSY5Y, 0.5 μM, ()SRP14- AS1, -1.9, HT1080, 0.2 μM), (SRP14-AS1, -2.2, HEK293, 0.5 μM), (SRP14-AS1, -3, HEK293, 5 μM), (SRPX, 1.3, SHSY5Y, 5 μM), (SSBP2, -1.3, HEK293, 2.5 gM), (SSH1, -1, HEK293, 1 |1M), (SSX2IP, -1, SHSY5Y, 2.5 μM), (ST6GAL1, -1.1, HT1080, 0.2 μM), (ST6GAL1, -1.6, HEK293, 1 μM), (ST6GAL1, -1.9, HEK293, 2.5 μM), (ST6GAL1, -1.8, HEK293, 5 μM), (ST6GAL1, -1.4, HEK293, 5 μM), (ST6GAL1, -1.7, HEK293, 5 μM), (ST6GALNAC4, -2.4, SHSY5Y, 5 μM), (ST7L, -1.6, HT1080, 0.2 μM), (ST7L, -1.1, HEK293, 0.5 μM), (ST7L, -1.5, HEK293, 1 μM), (ST7L, -1.2, SHSY5Y, 1 gM), (ST7L, -1.9, SHSY5Y, 2.5 μM), (STAC, -1.2, SHSY5Y, 1 μM), (STAT5B, -1, HEK293, 1 μM), (STK38L, 1, HT1080, 0.2 μM), (STX16, -1.4, SHSY5Y, 1 μM), (STXBP3, -3.3, HT1080, 0.2 μM), (STXBP3, -4.2, HEK293, 0.5 ^M), (STXBP3, -3.2, SHSY5Y, 0.5 gM), (STXBP3, -3.1, HEK293, 1 μM,) (STXBP3, -3.2, SHSY5Y,
1 μM), (STXBP3, -1.3, HEK293, 2.5 μM), (STXBP3, -8.7, SHSY5Y, 2.5 μM), (STXBP3, -1.9, HEK293, 5 μM), (STXBP3, -2.7, SHSY5Y, 5 μM), (STXBP3, -3.3, HEK293, 5 μM), (STXBP3, -2.8, HEK293, 5 μM), (SUCLG2-AS1, -1.8, HT1080, 0.2 μM), (SULF1, -1.4, HEK293, 2.5 μM), (SUMF1, -1.3, SHSY5Y, 0.5 μM), (SUMF1, -3.1, SHSY5Y, 1 μM), (SUMF1, -1.8, SHSY5Y, 5 μM), (SUPT3H, -4.6, SHSY5Y, 1 μM), (SWT1, -1.3, HEK293, 1 μM), (SWT1, - 4.1, SHSY5Y, 1 μM), (SWT1, -1.4, HEK293, 5 μM), (SYCP2L, -1.6, HEK293, 0.5 μM), (SYNE2, 1.1, HT1080, 0.2 μM), (TANGO2, 1.4, SHSY5Y, 1 μM), (TAOK1, 1, SHSY5Y, 5 μM), (TAOK2, -1.4, SHSY5Y, 1 μM), (TARSL2, -1.1, HT1080, 0.2 μM), (TARSL2, -2.2, HEK293, 0.5 μM), (TARSL2, -1.7, HEK293, 1 μM), (TARSL2, -1.3, HEK293, 2.5 μM), (TARSL2, -1.1, HEK293, 5 μM), (TARSL2, -1.4, HEK293, 5 μM), (TARSL2, -1.5, HEK293, 5 μM), (TASP1, -2, SHSY5Y, 1 μM), (TASP1, -1.5, SHSY5Y, 5 μM), (TBC1D19, -2.7, HT1080, 0.2 μM), (TBC1D19, -1.7, HEK293, 0.5 μM), (TBC1D19, -2.3, HEK293, 1 μM), (TBC1D19, -
9.4, SHSY5Y, 1 μM), (TBC1D19, -2, HEK293, 2.5 μM), (TBC1D19, -4.2, SHSY5Y, 2.5 μM), (TBC1D19, -2.3, HEK293, 5 μM), (TBC1D19, -3.1, SHSY5Y, 5 μM), (TBC1D19, -2.2, HEK293, 5 μM), (TBC1D19, -1.5, HEK293, 5 μM), (TBC1D22A, -3.7, SHSY5Y, 1 μM), (TBC1D5, -1.7, SHSY5Y, 1 μM), (TBC1D5, -1.3, HEK293, 2.5 μM), (TBCK, -1.5, HT1080, 0.2 μM), (TBCK, -2.6, HEK293, 0.5 μM), (TBCK, -3.2, SHSY5Y, 0.5 μM), (TBCK, -2.5, HEK293, 1 μM), (TBCK, -1.3, SHSY5Y, 1 μM), (TBCK, -1.9, HEK293, 2.5 μM), (TBCK, -4.5, SHSY5Y, 2.5 μM), (TBCK, -2.5, HEK293, 5 μM), (TBCK, -1.9, SHSY5Y, 5 μM), (TBCK, -
1.3, HEK293, 5 μM), (TBCK, -1.3, HEK293, 5 μM), (TDG, -1.1, SHSY5Y, 0.5 μM), (TDG, -
1.4, SHSY5Y, 5 μM), (TDP1, -1.7, HT1080, 0.2 μM), (TDP1, -1.5, HEK293, 0.5 μM), (TDP1, -
2.3, SHSY5Y, 0.5 μM), (TDP1, -1.7, HEK293, 1 μM), (TDP1, -5.5, SHSY5Y, 1 μM), (TDP1, -
1.5, HEK293, 2.5 μM), (TDP1, -1.8, SHSY5Y, 2.5 μM), (TDP1, -1.6, HEK293, 5 μM), (TDP1, -
2.4, SHSY5Y, 5 μM), (TDP1, -1.4, HEK293, 5 μM), (TDP1, -1.3, HEK293, 5 μM), (TESK2, - 2.7, SHSY5Y, 5 μM), (TET2, 1.4, SHSY5Y, 5 μM), (TEX9, -2, HEK293, 0.5 μM), (TEX9, -1.6, HEK293, 1 μM), (TEX9, -8.6, SHSY5Y, 2.5 μM), (TEX9, -1.3, HEK293, 5 μM), (TFB1M, -1.1, HT1080, 0.2 μM), (TFCP2, -1.5, HT1080, 0.2 μM), (TFCP2, -1.1, HEK293, 0.5 μM), (TFCP2, -
1.4, SHSY5Y, 0.5 μM), (TFCP2, -1.1, HEK293, 1 μM), (TFCP2, -1.5, SHSY5Y, 1 μM), (TFCP2, -1.1, SHSY5Y, 5 μM), (TFCP2, -1.1, HEK293, 5 μM), (TFCP2, -1.1, HEK293, 5 μM), (THBS4, -2.2, HT1080, 0.2 μM), (THBS4, -2.9, HEK293, 5 μM), (THBS4, -2.1, HEK293, 5 μM), (THOC2, -1.2, HT1080, 0.2 μM), (THOC2, -1.3, HEK293, 0.5 μM), (THOC2, -1.3, SHSY5Y, 0.5 μM), (THOC2, -1.5, HEK293, 1 μM), (THOC2, -1.1, SHSY5Y, 1 μM), (THOC2, -1.3, HEK293, 2.5 μM), (THOC2, -1.4, SHSY5Y, 2.5 μM), (THOC2, -1.3, HEK293, 5 μM), (THOC2, -1.4, HEK293, 5 μM), (THSD7A, 1.1, SHSY5Y, 5 μM), (TIA1, -1.4, HT1080, 0.2 μM), (T1A1, -1.8, HEK293, 0.5 μM), (T1A1, -1.9, SHSY5Y, 0.5 μM), (T1A1, -1.6, HEK293, 1 μM), (TIA1, -1.6, SHSY5Y, 1 μM), (TIA1, -1.4, HEK293, 2.5 μM), (TIA1, -1.9, SHSY5Y, 2.5 μM), (TIA1, -1.7, HEK293, 5 μM), (TIA1, -2.6, SHSY5Y, 5 μM), (TIMM23, -1.1, SHSY5Y, 5 μM), (TIMM23B, -1.1, HEK293, 0.5 μM), (TIMM23B, -4.2, SHSY5Y, 1 μM), (TIMM23B, -
1.5, HEK293, 2.5 μM), (TIMM23B, -3.1, SHSY5Y, 2.5 μM), (TIMM23B, -1.9, HEK293, 5 μM), (TKFC, -1.8, SHSY5Y, 5 μM), (TLL2, 1.1, HEK293, 2.5 μM), (TM2D3, -1.6, SHSY5Y, 5 μM), (TMEM106C, -1.6, HT1080, 0.2 μM), (TMEM106C, -1.1, HEK293, 0.5 μM), (TMEM106C, -1.2, SHSY5Y, 0.5 μM), (TMEM106C, -1, HEK293, 1 μM), (TMEM106C, -1.2, SHSY5Y, 1 μM), (TMEM106C, -1.3, SHSY5Y, 2.5 μM), (TMEM106C, -1.3, HEK293, 5 μM), (TMEM106C, -2.2, SHSY5Y, 5 μM), (TMEM106C, -1.1, HEK293, 5 μM), (TMEM106C, -1.3, HEK293, 5 μM), (TMEM116, -1.1, HEK293, 5 μM), (TMEM120A, -1, SHSY5Y, 5 μM),
(TMEM144, -1.5, HEK293, 0.5 μM), (TMEM144, -1.6, HEK293, 1 μM), (TMEM144, -1.6, HEK293, 2.5 μM), (TMEM144, -1.7, HEK293, 5 μM), (TMEM144, -1.4, HEK293, 5 μM), (TMEM144, -1.2, HEK293, 5 μM), (TMEM161B-AS1, -1.3, HT1080, 0.2 μM), (TMEM161B- AS1, -3.6, SHSY5Y, 1 μM), (TMEM161B-AS1, -1.6, HEK293, 5 μM), (TMEM214, -1.3, SHSY5Y, 1 μM), (TMEM218, -3.3, SHSY5Y, 5 μM), (TMEM222, -1, HT1080, 0.2 μM), (TMEM222, -1.2, SHSY5Y, 0.5 μM), (TMEM222, -1.4, SHSY5Y, 5 μM), (TMEM237, -1.3, SHSY5Y, 0.5 μM), (TMEM237, -1.2, SHSY5Y, 1 μM), (TMEM237, -1.2, SHSY5Y, 5 μM), (TMEM260, -1.1, HEK293, 1 μM), (TMEM260, -1.1, HEK293, 2.5 μM), (TMEM260, -1.2, HEK293, 5 μM), (TMEM39A, -1.4, SHSY5Y, 5 μM), (TMEM41B, -2.3, SHSY5Y, 5 μM), (TMEM45A, -6.5, SHSY5Y, 5 μM), (TMEM62, -1.4, SHSY5Y, 1 μM), (TMEM62, -2.6, SHSY5Y, 5 μM), (TMEM65, -1.1, EIEK293, 2.5 μM), (TMEM67, -2.2, SHSY5Y, 1 μM), (TMEM67, -1.7, SHSY5Y, 2.5 μM), (TMEM67, -1, HEK293, 5 μM), (TMTC1, 1.3, HT1080, 0.2 μM), (TMX2, -1.2, HT1080, 0.2 μM), (TMX2, -1.2, SHSY5Y, 0.5 μM), (TMX2, -1, SHSY5Y, 1 μM), (TMX2, -1.3, SHSY5Y, 5 μM), (TMX3, -2.3, HT1080, 0.2 μM), (TMX3, -1.6, HEK293, 0.5 μM), (TMX3, -1.5, SHSY5Y, 0.5 μM), (TMX3, -1.4, HEK293, 1 μM), (TMX3, - 3.1, SHSY5Y, 1 μM), (TMX3, -1.4, HEK293, 2.5 μM), (TMX3, -1.4, HEK293, 5 μM), (TMX3, -2.9, SHSY5Y, 5 μM), (TMX3, -1.9, HEK293, 5 μM), (TMX3, -1.7, HEK293, 5 μM), (TNFRSF12A, -2.3, SHSY5Y, 1 μM), (TNKS2, -1.2, HT1080, 0.2 μM), (TNKS2, -1.5, HEK293, 0.5 μM), (TNKS2, -1.9, SHSY5Y, 0.5 μM), (TNKS2, -1.2, HEK293, 1 μM), (TNKS2, -1.1, SHSY5Y, 1 μM), (TNKS2, -1.6, SHSY5Y, 2.5 μM), (TNKS2, -1, HEK293, 5 μM), (TNKS2, -1.3, SHSY5Y, 5 μM), (TOM1L2, -1.1, HEK293, 0.5 μM), (TOM1L2, -1.5, HEK293, 1 μM), (TOM1L2, -1.5, HEK293, 5 μM), (TRAIP, -1.1, SHSY5Y, 2.5 μM), (TRAPPC13, -1.4, SHSY5Y, 2.5 μM), (TRMT1, -1.8, SHSY5Y, 5 μM), (TRMT10A, -2.4, SHSY5Y, 0.5 μM), (TRMT10A, -7, SHSY5Y, 1 μM), (TRMT11, -1.1, SHSY5Y, 5 μM), (TRMT61B, -1.4, SHSY5Y, 0.5 μM), (TRMT61B, -2.3, SHSY5Y, 1 μM), (TRMT61B, -2.4, SHSY5Y, 2.5 μM), (TRMT61B, -1.7, SHSY5Y, 5 μM), (TRPM2, 1.1, HT1080, 0.2 μM), (TRPM4, -1.8, HEK293, 1 μM), (TRPM4, -8.6, SHSY5Y, 1 μM), (TRPM4, -1, HEK293, 5 μM), (TRPT1, -3.2, SHSY5Y, 5 μM), (TSFM, -1.8, SHSY5Y, 5 μM), (TSNARE1, -7.5, SHSY5Y, 5 μM), (TSPAN5, -3.1, SHSY5Y, 1 μM), (TTBK2, 1.1, SHSY5Y, 5 μM), (TTC12, -1.7, HT1080, 0.2 μM), (TTC12, - 1.5, HEK293, 0.5 μM), (TTC12, -1.6, HEK293, 1 μM), (TTC12, -1.2, HEK293, 2.5 μM), (TTC12, -1.7, HEK293, 5 μM), (TTC12, -1.6, HEK293, 5 μM), (TTC12, -1.5, HEK293, 5 μM), (TTC13, 1.1, SHSY5Y, 0.5 μM), (TTC13, 1.3, SHSY5Y, 1 μM), (TTC13, 1.4, SHSY5Y, 5 μM), (TTC28-AS1, -1.1, HT1080, 0.2 μM), (TTC39C, -1.5, HT1080, 0.2 μM), (TTC39C, -1.5, HEK293, 0.5 μM), (TTC39C, -1.3, HEK293, 1 μM), (TTC39C, -1.4, HEK293, 5 μM), (TTYH2, -1.7, HEK293, 0.5 μM), (TTYH2, -8.7, SHSY5Y, 5 μM), (TTYH2, -1.6, HEK293, 5 μM), (TTYH2, -1.4, HEK293, 5 μM), (TXNDC11, -1.2, HT1080, 0.2 μM), (TXNDC11, -1.3, HEK293, 0.5 μM), (TXNDC11, -1.3, SHSY5Y, 0.5 μM), (TXNDC11, -1.4, HEK293, 1 μM), (TXNDC11, -1.2, SHSY5Y, 1 μM), (TXNDC11, -1.9, SHSY5Y, 2.5 μM), (TXNDC11, -1.1, HEK293, 5 μM), (TXNDC16, -1.1, HT1080, 0.2 μM), (TXNDC16, -1.2, HEK293, 0.5 μM), (TXNDC16, -1.3, SHSY5Y, 0.5 μM), (TXNDC16, -1.5, HEK293, 1 μM), (TXNDC16, -1.1, SHSY5Y, 1 μM), (TXNDC16, -1.1, HEK293, 2.5 μM), (TXNDC16, -1.5, SHSY5Y, 2.5 μM), (TXNDC16, -1.1, HEK293, 5 μM), (TXNDC16, -1.7, HEK293, 5 μM), (TXNDC16, -1.7, HEK293, 5 μM), (UBA2, -1.7, HT1080, 0.2 μM), (UBA2, -1.6, HEK293, 0.5 μM), (UBA2, -1.4, SHSY5Y, 0.5 μM), (UBA2, -1.5, HEK293, 1 μM), (UBA2, -1.5, SHSY5Y, 1 μM), (UBA2, -1.1, HEK293, 2.5 μM), (UBA2, -1.8, SHSY5Y, 2.5 μM), (UBA2, -1.4, HEK293, 5 μM), (UBA2, -
2.1, SHSY5Y, 5 μM), (UBA2, -1.3, HEK293, 5 μM), (UBA2, -1.4, HEK293, 5 μM), (UBA6, -
1.3, HT1080, 0.2 gM), (UBA6, -1, SHSY5Y, 0.5 μM,) (UBA6, -2, SHSY5Y, 1 gM), (UBAC2, -
1.5, HT1080, 0.2 μM), (UBAC2, -1.3, HEK293, 0.5 μM), (UBAC2, -1.4, HEK293, 1 μM), (UBAC2, -1.1, SHSY5Y, 1 μM), (UBAC2, -1.1, HEK293, 2.5 μM), (UBAC2, -1.6, HEK293, 5 gM), (UBAC2, -2, SHSY5Y, 5 μM), (UBAC2, -1.3, HEK293, 5 μM), (UBAC2, -1.5, HEK293, 5 piM), (UBR4, 1.2, HT1080, 0.2 μM), (UGGT2, -1.1, HT1080, 0.2 μM), (UGGT2, -2.1, HEK293, 0.5 μM), (UGGT2, -2.9, SHSY5Y, 0.5 μM,) (UGGT2, -2.2, HEK293, 1 μM, ) (UGGT2, -3, SHSY5Y, 1 μM), (UGGT2, -1.8, HEK293, 2.5 μM), (UGGT2, -1.5, SHSY5Y, 2.5 gM), (UGGT2, -1.9, HEK293, 5 μM), (UGGT2, -2, SHSY5Y, 5 μM,) (UGGT2, -1.1, HEK293, 5 μM), (UGGT2, -1.2, HEK293, 5 μM), (ULKA, -2.8, SHSY5Y, 5 gM), (UNC50, -1.1, HT1080, 0.2 nM), (UNC50, -2.9, SHSY5Y, 1 μM), (UNC50, -1.2, HEK293, 5 μM), (UNC50, -1 A, SHSY5Y, 5 μM), (UPF2, -1.2, HEK293, 1 gM), (USP16, -1.7, SHSY5Y, 1 gM), (USP25, -1.3, SHSY5Y, 1 μM), (UTRN, -1.2, HEK293, 0.5 μM), (UTRN, -1.6, HEK293, 1 gM), (UTRN, -1.5, HEK293, 2.5 μM), (VAV2, -1, HEK293, 2.5 ^M), (VAV3, -1.9, HEK293, 0.5 μM,) (VAV3, -
7.5, SHSY5Y, 5 μM), (VDAC2, -1.5, SHSY5Y, 5 μM), (VEGFA, 1.8, SHSY5Y, 1 ^M), (VPS13C, -1.3, SHSY5Y, 1 μM), (VPS29, -1.4, SHSY5Y, 5 μM), (VPS8, -1.2, HEK293, 0.5 gM), (VPS8, -1.7, SHSY5Y, 0.5 μM), (VPS8, -1.2, HEK293, 1 μM), (VPS8, -1.9, SHSY5Y, 1 UM), (VPS8, -1.5, HEK293, 2.5 μM), (VPS8, -1.8, SHSY5Y, 2.5 μM), (VPS8, -1.5, SHSY5Y, 5 UM), (VPS9D1-AS1, -6.2, SHSY5Y, 1 gM), (WASHC2A, -3.3, SHSY5Y, 1 μM,) (WDFY2, -1, HT1080, 0.2 μM), (WDFY2, -1.2, HEK293, 1 gM), (WDFY2, -1.3, HEK293, 2.5 μM), (WDFY2, -1.1, HEK293, 5 μM), (WDFY2, -2.3, SHSY5Y, 5 ^M), (WDPCP, -2.3, SHSY5Y, 1 gM), (WDR11, -1, SHSY5Y, 0.5 μM), (WDR11, -1.1, SHSY5Y, 2.5 μM), (WDR27, -1.1, HT1080, 0.2 μM), (WDR27, -1.7, HEK293, 0.5 μM), (WDR27, -1.9, HEK293, 1 μM), (WDR27, -1.4, SHSY5Y, 5 μM), (WDR27, -1.1, HEK293, 5 gM), (WDR4, -1.6, HT1080, 0.2 |1M), (WDR4, -1.9, HEK293, 0.5 μM), (WDR4, -2.2, SHSY5Y, 0.5 μM), (WDR4, -1.9, HEK293, 1 μM), (WDR4, -1.3, SHSY5Y, 1 μM,) (WDR4, -1.5, HEK293, 2.5 μM, ()WDR4, -
2.3, SHSY5Y, 2.5 μM), (WDR4, -1.5, HEK293, 5 μM), (WDR4, -2.4, SHSY5Y, 5 gM), (WDR4, -1.2, HEK293, 5 μM), (WDR4, -1.1, HEK293, 5 ^M), (WDR48, -1.1, SHSY5Y, 0.5 gM), (WDR70, -1.9, HT1080, 0.2 ^M), (WDR70, -1.9, HEK293, 0.5 μM), (WDR70, -2.7, SHSY5Y, 0.5 gM), (WDR70, -2, HEK293, 1 μM), (WDR70, -2.7, SHSY5Y, 1 μM), (WDR70, -
1.7, HEK293, 2.5 gM), (WDR70, -2.2, SHSY5Y, 2.5 μM), (WDR70, -2.3, HEK293, 5 μM), (WDR70, -1.7, SHSY5Y, 5 μM), (WDR70, -1.5, HEK293, 5 gM), (WDR70, -1.7, HEK293, 5 gM), (WDSUB1, -1.2, HEK293, 0.5 μM), (WRN, -1.1, SHSY5Y, 0.5 μM,) (WWOX, 1.4, HT1080, 0.2 μM), (XRCC2, -2.1, SHSY5Y, 1 gM), (XYLB, -8.2, SHSY5Y, 1 μM), (XYLB, -
4.7, SHSY5Y, 2.5 μM), (YAF2, -1.1, SHSY5Y, 5 μM,) (YEATS2, 1.2, SHSY5Y, 5 μM, ) (YEATS4, -1.4, HT1080, 0.2 μM), (YEATS4, -1.3, SHSY5Y, 1 μM), (YEATS4, -1.4, SHSY5Y, 2.5 μM), (YEATS4, -1.1, HEK293, 5 μM), (YEATS4, -1.4, SHSY5Y, 5 μM), (YIPF1, -1.7, SHSY5Y, 0.5 gM), (YIPF1, -1.7, SHSY5Y, 1 μM,) (YIPF1, -1.5, SHSY5Y, 5 μM, ()YIPF1, -
1.1, HEK293, 5 gM), (YPEL3, 1.7, HT1080, 0.2 ^M), (YPEL3, 1.6, HEK293, 2.5 μM), (ZBED6, 1.9, HT1080, 0.2 ^M), (ZBED6, 1.1, HEK293, 0.5 μM,) (ZBED6, 1.5, HEK293, 5 gM), (ZBED6, 3, HEK293, 5 μM), (ZBED6, 3, HEK293, 5 ^M), (ZBTB25, -8.1, SHSY5Y, 1 μM), (ZBTB48, -1.5, SHSY5Y, 0.5 μM), (ZC3H10, -1, SHSY5Y, 5 gM), (ZC3H7A, -1.4, HEK293, 0.5 μM), (ZC3H7A, -1.3, HEK293, 1 μM), (ZC3H7A, -1.1, HEK293, 2.5 μM), (ZC3H7A, -1.3, SHSY5Y, 2.5 ^M), (ZC3H7A, -1, HEK293, 5 gM), (ZC3H7A, -1.1, HEK293, 5 gM), (ZDHHC14, -8.2, SHSY5Y, 1 ^M), (ZDHHC14, -4.1, SHSY5Y, 2.5 μM,) (ZDHHC16, -
Compound 57
[00627] Table 60 provides further detail of results (Cpd = Compound, Gene = Gene, Cone = Concentration, L2FC = log2 fold change) for genes exhibiting a two fold change, or more, in gene expression (a Log2 fold change of 1.0 or above, or -1.0 or below) together with a change in Percent Spliced In (APSI) of 50% to 100%, or -50% to -100%, at a p value (pVal) of < 0.001 in the presence of Compound 57.
[00628] The cell lines tested included Familial Dysautonomia patient fibroblasts (FDPF), HEK293, stimulated PBMC (sPBMC), differentiated SY5Y (diffSY5Y), SHSY5Y, M0LM13 and HT1080.
Inclusion Results (Compound 57)
[00630] RNAseq experiments showed that Compound 57 induced exon inclusion with a PSI change (APSI) of +50% to +100% and P-value <0.001 in 106 genes:
[00632] RNAseq experiments showed that Compound 57 induced exon inclusion with a PSI change (APSI) of +50% to +100% and P-value <0.001 in genes having a 5' splice site as follows (161 entries):
Inclusion and NMD Results (Compound 57)
[00634] RNAseq experiments showed that Compound 57 induced exon inclusion associated with nonsense mediated decay with a PSI change (APSI) of +50% to +100% and P- value <0.001in 12 genes:
[00636] RNAseq experiments showed that Compound 57 induced exon inclusion associated with nonsense mediated decay with a PSI change (APSI) of +50% to +100% and P- value <0.001in genes having a 5' splice site as follows (12 entries):
Skipping Results (Compound 57)
[00638] RNAseq experiments showed that Compound 57 induced exon skipping with a
PSI change (APSI) of -50% to -100% and P-value <0.001 in 400 genes:
[00640] RNAseq experiments showed that Compound 57 induced exon skipping with a
PSI change (APSI) of -50% to -100% and P-value <0.001 in genes having a 5' splice site as follows (425 entries):
[00641] Table 66
ACAAgtgagt, ACACgtaagc, ACACgtaagt, ACACgtgagt, ACAGgtaaac, ACAGgtaaat, ACAGgtaaga, ACAGgtaagc, ACAGgtaata, ACAGgtaatg, ACAGgtaccc, ACAGgtaccg, ACAGgtacct, ACAGgtacgt, ACAGgtactg, ACAGgtatga, ACAGgtatgt, ACAGgtattc, ACAGgtattt, ACAGgtgaga, ACAGgtgagg, ACAGgtgagt, ACAGgtgcgt, ACAGgtgtgt, ACAGgttgca, ACATgtaagc, ACATgtaagt, ACATgtaatg, ACATgtgagt, ACCAgtgagt, ACCCgtgaga, ACCCgtgtga, ACCTgtgagt, ACGGgtgagt, ACTGgtaaga, ACTGgtaagt, ACTGgtgaat, ACTGgtgagt, AGAAgtaagt, AGAAgtgagt, AGACgtatgt, AGAGgtaaag, AGAGgtaaat, AGAGgtaaga, AGAGgtaagg, AGAGgtacaa, AGAGgtacag, AGAGgtatga, AGAGgtatgc, AGAGgtgagc, AGAGgtgagt, AGATgtaagt, AGATgtgagt, AGCCgtgtgt, AGCTatttac, AGCTgtaagt, AGCTgtatgt, AGCTgtgagt, AGGGgtgaga, AGTGgtaagg, AGTGgtaagt, AGTGgtgagt, AGTTgtaagt, ATAGgtaatt, ATAGgtgagt, ATATgtaagt, ATATgtgagt, ATCCgtgagt, ATCTgtaaga, ATCTgtaagt, ATCTgtgaga, ATCTgtgagt, ATGAaaaggt, ATGAgtaagt, ATGAgtatgt, ATGAgtgagt, ATGGgtgagt, ATGTgtgagt, ATTGgtgagg, ATTGgtgagt, ATTGgtgtga, ATTTgtaagt, ATTTgtgagt, CAAAgtactg, CAAAgtagga, CAAAgtattg, CAAAgtgagt, CAACataagt, CAACgtaagt, CAAGgtaaaa, CAAGgtaaga, CAAGgtaatg, CAAGgtacag, CAAGgtacca, CAAGgtacgt, CAAGgtagaa, CAAGgtatgt, CAAGgtattc, CAAGgtgact, CAAGgtggga, CAAGgtgggt, CAAGgttagt, CAATgtaagt, CACAgtaagt, CACAgtgagt, CACCgtgagt, CACGgtaagt, CACGgtgaga, CACGgtgagg, CACTgtaagt, CACTgtgagt, CACTgtgcgt, CAGCgtaagt, CAGCtgggcg, CAGGgtaagc, CAGGgtaagt, CAGGgtgagt, CAGTgtgagt, CATCgtgagt, CATGgtaagc, CATGgtaagt, CATGgtatgt, CATGgtgagt, CATTgtgagt, CCACgtgagt, CCAGgtaaag, CCAGgtaaca, CCAGgtaagc, CCAGgtaagg, CCAGgtaatg, CCAGgtaatt, CCAGgtacgc, CCAGgtacta, CCAGgtaggg, CCAGgtatgt, CCAGgtattt, CCAGgtctga, CCAGgtgaga, CCAGgtgagt, CCAGgtgggt, CCAGgtgtgt, CCAGgttagt, CCAGgtttgt, CCATgtaagt, CCATgtgagt, CCCAggtaat, CCCAgtgagt, CCCGgtatgt, CCCTgtaagt, CCGGgtaagt, CCGGgtgaga, CCGTgtaagt, CCGTgtgagt, CCTGgtaagc, CCTGgtaagt, CCTGgtgaag, CCTGgtgagt, CCTGgtgcgt, CCTTgtaagt, CCTTgtgagt, CGACgtgagt, CGAGgtaaga, CGAGgtaagc, CGAGgtacga, CGAGgtaggg, CGAGgtatgc, CGATgtaagt, CGCAgtgagc, CGCGgtaaga, CGCTgtaagc, CGCTgtgagt, CGGGgtgagt, CGTGgtgagc, CTAAgtaagt, CTAGgtaata, CTATgtaaga, CTATgtaagt, CTCAgtaagt, CTCAgtgagt, CTCCgtgagt, CTCGgtaagg, CTCGgtgaga, CTCTgtaagt, CTCTgtgagt, CTGAgtaagt, CTGAgtgagt, CTGCgtgagt, CTGGgtaagc, CTGGgtaagg, CTGGgtaagt, CTGGgtaata, CTGGgtgagc, CTGGgtgagt, CTGTgtaagt, CTTCgtaagt, CTTCgtgagt, CTTGgtaagt, CTTTgtaagt, GAAAgtaagt, GAAAgtgtga, GAACgtgagt, GAAGgtaatg, GAAGgtacaa, GAAGgtagtt, GAAGgtcagt, GAAGgtgagg, GAAGgtgggc, GAATgtaagt, GAATtgtaag, GACAgtgagt, GACCgtaagt, GACCgtgagt, GACTgtaagt, GACTgtgagt, GATAgtaagt, GATCgtaagt, GATGgtaagt, GATGgtaatg, GATGgtatgt, GATGgtgagt, GATTgtaagt, GATTgtgagt, GCACgtaagt, GCAGgtaaca, GCAGgtaaga, GCAGgtaagt, GCAGgtacag, GCAGgtatga, GCAGgtatgg, GCAGgtcagg, GCAGgtgagg, GCAGgtgagt, GCATgtaagt, GCATgtgagt, GCCCgtatgt, GCCGgtaaga, GCCGgtaagt, GCCGgtgagt, GCCTgtaagt, GCCTgtgagt, GCTAgtgagt, GCTGgtaaat, GCTGgtaagt, GCTGgtgagt, GCTTgtatgt, GCTTgtgagt, GGAGgtaaag, GGAGgtaaga, GGAGgtaagg, GGAGgtaagt, GGAGgtaggg, GGAGgtatgt, GGAGgtatta, GGAGgtgaga, GGAGgtgagg, GGAGgtgagt, GGATgtatcc, GGATgtgagt, GGATgttagc, GGCGgtaaga, GGCTgtaagt, GGCTgtgagt, GGGCgtaagt, GGGGgtgagt, GGTGgtaagt, GGTGgtgagt, GTCGgtaagt, GTCTgaagag, GTCTgtaagt, GTGGgtgagg, GTGGgtgagt,
Skipping and NMD Results (Compound 57)
[00642] RNAseq experiments showed that Compound 57 induced exon skipping associated with nonsense mediated decay with a PSI change (APSI) of -50% to -100% and P- value <0.001 in 155 genes:
[00643] Table 67
[00644] RNAseq experiments showed that Compound 57 induced exon skipping associated with nonsense mediated decay with a PSI change (APSI) of -50% to -100% and P- value <0.001 in genes having a 5' splice site as follows (141 entries):
Gene Expression Results (Compound 57)
[00646] RNAseq experiments showed that Compound 57 modulated expression of various genes by a factor of 2 or more. The following table identifies genes from Table 5 which resulted in a log 2 fold change (L2FC) of 1 or above (increased expression), or -1 or below (decreased expression), upon treatment with Compound 57:
[00647] Table 69
HEK293, 5 μM), (ADAM22, -1.3, HEK293, 0.3 μM), (ADAM22, -1.3, HEK293, 3 μM), (ADAM22, -1.2, HEK293, 5 μM), (ADAM22, -1.2, HEK293, 5 μM), (AFMID, 1, HEK293, 0.3 μM), (AFMID, 1.1, HEK293, 3 μM), (AFMID, 1.1, HEK293, 5 μM), (AHH, -1.1, HEK293, 0.3 μM), (AHH, -1.2, HEK293, 3 μM), (AKIP1, -1, HEK293, 3 μM), (ALDH1L2, -2.3, HEK293, 3 μM), (ALDH1L2, -2.9, HEK293, 5 μM), (ALDH1L2, -2.9, HEK293, 5 μM), (ALDH4A1, -1.3, HEK293, 0.3 μM), (ALDH4A1, -1.3, HEK293, 3 μM), (ALDH4A1, -1.5, HEK293, 5 μM), (ALDH4A1, -1.3, HEK293, 5 μM), (AMN1, -1, HEK293, 3 μM), (ANKMY2, -1.2, HEK293, 0.3 μM), (ANKMY2, -1.3, HEK293, 3 μM), (ANKMY2, -1.1, HEK293, 5 μM), (ANKMY2, - 1.2, HEK293, 5 μM), (ANLN, -1.4, HEK293, 0.3 μM), (ANLN, -1.4, HEK293, 3 μM), (ANLN, -1.1, HEK293, 5 μM), (ANLN, -1.3, HEK293, 5 μM), (AP2A2, -1.5, HEK293, 0.3 μM), (AP2A2, -1.6, HEK293, 3 μM), (AP2A2, -1.6, HEK293, 5 μM), (AP2A2, -1.5, HEK293, 5 μM), (ARFGAP2, -1.3, HEK293, 0.3 μM), (ARFGAP2, -1.3, HEK293, 3 μM), (ARFGAP2, -1, HEK293, 5 μM), (ARFGAP2, -1.1, HEK293, 5 μM), (ARMC9, -1.1, HEK293, 3 μM), (ASAP2, -1, HEK293, 3 μM), (ATF7IP2, 1, HEK293, 0.3 μM), (ATG7, -1.2, HEK293, 0.03 μM), (ATG7, -2, HEK293, 0.3 μM), (ATG7, -1.9, HEK293, 3 μM), (ATG7, -1.7, HEK293, 5 μM), (ATG7, - 1.9, HEK293, 5 μM), (ATP5S, -1.5, HEK293, 0.03 μM), (ATP5S, -2.1, HEK293, 0.3 μM), (ATP5S, -2.6, HEK293, 3 μM), (ATP5S, -2, HEK293, 5 μM), (ATP5S, -2, HEK293, 5 μM), (ATP6V0A2, -1.3, HEK293, 0.3 μM), (ATP6V0A2, -1.6, HEK293, 3 μM), (ATP6V0A2, -1.3, HEK293, 5 μM), (ATP9A, -1.9, HEK293, 0.3 μM), (ATP9A, -2.6, HEK293, 3 μM), (ATP9A, - 1.8, HEK293, 5 μM), (ATP9A, -2.3, HEK293, 5 μM), (BABAM2, -1.5, HEK293, 0.3 μM), (BABAM2, -1.8, HEK293, 3 μM), (BABAM2, -2.1, HEK293, 5 μM), (BABAM2, -1.3, HEK293, 5 μM), (BBS4, -1.9, HEK293, 0.3 μM), (BBS4, -2.3, HEK293, 3 μM), (BBS4, -1.6, HEK293, 5 μM), (BBS4, -1.9, HEK293, 5 μM), (BCL2L13, -1, HEK293, 0.3 μM), (BCL2L13, - 1.1, HEK293, 5 μM), (BLZF1, -1.2, HEK293, 0.03 μM), (BLZF1, -1.4, HEK293, 0.3 μM), (BLZF1, -1.4, HEK293, 3 μM), (BLZF1, -1.2, HEK293, 5 μM), (BLZF1, -1.6, HEK293, 5 μM), (BRSK2, -1, HEK293, 0.3 μM), (BRSK2, -1.3, HEK293, 3 μM), (CACNA2D1, -1.4, HEK293, 0.3 μM), (CACNA2D1, -1.5, HEK293, 3 μM), (CACNA2D1, -1.5, HEK293, 5 μM), (CACNA2D1, -1.8, HEK293, 5 μM), (CAPS2, -1.7, HEK293, 5 μM), (CCDC25, -1.3, HEK293, 0.3 μM), (CCDC25, -1.5, HEK293, 3 μM), (CCDC25, -1.2, HEK293, 5 μM), (CCDC25, -1.2, HEK293, 5 μM), (CDYL, -1.1, HEK293, 3 μM), (CENPH, -1, HEK293, 0.03 μM), (CENPH, - 1.4, HEK293, 0.3 μM), (CENPH, -1.3, HEK293, 3 μM), (CENPH, -1.5, HEK293, 5 μM), (CENPH, -1.3, HEK293, 5 μM), (CENPI, -1.8, HEK293, 0.3 μM), (CENPI, -2.2, HEK293, 3 μM), (CENPI, -1.9, HEK293, 5 μM), (CENPI, -1.6, HEK293, 5 μM), (CEP83, -1.1, HEK293, 0.03 μM), (CEP83, -1.1, HEK293, 3 μM), (CHD1L, -1.3, HEK293, 0.3 μM), (CHD1L, -1.4, HEK293, 3 μM), (CHD1L, -1.3, HEK293, 5 μM), (CHD1L, -1.2, HEK293, 5 μM), (CHEK2, - 1.6, HEK293, 0.3 μM), (CHEK2, -2, HEK293, 3 μM), (CHEK2, -1.7, HEK293, 5 μM), (CHEK2, -1.8, HEK293, 5 μM), (CNIH3, -1.9, HEK293, 0.3 μM), (CNIH3, -2.6, HEK293, 3 μM), (CNIH3, -2.1, HEK293, 5 μM), (CNIH3, -1.2, HEK293, 5 μM), (CPXM1, -1.4, HEK293, 0.3 μM), (CPXM1, -1.1, HEK293, 5 μM), (CRELD1, -1.5, HEK293, 0.3 μM), (CRELD1, -1.3, HEK293, 3 μM), (CYP2U1, -1.4, HEK293, 0.3 μM), (CYP2U1, -1.8, HEK293, 3 μM), (CYP2U1, -1.3, HEK293, 5 μM), (CYP2U1, -2.2, HEK293, 5 μM), (DAAM1, -1.6, HEK293, 0.3 μM), (DAAM1, -1.9, HEK293, 3 μM), (DAAM1, -1.6, HEK293, 5 μM), (DAAM1, -1.6, HEK293, 5 μM), (DENND5A, -1.9, HEK293, 0.3 μM), (DENND5A, -1.9, HEK293, 3 μM), (DENND5A, -1.8, HEK293, 5 μM), (DENND5A, -1.7, HEK293, 5 μM), (DGKA, -1.7, HEK293, 0.3 μM), (DGKA, -1.5, HEK293, 3 μM), (DGKA, -2.1, HEK293, 5 μM), (DGKA, -
1.4, HEK293, 5 μM), (DHRS12, 1.4, HEK293, 5 μM), (DHRS4L2, -1.7, HEK293, 5 μM), (DIMT1, -1.7, HEK293, 0.03 μM), (DIMT1, -2.4, HEK293, 0.3 μM), (DIMT1, -2.6, HEK293, 3 μM), (DIMT1, -2.5, HEK293, 5 μM), (DIMT1, -2, HEK293, 5 μM), (DLEU2, -1.3, HEK293, 3 μM), (DNAJB12, -1.2, HEK293, 0.3 μM), (DNAIB12, -1.3, HEK293, 3 μM), (DNAJB12, -1.4, HEK293, 5 μM), (DNAJB12, -1.5, HEK293, 5 μM), (DTNB, -1, HEK293, 5 μM), (EMC2, -1.8, HEK293, 0.3 μM), (EMC2, -1.8, HEK293, 3 μM), (EMC2, -1.4, HEK293, 5 μM), (EMC2, -1.4, HEK293, 5 μM), (EPS8, -1.1, HEK293, 0.03 μM), (EPS8, -2.2, HEK293, 0.3 μM), (EPS8, -2.7, HEK293, 3 μM), (EPS8, -2.3, HEK293, 5 μM), (EPS8, -2.1, HEK293, 5 μM), (ERGIC1, -1.5, HEK293, 0.3 μM), (ERGIC1, -1.7, HEK293, 3 μM), (ERGIC1, -1.4, HEK293, 5 μM), (ERGIC1, -1.7, HEK293, 5 μM), (EXD3, -1.1, HEK293, 5 μM), (EXOC3, -1, HEK293, 0.03 μM), (EXOC3, -1.2, HEK293, 0.3 μM), (EXOC3, -1.3, HEK293, 3 μM), (F8, -3.4, HEK293, 0.3 μM), (F8, -2.4, HEK293, 5 μM), (F8, -2.4, HEK293, 5 μM), (FAM208A, -1.3, HEK293, 0.3 μM), (FAM208A, -1.4, HEK293, 3 μM), (FAM208A, -1.1, HEK293, 5 μM), (FAM208A, -1.3, HEK293, 5 μM), (FANCI, -1.2, HEK293, 0.03 μM), (FANCI, -1.7, HEK293, 0.3 μM), (FANCI, -1.8, HEK293, 3 μM), (FANCI, -1.5, HEK293, 5 μM), (FANCI, -1.6, HEK293, 5 μM), (FANCL, -1.5, HEK293, 0.03 μM), (FANCL, -2.1, HEK293, 0.3 μM), (FANCL, -2.1, HEK293, 3 μM), (FANCL, -2.2, HEK293, 5 μM), (FANCL, -2, HEK293, 5 μM), (FER1L4, -1.6, HEK293, 5 μM), (FGGY, -1.6, HEK293, 0.03 μM), (FGGY, -2.1, HEK293, 0.3 μM), (FGGY, -
2.3, HEK293, 3 μM), (FIG4, -1.4, HEK293, 0.3 μM), (FIG4, -1.6, HEK293, 3 μM), (FIG4, -1.1, HEK293, 5 μM), (FIG4, -1.2, HEK293, 5 μM), (FOXRED1, -1, HEK293, 0.3 μM), (FOXRED1, -1.5, HEK293, 3 μM), (GALNT6, -1.6, HEK293, 0.3 μM), (GALNT6, -1.5, HEK293, 3 μM), (GEMIN2, -1, HEK293, 3 μM), (GLB1, -1.2, HEK293, 0.3 μM), (GLB1, -1.3, HEK293, 3 μM), (GNPTG, -1.1, HEK293, 3 μM), (GNPTG, -1.2, HEK293, 5 μM), (GPR155, -1.8, HEK293, 0.3 μM), (GPR155, -1.3, HEK293, 3 μM), (GPR155, -1.1, HEK293, 5 μM), (GPR155, -1.2, HEK293, 5 μM), (GTF2I, -1.9, HEK293, 0.3 μM), (GTF2I, -2.4, HEK293, 3 μM), (GTF2I, -1.7, HEK293, 5 μM), (GTF2I, -2, HEK293, 5 μM), (GTF2IP1, -1.2, HEK293, 0.3 μM), (GTF2IP1, -
1.5, HEK293, 3 μM), (GTF2IP1, -1.8, HEK293, 5 μM), (GTF2IP1, -1.7, HEK293, 5 μM), (GTF2IP4, -1.2, HEK293, 0.3 μM), (GTF2IP4, -1.5, HEK293, 3 μM), (GTF2IP4, -1.8, HEK293, 5 μM), (GTF2IP4, -1.7, HEK293, 5 μM), (HACL1, -1, HEK293, 0.03 μM), (HACL1, -1.3, HEK293, 0.3 μM), (HACL1, -1.2, HEK293, 3 μM), (HACL1, -1.1, HEK293, 5 μM), (HACL1, -
1.3, HEK293, 5 μM), (HERC2, -1, HEK293, 5 μM), (HSD17B4, -1, HEK293, 0.003 μM), (HSD17B4, -1.8, HEK293, 0.03 μM), (HSD17B4, -1.7, HEK293, 0.3 μM), (HSD17B4, -1.8, HEK293, 3 μM), (HSD17B4, -1.6, HEK293, 5 μM), (HSD17B4, -1.6, HEK293, 5 μM), (IFI27L1, -1.2, HEK293, 5 μM), (IQCG, -1.4, HEK293, 3 μM), (IQCG, -1.3, HEK293, 5 μM), (IQCG, -1.2, HEK293, 5 μM), (1TPR1, 1, HEK293, 3 μM), (KATNAL2, -1.6, HEK293, 3 μM), (KCNT2, -1.4, HEK293, 0.03 μM), (KIAA0319L, -1.2, HEK293, 3 μM), (KIAA0319L, -1.1, HEK293, 5 μM), (KIAA0556, -1.1, HEK293, 0.3 μM), (KIAA0556, -1.1, HEK293, 3 μM), (KIAA0556, -1.1, HEK293, 5 μM), (KIAA0556, -1.1, HEK293, 5 μM), (KLRG2, -1.1, HEK293, 3 μM), (KLRG2, -1.9, HEK293, 5 μM), (LGR5, -1.1, HEK293, 0.3 μM), (LGR5, -1.7, HEK293, 3 μM), (LGR5, -1.7, HEK293, 5 μM), (LGR5, -1.5, HEK293, 5 μM), (LGC100506844, -1.6, HEK293, 0.03 μM), (LGC100506844, -2.3, HEK293, 0.3 μM), (LOCI 00506844, -2.3, HEK293, 3 μM), (LOCI 00506844, -1.7, HEK293, 5 μM), (LOCI 00506844, -2.4, HEK293, 5 μM), (LOC102606465, -2, HEK293, 0.3 μM), (LOCI 02606465, -1.9, HEK293, 3 μM), (LOC102606465, -2, HEK293, 5 μM), (LOCI 02724532, -2.6, HEK293, 0.3 μM), (LOC728730,
1.5, HEK293, 3 μM), (LOC728730, 1.5, HEK293, 5 μM), (LRRC34, -1, HEK293, 3 μM),
(LRTOMT, -1.2, HEK293, 5 μM), (LY75-CD302, -1.3, HEK293, 0.03 μM), (MAGI2-AS3, -1.1, HEK293, 0.3 μM), (MAGI2-AS3, -1.3, HEK293, 3 μM), (MBOAT2, -1.1, HEK293, 0.3 μM), (MBOAT2, -1.1, HEK293, 3 μM), (MBOAT2, -1, HEK293, 5 μM), (MELTF, -1.3, HEK293, 3 μM), (MELTF, -1.1, HEK293, 5 μM), (MICAL1, -1.2, HEK293, 3 μM), (MICALL1, -1, HEK293, 3 μM), (MLH1, -1.6, HEK293, 0.3 μM), (MLH1, -1.6, HEK293, 3 μM), (MLH1, -1.7, HEK293, 5 μM), (MLH1, -1.7, HEK293, 5 μM), (MMAB, -1, HEK293, 0.3 μM), (MMAB, -1.1, HEK293, 3 μM), (MMAB, -1.4, HEK293, 5 μM), (MMAB, -1, HEK293, 5 μM), (MOSPD2, - 1.2, HEK293, 0.3 μM), (MOSPD2, -1.4, HEK293, 3 μM), (MOSPD2, -1.6, HEK293, 5 μM), (MROH6, -1.5, HEK293, 5 μM), (MROH6, -1.4, HEK293, 5 μM), (MYLK, -1.1, HEK293, 3 μM), (MYO5C, -1.1, HEK293, 0.3 μM), (MYO5C, -1.2, HEK293, 3 μM), (MYOM2, -1, HEK293, 0.3 μM), (MYOM2, -1.2, HEK293, 3 μM), (NARS2, -1, HEK293, 3 μM), (NECAB3, -1.2, HEK293, 3 μM), (NECAB3, -1.2, HEK293, 5 μM), (NEK1, -1.1, HEK293, 0.03 μM), (NEK1, -1.5, HEK293, 0.3 μM), (NEK1, -1.9, HEK293, 3 μM), (NEK1, -1.6, HEK293, 5 μM), (NEK1, -1.5, HEK293, 5 μM), (NFATC2IP, -1.2, HEK293, 5 μM), (NOTCH3, -1.2, HEK293, 3 μM), (NOTCH3, -1, HEK293, 5 μM), (NOTCH3, -1.2, HEK293, 5 μM), (NUP43, -1.1, HEK293, 3 μM), (NUPL2, -1.2, HEK293, 3 μM), (NUPL2, -1, HEK293, 5 μM), (NUPL2, -1, HEK293, 5 μM), (OARD1, -1, HEK293, 0.3 μM), (OARD1, -1.2, HEK293, 3 μM), (OARD1, - 1, HEK293, 5 μM), (OLMALINC, -2, HEK293, 0.03 μM), (OLMALINC, -4.9, HEK293, 0.3 μM), (OLMALINC, -4.1, HEK293, 3 μM), (OLMALINC, -4.4, HEK293, 5 μM), (OLMALINC, -7.2, HEK293, 5 μM), (P2RX4, -1.3, HEK293, 0.3 μM), (P2RX4, -1, HEK293, 3 μM), (P2RX4, -1.4, HEK293, 5 μM), (P2RX4, -1.3, HEK293, 5 μM), (PAAF1, -1, HEK293, 0.3 μM), (PAAF1, -1.1, HEK293, 3 μM), (PARVB, -1.2, HEK293, 0.3 μM), (PARVB, -1.3, HEK293, 3 μM), (PARVB, -1.2, HEK293, 5 μM), (PCCB, -1.1, HEK293, 0.03 μM), (PCCB, -1.7, HEK293, 0.3 μM), (PCCB, -1.8, HEK293, 3 μM), (PCCB, -1.6, HEK293, 5 μM), (PCCB, -1.7, HEK293, 5 μM), (PCID2, -1.7, HEK293, 0.3 μM), (PCID2, -2.2, HEK293, 3 μM), (PCID2, -1.9, HEK293, 5 μM), (PCID2, -2, HEK293, 5 μM), (PDIA5, -1.5, HEK293, 0.3 μM), (PDIA5, -1.6, HEK293, 3 μM), (PDIA5, -1.7, HEK293, 5 μM), (PDIA5, -1.1, HEK293, 5 μM), (PEX6, -1.3, HEK293, 0.03 μM), (PEX6, -1.8, HEK293, 0.3 μM), (PEX6, -1.8, HEK293, 3 μM), (PEX6, -1.3, HEK293, 5 μM), (PEX6, -1.7, HEK293, 5 μM), (PGAP1, -1.1, HEK293, 0.3 μM), (PHKG2, -1.3, HEK293, 0.3 μM), (PHKG2, -1.5, HEK293, 3 μM), (PHKG2, -1, HEK293, 5 μM), (PHKG2, -1, HEK293, 5 μM), (PLBD2, -1, HEK293, 3 μM), (PLBD2, -1.3, HEK293, 5 μM), (POLA2, -1.5, HEK293, 0.3 μM), (POLA2, -1.6, HEK293, 3 μM), (POLA2, -1.2, HEK293, 5 μM), (POLA2, - 1.2, HEK293, 5 μM), (POLN, -1.4, HEK293, 0.3 μM), (POLN, -1.6, HEK293, 3 μM), (POLN, - 1.4, HEK293, 5 μM), (POLN, -1.3, HEK293, 5 μM), (POLR2I4, 1.2, HEK293, 0.03 μM), (POLR2J4, 1.8, HEK293, 0.3 μM), (POLR2J4, 1.6, HEK293, 3 μM), (POLR2J4, 1.1, HEK293, 5 μM), (POLR2J4, 1.3, HEK293, 5 μM), (POLR3GL, -1.1, HEK293, 5 μM), (PPP2R3C, -1.1, HEK293, 0.3 μM), (PPP2R3C, -1.4, HEK293, 3 μM), (PPP4R4, -1.4, HEK293, 0.03 μM), (PPP4R4, -1.2, HEK293, 0.3 μM), (PPP4R4, -1.7, HEK293, 3 μM), (PPP4R4, -1.5, HEK293, 5 μM), (PRKAG1, -1.2, HEK293, 0.3 μM), (PRKAG1, -1.3, HEK293, 3 μM), (PRKAG1, -1, HEK293, 5 μM), (PRKAG1, -1.1, HEK293, 5 μM), (PRPF40B, -1, HEK293, 0.3 μM), (PRPF40B, -1.1, HEK293, 3 μM), (PRPF40B, -1, HEK293, 5 μM), (PSEN2, -1.1, HEK293, 3 μM), (PTPN18, -1.4, HEK293, 0.3 μM), (PTPN18, -2.1, HEK293, 3 μM), (PTPN18, -2.3, HEK293, 5 μM), (PTPN18, -1.6, HEK293, 5 μM), (PXDN, -1, HEK293, 5 μM), (RAB4B, -1, HEK293, 0.03 μM), (RAB4B, -1.3, HEK293, 0.3 μM), (RAB4B, -1.2, HEK293, 3 μM), (RAB4B, -1.1, HEK293, 5 μM), (RAB4B, -1, HEK293, 5 μM), (RABL6, -1, HEK293, 3 μM),
(RADIL, -1.4, HEK293, 3 μM), (RADIL, -1.8, HEK293, 5 μM), (RADIL, -1.6, HEK293, 5 μM), (RASGRF2, -1.2, HEK293, 5 μM), (RBM20, -1.2, HEK293, 3 μM), (RECK, -1.4, HEK293, 3 μM), (RNF123, -1.3, HEK293, 0.3 μM), (RNF123, -1.4, HEK293, 3 μM), (RNFT1, -1, HEK293, 3 μM), (RRNAD1, -1.4, HEK293, 0.3 μM), (RRNAD1, -1.3, HEK293, 3 μM), (RRNAD1, -1.4, HEK293, 5 μM), (RRNAD1, -1.3, HEK293, 5 μM), (RTEL1, -1.1, HEK293, 0.3 μM), (RTEL1, -1.3, HEK293, 3 μM), (RTEL1-TNFRSF6B, -1.1, HEK293, 0.3 μM), (RTEL1-TNFRSF6B, -1.3, HEK293, 3 μM), (SEC31B, 1.4, HEK293, 0.03 μM), (SEC31B, 2, HEK293, 0.3 μM), (SEC31B, 2, HEK293, 3 μM), (SEMA4A, -3.8, HEK293, 5 μM), (SLC24A1, -1.4, HEK293, 3 μM), (SLC25A14, -1, HEK293, 3 μM), (SLC25A40, -1.2, HEK293, 0.3 μM), (SLC25A40, -1.5, HEK293, 3 μM), (SLC25A40, -1.3, HEK293, 5 μM), (SLC25A40, -1.5, HEK293, 5 μM), (SLC38A6, -1.9, HEK293, 0.03 μM), (SLC38A6, -1.8, HEK293, 0.3 μM), (SLC38A6, -2.6, HEK293, 3 μM), (SLC38A6, -1.5, HEK293, 5 μM), (SLC38A6, -1.1, HEK293, 5 μM), (SLC3A2, 1.2, HEK293, 3 μM), (SLC43A1, -1.2, HEK293, 0.03 μM), (SLC43A1, -1.4, HEK293, 0.3 μM), (SLC43A1, -1.8, HEK293, 3 μM), (SLC43A1, -2.1, HEK293, 5 μM), (SLC43A1, -1.1, HEK293, 5 μM), (SLC47A1, -1.3, HEK293, 0.3 μM), (SLC47A1, -1.4, HEK293, 3 μM), (SLC47A1, -1.5, HEK293, 5 μM), (SLC47A1, -1.2, HEK293, 5 μM), (SLC4A7, -1.2, HEK293, 0.03 μM), (SLC4A7, -1.9, HEK293, 0.3 μM), (SLC4A7, -2.1, HEK293, 3 μM), (SLC4A7, -1.6, HEK293, 5 μM), (SLC4A7, -1.8, HEK293, 5 μM), (SLIT1, -
1.4, HEK293, 0.3 μM), (SLIT1, -2.1, HEK293, 3 μM), (SLIT1, -1.8, HEK293, 5 μM), (SLIT1, -
1.4, HEK293, 5 μM), (SLIT3, -3, HEK293, 0.3 μM), (SLIT3, -3.3, HEK293, 3 μM), (SLIT3, -
2.5, HEK293, 5 μM), (SLIT3, -2.8, HEK293, 5 μM), (SNCAIP, 1.3, HEK293, 0.3 μM), (SNCAIP, 1.2, HEK293, 3 μM), (SNCAIP, 1, HEK293, 5 μM), (SPATA6, -1.1, HEK293, 5 μM), (ST6GAL1, -1.3, HEK293, 0.3 μM), (ST6GAL1, -1.6, HEK293, 3 μM), (ST6GAL1, -2.2, HEK293, 5 μM), (ST6GAL1, -1.8, HEK293, 5 μM), (ST7L, -1, HEK293, 0.03 μM), (ST7L, -
1.3, HEK293, 0.3 μM), (ST7L, -1.4, HEK293, 3 μM), (ST7L, -1.1, HEK293, 5 μM), (STXBP3, -
1.5, HEK293, 0.03 μM), (STXBP3, -3.3, HEK293, 0.3 μM), (STXBP3, -3.4, HEK293, 3 μM), (STXBP3, -3.1, HEK293, 5 μM), (STXBP3, -2.7, HEK293, 5 μM), (TARSL2, -1.5, HEK293, 0.3 μM), (TARSL2, -1.8, HEK293, 3 μM), (TARSL2, -1.7, HEK293, 5 μM), (TARSL2, -1.5, HEK293, 5 μM), (TBC1D19, -1.3, HEK293, 0.03 μM), (TBC1D19, -2.6, HEK293, 0.3 μM), (TBC1D19, -3, HEK293, 3 μM), (TBC1D19, -1.3, HEK293, 5 μM), (TBC1D19, -2.1, HEK293, 5 μM), (TBCK, -1.8, HEK293, 0.03 μM), (TBCK, -2.1, HEK293, 0.3 μM), (TBCK, -1.7, HEK293, 3 μM), (TBCK, -1.4, HEK293, 5 μM), (TBCK, -1.3, HEK293, 5 μM), (TDP1, -1.1, HEK293, 0.03 μM), (TDP1, -1.8, HEK293, 0.3 μM), (TDP1, -1.7, HEK293, 3 μM), (TDP1, -1.5, HEK293, 5 μM), (TDP1, -1.5, HEK293, 5 μM), (TFCP2, -1.2, HEK293, 0.3 μM), (TFCP2, -1.4, HEK293, 3 μM), (TFCP2, -1.1, HEK293, 5 μM), (THOC2, -1, HEK293, 0.03 μM), (THOC2, -
1.4, HEK293, 0.3 μM), (THOC2, -1.5, HEK293, 3 μM), (THOC2, -1.2, HEK293, 5 μM), (THOC2, -1.5, HEK293, 5 μM), (TIA1, -1, HEK293, 0.3 μM), (TIA1, -1.2, HEK293, 3 μM), (TMEM106C, -1.3, HEK293, 0.3 μM), (TMEM106C, -1.5, HEK293, 3 μM), (TMEM106C, -1.4, HEK293, 5 μM), (TMEM106C, -1.3, HEK293, 5 μM), (TMEM144, -1.4, HEK293, 5 μM), (TMX3, -1.6, HEK293, 0.3 μM), (TMX3, -1.4, HEK293, 3 μM), (TMX3, -1.6, HEK293, 5 μM), (TMX3, -1.7, HEK293, 5 μM), (TNKS2, -1.1, HEK293, 0.3 μM), (TNKS2, -1.1, HEK293, 3 μM), (TNKS2, -1, HEK293, 5 μM), (TOM1L2, -1.3, HEK293, 0.3 μM), (TOM1L2, -1.3, HEK293, 3 μM), (TOM1L2, -1, HEK293, 5 μM), (TOM1L2, -1.2, HEK293, 5 μM), (TRIM16, 1.1, HEK293, 0.3 μM), (TRIM16, 1.2, HEK293, 5 μM), (TRMT10A, -1.1, HEK293, 5 μM), (TRPM4, -1.2, HEK293, 0.3 μM), (TRPM4, -1.1, HEK293, 3 μM), (TTC12, -1.8, HEK293, 0.3
Compound 59
Inclusion Results (Compound 59)
[00648] RNAseq experiments showed that Compound 59 did not induce exon inclusion with a PSI change (APSI) of +50% to +100% and P-value <0.001, or -50% to -100% and P-value <0.001 :
[00649] For the genes listed in Table 5, treatment with Compound 59 did not show a change in gene expression of 2 fold or greater, as measured based on a log 2 fold change (L2FC) of 1 or above (increased expression), or -1 or below (decreased expression):
Compound 89
[00650] Table 70 provides further detail of results (Cpd = Compound, Gene = Gene, Cone = Concentration, L2FC = log2 fold change) for genes exhibiting a two fold change, or more, in
gene expression (a Log2 fold change of 1.0 or above, or -1.0 or below) together with a change in Percent Spliced In (APSI) of 50% to 100%, or -50% to -100%, at a p value (pVal) of < 0.001 in the presence of Compound 89.
[00651] The cell lines tested included Familial Dysautonomia patient fibroblasts (FDPF), HEK293, stimulated PBMC (sPBMC), differentiated SY5Y (diffSY5Y), SHSY5Y, M0LM13 and HT1080.
Inclusion Results (Compound 89)
[00653] RNAseq experiments showed that Compound 89 induced exon inclusion with a
PSI change (APSI) of +50% to +100% and P-value <0.001 in 110 genes:
[00655] RNAseq experiments showed that Compound 89 induced exon inclusion with a
PSI change (APSI) of +50% to +100% and P-value <0.001 in genes having a 5' splice site as follows (114 entries):
Inclusion and NMD Results (Compound 89)
[00657] RNAseq experiments showed that Compound 89 induced exon inclusion associated with nonsense mediated decay with a PSI change (APSI) of +50% to +100% and P- value <0.001 in 27 genes:
[00659] RNAseq experiments showed that Compound 89 induced exon inclusion associated with nonsense mediated decay with a PSI change (APSI) of +50% to +100% and P- value <0.001in genes having a 5' splice site as follows (30 entries):
• Skipping Results (Compound 89)
[00661] RNAseq experiments showed that Compound 89 induced exon skipping with a
PSI change (APSI) of -50% to -100% and P-value <0.001 in 787 genes:
[00662] Table 75
BRD8, BRIP1, BRSK2, C12orf4, C19orf47, Clorf54, C2CD2L, C3orf67, C4orf33, C5orf42, CACNA2D1, CACNA2D3, CAMSAP1, CAP2, CASD1, CASP9, CBY1, CCDC125, CCDC14, CCDC66, CCDC88A, CCNYL1, CCNYL2, CDC14A, CDC16, CDC25C, CDK5RAP1, CDS1, CDYL, CENPE, CENPT, CEP112, CEP164, CEP170, CEP192, CEP290, CEP350, CEP44, CEP85, CEP97, CERS4, CES2, CHD1L, CHEK2, CHFR, CIP2A, CIT, CIZ1, CLCC1, CLDND1, CLEC16A, CMSS1, CMTM7, CMTR1, CNOTIO, CNOT2, COP1, COQ3, COQ6, CPSF7, CPT2, CPXM1, CRBN, CREB3L4, CRLS1, CRNDE, CRYZ, CSNK1G1, CSPP1, CSRNP2, CTNS, CTSF, CUEDC1, CYB561D2, DAPK1, DBF4, DBT, DCAF11, DCAF17, DCUN1D4, DDIAS, DDX11, DDX12P, DDXI9B, DECR2, DENNDIA, DENND4B, DENND4C, DENND5A, DESI1, DFFB, DHX35, DHX57, DIAPH2, DIMT1, DIP2A, DLG1, DLST, DMD, DMPK, DMXL1, DMXL2, DNAJB12, DNM1L, DOC2B, DPCD, DPY19L3, DRAM2, DSE, DST, DTNBP1, DUSP11, DYM, DYNC1LI2, DYRK3, DZIP3, EBPL, EEF1AKMT2, EFS, EIF2AK4, EIF4E2, ELF2, ELMOD1, ELMOD3, ELP2, EMB, ENTPD5, EOGT, EPB41L1, EPB41L5, ERMARD, ETHE1, EXD2, EXOCI, EXOC3, EXOC6, FAHD2A, FAM118B, FAM120B, FAM135A, FAM13A, FAM151B, FAM169A, FAM171A1, FAM172A, FAM173B, FAM207A, FAM208A, FAM208B, FAM45BP, FANCA, FANCE, FANCI, FANCL, FBXO16, FBXO9, FDX1, FIG4, FKBP15, FMRI, FNIP1, FOXRED1, FPGT- TNNI3K, FRAS1, FYN, G2E3, GABPA, GALNT6, GAS2L3, GCA, GCH1, GEMIN2, GEN1, GINS1, GIT2, GLMN, GLYR1, GNPTG, GOLT1B, GPATCH2L, GPCPD1, GPR107, GPR180, GRIP API, GRK3, GTF2H2, GTF2IP1, GTF3C2, GUCD1, GUF1, HACD1, HEATR5A, HGSNAT, HMGN5, HOOK3, HPS1, HPS3, HPS4, HR, HSCB, HTD2, IFNAR2, IFT122, IFT140, IFT172, IFT80, IFT88, IGF2BP2, IKBKB, IL11RA, IMMP1L, ING3, ING4, INO80C, INPP5F, INPPL1, IQCB1, IQSEC1, IST1, IVD, KCNQ5, KCTD9, KDM1B, KDM6A, KIAA0100, KIAA0319L, KIDINS220, KIF14, KIF3A, KLHL22, KLRG2, KNL1, LARS, LCORL, LDLRAD3, LDLRAD4, LEPR, LGR4, LGR5, LIMCH1, LIN52, LINC00630, LMBR1, LMBR1L, LMBRD1, LMO7, LOC100288778, LOC389906, LRIG3, LRP8, LRRC28, LRRC40, LRRC58, LRSAM1, LSS, LTBP1, LTBP4, LYRM7, MAD1L1, MADD, MAGI3, MAP2K4, MAP2K6, MAP3K3, MARCH6, MARFI, MBIP, MBOAT2, MDMI, MDN1, MECR, MED12, MED15, MED25, MEGF8, MEMO1, METTL8, MFF, MFSD12, MFSD8, MFSD9, MGA, MGAT4C, MKL1, MKL2, MKNK1, MKS1, MLF1, MLH1, MMS19, MMS22L, MND1, MOCS1, MOSPD1, MOSPD2, MPND, MTCH2, MTERF4, MTMR6, MTR, MTRR, MUTYH, MYBL2, MYH14, MYO5A, MYSM1, NAA25, NAALAD2, NAGK, NAGPA, NARS2, NAXD, NBN, NBPF3, NBPF9, NCOA2, NCOA6, NCOR2, NCSTN, NDOR1, NDRG3, NDUFB6, NECAB3, NEIL3, NEK1, NF2, NFATC2IP, NIPA2, NOLIO, NOTCH2, NPRL3, NRDC, NSUN6, NT5C2, NUB1, NUDT22, NUP54, NUP58, NUPL2, OAZ1, OCRL, OGGI, OGT, OIP5, OMA1, OSBPL6, OSBPL9, 0STF1, OXCT1, P2RX4, PACRGL, PAPD7, PAPOLG, PAQR3, PARP2, PARP8, PARPBP, PAXX, PCBP3, PCGF6, PCID2, PCSK6, PDE8A, PDK3, PDLIM2, PDLIM4, PDSS1, PEX11A, PFDN1, PHKA1, PHKG2, PICALM, PICK1, PIGN, PIK3C2A, PITPNA, PITPNC1, PKDCC, PKIB, PKNOX2, PLA2G12A, PLAGL1, PLBD2, PLEKHA5, PLEKHA6, PLEKHG4, PMS1, POC1A, POFUT1, POLA1, POLE2, POLR1A, POLR2J3, POLR3F, POLR3H, PPCDC, PPIL2, PPM1K, PPM1M, PPP1R21, PPP2R3C, PPP4C, PPP6R2, PPRC1, PRDM4, PRIMPOL, PRKAA2, PRKAG1, PRKCZ, PRKD2, PRKRA, PRMT2, PRPF4B, PRR14, PRRG1, PRRT4, PRSS16, PSD3, PSME4, PSTPIP1, PTAR1, PTCHI, PTPN13, PTPN2, PTPN4, PTPRG-AS1, PUM2, PXDN, PYROXD1, QPCTL, QRICH1, R3HCC1L, R3HDM1, R3HDM2, RAB22A, RAB3IP, RAD18,
[00663] RNAseq experiments showed that Compound 89 induced exon skipping with a
PSI change (APSI) of -50% to -100% and P-value <0.001 in genes having a 5' splice site as follows (704 entries):
[00664] Table 76
AATGgtaaat, AATGgtaagc, AATGgtagga, AATGgtaggt, AATGgtgaga, AATGgtgagg, AATGgtgagt, AATGgtttga, AATTgtaagt, AATTgtgagt, ACAAgtaagt, ACACgtaagc, ACACgtaagt, ACACgtgagt, ACAGagtaag, ACAGgcaagt, ACAGgtaaag, ACAGgtaaat, ACAGgtaaca, ACAGgtaaga, ACAGgtaagc, ACAGgtaagt, ACAGgtaata, ACAGgtaatc, ACAGgtaatt, ACAGgtacat, ACAGgtacca, ACAGgtacct, ACAGgtacgt, ACAGgtagag, ACAGgtatac, ACAGgtatct, ACAGgtatga, ACAGgtattt, ACAGgtctct, ACAGgtgaac, ACAGgtgact, ACAGgtgagc, ACAGgtgagg, ACAGgtgatg, ACAGgtgcgg, ACAGgtgcgt, ACAGgtgggc, ACAGgtgtct, ACAGgttagc, ACAGgttcgg, ACAGgttgca, ACATgtaaga, ACATgtaagc, ACATgtaatg, ACATgtgagt, ACCAgtaaga, ACCAgtaagt, ACCAgtgagg, ACCAgtgagt, ACCCgtgaga, ACCCgtgagt, ACCCgtgtga, ACCGgtaagg, ACCTgtaagc, ACCTgtaagt, ACCTgtgagt, ACGGgtacta, ACGGgtgagt, ACTAgtaagt, ACTGagtccc, ACTGgtaagc, ACTGgtaagt, ACTGgtagag, ACTGgtaggg, ACTGgtatgt, ACTGgtgagt, ACTTgtaagt, AGAAgtaagt, AGAAgtgagt, AGAAgtgcgt, AGACgtatgt, AGAGagggta, AGAGgtaaaa, AGAGgtaaac, AGAGgtaaat, AGAGgtaact, AGAGgtaagg, AGAGgtaagt, AGAGgtacaa, AGAGgtacag, AGAGgtagct, AGAGgtagga, AGAGgtaggt, AGAGgtatgg, AGAGgtattg, AGAGgtgagc, AGAGgtgagg, AGAGgtgggg, AGAGgtttgc, AGATgtaaga, AGATgtaagc, AGATgtaagt, AGATgtgagt, AGCAggtcag, AGCAgtgagt, AGCCgtatgt, AGCGgtaagc, AGCGgtgagg, AGCGgtgagt, AGCTcaggtg, AGCTgtaagt, AGCTgtatgt, AGCTgtgagt, AGGCgtaagt, AGGGgtaagg, AGGGgtaggt, AGGGgtatga, AGTCgtatcc, AGTCgtgagt, AGTGgtaatc, AGTGgtatgt, AGTGgtgagg, ATAAgtatgt, ATACgtaagt, ATAGgcaagt, ATAGgtaaga, ATAGgtaagt, ATAGgtatga, ATAGgtgagt, ATAGgttagt, ATATgtaagt, ATATgtgagt, ATCAgtaagt, ATCAgtgagt, ATCCgtgagt, ATCGgtaagg, ATCTgtaaga, ATCTgtaagt, ATCTgtgaga, ATCTgtgagt, ATGAgtatgt, ATGAgtgagt, ATGAgtgtga, ATGGgtaaac, ATGGgtaaat, ATGGgtaaga, ATGGgtaagc, ATGGgtaagt, ATGGgtatga, ATGGgtgagt, ATGGtggtga, ATGTgtaagt, ATGTgtgagt, ATTAgtgagt, ATTGgcatgc, ATTGgtaaga, ATTGgtaagc, ATTGgtaagg, ATTGgtaagt, ATTGgtaata, ATTGgtagta, ATTGgtgagg, ATTGgtgagt, ATTGgtgtga, ATTTgtaagt, ATTTgtgagt, CAAAgtgagt, CAACgtaagt, CAACgtgagt, CAAGgcaagt, CAAGgtaaac, CAAGgtaact, CAAGgtaaga, CAAGgtaagt, CAAGgtaata, CAAGgtacac, CAAGgtagag, CAAGgtaggc, CAAGgtaggt, CAAGgtagtc, CAAGgtagtt, CAAGgtatga, CAAGgtatgg, CAAGgtattc, CAAGgtgaga, CAAGgtgagt, CAAGgttagt, CAAGgtttcc, CAAGgtttct, CAATgctggg, CAATgtaagt, CAATgtgagt, CACAgtaagc, CACAgtaagt, CACAgtgagt, CACCgtaagt, CACGgtaaca, CACGgtaagt, CACGgtgagt, CACGgtgtgt, CACTgtaagt, CACTgtaatg, CACTgtgagt, CAGAgtaagt, CAGAgtgagt, CAGCgtaagt, CAGGgtaaaa, CAGGgtaagc, CAGGgtaagt, CAGGgtaggt, CAGGgtatgg, CAGGgtatgt, CAGGgtgaga, CAGGgtgagt, CAGTgtaagt, CAGTgtgagt, CATCgtgtga, CATGgtaagc, CATGgtaagg, CATGgtatgt, CATGgtgaga, CATGgtgagt, CATGgtgtgt, CATTagtgag, CATTgtgagt, CCAAatgcaa, CCAAgtaggc, CCAAgtgagc, CCACgtatga, CCACgtgagt, CCAGgcaaga, CCAGgtaaaa, CCAGgtaaac, CCAGgtaaag, CCAGgtaagg, CCAGgtaagt, CCAGgtaatt, CCAGgtacac, CCAGgtacct, CCAGgtactg, CCAGgtagaa, CCAGgtaggt, CCAGgtatga, CCAGgtatgg, CCAGgtatgt, CCAGgtatta, CCAGgtcggt, CCAGgtctga, CCAGgtgaag, CCAGgtgaga, CCAGgtgagc, CCAGgtgagt, CCAGgtgcgg, CCAGgtgggt, CCAGgtgtgt, CCAGgttagt, CCAGgttctg, CCAGgttggt, CCAGgtttgt, CCATgtaaga, CCATgtaagc, CCATgtaagt, CCATgtgagt, CCCAgtgagt, CCCGgtgagc, CCCTgtaagt, CCCTgtgcgt, CCGAgtgagc, CCGAgtgagt, CCGGgtagga, CCGGgtgagt, CCGGgtgtgt, CCTAgtaagt, CCTGgtaacc,
CCTGgtaaga, CCTGgtaagc, CCTGgtaagt, CCTGgtgagc, CCTGgtgagg, CCTGgtgagt, CCTTgtaagt, CCTTgtgagc, CGACgtgagt, CGAGgtactt, CGAGgtaggg, CGAGgtaggt, CGAGgtgaga, CGAGgtgatg, CGATgtaagt, CGATgtgagt, CGCAgtaagt, CGCAgtgagc, CGCAgtgagt, CGCTgtaagc, CGCTgtgagt, CGGGgtgagt, CGTGgtaagg, CGTGgtaagt, CGTGgtgagt, CTAAgtaagc, CTAGgtaatg, CTAGgtatct, CTAGgtcagt, CTATgtaact, CTATgtaaga, CTATgtaagt, CTCAgtaagt, CTCAgtgagt, CTCCgtatgt, CTCCgtgagt, CTCGgtaagt, CTCGgtcagt, CTCTgtaaga, CTCTgtaagt, CTCTgtgagt, CTGAgtaagc, CTGAgtaagt, CTGAgtgagt, CTGCaggggg, CTGGgtaact, CTGGgtaaga, CTGGgtaagc, CTGGgtaagt, CTGGgtaggt, CTGGgtcagt, CTGGgtgaga, CTGGgtgagg, CTGGgtgagt, CTGTgtaagt, CTGTgtgagt, CTTCgtgagt, CTTGatttta, CTTGgtatac, CTTGgtatgg, CTTGgtgagc, CTTGgtgagg, CTTGgtgagt, CTTGgtgggt, CTTTgtaagt, CTTTgtgagt, GAAAgtaagt, GAAAgtatgt, GAAAgtgagt, GAACgtatgt, GAACgtgagt, GAAGgcaagt, GAAGgtaaaa, GAAGgtaaat, GAAGgtaaga, GAAGgtaagc, GAAGgtaagt, GAAGgtactc, GAAGgtagcc, GAAGgtagga, GAAGgtagta, GAAGgtatag, GAAGgtatgt, GAAGgtatta, GAAGgtgaag, GAAGgtgagc, GAAGgtgagt, GAAGgtgatg, GAAGgtgggc, GAAGgtgtaa, GAAGgttggt, GAAGgtttgt, GAATgcaagg, GAATgtaagt, GAATgtgagc, GAATgtgagt, GACAgtaagt, GACAgtgagt, GACCgtaagt, GACCgtatgt, GACCgtgagt, GACCgtgggt, GACGgtaaag, GACGgtaatt, GACGgtgaga, GACTgtaagt, GACTgtgagt, GAGAgtaaga, GAGAgtaagc, GAGAgtaagt, GAGAgtgagt, GAGAtgctgc, GAGGagtgtg, GAGGgtaagc, GAGGgtatgt, GAGGgtgagt, GAGTgtgagt, GATAgtaagt, GATAgtgagt, GATGgcaatc, GATGgtaagc, GATGgtaagt, GATGgtaata, GATGgtatgt, GATGgtgagg, GATGgtgagt, GATGgtggga, GATGtgggtt, GATTgtaagt, GATTgtgagt, GATTtgcatg, GCAAgtaagt, GCAAgtatgg, GCAAgtgagt, GCACgtaagt, GCACgtgagt, GCAGgtaaaa, GCAGgtaaac, GCAGgtaaag, GCAGgtaaga, GCAGgtaagc, GCAGgtaagg, GCAGgtacag, GCAGgtacca, GCAGgtagga, GCAGgtgaga, GCAGgtgagc, GCAGgtgagg, GCAGgtgagt, GCAGgtgggt, GCATgtaagt, GCATgtgagt, GCCAgtgagt, GCCCgtgagt, GCCGgtgagt, GCCGgtgggt, GCCTgtaagt, GCCTgtgagt, GCGAgtgagt, GCGGgtgagt, GCTAgtgagt, GCTAgtgcgt, GCTCtcttgt, GCTGgtaagt, GCTGgtgaga, GCTGgtgagt, GCTGgtgtgt, GCTTgtatgt, GCTTgtgagt, GGAGgtaagg, GGAGgtaatg, GGAGgtacga, GGAGgtagga, GGAGgtaggt, GGAGgtatat, GGAGgtcagt, GGAGgtgaga, GGAGgtgagg, GGAGgtgagt, GGAGgtgggc, GGAGgtgggt, GGATgtgagt, GGATgttagc, GGCAgtaagt, GGCGgtgagt, GGCTgtaagt, GGCTgtgagt, GGGGgtaagt, GTAGgtaggt, GTCCgtaagt, GTCTgtaagt, GTGAgtaagt, GTGGgtgagt, GTGTctccca, GTTAgtaagt, GTTAtggtga, GTTGgtgaga, GTTTgtaagt, GTTTgtgagt, TAAAgtgagt, TAACgtgagt, TAAGgtaaaa, TAAGgtaaga, TAAGgtaagt, TAAGgtatgc, TAAGgtcagt, TAAGgtgagg, TAAGgtggat, TAATgcaagt, TAATgtaagt, TAATgtgagt, TACAgtgagt, TACCaaaggg, TACCgtaagt, TACGgtgagt, TACTgtaagt, TACTgtgagt, TAGAgtaagt, TAGAgtatta, TAGGgtaaga, TAGGgtaagt, TAGGgtaggt, TAGTgtaagg, TAGTgtaagt, TATAtaaggt, TATCgtgagt, TATGgtaact, TATGgtaaga, TATGgtaagt, TATGgtaatg, TATGgtcagc, TATGgtgagg, TATGgtgagt, TATTgtaagt, TATTgtgagt, TCACgtaagt, TCACgtatgt, TCAGgtaaaa, TCAGgtaaat, TCAGgtaaga, TCAGgtaagg, TCAGgtaatg, TCAGgtaatt, TCAGgtagat, TCAGgtagga, TCAGgtaggt, TCAGgtatca, TCAGgtatga, TCAGgtatgg, TCAGgtattt, TCAGgtcaga, TCAGgtcagt, TCAGgtctgc, TCAGgtctgt, TCAGgtgaag, TCAGgtgaga, TCAGgtgagc, TCAGgtgagt, TCAGgtgcca, TCAGgtgcga, TCAGgtgggg, TCAGgtgtaa, TCAGgtgtga, TCAGgtgtgc, TCAGgtgtgt, TCAGgttagc,
Skipping and NMD Results (Compound 89)
[00665] RNAseq experiments showed that Compound 89 induced exon skipping associated with nonsense mediated decay with a PSI change (APS1) of -50% to -100% and P- value <0.001 in 423 genes:
[00667] RNAseq experiments showed that Compound 89 induced exon skipping associated with nonsense mediated decay with a PSI change (APSI) of -50% to -100% and P- value <0.001 in genes having a 5' splice site as follows (411 entries):
[00668] Table 78
ACCTgtaagt, ACCTgtgagt, ACGGgtacta, ACGGgtgagt, ACTAgtaagt, ACTGgtaagt, ACTGgtaggg, ACTGgtgagt, ACTTgtaagt, AGAAgtaagt, AGAAgtgagt, AGACgtatgt, AGAGgtaaaa, AGAGgtaaac, AGAGgtaaat, AGAGgtaact, AGAGgtacaa, AGAGgtacag, AGAGgtagct, AGAGgtaggt, AGAGgtgagc, AGATgtaagc, AGATgtaagt, AGATgtgagt, AGCAgtgagt, AGCGgtgagt, AGCTgtaagt, AGCTgtatgt, AGCTgtgagt, AGGGgtaggt, AGTCgtgagt, AGTGgtaatc, ATAAgtatgt, ATACgtaagt, ATAGgtaagt, ATAGgtatga, ATAGgttagt, ATATgtaagt, ATATgtgagt, ATCAgtaagt, ATCCgtgagt, ATCGgtaagg, ATCTgtaagt, ATCTgtgagt, ATGAgtatgt, ATGAgtgtga, ATGGgtaaga, ATGGgtaagc, ATGGgtgagt, ATGTgtaagt, ATTGgtaagc, ATTGgtaagt, ATTGgtaata, ATTGgtgagg, ATTGgtgagt, ATTGgtgtga, ATTTgtaagt, CAAAgtgagt, CAACgtaagt, CAACgtgagt, CAAGgtaaac, CAAGgtaact, CAAGgtaaga, CAAGgtaagt, CAAGgtagtt, CAAGgtatgg, CAAGgtattc, CAAGgtgaga, CAAGgttagt, CAAGgtttct, CAATgtaagt, CACAgtaagc, CACAgtgagt, CACCgtaagt, CACGgtaaca, CACGgtaagt, CACGgtgtgt, CACTgtaagt, CACTgtgagt, CAGAgtaagt, CAGAgtgagt, CAGGgtaaaa, CAGGgtaagc, CAGGgtaagt, CAGGgtatgg, CAGGgtgaga, CAGGgtgagt, CAGTgtaagt, CAGTgtgagt, CATCgtgtga, CATGgtaagc, CATGgtatgt, CATGgtgagt, CATTagtgag, CATTgtgagt, CCAAgtgagc, CCACgtatga, CCACgtgagt, CCAGgtaaaa, CCAGgtaaac, CCAGgtaagg, CCAGgtaagt, CCAGgtaatt, CCAGgtactg, CCAGgtagaa, CCAGgtcggt, CCAGgtctga, CCAGgtgaag, CCAGgtgaga, CCAGgtgagc, CCAGgtgggt, CCAGgtgtgt, CCAGgttctg, CCAGgttggt, CCAGgtttgt, CCATgtaaga, CCATgtaagt, CCATgtgagt, CCCAgtgagt, CCCTgtaagt, CCGGgtagga, CCGGgtgagt, CCGGgtgtgt, CCTGgtaacc, CCTGgtaagc, CCTGgtaagt, CCTGgtgagt, CCTTgtaagt, CCTTgtgagc, CGACgtgagt, CGAGgtaggt, CGAGgtgaga, CGAGgtgatg, CGATgtgagt, CGCAgtaagt, CGCAgtgagt, CGCTgtaagc, CGGGgtgagt, CGTGgtaagg, CGTGgtaagt, CGTGgtgagt, CTAAgtaagc, CTAGgtatct, CTAGgtcagt, CTATgtaaga, CTCAgtaagt, CTCAgtgagt, CTCGgtaagt, CTCGgtcagt, CTCTgtaaga, CTCTgtaagt, CTCTgtgagt, CTGAgtaagc, CTGAgtaagt, CTGGgtaact, CTGGgtaagc, CTGGgtaagt, CTGGgtaggt, CTGGgtgaga, CTGGgtgagt, CTGTgtgagt, CTTCgtgagt, CTTGgtgagc, CTTGgtgagt, GAAAgtaagt, GAACgtatgt, GAACgtgagt, GAAGgtaaaa, GAAGgtaaat, GAAGgtaaga, GAAGgtaagc, GAAGgtagta, GAAGgtatag, GAAGgtatta, GAAGgtgtaa, GAATgtaagt, GAATgtgagt, GACAgtgagt, GACCgtgagt, GACGgtaaag, GACGgtaatt, GACGgtgaga, GACTgtgagt, GAGAgtaaga, GAGAgtaagc, GAGAgtaagt, GATGgtaagc, GATGgtaagt, GATGgtatgt, GATGgtgagg, GATGgtgagt, GATGgtggga, GATTgtaagt, GCACgtgagt, GCAGgtaaaa, GCAGgtaaac, GCAGgtaaag, GCAGgtaaga, GCAGgtaagc, GCAGgtacag, GCAGgtacca, GCAGgtagga, GCAGgtgaga, GCAGgtgagg, GCAGgtgagt, GCATgtgagt, GCCTgtaagt, GCCTgtgagt, GCTAgtgcgt, GCTGgtaagt, GCTGgtgaga, GCTGgtgagt, GCTTgtatgt, GGAGgtacga, GGAGgtgggc, GGATgtgagt, GGATgttagc, GGCGgtgagt, GGCTgtaagt, GGCTgtgagt, GTCCgtaagt, GTGAgtaagt, GTGGgtgagt, GTTAgtaagt, GTTTgtaagt, GTTTgtgagt, TAAAgtgagt, TAAGgtaaaa, TAAGgtatgc, TAAGgtcagt, TAATgtaagt, TACAgtgagt, TACTgtaagt, TACTgtgagt, TAGAgtaagt, TAGGgtaagt, TAGGgtaggt, TAGTgtaagg, TAGTgtaagt, TATCgtgagt, TATGgtaaga, TATGgtcagc, TATGgtgagg, TATGgtgagt, TATTgtaagt, TCACgtaagt, TCACgtatgt, TCAGgtaaaa, TCAGgtaaat, TCAGgtaaga, TCAGgtaatg, TCAGgtaatt, TCAGgtagat, TCAGgtagga, TCAGgtatca, TCAGgtatga, TCAGgtgaga, TCAGgtgagc, TCAGgtgagt, TCAGgtgcca, TCAGgtgcga, TCAGgtgggg, TCAGgtgtga, TCAGgtgtgt, TCAGgttagt, TCAGgtttgt, TCAGgttttt, TCATgtaaat, TCATgtaaga, TCATgtaagt, TCATgtgagt,
Gene Expression Results (Compound 89)
[00669] RNAseq experiments showed that Compound 89 modulated expression of various genes by a factor of 2 or more. The following table identifies genes from Table 5 which resulted in a log 2 fold change (L2FC) of 1 or above (increased expression), or -1 or below (decreased expression), upon treatment with Compound 89:
[00670] Table 79
SHSY5Y, 1 μM), (ADAM22, -1.4, HEK293, 2.5 μM), (ADAM22, -2.5, SHSY5Y, 2.5 μM), (ADAM22, -1.4, HEK293, 5 μM), (ADAM22, -2, SHSY5Y, 5 μM), (ADAM22, -1.1, HEK293, 5 μM), (ADAMTS9, -1.1, SHSY5Y, 1 μM), (ADGRB2, -1, HEK293, 1 μM), (ADGRB2, -1.2, HEK293, 5 μM), (AG04, -1.2, SHSY5Y, 2.5 μM), (AGTPBP1, 1.1, SHSY5Y, 5 μM), (AHI1, - 1, HEK293, 0.5 μM), (AHI1, -2.4, SHSY5Y, 0.5 μM), (AHI1, -1.1, HEK293, 1 μM), (AHI1, -
2.3, SHSY5Y, 1 μM), (AHI1, -1.4, HEK293, 2.5 μM), (AHI1, -1.5, SHSY5Y, 2.5 μM), (AHI1, -
1.1, HEK293, 5 μM), (AHI1, -1.7, SHSY5Y, 5 μM), (AHI1, -1.2, HEK293, 5 μM), (ALDH1L2, -2.4, HEK293, 0.5 μM), (ALDH1L2, -2.4, SHSY5Y, 0.5 μM), (ALDH1L2, -2.5, HEK293, 1 μM), (ALDH1L2, -2.7, SHSY5Y, 1 μM), (ALDH1L2, -2.8, HEK293, 2.5 μM), (ALDH1L2, -
2.4, SHSY5Y, 2.5 μM), (ALDH1L2, -3.2, HEK293, 5 μM), (ALDH1L2, -2.7, SHSY5Y, 5 μM), (ALDH1L2, -2.7, HEK293, 5 μM), (ALDH4A1, -1.5, HEK293, 0.5 μM), (ALDH4A1, -1.5, HEK293, 1 μM), (ALDH4A1, -1.5, HEK293, 2.5 μM), (ALDH4A1, -1.5, HEK293, 5 μM), (ALDH4A1, -1.5, HEK293, 5 μM), (ALG9, 1, SHSY5Y, 1 μM), (AMN1, -1.3, HEK293, 2.5 μM), (AMN1, -1.1, HEK293, 5 μM), (AMN1, -1.2, HEK293, 5 μM), (ANKMY2, -1.2, HEK293, 0.5 μM), (ANKMY2, -1.1, HEK293, 1 μM), (ANKMY2, -1.1, HEK293, 2.5 μM), (ANKMY2, -1.5, HEK293, 5 μM), (ANKMY2, -1.9, SHSY5Y, 5 μM), (ANKRD36, -1.3, HEK293, 2.5 μM), (ANLN, -1.2, HEK293, 0.5 μM), (ANLN, -1.8, SHSY5Y, 0.5 μM), (ANLN, -1.3, HEK293, 1 μM), (ANLN, -1.9, SHSY5Y, 1 μM), (ANLN, -1.2, HEK293, 2.5 μM), (ANLN, -2.2, SHSY5Y, 2.5 μM), (ANLN, -1.1, HEK293, 5 μM), (ANLN, -1.7, SHSY5Y, 5 μM), (ANLN, -1, HEK293, 5 μM), (AP2A2, -1.5, HEK293, 0.5 μM), (AP2A2, -1.9, SHSY5Y, 0.5 μM), (AP2A2, -1.6, HEK293, 1 μM), (AP2A2, -1.9, SHSY5Y, 1 μM), (AP2A2, -1.7, HEK293, 2.5 μM), (AP2A2, -1.6, SHSY5Y, 2.5 μM), (AP2A2, -1.7, HEK293, 5 μM), (AP2A2, -1.5, SHSY5Y, 5 μM), (AP2A2, -1.2, HEK293, 5 μM), (APOOL, -2.5, SHSY5Y, 0.5 μM), (APOOL, -2.7, SHSY5Y, 1 μM), (ARFGAP2, -1.4, HEK293, 0.5 μM), (ARFGAP2, -1.3, SHSY5Y, 0.5 μM), (ARFGAP2, -1.5, HEK293, 1 μM), (ARFGAP2, -1.6, SHSY5Y, 1 μM), (ARFGAP2, -1.6, HEK293, 2.5 μM), (ARFGAP2, -1.7, SHSY5Y, 2.5 μM), (ARFGAP2, -1.6, HEK293, 5 μM), (ARFGAP2, -1.7, SHSY5Y, 5 μM), (ARFGAP2, -1.1, HEK293, 5 μM), (ARHGEF39, -1.6, SHSY5Y, 0.5 μM), (ASAP1, -1.8, SHSY5Y, 0.5 μM), (ASAP1, -1.1, HEK293, 1 μM), (ASAP1, -2.1, SHSY5Y, 1 μM), (ASAP2, -1.5, HEK293, 0.5 μM), (ASAP2, -
6.2, SHSY5Y, 0.5 μM), (ASAP2, -1.5, HEK293, 1 μM), (ASAP2, -2, SHSY5Y, 1 μM), (ASAP2, -1.9, HEK293, 2.5 μM), (ASAP2, -1.8, SHSY5Y, 2.5 μM), (ASAP2, -1.6, HEK293, 5 μM), (ASAP2, -3.2, SHSY5Y, 5 μM), (ASAP2, -1.3, HEK293, 5 μM), (ATF7IP2, 1.1, HEK293, 0.5 μM), (ATF7IP2, 1.3, HEK293, 1 μM), (ATF7IP2, 1.2, HEK293, 2.5 μM), (ATF7IP2, 1.2, HEK293, 5 μM), (ATG7, -1.8, HEK293, 0.5 μM), (ATG7, -1.4, SHSY5Y, 0.5 μM), (ATG7, - 1.9, HEK293, 1 μM), (ATG7, -2.9, SHSY5Y, 1 μM), (ATG7, -2.4, HEK293, 2.5 μM), (ATG7, - 1.9, SHSY5Y, 2.5 μM), (ATG7, -2.4, HEK293, 5 μM), (ATG7, -2.4, SHSY5Y, 5 μM), (ATG7, -
1.5, HEK293, 5 μM), (ATP5S, -1.7, HEK293, 0.5 μM), (ATP5S, -2.3, HEK293, 1 μM), (ATP5S, -6.3, SHSY5Y, 1 μM), (ATP5S, -2.2, HEK293, 2.5 μM), (ATP5S, -2.5, SHSY5Y, 2.5 μM), (ATP5S, -2.5, HEK293, 5 μM), (ATP5S, -8.5, SHSY5Y, 5 μM), (ATP5S, -2.1, HEK293, 5 μM), (ATP6V0A2, -1.4, HEK293, 0.5 μM), (ATP6V0A2, -1.2, HEK293, 1 μM), (ATP6V0A2, -
1.5, HEK293, 2.5 μM), (ATP6V0A2, -1.5, HEK293, 5 μM), (ATP6V0A2, -1.6, HEK293, 5 μM), (ATP6V0D1, -1.1, HEK293, 5 μM), (ATP9A, -2.4, HEK293, 0.5 μM), (ATP9A, -2, SHSY5Y, 0.5 μM), (ATP9A, -2.3, HEK293, 1 μM), (ATP9A, -3, SHSY5Y, 1 μM), (ATP9A, -
2.5, HEK293, 2.5 μM), (ATP9A, -2.5, HEK293, 5 μM), (ATP9A, -2, HEK293, 5 μM), (BABAM2, -1.5, HEK293, 0.5 μM), (BABAM2, -3.6, SHSY5Y, 0.5 μM), (BABAM2, -1.4,
HEK293, 1 μM), (BABAM2, -1.9, SHSY5Y, 1 μM), (BABAM2, -1.6, HEK293, 2.5 μM), (BABAM2, -3.1, SHSY5Y, 2.5 μM), (BABAM2, -1.9, HEK293, 5 μM), (BABAM2, -1.9, HEK293, 5 μM), (BBS4, -2.8, HEK293, 0.5 μM), (BBS4, -2.7, SHSY5Y, 0.5 μM), (BBS4, -2.5, HEK293, 1 μM), (BBS4, -3.3, SHSY5Y, 1 μM), (BBS4, -2.6, HEK293, 2.5 μM), (BBS4, -4.4, SHSY5Y, 2.5 μM), (BBS4, -3.4, HEK293, 5 μM), (BBS4, -3.4, SHSY5Y, 5 μM), (BBS4, -2.4, HEK293, 5 μM), (BCL2L13, -1.1, HEK293, 0.5 μM), (BCL2L13, -1, HEK293, 2.5 μM), (BCL2L13, -1.1, HEK293, 5 μM), (BCL2L13, -1.1, HEK293, 5 μM), (BICRAL, -1.3, HEK293, 5 μM), (BIRC5, -1.2, SHSY5Y, 5 μM), (BLM, -1.2, SHSY5Y, 1 μM), (BLM, -1.1, SHSY5Y, 2.5 μM), (BLM, -1, HEK293, 5 μM), (BLM, -1.2, SHSY5Y, 5 μM), (BLZF1, -1.8, HEK293, 0.5 μM), (BLZF1, -1.7, SHSY5Y, 0.5 μM), (BLZF1, -1.6, HEK293, 1 μM), (BLZF1, -1.9, HEK293, 2.5 μM), (BLZF1, -1.4, SHSY5Y, 2.5 μM), (BLZF1, -2, HEK293, 5 μM), (BLZF1, -1.6, HEK293, 5 μM), (BOLA3, -1.2, SHSY5Y, 0.5 μM), (BRSK2, -1.1, HEK293, 0.5 μM), (BRSK2, -4.3, SHSY5Y, 0.5 μM), (BRSK2, -1.2, HEK293, 2.5 μM), (BRSK2, -1.1, HEK293, 5 μM), (BTD, 1.2, SHSY5Y, 1 μM), (BTD, 1.2, SHSY5Y, 5 μM), (C10orfl43, -2.3, HEK293, 0.5 μM), (C10orfl43, -3, HEK293, 1 μM), (C10orfl43, -2.7, HEK293, 2.5 μM), (C10orfl43, -2.7, HEK293, 5 μM), (C12orf4, -1.1, SHSY5Y, 5 μM), (C15orf38-AP3S2, -1.7, SHSY5Y, 0.5 μM), (C15orf38-AP3S2, -1.3, SHSY5Y, 5 μM), (C19orf57, -1.3, HEK293, 0.5 μM), (C19orf57, -1.1, HEK293, 1 μM), (C4orf33, -1, HEK293, 0.5 μM), (C4orf33, -1, HEK293, 2.5 μM), (C4orf33, - 1.1, HEK293, 5 μM), (C5, -1.5, HEK293, 5 μM), (CACNA2D1, -1.6, HEK293, 0.5 μM), (CACNA2D1, -2.6, SHSY5Y, 0.5 μM), (CACNA2D1, -2, HEK293, 1 μM), (CACNA2D1, -2.2, SHSY5Y, 1 μM), (CACNA2D1, -2.1, HEK293, 2.5 μM), (CACNA2D1, -2.9, SHSY5Y, 2.5 μM), (CACNA2D1, -2.3, HEK293, 5 μM), (CACNA2D1, -2, SHSY5Y, 5 μM), (CACNA2D1, - 1.6, HEK293, 5 μM), (CAPS2, -1.8, HEK293, 0.5 μM), (CAPS2, -7.9, SHSY5Y, 0.5 μM), (CAPS2, -3.8, HEK293, 1 μM), (CAPS2, -8, SHSY5Y, 1 μM), (CAPS2, -1.6, HEK293, 2.5 μM), (CAPS2, -1.5, HEK293, 5 μM), (CBY1, -1.5, SHSY5Y, 5 μM), (CCDC18, -3.9, SHSY5Y, 0.5 μM), (CCDC25, -1.2, HEK293, 2.5 μM), (CCDC25, -1.2, HEK293, 5 μM), (CCDC88A, -1, HEK293, 1 μM), (CDC25C, -1.2, HEK293, 0.5 μM), (CDC25C, -1, HEK293, 1 μM), (CDC25C, -1.2, HEK293, 2.5 μM), (CDC25C, -1.2, SHSY5Y, 2.5 μM), (CDC25C, -1.3, HEK293, 5 μM), (CDC25C, -1.1, HEK293, 5 μM), (CDYL, -1.4, SHSY5Y, 0.5 μM), (CDYL, -1.1, HEK293, 1 μM), (CDYL, -2, SHSY5Y, 1 μM), (CDYL, -1, HEK293, 2.5 μM), (CDYL, -2.5, SHSY5Y, 2.5 μM), (CDYL, -1.1, HEK293, 5 μM), (CDYL, -2.1, SHSY5Y, 5 μM), (CDYL, -1.1, HEK293, 5 μM), (CELSR3, -1, HEK293, 1 μM), (CENPH, -1.6, HEK293, 0.5 μM), (CENPH, -1.8, SHSY5Y, 0.5 μM), (CENPH, -1.7, HEK293, 1 μM), (CENPH, -1.6, SHSY5Y, 1 μM), (CENPH, -1.9, HEK293, 2.5 μM), (CENPH, -2.3, SHSY5Y, 2.5 μM), (CENPH, -1.8, HEK293, 5 μM), (CENPH, -2.2, SHSY5Y, 5 μM), (CENPH, -1.6, HEK293, 5 μM), (CENP1, -1.9, HEK293, 0.5 μM), (CENPI, -3.1, SHSY5Y, 0.5 μM), (CENPI, -2.1, HEK293, 1 μM), (CENPI, -2.4, SHSY5Y, 1 μM), (CENPI, -2.3, HEK293, 2.5 μM), (CENPI, -2.3, SHSY5Y, 2.5 μM), (CENPI, -2.6, HEK293, 5 μM), (CENPI, -1.8, SHSY5Y, 5 μM), (CENPI, -2.1, HEK293, 5 μM), (CEP295, - 1.4, SHSY5Y, 2.5 μM), (CEP83, -1.4, HEK293, 0.5 μM), (CEP83, -1.7, HEK293, 1 μM), (CEP83, -1.6, HEK293, 2.5 μM), (CEP83, -1.8, HEK293, 5 μM), (CHD1L, -1.9, HEK293, 0.5 μM), (CHD1L, -2.5, SHSY5Y, 0.5 μM), (CHD1L, -2, HEK293, 1 μM), (CHD1L, -2, SHSY5Y, 1 μM), (CHD1L, -1.9, HEK293, 2.5 μM), (CHD1L, -2.4, SHSY5Y, 2.5 μM), (CHD1L, -2, HEK293, 5 μM), (CHD1L, -2.4, SHSY5Y, 5 μM), (CHD1L, -1.4, HEK293, 5 μM), (CHEK2, -2, HEK293, 0.5 μM), (CHEK2, -1.9, SHSY5Y, 0.5 μM), (CHEK2, -2.2, HEK293, 1 μM), (CHEK2, -2, SHSY5Y, 1 μM), (CHEK2, -2.5, HEK293, 2.5 μM), (CHEK2, -1.4, SHSY5Y, 2.5
μM), (CHEK2, -2.6, HEK293, 5 μM), (CHEK2, -2.7, SHSY5Y, 5 μM), (CHEK2, -1.7, HEK293, 5 μM), (CNIH3, -2.4, HEK293, 0.5 μM), (CNIH3, -2.7, HEK293, 2.5 μM), (CNIH3, -2.4, HEK293, 5 μM), (CPXM1, -1.8, SHSY5Y, 0.5 μM), (CPXM1, -1.5, SHSY5Y, 1 μM), (CPXM1, -1.4, SHSY5Y, 2.5 μM), (CRELD1, -2.1, HEK293, 0.5 μM), (CRELD1, -1.7, HEK293, 1 μM), (CRELD1, -2.2, HEK293, 2.5 μM), (CRELD1, -1.7, HEK293, 5 μM), (CRELD1, -1.2, HEK293, 5 μM), (CRYBG3, -1.6, SHSY5Y, 0.5 μM), (CRYBG3, -1, HEK293, 1 μM), (CXorf38, 1.6, SHSY5Y, 5 μM), (CYP2U1, -1.5, HEK293, 0.5 μM), (CYP2U1, -1.2, HEK293, 1 μM), (CYP2U1, -1.4, HEK293, 2.5 μM), (CYP2U1, -1.3, HEK293, 5 μM), (CYP2U1, -1.8, HEK293, 5 μM), (DAAM1, -1.4, HEK293, 0.5 μM), (DAAM1, -2.2, SHSY5Y, 0.5 μM), (DAAM1, -1.4, HEK293, 1 μM), (DAAM1, -2.1, SHSY5Y, 1 μM), (DAAM1, -1.9, HEK293, 2.5 μM), (DAAM1, -2, SHSY5Y, 2.5 μM), (DAAM1, -1.8, HEK293, 5 μM), (DAAM1, -1.4, SHSY5Y, 5 μM), (DAAM1, -1.3, HEK293, 5 μM), (DAPK1, -1.2, HEK293, 0.5 μM), (DAPK1, -1.3, HEK293, 1 μM), (DAPK1, -1.3, SHSY5Y, 1 μM), (DAPK1, -1.1, HEK293, 2.5 μM), (DAPK1, -
1.4, SHSY5Y, 2.5 μM), (DAPK1, -1.4, HEK293, 5 μM), (DAPK1, -1.4, SHSY5Y, 5 μM), (DCAF17, -1.1, SHSY5Y, 5 μM), (DCP1B, -2.6, SHSY5Y, 0.5 μM), (DDC, -2.2, SHSY5Y, 0.5 μM), (DDC, -2, SHSY5Y, 1 μM), (DDC, -2.1, SHSY5Y, 2.5 μM), (DDC, -2.6, SHSY5Y, 5 μM), (DDX11, -1.2, SHSY5Y, 1 μM), (DDX11, -1.2, SHSY5Y, 2.5 μM), (DDX19B, -1.3, SHSY5Y, 1 μM), (DDX19B, -1.9, SHSY5Y, 5 μM), (DEAF1, -1.1, SHSY5Y, 0.5 μM), (DEAF1, -1.6, SHSY5Y, 1 μM), (DEAF1, -1.1, SHSY5Y, 2.5 μM), (DECR2, -1.2, HEK293, 0.5 μM), (DECR2, -1.7, SHSY5Y, 0.5 μM), (DECR2, -2.4, SHSY5Y, 1 μM), (DECR2, -1.3, HEK293, 2.5 μM), (DECR2, -2.3, SHSY5Y, 2.5 μM), (DECR2, -1.4, HEK293, 5 μM), (DECR2, -1.4, HEK293, 5 μM), (DENND3, -1.1, HEK293, 0.5 μM), (DENND4B, -1.3, SHSY5Y, 0.5 μM), (DENND4C, -1.1, SHSY5Y, 1 μM), (DENND5A, -1.7, HEK293, 0.5 μM), (DENND5A, - 2.8, SHSY5Y, 0.5 μM), (DENND5A, -1.9, HEK293, 1 μM), (DENND5A, -2.9, SHSY5Y, 1 μM), (DENND5A, -1.8, HEK293, 2.5 μM), (DENND5A, -2.5, SHSY5Y, 2.5 μM), (DENND5A, -2, HEK293, 5 μM), (DENND5A, -2.1, SHSY5Y, 5 μM), (DENND5A, -1.6, HEK293, 5 μM), (DESI1, -2.6, SHSY5Y, 1 μM), (DGKA, -2.9, HEK293, 0.5 μM), (DGKA, -2.5, SHSY5Y, 0.5 μM), (DGKA, -2.2, HEK293, 1 μM), (DGKA, -3, SHSY5Y, 1 μM), (DGKA, -2.9, HEK293, 2.5 μM), (DGKA, -5.8, SHSY5Y, 2.5 μM), (DGKA, -2.2, HEK293, 5 μM), (DGKA, -3.1, SHSY5Y, 5 μM), (DGKA, -1.7, HEK293, 5 μM), (DGKI, -1.5, SHSY5Y, 0.5 μM), (DGKI, -1.4, SHSY5Y, 2.5 μM), (DGKI, -1.1, SHSY5Y, 5 μM), (DGKZ, -1.1, SHSY5Y, 1 μM), (DHPS, -1.1, SHSY5Y, 1 μM), (DHPS, -1, SHSY5Y, 5 μM), (DHRS12, 2.5, SHSY5Y, 0.5 μM), (DHRS12,
2.5, SHSY5Y, 1 μM), (DHRS12, 2.1, SHSY5Y, 2.5 μM), (DHRS12, 2.1, SHSY5Y, 5 μM), (DIMT1, -2.4, HEK293, 0.5 μM), (DIMT1, -2.5, SHSY5Y, 0.5 μM), (DIMT1, -2.5, HEK293, 1 μM), (DIMT1, -2.6, SHSY5Y, 1 μM), (D1MT1, -3, HEK293, 2.5 μM), (DIMT1, -2.7, SHSY5Y, 2.5 μM), (DIMT1, -3, HEK293, 5 μM), (DIMT1, -2.9, SHSY5Y, 5 μM), (DIMT1, -2.6, HEK293, 5 μM), (DLST, -1, SHSY5Y, 0.5 μM), (DLST, -1.1, HEK293, 1 μM), (DLST, -1.2, HEK293, 2.5 μM), (DLST, -1.3, HEK293, 5 μM), (DLST, -1.2, SHSY5Y, 5 μM), (DMXL2, -1, HEK293, 0.5 μM), (DMXL2, -1.2, HEK293, 1 μM), (DMXL2, -1.2, HEK293, 2.5 μM), (DMXL2, -1.3, HEK293, 5 μM), (DNA2, -1.1, SHSY5Y, 5 μM), (DNAJB12, -1.7, HEK293, 0.5 μM), (DNAJB12, -3.1, SHSY5Y, 0.5 μM), (DNAJB12, -1.4, HEK293, 1 μM), (DNAJB12, -1.7, SHSY5Y, 1 μM), (DNAJB12, -1.5, HEK293, 2.5 μM), (DNAJB12, -2.5, SHSY5Y, 2.5 μM), (DNAJB12, -1.6, HEK293, 5 μM), (DNAJB12, -3.5, SHSY5Y, 5 μM), (DNAJB12, -1.6, HEK293, 5 μM), (DNAJC4, -1.1, HEK293, 1 μM), (DOCK11, -1.1, HEK293, 0.5 μM), (DOCK11, -1.2, HEK293, 1 μM), (DOCK11, -1.2, SHSY5Y, 1 μM), (DOCK11, -1.1, HEK293,
2.5 μM), (D0CK11, -1.4, SHSY5Y, 2.5 μM), (DOCK11, -1.3, HEK293, 5 μM), (DOCK11, -1.1, SHSY5Y, 5 μM), (DOCK11, -1.1, HEK293, 5 μM), (DOPEY1, -1.4, SHSY5Y, 0.5 μM), (DOPEY1, -1.2, HEK293, 1 μM), (DOPEY1, -1.3, SHSY5Y, 1 μM), (DOPEY1, -1, SHSY5Y,
2.5 μM), (DOPEY1, -1, HEK293, 5 μM), (DOPEY1, -1.3, SHSY5Y, 5 μM), (DOT1L, -1.7, SHSY5Y, 1 μM), (DPY19L3, 1, SHSY5Y, 0.5 μM), (DPY19L3, 1, HEK293, 2.5 μM), (DTNB, -1.1, HEK293, 5 μM), (DTNB, -4.5, SHSY5Y, 5 μM), (DYM, -1.1, SHSY5Y, 5 μM), (DYNC2LI1, -1.2, HEK293, 5 μM), (DZIP3, -1.4, SHSY5Y, 0.5 μM), (DZIP3, -1.1, HEK293, 5 μM), (ELN, -3.2, SHSY5Y, 0.5 μM), (EMC2, -1.6, HEK293, 0.5 μM), (EMC2, -2, SHSY5Y, 0.5 μM), (EMC2, -1.7, HEK293, 1 μM), (EMC2, -2.6, SHSY5Y, 1 μM), (EMC2, -1.7, HEK293,
2.5 μM), (EMC2, -2.5, SHSY5Y, 2.5 μM), (EMC2, -2, HEK293, 5 μM), (EMC2, -2.3, SHSY5Y, 5 μM), (EMC2, -1.8, HEK293, 5 μM), (EML4, -1.4, SHSY5Y, 0.5 μM), (EML4, -1.9, SHSY5Y, 1 μM), (EML4, -1.9, SHSY5Y, 2.5 μM), (EML4, -1.7, SHSY5Y, 5 μM), (EML6, - 2.9, SHSY5Y, 0.5 μM), (EML6, -1.1, HEK293, 1 μM), (EML6, -1, HEK293, 5 μM), (ENDOV, -1.8, SHSY5Y, 1 μM), (ENDOV, -1.8, SHSY5Y, 2.5 μM), (EOGT, -1, HEK293, 1 μM), (EOGT, -1, HEK293, 2.5 μM), (EOGT, -1.4, HEK293, 5 μM), (EOGT, -1.2, HEK293, 5 μM), (EPB41L4A, -1.2, HEK293, 0.5 μM), (EPB41L4A, -1.1, HEK293, 5 μM), (EPG5, -1.3, SHSY5Y, 0.5 μM), (EPG5, -1, SHSY5Y, 2.5 μM), (EPS8, -2.6, HEK293, 0.5 μM), (EPS8, -2.2, SHSY5Y, 0.5 μM), (EPS8, -2.3, HEK293, 1 μM), (EPS8, -2.4, SHSY5Y, 1 μM), (EPS8, -2.7, HEK293, 2.5 μM), (EPS8, -2.9, SHSY5Y, 2.5 μM), (EPS8, -3, HEK293, 5 μM), (EPS8, -2, SHSY5Y, 5 μM), (EPS8, -2.3, HEK293, 5 μM), (ERGIC1, -1.4, HEK293, 0.5 μM), (ERGIC1, - 2.5, SHSY5Y, 0.5 μM), (ERGIC1, -1.4, HEK293, 1 μM), (ERGIC1, -1.3, SHSY5Y, 1 μM), (ERGIC1, -1.7, HEK293, 2.5 μM), (ERGIC1, -1.1, SHSY5Y, 2.5 μM), (ERGIC1, -2, HEK293, 5 μM), (ERGIC1, -1.2, SHSY5Y, 5 μM), (ERGIC1, -2.1, HEK293, 5 μM), (ETHE1, -1.1, HEK293, 0.5 μM), (ETHE1, -2.3, SHSY5Y, 0.5 μM), (ETHE1, -1.1, HEK293, 1 μM), (ETHE1, -1.6, SHSY5Y, 1 μM), (ETHE1, -1.3, HEK293, 2.5 μM), (ETHE1, -1.6, SHSY5Y, 2.5 μM), (ETHE1, -1.2, HEK293, 5 μM), (EXD2, -1, HEK293, 2.5 μM), (EXOC3, -1.8, HEK293, 0.5 μM), (EXOC3, -2, SHSY5Y, 0.5 μM), (EXOC3, -1.7, HEK293, 1 μM), (EXOC3, -3.6, SHSY5Y, 1 μM), (EXOC3, -1.8, HEK293, 2.5 μM), (EXOC3, -1.9, SHSY5Y, 2.5 μM), (EXOC3, -1.6, HEK293, 5 μM), (EXOC3, -1.7, SHSY5Y, 5 μM), (F8, -1.4, HEK293, 0.5 μM), (F8, -4, HEK293, 1 μM), (F8, -2.3, HEK293, 2.5 μM), (F8, -2.6, HEK293, 5 μM), (F8, -2.9, HEK293, 5 μM), (FAM114A2, -1.3, SHSY5Y, 0.5 μM), (FAM114A2, -1.1, SHSY5Y, 1 μM), (FAM114A2, -1.3, SHSY5Y, 2.5 μM), (FAM208A, -1.2, SHSY5Y, 0.5 μM), (FAM208A, -1.3, SHSY5Y, 1 μM), (FAM208A, -1.5, SHSY5Y, 2.5 μM), (FAM208A, -1.1, HEK293, 5 μM), (FAM208A, -1.3, SHSY5Y, 5 μM), (FANCA, -1.2, HEK293, 1 μM), (FANCA, -1.1, HEK293,
2.5 μM), (FANCA, -1.1, HEK293, 5 μM), (FANCI, -1.9, HEK293, 0.5 μM), (FANCI, -2.3, SHSY5Y, 0.5 μM), (FANCI, -2, HEK293, 1 μM), (FANCI, -3, SHSY5Y, 1 μM), (FANCI, -2.3, HEK293, 2.5 μM), (FANCI, -2.7, SHSY5Y, 2.5 μM), (FANCI, -2.2, HEK293, 5 μM), (FANCI, -2.5, SHSY5Y, 5 μM), (FANCI, -1.5, HEK293, 5 μM), (FANCL, -2.1, HEK293, 0.5 μM), (FANCL, -1.7, SHSY5Y, 0.5 μM), (FANCL, -2.2, HEK293, 1 μM), (FANCL, -2.2, SHSY5Y, 1 μM), (FANCL, -2.7, HEK293, 2.5 μM), (FANCL, -1.8, SHSY5Y, 2.5 μM), (FANCL, -2.5, HEK293, 5 μM), (FANCL, -4.5, SHSY5Y, 5 μM), (FANCL, -1.8, HEK293, 5 μM), (FBXO9, - 1.4, SHSY5Y, 0.5 μM), (FBXO9, -1.5, SHSY5Y, 1 μM), (FBXO9, -1.7, SHSY5Y, 2.5 μM), (FBXO9, -1.6, SHSY5Y, 5 μM), (FBXW8, -1.6, SHSY5Y, 0.5 μM), (FGGY, -2.1, HEK293, 0.5 μM), (FGGY, -2.3, HEK293, 2.5 μM), (FGGY, -1.9, HEK293, 5 μM), (FGGY, -3.6, HEK293, 5 μM), (FIG4, -1.5, HEK293, 0.5 μM), (FIG4, -1.4, SHSY5Y, 0.5 μM), (FIG4, -1.6, HEK293, 1
|1M), (FIG4, -1.8, HEK293, 2.5 μM), (FIG4, -1.2, SHSY5Y, 2.5 μM), (FIG4, -2, HEK293, 5 |1M), (FIG4, -1.6, SHSY5Y, 5 μM), (FIG4, -1.6, HEK293, 5 μM,) (F0XRED1, -1.3, HEK293, 0.5 μM), (FOXRED1, -1.4, SHSY5Y, 0.5 μM), (FOXRED1, -1.2, HEK293, 1 μM), (FOXRED1, -1.5, SHSY5Y, 1 nM), (FOXRED1, -1.5, HEK293, 2.5 μM), (FOXRED1, -1.3, SHSY5Y, 2.5 |1M), (FOXRED1, -1.9, HEK293, 5 μM), (FOXRED1, -1.5, SHSY5Y, 5 μM), (FXR2, -1.2, SHSY5Y, 0.5 gM), (FXR2, -1.1, SHSY5Y, 1 μM), (FXR2, -1.3, SHSY5Y, 2.5 μM), (GALNT6, -1.2, HEK293, 1 μM), (GALNT6, -2.2, SHSY5Y, 1 μM,) (GALNT6, -1.2, HEK293, 2.5 gM), (GALNT6, -1.8, SHSY5Y, 2.5 μM), (GALNT6, -3, SHSY5Y, 5 μM), (GALNT6, -1.2, HEK293, 5 nM), (GARNL3, -1.3, HEK293, 0.5 μM), (GARNL3, -1.2, HEK293, 2.5 μM,) (GDPD5, -1.1, HEK293, 2.5 μM), (GEMIN2, -1.2, HEK293, 0.5 μM), (GEMIN2, -1.3, HEK293, 2.5 μM), (GEMTN2, -1.4, HEK293, 5 μM), (GEMTN2, -1.3, HEK293, 5 μM), (GFM2, -1.1, SHSY5Y, 5 |1M), (GLB1, -1.1, SHSY5Y, 0.5 μM), (GLB1, -1.1, HEK293, 2.5 μM), (GLB1, -1.2, SHSY5Y, 2.5 μM), (GLB1, -1.1, HEK293, 5 μM), (GLB1, -1.2, HEK293, 5 μM), (GNPTG, -1.1, HEK293, 0.5 nM), (GNPTG, -2.3, SHSY5Y, 0.5 μM), (GNPTG, -1.1, HEK293, 2.5 ^M), (GOLGA2, -1.5, SHSY5Y, 0.5 μM), (GPR155, -1.2, HEK293, 5 μM), (GPR155, -1.6, HEK293, 5 gM), (GTF2I, - 2.2, HEK293, 0.5 gM), (GTF21, -2.8, SHSY5Y, 0.5 gM), (GTF21, -2.4, HEK293, 1 μM, ) (GTF2I, -2.7, SHSY5Y, 1 μM), (GTF2I, -2.8, HEK293, 2.5 μM), (GTF2I, -3.2, SHSY5Y, 2.5 |1M), (GTF2I, -2.7, HEK293, 5 μM), (GTF2I, -2.7, SHSY5Y, 5 μM), (GTF2I, -2, HEK293, 5 μM), (GTF2IP1, -1.9, SHSY5Y, 0.5 μM,) (GTF2IP1, -1.8, HEK293, 1 μM, ()GTF2IP1, -2.4, HEK293, 2.5 μM), (GTF2IP1, -1.9, SHSY5Y, 2.5 gM), (GTF2IP1, -1.5, HEK293, 5 gM), (GTF2IP1, -1.5, SHSY5Y, 5 ^M), (GTF2IP1, -2.1, HEK293, 5 gM), (GTF2IP4, -1.9, SHSY5Y, 0.5 μM), (GTF2IP4, -1.8, HEK293, 1 gM), (GTF2IP4, -2.4, HEK293, 2.5 gM), (GTF2IP4, -1.9, SHSY5Y, 2.5 μM), (GTF2IP4, -1.5, HEK293, 5 μM), (GTF2IP4, -1.5, SHSY5Y, 5 μM), (GTF2IP4, -2.1, HEK293, 5 μM), (HACL1, -1.4, HEK293, 0.5 gM), (HACL1, -1.5, SHSY5Y, 0.5 piM), (HACL1, -1.1, HEK293, 1 μM), (HACL1, -1.3, HEK293, 2.5 μM), (HACL1, -1.4, SHSY5Y, 2.5 gM), (HACL1, -1.4, HEK293, 5 ^M), (HACL1, -1.1, HEK293, 5 μM,) (HEATR5B, -1.4, SHSY5Y, 2.5 ^M), (HEATR5B, -1.1, SHSY5Y, 5 μM), (HERC2, -1.6, HEK293, 0.5 μM), (HERC2, -2.6, SHSY5Y, 0.5 μM,) (HERC2, -1.6, HEK293, 1 ^M), (HERC2, -2.7, SHSY5Y, 1 μM), (HERC2, -1.7, HEK293, 2.5 gM), (HERC2, -1.5, HEK293, 5 gM), (HERC3, 1.6, SHSY5Y, 1 gM), (HIBADH, -1, HEK293, 0.5 gM), (HOGA1, -7.9, SHSY5Y, 0.5 |1M), (HOOK3, -1.8, SHSY5Y, 1 μM), (HPS3, -1, HEK293, 1 μM), (HPS3, -1.1, HEK293, 2.5 gM), (HPS3, -1.1, HEK293, 5 μM), (HSD17B4, -1.5, HEK293, 0.5 μM), (HSD17B4, -1.6, SHSY5Y, 0.5 μM), (HSD17B4, -1.6, HEK293, 1 μM,) (HSD17B4, -1.6, SHSY5Y, 1 μM, ) (HSD17B4, -1.5, HEK293, 2.5 μM), (HSD17B4, -1.7, SHSY5Y, 2.5 ^M), (HSD17B4, -1.6, HEK293, 5 μM), (HSD17B4, -1.3, SHSY5Y, 5 μM,) (HSD17B4, -1.3, HEK293, 5 μM, ) (HYAL3, -1, HEK293, 1 μM), (HYAL3, -1, HEK293, 2.5 μM), (ICA1L, -2.2, SHSY5Y, 0.5 |1M), (IFI27L1, -1, HEK293, 0.5 μM), (IFI27L1, -4.5, SHSY5Y, 5 gM), (IFT172, -1.4, SHSY5Y, 0.5 gM), (IFT172, -1.2, SHSY5Y, 1 ^M), (IKBKB, -1.4, SHSY5Y, 1 μM,) (IL11RA, -1.1, HEK293, 2.5 μM), (IMMP1L, -1.6, SHSY5Y, 5 μM), (INTU, -1.5, HEK293, 1 μM), (IQCB1, -1.6, SHSY5Y, 2.5 gM), (IQCB1, -1.6, SHSY5Y, 5 μM), (IQCG, -1.7, HEK293, 0.5 |1M), (IQCG, -1.1, HEK293, 1 ^M), (IQCG, -2.3, SHSY5Y, 1 μM), (IQCG, -1.3, HEK293, 2.5 μM), (IQCG, -1.2, HEK293, 5 μM), (IQCH, -1.4, HEK293, 2.5 μM), (IQCH, -1.9, HEK293, 5 gM), (IQCH, -1.4, HEK293, 5 μM), (IQSEC1, -2.1, SHSY5Y, 0.5 gM), (ITGA3, -1, HEK293, 5 ^M), (KATNAL2, -1.9, HEK293, 5 ^M), (KCNT2, -1.6, HEK293, 0.5 μM), (KCNT2, -1.4, SHSY5Y, 0.5 gM), (KCNT2, -1.4, HEK293, 1 ^M), (KCNT2, -1.7, SHSY5Y, 1 μM,) (KCNT2,
-1.7, HEK293, 2.5 μM), (KCNT2, -2.4, SHSY5Y, 2.5 gM), (KCNT2, -1.7, HEK293, 5 ^M), (KCNT2, -1.5, SHSY5Y, 5 μM), (KIAA0319L, -1.3, SHSY5Y, 0.5 μM,)(KIAA0319L, -1, SHSY5Y, 2.5 μM), (KIAA0319L, -1, HEK293, 5 μM), (KIAA0556, -1.7, HEK293, 0.5 μM), (KIAA0556, -1.5, HEK293, 1 gM), (KIAA0556, -1.7, HEK293, 2.5 gM), (KIAA0556, -1.7, HEK293, 5 μM), (KIAA0556, -1.2, HEK293, 5 μM), (KIAA0825, -8, SHSY5Y, 5 μM), (KIF9, - 3.6, SHSY5Y, 1 μM), (KLHDC4, -1, SHSY5Y, 0.5 μM), (KLHDC4, -1.1, SHSY5Y, 1 μM), (KMT5C, -2.1, SHSY5Y, 1 μM), (KYAT3, -1.1, HEK293, 5 μM,) (L3MBTL2, -1.6, SHSY5Y, 0.5 μM), (L3MBTL2, -1.4, SHSY5Y, 1 ^M), (LAMA3, -1.2, HEK293, 0.5 μM), (LAMA3, -1.2, HEK293, 1 μM), (LAMA3, -1.2, HEK293, 2.5 ^M), (LAMA3, -1.6, HEK293, 5 μM), (LAS1L, -
1.2, SHSY5Y, 2.5 μM), (LCORL, 1.4, SHSY5Y, 0.5 μM), (LCORL, 1.2, SHSY5Y, 1 μM), (LIG1, -1.1,HEK293, 0.5 μM), (LTG1, -1.1,HEK293, 2.5 μM), (LIG1, -1.1,HEK293, 5 ^M), (LGC100506844, -1.7, HEK293, 0.5 μM), (LOCI 00506844, -2.1, SHSY5Y, 0.5 μM), (LOC100506844, -1.5, HEK293, 1 μM), (LOCI 00506844, -1.9, SHSY5Y, 1 μM), (LOC100506844, -2.1, HEK293, 2.5 μM), (LOCI 00506844, -1.9, SHSY5Y, 2.5 μM,) (LOC100506844, -2.1, HEK293, 5 μM), (LOCI 00506844, -2.1, SHSY5Y, 5 μM), (LOC100506844, -2.5, HEK293, 5 μM), (LOCI 00507291, -2.4, HEK293, 0.5 μM,) (LOC100507291, -2.1, HEK293, 5 μM), (LOCI 01927027, -1.3, HEK293, 1 μM),
(LOCI 01927027, -1.6, HEK293, 5 μM), (LOCI 01927027, -1.5, HEK293, 5 μM), (LOC102606465, -1.7, HEK293, 0.5 μM), (LOCI 02606465, -2.7, HEK293, 1 μM,) (LOCI 02606465, -1.4, HEK293, 2.5 μM), (LOCI 02606465, -2.5, HEK293, 5 μM), (LOC102606465, -2.8, HEK293, 5 μM), (LOCI 02724532, -1.8, HEK293, 0.5 μM,) (LOC102724532, -2.3, HEK293, 1 μM), (LOCI 02724532, -2.3, HEK293, 2.5 μM), (LOC102724532, -2.6, HEK293, 5 μM), (LOCI 02724532, -8.5, SHSY5Y, 5 μM), (LOC399815,
1.3, HEK293, 5 gM), (LRRC34, -1, HEK293, 5 μM), (LRSAM1, -1.2, SHSY5Y, 0.5 μM), (LRSAM1, -1.8, SHSY5Y, 1 μM), (LRSAM1, -1.2, SHSY5Y, 2.5 μM), (LRSAM1, -1.2, HEK293, 5 μM), (LRTOMT, -1, HEK293, 5 gM), (LSS, -1, SHSY5Y, 1 μM, ()LSS, -1.1, HEK293, 2.5 μM), (LSS, -1, HEK293, 5 μM), (LYST, -1.1, HEK293, 1 gM), (MAGI2-AS3, - 1.1, HEK293, 1 μM), (MAGI2-AS3, -1.2, HEK293, 2.5 gM), (MAGI2-AS3, -1.1, HEK293, 5 gM), (MAGI2-AS3, -1.3, HEK293, 5 gM), (MAP2, -1.3, SHSY5Y, 1 μM), (MAP2, -1.2, SHSY5Y, 5 μM), (MAP3K5, -1.3, SHSY5Y, 1 μM), (MAP3K5, -1.2, SHSY5Y, 2.5 μM), (MAPK11, -4.8, SHSY5Y, 1 μM), (MBOAT2, -1.1, SHSY5Y, 0.5 μM), (MBOAT2, -1.1, HEK293, 1 μM), (MBOAT2, -1.1, HEK293, 2.5 gM), (MBOAT2, -1.1, SHSY5Y, 2.5 μM), (MBOAT2, -1.2, HEK293, 5 μM), (MBOAT2, -1.3, HEK293, 5 μM), (MCOLN1, 1.2, SHSY5Y, 2.5 μM), (MCOLN1, 1.5, SHSY5Y, 5 μM), (MCOLN1, 1, HEK293, 5 μM), (MCOLN3, -1.3, HEK293, 0.5 μM), (MCOLN3, -1.4, HEK293, 2.5 μM,) (MCOLN3, -1.2, HEK293, 5 μM, ) (MEGF8, -1.1, HEK293, 2.5 ^M), (MEGF8, -1, HEK293, 5 μM), (MEIS1, -1.9, SHSY5Y, 1 |1M), (MELTF, -1.4, HEK293, 1 μM), (MELTF, -1.9, SHSY5Y, 1 μM), (MELTF, -1.4, HEK293, 5 μM), (MIATNB, -1.7, HEK293, 5 μM,) (MICAL1, -2.5, SHSY5Y, 0.5 gM), (MICAL1, -1.2, HEK293, 1 μM), (MICAL1, -1.6, SHSY5Y, 1 gM), (MICAL1, -1.3, HEK293, 2.5 nM), (MICAL1, -1.6, SHSY5Y, 2.5 μM), (MICAL1, -1.5, HEK293, 5 ^M), (MICAL1, -1, SHSY5Y, 5 μM), (MIR924HG, -1.1, HEK293, 5 μM), (MKS1, -1.1, HEK293, 0.5 μM), (MKS1, -1.1, HEK293, 1 μM), (MKS1, -1.4, HEK293, 2.5 μM), (MKS1, -1.2, HEK293, 5 μM), (MLH1, -1.4, SHSY5Y, 0.5 μM), (MLH1, -1.6, SHSY5Y, 1 μM), (MLH1, -1.6, SHSY5Y, 2.5 μM), (MLH1, -2.4, SHSY5Y, 5 μM), (MMAB, -1.1, HEK293, 2.5 μM), (MMAB, -1.5, SHSY5Y, 2.5 gM), (MMAB, -1.2, HEK293, 5 ^M), (MMAB, -1.5, SHSY5Y, 5 μM,) (MOSPD2, -1.6,
HEK293, 0.5 μM), (MOSPD2, -6.1, SHSY5Y, 0.5 ^M), (MOSPD2, -1.8, HEK293, 1 μM), (MOSPD2, -2, HEK293, 2.5 gM), (MOSPD2, -1.9, HEK293, 5 μM,) (MOSPD2, -1.9, HEK293, 5 μM), (MRPL43, -1.1, SHSY5Y, 5 μM), (MRRF, -1.3, SHSY5Y, 2.5 μM), (MYLK, -1.5, HEK293, 1 μM), (MYLK, -2.7, SHSY5Y, 1 μM), (MYLK, -1.4, HEK293, 2.5 μM), (MYLK, - 1.6, HEK293, 5 gM), (MYLK, -1.7, HEK293, 5 μM), (MYO5C, -1.1, HEK293, 0.5 μM), (MYO5C, -4.3, SHSY5Y, 0.5 μM), (MYO5C, -1.1, HEK293, 1 μM), (MYO5C, -1, HEK293, 5 gM), (MYOM2, -1.4, HEK293, 0.5 gM), (MYOM2, -1.3, HEK293, 1 μM,) (MYOM2, -1.1, HEK293, 5 μM), (MYOM2, -1.4, HEK293, 5 μM), (NARS2, -1, HEK293, 0.5 μM), (NARS2, - 1.3, SHSY5Y, 2.5 μM), (NBPF9, -1.9, SHSY5Y, 0.5 μM,) (NDUFB6, -1.1, SHSY5Y, 5 μM), (NECAB3, -1.4, HEK293, 0.5 μM), (NECAB3, -1.8, HEK293, 1 μM), (NECAB3, -1.7, HEK293, 2.5 μM), (NECAB3, -2.4, SHSY5Y, 2.5 piM), (NECAB3, -1.7, HEK293, 5 μM), (NEK1, -1.8, HEK293, 0.5 μM), (NEK1, -2.3, SHSY5Y, 0.5 μM), (NEK1, -1.9, HEK293, 1 |1M), (NEK1, -2.2, SHSY5Y, 1 μM), (NEK1, -1.8, HEK293, 2.5 gM), (NEK1, -2.5, SHSY5Y, 2.5 nM), (NEK1, -2.1, HEK293, 5 μM), (NEK1, -2.4, SHSY5Y, 5 gM), (NEK1, -1.5, HEK293, 5 μM), (NFATC2IP, -3.6, SHSY5Y, 1 μM), (NFATC2IP, -1, HEK293, 2.5 μM), (NFATC2IP, -
1.8, SHSY5Y, 2.5 μM), (NFATC21P, -1, HEK293, 5 μM,)(NFATC2IP, -1.6, SHSY5Y, 5 μM), (NMNAT1, -1.2, HEK293, 1 μM), (NOX4, -2.8, SHSY5Y, 1 μM), (NTRK1, -3.3, SHSY5Y, 5 |1M), (NUBPL, -1.1, HEK293, 2.5 μM), (NUBPL, -1.2, SHSY5Y, 2.5 μM), (NUP43, -1.8, SHSY5Y, 0.5 gM), (NUP43, -1.3, SHSY5Y, 1 μM,) (NUP43, -1.3, SHSY5Y, 2.5 μM, ()NUP43, -1.4, SHSY5Y, 5 μM), (NUP58, -1.1, SHSY5Y, 0.5 μM), (NUP58, -1, SHSY5Y, 1 μM,) (NUP58, -1.3, SHSY5Y, 2.5 μM), (NUP58, -1.4, SHSY5Y, 5 μM,) (NUPL2, -1.2, HEK293, 0.5 |1M), (NUPL2, -1.2, SHSY5Y, 0.5 μM), (NUPL2, -1.2, HEK293, 1 μM), (NUPL2, -1.1, SHSY5Y, 1 gM), (NUPL2, -1.2, HEK293, 2.5 μM), (NUPL2, -1.4, SHSY5Y, 2.5 μM), (NUPL2, -1.3, HEK293, 5 gM), (NUPL2, -1.3, SHSY5Y, 5 μM), (NUPL2, -1.3, HEK293, 5 |1M), (OARD1, -1.7, SHSY5Y, 0.5 μM), (OARD1, -1.2, HEK293, 5 μM,) (OARD1, -1.5, SHSY5Y, 5 μM), (OARD1, -1.5, HEK293, 5 μM,) (OAZ1, -1.1, HEK293, 2.5 μM, ()OAZ1, - 1.1, HEK293, 5 gM), (OAZ1, -1, HEK293, 5 μM), (OGGI, -1.2, SHSY5Y, 0.5 μM), (OGT, 1.1, SHSY5Y, 0.5 μM), (OLMALINC, -3.6, HEK293, 0.5 μM), (OLMALINC, -3.1, HEK293, 1 |1M), (OLMALINC, -3.9, HEK293, 2.5 gM), (OLMALINC, -4.8, HEK293, 5 μM), (OLMALINC, -5.4, HEK293, 5 gM), (OTUD5, -1.3, HEK293, 0.5 μM), (OTUD5, -1.3, HEK293, 1 μM), (OTUD5, -1.2, HEK293, 2.5 gM), (OTUD5, -1.2, HEK293, 5 μM,) (OXCT1, - 1.3, SHSY5Y, 0.5 μM), (OXCT1, -1.2, SHSY5Y, 1 μM), (OXCT1, -1.1, HEK293, 5 gM), (OXCT1, -1.4, SHSY5Y, 5 μM), (P2RX4, -1.5, HEK293, 0.5 μM,) (P2RX4, -1.2, HEK293, 1 gM), (P2RX4, -1.1, HEK293, 2.5 μM), (P2RX4, -1.4, HEK293, 5 μM), (P2RX4, -1.1, HEK293, 5μM), (PAAF1, -1, HEK293, 2.5 μM), (PAAF1, -1.2, HEK293, 5 gM), (PAAF1, -1.4, SHSY5Y, 5 μM), (PAAF1, -1.1, HEK293, 5 gM), (PARPBP, 1.2, SHSY5Y, 0.5 μM), (PARVB, -1.1, SHSY5Y, 0.5 μM), (PARVB, -1.2, HEK293, 5 μM,) (PARVB, -1.3, SHSY5Y, 5 μM), (PCCB, -1.6, HEK293, 0.5 μM), (PCCB, -1, SHSY5Y, 0.5 μM,) (PCCB, -1.5, HEK293, 1 gM), (PCCB, -1.2, SHSY5Y, 1 μM), (PCCB, -1.6, HEK293, 2.5 μM), (PCCB, -1.4, SHSY5Y, 2.5 |1M), (PCCB, -1.8, HEK293, 5 μM,) (PCCB, -1.5, SHSY5Y, 5 μM,) (PCCB, -1.5, HEK293, 5 |1M), (PCID2, -2.1, HEK293, 0.5 μM), (PCID2, -2.4, SHSY5Y, 0.5 μM), (PCID2, -1.9, HEK293, 1 μM), (PCID2, -2.3, SHSY5Y, 1 μM), (PCID2, -2.7, HEK293, 2.5 ^M), (PCID2, -
2.9, SHSY5Y, 2.5 μM), (PCID2, -2.8, HEK293, 5 gM), (PCID2, -2.3, SHSY5Y, 5 μM), (PCID2, -2.2, HEK293, 5 μM), (PDIA5, -1.9, HEK293, 0.5 ^M), (PDIA5, -2.6, SHSY5Y, 0.5 gM), (PDIA5, -2, HEK293, 1 μM), (PDIA5, -2.4, SHSY5Y, 1 μM,) (PDIA5, -1.7, HEK293, 2.5
μM), (PDIA5, -2.1, SHSY5Y, 2.5 μM), (PDIA5, -1.9, HEK293, 5 μM), (PDIA5, -2.5, SHSY5Y, 5 μM), (PDIA5, -1.9, HEK293, 5 μM), (PEX6, -1.3, HEK293, 0.5 μM), (PEX6, -1.5, SHSY5Y, 0.5 μM), (PEX6, -1.2, HEK293, 1 μM), (PEX6, -1.2, SHSY5Y, 1 μM), (PEX6, -1.2, HEK293,
2.5 μM), (PEX6, -1.2, HEK293, 5 μM), (PEX6, -1.1, SHSY5Y, 5 μM), (PEX6, -1.2, HEK293, 5 μM), (PFDN1, -1.4, SHSY5Y, 0.5 μM), (PGS1, -1.4, SHSY5Y, 0.5 μM), (PHKG2, -1.6, HEK293, 0.5 μM), (PHKG2, -1.7, SHSY5Y, 0.5 μM), (PHKG2, -1.6, HEK293, 1 μM), (PHKG2, -2.6, SHSY5Y, 1 μM), (PHKG2, -1.8, HEK293, 2.5 μM), (PHKG2, -2.6, SHSY5Y,
2.5 μM), (PHKG2, -1.7, HEK293, 5 μM), (PHKG2, -1.5, SHSY5Y, 5 μM), (PHKG2, -1.4, HEK293, 5 μM), (PHLDB1, -2.3, SHSY5Y, 1 μM), (PHLDB1, -1.5, SHSY5Y, 5 μM), (PICK!, -1.9, SHSY5Y, 1 μM), (PIK3C2A, -1.1, SHSY5Y, 1 μM), (PIK3C2A, -1.1, SHSY5Y, 2.5 μM), (PIK3C2A, -1, SHSY5Y, 5 μM), (PTTPNA, -1.3, SHSY5Y, 1 μM), (PLBD2, -1.1, HEK293, 1 μM), (PLBD2, -1.1, HEK293, 5 μM), (PLBD2, -1.2, HEK293, 5 μM), (PLEKHA4, -1.3, SHSY5Y, 1 μM), (POLA2, -1.2, HEK293, 0.5 μM), (POLA2, -1.2, SHSY5Y, 0.5 μM), (POLA2, -1.3, HEK293, 1 μM), (POLA2, -1.5, HEK293, 2.5 μM), (POLA2, -1.6, HEK293, 5 μM), (POLA2, -1.5, HEK293, 5 μM), (POLN, -1.3, HEK293, 0.5 μM), (POLN, -1.1, HEK293, 1 μM), (POLN, -1.4, HEK293, 2.5 μM), (POLN, -1.5, HEK293, 5 μM), (POLN, -1.3, HEK293, 5 μM), (POLQ, -1.9, SHSY5Y, 0.5 μM), (POLR2J4, 2.3, HEK293, 0.5 μM), (POLR2J4, 2.5, HEK293, 1 μM), (POLR2J4, 2.9, SHSY5Y, 1 μM), (POLR2J4, 2.5, HEK293, 2.5 μM), (POLR2J4, 2.5, SHSY5Y, 2.5 μM), (POLR2J4, 2.7, HEK293, 5 μM), (POLR2J4, 2.3, SHSY5Y, 5 μM), (POLR2J4, 1.6, HEK293, 5 μM), (PPP1R35, -1.1, SHSY5Y, 5 μM), (PPP2R3C, -1.1, HEK293, 0.5 μM), (PPP2R3C, -1.2, HEK293, 1 μM), (PPP2R3C, -1.4, HEK293, 2.5 μM), (PPP2R3C, -1.3, SHSY5Y, 2.5 μM), (PPP2R3C, -1.4, HEK293, 5 μM), (PPP2R3C, -1.4, SHSY5Y, 5 μM), (PPP2R3C, -1.1, HEK293, 5 μM), (PPP4R4, -1.3, HEK293, 2.5 μM), (PPP4R4, -1.3, HEK293, 5 μM), (PPP4R4, -1.4, HEK293, 5 μM), (PPP6R2, -1, HEK293, 0.5 μM), (PPP6R2, -1.4, SHSY5Y, 0.5 μM), (PPP6R2, -1.2, HEK293, 1 μM), (PPP6R2, -1.2, SHSY5Y, 1 μM), (PPP6R2, -1.1, HEK293, 2.5 μM), (PRKAG1, -1.5, HEK293, 0.5 μM), (PRKAG1, -1.8, SHSY5Y, 0.5 μM), (PRKAG1, -1.3, HEK293, 1 μM), (PRKAG1, -1.4, SHSY5Y, 1 μM), (PRKAG1, -1.5, HEK293, 2.5 μM), (PRKAG1, -1.6, SHSY5Y, 2.5 μM), (PRKAG1, -1.7, HEK293, 5 μM), (PRKAG1, -1.9, SHSY5Y, 5 μM), (PRKAG1, -1.5, HEK293, 5 μM), (PRKRA, -1.3, SHSY5Y, 0.5 μM), (PRKRA, -1.8, SHSY5Y, 5 μM), (PRPF40B, -2.2, HEK293, 0.5 μM), (PRPF40B, -6.2, SHSY5Y, 0.5 μM), (PRPF40B, -2.4, HEK293, 1 μM), (PRPF40B, -2.7, SHSY5Y, 1 μM), (PRPF40B, -1.8, HEK293, 2.5 μM), (PRPF40B, -2.5, SHSY5Y, 2.5 μM), (PRPF40B, -1.6, HEK293, 5 μM), (PRPF40B, -4.1, SHSY5Y, 5 μM), (PRPF40B, -1.1, HEK293, 5 μM), (PRPF4B, -1.2, SHSY5Y, 1 μM), (PRPF4B, -1.2, SHSY5Y,
2.5 μM), (PRRT4, -1.5, SHSY5Y, 1 μM), (PRRT4, -1.1, HEK293, 5 μM), (PRSS16, -1.5, HEK293, 5 μM), (PSEN2, -1.1, HEK293, 0.5 μM), (PTPN18, -1.6, HEK293, 0.5 μM), (PTPN18, -1.8, HEK293, 1 μM), (PTPN18, -2, HEK293, 2.5 μM), (PTPN18, -2.5, SHSY5Y, 2.5 μM), (PTPN18, -1.9, HEK293, 5 μM), (PTPN18, -1.4, HEK293, 5 μM), (PTPN21, -1.6, SHSY5Y, 1 μM), (PTPRA, -1, HEK293, 1 μM), (PTPRA, -1, HEK293, 2.5 μM), (PTPRA, -1.1, HEK293, 5 μM), (PTPRG-AS1, -1.2, HEK293, 5 μM), (PTPRG-AS1, -1.2, HEK293, 5 μM), (PXDN, -1, HEK293, 5 μM), (PYROXD1, -1.5, SHSY5Y, 5 μM), (RAB3GAP1, -2, SHSY5Y, 0.5 μM), (RAB3GAP1, -1.9, SHSY5Y, 1 μM), (RAB3GAP1, -1.7, SHSY5Y, 2.5 μM), (RAB3GAP1, -2.2, SHSY5Y, 5 μM), (RAB4B, -1.2, HEK293, 0.5 μM), (RAB4B, -1.3, HEK293, 1 μM), (RAB4B, -2.1, SHSY5Y, 1 μM), (RAB4B, -1.2, HEK293, 2.5 μM), (RAB4B, - 1.3, HEK293, 5 μM), (RABGAP1L, -1, HEK293, 0.5 μM), (RABL6, -1.1, SHSY5Y, 0.5 μM),
(RABL6, -1.4, SHSY5Y, 1 μM), (RAD18, 1.1, SHSY5Y, 0.5 μM), (RAD18, 1.1, SHSY5Y, 1 μM), (RAD51AP1, -1.3, SHSY5Y, 5 μM), (RADIL, -1.3, HEK293, 0.5 μM), (RADIL, -1.3, HEK293, 1 μM), (RADIL, -2, SHSY5Y, 1 μM), (RADIL, -1.3, HEK293, 2.5 μM), (RADIL, -
1.8, HEK293, 5 μM), (RADIL, -2, SHSY5Y, 5 μM), (RADIL, -1.2, HEK293, 5 μM), (RANBP17, -1, HEK293, 5 μM), (RARA, -1.9, SHSY5Y, 1 μM), (RBM20, -1.1, HEK293, 0.5 μM), (RBM20, -1.4, HEK293, 1 μM), (RBM20, -2, SHSY5Y, 1 μM), (RBM20, -1.8, HEK293, 2.5 μM), (RBM20, -2.2, SHSY5Y, 2.5 μM), (RBM20, -1.8, HEK293, 5 μM), (RBM20, -1.9, SHSY5Y, 5 μM), (RBM26-AS1, -1.1, HEK293, 5 μM), (RBM5, -1, SHSY5Y, 0.5 μM), (RBM5, -1.1, SHSY5Y, 5 μM), (RECK, -1.2, HEK293, 0.5 μM), (RECK, -1, HEK293, 1 μM), (RECK, - 2, SHSY5Y, 1 μM), (RECK, -1.3, HEK293, 5 μM), (RECK, -1.2, SHSY5Y, 5 μM), (RETREG1, -1.2, HEK293, 5 μM), (REXO5, -1.1, HEK293, 1 μM), (REXO5, -1.5, HEK293, 5 μM), (REXO5, -1.1, HEK293, 5 μM), (RHOT1, -1.3, HEK293, 5 μM), (RIMS2, -3.5, SHSY5Y, 0.5 μM), (RINT1, -1, SHSY5Y, 2.5 μM), (RINT1, -1.4, SHSY5Y, 5 μM), (RNF123, -1.6, HEK293, 0.5 μM), (RNF123, -2.3, SHSY5Y, 0.5 μM), (RNF123, -1.3, HEK293, 1 μM), (RNF123, -2.4, SHSY5Y, 1 μM), (RNF123, -1.7, HEK293, 2.5 μM), (RNF123, -1.8, SHSY5Y, 2.5 μM), (RNF123, -1.7, HEK293, 5 μM), (RNF123, -1.8, SHSY5Y, 5 μM), (RNF170, -1.5, SHSY5Y, 2.5 μM), (RNF214, -1.3, SHSY5Y, 0.5 μM), (ROGDI, -1.1, SHSY5Y, 5 μM), (RPGRIP1L, -1.4, SHSY5Y, 0.5 μM), (RRNAD1, -1.3, HEK293, 0.5 μM), (RRNAD1, -1.7, SHSY5Y, 0.5 μM), (RRNAD1, -1.5, HEK293, 1 μM), (RRNAD1, -1.1, HEK293, 2.5 μM), (RRNAD1, -1.4, HEK293, 5 μM), (RRNAD1, -1.1, HEK293, 5 μM), (RSRP1, 1.5, SHSY5Y, 5 μM), (RTEL1, -
1.9, HEK293, 0.5 μM), (RTEL1, -1.9, HEK293, 1 μM), (RTEL1, -3, SHSY5Y, 1 μM), (RTEL1, -1.8, HEK293, 2.5 μM), (RTEL1, -1.8, HEK293, 5 μM), (RTEL1-TNFRSF6B, -1.9, HEK293, 0.5 μM), (RTEL1-TNFRSF6B, -1.8, HEK293, 1 μM), (RTEL1-TNFRSF6B, -3.1, SHSY5Y, 1 μM), (RTEL1-TNFRSF6B, -1.8, HEK293, 2.5 μM), (RTEL1-TNFRSF6B, -1.7, HEK293, 5 μM), (SCARB1, -1.5, SHSY5Y, 2.5 μM), (SDCCAG3, -1, SHSY5Y, 1 μM), (SEC31B, 1, HEK293, 5 μM), (SEMA4A, -6.9, HEK293, 2.5 μM), (SEMA4A, -6.8, HEK293, 5 μM), (SEMA4A, -3.9, HEK293, 5 μM), (SFI1, -1.5, HEK293, 0.5 μM), (SFI1, -1.4, HEK293, 1 μM), (SFI1, -1.5, HEK293, 2.5 μM), (SFI1, -1.1, HEK293, 5 μM), (SFI1, -1.6, SHSY5Y, 5 μM), (SFMBT1, -1.6, SHSY5Y, 0.5 μM), (SFXN2, -2, SHSY5Y, 0.5 μM), (SFXN2, -1.2, SHSY5Y, 1 μM), (SFXN2, -1.7, SHSY5Y, 2.5 μM), (SFXN2, -2.8, SHSY5Y, 5 μM), (SH2B1, -1.7, SHSY5Y, 0.5 μM), (SH2B1, -1.1, SHSY5Y, 1 μM), (SLC24A1, -1.1, HEK293, 0.5 μM), (SLC24A1, -8.3, SHSY5Y, 0.5 μM), (SLC24A1, -1.3, HEK293, 2.5 μM), (SLC24A1, -1.2, HEK293, 5 μM), (SLC24A1, -1.1, HEK293, 5 μM), (SLC25A14, -1.7, HEK293, 0.5 μM), (SLC25A14, -1.4, HEK293, 1 μM), (SLC25A14, -1.7, HEK293, 2.5 μM), (SLC25A14, -1.9, HEK293, 5 μM), (SLC25A14, -1.4, SHSY5Y, 5 μM), (SLC25A14, -1.3, HEK293, 5 μM), (SLC25A32, -1.3, SHSY5Y, 1 μM), (SLC25A32, -1.2, SHSY5Y, 2.5 μM), (SLC25A32, -1, HEK293, 5 μM), (SLC25A32, -1.2, SHSY5Y, 5 μM), (SLC25A32, -1.3, HEK293, 5 μM), (SLC25A40, -1.5, HEK293, 0.5 μM), (SLC25A40, -1.5, SHSY5Y, 0.5 μM), (SLC25A40, -2, HEK293, 1 μM), (SLC25A40, -1.8, SHSY5Y, 1 μM), (SLC25A40, -2, HEK293, 2.5 μM), (SLC25A40, -1.7, SHSY5Y, 2.5 μM), (SLC25A40, -2, HEK293, 5 μM), (SLC25A40, -1.9, SHSY5Y, 5 μM), (SLC25A40, -1.5, HEK293, 5 μM), (SLC25A53, -3.6, HEK293, 2.5 μM), (SLC2A11, -1.1, HEK293, 5 μM), (SLC38A6, -2.5, HEK293, 0.5 μM), (SLC38A6, -2.3, HEK293, 1 μM), (SLC38A6, -1.8, HEK293, 2.5 μM), (SLC38A6, -2.2, HEK293, 5 μM), (SLC38A6, -5.3, SHSY5Y, 5 μM), (SLC38A6, -2, HEK293, 5 μM), (SLC38A7, -1.9, SHSY5Y, 0.5 μM), (SLC43A1, -1.3, HEK293, 0.5 μM), (SLC43A1, -1.3, HEK293, 1 μM), (SLC43A1, -2,
HEK293, 2.5 μM), (SLC43A1, -1.9, HEK293, 5 μM), (SLC43A1, -2, HEK293, 5 μM), (SLC47A1, -1.4, HEK293, 0.5 μM), (SLC47A1, -1.2, HEK293, 1 μM), (SLC47A1, -1.3, HEK293, 2.5 μM), (SLC47A1, -1.3, HEK293, 5 μM), (SLC47A1, -1, HEK293, 5 μM), (SLC4A7, -1.8, HEK293, 0.5 μM), (SLC4A7, -1.8, SHSY5Y, 0.5 μM), (SLC4A7, -2, HEK293, 1 μM), (SLC4A7, -2.3, SHSY5Y, 1 μM), (SLC4A7, -2.1, HEK293, 2.5 μM), (SLC4A7, -2.3, SHSY5Y, 2.5 μM), (SLC4A7, -2.1, HEK293, 5 μM), (SLC4A7, -2.6, SHSY5Y, 5 μM), (SLC4A7, -1.6, HEK293, 5 μM), (SLIT1, -1.9, HEK293, 5 μM), (SMCHD1, -1.7, SHSY5Y, 0.5 μM), (SMCHD1, -1.6, SHSY5Y, 1 μM), (SMCHD1, -2, SHSY5Y, 2.5 μM), (SMCHD1, -1.7, SHSY5Y, 5 μM), (SNHG12, -6.1, SHSY5Y, 0.5 μM), (SNX24, -1.3, SHSY5Y, 5 μM), (SPATA6, -1.2, HEK293, 2.5 μM), (SPATA6, -1.5, HEK293, 5 μM), (SRP14-AS1, -2, HEK293, 0.5 μM), (SRP14-AS1, -2, HEK293, 2.5 μM), (SRP14-AS1, -2.1, HEK293, 5 μM), (SRP14- AS1, -4, HEK293, 5 μM), (ST6GAL1, -2.2, HEK293, 1 μM), (ST6GAL1, -1.7, HEK293, 2.5 μM), (ST6GAL1, -2, HEK293, 5 μM), (ST6GAL1, -1.9, HEK293, 5 μM), (ST7L, -1.2, HEK293, 2.5 μM), (ST7L, -1.2, HEK293, 5 μM), (ST7L, -1.3, HEK293, 5 μM), (STAT5B, -1.1, HEK293, 2.5 μM), (STAT5B, -1, HEK293, 5 μM), (STXBP3, -2.5, HEK293, 0.5 μM), (STXBP3, -5.3, SHSY5Y, 0.5 μM), (STXBP3, -3.1, HEK293, 1 μM), (STXBP3, -3.1, SHSY5Y, 1 μM), (STXBP3, -3.6, HEK293, 2.5 μM), (STXBP3, -4.9, SHSY5Y, 2.5 μM), (STXBP3, -3.4, HEK293, 5 μM), (STXBP3, -4.3, SHSY5Y, 5 μM), (STXBP3, -2.8, HEK293, 5 μM), (SULF1, -
1.1, HEK293, 5 μM), (SUMF1, -2.2, SHSY5Y, 5 μM), (SWT1, -1, HEK293, 0.5 μM), (SWT1, -
1.2, HEK293, 1 μM), (SWT1, -1.2, HEK293, 2.5 μM), (SWT1, -1.1, HEK293, 5 μM), (SWT1, - 2, SHSY5Y, 5 μM), (TARSL2, -1.6, HEK293, 0.5 μM), (TARSL2, -1.6, HEK293, 1 μM), (TARSL2, -1.8, HEK293, 2.5 μM), (TARSL2, -1.8, HEK293, 5 μM), (TARSL2, -1.6, HEK293, 5 μM), (TBC1D19, -2.5, HEK293, 0.5 μM), (TBC1D19, -2.9, SHSY5Y, 0.5 μM), (TBC1D19, -
2.2, HEK293, 1 μM), (TBC1D19, -9.5, SHSY5Y, 1 μM), (TBC1D19, -2, HEK293, 2.5 μM), (TBC1D19, -4.4, SHSY5Y, 2.5 μM), (TBC1D19, -2.6, HEK293, 5 μM), (TBC1D19, -1.7, SHSY5Y, 5 μM), (TBC1D19, -2.4, HEK293, 5 μM), (TBCK, -2.4, HEK293, 0.5 μM), (TBCK, - 1.7, SHSY5Y, 0.5 μM), (TBCK, -2.3, HEK293, 1 μM), (TBCK, -2.7, SHSY5Y, 1 μM), (TBCK, -3.4, HEK293, 2.5 μM), (TBCK, -2.1, SHSY5Y, 2.5 μM), (TBCK, -2.7, HEK293, 5 μM), (TBCK, -3.2, SHSY5Y, 5 μM), (TBCK, -1.6, HEK293, 5 μM), (TDG, -1, SHSY5Y, 1 μM), (TDG, -1, SHSY5Y, 2.5 μM), (TDG, -1.1, SHSY5Y, 5 μM), (TDP1, -1.7, HEK293, 0.5 μM), (TDP1, -2, SHSY5Y, 0.5 μM), (TDP1, -1.6, HEK293, 1 μM), (TDP1, -1.9, SHSY5Y, 1 μM), (TDP1, -1.8, HEK293, 2.5 μM), (TDP1, -2.5, SHSY5Y, 2.5 μM), (TDP1, -1.8, HEK293, 5 μM), (TDP1, -3, SHSY5Y, 5 μM), (TDP1, -1.6, HEK293, 5 μM), (TEX9, -1.3, HEK293, 0.5 μM), (TEX9, -2.3, HEK293, 1 μM), (TEX9, -1.9, HEK293, 2.5 μM), (TEX9, -1.1, HEK293, 5 μM), (TFCP2, -1.2, HEK293, 0.5 μM), (TFCP2, -1.2, SHSY5Y, 0.5 μM), (TFCP2, -1.1, HEK293, 1 μM), (TFCP2, -1.8, SHSY5Y, 1 μM), (TFCP2, -1.2, HEK293, 2.5 μM), (TFCP2, -1.7, SHSY5Y, 2.5 μM), (TFCP2, -1.2, HEK293, 5 μM), (TFCP2, -1.6, SHSY5Y, 5 μM), (TFCP2, -1.2, HEK293, 5 μM), (THOC2, -1, HEK293, 0.5 μM), (THOC2, -1.2, SHSY5Y, 0.5 μM), (THOC2, - 1, HEK293, 1 μM), (THOC2, -1.6, SHSY5Y, 1 μM), (THOC2, -1.1, HEK293, 2.5 μM), (THOC2, -1.3, SHSY5Y, 2.5 μM), (THOC2, -1, HEK293, 5 μM), (THOC2, -1.6, SHSY5Y, 5 μM), (THOC2, -1.1, HEK293, 5 μM), (TIA1, -1.4, HEK293, 0.5 μM), (TIA1, -1, SHSY5Y, 0.5 μM), (TIA1, -1.3, HEK293, 1 μM), (TIA1, -1.5, HEK293, 2.5 μM), (TIA1, -1.5, SHSY5Y, 2.5 μM), (TIA1, -1.7, HEK293, 5 μM), (TIA1, -1.1, SHSY5Y, 5 μM), (TIMM23, -1, SHSY5Y, 5 μM), (TIMM23B, -1.2, HEK293, 1 μM), (TIMM23B, -1.2, HEK293, 2.5 μM), (TIMM23B, -1.3, HEK293, 5 μM), (TKFC, -1.3, SHSY5Y, 1 μM), (TLL2, 1.6, HEK293, 5 μM), (TM2D3, -1.3,
SHSY5Y, 5 μM), (TM9SF4, -1.1, SHSY5Y, 0.5 μM), (TM9SF4, -1.1, SHSY5Y, 1 μM), (TMCC1, -1.6, SHSY5Y, 0.5 μM), (TMEM106C, -1.3, HEK293, 0.5 μM), (TMEM106C, -1.2, SHSY5Y, 0.5 μM), (TMEM106C, -1.2, HEK293, 1 μM), (TMEM106C, -1.1, SHSY5Y, 1 μM), (TMEM106C, -1.5, HEK293, 2.5 μM), (TMEM106C, -1.4, SHSY5Y, 2.5 μM), (TMEM106C, -
1.7, HEK293, 5 μM), (TMEM106C, -1.6, SHSY5Y, 5 μM), (TMEM106C, -1.6, HEK293, 5 μM), (TMEM144, -1.4, HEK293, 0.5 μM), (TMEM144, -1.1, HEK293, 1 μM), (TMEM144, - 1.9, HEK293, 2.5 μM), (TMEM144, -2.1, HEK293, 5 μM), (TMEM144, -1.6, HEK293, 5 μM), (TMEM161B-AS1, -1.4, HEK293, 0.5 μM), (TMEM161B-AS1, -1.5, HEK293, 2.5 μM), (TMEM161B-AS1, -1.3, HEK293, 5 μM), (TMEM214, -1.9, SHSY5Y, 1 μM), (TMEM214, -1, HEK293, 5 μM), (TMEM222, -1.1, SHSY5Y, 0.5 μM), (TMEM222, -1.1, SHSY5Y, 2.5 μM), (TMEM222, -1.1, HEK293, 5 μM), (TMEM237, -1.1, SHSY5Y, 5 μM), (TMEM63B, -1.3, SHSY5Y, 1 μM), (TMEM65, -1.1, HEK293, 0.5 μM), (TMEM65, -1.5, HEK293, 1 μM), (TMEM67, -1, HEK293, 2.5 μM), (TMX2, -1, HEK293, 5 μM), (TMX2, -1, SHSY5Y, 5 μM), (TMX2, -1, HEK293, 5 μM), (TMX3, -1.7, HEK293, 0.5 μM), (TMX3, -1.7, HEK293, 1 μM), (TMX3, -1.5, SHSY5Y, 1 μM), (TMX3, -2, HEK293, 2.5 μM), (TMX3, -1.9, SHSY5Y, 2.5 μM), (TMX3, -2, HEK293, 5 μM), (TMX3, -2.1, SHSY5Y, 5 μM), (TMX3, -1.5, HEK293, 5 μM), (TNKS2, -1.3, HEK293, 0.5 μM), (TNKS2, -1.4, SHSY5Y, 0.5 μM), (TNKS2, -1.1, HEK293, 1 μM), (TNKS2, -2.2, SHSY5Y, 1 μM), (TNKS2, -1.3, HEK293, 2.5 μM), (TNKS2, -
1.7, SHSY5Y, 2.5 μM), (TNKS2, -1.5, HEK293, 5 μM), (TNKS2, -1.7, SHSY5Y, 5 μM), (TNKS2, -1.5, HEK293, 5 μM), (TOM1L1, 1, SHSY5Y, 1 μM), (TOM1L2, -1, HEK293, 0.5 μM), (TOM1L2, -1, HEK293, 1 μM), (TOM1L2, -1.4, HEK293, 5 μM), (TRIM16, 1, HEK293, 0.5 μM), (TRIM16, 1, HEK293, 1 μM), (TRIM16, 1, HEK293, 2.5 μM), (TRIM16, 1.1, HEK293, 5 μM), (TRMT61B, -1.4, SHSY5Y, 0.5 μM), (TRMT61B, -1.4, SHSY5Y, 1 μM), (TRMT61B, -1.7, SHSY5Y, 5 μM), (TRPM4, -4.5, SHSY5Y, 0.5 μM), (TRPM4, -1.1, HEK293, 1 μM), (TRPM4, -3.7, SHSY5Y, 1 μM), (TRPM4, -1.3, HEK293, 2.5 μM), (TRPM4, -1.2, HEK293, 5 μM), (TTC12, -1.7, HEK293, 0.5 μM), (TTC12, -1.5, HEK293, 1 μM), (TTC12, -
1.7, HEK293, 2.5 μM), (TTC12, -1.8, HEK293, 5 μM), (TTC12, -1.7, HEK293, 5 μM), (TTC13, 1.3, SHSY5Y, 0.5 μM), (TTC13, 1.3, SHSY5Y, 1 μM), (TTC13, 1.1, SHSY5Y, 2.5 μM), (TTC13, 1.2, SHSY5Y, 5 μM), (TTC28-AS1, 1.1, HEK293, 5 μM), (TTC39C, -1.2, HEK293, 0.5 μM), (TTC39C, -2.9, SHSY5Y, 0.5 μM), (TTC39C, -1.5, HEK293, 1 μM), (TTC39C, -1.9, SHSY5Y, 1 μM), (TTC39C, -1.1, HEK293, 2.5 μM), (TTC39C, -2.6, SHSY5Y, 2.5 μM), (TTC39C, -1.4, HEK293, 5 μM), (TTC39C, -2.3, SHSY5Y, 5 μM), (TTC39C, -1.2, HEK293, 5 μM), (TTYH2, -1.2, HEK293, 0.5 μM), (TTYH2, -2.4, SHSY5Y, 0.5 μM), (TTYH2, -1.9, HEK293, 1 μM), (TTYH2, -2.6, SHSY5Y, 2.5 μM), (TTYH2, -1.6, HEK293, 5 μM), (TXNDC11, -1.3, HEK293, 0.5 μM), (TXNDC11, -1.3, HEK293, 1 μM), (TXNDC11, -1.2, HEK293, 2.5 μM), (TXNDC11, -1.1, HEK293, 5 μM), (TXNDC11, -1.2, HEK293, 5 μM), (TXNDC16, -1.4, HEK293, 0.5 μM), (TXNDC16, -1.3, SHSY5Y, 0.5 μM), (TXNDC16, -1.1, HEK293, 1 μM), (TXNDC16, -1.7, SHSY5Y, 1 μM), (TXNDC16, -1.5, HEK293, 2.5 μM), (TXNDC16, -1.5, SHSY5Y, 2.5 μM), (TXNDC16, -1.5, HEK293, 5 μM), (TXNDC16, -1.5, SHSY5Y, 5 μM), (TXNDC16, -1.4, HEK293, 5 μM), (UBA2, -1.4, HEK293, 0.5 μM), (UBA2, - 1, SHSY5Y, 0.5 μM), (UBA2, -1.4, HEK293, 1 μM), (UBA2, -1.3, SHSY5Y, 1 μM), (UBA2, -
1.7, HEK293, 2.5 μM), (UBA2, -1.3, SHSY5Y, 2.5 μM), (UBA2, -1.8, HEK293, 5 μM), (UBA2, -1.5, SHSY5Y, 5 μM), (UBA2, -1.6, HEK293, 5 μM), (UBA6, -1, SHSY5Y, 0.5 μM), (UBA6, -1.5, SHSY5Y, 2.5 μM), (UBAC2, -1.4, HEK293, 0.5 μM), (UBAC2, -1.3, SHSY5Y, 0.5 μM), (UBAC2, -1.6, HEK293, 1 μM), (UBAC2, -1.2, SHSY5Y, 1 μM), (UBAC2, -1.9,
Compound 141
[00671] Table 80 provides further detail of results (Cpd = Compound, Gene = Gene, Cone = Concentration, L2FC = log2 fold change) for genes exhibiting a two fold change, or more, in gene expression (a Log2 fold change of 1.0 or above, or -1.0 or below) together with a change in Percent Spliced In (APSI) of 50% to 100%, or -50% to -100%, at a p value (pVal) of < 0.001 in the presence of Compound 141.
[00672] The cell lines tested included Familial Dysautonomia patient fibroblasts (FDPF), HEK293, stimulated PBMC (sPBMC), differentiated SY5Y (diffSY5Y), SHSY5Y, M0LM13 and HT1080.
Inclusion Results (Compound 141)
[00674] RNAseq experiments showed that Compound 141 induced exon inclusion with a PSI change (APSI) of +50% to +100% and P-value <0.001 in 64 genes:
[00675] Table 81
[00676] RNAseq experiments showed that Compound 141 induced exon inclusion with a PSI change (APSI) of +50% to +100% and P-value <0.001 in genes having a 5' splice site as follows (70 entries):
Inclusion and NMD Results (Compound 141)
[00678] RNAseq experiments showed that Compound 141 induced exon inclusion associated with nonsense mediated decay with a PSI change (APSI) of +50% to +100% and P- value <0.001 in 9 genes:
[00680] RNAseq experiments showed that Compound 141 induced exon inclusion associated with nonsense mediated decay with a PSI change (APSI) of +50% to +100% and P- value <0.001in genes having a 5' splice site as follows (10 entries):
• Skipping Results (Compound 141)
[00682] RNAseq experiments showed that Compound 141 induced exon skipping with a
PSI change (APSI) of -50% to -100% and P-value <0.001 in 334 genes:
[00684] RNAseq experiments showed that Compound 141 induced exon skipping with a PSI change (APSI) of -50% to -100% and P-value <0.001 in genes having a 5' splice site as follows (333 entries):
[00685] Table 86
AAGGgtaaga, AAGGgtgagt, AAGGgtgtgt, AAGTgtgagt, AATAgtgagt, AATCgtaagt, AATCgtgagt, AATGgtgagg, AATTgtaagt, ACACgtaaga, ACACgtaagt, ACACgtgagt, ACAGgcaagt, ACAGgtaaaa, ACAGgtaacc, ACAGgtaaga, ACAGgtaatt, ACAGgtacca, ACAGgtacgt, ACAGgtacta, ACAGgtatat, ACAGgtatct, ACAGgtgaaa, ACAGgtgaga, ACAGgtgagg, ACAGgtgagt, ACAGgtgcgt, ACAGgtgggt, ACAGgttggt, ACATgtaagc, ACATgtaagt, ACATgtaatg, ACATgtgagt, ACCCgtgaga, ACCTgtaagt, ACCTgtatgg, ACCTgtgagt, ACGGgtgagt, ACTGgtaaaa, ACTGgtaggt, ACTGgtgagt, ACTTgtacgt, AGAAaggtga, AGACgtgagt, AGAGgcgtga, AGAGgtaaac, AGAGgtaaga, AGAGgtacag, AGAGgtactg, AGAGgtaggt, AGAGgtattg, AGATgtaagt, AGATgtaatt, AGATgtgagt, AGATgtgggt, AGCAgtgagt, AGCCgtgtgt, AGCGgtaagt, AGCTgtaagt, AGCTgtatgt, AGCTgtgagt, AGTGgtgagt, ATAAgtaagt, ATAGgtaaaa, ATAGgtaagg, ATAGgtatga, ATAGgtgata, ATAGgttagt, ATATgtgagc, ATATgtgagt, ATCCagaaac, ATCTgtaaga, ATCTgtaagt, ATCTgtgaga, ATGAgtgtga, ATGGgtaaaa, ATGGgtgagt, ATTGgtaaaa, ATTGgtaagg, ATTGgtaggt, ATTGgtagta, ATTGgtgaga, ATTGgtgagt, ATTGgtgtga, ATTTgtaagt, ATTTgtgagt, CAAAgtaaag, CAAAgtgagt, CAACgtaagt, CAAGgtaaga, CAAGgtaatt, CAAGgtatag, CAAGgtattc, CAAGgtgact, CAAGgtgaga, CAAGgttagt, CAATgtaagt, CACAgtgagt, CACGgtgagg, CACGgtgagt, CACTgtgagt, CAGAgtaagt, CAGCgtaagt, CAGGgtaagt, CATCgtgagt, CATGgtaaga, CATGgtaagc, CATGgttagt, CATTgtaagt, CATTgtgagt, CCACgtgagt, CCAGgtaaaa, CCAGgtaaga, CCAGgtaagc, CCAGgtactg, CCAGgtatat, CCAGgtctga, CCAGgtgggc, CCAGgtgtgg, CCAGgtgtgt, CCAGgttagt, CCATgtaaga, CCATgtaagt, CCATgtgagt, CCCAgtgagt, CCCGgtaggt, CCCTgtaagt, CCGCgtgagt, CCTAgtaagt, CCTGgtaagt, CCTGgtgagt, CCTGgtgcgt, CCTTgtaagt, CGAGgtaagt, CGCAgtgagc, CGCCatggcc, CGGGgtgagg, CGGGgtgagt, CGTGgtgagt, CTCAgtaagt, CTCTgtaagt, CTGAgtaagt, CTGAgtgagt, CTGCgtgagt, CTGGgtaagt, CTGGgtaata, CTGGgtgaga, CTGGgtgagc, CTGGgtgagg, CTGGgtgagt, CTTCgtgagt, CTTGgtaacc, CTTGgtaaga, CTTGgtgagc, CTTGgtgagt, CTTTgtaagt, CTTTgtgagt, GAAAggtaat, GAAAgtaagt, GAAGgtaaac, GAAGgtaagt, GAAGgtatag, GAAGgtatat, GAAGgtatga, GAAGgtattt, GAAGgtcaga, GAAGgtcagg, GAAGgtgaag, GAAGgtgaga, GAAGgtgagc, GAAGgtgatg, GAAGgtgggt, GAATgtaagg, GACAgtaagt, GACCgtaagt, GACCgtatgt, GACGgtgggc, GACTgtaaga, GAGAgtaagt, GAGGgtatgt, GATAgtaagt, GATGgtaagt, GATGgtatga, GATGgtgagc, GATGgtgagg, GATGgtgagt, GCAAgtatgg, GCAGgtaaga, GCAGgtatga, GCAGgtatta, GCAGgtattt, GCAGgtgagg, GCAGgtgagt, GCATgtaagt, GCATgtgagt, GCCGgtaagt, GCCTgtaagt, GCCTgtgagt, GCGAgtgagt, GCGGgtaagg, GCGGgtgagc, GCTAgtgagt, GCTGgtaagt, GCTTgtatgt, GCTTgtgagt, GGAAaaggta, GGAAggtcag, GGAAgtgagt, GGAGgtaacc, GGAGgtagga, GGAGgtgagt, GGAGgtgggc, GGATatgtaa, GGATgtgagt, GGCGgtaagt, GGCGgtgagt, GGCTgtaagt, GGCTgtgagt, GTGGgtgagt, GTTGgtaaga, GTTTgtaagt, TAACgtgagt, TAAGgtaaaa, TAAGgtaggt, TAAGgtgagt, TACAgtgagt, TACCaaaggg, TACTgtaagt, TACTgtatgt, TAGGgtaggt, TATGgtgagt, TATTgtaagt, TATTgtgagt, TCACgtatgt, TCAGgtaaat, TCAGgtaact, TCAGgtaaga, TCAGgtaagg, TCAGgtacat, TCAGgtacca, TCAGgtaggt, TCAGgtatgg, TCAGgtcaga, TCAGgtctgc, TCAGgtgggc, TCAGgttgaa, TCAGgttttt, TCATgtaaat, TCATgtatgt, TCCCgtgagt, TCCTgtaagt, TCCTgtgaga, TCGCgtatgt, TCGCgtgagt, TCGTgtgagt, TCTAgtgagt, TCTGgtaaat, TCTGgtaaga, TCTGgtaagt, TCTGgtgagc, TCTGgtgagg, TCTGgtttgt, TCTTgtaagt, TCTTgtgagt, TGAAaaggta, TGAAgtaact, TGAAgtaagt, TGAAgtccgt, TGAGgtaaag, TGAGgtatag, TGAGgtattc, TGAGgtcagc,
• Skipping and NMD Results (Compound 141)
[00686] RNAseq experiments showed that Compound 141 induced exon skipping associated with nonsense mediated decay with a PSI change (APSI) of -50% to -100% and P- value <0.001 in 156 genes:
[00688] RNAseq experiments showed that Compound 141 induced exon skipping associated with nonsense mediated decay with a PSI change (APSI) of -50% to -100% and P- value <0.001 in genes having a 5' splice site as follows (158 entries):
Gene Expression Results (Compound 141)
[00690] RNAseq experiments showed that Compound 141 modulated expression of various genes by a factor of 2 or more. The following table identifies genes from Table 5 which resulted in a log 2 fold change (L2FC) of 1 or above (increased expression), or -1 or below (decreased expression), upon treatment with Compound 141 :
1.6, HEK293, 5 gM), (ATG7, -1.6, SHSY5Y, 5 μM), (ATP5S, -1.4, HEK293, 2.5 μM,) (ATP5S, -1.5, HEK293, 5 μM), (ATP6V0A2, -1.3, HEK293, 5 μM), (ATP9A, -2.5, HEK293, 5 gM), (ATP9A, -1.3, HEK293, 5 gM), (ATXN3, -1, HEK293, 5 μM), (BABAM2, -1.6, HEK293, 5 gM), (BABAM2, -1.4, SHSY5Y, 5 μM), (BAZ2B, -1.8, HEK293, 5 gM), (BBS4, -1.1, HEK293, 2.5 μM), (BBS4, -1.6, SHSY5Y, 2.5 gM), (BBS4, -2.3, HEK293, 5 gM), (BBS4, -1.9, HEK293, 5 μM), (BBS4, -2.4, SHSY5Y, 5 gM), (BCL11A, -1.1, HEK293, 5 μM,) (BCL9L, -
1.6, HEK293, 5 gM), (BLZF1, -1.1, SHSY5Y, 2.5 ^M), (BLZF1, -1.1, HEK293, 5 gM), (BLZF1, -1.3, SHSY5Y, 5 μM), (BPTF, -1.8, HEK293, 5 μM), (BRPF1, -1.1, HEK293, 5 μM, ) (BRSK2, -1.5, HEK293, 5 gM), (C10orfl43, -2.3, HEK293, 2.5 μM), (C10orfl43, -4.4, HEK293, 5 μM), (C10orfl43, -2.4, HEK293, 5 μM), (CACNA2D1, -1.5, SHSY5Y, 2.5 μM), (CACNA2D1, -1.8, HEK293, 5 μM), (CACNA2D1, -1.3, HEK293, 5 μM), (CACNA2D1, -1.7, SHSY5Y, 5 μM), (CAMSAP1, -1.1, HEK293, 5 gM), (CAMSAP3, -1, HEK293, 5 gM), (CAPRIN2, -1.9, HEK293, 5 μM), (CAPS2, -3.1, HEK293, 5 μM,) (CCDC125, -1.4, HEK293, 5 |1M), (CCDC18, -1.9, HEK293, 5 gM), (CCDC25, -1.1, HEK293, 5 μM), (CCDC40, -2.3, HEK293, 5 μM), (CCDC57, -1.3, HEK293, 5 μM), (CCDC88A, -1.8, HEK293, 5 μM,) (CCDC88C, -3.1, HEK293, 5 μM), (CELSR2, -1.5, HEK293, 5 μM), (CELSR3, -1.5, HEK293,
5 μM), (CENPE, -2.2, HEK293, 5 ^M), (CENPH, -1.1, SHSY5Y, 2.5 gM), (CENPH, -1, HEK293, 5 μM), (CENPI, -1, HEK293, 2.5 μM,) (CENPI, -1.3, SHSY5Y, 2.5 μM, ()CENPI, -
1.7, HEK293, 5 gM), (CENPI, -1.5, HEK293, 5 μM), (CENPI, -2.5, SHSY5Y, 5 μM), (CEP128, -1.3, HEK293, 5 μM), (CEP131, -1.3, HEK293, 5 μM,) (CEP164, -1.3, HEK293, 5 ^M), (CEP170, -1, HEK293, 5 ^M), (CEP290, -1.6, HEK293, 5 μM), (CEP295, -1.2, HEK293, 5 μM), (CEP35O, -1.7, HEK293, 5 μM), (CEP83, -1.1, HEK293, 1 μM), (CEP83, -1.2, HEK293, 2.5 μM), (CEP83, -1.7, HEK293, 5 μM), (CERCAM, -1, HEK293, 5 μM), (CFAP44, -1.8, HEK293, 5 μM), (CHD1L, -1, SHSY5Y, 2.5 piM), (CHD1L, -1.6, HEK293, 5 μM), (CHD1L, -
1.8, SHSY5Y, 5 μM), (CHD6, -1.3, HEK293, 5 μM,) (CHEK2, -1, HEK293, 2.5 μM, ()CHEK2, -1.7, HEK293, 5 μM), (CHEK2, -1.5, HEK293, 5 μM), (CHEK2, -2, SHSY5Y, 5 μM), (CIT, - 1.6, HEK293, 5 gM), (CKMT1A, -6.4, SHSY5Y, 2.5 μM,) (CLIP2, -1.4, HEK293, 5 ^M), (CLSPN, -1.2, HEK293, 5 gM), (CNIH3, -2.2, HEK293, 5 μM), (CNIH3, -2.6, HEK293, 5 μM), (CNTRL, -1.9, HEK293, 5 ^M), (COL24A1, -2, HEK293, 5 μM), (CPXM1, -1.5, HEK293, 5 |1M), (CPXM1, -1.1, SHSY5Y, 5 μM), (CRELD1, -1.4, HEK293, 2.5 μM), (CRELD1, -1.5, HEK293, 5 μM), (CRELD1, -1.7, HEK293, 5 μM), (CRELD1, -1.2, SHSY5Y, 5 μM), (CROCC, -1.1, HEK293, 5 μM), (CRYBG3, -1.5, HEK293, 5 μM), (CYP2U1, -1.1, HEK293, 2.5 μM, ) (CYP2U1, -2.5, HEK293, 5 μM), (CYP2U1, -2.1, HEK293, 5 μM), (CZ1P-ASNS, 1.2, HEK293, 5μM), (DAAM1, -2.1, HEK293, 5 μM), (DAAM1, -1.1, HEK293, 5 μM,) (DCST1-AS1, 1.1, HEK293, 2.5 μM), (DDC, -1.4, SHSY5Y, 2.5 μM), (DDC, -1.8, SHSY5Y, 5 μM), (DECR2, - 1.6, HEK293, 2.5 μM), (DECR2, -1.4, SHSY5Y, 2.5 μM), (DECR2, -1.2, HEK293, 5 μM), (DENND3, -2, HEK293, 5 ^M), (DENND5A, -2.3, HEK293, 5 μM,) (DGKA, -1.9, SHSY5Y, 1 |1M), (DGKA, -2.3, SHSY5Y, 2.5 ^M), (DGKA, -2.4, HEK293, 5 μM), (DGKA, -1.5, HEK293, 5 nM), (DGKA, -2, SHSY5Y, 5 gM), (DHRS12, 1.6, HEK293, 5 μM,) (DHRS12, 1.1, HEK293, 5 μM), (DHRS4L2, -1.3, HEK293, 5 μM), (DIMT1, -1.3, HEK293, 2.5 μM), (DIMT1, -1.8, SHSY5Y, 2.5 μM), (DIMT1, -1.6, HEK293, 5 μM), (DIMT1, -1.7, HEK293, 5 μM), (DIMT1, - 2, SHSY5Y, 5 μM), (DMXL2, -1.1, HEK293, 5 μM), (DNAJB12, -1.5, SHSY5Y, 2.5 μM), (DNAJB12, -1.5, HEK293, 5 μM), (DNAJC4, -1.1, HEK293, 5 μM), (DNMT3A, -1.3, HEK293, 5 nM), (DOCK11, -1.4, HEK293, 5 ^M), (DOT1L, -1.1, HEK293, 5 ^M), (DPYSL5, -1.5,
HEK293, 5 μM), (DST, -1.9, HEK293, 5 μM), (DTNB, -1.9, SHSY5Y, 5 μM), (DZIP3, -1, SHSY5Y, 2.5 μM), (EMC2, -1.3, SHSY5Y, 2.5 μM,) (EMC2, -1.6, HEK293, 5 ^M), (EMC2, -
1.1, HEK293, 5 gM), (EMC2, -1.6, SHSY5Y, 5 μM), (EML6, -1.1, HEK293, 2.5 μM), (EML6, - 1.4, HEK293, 5 μM), (EML6, -1.2, HEK293, 5 μM), (EMSY, -1, HEK293, 5 μM), (EP300, -1.1, HEK293, 5 μM), (EPB41L1, -1.6, HEK293, 5 μM), (EPHX4, 1.1, HEK293, 5 μM), (EPS8, -1.2, HEK293, 2.5 μM), (EPS8, -2.1, SHSY5Y, 2.5 μM), (EPS8, -2.3, HEK293, 5 μM), (EPS8, -1.8, HEK293, 5 μM), (EPS8, -1.9, SHSY5Y, 5 μM,) (ERC1, -1.1, HEK293, 5 μM, ()ERGIC1, -1.7, HEK293, 5 μM), (ETHE1, -1.2, HEK293, 5 μM), (EX0C3, -1.7, HEK293, 5 μM), (F8, -1.2, HEK293, IμM), (F8, -1.9, HEK293, 2.5 μM,) (F8, -2.9, HEK293, 5 gM), (F8, -1.9, HEK293, 5 gM), (FAM114A2, -1.3, SHSY5Y, 5 μM), (FAM208A, -1, HEK293, 5 μM), (FAM81A, -1.4, HEK293, 5 μM), (FAM81 A, -1.4, HEK293, 5 μM), (FANCI, -1.1, HEK293, 2.5 μM), (FANCI, - 1.6, SHSY5Y, 2.5 μM), (FANCI, -1.6, HEK293, 5 μM), (FANCI, -1.4, HEK293, 5 ^M), (FANCI, -1.7, SHSY5Y, 5 gM), (FANCL, -1.1, SHSY5Y, 1 μM), (FANCL, -1.3, HEK293, 2.5 |1M), (FANCL, -1.9, SHSY5Y, 2.5 μM), (FANCL, -1.6, HEK293, 5 μM,) (FANCL, -2.1, HEK293, 5 μM), (FANCL, -1.8, SHSY5Y, 5 ^M), (FGGY, -1.6, HEK293, 5 μM), (FH0D3, - 1.6, HEK293, 5 gM), (FIG4, -1.4, HEK293, 5 μM), (F1G4, -1.2, HEK293, 5 μM, ()F1G4, -1.2, SHSY5Y, 5 μM), (F0XRED1, -1, HEK293, 5 μM), (FRAS1, -1.1, HEK293, 5 μM), (FRMD4A, -1.4, HEK293, 5 μM), (FXR2, -1, SHSY5Y, 2.5 μM), (GALNT6, -1.1, HEK293, 1 gM), (GALNT6, -2.5, HEK293, 5 gM), (GALNT6, -1.4, HEK293, 5 gM), (GARNL3, -2.4, SHSY5Y, 5 μM), (GDPD5, -1.4, HEK293, 2.5 μM), (GDPD5, -1.1, HEK293, 5 μM), (GIT1, -1.1, HEK293, 5 μM), (GNAS-AS1, -1.1, HEK293, 5 μM), (GOLGA4, -2, HEK293, 5 μM, ()GOSR2, -1.4, SHSY5Y, 5 μM), (GPR155, -1.6, HEK293, 5 μM), (GTF2I, -2.4, HEK293, 5 μM), (GTF2IP1, -2.4, HEK293, 5 μM), (GTF2IP4, -2.4, HEK293, 5 μM), (HACL1, -1, HEK293, 2.5 gM), (HACL1, -1.1, HEK293, 5 μM), (HACL1, -1.2, HEK293, 5 μM), (HACL1, -1.2, SHSY5Y, 5 piM), (HECTD4, -1.4, HEK293, 5 piM), (HERC2, -2.2, HEK293, 5 μM), (HIVEP1, -1.7, HEK293, 5 μM), (HSD17B4, -1.4, HEK293, 0.5 ^M), (HSD17B4, -1.5, SHSY5Y, 0.5 gM), (HSD17B4, -1.6, HEK293, 1 μM), (HSD17B4, -1.6, SHSY5Y, 1 ^M), (HSD17B4, -1.9, HEK293, 2.5 μM), (HSD17B4, -1.9, SHSY5Y, 2.5 μM,) (HSD17B4, -1.7, HEK293, 5 gM), (HSD17B4, -2, HEK293, 5 μM), (HSD17B4, -1.8, SHSY5Y, 5 μM), (HTT, -1.2, HEK293, 5 |1M), (IFT140, -1.1, HEK293, 5 gM), (IFT172, -1, HEK293, 5 μM), (IKBKB, -1.1, HEK293, 5 gM), (IMMP2L, -3.6, SHSY5Y, 5 μM), (INPPL1, -1, HEK293, 5 μM), (IQCE, -1.6, HEK293, 5 gM), (IQCG, -1.7, HEK293, 5 ^M), (IQCG, -1.3, HEK293, 5 μM), (IQCK, -1.4, HEK293, 5 |1M), (ITGA3, -1.7, HEK293, 5 μM,) (ITSN1, -1.3, HEK293, 5 μM, ()JADE2, -1.1, HEK293, 5 |1M), (JMJD1C, -1.1, HEK293, 5 μM), (KAT6B, -1.2, HEK293, 5 μM), (KCNG1, -1, HEK293,
5μM), (KCNT2, -1.2, HEK293, 2.5 μM,) (KCNT2, -1, SHSY5Y, 2.5 μM, ()KCNF2, -1.4, HEK293, 5 μM), (KCNT2, -1.6, HEK293, 5 μM), (KCNT2, -1.4, SHSY5Y, 5 μM), (KIAA0319L, -1, HEK293, 5 μM), (KIAA0556, -1.4, HEK293, 5 μM), (KIAA0825, -8.4, SHSY5Y, 5 μM), (KIF13B, -1.3, HEK293, 5 ^M), (KIF24, -1.4, HEK293, 5 μM,) (KLRG1, 1.8, HEK293, 5 μM), (KMT2B, -1.2, HEK293, 5 gM), (KNL1, -1.8, HEK293, 5 μM), (KREMEN1, -
1.2, HEK293, 5 gM), (LAMA3, -1.8, HEK293, 5 μM,) (LGR5, -1.5, HEK293, 5 μM), (LIMCH1, -1.9, HEK293, 5 μM), (LINGO 1, -1.1, HEK293, 5 μM), (LMO7, -1.3, HEK293, 5 μM), (LOC100288637, -1.7, HEK293, 5 μM), (LOCI 00506844, -1, HEK293, 2.5 μM), (LOC100506844, -1.2, HEK293, 5 μM), (LOCI 00506844, -1.2, HEK293, 5 μM), (LOC100506844, -2.5, SHSY5Y, 5 gM), (LOCI 02606465, -1.3, HEK293, 5 μM), (LOC102606465, -1.7, HEK293, 5 μM), (LOCI 02724532, -1.9, HEK293, 2.5 μM,)
(LOC102724532, -1.4, HEK293, 5 μM), (LOCI 02724532, -1.9, HEK293, 5 μM), (LOC102724593, -2.6, HEK293, 5 μM), (LPCAT4, -1.3, HEK293, 5 μM,) (LRP1, -1.4, HEK293, 5 μM), (LY75-CD302, -1.1, HEK293, 5 μM), (LYST, -1.5, HEK293, 5 ^M), (MACF1, -1.9, HEK293, 5 μM), (MAML3, -1.7, HEK293, 5 μM), (MAP2, -3.4, HEK293, 5 gM), (MAP3K20, -1.3, SHSY5Y, 5 ^M), (MAP3K5, -1.3, HEK293, 5 μM), (MAPK7, -1, HEK293, 5 μM), (MAST4, -1.4, HEK293, 5 gM), (MBOAT2, -1.2, HEK293, 5 μM), (MBOAT2, -1.4, SHSY5Y, 5 μM), (MCOLN1, 1, SHSY5Y, 5 μM,) (MDN1, -1, HEK293, 5 gM), (MEGF8, -1.8, HEK293, 5 μM), (MELTF, -1.4, HEK293, 5 μM), (MELTF, -1.3, HEK293, 5 nM), (MELTF, -1.6, SHSY5Y, 5 μM), (MICAL1, -1.3, HEK293, 5 μM,) (MICALL1, -1.5, HEK293, 5 μM), (MINK1, -1.1, HEK293, 5 μM), (MKI67, -2.2, HEK293, 5 μM), (MLH1, -1.4, SHSY5Y, 2.5 μM), (MLH1, -1.2, HEK293, 5 μM), (MLH1, -1.3, SHSY5Y, 5 μM), (MOSPD2, -
2.2, SHSY5Y, 2.5 μM), (MOSPD2, -1.2, HEK293, 5 μM), (MOSPD2, -2.4, SHSY5Y, 5 μM), (MVB12B, -1.1, HEK293, 5 gM), (MYH14, -2.8, HEK293, 5 μM), (MYLK, -2.6, HEK293, 5 |1M), (MYO18A, -1.8, HEK293, 5 μM,) (MYO5A, -1.1, HEK293, 5 μM), (MYO5B, -1.3, HEK293, 5 μM), (MYO5C, -2, HEK293, 5 ^M), (MY0M2, -1.2, HEK293, 5 gM), (NAV2, -1.7, HEK293, 5 μM), (NBEAL2, -1.3, HEK293, 5 μM), (NBPF1, -1.2, HEK293, 5 μM,) (NBPF10, - 1.4, HEK293, 5 gM), (NBPF25P, -1.4, HEK293, 5 μM), (NCOA2, -1.2, HEK293, 5 μM), (NCOR2, -2.5, HEK293, 5 ^M), (NECAB3, -1.4, HEK293, 5 μM), (NEK1, -1.3, HEK293, 2.5 |1M), (NEK1, -1.3, SHSY5Y, 2.5 μM,) (NEK1, -2.1, HEK293, 5 μM, ()NEK1, -1.5, HEK293, 5 |1M), (NEK1, -1.2, SHSY5Y, 5 μM), (NFATC2IP, -1, SHSY5Y, 1 gM), (NFATC2IP, -1.3, SHSY5Y, 2.5 μM), (NFATC2IP, -1.2, SHSY5Y, 5 μM,) (NIPBL, -1.1, HEK293, 5 ^M), (NOTCH1, -1.8, HEK293, 5 gM), (NOTCH3, -2, HEK293, 5 ^M), (OBSCN, -2.4, HEK293, 5 μM), (OCA2, -1.8, HEK293, 5 μM), (OLFM2, -1.5, HEK293, 5 μM), (OLMALINC, -2.1, HEK293, 2.5 μM), (OLMALINC, -3.9, HEK293, 5 μM), (OLMALINC, -2.8, HEK293, 5 μM), (OTUD5, -1.1, HEK293, 5 ^M), (P2RX4, -1.4, HEK293, 5 gM), (PARVB, -1.2, HEK293, 5 |1M), (PCCB, -1, HEK293, 5 μM), (PCCB, -1.2, HEK293, 5 μM,) (PCID2, -1.4, HEK293, 5 |1M), (PCID2, -1.1, HEK293, 5 μM), (PCID2, -1.2, SHSY5Y, 5 μM), (PCLO, -1.9, HEK293, 5 |1M), (PCM1, -1.1, HEK293, 5 μM,) (PCNT, -1.7, HEK293, 5 μM), (PCNX3, -1.3, HEK293, 5 |1M), (PDIA5, -1.1, HEK293, 2.5 μM), (PDIA5, -2, SHSY5Y, 2.5 μM), (PDIA5, -1.4, HEK293, 5 μM), (PDIA5, -1.2, HEK293, 5 μM), (PDIA5, -1.2, SHSY5Y, 5 μM), (PELI3, -1.1, HEK293,
5 μM), (PEX6, -1.3, SHSY5Y, 2.5 μM), (PEX6, -1.5, HEK293, 5 μM), (PHF12, -1.2, HEK293, 5 μM), (PHKG2, -1.1, HEK293, 2.5 μM), (PHKG2, -1.5, HEK293, 5 μM), (PHKG2, -1.1, HEK293, 5 μM), (PHKG2, -1.3, SHSY5Y, 5 μM,) (PHLDB1, -1.3, HEK293, 5 μM), (PKNOX2, -1.8, HEK293, 5 μM), (PLBD2, -1.4, HEK293, 5 μM), (PLCB4, -1.3, HEK293, 5 μM), (PLEKHA5, -1.1, HEK293, 5 μM), (PLEKHA7, -1.1, HEK293, 5 μM,) (PLEKHG2, -1.5, HEK293, 5 μM), (POLN, -1.1, HEK293, 2.5 μM), (POLN, -1.3, HEK293, 5 μM), (POLN, -1.4, HEK293, 5 μM), (POLR2J4, 1.4, HEK293, 2.5 μM), (POLR2J4, 2.5, HEK293, 5 μM), (POLR2J4, 1.6, HEK293, 5 μM), (POLR2J4, 1.9, SHSY5Y, 5 μM), (POLR3GL, -1.3, HEK293, 5 μM), (PPP2R3C, -1.1, SHSY5Y, 2.5 μM), (PPP2R3C, -1.1, SHSY5Y, 5 μM), (PPP4R4, -1.4, HEK293, 5 μM), (PPP4R4, -1.1, HEK293, 5 μM), (PPP6R2, -1.4, HEK293, 5 μM), (PRKAG1, -
1.2, HEK293, 5 μM), (PRKAG1, -1.4, HEK293, 5 μM), (PRKAG1, -1.5, SHSY5Y, 5 μM), (PRPF40B, -2.4, HEK293, 5 μM), (PRPF40B, -1.3, HEK293, 5 μM), (PRPF4B, -1.2, HEK293, 5 nM), (PRRC2B, -1.6, HEK293, 5 gM), (PRRC2C, -1.6, HEK293, 5 μM), (PRRT4, -1.5, HEK293, 5 μM), (PTPN13, -1.6, HEK293, 5 ^M), (PTPN18, -1.8, HEK293, 5 μM), (PTPN21, - 1.1, HEK293, 5 gM), (PTPRA, -1.6, HEK293, 5 gM), (PTPRG-AS1, -1, HEK293, 2.5 μM,)
(PTPRS, -1.6, HEK293, 5 μM), (PXDN, -2.1, HEK293, 5 μM), (RAB3GAP1, -1.3, SHSY5Y,
2.5 μM), (RAB3GAP1, -1.1, SHSY5Y, 5 μM), (RAB4B, -1.3, HEK293, 2.5 μM), (RAB4B, -1.6, SHSY5Y, 2.5 μM), (RAB4B, -1.2, HEK293, 5 μM), (RABGAP1L, -1, HEK293, 5 μM), (RABL6, -1.4, HEK293, 5 μM), (RAD18, 1, HEK293, 5 μM), (RADIL, -2, HEK293, 5 μM), (RBBP6, -1.3, HEK293, 5 μM), (RBM20, -2.4, HEK293, 5 μM), (RECK, -1.9, HEK293, 5 μM), (RERE, -1.2, HEK293, 5 μM), (REV3L, -2.1, HEK293, 5 μM), (RHBDF2, -1, HEK293, 5 μM), (RNF123, -1, HEK293, 2.5 μM), (RNF123, -1.7, HEK293, 5 μM), (RNF123, -1, HEK293, 5 μM), (R0B01, -1.1, HEK293, 5 μM), (ROGDI, -1.4, HEK293, 5 μM), (RPP40, 1.3, HEK293, 5 μM), (RRNAD1, -1.2, SHSY5Y, 2.5 μM), (REEL!, -1.8, HEK293, 5 μM), (RTEL1- TNFRSF6B, -1.8, HEK293, 5 μM), (SATB1-AS1, -2.5, SHSY5Y, 2.5 μM), (SCAPER, -1, HEK293, 5 μM), (SCARB1, -1.1, HEK293, 5 μM), (SEC31B, 1.4, HEK293, 5 μM), (SEMA3F, -1.1, HEK293, 5 μM), (SETD2, -1.1, HEK293, 5 μM), (SEZ6L2, -1.1, HEK293, 5 μM), (SFXN4, 1.3, SHSY5Y, 2.5 μM), (SFXN4, 1.2, HEK293, 5 μM), (SIM2, -1.1, HEK293, 5 μM), (SLC22A23, -1.1, HEK293, 5 μM), (SLC24A1, -2.7, SHSY5Y, 1 μM), (SLC24A1, -1.7, HEK293, 5 μM), (SLC25A14, -1.8, SHSY5Y, 5 μM), (SLC25A32, -1.1, SHSY5Y, 5 μM), (SLC25A40, -1.4, SHSY5Y, 2.5 μM), (SLC25A40, -1.4, HEK293, 5 μM), (SLC25A40, -1.6, HEK293, 5 μM), (SLC25A40, -1.4, SHSY5Y, 5 μM), (SLC29A4, -1.1, HEK293, 5 μM), (SLC38A6, -1.7, HEK293, 2.5 μM), (SLC38A6, -1.5, HEK293, 5 μM), (SLC38A6, -1.8, HEK293, 5 μM), (SLC3A2, 1.3, HEK293, 5 μM), (SLC43A1, -1.5, HEK293, 5 μM), (SLC43A1, -1.2, HEK293, 5 μM), (SLC47A1, -1.4, HEK293, 5 μM), (SLC4A7, -1, HEK293,
2.5 μM), (SLC4A7, -1.5, SHSY5Y, 2.5 μM), (SLC4A7, -1.6, HEK293, 5 μM), (SLC4A7, -1.3, HEK293, 5 μM), (SLC4A7, -1.6, SHSY5Y, 5 μM), (SLIT1, -1.5, HEK293, 5 μM), (SLMAP, -
1.4, HEK293, 5 μM), (SMARCC2, -1.1, HEK293, 5 μM), (SORL1, -1.4, HEK293, 5 μM), (SPATA13, -1.1, HEK293, 5 μM), (SPEN, -1.8, HEK293, 5 μM), (SPG7, -1.1, SHSY5Y, 2.5 μM), (SPG7, -1.3, SHSY5Y, 5 μM), (SPTAN1, -1.5, HEK293, 5 μM), (SRCIN1, -1.7, HEK293, 5 μM), (ST6GAL1, -1.7, HEK293, 5 μM), (ST7L, -1.3, SHSY5Y, 5 μM), (STK10, -1.2, HEK293, 5 μM), (STXBP3, -1.3, HEK293, 2.5 μM), (STXBP3, -1.9, SHSY5Y, 2.5 μM), (STXBP3, -2.6, HEK293, 5 μM), (STXBP3, -1.7, HEK293, 5 μM), (STXBP3, -2.6, SHSY5Y, 5 μM), (SULF2, -1.7, HEK293, 5 μM), (SYCP2L, -1.7, HEK293, 5 μM), (SYNE2, -2.1, HEK293, 5 μM), (TARSL2, -1, HEK293, 2.5 μM), (TARSL2, -1.7, HEK293, 5 μM), (TARSL2, -1, HEK293, 5 μM), (TBC1D17, -1.2, HEK293, 5 μM), (TBC1D19, -1.3, HEK293, 2.5 μM), (TBC1D19, -2.6, HEK293, 5 μM), (TBC1D19, -2, HEK293, 5 μM), (TBC1D19, -3.1, SHSY5Y, 5 μM), (TBC1D5, -1, HEK293, 5 μM), (TBCK, -1.1, HEK293, 1 μM), (TBCK, -1.7, HEK293,
2.5 μM), (TBCK, -1.1, SHSY5Y, 2.5 μM), (TBCK, -1.1, HEK293, 5 μM), (TBCK, -1.6, HEK293, 5 μM), (TBCK, -1.5, SHSY5Y, 5 μM), (TCF7L1, -1.8, HEK293, 5 μM), (TDP1, -1, HEK293, 2.5 μM), (TDP1, -1.3, SHSY5Y, 2.5 μM), (TDP1, -1.5, HEK293, 5 μM), (TDP1, -1, HEK293, 5 μM), (TDP1, -1.6, SHSY5Y, 5 μM), (TENM4, -2.4, HEK293, 5 μM), (TEX15, -1.4, HEK293, 5 μM), (TEX9, -1.3, HEK293, 2.5 μM), (TEX9, -1.3, HEK293, 5 μM), (TEX9, -1.3, HEK293, 5 μM), (THBS4, -4.9, HEK293, 5 μM), (THOC2, -2.1, HEK293, 5 μM), (TMCO4, - 1.2, HEK293, 5 μM), (TMEM106C, -1.1, HEK293, 5 μM), (TMEM106C, -1, HEK293, 5 μM), (TMEM144, -1.2, HEK293, 5 μM), (TMEM161B, 1.1, HEK293, 5 μM), (TMEM161B-AS1, -
1.5, HEK293, 2.5 μM), (TMEM161B-AS1, -1.9, HEK293, 5 μM), (TMEM67, -1.8, SHSY5Y, 5 μM), (TMEM94, -1.2, HEK293, 5 μM), (TMX3, -1.2, HEK293, 2.5 μM), (TMX3, -1.3, SHSY5Y, 2.5 μM), (TMX3, -1.3, HEK293, 5 μM), (TMX3, -1.4, SHSY5Y, 5 μM), (TNKS2, - 1.1, SHSY5Y, 2.5 μM), (TNKS2, -1.1, SHSY5Y, 5 μM), (TOM1L2, -1.1, HEK293, 5 μM),
Compound 143
[00692] Table 90 provides further detail of results (Cpd = Compound, Gene = Gene, Cone = Concentration, L2FC = log2 fold change) for genes exhibiting a two fold change, or more, in gene expression (a Log2 fold change of 1.0 or above, or -1.0 or below) together with a change in Percent Spliced In (APSI) of 50% to 100%, or -50% to -100%, at a p value (pVal) of < 0.001 in the presence of Compound 143.
[00693] The cell lines tested included Familial Dysautonomia patient fibroblasts (FDPF), HEK293, stimulated PBMC (sPBMC), differentiated SY5Y (diffSY5Y), SHSY5Y, M0LM13 and HT1080.
[00695] RNAseq experiments showed that Compound 143 induced exon inclusion with a
PSI change (APSI) of +50% to +100% and P-value <0.001 in 5 genes:
[00697] RNAseq experiments showed that Compound 143 induced exon inclusion with a PSI change (APSI) of +50% to +100% and P-value <0.001 in genes having a 5' splice site as follows (5 entries):
[00698] Table 92
Inclusion and NMD Results (Compound 143)
[00699] RNAseq experiments showed that Compound 143 induced exon inclusion associated with nonsense mediated decay with a PSI change (APSI) of +50% to +100% and P- value <0.001 in 2 genes:
[00701] RNAseq experiments showed that Compound 143 induced exon inclusion associated with nonsense mediated decay with a PSI change (APSI) of +50% to +100% and P- value <0.001in genes having a 5' splice site as follows (2 entries):
[00702] Table 94
Skipping Results (Compound 143)
[00703] RNAseq experiments showed that Compound 143 induced exon skipping with a
PSI change (APSI) of -50% to -100% and P-value <0.001 in 73 genes:
[00705] RNAseq experiments showed that Compound 143 induced exon skipping with a
PSI change (APSI) of -50% to -100% and P-value <0.001 in genes having a 5' splice site as follows (69 entries):
Skipping and NMD Results (Compound 143)
[00707] RNAseq experiments showed that Compound 143 induced exon skipping associated with nonsense mediated decay with a PSI change (APSI) of -50% to -100% and P- value <0.001 in 27 genes:
[00709] RNAseq experiments showed that Compound 143 induced exon skipping associated with nonsense mediated decay with a PSI change (APSI) of -50% to -100% and P- value <0.001 in genes having a 5' splice site as follows (26 entries):
Gene Expression Results (Compound 143)
[00711] RNAseq experiments showed that Compound 143 modulated expression of various genes by a factor of 2 or more. The following table identifies genes from Table 5 which resulted in a log 2 fold change (L2FC) of 1 or above (increased expression), or -1 or below (decreased expression), upon treatment with Compound 143:
Discussion
The results herein demonstrate that compounds of Formula (I) modulated the type and amount of RNA transcript isoforms for various genes. In various examples, such modification can serve to modify resulting protein isoform levels due to exon inclusion or exon skipping. In further examples, the compound induced exon inclusion or exon skipping can result in nonsense mediated decay. Certain examples demonstrate a dose (concentration) dependent effect on modulation. Moreover, these results show that in various examples the compounds of Formula (I) indicate a splicing event resulting in non-sense mediated decay together with a decrease in gene expression. Control of RNA expression can be used for downstream regulation of protein expression, for example, via modulating the amount or type of mature RNA such as control of functional RNA isoforms, or by inducing nonsense mediated decay. See, for example, Nickless et al., Control of Gene Expression through nonsense-mediated RNA decay pathway. Cell & Bioscience 7, 26, (2017). Without intending to limit to any particular theory, mechanism, or mode of use, it is thought that such results suggest that the compounds will be useful for modifying a pathology related to a gene, exon, genomic coordinates, or isoform described herein. [00713] It will be appreciated that, although specific aspects of the invention have been described herein for purposes of illustration, the invention described herein is not to be limited in scope by the specific aspects herein disclosed. These aspects are intended as illustrations of several aspects of the invention. Any equivalent aspects are intended to be within the scope of this invention. Indeed, various modifications of the invention in addition to those shown and described herein will become apparent to those skilled in the art from the foregoing description, which modification also intended to be within the scope of this invention.
[00714] All references cited herein are incorporated herein by reference in their entirety and for all purposes to the same extent as if each individual publication or patent or patent application was specifically and individually indicated to be incorporated by reference in its entirety for all purposes.
Additional Aspects
[00715] The following exemplary aspects are provided, the numbering of which is not to be construed as designating levels of importance:
[00716] Aspect 1 provides a method for modulating an amount or type of a mature RNA transcript expressed, comprising contacting a compound of Formula (I), or form thereof, with a pre-mRNA transcript transcribed from a gene, wherein the gene comprises a DNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 1 to SEQ ID NO. 5775, and the pre-mRNA transcript transcribed from the gene comprises a RNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 5776 to SEQ ID NO. 11550, wherein, the compound of Formula (I) has the structure:
[00717] wherein:
[00718] Ri is phenyl or heteroaryl, optionally substituted with one, two, three, or four, independently selected Ria substituents,
[00719] wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S;
[00720] Ria is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, or C1-6alkoxy;
[00721] R3 is hydrogen, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, and C1-6alkyl-amino,
[00722] wherein C1-6alkyl, C2-6alkenyl, and C2-6alkynyl is optionally substituted with one, two, three, or four independently selected Rsa substituents, and
[00723] wherein each instance of C1-6alkyl, C2-6alkenyl, and C2-6alkynyl may optionally contain a chiral carbon having an (R) or (S) configuration;
[00724] Rsa is cyano, halo, hydroxy, oxo, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, halo-C1-6alkoxy, carboxyl, amino, Ci -ealkoxy -carbonyl, C1-6alkyl-amino, halo-C1-6alkyl-amino, (C1-6alkyl)2-amino, phenyl-amino, heterocyclyl-amino, heteroaryl-amino, phenyl-(C1-6alkyl)-amino, heterocyclyl-(C1-6alkyl)-amino, heteroaryl-(C1-6alkyl)-amino, C1-6alkyl-thio, C1-6alkyl-sulfoxyl, and C1-6alkyl-sulfonyl,
[00725] wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S,
[00726] wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S;
[00727] wherein each instance of phenyl, heterocyclyl, and heteroaryl is optionally substituted with one, two, three or four independently selected Rsa’ substituents;
[00728] Raa’ is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, or amino; [00729] Rr is hydrogen, cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, halo-C1-6alkoxy, amino, C1-6alkyl-amino, (C1-6alkyl)2-amino, C3-10cycloalkyl, phenyl, heterocyclyl, or heteroaryl,
[00730] wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S,
[00731] wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S, and [00732] wherein each instance of C1-6alkyl, C3-10cycloalkyl, phenyl, heterocyclyl, or heteroaryl are optionally substituted with one, two, three, or four independently selected R4a substituents;
[00733] R4a is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, or C1-6alkoxy;
[00734] R5 is hydrogen, cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, carbamoyl, C3-10cycloalkyl, or heterocyclyl,
[00735] wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S; and [00736] Re is hydrogen, halo, or Cl-6alkyl,
[00737] wherein the form of the compound is selected from the group consisting of a salt, hydrate, solvate, and tautomer form thereof,
[00738] wherein the compound is contacted with the RNA REMS nucleotide sequence in a cell lysate or in a cell in cell culture, whether in vivo or ex vivo, to express the mature RNA transcript, wherein the amount or type of mature RNA transcript expressed in the presence of the compound is modulated compared to the amount or type of mature RNA transcript expressed in the absence of the compound, and wherein the mature RNA transcript is selected from a wildtype or non-wildtype mature RNA transcript.
[00739] Aspect 2 provides a method of Aspect 1, wherein the gene is selected from Table
1 or Table 3.
[00740] Aspect 3 provides a method of Aspect 1, wherein the gene is selected from Table
2 or Table 4.
[00742] or a form thereof.
[00744] or a form thereof.
[00746] or a form thereof.
[00747] Aspect 7 provides a method of Aspect 1, wherein the compound of Formula (I) is:
[00748] or a form thereof.
[00750] or a form thereof.
[00752] or a form thereof.
[00753] Aspect 10 provides a method of Aspect 1, wherein the compound of Formula (I) is:
[00754] or a form thereof.
[00756] or a form thereof
141
[00758] or a form thereof.
[00760] or a form thereof.
[00761] Aspect 14 provides a method of any one of Aspects 1-13, wherein modulating the amount or type of the mature RNA transcript expressed comprises inducing exon inclusion in the mature RNA transcript.
[00762] Aspect 15 provides a method of Aspect 14, wherein the gene is selected from Table 11.
[00763] Aspect 16 provides a method of any one of Aspects 1-13, wherein modulating the amount or type of the mature RNA transcript expressed comprises inducing exon skipping in the mature RNA transcript.
[00764] Aspect 17 provides a method of Aspect 16, wherein the gene is selected from Table 12.
[00765] Aspect 18 provides a method of any one of Aspects 1 -17, wherein the type of the mature RNA transcript expressed in the presence of the compound is modulated compared to the type of the mature RNA transcript expressed in the absence of the compound.
[00766] Aspect 19 provides a method of any one of Aspects 1-17, wherein the type of the mature RNA transcript expressed in the presence of the compound is an aberrant transcript.
[00767] Aspect 20 provides a method of any one of Aspects 1-17, wherein the type of the mature RNA transcript expressed in the absence of the compound is an aberrant transcript.
[00768] Aspect 21 provides a method of any one of Aspects 1-17, wherein the type of the mature RNA transcript expressed in the presence of the compound is a transcript that undergoes nonsense mediated decay.
[00769] Aspect 22 provides a method of any one of Aspects 1-17, wherein the type of the mature RNA transcript expressed in the presence of the compound is a transcript that is subsequently translated to provide a protein isoform differing from a protein isoform expressed in the absence of the compound.
[00770] Aspect 23 provides a method of of any one of Aspects 1-17, wherein the amount of mature RNA transcript expressed in the absence of the compound is an amount associated with a disease or pathology associated with the gene.
[00771] Aspect 24 provides a method of any one of Aspects 1-17, wherein the amount of mature RNA transcript expressed in the presence of the compound is modulated compared to the amount of mature RNA transcript expressed in the absence of the compound.
[00772] Aspect 25 provides a method of any one of Aspects 1-17, wherein the amount of mature RNA transcript expressed in the presence of the compound is an aberrant amount.
[00773] Aspect 26 provides a method of any one of Aspects 1-17, wherein the amount of mature RNA transcript expressed in the absence of the compound is an aberrant amount.
[00774] Aspect 27 provides a method of any one of Aspects 1-17, wherein the amount of mature RNA transcript expressed in the presence of the compound is increased relative to the amount of mature RNA transcript expressed in the absence of the compound.
[00775] Aspect 28 provides a method of any one of Aspects 1-17, wherein the amount of mature RNA transcript expressed in the presence of the compound is decreased relative to the amount of mature RNA transcript expressed in the absence of the compound.
[00776] Aspect 29 provides a method of any one of Aspects 1-17, wherein the amount of mature RNA transcript expressed in the absence of the compound is an amount associated with a disease or pathology associated with the gene.
[00777] Aspect 30 provides a method of any one of Aspects 1-17, wherein the amount of mature RNA transcript expressed in the absence of the compound is an amount effective to influence downstream translation of a functional protein associated with the gene.
[00778] Aspect 31 provides a method of Aspect 4, wherein the compound is Compound 3, and the gene is selected from Table 28, 29 or 31.
[00779] Aspect 32 provides a method of Aspect 4, wherein the compound is Compound 3, and the gene comprises a sequence selected from Table 30.
[00780] Aspect 33 provides a method of Aspect 5, wherein compound is Compound 18, and the gene is selected from Table 18, 19, 21, 23, 25, or 27.
[00781] Aspect 34 provides a method of Aspect 5, wherein the compound is Compound
18, and the gene comprises a sequence selected from Table 20, 22, 24 or 26.
[00782] Aspect 35 provides a method of Aspect 6, wherein compound is Compound 26, and the gene is selected from Table 32, 33, 35, 37 or 39.
[00783] Aspect 36 provides a method of Aspect 6, wherein the compound is Compound 26, and the gene comprises a sequence selected from Table 34, 36 or 38.
[00784] Aspect 37 provides a method of Aspect 7, wherein compound is Compound 28, and the gene is selected from Table 40, 41, 43, 45, 47, or 49.
[00785] Aspect 38 provides a method of Aspect 7, wherein the compound is Compound
28, and the gene comprises a sequence selected from Table 42, 44, 46, or 48.
[00786] Aspect 39 provides a method of Aspect 8, wherein compound is Compound 52, and the gene is selected from Table 50, 51, 53, 55, 57, or 59.
[00787] Aspect 40 provides a method of Aspect 8, wherein the compound is Compound 52, and the gene comprises a sequence selected from Table 52, 54, 56, or 58.
[00788] Aspect 41 provides a method of Aspect 9, wherein compound is Compound 57, and the gene is selected from Table 60, 61, 63, 65, 67, or 69.
[00789] Aspect 42 provides a method of Aspect 9, wherein the compound is Compound 57, and the gene comprises a sequence selected from Table 62, 64, 66, or 68.
[00790] Aspect 43 provides a method of Aspect 11, wherein compound is Compound 89, and the gene is selected from Table 70, 71, 73, 75, 77, or 79.
[00791] Aspect 44 provides a method of Aspect 11, wherein the compound is Compound 89, and the gene comprises a sequence selected from Table 72, 74, 76, or 78.
[00792] Aspect 45 provides a method of Aspect 12, wherein compound is Compound 141, and the gene is selected from Table 80, 81, 83, 85, 87, or 89.
[00793] Aspect 46 provides a method of Aspect 12, wherein the compound is Compound 141, and the gene comprises a sequence selected from Table 82, 84, 86, or 88.
[00794] Aspect 47 provides a method of Aspect 13, wherein compound is Compound 143, and the gene is selected from Table 90, 91, 93, 95, 97, or 99.
[00795] Aspect 48 provides a method of Aspect 13, wherein the compound is Compound 143, and the gene comprises a sequence selected from Table 92, 94, 96, or 98.
[00796] Aspect 49 provides a method of any one of Aspects 1-48, wherein the gene is endogenous.
[00797] Aspect 50 provides a method of any one of Aspects 1-48, wherein the gene is non-endogenous.
[00798] Aspect 51 provides a method of any one of Aspects 1-50, wherein mature RNA transcript is an exon skipped RNA isoform.
[00799] Aspect 52 provides a method of any one of Aspects 1-51, wherein mature RNA transcript is an exon included RNA isoform.
[00800] Aspect 53 provides a method of any one of Aspects 1-52, wherein the mature RNA transcript undergoes nonsense mediated decay.
[00801] Aspect 54 provides a method of any one of Aspects 1-54, wherein the gene, the pre-mRNA transcript, or both, comprises:
[00802] exons, a 3' splice site(s) and a branch point(s), wherein a nucleotide sequence encoding an exon, which is upstream of a nucleotide sequence encoding a branch point and a nucleotide sequence encoding a 3' splice site,
[00803] exons and one, two or more introns, wherein a nucleotide sequence encoding a 5' splice site, which is upstream of a nucleotide sequence encoding a branch point and a nucleotide sequence encoding a 3' splice site; or
[00804] exons, a 5' splice site(s), a 3' splice site(s) and a branch point(s), wherein a nucleotide sequence encoding a 5' splice site, which is upstream of a nucleotide sequence encoding a 3' splice site.
[00805] Aspect 55 provides a artificial gene construct, which comprises:
[00806] DNA encoding exons, a 3' splice site(s) and a branch point(s), wherein a nucleotide sequence encoding an exon, which is upstream of a nucleotide sequence encoding a branch point and a nucleotide sequence encoding a 3' splice site,
[00807] DNA encoding exons and one, two or more introns, wherein a nucleotide sequence encoding a 5' splice site, which is upstream of a nucleotide sequence encoding a branch point and a nucleotide sequence encoding a 3' splice site; or
[00808] DNA encoding exons, a 5' splice site(s), a 3' splice site(s) and a branch point(s), wherein a nucleotide sequence encoding a 5' splice site, which is upstream of a nucleotide sequence encoding a 3' splice site; and
[00809] wherein the artificial gene construct is modified to introduce a nucleotide sequence encoding a non-endogenous REMS comprising a sequence selected from the group consisting of SEQ ID NO. 1 to SEQ ID NO. 5775.
[00810] Aspect 56 provides a vector comprising the artificial gene construct of Aspect 55
[00811] Aspect 57 provides a cell comprising the artificial gene construct of Aspect 55 or the vector of Aspect 56.
[00812] Aspect 58 provides a method for modulating the amount or type of a mature RNA transcript expressed, comprising contacting a pre-mRNA transcript with a compound of Formula (I), or form thereof, wherein the pre-mRNA transcript is (a) transcribed from a gene comprising a DNA REMS nucleotide sequence sele cted from the group consisting of SEQ ID NO. 1 to SEQ ID NO. 5775, (b) transcribed from a gene selected from Table 5, and/or (c) comprises an RNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 5776 to SEQ ID NO. 11550, wherein the compound of Formula (I) has the structure
[00813] wherein:
[00814] Ri is phenyl or heteroaryl, optionally substituted with one, two, three, or four, independently selected Ria substituents,
[00815] wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S;
[00816] Ria is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, or C1-6alkoxy;
[00817] Rs is hydrogen, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, and C1-6alkyl-amino,
[00818] wherein C1-6alkyl, C2-6alkenyl, and C2-6alkynyl is optionally substituted with one, two, three, or four independently selected Rsa substituents, and
[00819] wherein each instance of C1-6alkyl, C2-6alkenyl, and C2-6alkynyl may optionally contain a chiral carbon having an (R) or (S) configuration;
[00820] Rsa is cyano, halo, hydroxy, oxo, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, halo-C1-6alkoxy, carboxyl, amino, Ci -ealkoxy -carbonyl, C1-6alkyl-amino, halo-C1-6alkyl-amino, (C1-6alkyl)2-amino, phenyl-amino, heterocyclyl-amino, heteroaryl-amino, phenyl-(C1-6alkyl) amino, heterocyclyl-(C1-6alkyl)-amino, heteroaryl-(C1-6alkyl)-amino, C1-6alkyl-thio, C1-6alkyl-sulfoxyl, and C1-6alkyl-sulfonyl,
[00821] wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S,
[00822] wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S;
[00823] wherein each instance of phenyl, heterocyclyl, and heteroaryl is optionally substituted with one, two, three or four independently selected Rsa' substituents;
[00824] Rsa' is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, or amino; [00825] R4 is hydrogen, cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, halo-C1-6alkoxy, amino, C1-6alkyl-amino, (C1-6alkyl)2-amino, C3-10cycloalkyl, phenyl, heterocyclyl, or heteroaryl,
[00826] wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S,
[00827] wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S, and
[00828] wherein each instance of C1-6alkyl, C3-10cycloalkyl, phenyl, heterocyclyl, or heteroaryl are optionally substituted with one, two, three, or four independently selected R4a substituents;
[00829] R.4a is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, or C1-6alkoxy;
[00830] R5 is hydrogen, cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, carbamoyl, C3-10cycloalkyl, or heterocyclyl,
[00831] wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S; and
[00832] Rs is hydrogen, halo, or C1-6alkyl;
[00833] wherein the form of the compound is selected from the group consisting of a salt, hydrate, solvate, and tautomer form thereof,
[00834] wherein the compound is contacted with the RNA REMS nucleotide sequence in a cell lysate or in a cell in cell culture, whether in vivo or ex vivo, to express the mature RNA transcript, wherein the amount or type of mature RNA transcript expressed in the presence of the compound is modulated compared to the amount or type of mature RNA transcript expressed in the absence of the compound, and wherein the mature RNA transcript is selected from a wildtype or non-wildtype mature RNA transcript.
[00835] Aspect 59 provides a method of regulating the amount or type of a protein produced by a gene, comprising contacting a compound of Formula (I), or form thereof, with a pre-mRNA transcript transcribed from a gene, wherein the gene comprises a DNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 1 to SEQ ID NO. 5775, and the pre-mRNA transcript transcribed from the gene comprises a RNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 5776 to SEQ ID NO. 11550, wherein, the compound of Formula (I) has the structure:
[00836] wherein:
[00837] Ri is phenyl or heteroaryl, optionally substituted with one, two, three, or four, independently selected Ria substituents,
[00838] wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S;
[00839] Ria is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, or C1-6alkoxy;
[00840] Rs is hydrogen, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, and C1-6alkyl-amino,
[00841] wherein C1-6alkyl, C2-6alkenyl, and C2-6alkynyl is optionally substituted with one, two, three, or four independently selected Rsa substituents, and
[00842] wherein each instance of C1-6alkyl, C2-6alkenyl, and C2-6alkynyl may optionally contain a chiral carbon having an (R) or (S) configuration;
[00843] Rsa is cyano, halo, hydroxy, oxo, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, halo-C1-6alkoxy, carboxyl, amino, Ci -ealkoxy -carbonyl, C1-6alkyl-amino, halo-C1-6alkyl-amino, (C1-6alkyl)2-amino, phenyl-amino, heterocyclyl-amino, heteroaryl-amino, phenyl-(C1-6alkyl)-amino, heterocyclyl-(C1-6alkyl)-amino, heteroaryl-(C1-6alkyl)-amino, C1-6alkyl-thio, C1-6alkyl-sulfoxyl, and C1-6alkyl-sulfonyl,
[00844] wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S,
[00845] wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S;
[00846] wherein each instance of phenyl, heterocyclyl, and heteroaryl is optionally substituted with one, two, three or four independently selected Rsa' substituents;
[00847] Rsa' is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, or amino; [00848] R4 is hydrogen, cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, halo-C1-6alkoxy, amino, C1-6alkyl-amino, (C1-6alkyl)2-amino, C3-10cycloalkyl, phenyl, heterocyclyl, or heteroaryl,
[00849] wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S,
[00850] wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S, and
[00851] wherein each instance of C1-6alkyl, C3-10cycloalkyl, phenyl, heterocyclyl, or heteroaryl are optionally substituted with one, two, three, or four independently selected R4a substituents;
[00852] R.4a is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, or C1-6alkoxy;
[00853] R5 is hydrogen, cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, carbamoyl, C3-10cycloalkyl, or heterocyclyl,
[00854] wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S; and
[00855] Rs is hydrogen, halo, or C1-6alkyl;
[00856] wherein the form of the compound is selected from the group consisting of a salt, hydrate, solvate, and tautomer form thereof,
[00857] wherein the compound is contacted with the RNA REMS nucleotide sequence in a cell lysate or in a cell in cell culture, whether in vivo or ex vivo, to express the mature RNA transcript, wherein the amount or type of the protein produced by the gene is regulated compared to the amount or type of protein expressed in the absence of the compound, and wherein the mature RNA transcript is selected from a wildtype or non-wildtype mature RNA transcript.
[00858] Aspect 60 provides a method of Aspect 59, wherein the protein is a functional protein.
[00859] Aspect 61 provides a method of Aspect 59, wherein the protein is reduced as a result of nonsense mediated decay of the mature RNA transcript.
[00860] Aspect 62 provides a method according to any one or combination of the preceding aspects wherein the gene or sequence is selected from any one or more of the genes or sequences set forth in Tables 1-91.
[00861] Aspect 63 provides a method according to any one or combination of the preceding aspects optionally with the proviso that the gene or sequence is other than any one or more of the genes or sequences set forth in Tables 1-91.
[00862] Aspect 64 provides a method according to any one or combination of the preceding aspects optionally configured such that all elements or options are available to use or select therefrom.
Claims
1. A method for modulating an amount or type of a mature RNA transcript expressed, comprising contacting a compound of Formula (I), or form thereof, with a pre-mRNA transcript transcribed from a gene, wherein the gene comprises a DNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 1 to SEQ ID NO. 5775, and the pre-mRNA transcript transcribed from the gene comprises a RNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 5776 to SEQ ID NO. 11550, wherein, the compound of Formula (I) has the structure:
wherein:
Ri is phenyl or heteroaryl, optionally substituted with one, two, three, or four, independently selected Ria substituents, wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S;
Ria is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, or C1-6alkoxy;
R3 is hydrogen, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, and C1-6alkyl-amino, wherein C1-6alkyl, C2-6alkenyl, and C2-6alkynyl is optionally substituted with one, two, three, or four independently selected Rsa substituents, and wherein each instance of C1-6alkyl, C2-6alkenyl, and C2-6alkynyl may optionally contain a chiral carbon having an (R) or (S) configuration;
R3a is cyano, halo, hydroxy, oxo, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, halo-C1-6alkoxy, carboxyl, amino, C1-6alkoxy-carbonyl, C1-6alkyl-amino, halo-C1-6alkyl-amino, (C1-6alkyl)2-amino, phenyl-amino, heterocyclyl-amino, heteroaryl-amino,
phenyl-(C1-6alkyl)-amino, heterocyclyl-(C1-6alkyl)-amino, heteroaryl-(C1-6alkyl)-amino, C1-6alkyl-thio, C1-6alkyl-sulfoxyl, and C1-6alkyl-sulfonyl, wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S, wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S; wherein each instance of phenyl, heterocyclyl, and heteroaryl is optionally substituted with one, two, three or four independently selected Rsa' substituents;
R.3a’ is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, or amino;
R4 is hydrogen, cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, halo-C1-6alkoxy, amino, C1-6alkyl-amino, (C1-6alkyl)2-amino, C3-10cycloalkyl, phenyl, heterocyclyl, or heteroaryl, wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S, wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S, and wherein each instance of C1-6alkyl, C3-10cycloalkyl, phenyl, heterocyclyl, or heteroaryl are optionally substituted with one, two, three, or four independently selected R.4a substituents;
R4a is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, or C1-6alkoxy; R5 is hydrogen, cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, carbamoyl, C3-10cycloalkyl, or heterocyclyl, wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S; and
Re is hydrogen, halo, or C1-6alkyl; wherein the form of the compound is selected from the group consisting of a salt, hydrate, solvate, and tautomer form thereof, wherein the compound is contacted with the RNA REMS nucleotide sequence in a cell lysate or in a cell in cell culture, whether in vivo or ex vivo, to express the mature RNA transcript, wherein the amount or type of mature RNA transcript expressed in the
presence of the compound is modulated compared to the amount or type of mature RNA transcript expressed in the absence of the compound, and wherein the mature RNA transcript is selected from a wildtype or non-wildtype mature RNA transcript.
2. The method of claim 1, wherein the gene is selected from Table 5.
3. The method of claim 1, wherein the gene is selected from Table 6.
89 or a form thereof.
143 or a form thereof.
14. The method of any one of claims 1-13, wherein the gene is endogenous.
15. The method of any one of claims 1-13, wherein the gene is non-endogenous.
16. The method of any one of claims 1-15, wherein the expressed mature RNA transcript is an exon included RNA isoform.
17. The method of any one of claims 1-16, wherein the expressed mature RNA transcript is an exon skipped RNA isoform.
18. The method of any one of claims 1-17, wherein the expressed mature RNA transcript undergoes nonsense mediated decay.
19. An artificial gene construct, which comprises: a) DNA encoding exons, a 3' splice site(s) and a branch point(s), wherein a nucleotide sequence encoding an exon, which is upstream of a nucleotide sequence encoding a branch point and a nucleotide sequence encoding a 3' splice site,
b) DNA encoding exons and one, two or more introns, wherein a nucleotide sequence encoding a 5' splice site, which is upstream of a nucleotide sequence encoding a branch point and a nucleotide sequence encoding a 3' splice site; or c) DNA encoding exons, a 5' splice site(s), a 3' splice site(s) and a branch point(s), wherein a nucleotide sequence encoding a 5' splice site, which is upstream of a nucleotide sequence encoding a 3' splice site; and wherein the artificial gene construct is modified to introduce a nucleotide sequence encoding a non-endogenous REMS comprising a sequence selected from the group consisting of SEQ ID NO. 1 to SEQ ID NO. 5775.
20. A method of regulating an amount or type of a protein produced by a gene, comprising contacting a compound of Formula (I), or form thereof, with a pre-mRNA transcript transcribed from a gene, wherein the gene comprises a DNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 1 to SEQ ID NO. 5775, and the pre-mRNA transcript transcribed from the gene comprises a RNA REMS nucleotide sequence selected from the group consisting of SEQ ID NO. 5776 to SEQ ID NO. 11550, wherein, the compound of Formula (I) has the structure:
wherein:
Ri is phenyl or heteroaryl, optionally substituted with one, two, three, or four, independently selected Ria substituents, wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S;
Ria is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, or C1-6alkoxy;
Rs is hydrogen, C1-6alkyl, C2-salkenyl, C2-6alkynyl, and C1-6alkyl-amino, wherein C1-6alkyl, C2-6alkenyl, and C2-6alkynyl is optionally substituted with one, two, three, or four independently selected Rsa substituents, and wherein each instance of C1-6alkyl, C2-6alkenyl, and C2-6alkynyl may optionally contain a chiral carbon having an (R) or (S) configuration;
Rsa is cyano, halo, hydroxy, oxo, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, halo-C1-6alkoxy, carboxyl, amino, C1-6alkoxy-carbonyl, C1-6alkyl-amino, halo-C1-6alkyl-amino, (C1-6alkyl)2-amino, phenyl-amino, heterocyclyl-amino, heteroaryl-amino, phenyl-(C1-6alkyl)-amino, heterocyclyl-(C1-6alkyl)-amino, heteroaryl-(C1-6alkyl)-amino, C1-6alkyl-thio, C1-6alkyl-sulfoxyl, and C1-6alkyl-sulfonyl, wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S, wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S; wherein each instance of phenyl, heterocyclyl, and heteroaryl is optionally substituted with one, two, three or four independently selected Rsa' substituents;
Ria' is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, or amino; R4 is hydrogen, cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, halo-C1-6alkoxy, amino, C1-6alkyl-amino, (C1-6alkyl)2-amino, Ci-iocycloalkyl, phenyl, heterocyclyl, or heteroaryl, wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S, wherein heteroaryl is a 5-8 membered monocyclic or bicyclic aromatic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S, and wherein each instance of C1-6alkyl, Ci-iocycloalkyl, phenyl, heterocyclyl, or heteroaryl are optionally substituted with one, two, three, or four independently selected R4a substituents;
R4a is cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, or C1-6alkoxy; R5 is hydrogen, cyano, halo, hydroxy, C1-6alkyl, halo-C1-6alkyl, C1-6alkoxy, carbamoyl, C3-10cycloalkyl, or heterocyclyl,
wherein heterocyclyl is a 3-7 membered monocyclic carbon atom ring structure radical containing 1-3 heteroatoms selected from N, O, and S; and Re is hydrogen, halo, or C1-6alkyl; wherein the form of the compound is selected from the group consisting of a salt, hydrate, solvate, and tautomer form thereof, wherein the compound is contacted with the RNA REMS nucleotide sequence in a cell lysate or in a cell in cell culture, whether in vivo or ex vivo, to express the mature RNA transcript, wherein the amount or type of the protein produced by the gene is regulated compared to the amount or type of protein expressed in the absence of the compound, and wherein the mature RNA transcript is selected from a wildtype or non-wildtype mature RNA transcript.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202263370902P | 2022-08-09 | 2022-08-09 | |
US63/370,902 | 2022-08-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2024036143A2 true WO2024036143A2 (en) | 2024-02-15 |
WO2024036143A3 WO2024036143A3 (en) | 2024-03-28 |
Family
ID=89852473
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2023/071833 WO2024036143A2 (en) | 2022-08-09 | 2023-08-08 | Methods for modulating rna splicing |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2024036143A2 (en) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007121326A2 (en) * | 2006-04-12 | 2007-10-25 | Crosslink Genetics Corporation | Compositions and methods for modulating gene expression |
WO2016106236A1 (en) * | 2014-12-23 | 2016-06-30 | The Broad Institute Inc. | Rna-targeting system |
AU2017363369A1 (en) * | 2016-11-28 | 2019-05-30 | Ptc Therapeutics, Inc | Methods for modulating RNA splicing |
EP3920920A4 (en) * | 2019-02-05 | 2022-09-28 | Skyhawk Therapeutics, Inc. | Methods and compositions for modulating splicing |
KR20210137040A (en) * | 2019-02-13 | 2021-11-17 | 피티씨 테라퓨틱스, 인크. | Thioeno[3,2-B]pyridin-7-amine compound for the treatment of familial ataxia |
-
2023
- 2023-08-08 WO PCT/US2023/071833 patent/WO2024036143A2/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2024036143A3 (en) | 2024-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11623932B2 (en) | Protein degraders and uses thereof | |
US11932635B2 (en) | CRBN ligands and uses thereof | |
US11485743B2 (en) | Protein degraders and uses thereof | |
US11358948B2 (en) | CRBN ligands and uses thereof | |
US11897882B2 (en) | Tricyclic crbn ligands and uses thereof | |
US20220244263A1 (en) | Methods for treating small cell neuroendocrine and related cancers | |
US20200399714A1 (en) | Cancer-related biological materials in microvesicles | |
US20210104321A1 (en) | Machine learning disease prediction and treatment prioritization | |
US20210147831A1 (en) | Sequencing-based proteomics | |
US20180305689A1 (en) | Sarna compositions and methods of use | |
WO2021011631A1 (en) | Fused-glutarimide crbn ligands and uses thereof | |
US20210137911A1 (en) | Novel chronotherapy based on circadian rhythms | |
US20230093080A1 (en) | Protein degraders and uses thereof | |
EP4301359A1 (en) | Covalent binding compounds for the treatment of disease | |
WO2019008415A1 (en) | Exosome and pbmc based gene expression analysis for cancer management | |
WO2019008412A1 (en) | Utilizing blood based gene expression analysis for cancer management | |
WO2019008414A1 (en) | Exosome based gene expression analysis for cancer management | |
US20240041851A1 (en) | Method of treating and preventing viral infection | |
US20230112964A1 (en) | Assessment of melanoma therapy response | |
WO2024036143A2 (en) | Methods for modulating rna splicing | |
WO2023192578A1 (en) | Protein degraders and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23853472 Country of ref document: EP Kind code of ref document: A2 |